PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stremmel, W; Staffer, S; Wannhoff, A; Pathil, A; Chamulitrat, W				Stremmel, Wolfgang; Staffer, Simone; Wannhoff, Andreas; Pathil, Anita; Chamulitrat, Walee			Plasma membrane phospholipase A(2) controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						cJun N-terminal kinase; detergent-resistant membranes; lysophosphatidylcholine; ursodeoxycholate-lysophosphatidyletanolamide	URSODEOXYCHOLYL LYSOPHOSPHATIDYLETHANOLAMIDE; CELLULAR UPTAKE; BINDING; TRANSPORT; PROTEIN; METABOLISM; SYSTEM; OLEATE; DRIVEN; SERUM	Excess hepatic fat accumulation leads to nonalcoholic steatohepatitis (NASH), a serious threat to health for which no effective treatment is available. However, the mechanism responsible for fatty acid uptake by hepatocytes remains unclear. Using the human hepatocyte-derived tumor cell line HepG2, we found that fatty acid influx is mediated by a heterotetrameric plasma membrane protein complex consisting of plasma membrane fatty acid-binding protein, caveolin-1, CD36, and calcium-independent membrane phospholipase A(2) (iPLA(2)beta). Blocking iPLA(2)beta with the bile acid-phospholipid conjugate ursodeoxycholate-lysophosphatidylethanolamide (UDCA-LPE) caused the dissociation of the complex, thereby inhibiting fatty acid influx (IC50 47 mu M), and suppressed the synthesis of all subunits through a reduction in lysophosphatidylcholine from 8.0 to 3.5 mu mol/mg of protein and corresponding depletion of phosphorylated c-Jun N-terminal kinase. These findings were substantiated by an observed 56.5% decrease in fatty acid influx in isolated hepatocytes derived from iPLA(2)beta-knockout mice. Moreover, steatosis and inflammation were abrogated by UDCA-LPE treatment in a cellular model of NASH. Thus, iPLA(2)beta acts as an upstream checkpoint for mechanisms that regulate fatty acid uptake, and its inhibition by UDCA-LPE qualifies this nontoxic compound as a therapeutic candidate for the treatment of NASH.	[Stremmel, Wolfgang; Staffer, Simone; Wannhoff, Andreas; Pathil, Anita; Chamulitrat, Walee] Univ Heidelberg Hosp, Dept Gastroenterol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Stremmel, W (corresponding author), Univ Heidelberg Hosp, Dept Gastroenterol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	wolfgang.stremmel@med.uni-heidelberg.de		Stremmel, Wolfgang/0000-0002-8545-1753	Deutsche Forschungsgemeinschaft [STR 216/15-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Weihong Xu for assistance with the mouse hepatocyte preparation and Dieter Stefan (Institute for Immunology, Heidelberg, Germany) for performing the FACS analysis, and the group of Dr. Joachim Fullekrug (Department of Gastroenterology, University Hospital Heidelberg, Heidelberg, Germany) for technical advice and reagents. This project was funded by Deutsche Forschungsgemeinschaft STR 216/15-4. W. S. designed the experiments, analyzed the data, and wrote the manuscript. S. S. performed the experiments. A. W. prepared the figures and performed statistical analyses. W. C. and A. P. contributed equally by providing conceptual advice and experimental support. The authors declare no conflicts of interests.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; BHAT MK, 1993, BIOCHIM BIOPHYS ACTA, V1166, P244, DOI 10.1016/0005-2760(93)90104-H; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; CHAM BE, 1976, J LIPID RES, V17, P176; Chamulitrat W, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00024; Chamulitrat W, 2009, HEPATOLOGY, V50, P143, DOI 10.1002/hep.22955; Digel M, 2011, AM J PHYSIOL-ENDOC M, V301, pE785, DOI 10.1152/ajpendo.00079.2011; Fang XJ, 1997, J BIOL CHEM, V272, P13683, DOI 10.1074/jbc.272.21.13683; GORESKY CA, 1994, CIRC RES, V74, P1015, DOI 10.1161/01.RES.74.6.1015; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hoffmann MJ, 1999, TOXICOL SCI, V49, P40, DOI 10.1093/toxsci/49.1.40; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Kakisaka K., 2012, AM J PHYSIOL-GASTR L, V302, P677; Kishimoto T, 2002, CLIN BIOCHEM, V35, P411, DOI 10.1016/S0009-9120(02)00327-2; Krarup NT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040376; Lehmann R, 2013, DIABETES CARE, V36, P2331, DOI 10.2337/dc12-1760; Marzluff W F Jr, 1978, Methods Cell Biol, V19, P317; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Pan YH, 2007, J MOL BIOL, V369, P439, DOI 10.1016/j.jmb.2007.03.034; Pathil A, 2012, HEPATOLOGY, V55, P1369, DOI 10.1002/hep.25531; Pathil A, 2011, J HEPATOL, V54, P674, DOI 10.1016/j.jhep.2010.07.028; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; STREMMEL W, 1985, P NATL ACAD SCI USA, V82, P4, DOI 10.1073/pnas.82.1.4; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; STREMMEL W, 1987, J BIOL CHEM, V262, P6284; Sun Q, 2012, EXP BIOL MED, V237, P178, DOI 10.1258/ebm.2011.011261; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123	35	27	28	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3159	3170		10.1096/fj.14-249763	http://dx.doi.org/10.1096/fj.14-249763			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24719358				2022-12-25	WOS:000337949400036
J	Hofherr, A; Wagner, C; Fedeles, S; Somlo, S; Kottgen, M				Hofherr, Alexis; Wagner, Claudius; Fedeles, Sorin; Somlo, Stefan; Koettgen, Michael			N-Glycosylation Determines the Abundance of the Transient Receptor Potential Channel TRPP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC LIVER-DISEASE; INTEGRAL MEMBRANE-PROTEIN; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; VANILLOID RECEPTOR-1; PLASMA-MEMBRANE; CATION CHANNEL; KIDNEY-DISEASE; GLUCOSIDASE-II; ION CHANNELS	Glycosylation plays a critical role in the biogenesis and function of membrane proteins. Transient receptor potential channel TRPP2 is a nonselective cation channel that is mutated in autosomal dominant polycystic kidney disease. TRPP2 has been shown to be heavily N-glycosylated, but the glycosylation sites and the biological role of N-linked glycosylation have not been investigated. Here we show, using a combination of mass spectrometry and biochemical approaches, that native TRPP2 is glycosylated at five asparagines in the first extracellular loop. Glycosylation is required for the efficient biogenesis of TRPP2 because mutations of the glycosylated asparagines result in strongly decreased protein expression of the ion channel. Wildtype and N-glycosylation-deficient TRPP2 is degraded in lysosomes, as shown by increased TRPP2 protein levels upon chemical inhibition of lysosomal degradation. In addition, using pharmacological and genetic approaches, we demonstrate that glucosidase II (GII) mediates glycan trimming of TRPP2. The non-catalytic beta subunit of glucosidase II (GII beta) is encoded by PRKCSH, one of the genes causing autosomal dominant polycystic liver disease (ADPLD). The impaired GII beta-dependent glucose trimming of TRPP2 glycosylation in ADPLD may explain the decreased TRPP2 protein expression in Prkcsh(-/-) mice and the genetic interaction observed between TRPP2 and PRKCSH in ADPLD. These results highlight the biological importance of N-linked glycosylation and GII-mediated glycan trimming in the control of biogenesis and stability of TRPP2.	[Hofherr, Alexis; Wagner, Claudius; Koettgen, Michael] Univ Med Ctr Freiburg, Div Renal, Dept Med, D-79106 Freiburg, Germany; [Hofherr, Alexis] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Hofherr, Alexis] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Fedeles, Sorin; Somlo, Stefan] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Fedeles, Sorin; Somlo, Stefan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Freiburg; University of Freiburg; University of Freiburg; Yale University; Yale University	Hofherr, A (corresponding author), Univ Med Ctr Freiburg, Div Renal, Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	alexis.hofherr@uniklinik-freiburg.de; michael.koettgen@uniklinik-freiburg.de	Fedeles, Sorin/AAI-7395-2020	Kottgen, Michael/0000-0003-2406-5039; , Alexis/0000-0003-2842-6161	NIDDK [P30 DK090868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051041, R01DK054053, P30DK090868] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies utilized reagents provided by the NIDDK sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center, P30 DK090868. We thank Feng Qian for providing plasmids, Gerd Walz for TRPP2 antibodies, and Simone Diederichsen and Julia Merkel for technical assistance.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoffmeister H, 2011, J CELL BIOL, V192, P631, DOI 10.1083/jcb.201007050; Hoffmeister H, 2011, BIOCHEM J, V433, P285, DOI 10.1042/BJ20101141; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Qian F, 2005, PFLUG ARCH EUR J PHY, V451, P277, DOI 10.1007/s00424-005-1469-4; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Streets AJ, 2010, MOL BIOL CELL, V21, P3853, DOI 10.1091/mbc.E10-04-0377; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; United States Renal Data System, 2012, USRDS 2012 ANN DAT R, P362; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	60	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14854	14867		10.1074/jbc.M114.562264	http://dx.doi.org/10.1074/jbc.M114.562264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719335	Green Published, hybrid			2022-12-25	WOS:000337248100038
J	Ray, MS; Moskovich, O; Iosefson, O; Fishelson, Z				Ray, Moran Saar; Moskovich, Oren; Iosefson, Ohad; Fishelson, Zvi			Mortalin/GRP75 Binds to Complement C9 and Plays a Role in Resistance to Complement-dependent Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; HUMAN-NEUTROPHILS; NUCLEATED CELLS; PLASMA-MEMBRANE; REMOVAL; RECOVERY; ANTIBODY; LEVEL	Mortalin/GRP75, the mitochondrial heat shock protein 70, plays a role in cell protection from complement-dependent cytotoxicity (CDC). As shown here, interference with mortalin synthesis enhances sensitivity of K562 erythroleukemia cells to CDC, whereas overexpression of mortalin leads to their resistance to CDC. Quantification of the binding of the C5b-9 membrane attack complex to cells during complement activation shows an inverse correlation between C5b-9 deposition and the level of mortalin in the cell. Following transfection, mortalin-enhanced GFP (EGFP) is located primarily in mitochondria, whereas mortalin Delta 51-EGFP lacking the mitochondrial targeting sequence is distributed throughout the cytoplasm. Over-expressed cytosolic mortalin Delta 51-EGFP has a reduced protective capacity against CDC relative to mitochondrial mortalin-EGFP. Mortalin was previously shown by us to bind to components of the C5b-9 complex. Two functional domains of mortalin, the N-terminal ATPase domain and the C-terminal substrate-binding domain, were purified after expression in bacteria. Similar to intact mortalin, the ATPase domain, but not the substrate-binding domain, was found to bind to complement proteins C8 and C9 and to inhibit zinc-induced polymerization of C9. Binding of mortalin to complement C9 and C8 occurs through an ionic interaction that is nucleotide-sensitive. We suggest that to express its full protective effect from CDC, mortalin must first reach the mitochondria. In addition, mortalin can potentially target the C8 and C9 complement components through its ATPase domain and inhibit C5b-9 assembly and stability.	[Ray, Moran Saar; Moskovich, Oren; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Iosefson, Ohad] Tel Aviv Univ, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Fishelson, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	lifish@post.tau.ac.il			Israel Science Foundation; German-Israel Science Foundation; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); German-Israel Science Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Cancer Association	This work was supported in part by grants from the Israel Science Foundation, the German-Israel Science Foundation, and the Israel Cancer Association.	BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; CARNEY DF, 1985, J IMMUNOL, V134, P1804; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Gancz D, 2009, MOL IMMUNOL, V46, P2794, DOI 10.1016/j.molimm.2009.05.009; Iosefson O, 2010, FEBS LETT, V584, P1080, DOI 10.1016/j.febslet.2010.02.019; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; MORGAN BP, 1987, J IMMUNOL, V138, P246; MORGAN BP, 1989, BIOCHEM J, V264, P1; Morris JC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001215; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Moskovich O, 2012, J BIOL CHEM, V287, P19904, DOI 10.1074/jbc.M111.333039; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; REITER Y, 1992, EUR J IMMUNOL, V22, P1207, DOI 10.1002/eji.1830220515; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Taurin S, 2002, CIRC RES, V91, P915, DOI 10.1161/01.RES.0000043020.45534.3E; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; TSCHOPP J, 1984, J BIOL CHEM, V259, P569; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Ziporen L, 2009, J IMMUNOL, V182, P515, DOI 10.4049/jimmunol.182.1.515	29	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15014	15022		10.1074/jbc.M114.552406	http://dx.doi.org/10.1074/jbc.M114.552406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719326	Green Published, hybrid			2022-12-25	WOS:000337248100053
J	Chiang, TS; Yang, KC; Chiou, LL; Huang, GT; Lee, HS				Chiang, Tsai-Shin; Yang, Kai-Chiang; Chiou, Ling-Ling; Huang, Guan-Tarn; Lee, Hsuan-Shu			Enhancement of CYP3A4 Activity in Hep G2 Cells by Lentiviral Transfection of Hepatocyte Nuclear Factor-1 Alpha	PLOS ONE			English	Article							PREGNANE X RECEPTOR; DRUG-METABOLISM; TRANSCRIPTION FACTORS; CYTOCHROME-P450; EXPRESSION; INDUCTION; NIFEDIPINE; ENZYMES; GENES; TOOL	Human hepatoma cell lines are commonly used as alternatives to primary hepatocytes for the study of drug metabolism in vitro. However, the phase I cytochrome P450 (CYP) enzyme activities in these cell lines occur at a much lower level than their corresponding activities in primary hepatocytes, and thus these cell lines may not accurately predict drug metabolism. In the present study, we selected hepatocyte nuclear factor-1 alpha (HNF1 alpha) from six transcriptional regulators for lentiviral transfection into Hep G2 cells to optimally increase their expression of the CYP3A4 enzyme, which is the major CYP enzyme in the human body. We subsequently found that HNF1 alpha-transfected Hep G2 enhanced the CYP3A4 expression in a time- and dose-dependent manner and the activity was noted to increase with time and peaked 7 days. With a multiplicity of infection (MOI) of 100, CYP3A4 expression increased 19-fold and enzyme activity more than doubled at day 7. With higher MOI (1,000 to 3,000), the activity increased 8- to 10-fold; however, it was noted the higher MOI, the higher cell death rate and lower cell survival. Furthermore, the CYP3A4 activity in the HNF1 alpha-transfected cells could be induced by CYP3A4-specific inducer, rifampicin, and metabolized nifedipine in a dose-dependent manner. With an MOI of 3,000, nifedipine-metabolizing activity was 6-fold of control and as high as 66% of primary hepatocytes. In conclusion, forceful delivery of selected transcriptional regulators into human hepatoma cells might be a valuable method to enhance the CYP activity for a more accurate determination of drug metabolism in vitro.	[Chiang, Tsai-Shin; Lee, Hsuan-Shu] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Yang, Kai-Chiang] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Huang, Guan-Tarn; Lee, Hsuan-Shu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Guan-Tarn; Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Taiwan University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan	Huang, GT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	gthuang@ntu.edu.tw; benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434; Huang, Guan-Tarn/0000-0001-7004-826X	National Science Council [NSC 101-3114-B-002-003, NSC 102-2313-B-002-014]; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC 101-3114-B-002-003 and NSC 102-2313-B-002-014), and Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Cali JJ, 2009, CYP3A4 P450 GLO ASSA; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chiang TS, 2012, BIOMATERIALS, V33, P5187, DOI 10.1016/j.biomaterials.2012.04.014; Choi S, 2009, XENOBIOTICA, V39, P205, DOI 10.1080/00498250802613620; Cooper BW, 2008, TOXICOL SCI, V103, P268, DOI 10.1093/toxsci/kfn047; Donato MT, 2008, CURR DRUG METAB, V9, P1; Elizondo G, 2003, LIFE SCI, V73, P141, DOI 10.1016/S0024-3205(03)00262-5; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021; Haas DM, 2012, J MATERN-FETAL NEO M, V25, P419, DOI 10.3109/14767058.2011.583700; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Jover R, 1998, FEBS LETT, V431, P227, DOI 10.1016/S0014-5793(98)00746-7; Kacevska M, 2012, BIOCHIMIE, V94, P2338, DOI 10.1016/j.biochi.2012.07.013; Leite SB, 2012, TOXICOL SCI, V130, P106, DOI 10.1093/toxsci/kfs232; Leung T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3574; Luo G, 2004, CURR DRUG METAB, V5, P483, DOI 10.2174/1389200043335397; Martinez-Jimenez CP, 2007, CURR DRUG METAB, V8, P185, DOI 10.2174/138920007779815986; Meyer UA, 1996, J PHARMACOKINET BIOP, V24, P449, DOI 10.1007/BF02353473; Moore JT, 2000, TOXICOLOGY, V153, P1, DOI 10.1016/S0300-483X(00)00300-0; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nakamura K, 2011, J TOXICOL SCI, V36, P625; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Patki KC, 2003, DRUG METAB DISPOS, V31, P938, DOI 10.1124/dmd.31.7.938; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd1131; Reimold AM, 2000, GENE DEV, V14, P152; Takayama K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021780; Tarantino G, 2009, WORLD J GASTROENTERO, V15, P2817, DOI 10.3748/wjg.15.2817; Tolosa L, 2012, TOXICOL IN VITRO, V26, P1272, DOI 10.1016/j.tiv.2011.11.008; Wang HB, 2003, CLIN PHARMACOKINET, V42, P1331, DOI 10.2165/00003088-200342150-00003; Wang XD, 2007, J CHROMATOGR B, V852, P534, DOI 10.1016/j.jchromb.2007.02.026; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789	36	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94885	10.1371/journal.pone.0094885	http://dx.doi.org/10.1371/journal.pone.0094885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733486	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400127
J	Olivo-Marston, SE; Hursting, SD; Perkins, SN; Schetter, A; Khan, M; Croce, C; Harris, CC; Lavigne, J				Olivo-Marston, Susan E.; Hursting, Stephen D.; Perkins, Susan N.; Schetter, Aaron; Khan, Mohammed; Croce, Carlo; Harris, Curtis C.; Lavigne, Jackie			Effects of Calorie Restriction and Diet-Induced Obesity on Murine Colon Carcinogenesis, Growth and Inflammatory Factors, and MicroRNA Expression	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; MALE F344 RATS; COLORECTAL-CANCER; FACTOR-I; PLASMA ADIPONECTIN; PHYSICAL-ACTIVITY; BINDING PROTEIN-3; ENERGY-BALANCE; OB/OB MICE; RISK	Obesity is an established colon cancer risk factor, while preventing or reversing obesity via a calorie restriction (CR) diet regimen decreases colon cancer risk. Unfortunately, the biological mechanisms underlying these associations are poorly understood, hampering development of mechanism-based approaches for preventing obesity-related colon cancer. We tested the hypotheses that diet-induced obesity (DIO) would increase (and CR would decrease) colon tumorigenesis in the mouse azoxymethane (AOM) model. In addition, we established that changes in inflammatory cytokines, growth factors, and microRNAs are associated with these energy balance-colon cancer links, and thus represent mechanism-based targets for colon cancer prevention. Mice were injected with AOM once a week for 5 weeks and randomized to: 1) control diet; 2) 30% CR diet; or 3) DIO diet. Mice were euthanized at week 5 (n = 12/group), 10 (n = 12/group), and 20 (n = 20/group) after the last AOM injection. Colon tumors were counted, and cytokines, insulin-like growth factor 1 (IGF-1), IGF binding protein 3 (IGFBP-3), adipokines, proliferation, apoptosis, and expression of microRNAs (miRs) were measured. The DIO diet regimen induced an obese phenotype (similar to 36% body fat), while CR induced a lean phenotype (similar to 14% body fat); controls were intermediate (similar to 26% body fat). Relative to controls, DIO increased (and CR decreased) the number of colon tumors (p = 0.01), cytokines (p<0.001), IGF-1 (p = 0.01), and proliferation (p<0.001). DIO decreased (and CR increased) IGFBP-3 and apoptosis (p<0.001). miRs including mir-425, mir-196, mir-155, mir-150, mir-351, mir-16, let-7, mir34, and mir-138 were differentially expressed between the dietary groups. We conclude that the enhancing effects of DIO and suppressive effects of CR on colon carcinogenesis are associated with alterations in several biological pathways, including inflammation, IGF-1, and microRNAs.	[Olivo-Marston, Susan E.; Schetter, Aaron; Khan, Mohammed; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Olivo-Marston, Susan E.] Ohio State Univ, Div Epidemio, Coll Publ Hlth, Columbus, OH 43210 USA; [Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Hursting, Stephen D.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Perkins, Susan N.] NCI, Ctr Canc Training, NIH, Bethesda, MD 20892 USA; [Croce, Carlo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Lavigne, Jackie] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Olivo-Marston, SE (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	solivo-marston@cph.osu.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [P30 CA016058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011492, P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abolhassani M, 2008, CANCER RES, V68, P9423, DOI 10.1158/0008-5472.CAN-08-1017; ALBANES D, 1987, Nutrition and Cancer, V9, P199; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Bobe G, 2008, NUTR CANCER, V60, P373, DOI 10.1080/01635580701775142; Ealey KN, 2008, MOL CARCINOGEN, V47, P667, DOI 10.1002/mc.20419; Farquharson A, MOL BIOL REPORTS, P1; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; GIOVANELLA BC, 1982, JNCI-J NATL CANCER I, V68, P249; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2000, GROWTH HORM IGF RES, V10, pS30, DOI 10.1016/S1096-6374(00)90014-5; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Huang XF, 2009, GUT, V58, P1169; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Hursting SD, 2007, CURR CANCER DRUG TAR, V7, P484; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KLURFELD DM, 1987, CANCER RES, V47, P2759; KOENUMA M, 1989, JPN J CANCER RES, V80, P51, DOI 10.1111/j.1349-7006.1989.tb02244.x; KUMAR SP, 1990, CANCER RES, V50, P5761; Lashinger LM, CANC PREVENTION RES, V4, P11051; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu Z, J NUTR BIOCH; MACRAE FA, 1993, PREV MED, V22, P750, DOI 10.1006/pmed.1993.1069; Mai V, 2003, CANCER RES, V63, P1752; Mentor-Marcel RA, 2009, CANCER PREV RES, V2, P60, DOI 10.1158/1940-6207.CAPR-08-0086; Moore T, 2008, CANC PREVENTION RES, V76; Olivo SE, 2005, CARCINOGENESIS, V26, P1563, DOI 10.1093/carcin/bgi118; Olivo-Marston SE, 2009, MOL CARCINOGEN, V48, P1071, DOI 10.1002/mc.20577; Otake S, 2005, CLIN CANCER RES, V11, P3642, DOI 10.1158/1078-0432.CCR-04-1868; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Padidar S, 2011, J CELL PHYSIOL, V226, P2123, DOI 10.1002/jcp.22546; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Raju J, 2003, CANCER RES, V63, P6595; REDDY BS, 1987, CANCER RES, V47, P1226; Rondini EA, 2011, MOL CARCINOGEN, V50, P370, DOI 10.1002/mc.20720; Ruhl CE, 2007, AM J CLIN NUTR, V85, P1121; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Slattery ML, 1997, CANCER RES, V57, P75; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; TANNENBAUM A, 1947, ANN NY ACAD SCI, V49, P5, DOI 10.1111/j.1749-6632.1947.tb30929.x; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Weber RV, 2000, DIGEST DIS SCI, V45, P890, DOI 10.1023/A:1005560621722; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zeng H, 2011, CLIN EXPT PHARM PHYS	53	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94765	10.1371/journal.pone.0094765	http://dx.doi.org/10.1371/journal.pone.0094765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732966	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400096
J	Pedroni, SMA; Turban, S; Kipari, T; Dunbar, DR; McInnes, K; Saunders, PTK; Morton, NM; Norman, JE				Pedroni, Silvia M. A.; Turban, Sophie; Kipari, Tiina; Dunbar, Donald R.; McInnes, Kerry; Saunders, Philippa T. K.; Morton, Nicholas M.; Norman, Jane E.			Pregnancy in Obese Mice Protects Selectively against Visceral Adiposity and Is Associated with Increased Adipocyte Estrogen Signalling	PLOS ONE			English	Article							HIGH-FAT DIET; RECEPTOR-ALPHA; INSULIN-RESISTANCE; TISSUE; EXPRESSION; INFLAMMATION; METABOLISM; WOMEN; SENSITIVITY; ESTRADIOL	Maternal obesity is linked with increased adverse pregnancy outcomes for both mother and child. The metabolic impact of excessive fat within the context of pregnancy is not fully understood. We used a mouse model of high fat (HF) feeding to induce maternal obesity to identify adipose tissue-mediated mechanisms driving metabolic dysfunction in pregnant and non-pregnant obese mice. As expected, chronic HF-feeding for 12 weeks preceding pregnancy increased peripheral (subcutaneous) and visceral (mesenteric) fat mass. However, unexpectedly at late gestation (E18.5) HF-fed mice exhibited a remarkable normalization of visceral but not peripheral adiposity, with a 53% reduction in non-pregnant visceral fat mass expressed as a proportion of body weight (P < 0.001). In contrast, in control animals, pregnancy had no effect on visceral fat mass proportion. Obesity exaggerated glucose intolerance at mid-pregnancy (E14.5). However by E18.5, there were no differences, in glucose tolerance between obese and control mice. Transcriptomic analysis of visceral fat from HF-fed dams at E18.5 revealed reduced expression of genes involved in de novo lipogenesis (diacylglycerol O-acyltransferase 2 - Dgat2) and inflammation (chemokine C-C motif ligand 2 -Ccl2) and upregulation of estrogen receptor alpha (ER alpha) compared to HF non pregnant. Attenuation of adipose inflammation was functionally confirmed by a 45% reduction of CD11b(+)CD11c(+) adipose tissue macrophages (expressed as a proportion of all stromal vascular fraction cells) in HF pregnant compared to HF non pregnant animals (P < 0.001). An ER alpha selective agonist suppressed both de novo lipogenesis and expression of lipogenic genes in adipocytes in vitro. These data show that, in a HF model of maternal obesity, late gestation is associated with amelioration of visceral fat hypertrophy, inflammation and glucose intolerance, and suggest that these effects are mediated in part by elevated visceral adipocyte ER alpha signaling.	[Pedroni, Silvia M. A.; Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [Pedroni, Silvia M. A.; Saunders, Philippa T. K.; Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Turban, Sophie; Kipari, Tiina; Dunbar, Donald R.; McInnes, Kerry] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Morton, Nicholas M.] Univ Edinburgh, Queens Med Res Inst, Mol Metab Grp, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Norman, JE (corresponding author), Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland.	jane.norman@ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020; Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Norman, Jane/0000-0001-6031-6953; Pedroni, Silvia MA/0000-0002-3626-891X	Tommy's the Baby Charity; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [G1100356, G1002033] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [G1100356, G1002033] Funding Source: researchfish	Tommy's the Baby Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Tommy's the Baby Charity [http://www.tommys.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; de Castro J, 2011, ENDOCRINOLOGY, V152, P4094, DOI 10.1210/en.2011-0068; Fernandes FS, 2012, PROSTAG LEUKOTR ESS, V86, P167, DOI 10.1016/j.plefa.2012.03.001; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Friis CM, 2013, OBESITY, V21, pE124, DOI 10.1002/oby.20120; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Homma H, 2000, J BIOL CHEM, V275, P11404, DOI 10.1074/jbc.275.15.11404; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Jung US, 2013, INT J MOL MED, V32, P723, DOI 10.3892/ijmm.2013.1440; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; King V, 2013, ENDOCRINOLOGY, V154, P2514, DOI 10.1210/en.2013-1013; Kjerulff LE, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.03.021; Locher LF, 2011, J DAIRY SCI, V94, P4514, DOI 10.3168/jds.2011-4145; MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Piermaria J, 2003, ENDOCRINE, V20, P239, DOI 10.1385/ENDO:20:3:239; Resi V, 2012, AM J PHYSIOL-ENDOC M, V303, pE832, DOI 10.1152/ajpendo.00002.2012; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yi KW, 2008, OBESITY, V16, P2393, DOI 10.1038/oby.2008.389; Zhang LY, 2011, J MOL ENDOCRINOL, V47, P157, DOI 10.1530/JME-11-0030	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94680	10.1371/journal.pone.0094680	http://dx.doi.org/10.1371/journal.pone.0094680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732937	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400069
J	Riteau, AS; Tassin, M; Chambon, G; Le Vaillant, C; de Laveaucoupet, J; Quere, MP; Joubert, M; Prevot, S; Philippe, HJ; Benachi, A				Riteau, Anne-Sophie; Tassin, Mikael; Chambon, Guillemette; Le Vaillant, Claudine; de Laveaucoupet, Jocelyne; Quere, Marie-Pierre; Joubert, Madeleine; Prevot, Sophie; Philippe, Henri-Jean; Benachi, Alexandra			Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; ANTENATAL DIAGNOSIS; ADHERENT PLACENTA; PREVIA ACCRETA; ULTRASOUND; MRI; SONOGRAPHY; MANAGEMENT; LACUNAE; WOMEN	Purpose: To evaluate the accuracy of ultrasonography and magnetic resonance imaging (MRI) in the diagnosis of placenta accreta and to define the most relevant specific ultrasound and MRI features that may predict placental invasion. Material and Methods: This study was approved by the institutional review board of the French College of Obstetricians and Gynecologists. We retrospectively reviewed the medical records of all patients referred for suspected placenta accreta to two university hospitals from 01/2001 to 05/2012. Our study population included 42 pregnant women who had been investigated by both ultrasonography and MRI. Ultrasound images and MRI were blindly reassessed for each case by 2 raters in order to score features that predict abnormal placental invasion. Results: Sensitivity in the diagnosis of placenta accreta was 100% with ultrasound and 76.9% for MRI (P = 0.03). Specificity was 37.5% with ultrasonography and 50% for MRI (P = 0.6). The features of greatest sensitivity on ultrasonography were intraplacental lacunae and loss of the normal retroplacental clear space. Increased vascularization in the uterine serosa-bladder wall interface and vascularization perpendicular to the uterine wall had the best positive predictive value (92%). At MRI, uterine bulging had the best positive predictive value (85%) and its combination with the presence of dark intraplacental bands on T2-weighted images improved the predictive value to 90%. Conclusion: Ultrasound imaging is the mainstay of screening for placenta accreta. MRI appears to be complementary to ultrasonography, especially when there are few ultrasound signs.	[Riteau, Anne-Sophie; Tassin, Mikael; Chambon, Guillemette; Benachi, Alexandra] Hop Antoine Beclere, AP HP, Dept Obstet & Gynecol, Clamart, France; [Riteau, Anne-Sophie; Le Vaillant, Claudine; Philippe, Henri-Jean] CHU Nantes, Hop Mere Enfant, Dept Obstet & Gynecol, F-44035 Nantes 01, France; [de Laveaucoupet, Jocelyne] Hop Antoine Beclere, AP HP, Dept Radiol, Clamart, France; [Quere, Marie-Pierre] CHU Nantes, Hop Mere Enfant, Dept Radiol, F-44035 Nantes 01, France; [Joubert, Madeleine] CHU Nantes, Hop Mere Enfant, Dept Pathol, F-44035 Nantes 01, France; [Prevot, Sophie] Hop Antoine Beclere, AP HP, Dept Pathol, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Benachi, A (corresponding author), Hop Antoine Beclere, AP HP, Dept Obstet & Gynecol, Clamart, France.	alexandra.benachi@abc.aphp.fr		Riteau, Anne-Sophie/0000-0003-1902-8436				Baughman WC, 2008, RADIOGRAPHICS, V28, P1905, DOI 10.1148/rg.287085060; Bauwens J, 2014, GYNECOL OBSTET FERTI, V42, P306, DOI 10.1016/j.gyobfe.2014.01.009; Bowman ZS, 2014, AM J PERINAT, V31, P799, DOI 10.1055/s-0033-1361833; Cali G, 2013, ULTRASOUND OBST GYN, V41, P406, DOI 10.1002/uog.12385; Chou MM, 2000, ULTRASOUND OBST GYN, V15, P28, DOI 10.1046/j.1469-0705.2000.00018.x; Chou MM, 2002, ULTRASOUND OBST GYN, V19, P625, DOI 10.1046/j.1469-0705.2002.00731_2.x; Comstock CH, 2004, AM J OBSTET GYNECOL, V190, P1135, DOI 10.1016/j.ajog.2003.11.024; D'Antonio F, 2014, ULTRASOUND OBST GYN, V44, P8, DOI 10.1002/uog.13327; D'Antonio F, 2013, ULTRASOUND OBST GYN, V42, P509, DOI 10.1002/uog.13194; Derman AY, 2011, AM J ROENTGENOL, V197, P1514, DOI 10.2214/AJR.10.5443; Dwyer BK, 2008, J ULTRAS MED, V27, P1275, DOI 10.7863/jum.2008.27.9.1275; Elhawary TM, 2013, J MATERN-FETAL NEO M, V26, P1443, DOI 10.3109/14767058.2013.784740; FINBERG HJ, 1992, J ULTRAS MED, V11, P333; Fitzpatrick KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052893; Hamada S, 2011, PRENATAL DIAG, V31, P1062, DOI 10.1002/pd.2833; Japaraj RP, 2007, J OBSTET GYNAECOL RE, V33, P431, DOI 10.1111/j.1447-0756.2007.00549.x; Kanal E, 2013, J MAGN RESON IMAGING, V37, P501, DOI 10.1002/jmri.24011; Kayem G, 2007, GYNECOL OBSTET FERTI, V35, P186, DOI 10.1016/j.gyobfe.2007.01.021; Lam G, 2002, J SOC GYNECOL INVEST, V9, P37, DOI 10.1016/S1071-5576(01)00146-0; Lax A, 2007, MAGN RESON IMAGING, V25, P87, DOI 10.1016/j.mri.2006.10.007; LERNER JP, 1995, ULTRASOUND OBST GYN, V5, P198, DOI 10.1046/j.1469-0705.1995.05030198.x; Levine D, 1997, RADIOLOGY, V205, P773, DOI 10.1148/radiology.205.3.9393534; Lim PS, 2011, AM J ROENTGENOL, V197, P1506, DOI 10.2214/AJR.11.6858; Maher MA, 2013, ACTA OBSTET GYN SCAN, V92, P1017, DOI 10.1111/aogs.12187; Masselli G, 2008, EUR RADIOL, V18, P1292, DOI 10.1007/s00330-008-0862-8; McLean LA, 2011, ACAD RADIOL, V18, P1175, DOI 10.1016/j.acra.2011.04.018; Meng XY, 2013, ULTRASOUND MED BIOL, V39, P1958, DOI 10.1016/j.ultrasmedbio.2013.05.017; Millischer-Bellaiche AE, 2009, IMAG FEMME, V19, P84, DOI 10.1016/j.femme.2009.04.001; Peker N, 2013, GINEKOL POL, V84, P186; THORP JM, 1992, OBSTET GYNECOL, V80, P506; Tikkanen M, 2011, ACTA OBSTET GYN SCAN, V90, P1140, DOI 10.1111/j.1600-0412.2011.01147.x; Twickler D M, 2000, J Matern Fetal Med, V9, P330; Warshak CR, 2006, OBSTET GYNECOL, V108, P573, DOI 10.1097/01.AOG.0000233155.62906.6d; Warshak CR, 2010, OBSTET GYNECOL, V115, P65, DOI 10.1097/AOG.0b013e3181c4f12a; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074; Yang JI, 2006, ULTRASOUND OBST GYN, V28, P178, DOI 10.1002/uog.2797	36	60	75	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94866	10.1371/journal.pone.0094866	http://dx.doi.org/10.1371/journal.pone.0094866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733409	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400125
J	Shivahare, R; Vishwakarma, P; Parmar, N; Yadav, PK; Haq, W; Srivastava, M; Gupta, S; Kar, S				Shivahare, Rahul; Vishwakarma, Preeti; Parmar, Naveen; Yadav, Pawan Kumar; Haq, Wahajul; Srivastava, Mrigank; Gupta, Suman; Kar, Susanta			Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis	PLOS ONE			English	Article							NITRIC-OXIDE; RESISTANT STRAINS; SEX-DIFFERENCES; DONOVANI; INFECTION; CHEMOTHERAPY; GENERATION; RESPONSES; EFFICACY; HAMSTERS	Immuno-modulators in combination with antileishmanial drug miltefosine is a better therapeutic approach for treatment of Visceral Leishmaniasis (VL) as it not only reduces the dose of miltefosine but also shortens the treatment regimen. However, immunological mechanisms behind the perceived benefits of this combination therapy have not been investigated in detail. In the present study, we hypothesized that potential use of drugs that target the host in addition to the parasite might represent an alternative strategy for combination therapy. We investigated immune responses generated in Leishmania donovani infected animals (hamsters and mice) treated with combination of CpG-ODN-2006 and miltefosine at short dose regimen. Infected animals were administered CpG-ODN-2006 (0.4 mg/kg, single dose), as free and liposomal form, either alone or in combination with miltefosine for 5 consecutive days and parasite clearance was evaluated at day 4 and 7 post treatment. Animals that received liposomal CpG-ODN-2006 (lipo-CpG-ODN-2006) and sub-curative miltefosine (5 mg/kg) showed the best inhibition of parasite multiplication (similar to 97%) which was associated with a biased Th1 immune response in. Moreover, compared to all the other treated groups, we observed increased mRNA expression levels of pro-inflammatory cytokines (IFN-gamma, TNF-alpha and IL-12) and significantly suppressed levels of Th2 cytokines (IL-10 and TGF-beta) on day 4 post treatment in animals that underwent combination therapy with lipo-CpG-ODN-2006 and sub-curative miltefosine. Additionally, same therapy also induced heightened iNOS mRNA levels and NO generation, increased IgG2 antibody level and strong T-cell response in these hamsters compared with all the other treated groups. Collectively, our results suggest that combination of lipo-CpG-ODN-2006 and sub-curative miltefosine generates protective T-cell response in an animal model of visceral leishmaniasis which is characterized by strong Th1 biased immune response thereby underlining our hypothesis that combination therapy, at short dose regimen can be used as a novel way of treating visceral leishmaniasis.	[Shivahare, Rahul; Vishwakarma, Preeti; Parmar, Naveen; Yadav, Pawan Kumar; Srivastava, Mrigank; Gupta, Suman; Kar, Susanta] CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Haq, Wahajul] CSIR Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Kar, S (corresponding author), CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	susantakar@cdri.res.in	Shivahare, Rahul/M-4385-2017; Srivastava, Mrigank/AAQ-3146-2020	Shivahare, Rahul/0000-0002-2078-7125; Srivastava, Mrigank/0000-0001-9324-7843	Department of Science and Technology; Council of Scientific and Industrial Research - Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research - Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology and the Council of Scientific and Industrial Research - Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2012, J ANTIMICROB CHEMOTH, V67, P2892, DOI 10.1093/jac/dks315; Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003; ALEXANDER J, 1988, PARASITOLOGY, V96, P297, DOI 10.1017/S0031182000058303; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; ANURADHA, 1990, INDIAN J EXP BIOL, V28, P876; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; Ashutosh, 2005, ANTIMICROB AGENTS CH, V49, P3776, DOI 10.1128/AAC.49.9.3776-3783.2005; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Banerjee A, 2011, ANTIMICROB AGENTS CH, V55, P1661, DOI 10.1128/AAC.00524-10; Banerjee R, 2011, IMMUNOL CELL BIOL, V89, P466, DOI 10.1038/icb.2010.108; Barry ME, 1999, HUM GENE THER, V10, P2461, DOI 10.1089/10430349950016816; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Bhattacharjee S, 2009, J ANTIMICROB CHEMOTH, V63, P317, DOI 10.1093/jac/dkn479; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Croft SL, 2006, INDIAN J MED RES, V123, P399; DEBEER P, 1991, AM J TROP MED HYG, V44, P283, DOI 10.4269/ajtmh.1991.44.283; Dereure J, 2003, J INFECTION, V47, P77, DOI 10.1016/S0163-4453(03)00002-1; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dube A, 1998, PARASITOLOGY, V116, P219, DOI 10.1017/S0031182097002175; El-On J, 2007, EXP PARASITOL, V116, P156, DOI 10.1016/j.exppara.2006.12.004; ELLARD GA, 1984, INT J LEPROSY, V52, P395; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Gupta R, 2012, J ANTIMICROB CHEMOTH, V67, P440, DOI 10.1093/jac/dkr485; Gupta S, 2011, ANTIMICROB AGENTS CH, V55, P3461, DOI 10.1128/AAC.00137-11; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Herwaldt BL, 1999, NEW ENGL J MED, V341, P1840, DOI 10.1056/NEJM199912093412411; JAHN A, 1986, J TROP MED HYG, V89, P91; Jawahar MS, 2004, INDIAN J MED RES, V120, P398; Jha TK, 2006, INDIAN J MED RES, V123, P389; Kandimalla ER, 2004, TINA RICH TOLL TOLL, P181; Kar S, 2011, J ANTIMICROB CHEMOTH, V66, P618, DOI 10.1093/jac/dkq502; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Kushawaha PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045766; Mathias R, 2001, BRAZ J MED BIOL RES, V34, P539, DOI 10.1590/S0100-879X2001000400015; Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988; Moreira ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047907; Mukherjee S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001987; Musa AM, 2010, T ROY SOC TROP MED H, V104, P1, DOI 10.1016/j.trstmh.2009.07.026; NANDY A, 1988, T ROY SOC TROP MED H, V82, P411, DOI 10.1016/0035-9203(88)90139-3; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; Sane SA, 2011, EXP PARASITOL, V127, P376, DOI 10.1016/j.exppara.2010.09.003; Satoskar A, 1998, IMMUNOL CELL BIOL, V76, P159, DOI 10.1046/j.1440-1711.1998.00730.x; Seifert Karin, 2011, Open Med Chem J, V5, P31, DOI 10.2174/1874104501105010031; Shakya N, 2012, EXP PARASITOL, V131, P377, DOI 10.1016/j.exppara.2012.05.007; Stauber AL, 1956, RICE I PAM, V45, P80; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Travi BL, 2002, INFECT IMMUN, V70, P2288, DOI 10.1128/IAI.70.5.2288-2296.2002; VERESS B, 1977, IMMUNOLOGY, V33, P605; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zaffaroni E, 1999, VET PARASITOL, V81, P11, DOI 10.1016/S0304-4017(98)00237-4; Zimmermann S, 1998, J IMMUNOL, V160, P3627	67	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94596	10.1371/journal.pone.0094596	http://dx.doi.org/10.1371/journal.pone.0094596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732039	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400054
J	Zhang, PP; Shao, MA				Zhang, Pingping; Shao, Ming'an			Spatial Variability and Stocks of Soil Organic Carbon in the Gobi Desert of Northwestern China	PLOS ONE			English	Article							HORQIN SANDY LAND; LOESS PLATEAU; WIND EROSION; BACKGROUND CONCENTRATIONS; ENVIRONMENTAL-FACTORS; TRACE-ELEMENTS; INNER-MONGOLIA; N CONTENT; GRASSLAND; STORAGE	Soil organic carbon (SOC) plays an important role in improving soil properties and the C global cycle. Limited attention, though, has been given to assessing the spatial patterns and stocks of SOC in desert ecosystems. In this study, we quantitatively evaluated the spatial variability of SOC and its influencing factors and estimated SOC storage in a region (40 km(2)) of the Gobi desert. SOC exhibited a log-normal depth distribution with means of 1.6, 1.5, 1.4, and 1.4 g kg(-1) for the 0-10, 10-20, 20-30, and 30-40 cm layers, respectively, and was moderately variable according to the coefficients of variation (37-42%). Variability of SOC increased as the sampling area expanded and could be well parameterized as a power function of the sampling area. Significant correlations were detected between SOC and soil physical properties, i.e. stone, sand, silt, and clay contents and soil bulk density. The relatively coarse fractions, i.e. sand, silt, and stone contents, had the largest effects on SOC variability. Experimental semivariograms of SOC were best fitted by exponential models. Nugget-tosill ratios indicated a strong spatial dependence for SOC concentrations at all depths in the study area. The surface layer (0-10 cm) had the largest spatial dependency compared with the other layers. The mapping revealed a decreasing trend of SOC concentrations from south to north across this region of the Gobi desert, with higher levels close to an oasis and lower levels surrounded by mountains and near the desert. SOC density to depths of 20 and 40 cm for this 40 km(2) area was estimated at 0.42 and 0.68 kg C m(-2), respectively. This study provides an important contribution to understanding the role of the Gobi desert in the global carbon cycle.	[Zhang, Pingping; Shao, Ming'an] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Shao, Ming'an] Chinese Acad Sci, Inst Geog Sci & Nat Resources, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Shao, MA (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	mashao@ms.iswc.ac.cn			National Natural Science Foundation of China [91025018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major Program of the National Natural Science Foundation of China No. 91025018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; [Anonymous], 1982, AGRONOMY MONOGRAPH; Arriaga FJ, 2005, SOIL TILL RES, V81, P155, DOI 10.1016/j.still.2004.09.004; Arrouays D, 2001, SOIL USE MANAGE, V17, P7, DOI 10.1111/j.1475-2743.2001.tb00002.x; Baritz R, 2010, FOREST ECOL MANAG, V260, P262, DOI 10.1016/j.foreco.2010.03.025; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Batjes NH, 1999, GEODERMA, V89, P273, DOI 10.1016/S0016-7061(98)00086-X; Batjes NH, 1999, 30 ISRIC DUTCH NAT R; Bond-Lamberty B, 2006, CAN J FOREST RES, V36, P2794, DOI 10.1139/X06-160; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Cao CY, 2011, ECOL ENG, V37, P1467, DOI 10.1016/j.ecoleng.2011.03.012; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Don A, 2007, GEODERMA, V141, P272, DOI 10.1016/j.geoderma.2007.06.003; Duan ZH, 2001, ATMOS ENVIRON, V35, P5915, DOI 10.1016/S1352-2310(01)00406-X; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; [范宇 Fan Yu], 2006, [生态学报, Acta Ecologica Sinica], V26, P2834; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; FAO-Unesco (Food and Agriculture Organization-Unesco), 1997, SOIL MAP WORLD 15000, V6; Feng Q, 2002, GEODERMA, V106, P21, DOI 10.1016/S0016-7061(01)00099-4; Feng Q, 2001, CLIMATIC CHANGE, V48, P535, DOI 10.1023/A:1005664307625; Feng YZ, 2003, COUNTERMEASURES SUST, P102; Grimm R, 2008, GEODERMA, V146, P102, DOI 10.1016/j.geoderma.2008.05.008; Gruneberg E, 2010, GEODERMA, V155, P426, DOI 10.1016/j.geoderma.2010.01.002; Hoffmann U, 2012, J SOIL SEDIMENT, V12, P811, DOI 10.1007/s11368-012-0499-8; Hu Wei, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P11; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Lei ZD, 1985, J HYDRAULIC ENG, V9, P10; Li H, 2004, PLANT SOIL, V265, P355, DOI 10.1007/s11104-005-0753-6; Li J, 2008, BIOGEOCHEMISTRY, V88, P73, DOI 10.1007/s10533-008-9195-6; Li J, 2007, BIOGEOCHEMISTRY, V85, P317, DOI 10.1007/s10533-007-9142-y; [李秋艳 Li Qiuyan], 2004, [中国沙漠, Journal of Desert Research], V24, P484; Li XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068372; Li Z, 2001, WATER AIR SOIL POLL, V129, P45, DOI 10.1023/A:1010356828990; Lioubimtseva E, 1998, GLOBAL PLANET CHANGE, V17, P95, DOI 10.1016/S0921-8181(98)00015-0; Liu ZP, 2012, SOIL RES, V50, P114, DOI 10.1071/SR11183; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Loescher H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083216; Marchetti A, 2012, PEDOSPHERE, V22, P230, DOI 10.1016/S1002-0160(12)60010-1; MARLAND G, 1999, ENVIRON SCI POLICY, V2, P111, DOI DOI 10.1016/S1462-9011(99)00008-8; Murdock LW, 1983, PUBLICATION U KENTUC, V102; Office National Soil Survey, 1993, CHIN SOIL SER, V1; Pei SF, 2008, AGR ECOSYST ENVIRON, V124, P33, DOI 10.1016/j.agee.2007.08.008; Rossi J, 2009, CATENA, V77, P19, DOI 10.1016/j.catena.2008.12.003; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2008, J GEOCHEM EXPLOR, V98, P57, DOI 10.1016/j.gexplo.2007.12.001; Su ZY, 2006, PEDOSPHERE, V16, P10, DOI 10.1016/S1002-0160(06)60020-9; Tack FMG, 1997, SCI TOTAL ENVIRON, V201, P113, DOI 10.1016/S0048-9697(97)00096-X; TRANGMAR BB, 1985, ADV AGRON, V38, P45; United Nations Framework Convention on Climate Change, 2007, TOOL DEM ASS ADD A R; Venteris ER, 2004, SOIL SCI, V169, P787, DOI 10.1097/01.ss.0000148742.75369.55; Wang DD, 2010, GEODERMA, V154, P302, DOI 10.1016/j.geoderma.2009.10.018; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; Wang S., 1999, GEOGRAPHICAL RES, V18, P349, DOI [10.11821/yj1999040003, DOI 10.3321/J.ISSN:1000-0585.1999.04.003]; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Watson R. T., 2000, LAND USE LAND USE CH, P1; Wei JB, 2006, ENVIRON MONIT ASSESS, V121, P597, DOI 10.1007/s10661-005-9158-5; Yan H, 2005, GLOBAL CHANGE BIOL, V11, P828, DOI 10.1111/j.1365-2486.2005.00950.x; Yang X, 2008, GLOBAL PLANET CHANGE, V61, P70, DOI 10.1016/j.gloplacha.2007.08.007; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Zhang CS, 2004, GEODERMA, V119, P261, DOI 10.1016/j.geoderma.2003.08.004; [张法升 ZHANG Fa-Sheng], 2009, [中国科学院研究生院学报, Journal of the Graduate School of the Academy of Sciences], V26, P350; Zhang XPP, 2002, J ASIAN EARTH SCI, V21, P167, DOI 10.1016/S1367-9120(02)00026-3; Zhang Y, 2008, GEODERMA, V146, P449, DOI 10.1016/j.geoderma.2008.06.015; Zhao HL, 2009, CATENA, V77, P187, DOI 10.1016/j.catena.2008.12.007; Zhou RL, 2008, GEODERMA, V145, P370, DOI 10.1016/j.geoderma.2008.04.003; Zhou ZY, 2011, PLANT SOIL, V341, P257, DOI 10.1007/s11104-010-0641-6; Zhu ZD, 1994, SANDY DESERTIFICATIO, P20; Zibilske LM, 2002, SOIL TILL RES, V66, P153, DOI 10.1016/S0167-1987(02)00023-5; Zuo XA, 2008, SOIL TILL RES, V99, P202, DOI 10.1016/j.still.2008.02.008; Zuo XA, 2009, PLANT SOIL, V318, P153, DOI 10.1007/s11104-008-9826-7	76	20	24	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93584	10.1371/journal.pone.0093584	http://dx.doi.org/10.1371/journal.pone.0093584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733073	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400009
J	Aghdam, R; Ganjali, M; Eslahchi, C				Aghdam, Rosa; Ganjali, Mojtaba; Eslahchi, Changiz			IPCA-CMI: An Algorithm for Inferring Gene Regulatory Networks based on a Combination of PCA-CMI and MIT Score	PLOS ONE			English	Article							LEARNING BAYESIAN NETWORKS; MUTUAL INFORMATION; PROBABILISTIC NETWORKS; EXPRESSION DATA; INFERENCE; IDENTIFICATION; DISTRIBUTIONS; METHODOLOGY; MODELS; GRAPHS	Inferring gene regulatory networks (GRNs) is a major issue in systems biology, which explicitly characterizes regulatory processes in the cell. The Path Consistency Algorithm based on Conditional Mutual Information (PCA-CMI) is a well-known method in this field. In this study, we introduce a new algorithm (IPCA-CMI) and apply it to a number of gene expression data sets in order to evaluate the accuracy of the algorithm to infer GRNs. The IPCA-CMI can be categorized as a hybrid method, using the PCA-CMI and Hill-Climbing algorithm (based on MIT score). The conditional dependence between variables is determined by the conditional mutual information test which can take into account both linear and nonlinear genes relations. IPCA-CMI uses a score and search method and defines a selected set of variables which is adjacent to one of X or Y. This set is used to determine the dependency between X and Y. This method is compared with the method of evaluating dependency by PCA-CMI in which the set of variables adjacent to both X and Y, is selected. The merits of the IPCA-CMI are evaluated by applying this algorithm to the DREAM3 Challenge data sets with n variables and n samples (n = 10,50,100) and to experimental data from Escherichia coli containing 9 variables and 9 samples. Results indicate that applying the IPCA-CMI improves the precision of learning the structure of the GRNs in comparison with that of the PCA-CMI.	[Aghdam, Rosa; Ganjali, Mojtaba] Shahid Beheshti Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Eslahchi, Changiz] Shahid Beheshti Univ, Fac Math Sci, Dept Comp Sci, Tehran, Iran; [Eslahchi, Changiz] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran	Shahid Beheshti University; Shahid Beheshti University	Eslahchi, C (corresponding author), Shahid Beheshti Univ, Fac Math Sci, Dept Comp Sci, Tehran, Iran.	ch-eslahchi@sbu.ac.ir	Aghdam, Rosa/I-5159-2019	Aghdam, Rosa/0000-0001-9045-9592	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation (INSF) [92038832]	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation (INSF)(Iran National Science Foundation (INSF))	The authors would like to thank Departments of Research Affairs of Shahid Beheshti university. The research presented in this study was carried out on the High Performance Computing Cluster supported by the Computer Science department of Institute for Research in Fundamental Sciences (IPM). We are also grateful to Luis M. De Campos and Xiujun Zhang for their excellent comments on several parts of this work. The authors would like to take the opportunity to thank the referees for many valuable comments. Changiz Eslahchi would like to thank the Iranian National Science Foundation (INSF 92038832) for their support.	Acid S, 2003, J ARTIF INTELL RES, V18, P445, DOI 10.1613/jair.1061; Acid S, 2001, INT J APPROX REASON, V27, P235, DOI 10.1016/S0888-613X(01)00041-X; AHMED NA, 1989, IEEE T INFORM THEORY, V35, P688, DOI 10.1109/18.30996; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bonissone P., 1991, P 6 C UNC ART INT, P255; Bouckaert R.R., 1995, BAYESIAN BELIEF NETW; Brunel H, 2010, BIOINFORMATICS, V26, P1811, DOI 10.1093/bioinformatics/btq273; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Buntine W., 1991, P 7 C UNC ART INT, P52, DOI DOI 10.1016/B978-1-55860-203-8.50010-3; CATLETT J, 1991, LECT NOTES ARTIF INT, V482, P164, DOI 10.1007/BFb0017012; Cheng J., 1998, LEARNING BAYESIAN NE; Chickering D.M., 1996, LEARNING DATA ARTIFI, P121, DOI [DOI 10.1007/978-1-4612-2404-4_12, DOI 10.1007/978-1-4612-2404-412]; Chickering DM, 2002, J MACH LEARN RES, V2, P445, DOI 10.1162/153244302760200696; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Campos LM, 2006, J MACH LEARN RES, V7, P2149; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gamez JA, 2007, LECT NOTES ARTIF INT, V4724, P585; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Imoto Seiya, 2002, Pac Symp Biocomput, P175; Jensen F.V., 1996, INTRO BAYESIAN NETWO, V210; Kalisch M, 2007, J MACH LEARN RES, V8, P613; KAYAALP M, 2002, P 18 C UNC ART INT, P251; KERBER R, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P123; Larranaga P, 1996, IEEE T PATTERN ANAL, V18, P912, DOI 10.1109/34.537345; Li Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-520; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J., 2000, CAUSALITY MODELS REA, V29; Pena JM, 2005, BIOINFORMATICS, V21, P224, DOI 10.1093/bioinformatics/bti1137; Robinson RW., 1977, LECT NOTES MATH, P28, DOI DOI 10.1007/BFB0069178; Saito S, 2010, IEEE INT C BIOINFORM, P296, DOI 10.1109/BIBM.2010.5706580; Spirtes P., 2000, CAUSATION PREDICTION, V81; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yang SL, 2002, IEEE T SYST MAN CY A, V32, P419, DOI 10.1109/TSMCA.2002.803772; Zhang XJ, 2013, BIOINFORMATICS, V29, P106, DOI 10.1093/bioinformatics/bts619; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626	47	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92600	10.1371/journal.pone.0092600	http://dx.doi.org/10.1371/journal.pone.0092600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728051	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200011
J	Bjergved, L; Jorgensen, T; Perrild, H; Laurberg, P; Krejbjerg, A; Ovesen, L; Rasmussen, LB; Knudsen, N				Bjergved, Lena; Jorgensen, Torben; Perrild, Hans; Laurberg, Peter; Krejbjerg, Anne; Ovesen, Lars; Rasmussen, Lone Banke; Knudsen, Nils			Thyroid Function and Body Weight: A Community-Based Longitudinal Study	PLOS ONE			English	Article							SERUM TSH; MASS INDEX; EUTHYROID SUBJECTS; OBESE CHILDREN; WHOLE-BODY; FOLLOW-UP; FREE T4; THYROTROPIN; HORMONE; LEPTIN	Objective: Body weight and overt thyroid dysfunction are associated. Cross-sectional population-based studies have repeatedly found that thyroid hormone levels, even within the normal reference range, might be associated with body weight. However, for longitudinal data, the association is less clear. Thus, we tested the association between serum thyrotropin (TSH) and body weight in a community-based sample of adult persons followed for 11 years. Methods: A random sample of 4,649 persons aged 18-65 years from a general population participated in the DanThyr study in 1997-8. We included 2,102 individuals who participated at 11-year follow-up, without current or former treatment for thyroid disease and with measurements of TSH and weight at both examinations. Multiple linear regression models were used, stratified by sex and adjusted for age, smoking status, and leisure time physical activity. Results: Baseline TSH concentration was not associated with change in weight (women, P = 0.17; men, P = 0.72), and baseline body mass index (BMI) was not associated with change in TSH (women, P = 0.21; men, P = 0.85). Change in serum TSH and change in weight were significantly associated in both sexes. Weight increased by 0.3 kg (95% confidence interval [CI] 0.1, 0.4, P = 0.005) in women and 0.8 kg (95% CI 0.1, 1.4, P = 0.02) in men for every one unit TSH (mU/L) increase. Conclusions: TSH levels were not a determinant of future weight changes, and BMI was not a determinant for TSH changes, but an association between weight change and TSH change was present.	[Bjergved, Lena; Jorgensen, Torben] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Bjergved, Lena; Perrild, Hans; Knudsen, Nils] Bispebjerg Hosp, Dept Endocrinol, Copenhagen, Denmark; [Jorgensen, Torben] Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben; Laurberg, Peter] Aalborg Univ, Fac Med, Aalborg, Denmark; [Laurberg, Peter; Krejbjerg, Anne] Aalborg Univ Hosp, Dept Endocrinol, Aalborg, Denmark; [Ovesen, Lars] Slagelse Hosp, Dept Gastroenterol, Slagelse, Denmark; [Rasmussen, Lone Banke] Tech Univ Denmark, Natl Food Inst, Dept Nutr, Soborg, Denmark	University of Copenhagen; Bispebjerg Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Technical University of Denmark	Bjergved, L (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	lbjergved@gmail.com	Jørgensen, Torben/Z-1335-2018	Linneberg, Allan/0000-0002-0994-0184; Jorgensen, Torben/0000-0001-9453-2830	Danish Council for Independent Research, Medical Sciences; Pharmacy Foundation; North Jutland County Research Foundation; Tommerhandler Wilhelm Bangs Foundation; Copenhagen Hospital Corporation Research Foundation; Ministry of Food, Agriculture and Fisheries of Denmark; Danish Agency for Science, Technology and Innovation; King Christian and Queen Louise Jubilee Scholarship	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Pharmacy Foundation; North Jutland County Research Foundation; Tommerhandler Wilhelm Bangs Foundation; Copenhagen Hospital Corporation Research Foundation; Ministry of Food, Agriculture and Fisheries of Denmark; Danish Agency for Science, Technology and Innovation; King Christian and Queen Louise Jubilee Scholarship	This work was supported by the Danish Council for Independent Research, Medical Sciences; the 1991 Pharmacy Foundation; North Jutland County Research Foundation; Tommerhandler Wilhelm Bangs Foundation; Copenhagen Hospital Corporation Research Foundation; Ministry of Food, Agriculture and Fisheries of Denmark; the Danish Agency for Science, Technology and Innovation; and King Christian and Queen Louise Jubilee Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2010, J CLIN ENDOCR METAB, V95, P5412, DOI 10.1210/jc.2010-1169; AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118; Andersen S, 2003, THYROID, V13, P1069, DOI 10.1089/105072503770867237; Araujo RL, 2010, ENDOCRINOLOGY, V151, P3460, DOI 10.1210/en.2010-0026; Asvold BO, 2009, J CLIN ENDOCR METAB, V94, P5023, DOI 10.1210/jc.2009-1180; Bjergved L, 2012, J CLIN ENDOCR METAB, V97, P4022, DOI 10.1210/jc.2012-2508; Bulow PI, 2011, CLIN ENDOCRINOL OXF, DOI [10.1111/j.1365-2265.2011.04008.x, DOI 10.1111/J.1365-2265.2011.04008.X]; BURMEISTER LA, 1992, J CLIN ENDOCR METAB, V75, P344, DOI 10.1210/jc.75.2.344; Chikunguwo S, 2007, SURG OBES RELAT DIS, V3, P631, DOI 10.1016/j.soard.2007.07.011; Dalamaga M, 2013, CELL METAB, V18, P29, DOI 10.1016/j.cmet.2013.05.010; Dall'Asta C, 2010, OBESITY, V18, P854, DOI 10.1038/oby.2009.320; Ercan-Fang S, 2000, J CLIN ENDOCR METAB, V85, P2299, DOI 10.1210/jc.85.6.2299; Feldt-Rasmussen U, 2007, THYROID, V17, P413, DOI 10.1089/thy.2007.0032; Fox CS, 2008, ARCH INTERN MED, V168, P587, DOI 10.1001/archinte.168.6.587; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; Gopinath B, 2008, ARCH INTERN MED, V168, P2283, DOI 10.1001/archinte.168.20.2283; Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979; Knudsen N, 2000, EUR J ENDOCRINOL, V143, P485, DOI 10.1530/eje.0.1430485; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; LAURBERG P, 1987, J CLIN ENDOCR METAB, V64, P969, DOI 10.1210/jcem-64-5-969; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P219, DOI 10.1530/eje.1.02210; Laurberg P, 2012, EUR THYROID J, V1, P159, DOI 10.1159/000342994; Makepeace AE, 2008, CLIN ENDOCRINOL, V69, P648, DOI 10.1111/j.1365-2265.2008.03239.x; Manji N, 2006, CLIN ENDOCRINOL, V64, P125, DOI 10.1111/j.1365-2265.2006.02433.x; Nillni EA, 2000, J BIOL CHEM, V275, P36124, DOI 10.1074/jbc.M003549200; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Pedersen IB, 2003, CLIN ENDOCRINOL, V58, P36, DOI 10.1046/j.1365-2265.2003.01633.x; Reinehr T, 2006, J CLIN ENDOCR METAB, V91, P3088, DOI 10.1210/jc.2006-0095; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Riis ALD, 2002, J CLIN ENDOCR METAB, V87, P4747, DOI 10.1210/jc.2002-020174; Riis ALD, 2005, AM J PHYSIOL-ENDOC M, V288, pE1067, DOI 10.1152/ajpendo.00253.2004; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; Svare A, 2011, CLIN ENDOCRINOL, V74, P769, DOI 10.1111/j.1365-2265.2011.04009.x; Twisk JWR, 2003, APPL LONGITUDINAL DA; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; WILSON B, 1967, South African Journal of Medical Sciences, V32, P70; Zimmermann-Belsing T, 2003, EUR J ENDOCRINOL, V149, P257, DOI 10.1530/eje.0.1490257; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	38	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93515	10.1371/journal.pone.0093515	http://dx.doi.org/10.1371/journal.pone.0093515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728291	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200018
J	Milisenda, G; Rosa, S; Fuentes, VL; Boero, F; Guglielmo, L; Purcell, JE; Piraino, S				Milisenda, Giacomo; Rosa, Sara; Fuentes, Veronica L.; Boero, Ferdinando; Guglielmo, Letterio; Purcell, Jennifer E.; Piraino, Stefano			Jellyfish as Prey: Frequency of Predation and Selective Foraging of Boops boops (Vertebrata, Actinopterygii) on the Mauve Stinger Pelagia noctiluca (Cnidaria, Scyphozoa)	PLOS ONE			English	Article							GELATINOUS PLANKTON; MEDITERRANEAN-SEA; CYANEA-CAPILLATA; FISH PREDATION; MOON JELLYFISH; FOOD-CHAIN; CTENOPHORES; REPRODUCTION; SCYPHOMEDUSA; COMPETITORS	In recent years, jellyfish blooms have attracted considerable scientific interest for their potential impacts on human activities and ecosystem functioning, with much attention paid to jellyfish as predators and to gelatinous biomass as a carbon sink. Other than qualitative data and observations, few studies have quantified direct predation of fish on jellyfish to clarify whether they may represent a seasonally abundant food source. Here we estimate predation frequency by the commercially valuable Mediterranean bogue, Boops boops on the mauve stinger jellyfish, Pelagia noctiluca, in the Strait of Messina (NE Sicily). A total of 1054 jellyfish were sampled throughout one year to quantify predation by B. boops from bite marks on partially eaten jellyfish and energy density of the jellyfish. Predation by B. boops in summer was almost twice that in winter, and they selectively fed according to medusa gender and body part. Calorimetric analysis and biochemical composition showed that female jellyfish gonads had significantly higher energy content than male gonads due to more lipids and that gonads had six-fold higher energy content than the somatic tissues due to higher lipid and protein concentrations. Energetically, jellyfish gonads represent a highly rewarding food source, largely available to B. boops throughout spring and summer. During the remainder of the year, when gonads were not very evident, fish predation switched towards less-selective foraging on the somatic gelatinous biomass. P. noctiluca, the most abundant jellyfish species in the Mediterranean Sea and a key planktonic predator, may represent not only a nuisance for human leisure activities and a source of mortality for fish eggs and larvae, but also an important resource for fish species of commercial value, such as B. boops.	[Milisenda, Giacomo; Boero, Ferdinando; Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy; [Milisenda, Giacomo; Boero, Ferdinando; Purcell, Jennifer E.; Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare CoNISMa, Rome, Italy; [Rosa, Sara; Guglielmo, Letterio] Univ Messina, Dept Anim Biol & Marine Ecol, Messina, Italy; [Fuentes, Veronica L.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Boero, Ferdinando] Natl Res Council ISMAR CNR, Inst Marine Sci, Genoa, Italy; [Purcell, Jennifer E.] Western Washington Univ, Shannon Point Marine Ctr, Anacortes, WA USA	University of Salento; CoNISMa; University of Messina; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Western Washington University	Milisenda, G (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lecce, Italy.	giacomo.milisenda@unisalento.it; stefano.piraino@unisalento.it	Rosa, Sara/GWV-3021-2022; Milisenda, Giacomo/L-6882-2019; Fuentes, Verónica L/K-7589-2014; Piraino, Stefano/J-5234-2012; CNR, Ismar/P-1247-2014	Milisenda, Giacomo/0000-0003-1334-9749; Fuentes, Verónica L/0000-0002-6380-0174; Piraino, Stefano/0000-0002-8752-9390; CNR, Ismar/0000-0001-5351-1486; Boero, Ferdinando/0000-0002-6317-2710; GUGLIELMO, Letterio/0000-0001-7547-8058	European Community [266445]	European Community(European Commission)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS, http://www.marine-vectors.eu). Logistic/technical support was also provided by the FP7 EU projects COCONET, PERSEUS, the ENPI CBCMED programme MED-JELLYRISK, and by the Italian Flagship project RITMARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1986, CHEM SIGNAL, V4, P45, DOI DOI 10.1007/978-1-4613-2235-1_5; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Arai MN, 2003, CAN J FISH AQUAT SCI, V60, P825, DOI [10.1139/f03-071, 10.1139/F03-071]; ARAI MN, 1988, CAN J ZOOL, V66, P1913, DOI 10.1139/z88-280; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Arkhipkin A, 2013, J FISH BIOL, V83, P1210, DOI 10.1111/jfb.12217; ATES R M L, 1988, Zoologische Mededelingen (Leiden), V62, P29; ATES RML, 1991, HYDROBIOLOGIA, V216, P305, DOI 10.1007/BF00026479; AVIAN M, 1991, HYDROBIOLOGIA, V216, P189, DOI 10.1007/BF00026461; Azzaro F., 1995, RAPP COMM INT MER M, V34, P167; Azzaro F, 2007, OCEAN SCI DISCUSS, V4, P415; Bamstedt U, 1997, SARSIA, V82, P269, DOI 10.1080/00364827.1997.10413654; BARNES H, 1973, Journal of Experimental Marine Biology and Ecology, V12, P103, DOI 10.1016/0022-0981(73)90040-3; Bauchot M.-L., 1986, P883; Bayha KM, 2012, HYDROBIOLOGIA, V690, P189, DOI 10.1007/s10750-012-1038-8; Bjorndal Karen A., 1997, P199; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F., 2013, F1000RESEARCH, V2, P181, DOI [10.12688/f1000research.2-181.v1, DOI 10.12688/F1000RESEARCH.2-181.V1]; Boero F, 2013, FAO FISHERIES REPORT, V92, P64; Brodeur RD, 2008, MAR BIOL, V154, P649, DOI 10.1007/s00227-008-0958-3; Buecher E, 2001, J PLANKTON RES, V23, P1073, DOI 10.1093/plankt/23.10.1073; Canepa Antonio, 2014, P237; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Condon R.H., 2011, ECOLOGY, V92, P1704, DOI [10.1890/11-0302.1, DOI 10.1890/11-0302.1]; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; De Domenico M, 1988, ATTI AIOL, V8, P337; Derbal F, 2008, CYBIUM, V32, P325; DITTRICH B, 1988, HELGOLANDER MEERESUN, V42, P79, DOI 10.1007/BF02364205; Dobroslavic T, 2013, J APPL ICHTHYOL, V29, P181, DOI 10.1111/j.1439-0426.2012.02046.x; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Galil Bella S., 2013, BioInvasions Records, V2, P191, DOI 10.3391/bir.2013.2.3.03; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Carman VG, 2014, MAR BIOL, V161, P339, DOI 10.1007/s00227-013-2339-9; Guidetti P, 2004, J MAR BIOL ASSOC UK, V84, P669, DOI 10.1017/S0025315404009725h; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; KINDER TH, 1990, NATO ADV SCI I C-MAT, V318, P295; Laval P., 1980, Oceanography and Marine Biology an Annual Review, V18, P11; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Lynam CP, 2005, MAR ECOL PROG SER, V298, P157, DOI 10.3354/meps298157; MAGAZZU G, 1995, AQUAT MICROB ECOL, V9, P97, DOI 10.3354/ame009097; MALEJ A, 1993, MAR BIOL, V116, P565, DOI 10.1007/BF00355475; Malej A, 1986, NOV THALASS, V8, P107; Mianzan H, 2001, HYDROBIOLOGIA, V451, P45, DOI 10.1023/A:1011836022232; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Miyajima Yuko, 2011, Plankton & Benthos Research, V6, P12; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; PURCELL JE, 1991, HYDROBIOLOGIA, V216, P335, DOI 10.1007/BF00026483; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; REINAHERVAS JA, 1987, MAR BIOL, V95, P501, DOI 10.1007/BF00393093; Riede K., 2004, GLOBAL REGISTER MIGR; Rosa S, 2013, J MARINE SYST, V111, P97, DOI 10.1016/j.jmarsys.2012.10.001; Sabates A, 1996, MAR ECOL PROG SER, V135, P11, DOI 10.3354/meps135011; Sanches J.P., 1992, GUIA IDENTIFICACAO P; SCHNEIDER G, 1992, HELGOLANDER MEERESUN, V46, P377, DOI 10.1007/BF02367205; Sibly R. M., 1986, PHYSL ECOLOGY ANIMAL; Sommer U, 2002, HYDROBIOLOGIA, V484, P11, DOI 10.1023/A:1021340601986; Spallanzani L, 1799, MEDUSES PHOSPHORIQUE, V4, P137; Spallanzani L, 1799, MEDUSES PHOSPHORIQUE, V1, P1; Svensson JE, 1997, HYDROBIOLOGIA, V344, P155, DOI 10.1023/A:1002966614054; Tilves U, 2013, J PLANKTON RES, V35, P218, DOI 10.1093/plankt/fbs082; Titelman J, 2007, MAR BIOL, V152, P745, DOI 10.1007/s00227-007-0721-1; Utne-Palm AC, 2010, SCIENCE, V329, P333, DOI 10.1126/science.1190708; Vucetic T., 1988, FAO Fisheries Reports, P133; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	73	62	66	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94600	10.1371/journal.pone.0094600	http://dx.doi.org/10.1371/journal.pone.0094600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727977	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200104
J	Sarfo, FS; Sarfo, MA; Norman, B; Phillips, R; Chadwick, D				Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard; Chadwick, David			Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADVERSE EVENTS; RISK-FACTORS; REGIMENS; TOXICITY; ZIDOVUDINE; EFFICACY; PROGRAM; SAFETY; SEX	Non-nucleoside reverse transcriptase inhibitor (NNRTI) associated rash is common and frequently leads to discontinuation of NNRTIs. This study assessed the risk of developing rashes and discontinuing NNRTIs and associated factors in a large clinic in central Ghana. In this retrospective cohort study, clinical data were obtained in patients starting efavirenz or nevirapine between 2004-2010. Factors associated with rashes were explored using a multivariate Cox proportional hazards regression model. Of 3,999 patients who started NNRTI-based ART, 281 (7.0%) experienced at least one episode of NNRTI-related rash with an incidence of 2.63 events/100 person-years, occurring in 10.2% and 5.6% of patients taking nevirapine and efavirenz respectively. Most rashes (94%) were grade 1 or 2 and were reported a median of 2 months following initiation of ART. In multivariate analysis developing a rash was associated with nevirapine use (aHR 1.67, 95% CI 1.28-2.10), female gender (aHR of 1.39, 95% CI 1.01-1.92) and lower baseline CD4 counts (aHR 0.88, 95% CI 0.82-0.95 per 50 cells/mm(3) increment). Patients with nevirapine-associated rash were 11 times more likely to discontinue treatment as patients with efavirenz-associated rash. In contrast to findings in other studies, NNRTI-associated rashes in Ghanaians appear more common in patients with lower baseline CD4 counts. Given the increased frequency of rashes with nevirapine and subsequent discontinuations in many patients, along with other treatment-limiting toxicities, this provides further impetus for the replacement of nevirapine by efavirenz as the first-line NNRTI treatment of choice in Africa.	[Sarfo, Fred Stephen; Sarfo, Maame Anima; Norman, Betty; Phillips, Richard] Komfo Anokye Teaching Hosp, Dept Med, Kumasi, Ghana; [Sarfo, Fred Stephen; Phillips, Richard] Kwame Nkrumah Univ Sci & Technol, Dept Med, Kumasi, Ghana; [Chadwick, David] James Cook Univ Hosp, Ctr Clin Infect, Middlesbrough, Cleveland, England	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; James Cook University Hospital	Sarfo, FS (corresponding author), Komfo Anokye Teaching Hosp, Dept Med, Kumasi, Ghana.	stephensarfo78@gmail.com	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222	HIV Research Trust Scholarship; MRC [MR/J01477X/1] Funding Source: UKRI; Medical Research Council [MR/J01477X/1] Funding Source: researchfish	HIV Research Trust Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received financial support via an HIV Research Trust Scholarship to FSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2013, AIDS, V27, P803, DOI 10.1097/QAD.0b013e32835cb997; Ananworanich J, 2005, AIDS, V19, P185, DOI 10.1097/00002030-200501280-00011; [Anonymous], 2007, WHO SURV QUAL ANT ME; Antinori A, 2001, AIDS, V15, P1579, DOI 10.1097/00002030-200108170-00018; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Boulle A, 2007, ANTIVIR THER, V12, P753; Coffie PA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-188; d'Arminio Monteforte A, 2000, AIDS, V14, P499; de Beaudrap P, 2008, AIDS RES HUM RETROV, V24, P753, DOI 10.1089/aid.2007.0295; Dong BJ, 2012, AIDS, V26, P833, DOI 10.1097/QAD.0b013e328351a521; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Keiser Philip, 2002, HIV Clin Trials, V3, P296; Laurent C, 2008, AIDS RES HUM RETROV, V24, P393, DOI 10.1089/aid.2007.0219; Marazzi MC, 2006, HIV MED, V7, P338, DOI 10.1111/j.1468-1293.2006.00386.x; Mehta U, 2007, LANCET INFECT DIS, V7, P733, DOI 10.1016/S1473-3099(07)70262-1; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Munderi P, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2007.01973.x; Phanuphak N, 2007, HIV MED, V8, P357, DOI 10.1111/j.1468-1293.2007.00477.x; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Umapathy S, 2011, J PHARMACOL PHARMACO, V2, P114, DOI 10.4103/0976-500X.81905; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; World Health Organisation, 2011, ANT THER ART COV ALL; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2011, TREATM 2 0 FRAM ACT	26	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94854	10.1371/journal.pone.0094854	http://dx.doi.org/10.1371/journal.pone.0094854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728406	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200135
J	Balakuntla, J; Prabhakara, S; Arakere, G				Balakuntla, Jayanth; Prabhakara, Sushma; Arakere, Gayathri			Novel Rearrangements in the Staphylococcal Cassette Chromosome Mec Type V Elements of Indian ST772 and ST672 Methicillin Resistant Staphylococcus aureus Strains	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; DISEASE CLONE; EMERGENCE; INFECTIONS; GUIDELINES; GENES	Staphylococcus aureus is a commensal gram positive bacteria which causes severe and non severe infections in humans and livestock. In India, ST772 is a dominant and ST672 is an emerging clone of Staphylococcus aureus. Both cause serious human diseases, and carry type V SCCmec elements. The objective of this study was to characterize SCCmec type V elements of ST772 and ST672 because the usual PCR methods did not amplify all primers specific to the type. Whole genome sequencing analysis of seven ST772 and one ST672 S. aureus isolates revealed that the SCCmec elements of six of the ST772 isolates were the smallest of the extant type V elements and in addition have several other novel features. Only one ST772 isolate and the ST672 isolate carried bigger SCCmec cassettes which were composites carrying multiple ccrC genes. These cassettes had some similarities to type V SCCmec element from M013 isolate (ST59) from Taiwan in certain aspects. SCCmec elements of all Indian isolates had an inversion of the mec complex, similar to the bovine SCCmec type X. This study reveals that six out of seven ST772 S. aureus isolates have a novel type V (5C2) SCCmec element while one each of ST772 and ST672 isolates have a composite SCCmec type V element (5C2&5) formed by the integration of type V SCCmec into a MSSA carrying a SCC element, in addition to the mec gene complex inversions and extensive recombinations.	[Balakuntla, Jayanth; Prabhakara, Sushma; Arakere, Gayathri] Indian Inst Sci, Soc Innovat & Dev, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Arakere, G (corresponding author), Indian Inst Sci, Soc Innovat & Dev, Bangalore 560012, Karnataka, India.	gayathri.arakere@gmail.com			Department of Biotechnology [BT/IN/New Indigo/16/GA/2010]; Swedish International Development Agency grant	Department of Biotechnology; Swedish International Development Agency grant	This work has been made possible through a Department of Biotechnology grant (BT/IN/New Indigo/16/GA/2010) and Swedish International Development Agency grant to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2008, JPN J INFECT DIS, V61, P393; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chlebowicz MA, 2013, INT J MED MICROBIOL, V303, P422, DOI 10.1016/j.ijmm.2013.05.005; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Khedkar S, 2012, J BACTERIOL, V194, P6946, DOI 10.1128/JB.01868-12; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Nadig S, 2012, CLIN OPHTHALMOL, V6, P165, DOI 10.2147/OPTH.S23878; Neela Vasanthakumari, 2009, Int J Infect Dis, V13, pe131, DOI 10.1016/j.ijid.2008.07.009; O'Brien FG, 2005, ANTIMICROB AGENTS CH, V49, P5129, DOI 10.1128/AAC.49.12.5129-5132.2005; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Prabhakara S, 2012, J BACTERIOL, V194, P3727, DOI 10.1128/JB.00480-12; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Yamaguchi T, 2012, JPN J INFECT DIS, V65, P175; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	33	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94293	10.1371/journal.pone.0094293	http://dx.doi.org/10.1371/journal.pone.0094293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722327	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336909100050
J	Camberg, JL; Viola, MG; Rea, L; Hoskins, JR; Wickner, S				Camberg, Jodi L.; Viola, Marissa G.; Rea, Leslie; Hoskins, Joel R.; Wickner, Sue			Location of Dual Sites in E. coli FtsZ Important for Degradation by ClpXP; One at the C-Terminus and One in the Disordered Linker	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASES; DIVISION PROTEIN FTSZ; ESCHERICHIA-COLI; CYTOSKELETAL PROTEIN; BACTERIAL CYTOKINESIS; BINDING DOMAIN; CHAPERONE CLPX; RECOGNITION; SUBSTRATE; EXPRESSION	ClpXP is a two-component ATP-dependent protease that unfolds and degrades proteins bearing specific recognition signals. One substrate degraded by Escherichia coli ClpXP is FtsZ, an essential cell division protein. FtsZ forms polymers that assemble into a large ring-like structure, termed the Z-ring, during cell division at the site of constriction. The FtsZ monomer is composed of an N-terminal polymerization domain, an unstructured linker region and a C-terminal conserved region. To better understand substrate selection by ClpXP, we engineered FtsZ mutant proteins containing amino acid substitutions or deletions near the FtsZ C-terminus. We identified two discrete regions of FtsZ important for degradation of both FtsZ monomers and polymers by ClpXP in vitro. One region is located 30 residues away from the C-terminus in the unstructured linker region that connects the polymerization domain to the C-terminal region. The other region is near the FtsZ C-terminus and partially overlaps the recognition sites for several other FtsZ-interacting proteins, including MinC, ZipA and FtsA. Mutation of either region caused the protein to be more stable and mutation of both caused an additive effect, suggesting that both regions are important. We also observed that in vitro MinC inhibits degradation of FtsZ by ClpXP, suggesting that some of the same residues in the C-terminal site that are important for degradation by ClpXP are important for binding MinC.	[Camberg, Jodi L.; Rea, Leslie; Hoskins, Joel R.; Wickner, Sue] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Camberg, Jodi L.; Viola, Marissa G.] Univ Rhode Isl, Dept Cell & Mol Biol, Coll Environm & Life Sci, Kingston, RI 02881 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Rhode Island	Camberg, JL (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	cambergj@mail.uri.edu; wickners@mail.nih.gov	Camberg, Jodi/AAX-3737-2020		NIH National Cancer Institute, Center for Cancer Research [1ZIABC008710-35]; Rhode Island Foundation Medical Research Fund [20123829]; NATIONAL CANCER INSTITUTE [ZIABC008710] Funding Source: NIH RePORTER	NIH National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rhode Island Foundation Medical Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH National Cancer Institute, Center for Cancer Research (Award #1ZIABC008710-35) and the Rhode Island Foundation Medical Research Fund (Award # #20123829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Dougan DA, 2003, MOL CELL; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Feng JY, 2013, J PROTEOME RES, V12, P547, DOI 10.1021/pr300394r; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gardner KAJA, 2013, MOL MICROBIOL, V89, P264, DOI 10.1111/mmi.12279; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Szeto TH, 2001, J BACTERIOL, V183, P6684, DOI 10.1128/JB.183.22.6684-6687.2001; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Thibault G, 2012, J PHYS CHEM B, V116, P6717, DOI 10.1021/jp212024b; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	48	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94964	10.1371/journal.pone.0094964	http://dx.doi.org/10.1371/journal.pone.0094964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722340	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100147
J	Kim, Y; Kim, H; Son, H; Choi, GJ; Kim, JC; Lee, YW				Kim, Yongsoo; Kim, Hun; Son, Hokyoung; Choi, Gyung Ja; Kim, Jin-Cheol; Lee, Yin-Won			MYT3, A Myb-Like Transcription Factor, Affects Fungal Development and Pathogenicity of Fusarium graminearum	PLOS ONE			English	Article							NITROGEN METABOLITE REPRESSION; GIBBERELLA-ZEAE; ASPERGILLUS-NIDULANS; FUNCTIONAL ANALYSES; FEMALE FERTILITY; BINDING PROTEIN; CELL-DEATH; GENE; BIOSYNTHESIS; EXPRESSION	We previously characterized members of the Myb protein family, MYT1 and MYT2, in Fusarium graminearum. MYT1 and MYT2 are involved in female fertility and perithecium size, respectively. To expand knowledge of Myb proteins in F. graminearum, in this study, we characterized the functions of the MYT3 gene, which encodes a putative Myb-like transcription factor containing two Myb DNA-binding domains and is conserved in the subphylum Pezizomycotina of Ascomycota. MYT3 proteins were localized in nuclei during most developmental stages, suggesting the role of MYT3 as a transcriptional regulator. Deletion of MYT3 resulted in impairment of conidiation, germination, and vegetative growth compared to the wild type, whereas complementation of MYT3 restored the wild-type phenotype. Additionally, the Delta myt3 strain grew poorly on nitrogen-limited media; however, the mutant grew robustly on minimal media supplemented with ammonium. Moreover, expression level of nitrate reductase gene in the Delta myt3 strain was decreased in comparison to the wild type and complemented strain. On flowering wheat heads, the Delta myt3 strain exhibited reduced pathogenicity, which corresponded with significant reductions in trichothecene production and transcript levels of trichothecene biosynthetic genes. When the mutant was selfed, mated as a female, or mated as a male for sexual development, perithecia were not observed on the cultures, indicating that the Delta myt3 strain lost both male and female fertility. Taken together, these results demonstrate that MYT3 is required for pathogenesis and sexual development in F. graminearum, and will provide a robust foundation to establish the regulatory networks for all Myb-like proteins in F. graminearum.	[Kim, Yongsoo; Kim, Hun; Son, Hokyoung; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Yongsoo; Kim, Hun; Son, Hokyoung; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Div Convergence Chem, Res Ctr Biobased Chem, Ecofriendly New Mat Res Grp, Taejon 305606, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT)	Lee, YW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Son, Hokyoung/0000-0001-5080-7951	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2008-0061897]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT & Future Planning (No. 2008-0061897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON IA, 1988, NATURE, V336, P719, DOI 10.1038/336719a0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arratia-Quijada J, 2012, EUKARYOT CELL, V11, P1132, DOI 10.1128/EC.00101-12; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; He JW, 2007, J CHROMATOGR A, V1151, P187, DOI 10.1016/j.chroma.2007.01.112; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; HOWE KM, 1990, EMBO J, V9, P161, DOI 10.1002/j.1460-2075.1990.tb08092.x; Imamura S, 2009, P NATL ACAD SCI USA, V106, P12548, DOI 10.1073/pnas.0902790106; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2012, MICROBIOL-SGM, V158, P1723, DOI 10.1099/mic.0.059188-0; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Lin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037859; Lin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025586; Lipsick JS, 1996, ONCOGENE, V13, P223; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mateos L, 2006, APPL ENVIRON MICROB, V72, P5052, DOI 10.1128/AEM.00424-06; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Park AR, 2012, FUNGAL GENET BIOL, V49, P511, DOI 10.1016/j.fgb.2012.05.006; Paulitz TC, 1996, PLANT DIS, V80, P674, DOI 10.1094/PD-80-0674; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Rodriguez-Sanchez L, 2011, J CELL SCI, V124, P25, DOI 10.1242/jcs.070987; Sambrook J, 2001, MOL CLONING LAB MANU; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Todd RB, 2005, EUKARYOT CELL, V4, P1646, DOI 10.1128/EC.4.10.1646-1653.2005; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Xiang QJ, 2010, GENE, V453, P1, DOI 10.1016/j.gene.2009.12.006; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040246	66	15	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94359	10.1371/journal.pone.0094359	http://dx.doi.org/10.1371/journal.pone.0094359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722578	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100058
J	Lv, JJ; Liu, P; Gao, BQ; Wang, Y; Wang, Z; Chen, P; Li, J				Lv, Jianjian; Liu, Ping; Gao, Baoquan; Wang, Yu; Wang, Zheng; Chen, Ping; Li, Jian			Transcriptome Analysis of the Portunus trituberculatus: De Novo Assembly, Growth-Related Gene Identification and Marker Discovery	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SWIMMING CRAB; KYOTO ENCYCLOPEDIA; MOLECULAR-CLONING; COG DATABASE; CDNA LIBRARY; SHRIMP; ACTIN; GENERATION; RESOURCE	Background: The swimming crab, Portunus trituberculatus, is an important farmed species in China, has been attracting extensive studies, which require more and more genome background knowledge. To date, the sequencing of its whole genome is unavailable and transcriptomic information is also scarce for this species. In the present study, we performed de novo transcriptome sequencing to produce a comprehensive transcript dataset for major tissues of Portunus trituberculatus by the Illumina paired-end sequencing technology. Results: Total RNA was isolated from eyestalk, gill, heart, hepatopancreas and muscle. Equal quantities of RNA from each tissue were pooled to construct a cDNA library. Using the Illumina paired-end sequencing technology, we generated a total of 120,137 transcripts with an average length of 1037 bp. Further assembly analysis showed that all contigs contributed to 87,100 unigenes, of these, 16,029 unigenes (18.40% of the total) can be matched in the GenBank non-redundant database. Potential genes and their functions were predicted by GO, KEGG pathway mapping and COG analysis. Based on our sequence analysis and published literature, many putative genes with fundamental roles in growth and muscle development, including actin, myosin, tropomyosin, troponin and other potentially important candidate genes were identified for the first time in this specie. Furthermore, 22,673 SSRs and 66,191 high-confidence SNPs were identified in this EST dataset. Conclusion: The transcriptome provides an invaluable new data for a functional genomics resource and future biological research in Portunus trituberculatus. The data will also instruct future functional studies to manipulate or select for genes influencing growth that should find practical applications in aquaculture breeding programs. The molecular markers identified in this study will provide a material basis for future genetic linkage and quantitative trait loci analyses, and will be essential for accelerating aquaculture breeding programs with this species.	[Lv, Jianjian; Liu, Ping; Gao, Baoquan; Wang, Yu; Wang, Zheng; Chen, Ping; Li, Jian] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China; [Wang, Yu; Wang, Zheng] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Li, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Peoples R China.	jianjian997@163.com			National High Technology Research and Development Program of China [2012AA10A409]; Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology [2013GB23260589]; National Natural Science Foundation of China [41306177]; National Science Foundation for Post-doctoral Scientists of China [2013M531657]; Special Scientific Research Funds for Central Non-profit Institutes; Yellow Sea Fisheries Research Institute [20603022013039]; Projects of independent innovation in Shandong Province [2013CXC80202]; Project development of science and technology in Shandong Province [2011GHY11526]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Special Scientific Research Funds for Central Non-profit Institutes; Yellow Sea Fisheries Research Institute; Projects of independent innovation in Shandong Province; Project development of science and technology in Shandong Province	Financial support for this study was provided by the National High Technology Research and Development Program of China (Project 2012AA10A409), Agricultural science and Technology Achievements Transformation Fund Project of the Ministry of science and technology (Project 2013GB23260589), the National Natural Science Foundation of China (Grant No. 41306177), the National Science Foundation for Post-doctoral Scientists of China (Project 2013M531657), Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institute (Project 20603022013039), Projects of independent innovation in Shandong Province (Project 2013CXC80202), Project development of science and technology in Shandong Province (Project 2011GHY11526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cao CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058914; Cesar JRO, 2007, MOL REPROD DEV, V74, P554, DOI 10.1002/mrd.20605; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chen P, 2011, AQUACULTURE, V322, P10, DOI 10.1016/j.aquaculture.2011.09.009; Cho EM, 2009, ANIM CELLS SYST, V13, P305, DOI 10.1080/19768354.2009.9647223; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui ZX, 2012, FISH SHELLFISH IMMUN, V33, P937, DOI 10.1016/j.fsi.2012.08.002; Dai A.Y., 1986, MARINE CRABS CHINA S; De Santis C, 2011, J EXP BIOL, V214, P2671, DOI 10.1242/jeb.056374; Devaraj H, 2006, FEBS J, V273, P839, DOI 10.1111/j.1742-4658.2006.05117.x; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Glenn KL, 2005, ANIM GENET, V36, P235, DOI 10.1111/j.1365-2052.2005.01274.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo EM, 2012, MOL BIOL REP, V39, P1453, DOI 10.1007/s11033-011-0882-3; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; He LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047195; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Jung H, 2013, REV AQUACULTURE; Jung H, 2013, REV AQUACULT, V5, P77, DOI 10.1111/raq.12005; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamimura MT, 2008, AQUAC RES, V39, P200, DOI 10.1111/j.1365-2109.2007.01885.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kim BK, 2009, COMP BIOCHEM PHYS B, V153, P178, DOI 10.1016/j.cbpb.2009.02.013; Kim WJ, 2011, MAR BIOTECHNOL, V13, P127, DOI 10.1007/s10126-010-9280-4; Kuballa Anna, 2007, Bulletin of Fisheries Research Agency, P53; Lee HJ, 2013, GENES GENOM, V35, P77, DOI 10.1007/s13258-013-0062-z; Leekitcharoenphon Pimlapas, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-295; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li C., 2012, PLOS ONE, V7; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liu Y, 2013, FISH SHELLFISH IMMUN, V34, P652, DOI 10.1016/j.fsi.2012.12.002; Liu YA, 2011, FISH SHELLFISH IMMUN, V30, P583, DOI 10.1016/j.fsi.2010.12.005; Liu YG, 2012, BIOCHEM SYST ECOL, V41, P91, DOI 10.1016/j.bse.2011.12.024; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Ma KY, 2012, PLOS ONE, V7; Marti SM, 2010, SPAN J AGRIC RES, V8, P53, DOI 10.5424/sjar/2010081-1162; McPherron AC, 1997, REGULATION SKELETAL; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Tangprasittipap A, 2010, AQUACULTURE, V307, P150, DOI 10.1016/j.aquaculture.2010.07.008; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Wang HX, 2012, AQUACULT INT, V20, P649, DOI 10.1007/s10499-011-9493-1; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P331, DOI 10.1016/j.fsi.2011.11.025; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XL, 2010, COMP BIOCHEM PHYS B, V155, P327, DOI 10.1016/j.cbpb.2009.12.001; Wei Q, 2013, CONSERV GENET RESOUR, V5, P511, DOI 10.1007/s12686-012-9840-1; Xu QH, 2012, CELL STRESS CHAPERON, V17, P589, DOI 10.1007/s12192-012-0334-6; Xu QH, 2010, J EXP MAR BIOL ECOL, V394, P105, DOI 10.1016/j.jembe.2010.08.002; Yamauchi MM, 2003, GENE, V311, P129, DOI 10.1016/S0378-1119(03)00582-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu C, 2006, OCEANOLOGIA LIMNOLOG, V37, P60; Yu CG, 2003, J ZHEJIANG OCEAN U, V22, P108; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhao X., 2012, PLOS ONE, V7; Zhu XJ, 2005, COMP BIOCHEM PHYS B, V140, P599, DOI 10.1016/j.cbpc.2004.12.010	78	66	70	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94055	10.1371/journal.pone.0094055	http://dx.doi.org/10.1371/journal.pone.0094055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722690	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100037
J	Jian, WX; Peng, WH; Xiao, SM; Li, HL; Jin, J; Qin, L; Dong, Y; Su, Q				Jian, Weixia; Peng, Wenhui; Xiao, Sumei; Li, Hailing; Jin, Jie; Qin, Li; Dong, Yan; Su, Qing			Role of Serum Vaspin in Progression of Type 2 Diabetes: A 2-Year Cohort Study	PLOS ONE			English	Article							INSULIN SENSITIVITY; ADIPOSE-TISSUE; CIRCULATING VASPIN; ADIPOKINE VASPIN; GENE-EXPRESSION; ADIPONECTIN; RESISTANCE; WOMEN; SECRETION; OBESITY	Vaspin is a novel adipocytokine that has potential insulin-sensitizing effects. The aim of this study is to explore the role of vaspin in the progression of type 2 diabetes mellitus (T2DM) in humans through a longitudinal process. This was a 2-year follow-up study that included 132 patients with T2DM and 170 non-diabetic subjects. The serum vaspin and adiponectin levels were determined with ELISA. Anthropometric measurements, circulating glucose, hemoglobin A1c, insulin level, liver function, kidney function, and lipid profile were measured for each participant. The new onset of T2DM was counted in nondiabetic subjects and the glycemic control was analyzed in T2DM patients at follow-up. At enrollment, the serum vaspin and adiponectin levels were lower in T2DM patients compared with non-diabetic subjects. Significant positive correlation between serum vaspin and HDL-C levels (r = 0.23, P = 0.006) was observed in non-diabetic controls. The serum vaspin concentration was also significantly correlated with body mass index (BMI) (r = 0.19, P = 0.028), waist-hip ratio (WHR) (r = 0.17, P = 0.035) and homeostasis model assessment of insulin resistance (HOMA-IR) (r = 0.14, P = 0.029) in T2DM patients. In cohort analyses, it was found that lower serum vaspin [odds ratio (OR) = 0.52, 95% confidence interval (CI): 0.10-0.87, P = 0.015] and adiponectin (OR = 0.35, 95% CI: 0.20-0.72, P = 0.015) levels at baseline were risk factors for new onset of T2DM at follow-up. The percentage of insulin treatment in T2DM patients was higher in the sub-group with lower serum vaspin level than that in the sub-group with higher vaspin level at follow-up (55.3% vs. 44.7%, P = 0.020). Our study indicates that low serum concentration of vaspin is a risk factor for the progression of T2DM.	[Jian, Weixia; Jin, Jie; Qin, Li; Dong, Yan; Su, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Xinhua Hosp, Shanghai 200030, Peoples R China; [Peng, Wenhui; Li, Hailing] Tongji Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Xiao, Sumei] Univ Hong Kong, Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Tongji University; University of Hong Kong	Su, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Xinhua Hosp, Shanghai 200030, Peoples R China.	suqingxinhua@163.com			National Natural Science Foundation of China [30900699]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from National Natural Science Foundation of China (No. 30900699). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2011, METABOLISM, V60, P544, DOI 10.1016/j.metabol.2010.05.008; Auguet T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-60; Aust G, 2009, ATHEROSCLEROSIS, V204, P262, DOI 10.1016/j.atherosclerosis.2008.08.028; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cakal E, 2011, GYNECOL ENDOCRINOL, V27, P491, DOI 10.3109/09513590.2010.501874; Choi SH, 2011, CLIN ENDOCRINOL, V75, P628, DOI 10.1111/j.1365-2265.2011.04095.x; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Fagerberg B, 2011, J INTERN MED, V269, P636, DOI 10.1111/j.1365-2796.2010.02336.x; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Genc H, 2011, SCAND J GASTROENTERO, V46, P1355, DOI 10.3109/00365521.2011.603163; Giomisi A, 2011, EUR J ENDOCRINOL, V164, P579, DOI 10.1530/EJE-10-1020; Grimaldi A, 1999, Rev Prat, V49, P16; Gulcelik NE, 2009, EUR J ENDOCRINOL, V160, P65, DOI 10.1530/EJE-08-0723; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Korner A, 2011, INT J OBESITY, V35, P578, DOI 10.1038/ijo.2010.196; Li HL, 2011, CLIN CHEM LAB MED, V49, P1547, DOI 10.1515/CCLM.2011.236; Li YY, 2012, DIABETES-METAB RES, V28, P349, DOI 10.1002/dmrr.2277; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Seeger J, 2008, J CLIN ENDOCR METAB, V93, P247, DOI 10.1210/jc.2007-1853; Shaker OG, 2013, MOL CELL BIOCHEM, V373, P229, DOI 10.1007/s11010-012-1494-5; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Suleymanoglu S, 2009, DIABETES RES CLIN PR, V84, P325, DOI 10.1016/j.diabres.2009.03.008; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; von Loeffelholz C, 2010, EUR J ENDOCRINOL, V162, P507, DOI 10.1530/EJE-09-0737; Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI 10.1517/13543784.17.3.327 ; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045	35	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94763	10.1371/journal.pone.0094763	http://dx.doi.org/10.1371/journal.pone.0094763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732788	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400094
J	Pryshliak, M; Hammerl, JA; Reetz, J; Strauch, E; Hertwig, S				Pryshliak, Mark; Hammerl, Jens A.; Reetz, Jochen; Strauch, Eckhard; Hertwig, Stefan			Vibrio vulnificus Phage PV94 Is Closely Related to Temperate Phages of V. cholerae and Other Vibrio Species	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIOPHAGE-P2 DNA-REPLICATION; A-PROTEIN; OYSTERS; TRANSPOSON; DATABASE; SITE	Background: Vibrio vulnificus is an important pathogen which can cause serious infections in humans. Yet, there is limited knowledge on its virulence factors and the question whether temperate phages might be involved in pathogenicity, as is the case with V. cholerae. Thus far, only two phages (SSP002 and VvAW1) infecting V. vulnificus have been genetically characterized. These phages were isolated from the environment and are not related to Vibrio cholerae phages. The lack of information on temperate V. vulnificus phages prompted us to isolate those phages from lysogenic strains and to compare them with phages of other Vibrio species. Results: In this study the temperate phage PV94 was isolated from a V. vulnificus biotype 1 strain by mitomycin C induction. PV94 is a myovirus whose genome is a linear double-stranded DNA of 33,828 bp with 5'-protruding ends. Sequence analysis of PV94 revealed a modular organization of the genome. The left half of the genome comprising the immunity region and genes for the integrase, terminase and replication proteins shows similarites to V. cholerae kappa phages whereas the right half containing genes for structural proteins is closely related to a prophage residing in V. furnissii NCTC 11218. Conclusion: We present the first genomic sequence of a temperate phage isolated from a human V. vulnificus isolate. The sequence analysis of the PV94 genome demonstrates the wide distribution of closely related prophages in various Vibrio species. Moreover, the mosaicism of the PV94 genome indicates a high degree of horizontal genetic exchange within the genus Vibrio, by which V. vulnificus might acquire virulence-associated genes from other species.	[Pryshliak, Mark; Hammerl, Jens A.; Reetz, Jochen; Strauch, Eckhard; Hertwig, Stefan] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Federal Institute for Risk Assessment	Hertwig, S (corresponding author), Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	stefan.hertwig@bfr.bund.de	Hammerl, Jens Andre/Y-6406-2018	Hammerl, Jens Andre/0000-0002-6930-4358	Federal Ministry of Education and Research (VibrioNet, BMBF) [01KI1015A]; Federal Ministry of Education and Research (SiLeBAT) [13N11202]	Federal Ministry of Education and Research (VibrioNet, BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Education and Research (SiLeBAT)	This work was supported by the Federal Ministry of Education and Research (VibrioNet, BMBF grant 01KI1015A). The work of JAH was supported by a grant of the Federal Ministry of Education and Research (SiLeBAT, project no. 13N11202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Bellstein F, 2008, VIROLOGY, V373, P25, DOI 10.1016/j.virol.2007.11.016; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P3119, DOI 10.1093/nar/21.13.3119; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Daniels NA, 2011, CLIN INFECT DIS, V52, P788, DOI 10.1093/cid/ciq251; DePaola A, 1998, APPL ENVIRON MICROB, V64, P346; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; FUNNELL BE, 1983, J MOL BIOL, V167, P311, DOI 10.1016/S0022-2836(83)80338-6; Gulig PA, 2005, J MICROBIOL, V43, P118; Harwood VJ, 2004, J MICROBIOL METH, V59, P301, DOI 10.1016/j.mimet.2004.08.001; Hertwig S, 2003, J MOL BIOL, V331, P605, DOI 10.1016/S0022-2836(03)00763-0; Kapfhammer D, 2002, J BACTERIOL, V184, P6592, DOI 10.1128/JB.184.23.6592-6601.2002; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Lee HS, 2012, J VIROL, V86, P7711, DOI 10.1128/JVI.00972-12; LIU YF, 1994, NUCLEIC ACIDS RES, V22, P5204, DOI 10.1093/nar/22.24.5204; Lux TM, 2011, J BACTERIOL, V193, P1487, DOI 10.1128/JB.01512-10; Nigro OD, 2012, STAND GENOMIC SCI, V6, P415, DOI 10.4056/sigs.2846206; Odegrip R, 2001, J MOL BIOL, V308, P147, DOI 10.1006/jmbi.2001.4607; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; PELON W, 1995, CURR MICROBIOL, V30, P331, DOI 10.1007/BF00369859; Reidl J, 1995, MOL MICROBIOL, V18, P685, DOI 10.1111/j.1365-2958.1995.mmi_18040685.x; Sambrook J, 2001, MOL CLONING LAB MANU; Strauch E, 2000, J BIOTECHNOL, V79, P63, DOI 10.1016/S0168-1656(00)00216-9; Villa AA, 2012, J VIROL, V86, P13851, DOI 10.1128/JVI.02666-12; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990	28	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94707	10.1371/journal.pone.0094707	http://dx.doi.org/10.1371/journal.pone.0094707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732980	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400079
J	Smith, KLJ; Saini, D; Bardarov, S; Larsen, M; Frothingham, R; Gandhi, NR; Jacobs, WR; Sturm, AW; Lee, S				Smith, Kristen L. Jurcic; Saini, Divey; Bardarov, Svetoslav; Larsen, Michelle; Frothingham, Richard; Gandhi, Neel R.; Jacobs, William R., Jr.; Sturm, A. Willem; Lee, Sunhee			Reduced Virulence of an Extensively Drug-Resistant Outbreak Strain of Mycobacterium tuberculosis in a Murine Model	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SOUTH-AFRICA; FITNESS COST; TRANSMISSION; F15/LAM4/KZN; EMERGENCE; EVOLUTION; FAMILY; SPREAD	Bacterial drug resistance is often associated with a fitness cost. Large outbreaks of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB have been described that predominately affect persons with HIV infection. We obtained four closely-related Mycobacterium tuberculosis strains (genotype F15/LAM4/KZN) from an outbreak in KwaZulu-Natal (KZN), South Africa, including drug-sensitive, MDR, and XDR clinical isolates. We compared the virulence of these strains in a murine model of aerosol M. tuberculosis infection for four phenotypes: (1) competitive in vivo growth in lung and spleen, (2) non-competitive in vivo growth in lung and spleen, (3) murine survival time, and (4) lung pathology. When mixtures of sensitive, MDR, and XDR KZN strains were aerosolized (competitive model), lung CFUs were similar at 60 days after infection, and spleen CFUs were ordered as follows: sensitive > MDR > XDR. When individual strains were aerosolized (noncompetitive model), modest differences in lung and spleen CFUs were observed with the same ordering. C57BL/6, C3H/FeJ, and SCID mice all survived longer after infection with MDR as compared to sensitive strains. SCID mice infected with an XDR strain survived longer than those infected with MDR or sensitive strains. Lung pathology was reduced after XDR TB infection compared to sensitive or MDR TB infection. In summary, increasing degrees of drug resistance were associated with decreasing murine virulence in this collection of KZN strains as measured by all four virulence phenotypes. The predominance of HIV-infected patients in MDR and XDR TB outbreaks may be explained by decreased virulence of these strains in humans.	[Smith, Kristen L. Jurcic; Saini, Divey; Frothingham, Richard; Lee, Sunhee] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA; [Bardarov, Svetoslav] South Nassau Communities Hosp, Oceanside, NY USA; [Larsen, Michelle; Jacobs, William R., Jr.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Sturm, A. Willem] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa	Duke University; Yeshiva University; Albert Einstein College of Medicine; Emory University; Rollins School Public Health; University of Kwazulu Natal	Lee, S (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA.	sunhee.lee@duke.edu		Jacobs, William/0000-0003-3321-3080	National Institute of Health [U54 AI057157, UC6 AI058607]; Duke Center for Translational Research [P30 AI051445]; Center for AIDS Research at Emory University [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063537, P30AI051445, P30AI050409, R01AI089349, UC6AI058607, U54AI057157, R01AI087465] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Center for Translational Research; Center for AIDS Research at Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health grants U54 AI057157 (Southeast Regional Center of Excellence for Emerging Infections and Biodefense), UC6 AI058607 (Regional Biocontainment Laboratory at Duke), and by P30 AI051445 (Duke Center for Translational Research). NRG is supported in part by the Center for AIDS Research at Emory University (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Ashiru OT, 2010, J MED MICROBIOL, V59, P528, DOI 10.1099/jmm.0.016006-0; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Heysell SK, 2010, EMERG INFECT DIS, V16, P557, DOI 10.3201/eid1603.091486; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Li JH, 2007, J PUBLIC HEALTH MAN, V13, P252; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Motiwala AS, 2010, J INFECT DIS, V201, P881, DOI 10.1086/650999; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007; Saini D, 2011, J PHARMACOL TOX MET, V63, P143, DOI 10.1016/j.vascn.2010.09.002; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; World Health Organization, 2010, MED EL CRIT CONTR US, P15; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	35	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94953	10.1371/journal.pone.0094953	http://dx.doi.org/10.1371/journal.pone.0094953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733050	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400136
J	Torres, ECN; Yang, BX; Janardhanan, R; Brahmbhatt, A; Leof, E; Mukhopadhyay, D; Misra, S				Torres, Evelyn C. Nieves; Yang, Binxia; Janardhanan, Rajiv; Brahmbhatt, Akshaar; Leof, Ed; Mukhopadhyay, Debabrata; Misra, Sanjay			Adventitial Delivery of Lentivirus-shRNA-ADAMTS-1 Reduces Venous Stenosis Formation in Arteriovenous Fistula	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; INCREASED EXPRESSION; HEMATOPOIETIC-CELLS; HEMODIALYSIS; ADAMTS-1; VEGF; HYPERPLASIA; DISINTEGRIN; PROTEIN; FAMILY	Hemodialysis vascular access can develop venous neointimal hyperplasia (VNH) causing stenosis. Recent clinical and experimental data has demonstrated that there is increased expression of a disintegrin and metalloproteinase thrombospondin motifs-1 (ADAMTS-1) at site of VNH. The experiments outlined in the present paper were designed to test the hypothesis that targeting of the adventitia of the outflow vein of murine arteriovenous fistula (AVF) using a small hairpin RNA that inhibits ADAMTS-1 expression (LV-shRNA-ADAMTS-1) at the time of fistula creation will decrease VNH. At early time points, ADAMTS-1 expression was significantly decreased associated with a reduction in vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase-9 (MMP-9) (LV-shRNA-ADAMTS-1 transduced vessels vs. controls). These changes in gene and protein expression resulted in favorable vascular remodeling with a significant increase in mean lumen vessel area, decrease in media/adventitia area, with a significant increase in TUNEL staining accompanied with a decrease in cellular proliferation accompanied with a reduction in CD68 staining. Collectively, these results demonstrate that ADAMTS-1 transduced vessels of the outflow vein of AVF have positive vascular remodeling.	[Torres, Evelyn C. Nieves; Yang, Binxia; Janardhanan, Rajiv; Brahmbhatt, Akshaar; Misra, Sanjay] Mayo Clin, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Rochester, MN 55905 USA; [Leof, Ed; Mukhopadhyay, Debabrata; Misra, Sanjay] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Misra, S (corresponding author), Mayo Clin, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Rochester, MN 55905 USA.	misra.sanjay@mayo.edu			National Heart, Lung, and Blood Institute [R01HL098967]; Society of Interventional Radiology Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Society of Interventional Radiology Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a R01HL098967 (SM) from the National Heart, Lung, and Blood Institute, Society of Interventional Radiology Foundation (RJ), and Howard Hughes Medical Institute (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese TA, 1998, SURGERY, V124, P328, DOI 10.1016/S0039-6060(98)70138-2; [Anonymous], 1996, COMM; [Anonymous], 2006, NATL KIDNEY FDN NKF; Ashlin TG, 2013, CYTOKINE, V64, P234, DOI 10.1016/j.cyto.2013.06.315; Baboolal K, 1998, AM J KIDNEY DIS, V31, P971, DOI 10.1053/ajkd.1998.v31.pm9631841; Cheema AN, 2006, J AM COLL CARDIOL, V47, P1067, DOI 10.1016/j.jacc.2005.08.076; Chen M, 2007, NEPHROL DIAL TRANSPL, V22, P139, DOI 10.1093/ndt/gfl509; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Fu YN, 2011, J HISTOCHEM CYTOCHEM, V59, P463, DOI 10.1369/0022155411401748; Janardhanan R, 2013, SIMVASTATIN REDUCES; Janardhanan R, 2013, KIDNEY INT, V84, P338, DOI 10.1038/ki.2013.112; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; KATOH O, 1995, CANCER RES, V55, P5687; Katoh O, 1998, CANCER RES, V58, P5565; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Lee CW, 2011, J CLIN PATHOL, V64, P399, DOI 10.1136/jcp.2010.088484; Li L, 2007, NEPHROL DIAL TRANSPL, V22, P3139, DOI 10.1093/ndt/gfm415; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Misra S, 2005, KIDNEY INT, V68, P2890, DOI 10.1111/j.1523-1755.2005.00763.x; Misra S, 2010, J VASC INTE IN PRESS; Misra S, 2008, AM J PHYSIOL-HEART C, V294, pH2219, DOI 10.1152/ajpheart.00650.2007; Misra S, 2008, J VASC INTERV RADIOL, V19, P587, DOI 10.1016/j.jvir.2008.01.005; Misra S, 2008, J VASC INTERV RADIOL, V19, P252, DOI 10.1016/j.jvir.2007.10.031; Misra S, 2008, J VASC INTERV RADIOL, V19, P111, DOI 10.1016/j.jvir.2007.08.040; Misra S, 2010, J VASC INTERV RADIOL, V21, P1255, DOI 10.1016/j.jvir.2010.02.043; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Rooijens PPGM, 2004, EUR J VASC ENDOVASC, V28, P583, DOI 10.1016/j.ejvs.2004.08.014; Rotmans JI, 2004, J VASC SURG, V39, P432, DOI 10.1016/j.jvs.2003.07.009; SULLIVAN KL, 1993, RADIOLOGY, V186, P867, DOI 10.1148/radiology.186.3.8430200; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Xu ZH, 2006, INVEST OPHTH VIS SCI, V47, P4059, DOI 10.1167/iovs.05-1528; Yang B, 2013, ADVENTITIAL TRANSDUC; Yang BX, 2009, J VASC INTERV RADIOL, V20, P946, DOI 10.1016/j.jvir.2009.03.044	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94510	10.1371/journal.pone.0094510	http://dx.doi.org/10.1371/journal.pone.0094510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732590	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400045
J	Ulzurrun, E; Stephens, C; Ruiz-Cabello, F; Robles-Diaz, M; Saenz-Lopez, P; Hallal, H; Soriano, G; Roman, E; Fernandez, MC; Lucena, MI; Andrade, RJ				Ulzurrun, Eugenia; Stephens, Camilla; Ruiz-Cabello, Francisco; Robles-Diaz, Mercedes; Saenz-Lopez, Pablo; Hallal, Hacibe; Soriano, German; Roman, Eva; Carmen Fernandez, M.; Isabel Lucena, M.; Andrade, Raul J.			Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort	PLOS ONE			English	Article							INDUCED LIVER-INJURY; MULTIDRUG-RESISTANCE; PLASMA-MEMBRANE; TRANSPORTER; HAPLOTYPES; SUSCEPTIBILITY; VARIANTS; PHARMACOGENETICS; VARIABILITY; EXPRESSION	Background and Aims: Flawed ABC transporter functions may contribute to increased risk of drug-induced liver injury (DILI). We aimed to analyse the influence of genetic variations in ABC transporters on the risk of DILI development and clinical presentations in a large Spanish DILI cohort. Methods: A total of ten polymorphisms in ABCB1 (1236T>C, 2677G>T, A, 3435T>C), ABCB4 (1954A>G) and ABCC2 (-1774G>del, -1549A>G, -24C>T, 1249G>A, 3972C>T and 4544G>A) were genotyped using Taqman 59 allelic discrimination assays or sequencing in 141 Spanish DILI patients and 161 controls. The influence of specific genotypes, alleles and haplotypes on the risk of DILI development and clinical presentations was analysed. Results: None of the individual polymorphisms or haplotypes was found to be associated with DILI development. Carriers homozygous for the ABCC2 -1774del allele were however only found in DILI patients. Hence, this genotype could potentially be associated with increased risk, though its low frequency in our Spanish cohort prevented a final conclusion. Furthermore, carriers homozygous for the ABCC2 -1774G/-1549A/-24T/1249G/3972T/4544G haplotype were found to have a higher propensity for total bilirubin elevations when developing DILI. Conclusions: Our findings do not support a role for the analysed polymorphisms in the ABCB1, ABCB4 and ABCC2 transporter genes in DILI development in Spanish patients. The ABCC2 -1774deldel genotype was however restricted to DILI cases and could potentially contribute to enhanced DILI susceptibility.	[Ulzurrun, Eugenia; Stephens, Camilla; Robles-Diaz, Mercedes; Isabel Lucena, M.; Andrade, Raul J.] Univ Malaga, Farmacol Clin S, E-29071 Malaga, Spain; [Ulzurrun, Eugenia; Stephens, Camilla; Robles-Diaz, Mercedes; Isabel Lucena, M.; Andrade, Raul J.] Univ Malaga, UGC Gastroenterol & Hepatol, Inst Invest Biomed Malaga IBIMA, Hosp Univ Virgen de la Victoria, E-29071 Malaga, Spain; [Ulzurrun, Eugenia; Stephens, Camilla; Robles-Diaz, Mercedes; Soriano, German; Roman, Eva; Isabel Lucena, M.; Andrade, Raul J.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Ruiz-Cabello, Francisco; Saenz-Lopez, Pablo] Univ Granada, Hosp Univ de las Virgen Nieves, Dept Bioquim & Biol Mol Inmunol 3, Granada, Spain; [Ruiz-Cabello, Francisco] Inst Invest Biosanitario Granada, Granada, Spain; [Hallal, Hacibe] Hosp Morales Meseguer, Serv Aparato Digest, Murcia, Spain; [Soriano, German; Roman, Eva] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Gastroenterol, E-08193 Barcelona, Spain; [Roman, Eva] Univ Autonoma Barcelona, Escola Univ Infermeria EUI St Pau, E-08193 Barcelona, Spain; [Carmen Fernandez, M.] Hosp Torrecardenas, Unidad Gest Clin Farm, Almeria, Spain	Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Torrecardenas	Lucena, MI (corresponding author), Univ Malaga, Farmacol Clin S, E-29071 Malaga, Spain.	lucena@uma.es	Ruiz-Cabello, Francisco/ABG-8828-2020; Roman, Eva/P-2377-2016	Ruiz-Cabello, Francisco/0000-0002-2247-3293; Andrade Bellido, Raul Jesus/0000-0002-1565-0757; Roman, Eva/0000-0001-9084-8555; Lucena Gonzalez, Maria Isabel/0000-0001-9586-4896; Soriano, German/0000-0002-9267-6811; Robles Diaz, Mercedes/0000-0002-2365-2787	Agencia Espanola del Medicamento; Fondo de Investigacion Sanitaria [PS 09/01384]; Instituto de Salud Carlos III	Agencia Espanola del Medicamento; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported, in part, by research grants from the Agencia Espanola del Medicamento and Fondo de Investigacion Sanitaria (PS 09/01384). CIBERehd and Red Genomica del Cancer are funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse AJLHJ, 2008, PHARMACOGENET GENOM, V18, P299, DOI 10.1097/FPC.0b013e3282f70458; Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58; Andrade RJ, 2009, PHARMACOGENOMICS, V10, P1467, DOI [10.2217/pgs.09.111, 10.2217/PGS.09.111]; Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006; BENICHOU C, 1990, J HEPATOL, V11, P272; Bodor M, 2005, AAPS J, V7, pE1, DOI 10.1208/aapsj070101; Choi JH, 2007, PHARMACOGENET GENOM, V17, P403, DOI 10.1097/01.fpc.0000236337.41799.b3; Ciccacci C, 2010, PHARMACOGENOMICS, V11, P23, DOI 10.2217/PGS.09.142; Daly AK, 2007, GASTROENTEROLOGY, V132, P272, DOI 10.1053/j.gastro.2006.11.023; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Haas DW, 2006, CLIN INFECT DIS, V43, P783, DOI 10.1086/507097; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Jeannesson E, 2007, FUND CLIN PHARMACOL, V21, P411, DOI 10.1111/j.1472-8206.2007.00507.x; Kamisako T, 1999, J GASTROEN HEPATOL, V14, P405, DOI 10.1046/j.1440-1746.1999.01886.x; Kim SH, 2012, TUBERCULOSIS, V92, P100, DOI 10.1016/j.tube.2011.09.007; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Laechelt S, 2011, PHARMACOGENOMICS J, V11, P25, DOI 10.1038/tpj.2010.20; Lang T, 2006, DRUG METAB DISPOS, V34, P1582, DOI 10.1124/dmd.105.008854; Lee YMA, 2004, PHARMACOGENETICS, V14, P213, DOI 10.1097/00008571-200404000-00001; Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67; Livak Kenneth J, 2003, Methods Mol Biol, V212, P129; Meier Y, 2006, HEPATOLOGY, V44, P62, DOI 10.1002/hep.21214; Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Pachkoria K, 2007, BRIT J PHARMACOL, V150, P808, DOI 10.1038/sj.bjp.0707122; Ritchie MD, 2006, CLIN INFECT DIS, V43, P779, DOI 10.1086/507101; Sai K, 2008, DRUG METAB PHARMACOK, V23, P139, DOI 10.2133/dmpk.23.139; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Stapelbroek JM, 2010, J HEPATOL, V52, P258, DOI 10.1016/j.jhep.2009.11.012; Takikawa Hajime, 2002, J Hepatobiliary Pancreat Surg, V9, P443, DOI 10.1007/s005340200055; Ulzurrun E, 2013, LIVER INT, V33, P1378, DOI 10.1111/liv.12193; Urban TJ, 2012, PHARMACOGENET GENOM, V22, P784, DOI 10.1097/FPC.0b013e3283589a76; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94675	10.1371/journal.pone.0094675	http://dx.doi.org/10.1371/journal.pone.0094675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732756	gold, Green Published			2022-12-25	WOS:000336970400067
J	Wampfler, PB; Tosevski, V; Nanni, P; Spycher, C; Hehl, AB				Wampfler, Petra B.; Tosevski, Vinko; Nanni, Paolo; Spycher, Cornelia; Hehl, Adrian B.			Proteomics of Secretory and Endocytic Organelles in Giardia lamblia	PLOS ONE			English	Article							CYST WALL PROTEINS; PRIMITIVE EUKARYOTE; ANCIENT EUKARYOTE; PERIPHERAL VACUOLES; ANTIGENIC VARIATION; GRANULE BIOGENESIS; ENCYSTATION; VESICLES; IDENTIFICATION; INTESTINALIS	Giardia lamblia is a flagellated protozoan enteroparasite transmitted as an environmentally resistant cyst. Trophozoites attach to the small intestine of vertebrate hosts and proliferate by binary fission. They access nutrients directly via uptake of bulk fluid phase material into specialized endocytic organelles termed peripheral vesicles (PVs), mainly on the exposed dorsal side. When trophozoites reach the G2/M restriction point in the cell cycle they can begin another round of cell division or encyst if they encounter specific environmental cues. They induce neogenesis of Golgi-like organelles, encystation-specific vesicles (ESVs), for regulated secretion of cyst wall material. PVs and ESVs are highly simplified and thus evolutionary diverged endocytic and exocytic organelle systems with key roles in proliferation and transmission to a new host, respectively. Both organelle systems physically and functionally intersect at the endoplasmic reticulum (ER) which has catabolic as well as anabolic functions. However, the unusually high degree of sequence divergence in Giardia rapidly exhausts phylogenomic strategies to identify and characterize the molecular underpinnings of these streamlined organelles. To define the first proteome of ESVs and PVs we used a novel strategy combining flow cytometry-based organelle sorting with in silico filtration of mass spectrometry data. From the limited size datasets we retrieved many hypothetical but also known organelle-specific factors. In contrast to PVs, ESVs appear to maintain a strong physical and functional link to the ER including recruitment of ribosomes to organelle membranes. Overall the data provide further evidence for the formation of a cyst extracellular matrix with minimal complexity. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium with the dataset identifier PXD000694.	[Wampfler, Petra B.; Spycher, Cornelia; Hehl, Adrian B.] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Tosevski, Vinko] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Nanni, Paolo] Funct Genom Ctr Zurich, Zurich, Switzerland; [Spycher, Cornelia] Univ Bern, Inst Parasitol, Bern, Switzerland	University of Zurich; University of Zurich; University of Bern	Spycher, C (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	cornelia.spycher@vetsuisse.unibe.ch; adrian.hehl@access.uzh.ch		Nanni, Paolo/0000-0001-8429-3557; Spycher, Cornelia/0000-0002-7579-9668; Hehl, Adrian/0000-0002-2110-4445	Swiss National Science Foundation [31003A-125389, 31003A_140803, PZ00P3_132120]; Forschungsforderung der Universitat Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungsforderung der Universitat Zurich	This work was funded by Swiss National Science Foundation grants #31003A-125389 and 31003A_140803 to ABH. PW was the recipient of a fellowship for graduate studies from the "Forschungsforderung der Universitat Zurich". CS was funded by Ambizione Grant #PZ00P3_132120 of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Wahid A, 2004, BIOCHEM BIOPH RES CO, V324, P1069, DOI 10.1016/j.bbrc.2004.09.167; Abodeely M, 2009, EUKARYOT CELL, V8, P1665, DOI 10.1128/EC.00123-09; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Aguilar RM, 1999, ANAL BIOCHEM, V267, P344, DOI 10.1006/abio.1998.3018; Banerjee S, 2008, MOL BIOCHEM PARASIT, V159, P44, DOI 10.1016/j.molbiopara.2008.01.004; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Birkeland SR, 2010, MOL BIOCHEM PARASIT, V174, P62, DOI 10.1016/j.molbiopara.2010.05.010; BOCKMAN DE, 1968, J PROTOZOOL, V15, P26, DOI 10.1111/j.1550-7408.1968.tb02085.x; Brunner Y, 2009, MASS SPECTROM REV, V28, P844, DOI 10.1002/mas.20211; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Castillo-Romero A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000697; Chatterjee A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001059; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Dacks JB, 2008, PARASITOL INT, V57, P97, DOI 10.1016/j.parint.2007.11.004; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Davids BJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000044; Davids BJ, 2004, MOL BIOCHEM PARASIT, V136, P173, DOI 10.1016/j.molbiopara.2004.03.011; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Elias EV, 2008, J BIOL CHEM, V283, P35996, DOI 10.1074/jbc.M806545200; Faso C, 2012, CELLULAR MICROBIOLOG; Faso C, 2013, PLOS ONE IN PRESS; Faso C, 2011, INT J PARASITOL, V41, P471, DOI 10.1016/j.ijpara.2010.12.014; FEELY DE, 1987, J PROTOZOOL, V34, P80, DOI 10.1111/j.1550-7408.1987.tb03137.x; Jimenez-Garcia LF, 2008, INT J PARASITOL, V38, P1297, DOI 10.1016/j.ijpara.2008.04.012; Gaechter V, 2008, TRAFFIC, V9, P57, DOI 10.1111/j.1600-0854.2007.00657.x; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Gerwig GJ, 2002, GLYCOBIOLOGY, V12, P499, DOI 10.1093/glycob/cwf059; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Hong W., 2013, TRENDS CELL BIOL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JARROLL EL, 1989, MOL BIOCHEM PARASIT, V32, P121, DOI 10.1016/0166-6851(89)90063-7; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Jerlstrom-Hultqvist J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3493; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Konrad C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000835; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Lanfredi-Rangel A, 2003, J STRUCT BIOL, V143, P153, DOI 10.1016/S1047-8477(03)00123-0; Lee YH, 2010, PROTEOMICS, V10, P3935, DOI 10.1002/pmic.201000289; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; LINDMARK DG, 1988, EXP PARASITOL, V65, P141, DOI 10.1016/0014-4894(88)90116-6; Lopez AB, 2007, J EUKARYOT MICROBIOL, V54, P154, DOI 10.1111/j.1550-7408.2007.00246.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; MACECHKO PT, 1992, MOL BIOCHEM PARASIT, V56, P301, DOI 10.1016/0166-6851(92)90179-N; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; MCCAFFERY JM, 1994, EXP PARASITOL, V79, P236, DOI 10.1006/expr.1994.1087; Morf L, 2010, EUKARYOT CELL, V9, P1566, DOI 10.1128/EC.00100-10; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NASH TE, 1989, EXP PARASITOL, V68, P238, DOI 10.1016/0014-4894(89)90104-5; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; REINER DS, 1990, EUR J CELL BIOL, V53, P142; Rivero MR, 2011, MOL MICROBIOL, V79, P1204, DOI 10.1111/j.1365-2958.2010.07512.x; Rivero MR, 2010, BIOCHEM J, V428, P33, DOI 10.1042/BJ20100096; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Soltys BJ, 1996, J CELL SCI, V109, P1909; Stefanic S, 2006, J BIOL CHEM, V281, P7595, DOI 10.1074/jbc.M510940200; Stefanic S, 2009, J CELL SCI, V122, P2846, DOI 10.1242/jcs.049411; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Svard SG, 1998, MOL MICROBIOL, V30, P979, DOI 10.1046/j.1365-2958.1998.01125.x; Touz Maria C, 2012, Front Biosci (Elite Ed), V4, P1898; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Turkewitz AP, 2004, TRAFFIC, V5, P63, DOI 10.1046/j.1600-0854.2003.00155.x; Vazquez-Martinez R, 2012, GEN COMP ENDOCR, V175, P1, DOI 10.1016/j.ygcen.2011.08.017; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; Ward W, 1997, CELL, V89, P437, DOI 10.1016/S0092-8674(00)80224-X	75	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94089	10.1371/journal.pone.0094089	http://dx.doi.org/10.1371/journal.pone.0094089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732305	Green Published, gold, Green Accepted			2022-12-25	WOS:000336970400019
J	Wurzbacher, C; Rosel, S; Rychla, A; Grossart, HP				Wurzbacher, Christian; Roesel, Stefan; Rychla, Anna; Grossart, Hans-Peter			Importance of Saprotrophic Freshwater Fungi for Pollen Degradation	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; DISSOLVED ORGANIC-CARBON; MICROBIAL COMMUNITY; MOLECULAR DIVERSITY; PARASITIC CHYTRIDS; ZOOSPORIC FUNGI; DECAYING LEAVES; RIBOSOMAL DNA; LEAF-LITTER; SOIL-PH	Fungi and bacteria are the major organic matter (OM) decomposers in aquatic ecosystems. While bacteria are regarded as primary mineralizers in the pelagic zone of lakes and oceans, fungi dominate OM decomposition in streams and wetlands. Recent findings indicate that fungal communities are also active in lakes, but little is known about their diversity and interactions with bacteria. Therefore, the decomposer niche overlap of saprotrophic fungi and bacteria was studied on pollen (as a seasonally recurring source of fine particulate OM) by performing microcosm experiments with three different lake types. Special emphasis was placed on analysis of fungal community composition and diversity. We hypothesized that (I) pollen select for small saprotrophic fungi and at the same time for typical particle-associated bacteria; (II) fungal communities form specific free-living and attached sub-communities in each lake type; (III) the ratio between fungi or bacteria on pollen is controlled by the lake's chemistry. Bacteria-to-fungi ratios were determined by quantitative PCR (qPCR), and bacterial and fungal diversity were studied by clone libraries and denaturing gradient gel electrophoresis (DGGE) fingerprints. A protease assay was used to identify functional differences between treatments. For generalization, systematic differences in bacteria-to-fungi ratios were analyzed with a dataset from the nearby Baltic Sea rivers. High abundances of Chytridiomycota as well as occurrences of Cryptomycota and yeast-like fungi confirm the decomposer niche overlap of saprotrophic fungi and bacteria on pollen. As hypothesized, microbial communities consistently differed between the lake types and exhibited functional differences. Bacteria-to-fungi ratios correlated well with parameters such as organic carbon and pH. The importance of dissolved organic carbon and nitrogen for bacteria-to-fungi ratios was supported by the Baltic Sea river dataset. Our findings highlight the fact that carbon-to-nitrogen ratios may also control fungal contributions to OM decomposition in aquatic ecosystems.	[Wurzbacher, Christian; Roesel, Stefan; Rychla, Anna; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Brandenburg, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Brandenburg, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Wurzbacher, C (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Brandenburg, Germany.	christian@wurzbacher.cc			"REAL" project (Pact for innovation and research of the Gottfried Wilhelm Leibniz scientific community); German Research Foundation (DFG) [GR 1540/12-1]	"REAL" project (Pact for innovation and research of the Gottfried Wilhelm Leibniz scientific community); German Research Foundation (DFG)(German Research Foundation (DFG))	This project was financially supported by the "REAL" project (Pact for innovation and research of the Gottfried Wilhelm Leibniz scientific community) and the German Research Foundation (DFG, GR 1540/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2007, ENVIRON MICROBIOL, V9, P2728, DOI 10.1111/j.1462-2920.2007.01385.x; Allgaier M, 2006, AQUAT MICROB ECOL, V45, P115, DOI 10.3354/ame045115; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Chan OC, 2005, ENVIRON MICROBIOL, V7, P1139, DOI 10.1111/j.1462-2920.2005.00790.x; CHROST RJ, 1993, MICROBIAL ECOL, V25, P131, DOI 10.1007/BF00177191; CHROST RJ, 1989, J PLANKTON RES, V11, P223, DOI 10.1093/plankt/11.2.223; COLE JJ, 1990, LIMNOL OCEANOGR, V35, P1230, DOI 10.4319/lo.1990.35.6.1230; Czeczuga B, 2001, POL J ENVIRON STUD, V10, P89; Dangles O, 2004, J APPL ECOL, V41, P365, DOI 10.1111/j.0021-8901.2004.00888.x; DOSKEY PV, 1989, ATMOS ENVIRON, V23, P2761, DOI 10.1016/0004-6981(89)90556-8; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgcomb V, 2011, ISME J, V5, P1237, DOI 10.1038/ismej.2011.10; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eriksson M, 2003, APPL ENVIRON MICROB, V69, P275, DOI 10.1128/AEM.69.1.275-284.2003; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Findlay S, 2002, MICROB ECOL, V43, P55, DOI 10.1007/s00248-001-1020-x; FINDLAY SEG, 1989, FRESHWATER BIOL, V21, P261, DOI 10.1111/j.1365-2427.1989.tb01364.x; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fischer H, 2006, ARCH HYDROBIOL, V166, P79, DOI 10.1127/0003-9136/2006/0166-0079; Fischer H, 2009, FRESHWATER BIOL, V54, P2276, DOI 10.1111/j.1365-2427.2009.02257.x; Gleason F.H., 2009, INOCULUM, V60, P1; GOLDSTEIN S, 1960, ECOLOGY, V41, P543, DOI 10.2307/1933329; Graham MD, 2006, LIMNOL OCEANOGR, V51, P1524, DOI 10.4319/lo.2006.51.3.1524; Gude A, 2012, SOIL BIOL BIOCHEM, V47, P209, DOI 10.1016/j.soilbio.2012.01.003; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gulis V, 2003, MICROBIAL ECOL, V45, P11, DOI 10.1007/s00248-002-1032-1; Holfeld H, 1998, NEW PHYTOL, V138, P507, DOI 10.1046/j.1469-8137.1998.00126.x; Hoppe H-G, 1993, HDB METHODS AQUATIC, P423, DOI DOI 10.1201/9780203752746-49; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; Hutchison LJ, 1997, MYCOL RES, V101, P191, DOI 10.1017/S095375629600233X; James TY, 2012, BIOESSAYS, V34, P94, DOI 10.1002/bies.201100110; Jobard M, 2012, ENVIRON MICROBIOL, V14, P2480, DOI 10.1111/j.1462-2920.2012.02771.x; Johnson PTJ, 2006, FRESHWATER BIOL, V51, P634, DOI 10.1111/j.1365-2427.2006.01517.x; Jones MDM, 2011, IMA FUNGUS, V2, P173, DOI 10.5598/imafungus.2011.02.02.08; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Jorgensen NOG, 2009, HYDROBIOLOGIA, V623, P105, DOI 10.1007/s10750-008-9651-2; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2012, MICROB ECOL, V63, P358, DOI 10.1007/s00248-011-9913-9; Kagami M, 2011, HYDROBIOLOGIA, V659, P49, DOI 10.1007/s10750-010-0274-z; Kiorboe T, 2002, APPL ENVIRON MICROB, V68, P3996, DOI 10.1128/AEM.68.8.3996-4006.2002; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lefevre E, 2012, AQUAT MICROB ECOL, V67, P91, DOI 10.3354/ame01592; Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANTEL N, 1967, CANCER RES, V27, P209; Marano AV, 2011, HYDROBIOLOGIA, V659, P93, DOI 10.1007/s10750-009-0006-4; Masclaux H, 2011, LIMNOL OCEANOGR, V56, P939, DOI 10.4319/lo.2011.56.3.0939; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Mille-Lindblom C, 2006, FRESHWATER BIOL, V51, P730, DOI 10.1111/j.1365-2427.2006.01532.x; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; MULLER U, 1983, OECOLOGIA, V58, P215, DOI 10.1007/BF00399219; MUNSTER U, 1992, HYDROBIOLOGIA, V229, P225, DOI 10.1007/BF00007002; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neubert K, 2006, APPL ENVIRON MICROB, V72, P1118, DOI 10.1128/AEM.72.2.1118-1128.2006; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nikolcheva Liliya G., 2004, Mycological Progress, V3, P41, DOI 10.1007/s11557-006-0075-y; Oksanen J., 2011, VEGAN PACKAGE COMMUN; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rosel S, 2012, MICROB ECOL, V64, P571, DOI 10.1007/s00248-012-0049-3; Rosel S, 2012, AQUAT SCI, V74, P87, DOI 10.1007/s00027-011-0198-3; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sampaio A, 2007, FEMS YEAST RES, V7, P595, DOI 10.1111/j.1567-1364.2007.00218.x; Shearer CA, 2009, STUD MYCOL, P145, DOI 10.3114/sim.2009.64.08; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; SMIRNOV N. N., 1964, HYDROBIOLOGIA, V24, P421, DOI 10.1007/BF00170413; SMITH EL, 1955, J BIOL CHEM, V212, P271; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Steinberg CEW, 2008, ENVIRON SCI POLLUT R, V15, P128, DOI 10.1065/espr2007.07.434; Stepanauskas R, 1999, MICROBIAL ECOL, V38, P264, DOI 10.1007/s002489900176; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Strongman DB, 2008, BOTANY, V86, P1449, DOI 10.1139/B08-107; Stubner S, 2002, J MICROBIOL METH, V50, P155, DOI 10.1016/S0167-7012(02)00024-6; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; Van Donk E., 1992, ALGAL SYMBIOSIS PLAN, P567; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P2478; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Weiss P, 1996, APPL ENVIRON MICROB, V62, P1998, DOI 10.1128/AEM.62.6.1998-2005.1996; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wurzbacher CM, 2010, AQUAT MICROB ECOL, V59, P125, DOI 10.3354/ame01385	100	63	64	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94643	10.1371/journal.pone.0094643	http://dx.doi.org/10.1371/journal.pone.0094643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732324	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400062
J	Carrasco-Miranda, JS; Lopez-Zavala, AA; Arvizu-Flores, AA; Garcia-Orozco, KD; Stojanoff, V; Rudino-Pinera, E; Brieba, LG; Sotelo-Mundo, RR				Carrasco-Miranda, Jesus S.; Lopez-Zavala, Alonso A.; Arvizu-Flores, Aldo A.; Garcia-Orozco, Karina D.; Stojanoff, Vivian; Rudino-Pinera, Enrique; Brieba, Luis G.; Sotelo-Mundo, Rogerio R.			Crystal Structure of the Shrimp Proliferating Cell Nuclear Antigen: Structural Complementarity with WSSV DNA Polymerase PIP-Box	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; PCNA-BINDING; CLAMP; IDENTIFICATION; PROCESSIVITY; PATHOGENESIS; PROTEINS; GENE	DNA replication requires processivity factors that allow replicative DNA polymerases to extend long stretches of DNA. Some DNA viruses encode their own replicative DNA polymerase, such as the white spot syndrome virus (WSSV) that infects decapod crustaceans but still require host replication accessory factors. We have determined by X-ray diffraction the three-dimensional structure of the Pacific white leg shrimp Litopenaeus vannamei Proliferating Cell Nuclear Antigen (LvPCNA). This protein is a member of the sliding clamp family of proteins, that binds DNA replication and DNA repair proteins through a motif called PIP-box (PCNA-Interacting Protein). The crystal structure of LvPCNA was refined to a resolution of 3 angstrom, and allowed us to determine the trimeric protein assembly and details of the interactions between PCNA and the DNA. To address the possible interaction between LvPCNA and the viral DNA polymerase, we docked a theoretical model of a PIP-box peptide from the WSSV DNA polymerase within LvPCNA crystal structure. The theoretical model depicts a feasible model of interaction between both proteins. The crystal structure of shrimp PCNA allows us to further understand the mechanisms of DNA replication processivity factors in non-model systems.	[Carrasco-Miranda, Jesus S.; Lopez-Zavala, Alonso A.; Garcia-Orozco, Karina D.; Sotelo-Mundo, Rogerio R.] Ctr Invest Alimentac & Desarrollo AC, Hermosillo, Sonora, Mexico; [Arvizu-Flores, Aldo A.] Univ Sonora, Dept Ciencias Quim Biol, Hermosillo 83000, Sonora, Mexico; [Stojanoff, Vivian] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Rudino-Pinera, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Brieba, Luis G.] Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Universidad de Sonora; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Brieba, LG (corresponding author), Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	lgbrieba@langebio.cinvestav.mx; rrs@ciad.mx	stojanoff, vivian/I-7290-2012; Sotelo-Mundo, Rogerio/A-6097-2011; Brieba, Luis/I-8447-2016	stojanoff, vivian/0000-0002-6650-512X; Sotelo-Mundo, Rogerio/0000-0001-5543-6889; Brieba, Luis/0000-0002-6073-5207; Rudino-Pinera, Enrique/0000-0001-8170-6379; Arvizu-Flores, Aldo/0000-0001-9837-5625	CONACyT (Mexico's National Science and Research Council); CONACyT [CB-2009-131859, CB-2009-128647]; NIGMS [GM-0080]; US Department of Energy [DE-AC02-98CH10886]	CONACyT (Mexico's National Science and Research Council); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy(United States Department of Energy (DOE))	J.S. Carrasco-Miranda and A. A. Lopez-Zavala were supported by Ph.D. fellowships from CONACyT (Mexico's National Science and Research Council). R. Sotelo-Mundo acknowledges financial support from CONACyT grant CB-2009-131859. L. G. Brieba acknowledges financial support of CONACyT grant CB-2009-128647. We thank the staff at BNL-NSLS beamlines X4C and X6A (Dr. John Schwanoff) for data-collection facilities. Beamline X6A is funded by NIGMS (GM-0080) and the US Department of Energy (No. DE-AC02-98CH10886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bustillo-Ruiz MI, 2009, REV BIOL MAR OCEANOG, V44, P1; Cardona-Felix CS, 2011, ACTA CRYSTALLOGR D, V67, P497, DOI 10.1107/S0907444911010547; Carrasco-Miranda JS, 2012, ACTA CRYSTALLOGR F, V68; Chen LL, 2002, VIROLOGY, V301, P136, DOI 10.1006/viro.2002.1536; Chia N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010866; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; De-la-Re-Vega E, 2011, RESULTS IMMUNOLOGY; de-la-Re-Vega E, 2011, MOLECULES, V16, P532, DOI 10.3390/molecules16010532; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Li P, 2010, COMP BIOCHEM PHYS A, V157, P170, DOI 10.1016/j.cbpa.2010.06.163; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Strzalka W, 2012, J EXP BOT, V63, P2971, DOI 10.1093/jxb/ers002; Strzalka W, 2009, PROTEIN SCI, V18, P1072, DOI 10.1002/pro.117; TABOR S, 1987, J BIOL CHEM, V262, P16212; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang K, 2013, ACTA CRYSTALLOGR F, V69, P387, DOI 10.1107/S1744309113004971; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu CL, 2008, PROTEOMICS, V8, P4226, DOI 10.1002/pmic.200800177; Xie YS, 2008, COMP BIOCHEM PHYS B, V151, P225, DOI 10.1016/j.cbpb.2008.07.006; Zhuang Z, 2009, BIOCHIM BIOPHYS ACTA, V1804, P1081	42	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94369	10.1371/journal.pone.0094369	http://dx.doi.org/10.1371/journal.pone.0094369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728082	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200067
J	Li, WZ; Wang, J; Long, R; Su, GH; Bukhory, DK; Dai, J; Jin, N; Huang, SY; Jia, P; Li, T; Fan, C; Liu, K; Wang, ZH				Li, Wen-Zhu; Wang, Jue; Long, Rui; Su, Guan-Hua; Bukhory, Dinesh-Kumar; Dai, Jing; Jin, Nan; Huang, Shi-Yuan; Jia, Peng; Li, Ting; Fan, Chen; Liu, Kun; Wang, Zhaohui			Novel Antibody against a Glutamic Acid-Rich Human Fibrinogen-Like Protein 2-Derived Peptide near Ser91 Inhibits hfgl2 Prothrombinase Activity	PLOS ONE			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; THROMBIN GENERATION; BLOOD-COAGULATION; ENDOTHELIAL-CELL; EXPRESSION; FGL2; CONTRIBUTES; INDUCTION; PROLIFERATION; RECEPTOR	Fibrinogen-like protein 2 (fgl2) is highly expressed in microvascular endothelial cells in diseases associated with microcirculatory disturbances and plays a crucial role in microthrombosis. Previous studies have demonstrated that the Ser89 residue is a critical site for mouse fgl2 prothrombinase activity. The aim of this study was to investigate the prothrombinase inhibitory ability of antibodies against an hfgl2-derived peptide. The peptide was termed NPG-12 because it is located at the N-terminus of membrane-bound hfgl2, contains 12 amino acid residues (corresponding to residues 76 to 87), and is rich in Glu. This peptide was selected as an antigenic determinant to produce antibodies in immunized rabbits using the DNAStar and HomoloGene software program. Abundant hfgl2 expression was induced in human umbilical vein endothelial cells through treatment with TNF-alpha. The generated anti-NPG-12 antibodies specifically recognize fgl2, as determined by ELISA, Western Blot and immunostaining. Moreover, one-stage clotting and thrombin generation tests provide evidence that the antibodies can reduce the hfgl2 prothrombinase activity without affecting the platelet-poor plasma prothrombin time (PT) or the activated partial thromboplastin time (APTT). In addition, the antibodies exerted undetectable influence on the proliferation or activation of bulk T cell populations. In conclusion, the selected peptide sequence NPG-12 may be a critical domain for hfgl2 prothrombinase activity, and the development of inhibitors against this sequence may be promising for research or management of hfgl2-associated microcirculatory disturbances.	[Li, Wen-Zhu; Su, Guan-Hua; Bukhory, Dinesh-Kumar; Huang, Shi-Yuan; Jia, Peng; Li, Ting; Fan, Chen; Liu, Kun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430074, Peoples R China; [Wang, Jue] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Wuhan 430074, Peoples R China; [Long, Rui; Dai, Jing; Jin, Nan; Wang, Zhaohui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Geriatr,Inst Geriatr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430074, Peoples R China.	liukun@hust.edu.cn; zhaohuiwang@hust.edu.cn	guanhua, SU/GXM-7101-2022		National Natural Science Foundation of China [81270267]; Key Program for Scientific and Technological Innovation of Wuhan [201161038340-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Scientific and Technological Innovation of Wuhan	This work is supported by the National Natural Science Foundation of China (No. 81270267) and the Key Program for Scientific and Technological Innovation of Wuhan (No. 201161038340-08). http://www.nsfc.gov.cn/Portal0/default152.htm; http://www.whst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.91; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Baratelli F, 2010, AM J TRANSL RES, V2, P356; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bharadwaj A, 1998, INFECT IMMUN, V66, P3232, DOI 10.1128/IAI.66.7.3232-3241.1998; Bian GH, 2010, MOL BIOL REP, V37, P2387, DOI 10.1007/s11033-009-9746-5; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; Clark DA, 2001, MOL HUM REPROD, V7, P185, DOI 10.1093/molehr/7.2.185; Darghouth D, 2006, BLOOD, V108, P1925, DOI 10.1182/blood-2005-12-010660; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; Ding YP, 2010, J HUAZHONG U SCI-MED, V30, P575, DOI 10.1007/s11596-010-0545-y; Dong XJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-133; Furugohri T, 2011, THROMB HAEMOSTASIS, V106, P1076, DOI 10.1160/TH11-06-0382; Ghanekar A, 2004, J IMMUNOL, V172, P5693, DOI 10.4049/jimmunol.172.9.5693; Gilbert GE, 1996, J BIOL CHEM, V271, P11120, DOI 10.1074/jbc.271.19.11120; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Howlett AC, 1998, MOL PHARMACOL, V53, P504, DOI 10.1124/mol.53.3.504; Huse K, 2002, J BIOCHEM BIOPH METH, V51, P217, DOI 10.1016/S0165-022X(02)00017-9; Itoh K, 2009, CANCER SCI, V100, P126, DOI 10.1111/j.1349-7006.2008.00998.x; Jaffe R, 2010, JACC-CARDIOVASC INTE, V3, P695, DOI 10.1016/j.jcin.2010.05.004; Jia P, 2013, MICROCIRCULATION, V20, P524, DOI 10.1111/micc.12050; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268; LEVY GA, 1981, J EXP MED, V154, P1150, DOI 10.1084/jem.154.4.1150; Levy GA, 2000, AM J PATHOL, V156, P1217, DOI 10.1016/S0002-9440(10)64992-9; Li CH, 2004, CELL RES, V14, P480, DOI 10.1038/sj.cr.7290251; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Marazzi S, 1998, J IMMUNOL, V161, P138; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; Mendicino M, 2005, CIRCULATION, V112, P248, DOI 10.1161/CIRCULATIONAHA.105.534271; Mendoza L, 2010, THEOR BIOSCI, V129, P283, DOI 10.1007/s12064-010-0112-x; Mu J, 2007, PHYSIOL GENOMICS, V31, P53, DOI 10.1152/physiolgenomics.00026.2007; NELSESTUEN GL, 1976, J BIOL CHEM, V251, P6886; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; OBRIEN DP, 1991, BLOOD, V78, P132; Prezelj A, 2007, CURR PHARM DESIGN, V13, P287, DOI 10.2174/138161207779313605; Refino CJ, 1999, THROMB HAEMOSTASIS, V82, P1188; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Rychlik DF, 2003, J SOC GYNECOL INVEST, V10, P67, DOI 10.1016/S1071-5576(02)00252-6; Selzner N, 2012, J HEPATOL, V56, P153, DOI 10.1016/j.jhep.2011.05.033; Shalev I, 2010, RAMBAM MAIMONIDES ME, V1, DOI 10.5041/RMMJ.10004; Shao L, 2013, CLIN APPL THROMB-HEM, V19, P19, DOI 10.1177/1076029612437577; Su K, 2008, WORLD J GASTROENTERO, V14, P5980, DOI 10.3748/wjg.14.5980; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036379; Yuwaraj S, 2001, GENOMICS, V71, P330, DOI 10.1006/geno.2000.6444; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	56	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94551	10.1371/journal.pone.0094551	http://dx.doi.org/10.1371/journal.pone.0094551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728278	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200093
J	Li, XJ; Yang, J; Gao, J; Luo, X; Zhou, ZY; Hu, YJ; Wu, EX; Wan, MX				Li, Xianjun; Yang, Jian; Gao, Jie; Luo, Xue; Zhou, Zhenyu; Hu, Yajie; Wu, Ed X.; Wan, Mingxi			A Robust Post-Processing Workflow for Datasets with Motion Artifacts in Diffusion Kurtosis Imaging	PLOS ONE			English	Article							TENSORS	Purpose: The aim of this study was to develop a robust post-processing workflow for motion-corrupted datasets in diffusion kurtosis imaging (DKI). Materials and methods: The proposed workflow consisted of brain extraction, rigid registration, distortion correction, artifacts rejection, spatial smoothing and tensor estimation. Rigid registration was utilized to correct misalignments. Motion artifacts were rejected by using local Pearson correlation coefficient (LPCC). The performance of LPCC in characterizing relative differences between artifacts and artifact-free images was compared with that of the conventional correlation coefficient in 10 randomly selected DKI datasets. The influence of rejected artifacts with information of gradient directions and b values for the parameter estimation was investigated by using mean square error (MSE). The variance of noise was used as the criterion for MSEs. The clinical practicality of the proposed workflow was evaluated by the image quality and measurements in regions of interest on 36 DKI datasets, including 18 artifact-free (18 pediatric subjects) and 18 motion-corrupted datasets (15 pediatric subjects and 3 essential tremor patients). Results: The relative difference between artifacts and artifact-free images calculated by LPCC was larger than that of the conventional correlation coefficient (p<0.05). It indicated that LPCC was more sensitive in detecting motion artifacts. MSEs of all derived parameters from the reserved data after the artifacts rejection were smaller than the variance of the noise. It suggested that influence of rejected artifacts was less than influence of noise on the precision of derived parameters. The proposed workflow improved the image quality and reduced the measurement biases significantly on motion-corrupted datasets (p<0.05). Conclusion: The proposed post-processing workflow was reliable to improve the image quality and the measurement precision of the derived parameters on motion-corrupted DKI datasets. The workflow provided an effective post-processing method for clinical applications of DKI in subjects with involuntary movements.	[Li, Xianjun; Yang, Jian; Gao, Jie; Zhou, Zhenyu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Li, Xianjun; Yang, Jian; Luo, Xue; Hu, Yajie; Wan, Mingxi] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Hong Kong	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com; mxwan@mail.xjtu.edu.cn	Li, Xianjun/G-4472-2018; Wu, Ed Xuekui/C-1579-2009	Li, Xianjun/0000-0001-7690-9155; Wu, Ed Xuekui/0000-0001-5581-1546	National Natural Science Foundation of China [81171317]; New Century Excellent Talent Support Plan from the Ministry of Education of China [DWYXSJ11000007]; Fund for the National Clinical Key Specialty from the Ministry of Health of China; National Basic Research Program 973 [2011CB707903, 2010CB732603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talent Support Plan from the Ministry of Education of China; Fund for the National Clinical Key Specialty from the Ministry of Health of China; National Basic Research Program 973(National Basic Research Program of China)	This work was supported by the grant from National Natural Science Foundation of China (No. 81171317), the 2011 New Century Excellent Talent Support Plan from the Ministry of Education of China (DWYXSJ11000007), the Fund for the National Clinical Key Specialty from the Ministry of Health of China, and National Basic Research Program 973 (Nos. 2011CB707903 and 2010CB732603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Fukunaga I, 2013, RADIOL PHYS TECHNOL, V6, P343, DOI 10.1007/s12194-013-0206-5; Heemskerk AM, 2013, AM J NEURORADIOL, V34, P1496, DOI 10.3174/ajnr.A3465; Holdsworth SJ, 2012, J MAGN RESON IMAGING, V36, P961, DOI 10.1002/jmri.23710; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Ji L, 2006, PHOTOGRAMM ENG REM S, V72, P823, DOI 10.14358/PERS.72.7.823; Jiang H, 2009, P 17 ANN M ISMRM SAN, P1404; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049764; Liu Z, 2010, P SOC PHOTO-OPT INS, DOI DOI 10.1117/12.844748; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Pannek K, 2012, PEDIATR RADIOL, V42, P1169, DOI 10.1007/s00247-012-2427-x; Pierpaoli C, 2010, DIFFUSION MRI THEORY, P303; Qi LQ, 2008, J COMPUT APPL MATH, V221, P150, DOI 10.1016/j.cam.2007.10.012; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhou ZY, 2011, MAGN RESON IMAGING, V29, P230, DOI 10.1016/j.mri.2010.06.022	22	15	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94592	10.1371/journal.pone.0094592	http://dx.doi.org/10.1371/journal.pone.0094592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727862	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200102
J	Seiss, E; Klippel, M; Hope, C; Boy, F; Sumner, P				Seiss, Ellen; Klippel, Marie; Hope, Christopher; Boy, Frederic; Sumner, Petroc			The Relationship between Reversed Masked Priming and the Tri-Phasic Pattern of the Lateralised Readiness Potential	PLOS ONE			English	Article							NEGATIVE COMPATIBILITY; REPETITION BLINDNESS; MOTOR ACTIVATION; CAUTIONARY TALE; INHIBITION; RESPONSES; STIMULI	One of the potential explanations for negative compatibility effects (NCE) in subliminal motor priming tasks has been perceptual prime-target interactions. Here, we investigate whether the characteristic tri-phasic LRP pattern associated with the NCE is caused by these prime-target interactions. We found that both the prime-related phase and the critical reversal phase remain present even on trials where the target is omitted, confirming they are elicited by the prime and mask, not by prime-target interactions. We also report that shape and size of the reversal phase are associated with response speed, consistent with a causal role for the reversal for the subsequent response latency. Additionally, we analysed sequential modulation of the NCE by previous conflicting events, even though such conflict is subliminal. In accordance with previous literature, this modulation is small but significant.	[Seiss, Ellen; Hope, Christopher] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Klippel, Marie] Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany; [Boy, Frederic; Sumner, Petroc] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	University of Surrey; Humboldt University of Berlin; Cardiff University	Seiss, E (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England.	e.seiss@surrey.ac.uk	Seiss, Ellen/Y-6216-2019		Economic and Social Research Council [ES/K002325/1]; ESRC [ES/K002325/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Petroc Sumner's work on this article was sponsored by the Economic and Social Research Council grant ES/K002325/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bavelier D, 2000, PERCEPT PSYCHOPHYS, V62, P100, DOI 10.3758/BF03212064; Bowman H, 2006, VIS COGN, V13, P401, DOI 10.1080/13506280444000823; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Hochhaus L, 1996, J EXP PSYCHOL HUMAN, V22, P355; Huber DE, 2008, J EXP PSYCHOL GEN, V137, P324, DOI 10.1037/0096-3445.137.2.324; Jaskowski P, 2005, ACTA NEUROBIOL EXP, V65, P409; Jaskowski P, 2008, CONSCIOUS COGN, V17, P765, DOI 10.1016/j.concog.2007.12.002; Jaskowski P, 2007, J EXP PSYCHOL HUMAN, V33, P456, DOI 10.1037/0096-1523.33.2.456; Johnston JC, 2002, J EXP PSYCHOL HUMAN, V28, P477, DOI 10.1037//0096-1523.28.2.477; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Klapp ST, 2002, J EXP PSYCHOL GEN, V131, P255, DOI 10.1037//0096-3445.131.2.255; Lang W., 2003, BEREITSCHAFTSPOTENTI, P19, DOI [10.1007/978-1-4615-0189-3_2, DOI 10.1007/978-1-4615-0189-3_2]; Lleras A, 2005, J EXP PSYCHOL GEN, V134, P436, DOI 10.1037/0096-3445.134.3.436; Lleras A, 2004, J EXP PSYCHOL GEN, V133, P475, DOI 10.1037/0096-3445.133.4.475; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Praamstra P, 2005, J COGNITIVE NEUROSCI, V17, P483, DOI 10.1162/0898929053279513; Schlaghecken F, 2002, PERCEPT PSYCHOPHYS, V64, P148, DOI 10.3758/BF03194564; Schlaghecken F, 2006, J EXP PSYCHOL HUMAN, V32, P618, DOI 10.1037/0096-1523.32.3.618; Seiss E, 2004, BRAIN, V127, P330, DOI 10.1093/brain/awh043; Sohrabi A, 2008, ANN M COGN SCI SOC W; Sumner Petroc, 2008, Adv Cogn Psychol, V3, P317, DOI 10.2478/v10053-008-0033-0; Sumner P, 2006, P NATL ACAD SCI USA, V103, P10520, DOI 10.1073/pnas.0601974103; van Leeuwen C, 2004, PERCEPT PSYCHOPHYS, V66, P908, DOI 10.3758/BF03194984; Verleger R, 2004, J EXP PSYCHOL GEN, V133, P494, DOI 10.1037/0096-3445.133.4.494	26	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93876	10.1371/journal.pone.0093876	http://dx.doi.org/10.1371/journal.pone.0093876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728088	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200031
J	Gonzalez-Hernandez, MJ; Pal, A; Gyan, KE; Charbonneau, ME; Showalter, HD; Donato, NJ; O'Riordan, M; Wobus, CE				Gonzalez-Hernandez, Marta J.; Pal, Anupama; Gyan, Kofi E.; Charbonneau, Marie-Eve; Showalter, Hollis D.; Donato, Nicholas J.; O'Riordan, Mary; Wobus, Christiane E.			Chemical Derivatives of a Small Molecule Deubiquitinase Inhibitor Have Antiviral Activity against Several RNA Viruses	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; NOROVIRUS; REPLICATION; CYCLOPHILIN; IDENTIFICATION; ANTIBIOTICS; DEBIO-025; DISCOVERY; REPLICON; DISEASE	Most antiviral treatment options target the invading pathogen and unavoidably encounter loss of efficacy as the pathogen mutates to overcome replication restrictions. A good strategy for circumventing drug resistance, or for pathogens without treatment options, is to target host cell proteins that are utilized by viruses during infection. The small molecule WP1130 is a selective deubiquitinase inhibitor shown previously to successfully reduce replication of noroviruses and some other RNA viruses. In this study, we screened a library of 31 small molecule derivatives of WP1130 to identify compounds that retained the broad-spectrum antiviral activity of the parent compound in vitro but exhibited improved drug-like properties, particularly increased aqueous solubility. Seventeen compounds significantly reduced murine norovirus infection in murine macrophage RAW 264.7 cells, with four causing decreases in viral titers that were similar or slightly better than WP1130 (1.9 to 2.6 log scale). Antiviral activity was observed following pre-treatment and up to 1 hour postinfection in RAW 264.7 cells as well as in primary bone marrow-derived macrophages. Treatment of the human norovirus replicon system cell line with the same four compounds also decreased levels of Norwalk virus RNA. No significant cytotoxicity was observed at the working concentration of 5 mu M for all compounds tested. In addition, the WP1130 derivatives maintained their broad-spectrum antiviral activity against other RNA viruses, Sindbis virus, LaCrosse virus, encephalomyocarditis virus, and Tulane virus. Thus, altering structural characteristics of WP1130 can maintain effective broad-spectrum antiviral activity while increasing aqueous solubility.	[Gonzalez-Hernandez, Marta J.; Gyan, Kofi E.; Charbonneau, Marie-Eve; O'Riordan, Mary; Wobus, Christiane E.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Pal, Anupama; Donato, Nicholas J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Showalter, Hollis D.] Univ Michigan, Coll Pharm, Dept Med Chem, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wobus, CE (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	cwobus@umich.edu		O'Riordan, Mary/0000-0001-6014-4637; Wobus, Christiane/0000-0001-5286-0924	NIH [1 R21 AI 102106]; Leukemia Lymphoma Society; University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR [U024225]; Medical Scientist Training Program from the University of Michigan Medical School; Fond de recherche sante Quebec [27881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR; Medical Scientist Training Program from the University of Michigan Medical School; Fond de recherche sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by NIH grant 1 R21 AI 102106 to MOR and CEW. These studies were partially supported by a grant from the Leukemia Lymphoma Society to NJD and HDS, the University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund to HDS, and the University of Michigan Institute for Clinical and Health Research MICHR U024225 to NJD and HDS. KG was supported by the Medical Scientist Training Program from the University of Michigan Medical School. MEC was supported in part by a fellowship from the Fond de recherche sante Quebec (Fellowship #27881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Antonelli G, 2012, INT J ANTIMICROB AG, V40, P95, DOI 10.1016/j.ijantimicag.2012.04.005; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bartholomeusz GA, 2007, BLOOD, V109, P3470, DOI 10.1182/blood-2006-02-005579; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Burkholder KM, 2011, INFECT IMMUN, V79, P4850, DOI 10.1128/IAI.05456-11; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Daelemans D, 2010, ANTIVIR RES, V85, P418, DOI 10.1016/j.antiviral.2009.10.009; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J GEN VIROL, V91, P734, DOI 10.1099/vir.0.015263-0; Filone CM, 2013, CHEM BIOL, V20, P424, DOI 10.1016/j.chembiol.2013.02.011; Gotte M, 2012, CURR OPIN VIROL, V2, P644, DOI 10.1016/j.coviro.2012.08.004; Green K. Y., 2007, FIELDS VIROLOGY, P949; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; HULL RN, 1962, J EXP MED, V115, P903, DOI 10.1084/jem.115.5.903; Inoue K, 2007, HEPATOLOGY, V45, P921, DOI 10.1002/hep.21587; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Krumm SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020069; Lee BY, 2011, INFECT CONT HOSP EP, V32, P191, DOI 10.1086/657910; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marshall JA, 2011, INT J ENV RES PUB HE, V8, P1141, DOI 10.3390/ijerph8041141; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Perry JW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002783; Prudencio M, 2013, CURR PHARM DESIGN, V19, P290, DOI 10.2174/138161213804070276; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; SILVER LL, 1993, ANTIMICROB AGENTS CH, V37, P377, DOI 10.1128/AAC.37.3.377; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05	49	24	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94491	10.1371/journal.pone.0094491	http://dx.doi.org/10.1371/journal.pone.0094491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722666	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100081
J	Nelson, MC; Morrison, HG; Benjamino, J; Grim, SL; Graf, J				Nelson, Michael C.; Morrison, Hilary G.; Benjamino, Jacquelynn; Grim, Sharon L.; Graf, Joerg			Analysis, Optimization and Verification of Illumina-Generated 16S rRNA Gene Amplicon Surveys	PLOS ONE			English	Article							DIGESTIVE-TRACT MICROBIOTA; SEQUENCE DATA; COMMUNITY; DIVERSITY; QUALITY; CORE; DNA	The exploration of microbial communities by sequencing 16S rRNA genes has expanded with low-cost, high-throughput sequencing instruments. Illumina-based 16S rRNA gene sequencing has recently gained popularity over 454 pyrosequencing due to its lower costs, higher accuracy and greater throughput. Although recent reports suggest that Illumina and 454 pyrosequencing provide similar beta diversity measures, it remains to be demonstrated that pre-existing 454 pyrosequencing workflows can transfer directly from 454 to Illumina MiSeq sequencing by simply changing the sequencing adapters of the primers. In this study, we modified 454 pyrosequencing primers targeting the V4-V5 hypervariable regions of the 16S rRNA gene to be compatible with Illumina sequencers. Microbial communities from cows, humans, leeches, mice, sewage, and termites and a mock community were analyzed by 454 and MiSeq sequencing of the V4-V5 region and MiSeq sequencing of the V4 region. Our analysis revealed that reference-based OTU clustering alone introduced biases compared to de novo clustering, preventing certain taxa from being observed in some samples. Based on this we devised and recommend an analysis pipeline that includes read merging, contaminant filtering, and reference-based clustering followed by de novo OTU clustering, which produces diversity measures consistent with de novo OTU clustering analysis. Low levels of dataset contamination with Illumina sequencing were discovered that could affect analyses that require highly sensitive approaches. While moving to Illumina-based sequencing platforms promises to provide deeper insights into the breadth and function of microbial diversity, our results show that care must be taken to ensure that sequencing and processing artifacts do not obscure true microbial diversity.	[Nelson, Michael C.; Benjamino, Jacquelynn; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Morrison, Hilary G.; Grim, Sharon L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	University of Connecticut; Marine Biological Laboratory - Woods Hole	Graf, J (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	joerg.graf@uconn.edu	Graf, Joerg/ABI-2447-2020	Graf, Joerg/0000-0001-5320-2712; Benjamino, Jacquelynn/0000-0001-8746-9124; Nelson, Michael/0000-0002-9042-5904; Morrison, Hilary/0000-0003-0281-326X	Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant; US National Science Foundation; NIH [RO1 GM095390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095390] Funding Source: NIH RePORTER	Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant; US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially funded by an Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant awarded by the US National Science Foundation to Joerg Graf and NIH RO1 GM095390 to JG and HGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Illumina, 2013, BEST PRACT HIGH SENS; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marteinsson VT, 2013, ISME J, V7, P427, DOI 10.1038/ismej.2012.97; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ram JL, 2011, SYST BIOL REPROD MED, V57, P162, DOI 10.3109/19396368.2011.555598; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STAHL DA, 1985, APPL ENVIRON MICROB, V49, P1379, DOI 10.1128/AEM.49.6.1379-1384.1985; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	220	229	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94249	10.1371/journal.pone.0094249	http://dx.doi.org/10.1371/journal.pone.0094249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722003	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100044
J	Yang, YL; Liu, L; Wang, XX; Wang, Y; Wang, L				Yang, Yi-Long; Liu, Li; Wang, Xiao-Xi; Wang, Yang; Wang, Lie			Prevalence and Associated Positive Psychological Variables of Depression and Anxiety among Chinese Cervical Cancer Patients: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-EFFICACY; EMOTIONAL DISTRESS; HOSPITAL ANXIETY; EARLY-STAGE; OPTIMISM; SURVIVORS; HOPE; DISEASE; IMPACT	Background: The prevalence of depression and anxiety and its associated factors in cervical cancer are not well evaluated in China. Meanwhile, with increasing attention given to positive psychological variables in oncology field, there is a need to conduct a study to explore the integrative effects of positive psychological variables on depression/anxiety so as to provide patients a more holistic cancer care. The aim of this study was to assess the prevalence of depression/anxiety as well as the integrative effects of hope, optimism and general self-efficacy on depression/anxiety among Chinese cervical cancer patients. Methods: A multi-centre, cross-sectional study was conducted of consecutive inpatients at the Liaoning Cancer Hospital & Institute and the Shengjing Hospital of China Medical University in Liaoning Province, northeast China. A total of 224 cervical cancer patients eligible for this study completed questionnaires on demographic and clinic variables, Hospital Anxiety and Depression Scale, Herth Hope Index, Life Orientation Scale-Revised, and General Self-Efficacy Scale during February and August 2013. Results: The prevalence of depression and anxiety was 52.2% and 65.6% in cervical cancer patients. The anxiety score was significantly higher in patients at the period of 4-6 months after diagnose and at cancer stage II. Hierarchical regression analyses indicated that hope, optimism and general self-efficacy as a whole accounted for 31.3% variance of depression and 35.6% variance of anxiety. Under standardized estimate (beta) sequence, hope, optimism and general self-efficacy significantly associated with depression, respectively; hope and optimism were also significant individual predictors of anxiety. Conclusions: The high prevalence of depression and anxiety among cervical cancer patients should receive more attention in Chinese medical settings. More importantly, efforts to develop the integrated psychosocial interventions are effective and necessary to alleviate depression/anxiety in cervical cancer patients by synthesizing and integrating the individual protective effects of hope, optimism and general self-efficacy.	[Yang, Yi-Long; Liu, Li; Wang, Yang; Wang, Lie] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China; [Wang, Xiao-Xi] China Med Univ, Sch Clin Med, Shenyang, Liaoning, Peoples R China; [Wang, Xiao-Xi] China Med Univ, Pharmaceut Coll, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, L (corresponding author), China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China.	liewang@mail.cmu.edu.cn						Albrecht K, 2013, PSYCHO-ONCOLOGY, V22, P1972, DOI 10.1002/pon.3238; Bandura A, 1997, SELF EFFICACY EXERCI; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; Butt Clare M, 2011, Oncol Nurs Forum, V38, pE341, DOI 10.1188/11.ONF.E341-E350; Carter J, 2010, GYNECOL ONCOL, V119, P358, DOI 10.1016/j.ygyno.2010.07.016; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; Cohen L, 2001, CANCER, V91, P1949, DOI 10.1002/1097-0142(20010515)91:10<1949::AID-CNCR1218>3.0.CO;2-A; Coyne JC, 2010, ANN BEHAV MED, V39, P35, DOI 10.1007/s12160-010-9157-9; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Distefano M, 2008, GYNECOL ONCOL, V111, P144, DOI 10.1016/j.ygyno.2008.06.034; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Edge SB, 2010, AJCC CANC STAGING MA, P395; Ferrandina G, 2012, GYNECOL ONCOL, V124, P389, DOI 10.1016/j.ygyno.2011.09.041; Hackett TP, 1987, MASSACHUSETTS GEN HO; Hengrasmee Pattaya, 2004, Journal of the Medical Association of Thailand, V87, pS74; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Herth K, 2000, J ADV NURS, V32, P1431, DOI 10.1046/j.1365-2648.2000.01619.x; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Hopwood P, 2000, J CLIN ONCOL, V18, P893, DOI 10.1200/JCO.2000.18.4.893; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; Kim SH, 2010, INT J GYNECOL CANCER, V20, P1017, DOI 10.1111/IGC.0b013e3181e4a704; Kobayashi M, 2009, INT J GYNECOL CANCER, V19, P1264, DOI 10.1111/IGC.0b013e3181a3e124; Kornblith AB, 2001, CANCER-AM CANCER SOC, V91, P443, DOI 10.1002/1097-0142(20010115)91:2<443::AID-CNCR1020>3.0.CO;2-Z; Lauver D, 1995, NURS RES, V44, P202; Lebel S, 2008, FUTURE ONCOL, V4, P717, DOI 10.2217/14796694.4.5.717; 감성희, 2003, [Korean Journal of Adult Nursing, 성인간호학회지], V15, P660; Li TF, 2005, PRACTICAL J CLIN MED, V2, P19; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Mantegna G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-127; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; McClement SE, 2008, EUR J CANCER, V44, P1169, DOI 10.1016/j.ejca.2008.02.031; Merck Manual Home Edition, 2007, CER CANC CANC FEM RE; Miller DL, 1996, J CLIN PSYCHOL MED S, V3, P115, DOI 10.1007/BF01996132; Miller K, 2006, CANCER J, V12, P388, DOI 10.1097/00130404-200609000-00008; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Mystakidou K, 2005, QUAL LIFE RES, V14, P1825, DOI 10.1007/s11136-005-4324-3; Mystakidou K, 2008, SUPPORT CARE CANCER, V16, P1317, DOI 10.1007/s00520-008-0443-z; Mystakidou K, 2013, PSYCHO-ONCOLOGY, V22, P1089, DOI 10.1002/pon.3106; Park SY, 2007, CANCER-AM CANCER SOC, V110, P2716, DOI 10.1002/cncr.23094; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Rajandram Rama K, 2011, BMC Res Notes, V4, P519, DOI 10.1186/1756-0500-4-519; Sanatani M, 2008, SUPPORT CARE CANCER, V16, P493, DOI 10.1007/s00520-007-0336-6; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schwarzer R, 2005, PERS INDIV DIFFER, V39, P807, DOI 10.1016/j.paid.2004.12.016; Schwarzer R., 1995, CAUSAL CONTROL BELIE, P35, DOI DOI 10.1037/T00393-000; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; Suzuki N, 2011, J OBSTET GYNAECOL RE, V37, P800, DOI 10.1111/j.1447-0756.2010.01437.x; Tavoli A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-28; Thompson DS, 1998, GEN HOSP PSYCHIAT, V20, P241, DOI 10.1016/S0163-8343(98)00030-9; Vistad I, 2006, GYNECOL ONCOL, V102, P563, DOI 10.1016/j.ygyno.2006.03.050; Wan YH, 2011, CHINESE J SOCIAL MED, V28, P98; Wang Y., 2010, CHINESE NURSING RES, V24, P20, DOI [DOI 10.3969/J.ISSN.1009-6493.2010.01.008, 10.3969/j.issn.1009-6493.2010.01.008]; Wang YR, 2012, CHINA J PHARM EC, V3, P112; WEISMAN AD, 1976, INT J PSYCHIAT MED, V7, P1, DOI 10.2190/UQ2G-UGV1-3PPC-6387; Yang YL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-393; Zenger M, 2010, PSYCHO-ONCOLOGY, V19, P879, DOI 10.1002/pon.1635; [张国华 ZHANG Guohua], 2006, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V14, P591; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	48	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94804	10.1371/journal.pone.0094804	http://dx.doi.org/10.1371/journal.pone.0094804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722558	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100134
J	McGee, SL; Swinton, C; Morrison, S; Gaur, V; Campbell, DE; Jorgensen, SB; Kemp, BE; Baar, K; Steinberg, GR; Hargreaves, M				McGee, Sean L.; Swinton, Courtney; Morrison, Shona; Gaur, Vidhi; Campbell, Duncan E.; Jorgensen, Sebastian B.; Kemp, Bruce E.; Baar, Keith; Steinberg, Gregory R.; Hargreaves, M.			Compensatory regulation of HDAC5 in muscle maintains metabolic adaptive responses and metabolism in response to energetic stress	FASEB JOURNAL			English	Article						AMP-activated protein kinase; protein kinase D; skeletal muscle; exercise	HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE-D; II HISTONE DEACETYLASES; ENDURANCE EXERCISE; NUCLEAR EXPORT; EXPRESSION; GLUT4; AMPK; TRANSCRIPTION; ACTIVATION	Some gene deletions or mutations have little effect on metabolism and metabolic adaptation because of redundancy and/or compensation in metabolic pathways. The mechanisms for redundancy and/or compensation in metabolic adaptation in mammalian cells are unidentified. Here, we show that in mouse muscle and myogenic cells, compensatory regulation of the histone deacetylase (HDAC5) transcriptional repressor maintains metabolic integrity. HDAC5 phosphorylation regulated the expression of diverse metabolic genes and glucose metabolism in mouse C2C12 myogenic cells. However, loss of AMP-activated protein kinase (AMPK), a HDAC5 kinase, in muscle did not affect HDAC5 phosphorylation in mouse skeletal muscle during exercise, but resulted in a compensatory increase (32.6%) in the activation of protein kinase D (PKD), an alternate HDAC5 kinase. Constitutive PKD activation in mouse C2C12 myogenic cells regulated metabolic genes and glucose metabolism. Although aspects of this response were HDAC5 phosphorylation dependent, blocking HDAC5 phosphorylation when PKD was active engaged an alternative compensatory adaptive mechanism, which involved post-transcriptional reductions in HDAC5 mRNA (-93.1%) and protein. This enhanced the expression of a specific subset of metabolic genes and mitochondrial metabolism. These data show that compensatory regulation of HDAC5 maintains metabolic integrity in mammalian cells and reinforces the importance of preserving the cellular metabolic adaptive response.	[McGee, Sean L.; Swinton, Courtney; Morrison, Shona; Gaur, Vidhi; Campbell, Duncan E.] Deakin Univ, Sch Med, Metab Remodelling Lab, Metab Res Unit, Waurn Ponds, Vic 3217, Australia; [McGee, Sean L.] Baker Int Diabet Inst, Heart & Diabet Inst, Div Cell Signalling & Metab, Melbourne, Vic, Australia; [Campbell, Duncan E.; Hargreaves, M.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Jorgensen, Sebastian B.; Kemp, Bruce E.; Steinberg, Gregory R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Jorgensen, Sebastian B.] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada	Deakin University; University of Melbourne; St. Vincent's Institute of Medical Research; Novo Nordisk; University of California System; University of California Davis; McMaster University	McGee, SL (corresponding author), Deakin Univ, Sch Med, Metab Remodelling Lab, Metab Res Unit, Pigdons Rd, Waurn Ponds, Vic 3217, Australia.	sean.mcgee@deakin.edu.au	Kemp, Bruce/G-9602-2019; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Kemp, Bruce E/0000-0001-6735-5082; Steinberg, Gregory/0000-0001-5425-8275; Baar, Keith/0000-0001-9337-6186	Australia National Health and Medical Research Council (NHMRC); Diabetes Australia Research Trust Viertel Award; NHMRC	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust Viertel Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Frosa Katsis (St. Vincent's Institute, Fitzroy, VIC, Australia) for the generation of HDAC5 and ACC phospho-specific antibodies and Professor Doreen Cantrell (The University of Dundee, Dundee, UK) for the PKD plasmids. This study was supported by grants from the Australia National Health and Medical Research Council (NHMRC) to S. L. M., B. E. K., and G. R. S. S. L. M. is supported by the Diabetes Australia Research Trust Viertel Award and a Career Development Fellowship from the NHMRC. Author contributions: S. L. M. and M. H. conceived the research; S. L. M., C. S., S. M., V. G., D. E. C., and S.B.J. performed experiments and analyzed data; B. E. K., K. B., and G. R. S. provided technical expertise and reagents; S. L. M. wrote the paper; all authors edited the paper and approved the final version.	Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Holmes BF, 2004, AM J PHYSIOL-ENDOC M, V287, pE739, DOI 10.1152/ajpendo.00080.2004; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Hoppeler H, 2011, COMPR PHYSIOL, V1, P1383, DOI 10.1002/cphy.c100042; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2007, APPL PHYSIOL NUTR ME, V32, P852, DOI 10.1139/H07-082; McGee SL, 2011, CELL PHYSIOL BIOCHEM, V28, P157, DOI 10.1159/000331724; McGee SL, 2010, CLIN EXP PHARMACOL P, V37, P392, DOI 10.1111/j.1440-1681.2009.05311.x; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Min Y, 2011, J THEOR BIOL, V270, P63, DOI 10.1016/j.jtbi.2010.11.012; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Soyer OS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000907; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Zabet NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073714; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	46	35	38	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3384	3395		10.1096/fj.14-249359	http://dx.doi.org/10.1096/fj.14-249359			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24732133				2022-12-25	WOS:000340265400010
J	Bohm, M; Schultz, S; Koussoroplis, AM; Kainz, MJ				Boehm, Markus; Schultz, Sebastian; Koussoroplis, Apostolos-Manuel; Kainz, Martin J.			Tissue-Specific Fatty Acids Response to Different Diets in Common Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							FISH-OIL; DOCOSAHEXAENOIC ACID; GROWTH-PERFORMANCE; NUTRITION; QUALITY; COD; REPLACEMENT; TEMPERATURE; DEFICIENCY; DEPOSITION	Fish depend on dietary fatty acids (FA) to support their physiological condition and health. Exploring the FA distribution in common carp (Cyprinus carpio), one of the world's most consumed freshwater fish, is important to understand how and where FA of different sources are allocated. We investigated diet effects on the composition of polar and neutral lipid fatty acids (PLFA and NLFA, respectively) in eight different tissues (dorsal and ventral muscle, heart, kidney, intestine, eyes, liver and adipose tissue) of common carp. Two-year old carp were exposed to three diet sources (i.e., zooplankton, zooplankton plus supplementary feeds containing vegetable, VO, or fish oil, FO) with different FA composition. The PLFA and NLFA response was clearly tissue-specific after 210 days of feeding on different diets. PLFA were generally rich in omega-3 polyunsaturated FA and only marginally influenced by dietary FA, whereas the NLFA composition strongly reflected dietary FA profiles. However, the NLFA composition in carp tissues varied considerably at low NLFA mass ratios, suggesting that carp is able to regulate the NLFA composition and thus FA quality in its tissues when NLFA contents are low. Finally, this study shows that FO were 3X more retained than VO as NLFA particularly in muscle tissues, indicating that higher nutritional quality feeds are selectively allocated into tissues and thus available for human consumption.	[Boehm, Markus; Schultz, Sebastian; Koussoroplis, Apostolos-Manuel; Kainz, Martin J.] WasserCluster Biolog Stn Lunz, Lunz Am See, Austria; [Boehm, Markus; Schultz, Sebastian] Univ Vienna, Dept Limnol, Vienna, Austria	University of Vienna	Kainz, MJ (corresponding author), WasserCluster Biolog Stn Lunz, Dr Carl Kupelwieser, Lunz Am See, Austria.	martin.kainz@donau-uni.ac.at	Kainz, Martin/AAG-6268-2021; Koussoroplis, Apostolos‐Manuel/AAP-5235-2021	Koussoroplis, Apostolos‐Manuel/0000-0002-5218-5604	Austrian Science Fund [L516-B17]; Austrian Science Fund (FWF) [L 516] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (L516-B17) to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; BELL MV, 1995, LIPIDS, V30, P443, DOI 10.1007/BF02536303; Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1; Benedito-Palos L, 2010, J ANIM SCI, V88, P1759, DOI 10.2527/jas.2009-2564; Black K.D., 1998, BIOL FARMED FISH, P114; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Cook H.W., 2004, BIOCH LIPIDS LIPOPRO, P181; Crawford MA, 1999, LIPIDS, V34, pS39, DOI 10.1007/BF02562227; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Du ZY, 2006, BRIT J NUTR, V95, P905, DOI 10.1079/BJN20061733; FAO, 2012, FISH AQ STAT AQ PROD; FAUCONNEAU B, 1995, AQUACULTURE, V129, P265, DOI 10.1016/0044-8486(94)00309-C; Francis DS, 2006, AQUACULTURE, V253, P547, DOI 10.1016/j.aquaculture.2005.08.008; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Hadjinikolova L, 2004, ARCH POLISH FISHERIE, V12, P111; Heissenberger M, 2010, HYDROBIOLOGIA, V650, P243, DOI 10.1007/s10750-010-0266-z; Jobling M, 2004, AQUACULTURE, V232, P551, DOI 10.1016/j.aquaculture.2003.07.001; Lands WEM, 2005, J MEMBRANE BIOL, V206, P75, DOI 10.1007/s00232-005-0785-0; LIE O, 1986, AQUACULTURE, V59, P187, DOI 10.1016/0044-8486(86)90003-7; LINARES F, 1991, J FISH BIOL, V38, P335, DOI 10.1111/j.1095-8649.1991.tb03124.x; Morkore T, 2007, AQUACULTURE, V267, P236, DOI 10.1016/j.aquaculture.2007.01.033; Mourente G, 2005, AQUACULT NUTR, V11, P25, DOI 10.1111/j.1365-2095.2004.00320.x; Nanton DA, 2007, AQUACULTURE, V265, P230, DOI 10.1016/j.aquaculture.2006.03.053; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; SARDESAI VM, 1992, J NUTR BIOCHEM, V3, P562, DOI 10.1016/0955-2863(92)90050-S; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sargent John R., 2002, P181; Schlott K, 2007, PLANKTISCHE NATURNAH; Schultz S, 2012, AQUACULTURE, V338, P105, DOI 10.1016/j.aquaculture.2012.01.006; SHIKATA T, 1994, FISHERIES SCI, V60, P735, DOI 10.2331/fishsci.60.735; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Skalli A, 2006, AQUACULTURE, V255, P223, DOI 10.1016/j.aquaculture.2005.12.006; StanleySamuelson DW, 1996, INSECT BIOCHEM MOLEC, V26, P223, DOI 10.1016/0965-1748(95)00092-5; STANSBY ME, 1990, FISH OILS NUTR, P289; Steffens W, 1997, AQUACULTURE, V151, P97, DOI 10.1016/S0044-8486(96)01493-7; Steffens W, 2007, AQUACULT INT, V15, P313, DOI 10.1007/s10499-007-9088-z; Stoknes IS, 2004, COMP BIOCHEM PHYS B, V138, P183, DOI 10.1016/j.cbpc.2004.03.009; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; van Dooremalen C, 2011, J INSECT PHYSIOL, V57, P1267, DOI 10.1016/j.jinsphys.2011.05.017; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; Wang JT, 2005, AQUACULTURE, V249, P439, DOI 10.1016/j.aquaculture.2005.04.038	42	27	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94759	10.1371/journal.pone.0094759	http://dx.doi.org/10.1371/journal.pone.0094759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733499	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400091
J	Goodwin, EC; Motamedi, N; Lipovsky, A; Fernandez-Busnadiego, R; DiMaio, D				Goodwin, Edward C.; Motamedi, Nasim; Lipovsky, Alex; Fernandez-Busnadiego, Ruben; DiMaio, Daniel			Expression of DNAJB12 or DNAJB14 Causes Coordinate Invasion of the Nucleus by Membranes Associated with a Novel Nuclear Pore Structure	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; NUCLEOLAR CHANNEL SYSTEM; ENDOPLASMIC-RETICULUM; HUMAN ENDOMETRIUM; J-PROTEIN; ENVELOPE; CELLS; HSC70; INFECTION; PATHWAY	DNAJB12 and DNAJB14 are transmembrane proteins in the endoplasmic reticulum (ER) that serve as co-chaperones for Hsc70/Hsp70 heat shock proteins. We demonstrate that over-expression of DNAJB12 or DNAJB14 causes the formation of elaborate membranous structures within cell nuclei, which we designate DJANGOS for DNAJ-associated nuclear globular structures. DJANGOS contain DNAJB12, DNAJB14, Hsc70 and markers of the ER lumen and ER and nuclear membranes. Strikingly, they are evenly distributed underneath the nuclear envelope and are of uniform size in any one nucleus. DJANGOS are composed primarily of single-walled membrane tubes and sheets that connect to the nuclear envelope via a unique configuration of membranes, in which the nuclear pore complex appears anchored exclusively to the outer nuclear membrane, allowing both the inner and outer nuclear membranes to flow past the circumference of the nuclear pore complex into the nucleus. DJANGOS break down rapidly during cell division and reform synchronously in the daughter cell nuclei, demonstrating that they are dynamic structures that undergo coordinate formation and dissolution. Genetic studies showed that the chaperone activity of DNAJ/Hsc70 is required for the formation of DJANGOS. Further analysis of these structures will provide insight into nuclear pore formation and function, activities of molecular chaperones, and mechanisms that maintain membrane identity.	[Goodwin, Edward C.; Motamedi, Nasim; Lipovsky, Alex; DiMaio, Daniel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Fernandez-Busnadiego, Ruben] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [DiMaio, Daniel] Yale Canc Ctr, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	DiMaio, D (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	daniel.dimaio@yale.edu		Fernandez-Busnadiego, Ruben/0000-0002-8366-7622	National Cancer Institute [CA016038]; Bavarian Research Foundation; James Hudson Brown - Alexander Brown Coxe foundation; Feodor Lynen Fellowship from the Alexander von Humboldt foundation; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bavarian Research Foundation; James Hudson Brown - Alexander Brown Coxe foundation; Feodor Lynen Fellowship from the Alexander von Humboldt foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute to D.D. (CA016038). N.M. was supported by postdoctoral fellowships of the Bavarian Research Foundation and the James Hudson Brown - Alexander Brown Coxe foundation. R.F.-B. is a recipient of a Feodor Lynen Fellowship from the Alexander von Humboldt foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2008, AM J THER, V15, P304, DOI 10.1097/MJT.0b013e3181754134; Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Arispe N, 2002, CELL STRESS CHAPERON, V7, P330, DOI 10.1379/1466-1268(2002)007<0330:LIDTCA>2.0.CO;2; Berk JM, 2013, NUCLEUS-PHILA, V4, P298, DOI 10.4161/nucl.25751; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Caruso RA, 2010, ANTICANCER RES, V30, P699; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen B, 2005, MOL ENDOCRINOL, V19, P1978, DOI 10.1210/me.2004-0274; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; DUBRAUSZKY V, 1960, NATURWISSENSCHAFTEN, V47, P523, DOI 10.1007/BF00641133; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; FERRANS VJ, 1975, AM J PATHOL, V78, P427; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Guffanti E, 2008, J CELL SCI, V121, P2037, DOI 10.1242/jcs.030437; Imamoto N, 2012, CURR OPIN CELL BIOL, V24, P453, DOI 10.1016/j.ceb.2012.06.004; Isaac C, 2001, J CELL SCI, V114, P4253; KARASAKI S, 1970, CANCER RES, V30, P1736; KAWANAMI O, 1979, AM J PATHOL, V94, P301; Kittur N, 2007, MOL BIOL CELL, V18, P2296, DOI 10.1091/mbc.E07-02-0154; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; Lippincott-Schwartz J, 2002, NATURE, V416, P31, DOI 10.1038/416031a; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Meier I, 2010, BIOCHEM SOC T, V38, P733, DOI 10.1042/BST0380733; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ralle T, 2004, J CELL SCI, V117, P6095, DOI 10.1242/jcs.01528; Ring BA, 2013, J VIROL, V87, P9199, DOI 10.1128/JVI.00637-13; Saphire ACS, 2000, J BIOL CHEM, V275, P4298, DOI 10.1074/jbc.275.6.4298; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Sorensen V, 2004, J CELL SCI, V117, P1807, DOI 10.1242/jcs.01047; TORIKATA C, 1977, CANCER, V40, P1194, DOI 10.1002/1097-0142(197709)40:3<1194::AID-CNCR2820400331>3.0.CO;2-7; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Yamamoto Y, 2010, CELL STRUCT FUNCT, V35, P107, DOI 10.1247/csf.10023; Zuleger N, 2012, CELL MOL LIFE SCI, V69, P2205, DOI 10.1007/s00018-012-0929-1	48	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94322	10.1371/journal.pone.0094322	http://dx.doi.org/10.1371/journal.pone.0094322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732912	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400031
J	Pogoda, M; Bosse, JB; Conzelmann, KK; Koszinowski, UH; Ruzsics, Z				Pogoda, Madlen; Bosse, Jens B.; Conzelmann, Karl-Klaus; Koszinowski, Ulrich H.; Ruzsics, Zsolt			A Modified Screening System for Loss-of-Function and Dominant Negative Alleles of Essential MCMV Genes	PLOS ONE			English	Article							TEGUMENT PROTEIN PP28; SIMPLEX-VIRUS TYPE-1; BACTERIAL ARTIFICIAL CHROMOSOME; EPSTEIN-BARR-VIRUS; HUMAN CYTOMEGALOVIRUS; ESCHERICHIA-COLI; NUCLEAR EGRESS; CYTOPLASMIC ENVELOPMENT; SECONDARY ENVELOPMENT; PSEUDORABIES VIRUS	Inactivation of gene products by dominant negative mutants is a valuable tool to assign functions to yet uncharacterized proteins, to map protein-protein interactions or to dissect physiological pathways. Detailed functional and structural knowledge about the target protein would allow the construction of inhibitory mutants by targeted mutagenesis. Yet, such data are limited for the majority of viral proteins, so that the target gene needs to be subjected to random mutagenesis to identify suitable mutants. However, for cytomegaloviruses this requires a two-step screening approach, which is time-consuming and labor-intensive. Here, we report the establishment of a high-throughput suitable screening system for the identification of inhibitory alleles of essential genes of the murine cytomegalovirus (MCMV). In this screen, the site-specific recombination of a specifically modified MCMV genome was transferred from the bacterial background to permissive host cells, thereby combining the genetic engineering and the rescue test in one step. Using a reference set of characterized pM53 mutants it was shown that the novel system is applicable to identify non-complementing as well as inhibitory mutants in a high-throughput suitable setup. The new cis-complementation assay was also applied to a basic genetic characterization of pM99, which was identified as essential for MCMV growth. We believe that the here described novel genetic screening approach can be adapted for the genetic characterization of essential genes of any large DNA viruses.	[Pogoda, Madlen; Bosse, Jens B.; Conzelmann, Karl-Klaus; Koszinowski, Ulrich H.; Ruzsics, Zsolt] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Pogoda, Madlen; Ruzsics, Zsolt] DZIF German Ctr Infect Res, Munich, Germany	University of Munich; German Center for Infection Research	Ruzsics, Z (corresponding author), Univ Munich, Max von Pettenkofer Inst, Munich, Germany.	ruzsics@mvp.uni-muenchen.de	Conzelmann, Karl-Klaus/L-7239-2013; Ruzsics, Zsolt/D-6284-2014; Bosse, Jens Bernhard/D-7336-2011	Bosse, Jens Bernhard/0000-0001-7252-5541; Conzelmann, Karl-Klaus/0000-0002-8614-3656	German Center of Infection Diseases [TTU 07-802]	German Center of Infection Diseases	This study was funded by German Center of Infection Diseases through project TTU 07-802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; BAINES JD, 1992, J VIROL, V66, P5168, DOI 10.1128/JVI.66.8.5168-5174.1992; Bertram B, 2012, J NEUROSCI METH, V209, P420, DOI 10.1016/j.jneumeth.2012.06.024; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Britt WJ, 2004, J VIROL, V78, P539, DOI 10.1128/JVI.78.1.539-543.2004; Bubeck A, 2004, J VIROL, V78, P8026, DOI 10.1128/JVI.78.15.8026-8035.2004; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chiu YF, 2012, J VIROL, V86, P9647, DOI 10.1128/JVI.01126-12; Cockrell SK, 2009, J VIROL, V83, P47, DOI 10.1128/JVI.01889-08; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Hall RN, 2012, VIRUSES-BASEL, V4, P211, DOI 10.3390/v4020211; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Jones TR, 2004, J VIROL, V78, P1488, DOI 10.1128/JVI.78.3.1488-1502.2004; Kopp M, 2003, J VIROL, V77, P5339, DOI 10.1128/JVI.77.9.5339-5351.2003; Liu YL, 2009, VIROLOGY, V388, P68, DOI 10.1016/j.virol.2009.03.007; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; MACLEAN CA, 1992, J GEN VIROL, V73, P539, DOI 10.1099/0022-1317-73-3-539; Maninger S, 2011, J VIROL, V85, P9254, DOI 10.1128/JVI.00443-11; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; McVoy MA, 1998, J VIROL, V72, P48, DOI 10.1128/JVI.72.1.48-56.1998; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Mohr H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002728; Muhlbach H, 2009, VIRUSES-BASEL, V1, P420, DOI 10.3390/v1030420; Pogoda M, 2012, J VIROL, V86, P12512, DOI 10.1128/JVI.00471-12; Popa M, 2010, J VIROL, V84, P9035, DOI 10.1128/JVI.00681-10; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; Rubinchik S, 2000, GENE THER, V7, P875, DOI 10.1038/sj.gt.3301172; Rupp B, 2005, J VIROL, V79, P486, DOI 10.1128/JVI.79.1.486-494.2005; Rupp B, 2007, J VIROL, V81, P5508, DOI 10.1128/JVI.02796-06; Ruzsics Z, 2008, CURR TOP MICROBIOL, V325, P41; Ruzsics Z, 2006, J VIROL, V80, P8100, DOI 10.1128/JVI.00687-06; Sadaoka T, 2007, J VIROL, V81, P12654, DOI 10.1128/JVI.01183-07; SADOWSKI P, 1986, J BACTERIOL, V165, P341, DOI 10.1128/jb.165.2.341-347.1986; Saeki Y, 1998, HUM GENE THER, V9, P2787, DOI 10.1089/hum.1998.9.18-2787; Schaffer P A, 1975, Curr Top Microbiol Immunol, V70, P51; Schnee M, 2006, J VIROL, V80, P11658, DOI 10.1128/JVI.01662-06; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo JY, 2007, J VIROL, V81, P6536, DOI 10.1128/JVI.02852-06; Seo JY, 2006, J VIROL, V80, P5611, DOI 10.1128/JVI.02630-05; Silva MC, 2005, P NATL ACAD SCI USA, V102, P2081, DOI 10.1073/pnas.0409597102; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Smith GA, 1999, J VIROL, V73, P6405, DOI 10.1128/JVI.73.8.6405-6414.1999; Straus SE, 2001, FIELDS VIROLOGY, P2479; TENGELSEN LA, 1993, J VIROL, V67, P3470, DOI 10.1128/JVI.67.6.3470-3480.1993; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Trompeter HI, 2003, J IMMUNOL METHODS, V274, P245, DOI 10.1016/S0022-1759(02)00431-3; Wagner M, 2002, TRENDS MICROBIOL, V10, P318, DOI 10.1016/S0966-842X(02)02394-6; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94918	10.1371/journal.pone.0094918	http://dx.doi.org/10.1371/journal.pone.0094918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733555	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400132
J	Steinberg, EE; Boivin, JR; Saunders, BT; Witten, IB; Deisseroth, K; Janak, PH				Steinberg, Elizabeth E.; Boivin, Josiah R.; Saunders, Benjamin T.; Witten, Ilana B.; Deisseroth, Karl; Janak, Patricia H.			Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus Accumbens	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; REWARD-SEEKING BEHAVIOR; GOAL-DIRECTED BEHAVIOR; VENTRAL TEGMENTAL AREA; OPTOGENETIC CONTROL; INCENTIVE SALIENCE; STRIATAL NEURONS; TERMINAL FIELDS; D-2 RECEPTORS; SYSTEMS	The neural basis of positive reinforcement is often studied in the laboratory using intracranial self-stimulation (ICSS), a simple behavioral model in which subjects perform an action in order to obtain exogenous stimulation of a specific brain area. Recently we showed that activation of ventral tegmental area (VTA) dopamine neurons supports ICSS behavior, consistent with proposed roles of this neural population in reinforcement learning. However, VTA dopamine neurons make connections with diverse brain regions, and the specific efferent target(s) that mediate the ability of dopamine neuron activation to support ICSS have not been definitively demonstrated. Here, we examine in transgenic rats whether dopamine neuron-specific ICSS relies on the connection between the VTA and the nucleus accumbens (NAc), a brain region also implicated in positive reinforcement. We find that optogenetic activation of dopaminergic terminals innervating the NAc is sufficient to drive ICSS, and that ICSS driven by optical activation of dopamine neuron somata in the VTA is significantly attenuated by intra-NAc injections of D1 or D2 receptor antagonists. These data demonstrate that the NAc is a critical efferent target sustaining dopamine neuron-specific ICSS, identify receptor subtypes through which dopamine acts to promote this behavior, and ultimately help to refine our understanding of the neural circuitry mediating positive reinforcement.	[Steinberg, Elizabeth E.; Boivin, Josiah R.; Saunders, Benjamin T.; Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Steinberg, Elizabeth E.; Boivin, Josiah R.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA USA; [Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Witten, Ilana B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Princeton University; Princeton University; Howard Hughes Medical Institute; Stanford University; Stanford University	Steinberg, EE (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	elizabeth.steinberg@stanford.edu	Core, Vector/CAF-4832-2022	Janak, Patricia/0000-0002-3333-9049; Boivin, Josiah/0000-0001-9895-4141; Saunders, Benjamin/0000-0002-4733-1101	US National Institutes of Health [DA015096, AA17072]; State of California through UCSF; National Science Foundation; National Institutes of Health; US National Institutes of Health from NIMH; US National Institutes of Health from NIDA; Michael J Fox Foundation; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149, R01DA035943, R01DA015096] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California through UCSF; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health from NIMH; US National Institutes of Health from NIDA; Michael J Fox Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by US National Institutes of Health grants DA015096, AA17072 and funds from the State of California for medical research on alcohol and substance abuse through UCSF (PHJ); an National Science Foundation Graduate Research Fellowship (EES); a National Institutes of Health New Innovator award, Pew Scholarship and Sloan Fellowship (IBW); and US National Institutes of Health grants from NIMH and NIDA, the Michael J Fox Foundation, the Howard Hughes Medical Institute, and the Defense Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program (KD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; COLLE LM, 1987, BRAIN RES, V407, P285, DOI 10.1016/0006-8993(87)91106-1; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hopf FW, 2003, J NEUROSCI, V23, P5079; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KURUMIYA S, 1988, BRAIN RES, V448, P1, DOI 10.1016/0006-8993(88)91095-5; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; NAUTA WJH, 1978, NEUROSCIENCE, V3, P385, DOI 10.1016/0306-4522(78)90041-6; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; PRADOALCALA R, 1984, BRAIN RES, V301, P209, DOI 10.1016/0006-8993(84)91089-8; PRADOALCALA R, 1984, BRAIN RES, V297, P265, DOI 10.1016/0006-8993(84)90567-5; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Rossi MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065799; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Steinberg EE, 2013, BRAIN RES, V1511, P46, DOI 10.1016/j.brainres.2012.09.036; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yun IA, 2004, EUR J NEUROSCI, V20, P249, DOI 10.1111/j.1460-9568.2004.03476.x; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang H, 2012, BASAL GANGLIA, V2, P5, DOI 10.1016/j.baga.2011.11.004	40	97	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94771	10.1371/journal.pone.0094771	http://dx.doi.org/10.1371/journal.pone.0094771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733061	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400098
J	Adams, DC; Felice, RN				Adams, Dean C.; Felice, Ryan N.			Assessing Trait Covariation and Morphological Integration on Phylogenies Using Evolutionary Covariance Matrices	PLOS ONE			English	Article							DEVELOPMENTAL MODULARITY; MORPHOMETRIC INTEGRATION; PLETHODON SALAMANDERS; CONTINUOUS CHARACTERS; CRANIAL INTEGRATION; SHAPE; BEHAVIOR; LIKELIHOOD; RATES; DIVERSIFICATION	Morphological integration describes the degree to which sets of organismal traits covary with one another. Morphological covariation may be evaluated at various levels of biological organization, but when characterizing such patterns across species at the macroevolutionary level, phylogeny must be taken into account. We outline an analytical procedure based on the evolutionary covariance matrix that allows species-level patterns of morphological integration among structures defined by sets of traits to be evaluated while accounting for the phylogenetic relationships among taxa, providing a flexible and robust complement to related phylogenetic independent contrasts based approaches. Using computer simulations under a Brownian motion model we show that statistical tests based on the approach display appropriate Type I error rates and high statistical power for detecting known levels of integration, and these trends remain consistent for simulations using different numbers of species, and for simulations that differ in the number of trait dimensions. Thus, our procedure provides a useful means of testing hypotheses of morphological integration in a phylogenetic context. We illustrate the utility of this approach by evaluating evolutionary patterns of morphological integration in head shape for a lineage of Plethodon salamanders, and find significant integration between cranial shape and mandible shape. Finally, computer code written in R for implementing the procedure is provided.	[Adams, Dean C.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Felice, Ryan N.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	Iowa State University; University System of Ohio; Ohio University	Adams, DC (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	dcadams@iastate.edu	Felice, Ryan/ABG-9737-2021	Dean, Adams/0000-0001-9172-7894	National Science Foundation [DEB-1257827, DEB-111884]	National Science Foundation(National Science Foundation (NSF))	DCA received support from National Science Foundation grants DEB-1257827 and DEB-111884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D. C., 2012, GEOMORPH SOFTWARE GE; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P383; Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Adams DC, 1999, EVOL ECOL RES, V1, P959; Adams DC, 2014, SYSTEMATIC IN PRESS; Adams DC, 2007, J ANIM ECOL, V76, P289, DOI 10.1111/j.1365-2656.2007.01210.x; Adams DC, 2014, SYST BIOL, V63, P166, DOI 10.1093/sysbio/syt105; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2013, SYST BIOL, V62, P181, DOI 10.1093/sysbio/sys083; Adams DC, 2011, EVOL BIOL, V38, P278, DOI 10.1007/s11692-011-9120-0; Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-72; Anthony CD, 1997, BEHAVIOUR, V134, P71, DOI 10.1163/156853997X00287; Arif S, 2007, EVOL ECOL RES, V9, P843; Arnqvist G, 2002, EVOLUTION, V56, P936; Blomberg SP, 2012, SYST BIOL, V61, P382, DOI 10.1093/sysbio/syr118; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, DEV PSYCHOL, V32, P404; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chernoff B, 1999, MORPHOLOGICAL INTEGR, P316; Cheverud JM, 1996, AM ZOOL, V36, P44; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Deitloff J, 2013, HERPETOLOGICA, V69, P1; Dornburg A, 2011, EVOLUTION, V65, P1912, DOI 10.1111/j.1558-5646.2011.01275.x; Edwards A. W. F., 1964, PHENETIC PHYLOGENETI, P67; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fischer-Rousseau L, 2009, EVOL DEV, V11, P740, DOI 10.1111/j.1525-142X.2009.00381.x; Fruciano C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069376; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gomez-Robles A, 2012, EVOLUTION, V66, P1024, DOI 10.1111/j.1558-5646.2011.01508.x; Goswami A, 2006, EVOLUTION, V60, P169; Hallgrimsson B, 2002, YEARB PHYS ANTHROPOL, V45, P131, DOI 10.1002/ajpa.10182; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hohenlohe PA, 2008, AM NAT, V171, P366, DOI 10.1086/527498; JAEGER RG, 1993, HERPETOLOGICA, V49, P163; JAEGER RG, 1982, ANIM BEHAV, V30, P490, DOI 10.1016/S0003-3472(82)80061-4; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2013, HYSTRIX, V24, P43, DOI 10.4404/hystrix-24.1-6367; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Laffont R, 2009, EVOL DEV, V11, P302, DOI 10.1111/j.1525-142X.2009.00332.x; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Maerz JC, 2006, EVOL ECOL RES, V8, P23; MAGLIA AM, 1995, J EXP ZOOL, V272, P167, DOI 10.1002/jez.1402720302; Magwene PM, 2009, SYST BIOL, V58, P146, DOI 10.1093/sysbio/syp007; Magwene PM, 2001, EVOLUTION, V55, P1734; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Meloro C, 2011, EVOL BIOL, V38, P465, DOI 10.1007/s11692-011-9135-6; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2012, EVOL BIOL, V39, P536, DOI 10.1007/s11692-012-9178-3; Monteiro LR, 2010, EVOLUTION, V64, P724, DOI 10.1111/j.1558-5646.2009.00857.x; Monteiro LR, 2013, HYSTRIX, V24, P25, DOI 10.4404/hystrix-24.1-6282; Monteiro LR, 2005, EVOL DEV, V7, P429, DOI 10.1111/j.1525-142X.2005.05047.x; Myers EM, 2008, HERPETOLOGICA, V64, P281, DOI 10.1655/07-080.1; NISHIKAWA KC, 1985, EVOLUTION, V39, P1282, DOI 10.1111/j.1558-5646.1985.tb05694.x; Nogueira MR, 2009, FUNCT ECOL, V23, P715, DOI 10.1111/j.1365-2435.2009.01549.x; O'Meara BC, 2006, EVOLUTION, V60, P922; Olson E. C., 1958, MORPHOLOGICAL INTEGR; OLSON EC, 1951, EVOLUTION, V5, P325, DOI 10.2307/2405677; Parsons KJ, 2012, AM NAT, V179, P64, DOI 10.1086/663200; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Revell LJ, 2008, AM NAT, V172, P140, DOI 10.1086/588078; Revell LJ, 2008, EVOL ECOL RES, V10, P311; Revell LJ, 2008, BIOINFORMATICS, V24, P1018, DOI 10.1093/bioinformatics/btn065; Revell LJ, 2009, EVOLUTION, V63, P1090, DOI 10.1111/j.1558-5646.2009.00616.x; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Santana SE, 2013, J EVOLUTION BIOL, V26, P2520, DOI 10.1111/jeb.12235; Thomas GH, 2006, P ROY SOC B-BIOL SCI, V273, P1619, DOI 10.1098/rspb.2006.3488; Wiens JJ, 2006, EVOLUTION, V60, P2585; Young RL, 2006, EVOLUTION, V60, P1291, DOI 10.1111/j.0014-3820.2006.tb01206.x; Zelditch ML, 2008, EVOL DEV, V10, P756, DOI 10.1111/j.1525-142X.2008.00290.x	86	118	118	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94335	10.1371/journal.pone.0094335	http://dx.doi.org/10.1371/journal.pone.0094335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728003	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200065
J	Dorazio, RM; Connor, EF				Dorazio, Robert M.; Connor, Edward F.			Estimating Abundances of Interacting Species Using Morphological Traits, Foraging Guilds, and Habitat	PLOS ONE			English	Article							NULL MODEL ANALYSIS; COOCCURRENCE PATTERNS; BIOLOGICAL DIVERSITY; CENSUS-DATA; COMMUNITIES; LANDSCAPE; ASSEMBLAGES; COMPETITION; FOREST; BIRDS	We developed a statistical model to estimate the abundances of potentially interacting species encountered while conducting point-count surveys at a set of ecologically relevant locations - as in a metacommunity of species. In the model we assume that abundances of species with similar traits (e. g., body size) are potentially correlated and that these correlations, when present, may exist among all species or only among functionally related species (such as members of the same foraging guild). We also assume that species-specific abundances vary among locations owing to systematic and stochastic sources of heterogeneity. For example, if abundances differ among locations due to differences in habitat, then measures of habitat may be included in the model as covariates. Naturally, the quantitative effects of these covariates are assumed to differ among species. Our model also accounts for the effects of detectability on the observed counts of each species. This aspect of the model is especially important for rare or uncommon species that may be difficult to detect in community-level surveys. Estimating the detectability of each species requires sampling locations to be surveyed repeatedly using different observers or different visits of a single observer. As an illustration, we fitted models to species-specific counts of birds obtained while sampling an avian community during the breeding season. In the analysis we examined whether species abundances appeared to be correlated due to similarities in morphological measures (body mass, beak length, tarsus length, wing length, tail length) and whether these correlations existed among all species or only among species of the same foraging guild. We also used the model to estimate the effects of forested area on species abundances and the effects of sound power output (as measured by body size) on species detection probabilities.	[Dorazio, Robert M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA; [Connor, Edward F.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	United States Department of the Interior; United States Geological Survey; California State University System; San Francisco State University	Dorazio, RM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA.	bdorazio@usgs.gov			National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; U.S. Geological Survey's Status and Trends program; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; U.S. Geological Survey's Status and Trends program; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as a part of the Binary Matrices Working Group at the National Institute for Mathematical and Biological Synthesis, sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. One author (RD) also received financial support from the U.S. Geological Survey's Status and Trends program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1989, BIOMETRIKA, V76, P643; ASKINS RA, 1987, BIOL CONSERV, V39, P129, DOI 10.1016/0006-3207(87)90030-9; Barnagaud JY, 2014, ECOLOGY, V95, P78, DOI 10.1890/13-0791.1; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; CALDER WA, 1990, ECOLOGY, V71, P1810; Carvell C, 2002, BIOL CONSERV, V103, P33, DOI 10.1016/S0006-3207(01)00114-8; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Clausen HD, 2001, BIOL CONSERV, V98, P167, DOI 10.1016/S0006-3207(00)00151-8; COLE LC, 1949, ECOLOGY, V30, P411, DOI 10.2307/1932444; Collinge SK, 2003, CONSERV BIOL, V17, P178, DOI 10.1046/j.1523-1739.2003.01315.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Dallimer M, 2012, ECOGRAPHY, V35, P134, DOI 10.1111/j.1600-0587.2011.07040.x; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; Diamond J.M., 1975, P342; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Dorazio RM, 2010, ECOLOGY, V91, P2466, DOI 10.1890/09-1033.1; Dunning J.B., 2007, CRC HDB AVIAN BODY M; Engen S, 2002, AM NAT, V160, P60, DOI 10.1086/340612; Fox BJ, 1996, OIKOS, V77, P291, DOI 10.2307/3546068; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Geyer CJ, 2011, CH CRC HANDB MOD STA, P3; GILPIN ME, 1982, OECOLOGIA, V52, P75, DOI 10.1007/BF00349014; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Gotelli NJ, 2010, PHILOS T R SOC B, V365, P3621, DOI 10.1098/rstb.2010.0262; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2013, ECOSIMR 1 00; Graham CH, 2001, ECOL APPL, V11, P1709, DOI 10.1890/1051-0761(2001)011[1709:IOPALL]2.0.CO;2; GRAVES GR, 1993, P NATL ACAD SCI USA, V90, P1388, DOI 10.1073/pnas.90.4.1388; Hausdorf B, 2007, OIKOS, V116, P818, DOI 10.1111/j.2007.0030-1299.15661.x; Haven Wiley R., 1982, P131; He FL, 2003, AM NAT, V162, P366, DOI 10.1086/377190; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Kirk DA, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00503-070104; Lester Philip J., 2009, BMC Ecology, V9, P3, DOI 10.1186/1472-6785-9-3; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; Mutshinda CM, 2011, OECOLOGIA, V166, P241, DOI 10.1007/s00442-010-1831-x; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Poole A., 2005, BIRDS N AM ONLINE; Ribeiro DB, 2012, BIODIVERS CONSERV, V21, P811, DOI 10.1007/s10531-011-0222-x; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ricklefs RE, 2011, P NATL ACAD SCI USA, V108, P2300, DOI 10.1073/pnas.1018642108; Rickman JK, 2003, ECOGRAPHY, V26, P777, DOI 10.1111/j.0906-7590.2003.03345.x; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Schmidt A.M., 2011, BAYESIAN STAT, P611; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Shenbrot G, 2002, OIKOS, V99, P47, DOI 10.1034/j.1600-0706.2002.990105.x; SIMBERLOFF DS, 1970, EVOLUTION, V24, P23, DOI 10.1111/j.1558-5646.1970.tb01738.x; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Tworek S, 2002, ECOL RES, V17, P339, DOI 10.1046/j.1440-1703.2002.00493.x; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wikle CK, 2010, CH CRC HANDB MOD STA, P89; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wisheu IC, 1998, OIKOS, V83, P246, DOI 10.2307/3546836; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	66	17	17	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94323	10.1371/journal.pone.0094323	http://dx.doi.org/10.1371/journal.pone.0094323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727898	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200063
J	Kolodziejczyk, K; Parsons, MP; Southwell, AL; Hayden, MR; Raymond, LA				Kolodziejczyk, Karolina; Parsons, Matthew P.; Southwell, Amber L.; Hayden, Michael R.; Raymond, Lynn A.			Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease	PLOS ONE			English	Article							NMDA RECEPTOR FUNCTION; MUTANT HUNTINGTIN; DEPENDENT ALTERATIONS; TRANSGENIC MICE; REPEAT-LENGTH; LOCALIZATION; ACTIVATION; TOXICITY; MUTATION; CALPAIN	Huntington disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in the gene (HTT) encoding the huntingtin protein (HTT). This mutation leads to multiple cellular and synaptic alterations that are mimicked in many current HD animal models. However, the most commonly used, well-characterized HD models do not accurately reproduce the genetics of human disease. Recently, a new 'humanized' mouse model, termed Hu97/18, has been developed that genetically recapitulates human HD, including two human HTT alleles, no mouse Hdh alleles and heterozygosity of the HD mutation. Previously, behavioral and neuropathological testing in Hu97/18 mice revealed many features of HD, yet no electrophysiological measures were employed to investigate possible synaptic alterations. Here, we describe electrophysiological changes in the striatum and hippocampus of the Hu97/18 mice. At 9 months of age, a stage when cognitive deficits are fully developed and motor dysfunction is also evident, Hu97/18 striatal spiny projection neurons (SPNs) exhibited small changes in membrane properties and lower amplitude and frequency of spontaneous excitatory postsynaptic currents (sEPSCs); however, release probability from presynaptic terminals was unaltered. Strikingly, these mice also exhibited a profound deficiency in long-term potentiation (LTP) at CA3-to-CA1 synapses. In contrast, at 6 months of age we found only subtle alterations in SPN synaptic transmission, while 3-month old animals did not display any electrophysiologically detectable changes in the striatum and CA1 LTP was intact. Together, these data reveal robust, progressive deficits in synaptic function and plasticity in Hu97/18 mice, consistent with previously reported behavioral abnormalities, and suggest an optimal age (9 months) for future electrophysiological assessment in preclinical studies of HD.	[Kolodziejczyk, Karolina; Parsons, Matthew P.; Raymond, Lynn A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada; [Southwell, Amber L.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia	Raymond, LA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada.	lynn.raymond@ubc.ca	Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Raymond, Lynn A./R-6707-2016	Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A./0000-0002-8610-1042; Southwell, Amber/0000-0002-6353-5008	Canadian Institutes of Health Research [MOP-12699, MOP-84438]; Cure Huntington Disease Foundation; Michael Smith Foundation for Health Research Fellowship Award; Huntington Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cure Huntington Disease Foundation; Michael Smith Foundation for Health Research Fellowship Award; Huntington Society of Canada	Funding was provided by the Canadian Institutes of Health Research (MOP-12699 to L. A. R. and MOP-84438 to M. R. H.) and the Cure Huntington Disease Foundation (M. R. H.). M. P. P was supported by a Michael Smith Foundation for Health Research Fellowship Award. A. L. S. was supported by a Michael Smith Foundation for Health Research Fellowship Award, Canadian Institutes of Health Research and Huntington Society of Canada. CHDI: http://chdifoundation.org/ CIHR: http://www.cihr-irsc.gc.ca/ MSF: http://www.msfhr.org/ HSC: http://huntingtonsociety.ca/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Cowan CM, 2008, J NEUROSCI, V28, P12725, DOI 10.1523/JNEUROSCI.4619-08.2008; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Cummings DM, 2010, ASN NEURO, V2, P147, DOI 10.1042/AN20100007; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Di Filippo M, 2007, CURR OPIN PHARMACOL, V7, P106, DOI 10.1016/j.coph.2006.08.010; Ghiglieri V, 2012, NEUROSCIENCE, V211, P165, DOI 10.1016/j.neuroscience.2011.06.075; Gladding CM, 2012, HUM MOL GENET, V21, P3739, DOI 10.1093/hmg/dds154; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Joshi PR, 2009, J NEUROSCI, V29, P2414, DOI 10.1523/JNEUROSCI.5687-08.2009; Kiraly DD, 2011, J NEUROSCI, V31, P12554, DOI 10.1523/JNEUROSCI.3143-11.2011; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Martinez T, 2013, HUM GENET, V132, P481, DOI 10.1007/s00439-013-1288-1; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	40	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94562	10.1371/journal.pone.0094562	http://dx.doi.org/10.1371/journal.pone.0094562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728353	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200095
J	Yeh, JJ; Neoh, CA; Chen, CR; Chou, CYT; Wu, MT				Yeh, Jun-Jun; Neoh, Choo-Aun; Chen, Cheng-Ren; Chou, Christine Yi-Ting; Wu, Ming-Ting			A High Resolution Computer Tomography Scoring System to Predict Culture-Positive Pulmonary Tuberculosis in the Emergency Department	PLOS ONE			English	Article							ACUTE RESPIRATORY ILLNESS; IMMUNOCOMPROMISED PATIENTS; FLEISCHNER-SOCIETY; DIAGNOSTIC-TESTS; LUNG-DISEASE; CHEST CT; PNEUMONIA; MANAGEMENT; UTILITY; RISK	This study evaluated the use of high-resolution computed tomography (HRCT) to predict the presence of culture-positive pulmonary tuberculosis (PTB) in adult patients with pulmonary lesions in the emergency department (ED). The study included a derivation phase and validation phase with a total of 8,245 patients with pulmonary disease. There were 132 patients with culture-positive PTB in the derivation phase and 147 patients with culture-positive PTB in the validation phase. Imaging evaluation of pulmonary lesions included morphology and segmental distribution. The post-test probability ratios between both phases in three prevalence areas were analyzed. In the derivation phase, a multivariate analysis model identified cavitation, consolidation, and clusters/nodules in right or left upper lobe (except anterior segment) and consolidation of the superior segment of the right or left lower lobe as independent positive factors for culture-positive PTB, while consolidation of the right or left lower lobe (except superior segment) were independent negative factors. An ideal cutoff point based on the receiver operating characteristic (ROC) curve analysis was obtained at a score of 1. The sensitivity, specificity, positivity predictive value, and negative predictive value from derivation phase were 98.5% (130/132), 99.7% (3997/4008), 92.2% (130/141), and 99.9% (3997/3999). Based on the predicted positive likelihood ratio value of 328.33 in derivation phase, the post-test probability was observed to be 91.5% in the derivation phase, 92.5% in the validation phase, 94.5% in a high TB prevalence area, 91.0% in a moderate prevalence area, and 76.8% in moderate-to-low prevalence area. Our model using HRCT, which is feasible to perform in the ED, can promptly diagnose culture-positive PTB in moderate and moderate-to-low prevalence areas.	[Yeh, Jun-Jun; Chen, Cheng-Ren] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Yeh, Jun-Jun; Neoh, Choo-Aun] Pingtung Christian Hosp, Pingtung, Taiwan; [Chou, Christine Yi-Ting] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu, Ming-Ting] Kaohsiung Vet Gen Hosp, Sect Thorac & Circulat Imaging, Dept Radiol, Kaohsiung, Taiwan	Chia Nan University of Pharmacy & Science; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Yeh, JJ (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan.	anvin.funlan@msa.hinet.net; wu.mingting@gmail.com	Wu, Ming-Ting/C-5428-2009	Wu, Ming-Ting/0000-0002-2850-1400				Agoritsas T, 2011, J GEN INTERN MED, V26, P373, DOI 10.1007/s11606-010-1540-5; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Arroll B, 2012, J PRIM HEALTH CARE, V4, P166, DOI 10.1071/HC12166; CORCORAN HL, 1992, RADIOGRAPHICS, V12, P917, DOI 10.1148/radiographics.12.5.1529134; Davidson M, 2002, AUST J PHYSIOTHER, V48, P227, DOI 10.1016/S0004-9514(14)60228-2; Coelho LOD, 2009, J BRAS PNEUMOL, V35, P431, DOI 10.1590/S1806-37132009000500007; Elicker Brett, 2008, J. bras. pneumol., V34, P715; ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hauser M, 1996, SCHWEIZ MED WSCHR, V126, P398; Heitkamp DE, 2012, J AM COLL RADIOL, V9, P164, DOI 10.1016/j.jacr.2011.12.005; IKEZOE J, 1992, AM J ROENTGENOL, V159, P1175, DOI 10.2214/ajr.159.6.1442377; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Kirsch J, 2011, J THORAC IMAG, V26, pW42, DOI 10.1097/RTI.0b013e31820ffe0f; Kowada A, 2013, EUR J RADIOL, V82, P1353, DOI 10.1016/j.ejrad.2013.02.017; Lee KS, 1996, CHEST, V110, P977, DOI 10.1378/chest.110.4.977; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; Mayo JR, 2003, RADIOLOGY, V228, P15, DOI 10.1148/radiol.2281020874; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; MORAN GJ, 1995, ANN EMERG MED, V26, P290, DOI 10.1016/S0196-0644(95)70074-9; Moran GJ, 2008, INFECT DIS CLIN N AM, V22, P53, DOI 10.1016/j.idc.2007.10.003; Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027; Nakanishi M, 2010, EUR J RADIOL, V73, P545, DOI 10.1016/j.ejrad.2008.12.009; Nishino M, 2013, EUR J RADIOL; PADLEY S, 1995, BRIT J RADIOL, V68, P105, DOI 10.1259/0007-1285-68-806-105; Paulo Sergio, 2004, Rev Port Cardiol, V23, P1187; Piatek AS, 2013, GLOB HEALTH-SCI PRAC, V1, P18, DOI 10.9745/GHSP-D-12-00004; Pinto LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054235; Poey C, 1997, J COMPUT ASSIST TOMO, V21, P601, DOI 10.1097/00004728-199707000-00014; PRIMACK SL, 1994, RADIOL CLIN N AM, V32, P731; Shimura S, 1998, INTERNAL MED, V37, P901, DOI 10.2169/internalmedicine.37.901; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; Thomson RM, 2009, RESPIROLOGY, V14, P12, DOI 10.1111/j.1440-1843.2008.01408.x; Verbakel JY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-10; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453; World Health Organization, 1994, WHO TUB PROGR FRAM E; WORTHY S, 1995, SEMIN ULTRASOUND CT, V16, P353, DOI 10.1016/0887-2171(95)90024-1; Yeh JJ, 2012, EUR J RADIOL, V81, P195, DOI 10.1016/j.ejrad.2010.09.040; Yeh JJ, 2010, EUR RADIOL, V20, P2135, DOI 10.1007/s00330-010-1796-5	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93847	10.1371/journal.pone.0093847	http://dx.doi.org/10.1371/journal.pone.0093847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727951	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200028
J	Yu, J; Hu, SL; Ma, K; Sun, LC; Hu, HX; Zou, FF; Guo, Q; Lei, ZT; Zhou, D; Sun, Y; Zhang, DH; Ma, L; Shen, B; Zhu, CL				Yu, Jing; Hu, Shengli; Ma, Kai; Sun, Linchun; Hu, Hongxia; Zou, Feifei; Guo, Qin; Lei, Zhentao; Zhou, Dan; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang			Ribosomal Protein S29 Regulates Metabolic Insecticide Resistance through Binding and Degradation of CYP6N3	PLOS ONE			English	Article							PURIFICATION; PROTEASOME	Background: Many diseases are transmitted by mosquitoes, including malaria, dengue fever, yellow fever, filariasis, and West Nile fever. Chemical control plays a major role in managing mosquito-borne diseases. However, excessive and continuous application of insecticides has caused the development of insecticide resistance in many species including mosquito, and this has become the major obstacle to controlling mosquito-borne diseases. Insecticide resistance is the result of complex polygenic inheritance, and the mechanisms are not well understood. Ribosomal protein RPS29 was found to be associated with DM resistance in our previous study. In this study, we aim to further investigate the involvement of RPS29 in deltamethrin resistance. Methodology and Principal Findings: In this study, tandem affinity purification was used to identify proteins that can interact with RPS29. Among the candidate proteins, CYP6N3, a member of the CYP450 superfamily, was identified, and binding to RPS29 was confirmed in vitro and in vivo by GST pull-down and immunofluorescence. CCK-8 assay was used to investigate the RPS29-CTP6N3 interaction in relation to DM resistance. CYP6N3 overexpression significantly enhanced DM resistance and insect cell viability, but this was reversed by RPS29 overexpression. Western blot was used to study the mechanism of interaction between RPS29 and CYP6N3. RPS29 increases CYP6N3 protein degradation through the proteasome. Conclusions and Significance: These observations indicate that CYP6N3, a novel RPS29-interacting partner, could stimulate deltamethrin resistance in mosquito cells and RPS29 overexpression targeted CYP6N3 for proteosomal degradation, abrogating the CYP6N3-associated resistence to deltamethrin. Our findings provide a novel mechanism associated with CYP450s mediated DM resistance.	[Yu, Jing; Hu, Shengli; Ma, Kai; Hu, Hongxia; Zou, Feifei; Guo, Qin; Lei, Zhentao; Zhou, Dan; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Sun, Linchun] Nanjing Med Univ, Pediat Res Ctr, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shen, B (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	shenbo@njmu.edu.cn; clzhu@njmu.edu.cn			National Institutes of Health (NIH) of the United States [2R01AI075746-05]; National Natural Science Foundation of China [30901244, 30972564, 81171900, 81101279]; National S & T Major Program [2012ZX10004-219, 2008ZX10004-010, 2012ZX10004-220, 2008ZX10004-011]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113234120007]; Natural Science Foundation of Jiangsu Province [81101279]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health (NIH) of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) of the United States (Grant No. 2R01AI075746-05), the National Natural Science Foundation of China (Grant Nos. 30901244, 30972564, 81171900 and 81101279), the National S & T Major Program (Grant Nos. 2012ZX10004-219, 2008ZX10004-010, 2012ZX10004-220 and 2008ZX10004-011), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20113234120007), the Natural Science Foundation of Jiangsu Province (Grant No. 81101279), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Dahlmann B, 2005, ESSAYS BIOCHEM, V41, P31, DOI 10.1042/EB0410031; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Khanna N, 2003, BIOCHEM BIOPH RES CO, V304, P26, DOI 10.1016/S0006-291X(03)00532-1; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; KOSTYUKOV M A, 1986, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P76; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Mangiarotti G, 2003, BIOCHEM J, V370, P713, DOI 10.1042/BJ20020638; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Matambo TS, 2010, GENET MOL RES, V9, P554, DOI 10.4238/vol9-1gmr719; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stolk WA, 2005, AM J TROP MED HYG, V73, P881, DOI 10.4269/ajtmh.2005.73.881; Sun HB, 2011, PARASITOL RES, V109, P1689, DOI 10.1007/s00436-011-2443-z; Tian H S, 2001, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V19, P193; Wang XJ, 2013, CIRC RES, V112, P367, DOI 10.1161/CIRCRESAHA.112.268706; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Zhong DB, 2013, PLOS ONE, V8	32	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94611	10.1371/journal.pone.0094611	http://dx.doi.org/10.1371/journal.pone.0094611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728095	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200108
J	Zhang, R; Lee, JY; Wang, XF; Xu, WH; Hu, XX; Lu, XL; Niu, YM; Tang, RR; Li, SB; Li, Y				Zhang, Rui; Lee, Ji-Yun; Wang, Xianfu; Xu, Weihong; Hu, Xiaoxia; Lu, Xianglan; Niu, Yimeng; Tang, Rurong; Li, Shibo; Li, Yan			Identification of Novel Genomic Aberrations in AML-M5 in a Level of Array CGH	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SQUAMOUS-CELL CARCINOMA; COPY NUMBER ALTERATIONS; ACUTE LYMPHOBLASTIC-LEUKEMIA; WORLD-HEALTH-ORGANIZATION; ADULT ACUTE-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; HYBRIDIZATION; REVEALS; CLASSIFICATION	To assess the possible existence of unbalanced chromosomal abnormalities and delineate the characterization of copy number alterations (CNAs) of acute myeloid leukemia-M5 (AML-M5), R-banding karyotype, oligonucelotide array CGH and FISH were performed in 24 patients with AML-M5. A total of 117 CNAs with size ranging from 0.004 to 146.263 Mb was recognized in 12 of 24 cases, involving all chromosomes other than chromosome 1, 4, X and Y. Cryptic CNAs with size less than 5 Mb accounted for 59.8% of all the CNAs. 12 recurrent chromosomal alterations were mapped. Seven out of them were described in the previous AML studies and five were new candidate AML-M5 associated CNAs, including gains of 3q26.2-qter and 13q31.3 as well as losses of 2q24.2, 8p12 and 14q32. Amplication of 3q26.2-qter was the sole large recurrent chromosomal anomaly and the pathogenic mechanism in AML-M5 was possibly different from the classical recurrent 3q21q26 abnormality in AML. As a tumor suppressor gene, FOXN3, was singled out from the small recurrent CNA of 14q32, however, it is proved that deletion of FOXN3 is a common marker of myeloid leukemia rather than a specific marker for AML-M5 subtype. Moreover, the concurrent amplication of MLL and deletion of CDKN2A were noted and it might be associated with AML-M5. The number of CNA did not show a significant association with clinico-biological parameters and CR number of the 22 patients received chemotherapy. This study provided the evidence that array CGH served as a complementary platform for routine cytogenetic analysis to identify those cryptic alterations in the patients with AML-M5. As a subtype of AML, AML-M5 carries both common recurrent CNAs and unique CNAs, which may harbor novel oncogenes or tumor suppressor genes. Clarifying the role of these genes will contribute to the understanding of leukemogenic network of AML-M5.	[Zhang, Rui; Niu, Yimeng; Tang, Rurong; Li, Yan] China Med Univ, Affiliated Hosp 1, Dept Hematol, Shenyang, Liaoning, Peoples R China; [Zhang, Rui; Lee, Ji-Yun; Wang, Xianfu; Xu, Weihong; Hu, Xiaoxia; Lu, Xianglan; Li, Shibo] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Lee, Ji-Yun] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea	China Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Korea University; Korea University Medicine (KU Medicine)	Li, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Hematol, Shenyang, Liaoning, Peoples R China.	liyan2@medmail.com.cn			Science and Technology Project of Shenyang [F12-277-1-21]; National Natural Science Foundation of China (NSFC) [81170519]	Science and Technology Project of Shenyang; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the "Science and Technology Project of Shenyang" grant (grant number: F12-277-1-21) (URL: www.systplan.gov.cn) and the National Natural Science Foundation of China (NSFC)(grant number: 81170519). The supplementary FISH and PCR tests in this study were supported by these funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P213, DOI 10.3324/haematol.13024; Armengol G, 2010, LEUKEMIA LYMPHOMA, V51, P114, DOI 10.3109/10428190903350397; Bajaj R, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-3; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Chang JT, 2005, INT J CANCER, V114, P942, DOI 10.1002/ijc.20663; Chim CS, 2001, CANCER, V91, P2222, DOI 10.1002/1097-0142(20010615)91:12<2222::AID-CNCR1252>3.0.CO;2-R; De Braekeleer E, 2013, ANTICANCER RES, V33, P639; Gross M, 2009, INT J ONCOL, V34, P417, DOI 10.3892/ijo_00000165; Huang KF, 2007, J FORMOS MED ASSOC, V106, P894, DOI 10.1016/S0929-6646(08)60059-5; HURET JL, 2005, ATLAS GENET CYTOGENE, DOI DOI 10.4267/2042/38290; HURET JL, 2003, ATLAS GENET CYTOGENE, DOI DOI 10.4267/2042/38020; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Itzhar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016623; Kearney L, 2005, CHROMOSOMA, V114, P286, DOI 10.1007/s00412-005-0002-z; Kim M, 2009, CANCER GENET CYTOGEN, V195, P59, DOI 10.1016/j.cancergencyto.2009.06.013; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Lu Ying, 2010, Zhejiang Da Xue Xue Bao Yi Xue Ban, V39, P241; Matteucci C, 2010, BRIT J HAEMATOL, V149, P70, DOI 10.1111/j.1365-2141.2009.08056.x; Mrozek K, 2008, SEMIN ONCOL, V35, P365, DOI 10.1053/j.seminoncol.2008.04.007; Noutomi Y, 2006, J PATHOL, V210, P67, DOI 10.1002/path.2015; Pati D, 1997, MOL CELL BIOL, V17, P3037, DOI 10.1128/MCB.17.6.3037; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Schiffman JD, 2009, CANCER GENET CYTOGEN, V193, P9, DOI 10.1016/j.cancergencyto.2009.03.005; Scott KL, 2005, GENE, V359, P119, DOI 10.1016/j.gene.2005.06.014; Slovak ML, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-23; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Suela J, 2007, LEUKEMIA, V21, P1224, DOI 10.1038/sj.leu.2404653; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Tyybakinoja A, 2007, LEUKEMIA, V21, P571, DOI 10.1038/sj.leu.2404543; Ueno T, 2002, CLIN CANCER RES, V8, P526; Usvasalo A, 2010, LEUKEMIA RES, V34, P1476, DOI 10.1016/j.leukres.2010.02.031; Usvasalo A, 2010, GENE CHROMOSOME CANC, V49, P309, DOI 10.1002/gcc.20741; Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Yasar D, 2010, CANCER GENET CYTOGEN, V197, P122, DOI 10.1016/j.cancergencyto.2009.11.018	38	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e87637	10.1371/journal.pone.0087637	http://dx.doi.org/10.1371/journal.pone.0087637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727659	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200002
J	Chiu, HY; Hsu, HY; Kuo, LC; Su, FC; Yu, HI; Hua, SC; Lu, CH				Chiu, Haw-Yen; Hsu, Hsiu-Yun; Kuo, Li-Chieh; Su, Fong-Chin; Yu, Hui-I; Hua, Shih-Che; Lu, Chieh-Hsiang			How the Impact of Median Neuropathy on Sensorimotor Control Capability of Hands for Diabetes: An Achievable Assessment from Functional Perspectives	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; PERIPHERAL NEUROPATHY; PRECISION GRIP; SUBCLINICAL NEUROPATHY; MELLITUS; FORCE; COORDINATION; DIAGNOSIS; COMPLICATIONS; MANIPULATION	To comprehend the sensorimotor control ability in diabetic hands, this study investigated the sensation, motor function and precision pinch performances derived from a pinch-holding-up activity (PHUA) test of the hands of diabetic patients and healthy subjects. The precision, sensitivity and specificity of the PHUA test in the measurements of diabetic patients were also analyzed. We hypothesized that the diabetic hands would have impacts on the sensorimotor functions of the hand performances under functionally quantitative measurements. One hundred and fifty-nine patients with clinically defined diabetes mellitus (DM) and 95 age-and gender-matched healthy controls were included. Semmes-Weinstein monofilament (SWM), static and moving two-point discrimination (S2PD and M2PD), maximal pinch strength and precision pinch performance tests were conducted to evaluate the sensation, motor and sensorimotor status of the recruited hands. The results showed that there were significant differences (all p<0.05) in SWM, S2PD, M2PD and maximum pinch strength between the DM and control groups. A higher force ratio in the DM patients than in the controls (p<0.001) revealed a poor ability of pinch force adjustment in the DM patients. The percentage of maximal pinch strength was also significantly different (p<0.001) between the DM and control groups. The sensitivity, specificity and area under the receiver operating characteristic curve were 0.85, 0.51, and 0.724, respectively, for the PHUA test. Statistically significant degradations in sensory and motor functions and sensorimotor control ability were observed in the hands of the diabetic patients. The PHUA test could be feasibly used as a clinical tool to determine the sensorimotor function of the hands of diabetic patients from a functional perspective.	[Chiu, Haw-Yen] Chi Mei Med Ctr, Dept Surg, Sect Plast Surg, Tainan, Taiwan; [Hsu, Hsiu-Yun] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Hsu, Hsiu-Yun; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan; [Kuo, Li-Chieh; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Yu, Hui-I; Hua, Shih-Che; Lu, Chieh-Hsiang] Chiayi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Chiayi, Taiwan; [Lu, Chieh-Hsiang] Natl Chung Cheng Univ, Coll Management, Dept Business Adm, Chiayi, Chiayi County, Taiwan; [Lu, Chieh-Hsiang] Ta Tung Inst Commerce & Technol, Chiayi, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chia-Yi Christian Hospital; National Chung Cheng University	Lu, CH (corresponding author), Chiayi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Chiayi, Taiwan.	chhslu@gmail.com	SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021; Hsu, Hsiu-Yun/AGZ-2698-2022	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Kuo, Li-Chieh/0000-0002-5644-655X	Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan	Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan	This work was supported by a research grant from the Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Bertora P, 1998, J NEUROL, V245, P81, DOI 10.1007/s004150050182; BORSEY DQ, 1983, DIABETES CARE, V6, P10, DOI 10.2337/diacare.6.1.10; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Cederlund RI, 2009, J DIABETES COMPLICAT, V23, P32, DOI 10.1016/j.jdiacomp.2007.09.002; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Cheliout-Heraut F, 2005, JOINT BONE SPINE, V72, P412, DOI 10.1016/j.jbspin.2004.10.003; Chiu HY, 2009, J ORTHOP RES, V27, P1116, DOI 10.1002/jor.20859; De Vegt F, 1998, DIABETES CARE, V21, P1686, DOI 10.2337/diacare.21.10.1686; El-Salem K, 2009, J CLIN NEUROPHYSIOL, V26, P50, DOI 10.1097/WNP.0b013e31819862ee; Fitzgibbons PG, 2008, J HAND SURG-AM, V33A, P771, DOI 10.1016/j.jhsa.2008.01.038; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P632, DOI 10.2106/00004623-198365050-00008; Gibbons CH, 2010, DIABETES CARE, V33, P2629, DOI 10.2337/dc10-0763; Hsu HY, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-26; JABLECKI CK, 1993, MUSCLE NERVE, V16, P1392; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Jurado J, 2009, EUR J CLIN INVEST, V39, P183, DOI 10.1111/j.1365-2362.2008.02074.x; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Lee SY, 2003, J KOREAN MED SCI, V18, P103; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; MCPHEE SD, 1987, AM J OCCUP THER, V41, P158, DOI 10.5014/ajot.41.3.158; Moharic M, 2012, J DIABETES COMPLICAT, V26, P319, DOI 10.1016/j.jdiacomp.2012.04.008; Nowak DA, 2005, MOVEMENT DISORD, V20, P11, DOI 10.1002/mds.20299; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; PIRART J, 1977, DIABETES METAB, V3, P245; Redmond CL, 2012, J DIABETES COMPLICAT, V26, P313, DOI 10.1016/j.jdiacomp.2012.04.009; Redmond CL, 2009, J RHEUMATOL, V36, P2766, DOI 10.3899/jrheum.090239; Sahin S, 2009, NEUROL SCI, V30, P281, DOI 10.1007/s10072-009-0089-8; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Soreide K, 2011, ANN SURG, V253, P27, DOI 10.1097/SLA.0b013e318204a892; Su PH, 2013, ULTRASOUND IN PRESS; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; VINIK AI, 1999, AM J MED, V107, P17, DOI DOI 10.1016/S0002-9343(99)00009-1; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	39	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94452	10.1371/journal.pone.0094452	http://dx.doi.org/10.1371/journal.pone.0094452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722361	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100072
J	Grunbacher, A; Throm, T; Seidel, C; Gutt, B; Rohrig, J; Strunk, T; Vincze, P; Walheim, S; Schimmel, T; Wenzel, W; Fischer, R				Gruenbacher, Andre; Throm, Tanja; Seidel, Constanze; Gutt, Beatrice; Roehrig, Julian; Strunk, Timo; Vincze, Paul; Walheim, Stefan; Schimmel, Thomas; Wenzel, Wolfgang; Fischer, Reinhard			Six Hydrophobins Are Involved in Hydrophobin Rodlet Formation in Aspergillus nidulans and Contribute to Hydrophobicity of the Spore Surface	PLOS ONE			English	Article							FUNGAL; MUTANTS; REVEALS; PCR	Hydrophobins are amphiphilic proteins able to self-assemble at water-air interphases and are only found in filamentous fungi. In Aspergillus nidulans two hydrophobins, RodA and DewA, have been characterized, which both localize on the conidiospore surface and contribute to its hydrophobicity. RodA is the constituent protein of very regularly arranged rodlets, 10 nm in diameter. Here we analyzed four more hydrophobins, DewB-E, in A. nidulans and found that all six hydrophobins contribute to the hydrophobic surface of the conidiospores but only deletion of rodA caused loss of the rodlet structure. Analysis of the rodlets in the dewB-E deletion strains with atomic force microscopy revealed that the rodlets appeared less robust. Expression of DewA and DewB driven from the rodA promoter and secreted with the RodA secretion signal in a strain lacking RodA, restored partly the hydrophobicity. DewA and B were able to form rodlets to some extent but never reached the rodlet structure of RodA. The rodlet-lacking rodA-deletion strain opens the possibility to systematically study rodlet formation of other natural or synthetic hydrophobins.	[Gruenbacher, Andre; Throm, Tanja; Seidel, Constanze; Gutt, Beatrice; Roehrig, Julian; Fischer, Reinhard] Karlsruhe Inst Technol, IAB, Dept Microbiol, D-76021 Karlsruhe, Germany; [Strunk, Timo; Wenzel, Wolfgang] KIT, Inst Nanotechnolgy INT, Eggenstein Leopoldshafen, Germany; [Vincze, Paul; Walheim, Stefan; Schimmel, Thomas] KIT, Inst Appl Phys & INT, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Fischer, R (corresponding author), Karlsruhe Inst Technol, IAB, Dept Microbiol, Campus South, D-76021 Karlsruhe, Germany.	Reinhard.fischer@kit.edu	Wenzel, Wolfgang/B-3207-2009; Fischer, Reinhard/I-1220-2016	Wenzel, Wolfgang/0000-0001-9487-4689; Fischer, Reinhard/0000-0002-6704-2569; Strunk, Timo/0000-0003-0582-6015	Baden Wurttemberg Stiftung; German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	Baden Wurttemberg Stiftung; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Baden Wurttemberg Stiftung, the German Federal Ministry of Education and Research (BMBF) to R. F., the Baden-Wurttemberg Stiftung and the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Boeuf S, 2012, ACTA BIOMATER, V8, P1037, DOI 10.1016/j.actbio.2011.11.022; DONS JJM, 1984, J BACTERIOL, V157, P802, DOI 10.1128/JB.157.3.802-808.1984; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hill TW., 2001, FUNGAL GENET NEWSL, V48, P20, DOI [DOI 10.4148/1941-4765.1173, 10.4148/1941-4765.1173]; Jensen Britt G, 2010, BMC Res Notes, V3, P344, DOI 10.1186/1756-0500-3-344; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Kershaw MJ, 1998, EMBO J, V17, P3838, DOI 10.1093/emboj/17.14.3838; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Kwan AH, 2008, J MOL BIOL, V382, P708, DOI 10.1016/j.jmb.2008.07.034; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacroix H, 2008, FEMS MICROBIOL LETT, V286, P136, DOI 10.1111/j.1574-6968.2008.01227.x; Lacroix H, 2009, APPL ENVIRON MICROB, V75, P542, DOI 10.1128/AEM.01816-08; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Littlejohn KA, 2012, FOOD HYDROCOLLOID, V27, P503, DOI 10.1016/j.foodhyd.2011.08.018; Morris VK, 2013, J MOL BIOL, V425, P244, DOI 10.1016/j.jmb.2012.10.021; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paris S, 2003, APPL ENVIRON MICROB, V69, P1581, DOI 10.1128/AEM.69.3.1581-1588.2003; Sambrook J., 1999, MOL CLONING LAB MANU; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; STRINGER MA, 1995, MOL MICROBIOL, V16, P33, DOI 10.1111/j.1365-2958.1995.tb02389.x; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Wessels JGH, 1996, TRENDS PLANT SCI, V1, P9, DOI 10.1016/S1360-1385(96)80017-3; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wohlleben W, 2010, EUR BIOPHYS J BIOPHY, V39, P457, DOI 10.1007/s00249-009-0430-4; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x	34	44	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94546	10.1371/journal.pone.0094546	http://dx.doi.org/10.1371/journal.pone.0094546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722460	Green Published, gold			2022-12-25	WOS:000336909100094
J	Luch, A; Frey, FCC; Meier, R; Fei, J; Naegeli, H				Luch, Andreas; Frey, Flurina C. Clement; Meier, Regula; Fei, Jia; Naegeli, Hanspeter			Low-Dose Formaldehyde Delays DNA Damage Recognition and DNA Excision Repair in Human Cells	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CANCER; RELEASERS; LESIONS; RISK	Objective: Formaldehyde is still widely employed as a universal crosslinking agent, preservative and disinfectant, despite its proven carcinogenicity in occupationally exposed workers. Therefore, it is of paramount importance to understand the possible impact of low-dose formaldehyde exposures in the general population. Due to the concomitant occurrence of multiple indoor and outdoor toxicants, we tested how formaldehyde, at micromolar concentrations, interferes with general DNA damage recognition and excision processes that remove some of the most frequently inflicted DNA lesions. Methodology/Principal Findings: The overall mobility of the DNA damage sensors UV-DDB (ultraviolet-damaged DNA-binding) and XPC (xeroderma pigmentosum group C) was analyzed by assessing real-time protein dynamics in the nucleus of cultured human cells exposed to non-cytotoxic (<100 mu M) formaldehyde concentrations. The DNA lesion-specific recruitment of these damage sensors was tested by monitoring their accumulation at local irradiation spots. DNA repair activity was determined in host-cell reactivation assays and, more directly, by measuring the excision of DNA lesions from chromosomes. Taken together, these assays demonstrated that formaldehyde obstructs the rapid nuclear trafficking of DNA damage sensors and, consequently, slows down their relocation to DNA damage sites thus delaying the excision repair of target lesions. A concentration-dependent effect relationship established a threshold concentration of as low as 25 micromolar for the inhibition of DNA excision repair. Conclusions/Significance: A main implication of the retarded repair activity is that low-dose formaldehyde may exert an adjuvant role in carcinogenesis by impeding the excision of multiple mutagenic base lesions. In view of this generally disruptive effect on DNA repair, we propose that formaldehyde exposures in the general population should be further decreased to help reducing cancer risks.	[Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Prod Safety, Berlin, Germany; [Frey, Flurina C. Clement; Meier, Regula; Fei, Jia; Naegeli, Hanspeter] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland	Federal Institute for Risk Assessment; University of Zurich	Naegeli, H (corresponding author), Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland.	naegelih@vetpharm.uzh.ch	Fei, Jia/K-3287-2016		German Federal Institute for Risk Assessment (BfR) [FK-1329-038]	German Federal Institute for Risk Assessment (BfR)	This research was supported by the German Federal Institute for Risk Assessment (BfR) (project FK-1329-038); http://www.bfr.bund.de/en/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; de Groot AC, 2010, CONTACT DERMATITIS, V62, P221, DOI 10.1111/j.1600-0536.2009.01623.x; Donaldson MR, 2011, SEMIN CUTAN MED SURG, V30, P3, DOI 10.1016/j.sder.2011.01.002; Emri G, 2004, EXP DERMATOL, V13, P305, DOI 10.1111/j.0906-6705.2004.00157.x; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; FLYVHOLM MA, 1993, AM J IND MED, V24, P533, DOI 10.1002/ajim.4700240505; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furuta T, 2002, CANCER RES, V62, P4899; Garcia CL, 2009, MUTAT RES-FUND MOL M, V662, P3, DOI 10.1016/j.mrfmmm.2008.11.008; GRAFSTROM RC, 1983, SCIENCE, V220, P216, DOI 10.1126/science.6828890; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Houtsmuller AB, 2001, HISTOCHEM CELL BIOL, V115, P13, DOI 10.1007/s004180000234; Hubal EAC, 1997, TOXICOL APPL PHARM, V143, P47; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; IVERSEN O H, 1986, Environment International, V12, P541, DOI 10.1016/0160-4120(86)90148-0; KERNS WD, 1983, CANCER RES, V43, P4382; LUCE D, 1993, INT J CANCER, V53, P224, DOI 10.1002/ijc.2910530209; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mitchell D, 2006, P NATL ACAD SCI USA, V103, P13567, DOI 10.1073/pnas.0605833103; National Toxicology Program, 2011, 12 NAT TOX PROGR; OCONNOR PM, 1989, J BIOL CHEM, V264, P6391; Parsons JL, 2013, DNA REPAIR, V12, P326, DOI 10.1016/j.dnarep.2013.02.001; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rager JE, 2013, ENVIRON HEALTH PERSP, V121, P339, DOI 10.1289/ehp.1205582; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; ROBBINS JD, 1984, J TOXICOL ENV HEALTH, V14, P453, DOI 10.1080/15287398409530592; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; SZARVAS T, 1986, J RADIOAN NUCL CH LE, V106, P357, DOI 10.1007/BF02163668; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Vaughan TL, 2000, OCCUP ENVIRON MED, V57, P376, DOI 10.1136/oem.57.6.376; WALRATH J, 1983, INT J CANCER, V31, P407, DOI 10.1002/ijc.2910310403; Working I, 2012, IARC MONOGR EVAL CAR, V94, P1; Zhang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074974; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94149	10.1371/journal.pone.0094149	http://dx.doi.org/10.1371/journal.pone.0094149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722772	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336909100040
J	Monajemi, M; Woodworth, CF; Zipperlen, K; Gallant, M; Grant, MD; Larijani, M				Monajemi, Mahdis; Woodworth, Claire F.; Zipperlen, Katrin; Gallant, Maureen; Grant, Michael D.; Larijani, Mani			Positioning of APOBEC3G/F Mutational Hotspots in the Human Immunodeficiency Virus Genome Favors Reduced Recognition by CD8(+) T Cells	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CELLULAR IMMUNE-RESPONSES; DENDRITIC CELLS; VIF PROTEIN; CYTIDINE DEAMINATION; LYMPHOCYTE ACTIVITY; TYPE-1 INFECTION; CTL RECOGNITION; VIRAL ESCAPE; IN-VIVO	Due to constitutive expression in cells targeted by human immunodeficiency virus (HIV), and immediate mode of viral restriction upon HIV entry into the host cell, APOBEC3G (A3G) and APOBEC3F (A3F) have been considered primarily as agents of innate immunity. Recent bioinformatic and mouse model studies hint at the possibility that mutation of the HIV genome by these enzymes may also affect adaptive immunity but whether this occurs in HIV-infected individuals has not been examined. We evaluated whether APOBEC-mediated mutations within common HIV CD8(+) T cell epitopes can potentially enhance or diminish activation of HIV-specific CD8(+) T cells from infected individuals. We compared ex vivo activation of CD8(+) T lymphocytes from HIV-infected individuals by wild type HIV peptide epitopes and synthetic variants bearing simulated A3G/F-induced mutations by measuring interferon-gamma (IFN-gamma) production. We found that A3G/F-induced mutations consistently diminished HIV-specific CD8(+) T cell responses against the common epitopes we tested. If this reflects a significant trend in vivo, then adaptation by HIV to enrich sequences that are favored for mutation by A3G/F (A3G/F hotspots) in portions of its genome that encode immunogenic CD8(+) T cell epitopes would favor CTL escape. Indeed, we found the most frequently mutated A3G motif (CCC) is enriched up to 6-fold within viral genomic sequences encoding immunodominant CD8(+) T cell epitopes in Gag, Pol and Nef. Within each gene, A3G/F hotspots are more abundant in sequences encoding epitopes that are commonly recognized due to their HLA restriction. Thus, in our system, mutations of the HIV genome, mimicking A3G/F activity, appeared to abrogate or severely reduce CTL recognition. We suggest that the physiological significance of this potential effect in facilitating CTL escape is echoed in the adaptation of the HIV genome to enrich A3G/F hotspots in sequences encoding CTL epitopes that are more immunogenic at the population level.	[Monajemi, Mahdis; Woodworth, Claire F.; Zipperlen, Katrin; Gallant, Maureen; Grant, Michael D.; Larijani, Mani] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada	Memorial University Newfoundland	Grant, MD (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada.	mgrant@mun.ca; mlarijani@mun.ca			CIHR [MOP111132, OCH131580, HOP-111725, HOP-93428, HC1-112568]; Canadian Foundation for AIDS Research (CANFAR); Wallace Ingram Award; Research and Development Corporation (Newfoundland)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research (CANFAR); Wallace Ingram Award; Research and Development Corporation (Newfoundland)	This work was supported by CIHR (MOP111132 and OCH131580) and Canadian Foundation for AIDS Research (CANFAR) operating grants, the Wallace Ingram Award, the Research and Development Corporation (Newfoundland) funding to ML, and by CIHR operating grants (HOP-111725, HOP-93428) and CIHR catalyst grant (HC1-112568) to MG. ML holds a CIHR New Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Barouch DH, 2002, VACCINE, V20, pA66, DOI 10.1016/S0264-410X(02)00390-0; Belanger K, 2013, NUCLEIC ACIDS RES, V41, P7438, DOI 10.1093/nar/gkt527; Betts MR, 1999, AIDS RES HUM RETROV, V15, P1219, DOI 10.1089/088922299310313; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brennan CA, 2012, J VIROL; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chiu YL, 2011, METHODS MOL BIOL, V718, P185, DOI 10.1007/978-1-61779-018-8_12; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Fourati S, 2010, AIDS, V24, P2313, DOI 10.1097/QAD.0b013e32833e515a; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Gladney KH, 2012, VACCINE, V30, P6997, DOI 10.1016/j.vaccine.2012.09.067; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huang XL, 2000, CLIN DIAGN LAB IMMUN, V7, P279, DOI 10.1128/CDLI.7.2.279-287.2000; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2001, J CLIN INVEST, V107, P273, DOI 10.1172/JCI12174; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Monajemi M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-35; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Pohling J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-129; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rohowsky-Kochan C, 1998, HUM IMMUNOL, V59, P802, DOI 10.1016/S0198-8859(98)00086-X; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yamanaka R, 2007, BIOSCI TRENDS, V1, P52; Yebra G, 2011, J ANTIMICROB CHEMOTH, V66, P941, DOI 10.1093/jac/dkr012; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	78	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93428	10.1371/journal.pone.0093428	http://dx.doi.org/10.1371/journal.pone.0093428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722422	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000336909100016
J	Morgan, KL; Rahman, MA; Hill, RA; Zhou, SM; Bijlsma, G; Khanom, A; Lyons, RA; Brophy, ST				Morgan, Kelly L.; Rahman, Muhammad A.; Hill, Rebecca A.; Zhou, Shang-Ming; Bijlsma, Gunnar; Khanom, Ashrafunnesa; Lyons, Ronan A.; Brophy, Sinead T.			Physical Activity and Excess Weight in Pregnancy Have Independent and Unique Effects on Delivery and Perinatal Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; CESAREAN DELIVERY; RISK-FACTOR; NULLIPAROUS WOMEN; EXERCISE; LABOR; COMPLICATIONS; HEALTH; FETAL	Background: This study examines the effect of low daily physical activity levels and overweight/obesity in pregnancy on delivery and perinatal outcomes. Methods: A prospective cohort study combining manually collected postnatal notes with anonymised data linkage. A total of 466 women sampled from the Growing Up in Wales: Environments for Healthy Living study. Women completed a questionnaire and were included in the study if they had an available Body mass index (BMI) (collected at 12 weeks gestation from antenatal records) and/or a physical activity score during pregnancy (7-day Actigraph reading). The full statistical model included the following potential confounding factors: maternal age, parity and smoking status. Main outcome measures included induction rates, duration of labour, mode of delivery, infant health and duration of hospital stay. Findings: Mothers with lower physical activity levels were more likely to have an instrumental delivery (including forceps, ventouse and elective and emergency caesarean) in comparison to mothers with higher activity levels (adjusted OR: 1.72(95% CI: 1.05 to 2.9)). Overweight/obese mothers were more likely to require an induction (adjusted OR: 1.93 (95% CI 1.14 to 3.26), have a macrosomic baby (adjusted OR: 1.96 (95% CI 1.08 to 3.56) and a longer hospital stay after delivery (adjusted OR: 2.69 (95% CI 1.11 to 6.47). Conclusions: The type of delivery was associated with maternal physical activity level and not BMI. Perinatal outcomes (large for gestational age only) were determined by maternal BMI.	[Morgan, Kelly L.; Rahman, Muhammad A.; Hill, Rebecca A.; Zhou, Shang-Ming; Khanom, Ashrafunnesa; Brophy, Sinead T.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Bijlsma, Gunnar] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Lyons, Ronan A.] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales	Swansea University; Radboud University Nijmegen; Swansea University	Morgan, KL (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	kelly.morgan@swansea.ac.uk	Rahman, Muhammad Azizur/GLR-8606-2022; Zhou, Shang-Ming/A-8443-2008	Rahman, Muhammad Azizur/0000-0002-0805-7461; Khanom, Ashrafunnesa/0000-0002-5735-6601; Brophy, Sinead/0000-0001-7417-2858; Morgan, Kelly/0000-0002-8685-1177; Lyons, Ronan/0000-0001-5225-000X; Zhou, Shang-Ming/0000-0002-0719-9353	Swansea University; National Institute for Social Care and Health Research; MRC [MR/K023233/1, MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K023233/1, MR/K006525/1] Funding Source: researchfish	Swansea University; National Institute for Social Care and Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for the study was provided by Swansea University and National Institute for Social Care and Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Barakat R, 2008, BRIT J SPORT MED, V42, P674, DOI 10.1136/bjsm.2008.047837; Barakat R, 2012, J MATERN-FETAL NEO M, V25, P2372, DOI 10.3109/14767058.2012.696165; BECKMANN CRB, 1990, J REPROD MED, V35, P704; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Botkin C, 1991, Fam Pract Res J, V11, P387; Brophy S ZS-M, 2013, 3 INT C AMB MON PHYS; Bungum T J, 2000, J Obstet Gynecol Neonatal Nurs, V29, P258, DOI 10.1111/j.1552-6909.2000.tb02047.x; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cheng YW, 2010, OBSTET GYNECOL, V116, P1127, DOI 10.1097/AOG.0b013e3181f5eaf0; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; CLAPP JF, 1984, MED SCI SPORT EXER, V16, P556; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Department of Health, 2006, NHS MAT STAT E 2004; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Duncombe D, 2006, AUST NZ J OBSTET GYN, V46, P288, DOI 10.1111/j.1479-828X.2006.00594.x; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Mesas AE, 2012, J NUTR, V142, P1321, DOI 10.3945/jn.112.158154; Evans GW, 2012, PEDIATRICS, V129, pE68, DOI 10.1542/peds.2010-3647; Evenson KR, 2002, EPIDEMIOLOGY, V13, P653, DOI 10.1097/00001648-200211000-00009; Fleten C, 2010, OBSTET GYNECOL, V115, P331, DOI 10.1097/AOG.0b013e3181ca4414; Forouhari S, 2009, IRANIAN CRESCENT MED, V11; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Freinkel N, 2008, CIBA FDN S 63 PREGN, P3; Haakstad LAH, 2007, ACTA OBSTET GYN SCAN, V86, P559, DOI 10.1080/00016340601185301; Hill R, 2010, PROTOCOL BASELINE AS, P1; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P239, DOI 10.1067/mob.2003.441; Kapellou O, 2011, ACTA PAEDIATR, V100, P1416, DOI 10.1111/j.1651-2227.2011.02427.x; Kardel KR, 1998, AM J OBSTET GYNECOL, V178, P280, DOI 10.1016/S0002-9378(98)80013-6; Koepp UMS, 2012, ACTA OBSTET GYN SCAN, V91, P243, DOI 10.1111/j.1600-0412.2011.01321.x; Kramer MS MS, 2006, COCHRANE DATABASE SY, V19; Lof M, 2008, ACTA OBSTET GYN SCAN, V87, P524, DOI 10.1080/00016340802012288; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Maternity Care Working Party, 2007, MAK NORM BIRTH REAL; MCWP MCWP, 2007, MAK NORM BIRTH REAL, P1; Melzer K, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.876; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; PARILLA BV, 1993, OBSTET GYNECOL, V81, P392; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Raebel MA, 2004, ARCH INTERN MED, V164, P2135, DOI 10.1001/archinte.164.19.2135; RICE PL, 1991, J SPORT MED PHYS FIT, V31, P95; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sheiner E, 2004, PAEDIATR PERINAT EP, V18, P196, DOI 10.1111/j.1365-3016.2004.00557.x; Smith JF, 1997, OBSTET GYNECOL, V90, P344, DOI 10.1016/S0029-7844(97)00284-6; STERNFELD B, 1995, MED SCI SPORT EXER, V27, P634; Sui ZX, 2013, INT J WOMENS HEALTH, V5, P389, DOI 10.2147/IJWH.S34042; Syngelaki A, 2011, FETAL DIAGN THER, V30, P250, DOI 10.1159/000328083; TREFFERS PE, 1993, BMJ-BRIT MED J, V307, P1017, DOI 10.1136/bmj.307.6911.1017; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; Vasudevan C, 2011, ARCH DIS CHILD-FETAL, V96, pF378, DOI 10.1136/adc.2009.170928; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2010, GLOB STAT REP NONC D; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; WOLFE LA, 1989, SPORTS MED, V8, P273, DOI 10.2165/00007256-198908050-00003	61	24	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94532	10.1371/journal.pone.0094532	http://dx.doi.org/10.1371/journal.pone.0094532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722411	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100092
J	Nakatsu, Y; Matsuoka, M; Chang, TH; Otsuki, N; Noda, M; Kimura, H; Sakai, K; Kato, H; Takeda, M; Kubota, T				Nakatsu, Yuichiro; Matsuoka, Mayumi; Chang, Tsung-Hsien; Otsuki, Noriyuki; Noda, Masahiro; Kimura, Hirokazu; Sakai, Kouji; Kato, Hiroshi; Takeda, Makoto; Kubota, Toru			Functionally Distinct Effects of the C-Terminal Regions of IKK epsilon and TBK1 on Type I IFN Production	PLOS ONE			English	Article							BINDING KINASE 1; CRYSTAL-STRUCTURE; BETA; ACTIVATION; TANK; INFLAMMATION; ENHANCEOSOME; INFECTION; INHIBITOR; MECHANISM	Inhibitor of kappa B kinase epsilon (IKK epsilon) and TANK binding kinase 1 (TBK1), so-called non-canonical IKKs or IKK-related kinases, are involved in the cellular innate immunity by inducing type I IFNs. Two kinases commonly phosphorylate transcription factors IRF3 and IRF7 in type I IFN production pathway. In contrast to TBK1, underlying mechanisms of IKK epsilon activation and regions required for activation of downstream molecules are poorly understood. In this study, we investigated regions of IKK epsilon required for the activation of type I IFN promoter specially, by focusing on the C-terminal region. To show the functional significance of the IKK epsilon C-terminal region on type I IFN production, we employed various mutant forms of IKK epsilon and compared to corresponding region of TBK1. We identified the specific regions and residues of IKK epsilon involved in the activation of downstream signaling. Interestingly, corresponding region and residues are not required for activation of downstream signaling by TBK1. The results highlight the importance of the C-terminal region in the functional activity of IKK epsilon in innate immune response and also the difference in activation mechanisms between IKK epsilon and the closely related TBK1.	[Nakatsu, Yuichiro; Otsuki, Noriyuki; Sakai, Kouji; Kato, Hiroshi; Takeda, Makoto; Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacteriol 3, Tokyo, Japan; [Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Noda, Masahiro; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kaohsiung Veterans General Hospital; National Institute of Infectious Diseases (NIID)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.	kubota@nih.go.jp	SAKAI, KOUJI/J-4436-2018; Takeda, Makoto/J-2550-2018; Chang, Tsung-Hsien/AAG-9384-2019	Takeda, Makoto/0000-0002-8194-7727; Chang, Tsung-Hsien/0000-0003-4806-7864	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460582]; Grants-in-Aid for Scientific Research [25460582] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid 25460582 for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pham AM, 2010, VIRUSES-BASEL, V2, P55, DOI 10.3390/v2010055; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Verhelst K, 2013, BIOCHEM PHARMACOL, V85, P873, DOI 10.1016/j.bcp.2013.01.007; Wang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043756; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94999	10.1371/journal.pone.0094999	http://dx.doi.org/10.1371/journal.pone.0094999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722368	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100149
J	Murillo-Amador, B; Cordoba-Matson, MV; Villegas-Espinoza, JA; Hernandez-Montiel, LG; Troyo-Dieguez, E; Garcia-Hernandez, JL				Murillo-Amador, Bernardo; Victor Cordoba-Matson, Miguel; Arnoldo Villegas-Espinoza, Jorge; Guillermo Hernandez-Montiel, Luis; Troyo-Dieguez, Enrique; Luis Garcia-Hernandez, Jose			Mineral Content and Biochemical Variables of Aloe vera L. under Salt Stress	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; PHOSPHOENOLPYRUVATE CARBOXYLASE; ABSCISIC-ACID; GLYCINE-MAX; TOLERANCE; SALINITY; PLANTS; GROWTH; RESPONSES; SEEDLINGS	Despite the proven economic importance of Aloe vera, studies of saline stress and its effects on the biochemistry and mineral content in tissues of this plant are scarce. The objective of this study was to grow Aloe under NaCl stress of 0, 30, 60, 90 and 120 mM and compare: (1) proline, total protein, and enzyme phosphoenolpyruvate carboxylase (PEP-case) in chlorenchyma and parenchyma tissues, and (2) ion content (Na, K, Ca, Mg, Cl, Fe, P. N, Zn, B, Mn, and Cu) in roots, stems, leaves and sprouts. Proline and PEP-case increased as salinity increased in both parenchyma and chlorenchyma, while total protein increased in parenchyma and decreased in chlorenchyma, although at similar salt concentrations total protein was always higher in chlorenchyma. As salinity increased Na and Cl ions increased in roots, stems, leaves, while K decreased only significantly in sprouts. Salinity increases typically caused mineral content in tissue to decrease, or not change significantly. In roots, as salinity increased Mg decreased, while all other minerals failed to show a specific trend. In stems, the mineral concentrations that changed were Fe and P which increased with salinity while Cu decreased. In leaves, Mg, Mn, N, and B decreased with salinity, while Cu increased. In sprouts, the minerals that decreased with increasing salinity were Mg, Mn, and Cu. Zinc did not exhibit a trend in any of the tissues. The increase in protein, proline and PEP-case activity, as well as the absorption and accumulation of cations under moderate NaCl stress caused osmotic adjustment which kept the plant healthy. These results suggest that Aloe may be a viable crop for soil irrigated with hard water or affected by salinity at least at concentrations used in the present study.	[Murillo-Amador, Bernardo; Victor Cordoba-Matson, Miguel; Guillermo Hernandez-Montiel, Luis; Troyo-Dieguez, Enrique] Ctr Invest Biol Noroeste, Sc La Paz, Baja California, Mexico; [Arnoldo Villegas-Espinoza, Jorge] Univ Autonoma Baja California Sur, La Paz, Baja California, Mexico; [Luis Garcia-Hernandez, Jose] Univ Juarez Estado Durango, Durango, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Universidad Autonoma de Baja California; Universidad Juarez del Estado de Durango	Garcia-Hernandez, JL (corresponding author), Univ Juarez Estado Durango, Durango, Mexico.	josel.garciahernandez@yahoo.com	GARCIA-HERNANDEZ, JOSE L./AAH-8215-2021; Troyo-Diéguez, Enrique/H-9713-2017; Murillo-Amador, Bernardo/AAF-1351-2019	Murillo-Amador, Bernardo/0000-0002-9489-4054; Hernandez-Montiel, Luis/0000-0002-8236-1074	CIBNOR [ZA3.1]; project Fundacion Produce Baja California Sur; project CIBNOR-UABCS; project SEP-CONACYT [180C]	CIBNOR; project Fundacion Produce Baja California Sur; project CIBNOR-UABCS; project SEP-CONACYT	This research was support by grant ZA3.1 from CIBNOR, project Fundacion Produce Baja California Sur, A.C., project CIBNOR-UABCS and project SEP-CONACYT 180C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A., 2008, Australian Journal of Basic and Applied Sciences, V2, P37; Agarie S, 2007, J EXP BOT, V58, P1957, DOI 10.1093/jxb/erm057; Alam S.M., 1999, HDB PLANT CROP STRES, P285, DOI DOI 10.1201/9780824746728.CH12; AMZALLAG GN, 1990, J EXP BOT, V41, P1529, DOI 10.1093/jxb/41.12.1529; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Balibrea ME, 1999, AUST J PLANT PHYSIOL, V26, P781, DOI 10.1071/PP99092; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Boughalleb F., 2011, Agricultural Journal, V6, P327; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY CJ, 1984, PLANT CELL ENVIRON, V7, P571, DOI 10.1111/1365-3040.ep11591840; Candan N, 2003, PLANT PHYSIOL BIOCH, V41, P35, DOI 10.1016/S0981-9428(02)00006-2; Cardemil L, 2007, FISIOLOGIA VEGETAL; Ceusters J, 2009, ANN BOT, V102, P389; Chu T, 1974, AUST J PLANT PHYSL, V1, P87, DOI [10.1071/PP9740087, DOI 10.1071/PP9740087]; Cousins AB, 2007, PLANT PHYSIOL, V145, P1006, DOI 10.1104/pp.107.103390; Lobato AKD, 2008, AUST J CROP SCI, V2, P25; de Lacerda CF, 2005, ENVIRON EXP BOT, V54, P69, DOI 10.1016/j.envexpbot.2004.06.004; Delatorre-Herrera J, 2010, AGR WATER MANAGE, V97, P1564, DOI 10.1016/j.agwat.2010.05.008; Dierig DA, 2003, IND CROP PROD, V17, P15, DOI 10.1016/S0926-6690(02)00054-7; Echevaria E, 2001, PLANTA, V214, P283, DOI 10.1007/s004250100616; El-Shintinawy F, 2001, BIOL PLANTARUM, V44, P541, DOI 10.1023/A:1013738603020; FAETH SH, 1981, AM NAT, V117, P409, DOI 10.1086/283724; Flowers TJ, 2010, FUNCT PLANT BIOL, V37, P604, DOI 10.1071/FP09269; Geissler N, 2009, ENVIRON EXP BOT, V65, P220, DOI 10.1016/j.envexpbot.2008.11.001; Gilbert GA, 1998, J EXP BOT, V49, P107, DOI 10.1093/jexbot/49.318.107; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hichem H, 2009, IND CROP PROD, V30, P144, DOI 10.1016/j.indcrop.2009.03.003; HOFNER R, 1987, PLANT PHYSIOL, V83, P915, DOI 10.1104/pp.83.4.915; HOLTUM JAM, 1982, PLANTA, V155, P8, DOI 10.1007/BF00402925; Huang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062085; Jacoby B., 1999, HDB PLANT CROP STRES, V2, P97; Jin ZM, 2007, PROCESS BIOCHEM, V42, P710, DOI 10.1016/j.procbio.2006.11.002; Johnson D., 1998, APPL MULTIVARIATE ME; KENT LM, 1985, PLANT CELL ENVIRON, V8, P155, DOI 10.1111/j.1365-3040.1985.tb01223.x; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; LI B, 1993, ARCH BIOCHEM BIOPHYS, V307, P416, DOI 10.1006/abbi.1993.1609; Liu CH, 2007, PROCESS BIOCHEM, V42, P961, DOI 10.1016/j.procbio.2007.03.004; Liu Y.L., 1998, PLANT PHYSL MOL BIOL, P752; Long XH, 2009, PEDOSPHERE, V19, P208, DOI 10.1016/S1002-0160(09)60110-7; Luo QY, 2005, J PLANT PHYSIOL, V162, P1003, DOI 10.1016/j.jplph.2004.11.008; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Naidoo G, 1995, BIOL SALT TOLERANT P, P121; Neffati M, 2008, IND CROP PROD, V28, P137, DOI 10.1016/j.indcrop.2008.02.005; Newton LE, 2004, MED AROM PLANTS, V38, P3; Ning JF, 2005, ACTA AGR BOREALI SIN, V5; Ning JianFeng, 2005, Acta Horticulturae Sinica, V32, P663; O'Leary JO, 1988, ARID LANDS TODAY TOM, P773; OSTREM JA, 1987, PLANT PHYSIOL, V84, P1270, DOI 10.1104/pp.84.4.1270; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida Asish, 2002, Journal of Plant Biology, V45, P28; Peng YH, 2004, J EXP BOT, V55, P939, DOI 10.1093/jxb/erh071; Popova LP, 1995, J PLANT GROWTH REGUL, V14, P211, DOI 10.1007/BF00204914; Rahi TS, 2013, IND CROP PROD, V44, P528, DOI 10.1016/j.indcrop.2012.10.001; Rahimi-Dehgolan R., 2012, Journal of Herbs, Spices & Medicinal Plants, V18, P222, DOI 10.1080/10496475.2012.671802; Ranganathan TP, 1970, THESIS BOMBAY U; Sahu P. K., 2011, International Journal of Drug Discovery and Herbal Research (IJDDHR), P14; SANKHLA N, 1975, Z PFLANZENPHYSIOL, V74, P267, DOI 10.1016/S0044-328X(75)80172-3; Shi DeCheng, 1997, Acta Prataculturae Sinica, V6, P51; Silva H, 2010, IND CROP PROD, V31, P20, DOI 10.1016/j.indcrop.2009.08.001; Sun SB, 2003, ACTA BIOCH BIOPH SIN, V35, P423; THOMAS JC, 1992, PLANT PHYSIOL, V100, P416, DOI 10.1104/pp.100.1.416; Xu Cheng-Xiang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P73; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang CW, 2008, PLANT GROWTH REGUL, V56, P179, DOI 10.1007/s10725-008-9299-y; Yildiz M, 2007, J INTEGR PLANT BIOL, V49, P975, DOI 10.1111/j.1672-9072.2007.00465.x; Zapata PJ, 2013, IND CROP PROD, V42, P223, DOI 10.1016/j.indcrop.2012.06.002; Zheng QS, 2009, J PLANT NUTR SOIL SC, V172, P875, DOI 10.1002/jpln.200900122; Zheng QingSong, 2004, Acta Phytoecologica Sinica, V28, P823	71	27	29	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94870	10.1371/journal.pone.0094870	http://dx.doi.org/10.1371/journal.pone.0094870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736276	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600098
J	Gong, L; Chen, JX; Lu, JG; Fan, LZ; Huang, JH; Zhang, Y; Lv, B; Hui, RT; Wang, YB				Gong, Ling; Chen, Jinxing; Lu, Jinguo; Fan, Lizi; Huang, Jinghan; Zhang, Yu; Lv, Bin; Hui, Rutai; Wang, Yibo			The 9p21 Locus Is Associated with Coronary Artery Disease and Cardiovascular Events in the Presence (but Not in the Absence) of Coronary Calcification	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; ABDOMINAL AORTIC-ANEURYSM; GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; CHROMOSOME 9P21; 4 SNPS; INTRAVASCULAR ULTRASOUND; VASCULAR CALCIFICATION; ANGIOGRAPHIC OUTCOMES; GENETIC-VARIANTS	Variants at the 9p21 locus have been associated with coronary artery disease (CAD); coronary artery calcification (CAC) is related to CAD and other cardiovascular events. To determine the association of the 9p21 locus with CAD in the presence and absence of CAC, 4 groups were enrolled in a case-control study, including 527 CAD patients without CAC, 692 CAD patients with CAC, 585 individuals with simple CAC but no CAD, and 725 healthy controls. The rs1333049 representing the locus was associated with CAD in the presence of CAC (odds ratio = 1.38 in allelic analysis, 95%CI, 1.19-1.60, P<0.001), but not in the absence of CAC. Additionally, rs1333049 was not associated with simple CAC or CAC severity/extent in CAD patients with CAC. 849 CAD patients undergoing revascularization (660 with CAC and 189 without CAC) were enrolled in a cohort study to test its association with cardiovascular events in CAD patients with and without CAC in a 3-year follow-up. rs1333049 was significantly associated with the incidence of cardiovascular events in non-target vessels in patients with CAC (hazard ratio = 1.44, 95%CI, 1.08-1.91, P = 0.012), but not in those without CAC. The variants at the 9p21 locus were related to CAD and post-revascularization events only in the presence of CAC, suggesting that they may confer risk of calcification-related coronary atherosclerosis.	[Gong, Ling; Chen, Jinxing; Zhang, Yu; Hui, Rutai; Wang, Yibo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Sinogerman Lab Mol Med,Fuwai Hosp, Beijing 100730, Peoples R China; [Gong, Ling; Chen, Jinxing; Lu, Jinguo; Fan, Lizi; Huang, Jinghan; Zhang, Yu; Lv, Bin; Hui, Rutai; Wang, Yibo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Jinguo; Lv, Bin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol, Beijing 100730, Peoples R China; [Fan, Lizi] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Med Ultrason, Beijing 100730, Peoples R China; [Huang, Jinghan] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Heart Funct Testing Ctr, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Hui, RT (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Sinogerman Lab Mol Med,Fuwai Hosp, Beijing 100730, Peoples R China.	huirutai@gmail.com; yibowang@hotmail.com		Wang, Yibo/0000-0001-9984-581X	NSFC [81322002/81270333/31171220]; 973 program [2012CB517804]; Fundamental Research Funds for the Central Universities [2012Y04]	NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by NSFC projects 81322002/81270333/31171220, 973 program 2012CB517804, and the Fundamental Research Funds for the Central Universities with grant 2012Y04 to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Anderson JL, 2008, AM HEART J, V156, P1155, DOI 10.1016/j.ahj.2008.07.006; [Anonymous], 2007, NATURE, V447, P661; Ardissino D, 2011, J AM COLL CARDIOL, V58, P426, DOI 10.1016/j.jacc.2010.11.075; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Bamberg F, 2008, ARTERIOSCL THROM VAS, V28, P568, DOI 10.1161/ATVBAHA.107.155010; Bluemke DA, 2008, CIRCULATION, V118, P586, DOI 10.1161/CIRCULATIONAHA.108.189695; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Cannata-Andia JB, 2006, J AM SOC NEPHROL, V17, pS267, DOI 10.1681/ASN.2006080925; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dunphy MPS, 2005, J NUCL MED, V46, P1278; Ellis KL, 2010, CIRC-CARDIOVASC GENE, V3, P286, DOI 10.1161/CIRCGENETICS.109.917443; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hassam SE, 2006, J AM COLL CARDIOL, V47, P2413, DOI 10.1016/j.jacc.2005.11.091; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Horne BD, 2008, CIRC-CARDIOVASC GENE, V1, P85, DOI 10.1161/CIRCGENETICS.108.793158; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Johnson AD, 2013, CIRCULATION, V127, P799, DOI 10.1161/CIRCULATIONAHA.112.111559; Karohl C, 2011, NAT REV NEPHROL, V7, P567, DOI 10.1038/nrneph.2011.110; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Lu JG, 2010, EUR J RADIOL, V75, P159, DOI 10.1016/j.ejrad.2009.04.035; Maier A, 2010, BIOMECH MODEL MECHAN, V9, P511, DOI 10.1007/s10237-010-0191-0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P445, DOI 10.1161/CIRCGENETICS.109.923508; Nicoll R, 2013, INT J CARDIOL, V167, P322, DOI 10.1016/j.ijcard.2012.06.110; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Pechlivanis S, 2010, ARTERIOSCL THROM VAS, V30, P1867, DOI 10.1161/ATVBAHA.110.208496; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Siegel E, 2013, INT J CARDIOL, V167, P1616, DOI 10.1016/j.ijcard.2012.04.107; Wang YB, 2013, HUM GENET, V132, P29, DOI 10.1007/s00439-012-1222-y; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94823	10.1371/journal.pone.0094823	http://dx.doi.org/10.1371/journal.pone.0094823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732910	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400115
J	Martinez-Ramirez, D; Giugni, J; Vedam-Mai, V; Shukla, AW; Malaty, IA; McFarland, NR; Rodriguez, RL; Foote, KD; Okun, MS				Martinez-Ramirez, Daniel; Giugni, Juan; Vedam-Mai, Vinata; Shukla, Aparna Wagle; Malaty, Irene A.; McFarland, Nikolaus R.; Rodriguez, Ramon L.; Foote, Kelly D.; Okun, Michael S.			The "Brittle Response" to Parkinson's Disease Medications: Characterization and Response to Deep Brain Stimulation	PLOS ONE			English	Article							LEVODOPA-INDUCED-DYSKINESIAS; RISK-FACTORS; MOTOR FLUCTUATIONS; CLINICAL-FEATURES; WEIGHT; MECHANISMS; THERAPY	Objective: Formulate a definition and describe the clinical characteristics of PD patients with a "brittle response" (BR) to medications versus a "non-brittle response" (NBR), and characterize the use of DBS for this population. Methods: An UF IRB approved protocol used a retrospective chart review of 400 consecutive PD patients presenting to the UF Center for Movement Disorders and Neurorestoration. Patient records were anonymized and de-identified prior to analysis. SPSS statistics were used to analyze data. Results: Of 345 included patients, 19 (5.5%) met criteria for BR PD. The BR group was comprised of 58% females, compared to 29% in the NBR group (P = .008). The former had a mean age of 63.4 compared to 68.1 in the latter. BR patients had lower mean weight (63.5 vs. 79.6, P=<.001), longer mean disease duration (12.6 vs. 8.9 years, P=.003), and had been on LD for more years compared to NBR patients (9.8 vs. 5.9, P=.001). UPDRS motor scores were higher (40.4 vs. 30.0, P=.001) in BR patients. No differences were observed regarding the Schwab and England scale, PDQ-39, and BDI-II. Sixty-three percent of the BR group had undergone DBS surgery compared to 18% (P=.001). Dyskinesias were more common, severe, and more often painful (P=<.001) in the BR group. There was an overall positive benefit from DBS. Conclusion: BR PD occurred more commonly in female patients with a low body weight. Patients with longer disease duration and longer duration of LD therapy were also at risk. The BR group responded well to DBS.	[Martinez-Ramirez, Daniel; Giugni, Juan; Vedam-Mai, Vinata; Shukla, Aparna Wagle; Malaty, Irene A.; McFarland, Nikolaus R.; Rodriguez, Ramon L.; Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA; [Vedam-Mai, Vinata; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu	Malaty, Irene/AAE-2553-2020; Martinez-Ramirez, Daniel/H-2546-2016; McFarland, Nikolaus R/I-4209-2017; Shukla, Aparna Wagle/AAN-1344-2020; Ramirez, Daniel Martinez/O-6719-2018	Martinez-Ramirez, Daniel/0000-0001-8003-0610; McFarland, Nikolaus R/0000-0002-8699-8857; Ramirez, Daniel Martinez/0000-0001-8003-0610; Okun, Michael/0000-0002-6247-9358; Foote, Kelly/0000-0002-2436-4138; WAGLE SHUKLA, APARNA/0000-0002-9757-9973	University of Florida Foundation; UF INFORM database; NIH [KL2 TR000065]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000065] Funding Source: NIH RePORTER	University of Florida Foundation(University of Florida); UF INFORM database; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Source of funding: University of Florida Foundation, the UF INFORM database and the NIH KL2 TR000065 (AWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Chase TN, 2000, ANN NEUROL, V47, pS122; Fahn S, 2004, NEW ENGL J MED, V351, P2498; GOETZ CG, 1994, MOVEMENT DISORD, V9, P390, DOI 10.1002/mds.870090403; Grandas F, 1999, J NEUROL, V246, P1127, DOI 10.1007/s004150050530; Hauser RA, 2006, ARCH NEUROL-CHICAGO, V63, P1756, DOI 10.1001/archneur.63.12.1756; Locke MC, 2011, NEUROSURGERY, V68, P1233, DOI 10.1227/NEU.0b013e31820b52c5; Manson A, 2012, J PARKINSON DIS, V2, P189, DOI 10.3233/JPD-2012-120103; MCLELLAN DL, 1982, BRIT MED J, V284, P1001, DOI 10.1136/bmj.284.6321.1001; Mills KA, 2012, STEREOT FUNCT NEUROS, V90, P386, DOI 10.1159/000340071; MOURADIAN MM, 1990, ANN NEUROL, V27, P18, DOI 10.1002/ana.410270105; Muller T, 2000, PARKINSONISM RELAT D, V6, P171, DOI 10.1016/S1353-8020(00)00005-5; Oh JY, 2009, ARCH GERONTOL GERIAT, V49, P351, DOI 10.1016/j.archger.2008.11.013; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; Peneau S, 2013, AM J CLIN NUTR, V97, P1307, DOI 10.3945/ajcn.112.054916; Putterman DB, 2007, J PHARMACOL EXP THER, V323, P277, DOI 10.1124/jpet.107.126219; Schrag A, 1998, MOVEMENT DISORD, V13, P885, DOI 10.1002/mds.870130605; Stocchi F, 2010, ANN NEUROL, V68, P18, DOI 10.1002/ana.22060; Van Gerpen JA, 2006, ARCH NEUROL-CHICAGO, V63, P205, DOI 10.1001/archneur.63.2.205; Voulgari C, 2012, DIABETES TECHNOL THE, V14, P835, DOI 10.1089/dia.2012.0058	20	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94856	10.1371/journal.pone.0094856	http://dx.doi.org/10.1371/journal.pone.0094856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733172	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400121
J	Zhang, CH; Rui, YY; Zhou, YY; Ju, Z; Zhang, HH; Hu, CY; Xiao, Y; Xu, GY				Zhang, Chunhua; Rui, Yun-Yun; Zhou, Yuan-Yuan; Ju, Zhong; Zhang, Hong-Hong; Hu, Chuang-Ying; Xiao, Ying; Xu, Guang-Yin			Adrenergic beta(2)-Receptors Mediates Visceral Hypersensitivity Induced by Heterotypic Intermittent Stress in Rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DORSAL-ROOT GANGLION; AFFERENT NEURONS; BETA-2-ADRENERGIC RECEPTORS; COLON IRRITATION; BRAIN; MODEL; PAIN; EXCITABILITY; POTASSIUM	Chronic visceral pain in patients with irritable bowel syndrome (IBS) has been difficult to treat effectively partially because its pathophysiology is not fully understood. Recent studies show that norepinephrine (NE) plays an important role in the development of visceral hypersensitivity. In this study, we designed to investigate the role of adrenergic signaling in visceral hypersensitivity induced by heterotypical intermittent stress (HIS). Abdominal withdrawal reflex scores (AWRs) used as visceral sensitivity were determined by measuring the visceromoter responses to colorectal distension. Colon-specific dorsal root ganglia neurons (DRGs) were labeled by injection of DiI into the colon wall and were acutely dissociated for whole-cell patch-clamp recordings. Blood plasma level of NE was measured using radioimmunoassay kits. The expression of beta(2)-adrenoceptors was measured by western blotting. We showed that HIS-induced visceral hypersensitivity was attenuated by systemic administration of a beta-adrenoceptor antagonist propranolol, in a dose-dependent manner, but not by a alpha-adrenoceptor antagonist phentolamine. Using specific beta-adrenoceptor antagonists, HIS-induced visceral hypersensitivity was alleviated by beta(2) adrenoceptor antagonist but not by beta(1)-or beta(3)-adrenoceptor antagonist. Administration of a selective beta(2)-adrenoceptor antagonist also normalized hyperexcitability of colon-innervating DRG neurons of HIS rats. Furthermore, administration of beta-adrenoceptor antagonist suppressed sustained potassium current density (I-K) without any alteration of fast-inactivating potassium current density (I-A). Conversely, administration of NE enhanced the neuronal excitability and produced visceral hypersensitivity in healthy control rats, and blocked by beta(2)-adrenoceptor antagonists. In addition, HIS significantly enhanced the NE concentration in the blood plasma but did not change the expression of beta(2)-adrenoceptor in DRGs and the muscularis externa of the colon. The present study might provide a potential molecular target for therapy of visceral hypersensitivity in patents with IBS.	[Zhang, Chunhua; Hu, Chuang-Ying; Xu, Guang-Yin] Soochow Univ, Affiliated Hosp 2, Dept Gastroenterol, Suzhou, Peoples R China; [Zhang, Chunhua; Rui, Yun-Yun; Zhou, Yuan-Yuan; Ju, Zhong; Zhang, Hong-Hong; Xiao, Ying; Xu, Guang-Yin] Soochow Univ, Dept Neurobiol, Inst Neurosci, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Xiao, Y (corresponding author), Soochow Univ, Dept Neurobiol, Inst Neurosci, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou, Peoples R China.	et790906@hotmail.com; guangyinxu@suda.edu.cn			National Natural Science Foundation of China [81070884, 81230024, 31300909]; Jiangsu Distinguished Professor Program of Jiangsu Province [SR21500111]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Distinguished Professor Program of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from National Natural Science Foundation of China (81070884, 81230024 and 31300909) and from Jiangsu Distinguished Professor Program of Jiangsu Province (SR21500111) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Aley KO, 2001, J NEUROSCI, V21, P6933, DOI 10.1523/JNEUROSCI.21-17-06933.2001; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Berman S, 2012, NEUROIMAGE; Choudhury BK, 2009, AM J PHYSIOL-GASTR L, V296, pG1238, DOI 10.1152/ajpgi.90712.2008; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Feng XM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-4; Fukudo S, 2013, PAIN; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; IWATA SI, 1993, PHARMACOL BIOCHEM BE, V44, P611, DOI 10.1016/0091-3057(93)90175-S; Keszthelyi D, 2012, AM J PHYSIOL-GASTR L, V303, pG141, DOI 10.1152/ajpgi.00060.2012; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kirkup AJ, 2001, AM J PHYSIOL-GASTR L, V280, pG787, DOI 10.1152/ajpgi.2001.280.5.G787; LANDMANN R, 1992, EUR J CLIN INVEST, V22, P30; Lembo T, 1999, AM J GASTROENTEROL, V94, P1320, DOI 10.1111/j.1572-0241.1999.01009.x; Levy BH, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00024; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/S0165-6147(96)10022-5; Nicholson R, 2005, NEUROSCI LETT, V380, P316, DOI 10.1016/j.neulet.2005.01.079; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; SALM AK, 1992, BRAIN RES BULL, V29, P265, DOI 10.1016/0361-9230(92)90056-4; Skeberdis Vytenis Arvydas, 2004, Medicina (Kaunas), V40, P407; Stewart T, 2003, J PHYSIOL-LONDON, V552, P797, DOI 10.1113/jphysiol.2003.046409; STONE EA, 1989, BRAIN RES REV, V14, P297, DOI 10.1016/0165-0173(89)90015-5; Tan ZY, 2006, J NEUROPHYSIOL, V95, P1115, DOI 10.1152/jn.00830.2005; Thompson WG, 1999, GUT, V45, P43; van der Veek PPJ, 2008, CLIN GASTROENTEROL H, V6, P321, DOI 10.1016/j.cgh.2007.12.005; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053165; Winston J, 2007, GASTROENTEROLOGY, V132, P615, DOI 10.1053/j.gastro.2006.11.014; Winston JH, 2010, GASTROENTEROLOGY, V138, P294, DOI 10.1053/j.gastro.2009.09.054; Wong DL, 2012, CELL MOL NEUROBIOL, V32, P737, DOI 10.1007/s10571-011-9768-0; Xu GY, 2008, GUT, V57, P1230, DOI 10.1136/gut.2007.134221; Xu GY, 2006, AM J PHYSIOL-GASTR L, V291, pG424, DOI 10.1152/ajpgi.00560.2005; Yoshimura N, 1999, J NEUROSCI, V19, P4644; Zhang J, 2009, AM J PHYSIOL-GASTR L, V297, pG269, DOI 10.1152/ajpgi.00076.2009; Zou N, 2008, TRANSL RES, V152, P283, DOI 10.1016/j.trsl.2008.10.002	39	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94726	10.1371/journal.pone.0094726	http://dx.doi.org/10.1371/journal.pone.0094726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733123	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400082
J	Linsler, S; Kraemer, D; Driess, C; Oertel, J; Kammers, K; Rahnenfuhrer, J; Ketter, R; Urbschat, S				Linsler, Stefan; Kraemer, Dennis; Driess, Christina; Oertel, Joachim; Kammers, Kai; Rahnenfuehrer, Joerg; Ketter, Ralf; Urbschat, Steffi			Molecular Biological Determinations of Meningioma Progression and Recurrence	PLOS ONE			English	Article							NUMERICAL CHROMOSOME-ABERRATIONS; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENES; IN-SITU HYBRIDIZATION; HUMAN CANCERS; PROMOTER HYPERMETHYLATION; CYTOGENETIC PROGRESSION; PROGNOSTIC-SIGNIFICANCE; ANAPLASTIC MENINGIOMAS; MALIGNANT PROGRESSION	Meningiomas are tumors that arise from the coverings of the brain or spinal cord. 5% of the cases turn into malignant forms with aggressive clinical behavior and increased risk of tumor recurrence. One hundred and five patients with meningiomas were operated by open surgery. To investigate predictors of meningioma recurrence in total 124 samples of 105 patients were investigated by iFISH. Dual-probe hybridization was performed to access chromosomal alterations of chromosomes 1p-, 9p- and 22q. Additionally, methylation of TIMP3 and p16 was analyzed with MS-PCR. Of the 105 investigated tumors 59.1% (62/105) were WHO grade I, 33.3% (35/105) were WHO grade II and 7.7% (8/105) were anaplastic meningiomas (grade III), respectively. The histopathological data correlates with the recurrence rate of the investigated meningiomas. Hypermethylation of TIMP3 was detected in 13.3% of all meningiomas: 10.9% in WHO grade I meningiomas, 25.0% in grade II and 14.3% in grade III meningiomas, respectively. No correlation of TIMP3 hypermethylation with tumor recurrence or WHO grade (p = 0.2) was observed. Interestingly, deletion of 1p36 emerged as a significant predictor of shorter overall survival (log rank test, p<0.001), whereas TIMP3 promoter methylation had no significant effect on overall survival (log rank test, p = 0.799). The results of the current study support the finding that the deletion of chromosome 1p is an independent marker of meningioma recurrence and progression (p = 0.0097). Therefore the measurement of genetic aberrations in meningiomas allows in a combined histological approach a more precise assessment of the prognosis of meningiomas than histopathology alone.	[Linsler, Stefan; Kraemer, Dennis; Driess, Christina; Oertel, Joachim; Ketter, Ralf; Urbschat, Steffi] Univ Saarland, Dept Neurosurg, Homburg, Germany; [Kammers, Kai; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Kammers, Kai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Saarland University; Dortmund University of Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ketter, R (corresponding author), Univ Saarland, Dept Neurosurg, Homburg, Germany.	ralf.ketter@uks.eu	Linsler, Stefan N./ADW-5829-2022; Oertel, Joachim/AAO-5012-2021	Linsler, Stefan N./0000-0001-9829-5879; Rahnenfuhrer, Jorg/0000-0002-8947-440X				Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210; Bachman KE, 1999, CANCER RES, V59, P798; Bai YX, 2007, WORLD J GASTROENTERO, V13, P3883; Barski D, 2010, BRAIN PATHOL, V20, P623, DOI 10.1111/j.1750-3639.2009.00340.x; BEKS JWF, 1988, ACTA NEUROCHIR, V95, P3, DOI 10.1007/BF01793074; BELLO MJ, 1994, GENE CHROMOSOME CANC, V9, P296, DOI 10.1002/gcc.2870090411; Bello MJ, 2004, ACTA NEUROPATHOL, V108, P413, DOI 10.1007/s00401-004-0911-6; Bostrom J, 2001, AM J PATHOL, V159, P661, DOI 10.1016/S0002-9440(10)61737-3; Deodhar K, 2012, J MED VIROL, V84, P1054, DOI 10.1002/jmv.23310; Esteller M, 2000, CANCER RES, V60, P129; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HENN W, 1995, CANCER GENET CYTOGEN, V79, P144, DOI 10.1016/0165-4608(94)00135-X; Herman JG, 1997, CANCER RES, V57, P837; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilska M, 2007, INT J CANCER, V121, P714, DOI 10.1002/ijc.22747; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; Ishino S, 1998, CANCER, V83, P360, DOI 10.1002/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Ketter R, 2001, J NEUROSURG, V95, P601, DOI 10.3171/jns.2001.95.4.0601; Ketter R, 2008, NEUROSURGERY, V62, P61, DOI 10.1227/01.NEU.0000311062.72626.D6; Ketter R, 2007, INT J CANCER, V121, P1473, DOI 10.1002/ijc.22855; Ketter R, 2007, J NEURO-ONCOL, V83, P213, DOI 10.1007/s11060-006-9318-7; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Liu YH, 2005, HUM PATHOL, V36, P416, DOI 10.1016/j.humpath.2005.02.006; Lomas J, 2005, GENE CHROMOSOME CANC, V42, P314, DOI 10.1002/gcc.20141; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Mellai M, 2012, J NEURO-ONCOL, V107, P617, DOI 10.1007/s11060-011-0787-y; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Muhlisch J, 2007, J NEURO-ONCOL, V83, P17, DOI 10.1007/s11060-006-9309-8; Muellenbach R, 1989, TRENDS GENET, V5, P391; Muller P, 1999, CLIN CANCER RES, V5, P3569; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Niedermayer I, 1997, J NEUROPATH EXP NEUR, V56, P879, DOI 10.1097/00005072-199708000-00006; Niedermayer I, 1996, CLIN NEUROPATHOL, V15, P330; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Perry A, 1996, CANCER, V77, P2567, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2567::AID-CNCR21>3.0.CO;2-P; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A., 2007, WHO CLASSIFICATION T; PULST SM, 1993, NEUROLOGY, V43, P2096, DOI 10.1212/WNL.43.10.2096; Righini CA, 2007, B CANCER, V94, P191; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sayagues JM, 2002, CYTOMETRY, V50, P153, DOI 10.1002/cyto.10075; Simon M, 2001, J NEURO-ONCOL, V55, P149, DOI 10.1023/A:1013863630293; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Stuart MA, 2013, J NEUROPATHOL EXP NE; Ueki T, 2000, CANCER RES, V60, P1835; Urbschat S, 2011, INT J ONCOL, V39, P1601, DOI 10.3892/ijo.2011.1199; van Tilborg AAG, 2006, J PATHOL, V208, P564, DOI 10.1002/path.1909; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827; ZANG KD, 1967, NATURE, V216, P84, DOI 10.1038/216084a0; ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2; Zang KD, 2001, CYTOGENET CELL GENET, V93, P207, DOI 10.1159/000056986; ZANG KD, 1968, ANGEW CHEM INT EDIT, V7, P709, DOI 10.1002/anie.196807091	58	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94987	10.1371/journal.pone.0094987	http://dx.doi.org/10.1371/journal.pone.0094987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722350	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100148
J	Sarkar, S; Ulett, GC; Totsika, M; Phan, MD; Schembri, MA				Sarkar, Sohinee; Ulett, Glen C.; Totsika, Makrina; Minh-Duy Phan; Schembri, Mark A.			Role of Capsule and O Antigen in the Virulence of Uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; SERUM RESISTANCE; ANTIBIOTIC-RESISTANCE; NUCLEOTIDE-SEQUENCE; FUNCTIONAL-ANALYSIS; GENE REPLACEMENTS; CHROMOSOMAL GENES; ALLELIC EXCHANGE; K-ANTIGENS; IN-VITRO	Urinary tract infection (UTI) is one of the most common bacterial infections in humans, with uropathogenic Escherichia coli (UPEC) the leading causative organism. UPEC has a number of virulence factors that enable it to overcome host defenses within the urinary tract and establish infection. The O antigen and the capsular polysaccharide are two such factors that provide a survival advantage to UPEC. Here we describe the application of the rpsL counter selection system to construct capsule (kpsD) and O antigen (waaL) mutants and complemented derivatives of three reference UPEC strains: CFT073 (O6:K2:H1), RS218 (O18:K1:H7) and 1177 (O1:K1:H7). We observed that while the O1, O6 and O18 antigens were required for survival in human serum, the role of the capsule was less clear and linked to O antigen type. In contrast, both the K1 and K2 capsular antigens provided a survival advantage to UPEC in whole blood. In the mouse urinary tract, mutation of the O6 antigen significantly attenuated CFT073 bladder colonization. Overall, this study contrasts the role of capsule and O antigen in three common UPEC serotypes using defined mutant and complemented strains. The combined mutagenesis-complementation strategy can be applied to study other virulence factors with complex functions both in vitro and in vivo.	[Sarkar, Sohinee; Totsika, Makrina; Minh-Duy Phan; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Ulett, Glen C.] Griffith Univ, Griffith Hlth Inst, Sch Med Sci, Gold Coast, Qld, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland	Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Totsika, Makrina/A-8993-2011; Phan, Minh-Duy/I-9147-2012	Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Phan, Minh-Duy/0000-0002-3426-1044; Sarkar, Sohinee/0000-0001-9364-1920; Ulett, Glen/0000-0002-9638-8091	Australian National Health and Medical Research Council [APP1012076, APP1005315]; Australian Research Council Future Fellowships [FT110101048, FT100100662]; Australian Research Council [DE130101169]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowships(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council (APP1012076 and APP1005315). GCU and MAS are supported by Australian Research Council Future Fellowships (FT110101048 and FT100100662, respectively). MT is supported by an Australian Research Council Discovery Early Career Researcher Award (DE130101169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Billips BK, 2009, J INFECT DIS, V200, P263, DOI 10.1086/599839; BINNS MM, 1982, INFECT IMMUN, V35, P654, DOI 10.1128/IAI.35.2.654-659.1982; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; BJORKSTEN B, 1976, J PEDIATR-US, V89, P892, DOI 10.1016/S0022-3476(76)80592-6; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BORTOLUSSI R, 1979, INFECT IMMUN, V25, P293, DOI 10.1128/IAI.25.1.293-298.1979; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Buonsenso D, 2012, MINERVA PEDIATR, V64, P145; Burns SM, 1999, INFECT IMMUN, V67, P3757, DOI 10.1128/IAI.67.8.3757-3762.1999; Burns SM, 1998, INFECT IMMUN, V66, P4244; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chenoweth CE, 2011, INFECT DIS CLIN N AM, V25, P103, DOI 10.1016/j.idc.2010.11.005; CRYZ SJ, 1990, INFECT IMMUN, V58, P373, DOI 10.1128/IAI.58.2.373-377.1990; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; EDEN CS, 1983, PROG ALLERGY, V33, P189; Emmerson JR, 2006, BIOL PROCED ONLINE, V8, P153, DOI 10.1251/bpo123; Enne VI, 2005, J ANTIMICROB CHEMOTH, V56, P544, DOI 10.1093/jac/dki255; Foxman B, 2002, AM J MED, V113, p5S; GADEBERG OV, 1990, ZBL BAKT-INT J MED M, V273, P492; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Goryshin IY, 2003, GENOME RES, V13, P644, DOI 10.1101/gr.611403; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Heinrichs DE, 1998, J BIOL CHEM, V273, P8849, DOI 10.1074/jbc.273.15.8849; HOLLINGSHEAD S, 1985, PLASMID, V13, P17, DOI 10.1016/0147-619X(85)90052-6; HOWARD CJ, 1971, IMMUNOLOGY, V20, P767; HUGHES C, 1982, INFECT IMMUN, V35, P270, DOI 10.1128/IAI.35.1.270-275.1982; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; KIM KS, 1992, J CLIN INVEST, V90, P897, DOI 10.1172/JCI115965; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; LEDERBERG J, 1951, J BACTERIOL, V61, P549, DOI 10.1128/JB.61.5.549-550.1951; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; LEYING H, 1990, INFECT IMMUN, V58, P222, DOI 10.1128/IAI.58.1.222-227.1990; Liu YF, 2012, INFECT IMMUN, V80, P1815, DOI 10.1128/IAI.06395-11; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; MCCABE WR, 1978, J INFECT DIS, V138, P33, DOI 10.1093/infdis/138.1.33; MEISSNER PS, 1987, P NATL ACAD SCI USA, V84, P4171, DOI 10.1073/pnas.84.12.4171; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MONTENEGRO MA, 1985, J GEN MICROBIOL, V131, P1511; Mosberg JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044638; Nicolle LE, 2001, INFECT CONT HOSP EP, V22, P167, DOI 10.1086/501886; Oelschlaeger TA, 2002, INT J ANTIMICROB AG, V19, P517, DOI 10.1016/S0924-8579(02)00092-4; Oelschlaeger Tobias A, 2002, Curr Opin Urol, V12, P33, DOI 10.1097/00042307-200201000-00007; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; PLUSCHKE G, 1983, INFECT IMMUN, V42, P907, DOI 10.1128/IAI.42.3.907-913.1983; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Roos V, 2006, MICROBIOL-SGM, V152, P1799, DOI 10.1099/mic.0.28711-0; Russo TA, 1996, INFECT IMMUN, V64, P2343, DOI 10.1128/IAI.64.6.2343-2348.1996; Sandvang D, 1999, ANTIMICROB AGENTS CH, V43, P3036, DOI 10.1128/AAC.43.12.3036; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schneider G, 2004, INFECT IMMUN, V72, P5993, DOI 10.1128/IAI.72.10.5993-6001.2004; Schwartz JA, 2006, J VIROL, V80, P769, DOI 10.1128/JVI.80.2.769-784.2006; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; SILVER RP, 1980, INFECT IMMUN, V29, P200, DOI 10.1128/IAI.29.1.200-206.1980; SILVER RP, 1987, J BACTERIOL, V169, P5489, DOI 10.1128/jb.169.12.5489-5495.1987; SILVER RP, 1984, J BACTERIOL, V157, P568, DOI 10.1128/JB.157.2.568-575.1984; SOUSSY CJ, 1993, ANTIMICROB AGENTS CH, V37, P2588, DOI 10.1128/AAC.37.12.2588; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; STAWSKI G, 1990, APMIS, V98, P828, DOI 10.1111/j.1699-0463.1990.tb05003.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; TAYLOR PW, 1976, J MED MICROBIOL, V9, P405, DOI 10.1099/00222615-9-4-405; TOMAS JM, 1988, J GEN MICROBIOL, V134, P1009; Totsika M, 2012, CURR DRUG TARGETS, V13, P1386, DOI 10.2174/138945012803530206; Tree JJ, 2008, J BACTERIOL, V190, P6909, DOI 10.1128/JB.00451-08; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tuntufye HN, 2011, FEMS MICROBIOL LETT, V325, P140, DOI 10.1111/j.1574-6968.2011.02421.x; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Watve MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009328; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; WEISS J, 1982, INFECT IMMUN, V38, P1149, DOI 10.1128/IAI.38.3.1149-1153.1982; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; White EA, 2005, J VIROL, V79, P7438, DOI 10.1128/JVI.79.12.7438-7452.2005; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Winterberg KM, 2005, APPL ENVIRON MICROB, V71, P451, DOI 10.1128/AEM.71.1.451-459.2005; WUNDER DE, 1994, J BACTERIOL, V176, P4025, DOI 10.1128/JB.176.13.4025-4033.1994	98	60	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94786	10.1371/journal.pone.0094786	http://dx.doi.org/10.1371/journal.pone.0094786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722484	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100132
J	Zhang, CR; Zhang, S; Xia, J; Li, FF; Xia, WQ; Liu, SS; Wang, XW				Zhang, Chang-Rong; Zhang, Shan; Xia, Jun; Li, Fang-Fang; Xia, Wen-Qiang; Liu, Shu-Sheng; Wang, Xiao-Wei			The Immune Strategy and Stress Response of the Mediterranean Species of the Bemisia tabaci Complex to an Orally Delivered Bacterial Pathogen	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; DROSOPHILA HOST-DEFENSE; DNA-DAMAGE RESPONSE; C-TYPE LECTIN; NF-KAPPA-B; PEA APHIDS; ACTIVATION; INFECTION; JNK; ENDOSYMBIONTS	Background: The whitefly, Bemisia tabaci, a notorious agricultural pest, has complex relationships with diverse microbes. The interactions of the whitefly with entomopathogens as well as its endosymbionts have received great attention, because of their potential importance in developing novel whitefly control technologies. To this end, a comprehensive understanding on the whitefly defense system is needed to further decipher those interactions. Methodology/Principal Findings: We conducted a comprehensive investigation of the whitefly's defense responses to infection, via oral ingestion, of the pathogen, Pseudomonas aeruginosa, using RNA-seq technology. Compared to uninfected whiteflies, 6 and 24 hours post-infected whiteflies showed 1,348 and 1,888 differentially expressed genes, respectively. Functional analysis of the differentially expressed genes revealed that the mitogen associated protein kinase (MAPK) pathway was activated after P. aeruginosa infection. Three knottin-like antimicrobial peptide genes and several components of the humoral and cellular immune responses were also activated, indicating that key immune elements recognized in other insect species are also important for the response of B. tabaci to pathogens. Our data also suggest that intestinal stem cell mediated epithelium renewal might be an important component of the whitefly's defense against oral bacterial infection. In addition, we show stress responses to be an essential component of the defense system. Conclusions/Significance: We identified for the first time the key immune-response elements utilized by B. tabaci against bacterial infection. This study provides a framework for future research into the complex interactions between whiteflies and microbes.	[Zhang, Chang-Rong; Zhang, Shan; Xia, Jun; Li, Fang-Fang; Xia, Wen-Qiang; Liu, Shu-Sheng; Wang, Xiao-Wei] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Wang, XW (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xwwang@zju.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120101110077]; Program for New Century Excellent Talents in University [NCET-12-0483]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this study was provided by the Specialized Research Fund for the Doctoral Program of Higher Education (20120101110077) and Program for New Century Excellent Talents in University (NCET-12-0483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ateyyat Mazen A., 2009, Jordan Journal of Biological Sciences, V2, P139; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Davidson EW, 2000, FLA ENTOMOL, V83, P159, DOI 10.2307/3496151; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ikeda A, 2001, FEBS LETT, V488, P190, DOI 10.1016/S0014-5793(00)02432-7; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Su YL, 2013, J ECON ENTOMOL, V106, P1446, DOI 10.1603/EC12459; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	71	17	19	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94477	10.1371/journal.pone.0094477	http://dx.doi.org/10.1371/journal.pone.0094477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722540	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100077
J	Zhang, D; Glasby, TM; Ralph, PJ; Gribben, PE				Zhang, Dilys; Glasby, Tim M.; Ralph, Peter J.; Gribben, Paul E.			Mechanisms Influencing the Spread of a Native Marine Alga	PLOS ONE			English	Article							CAULERPA-TAXIFOLIA; ROCKY REEFS; MACROALGAL ASSEMBLAGES; BIOLOGICAL INVASION; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; XANTHOPHYLL CYCLE; ECOLOGICAL CHANGE; FORMING ALGAE; DISTURBANCE	Like invasive macrophytes, some native macrophytes are spreading rapidly with consequences for community structure. There is evidence that the native alga Caulerpa filiformis is spreading along intertidal rocky shores in New South Wales, Australia, seemingly at the expense of native Sargassum spp. We experimentally investigated the role physical disturbance plays in the spread of C. filiformis and its possible consequences for Sargassum spp. Cleared patches within beds of C. filiformis (Caulerpa habitat) or Sargassum spp. (Sargassum habitat) at multiple sites showed that C. filiformis had significantly higher recruitment (via propagules) into its own habitat. The recruitment of Sargassum spp. to Caulerpa habitat was rare, possibly due in part to sediment accretion within Caulerpa habitat. Diversity of newly recruited epibiotic assemblages within Caulerpa habitat was significantly less than in Sargassum habitat. In addition, more C. filiformis than Sargassum spp. recruited to Sargassum habitat at some sites. On common boundaries between these two macroalgae, the vegetative growth of adjacent C. filiformis into cleared patches was significantly higher than for adjacent Sargassum spp. In both experiments, results were largely independent of the size of disturbance (clearing). Lastly, we used PAM fluorometry to show that the photosynthetic condition of Sargassum spp. fronds adjacent to C. filiformis was generally suppressed relative to those distant from C. filiformis. Thus, physical disturbance, combined with invasive traits (e. g. high levels of recruitment and vegetative growth) most likely facilitate the spread of C. filiformis, with the ramifications being lower epibiotic diversity and possibly reduced photosynthetic condition of co-occurring native macrophytes.	[Zhang, Dilys; Ralph, Peter J.; Gribben, Paul E.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Glasby, Tim M.] New South Wales Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia	University of Technology Sydney; NSW Department of Primary Industries	Gribben, PE (corresponding author), Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand.	p.gribben@massey.ac.nz	Glasby, Tim/AGR-1689-2022; Ralph, Peter/L-1527-2019; Ralph, Peter J/C-5029-2009; Glasby, Tim M/Q-3670-2016	Glasby, Tim/0000-0001-5011-7731; Ralph, Peter/0000-0002-3103-7346; Ralph, Peter J/0000-0002-3103-7346; Glasby, Tim M/0000-0001-5011-7731; Gribben, Paul/0000-0003-2650-5501	University of Technology, Sydney	University of Technology, Sydney	Funding was provided to Dilys Zhang by the University of Technology, Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2003, MAR BIOL, V143, P639, DOI 10.1007/s00227-003-1119-3; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arrontes J, 2002, MAR BIOL, V141, P1059, DOI 10.1007/s00227-002-0910-x; Beckley, 2008, 2 OCEANS GUIDE MARIN; BOBBINK R, 1987, BIOL CONSERV, V40, P301, DOI 10.1016/0006-3207(87)90122-4; BOROWITZKA MA, 1972, AUST J MAR FRESH RES, V23, P73; Bulleri F, 2008, MAR ECOL PROG SER, V364, P77, DOI 10.3354/meps07484; Bulleri F, 2010, ECOLOGY, V91, P2205, DOI 10.1890/09-1857.1; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; BUTLER AJ, 1986, J EXP MAR BIOL ECOL, V97, P13, DOI 10.1016/0022-0981(86)90065-1; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Chaerle L, 2001, BBA-GENE STRUCT EXPR, V1519, P153, DOI 10.1016/S0167-4781(01)00238-X; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P787, DOI 10.4319/lo.2003.48.2.0787; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; CLAYTON MN, 1988, BOT MAR, V31, P379, DOI 10.1515/botm.1988.31.5.379; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CRITCHLEY AT, 1991, BRIT PHYCOL J, V26, P303, DOI 10.1080/00071619100650271; Cummings DO, 2008, MAR FRESHWATER RES, V59, P279, DOI 10.1071/MF06238; DAHL AL, 1971, BOT MAR, V14, P76, DOI 10.1515/botm.1971.14.2.76; DAVANZO C, 1994, ESTUARIES, V17, P131, DOI 10.2307/1352562; Davis AR, 2005, MAR BIOL, V146, P859, DOI 10.1007/s00227-004-1499-z; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Deegan LA, 2002, AQUAT CONSERV, V12, P193, DOI 10.1002/aqc.490; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; DEVINNY JS, 1978, MAR BIOL, V48, P343, DOI 10.1007/BF00391638; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; DOBLIN MA, 1995, MAR BIOL, V122, P689, DOI 10.1007/BF00350691; Downes BJ, 2000, OECOLOGIA, V123, P569, DOI 10.1007/PL00008862; Dudgeon SR, 1999, ECOL MONOGR, V69, P331, DOI 10.1890/0012-9615(1999)069[0331:COSSIA]2.0.CO;2; Dumay O, 2002, J CHEM ECOL, V28, P343, DOI 10.1023/A:1017938225559; Edgar G, 2000, AUSTR MARINE LIFE PL; Edgar G.J., 1997, REED BOOKS; Gennaro P, 2011, MAR ECOL PROG SER, V427, P59, DOI 10.3354/meps09053; Glasby TM, 2005, AQUAT BOT, V82, P71, DOI 10.1016/j.aquabot.2005.02.004; Goodrich JM, 1995, CONSERV BIOL, V9, P1357, DOI 10.1046/j.1523-1739.1995.09061357.x; Gribben PE, 2006, OECOLOGIA, V149, P352, DOI 10.1007/s00442-006-0452-x; Gribben PE, 2013, OIKOS, V122, P816, DOI 10.1111/j.1600-0706.2012.20868.x; Gribben PE, 2009, OECOLOGIA, V158, P733, DOI 10.1007/s00442-008-1181-0; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Huisman JM, 2000, MARINE PLANTS AUSTR; Hurst A, 1999, BIOL CONSERV, V88, P75, DOI 10.1016/S0006-3207(98)00089-5; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Irving AD, 2002, PHYCOLOGIA, V41, P517, DOI 10.2216/i0031-8884-41-5-517.1; Jacobs WP, 1994, SCI AM, V271, P66; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Jenkins SR, 1999, J MAR BIOL ASSOC UK, V79, P341, DOI 10.1017/S0025315498000381; Kawamata S, 2012, MAR BIOL, V159, P723, DOI 10.1007/s00227-011-1849-6; Kelaher BP, 2003, OECOLOGIA, V135, P431, DOI 10.1007/s00442-003-1196-5; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P145, DOI 10.3354/meps040145; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Leliaert F, 2000, BOT MAR, V43, P359, DOI 10.1515/BOT.2000.036; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; LUCAS A. H. S., 1927, PROC LINN SOC N S WALES, V52, P555; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Magnusson G, 1997, MAR BIOL, V130, P203, DOI 10.1007/s002270050239; Martin-Smith KM, 2009, BOT MAR, V36, P267; MARTINSMITH KM, 1993, BOT MAR, V36, P327, DOI 10.1515/botm.1993.36.4.327; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MAY DI, 1991, PHYCOLOGIA, V30, P243, DOI 10.2216/i0031-8884-30-3-243.1; MAY V, 1976, Telopea, V1, P136; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Pillmann A, 1997, EUR J PHYCOL, V32, P379, DOI 10.1017/S0967026297001352; Ralph PJ, 2002, J EXP MAR BIOL ECOL, V271, P189, DOI 10.1016/S0022-0981(02)00047-3; Schiel DR, 2011, J EXP MAR BIOL ECOL, V407, P108, DOI 10.1016/j.jembe.2011.07.004; SEAPY RR, 1982, MAR BIOL, V71, P87, DOI 10.1007/BF00396995; Simberloff D, 2011, ENCY BIOL INVASIONS; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Sousa W.P., 1985, P101; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Thacker ET, 2008, RANGELAND ECOL MANAG, V61, P263, DOI 10.2111/07-043.1; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; Vaughn SF, 1999, J CHEM ECOL, V25, P2495, DOI 10.1023/A:1020874124645; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Williamson JE, 2004, ECOLOGY, V85, P1355, DOI 10.1890/02-4083; Wright JT, 2006, ECOLOGY, V87, P1744, DOI 10.1890/0012-9658(2006)87[1744:DFBCGA]2.0.CO;2; Wright JI, 2008, J APPL ECOL, V45, P1540, DOI 10.1111/j.1365-2664.2008.01541.x; Wright JT, 2005, MAR BIOL, V147, P559, DOI 10.1007/s00227-005-1561-5	86	9	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94647	10.1371/journal.pone.0094647	http://dx.doi.org/10.1371/journal.pone.0094647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722520	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100115
J	Zhong, L; Zhang, JM; Zhao, XD; Tan, RS; Wan, M				Zhong, Liang; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Min			Automatic Localization of the Left Ventricle from Cardiac Cine Magnetic Resonance Imaging: A New Spectrum-Based Computer-Aided Tool	PLOS ONE			English	Article							REGIONAL WALL CURVEDNESS; HEART-FAILURE; MR-IMAGES; EJECTION FRACTION; SEGMENTATION; STRESS; TRACKING; SHAPES; MODELS; SNAKES	Traditionally, cardiac image analysis is done manually. Automatic image processing can help with the repetitive tasks, and also deal with huge amounts of data, a task which would be humanly tedious. This study aims to develop a spectrum-based computer-aided tool to locate the left ventricle using images obtained via cardiac magnetic resonance imaging. Discrete Fourier Transform was conducted pixelwise on the image sequence. Harmonic images of all frequencies were analyzed visually and quantitatively to determine different patterns of the left and right ventricles on spectrum. The first and fifth harmonic images were selected to perform an anisotropic weighted circle Hough detection. This tool was then tested in ten volunteers. Our tool was able to locate the left ventricle in all cases and had a significantly higher cropping ratio of 0.165 than did earlier studies. In conclusion, a new spectrum-based computer aided tool has been proposed and developed for automatic left ventricle localization. The development of this technique, which will enable the automatic location and further segmentation of the left ventricle, will have a significant impact in research and in diagnostic settings. We envisage that this automated method could be used by radiographers and cardiologists to diagnose and assess ventricular function in patients with diverse heart diseases.	[Zhong, Liang; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Min] Natl Heart Ctr Singapore, Bioengn Dept, Singapore, Singapore; [Zhong, Liang; Tan, Ru San] Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Wan, Min] ASTAR, Inst High Performance Comp, Singapore, Singapore	National Heart Centre Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Wan, M (corresponding author), Natl Heart Ctr Singapore, Bioengn Dept, Singapore, Singapore.	wanmin1983@gmail.com		zhao, xiaodan/0000-0003-1469-8027; Tan, Ru San/0000-0003-2086-6517; ZHONG, LIANG/0000-0003-3608-4173; Zhang, Jun-Mei/0000-0002-2257-1803	National Research Foundation [NRF2011NRF-POC001-068]; National Medical Research Council [NMRC/EDG/1037/2011]; SERC Biomedical Engineering Programme Grants [1211480003, 1321480012]	National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SERC Biomedical Engineering Programme Grants	This work was supported by the National Research Foundation (NRF2011NRF-POC001-068), the National Medical Research Council (NMRC/EDG/1037/2011), and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Cocosco CA, 2004, INT CONGR SER, V1268, P1126, DOI 10.1016/j.ics.2004.03.179; Gering DT, 2003, LECT NOTES COMPUT SC, V2878, P524; GUPTA A, 1993, COMPUT CARDIOL, P747; Huang JZ, 2007, I S BIOMED IMAGING, P852, DOI 10.1109/ISBI.2007.356986; Huang W, 2010, J SIGNAL PROCESS SYS, V59, P143, DOI 10.1007/s11265-008-0294-3; Jolly MP, 2008, LECT NOTES COMPUT SC, V5241, P110, DOI 10.1007/978-3-540-85988-8_14; Jolly MP, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P501, DOI 10.1109/ICCV.2001.937558; Jones M., 2001, PROC CVPR IEEE, P1; Kaus MR, 2004, MED IMAGE ANAL, V8, P245, DOI 10.1016/j.media.2004.06.015; Lin X, 2006, LECT NOTES COMPUT SC, V4190, P728; Muller A, 2005, COMPUT CARDIOL, V32, P21; Nascimento J, 2008, IEEE IMAGE PROC, P553, DOI 10.1109/ICIP.2008.4711814; Nascimento JC, 2008, IEEE T IMAGE PROCESS, V17, P392, DOI 10.1109/TIP.2007.915552; Paragios N, 2002, INT J COMPUT VISION, V50, P345, DOI 10.1023/A:1020882509893; Pavani SK, 2010, PATTERN RECOGN, V43, P160, DOI 10.1016/j.patcog.2009.05.011; Pednekar A, 2006, IEEE T BIO-MED ENG, V53, P1425, DOI 10.1109/TBME.2006.873684; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; RANGANATH S, 1995, IEEE T MED IMAGING, V14, P328, DOI 10.1109/42.387714; Santarelli MF, 2003, MED ENG PHYS, V25, P149, DOI 10.1016/S1350-4533(02)00144-3; Silva I, 2010, INT J TOMOGRAPHY SIM, V13, P60; Sorgel W, 1997, PROC SPIE, V3034, P333, DOI 10.1117/12.274120; Wu KC, 2003, CIRC RES, V93, P1146, DOI 10.1161/01.RES.0000103863.40055.E8; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu Pham C., 2000, HDB MED IMAGING, P129, DOI 10.1117/3.831079.ch3; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011; Zhong L, 2013, INT J CARDIOL, V168, P1975, DOI 10.1016/j.ijcard.2012.12.084; Zhong L, 2012, AM J PHYSIOL-HEART C, V302, pH1306, DOI 10.1152/ajpheart.00679.2011; Zhong L, 2011, ANN ACAD MED SINGAP, V40, P179; Zhong L, 2009, AM J PHYSIOL-HEART C, V296, pH573, DOI 10.1152/ajpheart.00525.2008	30	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e92382	10.1371/journal.pone.0092382	http://dx.doi.org/10.1371/journal.pone.0092382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722328	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100011
J	Camps, J; Wangsa, D; Falke, M; Brown, M; Case, CM; Erdos, MR; Ried, T				Camps, Jordi; Wangsa, Darawalee; Falke, Martin; Brown, Markus; Case, Chanelle M.; Erdos, Michael R.; Ried, Thomas			Loss of lamin B1 results in prolongation of S phase and decondensation of chromosome territories	FASEB JOURNAL			English	Article						nuclear organization; alternative splicing	GILFORD-PROGERIA-SYNDROME; LARGE GENE LISTS; DNA-REPLICATION; NUCLEAR LAMINS; HUMAN FIBROBLASTS; HUMAN-CELLS; ORGANIZATION; CHROMATIN; ARCHITECTURE; SENESCENCE	Nuclear lamin B1 (LMNB1) constitutes one of the major structural proteins in the lamina mesh. We silenced the expression of LMNB1 by RNA interference in the colon cancer cell line DLD-1 and showed a dramatic redistribution of H3K27me3 from the periphery to a more homogeneous nuclear dispersion. In addition, we observed telomere attrition and an increased frequency of micronuclei and nuclear blebs. By 3D-FISH analyses, we demonstrated that the volume and surface of chromosome territories were significantly larger in LMNB1-depleted cells, suggesting that LMNB1 is required to maintain chromatin condensation in interphase nuclei. These changes led to a prolonged S phase due to activation of Chk1. Finally, silencing of LMNB1 resulted in extensive changes in alternative splicing of multiple genes and in a higher number of enlarged nuclear speckles. Taken together, our results suggest a mechanistic role of the nuclear lamina in the organization of chromosome territories, maintenance of genome integrity and proper gene splicing.	[Camps, Jordi; Wangsa, Darawalee; Falke, Martin; Brown, Markus; Case, Chanelle M.; Ried, Thomas] NCI, Sect Canc Genom, Genet Branch, Bethesda, MD 20893 USA; [Erdos, Michael R.] NHGRI, Genome Technol Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ried, T (corresponding author), NCI, Sect Canc Genom, Genet Branch, Ctr Canc Res,NIH, 50 South Dr,Bldg 50,Rm 1408, Bethesda, MD 20893 USA.	riedt@mail.nih.gov	Camps, Jordi/AAG-3080-2020	Camps, Jordi/0000-0002-3165-3640; Brown, Markus Alexander/0000-0002-2069-0120	Intramural Research Program of the U.S. National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010835] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Abdel Elkalhoun (director of the Microarray Core, National Human Genome Research Institute), Dr. Stephen M. Wincovitch and Dr. Amalia Dutra (Cytogenetics and Microscopy Core, National Human Genome Research Institute), and Barbara J. Taylor (Facility Head of the FACS Core Laboratory, National Cancer Institute) for technical support. The authors also thank Buddy Chen for editorial assistance. This project was supported by the Intramural Research Program of the U.S. National Institutes of Health, National Cancer Institute. The authors declare no conflicts of interest.	Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Ellis DJ, 1997, J CELL SCI, V110, P2507; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lund E, 2013, GENOME RES, V23, P1580, DOI 10.1101/gr.159400.113; Macville M, 1999, CANCER RES, V59, P141; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Martins S, 2003, J CELL BIOL, V160, P177, DOI 10.1083/jcb.200210026; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shimi T, 2010, COLD SH Q B, V75, P525, DOI 10.1101/sqb.2010.75.045; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Takebayashi S, 2012, NUCLEUS-PHILA, V3, P500, DOI 10.4161/nucl.22318; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Yoshida K, 2010, J CELL SCI, V123, P225, DOI 10.1242/jcs.058693	39	41	43	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3423	3434		10.1096/fj.14-250456	http://dx.doi.org/10.1096/fj.14-250456			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24732130	Green Published			2022-12-25	WOS:000340265400013
J	Barroso, M; Florindo, C; Kalwa, H; Silva, Z; Turanov, AA; Carlson, BA; de Almeida, IT; Blom, HJ; Gladyshev, VN; Hatfield, DL; Michel, T; Castro, R; Loscalzo, J; Handy, DE				Barroso, Madalena; Florindo, Cristina; Kalwa, Hermann; Silva, Zelia; Turanov, Anton A.; Carlson, Bradley A.; de Almeida, Isabel Tavares; Blom, Henk J.; Gladyshev, Vadim N.; Hatfield, Dolph L.; Michel, Thomas; Castro, Rita; Loscalzo, Joseph; Handy, Diane E.			Inhibition of Cellular Methyltransferases Promotes Endothelial Cell Activation by Suppressing Glutathione Peroxidase 1 Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Endothelial Cell; Glutathione Peroxidase; Oxidative Stress; Selenoprotein; S-Adenosylhomocysteine; tRNA Methylation	S-ADENOSYLHOMOCYSTEINE CONCENTRATIONS; INTERCELLULAR-ADHESION MOLECULE-1; TRANSFER-RNA; CARDIOVASCULAR EVENTS; ARGININE METHYLATION; DNA HYPOMETHYLATION; OXIDATIVE STRESS; SELENOCYSTEINE; THIOREDOXIN; HOMOCYSTEINE	Background: Methylation of tRNA(Sec) facilitates the incorporation of selenocysteine at a UGA codon during translation. Results: Accumulation of the homocysteine precursor S-adenosylhomocysteine decreases tRNA(Sec) methylation, reducing glutathione peroxidase 1 expression and increasing oxidative stress-induced inflammatory activation of endothelial cells. Conclusion: Methylation modulates the expression of selenoproteins to regulate redox-dependent inflammatory pathways. Significance: Hypomethylation stress promotes a proatherogenic endothelial cell phenotype. S-Adenosylhomocysteine (SAH) is a negative regulator of most methyltransferases and the precursor for the cardiovascular risk factor homocysteine. We have previously identified a link between the homocysteine-induced suppression of the selenoprotein glutathione peroxidase 1 (GPx-1) and endothelial dysfunction. Here we demonstrate a specific mechanism by which hypomethylation, promoted by the accumulation of the homocysteine precursor SAH, suppresses GPx-1 expression and leads to inflammatory activation of endothelial cells. The expression of GPx-1 and a subset of other selenoproteins is dependent on the methylation of the tRNA(Sec) to the Um34 form. The formation of methylated tRNA(Sec) facilitates translational incorporation of selenocysteine at a UGA codon. Our findings demonstrate that SAH accumulation in endothelial cells suppresses the expression of GPx-1 to promote oxidative stress. Hypomethylation stress, caused by SAH accumulation, inhibits the formation of the methylated isoform of the tRNA(Sec) and reduces GPx-1 expression. In contrast, under these conditions, the expression and activity of thioredoxin reductase 1, another selenoprotein, is increased. Furthermore, SAH-induced oxidative stress creates a proinflammatory activation of endothelial cells characterized by up-regulation of adhesion molecules and an augmented capacity to bind leukocytes. Taken together, these data suggest that SAH accumulation in endothelial cells can induce tRNA(Sec) hypomethylation, which alters the expression of selenoproteins such as GPx-1 to contribute to a proatherogenic endothelial phenotype.	[Barroso, Madalena; Kalwa, Hermann; Michel, Thomas; Loscalzo, Joseph; Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Barroso, Madalena; Florindo, Cristina; de Almeida, Isabel Tavares; Castro, Rita] Univ Lisbon, Res Inst Med & Pharmaceut Sci iMed UL, Fac Pharm, P-1649004 Lisbon, Portugal; [de Almeida, Isabel Tavares; Castro, Rita] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1649004 Lisbon, Portugal; [Silva, Zelia] Univ Nova Lisboa, Fac Ciencias Med, Dept Imunol, Chron Dis Res Ctr, P-1099085 Lisbon, Portugal; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Blom, Henk J.] Univ Hosp, Ctr Pediat & Adolescent Med, Dept Gen Pediat, D-79106 Freiburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Freiburg	Handy, DE (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Castro, Rita/J-7672-2019; de Almeida, Isabel Tavares/F-8319-2014; Kalwa, Hermann/ABG-2323-2021; Loscalzo, Joseph/ABD-8980-2021; iMed.ULisboa, MetGen/B-5293-2014; silva, zélia mc/O-7243-2015; Barroso, Madalena/AAT-9916-2020	Castro, Rita/0000-0002-4585-0741; silva, zélia mc/0000-0001-6660-426X; Barroso, Madalena/0000-0002-1600-890X; Blom, Henk/0000-0001-5202-9241; Florindo, Cristina/0000-0002-0664-5411; Handy, Diane/0000-0002-4310-8527; Gladyshev, Vadim/0000-0002-0372-7016; Tavares de Almeida, Isabel/0000-0002-4024-8305	National Institutes of Health [HL067195, HL070819, HL048743, HL107192, HL108630, HL46457, HL48743, GM061603]; American Heart Association; Portuguese Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-ORG/112683/2009, SFRH/BD/73021/2010]; NATIONAL CANCER INSTITUTE [ZIABC011620, ZIABC010767] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R37HL061795, R01HL067195, P50HL107192, R01HL061795, U01HL108630, R01HL046457, U54HL070819, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067195, HL070819, HL048743, HL107192, and HL108630 (to J. L.); HL46457 and HL48743 (to T. M.); and GM061603 (to V. N. G.). This work was also supported by an American Heart Association postdoctoral fellowship grant (to H. K.) and by Portuguese Fundacao para a Ciencia e a Tecnologia Grants PTDC/SAU-ORG/112683/2009 (to R. C.) and SFRH/BD/73021/2010 (M. B.).	Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Barroso M, 2012, AMINO ACIDS, V42, P1903, DOI 10.1007/s00726-011-0916-0; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Donovan J, 2010, ANTIOXID REDOX SIGN, V12, P881, DOI 10.1089/ars.2009.2878; Esse R, 2014, FASEB J, V28, P2686, DOI 10.1096/fj.13-246579; Esse R, 2013, BBA-MOL BASIS DIS, V1832, P1708, DOI 10.1016/j.bbadis.2013.05.013; Esse R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055483; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Frazier-Wood AC, 2012, PHARMACOGENET GENOM, V22, P750, DOI 10.1097/FPC.0b013e328357f6af; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hellebrekers DMEI, 2006, CANCER RES, V66, P10770, DOI 10.1158/0008-5472.CAN-06-1609; Howard MT, 2013, J BIOL CHEM, V288, P19401, DOI 10.1074/jbc.M113.481051; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Jeong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049204; Kalwa H, 2012, J BIOL CHEM, V287, P29147, DOI 10.1074/jbc.M112.381517; Kim GH, 2013, ANTIOXID REDOX SIGN, V18, P1920, DOI 10.1089/ars.2012.4926; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; King WD, 2012, MOL BIOL REP, V39, P7805, DOI 10.1007/s11033-012-1623-y; Kloor D, 2000, J HISTOCHEM CYTOCHEM, V48, P211, DOI 10.1177/002215540004800206; Kloor D, 2007, CELL PHYSIOL BIOCHEM, V19, P57, DOI 10.1159/000099192; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Le NT, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/678190; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Lubos E, 2011, J BIOL CHEM, V286, P35407, DOI 10.1074/jbc.M110.205708; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lubos E, 2010, FASEB J, V24, P2525, DOI 10.1096/fj.09-147421; Miller S, 2001, CLIN SCI, V100, P543, DOI 10.1042/CS20000299; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Pastori D, 2014, INTERN EMERG MED, V9, P123, DOI 10.1007/s11739-013-0999-6; Polotskaia A, 2007, CELL CYCLE, V6, P2524, DOI 10.4161/cc.6.20.4799; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schnabel R, 2005, J AM COLL CARDIOL, V45, P1631, DOI 10.1016/j.jacc.2005.02.053; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Smith AD, 2002, METHOD ENZYMOL, V347, P113; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Struys EA, 2000, CLIN CHEM, V46, P1650; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Xiao YJ, 2013, AM J CLIN NUTR, V98, P1162, DOI 10.3945/ajcn.113.058727; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P23, DOI 10.1007/978-1-4614-1025-6_2; Yan MSC, 2010, J APPL PHYSIOL, V109, P916, DOI 10.1152/japplphysiol.00131.2010; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007	65	35	35	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15350	15362		10.1074/jbc.M114.549782	http://dx.doi.org/10.1074/jbc.M114.549782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719327	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000337465400019
J	Bollmann, F; Wu, ZX; Oelze, M; Siuda, D; Xia, N; Henke, J; Daiber, A; Li, HG; Stumpo, DJ; Blackshear, PJ; Kleinert, H; Pautz, A				Bollmann, Franziska; Wu, Zhixiong; Oelze, Matthias; Siuda, Daniel; Xia, Ning; Henke, Jenny; Daiber, Andreas; Li, Huige; Stumpo, Deborah J.; Blackshear, Perry J.; Kleinert, Hartmut; Pautz, Andrea			Endothelial Dysfunction in Tristetraprolin-deficient Mice Is Not Caused by Enhanced Tumor Necrosis Factor-alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endothelial Dysfunction; NADPH Oxidase; Reactive Nitrogen Species; Reactive Oxygen Species (ROS); Tumor Necrosis Factor (TNF)	FINGER PROTEIN TRISTETRAPROLIN; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; TNF-ALPHA; CARDIOVASCULAR MORTALITY; REDUCES ATHEROSCLEROSIS; CHRONIC INFLAMMATION; OXIDATIVE STRESS	Cardiovascular events are important co-morbidities in patients with chronic inflammatory diseases like rheumatoid arthritis. Tristetraprolin (TTP) regulates pro-inflammatory processes through mRNA destabilization and therefore TTP-deficient mice (TTP-/- mice) develop a chronic inflammation resembling human rheumatoid arthritis. We used this mouse model to evaluate molecular signaling pathways contributing to the enhanced atherosclerotic risk in chronic inflammatory diseases. In the aorta of TTP-/- mice we observed elevated mRNA expression of known TTP targets like tumor necrosis factor- (TNF-) and macrophage inflammatory protein-1, as well as of other pro-atherosclerotic mediators, like Calgranulin A, Cathepsin S, and Osteopontin. Independent of cholesterol levels TTP-/- mice showed a significant reduction of acetylcholine-induced, nitric oxide-mediated vasorelaxation. The endothelial dysfunction in TTP-/- mice was associated with increased levels of reactive oxygen and nitrogen species (RONS), indicating an enhanced nitric oxide inactivation by RONS in the TTP-/- animals. The altered RONS generation correlates with increased expression of NADPH oxidase 2 (Nox2) resulting from enhanced Nox2 mRNA stability. Although TNF- is believed to be a central mediator of inflammation-driven atherosclerosis, genetic inactivation of TNF- neither improved endothelial function nor normalized Nox2 expression or RONS production in TTP-/- animals. Systemic inflammation caused by TTP deficiency leads to endothelial dysfunction. This process is independent of cholesterol and not mediated by TNF- solely. Thus, other mediators, which need to be identified, contribute to enhanced cardiovascular risk in chronic inflammatory diseases.	[Bollmann, Franziska; Wu, Zhixiong; Siuda, Daniel; Xia, Ning; Henke, Jenny; Li, Huige; Kleinert, Hartmut; Pautz, Andrea] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany; [Bollmann, Franziska; Siuda, Daniel] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Oelze, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin 2, D-55131 Mainz, Germany; [Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany.	kleinert@mail.uni-mainz.de; pautz@uni-mainz.de	Blackshear, Perry J./C-6206-2019; Xia, Ning/P-3535-2015; Kleinert, Hartmut/M-2988-2018; Li, Huige/M-2662-2013; Siuda, Daniel/K-2597-2012; Xia, Ning/AFT-8078-2022	Blackshear, Perry J./0000-0002-9561-8529; Xia, Ning/0000-0002-5553-1752; Kleinert, Hartmut/0000-0003-2202-3548; Li, Huige/0000-0003-3458-7391; Siuda, Daniel/0000-0001-5120-7931; Xia, Ning/0000-0002-5553-1752	Federal Ministry of Education and Research [BMBF 01EO1003]; Innovation Foundation of the State of Rhineland-Palatinate [961-386261/917K]; Deutsche Forschungsgemeinschaft [LI 1759/1-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Innovation Foundation of the State of Rhineland-Palatinate; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Federal Ministry of Education and Research Grant BMBF 01EO1003, Innovation Foundation of the State of Rhineland-Palatinate Grant 961-386261/917K, and Deutsche Forschungsgemeinschaft Grant LI 1759/1-1 (to H. K.).	Al-Aly Z, 2011, TRANSL RES, V157, P10, DOI 10.1016/j.trsl.2010.09.005; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Badimon L, 2010, CARDIOVASC THER, V28, P202, DOI 10.1111/j.1755-5922.2010.00189.x; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bobryshev YV, 2002, J VASC SURG, V35, P368, DOI 10.1067/mva.2002.121067; Bosello S, 2008, CLIN RHEUMATOL, V27, P833, DOI 10.1007/s10067-007-0803-y; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crook MF, 2002, J VASC RES, V39, P221, DOI 10.1159/000063687; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ghosh S, 2010, AM J PATHOL, V176, P1484, DOI 10.2353/ajpath.2010.090498; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; JAYAKODY L, 1988, BRIT J PHARMACOL, V94, P335, DOI 10.1111/j.1476-5381.1988.tb11535.x; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Kerekes G, 2008, J RHEUMATOL, V35, P398; Knorr M, 2011, ARTERIOSCL THROM VAS, V31, P2223, DOI 10.1161/ATVBAHA.111.232058; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lee HH, 2013, MOL CELLS, V36, P571, DOI 10.1007/s10059-013-0268-6; Li H, 2005, NITRIC OXIDE-BIOL CH, V12, P231, DOI 10.1016/j.niox.2005.04.001; Lim H, 2013, J BIOL CHEM, V288, P7572, DOI 10.1074/jbc.M112.414904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangan SH, 2007, CARDIOVASC RES, V76, P494, DOI 10.1016/j.cardiores.2007.07.017; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Moe KT, 2011, J CELL MOL MED, V15, P2601, DOI 10.1111/j.1582-4934.2011.01261.x; MORI L, 1992, J EXP MED, V176, P381, DOI 10.1084/jem.176.2.381; Munzel T, 2005, ARTERIOSCL THROM VAS, V25, P1551, DOI 10.1161/01.ATV.0000168896.64927.bb; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt N, 2012, J PHARMACOL EXP THER, V343, P106, DOI 10.1124/jpet.112.192047; Schmidt N, 2010, BIOCHEM PHARMACOL, V79, P722, DOI 10.1016/j.bcp.2009.10.012; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schuhmacher S, 2010, HYPERTENSION, V55, P897, DOI 10.1161/HYPERTENSIONAHA.109.149542; Siuda D, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0283-3; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Uddin MJ, 2013, FREE RADICAL BIO MED, V65, P1331, DOI 10.1016/j.freeradbiomed.2013.09.027; Yoshida LS, 2008, INT IMMUNOPHARMACOL, V8, P1377, DOI 10.1016/j.intimp.2008.05.004; Zhang HC, 2013, ARTERIOSCL THROM VAS, V33, P1212, DOI 10.1161/ATVBAHA.113.301496; Zhang JP, 2009, EXP CELL RES, V315, P304, DOI 10.1016/j.yexcr.2008.10.042	70	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15653	15665		10.1074/jbc.M114.566984	http://dx.doi.org/10.1074/jbc.M114.566984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727475	Green Published, hybrid			2022-12-25	WOS:000337465400047
J	Kinoshita, T; Nagamatsu, G; Saito, S; Takubo, K; Horimoto, K; Suda, T				Kinoshita, Taisuke; Nagamatsu, Go; Saito, Shigeru; Takubo, Keiyo; Horimoto, Katsuhisa; Suda, Toshio			Telomerase Reverse Transcriptase Has an Extratelomeric Function in Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Induced Pluripotent Stem (iPS) Cell; Microarray; Reprogramming; Telomeres	PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; TARGET GENE; MOUSE; PROMOTES; ESRRB; TERT; DIFFERENTIATION; PROLIFERATION	Reactivation of the endogenous telomerase reverse transcriptase (TERT) catalytic subunit and telomere elongation occur during the reprogramming of somatic cells to induced pluripotent stem (iPS) cells. However, the role of TERT in the reprogramming process is unclear. To clarify its function, the reprogramming process was examined in TERT-KO somatic cells. To exclude the effect of telomere elongation, tail-tip fibroblasts (TTFs) from first generation TERT-KO mice were used. Although iPS cells were successfully generated from TERT-KO TTFs, the efficiency of reprogramming these cells was markedly lower than that of WT TTFs. The gene expression profiles of iPS cells induced from TERT-KO TTFs were similar to those of WT iPS cells and ES cells, and TERT-KO iPS cells formed teratomas that differentiated into all three germ layers. These data indicate that TERT plays an extratelomeric role in the reprogramming process, but its function is dispensable. However, TERT-KO iPS cells showed transient defects in growth and teratoma formation during continuous growth. In addition, TERT-KO iPS cells developed chromosome fusions that accumulated with increasing passage numbers, consistent with the fact that TERT is essential for the maintenance of genome structure and stability in iPS cells. In a rescue experiment, an enzymatically inactive mutant of TERT (D702A) had a positive effect on somatic cell reprogramming of TERT-KO TTFs, which confirmed the extratelomeric role of TERT in this process.	[Kinoshita, Taisuke; Nagamatsu, Go; Takubo, Keiyo; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab, Tokyo 1608582, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Nagamatsu, Go] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka 8128582, Japan; [Saito, Shigeru] OPT Inc, Data Sci Lab, Tokyo 1020081, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST)	Nagamatsu, G (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	gonag@hgs.med.kyushu-u.ac.jp	Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592	PRESTO of the Japan Science and Technology Agency; funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research; Japan Society for the Promotion of Science [247121]; Project for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [12J07121] Funding Source: KAKEN	PRESTO of the Japan Science and Technology Agency; funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO of the Japan Science and Technology Agency, funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research (C), Grant-in-aid 247121 for JSPS Fellows from the Japan Society for the Promotion of Science, and in part by a grant from the Project for the Realization of Regenerative Medicine.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Kinoshita T, 2011, BIOCHEM BIOPH RES CO, V407, P321, DOI 10.1016/j.bbrc.2011.03.013; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagamatsu G, 2012, J BIOL CHEM, V287, P36273, DOI 10.1074/jbc.M112.380683; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	43	13	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15776	15787		10.1074/jbc.M113.536037	http://dx.doi.org/10.1074/jbc.M113.536037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733392	Green Published, hybrid			2022-12-25	WOS:000337465400057
J	Sharonov, GV; Bocharov, EV; Kolosov, PM; Astapova, MV; Arseniev, AS; Feofanov, AV				Sharonov, George V.; Bocharov, Eduard V.; Kolosov, Peter M.; Astapova, Maria V.; Arseniev, Alexander S.; Feofanov, Alexey V.			Point Mutations in Dimerization Motifs of the Transmembrane Domain Stabilize Active or Inactive State of the EphA2 Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GROWTH-FACTOR RECEPTOR-3; MEMBRANE-PROTEINS; BINDING DOMAIN; ACTIVATION; SEQUENCE; DIMER; DIVERSITY; MECHANISM; CLUSTERS	The EphA2 receptor tyrosine kinase plays a central role in the regulation of cell adhesion and guidance in many human tissues. The activation of EphA2 occurs after proper dimerization/ oligomerization in the plasma membrane, which occurs with the participation of extracellular and cytoplasmic domains. Our study revealed that the isolated transmembrane domain (TMD) of EphA2 embedded into the lipid bicelle dimerized via the heptad repeat motif L(535)X(3)G(539)X(2)A(542)X(3)V(546)X(2)L(549) rather than through the alternative glycine zipper motif A(536)X(3)G(540)X(3)G(544) (typical for TMD dimerization in many proteins). To evaluate the significance of TMD interactions for full-length EphA2, we substituted key residues in the heptad repeat motif (HR variant: G539I, A542I, G553I) or in the glycine zipper motif (GZ variant: G540I, G544I) and expressed YFP-tagged EphA2 (WT, HR, and GZ variants) in HEK293T cells. Confocal microscopy revealed a similar distribution of all EphA2-YFP variants in cells. The expression of EphA2-YFP variants and their kinase activity (phosphorylation of Tyr(588) and/or Tyr(594)) and ephrin-A3 binding were analyzed with flow cytometry on a single cell basis. Activation of any EphA2 variant is found to occur even without ephrin stimulation when the EphA2 content in cells is sufficiently high. Ephrin-A3 binding is not affected in mutant variants. Mutations in the TMD have a significant effect on EphA2 activity. Both ligand-dependent and ligand-independent activities are enhanced for the HR variant and reduced for the GZ variant compared with the WT. These findings allow us to suggest TMD dimerization switching between the heptad repeat and glycine zipper motifs, corresponding to inactive and active receptor states, respectively, as a mechanism underlying EphA2 signal transduction.	[Sharonov, George V.; Bocharov, Eduard V.; Astapova, Maria V.; Arseniev, Alexander S.; Feofanov, Alexey V.] Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Dept Biol Struct, Moscow 117997, Russia; [Sharonov, George V.] Moscow MV Lomonosov State Univ, Fac Med, Moscow 119992, Russia; [Kolosov, Peter M.] Inst Higher Nervous Act & Neurophysiol RAS, Dept Mol Neurobiol, Moscow 117485, Russia; [Feofanov, Alexey V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Feofanov, AV (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Dept Biol Struct, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	avfeofanov@yandex.ru	Feofanov, Alexey V/K-3082-2012; Sharonov, George V/B-1323-2014; Kolosov, Peter/T-9631-2017	Feofanov, Alexey V/0000-0002-1596-9506; Sharonov, George V/0000-0001-8610-5054; Kolosov, Peter/0000-0003-1231-7999	Russian Foundation for Basic Research [13-04-40105-H, 12-04-01816-a]; Russian Federation [MK-5003.2013.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	This work was supported by Russian Foundation for Basic Research Grants 13-04-40105-H and 12-04-01816-a).; Supported by President of the Russian Federation Grant MK-5003.2013.4.	Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Becker V, 2008, BIOCHEMISTRY-US, V47, P11771, DOI 10.1021/bi801425e; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; Bocharov EV, 2013, STRUCTURE, V21, P2087, DOI 10.1016/j.str.2013.08.026; Bocharov EV, 2010, CELL ADHES MIGR, V4, P284, DOI 10.4161/cam.4.2.11930; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; CAO H, 1992, EMBO J, V11, P923, DOI 10.1002/j.1460-2075.1992.tb05131.x; Choi Y, 2012, CELL SIGNAL, V24, P1522, DOI 10.1016/j.cellsig.2012.03.020; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fujii H, 2011, HUM REPROD, V26, P1163, DOI 10.1093/humrep/der034; Fuller-Espie S, 1998, INT IMMUNOL, V10, P923, DOI 10.1093/intimm/10.7.923; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Himanen JP, 2012, SEMIN CELL DEV BIOL, V23, P35, DOI 10.1016/j.semcdb.2011.10.025; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Huber O, 1999, J CELL SCI, V112, P4415; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Kaneko M, 2003, J NEUROSCI, V23, P11523; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nekrasova OV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1387, DOI 10.1134/S0006297912120073; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Reddy T, 2014, BIOCHEMISTRY-US, V53, P323, DOI 10.1021/bi401576k; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sharonov G. V., 2012, CURRENT MICROSCOPY C, P140; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Udayakumar D, 2011, ONCOGENE, V30, P4921, DOI 10.1038/onc.2011.210; Velghe AI, 2014, ONCOGENE, V33, P2568, DOI 10.1038/onc.2013.218; Volynsky PE, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016014; Volynsky PE, 2013, J AM CHEM SOC, V135, P8105, DOI 10.1021/ja4011942; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192	51	27	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14955	14964		10.1074/jbc.M114.558783	http://dx.doi.org/10.1074/jbc.M114.558783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733396	Green Published, hybrid			2022-12-25	WOS:000337248100045
J	Buzanskas, ME; Grossi, DA; Ventura, RV; Schenkel, FS; Sargolzaei, M; Meirelles, SLC; Mokry, FB; Higa, RH; Mudadu, MA; da Silva, MVGB; Niciura, SCM; Torres, RAA; Alencar, MM; Regitano, LCA; Munari, DP				Buzanskas, Marcos E.; Grossi, Daniela A.; Ventura, Ricardo V.; Schenkel, Flavio S.; Sargolzaei, Mehdi; Meirelles, Sarah L. C.; Mokry, Fabiana B.; Higa, Roberto H.; Mudadu, Mauricio A.; Barbosa da Silva, Marcos V. G.; Niciura, Simone C. M.; Torres Junior, Roberto A. A.; Alencar, Mauricio M.; Regitano, Luciana C. A.; Munari, Danisio P.			Genome-Wide Association for Growth Traits in Canchim Beef Cattle	PLOS ONE			English	Article							GENETIC-PARAMETERS; FUNCTIONAL TRAITS; GESTATION LENGTH; LOCI; SCAN; CARCASS; WEIGHT; PREDICTION; ACCURACY; FAMILY	Studies are being conducted on the applicability of genomic data to improve the accuracy of the selection process in livestock, and genome-wide association studies (GWAS) provide valuable information to enhance the understanding on the genetics of complex traits. The aim of this study was to identify genomic regions and genes that play roles in birth weight (BW), weaning weight adjusted for 210 days of age (WW), and long-yearling weight adjusted for 420 days of age (LYW) in Canchim cattle. GWAS were performed by means of the Generalized Quasi-Likelihood Score (GQLS) method using genotypes from the BovineHD BeadChip and estimated breeding values for BW, WW, and LYW. Data consisted of 285 animals from the Canchim breed and 114 from the MA genetic group (derived from crossings between Charolais sires and 1/2 Canchim + 1/2 Zebu dams). After applying a false discovery rate correction at a 10% significance level, a total of 4, 12, and 10 SNPs were significantly associated with BW, WW, and LYW, respectively. These SNPs were surveyed to their corresponding genes or to surrounding genes within a distance of 250 kb. The genes DPP6 (dipeptidyl-peptidase 6) and CLEC3B (C-type lectin domain family 3 member B) were highlighted, considering its functions on the development of the brain and skeletal system, respectively. The GQLS method identified regions on chromosome associated with birth weight, weaning weight, and long-yearling weight in Canchim and MA animals. New candidate regions for body weight traits were detected and some of them have interesting biological functions, of which most have not been previously reported. The observation of QTL reports for body weight traits, covering areas surrounding the genes (SNPs) herein identified provides more evidence for these associations. Future studies targeting these areas could provide further knowledge to uncover the genetic architecture underlying growth traits in Canchim cattle.	[Buzanskas, Marcos E.; Munari, Danisio P.] UNESP Univ Estadual Paulista, Dept Ciencias Exatas, Fac Ciencias Agr & Vet, Sao Paulo, Brazil; [Grossi, Daniela A.; Ventura, Ricardo V.; Schenkel, Flavio S.; Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, CGIL, Guelph, ON N1G 2W1, Canada; [Ventura, Ricardo V.] BIO, Guelph, ON, Canada; [Sargolzaei, Mehdi] Semex Alliance, Guelph, ON, Canada; [Meirelles, Sarah L. C.] Fed Univ Lavras UFLA, Dept Anim Sci, Lavras, MG, Brazil; [Mokry, Fabiana B.] Fed Univ Sao Carlos UFSCar, Dept Genet & Evolut, Sao Paulo, Brazil; [Mudadu, Mauricio A.; Niciura, Simone C. M.; Alencar, Mauricio M.; Regitano, Luciana C. A.] Embrapa Southeast Livestock, Sao Paulo, Brazil; [Higa, Roberto H.] Embrapa Agr Informat, Sao Paulo, Brazil; [Barbosa da Silva, Marcos V. G.] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil; [Torres Junior, Roberto A. A.] Embrapa Beef Cattle, Campo Grande, MS, Brazil	Universidade Estadual Paulista; University of Guelph; Universidade Federal de Lavras; Universidade Federal de Sao Carlos; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Munari, DP (corresponding author), UNESP Univ Estadual Paulista, Dept Ciencias Exatas, Fac Ciencias Agr & Vet, Sao Paulo, Brazil.	danisio@fcav.unesp.br	Buzanskas, Marcos Eli/C-8147-2012; Munari, Danisio P/C-6384-2012; Niciura, Simone C M/C-1150-2012; de Almeida Regitano, Luciana Correia/C-7002-2012; de Alvarenga Mudadu, Maurício/B-6524-2014; Barichello Mokry, Fabiana/E-4654-2012; Schenkel, Flavio/ABG-1842-2021; Laguna Conceição Meirelles, Sarah/HDN-5656-2022; Meirelles, Sarah/AAL-4591-2020; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020	Buzanskas, Marcos Eli/0000-0002-2728-079X; Munari, Danisio P/0000-0001-6915-038X; Niciura, Simone C M/0000-0003-0046-0050; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; de Alvarenga Mudadu, Maurício/0000-0002-2767-2507; Meirelles, Sarah/0000-0002-3331-2495; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; Alencar, Mauricio/0000-0002-6102-663X; Schenkel, Flavio/0000-0001-8700-0633	"National Council of Technological and Scientific Development" (CNPq) [142053/2010-4]; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (Capes) [5285-11-9]; University of Guelph; CNPq	"National Council of Technological and Scientific Development" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Guelph; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MEB would like to thank the "National Council of Technological and Scientific Development" (CNPq) (grantee n. 142053/2010-4) and the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (Capes) (grantee n. 5285-11-9). DAG was supported by a Post-Doctoral fellowship at the University of Guelph. DPM, MVGBS, LCAR and MMA were supported by a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LJ, 2007, ANIM GENET, V38, P413, DOI 10.1111/j.1365-2052.2007.01616.x; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Andrade PC, 2008, ANIM GENET, V39, P480, DOI 10.1111/j.1365-2052.2008.01755.x; Baldi F, 2010, J ANIM BREED GENET, V127, P289, DOI 10.1111/j.1439-0388.2010.00853.x; Barbosa PF, 2000, CANCHIM EMBRAPA PECU; Barwick SA, 2005, AUST J EXP AGR, V45, P923, DOI 10.1071/EA05068; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Buzanskas ME, 2010, LIVEST SCI, V132, P107, DOI 10.1016/j.livsci.2010.05.008; Casas E, 2000, J ANIM SCI, V78, P560; Crews DH, 2006, J ANIM SCI, V84, P25, DOI 10.2527/2006.84125x; Druet T, 2009, J ANIM BREED GENET, V126, P269, DOI 10.1111/j.1439-0388.2008.00788.x; Feng Z, 2011, ANN APPL STAT, V5, P2109, DOI 10.1214/11-AOAS465; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Gaviolli VRN, 2012, J APPL GENET, V53, P331, DOI 10.1007/s13353-012-0100-6; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Heyde C. C., 1997, QUASILIKELIHOOD ITS; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Illumina, 2013, TECHN NOT INF GEN DA; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Kneeland J, 2004, J ANIM SCI, V82, P3405; Kuhn C, 2003, J DAIRY SCI, V86, P360, DOI 10.3168/jds.S0022-0302(03)73614-5; Kukushkin NV, 2012, GLYCOBIOLOGY, V22, P1282, DOI 10.1093/glycob/cws088; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Machado MBB, 2003, GENET MOL BIOL, V26, P259, DOI 10.1590/S1415-47572003000300008; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller MJ, 1997, J BIOL CHEM, V272, P5600, DOI 10.1074/jbc.272.9.5600; Misztal I, 2008, J ANIM BREED GENET, V125, P363, DOI 10.1111/j.1439-0388.2008.00774.x; Mokry FB, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-47; Moser G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-37; Mucari TB, 2011, REV BRAS ZOOTECN, V40, P1211, DOI 10.1590/S1516-35982011000600008; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Schrooten C, 2000, J DAIRY SCI, V83, P795, DOI 10.3168/jds.S0022-0302(00)74942-3; Sherman EL, 2009, J ANIM SCI, V87, P37, DOI 10.2527/jas.2008-0876; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; STOOLMILLER AC, 1972, J BIOL CHEM, V247, P3525; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	48	42	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94802	10.1371/journal.pone.0094802	http://dx.doi.org/10.1371/journal.pone.0094802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733441	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400107
J	Farkas, R; Datkova, Z; Mentelova, L; Low, P; Benova-Liszekova, D; Beno, M; Sass, M; Rehulka, P; Rehulkova, H; Raska, O; Kovacik, L; Smigova, J; Raska, I; Mechler, BM				Farkas, Robert; Datkova, Zuzana; Mentelova, Lucia; Loew, Peter; Benova-Liszekova, Denisa; Beno, Milan; Sass, Miklos; Rehulka, Pavel; Rehulkova, Helena; Raska, Otakar; Kovacik, Lubomir; Smigova, Jana; Raska, Ivan; Mechler, Bernard M.			Apocrine Secretion in Drosophila Salivary Glands: Subcellular Origin, Dynamics, and Identification of Secretory Proteins	PLOS ONE			English	Article							SEQUENTIAL GENE ACTIVATION; ECDYSONE-INDUCIBLE GENE; PROGRAMMED CELL-DEATH; CARBONIC-ANHYDRASE-II; HIDRADENITIS SUPPURATIVA; HARDERIAN-GLAND; POLYTENE CHROMOSOMES; MEROCRINE SECRETION; ELECTRON-MICROSCOPY; MEMBRANE-FUSION	In contrast to the well defined mechanism of merocrine exocytosis, the mechanism of apocrine secretion, which was first described over 180 years ago, remains relatively uncharacterized. We identified apocrine secretory activity in the late prepupal salivary glands of Drosophila melanogaster just prior to the execution of programmed cell death (PCD). The excellent genetic tools available in Drosophila provide an opportunity to dissect for the first time the molecular and mechanistic aspects of this process. A prerequisite for such an analysis is to have pivotal immunohistochemical, ultrastructural, biochemical and proteomic data that fully characterize the process. Here we present data showing that the Drosophila salivary glands release all kinds of cellular proteins by an apocrine mechanism including cytoskeletal, cytosolic, mitochondrial, nuclear and nucleolar components. Surprisingly, the apocrine release of these proteins displays a temporal pattern with the sequential release of some proteins (e. g. transcription factor BR-C, tumor suppressor p127, cytoskeletal beta-tubulin, non-muscle myosin) earlier than others (e. g. filamentous actin, nuclear lamin, mitochondrial pyruvate dehydrogenase). Although the apocrine release of proteins takes place just prior to the execution of an apoptotic program, the nuclear DNA is never released. Western blotting indicates that the secreted proteins remain undegraded in the lumen. Following apocrine secretion, the salivary gland cells remain quite vital, as they retain highly active transcriptional and protein synthetic activity.	[Farkas, Robert; Datkova, Zuzana; Mentelova, Lucia; Benova-Liszekova, Denisa; Beno, Milan] Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava, Slovakia; [Datkova, Zuzana; Mentelova, Lucia] Comenius Univ, Dept Genet, Bratislava, Slovakia; [Loew, Peter; Sass, Miklos] Eotvos Lorand Univ, Dept Anat & Cell Biol, Budapest, Hungary; [Rehulka, Pavel] Univ Def, Fac Mil Hlth Sci, Inst Mol Pathol, Hradec Kralove, Czech Republic; [Rehulkova, Helena] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Cardioangiol 1, Hradec Kralove, Czech Republic; [Raska, Otakar; Kovacik, Lubomir; Smigova, Jana; Raska, Ivan; Mechler, Bernard M.] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Prague, Czech Republic; [Mechler, Bernard M.] Deutsch Krebsforschungszentrum, Heidelberg, Germany	Slovak Academy of Sciences; Comenius University Bratislava; Eotvos Lorand University; University of Defence - Czech Republic; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ)	Farkas, R (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava, Slovakia.	uenfark@savba.sk; mechler@bluewin.ch	Beno, Milan/ABA-4161-2021; Beňová Liszeková, Denisa/ABB-1723-2021; Raska, Ivan/H-2326-2017; Farkas, Robert/ABB-1990-2021; Mentelova, Lucia/ABE-5902-2020; Rehulkova, Helena/K-5759-2018; Raska, Otakar/E-7258-2017; Rehulka, Pavel/U-7681-2017; Low, Peter/A-3379-2013; Smigova, Jana/O-9579-2017	Raska, Ivan/0000-0002-2583-5595; Rehulkova, Helena/0000-0003-1220-6631; Raska, Otakar/0000-0001-5716-2746; Rehulka, Pavel/0000-0003-3263-4107; Low, Peter/0000-0003-2450-7087; Smigova, Jana/0000-0002-3152-5649; Farkas, Robert/0000-0002-9138-7567; Beno, Milan/0000-0003-3838-791X; Mentelova, Lucia/0000-0003-0296-4877	GACR (Grant Agency of Czech Republic) [P302/11/1640]; GACR grant [P302/12/G157]; University Centre of Excellence [UNCE 204022]; Charles University [Prvouk/LF1/1]; PMFHK Plan [1011]; VEGA (Scientific Grant Agency of the Slovak Academy of Sciences) [2/0170/10, 2/0109/13]; Supporting Program for International Science and Technology Cooperation of the Slovak Academy of Sciences with 7th Framework Programme of the European Commission [MVTS-32060600/ EC-INSTRUCT-FP7-211252]; EEA-Norwegian FM [SK-0086];  [CZ.1.07/2.3.00/30.0022]	GACR (Grant Agency of Czech Republic)(Grant Agency of the Czech Republic); GACR grant; University Centre of Excellence; Charles University; PMFHK Plan; VEGA (Scientific Grant Agency of the Slovak Academy of Sciences)(Slovak Academy of Sciences); Supporting Program for International Science and Technology Cooperation of the Slovak Academy of Sciences with 7th Framework Programme of the European Commission(Slovak Academy of Sciences); EEA-Norwegian FM; 	GACR (Grant Agency of Czech Republic) grant P302/11/1640 to B.M. M. (www.gacr.cz); GACR grant P302/12/G157 to I.R. (www.gacr.cz); University Centre of Excellence UNCE 204022 and Prvouk/LF1/1 from Charles University to I.R. (www.cuni.cz); PMFHK Plan no. 1011 to P.R. (www.pmfhk.cz); CZ.1.07/2.3.00/30.0022 to P.R. (http://ec.europa.eu/ esf/); VEGA (Scientific Grant Agency of the Slovak Academy of Sciences) 2/0170/10 to R. F. (www.sav.sk); VEGA (Scientific Grant Agency of the Slovak Academy of Sciences) 2/0109/13 to R. F. (www.sav.sk); MVTS-32060600/ EC-INSTRUCT-FP7-211252 (Supporting Program for International Science and Technology Cooperation of the Slovak Academy of Sciences with 7th Framework Programme of the European Commission) grant to R. F.(http://cordis.europa.eu/fp7/home_en.html/www.sav.sk); and EEA-Norwegian FM SK-0086 (European Economic Area and Norwegian Financial Mechanism) grant to R. F. (http://eeagrants.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam A, 2010, J CELL BIOL, V188, P415, DOI 10.1083/jcb.200908010; Ashburner M, 1972, Results Probl Cell Differ, V4, P101; Ashburner M., 1970, Adv. Insect. Physiol., V7, P1, DOI 10.1016/S0065-2806(08)60240-4; ASHBURNER M, 1973, COLD SPRING HARB SYM, V38, P655; Ashburner M, 1978, GENETICS BIOL DROS B, V2b, P315; Ashburner M., 1978, GENETICS BIOL DROS A, P1; Atoji Y, 1998, ANAT REC, V252, P403, DOI 10.1002/(SICI)1097-0185(199811)252:3<403::AID-AR8>3.0.CO;2-F; Aumuller G, 1999, ANN ANAT, V181, P437, DOI 10.1016/S0940-9602(99)80020-X; Baccari GC, 2000, J MORPHOL, V244, P137; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Beno M, 2007, MICROSC RES TECHNIQ, V70, P1022, DOI 10.1002/jemt.20507; Berendes H.D., 1978, P453; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Blok JL, 2013, BRIT J DERMATOL, V168, P243, DOI 10.1111/bjd.12104; BOYD M, 1977, J INSECT PHYSIOL, V23, P517, DOI 10.1016/0022-1910(77)90263-3; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; CHARLES A, 1959, J ANAT, V93, P226; Chi AC, 2010, J ORAL MAXIL SURG, V68, P451, DOI 10.1016/j.joms.2009.04.120; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clary D O, 1983, Nucleic Acids Res, V11, P2411, DOI 10.1093/nar/11.8.2411; Constantinou C, 2008, AM SURGEON, V74, P1177; Crowson AN, 2006, MODERN PATHOL, V19, pS93, DOI 10.1038/modpathol.3800511; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Elayat G, 2010, ANN DIAGN PATHOL, V14, P1, DOI 10.1016/j.anndiagpath.2009.05.001; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Farkas R, 2000, CELL DEATH DIFFER, V7, P89, DOI 10.1038/sj.cdd.4400621; Farkas R, 1998, IN VITRO CELL DEV-AN, V34, P813; Farkas R, 1991, DROS INF SERV, V70, P244; FRAENKEL G, 1953, BIOL BULL, V105, P442, DOI 10.2307/1538461; Gesase Ainory Peter, 2007, Italian Journal of Anatomy and Embryology, V112, P117; Gesase AP, 2003, HISTOL HISTOPATHOL, V18, P597, DOI 10.14670/HH-18.597; GESASE AP, 1995, ANAT EMBRYOL, V192, P319, DOI 10.1007/BF00710101; Gesase AP, 1996, CELL TISSUE RES, V285, P501, DOI 10.1007/s004410050666; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Glauert AM, 1975, PRACTICAL METHODS 1, V3, P5; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griffith JR, 2005, PEDIATRICS, V115, pE239, DOI 10.1542/peds.2004-1561; Groos S, 1999, CELL TISSUE RES, V295, P495, DOI 10.1007/s004410051255; Grus FH, 2005, INVEST OPHTH VIS SCI, V46, P863, DOI 10.1167/iovs.04-0448; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; HURLEY HJ, 1954, J INVEST DERMATOL, V22, P143, DOI 10.1038/jid.1954.19; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; KENNEDY JR, 1989, J ELECTRON MICR TECH, V11, P117, DOI 10.1002/jemt.1060110205; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Khalbuss WE, 2005, CLIN LAB MED, V25, P761, DOI 10.1016/j.cll.2005.08.004; KOBAYASHI S, 1993, BIOTECH HISTOCHEM, V68, P237, DOI 10.3109/10520299309104704; KORGE G, 1977, DEV BIOL, V58, P339, DOI 10.1016/0012-1606(77)90096-3; KORGE G, 1975, P NATL ACAD SCI USA, V72, P4550, DOI 10.1073/pnas.72.11.4550; Krbec AC, 2007, J AM ACAD NURSE PRAC, V19, P228, DOI 10.1111/j.1745-7599.2007.00219.x; Kuno Y., 1956, HUMAN PERSPIRATION; KUROSUMI K, 1984, INT REV CYTOL, V87, P253, DOI 10.1016/S0074-7696(08)62445-6; KUSHIDA H, 1964, J ELECTRON MICROSC, V13, P139; Kushida H, 1966, J Electron Microsc (Tokyo), V15, P94; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE NJ, 1972, ROUX ARCH DEV BIOL, V169, P216, DOI 10.1007/BF00582554; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Lasko LA, 2008, JAAPA-J AM ACAD PHYS, V21, P3; Lehmann M, 1996, BIOESSAYS, V18, P47, DOI 10.1002/bies.950180110; Leitzell K, 2007, J NEUROSCI, V27, P4231, DOI 10.1523/JNEUROSCI.0668-07.2007; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lucheroni A, 1986, Rhinology, V24, P57; MAIN T, 1976, LARYNGOSCOPE, V86, P1164, DOI 10.1288/00005537-197608000-00008; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; MANIN M, 1995, BIOL REPROD, V52, P50, DOI 10.1095/biolreprod52.1.50; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Maybeck V, 2009, GENETICS, V181, P543, DOI 10.1534/genetics.108.094052; MAZZA A, 1981, J SUBMICR CYTOL PATH, V13, P473; Montagna W, 1956, STRUCTURE FUNCTION S; Mozeika E, 2011, EXP DERMATOL, V20, P841, DOI 10.1111/j.1600-0625.2011.01344.x; MRAZ P, 1982, Z MIKROSK ANAT FORSC, V96, P130; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Ng V, 2000, GRAEF ARCH CLIN EXP, V238, P738, DOI 10.1007/s004170000140; O'Malley FP, 2008, HISTOPATHOLOGY, V52, P3, DOI 10.1111/j.1365-2559.2007.02888.x; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; PAYNE AP, 1994, J ANAT, V185, P1; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Purkinje J, 1833, JB WISSEN KRITIK, V1, P789; Ransom R, 1982, HDB DROSOPHILA DEV, P1; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rehulkova H, 2010, J MASS SPECTROM, V45, P104, DOI 10.1002/jms.1698; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDS G, 1976, DEV BIOL, V54, P264, DOI 10.1016/0012-1606(76)90304-3; RICHARDS G, 1976, DEV BIOL, V54, P256, DOI 10.1016/0012-1606(76)90303-1; RICHARDS GP, 1976, DEV BIOL, V48, P191, DOI 10.1016/0012-1606(76)90057-9; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rothman S, 1954, PHYSL BIOCH SKIN; Rutter GA, 2004, NEUROREPORT, V15, P79, DOI 10.1097/00001756-200401190-00016; Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084; SARMIENTO LA, 1982, DEV GENET, V3, P255, DOI 10.1002/dvg.1020030308; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Satoh Y, 1996, MICROSC RES TECHNIQ, V34, P104, DOI 10.1002/(SICI)1097-0029(19960601)34:2<104::AID-JEMT2>3.0.CO;2-S; SATOH Y, 1992, ACTA ANAT, V143, P7; SCHAUMBURGLEVER G, 1975, J INVEST DERMATOL, V64, P38, DOI 10.1111/1523-1747.ep12540893; Schiefferdecker P, 1922, ZOOLOGICA, V72, P1; Schneider MR, 2010, INT J BIOCHEM CELL B, V42, P181, DOI 10.1016/j.biocel.2009.11.017; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SEITZ J, 1990, HISTOCHEMISTRY, V93, P525, DOI 10.1007/BF00266412; Sellheyer K, 2008, J CUTAN PATHOL, V35, P701, DOI 10.1111/j.1600-0560.2008.01073.x; Shah N, 2005, AM FAM PHYSICIAN, V72, P1547; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMITH JD, 1979, ANAT RECORD, V193, P269, DOI 10.1002/ar.1091930208; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; STEINHOFF M, 1994, EUR J CELL BIOL, V65, P49; STINSON SF, 1978, J ANAT, V127, P291; STOLLE CA, 1991, GENE, V109, P265, DOI 10.1016/0378-1119(91)90619-M; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tincani A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-93; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; Velpeau A, 1839, DICT MED REPERTOIRE, V2, P86; Verneuil A, 1854, ARCH GEN MED, V4, P447; Versura P, 2010, EYE, V24, P1396, DOI 10.1038/eye.2010.7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Von Gaudecker B., 1972, Zeitschrift Zellforsch mikrosk Anat, V127, P50; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; WEBER K, 1969, J BIOL CHEM, V244, P4406; Westerink Remco H. S., 2006, CNS & Neurological Disorders-Drug Targets, V5, P57, DOI 10.2174/187152706784111597; Wilhelm B, 1998, J HISTOCHEM CYTOCHEM, V46, P505, DOI 10.1177/002215549804600410; Wrobel A, 2003, J INVEST DERMATOL, V120, P175, DOI 10.1046/j.1523-1747.2003.12029.x; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Zaviacic M, 2000, ANAT EMBRYOL, V201, P51; ZHIMULEV IF, 1981, ROUX ARCH DEV BIOL, V190, P351, DOI 10.1007/BF00863272; ZHIMULEV IF, 1975, ROUX ARCH DEV BIOL, V178, P15, DOI 10.1007/BF00848359; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	146	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94383	10.1371/journal.pone.0094383	http://dx.doi.org/10.1371/journal.pone.0094383			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732043	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400035
J	Finamore, A; Roselli, M; Imbinto, A; Seeboth, J; Oswald, IP; Mengheri, E				Finamore, Alberto; Roselli, Marianna; Imbinto, Ambra; Seeboth, Julie; Oswald, Isabelle P.; Mengheri, Elena			Lactobacillus amylovorus Inhibits the TLR4 Inflammatory Signaling Triggered by Enterotoxigenic Escherichia coli via Modulation of the Negative Regulators and Involvement of TLR2 in Intestinal Caco-2 Cells and Pig Explants	PLOS ONE			English	Article							IN-VITRO EVALUATION; TOLL-LIKE RECEPTORS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; IRAK-M; INNATE; MECHANISMS; EXPRESSION; RECOGNITION; CYTOKINE	Inflammation derived from pathogen infection involves the activation of toll-like receptor (TLR) signaling. Despite the established immunomodulatory activities of probiotics, studies relating the ability of such bacteria to inhibit the TLR signaling pathways are limited or controversial. In a previous study we showed that Lactobacillus amylovorus DSM 16698(T), a novel lactobacillus isolated from unweaned pigs, protects the intestinal cells from enterotoxigenic Escherichia coli (ETEC) K88 infection through cytokine regulation. In the present study we investigated whether the ability of L. amylovorus to counteract the inflammatory status triggered by ETEC in intestine is elicited through inhibition of the TLR4 signaling pathway. We used the human intestinal Caco-2/TC7 cells and intestinal explants isolated from 5 week-old crossbreed Pietrain/Duroc/Large-White piglets, treated with ETEC, L. amylovorus or L. amylovorus cell free supernatant, either alone or simultaneously with ETEC. Western blot analysis showed that L. amylovorus and its cell free supernatant suppress the activation of the different steps of TLR4 signaling in Caco-2/TC7 cells and pig explants, by inhibiting the ETEC induced increase in the level of TLR4 and MyD88, the phosphorylation of the IKK alpha, IKK beta, I kappa B alpha and NF-kappa B subunit p65, as well as the over-production of inflammatory cytokines IL-8 and IL-1 beta. The immunofluorescence analysis confirms the lack of phosphop-65 translocation into the nucleus. These anti-inflammatory effects are achieved through modulation of the negative regulators Tollip and IRAK-M. We also found that L. amylovorus blocks the up-regulation of the extracellular heat shock protein (Hsp)72 and Hsp90, that are critical for TLR4 function. By using anti-TLR2 antibody, we demonstrate that TLR2 is required for the suppression of TLR4 signaling activation. These results may contribute to develop therapeutic interventions using L. amylovorus in intestinal disorders of piglets and humans.	[Finamore, Alberto; Roselli, Marianna; Imbinto, Ambra; Mengheri, Elena] Consiglio Ric & Sperimentaz Agr CRA, Res Ctr Food & Nutr, CRA NUT, Rome, Italy; [Seeboth, Julie; Oswald, Isabelle P.] INRA, UMR Toxalim 1331, F-31931 Toulouse, France; [Seeboth, Julie; Oswald, Isabelle P.] Univ Toulouse, Natl Polytech Inst Toulouse INP, UMR Toxalim 1331, Toulouse, France	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); INRAE; Universite de Toulouse	Mengheri, E (corresponding author), Consiglio Ric & Sperimentaz Agr CRA, Res Ctr Food & Nutr, CRA NUT, Rome, Italy.	elena.mengheri@entecra.it	OSWALD, Isabelle/GPP-1123-2022; OSWALD, Isabelle P/A-8497-2013; Roselli, Marianna/L-6501-2019; Finamore, Alberto/AAP-6163-2020	OSWALD, Isabelle/0000-0001-9918-277X; OSWALD, Isabelle P/0000-0001-9918-277X; Roselli, Marianna/0000-0003-2355-3241; Finamore, Alberto/0000-0001-6869-3905	European Community [227549]; Italian MiPAAF funds; Qualita Alimentare e Funzionale-QUALIFU programme [2087/7303/09-29/1/2009]	European Community(European Commission); Italian MiPAAF funds; Qualita Alimentare e Funzionale-QUALIFU programme	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement no 227549, and partly from the Italian MiPAAF funds, Qualita Alimentare e Funzionale-QUALIFU programme, (D.M. 2087/7303/09-29/1/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asea Alexzander, 2008, V183, P111; Asea A, 2007, METHODS, V43, P194, DOI 10.1016/j.ymeth.2007.06.002; Bermudez-Brito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059370; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Cammarota M, 2009, INT J FOOD MICROBIOL, V135, P90, DOI 10.1016/j.ijfoodmicro.2009.08.022; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; CARO I, 1995, INT J PHARMACEUT, V116, P147, DOI 10.1016/0378-5173(94)00280-I; CHANTRET I, 1994, J CELL SCI, V107, P213; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Chung SW, 2009, BIOCHEM BIOPH RES CO, V378, P444, DOI 10.1016/j.bbrc.2008.11.063; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Finamore A, 2012, J NUTR, V142, P375, DOI 10.3945/jn.111.148924; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Grenier B, 2011, MOL NUTR FOOD RES, V55, P761, DOI 10.1002/mnfr.201000402; Haddad JJ, 2011, CELL IMMUNOL, V271, P5, DOI 10.1016/j.cellimm.2011.06.021; Haller D, 2010, J NUTR, V140, p690S, DOI 10.3945/jn.109.113746; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hosoya S, 2013, J MICROBIOL IMMUNOL, V46, P474, DOI 10.1016/j.jmii.2012.04.005; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Konstantinov S. R., 2006, Nutrition and immunity, P23; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Konstantinov SR, 2006, INT J SYST EVOL MICR, V56, P29, DOI 10.1099/ijs.0.63508-0; Lagler H, 2009, J IMMUNOL, V183, P2027, DOI 10.4049/jimmunol.0803862; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lehto EM, 1997, FEMS IMMUNOL MED MIC, V18, P125, DOI 10.1111/j.1574-695X.1997.tb01037.x; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; Martinez RCR, 2011, INT J FOOD MICROBIOL, V149, P152, DOI 10.1016/j.ijfoodmicro.2011.06.010; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ogino T, 2013, GASTROENTEROLOGY, V145, P1380, DOI 10.1053/j.gastro.2013.08.049; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rizzo A, 2013, INT IMMUNOPHARMACOL, V17, P453, DOI 10.1016/j.intimp.2013.07.005; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Takanashi N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-54; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Triantafilou M, 2002, J CELL SCI, V115, P2603; Villena J, 2012, CLIN VACCINE IMMUNOL, V19, P1038, DOI 10.1128/CVI.00199-12; Wang SG, 2008, WORLD J GASTROENTERO, V14, P1067, DOI 10.3748/wjg.14.1067; Wheeler DS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-31; Zeytun A, 2010, CRIT REV IMMUNOL, V30, P53, DOI 10.1615/CritRevImmunol.v30.i1.40; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005	60	94	103	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94891	10.1371/journal.pone.0094891	http://dx.doi.org/10.1371/journal.pone.0094891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733511	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400128
J	Kabaroff, L; Gupta, A; Menezes, S; Babichev, Y; Kandel, RC; Swallow, CJ; Dickson, BC; Gladdy, RA				Kabaroff, Leah; Gupta, Amar; Menezes, Serena; Babichev, Yael; Kandel, Rita C.; Swallow, Carol J.; Dickson, Brendan C.; Gladdy, Rebecca A.			Development of Genetically Flexible Mouse Models of Sarcoma Using RCAS-TVA Mediated Gene Delivery	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; RETROVIRAL VECTORS; PLEOMORPHIC RHABDOMYOSARCOMA; EMBRYONAL RHABDOMYOSARCOMA; TUMOR SUPPRESSION; CANCER; MICE; EXPRESSION; SYSTEM; RAS	Sarcomas are a heterogeneous group of mesenchymal malignancies and unfortunately there are limited functional genomics platforms to assess the molecular pathways contributing to sarcomagenesis. Thus, novel model systems are needed to validate which genes should be targeted for therapeutic intervention. We hypothesized that delivery of oncogenes into mouse skeletal muscle using a retroviral (RCAS-TVA) system would result in sarcomagenesis. We also sought to determine if the cell type transformed (mesenchymal progenitors vs. terminally differentiated tissues) would influence sarcoma biology. Cells transduced with RCAS vectors directing the expression of oncoproteins Kras(G12D), c-Myc and/or Igf2 were injected into the hindlimbs of mice that expressed the retroviral TVA receptor in neural/mesenchymal progenitors, skeletal/cardiac muscle or ubiquitously (N-tva, AKE and BKE strains respectively). Disrupting the G1 checkpoint CDKN2 (p16/p19(-/-)) resulted in sarcoma in 30% of p16/p19(-/-) xN-tva mice with a median latency of 23 weeks (range 8-40 weeks). A similar incidence occurred in p16/p19(-/-) xBKE mice (32%), however, a shorter median latency (10.4 weeks) was observed. p16/p19(-/-) xAKE mice also developed sarcomas (24% incidence; median 9 weeks) yet 31% of mice also developed lung sarcomas. Gene-anchored PCR demonstrated retroviral DNA integration in 86% of N-tva, 93% of BKE and 88% of AKE tumors. Kras(G12D) was the most frequent oncogene isolated. Oncogene delivery by the RCAS-TVA system can generate sarcomas in mice with a defective cell cycle checkpoint. Sarcoma biology differed between the different RCAS models we created, likely due to the cell population being transformed. This genetically flexible system will be a valuable tool for sarcoma research.	[Kabaroff, Leah; Gupta, Amar; Menezes, Serena; Babichev, Yael; Kandel, Rita C.; Swallow, Carol J.; Gladdy, Rebecca A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Gupta, Amar; Swallow, Carol J.; Gladdy, Rebecca A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kandel, Rita C.; Swallow, Carol J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kandel, Rita C.; Dickson, Brendan C.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Swallow, Carol J.; Gladdy, Rebecca A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Gladdy, Rebecca A.] Ontario Inst Canc Res, Canc Stem Cell Program, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Gladdy, RA (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	gladdy@lunenfeld.ca	Kandel, Rita/E-2149-2017; Dickson, Brendan C/J-2347-2016; Gladdy, Rebecca/A-2516-2013	Kandel, Rita/0000-0003-4047-3913; Dickson, Brendan C/0000-0003-2269-6216; Gladdy, Rebecca/0000-0003-4143-6620; Gupta, Amar/0000-0001-6444-9999	Ontario Institute for Cancer Research Clinician-Scientist Award; American Surgical Association Fellowship	Ontario Institute for Cancer Research Clinician-Scientist Award; American Surgical Association Fellowship	This work was supported by the following: 1. Ontario Institute for Cancer Research Clinician-Scientist Award. 2. American Surgical Association Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Cohen JA, 1997, HUM PATHOL, V28, P893, DOI 10.1016/S0046-8177(97)90003-4; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Ealba EL, 2013, DEVELOPMENT, V140, P3062, DOI 10.1242/dev.092676; Federspiel MJ, 1996, P NATL ACAD SCI USA, V93, P4931, DOI 10.1073/pnas.93.10.4931; FEDERSPIEL MJ, 1994, P NATL ACAD SCI USA, V91, P11241, DOI 10.1073/pnas.91.23.11241; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; Linardic CM, 2005, CANCER RES, V65, P4490, DOI 10.1158/0008-5472.CAN-04-3194; Nanni P, 2003, CANCER RES, V63, P2728; Nishijo K, 2009, CANCER RES, V69, P2902, DOI 10.1158/0008-5472.CAN-08-3723; Orlow I, 1999, J NATL CANCER I, V91, P73, DOI 10.1093/jnci/91.1.73; Orsulic S, 2002, MAMM GENOME, V13, P543, DOI 10.1007/s00335-002-4003-4; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pao W, 2003, P NATL ACAD SCI USA, V100, P8764, DOI 10.1073/pnas.1133333100; Perot G, 2010, AM J PATHOL, V177, P2080, DOI 10.2353/ajpath.2010.100104; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Springer ML, 2002, CURR PROTOC HUM GENE; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Werder A, 2012, NAT PROTOC, V7, P1167, DOI 10.1038/nprot.2012.060; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; YUN K, 1992, LAB INVEST, V67, P653	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94817	10.1371/journal.pone.0094817	http://dx.doi.org/10.1371/journal.pone.0094817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733554	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400111
J	Mubiru, JN; Yang, AS; Olsen, C; Nayak, S; Livi, CB; Dick, EJ; Owston, M; Garcia-Forey, M; Shade, RE; Rogers, J				Mubiru, James N.; Yang, Alice S.; Olsen, Christian; Nayak, Sudhir; Livi, Carolina B.; Dick, Edward J., Jr.; Owston, Michael; Garcia-Forey, Magdalena; Shade, Robert E.; Rogers, Jeffrey			Analysis of Prostate-Specific Antigen Transcripts in Chimpanzees, Cynomolgus Monkeys, Baboons, and African Green Monkeys	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; KALLIKREIN GENE FAMILY; HUMAN SEMINAL PLASMA; MOLECULAR-CLONING; EVOLUTION; PROTEIN; LIQUEFACTION; COAGULATION; EXPRESSION; SELECTION	The function of prostate-specific antigen (PSA) is to liquefy the semen coagulum so that the released sperm can fuse with the ovum. Fifteen spliced variants of the PSA gene have been reported in humans, but little is known about alternative splicing in nonhuman primates. Positive selection has been reported in sex-and reproductive-related genes from sea urchins to Drosophila to humans; however, there are few studies of adaptive evolution of the PSA gene. Here, using polymerase chain reaction (PCR) product cloning and sequencing, we study PSA transcript variant heterogeneity in the prostates of chimpanzees (Pan troglodytes), cynomolgus monkeys (Macaca fascicularis), baboons (Papio hamadryas anubis), and African green monkeys (Chlorocebus aethiops). Six PSA variants were identified in the chimpanzee prostate, but only two variants were found in cynomolgus monkeys, baboons, and African green monkeys. In the chimpanzee the full-length transcript is expressed at the same magnitude as the transcripts that retain intron 3. We have found previously unidentified splice variants of the PSA gene, some of which might be linked to disease conditions. Selection on the PSA gene was studied in 11 primate species by computational methods using the sequences reported here for African green monkey, cynomolgus monkey, baboon, and chimpanzee and other sequences available in public databases. A codon-based analysis (dN/dS) of the PSA gene identified potential adaptive evolution at five residue sites (Arg45, Lys70, Gln144, Pro189, and Thr203).	[Mubiru, James N.; Dick, Edward J., Jr.; Owston, Michael; Garcia-Forey, Magdalena; Shade, Robert E.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Yang, Alice S.] St Marys Univ, Dept Biol, San Antonio, TX USA; [Olsen, Christian] Biomatters Inc, Newark, NJ USA; [Nayak, Sudhir] Coll New Jersey, Dept Biol, Ewing, NJ USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78229 USA; [Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Texas Biomedical Research Institute; College of New Jersey; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine	Mubiru, JN (corresponding author), Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA.	jmubiru@txbiomed.org	Owston, Michael/E-2999-2015	Owston, Michael/0000-0002-2107-5883; Livi, Carolina/0000-0001-8389-2830	Office of the Director, National Institutes of Health [8K01OD010973-04]; Southwest National Primate Research Center grant from the National Center for Research Resources, National Institutes of Health [P51 RR013986]; Office of Research Infrastructure Programs [P51 OD013986]; Research Facilities Improvement Programs Grants from the National Center for Research Resources, National Institutes of Health [C06 RR015456, C06 RR014578]; National Institute on Minority Health and Health Disparities from the National Institutes of Health [G12MD007591]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986, C06RR014578, C06RR015456] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010973, P40OD010965, P51OD011133] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwest National Primate Research Center grant from the National Center for Research Resources, National Institutes of Health; Office of Research Infrastructure Programs; Research Facilities Improvement Programs Grants from the National Center for Research Resources, National Institutes of Health; National Institute on Minority Health and Health Disparities from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Mubiru was supported by the Office of the Director, National Institutes of Health under Award # 8K01OD010973-04. This investigation used resources that were supported by the Southwest National Primate Research Center grant P51 RR013986 from the National Center for Research Resources, National Institutes of Health and that are currently supported by the Office of Research Infrastructure Programs through P51 OD013986. Nonhuman primates were housed in facilities constructed with support from Research Facilities Improvement Programs Grants C06 RR015456 and C06 RR014578 from the National Center for Research Resources, National Institutes of Health. This work received computational support from Computational Systems Biology Core, funded by the National Institute on Minority Health and Health Disparities (G12MD007591) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; Dixson AF, 2002, FOLIA PRIMATOL, V73, P63, DOI 10.1159/000064784; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goodall J., 1986, CHIMPANZEES GOMBE PA; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Heuze-Vourc'h N, 2003, EUR J BIOCHEM, V270, P706, DOI 10.1046/j.1432-1033.2003.03425.x; Heuze-Vourc'h N, 2001, EUR J BIOCHEM, V268, P4408, DOI 10.1046/j.1432-1327.2001.02367.x; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lundwall A, 2002, MOL HUM REPROD, V8, P805, DOI 10.1093/molehr/8.9.805; LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9; Marques PI, 2012, GENOME BIOL EVOL, V4, P1331, DOI 10.1093/gbe/evs111; Marshall DJ, 2006, J MED PRIMATOL, V35, P12, DOI 10.1111/j.1600-0684.2005.00134.x; Mubiru JN, 2008, PROSTATE, V68, P1546, DOI 10.1002/pros.20814; Mubiru JN, 2004, GENE, V327, P89, DOI 10.1016/j.gene.2003.11.009; Pujolar JM, 2011, MOL ECOL, V20, P4968, DOI 10.1111/j.1365-294X.2011.05336.x; REIGMAN PHJ, 1989, BIOCHEM BIOPH RES CO, V159, P95, DOI 10.1016/0006-291X(89)92409-1; RIEGMAN PHJ, 1988, BIOCHEM BIOPH RES CO, V155, P181, DOI 10.1016/S0006-291X(88)81066-0; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; SENSABAUGH GF, 1978, J FORENSIC SCI, V23, P106; Steiner MS, 1999, J UROLOGY, V162, P1454, DOI 10.1016/S0022-5347(05)68340-1; Steinway SN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-284; TAUBER PF, 1980, J ANDROL, V1, P280; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Whitbread AK, 2010, BIOL CHEM, V391, P461, DOI 10.1515/BC.2010.043; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yousef GM, 2000, BIOCHEM BIOPH RES CO, V276, P125, DOI 10.1006/bbrc.2000.3448	41	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94522	10.1371/journal.pone.0094522	http://dx.doi.org/10.1371/journal.pone.0094522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732672	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400046
J	Saokaew, S; Tassaneeyakul, W; Maenthaisong, R; Chaiyakunapruk, N				Saokaew, Surasak; Tassaneeyakul, Wichittra; Maenthaisong, Ratree; Chaiyakunapruk, Nathorn			Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population	PLOS ONE			English	Article							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; ERYTHEMA MULTIFORME; UTILITY-ASSESSMENT; GOUT; ASSOCIATION; MANAGEMENT; MANIFESTATIONS; COMPLICATIONS; ALLELE	Background: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), caused by allopurinol therapy, are strongly associated with the human leukocyte antigen (HLA), HLA-B*5801. Identification of HLA-B*5801 genotype before prescribing allopurinol offers the possibility of avoiding allopurinol-induced SJS/TEN. As there is a paucity of evidence about economic value of such testing, this study aims to determine the cost-effectiveness of HLA-B*5801 testing compared with usual care (no genetic testing) before allopurinol administration in Thailand. Methods and Finding: A decision analytical and Markov model was used to estimate life time costs and outcomes represented as quality adjusted life years (QALYs) gained. The model was populated with relevant information of the association between gene and allopurinol-induced SJS/TEN, test characteristics, costs, and epidemiologic data for Thailand from a societal perspective. Input data were obtained from the literature and a retrospective database analysis. The results were expressed as incremental cost per QALY gained. A base-case analysis was performed for patients at age 30. A series of sensitivity analyses including scenario, one-way, and probabilistic sensitivity analyses were constructed to explore the robustness of the findings. Based on a hypothetical cohort of 1,000 patients, the incremental total cost was 923,919 THB (USD 29,804) and incremental QALY was 5.89 with an ICER of 156,937.04 THB (USD 5,062) per QALY gained. The cost of gout management, incidence of SJS/TEN, case fatality rate of SJS/TEN, and cost of genetic testing are considered very influential parameters on the cost-effectiveness value of HLA-B*5801 testing. Conclusions: The genetic testing for HLA-B*5801 before allopurinol administration is considered a highly potential cost-effective intervention in Thailand. The findings are sensitive to a number of factors. In addition to cost-effectiveness findings, consideration of other factors including ethical, legal, and social implications is needed for an informed policy decision making.	[Saokaew, Surasak; Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, CPOR, Phitsanulok, Thailand; [Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Ctr Hlth Outcomes Res & Therapeut Safety Cohorts, Phayao, Thailand; [Saokaew, Surasak] Univ Utah, Coll Pharm, PORC, Salt Lake City, UT 84112 USA; [Tassaneeyakul, Wichittra] Khon KaenUniv, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Tassaneeyakul, Wichittra] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Maenthaisong, Ratree] Mahasarakham Univ, Fac Pharm, Dept Clin Pharm, Clin Pharm Res Unit, Maha Sarakham, Thailand; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Naresuan University; University of Phayao; Utah System of Higher Education; University of Utah; Khon Kaen University; Khon Kaen University; Mahasarakham University; University of Wisconsin System; University of Wisconsin Madison; Monash University; Monash University Sunway; University of Queensland	Chaiyakunapruk, N (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, CPOR, Phitsanulok, Thailand.	nathorn.chaiyakunapruk@monash.edu	Saokaew, Surasak/AAI-9804-2021	Saokaew, Surasak/0000-0002-1382-0660; Tassaneeyakul, Wichittra/0000-0001-6722-8796; Sawangjit, Ratree/0000-0002-6868-4336	National Science and Technology Development Agency, Thailand; Higher Education Research Promotion and National Research University Project of Thailand, Office of the High Education Commission, through the Health cluster (SHeP-GMS); Talent Enhancement Scheme Research Grant (TES), Monash University Malaysia	National Science and Technology Development Agency, Thailand; Higher Education Research Promotion and National Research University Project of Thailand, Office of the High Education Commission, through the Health cluster (SHeP-GMS); Talent Enhancement Scheme Research Grant (TES), Monash University Malaysia	This study was supported by grants from National Science and Technology Development Agency, Thailand. Dr. Wichittra Tassaneeyakul was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the High Education Commission, through the Health cluster (SHeP-GMS). Dr. Nathorn Chaiyakunapruk was supported by Talent Enhancement Scheme Research Grant (TES), Monash University Malaysia. The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of data; and preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; [Anonymous], 2009, PUBL HLTH STAT; Ara R, 2012, MED CARE, V50, P452, DOI 10.1097/MLR.0b013e318234a04a; Atzori L, 2012, J EUR ACAD DERMATOL, V26, P1424, DOI 10.1111/j.1468-3083.2011.04313.x; Bank of Thailand, 2013, FOR EXCH RAT; Beard SM, 2014, EUR J HEALTH ECON, V15, P453, DOI 10.1007/s10198-013-0486-z; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Buchholz P, 2006, OCUL SURF, V4, P155, DOI 10.1016/S1542-0124(12)70043-5; Bureau of trade and economic indices Ministry of Commerce Thailand, 2013, REP CONS PRIC IND TH; Burns CM, 2012, THER ADV CHRONIC DIS, V3, P271, DOI 10.1177/2040622312462056; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Chao Jeannie, 2009, Curr Rheumatol Rep, V11, P135; Chiu MLS, 2012, BRIT J DERMATOL, V167, P44, DOI 10.1111/j.1365-2133.2012.10894.x; Di Pascuale MA, 2005, OPHTHALMOLOGY, V112, P904, DOI 10.1016/j.ophtha.2004.11.035; Drugs and Medical Supplies Information Center (DMSIC) Ministry of Public Health, 2013, REF DRUG PRIC; Gerull R, 2011, CRIT CARE MED, V39, P1521, DOI 10.1097/CCM.0b013e31821201ed; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; HALL GH, 1967, LANCET, V2, P555; Hamburger Max, 2011, Postgrad Med, V123, P3, DOI 10.3810/pgm.2011.11.2511; Harr T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-39; Hobbs FD, 1997, HEALTH TECHNOL ASSES, V1, p[i, 1]; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Limkobpaiboon S., 2010, CHULA MED J, V54, P467; Limwattananon Supon, 2008, J Med Assoc Thai, V91 Suppl 2, pS59; Perez-Ruiz F, 2000, NEPHRON, V86, P287, DOI 10.1159/000045783; Permsuwan Unchalee, 2008, J Med Assoc Thai, V91 Suppl 2, pS53; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Rheumatism Association of Thailand, 2012, GUID MAN GOUT; Riewpaiboon A., 2010, STANDARD COST LISTS; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; SCOTT JT, 1966, ANN RHEUM DIS, V25, P623, DOI 10.1136/ard.25.Suppl_6.623; Somkrua R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-118; Sub-committee of Thai Working Group on Health Technology Assessment, 2013, 2 ANN M; Suwankesawong W, 2011, MED HLTH PROD B 1, V4, P28; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Teerawattananon Yot, 2008, J Med Assoc Thai, V91 Suppl 2, pS11; Teng GG, 2006, DRUGS, V66, P1547, DOI 10.2165/00003495-200666120-00002; Thai Working Group on Health Technology Assessment Guidelines in Thailand, 2008, J MED ASS THAI S2, V91, pS1; Wises K, 2008, COST MANAGEMENT STEV; World Health Organization, 2011, GLOB HLTH OBS DAT RE; Wortmann RL, 2002, CURR OPIN RHEUMATOL, V14, P281, DOI 10.1097/00002281-200205000-00015; Yip LW, 2007, ALLERGY, V62, P527, DOI 10.1111/j.1398-9995.2006.01295.x; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	46	68	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94294	10.1371/journal.pone.0094294	http://dx.doi.org/10.1371/journal.pone.0094294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732692	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400028
J	Shao, FJ; Lu, SF				Shao, Fenjuan; Lu, Shanfa			Identification, Molecular Cloning and Expression Analysis of Five RNA-Dependent RNA Polymerase Genes in Salvia miltiorrhiza	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; MESSENGER-RNA; DICER-LIKE; ARABIDOPSIS; BIOGENESIS; ARGONAUTE; PATHWAY; FAMILY; BIOSYNTHESIS; MICRORNAS	RNA-dependent RNA polymerases (RDRs) act as key components of the small RNA biogenesis pathways and play significant roles in post-transcriptional gene silencing (PTGS) and antiviral defense. However, there is no information about the RDR gene family in Salvia miltiorrhiza, an emerging model medicinal plant with great economic value. Through genome-wide predication and subsequent molecular cloning, five full-length S. miltiorrhiza RDR genes, termed SmRDR1-SmRDR5, were identified. The length of SmRDR cDNAs varies between 3,262 (SmRDR5) and 4,130 bp (SmRDR3). The intron number of SmRDR genes varies from 3 (SmRDR1, SmRDR3 and SmRDR4) to 17 (SmRDR5). All of the deduced SmRDR protein sequences contain the conserved RdRp domain. Moreover, SmRDR2 and SmRDR4 have an additional RRM domain. Based on the phylogenetic tree constructed with sixteen RDRs from Arabidopsis, rice and S. miltiorrhiza, plant RDRs may be divided into four groups (RDR1-RDR4). The RDR1 group contains an AtRDR and an OsRDR, while includes two SmRDRs. On the contrary, the RDR3 group contains three AtRDRs and two OsRDRs, but has only one SmRDR. SmRDRs were differentially expressed in flowers, leaves, stems and roots of S. miltiorrhiza and responsive to methyl jasmonate treatment and cucumber mosaic virus infection. The results suggest the involvement of RDRs in S. miltiorrhiza development and response to abiotic and biotic stresses. It provides a foundation for further studying the regulation and biological functions of SmRDRs and the biogenesis pathways of small RNAs in S. miltiorrhiza.	[Lu, Shanfa] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lu, SF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sflu@implad.ac.cn	Lu, Shanfa/AAF-7424-2020	Lu, Shanfa/0000-0001-6284-4389	Natural Science Foundation of China [31370327]; Beijing Natural Science Foundation [5112026]; Major Scientific and Technological Special Project for Significant New Drugs Creation [2012ZX09301002-001-031]; Research Fund for the Doctoral Program of Higher Education of China [20111106110033]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1150]; Program for Xiehe Scholars in Chinese Academy of Medical Sciences & Peking Union Medical College	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Major Scientific and Technological Special Project for Significant New Drugs Creation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Xiehe Scholars in Chinese Academy of Medical Sciences & Peking Union Medical College	This work was supported by grants from the Natural Science Foundation of China (grant no. 31370327), the Beijing Natural Science Foundation (grant no. 5112026), the Major Scientific and Technological Special Project for Significant New Drugs Creation (grant no. 2012ZX09301002-001-031), the Research Fund for the Doctoral Program of Higher Education of China (grant no. 20111106110033), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, grant no. IRT1150), and the Program for Xiehe Scholars in Chinese Academy of Medical Sciences & Peking Union Medical College (to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASTIERMA.S, 1971, BIOCHIM BIOPHYS ACTA, V232, P484, DOI 10.1016/0005-2787(71)90602-2; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartlett JG, 2009, PLANT BIOTECHNOL J, V7, P856, DOI 10.1111/j.1467-7652.2009.00448.x; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng TO, 2006, J AM COLL CARDIOL, V47, P1498, DOI 10.1016/j.jacc.2006.01.001; Cogoni C, 1999, CURR OPIN MICROBIOL, V2, P657, DOI 10.1016/S1369-5274(99)00041-7; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; He S, 2012, BRIT J DERMATOL, V166, P564, DOI 10.1111/j.1365-2133.2011.10674.x; Hou XM, 2013, MOL BIOL REP, V40, P4301, DOI 10.1007/s11033-013-2517-3; Johnston Michael, 2011, Silence, V2, P5, DOI 10.1186/1758-907X-2-5; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JL, 2008, MOL GENET GENOMICS, V279, P563, DOI 10.1007/s00438-008-0333-6; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qian YX, 2011, PLANT CELL REP, V30, P1347, DOI 10.1007/s00299-011-1046-6; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Shao FJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-512; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Vrbsky J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000986; Walker JB, 2007, ANN BOT-LONDON, V100, P375, DOI 10.1093/aob/mcl176; Wang JW, 2010, APPL MICROBIOL BIOT, V88, P437, DOI 10.1007/s00253-010-2797-7; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Willmann Matthew R, 2011, Arabidopsis Book, V9, pe0146, DOI 10.1199/tab.0146; Xiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029713; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang LS, 2014, J INTEGR PLANT BIOL, V56, P38, DOI 10.1111/jipb.12111; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	53	20	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95117	10.1371/journal.pone.0095117	http://dx.doi.org/10.1371/journal.pone.0095117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733018	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400154
J	Wang, Q; Qi, YF; Yin, N; Lai, LH				Wang, Qian; Qi, Yifei; Yin, Ning; Lai, Luhua			Discovery of Novel Allosteric Effectors Based on the Predicted Allosteric Sites for Escherichia coli D-3-Phosphoglycerate Dehydrogenase	PLOS ONE			English	Article							SERINE BIOSYNTHESIS; 3-PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOGLYCERATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; HYBRID TETRAMERS; BINDING; MODEL; METABOLISM; MECHANISM; PATHWAYS	D-3-phosphoglycerate dehydrogenase (PGDH) from Escherichia coli catalyzes the first critical step in serine biosynthesis, and can be allosterically inhibited by serine. In a previous study, we developed a computational method for allosteric site prediction using a coarse-grained two-state Go Model and perturbation. Two potential allosteric sites were predicted for E. coli PGDH, one close to the active site and the nucleotide binding site (Site I) and the other near the regulatory domain (Site II). In the present study, we discovered allosteric inhibitors and activators based on site I, using a high-throughput virtual screen, and followed by using surface plasmon resonance (SPR) to eliminate false positives. Compounds 1 and 2 demonstrated a low-concentration activation and high-concentration inhibition phenomenon, with IC50 values of 34.8 and 58.0 mu M in enzymatic bioassays, respectively, comparable to that of the endogenous allosteric effector, L-serine. For its activation activity, compound 2 exhibited an AC(50) value of 34.7 nM. The novel allosteric site discovered in PGDH was L-serine-and substrate-independent. Enzyme kinetics studies showed that these compounds influenced K-m, k(cat), and k(cat)/K-m. We have also performed structure-activity relationship studies to discover high potency allosteric effectors. Compound 2-2, an analog of compound 2, showed the best in vitro activity with an IC50 of 22.3 mu M. Compounds targeting this site can be used as new chemical probes to study metabolic regulation in E. coli. Our study not only identified a novel allosteric site and effectors for PGDH, but also provided a general strategy for designing new regulators for metabolic enzymes.	[Wang, Qian; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS, Beijing 100871, Peoples R China; [Qi, Yifei; Yin, Ning; Lai, Luhua] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lai, LH (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS, Beijing 100871, Peoples R China.	lhlai@pku.edu.cn			Ministry of Science and Technology of China; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported in part by the Ministry of Science and Technology of China, and the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Burton RL, 2008, J BIOL CHEM, V283, P29706, DOI 10.1074/jbc.M805180200; CHEUNG GP, 1968, PLANT PHYSIOL, V43, P1813, DOI 10.1104/pp.43.11.1813; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Dey S, 2008, BIOCHEMISTRY-US, V47, P8271, DOI 10.1021/bi800212b; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; DUBROW R, 1977, J BIOL CHEM, V252, P1539; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2003, J BIOL CHEM, V278, P18170, DOI 10.1074/jbc.M213050200; HANFORD J, 1958, NATURE, V182, P532, DOI 10.1038/182532a0; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; JENSEN RA, 1969, J BIOL CHEM, V244, P2816; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; PIZER LI, 1963, J BIOL CHEM, V238, P3934; Qi YF, 2012, J CHEM THEORY COMPUT, V8, P2962, DOI 10.1021/ct300395h; Sa RJ, 2006, J PHYS CHEM B, V110, P5094, DOI 10.1021/jp051692m; SASKI R, 1975, EUR J BIOCHEM, V51, P415, DOI 10.1111/j.1432-1033.1975.tb03941.x; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; Slaughter J C, 1975, Methods Enzymol, V41, P278; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UMBARGER HE, 1962, BIOCHIM BIOPHYS ACTA, V62, P193, DOI 10.1016/0006-3002(62)90515-2; WALSH DA, 1966, J BIOL CHEM, V241, P4068; WALSH DA, 1965, BIOCHEMISTRY-US, V4, P1076, DOI 10.1021/bi00882a015; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; ZHOU GC, 1994, J BIOL CHEM, V269, P6784	37	164	165	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94829	10.1371/journal.pone.0094829	http://dx.doi.org/10.1371/journal.pone.0094829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733054	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400118
J	Wen, DC; Saiz, N; Rosenwaks, Z; Hadjantonakis, AK; Rafii, S				Wen, Duancheng; Saiz, Nestor; Rosenwaks, Zev; Hadjantonakis, Anna-Katerina; Rafii, Shahin			Completely ES Cell-Derived Mice Produced by Tetraploid Complementation Using Inner Cell Mass (ICM) Deficient Blastocysts	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE EMBRYOS; NUCLEAR TRANSFER; DIFFERENTIATION; TROPHECTODERM; BLASTOMERES; DERIVATION; ENDODERM	Tetraploid complementation is often used to produce mice from embryonic stem cells (ESCs) by injection of diploid (2n) ESCs into tetraploid (4n) blastocysts (ESC-derived mice). This method has also been adapted to mouse cloning and the derivation of mice from induced pluripotent stem (iPS) cells. However, the underlying mechanism(s) of the tetraploid complementation remains largely unclear. Whether this approach can give rise to completely ES cell-derived mice is an open question, and has not yet been unambiguously proven. Here, we show that mouse tetraploid blastocysts can be classified into two groups, according to the presence or absence of an inner cell mass (ICM). We designate these as type a (presence of ICM at blastocyst stage) or type b (absence of ICM). ESC lines were readily derived from type a blastocysts, suggesting that these embryos retain a pluripotent epiblast compartment; whereas the type b blastocysts possessed very low potential to give rise to ESC lines, suggesting that they had lost the pluripotent epiblast. When the type a blastocysts were used for tetraploid complementation, some of the resulting mice were found to be 2n/4n chimeric; whereas when type b blastocysts were used as hosts, the resulting mice are all completely ES cell-derived, with the newborn pups displaying a high frequency of abdominal hernias. Our results demonstrate that completely ES cell-derived mice can be produced using ICM-deficient 4n blastocysts, and provide evidence that the exclusion of tetraploid cells from the fetus in 2n/4n chimeras can largely be attributed to the formation of ICM-deficient blastocysts.	[Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10021 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Wen, Duancheng; Rosenwaks, Zev] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Saiz, Nestor; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Wen, DC (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10021 USA.	duw2001@med.cornell.edu; srafii@med.cornell.edu		Saiz, Nestor/0000-0003-0637-791X; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Wen, Duancheng/0000-0002-3160-6289; Rafii, Shahin/0000-0001-5605-1067	Tri-Institutional Stem Cell Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Tri-Institutional Stem Cell Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Tri-Institutional Stem Cell Initiative (Z.R. and S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Goto Y, 2002, INT J DEV BIOL, V46, P741; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; HENERY CC, 1992, J EXP ZOOL, V261, P472, DOI 10.1002/jez.1402610414; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; KAUFMAN MH, 1991, J ANAT, V179, P169; KAUFMAN MH, 1992, J ANAT, V180, P521; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; LU TY, 1980, P NATL ACAD SCI-BIOL, V77, P6012, DOI 10.1073/pnas.77.10.6012; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tarkowski AK, 2001, INT J DEV BIOL, V45, P591; Tarkowski AK, 2005, INT J DEV BIOL, V49, P825, DOI 10.1387/ijdb.052018at; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	36	12	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94730	10.1371/journal.pone.0094730	http://dx.doi.org/10.1371/journal.pone.0094730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733255	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400085
J	Zhao, YP; Xu, XY; Fang, M; Wang, H; You, Q; Yi, CH; Ji, J; Gu, X; Zhou, PT; Cheng, C; Gao, CF				Zhao, Yun-Peng; Xu, Xin-Yun; Fang, Meng; Wang, Hao; You, Qing; Yi, Chang-Hong; Ji, Jun; Gu, Xing; Zhou, Ping-Ting; Cheng, Cheng; Gao, Chun-Fang			Decreased Core-Fucosylation Contributes to Malignancy in Gastric Cancer	PLOS ONE			English	Article							SERUM N-GLYCOME; GDP-L-FUCOSE; HEPATOCELLULAR-CARCINOMA; IMMUNOGLOBULIN-G; MESSENGER-RNA; DIAGNOSIS; GLYCOSYLATION; EXPRESSION; BIOMARKERS; GLYCOPROTEOMICS	The object of the study is to identify N-glycan profiling changes associated with gastric cancer and explore the impact of core-fucosylation on biological behaviors of human gastric cancer cells. A total of 244 subjects including gastric cancer, gastric ulcer and healthy control were recruited. N-glycan profiling from serum and total proteins in gastric tissues was analyzed by DNA sequencer-assisted fluorophore-assisted capillary electrophoresis. The abundance of total core-fucosylated residues and the expression of enzymes involved in core-fucosylation were analyzed with lectin blot, quantitative reverse transcription-polymerase chain reaction, western blot, Immunohistochemical staining and lectin-histochemical staining. The recombinant plasmids of GDP-fucose transporter and alpha-1,6-fucosyltransferase (Fut8) were constructed and transfected into gastric cancer cell lines BGC-823 and SGC-7901. CCK-8 and wound healing assay were used to assess the functional impact of core-fucosylation modulation on cell proliferation and migration. Characteristic serum N-glycan profiles were found in gastric cancer. Compared with the healthy control, a trianntenary structure abundance, peak 9 (NA3Fb), was increased significantly in gastric cancer, while the total abundance of core-fucosylated residues (sumfuc) was decreased. Core-fucosylated structures, peak6(NA2F) and peak7(NA2FB) were deceased in gastric tumor tissues when compared with that in adjacent non-tumor tissues. Consistently, lens culinaris agglutinin (LCA)-binding proteins were decreased significantly in sera of gastric cancer, and protein level of Fut8 was decreased significantly in gastric tumor tissues compared with that in adjacent non-tumor tissues. Upregulation of GDP-Tr and Fut8 could inhibit proliferation, but had no significant influence on migration of BGC-823 and SGC-7901 cells. Core-fucosylation is down regulated in gastric cancer. Upregulation of core-fucosylation could inhibit proliferation of the human gastric cancer cells.	[Zhao, Yun-Peng; Fang, Meng; Yi, Chang-Hong; Ji, Jun; Gu, Xing; Zhou, Ping-Ting; Cheng, Cheng; Gao, Chun-Fang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China; [Xu, Xin-Yun; You, Qing] Second Mil Med Univ, Changzheng Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Wang, Hao] Second Mil Med Univ, Dept Lab Med, Changzheng Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Gao, CF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com			National Natural Science Foundation of China [81201697, 81101639, 81271925]; Science and Technology Commission of Shanghai Municipality [10ZR1439100, 11JC1416400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by National Natural Science Foundation of China (No. 81201697, 81101639 and No. 81271925); Science and Technology Commission of Shanghai Municipality (No. 10ZR1439100 and No. 11JC1416400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; Biskup K, 2013, J PROTEOME RES, V12, P4056, DOI 10.1021/pr400405x; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; Dai Z, 2009, ELECTROPHORESIS, V30, P2957, DOI 10.1002/elps.200900064; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Javaud C, 2003, GENETICA, V118, P157, DOI 10.1023/A:1024101625214; Kam RKT, 2007, CLIN CHEM, V53, P1254, DOI 10.1373/clinchem.2007.085563; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Li QK, 2012, PROTEOM CLIN APPL, V6, P244, DOI 10.1002/prca.201100042; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Margineanu Eliana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P432; Miwa HE, 2013, GLYCOBIOLOGY, V23, P1477, DOI 10.1093/glycob/cwt075; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Noda K, 2003, CANCER RES, V63, P6282; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Qiu XY, 2003, CANCER RES, V63, P6488; Saldova R, 2011, EPIGENETICS-US, V6, P1362, DOI 10.4161/epi.6.11.17977; Saldova R, 2011, GLYCOBIOLOGY, V21, P195, DOI 10.1093/glycob/cwq147; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Tian Y, 2010, PROTEOM CLIN APPL, V4, P124, DOI 10.1002/prca.200900161; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhao YP, 2012, CANCER-AM CANCER SOC, V118, P639, DOI 10.1002/cncr.26342; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; ZIMMERMANN W, 1983, ANN NY ACAD SCI, V417, P21, DOI 10.1111/j.1749-6632.1983.tb32844.x	39	74	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94536	10.1371/journal.pone.0094536	http://dx.doi.org/10.1371/journal.pone.0094536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732908	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400049
J	Ameqrane, I; Pouget, P; Wattiez, N; Carpenter, R; Missal, M				Ameqrane, Ilhame; Pouget, Pierre; Wattiez, Nicolas; Carpenter, Roger; Missal, Marcus			Implicit and Explicit Timing in Oculomotor Control	PLOS ONE			English	Article							TEMPORAL INTERVALS; ORIENTING ATTENTION; TIME; PERCEPTION; EXPECTATION; FOREPERIOD; PREDICTION; DOPAMINE; CONTEXT	The passage of time can be estimated either explicitly, e. g. before leaving home in the morning, or implicitly, e. g. when catching a flying ball. In the present study, the latency of saccadic eye movements was used to evaluate differences between implicit and explicit timing. Humans were required to make a saccade between a central and a peripheral position on a computer screen. The delay between the extinction of a central target and the appearance of an eccentric target was the independent variable that could take one out of four different values (400, 900, 1400 or 1900 ms). In target trials, the delay period lasted for one of the four durations randomly. At the end of the delay, a saccade was initiated by the appearance of an eccentric target. Cue&target trials were similar to target trials but the duration of the delay was visually cued. In probe trials, the duration of the upcoming delay was cued, but there was no eccentric target and subjects had to internally generate a saccade at the estimated end of the delay. In target and cue&target trials, the mean and variance of latency distributions decreased as delay duration increased. In cue&target trials latencies were shorter. In probe trials, the variance increased with increasing delay duration and scalar variability was observed. The major differences in saccadic latency distributions were observed between visually-guided (target and cue&target trials) and internally-generated saccades (probe trials). In target and cue&target trials the timing of the response was implicit. In probe trials, the timing of the response was internally-generated and explicitly based on the duration of the visual cue. Scalar timing was observed only during probe trials. This study supports the hypothesis that there is no ubiquitous timing system in the brain but independent timing processes active depending on task demands.	[Ameqrane, Ilhame; Missal, Marcus] Catholic Univ Louvain, Inst Neurosci IONS Cognit & Syst COSY, B-1200 Brussels, Belgium; [Pouget, Pierre; Wattiez, Nicolas] CNRS UMR 7225, ICM, Paris, France; [Carpenter, Roger] Univ Cambridge, Dept Physiol Dev & Neurosci PDN, Cambridge, England	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Cambridge	Missal, M (corresponding author), Catholic Univ Louvain, Inst Neurosci IONS Cognit & Syst COSY, B-1200 Brussels, Belgium.	marcus.missal@uclouvain.be	Pouget, Pierre/N-8031-2019	Pouget, Pierre/0000-0002-4721-7376; Carpenter, Roger/0000-0003-2572-1448	Fonds de la Recherche Scientifique Medicale (FRSM) [3.4.523.08.F]; Agence Nationale de la Recherche (ANR) [SHS 2 2012 PeDu]	Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was funded by a grant of the Fonds de la Recherche Scientifique Medicale (FRSM) number 3.4.523.08.F (www.fnrs.be/) and a grant from the Agence Nationale de la Recherche (ANR) SHS 2 2012 PeDu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; [Anonymous], 2003, NEURAL MECH VISUAL O; Badler JB, 2006, J NEUROSCI, V26, P4519, DOI 10.1523/JNEUROSCI.3739-05.2006; BARLOW RE, 1966, ANN MATH STAT, V37, P1574, DOI 10.1214/aoms/1177699149; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Cotti J, 2011, NEUROIMAGE, V54, P1221, DOI 10.1016/j.neuroimage.2010.09.038; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2013, NEUROPSYCHOLOGIA, V51, P309, DOI 10.1016/j.neuropsychologia.2012.08.017; de Hemptinne C, 2007, J NEUROSCI, V27, P4334, DOI 10.1523/JNEUROSCI.0388-07.2007; Droit-Volet S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00033; Gamache PL, 2010, PERCEPTION, V39, P1431, DOI 10.1068/p6652; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Joiner WM, 2006, EXP BRAIN RES, V175, P305, DOI 10.1007/s00221-006-0554-z; Jones CRG, 2008, BRAIN COGNITION, V68, P30, DOI 10.1016/j.bandc.2008.02.121; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Los S.A., 2010, ATTENTION TIME, P289, DOI [10.1093/acprof:oso/9780199563456.003.0021, DOI 10.1093/ACPROF:OSO/9780199563456.001.0001]; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Luce R. D, 1986, OXFORD PSYCHOL SERIE, V8; Lupianez J., 2010, ATTENTION TIME, P17; MacDonald CJ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00010; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; Piras F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018203; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; Steinborn MB, 2008, ACTA PSYCHOL, V129, P297, DOI 10.1016/j.actpsy.2008.08.005; Story GW, 2009, EXP BRAIN RES, V193, P287, DOI 10.1007/s00221-008-1624-1; Taatgen N, 2011, MEM COGNITION, V39, P1546, DOI 10.3758/s13421-011-0113-0; Vallesi A., 2010, ATTENTION TIME, P303, DOI [DOI 10.1093/ACPROF:OSO/9780199563456.003.0022, 10.1093/acprof:oso/9780199563456.003.0022]; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	45	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93958	10.1371/journal.pone.0093958	http://dx.doi.org/10.1371/journal.pone.0093958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3CI	24728140	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200033
J	Li, ZY; Wang, YH; Liu, Y; Guo, H; Li, T; Li, ZH; Shi, GA				Li, Zhiyong; Wang, Yanhui; Liu, Yuan; Guo, Hao; Li, Tao; Li, Zhen-Hua; Shi, Guoan			Long-Term Effects of Liming on Health and Growth of a Masson Pine Stand Damaged by Soil Acidification in Chongqing, China	PLOS ONE			English	Article							ABIES L. KARST.; NORWAY SPRUCE; FOREST SOIL; ROOT-GROWTH; ACID-RAIN; SOUTHWESTERN CHINA; PICEA-ABIES; ABOVEGROUND GROWTH; CENTRAL-EUROPE; DEPOSITION	In the last decades, the Masson pine (Pinus massoniana) forests in Chongqing, southwest China, have increasingly declined. Soil acidification was believed to be an important cause. Liming is widely used as a measure to alleviate soil acidification and its damage to trees, but little is known about long-term effects of liming on the health and growth of declining Masson pine forests. Soil chemical properties, health condition (defoliation and discoloration), and growth were evaluated following application of limestone powder (0 (unlimed control), 1, 2, 3, and 4 t ha(-1)) in an acidified and declining Masson pine stand at Tieshanping (TSP) of Chongqing. Eight years after liming, in the 0-20 cm and 20-40 cm mineral soil layers, soil pH values, exchangeable calcium (Ca) contents, and Ca/Al molar ratios increased, but exchangeable aluminum (Al) levels decreased, and as a result, length densities of living fine roots of Masson pine increased, with increasing dose. Mean crown defoliation of Masson pines (dominant, codominant and subdominant pines, according to Kraft classes 1-3) decreased with increasing dose, and it linearly decreased with length densities of living fine roots. However, Masson pines (Kraft classes 1-3) in all treatments showed no symptoms of discoloration. Mean current-year twig length, twig dry weight, needle number per twig, needle length per twig, and needle dry weight per twig increased with increasing dose. Over 8 years, mean height increment of Masson pines (Kraft classes 1-3) increased from 5.5 m in the control to 5.8, 6.9, 8.3, and 9.5 m in the 1, 2, 3, and 4 t ha(-1) lime treatments, and their mean DBH (diameter at breast height) increment increased from 3.1 to 3.2, 3.8, 4.9, and 6.2 cm, respectively. The values of all aboveground growth parameters linearly increased with length densities of living fine roots. Our results show that liming improved tree health and growth, and these effects increased with increasing dose.	[Li, Zhiyong; Shi, Guoan] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Li, Zhiyong; Wang, Yanhui; Li, Zhen-Hua] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Liu, Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guo, Hao] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Li, Tao] Hebei Univ, Baoding, Peoples R China	Henan University of Science & Technology; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Hebei University	Li, ZY (corresponding author), Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China.	pphdll@126.com	Guo, Hao/AAL-6232-2020; Liu, Yuan/E-8918-2016	Liu, Yuan/0000-0001-8672-6301	State Forestry Administration of China (SFA) [201304301-05]; Chinese-Norwegian cooperation project [209696/E10]; Key Laboratory of Forest Ecology and Environment of SFA	State Forestry Administration of China (SFA); Chinese-Norwegian cooperation project; Key Laboratory of Forest Ecology and Environment of SFA	This study was sponsored by the State Forestry Administration of China (SFA) with the project (201304301-05), the Chinese-Norwegian cooperation project "Forest in south China: an important sink for reactive nitrogen and a regional hotspot for N2O?" (209696/E10), and the Key Laboratory of Forest Ecology and Environment of SFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman JSK, 2003, SOIL BIOL BIOCHEM, V35, P1337, DOI 10.1016/S0038-0717(03)00213-X; Bakker MR, 2000, FOREST ECOL MANAG, V126, P121, DOI 10.1016/S0378-1127(99)00097-3; Bakker MR, 1999, PLANT SOIL, V217, P243, DOI 10.1023/A:1004518116551; Borja I, 2009, PLANT SOIL, V314, P109, DOI 10.1007/s11104-008-9710-5; Burke MP, 1998, P I CIVIL ENG-CIV EN, V126, P39, DOI 10.1680/icien.1998.30011; Caires EF, 2008, EUR J AGRON, V28, P57, DOI 10.1016/j.eja.2007.05.002; Chinese Society of Forestry, 1989, AC RAIN AGR; CRONAN CS, 1995, J ENVIRON QUAL, V24, P209, DOI 10.2134/jeq1995.00472425002400020002x; Dhief A, 2011, CAN J SOIL SCI, V91, P15, DOI 10.4141/CJSS09059; Du XM, 1996, RES ENV SCI, V9, P21; DURKA W, 1994, NATURE, V372, P765, DOI 10.1038/372765a0; Elias PE, 2009, FOREST ECOL MANAG, V258, P2175, DOI 10.1016/j.foreco.2009.05.004; Fischer R, 2007, APPL GEOCHEM, V22, P1129, DOI 10.1016/j.apgeochem.2007.03.004; Frank J, 2003, FOREST ECOL MANAG, V176, P371, DOI 10.1016/S0378-1127(02)00285-2; Gao JX, 1991, ACTA SCI CIRCUMSTANT, V11, P194; Guckland A, 2012, EUR J FOREST RES, V131, P1869, DOI 10.1007/s10342-012-0639-0; Guo JH, 2007, APPL GEOCHEM, V22, P388, DOI 10.1016/j.apgeochem.2006.11.003; Hahn G, 1998, PLANT SOIL, V199, P11, DOI 10.1023/A:1004254709452; Hao Ji-ming, 2000, Journal of Environmental Sciences (China), V12, P385; Harrison AF, 1999, FORESTRY, V72, P367, DOI 10.1093/forestry/72.4.367; Helmisaari HS, 1999, FOREST ECOL MANAG, V119, P99, DOI 10.1016/S0378-1127(98)00514-3; Hruska J, 2012, ECOL MODEL, V244, P28, DOI 10.1016/j.ecolmodel.2012.06.025; [黄永梅 HUANG YongMei], 2006, [生态学报, Acta Ecologica Sinica], V26, P786; HUETTL RF, 1993, FOREST ECOL MANAG, V61, P325, DOI 10.1016/0378-1127(93)90209-6; HUTCHINSON TC, 1986, WATER AIR SOIL POLL, V31, P283, DOI 10.1007/BF00630844; Ito K, 2011, WATER AIR SOIL POLL, V214, P197, DOI 10.1007/s11270-010-0416-y; [姜文华 Jiang Wenhua], 2002, [环境科学研究, Research of Environmental Sciences], V15, P8; Jin L, 2006, CHINESE SCI BULL, V51, P1818, DOI 10.1007/s11434-006-2040-1; Jonard M, 2010, EUR J FOREST RES, V129, P1203, DOI 10.1007/s10342-010-0410-3; Kakei M, 2002, FORESTRY, V75, P37, DOI 10.1093/forestry/75.1.37; Kreutzer K, 1998, PLANT SOIL, V199, P1, DOI 10.1023/A:1004384909535; Kuang YW, 2010, ENVIRON POLLUT, V158, P1963, DOI 10.1016/j.envpol.2009.10.028; Larssen T, 2000, ENVIRON POLLUT, V110, P89, DOI 10.1016/S0269-7491(99)00279-1; [李志勇 LI ZhiYong], 2007, [生态学报, Acta Ecologica Sinica], V27, P5245; Li ZY, 2009, FOREST HLTH ACIDIFIC; Liang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062207; Liu H. T., 1988, Acta Scientiae Circumstantiae, V8, P331; LJUNGSTROM M, 1995, FOREST ECOL MANAG, V74, P133, DOI 10.1016/0378-1127(94)03494-H; Lofgren S, 2009, FOREST ECOL MANAG, V258, P567, DOI 10.1016/j.foreco.2009.04.030; Lundstrom U.S., 2003, WATER AIR SOIL POLLU, V3, P5, DOI [DOI 10.1023/A:1024115111377, 10.1023/A:1024115111377]; MATZNER E, 1986, WATER AIR SOIL POLL, V31, P273, DOI 10.1007/BF00630843; MATZNER E, 1985, PLANT SOIL, V87, P405, DOI 10.1007/BF02181907; Matzner E, 1995, WATER AIR SOIL POLL, V85, P63, DOI 10.1007/BF00483689; Meiwes KJ, 2002, FOREST ECOL MANAG, V159, P27, DOI 10.1016/S0378-1127(01)00707-1; Misra RK, 1998, FOREST ECOL MANAG, V106, P283, DOI 10.1016/S0378-1127(97)00339-3; Moore JD, 2008, FOREST ECOL MANAG, V255, P3460, DOI 10.1016/j.foreco.2008.02.026; PERSSON H, 1990, WATER AIR SOIL POLL, V54, P365; Ponette Q, 1997, WATER AIR SOIL POLL, V95, P353, DOI 10.1023/A:1026426132174; Prietzel J, 2008, EUR J FOREST RES, V127, P43, DOI 10.1007/s10342-007-0181-7; Rizvi SH, 2012, APPL SOIL ECOL, V62, P81, DOI 10.1016/j.apsoil.2012.07.014; RODHE H, 1988, ACIDIFICATION TROPIC; Rosenberg W, 2003, SOIL BIOL BIOCHEM, V35, P155, DOI 10.1016/S0038-0717(02)00250-X; Seftigen K, 2013, EUR J FOREST RES, V132, P83, DOI 10.1007/s10342-012-0657-y; Sikstrom U, 1997, FOREST ECOL MANAG, V95, P261, DOI 10.1016/S0378-1127(97)00025-X; Staszewski T, 2012, EUR J FOREST RES, V131, P1163, DOI 10.1007/s10342-011-0587-0; Stofko P., 2010, Journal of Forest Science (Prague), V56, P353, DOI 10.17221/108/2009-JFS; Teng XR, 2005, FOREST INVENTORY PLA, V30, P73; Tkacz B, 2008, ENVIRON POLLUT, V155, P409, DOI 10.1016/j.envpol.2008.03.003; TVEITE B, 1990, WATER AIR SOIL POLL, V54, P409; ULRICH B, 1990, ENVIRON SCI TECHNOL, V24, P436, DOI 10.1021/es00074a002; Vogt RD, 2007, APPL GEOCHEM, V22, P1140, DOI 10.1016/j.apgeochem.2007.03.005; Wang YH, 2007, FOREST ECOL MANAG, V242, P530, DOI 10.1016/j.foreco.2007.01.065; Wu ZY, 1980, PLANTS CHINA; Zhao DW, 2001, WATER AIR SOIL POLL, V130, P1733; ZHAO DW, 1988, ATMOS ENVIRON, V22, P349, DOI 10.1016/0004-6981(88)90040-6; ZHAO DW, 1991, WATER AIR SOIL POLL, V60, P83, DOI 10.1007/BF00293967	66	28	28	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94230	10.1371/journal.pone.0094230	http://dx.doi.org/10.1371/journal.pone.0094230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728089	gold, Green Submitted, Green Published			2022-12-25	WOS:000336736200049
J	Paula, AA; Schechter, M; Tuboi, SH; Faulhaber, JC; Luz, PM; Veloso, VG; Moreira, RI; Grinsztejn, B; Harrison, LH; Pacheco, AG				Paula, Adelzon A.; Schechter, Mauro; Tuboi, Suely H.; Faulhaber, Jose Claudio; Luz, Paula M.; Veloso, Valdilea G.; Moreira, Ronaldo I.; Grinsztejn, Beatriz; Harrison, Lee H.; Pacheco, Antonio G.			Continuous Increase of Cardiovascular Diseases, Diabetes, and Non-HIV Related Cancers as Causes of Death in HIV-Infected Individuals in Brazil: An Analysis of Nationwide Data	PLOS ONE			English	Article							RIO-DE-JANEIRO; HIGH-INCOME COUNTRIES; ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; HAART ERA; MORTALITY; AIDS; TUBERCULOSIS; TRENDS	Introduction: After antiretroviral therapy (ART) became available, there was a decline in the number of deaths in persons infected with HIV. Thereafter, there was a decrease in the proportion of deaths attributed to opportunistic infections and an increase in the proportion of deaths attributed to chronic comorbidities. Herein we extend previous observations from a nationwide survey on temporal trends in causes of death in HIV-infected patients in Brazil. Methods: We describe temporal trends in causes of death among adults who had HIV/AIDS listed in the death certificate to those who did not. All death certificates issued in Brazil from 1999 to 2011 and listed in the national mortality database were included. Generalized linear mixed-effects logistic models were used to study temporal trends in proportions. Results: In the HIV-infected population, there was an annual adjusted average increase of 6.0%, 12.0%, 4.0% and 4.1% for cancer, external causes, cardiovascular diseases (CVD) and diabetes mellitus (DM), respectively, compared to 3.0%, 4.0%, 1.0% and 3.9%, in the non-HIV group. For tuberculosis (TB), there was an adjusted average increase of 0.3%/year and a decrease of 3.0%/year in the HIV and the non-HIV groups, respectively. Compared to 1999, the odds ratio (OR) for cancer, external causes, CVD, DM, or TB in the HIV group were, respectively, 2.31, 4.17, 1.76, 2.27 and 1.02, while for the non-HIV group, the corresponding OR were 1.31, 1.63, 1.14, 1.62 and 0.67. Interactions between year as a continuous or categorical variable and HIV were significant (p<0.001) for all conditions, except for DM when year was considered as a continuous variable (p = 0.76). Conclusions: Non HIV-related co-morbidities continue to increase more rapidly as causes of death among HIV-infected individuals than in those without HIV infection, highlighting the need for targeting prevention measures and surveillance for chronic diseases among those patients.	[Paula, Adelzon A.; Pacheco, Antonio G.] Fundacao Oswaldo Cruz, Programa Comp, Rio De Janeiro, Brazil; [Schechter, Mauro] Univ Fed Rio de Janeiro, Projeto Praca Onze, Hosp Escola Sao Francisco de Assis, Rio De Janeiro, Brazil; [Tuboi, Suely H.] GlaxoSmithKline, Rio De Janeiro, Brazil; [Faulhaber, Jose Claudio] Univ Estado Rio de Janeiro, Inst Matemat & Estat, BR-20550011 Rio De Janeiro, Brazil; [Luz, Paula M.; Veloso, Valdilea G.; Moreira, Ronaldo I.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Harrison, Lee H.] Univ Pittsburgh, Grad Sch Publ Hlth, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA; [Harrison, Lee H.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; GlaxoSmithKline; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pacheco, AG (corresponding author), Fundacao Oswaldo Cruz, Programa Comp, Rio De Janeiro, Brazil.	apacheco@fiocruz.br	Pacheco, Antonio Guilherme/E-6378-2013; Schechter, Mauro/AAG-7445-2020	Pacheco, Antonio Guilherme/0000-0003-3095-1774; Luz, Paula/0000-0001-9746-719X	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Capes; GlaxoSmithKline Group	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); GlaxoSmithKline Group(GlaxoSmithKline)	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ (www.faperj.br); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Capes (www.capes.gov.br). GlaxoSmithKline Group provided support in the form of a salary for author SHT (for part of the duration of this study), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Cortes CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074057; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Rezende ELLF, 2010, BRAZ J INFECT DIS, V14, P558, DOI [10.1016/S1413-8670(10)70112-4, 10.1590/S1413-86702010000600003]; Lee SH, 2013, J KOREAN MED SCI, V28, P67, DOI 10.3346/jkms.2013.28.1.67; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2011, AIDS RES HUM RETROV, V27, P25, DOI 10.1089/aid.2010.0089; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003132; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Stewart A, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/390406; Wolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494; Yang CH, 2008, HIV MED, V9, P535, DOI 10.1111/j.1468-1293.2008.00600.x	24	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94636	10.1371/journal.pone.0094636	http://dx.doi.org/10.1371/journal.pone.0094636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728320	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200113
J	Peng, J; Zeng, J; Cai, B; Yang, H; Cohen, MJ; Chen, W; Sun, MW; Lu, CD; Jiang, H				Peng, Jin; Zeng, Jun; Cai, Bin; Yang, Hao; Cohen, Mitchell Jay; Chen, Wei; Sun, Ming-Wei; Lu, Charles Damien; Jiang, Hua			Establishment of Quantitative Severity Evaluation Model for Spinal Cord Injury by Metabolomic Fingerprinting	PLOS ONE			English	Article							PROTEIN-TYROSINE NITRATION; ORNITHINE-DECARBOXYLASE ACTIVITY; MANGANESE SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; NITRIC-OXIDE; GLUCOSE; PEROXYNITRITE; TESTOSTERONE; INACTIVATION; HORMONE	Spinal cord injury (SCI) is a devastating event with a limited hope for recovery and represents an enormous public health issue. It is crucial to understand the disturbances in the metabolic network after SCI to identify injury mechanisms and opportunities for treatment intervention. Through plasma 1H-nuclear magnetic resonance (NMR) screening, we identified 15 metabolites that made up an "Eigen-metabolome'' capable of distinguishing rats with severe SCI from healthy control rats. Forty enzymes regulated these 15 metabolites in the metabolic network. We also found that 16 metabolites regulated by 130 enzymes in the metabolic network impacted neurobehavioral recovery. Using the Eigen-metabolome, we established a linear discrimination model to cluster rats with severe and mild SCI and control rats into separate groups and identify the interactive relationships between metabolic biomarkers in the global metabolic network. We identified 10 clusters in the global metabolic network and defined them as distinct metabolic disturbance domains of SCI. Metabolic paths such as retinal, glycerophospholipid, arachidonic acid metabolism; NAD-NADPH conversion process, tyrosine metabolism, and cadaverine and putrescine metabolism were included. In summary, we presented a novel interdisciplinary method that integrates metabolomics and global metabolic network analysis to visualize metabolic network disturbances after SCI. Our study demonstrated the systems biological study paradigm that integration of 1H-NMR, metabolomics, and global metabolic network analysis is useful to visualize complex metabolic disturbances after severe SCI. Furthermore, our findings may provide a new quantitative injury severity evaluation model for clinical use.	[Peng, Jin; Zeng, Jun; Cai, Bin; Yang, Hao; Cohen, Mitchell Jay; Chen, Wei; Lu, Charles Damien; Jiang, Hua] Sichuan Acad Med Sci, Program Computat Biol Syst Biol & Translat Res, Metabol & Multidisciplinary Lab Trauma Res, Inst Disaster & Emergency Med,Sichuan Prov People, Chengdu, Sichuan, Peoples R China; [Zeng, Jun; Cai, Bin; Sun, Ming-Wei; Jiang, Hua] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Trauma Surg, Chengdu, Sichuan, Peoples R China; [Yang, Hao; Jiang, Hua] Sichuan Acad Med Sci, Dept Computat Math & Biostat, Metabol & Multidisciplinary Lab Trauma Res, Inst Disaster & Emergency Med,Sichuan Prov People, Chengdu, Sichuan, Peoples R China; [Peng, Jin; Cohen, Mitchell Jay] Univ Calif San Francisco, Dept Surg, San Francisco Gen Hosp, San Francisco, CA USA; [Chen, Wei] Beijing Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jiang, H (corresponding author), Sichuan Acad Med Sci, Program Computat Biol Syst Biol & Translat Res, Metabol & Multidisciplinary Lab Trauma Res, Inst Disaster & Emergency Med,Sichuan Prov People, Chengdu, Sichuan, Peoples R China.	cdjianghua@gmail.com	Jiang, Hua/ABE-5811-2021	Jiang, Hua/0000-0003-1465-0170	Sichuan Department of Science and Technology [2011SZ0139, 2011SZ0336, 2012SZ0181, SZ20120209]; Bureau of Science and Technology of Chengdu [12PPYB181SF-002, 11PPYB099SF-289]; Sichuan Department of Health [090442, 100552, 100553]; China Scholarship Council [201206245103]	Sichuan Department of Science and Technology; Bureau of Science and Technology of Chengdu; Sichuan Department of Health; China Scholarship Council(China Scholarship Council)	This work was supported by grants from the Sichuan Department of Science and Technology (No. 2011SZ0139, 2011SZ0336, 2012SZ0181 and SZ20120209), the Bureau of Science and Technology of Chengdu (No. 12PPYB181SF-002 and 11PPYB099SF-289), and grants from the Sichuan Department of Health (No. 090442, No. 100552, and No. 100553). Dr. Jin Peng is supported by China Scholarship Council (No: 201206245103). The funders did not contribute to the study design, data collection and analysis, decision to publish, or manuscript preparation.	Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Biering-Sorensen B, 2009, MUSCLE NERVE, V40, P499, DOI 10.1002/mus.21391; BUGARESTI JM, 1992, PARAPLEGIA, V30, P401, DOI 10.1038/sc.1992.90; Clark MJ, 2008, AM J PHYS MED REHAB, V87, P758, DOI 10.1097/PHM.0b013e3181837f4f; de Groot S, 2008, SPINAL CORD, V46, P344, DOI 10.1038/sj.sc.3102147; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; DUCKWORTH WC, 1983, ARCH PHYS MED REHAB, V64, P107; Fujieda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043152; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GONZALEZ S, 1995, J STEROID BIOCHEM, V55, P85, DOI 10.1016/0960-0760(95)00160-2; Good PF, 1996, AM J PATHOL, V149, P21; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Huang TS, 1998, AM J PHYS MED REHAB, V77, P108, DOI 10.1097/00002060-199803000-00005; Jeon JY, 2002, SPINAL CORD, V40, P110, DOI 10.1038/sj.sc.3101260; Jiang H, 2010, CHINESE MED J-PEKING, V123, P2315, DOI 10.3760/cma.j.issn.0366-6999.2010.17.006; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; LeBrasseur NK, 2011, AM J PHYSIOL-ENDOC M, V300, pE3, DOI 10.1152/ajpendo.00512.2010; Li J., 2004, CHIN J REHABIL THEOR, V10, P412; Liu B, 2009, BBA-PROTEINS PROTEOM, V1794, P476, DOI 10.1016/j.bbapap.2008.12.008; Long YC, 2011, J APPL PHYSIOL, V110, P1204, DOI 10.1152/japplphysiol.00686.2010; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; Nemunaitis GA, 2010, PM&R, V2, P202, DOI 10.1016/j.pmrj.2010.01.010; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Toborek M, 1999, J NEUROCHEM, V73, P684, DOI 10.1046/j.1471-4159.1999.0730684.x; TSITOURAS PD, 1995, HORM METAB RES, V27, P287, DOI 10.1055/s-2007-979961; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405	35	18	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93736	10.1371/journal.pone.0093736	http://dx.doi.org/10.1371/journal.pone.0093736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727691	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200023
J	Re, MA; Azad, RK				Re, Miguel A.; Azad, Rajeev K.			Generalization of Entropy Based Divergence Measures for Symbolic Sequence Analysis	PLOS ONE			English	Article							JENSEN-SHANNON DIVERGENCE; SEGMENTATION; EDGE	Entropy based measures have been frequently used in symbolic sequence analysis. A symmetrized and smoothed form of Kullback-Leibler divergence or relative entropy, the Jensen-Shannon divergence (JSD), is of particular interest because of its sharing properties with families of other divergence measures and its interpretability in different domains including statistical physics, information theory and mathematical statistics. The uniqueness and versatility of this measure arise because of a number of attributes including generalization to any number of probability distributions and association of weights to the distributions. Furthermore, its entropic formulation allows its generalization in different statistical frameworks, such as, non-extensive Tsallis statistics and higher order Markovian statistics. We revisit these generalizations and propose a new generalization of JSD in the integrated Tsallis and Markovian statistical framework. We show that this generalization can be interpreted in terms of mutual information. We also investigate the performance of different JSD generalizations in deconstructing chimeric DNA sequences assembled from bacterial genomes including that of E. coli, S. enterica typhi, Y. pestis and H. influenzae. Our results show that the JSD generalizations bring in more pronounced improvements when the sequences being compared are from phylogenetically proximal organisms, which are often difficult to distinguish because of their compositional similarity. While small but noticeable improvements were observed with the Tsallis statistical JSD generalization, relatively large improvements were observed with the Markovian generalization. In contrast, the proposed Tsallis-Markovian generalization yielded more pronounced improvements relative to the Tsallis and Markovian generalizations, specifically when the sequences being compared arose from phylogenetically proximal organisms.	[Re, Miguel A.] Univ Tecnol Nacl, CIII Fac Reg Cordoba, Dept Ciencias Basicas, Cordoba, Argentina; [Re, Miguel A.] Univ Nacl Cordoba, Fac Matemat Astron & Fis, RA-5000 Cordoba, Argentina; [Azad, Rajeev K.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Azad, Rajeev K.] Univ N Texas, Dept Math, Denton, TX 76203 USA	National University of Cordoba; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Azad, RK (corresponding author), Univ Tecnol Nacl, CIII Fac Reg Cordoba, Dept Ciencias Basicas, Cordoba, Argentina.	Rajeev.Azad@unt.edu			UTN, FRC [UTI1655]; faculty start-up fund; JFSRF award from the University of North Texas	UTN, FRC; faculty start-up fund; JFSRF award from the University of North Texas	This work was supported by grant UTI1655, UTN, FRC to M. A. R., and a faculty start-up fund and 2013 JFSRF award from the University of North Texas to R. K. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo JC, 2010, PHYSICA A, V389, P899, DOI 10.1016/j.physa.2009.10.023; Arvey AJ, 2009, NUCLEIC ACIDS RES, V37, P5255, DOI 10.1093/nar/gkp576; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Azad RK, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks917; Azad RK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031913; Azad RK, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051909; BernaolaGalvan P, 1996, PHYS REV E, V53, P5181, DOI 10.1103/PhysRevE.53.5181; Borges EP, 2004, PHYSICA A, V340, P95, DOI 10.1016/j.physa.2004.03.082; BURBEA J, 1982, IEEE T INFORM THEORY, V28, P489, DOI 10.1109/TIT.1982.1056497; Carpena P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031908; Carpena P, 1999, PHYS REV B, V60, P201, DOI 10.1103/PhysRevB.60.201; Cover TM, 1991, ELEMENTS INFORM THEO; Elhaik E, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq532; Gell-Mann M., 2004, NONEXTENSIVE ENTROPY; Gomez-Lopera JF, 2000, J MATH IMAGING VIS, V13, P35, DOI 10.1023/A:1008325607354; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Lamberti PW, 2003, PHYSICA A, V329, P81, DOI 10.1016/S0378-4371(03)00566-1; LI W, 2001, DELINEATING RELATIVE; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Thakur V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011915; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYS REV E, V58, P1442, DOI 10.1103/PhysRevE.58.1442	23	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93532	10.1371/journal.pone.0093532	http://dx.doi.org/10.1371/journal.pone.0093532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728338	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200019
J	Tian, C; Yan, RN; Wen, SZ; Li, XL; Li, TF; Cai, ZM; Li, XX; Du, H; Chen, HM				Tian, Chen; Yan, Rengna; Wen, Shuzhen; Li, Xueling; Li, Tianfeng; Cai, Zhenming; Li, Xinxiu; Du, Hong; Chen, Huimei			A Splice Mutation and mRNA Decay of EXT2 Provoke Hereditary Multiple Exostoses	PLOS ONE			English	Article							HEPARAN-SULFATE; NONSENSE MUTATIONS; TUMOR SUPPRESSORS; GENE; HAPLOINSUFFICIENCY; OSTEOCHONDROMAS; TRANSLATION; MECHANISM; CLONING; FAMILY	Background: Hereditary multiple exostoses (HME) is an autosomal dominant disease. The classical paradigm of mutation screening seeks to relate alterations in the exostosin glycosyltransferase genes, EXT1 and EXT2, which are responsible for over 70% of HME cases. However, the pathological significance of the majority of these mutations is often unclear. Methods: In a Chinese family with HME, EXT1 and EXT2 genes were screened by direct sequencing. The consequence of a detected mutant was predicted by in silico analysis and confirmed by mRNA analysis. The EXT1 and EXT2 mRNA and protein levels and the HS patterns in the HME patients were compared with those in healthy controls. Results: A heterozygous transition (c.743+ 1G>A) in the EXT2 gene, which co-segregated with the HME phenotype in this family, was identified. The G residue at position +1 in intron 4 of EXT2 was predicted to be a 59 donor splice site. The mRNA analysis revealed an alternative transcript with a cryptic splice site 5 bp downstream of the wild-type site, which harbored a premature stop codon. However, the predicted truncated protein was not detected by western blot analysis. Decay of the mutant mRNA was shown by clone sequencing and quantification analysis. The corresponding downregulation of the EXT2 mRNA will contribute to the abnormal EXT1/EXT2 ratio and HS pattern that were detected in the patients with HME. Conclusion: The heterozygous mutation c.743+1G>A in the EXT2 gene causes HME as a result of abnormal splicing, mRNA decay, and the resulting haploinsufficiency of EXT2.	[Tian, Chen; Wen, Shuzhen; Li, Xueling; Li, Tianfeng; Cai, Zhenming; Li, Xinxiu; Chen, Huimei] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Tian, Chen; Wen, Shuzhen; Li, Xueling; Li, Tianfeng; Cai, Zhenming; Li, Xinxiu; Chen, Huimei] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Yan, Rengna; Du, Hong] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Du, H (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	duhong5@126.com; chenhuimei@nju.edu.cn		Chen, Huimei/0000-0001-7788-1334; Yan, Rengna/0000-0002-1755-3045	National Natural Science Foundation of China [81370788]; Jiangsu "Six Major Talent Summit" [WSN-071]; national undergraduate training programs for innovation and entrepreneurship [G1210284107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu "Six Major Talent Summit"; national undergraduate training programs for innovation and entrepreneurship	This work was supported by National Natural Science Foundation of China (grant number 81370788), Jiangsu "Six Major Talent Summit" (grant number WSN-071) and national undergraduate training programs for innovation and entrepreneurship (grant number G1210284107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bovee JV, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-3; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Divina P, 2009, EUR J HUM GENET, V17, P759, DOI 10.1038/ejhg.2008.257; Fang P, 2009, J CLIN ENDOCR METAB, V94, P1740, DOI 10.1210/jc.2008-1903; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; Heinritz W, 2009, ANN HUM GENET, V73, P283, DOI 10.1111/j.1469-1809.2009.00508.x; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; Li YC, 2009, GENET TEST MOL BIOMA, V13, P825, DOI 10.1089/gtmb.2009.0083; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McCormick C, 2000, REV MED VIROL, V10, P373, DOI 10.1002/1099-1654(200011/12)10:6<373::AID-RMV291>3.0.CO;2-N; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pannier S, 2008, BEST PRACT RES CL RH, V22, P45, DOI 10.1016/j.berh.2007.12.004; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; SUGIURA Y, 1976, JPN J HUM GENET, V21, P149; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vink GR, 2005, EUR J HUM GENET, V13, P470, DOI 10.1038/sj.ejhg.5201343; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wu YH, 2013, J ORTHOP RES, V31, P1492, DOI 10.1002/jor.22378; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547; Xia CY, 2001, BRIT J CANCER, V85, P176, DOI 10.1054/bjoc.2001.1880; Yang L, 2010, J ORTHOP RES, V28, P1522, DOI 10.1002/jor.21162	33	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94848	10.1371/journal.pone.0094848	http://dx.doi.org/10.1371/journal.pone.0094848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728384	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200134
J	Wendling, CC; Batista, FM; Wegner, KM				Wendling, Carolin C.; Batista, Frederico M.; Wegner, K. Mathias			Persistence, Seasonal Dynamics and Pathogenic Potential of Vibrio Communities from Pacific Oyster Hemolymph	PLOS ONE			English	Article							CRASSOSTREA-GIGAS THUNBERG; MULTIPLE SEQUENCE ALIGNMENT; SUMMER MORTALITY; PENAEUS-MONODON; GENOTYPIC DIVERSITY; BACILLARY NECROSIS; INTERACTIVE TREE; MASS MORTALITY; SPLENDIDUS; STRAINS	Bacteria of the genus Vibrio occur at a continuum from free-living to symbiotic life forms, including opportunists and pathogens, that can contribute to severe diseases, for instance summer mortality events of Pacific oysters Crassostrea gigas. While most studies focused on Vibrio isolated from moribund oysters during mortality outbreaks, investigations of the Vibrio community in healthy oysters are rare. Therefore, we characterized the persistence, diversity, seasonal dynamics, and pathogenicity of the Vibrio community isolated from healthy Pacific oysters. In a reciprocal transplant experiment we repeatedly sampled hemolymph from adult Pacific oysters to differentiate population from site-specific effects during six months of in situ incubation in the field. We characterized virulence phenotypes and genomic diversity based on multilocus sequence typing in a total of 70 Vibrio strains. Based on controlled infection experiments we could show that strains with the ability to colonize healthy adult oysters can also have the potential to induce high mortality rates on larvae. Diversity and abundance of Vibrio varied significantly over time with highest values during and after spawning season. Vibrio communities from transplanted and stationary oysters converged over time, indicating that communities were not population specific, but rather assemble from the surrounding environment forming communities, some of which can persist over longer periods.	[Wendling, Carolin C.; Wegner, K. Mathias] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Wadden Sea Stn Sylt, Schleswig Holstein, Germany; [Batista, Frederico M.] Inst Portugues Mar & Atmosfera, Estacao Moluscicultura Tavira, Olhao, Portugal	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Instituto Portugues do Mar e da Atmosfera	Wendling, CC (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Evolutionary Ecol Marine Fish Kiel FB3, Schleswig Holstein, Germany.	carolin.wendling@awi.de	Batista, Frederico/F-5651-2010; Wegner, K. Mathias/P-1149-2015	Batista, Frederico/0000-0002-2848-3011; Wegner, K. Mathias/0000-0002-2410-8898; Wendling, Carolin/0000-0003-4532-7528	Deutsche Forschungsgesellschaft [WE464-1]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgesellschaft, Emmy-Noether Grant WE464-1 given to KMW. http://www.dfg.de/foerderung/Programme/einzelfoerderung/emmy_noether/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guisande JA, 2008, J SHELLFISH RES, V27, P801, DOI 10.2983/0730-8000(2008)27[801:GDOCVS]2.0.CO;2; Austin B, 1997, SYST APPL MICROBIOL, V20, P89, DOI 10.1016/S0723-2020(97)80053-7; Beaz-Hidalgo R, 2010, ENV MICROBIOL REP, V2, P34, DOI 10.1111/j.1758-2229.2010.00135.x; Boer SI, 2013, MICROB ECOL, V65, P1052, DOI 10.1007/s00248-013-0221-4; BUCHRIESER C, 1995, APPL ENVIRON MICROB, V61, P1163, DOI 10.1128/AEM.61.3.1163-1168.1995; BUROKER NE, 1979, MAR BIOL, V54, P157, DOI 10.1007/BF00386595; Cheney DP, 2000, J SHELLFISH RES, V19, P353; DISALVO LH, 1978, APPL ENVIRON MICROB, V35, P219, DOI 10.1128/AEM.35.1.219-221.1978; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EFSA (European Food Safety Association), 2011, EUROPEAN FOOD SAFETY, V8, P1894; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Estes RM, 2004, DIS AQUAT ORGAN, V58, P223, DOI 10.3354/dao058223; FAO (Food and Agriculture Organization of the United Nations), 2011, YB FISH STAT SUMM TA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gomez-Gil B, 2010, J APPL MICROBIOL, V109, P918, DOI 10.1111/j.1365-2672.2010.04718.x; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; Goulletquer P., 1998, SUMMER MORTALITY PAC; GROUBERT TN, 1994, J FOOD PROTECT, V57, P224, DOI 10.4315/0362-028X-57.3.224; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HADA HS, 1984, INT J SYST BACTERIOL, V34, P1, DOI 10.1099/00207713-34-1-1; Haldar S, 2011, MICROBIOL-SGM, V157, P179, DOI 10.1099/mic.0.041475-0; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hidalgo RB, 2008, SYST APPL MICROBIOL, V31, P215, DOI 10.1016/j.syapm.2008.04.001; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Imai T, 1965, B TOHOKU NATL FISHER, V25, P27; Jackson JK, 1997, J CLIN MICROBIOL, V35, P2098, DOI 10.1128/JCM.35.8.2098-2101.1997; JEFFRIES VE, 1982, AQUACULTURE, V29, P201, DOI 10.1016/0044-8486(82)90136-3; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Lacoste A, 2001, DIS AQUAT ORGAN, V46, P139, DOI 10.3354/dao046139; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; LAVILLAPITOGO CR, 1990, AQUACULTURE, V91, P1, DOI 10.1016/0044-8486(90)90173-K; Le Roux F, 2002, AQUAT LIVING RESOUR, V15, P251, DOI 10.1016/S0990-7440(02)01176-2; Leano EM, 1998, AQUACULTURE, V164, P367, DOI 10.1016/S0044-8486(98)00201-4; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li Y, 2007, AM J PHYSIOL-REG I, V293, pR2353, DOI 10.1152/ajpregu.00463.2007; Li Y, 2009, AQUACULTURE, V293, P164, DOI 10.1016/j.aquaculture.2009.04.044; Li Y, 2009, AQUACULTURE, V286, P309, DOI 10.1016/j.aquaculture.2008.09.035; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maeda T, 2003, FISHERIES SCI, V69, P385, DOI 10.1046/j.1444-2906.2003.00633.x; Malham SK, 2009, AQUACULTURE, V287, P128, DOI 10.1016/j.aquaculture.2008.10.006; Oberbeckmann S, 2012, MICROB ECOL, V63, P543, DOI 10.1007/s00248-011-9990-9; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; PERDUE J A, 1981, Journal of Shellfish Research, V1, P9; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Pruzzo C, 2005, ENVIRON MICROBIOL, V7, P761, DOI 10.1111/j.1462-2920.2005.00792.x; Pruzzo C, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P217; RENAULT T, 1994, REV MED VET-TOULOUSE, V145, P735; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Saulnier D, 2010, MICROB ECOL, V59, P787, DOI 10.1007/s00248-009-9620-y; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soletchnik P, 2005, J SHELLFISH RES, V24, P197; Sugumar G, 1998, DIS AQUAT ORGAN, V33, P111, DOI 10.3354/dao033111; Thieltges DW, 2013, J SEA RES, V82, P122, DOI 10.1016/j.seares.2012.06.002; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; TUBIASH HS, 1970, J BACTERIOL, V103, P271, DOI 10.1128/JB.103.1.271-272.1970; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Waechter M, 2002, CR BIOL, V325, P231, DOI 10.1016/S1631-0691(02)01428-2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watermann BT, 2008, J FISH DIS, V31, P621, DOI 10.1111/j.1365-2761.2008.00953.x; Wegner KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-252; Wendling CC, 2013, AQUACULTURE, V412, P88, DOI 10.1016/j.aquaculture.2013.07.009	75	63	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94256	10.1371/journal.pone.0094256	http://dx.doi.org/10.1371/journal.pone.0094256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728233	Green Published, gold, Green Accepted			2022-12-25	WOS:000336736200053
J	Young, BN; Rendon, A; Rosas-Taraco, A; Baker, J; Healy, M; Gross, JM; Long, J; Burgos, M; Hunley, KL				Young, Bonnie N.; Rendon, Adrian; Rosas-Taraco, Adrian; Baker, Jack; Healy, Meghan; Gross, Jessica M.; Long, Jeffrey; Burgos, Marcos; Hunley, Keith L.			The Effects of Socioeconomic Status, Clinical Factors, and Genetic Ancestry on Pulmonary Tuberculosis Disease in Northeastern Mexico	PLOS ONE			English	Article							SLC11A1 FORMERLY NRAMP1; RISK-FACTORS; PROMOTER POLYMORPHISM; SOCIAL DETERMINANTS; MULTILEVEL ANALYSIS; SOUTHERN MEXICO; UNITED-STATES; HUMAN GENOME; ASSOCIATION; SUSCEPTIBILITY	Diverse socioeconomic and clinical factors influence susceptibility to tuberculosis (TB) disease in Mexico. The role of genetic factors, particularly those that differ between the parental groups that admixed in Mexico, is unclear. The objectives of this study are to identify the socioeconomic and clinical predictors of the transition from latent TB infection (LTBI) to pulmonary TB disease in an urban population in northeastern Mexico, and to examine whether genetic ancestry plays an independent role in this transition. We recruited 97 pulmonary TB disease patients and 97 LTBI individuals from a public hospital in Monterrey, Nuevo Leon. Socioeconomic and clinical variables were collected from interviews and medical records, and genetic ancestry was estimated for a subset of 142 study participants from 291,917 single nucleotide polymorphisms (SNPs). We examined crude associations between the variables and TB disease status. Significant predictors from crude association tests were analyzed using multivariable logistic regression. We also compared genetic ancestry between LTBI individuals and TB disease patients at 1,314 SNPs in 273 genes from the TB biosystem in the NCBI BioSystems database. In crude association tests, 12 socioeconomic and clinical variables were associated with TB disease. Multivariable logistic regression analyses indicated that marital status, diabetes, and smoking were independently associated with TB status. Genetic ancestry was not associated with TB disease in either crude or multivariable analyses. Separate analyses showed that LTBI individuals recruited from hospital staff had significantly higher European genetic ancestry than LTBI individuals recruited from the clinics and waiting rooms. Genetic ancestry differed between individuals with LTBI and TB disease at SNPs located in two genes in the TB biosystem. These results indicate that Monterrey may be structured with respect to genetic ancestry, and that genetic differences in TB susceptibility in parental populations may contribute to variation in disease susceptibility in the region.	[Young, Bonnie N.; Healy, Meghan; Gross, Jessica M.; Long, Jeffrey; Hunley, Keith L.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Rendon, Adrian] Univ Autonoma Nuevo Leon, Hosp Jose E Gonzalez, TB Clin, Monterrey, Nuevo Leon, Mexico; [Rosas-Taraco, Adrian] Univ Autonoma Nuevo Leon, Sch Med, Dept Immunol, Monterrey, Nuevo Leon, Mexico; [Baker, Jack] Univ New Mexico, Albuquerque, NM 87131 USA; [Burgos, Marcos] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University of New Mexico; University of New Mexico	Young, BN (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	byoung@salud.unm.edu; khunley@unm.edu	Rendon, Adrian/S-1531-2017; Young, Bonnie Nadyne/W-5226-2019; A., Rendon/AAE-5931-2021	Rendon, Adrian/0000-0001-8973-4024; A., Rendon/0000-0001-8973-4024; Gross, Jessica/0000-0002-5221-8218; Hunley, Keith/0000-0003-0987-8277; Young, Bonnie/0000-0002-6524-2348	Wenner-Gren Foundation for Anthropological Research [GR8044]; UNM Dept. of Anthropology [09]; UNM Latin American and Iberian Institute; UNM Office of Graduate Studies (GPSA-ST-SRAC); UNM Institute of Public Health (Rosenblatt and Lenneberg Endowment for TB Research)	Wenner-Gren Foundation for Anthropological Research; UNM Dept. of Anthropology; UNM Latin American and Iberian Institute; UNM Office of Graduate Studies (GPSA-ST-SRAC); UNM Institute of Public Health (Rosenblatt and Lenneberg Endowment for TB Research)	Funding sources: Wenner-Gren Foundation for Anthropological Research (Grant #GR8044, http://www.wennergren.org/); UNM Dept. of Anthropology (Field Site Development Grant 09, http://www.unm.edu/similar to anthro/pdf/grad/Grad%20funding%20guide13-14.pdf); UNM Latin American and Iberian Institute (Dissertation Fellowship 2010-2012, http://laii.unm.edu/); UNM Office of Graduate Studies (GPSA-ST-SRAC Grants, http://grad.unm.edu/funding/index.html); UNM Institute of Public Health (Rosenblatt and Lenneberg Endowment for TB Research 2009, http://hsc.unm.edu/community/iph/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMAI, 2009, AS MEX AG INV OP PUB; [Anonymous], WHO REP 2011 GLOB TU; Ates O, 2009, INT J IMMUNOGENET, V36, P15, DOI 10.1111/j.1744-313X.2008.00814.x; Awomoyi AA, 2002, J INFECT DIS, V186, P1808, DOI 10.1086/345920; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brewer TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025861; Caminero Luna JA, 2003, TUBERCULOSIS GUIDE S; Cann HM, 2002, SCIENCE, V296, P261; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; CDC, 2011, TUB SKIN TEST; CDC, 2012, REP TUB US 2011; Garcia-Sancho MC, 2009, REV INVEST CLIN, V61, P392; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P257, DOI 10.1002/ajhb.10020; Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P429, DOI 10.1002/ajhb.10058; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Davoodi-Semiromi A, 2002, DIABETES, V51, P2334, DOI 10.2337/diabetes.51.7.2334; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; ENDSA, 2008, BOL ENC NAC DEM SAL; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Garza G, 1996, ENVIRON URBAN, V8, P31, DOI 10.1177/095624789600800208; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gorodezky C, 2001, HUM IMMUNOL, V62, P979, DOI 10.1016/S0198-8859(01)00296-8; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Hirsch-Moverman Y, 2010, INT J TUBERC LUNG D, V14, P1104; Ho MJ, 2004, SOC SCI MED, V59, P753, DOI 10.1016/j.socscimed.2003.11.033; HORWITZ O, 1971, AM REV RESPIR DIS, V104, P22; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Illumina, 2012, HUMANCYTOSNP 12 DNA; Jin J, 2009, CLIN INFECT DIS, V48, P733, DOI 10.1086/597034; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Ladefoged K, 2011, INT J TUBERC LUNG D, V15, P44; Lei X, 2012, INFECT GENET EVOL; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Li XZ, 2011, FOOD ADDIT CONTAM A, V1, P1, DOI DOI 10.1002/T0X.20712; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lisker R, 1996, HUM BIOL, V68, P395; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Martinez-Fierro ML, 2009, J HUM GENET, V54, P504, DOI 10.1038/jhg.2009.65; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; Miao RF, 2011, TUBERCULOSIS, V91, P268, DOI 10.1016/j.tube.2011.01.006; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasanathan K, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P30, DOI 10.5588/ijtld.10.0691; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; Salud SD, 2011, SITUACION ACTUAL TUB; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sans M, 2000, HUM BIOL, V72, P155; Sharma S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-165; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Taype CA, 2006, INFECT GENET EVOL, V6, P361, DOI 10.1016/j.meegid.2006.01.002; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; Torche F, 2010, DEMOGRAPHY, V47, P481; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; UCSD, 2004, U CAL SAN DIEG TUB H; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; Wang XW, 2011, RESPIROLOGY, V16, P790, DOI 10.1111/j.1440-1843.2011.01976.x; WHO, 2012, TUB COUNTR PROF EP S; Yang ZH, 2001, INT J TUBERC LUNG D, V5, P313; Young F, 2010, J EPIDEMIOL COMMUNIT	81	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94303	10.1371/journal.pone.0094303	http://dx.doi.org/10.1371/journal.pone.0094303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3CI	24728409	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336736200059
J	Hsieh, MH; Tsai, JJ; Hsieh, MY; Huang, CF; Yeh, ML; Yang, JF; Chang, K; Lin, WR; Lin, CY; Chen, TC; Huang, JF; Dai, CY; Yu, ML; Chuang, WL				Hsieh, Meng-Hsuan; Tsai, Jih-Jin; Hsieh, Ming-Yen; Huang, Chung-Feng; Yeh, Ming-Lun; Yang, Jeng-Fu; Chang, Ko; Lin, Wei-Ru; Lin, Chun-Yu; Chen, Tun-Chieh; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long			Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection	PLOS ONE			English	Article							VIRAL-HEPATITIS; SOUTHERN TAIWAN; MOLECULAR EPIDEMIOLOGY; GENETIC-VARIATION; HIV-INFECTION; PREVALENCE; CLEARANCE; GENOTYPES; DISEASE; ANTIGEN	The aim of this study is to explore the prevalence of hepatitis C virus (HCV) infection among injection drug users (IDUs) with and without human immunodeficiency virus (HIV) infection in southern Taiwan. For 562 IDUs (265 anti-HIV negative, 297 anti-HIV positive), we analyzed liver function, anti-HIV antibody, anti-HCV antibody, HCV viral loads, and hepatitis B surface antigen (HBsAg). HIV RNA viral loads and CD4 cell count for anti-HIV-seropositive IDUs and the HCV genotype for HCV RNA-seropositive IDUs were measured. The seroprevalence rates of anti-HIV, anti-HCV, and HBsAg were 52.8%, 91.3%, and 15.3%, respectively. All the anti-HIV-seropositive IDUs were positive for HIV RNA. Anti-HCV seropositivity was the most important factor associated with HIV infection (odds ratio [OR], 25.06; 95% confidence intervals [CI], 8.97-74.9), followed by male gender (OR, 6.12; 95% CI, 4.05-9.39) and HBsAg seropositivity (OR, 1.90; 95% CI, 1.11-3.34). Among IDUs positive for anti-HCV, 80.7% had detectable HCV RNA. HCV viremia after HCV exposure was strongly related to HIV infection (OR, 6.262; 95% CI, 1.515-18.28), but negatively correlated to HBsAg seropositivity (OR, 0.161; 95% CI, 0.082-0.317). HCV genotype 6 was the most prevalent genotype among all IDUs (41.0%), followed by genotypes 1 (32.3%), 3 (12.8%), and 2 (5.6%). In conclusion, about half IDUs were infected with HIV and >90% with HCV infection. Male and seropositivity for HBsAg and anti-HCV were factors related to HIV infection among our IDUs. HIV was positively correlated, whereas hepatitis B co-infection was negatively correlated with HCV viremia among IDUs with HCV exposure. Different HCV molecular epidemiology was noted among IDUs.	[Hsieh, Meng-Hsuan; Yang, Jeng-Fu; Dai, Chia-Yen] Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan; [Hsieh, Meng-Hsuan; Tsai, Jih-Jin; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Med, Sch Med, Kaohsiung, Taiwan; [Tsai, Jih-Jin; Lin, Wei-Ru; Lin, Chun-Yu] Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ, Sch Med, Dept Internal Med, Coll Med, Kaohsiung, Taiwan; [Hsieh, Ming-Yen; Chen, Tun-Chieh] Kaohsiung Med Univ, Kaohsiung Muncipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Municipal Tatung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Ko; Huang, Jee-Fu] Kaohsiung Muncipal Hsiao Kang Hosp, Dept Med, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Yu, ML (corresponding author), Kaohsiung Med Univ, Fac Med, Sch Med, Kaohsiung, Taiwan.	fish6069@gmail.com	Hsieh, Meng Hsuan/AAY-7973-2021; Chen, Tun-Chieh/J-2877-2013; Chuang, Wan-Long/ABF-7427-2021; TSAI, JIH-JIN/GOP-2776-2022; Huang, Jee-Fu/AAX-4622-2020; Yu, Ming-Lung/AAZ-4306-2020	Chen, Tun-Chieh/0000-0002-9258-0692; Chuang, Wan-Long/0000-0002-2376-421X; TSAI, JIH-JIN/0000-0003-2226-8916; Huang, Jee-Fu/0000-0002-2752-7051; Yu, Ming-Lung/0000-0001-8145-1900; Chang, Ko/0000-0002-6447-8703; Hsieh, Meng-Hsuen/0000-0001-9739-3901	Taiwan Liver Research Foundation; Centers for Disease Control, ROC (Taiwan) [DOH97-DC-1004, DOH98-DC-1004, DOH99-DC-1004]	Taiwan Liver Research Foundation; Centers for Disease Control, ROC (Taiwan)	This study was supported by grants from the Taiwan Liver Research Foundation, and projects DOH97-DC-1004, DOH98-DC-1004, and DOH99-DC-1004 of the Centers for Disease Control, ROC (Taiwan) (http://www.cdc.gov.tw/english/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease contols ROC Taiwan, 2008, EFF CONTR HIV INF IN; Chang CJ, 1999, EUR J EPIDEMIOL, V15, P597, DOI 10.1023/A:1007662315835; Chang CJ, 1998, J FORMOS MED ASSOC, V97, P826; Chuang WL, 2005, ANTIVIR THER, V10, P125; Dai CY, 2007, GUT, V56, P737, DOI 10.1136/gut.2006.116384; Dai CY, 2010, J HEPATOL, V52, P160, DOI 10.1016/j.jhep.2009.11.017; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gish RG, 1997, VIRAL HEP REV, V3, P17; Goedert JJ, 2000, J INFECT DIS, V182, P590, DOI 10.1086/315712; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hung CC, 2005, INT J STD AIDS, V16, P42, DOI 10.1258/0956462052932629; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kumar Ramesh, 2008, Trop Gastroenterol, V29, P136; Lee CM, 2006, T ROY SOC TROP MED H, V100, P767, DOI 10.1016/j.trstmh.2005.10.008; Lee HC, 2008, J FORMOS MED ASSOC, V107, P404, DOI 10.1016/S0929-6646(08)60106-0; Lee YM, 2010, J INTERN MED TAIWAN, V21, P172; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; SHEEN IS, 1994, J INFECT DIS, V170, P358, DOI 10.1093/infdis/170.2.358; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tseng YT, 2012, J FORMOS MED ASSOC, V111, P431, DOI 10.1016/j.jfma.2011.06.022; UNAIDS, 2013, UNAIDS WORLD AIDS DA; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; WANG JT, 1995, J GASTROEN HEPATOL, V10, P454, DOI 10.1111/j.1440-1746.1995.tb01599.x; Yang CS, 2003, J FORMOS MED ASSOC, V102, P79; Yang JF, 2011, KAOHSIUNG J MED SCI, V27, P258, DOI 10.1016/j.kjms.2010.11.007; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Yu Ming-Lung, 1996, Kaohsiung Journal of Medical Sciences, V12, P605; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001	44	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94791	10.1371/journal.pone.0094791	http://dx.doi.org/10.1371/journal.pone.0094791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722534	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100133
J	Bini, EI; Espinosa, DM; Castillo, BM; Payan, JB; Colucci, D; Cruz, AF; Zatarain, ZL; Alfonseca, E; Pardo, MR; Bottasso, O; Pando, RH				Isabel Bini, Estela; Mata Espinosa, Dulce; Marquina Castillo, Brenda; Barrios Payan, Jorge; Colucci, Dario; Francisco Cruz, Alejandro; Lucia Zatarain, Zyanya; Alfonseca, Edgar; Romano Pardo, Marta; Bottasso, Oscar; Hernandez Pando, Rogelio			The Influence of Sex Steroid Hormones in the Immunopathology of Experimental Pulmonary Tuberculosis	PLOS ONE			English	Article							GENDER-DIFFERENCES; RISK-FACTORS; INFECTION; ESTROGEN; RESPONSES; IMMUNE; CELLS; RESISTANCE; MODULATE; GROWTH	The relation between men and women suffering pulmonary tuberculosis is 7/3 in favor to males. Sex hormones could be a significant factor for this difference, considering that testosterone impairs macrophage activation and pro-inflammatory cytokines production, while estrogens are proinflammatory mediator's inducer. The aim of this work was to compare the evolution of tuberculosis in male and female mice using a model of progressive disease. BALB/c mice, male and female were randomized into two groups: castrated or sham-operated, and infected by the intratracheal route with a high dose of Mycobacterium tuberculosis strain H37Rv. Mice were euthanized at different time points and in their lungs were determined bacilli loads, inflammation, cytokines expression, survival and testosterone levels in serum. Non-castrated male mice showed significant higher mortality and bacilli burdens during late disease than female and castrated male animals. Compared to males, females and castrated males exhibited significant higher inflammation in all lung compartments, earlier formation of granulomas and pneumonia, while between castrated and non-castrated females there were not significant differences. Females and castrated males expressed significant higher TNF-alpha, IFN gamma, IL12, iNOS and IL17 than non-castrated males during the first month of infection. Serum Testosterone of males showed higher concentration during late infection. Orchidectomy at day 60 post-infection produced a significant decrease of bacilli burdens in coexistence with higher expression of TNF alpha, IL12 and IFN gamma. Thus, male mice are more susceptible to tuberculosis than females and this was prevented by castration suggesting that testosterone could be a tuberculosis susceptibility factor.	[Isabel Bini, Estela; Mata Espinosa, Dulce; Marquina Castillo, Brenda; Barrios Payan, Jorge; Francisco Cruz, Alejandro; Lucia Zatarain, Zyanya; Alfonseca, Edgar; Hernandez Pando, Rogelio] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico; [Isabel Bini, Estela; Colucci, Dario; Bottasso, Oscar] Fac Med Sci, Inst Immunol, Rosario, Santa Fe, Argentina; [Romano Pardo, Marta] CINVESTAV, Dept Physiol & Biophys, Mexico City 14000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Pando, RH (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico.	rhdezpando@hotmail.com	Francisco-Cruz, Alejandro/AIC-9273-2022; Bini, Estela/F-8924-2018	Bini, Estela/0000-0001-9256-429X; Hernandez-Pando, Rogelio/0000-0003-1292-3833	University of United Nations (UNU_BIOLAC program); Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT [J000.345]; UNU-BIOLAC	University of United Nations (UNU_BIOLAC program); Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT; UNU-BIOLAC	This work was supported by grants from the University of United Nations (UNU_BIOLAC program), and Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT (contract: J000.345). E Bini was awarded with a Ph.D. scholarship from UNU-BIOLAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1985, AM J PATHOL, V121, P531; Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; BROWN IN, 1987, IMMUNOLOGY, V62, P587; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Bustamante J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043406; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; Cutolo M, 2002, ANN NY ACAD SCI, V966, P131, DOI 10.1111/j.1749-6632.2002.tb04210.x; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; EIDINGER D, 1972, J EXP MED, V136, P1098, DOI 10.1084/jem.136.5.1098; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; FOX HS, 1991, J IMMUNOL, V146, P4362; Hernandez Pando R, 1998, IMMUNOLOGY, V5, P234; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin CM, 2008, SLEEP MED REV, V12, P481, DOI 10.1016/j.smrv.2007.11.003; Martinez AN, 2000, INT J TUBERC LUNG D, V4, P26; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Okada M, 1997, CARDIOVASC RES, V34, P529, DOI 10.1016/S0008-6363(97)00060-6; Pando RH, 2010, INFECT IMMUN, V78, P3168, DOI 10.1128/IAI.00023-10; RHODES K, 1969, ANN RHEUM DIS, V28, P104, DOI 10.1136/ard.28.2.104; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Silver RF, 1998, J IMMUNOL, V160, P2408; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; Tsuyuguchi K, 2001, CLIN EXP IMMUNOL, V123, P428, DOI 10.1046/j.1365-2249.2001.01474.x; Uplekar M, 1999, WHOTB2000280; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; WHO, 2009, GLOB TUB CONTR 2009; YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; ZUCKERMAN SH, 1995, IMMUNOLOGY, V86, P18	45	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93831	10.1371/journal.pone.0093831	http://dx.doi.org/10.1371/journal.pone.0093831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722144	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100026
J	Li, XH; Yang, H; Huang, SM; Qiu, Y				Li, Xuehui; Yang, Hui; Huang, Suming; Qiu, Yi			Histone Deacetylase 1 and p300 Can Directly Associate with Chromatin and Compete for Binding in a Mutually Exclusive Manner	PLOS ONE			English	Article							GENE-TRANSCRIPTION; IN-VIVO; ACETYLATION; COMPLEX; RECRUITMENT; YEAST; METHYLATION; HDACS; DNA; PROMOTER	Lysine acetyltransferases (KATs) and histone deacetylases (HDACs) are important epigenetic modifiers and dynamically cycled on active gene promoters to regulate transcription. Although HDACs are recruited to gene promoters and DNA hypersensitive sites through interactions with DNA binding factors, HDAC activities are also found globally in intergenic regions where DNA binding factors are not present. It is suggested that HDACs are recruited to those regions through other distinct, yet undefined mechanisms. Here we show that HDACs can be directly recruited to chromatin in the absence of other factors through direct interactions with both DNA and core histone subunits. HDACs interact with DNA in a non-sequence specific manner. HDAC1 and p300 directly bind to the overlapping regions of the histone H3 tail and compete for histone binding. Previously we show that p300 can acetylate HDAC1 to attenuate deacetylase activity. Here we have further mapped two distinct regions of HDAC1 that interact with p300. Interestingly, these regions of HDAC1 also associate with histone H3. More importantly, p300 and HDAC1 compete for chromatin binding both in vitro and in vivo. Therefore, the mutually exclusive associations of HDAC1/p300, p300/histone, and HDAC1/histone on chromatin contribute to the dynamic regulation of histone acetylation by balancing HDAC or KAT activity present at histones to reorganize chromatin structure and regulate transcription.	[Li, Xuehui; Yang, Hui; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Qiu, Y (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, R01 HL091929, R01 HL 090589]; Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929, R01HL090589, R01HL095674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [R01 HL095674 to YQ, R01 HL091929 to SH, and R01 HL 090589 to SH]; and the Florida Bankhead Coley Research Foundation to YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WJ, 2003, J BIOL CHEM, V278, P1504, DOI 10.1074/jbc.M209355200; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Degenhardt T, 2009, J MOL BIOL, V388, P225, DOI 10.1016/j.jmb.2009.03.024; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Eckner R, 1996, BIOL CHEM, V377, P685; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Geisberg J. V., 2005, CURR PROTOC MOL BIOL, P8; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodman RH, 2000, GENE DEV, V14, P1553; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liu Y, 2012, J BIOL CHEM; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; RIKITAKE Y, 1992, MOL CELL BIOL, V12, P2826, DOI 10.1128/MCB.12.6.2826; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Simone C, 2004, ONCOGENE, V23, P2177, DOI 10.1038/sj.onc.1207327; Stavreva DA, 2012, BBA-GENE REGUL MECH, V1819, P657, DOI 10.1016/j.bbagrm.2012.03.004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	54	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94523	10.1371/journal.pone.0094523	http://dx.doi.org/10.1371/journal.pone.0094523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722339	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100089
J	Oladimeji, O; Isaakidis, P; Obasanya, OJ; Eltayeb, O; Khogali, M; Van den Bergh, R; Kumar, AMV; Hinderaker, SG; Abdurrahman, ST; Lawson, L; Cuevas, LE				Oladimeji, Olanrewaju; Isaakidis, Petros; Obasanya, Olusegun J.; Eltayeb, Osman; Khogali, Mohammed; Van den Bergh, Rafael; Kumar, Ajay M. V.; Hinderaker, Sven Gudmund; Abdurrahman, Saddiq T.; Lawson, Lovett; Cuevas, Luis E.			Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria	PLOS ONE			English	Article							COMMUNITY-BASED TREATMENT; SOUTH-AFRICA; METAANALYSIS; CULTURE; THERAPY; LIMA; PERU	Background: Nigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered across the globe have been poor, partly due to high loss-to-follow-up. To address this challenge, MDR-TB patients in Nigeria are hospitalized during the intensive-phase(IP) of treatment (first 6-8 months) and are provided with a package of care including standardized MDR-TB treatment regimen, antiretroviral therapy (ART) and cotrimoxazole prophylaxis (CPT) for HIV-infected patients, nutritional and psychosocial support. In this study, we report the end-IP treatment outcomes among them. Methods: In this retrospective cohort study, we reviewed the patient records of all bacteriologically-confirmed MDR-TB patients admitted for treatment between July 2010 and October 2012. Results: Of 162 patients, 105(65%) were male, median age was 34 years and 28(17%) were HIV-infected; all 28 received ART and CPT. Overall, 138(85%) were alive and culture negative at the end of IP, 24(15%) died and there was no loss-to-follow-up. Mortality was related to low CD4-counts at baseline among HIV-positive patients. The median increase in body mass index among those documented to be underweight was 2.6 kg/m(2) (p<0.01) and CD4-counts improved by a median of 52 cells/microL among the HIV-infected patients (p<0.01). Conclusions: End-IP treatment outcomes were exceptional compared to previously published data from international cohorts, thus confirming the usefulness of a hospitalized model of care. However, less than five percent of all estimated 3600 MDR-TB patients in Nigeria were initiated on treatment during the study period. Given the expected scale-up of MDR-TB care, the hospitalized model is challenging to sustain and the national TB programme is contemplating to move to ambulatory care. Hence, we recommend using both ambulatory and hospitalized approaches, with the latter being reserved for selected high-risk groups.	[Oladimeji, Olanrewaju; Lawson, Lovett] Zankli Med Ctr, Abuja, Nigeria; [Oladimeji, Olanrewaju; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Isaakidis, Petros; Khogali, Mohammed; Van den Bergh, Rafael] MSF, Operat Res Unit, Luxembourg, Luxembourg; [Obasanya, Olusegun J.] Fed Minist Hlth, Natl TB & Leprosy Control Unit, Abuja, Nigeria; [Eltayeb, Osman] Damien Fdn Belgium, Nigeria Project, Ibadan, Nigeria; [Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Abdurrahman, Saddiq T.] Fed Capital Terr, TB & Leprosy Control Program, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool; Doctors Without Borders; University of Bergen	Oladimeji, O (corresponding author), Zankli Med Ctr, Abuja, Nigeria.	droladfb@gmail.com	Oladimeji, Olanrewaju/AAE-9633-2019; Cuevas, Luis E/I-3697-2015	Oladimeji, Olanrewaju/0000-0002-5356-901X; Cuevas, Luis E/0000-0002-6581-0587; Lawson, Lovett/0000-0001-9019-7537; Isaakidis, Petros/0000-0002-7881-1554; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Van den Bergh, Rafael/0000-0001-6277-8713	Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg; Bloomberg Philanthropies; Department for International Development (DFID), UK; European and Developing Countries Clinical Trial Partnership (EDCTP)	Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg; Bloomberg Philanthropies; Department for International Development (DFID), UK; European and Developing Countries Clinical Trial Partnership (EDCTP)	Funding for the course was provided by Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg, the Bloomberg Philanthropies, and the Department for International Development (DFID), UK. Dr Olanrewaju Oladimeji is a research fellow based in Abuja Nigeria, jointly appointed by Zankli Medical Services, Nigeria and the Liverpool School of Tropical Medicine, United Kingdom and funded by a Strategic Award grant from the European and Developing Countries Clinical Trial Partnership (EDCTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2009, MAN MDR TB FIELD GUI; Brust J, 2010, PLOS ONE, V6; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Federal Ministry of Health Nigeria Department of Public Health, 2010, NAT TUB LEPR CONTR P, V5th; Federal Ministry of Health Nigeria (FMOH), 2012, NATL DRUG RES TB PRE; Hafkin J, 2013, INT J TUBERC LUNG D, V17, P348, DOI 10.5588/ijtld.12.0100; Harries AD, 2004, INT J TUBERC LUNG D, V8, P204; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; James C, 2011, CULTURE CONVERSION H; Jenkins HE, 2013, INT J TUBERC LUNG D, V17, P373, DOI 10.5588/ijtld.12.0464; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Khann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059903; Kilale AM, 2013, PUBLIC HEALTH ACTION, V3, P156, DOI 10.5588/pha.12.0103; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2012, MULT EXT DRUG RES TB; World Health Organization (WHO), 2013, MULT EXT DRUG RES	26	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94393	10.1371/journal.pone.0094393	http://dx.doi.org/10.1371/journal.pone.0094393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722139	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000336909100065
J	Pectasides, E; Rampias, T; Sasaki, C; Perisanidis, C; Kouloulias, V; Burtness, B; Zaramboukas, T; Rimm, D; Fountzilas, G; Psyrri, A				Pectasides, Eirini; Rampias, Theodoros; Sasaki, Clarence; Perisanidis, Christos; Kouloulias, Vassilis; Burtness, Barbara; Zaramboukas, Thomas; Rimm, David; Fountzilas, George; Psyrri, Amanda			Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; AUTOMATED QUANTITATIVE-ANALYSIS; E-CADHERIN EXPRESSION; BETA-CATENIN; NUCLEAR-LOCALIZATION; TISSUE MICROARRAYS; CANCER; ACTIVATION; BINDING; IDENTIFICATION	Background: Elucidating the molecular phenotype of cancers with high metastatic potential will facilitate the development of novel therapeutic approaches to the disease. Gene expression profiles link epithelial to mesenchymal transition (EMT) phenotype with high-risk HNSCC. We sought to determine the role of protein biomarkers of EMT in head and neck squamous carcinoma (HNSC) prognosis. Methods: Protein expression analysis of EGFR, beta-catenin and E-cadherin was performed on a cohort of 102 patients with HNSCC recruited between 1992 and 2005 using automated quantitative protein analysis (AQUA). We evaluated associations with clinicopathological parameters and prognosis. Results: There were 67 patients with primary squamous cell carcinoma of the head and neck in this cohort who met inclusion criteria and for whom we had complete E-cadherin, beta-catenin and EGFR expression data. High E-cadherin expressers had longer 5-year progression-free survival (PFS) compared to those with low E-cadherin (59.7% versus 40.6%, p = 0.04) and overall survival (OS) (69.6% versus 44.3%, p = 0.05). Kaplan-Meier analysis showed that patients with low beta-catenin-expressing tumors trended toward worse 5-year PFS (p = 0.057). High EGFR expressers had inferior OS compared to low EGFR expressers (27.7% vs. 54%, p = 0.029). In the multivariable analysis context, E-cadherin remained an independent predictor of improved OS (HR = 0.204, 95% CI 0.043 to 0.972, p = 0.046) while EGFR trended towards significance for OS. Conclusions: The putative markers of EMT defined within a panel of HNSCC using AQUA are associated with tumors of poor prognosis.	[Pectasides, Eirini; Psyrri, Amanda] Yale Univ, Sch Med, Dept Internal Med Med Oncol, New Haven, CT 06520 USA; [Rampias, Theodoros; Sasaki, Clarence; Psyrri, Amanda] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT USA; [Perisanidis, Christos] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria; [Kouloulias, Vassilis] Univ Athens, Attikon Univ Hosp, Dept Radiotherapy, Athens, Greece; [Kouloulias, Vassilis] Univ Athens, Attikon Univ Hosp, Dept Internal Med Med Oncol, Athens, Greece; [Burtness, Barbara] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Zaramboukas, Thomas] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Rimm, David] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, GR-54006 Thessaloniki, Greece	Yale University; Yale University; Medical University of Vienna; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; Fox Chase Cancer Center; Aristotle University of Thessaloniki; Yale University; Aristotle University of Thessaloniki	Psyrri, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med Med Oncol, New Haven, CT 06520 USA.	dp237@email.med.yale.edu	Rampias, Theodoros/AAX-7941-2020; Fountzilas, George/ABF-2139-2020; Kouloulias, Vassilis/AAD-7348-2019	Rampias, Theodoros/0000-0002-5460-5334; Fountzilas, George/0000-0001-8045-2186; Rimm, David/0000-0001-5820-4397	Yale School of Medicine Institutional startup funds; Virginia Alden Wright Fund	Yale School of Medicine Institutional startup funds; Virginia Alden Wright Fund	This study was funded by Yale School of Medicine Institutional startup funds (AP) and the Virginia Alden Wright Fund (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Camp RL, 2000, LAB INVEST, V80, P1943, DOI 10.1038/labinvest.3780204; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Harigopal M, 2005, CLIN CANCER RES, V11, P4083, DOI 10.1158/1078-0432.CCR-04-2191; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Orsulic S, 1999, J CELL SCI, V112, P1237; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pectasides E, 2010, CLIN CANCER RES, V16, P2427, DOI 10.1158/1078-0432.CCR-09-2658; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033	30	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94273	10.1371/journal.pone.0094273	http://dx.doi.org/10.1371/journal.pone.0094273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722213	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100048
J	Rex, K; Bharti, SK; Sah, S; Varshney, U				Rex, Kervin; Bharti, Sanjay Kumar; Sah, Shivjee; Varshney, Umesh			A Genetic Analysis of the Functional Interactions within Mycobacterium tuberculosis Single-Stranded DNA Binding Protein	PLOS ONE			English	Article							ESCHERICHIA-COLI; X-RAY; REPLICATION; COMPLEXES; MODES; GLYCOSYLASES; VARIABILITY; EXPRESSION; MULTIPLE; DOMAIN	Single-stranded DNA binding proteins (SSBs) are vital in all organisms. SSBs of Escherichia coli (EcoSSB) and Mycobacterium tuberculosis (MtuSSB) are homotetrameric. The N-terminal domains (NTD) of these SSBs (responsible for their tetramerization and DNA binding) are structurally well defined. However, their C-terminal domains (CTD) possess undefined structures. EcoSSB NTD consists of beta 1-beta 1'-beta 2-beta 3-alpha-beta 4-beta 45(1)-beta 45(2)-beta 5 secondary structure elements. MtuSSB NTD includes an additional beta-strand (beta 6) forming a novel hook-like structure. Recently, we observed that MtuSSB complemented an E. coli Delta ssb strain. However, a chimeric SSB (m beta 4-beta 5), wherein only the terminal part of NTD (beta 4-beta 5 region possessing L-45 loop) of EcoSSB was substituted with that from MtuSSB, failed to function in E. coli in spite of its normal DNA binding and oligomerization properties. Here, we designed new chimeras by transplanting selected regions of MtuSSB into EcoSSB to understand the functional significance of the various secondary structure elements within SSB. All chimeric SSBs formed homotetramers and showed normal DNA binding. The m beta 4-beta 6 construct obtained by substitution of the region downstream of beta 5 in m beta 4-beta 5 SSB with the corresponding region (beta 6) of MtuSSB complemented the E. coli strain indicating a functional interaction between the L-45 loop and the beta 6 strand of MtuSSB.	[Rex, Kervin; Bharti, Sanjay Kumar; Sah, Shivjee; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Varshney, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Varshney, Umesh/Q-6914-2019; sah, shivjee/S-7767-2019		Department of Biotechnology (DBT); Department of Science and Technology (DST), Government of India, New Delhi	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India, New Delhi(Department of Science & Technology (India))	Funds for this study were provided by the Department of Biotechnology (DBT), and Department of Science and Technology (DST), Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S M, 2012, Methods Mol Biol, V922, P23, DOI 10.1007/978-1-62703-032-8_2; Bharti SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027216; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CARLINI LE, 1993, MOL MICROBIOL, V10, P1067, DOI 10.1111/j.1365-2958.1993.tb00977.x; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; Handa P, 2000, NUCLEIC ACIDS RES, V28, P3823, DOI 10.1093/nar/28.19.3823; Kaushal PS, 2010, ACTA CRYSTALLOGR D, V66, P1048, DOI 10.1107/S0907444910032208; Kumar NV, 1997, NUCLEIC ACIDS RES, V25, P2336, DOI 10.1093/nar/25.12.2336; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LIEBERMAN HB, 1981, MOL GEN GENET, V183, P348, DOI 10.1007/BF00270639; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; Purnapatre K, 1999, NUCLEIC ACIDS RES, V27, P3487, DOI 10.1093/nar/27.17.3487; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94669	10.1371/journal.pone.0094669	http://dx.doi.org/10.1371/journal.pone.0094669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722671	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336909100119
J	Bezsonova, I				Bezsonova, Irina			Solution NMR Structure of the DNA-binding Domain from Scml2 (Sex Comb on Midleg-like 2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Epigenetics; NMR; Polycomb; Protein Structure	BRAIN-TUMOR REPEATS; LYSINE METHYLATION; POLYCOMB; RECOGNITION; PROTEINS; SEQA; CRYSTALLOGRAPHY; IDENTIFICATION; ARCHITECTURE; COMPLEXES	Scml2 is a member of the Polycomb group of proteins involved in epigenetic gene silencing. Human Scml2 is a part of a multisubunit protein complex, PRC1 (Polycomb repressive complex 1), which is responsible for maintenance of gene repression, prevention of chromatin remodeling, preservation of the stemness of the cell, and cell differentiation. Although the majority of PRC1 subunits have been recently characterized, the structure of Scml2 and its role in PRC1-mediated gene silencing remain unknown. In this work a conserved protein domain within human Scml2 has been identified, and its structure was determined by solution NMR spectroscopy. This module was named Scm-like embedded domain, or SLED. Evolutionarily, the SLED domain emerges in the first multicellular organisms, consistent with the role of Scml2 in cell differentiation. Furthermore, it is exclusively found within the Scm-like family of proteins, often accompanied by malignant brain tumor domain (MBT) and sterile motif (SAM) domains. The domain adopts a novel / fold with no structural analogues found in the Protein Data Bank (PDB). The ability of the SLED to bind double-stranded DNA was also examined, and the isolated domain was shown to interact with DNA in a sequence-specific manner. Because PRC1 complexes localize to the promoters of a specific subset of developmental genes in vivo, the SLED domain of Scml2 may provide an important link connecting the PRC1 complexes to their target genes.	[Bezsonova, Irina] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA	University of Connecticut	Bezsonova, I (corresponding author), Univ Connecticut, Ctr Hlth, 263 Farmington Ave, Farmington, CT 06032 USA.	bezsonova@uchc.edu			Charles H. Hood Foundation Child Health Research Fund; Department of Public Health Biomedical Research; Connecticut Stem Cell Research Grant	Charles H. Hood Foundation Child Health Research Fund; Department of Public Health Biomedical Research; Connecticut Stem Cell Research Grant	Supported by the Charles H. Hood Foundation Child Health Research Fund, a Connecticut Department of Public Health Biomedical Research Project Award, and a Connecticut Stem Cell Research Grant.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Bornemann D, 1998, GENETICS, V150, P675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chung YS, 2009, NUCLEIC ACIDS RES, V37, P3143, DOI 10.1093/nar/gkp151; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujikawa N, 2004, NUCLEIC ACIDS RES, V32, P82, DOI 10.1093/nar/gkh173; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Goddard T. D., 2008, SPARKY 3; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guarne A, 2002, NAT STRUCT BIOL, V9, P839, DOI 10.1038/nsb857; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Kassis JA, 2010, MOL CELL BIOL, V30, P2581, DOI 10.1128/MCB.00231-10; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Montini E, 1999, GENOMICS, V58, P65, DOI 10.1006/geno.1999.5755; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8	43	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15739	15749		10.1074/jbc.M113.524009	http://dx.doi.org/10.1074/jbc.M113.524009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727478	Green Published, hybrid			2022-12-25	WOS:000337465400054
J	Curtin, AE; Zhou, LM				Curtin, Antonia E.; Zhou, Leming			An Agent-Based Model of the Response to Angioplasty and Bare-Metal Stent Deployment in an Atherosclerotic Blood Vessel	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; ELUTING STENT; TGF-BETA; BALLOON ANGIOPLASTY; VULNERABLE PLAQUE; RESTENOSIS; INFLAMMATION; MECHANISMS	Purpose: While animal models are widely used to investigate the development of restenosis in blood vessels following an intervention, computational models offer another means for investigating this phenomenon. A computational model of the response of a treated vessel would allow investigators to assess the effects of altering certain vessel-and stent-related variables. The authors aimed to develop a novel computational model of restenosis development following an angioplasty and bare-metal stent implantation in an atherosclerotic vessel using agent-based modeling techniques. The presented model is intended to demonstrate the body's response to the intervention and to explore how different vessel geometries or stent arrangements may affect restenosis development. Methods: The model was created on a two-dimensional grid space. It utilizes the post-procedural vessel lumen diameter and stent information as its input parameters. The simulation starting point of the model is an atherosclerotic vessel after an angioplasty and stent implantation procedure. The model subsequently generates the final lumen diameter, percent change in lumen cross-sectional area, time to lumen diameter stabilization, and local concentrations of inflammatory cytokines upon simulation completion. Simulation results were directly compared with the results from serial imaging studies and cytokine levels studies in atherosclerotic patients from the relevant literature. Results: The final lumen diameter results were all within one standard deviation of the mean lumen diameters reported in the comparison studies. The overlapping-stent simulations yielded results that matched published trends. The cytokine levels remained within the range of physiological levels throughout the simulations. Conclusion: We developed a novel computational model that successfully simulated the development of restenosis in a blood vessel following an angioplasty and bare-metal stent deployment based on the characteristics of the vessel cross-section and stent. A further development of this model could ultimately be used as a predictive tool to depict patient outcomes and inform treatment options.	[Curtin, Antonia E.; Zhou, Leming] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Zhou, Leming] Univ Pittsburgh, Dept Hlth Informat Management, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhou, LM (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	lmzhou@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Zhou, Leming/0000-0003-4398-0267	National Science Foundation [IIS-0938393]	National Science Foundation(National Science Foundation (NSF))	This work is supported in part by a National Science Foundation Remove text grant to L.Z. (IIS-0938393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alsheikh-Ali AA, 2010, ANN INTERN MED, V153, P387, DOI 10.7326/0003-4819-153-6-201009210-00272; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Ashcroft GS, 1999, MICROBES INFECT, V1, P1275, DOI 10.1016/S1286-4579(99)00257-9; Auerbach D, 2012, HOSP STAYS CARDIAC S; Berndt MC, 2000, PLATELETS THROMBOSIS; Blann AD, 1996, ATHEROSCLEROSIS, V120, P221, DOI 10.1016/0021-9150(95)05713-7; Botnar RM, 2000, CIRCULATION, V102, P2582; Brown BN, 2011, MATH BIOSCI, V231, P186, DOI 10.1016/j.mbs.2011.03.005; Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010; Chamie D, 2010, JACC-CARDIOVASC INTE, V3, P191, DOI 10.1016/j.jcin.2009.11.014; Charo IF, 2011, NAT REV DRUG DISCOV, V10, P365, DOI 10.1038/nrd3444; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Chitkara Kamal, 2010, Eur J Cardiovasc Med, V1, P20; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Drakopoulou M, 2011, CURR PHARM DESIGN, V17, P4190, DOI 10.2174/138161211798764816; Facoetti A, 2009, INT J RADIAT BIOL, V85, P690, DOI 10.1080/09553000903020016; Ferkol T, 1996, P NATL ACAD SCI USA, V93, P101, DOI 10.1073/pnas.93.1.101; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fitridge R, 2007, MECH VASCULAR DIS TX, P173; Friedman H, 2013, AM J CARDIOVASC DRUG, V13, P273, DOI 10.1007/s40256-013-0026-3; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Groschel K, 2005, STROKE, V36, P367, DOI 10.1161/01.STR.0000152357.82843.9f; Hamid Huda, 2007, Mcgill J Med, V10, P105; Heidenreich S, 1999, J LEUKOCYTE BIOL, V65, P737, DOI 10.1002/jlb.65.6.737; Heikkilae HM, 2008, ARTERIOSCL THROM VAS, V28, P309, DOI 10.1161/ATVBAHA.107.151340; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Homoncik M, 2000, THROMB RES, V99, P461, DOI 10.1016/S0049-3848(00)00297-8; KARAS SP, 1992, J AM COLL CARDIOL, V20, P467, DOI 10.1016/0735-1097(92)90119-8; KIMURA T, 1993, J AM COLL CARDIOL, V21, P1557, DOI 10.1016/0735-1097(93)90368-B; King SB, 2002, VASCULAR BRACHYTHERA, P3; Kolodgie FD, 2007, NEUROIMAG CLIN N AM, V17, P285, DOI 10.1016/j.nic.2007.03.006; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Kovanen PT, 2005, HANDB EXP PHARM, V170, P745; Lee KH, 2013, CIRC J, V77, P2973, DOI 10.1253/circj.CJ-13-0594; Li NYK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002789; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; McCance KL, 2009, PATHOPHYSIOLOGY BIOL; Meadows TA, 2007, CIRC RES, V100, P1261, DOI 10.1161/01.RES.0000264509.36234.51; Mohan S, 2010, INT J ANGIOL, V19, pE66, DOI 10.1055/s-0031-1278368; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; MULLER DWM, 1992, J AM COLL CARDIOL, V19, P418, DOI 10.1016/0735-1097(92)90500-M; Mulukutla SR, 2013, AM J CARDIOL, V111, P486, DOI 10.1016/j.amjcard.2012.10.030; Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268; NAJEAN Y, 1969, ANNU REV MED, V20, P47, DOI 10.1146/annurev.me.20.020169.000403; Niazi M, 2011, SCIENTOMETRICS, V89, P479, DOI 10.1007/s11192-011-0468-9; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Otsuka Fumiyuki, 2012, Thrombosis, V2012, P608593, DOI 10.1155/2012/608593; Pappas C, 2013, INT J CARDIOL, V165, P380, DOI 10.1016/j.ijcard.2012.08.024; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Poorhosseini Hamid Reza, 2012, J Tehran Heart Cent, V7, P47; Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3; Schillinger M, 2005, VASC HEALTH RISK MAN, V1, P73, DOI 10.2147/vhrm.1.1.73.58932; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Seye CI, 2007, PURINERG SIGNAL, V3, P153, DOI 10.1007/s11302-006-9047-6; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Stedman, 2006, STEDMANS MED DICT; Stefanescu RA, 2012, SEIZURE-EUR J EPILEP, V21, P748, DOI 10.1016/j.seizure.2012.08.012; Stoeckel D, 2002, MINIM INVASIV THER, V11, P137, DOI 10.1080/136457002760273340; Subban V, 2012, CARDIOVASC J AFR, V23, pE9, DOI 10.5830/CVJA-2011-022; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Thim T, 2008, J INTERN MED, V263, P506, DOI 10.1111/j.1365-2796.2008.01947.x; Touchard AG, 2006, TOXICOL PATHOL, V34, P11, DOI 10.1080/01926230500499407; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Wasser K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022683; Waxman S, 2010, CIRC-CARDIOVASC INTE, V3, P193, DOI 10.1161/CIRCINTERVENTIONS.109.917955; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wildgruber M, 2007, EUR J VASC ENDOVASC, V34, P35, DOI 10.1016/j.ejvs.2007.02.009; Wilensky U, 1999, NETLOGO; Zhang F, 2012, INT J CARDIOL, V159, pE53, DOI 10.1016/j.ijcard.2011.12.013	82	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94411	10.1371/journal.pone.0094411	http://dx.doi.org/10.1371/journal.pone.0094411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732072	Green Published, gold			2022-12-25	WOS:000336970400036
J	Klein, RC; Saini, S; Risher, ML; Acheson, SK; Fleming, RL; Sexton, HG; Swartzwelder, HS; Moore, SD				Klein, Rebecca C.; Saini, Shyla; Risher, M-Louise; Acheson, Shawn K.; Fleming, Rebekah L.; Sexton, Hannah G.; Swartzwelder, H. Scott; Moore, Scott D.			Regional-Specific Effects of Ovarian Hormone Loss on Synaptic Plasticity in Adult Human APOE Targeted Replacement Mice	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; MILD COGNITIVE IMPAIRMENT; ESTROGEN-RECEPTOR-ALPHA; MOUSE CORTICAL-NEURONS; LONG-TERM POTENTIATION; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; BASOLATERAL AMYGDALA; HIPPOCAMPAL-NEURONS; DEPENDENT MECHANISM	The human apolipoprotein epsilon 4 allele (APOE4) has been implicated as one of the strongest genetic risk factors associated with Alzheimer's disease (AD) and in influencing normal cognitive functioning. Previous studies have demonstrated that mice expressing human apoE4 display deficits in behavioral and neurophysiological outcomes compared to those with apoE3. Ovarian hormones have also been shown to be important in modulating synaptic processes underlying cognitive function, yet little is known about how their effects are influenced by apoE. In the current study, female adult human APOE targeted replacement (TR) mice were utilized to examine the effects of human APOE genotype and long-term ovarian hormone loss on synaptic plasticity in limbic regions by measuring dendritic spine density and electrophysiological function. No significant genotype differences were observed on any outcomes within intact mice. However, there was a significant main effect of genotype on total spine density in apical dendrites in the hippocampus, with post-hoc t-tests revealing a significant reduction in spine density in apoE3 ovariectomized (OVX) mice compared to sham operated mice. There was also a significant main effect of OVX on the magnitude of LTP, with post-hoc t-tests revealing a decrease in apoE3 OVX mice relative to sham. In contrast, apoE4 OVX mice showed increased synaptic activity relative to sham. In the lateral amygdala, there was a significant increase in total spine density in apoE4 OVX mice relative to sham. This increase in spine density was consistent with a significant increase in spontaneous excitatory activity in apoE4 OVX mice. These findings suggest that ovarian hormones differentially modulate synaptic integrity in an apoE-dependent manner within brain regions that are susceptible to neurophysiological dysfunction associated with AD.	[Klein, Rebecca C.; Saini, Shyla; Risher, M-Louise; Acheson, Shawn K.; Fleming, Rebekah L.; Sexton, Hannah G.; Swartzwelder, H. Scott; Moore, Scott D.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Acheson, Shawn K.; Fleming, Rebekah L.; Sexton, Hannah G.; Swartzwelder, H. Scott] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA; [Klein, Rebecca C.; Moore, Scott D.] Durham Vet Affairs Med Ctr, MIRECC, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Klein, RC (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.	rck11@duke.edu	Acheson, Shawn/A-3299-2016; Risher, Louise/AAP-2646-2020	Risher, Louise/0000-0002-3139-4378	Institute for Medical Research; Duke University NPR Fellowship; DVAMC VISN 6 MIRECC; VA Merit Review; VA Career Development Award [I01BX007080, 2-010-10S]; NIAAA [U01-AA019925-01-NADIA]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001267, I01BX001271] Funding Source: NIH RePORTER	Institute for Medical Research; Duke University NPR Fellowship; DVAMC VISN 6 MIRECC; VA Merit Review(US Department of Veterans Affairs); VA Career Development Award; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Institute for Medical Research to RCK, Duke University NPR Fellowship to SS, DVAMC VISN 6 MIRECC to SDM and RCK, VA Merit Review to SDM, VA Career Development Award to SKA (I01BX007080) and RLF (2-010-10S), and NIAAA (U01-AA019925-01-NADIA) to HSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barker JM, 2009, GEN COMP ENDOCR, V164, P77, DOI 10.1016/j.ygcen.2009.05.008; BARLEY J, 1975, BRAIN RES, V100, P383, DOI 10.1016/0006-8993(75)90490-4; Barley J, 1975, J ENDOCRINOL, V64, p22P; Basso M, 2006, NEUROBIOL AGING, V27, P1416, DOI 10.1016/j.neurobiolaging.2005.08.002; Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; Bi RF, 2001, P NATL ACAD SCI USA, V98, P13391, DOI 10.1073/pnas.241507698; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Burkhardt MS, 2004, J ALZHEIMERS DIS, V6, P221; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; Foy M, 2004, NEURON GLIA BIOL, V1, P327, DOI 10.1017/S1740925X05000165; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Gonzalez-Burgos I, 2005, NEUROSCI LETT, V379, P52, DOI 10.1016/j.neulet.2004.12.043; GOULD E, 1990, J NEUROSCI, V10, P1286; Hunter JM, 2012, BRAIN RES, V1467, P120, DOI 10.1016/j.brainres.2012.05.048; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059478; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Klein RC, 2010, NEUROSCIENCE, V171, P1265, DOI 10.1016/j.neuroscience.2010.10.027; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; Levin-Allerhand J, 2001, J NEUROCHEM, V79, P796, DOI 10.1046/j.1471-4159.2001.00627.x; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Mori E, 1999, AM J PSYCHIAT, V156, P216; Murphy DD, 1998, J NEUROSCI, V18, P2550; Murphy DD, 1996, J NEUROSCI, V16, P4059; Nathan BP, 2004, ENDOCRINOLOGY, V145, P3065, DOI 10.1210/en.2003-1707; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Prange-Kiel J, 2006, NEUROSCIENCE, V138, P765, DOI 10.1016/j.neuroscience.2005.05.061; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Raber J, 2008, HORM BEHAV, V53, P706, DOI 10.1016/j.yhbeh.2008.02.012; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; Ryan J, 2009, NEUROLOGY, V73, P1729, DOI 10.1212/WNL.0b013e3181c34b0c; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Stone DJ, 1998, J NEUROSCI, V18, P3180; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Velazquez-Zamora DA, 2012, BRAIN RES, V1470, P1, DOI 10.1016/j.brainres.2012.06.012; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013; Wang JM, 2006, P NATL ACAD SCI USA, V103, P16983, DOI 10.1073/pnas.0608128103; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Womble MD, 2002, NEUROSCI LETT, V331, P83, DOI 10.1016/S0304-3940(02)00871-6; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yague JG, 2008, BRAIN RES, V1209, P115, DOI 10.1016/j.brainres.2008.02.061; YOSHIDA M, 1994, EXP BRAIN RES, V101, P1; Yue Y, 2007, ACTA PHARMACOL SIN, V28, P1129, DOI 10.1111/j.1745-7254.2007.00618.x; Yun SH, 2007, HIPPOCAMPUS, V17, P1153, DOI 10.1002/hipo.20357	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94071	10.1371/journal.pone.0094071	http://dx.doi.org/10.1371/journal.pone.0094071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732142	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400017
J	Munoz-Amatriain, M; Cuesta-Marcos, A; Endelman, JB; Comadran, J; Bonman, JM; Bockelman, HE; Chao, SM; Russell, J; Waugh, R; Hayes, PM; Muehlbauer, GJ				Munoz-Amatriain, Maria; Cuesta-Marcos, Alfonso; Endelman, Jeffrey B.; Comadran, Jordi; Bonman, John M.; Bockelman, Harold E.; Chao, Shiaoman; Russell, Joanne; Waugh, Robbie; Hayes, Patrick M.; Muehlbauer, Gary J.			The USDA Barley Core Collection: Genetic Diversity, Population Structure, and Potential for Genome-Wide Association Studies	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HORDEUM-VULGARE L.; LINKAGE DISEQUILIBRIUM; GROWTH HABIT; BETA-GLUCAN; GERMPLASM; RESISTANCE; ADAPTATION; ORIGIN; TECHNOLOGIES	New sources of genetic diversity must be incorporated into plant breeding programs if they are to continue increasing grain yield and quality, and tolerance to abiotic and biotic stresses. Germplasm collections provide a source of genetic and phenotypic diversity, but characterization of these resources is required to increase their utility for breeding programs. We used a barley SNP iSelect platform with 7,842 SNPs to genotype 2,417 barley accessions sampled from the USDA National Small Grains Collection of 33,176 accessions. Most of the accessions in this core collection are categorized as landraces or cultivars/breeding lines and were obtained from more than 100 countries. Both STRUCTURE and principal component analysis identified five major subpopulations within the core collection, mainly differentiated by geographical origin and spike row number (an inflorescence architecture trait). Different patterns of linkage disequilibrium (LD) were found across the barley genome and many regions of high LD contained traits involved in domestication and breeding selection. The genotype data were used to define 'mini-core' sets of accessions capturing the majority of the allelic diversity present in the core collection. These 'mini-core' sets can be used for evaluating traits that are difficult or expensive to score. Genome-wide association studies (GWAS) of 'hull cover', 'spike row number', and 'heading date' demonstrate the utility of the core collection for locating genetic factors determining important phenotypes. The GWAS results were referenced to a new barley consensus map containing 5,665 SNPs. Our results demonstrate that GWAS and high-density SNP genotyping are effective tools for plant breeders interested in accessing genetic diversity in large germplasm collections.	[Munoz-Amatriain, Maria; Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Cuesta-Marcos, Alfonso; Hayes, Patrick M.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Endelman, Jeffrey B.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Comadran, Jordi; Russell, Joanne; Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Bonman, John M.; Bockelman, Harold E.] ARS, USDA, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Chao, Shiaoman] ARS, USDA, Biosci Res Lab, Fargo, ND USA; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; University of Wisconsin System; University of Wisconsin Madison; James Hutton Institute; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Muehlbauer, GJ (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.	muehl003@umn.edu	Muñoz-Amatriaín, María/GNP-7350-2022	Muñoz-Amatriaín, María/0000-0002-4476-1691; Bonman, John/0000-0002-7414-044X	Triticeae Coordinated Agricultural Project (TCAP) [2011-68002-30029]; United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA); Biotechnology and Biological Sciences Research Council [BB/D522003/1] Funding Source: researchfish; BBSRC [BB/D522003/1] Funding Source: UKRI	Triticeae Coordinated Agricultural Project (TCAP); United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Triticeae Coordinated Agricultural Project (TCAP), grant no. 2011-68002-30029, funded by the United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuMweis SS, 2010, EUR J CLIN NUTR, V64, P1472, DOI 10.1038/ejcn.2010.178; AIDUN VL, 1990, CAN J PLANT SCI, V70, P481, DOI 10.4141/cjps90-056; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger GL, 2013, THEOR APPL GENET, V126, P693, DOI 10.1007/s00122-012-2011-7; Bonman JM, 2011, GENET RESOUR CROP EV, V58, P291, DOI 10.1007/s10722-010-9574-4; Bonman JM, 2005, CROP SCI, V45, P1271, DOI 10.2135/cropsci2004.0546; Bowman JGP, 2001, CROP SCI, V41, P863, DOI 10.2135/cropsci2001.413863x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brockman DA, 2013, EUR J NUTR, V52, P1743, DOI 10.1007/s00394-012-0478-2; BROWN AHD, 1994, EXS, V68, P357; Brueggeman R, 2008, P NATL ACAD SCI USA, V105, P14970, DOI 10.1073/pnas.0807270105; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Ceccarelli S, 2010, J AGR SCI-CAMBRIDGE, V148, P627, DOI 10.1017/S0021859610000651; Chutimanitsakun Y, 2013, PLANT BREEDING, V132, P563, DOI 10.1111/pbr.12086; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Casao MC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-164; Cuesta-Marcos A, 2008, MOL BREEDING, V21, P455, DOI 10.1007/s11032-007-9145-3; Cuesta-Marcos A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-707; Dahleen LS, 2012, CROP SCI, V52, P1651, DOI 10.2135/cropsci2011.09.0525; Djalali M, 1970, BARLEY GENET, VII, P201; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Endelman JB, 2014, BIOINFORMATICS, V30, P1623, DOI 10.1093/bioinformatics/btu091; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2010, 2 REP STAT WORDS PLA; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Friedt W, 2011, BARLEY PRODUCTION IM, P637, DOI DOI 10.1002/9780470958636.CH8; Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Gutierrez L, 2011, PLANT GENOME-US, V4, P256, DOI 10.3835/plantgenome2011.07.0020; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Knupffer H, 2009, PLANT GENET GENOMICS, V7, P31, DOI 10.1007/978-0-387-77489-3_2; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; LUNDQVIST U, 1988, HEREDITAS, V108, P13, DOI 10.1111/j.1601-5223.1988.tb00677.x; Lundqvist U, 1997, BARLEY GENET NEWSL, V26, P264; MARTIN JM, 1991, CROP SCI, V31, P1131, DOI 10.2135/cropsci1991.0011183X003100050009x; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; McVean G, 2007, GENETICS, V175, P1395, DOI 10.1534/genetics.106.062828; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Munoz-Amatriain M, 2014, BRIEF FUNCT GENOMICS, V13, P341, DOI 10.1093/bfgp/elu006; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Rasmusson DC, 1996, INCREASING YIELD POT, P28; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Russell JR, 2000, MOL BREEDING, V6, P553, DOI 10.1023/A:1011372312962; Sullivana P, 2013, TRENDS FOOD SCI TECH, V29, P124, DOI 10.1016/j.tifs.2012.10.005; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valkoun J, 2008, GLOBAL STRATEGY EX S; von Zitzewitz J, 2011, PLANT GENOME-US, V4, P76, DOI 10.3835/plantgenome2010.12.0030; Wang HY, 2012, THEOR APPL GENET, V124, P111, DOI 10.1007/s00122-011-1691-8; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Youssef HM, 2012, GENET RESOUR CROP EV, V59, P1319, DOI 10.1007/s10722-011-9759-5; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	79	136	147	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94688	10.1371/journal.pone.0094688	http://dx.doi.org/10.1371/journal.pone.0094688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732668	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400074
J	Ord, T; Innos, J; Lillevali, K; Tekko, T; Sutt, S; Ord, D; Koks, S; Vasar, E; Ord, T				Oerd, Tiit; Innos, Juergen; Lillevaeli, Kersti; Tekko, Triin; Suett, Silva; Oerd, Daima; Koeks, Sulev; Vasar, Eero; Oerd, Toenis			Trib3 Is Developmentally and Nutritionally Regulated in the Brain but Is Dispensable for Spatial Memory, Fear Conditioning and Sensing of Amino Acid-Imbalanced Diet	PLOS ONE			English	Article							CELL-DEATH; TRANSLATIONAL CONTROL; SYNAPTIC PLASTICITY; PIRIFORM CORTEX; ATF4 EXPRESSION; TRB3; GENE; DROSOPHILA; MORPHOGENESIS; TRIBBLES	Tribbles homolog 3 (TRIB3) is a mammalian pseudokinase that is induced in neuronal cell cultures in response to cell death-inducing stresses, including neurotrophic factor deprivation. TRIB3 is an inhibitor of activating transcription factor 4 (ATF4), the central transcriptional regulator in the eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation pathway that is involved in the cellular stress response and behavioral processes. In this article, we study the expression of Trib3 in the mouse brain, characterize the brain morphology of mice with a genetic ablation of Trib3 and investigate whether Trib3 deficiency alters eIF2 alpha-dependent cognitive abilities. Our data show that the consumption of a leucine-deficient diet induces Trib3 expression in the anterior piriform cortex, the brain region responsible for detecting essential amino acid intake imbalance. However, the aversive response to leucine-devoid diet does not differ in Trib3 knockout and wild type mice. Trib3 deletion also does not affect long-term spatial memory and reversal learning in the Morris water maze and auditory or contextual fear conditioning. During embryonic development, Trib3 expression increases in the brain and persists in the early postnatal stadium. Neuroanatomical characterization of mice lacking Trib3 revealed enlarged lateral ventricles. Thus, although the absence of Trib3 does not alter the eIF2 alpha pathway-dependent cognitive functions of several areas of the brain, including the hippocampus, amygdala and anterior piriform cortex, Trib3 may serve a role in other central nervous system processes and molecular pathways.	[Oerd, Tiit; Lillevaeli, Kersti] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Innos, Juergen; Lillevaeli, Kersti; Tekko, Triin; Suett, Silva; Vasar, Eero] Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, EE-50090 Tartu, Estonia; [Oerd, Daima; Oerd, Toenis] Univ Tartu, Estonian Bioctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Koeks, Sulev] Univ Tartu, Inst Biomed & Translat Med, Chair Pathol Physiol, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; Estonian Biocentre; University of Tartu; University of Tartu	Ord, T (corresponding author), Univ Tartu, Estonian Bioctr, Ulikooli 18, EE-50090 Tartu, Estonia.	tord@ebc.ee	Koks, Sulev/H-3655-2015; Lilleväli, Kersti/AGD-6838-2022; Vasar, Eero/H-4490-2015; Innos, Jürgen/AAG-7172-2019; Örd, Tõnis/G-8113-2012	Koks, Sulev/0000-0001-6087-6643; Lilleväli, Kersti/0000-0001-5470-3818; Örd, Tõnis/0000-0001-8778-2508; Ord, Tiit/0000-0002-3098-1749; Vasar, Eero/0000-0001-5226-345X; Tekko, Triin/0000-0003-2669-5835	Estonian Science Foundation [7683, 8408]; Estonian Ministry of Education and Research [SF0180175, SF0180148s08, SF0180019s11]; Estonian Research Council [269]; European Regional Development Fund; Archimedes Foundation through the Center of Excellence in Chemical Biology; Archimedes Foundation through Centre of Excellence for Translational Medicine	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission); Archimedes Foundation through the Center of Excellence in Chemical Biology; Archimedes Foundation through Centre of Excellence for Translational Medicine	This work was supported in part by Grants 7683 and 8408 from the Estonian Science Foundation, the long-term research programs SF0180175, SF0180148s08 and SF0180019s11 of the Estonian Ministry of Education and Research, Grant 269 of the personal research funding program of the Estonian Research Council, and the European Regional Development Fund and the Archimedes Foundation through the Center of Excellence in Chemical Biology and the Centre of Excellence for Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gietzen DW, 2007, ANNU REV NUTR, V27, P63, DOI 10.1146/annurev.nutr.27.061406.093726; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Juknat A, 2012, BRIT J PHARMACOL, V165, P2512, DOI 10.1111/j.1476-5381.2011.01461.x; Koehnle TJ, 2004, J NUTR, V134, P2365, DOI 10.1093/jn/134.9.2365; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ord T, 2012, CELL IMMUNOL, V280, P68, DOI 10.1016/j.cellimm.2012.11.011; Ord T, 2009, GENE, V444, P24, DOI 10.1016/j.gene.2009.06.001; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Philips MA, 2010, BEHAV BRAIN RES, V207, P182, DOI 10.1016/j.bbr.2009.10.005; Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	40	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94691	10.1371/journal.pone.0094691	http://dx.doi.org/10.1371/journal.pone.0094691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732777	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400076
J	Vartun, A; Flo, K; Acharya, G				Vartun, Ase; Flo, Kari; Acharya, Ganesh			Effect of Passive Leg Raising on Systemic Hemodynamics of Pregnant Women: A Dynamic Assessment of Maternal Cardiovascular Function at 22-24 Weeks of Gestation	PLOS ONE			English	Article							CARDIAC-OUTPUT; IMPEDANCE CARDIOGRAPHY; FLUID RESPONSIVENESS; PLASMA-VOLUME; BLOOD-FLOW; POSITION; PERFORMANCE; 2ND-HALF; INCREASE; DOPPLER	Objective: To investigate functional hemodynamic response to passive leg raising in healthy pregnant women and compare it with non-pregnant controls. Materials and Methods: This was a prospective cross-sectional study with a case-control design. A total of 108 healthy pregnant women at 22-24 weeks of gestation and 54 non-pregnant women were included. Cardiac function and systemic hemodynamics were studied at baseline and 90 seconds after passive leg raising using non-invasive impedance cardiography. Main outcome measures: Trends and magnitudes of changes in impedance cardiography derived parameters of cardiac function and systemic hemodynamics caused by passive leg raising, and preload responsiveness defined as >10% increase in stroke volume or cardiac output after passive leg raising compared to baseline. Results: The hemodynamic parameters in both pregnant and non-pregnant women changed significantly during passive leg raising compared to baseline, but the magnitude and trend of change was similar in both groups. The stroke volume increased both in pregnant (p = 0.042) and non-pregnant (p = 0.018) women, whereas the blood pressure and systemic vascular resistance decreased (p < 0.001) following passive leg raising in both groups. Only 14.8% of pregnant women and 18.5% of non-pregnant women were preload responsive and the difference between groups was not significant (p = 0.705). Conclusion: Static measures of cardiovascular status are different between healthy pregnant and non-pregnant women, but the physiological response to passive leg raising is similar and not modified by pregnancy at 22-24 weeks of gestation. Whether physiological response to passive leg raising is different in earlier and later stages of pregnancy merit further investigation.	[Vartun, Ase; Flo, Kari; Acharya, Ganesh] Univ Tromso, Dept Clin Med, Fac Hlth Sci, Womens Hlth & Perinatol Res Grp, Tromso, Norway; [Vartun, Ase; Flo, Kari; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynaecol, Tromso, Norway; [Acharya, Ganesh] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Karolinska Institutet	Vartun, A (corresponding author), Univ Tromso, Dept Clin Med, Fac Hlth Sci, Womens Hlth & Perinatol Res Grp, Tromso, Norway.	ase.vartun@uit.no			Regional Health Authority of North Norway; University of Tromso, Norway	Regional Health Authority of North Norway; University of Tromso, Norway	This study was funded by the Regional Health Authority of North Norway and the University of Tromso, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIVINS HG, 1985, ANN EMERG MED, V14, P641, DOI 10.1016/S0196-0644(85)80878-7; Bridges N, 2005, AM J CRIT CARE, V14, P364, DOI 10.4037/ajcc2005.14.5.364; BROOKS VL, 1995, CLIN EXP PHARMACOL P, V22, P152, DOI 10.1111/j.1440-1681.1995.tb01972.x; Brun C, 2013, INTENS CARE MED, V39, P593, DOI 10.1007/s00134-012-2770-2; Burlingame J, 2013, J PERINATOL, V33, P675, DOI 10.1038/jp.2013.35; Cavallaro F, 2010, INTENS CARE MED, V36, P1475, DOI 10.1007/s00134-010-1929-y; Chapman AB, 1997, AM J PHYSIOL-RENAL, V273, pF777, DOI 10.1152/ajprenal.1997.273.5.F777; DAVIES P, 1986, BRIT J OBSTET GYNAEC, V93, P717, DOI 10.1111/j.1471-0528.1986.tb07971.x; Del Bene R, 2001, BRIT J OBSTET GYNAEC, V108, P344, DOI 10.1016/S0306-5456(00)00099-1; DESWIET M, 1986, BRIT J OBSTET GYNAEC, V93, P721; DIRSCHEDL P, 1992, ACTA ASTRONAUT, V27, P41, DOI 10.1016/0094-5765(92)90173-G; DROSTE S, 1992, AM J OBSTET GYNECOL, V167, P89, DOI 10.1016/S0002-9378(11)91633-0; Du Bois D, 1989, Nutrition, V5, P303; EASTERLING TR, 1988, OBSTET GYNECOL, V72, P550; Edouard DA, 1998, AM J PHYSIOL-HEART C, V274, pH1605, DOI 10.1152/ajpheart.1998.274.5.H1605; ELSAYED H, 1995, CLIN SCI, V88, P463, DOI 10.1042/cs0880463; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Flo K, 2010, BJOG-INT J OBSTET GY, V117, P837, DOI 10.1111/j.1471-0528.2010.02548.x; GAFFNEY FA, 1982, J TRAUMA, V22, P190, DOI 10.1097/00005373-198203000-00003; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; HUNTER S, 1992, BRIT HEART J, V68, P540; HYTTEN FE, 1963, J OBSTET GYN BR COMM, V70, P402; Jabot J, 2009, INTENS CARE MED, V35, P85, DOI 10.1007/s00134-008-1293-3; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Keller G, 2008, CRIT CARE, V12, DOI 10.1186/cc6822; KYRIAKIDES ZS, 1994, INT J CARDIOL, V44, P288, DOI 10.1016/0167-5273(94)90294-1; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Marik PE, 2013, CHEST, V143, P364, DOI 10.1378/chest.12-1274; Marik PE, 2011, ANN INTENSIVE CARE, V1, DOI [10.1186/2110-5820-1-1, 10.1186/2110-5820-1-17]; Moertl MG, 2012, PHYSIOL MEAS, V33, P1015, DOI 10.1088/0967-3334/33/6/1015; Monnet X, 2006, CRIT CARE MED, V34, P1402, DOI 10.1097/01.CCM.0000215453.11735.06; Monnet X, 2008, INTENS CARE MED, V34, P659, DOI 10.1007/s00134-008-0994-y; MYHRMAN P, 1982, SCAND J CLIN LAB INV, V42, P513; Paelinck B P, 2003, Eur J Echocardiogr, V4, P196, DOI 10.1016/S1525-2167(02)00167-1; Pinsky MR, 2005, CRIT CARE, V9, P566, DOI 10.1186/cc3927; PIRANI BBK, 1973, J OBSTET GYN BR COMM, V80, P884; Russell A, 2013, J OBSTET GYNAECOL CA, V35, P802, DOI 10.1016/S1701-2163(15)30836-7; RUTLEN DL, 1981, CIRCULATION, V64, P146, DOI 10.1161/01.CIR.64.1.146; San-Frutos L, 2011, J MATERN-FETAL NEO M, V24, P1333, DOI 10.3109/14767058.2011.556203; Scardo JA, 2000, AM J OBSTET GYNECOL, V183, P911, DOI 10.1067/mob.2000.108892; Sodolski Tomasz, 2007, Cardiol J, V14, P115; SPATLING L, 1992, BRIT J OBSTET GYNAEC, V99, pUR3; Thiel SW, 2009, CRIT CARE, V13, DOI 10.1186/cc7955; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Villacorta H, 2012, ARQ BRAS CARDIOL, V99, P1149, DOI 10.1590/S0066-782X2012005000104; Volman MNM, 2007, BJOG-INT J OBSTET GY, V114, P576, DOI 10.1111/j.1471-0528.2007.01300.x; WONG DH, 1988, CRIT CARE MED, V16, P123, DOI 10.1097/00003246-198802000-00005; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94629	10.1371/journal.pone.0094629	http://dx.doi.org/10.1371/journal.pone.0094629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732308	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400060
J	Funda, DP; Fundova, P; Hansen, AK; Buschard, K				Funda, David P.; Fundova, Petra; Hansen, Axel Kornerup; Buschard, Karsten			Prevention or Early Cure of Type 1 Diabetes by Intranasal Administration of Gliadin in NOD Mice	PLOS ONE			English	Article							GLUTEN-FREE DIET; GLUTAMIC-ACID DECARBOXYLASE; CD4(+)CD25(+) T-CELLS; AUTOIMMUNE-DISEASES; IMMUNE-RESPONSES; CELIAC-DISEASE; WHEAT GLUTEN; INSULIN; LYMPHOCYTES; THERAPY	Induction of long-term tolerance to beta-cell autoantigens has been investigated both in animal models and in human type 1 diabetes (T1D) in order to prevent the disease. As regards external compounds, the dietary plant protein fraction has been associated with high penetrance of the disease, whereas gluten-free diets prevent T1D in animal models. Herewith we investigated whether intranasal (i.n.) administration of gliadin or gluten may arrest the diabetogenic process. I.n. administration of gliadin to 4-week-old NOD mice significantly reduced the diabetes incidence. Similarly, the insulitis was lowered. Intranasal gliadin also rescued a fraction of prediabetic 13-week-old NOD mice from progressing to clinical onset of diabetes compared to OVA-treated controls. Vaccination with i.n. gliadin led to an induction of CD4(+)Foxp3(+) T cells and even more significant induction of gamma delta T cells in mucosal, but not in non-mucosal lymphoid compartments. This prevention strategy was characterized by an increased proportion of IL-10 and a decreased proportion of IL-2, IL-4 and IFN-gamma-positive CD4(+)Foxp3(+) T cells, and IFN-gamma-positive gamma delta T cells, preferentially in mucosal lymphoid organs. In conclusion, i.n. vaccination with gliadin, an environmental antigen with possible etiological influence in T1D, may represent a novel, safer strategy for prevention or even early cure of T1D.	[Funda, David P.; Fundova, Petra; Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Funda, David P.; Fundova, Petra] Acad Sci Czech Republ, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Prague, Czech Republic; [Fundova, Petra] Charles Univ Prague, ENT Dept, Fac Med 3, Prague, Czech Republic; [Fundova, Petra] Cent Mil Hosp, Prague, Czech Republic; [Hansen, Axel Kornerup] Univ Copenhagen, Sect Biomed, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Military University Hospital Prague; University of Copenhagen	Funda, DP (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	funda@biomed.cas.cz	Fundova, Petra/J-8670-2014; Funda, David/J-8669-2014	Funda, David/0000-0001-8327-6931; Buschard, Karsten/0000-0002-0126-7423	Grant Agency of the Czech Republic [310/09/1640]; Grant Agency of the Ministry of Health of the Czech Republic [NS/10340-3]; Institute of Microbiology, v.v.i., Czech Acad. Sci. [AV0Z50200510]; Joint Proof-of-Concept Fund; Kirsten & Freddy Johansens Fund	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Ministry of Health of the Czech Republic; Institute of Microbiology, v.v.i., Czech Acad. Sci.; Joint Proof-of-Concept Fund; Kirsten & Freddy Johansens Fund	This study was supported by the Joint Proof-of-Concept Fund and Kirsten & Freddy Johansens Fund and in part also by grants from the Grant Agency of the Czech Republic 310/09/1640, the Grant Agency of the Ministry of Health of the Czech Republic (grant NS/10340-3) and by the Institutional Research Concept AV0Z50200510, Institute of Microbiology, v.v.i., Czech Acad. Sci. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antvorskov JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033315; Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Barker JM, 2007, DIABETOLOGIA, V50, P1603, DOI 10.1007/s00125-007-0694-0; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; BERGEROT I, 1994, J AUTOIMMUN, V7, P655, DOI 10.1006/jaut.1994.1050; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chatenoud L, 2005, INT REV IMMUNOL, V24, P247, DOI 10.1080/08830180590934994; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Daaboul J, 2003, REV ENDOCR METAB DIS, V4, P317, DOI 10.1023/A:1027308310837; Daniel D, 1996, ANN NY ACAD SCI, V778, P371, DOI 10.1111/j.1749-6632.1996.tb21146.x; Fousteri G, 2010, DIABETES, V59, P3148, DOI 10.2337/db10-0561; Fousteri Georgia, 2007, Curr Diab Rep, V7, P91, DOI 10.1007/s11892-007-0017-3; FUNDA D, 1995, IMMUNOL LETT, V45, P179, DOI 10.1016/0165-2478(95)00003-N; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Galipeau HJ, 2011, J IMMUNOL, V187, P4338, DOI 10.4049/jimmunol.1100854; Hanninen A, 2001, DIABETES, V50, P771, DOI 10.2337/diabetes.50.4.771; Hanninen Arno, 2004, Rev Diabet Stud, V1, P113, DOI 10.1900/RDS.2004.1.113; Hansen AK, 2006, DIABETES-METAB RES, V22, P220, DOI 10.1002/dmrr.609; Hansen D, 2006, DIABETES CARE, V29, P2452, DOI 10.2337/dc06-0990; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Homann D, 1999, J IMMUNOL, V163, P1833; HOORFAR J, 1993, BRIT J NUTR, V69, P597, DOI 10.1079/BJN19930059; HOORFAR J, 1991, J NUTR, V121, P908, DOI 10.1093/jn/121.6.908; Jaakkola I, 2003, EUR J IMMUNOL, V33, P3255, DOI 10.1002/eji.200324405; Ke Y, 1997, J IMMUNOL, V158, P3610; Klemetti P, 1998, SCAND J IMMUNOL, V47, P48; LANG FP, 1993, J AUTOIMMUN, V6, P107, DOI 10.1006/jaut.1993.1009; LANG FP, 1991, J AUTOIMMUN, V4, P925, DOI 10.1016/0896-8411(91)90055-H; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Locke NR, 2006, J IMMUNOL, V176, P6553, DOI 10.4049/jimmunol.176.11.6553; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Ramiya VK, 1997, AUTOIMMUNITY, V26, P139, DOI 10.3109/08916939708994736; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Scott FW, 1996, DIABETES METAB REV, V12, P341, DOI 10.1002/(SICI)1099-0895(199612)12:4&lt;341::AID-DMR173&gt;3.0.CO;2-O; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94530	10.1371/journal.pone.0094530	http://dx.doi.org/10.1371/journal.pone.0094530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728138	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200090
J	Kalcher, K; Boubela, RN; Huf, W; Bartova, L; Kronnerwetter, C; Derntl, B; Pezawas, L; Filzmoser, P; Nasel, C; Moser, E				Kalcher, Klaudius; Boubela, Roland N.; Huf, Wolfgang; Bartova, Lucie; Kronnerwetter, Claudia; Derntl, Birgit; Pezawas, Lukas; Filzmoser, Peter; Nasel, Christian; Moser, Ewald			The Spectral Diversity of Resting-State Fluctuations in the Human Brain	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; FMRI; CORTEX; NETWORK; MRI	In order to assess whole-brain resting-state fluctuations at a wide range of frequencies, resting-state fMRI data of 20 healthy subjects were acquired using a multiband EPI sequence with a low TR (354 ms) and compared to 20 resting-state datasets from standard, high-TR (1800 ms) EPI scans. The spatial distribution of fluctuations in various frequency ranges are analyzed along with the spectra of the time-series in voxels from different regions of interest. Functional connectivity specific to different frequency ranges (<0.1 Hz; 0.1-0.25 Hz; 0.25-0.75 Hz; 0.75-1.4 Hz) was computed for both the low-TR and (for the two lower-frequency ranges) the high-TR datasets using bandpass filters. In the low-TR data, cortical regions exhibited highest contribution of low-frequency fluctuations and the most marked low-frequency peak in the spectrum, while the time courses in subcortical grey matter regions as well as the insula were strongly contaminated by high-frequency signals. White matter and CSF regions had highest contribution of high-frequency fluctuations and a mostly flat power spectrum. In the high-TR data, the basic patterns of the low-TR data can be recognized, but the high-frequency proportions of the signal fluctuations are folded into the low frequency range, thus obfuscating the low-frequency dynamics. Regions with higher proportion of high-frequency oscillations in the low-TR data showed flatter power spectra in the high-TR data due to aliasing of the high-frequency signal components, leading to loss of specificity in the signal from these regions in high-TR data. Functional connectivity analyses showed that there are correlations between resting-state signal fluctuations of distant brain regions even at high frequencies, which can be measured using low-TR fMRI. On the other hand, in the high-TR data, loss of specificity of measured fluctuations leads to lower sensitivity in detecting functional connectivity. This underlines the advantages of low-TR EPI sequences for resting-state and potentially also task-related fMRI experiments.	[Kalcher, Klaudius; Boubela, Roland N.; Huf, Wolfgang; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Kalcher, Klaudius; Boubela, Roland N.; Huf, Wolfgang; Kronnerwetter, Claudia; Moser, Ewald] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria; [Kalcher, Klaudius; Boubela, Roland N.; Huf, Wolfgang; Filzmoser, Peter] Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria; [Bartova, Lucie; Pezawas, Lukas] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Kronnerwetter, Claudia] Med Univ Vienna, Dept Radiodiagnost & Nucl Med, Vienna, Austria; [Derntl, Birgit] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Nasel, Christian] Tulln Hosp, Dept Radiol, Tulln, Austria; [Moser, Ewald] Univ Penn, Dept Psychiat, Brain Behav Lab, Med Ctr, Philadelphia, PA 19104 USA	Medical University of Vienna; Medical University of Vienna; Technische Universitat Wien; Medical University of Vienna; Medical University of Vienna; RWTH Aachen University; University of Pennsylvania	Moser, E (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	ewald.moser@meduniwien.ac.at	Pezawas, Lukas/A-2367-2011; Filzmoser, Peter/A-7737-2015; Bartova, Lucie/ABC-1857-2021; Moser, Ewald/B-3666-2013	Pezawas, Lukas/0000-0002-1329-6352; Bartova, Lucie/0000-0002-1769-8025; Moser, Ewald/0000-0001-8278-9583; Filzmoser, Peter/0000-0002-8014-4682; Kalcher, Klaudius/0000-0003-4558-7987; Boubela, Roland/0000-0002-2870-0282; Nasel, Christian/0000-0002-1418-7924; Derntl, Birgit/0000-0003-0133-4486	Austrian Science Fund (FWF) [P22813, P23533]; Austrian Science Fund [SFB-35, F3514-B11]; Austrian Science Fund (FWF) [P 22813, P 23533] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was financially supported by the Austrian Science Fund (FWF; http://www.fwf.ac.at/) projects P22813 and P23533 as well as by the Special Research Project SFB-35 (http://sfb35.at/) of the Austrian Science Fund (F3514-B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boubela RN, 2014, FRONT PHYS, V2, DOI 10.3389/fphy.2014.00001; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Boubela RN, 2012, MAGN RESON MATER PHY, V25, P313, DOI 10.1007/s10334-011-0290-7; Boyacioglu R, 2012, GEN INVERSE IMAGING; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Kalcher K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00301; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; Schopf V, 2010, J NEUROSCI METH, V192, P207, DOI 10.1016/j.jneumeth.2010.07.028; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Van Oort E, 2012, RESTING STATE NETWOR; Windischberger C, 2008, J NEUROSCI METH, V169, P222, DOI 10.1016/j.jneumeth.2007.11.033; Zahneisen B, 2011, MAGN RESON MED, V65, P1260, DOI 10.1002/mrm.22711; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	28	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93375	10.1371/journal.pone.0093375	http://dx.doi.org/10.1371/journal.pone.0093375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728207	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200016
J	Li, JN; Zou, WX; Chang, KS				Li, June; Zou, Wen-Xin; Chang, Kun-Sang			Inhibition of Sp1 Functions by Its Sequestration into PML Nuclear Bodies	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PML; SUMO MODIFICATION; SUMOYLATION; BODY; TRANSCRIPTION; LOCALIZATION; DEGRADATION; ACTIVATION; APOPTOSIS; UBIQUITIN	Promyelocytic leukemia nuclear bodies (PML NBs) are comprised of PML and a striking variety of its associated proteins. Various cellular functions have been attributed to PML NBs, including the regulation of gene expression. We report here that induced expression of PML recruits Sp1 into PML NBs, leading to the reduction of Sp1 transactivation function. Specifically, Chromatin immunoprecipitation (ChIP) assay demonstrated that induced expression of PML significantly diminishes the amount of Sp1 binding to its target gene promoter, immunofluorescence staining showed dramatic increase in the co-localization between PML and Sp1 upon induction of PML expression, moreover, PML and Sp1 co-fractionated in the core nuclear matrix. Our study further showed that PML promotes SUMOylation of Sp1 in a RING-motif-dependent manner, SUMOylation of Sp1 facilitates physical interaction between Sp1 and PML and recruitment of Sp1 into the PML NBs, the SUMO binding motif of PML was also important for its interaction with Sp1. The results of this study demonstrate a novel mechanism by which PML regulates gene expression through sequestration of the transcription factor into PML NBs.	[Li, June; Zou, Wen-Xin; Chang, Kun-Sang] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Li, JN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.	junelijune2@yahoo.com; kchang@mdanderson.org			National Institutes of Health [CA 55577]; NATIONAL CANCER INSTITUTE [R01CA055577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant CA 55577 from the National Institutes of Health to KSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Boddy MN, 1997, J CELL SCI, V110, P2197; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; CHANG KS, 1995, BLOOD, V85, P3646, DOI 10.1182/blood.V85.12.3646.bloodjournal85123646; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Georges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025463; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hsu TI, 2012, MOL PHARMACOL, V82, P1115, DOI 10.1124/mol.112.078485; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Quimby BB, 2006, ONCOGENE, V25, P2999, DOI 10.1038/sj.onc.1209335; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Strudwick S, 2002, LEUKEMIA, V16, P1906, DOI 10.1038/sj.leu.2402724; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Vallian S, 1998, MOL CELL BIOL, V18, P7147, DOI 10.1128/MCB.18.12.7147; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wimmer P, 2010, ONCOGENE, V29, P5511, DOI 10.1038/onc.2010.284; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Xu ZX, 2004, J BIOL CHEM, V279, P1838, DOI 10.1074/jbc.M310987200; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zhu J, 2001, ONCOGENE, V20, P7257, DOI 10.1038/sj.onc.1204852	46	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94450	10.1371/journal.pone.0094450	http://dx.doi.org/10.1371/journal.pone.0094450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728382	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200075
J	Ong, KL; Allison, MA; Cheung, BMY; Wu, B; Barter, PJ; Rye, KA				Ong, Kwok-Leung; Allison, Matthew A.; Cheung, Bernard M. Y.; Wu, Ben J.; Barter, Philip J.; Rye, Kerry-Anne			The Relationship between Total Bilirubin Levels and Total Mortality in Older Adults: The United States National Health and Nutrition Examination Survey (NHANES) 1999-2004	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; SERUM BILIRUBIN; HEME OXYGENASE-1; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK; ASSOCIATION; HYPERCHOLESTEROLEMIA; POPULATION	Objective: Due to its anti-oxidant and anti-inflammatory properties, bilirubin has been associated with reduced cardiovascular risk. A recent study demonstrated an L-shaped association of pre-treatment total bilirubin levels with total mortality in a statin-treated cohort. We therefore investigated the association of total bilirubin levels with total mortality in a nationally representative sample of older adults from the general population. Methods: A total of 4,303 participants aged >= 60 years from the United States National Health and Nutrition Examination Survey 1999-2004 with mortality data followed up through December 31, 2006 were included in this analysis, with a mean follow-up period of 4.5 years. Results: Participants with total bilirubin levels of 0.1-0.4 mg/dl had the highest mortality rate (19.8%). Compared with participants with total bilirubin levels of 0.5-0.7 mg/dl and in a multivariable regression model, a lower total bilirubin level of 0.1-0.4 mg/dl was associated with higher risk of total mortality (hazard ratios, 1.36; 95% confidence interval, 1.07-1.72; P = 0.012), while higher levels (>= 0.8 mg/dl) also tended to be associated with higher risk of total mortality, but this did not reach statistical significance (hazard ratios, 1.24; 95% confidence interval, 0.98-1.56; P = 0.072). Conclusion: In this nationally representative sample of older adults, the association of total bilirubin levels with total mortality was the highest among those with a level between 0.1 and 0.4 mg/dl. Further studies are needed to investigate whether higher total bilirubin levels could be associated with a higher mortality risk, compared to a level of 0.5-0.7 mg/dl.	[Ong, Kwok-Leung; Wu, Ben J.; Barter, Philip J.; Rye, Kerry-Anne] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Ong, Kwok-Leung; Wu, Ben J.; Barter, Philip J.; Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Allison, Matthew A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Cheung, Bernard M. Y.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of New South Wales Sydney; University of Sydney; University of California System; University of California San Diego; University of Hong Kong	Ong, KL (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	oklws@yahoo.com.hk	Ong, Kwok Leung/B-9018-2009; /E-9829-2010	Ong, Kwok Leung/0000-0001-7229-7614; Wu, Ben/0000-0003-2826-4190; /0000-0001-9106-7363; Allison, Matthew/0000-0003-0777-8272	National Health and Medical Research Council of Australia [1037903]; National Heart Foundation of Australia [G 12S 6681]; University of New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); University of New South Wales	This work was supported by the National Health and Medical Research Council of Australia (Grant 1037903). Dr Ong was supported by a Grant-in-Aid (G 12S 6681) from the National Heart Foundation of Australia and the Vice-Chancellor's Postdoctoral Fellowship from the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajja R, 2011, AM J CARDIOL, V108, P1438, DOI 10.1016/j.amjcard.2011.06.067; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; BREIMER LH, 1995, CLIN CHEM, V41, P1504; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS), 1999, NAT HLTH NUTR EX SUR; Chen YH, 2011, CLIN J AM SOC NEPHRO, V6, P567, DOI 10.2215/CJN.06130710; Cox AJ, 2013, ATHEROSCLEROSIS, V229, P155, DOI 10.1016/j.atherosclerosis.2013.04.008; Curjuric I, 2014, EUR RESPIR J, V43, P1278, DOI 10.1183/09031936.00055813; Durante W, 2010, CURR DRUG TARGETS, V11, P1504, DOI 10.2174/1389450111009011504; Gul M, 2013, AM J CARDIOL, V111, P166, DOI 10.1016/j.amjcard.2012.09.011; Holme I, 2012, HEART, V98, P377, DOI 10.1136/heartjnl-2011-300475; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Horsfall LJ, 2011, JAMA-J AM MED ASSOC, V305, P691, DOI 10.1001/jama.2011.124; Hu M, 2012, ATHEROSCLEROSIS, V223, P427, DOI 10.1016/j.atherosclerosis.2012.06.002; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jo Jaeseong, 2012, J Prev Med Public Health, V45, P105, DOI 10.3961/jpmph.2012.45.2.105; Kaya MG, 2014, ANGIOLOGY, V65, P245, DOI 10.1177/0003319713504820; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Lin JP, 2010, CLIN CHEM, V56, P1535, DOI 10.1373/clinchem.2010.151043; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Nolting PRWD, 2011, J LIPID RES, V52, P1755, DOI 10.1194/jlr.P013193; Okuhara K, 2010, SOUTH MED J, V103, P876, DOI 10.1097/SMJ.0b013e3181eac06a; Ong KL, 2013, AM J EPIDEMIOL, V177, P1430, DOI 10.1093/aje/kws443; Ong KL, 2013, ANN EPIDEMIOL, V23, P80, DOI 10.1016/j.annepidem.2012.11.008; Ong KL, 2011, ATHEROSCLEROSIS, V219, P728, DOI 10.1016/j.atherosclerosis.2011.07.094; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Sahin O, 2013, ANGIOLOGY, V64, P200, DOI 10.1177/0003319712440619; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Stender S, 2013, J INTERN MED, V273, P59, DOI 10.1111/j.1365-2796.2012.02576.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Wu BJ, 2009, ARTERIOSCL THROM VAS, V29, P1537, DOI 10.1161/ATVBAHA.109.184713; Zucker SD, 2004, HEPATOLOGY, V40, P827, DOI 10.1002/hep.20407	36	12	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94479	10.1371/journal.pone.0094479	http://dx.doi.org/10.1371/journal.pone.0094479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728477	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200078
J	Peng, ZL; Sakai, Y; Kurgan, L; Sokolowski, B; Uversky, V				Peng, Zhenling; Sakai, Yoshihisa; Kurgan, Lukasz; Sokolowski, Bernd; Uversky, Vladimir			Intrinsic Disorder in the BK Channel and Its Interactome	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; SEQUENCE-BASED PREDICTION; C-TERMINAL DOMAIN; MOLECULAR RECOGNITION; CONDUCTANCE-VOLTAGE; POTASSIUM CHANNEL; FLEXIBLE NETS; WEB SERVER; PROTEINS; BINDING	The large-conductance Ca2+-activated K+ (BK) channel is broadly expressed in various mammalian cells and tissues such as neurons, skeletal and smooth muscles, exocrine cells, and sensory cells of the inner ear. Previous studies suggest that BK channels are promiscuous binders involved in a multitude of protein-protein interactions. To gain a better understanding of the potential mechanisms underlying BK interactions, we analyzed the abundance, distribution, and potential mechanisms of intrinsic disorder in 27 BK channel variants from mouse cochlea, 104 previously reported BK-associated proteins (BKAPS) from cytoplasmic and membrane/cytoskeletal regions, plus BK beta- and gamma-subunits. Disorder was evaluated using the MFDp algorithm, which is a consensus-based predictor that provides a strong and competitive predictive quality and PONDR, which can determine long intrinsically disordered regions (IDRs). Disorder-based binding sites or molecular recognition features (MoRFs) were found using MoRFpred and ANCHOR. BKAP functions were categorized based on Gene Ontology (GO) terms. The analyses revealed that the BK variants contain a number of IDRs. Intrinsic disorder is also common in BKAPs, of which similar to 5% are completely disordered. However, intrinsic disorder is very differently distributed within BK and its partners. Approximately 65% of the disordered segments in BK channels are long (IDRs) (>50 residues), whereas >60% of the disordered segments in BKAPs are short IDRs that range in length from 4 to 30 residues. Both alpha and gamma subunits showed various amounts of disorder as did hub proteins of the BK interactome. Our analyses suggest that intrinsic disorder is important for the function of BK and its BKAPs. Long IDRs in BK are engaged in protein-protein and protein-ligand interactions, contain multiple post-translational modification sites, and are subjected to alternative splicing. The disordered structure of BK and its BKAPs suggests one of the underlying mechanisms of their interaction.	[Peng, Zhenling; Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Sakai, Yoshihisa; Sokolowski, Bernd] Univ S Florida, Dept Otolaryngol Head & Neck Surg, Morsani Coll Med, Tampa, FL 33606 USA; [Uversky, Vladimir] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir] Univ S Florida, Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Uversky, Vladimir] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	University of Alberta; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; King Abdulaziz University; Russian Academy of Sciences	Sokolowski, B (corresponding author), Univ S Florida, Dept Otolaryngol Head & Neck Surg, Morsani Coll Med, Tampa, FL 33606 USA.	bsokolow@health.usf.edu	Peng, Zhenling/I-3745-2014; Kurgan, Lukasz/B-5721-2009; Uversky, Vladimir N./F-4515-2011	Kurgan, Lukasz/0000-0002-7749-0314; Uversky, Vladimir N./0000-0002-4037-5857; Peng, Zhenling/0000-0003-0303-6693	Russian Academy of Sciences for "Molecular and Cellular Biology"; Alberta Innovates Graduate Scholarship in Omics; Natural Sciences and Engineering Research Council (NSERC); NIH/NIDCD [R01 DC004295]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004295] Funding Source: NIH RePORTER	Russian Academy of Sciences for "Molecular and Cellular Biology"; Alberta Innovates Graduate Scholarship in Omics; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Programs of the Russian Academy of Sciences for "Molecular and Cellular Biology" (V. U.), the Alberta Innovates Graduate Scholarship in Omics (Z.P.), a Natural Sciences and Engineering Research Council (NSERC) Discovery grant (L. K.), and NIH/NIDCD grant R01 DC004295 (B. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Buljan M, 2013, CURR OPIN STRUC BIOL, V23, P443, DOI 10.1016/j.sbi.2013.03.006; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen RS, 2011, J GEN PHYSIOL, V138, P593, DOI 10.1085/jgp.201110707; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Disfani FM, 2012, MORFPRED COMPUTATION; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Gonzalez-Perez V, 2012, NATURE, V485, P133, DOI 10.1038/nature10994; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Johansson F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-388; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Magidovich E, 2006, BIOINFORMATICS, V22, P1546, DOI 10.1093/bioinformatics/btl137; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Monastyrskyy B, 2013, PROTEINS; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Peng Z, 2013, CELL DEATH DIFFER, V20, P1257, DOI 10.1038/cdd.2013.65; Peng Z, 2013, CELL MOL LIFE SCI; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Povarova OI, 2013, INTRINSICALLY DISORD, V1; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Roy S, 2006, COMPUT BIOL CHEM, V30, P241, DOI 10.1016/j.compbiolchem.2006.04.005; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Shi P, 2013, BIOCHEM BIOPH RES CO, V437, P408, DOI 10.1016/j.bbrc.2013.06.091; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sokolowski B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028532; Surguchev A, 2012, AM J PHYSIOL-CELL PH, V303, pC143, DOI 10.1152/ajpcell.00062.2012; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Toro L, 2013, PFLUGERS ARCH; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BIOPHYS J, p530A; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang K, 2006, BMC BIOINFORMATICS, V7; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yan J, 2013, BBA-PROTEINS PROTEOM, V1834, P1671, DOI 10.1016/j.bbapap.2013.05.022; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang JY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S7; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	93	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94331	10.1371/journal.pone.0094331	http://dx.doi.org/10.1371/journal.pone.0094331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727949	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200064
J	van den Berg, JP; Westerbeek, EAM; Smits, GP; van der Klis, FRM; Berbers, GAM; van Elburg, RM				van den Berg, Jolice P.; Westerbeek, Elisabeth A. M.; Smits, Gaby P.; van der Klis, Fiona R. M.; Berbers, Guy A. M.; van Elburg, Ruurd M.			Lower Transplacental Antibody Transport for Measles, Mumps, Rubella and Varicella Zoster in Very Preterm Infants	PLOS ONE			English	Article							MENINGITIDIS SEROGROUP C; INFLUENZAE TYPE-B; PLACENTAL-TRANSFER; MATERNAL ANTIBODIES; IMMUNOGLOBULIN-G; GESTATIONAL-AGE; MMR VACCINE; IMMUNITY; VIRUS; NETHERLANDS	Background: Maternal antibodies, transported over the placenta during pregnancy, contribute to the protection of infants from infectious diseases during the first months of life. In term infants, this protection does not last until the first recommended measles-mumps-rubella vaccination at 14 months in the Netherlands, while these viruses still circulate. The aim of the study was to investigate the antibody concentration against measles, mumps, rubella and varicella (MMRV) in mothers and preterm infants or healthy term infants at birth. Methods: Antibody concentrations specific for MMRV were measured in cord blood samples from preterm (gestational age <32 weeks and/or birth weight <1500 g) and term infants, and matched maternal serum samples, using a fluorescent bead-based multiplex immune-assay. Results: Due to lower placental transfer ratios of antibodies against MMRV in 96 preterm infants (range 0.75-0.87) compared to 42 term infants (range 1.39-1.65), the preterm infants showed 1.7-2.5 times lower geometric mean concentrations at birth compared to term infants. Maternal antibody concentration is the most important determinant of infant antibody concentration against MMRV. Conclusions: Preterm infants benefit to a lesser extent from maternal antibodies against measles, mumps, rubella and varicella than term infants, posing them even earlier at risk for infectious diseases caused by these still circulating viruses.	[van den Berg, Jolice P.; Westerbeek, Elisabeth A. M.; van Elburg, Ruurd M.] Vrije Univ Amsterdam, Med Ctr, Div Neonatol, Dept Paediat, Amsterdam, Netherlands; [Smits, Gaby P.; van der Klis, Fiona R. M.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [van Elburg, Ruurd M.] Nutricia Res, Ctr Specialised Nutr, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment; Danone Nutricia	van den Berg, JP (corresponding author), Vrije Univ Amsterdam, Med Ctr, Div Neonatol, Dept Paediat, Amsterdam, Netherlands.	jp.vandenberg@vumc.nl	Van Elburg, Roelof/AAX-1053-2020	van Elburg, Ruurd M/0000-0003-0310-6540				Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS169, DOI 10.1016/j.fertnstert.2008.08.056; Asfaw MM., 2013, NOTES FIELD MEASLES; Blume S, 2010, SOC SCI MED, V71, P1049, DOI 10.1016/j.socscimed.2010.06.023; Borras E, 2012, EPIDEMIOL INFECT, V140, P1599, DOI 10.1017/S0950268811002184; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; CHRISTENSON B, 1990, BIOLOGICALS, V18, P207, DOI 10.1016/1045-1056(90)90008-N; De Haas R, 1999, EPIDEMIOL INFECT, V123, P263, DOI 10.1017/S0950268899002939; de Voer RM, 2009, CLIN INFECT DIS, V49, P58, DOI 10.1086/599347; European Centre for Disease Prevention and Control, 2010, ANN EP REP COMM DIS; European Centre for Disease Prevention and Control, 2013, MEASL RUB MON; Greenland K, 2012, VACCINE, V30, P4676, DOI 10.1016/j.vaccine.2012.04.083; Hahne S, 2010, EMERG INFECT DIS, V16, P567, DOI 10.3201/eid1603.090114; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; Ichikawa T, 2013, PEDIATR INT, V55, P163, DOI 10.1111/ped.12064; Janaszek W, 2003, VACCINE, V21, P2948, DOI 10.1016/S0264-410X(03)00113-0; Jauniaux E, 1995, HUM REPROD, V10, P3297, DOI 10.1093/oxfordjournals.humrep.a135906; KACICA MA, 1995, J MED VIROL, V45, P227, DOI 10.1002/jmv.1890450220; Klinge J, 2000, VACCINE, V18, P3134, DOI 10.1016/S0264-410X(00)00096-7; Leineweber B, 2004, PEDIATR INFECT DIS J, V23, P361, DOI 10.1097/00006454-200404000-00019; Leuridan E, 2012, VACCINE, V30, P5905, DOI 10.1016/j.vaccine.2012.07.035; Linder N, 2000, J PEDIATR-US, V137, P85, DOI 10.1067/mpd.2000.106902; Linder N, 2004, VACCINE, V22, P1509, DOI 10.1016/j.vaccine.2003.10.009; MALDONADO YA, 1995, PEDIATRICS, V96, P447; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Malek A, 2003, VACCINE, V21, P3362, DOI 10.1016/S0264-410X(03)00333-5; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Mollema L, 2013, MEASLE SURVEILLANCE; Muscat M, 2009, LANCET, V373, P383, DOI 10.1016/S0140-6736(08)61849-8; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; National Institute of Public Health and the Environment, 2011, LCI GUID MEASL MORB; Ohsaki M, 1999, SCAND J INFECT DIS, V31, P17, DOI 10.1080/00365549950161826; PABST HF, 1992, PEDIATR INFECT DIS J, V11, P525, DOI 10.1097/00006454-199207000-00004; Pinsky NA, 2003, SCAND J INFECT DIS, V35, P107, DOI 10.1080/0036554021000027008; PITCHERWILMOTT RW, 1980, CLIN EXP IMMUNOL, V41, P303; Redd SC, 2004, J INFECT DIS, V189, pS116, DOI 10.1086/378691; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Smits GP, 2012, CLIN VACCINE IMMUNOL, V19, P396, DOI 10.1128/CVI.05537-11; Strebel P, 2008, VACCINES, P354; Swart E, 2013, MEASLES RUBELLA SURV; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77; van den Hof S, 2002, J INFECT DIS, V186, P1483, DOI 10.1086/344894; van den Hof S, 1999, VACCINE, V18, P931, DOI 10.1016/S0264-410X(99)00348-5; van der Zwet WC, 2002, PEDIATRICS, V109, P79, DOI 10.1542/peds.109.1.79; van Lier A, 2013, VACCINE, V31, P5127, DOI 10.1016/j.vaccine.2013.08.029; Waaijenborg S, 2013, J INFECT DIS, V208, P10, DOI 10.1093/infdis/jit143; Westerbeek EAM, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-46; Whelan J, 2012, EURO SURVEILL, V15; *WHO, 2005, EL MEASL RUB PREV CO; Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5	52	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94714	10.1371/journal.pone.0094714	http://dx.doi.org/10.1371/journal.pone.0094714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728480	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200119
J	Baxt, LA; Goldberg, MB				Baxt, Leigh A.; Goldberg, Marcia B.			Host and Bacterial Proteins That Repress Recruitment of LC3 to Shigella Early during Infection	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; N-WASP; ANTIBACTERIAL AUTOPHAGY; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; CELL LINES; HELA-CELLS; FLEXNERI; PATHOGENS; PHAGOCYTOSIS	Shigella spp. are intracytosolic gram-negative pathogens that cause disease by invasion and spread through the colonic mucosa, utilizing host cytoskeletal components to form propulsive actin tails. We have previously identified the host factor Toca-1 as being recruited to intracellular S. flexneri and being required for efficient bacterial actin tail formation. We show that at early times during infection (40 min.), the type three-secreted effector protein IcsB recruits Toca-1 to intracellular bacteria and that recruitment of Toca-1 is associated with repression of recruitment of LC3, as well as with repression of recruitment of the autophagy marker NDP52, around these intracellular bacteria. LC3 is best characterized as a marker of autophagosomes, but also marks phagosomal membranes in the process LC3-associated phagocytosis. IcsB has previously been demonstrated to be required for S. flexneri evasion of autophagy at late times during infection (4-6 hr) by inhibiting binding of the autophagy protein Atg5 to the Shigella surface protein IcsA (VirG). Our results suggest that IcsB and Toca-1 modulation of LC3 recruitment restricts LC3-associated phagocytosis and/or LC3 recruitment to vacuolar membrane remnants. Together with published results, our findings suggest that IcsB inhibits innate immune responses in two distinct ways, first, by inhibiting LC3-associated phagocytosis and/or LC3 recruitment to vacuolar membrane remnants early during infection, and second, by inhibiting autophagy late during infection.	[Baxt, Leigh A.; Goldberg, Marcia B.] Massachusetts Gen Hosp, Dept Med, Cambridge, MA USA; [Baxt, Leigh A.; Goldberg, Marcia B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Goldberg, MB (corresponding author), Massachusetts Gen Hosp, Dept Med, Cambridge, MA USA.	marcia.goldberg@mgh.harvard.edu	Goldberg, Marcia/U-8604-2019	Baxt, Leigh/0000-0001-8286-3907	National Institutes of Health (NIH) [R01 AI081724, R21 AI083624, F32 AI092967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083624, R01AI081724, F32AI092967] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by National Institutes of Health (NIH) R01 AI081724 (to MBG), NIH R21 AI083624 (to MBG) and NIH F32 AI092967 (to LAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Boyle KB, 2013, CURR OPIN MICROBIOL; Chen Y, 2013, SEMIN CELL DEV BIOL, V24, P280, DOI 10.1016/j.semcdb.2013.01.005; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Lam GY, 2013, AUTOPHAGY, V9, P985, DOI 10.4161/auto.24406; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Yan SL, 2013, J CELL SCI, V126, P1796, DOI 10.1242/jcs.118422	49	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94653	10.1371/journal.pone.0094653	http://dx.doi.org/10.1371/journal.pone.0094653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722587	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100117
J	Burnos, S; Hilfiker, P; Surucu, O; Scholkmann, F; Krayenbuhl, N; Grunwald, T; Sarnthein, J				Burnos, Sergey; Hilfiker, Peter; Sueruecue, Oguzkan; Scholkmann, Felix; Krayenbuehl, Niklaus; Grunwald, Thomas; Sarnthein, Johannes			Human Intracranial High Frequency Oscillations (HFOs) Detected by Automatic Time-Frequency Analysis	PLOS ONE			English	Article							80-500 HZ; TEMPORAL-LOBE; FAST RIPPLES; EEG; EPILEPSY; ELECTROCORTICOGRAPHY; MACROELECTRODES; RESECTION	Objectives: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogenic tissue. The exact characteristics of clinically relevant HFOs and their detection are still to be defined. Methods: We propose a new method for HFO detection, which we have applied to six patient iEEGs. In a first stage, events of interest (EoIs) in the iEEG were defined by thresholds of energy and duration. To recognize HFOs among the EoIs, in a second stage the iEEG was Stockwell-transformed into the time-frequency domain, and the instantaneous power spectrum was parameterized. The parameters were optimized for HFO detection in patient 1 and tested in patients 2-5. Channels were ranked by HFO rate and those with rate above half maximum constituted the HFO area. The seizure onset zone (SOZ) served as gold standard. Results: The detector distinguished HFOs from artifacts and other EEG activity such as interictal epileptiform spikes. Computation took few minutes. We found HFOs with relevant power at frequencies also below the 80-500 Hz band, which is conventionally associated with HFOs. The HFO area overlapped with the SOZ with good specificity. 90% for five patients and one patient was re-operated. The performance of the detector was compared to two well-known detectors. Conclusions: Compared to methods detecting energy changes in filtered signals, our second stage - analysis in the time-frequency domain - discards spurious detections caused by artifacts or sharp epileptic activity and improves the detection of HFOs. The fast computation and reasonable accuracy hold promise for the diagnostic value of the detector.	[Burnos, Sergey; Sueruecue, Oguzkan; Krayenbuehl, Niklaus; Sarnthein, Johannes] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Burnos, Sergey] ETH, Inst Neuroinformat, Zurich, Switzerland; [Hilfiker, Peter; Grunwald, Thomas] Swiss Epilepsy Ctr, Zurich, Switzerland; [Scholkmann, Felix] Univ Zurich Hosp, Dept Neonatol, Biomed Opt Res Lab, CH-8091 Zurich, Switzerland; [Grunwald, Thomas] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Sarnthein, Johannes] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Sarnthein, J (corresponding author), Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland.	johannes.sarnthein@usz.ch	Sarnthein, Johannes/E-7959-2010	Sarnthein, Johannes/0000-0001-9141-381X; Krayenbuehl, Niklaus/0000-0003-1089-221X	Vontobel Stiftung; EMDO Stiftung; Herzog-Egli Stiftung	Vontobel Stiftung; EMDO Stiftung; Herzog-Egli Stiftung	The authors thank Vontobel Stiftung, EMDO Stiftung and Herzog-Egli Stiftung for funding the PhD salary of SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Andrade-Valenca LP, 2011, NEUROLOGY, V77, P524, DOI 10.1212/WNL.0b013e318228bee2; Assous S, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-49; Benar CG, 2010, CLIN NEUROPHYSIOL, V121, P301, DOI 10.1016/j.clinph.2009.10.019; Birot G, 2013, J NEUROSCI METH, V213, P236, DOI 10.1016/j.jneumeth.2012.12.013; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Brazdil M, 2010, EPILEPSY RES, V90, P28, DOI 10.1016/j.eplepsyres.2010.03.003; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chaibi S, 2013, AM J SIGNAL PROCESS, V3, P25, DOI DOI 10.5923/J.AJSP.20130302.02; Cho JR, 2012, J CLIN NEUROL, V8, P22, DOI 10.3988/jcn.2012.8.1.22; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Crepon B, 2010, BRAIN, V133, P33, DOI 10.1093/brain/awp277; Dumpelmann M, 2012, CLIN NEUROPHYSIOL, V123, P1721, DOI 10.1016/j.clinph.2012.02.072; Gardner AB, 2007, CLIN NEUROPHYSIOL, V118, P1134, DOI 10.1016/j.clinph.2006.12.019; Haegelen C, 2013, EPILEPSIA; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Jacobs J, 2010, EPILEPSIA, V51, P573, DOI 10.1111/j.1528-1167.2009.02389.x; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Jacobs J, 2009, BRAIN, V132, P1022, DOI 10.1093/brain/awn351; Jirsch JD, 2006, BRAIN, V129, P1593, DOI 10.1093/brain/awl085; Kalitzin S, 2012, IEEE ENG MED BIO, P1024, DOI 10.1109/EMBC.2012.6346108; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; Kobayashi K, 2010, EPILEPSIA, V51, P2190, DOI 10.1111/j.1528-1167.2010.02565.x; Kral T, 2002, ZBL NEUROCHIR, V63, P106, DOI 10.1055/s-2002-35826; Otsubo H, 2008, CLIN NEUROPHYSIOL, V119, P862, DOI 10.1016/j.clinph.2007.12.014; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Salami P, 2012, J NEUROSCI METH, V211, P265, DOI 10.1016/j.jneumeth.2012.09.003; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Stockwell RG, 2007, FIELDS I COMMUN, V52, P279; Stockwell RG, 2007, DIGIT SIGNAL PROCESS, V17, P371, DOI 10.1016/j.dsp.2006.04.006; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Urrestarazu E, 2007, BRAIN, V130, P2354, DOI 10.1093/brain/awm149; Wellmer J, 2010, NEUROSURGERY, V66, P187, DOI 10.1227/01.NEU.0000359329.92781.B7; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006; Wu JY, 2010, NEUROLOGY, V75, P1686, DOI 10.1212/WNL.0b013e3181fc27d0; Zelmann R, 2012, CLIN NEUROPHYSIOL, V123, P106, DOI [10.1016/j.clinph.2011.06.006, 10.1016/j.clinph.2011.02.022]; Zelmann R, 2010, IEEE ENG MED BIO, P2329, DOI 10.1109/IEMBS.2010.5627464; Zelmann R, 2009, CLIN NEUROPHYSIOL, V120, P1457, DOI 10.1016/j.clinph.2009.05.029; Zijlmans M, 2012, EPILEPSIA, V53, P1799, DOI 10.1111/j.1528-1167.2012.03650.x; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548	41	101	102	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94381	10.1371/journal.pone.0094381	http://dx.doi.org/10.1371/journal.pone.0094381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722663	Green Published, Green Accepted, gold			2022-12-25	WOS:000336909100061
J	Husseiny, MI; Kaye, A; Zebadua, E; Kandeel, F; Ferreri, K				Husseiny, Mohamed I.; Kaye, Alexander; Zebadua, Emily; Kandeel, Fouad; Ferreri, Kevin			Tissue-Specific Methylation of Human Insulin Gene and PCR Assay for Monitoring Beta Cell Death	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; CD8 T-CELLS; TYPE-1; RISK; MOUSE; PATHOGENESIS; PREDICTION; RELATIVES; THERAPY; DISEASE	The onset of metabolic dysregulation in type 1 diabetes (T1D) occurs after autoimmune destruction of the majority of pancreatic insulin-producing beta cells. We previously demonstrated that the DNA encoding the insulin gene is uniquely unmethylated in these cells and then developed a methylation-specific PCR (MSP) assay to identify circulating beta cell DNA in streptozotocin-treated mice prior to the rise in blood glucose. The current study extends to autoimmune non-obese diabetic (NOD) mice and humans, showing in NOD mice that beta cell death occurs six weeks before the rise in blood sugar and coincides with the onset of islet infiltration by immune cells, demonstrating the utility of MSP for monitoring T1D. We previously reported unique patterns of methylation of the human insulin gene, and now extend this to other human tissues. The methylation patterns of the human insulin promoter, intron 1, exon 2, and intron 2 were determined in several normal human tissues. Similar to our previous report, the human insulin promoter was unmethylated in beta cells, but methylated in all other tissues tested. In contrast, intron 1, exon 2 and intron 2 did not exhibit any tissue-specific DNA methylation pattern. Subsequently, a human MSP assay was developed based on the methylation pattern of the insulin promoter and human islet DNA was successfully detected in circulation of T1D patients after islet transplantation therapy. Signal levels of normal controls and pre-transplant samples were shown to be similar, but increased dramatically after islet transplantation. In plasma the signal declines with time but in whole blood remains elevated for at least two weeks, indicating that association of beta cell DNA with blood cells prolongs the signal. This assay provides an effective method to monitor beta cell destruction in early T1D and in islet transplantation therapy.	[Husseiny, Mohamed I.; Kaye, Alexander; Zebadua, Emily; Kandeel, Fouad; Ferreri, Kevin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA; [Husseiny, Mohamed I.] Zagazig Univ, Fac Pharm, Zagazig, Egypt	City of Hope; Beckman Research Institute of City of Hope; Egyptian Knowledge Bank (EKB); Zagazig University	Ferreri, K (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA.	kferreri@coh.org		Elsayed, Mohamed Ibrahim Husseiny/0000-0002-3470-2858; Ferreri, Kevin/0000-0003-0379-0389	Juvenile Diabetes Research Foundation [JDRF 1-2008-1009]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was kindly supported by the Juvenile Diabetes Research Foundation (JDRF 1-2008-1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Burke ZD, 2012, STEM CELL REV REP, V8, P586, DOI 10.1007/s12015-012-9350-2; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Chen Hsin-Wei, 2007, Rev Diabet Stud, V4, P56, DOI 10.1900/RDS.2007.4.56; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Dabelea D, 2012, DIABETOLOGIA, V55, P3359, DOI 10.1007/s00125-012-2719-6; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eisenbarth GS, 2004, ADV EXP MED BIOL, V552, P268; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fisher MM, 2013, ENDOCRINOLOGY; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Husseiny MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047942; Korpos E, 2013, DIABETES, V62, P531, DOI 10.2337/db12-0432; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lebastchi J, 2013, DIABETES, V62, P1676, DOI 10.2337/db12-1207; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Meier JJ, 2012, DIABETOLOGIA; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Sosenko JM, 2013, DIABETES CARE, V36, P2615, DOI 10.2337/dc13-0425; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; VARDI P, 1991, DIABETOLOGIA, V34, P93, DOI 10.1007/BF00500379	31	52	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94591	10.1371/journal.pone.0094591	http://dx.doi.org/10.1371/journal.pone.0094591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722187	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100104
J	Ying, WJ; Sun, JQ; Liu, DR; Hui, XY; Yu, YH; Wang, JY; Wang, XC				Ying, Wenjing; Sun, Jinqiao; Liu, Danru; Hui, Xiaoying; Yu, Yeheng; Wang, Jingyi; Wang, Xiaochuan			Clinical Characteristics and Immunogenetics of BCGosis/BCGitis in Chinese Children: A 6 Year Follow-Up Study	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; BCG; INFECTION; TUBERCULOSIS; GAMMA	In this study, the clinical and immunogenetical features in a cohort of Chinese patients with BCGosis/BCGitis were investigated. For the patients with abnormal immunological functions, Sanger sequencing was used to identify the involved genes. There were 74 confirmed cases of BCGosis/BCGitis during 2007-2012. Classified by infected tissues and organs, no cases only had local infection, 39 patients had a regional infection, 21 patients had a distant infection and 14 patients had a disseminated infection. Thirty-two patients (43.2%) had definitive primary immunodeficiency diseases (PID) and chronic granulomatous disease (CGD) is the most common PID (n = 23, accounted for 71.9% of all PID patients). For CGD patients, based on the anti-tuberculosis treatment, administration of rhIFN-gamma resulted in better control of BCGosis/BCGitis. The results indicate that PIDs are associated with susceptibility to BCG disease. For children with BCGosis/BCGitis, immune function evaluation is necessary, and IFN-gamma treatment for BCGosis/BCGitis patients with CGD is effective.	[Ying, Wenjing; Sun, Jinqiao; Liu, Danru; Hui, Xiaoying; Yu, Yeheng; Wang, Jingyi; Wang, Xiaochuan] Fudan Univ, Dept Clin Immunol, Childrens Hosp, Shanghai 200433, Peoples R China	Fudan University	Wang, XC (corresponding author), Fudan Univ, Dept Clin Immunol, Childrens Hosp, Shanghai 200433, Peoples R China.	xchwang@shmu.edu.cn	WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81172877]; Shanghai Rising-Star Program [11QA1400700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by National Natural Science Foundation of China (81172877) and Shanghai Rising-Star Program (11QA1400700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin A, 1999, CLIN DIAGN LAB IMMUN, V6, P420; Arbelaez MP, 2000, INT J EPIDEMIOL, V29, P1085, DOI 10.1093/ije/29.6.1085; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Chiriaco M, 2009, GENET TEST MOL BIOMA, V13, P785, DOI 10.1089/gtmb.2009.0074; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Grange J M, 1998, Commun Dis Public Health, V1, P84; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Norouzi S, 2012, J INFECTION, V64, P543, DOI 10.1016/j.jinf.2012.03.012; Sologuren I, 2011, HUM MOL GENET, V20, P1509, DOI 10.1093/hmg/ddr029; Sun J, 2012, SCAND J IMMUNOL, V76, P512, DOI 10.1111/j.1365-3083.2012.02772.x; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; World Health Organization, SAF BCG VACC HIV INF	18	44	54	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94485	10.1371/journal.pone.0094485	http://dx.doi.org/10.1371/journal.pone.0094485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722620	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100079
J	Drewes, JL; Szeto, GL; Engle, EL; Liao, ZH; Shearer, GM; Zink, MC; Graham, DR				Drewes, Julia L.; Szeto, Gregory L.; Engle, Elizabeth L.; Liao, Zhaohao; Shearer, Gene M.; Zink, M. Christine; Graham, David R.			Attenuation of Pathogenic Immune Responses during Infection with Human and Simian Immunodeficiency Virus (HIV/SIV) by the Tetracycline Derivative Minocycline	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NONPATHOGENIC SIV INFECTION; CD4(+) T-CELLS; INTERFERON-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; LYMPHOID-TISSUE; HIV-INFECTION; UP-REGULATION; LIGAND TRAIL; CASPASE-3 EXPRESSION	HIV immune pathogenesis is postulated to involve two major mechanisms: 1) chronic innate immune responses that drive T cell activation and apoptosis and 2) induction of immune regulators that suppress T cell function and proliferation. Both arms are elevated chronically in lymphoid tissues of non-natural hosts, which ultimately develop AIDS. However, these mechanisms are not elevated chronically in natural hosts of SIV infection that avert immune pathogenesis despite similarly high viral loads. In this study we investigated whether minocycline could modulate these pathogenic antiviral responses in non-natural hosts of HIV and SIV. We found that minocycline attenuated in vitro induction of type I interferon (IFN) and the IFN-stimulated genes indoleamine 2,3-dioxygenase (IDO1) and TNF-related apoptosis inducing ligand (TRAIL) in human plasmacytoid dendritic cells and PBMCs exposed to aldrithiol-2 inactivated HIV or infectious influenza virus. Activation-induced TRAIL and expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4) in isolated CD4+ T cells were also reduced by minocycline. Translation of these in vitro findings to in vivo effects, however, were mixed as minocycline significantly reduced markers of activation and activation-induced cell death (CD25, Fas, caspase-3) but did not affect expression of IFN beta or the IFN-stimulated genes IDO1, FasL, or Mx in the spleens of chronically SIV-infected pigtailed macaques. TRAIL expression, reflecting the mixed effects of minocycline on activation and type I IFN stimuli, was reduced by half, but this change was not significant. These results show that minocycline administered after infection may protect against aspects of activation-induced cell death during HIV/SIV immune disease, but that in vitro effects of minocycline on type I IFN responses are not recapitulated in a rapid progressor model in vivo.	[Drewes, Julia L.; Szeto, Gregory L.; Engle, Elizabeth L.; Liao, Zhaohao; Zink, M. Christine; Graham, David R.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Shearer, Gene M.] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Graham, David R.] Johns Hopkins Sch Med, Div Cardiol, Dept Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine	Zink, MC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	mczink@jhmi.edu; dgraham@jhmi.edu	Szeto, Gregory/N-9648-2019	Szeto, Gregory/0000-0001-7604-1333; Drewes, Julia/0000-0002-5060-0624	NIH [R1MH087233, R1MH085554, R1NS055648]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P40RR019995]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085554, R01MH087233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055648] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD013117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following NIH grants: R1MH087233, R1MH085554, and R1NS055648, as well as the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P40RR019995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Bel M, 2011, VIRUSES-BASEL, V3, P312, DOI 10.3390/v3040312; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Campbell JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018688; Campillo-Gimenez L, 2010, J VIROL, V84, P1838, DOI 10.1128/JVI.01496-09; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chege D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013077; Chehimi J, 2010, J VIROL, V84, P2762, DOI 10.1128/JVI.01350-09; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chu HC, 2005, BRIT J PHARMACOL, V144, P275, DOI 10.1038/sj.bjp.0706079; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Dockrell DH, 1999, AIDS RES HUM RETROV, V15, P1509, DOI 10.1089/088922299309793; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Dutta K, 2010, J NEUROIMMUNE PHARM, V5, P553, DOI 10.1007/s11481-010-9233-8; Enose-Akahata Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-16; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fernandez-Gomez FJ, 2005, NEUROSCIENCE, V133, P959, DOI 10.1016/j.neuroscience.2005.03.019; FERNANDEZCRUZ E, 1995, AIDS, V9, P1025, DOI 10.1097/00002030-199509000-00007; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujikura D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055321; Gasper-Smith N, 2008, J VIROL, V82, P7700, DOI 10.1128/JVI.00605-08; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gibellini D, 2007, J MED VIROL, V79, P1446, DOI 10.1002/jmv.20938; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2009, AIDS, V23, P35, DOI 10.1097/QAD.0b013e32831cb907; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Ho EL, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-17; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jenabian MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078146; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Joks R, 2010, INT IMMUNOL, V22, P281, DOI 10.1093/intimm/dxq004; Kader M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003530; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Katabira ET, 1998, SEX TRANSM INFECT, V74, P265, DOI 10.1136/sti.74.4.265; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kim N, 2007, J VIROL, V81, P7584, DOI 10.1128/JVI.02616-06; Kloppenburg M, 1996, ANTIMICROB AGENTS CH, V40, P934, DOI 10.1128/AAC.40.4.934; Kloppenburg M, 1995, CLIN EXP IMMUNOL, V102, P635; KRAUS G, 1989, P NATL ACAD SCI USA, V86, P2892, DOI 10.1073/pnas.86.8.2892; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee SM, 2010, IMMUNOL LETT, V132, P53, DOI 10.1016/j.imlet.2010.05.008; Lehmann C, 2008, JAIDS-J ACQ IMM DEF, V48, P522, DOI 10.1097/QAI.0b013e31817f97cf; Lehmann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011110; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043211; Liegler TJ, 1998, J INFECT DIS, V178, P669, DOI 10.1086/515378; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD H, 1973, CLIN PHARMACOL THER, V14, P852; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Manches O, 2012, P NATL ACAD SCI USA, V109, P14122, DOI 10.1073/pnas.1204032109; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Meulendyke KA, 2012, J NEUROIMMUNE PHARM, V7, P454, DOI 10.1007/s11481-011-9332-1; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Nakasujja N, 2013, NEUROLOGY, V80, P196, DOI 10.1212/WNL.0b013e31827b9121; Naura AS, 2013, J BIOL CHEM, V288, P1458, DOI 10.1074/jbc.M112.419580; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Nikodemova M, 2006, J NEUROCHEM, V96, P314, DOI 10.1111/j.1471-4159.2005.03520.x; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Noble W, 2009, FASEB J, V23, P739, DOI 10.1096/fj.08-113795; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pang T, 2012, BBA-GEN SUBJECTS, V1820, P503, DOI 10.1016/j.bbagen.2012.01.011; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Ravimohan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042801; Reeves RK, 2007, VIROLOGY, V365, P356, DOI 10.1016/j.virol.2007.03.055; Reeves RK, 2012, J INFECT DIS, V206, P1462, DOI 10.1093/infdis/jis408; Rey-Cuille MA, 1998, J VIROL, V72, P3872; RIVERO J, 1994, BIOTHERAPY, V8, P23, DOI 10.1007/BF01878118; Ronquillo RE, 2010, JAIDS-J ACQ IMM DEF, V54, P110, DOI 10.1097/QAI.0b013e3181cbd469; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sandbulte MR, 2008, VIROLOGY, V381, P22, DOI 10.1016/j.virol.2008.08.018; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Singh M, 2014, IMMUNOLOGY; Skillman DR, 1996, J INFECT DIS, V173, P1107, DOI 10.1093/infdis/173.5.1107; Stary G, 2009, BLOOD, V114, P3854, DOI 10.1182/blood-2009-04-217927; Szeto GL, 2011, J BIOL CHEM; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Tai K, 2012, TRANSL RES; Tai K, 2013, TRANSL RES, V161, P99, DOI 10.1016/j.trsl.2012.10.001; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang RX, 2001, J IMMUNOL, V166, P1983, DOI 10.4049/jimmunol.166.3.1983; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	122	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94375	10.1371/journal.pone.0094375	http://dx.doi.org/10.1371/journal.pone.0094375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732038	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400034
J	Heuberger, M; Saglam, M; Todd, NS; Jahn, K; Schneider, E; Lehnen, N				Heuberger, Maria; Saglam, Murat; Todd, Nicholas S.; Jahn, Klaus; Schneider, Erich; Lehnen, Nadine			Covert Anti-Compensatory Quick Eye Movements during Head Impulses	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; DIAGNOSTIC-CRITERIA; VESTIBULAR MIGRAINE; VIDEO-OCULOGRAPHY; SACCADES; ACCURACY	Background: Catch-up saccades during passive head movements, which compensate for a deficient vestibulo-ocular reflex (VOR), are a well-known phenomenon. These quick eye movements are directed toward the target in the opposite direction of the head movement. Recently, quick eye movements in the direction of the head movement (covert anti-compensatory quick eye movements, CAQEM) were observed in older individuals. Here, we characterize these quick eye movements, their pathophysiology, and clinical relevance during head impulse testing (HIT). Methods: Video head impulse test data from 266 patients of a tertiary vertigo center were retrospectively analyzed. Forty-three of these patients had been diagnosed with vestibular migraine, and 35 with Meniere's disease. Results: CAQEM occurred in 38% of the patients. The mean CAQEM occurrence rate (per HIT trial) was 11 +/- 10% (mean +/- SD). Latency was 83 +/- 30 ms. CAQEM followed the saccade main sequence characteristics and were compensated by catch-up saccades in the opposite direction. Compensatory saccades did not lead to more false pathological clinical head impulse test assessments (specificity with CAQEM: 87%, and without: 85%). CAQEM on one side were associated with a lower VOR gain on the contralateral side (p<0.004) and helped distinguish Meniere's disease from vestibular migraine (p = 0.01). Conclusion: CAQEM are a common phenomenon, most likely caused by a saccadic/quick phase mechanism due to gain asymmetries. They could help differentiate two of the most common causes of recurrent vertigo: vestibular migraine and Meniere's disease.	[Heuberger, Maria; Saglam, Murat; Todd, Nicholas S.; Jahn, Klaus; Schneider, Erich; Lehnen, Nadine] Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Heuberger, Maria; Jahn, Klaus; Lehnen, Nadine] Munich Univ Hosp, Dept Neurol, Munich, Germany; [Schneider, Erich] Munich Univ Hosp, Inst Clin Neurosci, Munich, Germany; [Schneider, Erich] Brandenburg Inst Technol, Cottbus, Germany	University of Munich; University of Munich; University of Munich	Heuberger, M (corresponding author), Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany.	maria.heuberger@med.uni-muenchen.de	Jahn, Klaus/AAC-4969-2021; Saglam, Murat/L-3123-2014; Jahn, Klaus/F-9902-2010	Saglam, Murat/0000-0001-8766-3883; Jahn, Klaus/0000-0002-1669-3652	German Federal Ministry of Education and Research [01 EO 0901]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research was supported by the German Federal Ministry of Education and Research (Grant 01 EO 0901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2014, OTOL NEUROTOL, V35, P283, DOI 10.1097/MAO.0b013e3182995227; Aw ST, 1996, J NEUROPHYSIOL, V76, P4009, DOI 10.1152/jn.1996.76.6.4009; BARNES GR, 1979, J PHYSIOL-LONDON, V287, P127, DOI 10.1113/jphysiol.1979.sp012650; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; BOGHEN D, 1974, INVEST OPHTH VISUAL, V13, P619; Fife TD, 2000, NEUROLOGY, V55, P1431, DOI 10.1212/WNL.55.10.1431; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hufner K, 2008, NEUROLOGY, V71, P1006, DOI 10.1212/01.wnl.0000326594.91291.f8; Jorns-Haderli M, 2007, J NEUROL NEUROSUR PS, V78, P1113, DOI 10.1136/jnnp.2006.109512; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; Schmid-Priscoveanu A, 2001, JARO-J ASSOC RES OTO, V2, P72, DOI 10.1007/s101620010060; Schneider E, 2004, NEUROLOGY, V63, P1209, DOI 10.1212/01.WNL.0000141144.02666.8C; Tian JR, 2001, EXP BRAIN RES, V137, P309, DOI 10.1007/s002210000671; Weber KP, 2008, NEUROLOGY, V70, P454, DOI 10.1212/01.wnl.0000299117.48935.2e; Weber KP, 2009, NEUROLOGY, V72, P1417, DOI 10.1212/WNL.0b013e3181a18652; Weber KP, 2008, PROG BRAIN RES, V171, P195, DOI 10.1016/S0079-6123(08)00626-2; Zingler VC, 2007, ANN NEUROL, V61, P524, DOI 10.1002/ana.21105	20	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93086	10.1371/journal.pone.0093086	http://dx.doi.org/10.1371/journal.pone.0093086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732783	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400005
J	Horn, H; Bausinger, J; Staiger, AM; Sohn, M; Schmelter, C; Gruber, K; Kalla, C; Ott, MM; Rosenwald, A; Ott, G				Horn, Heike; Bausinger, Julia; Staiger, Annette M.; Sohn, Maximilian; Schmelter, Christopher; Gruber, Kim; Kalla, Claudia; Ott, M. Michaela; Rosenwald, Andreas; Ott, German			Numerical and Structural Genomic Aberrations Are Reliably Detectable in Tissue Microarrays of Formalin-Fixed Paraffin-Embedded Tumor Samples by Fluorescence In-Situ Hybridization	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; AMPLIFICATIONS; ABNORMALITIES; DELETIONS	Few data are available regarding the reliability of fluorescence in-situ hybridization (FISH), especially for chromosomal deletions, in high-throughput settings using tissue microarrays (TMAs). We performed a comprehensive FISH study for the detection of chromosomal translocations and deletions in formalin-fixed and paraffin-embedded (FFPE) tumor specimens arranged in TMA format. We analyzed 46 B-cell lymphoma (B-NHL) specimens with known karyotypes for translocations of IGH-, BCL2-, BCL6- and MYC-genes. Locus-specific DNA probes were used for the detection of deletions in chromosome bands 6q21 and 9p21 in 62 follicular lymphomas (FL) and six malignant mesothelioma (MM) samples, respectively. To test for aberrant signals generated by truncation of nuclei following sectioning of FFPE tissue samples, cell line dilutions with 9p21-deletions were embedded into paraffin blocks. The overall TMA hybridization efficiency was 94%. FISH results regarding translocations matched karyotyping data in 93%. As for chromosomal deletions, sectioning artefacts occurred in 17% to 25% of cells, suggesting that the proportion of cells showing deletions should exceed 25% to be reliably detectable. In conclusion, FISH represents a robust tool for the detection of structural as well as numerical aberrations in FFPE tissue samples in a TMA-based high-throughput setting, when rigorous cut-off values and appropriate controls are maintained, and, of note, was superior to quantitative PCR approaches.	[Horn, Heike; Bausinger, Julia; Staiger, Annette M.; Sohn, Maximilian; Gruber, Kim; Kalla, Claudia; Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Horn, Heike; Bausinger, Julia; Staiger, Annette M.; Sohn, Maximilian; Gruber, Kim; Kalla, Claudia; Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schmelter, Christopher; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Ott, M. Michaela] Caritas Hosp, Inst Pathol, Bad Mergentheim, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Caritas Hospital Bad Mergentheim	Ott, G (corresponding author), Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany.	german.ott@rbk.de			Robert-Bosch-Stiftung (Stuttgart, Germany)	Robert-Bosch-Stiftung (Stuttgart, Germany)	This study was supported by the Robert-Bosch-Stiftung (Stuttgart, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth TFE, 2013, PATHOLOGE, V34, P329, DOI 10.1007/s00292-012-1719-0; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Brown LA, 2007, J MOL HISTOL, V38, P151, DOI 10.1007/s10735-006-9069-y; Bubendorf L, 1999, CANCER RES, V59, P803; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; CHENG JQ, 1994, CANCER RES, V54, P5547; Dierlamm J, 1997, GENE CHROMOSOME CANC, V20, P155, DOI 10.1002/(SICI)1098-2264(199710)20:2<155::AID-GCC6>3.0.CO;2-2; Gao JS, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-33; Graham RPD, 2011, AM J SURG PATHOL, V35, P1615, DOI 10.1097/PAS.0b013e3182284a3f; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Krismann M, 2002, J PATHOL, V197, P363, DOI 10.1002/path.1128; Leich E, 2009, BLOOD, V114, P826, DOI 10.1182/blood-2009-01-198580; LICHTER P, 1995, METHOD ENZYMOL, V254, P334; Nordgren A, 2002, EUR J HAEMATOL, V68, P31, DOI 10.1034/j.1600-0609.2002.00547.x; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Stocklein H, 2008, ONCOGENE, V27, P2613, DOI 10.1038/sj.onc.1210901; Swerdlow E., 2008, WHO CLASSIFICATION T; Tanaka K, 1999, CANCER GENET CYTOGEN, V115, P32, DOI 10.1016/S0165-4608(99)00079-5; Travis W, 2004, WHO CLASSIFICATION T; van Rijk Anke, 2008, J Hematop, V1, P119, DOI 10.1007/s12308-008-0017-5; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Wilkens L, 2005, VIRCHOWS ARCH, V447, P586, DOI 10.1007/s00428-005-1211-9	23	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95047	10.1371/journal.pone.0095047	http://dx.doi.org/10.1371/journal.pone.0095047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733537	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400149
J	Klinshov, VV; Teramae, JN; Nekorkin, VI; Fukai, T				Klinshov, Vladimir V.; Teramae, Jun-nosuke; Nekorkin, Vladimir I.; Fukai, Tomoki			Dense Neuron Clustering Explains Connectivity Statistics in Cortical Microcircuits	PLOS ONE			English	Article							RAT VISUAL-CORTEX; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; WORKING-MEMORY; ADULT-RAT; NETWORK; CIRCUIT; ORGANIZATION; VARIABILITY; SPECIFICITY	Local cortical circuits appear highly non-random, but the underlying connectivity rule remains elusive. Here, we analyze experimental data observed in layer 5 of rat neocortex and suggest a model for connectivity from which emerge essential observed non-random features of both wiring and weighting. These features include lognormal distributions of synaptic connection strength, anatomical clustering, and strong correlations between clustering and connection strength. Our model predicts that cortical microcircuits contain large groups of densely connected neurons which we call clusters. We show that such a cluster contains about one fifth of all excitatory neurons of a circuit which are very densely connected with stronger than average synapses. We demonstrate that such clustering plays an important role in the network dynamics, namely, it creates bistable neural spiking in small cortical circuits. Furthermore, introducing local clustering in large-scale networks leads to the emergence of various patterns of persistent local activity in an ongoing network activity. Thus, our results may bridge a gap between anatomical structure and persistent activity observed during working memory and other cognitive processes.	[Klinshov, Vladimir V.; Nekorkin, Vladimir I.] Russian Acad Sci, Inst Appl Phys, Nonlinear Dynam Dept, Nizhnii Novgorod, Russia; [Klinshov, Vladimir V.; Teramae, Jun-nosuke; Fukai, Tomoki] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Klinshov, Vladimir V.; Nekorkin, Vladimir I.] Univ Nizhni Novgorod, Lab Nonlinear Oscillatory Wave Phys, Nizhnii Novgorod, Russia; [Teramae, Jun-nosuke] Osaka Univ, Dept Bioinformat Engn, Suita, Osaka, Japan; [Teramae, Jun-nosuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Nekorkin, Vladimir I.] Univ Nizhni Novgorod, Dept Oscillat Theory & Automat Control, Nizhnii Novgorod, Russia; [Fukai, Tomoki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; RIKEN; Lobachevsky State University of Nizhni Novgorod; Osaka University; Japan Science & Technology Agency (JST); Lobachevsky State University of Nizhni Novgorod; Japan Science & Technology Agency (JST)	Klinshov, VV (corresponding author), Russian Acad Sci, Inst Appl Phys, Nonlinear Dynam Dept, Nizhnii Novgorod, Russia.	vladimir.klinshov@gmail.com	Nekorkin, Vladimir/AAS-5232-2020; Klinshov, Vladimir V./M-6226-2014; Fukai, Tomoki/A-3936-2015	Nekorkin, Vladimir/0000-0003-0173-587X; Fukai, Tomoki/0000-0001-6977-5638; Teramae, Jun-nosuke/0000-0003-3255-0253	JST CREST program; JST PRESTO program; KAKENHI [25430028, 22115013]; JSPS [PE 11052]; Russian Foundation for Basic Research [12-02-00526, 12-04-31963, 13-02-00858, 13-02-97050, 14-02-00042, 14-02-31873]	JST CREST program(Core Research for Evolutional Science and Technology (CREST)Japan Science & Technology Agency (JST)); JST PRESTO program; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was partially supported by JST CREST and PRESTO programs as well as by KAKENHI (25430028 to J.T. and 22115013 to T.F.), JSPS Fellowship (PE 11052 to V. V. K.), and the Russian Foundation for Basic Research (12-02-00526, 12-04-31963, 13-02-00858, 13-02-97050, 14-02-00042 and 14-02-31873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Braitenberg V, 1991, ANATOMY CORTEX STAT; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fukai T, 1997, NEURAL COMPUT, V9, P77, DOI 10.1162/neco.1997.9.1.77; GABBOTT PLA, 1987, NEUROSCIENCE, V21, P833, DOI 10.1016/0306-4522(87)90040-6; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Gaiteri C, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00010; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Hiratani N, 2013, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00102; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Ikegaya Y, 2013, CEREB CORTEX, V23, P293, DOI 10.1093/cercor/bhs006; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kitano K, 2007, J COMPUT NEUROSCI, V23, P237, DOI 10.1007/s10827-007-0030-1; Klinshov VV, 2008, NETWORK-COMP NEURAL, V19, P119, DOI 10.1080/09548980801895452; Klinshov VV, 2008, INT J BIFURCAT CHAOS, V18, P2743, DOI 10.1142/S0218127408021968; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 2011, FRONT NEURAL CIRCUIT, V108, P5419; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Okamoto H, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000404; Pajevic S, 2012, NAT PHYS, DOI 1038/nphys2257; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; PETERS A, 1987, J COMP NEUROL, V260, P573, DOI 10.1002/cne.902600410; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; REN JQ, 1992, EXP BRAIN RES, V92, P1; Rockland KS, 2004, EXP BRAIN RES, V158, P265, DOI 10.1007/s00221-004-2024-9; Scott BH, 2012, P NATL ACAD SCI USA, V109, P12237, DOI 10.1073/pnas.1209685109; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; SZENTAGOTHAI J, 1990, Acta Morphologica Hungarica, V38, P159; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x; Wang LP, 2012, J COGNITIVE NEUROSCI, V24, P664, DOI 10.1162/jocn_a_00169; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhao Liqiong, 2011, Front Comput Neurosci, V5, P28, DOI 10.3389/fncom.2011.00028	64	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94292	10.1371/journal.pone.0094292	http://dx.doi.org/10.1371/journal.pone.0094292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732632	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400027
J	Chen, AP; Lichstein, JW; Osnas, JLD; Pacala, SW				Chen, Anping; Lichstein, Jeremy W.; Osnas, Jeanne L. D.; Pacala, Stephen W.			Species-Independent Down-Regulation of Leaf Photosynthesis and Respiration in Response to Shading: Evidence from Six Temperate Tree Species	PLOS ONE			English	Article							DARK RESPIRATION; LIGHT-INTENSITY; ECOSYSTEM DYNAMICS; BIOSPHERE MODEL; CARBON BALANCE; SPRUCE TWIGS; SUN; LEAVES; ACCLIMATION; GROWTH	The ability to down-regulate leaf maximum net photosynthetic capacity (Amax) and dark respiration rate (Rdark) in response to shading is thought to be an important adaptation of trees to the wide range of light environments that they are exposed to across space and time. A simple, general rule that accurately described this down-regulation would improve carbon cycle models and enhance our understanding of how forest successional diversity is maintained. In this paper, we investigated the light response of Amax and Rdark for saplings of six temperate forest tree species in New Jersey, USA, and formulated a simple model of down-regulation that could be incorporated into carbon cycle models. We found that full-sun values of Amax and Rdark differed significantly among species, but the rate of down-regulation (proportional decrease in Amax or Rdark relative to the full-sun value) in response to shade was not significantly species-or taxon-specific. Shade leaves of sun-grown plants appear to follow the same pattern of down-regulation in response to shade as leaves of shade-grown plants. Given the light level above a leaf and one species-specific number (either the full-sun Amax or full-sun Rdark), we provide a formula that can accurately predict the leaf's Amax and Rdark. We further show that most of the down regulation of per unit area Rdark and Amax is caused by reductions in leaf mass per unit area (LMA): as light decreases, leaves get thinner, while per unit mass Amax and Rdark remain approximately constant.	[Chen, Anping; Lichstein, Jeremy W.; Osnas, Jeanne L. D.; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Chen, AP (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	anpingc@Princeton.EDU	Chen, Anping/H-9960-2014; Lichstein, Jeremy/GMW-6555-2022	Chen, Anping/0000-0003-2085-3863; 	Carbon Mitigation Initiative (CMI) of the Princeton Environmental Institute; BP; Ford	Carbon Mitigation Initiative (CMI) of the Princeton Environmental Institute; BP; Ford	Funding was provided by the Carbon Mitigation Initiative (CMI) of the Princeton Environmental Institute. CMI is sponsored by BP and Ford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, FOREST ECOL MANAG, V31, P245, DOI 10.1016/0378-1127(90)90072-J; BAKER F. S., 1949, JOUR FOREST, V47, P179; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BAZZAZ FA, 1982, OECOLOGIA, V54, P313, DOI 10.1007/BF00379999; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BJORKMAN O, 1968, PHYSIOL PLANTARUM, V21, P1, DOI 10.1111/j.1399-3054.1968.tb07225.x; Bolker BM, 2006, ECOLOGICAL MODELS DA; Bossel H, 1996, ECOL MODEL, V90, P187, DOI 10.1016/0304-3800(95)00139-5; BROOKS JR, 1991, TREE PHYSIOL, V9, P325, DOI 10.1093/treephys/9.3.325; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Comeau PG, 1998, CAN J FOREST RES, V28, P1843, DOI 10.1139/cjfr-28-12-1843; ELLSWORTH DS, 1994, CAN J FOREST RES, V24, P2118, DOI 10.1139/x94-272; ELLSWORTH DS, 1993, OECOLOGIA, V96, P169, DOI 10.1007/BF00317729; Fisher JB, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003621; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Friend AD, 1997, ECOL MODEL, V95, P249, DOI 10.1016/S0304-3800(96)00034-8; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Herrick JD, 1999, TREE PHYSIOL, V19, P779; Huxman TE, 1998, PLANT CELL ENVIRON, V21, P1275, DOI 10.1046/j.1365-3040.1998.00396.x; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kitajima K, 2002, AM J BOT, V89, P1925, DOI 10.3732/ajb.89.12.1925; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; Koike T, 2001, TREE PHYSIOL, V21, P951, DOI 10.1093/treephys/21.12-13.951; Lange OL, 1986, TREES-STRUCT FUNCT, V1, P70, DOI 10.1007/BF00197027; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; MASAROVICOVA E, 1990, BIOL PLANTARUM, V32, P374, DOI 10.1007/BF02898503; MENG FR, 1993, CAN J FOREST RES, V23, P716, DOI 10.1139/x93-093; Miller J.H., 1990, SILVICS N AM, P461; Mitchell KA, 1999, TREE PHYSIOL, V19, P861; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Noguchi K, 2005, PLANT CELL ENVIRON, V28, P760, DOI 10.1111/j.1365-3040.2005.01322.x; O'Grady AP, 2008, FUNCT PLANT BIOL, V35, P439, DOI 10.1071/FP08127; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Pemac D, 1998, PLANT SYST EVOL, V209, P159, DOI 10.1007/BF00985227; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Reich PB, 1998, OECOLOGIA, V114, P471, DOI 10.1007/s004420050471; SAITO H, 1999, J FOR RES, V4, P27; SELLERS PJ, 1992, REMOTE SENS ENVIRON, V42, P187, DOI 10.1016/0034-4257(92)90102-P; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; SIMS DA, 1991, OECOLOGIA, V86, P447, DOI 10.1007/BF00317615; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; STRAUSSDEBENEDETTI S, 1991, OECOLOGIA, V87, P377, DOI 10.1007/BF00634595; Thornton PE, 2007, J CLIMATE, V20, P3902, DOI 10.1175/JCLI4222.1; Van Oijen M, 2010, ANN BOT-LONDON, V105, P793, DOI 10.1093/aob/mcq039; WALLACE LL, 1980, OECOLOGIA, V45, P331, DOI 10.1007/BF00540201; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Zaehle S, 2010, CYCLES, V24	48	11	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e91798	10.1371/journal.pone.0091798	http://dx.doi.org/10.1371/journal.pone.0091798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727745	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200006
J	Ding, MZ; Zou, Y; Song, H; Yuan, YJ				Ding, Ming-Zhu; Zou, Yang; Song, Hao; Yuan, Ying-Jin			Metabolomic Analysis of Cooperative Adaptation between Co-Cultured Bacillus cereus and Ketogulonicigenium vulgare	PLOS ONE			English	Article							MICROBIAL CONSORTIUM; KETOGULONIGENIUM-VULGARE; MYXOCOCCUS-XANTHUS; SWARMING MOTILITY; GENE-EXPRESSION; SPORULATION; SUBTILIS; EVOLUTION; MEGATERIUM	The cooperative adaptation of subcultivated Bacillus cereus and Ketogulonicigenium vulgare significantly increased the productivity of 2-keto-L-gulonic acid, the precursor of vitamin C. The mechanism of cooperative adaptation of the serial subcultivated B. cereus and K vulgare was investigated in this study by culturing the two strains orthogonally on agar plates. It was found that the swarming distance of cereus along the trace of K. vulgare on the plate decreased after 150 days' subcultivation. Metabolomic analysis on these co-cultured B. cereus and K. vulgare strains showed that their cooperative adaptation was accomplished by three key events: (i) the ability of nutrients (e.g., amino acids and purines) searching and intaking, and proteins. biosynthesis is increased in the evolved B. cereus, he capability of protein degradation and amino acids transportation is enhanced in evolved K. vulgare; (iii) the evolved B. cereus was found to provide more nutrients (mostly amino acids and purines) to K. vulgare, thus strengthening the oxidation and energy generation of K. vulgare. Our results provided novel insights into the systems-level understanding of he cooperative adaptation between strains in synergistic consortium.	[Ding, Ming-Zhu; Zou, Yang; Song, Hao; Yuan, Ying-Jin] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Ding, Ming-Zhu; Zou, Yang; Song, Hao; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Ding, Ming-Zhu; Zou, Yang; Song, Hao; Yuan, Ying-Jin] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Song, Hao/G-6207-2010	Song, Hao/0000-0001-5553-2539	National Basic Research Program of China ("973" Program) [2013CB733600]; National High Technology Research and Development Program ("863" Program) [2012AA02A701]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China)	This work was funded by the National Basic Research Program of China ("973" Program: 2013CB733600) and the National High Technology Research and Development Program ("863" Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding MZ, 2012, METABOLOMICS, V8, P232, DOI 10.1007/s11306-011-0303-6; Ding MZ, 2010, OMICS, V14, P553, DOI 10.1089/omi.2010.0015; Ding MZ, 2010, METABOLOMICS, V6, P42, DOI 10.1007/s11306-009-0173-3; Du J, 2012, METABOLOMICS, V8, P960, DOI 10.1007/s11306-011-0392-2; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Horemans B, 2013, FEMS MICROBIOL ECOL, V84, P24, DOI 10.1111/1574-6941.12033; Hosoya S, 2007, J BACTERIOL, V189, P2561, DOI 10.1128/JB.01738-06; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Leduc S, 2004, APPL MICROBIOL BIOT, V65, P163, DOI 10.1007/s00253-004-1562-1; Ma Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091789; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032156; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rath CM, 2011, ACS CHEM BIOL, V6, P1244, DOI 10.1021/cb200244t; RHAESE HJ, 1979, P NATL ACAD SCI USA, V76, P842, DOI 10.1073/pnas.76.2.842; Salvetti S, 2011, APPL ENVIRON MICROB, V77, P5149, DOI 10.1128/AEM.00245-11; Senesi S, 2002, MICROBIOL-SGM, V148, P1785, DOI 10.1099/00221287-148-6-1785; Smid EJ, 2013, CURR OPIN BIOTECH, V24, P148, DOI 10.1016/j.copbio.2012.11.007; Takagi Y, 2010, APPL MICROBIOL BIOT, V86, P469, DOI 10.1007/s00253-009-2312-1; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Velicer GJ, 2002, J BACTERIOL, V184, P2719, DOI 10.1128/JB.184.10.2719-2727.2002; Waller AS, 2012, APPL ENVIRON MICROB, V78, P1178, DOI 10.1128/AEM.06416-11; Wang LJ, 2007, J BACTERIOL, V189, P8467, DOI 10.1128/JB.01285-07; Zhang J, 2010, PROCESS BIOCHEM, V45, P602, DOI 10.1016/j.procbio.2009.11.016; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11; Zou W, 2013, CRIT REV MICROBIOL, V39, P247, DOI 10.3109/1040841X.2012.706250; Zou Y, 2013, BIORESOURCE TECHNOL, V132, P370, DOI 10.1016/j.biortech.2012.10.151	30	18	22	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94889	10.1371/journal.pone.0094889	http://dx.doi.org/10.1371/journal.pone.0094889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728527	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200139
J	Gu, L; Smith, S; Li, C; Hickey, RJ; Stark, JM; Fields, GB; Lang, WH; Sandoval, JA; Malkas, LH				Gu, Long; Smith, Shanna; Li, Caroline; Hickey, Robert J.; Stark, Jeremy M.; Fields, Gregg B.; Lang, Walter H.; Sandoval, John A.; Malkas, Linda H.			A PCNA-Derived Cell Permeable Peptide Selectively Inhibits Neuroblastoma Cell Growth	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; BREAK REPAIR PATHWAYS; DNA-REPLICATION; C-MYC; PROGNOSTIC-FACTOR; IN-VITRO; BINDING; CANCER; PROTEINS; DIFFERENTIATION	Proliferating cell nuclear antigen (PCNA), through its interaction with various proteins involved in DNA synthesis, cell cycle regulation, and DNA repair, plays a central role in maintaining genome stability. We previously reported a novel cancer associated PCNA isoform (dubbed caPCNA), which was significantly expressed in a broad range of cancer cells and tumor tissues, but not in non-malignant cells. We found that the caPCNA-specific antigenic site lies between L126 and Y133, a region within the interconnector domain of PCNA that is known to be a major binding site for many of PCNA's interacting proteins. We hypothesized that therapeutic agents targeting protein-protein interactions mediated through this region may confer differential toxicity to normal and malignant cells. To test this hypothesis, we designed a cell permeable peptide containing the PCNA L126-Y133 sequence. Here, we report that this peptide selectively kills human neuroblastoma cells, especially those with MYCN gene amplification, with much less toxicity to non-malignant human cells. Mechanistically, the peptide is able to block PCNA interactions in cancer cells. It interferes with DNA synthesis and homologous recombination-mediated double-stranded DNA break repair, resulting in S-phase arrest, accumulation of DNA damage, and enhanced sensitivity to cisplatin. These results demonstrate conceptually the utility of this peptide for treating neuroblastomas, particularly, the unfavorable MYCN-amplified tumors.	[Gu, Long; Smith, Shanna; Li, Caroline; Malkas, Linda H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Hickey, Robert J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA USA; [Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA USA; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Lang, Walter H.; Sandoval, John A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Torrey Pines Institute for Molecular Studies, Florida; St Jude Children's Research Hospital	Gu, L (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	lgu@coh.org			Department of Defense [W81XWH-11-1-0786]; National Institutes of Health/National Cancer Institute [R01 CA121289, RO1CA120954]; St Baldrick' Foundation; ANNA Fund; National Cancer Institute of the National Institutes of Health [P30CA033572]; NATIONAL CANCER INSTITUTE [R01CA121289, P30CA033572, R01CA120954] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St Baldrick' Foundation; ANNA Fund; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research awards to LHM from the Department of Defense (W81XWH-11-1-0786), National Institutes of Health/National Cancer Institute (R01 CA121289), St Baldrick' Foundation (www.stbaldricks.org), and the ANNA Fund (www.annafund.com) and by the National Institutes of Health/National Cancer Institute grant RO1CA120954 to JMS. In addition, research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under grant number P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1993, ANTICANCER RES, V13, P533; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhatnagar SN, 2012, INDIAN J PEDIATR, V79, P787, DOI 10.1007/s12098-012-0748-2; Bozza WP, 2012, ANAL BIOCHEM, V427, P69, DOI 10.1016/j.ab.2012.04.018; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; CHALLBERG MD, 1982, ANNU REV BIOCHEM, V51, P901, DOI 10.1146/annurev.bi.51.070182.004345; Chu JS, 1998, CANCER LETT, V131, P145, DOI 10.1016/S0304-3835(98)00118-9; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; De Bernardi B, 2009, J CLIN ONCOL, V27, P1034, DOI 10.1200/JCO.2008.17.5877; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ducoux M, 2001, J BIOL CHEM, V276, P49258, DOI 10.1074/jbc.M106990200; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Hashimoto Y, 2012, NAT STRUCT MOL BIOL, V19, P17, DOI 10.1038/nsmb.2177; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hoelz DJ, 2006, PROTEOMICS, V6, P4808, DOI 10.1002/pmic.200600142; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; MALKAS LH, 1990, BIOCHEMISTRY-US, V29, P6362, DOI 10.1021/bi00479a004; Malkas LH, 2006, P NATL ACAD SCI USA, V103, P19472, DOI 10.1073/pnas.0604614103; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070430; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Petroni M, 2011, MOL CANCER RES, V9, P67, DOI 10.1158/1541-7786.MCR-10-0227; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Stevenson CL, 2009, CURR PHARM BIOTECHNO, V10, P122, DOI 10.2174/138920109787048634; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; TAHAN SR, 1993, CANCER, V71, P3552, DOI 10.1002/1097-0142(19930601)71:11<3552::AID-CNCR2820711115>3.0.CO;2-N; Tan ZQ, 2012, MOL PHARMACOL, V81, P811, DOI 10.1124/mol.112.077735; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yu Un-Young, 2008, Cancer Res Treat, V40, P27, DOI 10.4143/crt.2008.40.1.27; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	54	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94773	10.1371/journal.pone.0094773	http://dx.doi.org/10.1371/journal.pone.0094773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728180	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200129
J	Guenette, S; Meissa, B; Gascuel, D				Guenette, Sylvie; Meissa, Beyah; Gascuel, Didier			Assessing the Contribution of Marine Protected Areas to the Trophic Functioning of Ecosystems: A Model for the Banc d'Arguin and the Mauritanian Shelf	PLOS ONE			English	Article							SPILLOVER; FISHERIES; RESERVES; FISH; ABUNDANCE; PATTERNS; ECOSPACE; ADJACENT; EFFICACY; ECOPATH	Most modelling studies addressed the effectiveness of marine protected areas (MPA) for fisheries sustainability through single species approach. Only a few models analysed the potential benefits of MPAs at the ecosystem level, estimating the potential export of fish biomass from the reserve or analysing the trophic relationships between organisms inside and outside the MPA. Here, we propose to use food web models to assess the contribution of a MPA to the trophic functioning of a larger ecosystem. This approach is applied to the Banc d'Arguin National Park, a large MPA located on the Mauritanian shelf. The ecosystem was modeled using Ecopath with Ecosim, a model that accounts for fisheries, food web structure, and some aspects of the spatial distribution of species, for the period 1991-2006. Gaps in knowledge and uncertainty were taken into account by building three different models. Results showed that the Banc d'Arguin contributes about 9 to 13% to the total consumption, is supporting about 23% of the total production and 18% of the total catch of the Mauritanian shelf ecosystem, and up to 50% for coastal fish. Of the 29 exploited groups, 15 depend on the Banc for more than 30% of their direct or indirect consumptions. Between 1991 and 2006, the fishing pressure increased leading to a decrease in biomass and the catch of high trophic levels, confirming their overall overexploitation. Ecosim simulations showed that adding a new fleet in the Banc d'Arguin would have large impacts on the species with a high reliance on the Banc for food, resulting in a 23% decrease in the current outside MPA catches. We conclude on the usefulness of food web models to assess MPAs contribution to larger ecosystem functioning.	[Guenette, Sylvie; Meissa, Beyah; Gascuel, Didier] Univ Europeenne Bretagne, UMR Agrocampus Ouest Inra Ecol & Sante Ecosyst, Rennes, France; [Meissa, Beyah] IMROP, Nouadhibou, Mauritania	INRAE; Institut Agro; Agrocampus Ouest; Universite de Bretagne Occidentale	Guenette, S (corresponding author), EcOceans, St Andrews, NB, Canada.	sylvie.guenette@gmail.com	Gascuel, Didier/C-1439-2011; martel, celine/O-6651-2016	Gascuel, Didier/0000-0001-5447-6977; martel, celine/0000-0002-1800-4558	ANR (Agence Nationale de la Recherche, in France) [ANR-07-BDIV-009-05]	ANR (Agence Nationale de la Recherche, in France)(French National Research Agency (ANR))	This study was part of the Project AMPHORE (AMP et gestion Halieutique par Optimisation des Ressources et des Ecosystemes), funded by ANR (Agence Nationale de la Recherche, in France) under contract ANR-07-BDIV-009-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2010, MAR ECOL PROG SER, V412, P207, DOI 10.3354/meps08679; Boely T, 1982, RAPP P V REUNI CONS, V180, P350; Botsford LW, 2006, EXP WORKSH MAR PROT, P825; Brey T, 2002, POPULATION DYNAMICS; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2004, COLLECTION RAPPORTS; Colleter M, 2012, ECOL MODEL, V232, P1, DOI 10.1016/j.ecolmodel.2012.01.019; DUINEVELD GCA, 1993, HYDROBIOLOGIA, V258, P107, DOI 10.1007/BF00006190; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Failler P, 2005, CINQUIEME GROUPE TRA; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Gasche L, 2012, J MARINE SYST, V90, P1, DOI 10.1016/j.jmarsys.2011.07.012; Gascuel D, 2007, AFR J MAR SCI, V29, P331, DOI 10.2989/AJMS.2007.29.3.3.333; Gascuel D, 2005, ICES J MAR SCI, V62, P443, DOI 10.1016/j.icesjms.2004.12.013; Gascuel D, 2009, ECOTROPH TROPHIC LEV, V17; Gascuel D, 2007, RECONSTRUCTION MARIN, P105; Gascuel D, 2008, ECOL MODEL, V217, P33, DOI 10.1016/j.ecolmodel.2008.05.012; GERLACH SA, 1971, OECOLOGIA, V6, P176, DOI 10.1007/BF00345719; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Halpern BS, 2003, ECOL APPL, V13, pS117; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hart DR, 2006, CAN J FISH AQUAT SCI, V63, P1445, DOI 10.1139/F06-071; JAGER Z, 1993, HYDROBIOLOGIA, V258, P185, DOI 10.1007/BF00006196; Jarre-Teichmann A, 1996, MASS BALANCE MODELS, V4, P38; Josse E, 1986, DESCRIPTION EVALUATI; Kaplan DM, 2009, MAR ECOL PROG SER, V377, P213, DOI 10.3354/meps07825; Labrosse P, 2010, ACT 6 GROUP TRAV IMR; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lubchenco J, 2003, ECOL APPL, V13, pS3; Ly A, 2009, THESIS MUSEUM NATL H; Martell SJD, 2005, CAN J FISH AQUAT SCI, V62, P1320, DOI 10.1139/F05-114; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Meissa B, 2013, AFR J MAR SCI, V35, P253, DOI 10.2989/1814232X.2013.798244; Mesnildrey L, 2013, AQUAT LIVING RESOUR, V26, P159, DOI 10.1051/alr/2013056; Millar RB, 1999, AUST NZ J STAT, V41, P383, DOI 10.1111/1467-842X.00092; Morissette L, 2010, MAR ECOL PROG SER, V404, P289, DOI 10.3354/meps08443; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; NCEAS National Center for Ecological Analysis and Synthesis, 2001, SCI CONS STAT MAR RE; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Pitchford JW, 2007, ECOL MODEL, V207, P286, DOI 10.1016/j.ecolmodel.2007.05.006; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Savina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061207; Sidi MM, 2003, FISH BIODIVERSITY LO, V14, P89; Taleb ould, 2003, MODELE ECOTROPHIQUE, V12, P4; Taleb ould, 2003, MODELE TROPHIQUE ZEE, p[12, 12]; Valls A, 2012, MAR ECOL PROG SER, V456, P201, DOI 10.3354/meps09701; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Walters CJ, 2007, CAN J FISH AQUAT SCI, V64, P1009, DOI 10.1139/F07-072; WOLFF WJ, 1993, HYDROBIOLOGIA, V258, P151, DOI 10.1007/BF00006193; WOLFF WJ, 1993, HYDROBIOLOGIA, V258, P211, DOI 10.1007/BF00006198; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	55	16	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94742	10.1371/journal.pone.0094742	http://dx.doi.org/10.1371/journal.pone.0094742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728033	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200125
J	Yang, XJ; Brisbin, J; Yu, H; Wang, Q; Yin, FG; Zhang, YG; Sabour, P; Sharif, S; Gong, J				Yang, Xiaojian; Brisbin, Jennifer; Yu, Hai; Wang, Qi; Yin, Fugui; Zhang, Yonggang; Sabour, Parviz; Sharif, Shayan; Gong, Joshua			Selected Lactic Acid-Producing Bacterial Isolates with the Capacity to Reduce Salmonella Translocation and Virulence Gene Expression in Chickens	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLANDS 1; SPENT MEDIA; PROBIOTICS; INVASION; HILA; COLONIZATION; GROWTH; SOPE2; AVRA	Background: Probiotics have been used to control Salmonella colonization/infection in chickens. Yet the mechanisms of probiotic effects are not fully understood. This study has characterized our previously-selected lactic acid-producing bacterial (LAB) isolates for controlling Salmonella infection in chickens, particularly the mechanism underlying the control. Methodology/Principal Findings: In vitro studies were conducted to characterize 14 LAB isolates for their tolerance to low pH (2.0) and high bile salt (0.3-1.5%) and susceptibility to antibiotics. Three chicken infection trials were subsequently carried out to evaluate four of the isolates for reducing the burden of Salmonella enterica serovar Typhimurium in the broiler cecum. Chicks were gavaged with LAB cultures (10(6-7) CFU/chick) or phosphate-buffered saline (PBS) at 1 day of age followed by Salmonella challenge (10(4) CFU/chick) next day. Samples of cecal digesta, spleen, and liver were examined for Salmonella counts on days 1, 3, or 4 post-challenge. Salmonella in the cecum from Trial 3 was also assessed for the expression of ten virulence genes located in its pathogenicity island-1 (SPI-1). These genes play a role in Salmonella intestinal invasion. Tested LAB isolates (individuals or mixed cultures) were unable to lower Salmonella burden in the chicken cecum, but able to attenuate Salmonella infection in the spleen and liver. The LAB treatments also reduced almost all SPI-1 virulence gene expression (9 out of 10) in the chicken cecum, particularly at the low dose. In vitro treatment with the extracellular culture fluid from a LAB culture also down-regulated most SPI-1 virulence gene expression. Conclusions/Significance: The possible correlation between attenuation of Salmonella infection in the chicken spleen and liver and reduction of Salmonella SPI-1 virulence gene expression in the chicken cecum by LAB isolates is a new observation. Suppression of Salmonella virulence gene expression in vivo can be one of the strategies for controlling Salmonella infection in chickens.	[Yang, Xiaojian; Yu, Hai; Wang, Qi; Yin, Fugui; Zhang, Yonggang; Sabour, Parviz; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Brisbin, Jennifer; Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; University of Guelph	Gong, J (corresponding author), Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada.	joshua.gong@agr.gc.ca		Wang, Qi/0000-0002-4926-4555	Agriculture & Agri-Food Canada; Ontario Ministry of Agriculture and Food Research - Food Safety Research Program	Agriculture & Agri-Food Canada(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture and Food Research - Food Safety Research Program	This research was supported by Agriculture & Agri-Food Canada and Ontario Ministry of Agriculture and Food Research - Food Safety Research Program. XY was a NSERC Visiting Fellows to the Canadian Federal Government Laboratories (NSERC-VF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OP SCI COMM AN NUTR; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Barrow PA., 2010, PATHOGENESIS BACTERI, P231, DOI [10.1002/9780470958209.ch14, DOI 10.1002/9780470958209.CH14]; Bayoumi MA, 2012, INT J FOOD MICROBIOL, V156, P255, DOI 10.1016/j.ijfoodmicro.2012.03.034; Bayoumi MA, 2010, J FOOD PROTECT, V73, P452, DOI 10.4315/0362-028X-73.3.452; Botteldoorn N, 2006, J MICROBIOL METH, V66, P125, DOI 10.1016/j.mimet.2005.11.003; Boyen F, 2008, VET MICROBIOL, V132, P319, DOI 10.1016/j.vetmic.2008.05.008; Boyen F, 2007, THESIS GHENT U GHENT; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Chambers JR, 2011, FOOD RES INT, V44, P3149, DOI 10.1016/j.foodres.2011.08.017; Choi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037059; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; Das JK, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-11; DAWSON PA, 1998, SLEISENGER FORDTRANS, P1052; Desin TS, 2013, EXPERT REV VACCINES, V12, P87, DOI [10.1586/ERV.12.138, 10.1586/erv.12.138]; Durant JA, 2000, J ENVIRON SCI HEAL B, V35, P599, DOI 10.1080/03601230009373295; Durant JA, 2000, J FOOD PROTECT, V63, P573, DOI 10.4315/0362-028X-63.5.573; Durant JA, 2000, J APPL MICROBIOL, V89, P63, DOI 10.1046/j.1365-2672.2000.01089.x; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; Haghighi HR, 2008, VET MICROBIOL, V126, P225, DOI 10.1016/j.vetmic.2007.06.026; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Hung CC, 2013, MOL MICROBIOL, V87, P1045, DOI 10.1111/mmi.12149; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; LEWUS CB, 1991, J MICROBIOL METH, V13, P145, DOI 10.1016/0167-7012(91)90014-H; Libby J. S., 2004, PATHOGENESIS BACTERI, P143; Lim S, 2006, RADIAT RES, V165, P430, DOI 10.1667/RR3507.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010505; MEAD GC, 1989, J FOOD PROTECT, V52, P500, DOI 10.4315/0362-028X-52.7.500; Mead GC, 2000, VET J, V159, P111, DOI 10.1053/tvjl.1999.0423; Medellin-Pena MJ, 2007, APPL ENVIRON MICROB, V73, P4259, DOI 10.1128/AEM.00159-07; Mizusaki H, 2008, J BACTERIOL, V190, P4624, DOI 10.1128/JB.01957-07; Nutt JD, 2002, J FOOD SAFETY, V22, P169, DOI 10.1111/j.1745-4565.2002.tb00339.x; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Ryan KA, 2009, J MED MICROBIOL, V58, P996, DOI 10.1099/jmm.0.009407-0; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Tsai YT, 2012, APPL MICROBIOL BIOT, V96, P853, DOI 10.1007/s00253-012-4407-3; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; Vandeplas S, 2010, J FOOD PROTECT, V73, P774, DOI 10.4315/0362-028X-73.4.774; Vikram A, 2012, APPL ENVIRON MICROB, V78, P7012, DOI 10.1128/AEM.01326-12; Wang CY, 2011, J FOOD PROTECT, V74, P86, DOI 10.4315/0362-028X.JFP-10-155; Wang Q, 2009, J APPL MICROBIOL, V107, P1781, DOI 10.1111/j.1365-2672.2009.04374.x; Wang YB, 2010, RES VET SCI, V89, P163, DOI 10.1016/j.rvsc.2010.03.009; Wang YP, 2009, VET MICROBIOL, V133, P328, DOI 10.1016/j.vetmic.2008.07.012; Wu HX, 2012, CELL MICROBIOL, V14, P28, DOI 10.1111/j.1462-5822.2011.01694.x	54	39	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93022	10.1371/journal.pone.0093022	http://dx.doi.org/10.1371/journal.pone.0093022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728092	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200013
J	Jiang, ZY; Yin, J; Fu, WF; Mo, YJ; Pan, YG; Dai, L; Huang, HD; Li, SW; Zhao, J				Jiang, Zeyong; Yin, Jun; Fu, Wenfan; Mo, Yijun; Pan, Youguang; Dai, Lu; Huang, Haoda; Li, Siwen; Zhao, Jian			miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MICRORNA CLUSTER; STEM-CELLS; CANCER; EXPRESSION; MIR-17-92; AXIS; EMT	MicroRNAs (miRNAs) have been proven to play crucial roles in cancer, including tumor chemotherapy resistance and metastasis of non-small-cell lung cancer (NSCLC). TGF beta signal pathway abnormality is widely found in cancer and correlates with tumor proliferation, apoptosis and metastasis. Here, miR-17, 20a, 20b were detected down-regulated in A549/DDP cells (cisplatin resistance) compared with A549 cells (cisplatin sensitive). Over-expression of miR-17, 20a, 20b can not only decrease cisplatin-resistant but also reduce migration by inhibiting epithelial-to-mesenchymal transition (EMT) in A549/DDP cells. These functions of miR-17, 20a, 20b may be caused at least in part via inhibition of TGF beta signal pathway, as miR-17, 20a, 20b are shown to directly target and repress TGF-beta receptor 2 (TGF beta R2) which is an important component of TGF beta signal pathway. Consequently, our study suggests that miRNA 17 family (including miR-17, 20a, 20b) can act as TGF beta R2 suppressor for reversing cisplatin-resistant and suppressing metastasis in NSCLC.	[Jiang, Zeyong; Yin, Jun; Fu, Wenfan; Mo, Yijun; Pan, Youguang; Dai, Lu; Huang, Haoda; Li, Siwen; Zhao, Jian] Guangzhou Med Univ, Ctr Canc, Dept Chest Surg, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zhao, J (corresponding author), Guangzhou Med Univ, Ctr Canc, Dept Chest Surg, Guangzhou, Guangdong, Peoples R China.	tottijun@163.com			Science and Technology Plan Project of Guangdong Province in China [2011B061300040, 2012B061700048]; Medical Science and Technology Project of Guangzhou City in China [20131A011163]	Science and Technology Plan Project of Guangdong Province in China; Medical Science and Technology Project of Guangzhou City in China	This research was supported by grants from the Science and Technology Plan Project of Guangdong Province in China (2011B061300040, 2012B061700048), Medical Science and Technology Project of Guangzhou City in China (20131A011163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi WR, 2012, HEPATO-GASTROENTEROL, V59, P1960, DOI 10.5754/hge11750; Chang CC, 2013, ORAL ONCOL, V49, P923, DOI 10.1016/j.oraloncology.2013.03.430; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Edme N, 2002, J CELL SCI, V115, P2591; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Judson I, 2000, DRUGS, V59, P29, DOI 10.2165/00003495-200059004-00004; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Rudd R, 1991, RESP DIS PRACTICE, V7, P12; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramaniam Sangeetha, 2013, J Carcinog, V12, P3, DOI 10.4103/1477-3163.107958; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Tan M, 2013, TOXICOL LETT, V223, P1, DOI 10.1016/j.toxlet.2013.08.011; Visbal AL, 2005, CHEST, V128, P2933, DOI 10.1378/chest.128.4.2933	31	73	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94639	10.1371/journal.pone.0094639	http://dx.doi.org/10.1371/journal.pone.0094639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722426	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100112
J	Nilsson, C; Waldo, ML; Nilsson, K; Santillo, A; Vestberg, S				Nilsson, Christer; Waldo, Maria Landqvist; Nilsson, Karin; Santillo, Alexander; Vestberg, Susanna			Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry	PLOS ONE			English	Article							EARLY-ONSET DEMENTIAS; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; PREVALENCE; DIAGNOSIS; EPIDEMIOLOGY; RELATIVES; ACCURACY; GENETICS	Objectives: Frontotemporal dementia (FTD) is considered to be a mainly early-onset neurodegenerative disorder with a strong hereditary component. The aim of the study was to investigate age-related incidence and family history in FTD compared to other dementia disorders, especially Alzheimer's disease (AD). Methods: The Swedish Dementia Registry (SveDem) registers all new cases of dementia diagnosed by the participating centres, including data on demographics, diagnosis, and investigations used. Data for the period 2008-2011 were extracted and compared with age-related population data on a regional and national level. Results: There were 20 305 patients registered in SveDem during 2008-2011, whereof 352 received a diagnosis of FTD. Mean age at diagnosis for FTD was 69.6 years and almost 70% of FTD cases were 65 years or older at the time of diagnosis. Both FTD and AD showed an increased incidence with age, which reached a maximum in the age group 80-84 years at 6.04 and 202 cases per 100 000 person-years, respectively. The proportion of cases with a positive family history was significantly lower in FTD than in AD. Conclusions: Contrary to general opinion within the field, data from SveDem show that the incidence of FTD increases with age, and that the majority of cases are diagnosed after the age of 65 years. In addition, data from SveDem might suggest that the importance of hereditary factors in general is similar in FTD and AD. The recognition of these findings has important consequences for the diagnosis, treatment and care of patients with FTD.	[Nilsson, Christer; Waldo, Maria Landqvist; Nilsson, Karin; Santillo, Alexander] Skane Univ Hosp, Dept Memory Disorders, Lund, Sweden; [Nilsson, Christer; Santillo, Alexander] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Waldo, Maria Landqvist; Nilsson, Karin; Vestberg, Susanna] Lund Univ, Dept Clin Sci, Geriatr Psychiat Unit, Lund, Sweden; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University	Nilsson, C (corresponding author), Skane Univ Hosp, Dept Memory Disorders, Lund, Sweden.	christer.nilsson@med.lu.se	Landqvist, Maria/B-6270-2019	Landqvist, Maria/0000-0003-3262-8938; Santillo, Alexander/0000-0001-9717-0820	Skane Regional Council; Lund University	Skane Regional Council; Lund University	The study was funded by grants from the regional agreement on medical training and clinical research (ALF) between the Skane Regional Council and Lund University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baborie A, 2012, ARCH NEUROL-CHICAGO, V69, P1052, DOI 10.1001/archneurol.2011.3323; Baborie A, 2011, ACTA NEUROPATHOL, V121, P365, DOI 10.1007/s00401-010-0765-z; Berg L, 2001, Lakartidningen, V98, P3531; Borroni B, 2010, J ALZHEIMERS DIS, V19, P111, DOI 10.3233/JAD-2010-1208; Boxer AL, 2013, LANCET NEUROL, V12, P149, DOI 10.1016/S1474-4422(12)70320-4; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; de Simone V, 2007, DEMENT GERIATR COGN, V23, P1, DOI 10.1159/000096317; Garre-Olmo J, 2010, NEUROLOGY, V75, P1249, DOI 10.1212/WNL.0b013e3181f5d4c4; Grasbeck A, 2005, DEMENT GERIATR COGN, V19, P145, DOI 10.1159/000082886; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Hodges JR, 2010, BRAIN, V133, P300, DOI 10.1093/brain/awp248; Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lobo A, 2000, NEUROLOGY S5, P54; Lovestone S, 2009, LISHMANS ORGANIC PSY, P543; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Paulson HL, 2011, SEMIN NEUROL, V31, P449, DOI 10.1055/s-0031-1299784; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Religa D, 2012, DEMENT GERIATR COGN, V33, P90, DOI 10.1159/000337038; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Seelaar H, 2008, NEUROLOGY, V71, P1220, DOI 10.1212/01.wnl.0000319702.37497.72; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541	37	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94901	10.1371/journal.pone.0094901	http://dx.doi.org/10.1371/journal.pone.0094901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722237	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100144
J	Pal, SK; Ruel, N; Villegas, S; Chang, M; DeWalt, K; Wilson, TG; Vogelzang, NJ; Yuh, BE				Pal, Sumanta K.; Ruel, Nora; Villegas, Sergio; Chang, Mark; DeWalt, Kara; Wilson, Timothy G.; Vogelzang, Nicholas J.; Yuh, Bertram E.			CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer	PLOS ONE			English	Article							CISPLATIN-BASED CHEMOTHERAPY; GLOMERULAR-FILTRATION-RATE; UROTHELIAL CARCINOMA; SERUM CREATININE; THERAPY; UNFIT	Clinical guidelines suggest neoadjuvant cisplatin-based chemotherapy prior to cystectomy in the setting of muscle-invasive bladder cancer (MIBC). A creatinine clearance (CrCl) >60 mL/min is frequently used to characterize cisplatin-eligible patients, and use of the CKD-EPI equation to estimate CrCl has been advocated. From a prospectively maintained institutional database, patients with MIBC who received cystectomy were identified and clinicopathologic information was ascertained. CrCl prior to surgery was computed using three equations: (1) Cockcroft-Gault (CG), (2) CKD-EPI, and (3) MDRD. The primary objective was to determine if the CG and CKD-EPI equations identified a different proportion of patients who were cisplatin-eligible, based on an estimated CrCl of >60 mL/min. Cisplatin-eligibility was also assessed in subsets based on age, CCI score and race. Actuarial rates of neoadjuvant cisplatin-based chemotherapy use were also reported. Of 126 patients, 70% and 71% of patients were found to be cisplatin-eligible by the CKD-EPI and CG equations, respectively (P = 0.9). The MDRD did not result in significantly different characterization of cisplatin-eligibility as compared to the CKD-EPI and CG equations. In the subset of patients age >80, the CKD-EPI equation identified a much smaller proportion of cisplatin-eligible patients (25%) as compared to the CG equation (50%) or the MDRD equation (63%). Only 34 patients (27%) received neoadjuvant cisplatin-based chemotherapy. Of the 92 patients who did not receive neoadjuvant chemotherapy, 64% had a CrCl >60 mL/min by CG. In contrast to previous reports, the CKD-EPI equation does not appear to characterize a broader span of patients as cisplatin-eligible. Older patients (age >80) may less frequently be characterized as cisplatin-eligible by CKD-EPI. The discordance between actual rates of neoadjuvant chemotherapy use and rates of cisplatin eligibility suggest that other factors (e. g., patient and physician preference) may guide clinical decision-making.	[Pal, Sumanta K.; Villegas, Sergio; Chang, Mark; DeWalt, Kara] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA; [Ruel, Nora] City Hope Comprehens Canc Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA; [Wilson, Timothy G.; Yuh, Bertram E.] City Hope Comprehens Canc Ctr, Dept Surg, Div Urol, Duarte, CA USA; [Vogelzang, Nicholas J.] US Oncol Res, Ctr Comprehens Canc, Las Vegas, NV USA	City of Hope; City of Hope; City of Hope; US Oncology Network	Pal, SK (corresponding author), City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA.	spal@coh.org		Ruel, Nora/0000-0002-4591-3618	NIH [K12 2K12CA001727-16A1]; NATIONAL CANCER INSTITUTE [K12CA001727, P30CA033572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K12 2K12CA001727-16A1 (SKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EUR UROL, V48, P202; [Anonymous], 2005, EUR UROL, V48, pdiscussion; [Anonymous], 2013, NCCN CLIN PRACT GUID; Bellmunt J, 2000, J CLIN ONCOL, V18, P3247, DOI 10.1200/JCO.2000.18.18.3247; Fedeli U, 2011, J UROLOGY, V185, P72, DOI 10.1016/j.juro.2010.09.015; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Galsky MD, 2011, LANCET ONCOL, V12, P211, DOI 10.1016/S1470-2045(10)70275-8; GOLDBERG TH, 1987, ARCH INTERN MED, V147, P1430, DOI 10.1001/archinte.147.8.1430; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; OSTROW S, 1980, CANCER, V46, P1715, DOI 10.1002/1097-0142(19801015)46:8<1715::AID-CNCR2820460802>3.0.CO;2-H; Pal SK, 2013, J NATL COMPR CANC NE, V11, P793, DOI 10.6004/jnccn.2013.0101; Pal SK, 2012, CLIN GENITOURIN CANC, V10, P246, DOI 10.1016/j.clgc.2012.08.004; Qu AQ, 2013, ASCO M, V31, P4530; Raj GV, 2011, CANCER-AM CANCER SOC, V117, P276, DOI 10.1002/cncr.25429; ROSSOF AH, 1979, CANCER TREAT REP, V63, P1557; Siefker-Radtke AO, 2012, CANCER; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Tsao CK, 2012, CLIN GENITOURIN CANC, V10, P15, DOI 10.1016/j.clgc.2011.10.004; Yuh BE, 2012, J UROL	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94471	10.1371/journal.pone.0094471	http://dx.doi.org/10.1371/journal.pone.0094471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722472	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100075
J	Porru, S; Pavanello, S; Carta, A; Arici, C; Simeone, C; Izzotti, A; Mastrangelo, G				Porru, Stefano; Pavanello, Sofia; Carta, Angela; Arici, Cecilia; Simeone, Claudio; Izzotti, Alberto; Mastrangelo, Giuseppe			Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling	PLOS ONE			English	Article							WHITE BLOOD-CELLS; POLYCYCLIC AROMATIC-HYDROCARBONS; RISK-ASSESSMENT; SMOKING; XRCC1; EPIDEMIOLOGY; EXPOSURES; BENZO<A>PYRENE; LYMPHOCYTES; SMOKERS	DNA adducts are considered an integrate measure of carcinogen exposure and the initial step of carcinogenesis. Their levels in more accessible peripheral blood lymphocytes (PBLs) mirror that in the bladder tissue. In this study we explore whether the formation of PBL DNA adducts may be associated with bladder cancer (BC) risk, and how this relationship is modulated by genetic polymorphisms, environmental and occupational risk factors for BC. These complex interrelationships, including direct and indirect effects of each variable, were appraised using the structural equation modeling (SEM) analysis. Within the framework of a hospital-based case/control study, study population included 199 BC cases and 213 non-cancer controls, all Caucasian males. Data were collected on lifetime smoking, coffee drinking, dietary habits and lifetime occupation, with particular reference to exposure to aromatic amines (AAs) and polycyclic aromatic hydrocarbons (PAHs). No indirect paths were found, disproving hypothesis on association between PBL DNA adducts and BC risk. DNA adducts were instead positively associated with occupational cumulative exposure to AAs (p = 0.028), whereas XRCC1 Arg 399 (p<0.006) was related with a decreased adduct levels, but with no impact on BC risk. Previous findings on increased BC risk by packyears (p<0.001), coffee (p<0.001), cumulative AAs exposure (p = 0.041) and MnSOD (p = 0.009) and a decreased risk by MPO (p<0.008) were also confirmed by SEM analysis. Our results for the first time make evident an association between occupational cumulative exposure to AAs with DNA adducts and BC risk, strengthening the central role of AAs in bladder carcinogenesis. However the lack of an association between PBL DNA adducts and BC risk advises that these snapshot measurements are not representative of relevant exposures. This would envisage new scenarios for biomarker discovery and new challenges such as repeated measurements at different critical life stages.	[Porru, Stefano; Carta, Angela; Arici, Cecilia] Univ Brescia, Dept Med Surg Specialties Radiol Sci & Publ Hlth, Sect Publ Hlth & Human Sci, Brescia, Italy; [Pavanello, Sofia; Mastrangelo, Giuseppe] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Unit Occupat Med, Padua, Italy; [Simeone, Claudio] Univ Brescia, Dept Med Surg Specialties Radiol Sci & Publ Hlth, Sect Surg Specialties, Brescia, Italy; [Izzotti, Alberto] Univ Genoa, Dept Hlth Sci, I-16126 Genoa, Italy; [Izzotti, Alberto] IRCCS Hosp Univ San Martino Co IST Natl Inst Canc, Mutagenesis Unit, Genoa, Italy	University of Brescia; University of Padua; University of Brescia; University of Genoa	Pavanello, S (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Unit Occupat Med, Padua, Italy.	sofia.pavanello@unipd.it	CARTA, Angela/AAS-4990-2021; Carta, Angela/AAL-5182-2021; Arici, Cecilia/AAO-7689-2020; Simeone, Claudio/R-7485-2019	CARTA, Angela/0000-0002-3620-8765; Arici, Cecilia/0000-0003-1493-590X; Pavanello, Sofia/0000-0002-5229-9900; izzotti, alberto/0000-0002-8588-0347	Italian Ministry of University and Research; University of Brescia	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Brescia	This work was funded by the Italian Ministry of University and Research and by the University of Brescia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2002, CARCINOGENESIS, V23, P861, DOI 10.1093/carcin/23.5.861; ALBERT RE, 1991, CARCINOGENESIS, V12, P1273, DOI 10.1093/carcin/12.7.1273; BARTSCH H, 1993, EUR J CANCER, V29A, P1199, DOI 10.1016/S0959-8049(05)80315-6; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Castano-Vinyals G, 2007, CANCER EPIDEM BIOMAR, V16, P2155, DOI 10.1158/1055-9965.EPI-07-0184; Chu HY, 2013, J BIOMED RES, V27, P170, DOI 10.7555/JBR.27.20130026; Covolo L, 2008, EUR J EPIDEMIOL, V23, P355, DOI 10.1007/s10654-008-9238-2; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064001; FREDERICKSON SM, 1994, CANCER EPIDEM BIOMAR, V3, P25; GUPTA RC, 1982, CARCINOGENESIS, V3, P1081, DOI 10.1093/carcin/3.9.1081; Hair J.F., 2006, MULTIVARIANT DATA AN, V6th; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Hung RJ, 2004, INT J CANCER, V110, P598, DOI 10.1002/ijc.20157; International Agency for Research on Cancer (IARC), 2010, IARC MON EV CARC RIS, V92; Izzotti A, 1998, TOXICOL METHOD, V8, P175, DOI 10.1080/105172398242880; JAHNKE GD, 1990, CARCINOGENESIS, V11, P205, DOI 10.1093/carcin/11.2.205; Ji GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013145; JONGENEELEN FJ, 1992, INT ARCH OCC ENV HEA, V63, P511, DOI 10.1007/BF00386338; KADLUBAR FF, 1991, XENOBIOTICS AND CANCER, P329; KAO J, 1985, TOXICOL APPL PHARM, V81, P502, DOI 10.1016/0041-008X(85)90421-1; Kline RB, 2005, PRINCIPLES PRACTICE; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Lunn RM, 1999, CANCER RES, V59, P2557; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; NG KME, 1992, TOXICOL APPL PHARM, V115, P216, DOI 10.1016/0041-008X(92)90326-N; PAVANELLO S, 1994, ENVIRON HEALTH PERSP, V102, P95, DOI 10.1289/ehp.94102s995; Pavanello S, 2008, MUTAT RES-FUND MOL M, V638, P195, DOI 10.1016/j.mrfmmm.2007.10.004; Pavanello S, 2010, EUR J EPIDEMIOL, V25, P491, DOI 10.1007/s10654-010-9479-8; Pelucchi C, 2006, NAT CLIN PRACT UROL, V3, P327, DOI 10.1038/ncpuro0510; Peluso M, 2005, CANCER RES, V65, P8042, DOI 10.1158/0008-5472.CAN-04-3488; Peluso M, 2000, CARCINOGENESIS, V21, P183, DOI 10.1093/carcin/21.2.183; Peluso M, 1998, CANCER EPIDEM BIOMAR, V7, P341; Perera FP, 1996, JNCI-J NATL CANCER I, V88, P496, DOI 10.1093/jnci/88.8.496; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; PHILLIPS DH, 1990, INT J CANCER, V46, P569, DOI 10.1002/ijc.2910460403; PHILLIPS DH, 1986, CARCINOGENESIS, V7, P2071, DOI 10.1093/carcin/7.12.2071; Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553; SAVELA K, 1991, CARCINOGENESIS, V12, P503, DOI 10.1093/carcin/12.3.503; Shen M, 2003, CANCER EPIDEM BIOMAR, V12, P1234; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; TALASKA G, 1994, CANCER LETT, V84, P93, DOI 10.1016/0304-3835(94)90362-X; TALASKA G, 1991, P NATL ACAD SCI USA, V88, P5350, DOI 10.1073/pnas.88.12.5350; VANMAANEN JMS, 1994, ENVIRON MOL MUTAGEN, V24, P46, DOI 10.1002/em.2850240106; VANROOIJ JGM, 1993, J TOXICOL ENV HEALTH, V38, P355, DOI 10.1080/15287399309531724; Wild CP, 2009, MUTAGENESIS, V24, P117, DOI 10.1093/mutage/gen061; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; WOLTERBEEK APM, 1995, CANCER LETT, V89, P107, DOI 10.1016/0304-3835(95)90165-5; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Yoon JI, 2012, CANCER PREV RES, V5, P299, DOI 10.1158/1940-6207.CAPR-11-0309; Zhou Q, 1997, MUTAT RES-GEN TOX EN, V393, P199, DOI 10.1016/S1383-5718(97)00097-1; Zhuo WL, 2013, EXP BIOL MED, V238, P66, DOI 10.1258/ebm.2012.012209	53	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94566	10.1371/journal.pone.0094566	http://dx.doi.org/10.1371/journal.pone.0094566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722645	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100099
J	Shabani, F; Kumar, L				Shabani, Farzin; Kumar, Lalit			Sensitivity Analysis of CLIMEX Parameters in Modeling Potential Distribution of Phoenix dactylifera L.	PLOS ONE			English	Article							SPECIES-DISTRIBUTION MODELS; DATE-PALM; CLIMATE-CHANGE; CUTTING PARAMETERS; TAGUCHI METHOD; ALIEN PLANT; OPTIMIZATION; DESIGN; UNCERTAINTY; INVASIONS	Using CLIMEX and the Taguchi Method, a process-based niche model was developed to estimate potential distributions of Phoenix dactylifera L. (date palm), an economically important crop in many counties. Development of the model was based on both its native and invasive distribution and validation was carried out in terms of its extensive distribution in Iran. To identify model parameters having greatest influence on distribution of date palm, a sensitivity analysis was carried out. Changes in suitability were established by mapping of regions where the estimated distribution changed with parameter alterations. This facilitated the assessment of certain areas in Iran where parameter modifications impacted the most, particularly in relation to suitable and highly suitable locations. Parameter sensitivities were also evaluated by the calculation of area changes within the suitable and highly suitable categories. The low temperature limit (DV2), high temperature limit (DV3), upper optimal temperature (SM2) and high soil moisture limit (SM3) had the greatest impact on sensitivity, while other parameters showed relatively less sensitivity or were insensitive to change. For an accurate fit in species distribution models, highly sensitive parameters require more extensive research and data collection methods. Results of this study demonstrate a more cost effective method for developing date palm distribution models, an integral element in species management, and may prove useful for streamlining requirements for data collection in potential distribution modeling for other species as well.	[Shabani, Farzin; Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Shabani, F (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	fshabani@myune.edu.au	shabani, Farzin/P-1033-2019; Kumar, Lalit/A-6397-2011	shabani, Farzin/0000-0002-5100-8921; Kumar, Lalit/0000-0002-9205-756X				ABBAS IH, 1991, MYCOL RES, V95, P509, DOI 10.1016/S0953-7562(09)80857-5; Ahmed MVOM, 2011, SCI HORTIC-AMSTERDAM, V127, P367, DOI 10.1016/j.scienta.2010.11.011; Al-Senaidy AM, 2011, SAUDI J BIOL SCI, V18, P293, DOI 10.1016/j.sjbs.2011.04.005; Al-Shahib W, 2003, INT J FOOD SCI NUTR, V54, P247, DOI [10.1080/09637480120091982, 10.1080/096374803766666120]; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; AUDA H, 1979, RADIAT PHYS CHEM, V14, P775, DOI 10.1016/0146-5724(79)90113-4; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bokhary H A, 2010, Saudi J Biol Sci, V17, P327, DOI 10.1016/j.sjbs.2010.06.005; Botes A., 2002, DATE PALM CULTIVATIO, P292; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Chao CT, 2007, HORTSCIENCE, V42, P1077, DOI 10.21273/HORTSCI.42.5.1077; Day M.D., 2003, Biocontrol News and Information, V24, p63N; Elhoumaizi M., 2001, GENETIC RESOURCES CR, V49, P483; Eshraghi P, 2005, AFR J BIOTECHNOL, V4, P1309; Ferry M, 2002, J INT PALM SOC, V46; Ghani JA, 2004, J MATER PROCESS TECH, V145, P84, DOI 10.1016/S0924-0136(03)00865-3; Gomez-Vidal S, 2006, MICRON, V37, P624, DOI 10.1016/j.micron.2006.02.003; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hallgren WS, 2000, GLOBAL CHANGE BIOL, V6, P483, DOI 10.1046/j.1365-2486.2000.00325.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hasan S., 2006, INT J AGRIC BIOL, V8, P1; HEAKAL MS, 1989, GEODERMA, V44, P261, DOI 10.1016/0016-7061(89)90035-9; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Jain SM, 2011, DATE PALM BIOTECHNOLOGY, P271, DOI 10.1007/978-94-007-1318-5_14; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Kassem HA, 2012, J SOIL SCI PLANT NUT, V12, P45, DOI 10.4067/S0718-95162012000100005; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Khavyat M., 2007, American-Eurasian Journal of Agricultural and Environmental Science, V2, P289; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lee KH, 1996, AIAA J, V34, P1059, DOI 10.2514/3.13187; Mahmoudi H., 2008, J ORGANIC SYSTEMS, V3, P30; Markhand GS, 2010, PAK J BOT, V42, P3715; Marques J, 2011, PLANT PHYSIOL BIOCH, V49, P388, DOI 10.1016/j.plaphy.2011.02.008; Merow C, 2011, AM NAT, V178, P30, DOI 10.1086/660295; Nalbant M, 2007, MATER DESIGN, V28, P1379, DOI 10.1016/j.matdes.2006.01.008; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Olfert O, 2006, ENTOMOL EXP APPL, V120, P221, DOI 10.1111/j.1570-7458.2006.00445.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phadke M.S., 1995, QUALITY ENG USING RO; Reilly D, 2012, GURRA DOWNS DATA PAL; Robertson MP, 2004, DIVERS DISTRIB, V10, P461, DOI 10.1111/j.1366-9516.2004.00108.x; Shabani F, 2014, J AGR SCI-CAMBRIDGE, V152, P543, DOI 10.1017/S0021859613000816; Shabani F, 2014, THEORETICAL APPL CLI, V115; Shabani F., 2013, J FOOD AGR ENV, V11; Shabani F, 2013, J EARTH SCI CLIMATE, V4; Shabani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083404; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Shayesteh N., 2010, Julius-Kuhn-Archiv, P151; Shayesteh N., 2010, 10 INT WORK C STOR P; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R. W., 2007, CLIMEX VERSION 3 USE, P10; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040969; Tengberg M., 2011, J ARID ENVIRON, V5, P1; THAMAN R R, 1974, Micronesica, V10, P17; Unal R, 1991, ANN C INT SOC PAR AN, P13; van Klinken RD, 2009, GLOBAL ECOL BIOGEOGR, V18, P688, DOI 10.1111/j.1466-8238.2009.00483.x; Waldner F, 2013, IMPLEMENTATION TAGUC; Weng WC, 2007, IEEE T ANTENN PROPAG, V55, P723, DOI 10.1109/TAP.2007.891548; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; Yang WH, 1998, J MATER PROCESS TECH, V84, P122, DOI 10.1016/S0924-0136(98)00079-X	68	24	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94867	10.1371/journal.pone.0094867	http://dx.doi.org/10.1371/journal.pone.0094867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722140	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100142
J	Tarafdar, S; Poe, JA; Smithgall, TE				Tarafdar, Sreya; Poe, Jerrod A.; Smithgall, Thomas E.			The Accessory Factor Nef Links HIV-1 to Tec/Btk Kinases in an Src Homology 3 Domain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; HIV-1; Nonreceptor Tyrosine Kinase; SH3 Domains; Src	PROTEIN-TYROSINE KINASES; LONG-TERM SURVIVOR; SH3 DOMAIN; CRYSTAL-STRUCTURE; C-SRC; TRANSGENIC MICE; DOWN-REGULATION; TEC KINASES; TYPE-1 NEF; FAMILY	The HIV-1 Nef virulence factor interacts with multiple host cell-signaling proteins. Nef binds to the Src homology 3 domains of Src family kinases, resulting in kinase activation important for viral infectivity, replication, and MHC-I down-regulation. Itk and other Tec family kinases are also present in HIV target cells, and Itk has been linked to HIV-1 infectivity and replication. However, the molecular mechanism linking Itk to HIV-1 is unknown. In this study, we explored the interaction of Nef with Tec family kinases using a cell-based bimolecular fluorescence complementation assay. In this approach, interaction of Nef with a partner kinase juxtaposes nonfluorescent YFP fragments fused to the C terminus of each protein, resulting in YFP complementation and a bright fluorescent signal. Using bimolecular fluorescence complementation, we observed that Nef interacts with the Tec family members Bmx, Btk, and Itk but not Tec or Txk. Interaction with Nef occurs through the kinase Src homology 3 domains and localizes to the plasma membrane. Allelic variants of Nef from all major HIV-1 subtypes interacted strongly with Itk in this assay, demonstrating the highly conserved nature of this interaction. A selective small molecule inhibitor of Itk kinase activity (BMS-509744) potently blocked wild-type HIV-1 infectivity and replication, but not that of a Nef-defective mutant. Nef induced constitutive Itk activation in transfected cells that was sensitive to inhibitor treatment. Taken together, these results provide the first evidence that Nef interacts with cytoplasmic tyrosine kinases of the Tec family and suggest that Nef provides a mechanistic link between HIV-1 and Itk signaling in the viral life cycle.	[Tarafdar, Sreya; Poe, Jerrod A.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Tarafdar, Sreya] Univ Pittsburgh, Dept Infect Dis & Microbiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102724]; Fogarty International HIV Research Training Program of the National Institutes of Health [TW001038]; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International HIV Research Training Program of the National Institutes of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057083 and AI102724 (to T.E.S.).; Supported by the Fogarty International HIV Research Training Program of the National Institutes of Health (TW001038).	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Joseph RE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004298; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lester GMS, 2013, VIROLOGY, V436, P235, DOI 10.1016/j.virol.2012.11.015; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	48	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15718	15728		10.1074/jbc.M114.572099	http://dx.doi.org/10.1074/jbc.M114.572099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722985	Green Published, hybrid			2022-12-25	WOS:000337465400052
J	Cubillos-Rojas, M; Amair-Pinedo, F; Peiro-Jordan, R; Bartrons, R; Ventura, F; Rosa, JL				Cubillos-Rojas, Monica; Amair-Pinedo, Fabiola; Peiro-Jordan, Roser; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose			The E3 Ubiquitin Protein Ligase HERC2 Modulates the Activity of Tumor Protein p53 by Regulating Its Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMULTANEOUS ELECTROPHORETIC ANALYSIS; GUANINE-NUCLEOTIDE EXCHANGE; DNA-DAMAGE; DEVELOPMENTAL DELAY; GIANT PROTEIN; RAB PROTEINS; LI-FRAUMENI; HECT FAMILY; TARGETS; CANCER	The tumor suppressor p53 is a transcription factor that coordinates the cellular response to several kinds of stress. p53 inactivation is an important step in tumor progression. Oligomerization of p53 is critical for its posttranslational modification and its ability to regulate the transcription of target genes necessary to inhibit tumor growth. Here we report that the HECT E3 ubiquitin ligase HERC2 interacts with p53. This interaction involves the CPH domain of HERC2 (a conserved domain within Cul7, PARC, and HERC2 proteins) and the last 43 amino acid residues of p53. Through this interaction, HERC2 regulates p53 activity. RNA interference experiments showed how HERC2 depletion reduces the transcriptional activity of p53 without affecting its stability. This regulation of p53 activity by HERC2 is independent of proteasome or MDM2 activity. Under these conditions, up-regulation of cell growth and increased focus formation were observed, showing the functional relevance of the HERC2-p53 interaction. This interaction was maintained after DNA damage caused by the chemotherapeutic drug bleomycin. In these stressed cells, p53 phosphorylation was not impaired by HERC2 knockdown. Interestingly, p53 mutations that affect its tetramerization domain disrupted the HERC2-p53 interaction, suggesting a role for HERC2 in p53 oligomerization. This regulatory role was shown using cross-linking assays. Thus, the inhibition of p53 activity after HERC2 depletion can be attributed to a reduction in p53 oligomerization. Ectopic expression of HERC2 (residues 2292-2923) confirmed these observations. Together, these results identify HERC2 as a novel regulator of p53 signaling.	[Cubillos-Rojas, Monica; Amair-Pinedo, Fabiola; Peiro-Jordan, Roser; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Rosa, JL (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Campus Bellvitge, Barcelona 08907, Spain.	joseluisrosa@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688	Spanish Ministerio de Ciencia e Innovacion [BFU2011-22498, BFU2009-07380]; Instituto de Salud Carlos III Grant RETIC [RD06/0020]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III Grant RETIC(Instituto de Salud Carlos III)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2011-22498 and BFU2009-07380) and by Instituto de Salud Carlos III Grant RETIC, RD06/0020.	Al-Hakim AK, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014233; Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Casas-Terradellas E, 2006, ELECTROPHORESIS, V27, P3935, DOI 10.1002/elps.200600141; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cruz C, 2001, FEBS LETT, V488, P74, DOI 10.1016/S0014-5793(00)02371-1; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Garcia-Gonzalo FR, 2003, FEBS LETT, V539, P78, DOI 10.1016/S0014-5793(03)00205-9; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hochrainer K, 2008, CELL MOL LIFE SCI, V65, P2105, DOI 10.1007/s00018-008-8148-5; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Izawa N, 2011, CANCER RES, V71, P5621, DOI 10.1158/0008-5472.CAN-11-0385; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kasper JS, 2006, BIOCHEM BIOPH RES CO, V348, P132, DOI 10.1016/j.bbrc.2006.07.013; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Kawai K, 2010, CANCER SCI, V101, P22, DOI 10.1111/j.1349-7006.2009.01373.x; Kroismayr R, 2004, J CELL SCI, V117, P4749, DOI 10.1242/jcs.01338; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuhnle S, 2011, J BIOL CHEM, V286, P19410, DOI 10.1074/jbc.M110.205211; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Linnert M, 2009, ANTI-CANCER DRUG, V20, P157, DOI 10.1097/CAD.0b013e328325465e; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Mashimo T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000784; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; White D, 2011, J HUM GENET, V56, P5, DOI 10.1038/jhg.2010.126; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009	60	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14782	14795		10.1074/jbc.M113.527978	http://dx.doi.org/10.1074/jbc.M113.527978			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722987	Green Published, hybrid			2022-12-25	WOS:000337248100034
J	Guizzetti, L; McGirr, R; Dhanvantari, S				Guizzetti, Leonardo; McGirr, Rebecca; Dhanvantari, Savita			Two Dipolar alpha-Helices within Hormone-encoding Regions of Proglucagon Are Sorting Signals to the Regulated Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYPEPTIDASE-E; PROHORMONE CONVERTASE-2; NEUROENDOCRINE CELLS; SECRETOGRANIN-III; ALPHA-TC1-6 CELLS; DIBASIC RESIDUES; PEPTIDE-HORMONES; CLEAVAGE SITE; A-CELLS; RECEPTOR	Proglucagon is expressed in pancreatic alpha cells, intestinal L cells, and some hypothalamic and brainstem neurons. Tissue-specific processing of proglucagon yields three major peptide hormones as follows: glucagon in the alpha cells and glucagon-like peptides (GLP)-1 and -2 in the L cells and neurons. Efficient sorting and packaging into the secretory granules of the regulated secretory pathway in each cell type are required for nutrient-regulated secretion of these proglucagon-derived peptides. Our previous work suggested that proglucagon is directed into granules by intrinsic sorting signals after initial processing to glicentin and major proglucagon fragment (McGirr, R., Guizzetti, L., and Dhanvantari, S. (2013) J. Endocrinol. 217, 229240), leading to the hypothesis that sorting signals may be present in multiple domains. In the present study, we show that the alpha-helices within glucagon and GLP-1, but not GLP-2, act as sorting signals by efficiently directing a heterologous secretory protein to the regulated secretory pathway. Biophysical characterization of these peptides revealed that glucagon and GLP-1 each encode a nonamphipathic, dipolar alpha-helix, whereas the helix in GLP-2 is not dipolar. Surprisingly, glicentin and major proglucagon fragment were sorted with different efficiencies, thus providing evidence that proglucagon is first sorted to granules prior to processing. In contrast to many other prohormones in which sorting is directed by ordered prodomains, the sorting determinants of proglucagon lie within the ordered hormone domains of glucagon and GLP-1, illustrating that each prohormone has its own sorting "signature."	[Guizzetti, Leonardo; Dhanvantari, Savita] Univ Western Ontario, Dept Med Biophys, London, ON N6A 3K7, Canada; [Dhanvantari, Savita] Univ Western Ontario, Dept Pathol, London, ON N6A 3K7, Canada; [Dhanvantari, Savita] Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada; [McGirr, Rebecca; Dhanvantari, Savita] Lawson Hlth Res Inst, Metab Diabet Program, London, ON N6A 4V2, Canada; [McGirr, Rebecca; Dhanvantari, Savita] Lawson Hlth Res Inst, Imaging Program, London, ON N6A 4V2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dhanvantari, S (corresponding author), Lawson Hlth Res Inst, 268 Grosvenor St, London, ON N6A 4V2, Canada.	sdhanvan@uwo.ca	Dhanvantari, Savita/B-5362-2015; Guizzetti, Leonardo/H-9346-2012	Guizzetti, Leonardo/0000-0001-5864-8422	Natural Sciences and Engineering Research Council of Canada; Lawson Health Research Institute Internal Research Fund; Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lawson Health Research Institute Internal Research Fund; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada, the Lawson Health Research Institute Internal Research Fund, and an Early Researcher Award from the Ontario Ministry of Research and Innovation.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Assadi M, 2004, BIOCHEMISTRY-US, V43, P7798, DOI 10.1021/bi036331g; Blanco EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059695; Brakch N, 2002, J NEUROCHEM, V81, P1166, DOI 10.1046/j.1471-4159.2002.00919.x; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; CHIDGEY MAJ, 1990, EUR J BIOCHEM, V190, P139, DOI 10.1111/j.1432-1033.1990.tb15556.x; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Damholt AB, 1999, ENDOCRINOLOGY, V140, P4800, DOI 10.1210/en.140.10.4800; Dey A, 2005, ENDOCRINOLOGY, V146, P713, DOI 10.1210/en.2004-1118; Dhanvantari S, 1998, ENDOCRINOLOGY, V139, P1630, DOI 10.1210/en.139.4.1630; Dhanvantari S, 2003, MOL ENDOCRINOL, V17, P1856, DOI 10.1210/me.2002-0380; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Dhanvantari S, 1996, MOL ENDOCRINOL, V10, P342, DOI 10.1210/me.10.4.342; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dikeakos JD, 2007, J BIOL CHEM, V282, P1136, DOI 10.1074/jbc.M605718200; Dikeakos JD, 2009, P NATL ACAD SCI USA, V106, P7408, DOI 10.1073/pnas.0809576106; Dirndorfer D, 2013, J BIOL CHEM, V288, P13961, DOI 10.1074/jbc.M112.430264; Dong CX, 2012, NAT REV GASTRO HEPAT, V9, P705, DOI 10.1038/nrgastro.2012.185; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Feliciangeli S, 2002, BIOCHEM BIOPH RES CO, V290, P191, DOI 10.1006/bbrc.2001.6137; Feliciangeli S, 2001, J BIOL CHEM, V276, P6140, DOI 10.1074/jbc.M009613200; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Garcia AL, 2005, J BIOL CHEM, V280, P41595, DOI 10.1074/jbc.M509122200; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jutras I, 2000, J BIOL CHEM, V275, P40337, DOI 10.1074/jbc.M004757200; Lacombe MJ, 2005, J BIOL CHEM, V280, P4803, DOI 10.1074/jbc.M408658200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li SK, 2014, DIABETOLOGIA, V57, P809, DOI 10.1007/s00125-013-3143-2; Loh YP, 2002, ANN NY ACAD SCI, V971, P416, DOI 10.1111/j.1749-6632.2002.tb04504.x; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Ma GQ, 2008, TRAFFIC, V9, P2165, DOI 10.1111/j.1600-0854.2008.00836.x; McGirr R, 2005, ENDOCRINOLOGY, V146, P4514, DOI 10.1210/en.2005-0402; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; Mouchantaf R, 2001, J BIOL CHEM, V276, P26308, DOI 10.1074/jbc.M102514200; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; NOE BD, 1977, J CELL BIOL, V74, P589, DOI 10.1083/jcb.74.2.589; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; Perello M, 2008, J BIOL CHEM, V283, P19936, DOI 10.1074/jbc.M800732200; RAVAZZOLA M, 1984, ENDOCRINOLOGY, V114, P481, DOI 10.1210/endo-114-2-481; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; SASAKI K, 1975, NATURE, V257, P751, DOI 10.1038/257751a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEINO S, 1986, FEBS LETT, V203, P25, DOI 10.1016/0014-5793(86)81429-6; Sirkis DW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003812; Stridsberg M, 2008, J ANAT, V212, P229, DOI 10.1111/j.1469-7580.2008.00857.x; Sun M, 2013, TRAFFIC, V14, P205, DOI 10.1111/tra.12029; Taupenot L, 2007, CURR PROTOC CELL BIO; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Venneti KC, 2011, FEBS LETT, V585, P346, DOI 10.1016/j.febslet.2010.12.011; Wu Y, 2012, J CELL BIOL, V198, P323, DOI 10.1083/jcb.201106158; Xia FZ, 2007, ENDOCRINOLOGY, V148, P2157, DOI 10.1210/en.2006-1296; Zhang CF, 1999, MOL ENDOCRINOL, V13, P527, DOI 10.1210/me.13.4.527	64	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14968	14980		10.1074/jbc.M114.563684	http://dx.doi.org/10.1074/jbc.M114.563684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727476	Green Published, hybrid			2022-12-25	WOS:000337248100049
J	Rice, AJ; Harrison, A; Alvarez, FJD; Davidson, AL; Pinkett, HW				Rice, Austin J.; Harrison, Alistair; Alvarez, Frances J. D.; Davidson, Amy L.; Pinkett, Heather W.			Small Substrate Transport and Mechanism of a Molybdate ATP Binding Cassette Transporter in a Lipid Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; ABC TRANSPORTER; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; BTUCD-F; PROTEINS; MEDIA; COMPETENCE; MUTANTS	Embedded in the plasma membrane of all bacteria, ATP binding cassette (ABC) importers facilitate the uptake of several vital nutrients and cofactors. The ABC transporter, MolBC-A, imports molybdate by passing substrate from the binding protein MolA to a membrane-spanning translocation pathway of MolB. To understand the mechanism of transport in the biological membrane as a whole, the effects of the lipid bilayer on transport needed to be addressed. Continuous wave-electron paramagnetic resonance and in vivo molybdate uptake studies were used to test the impact of the lipid environment on the mechanism and function of MolBC-A. Working with the bacterium Haemophilus influenzae, we found that MolBC-A functions as a low affinity molybdate transporter in its native environment. In periods of high extracellular molybdate concentration, H. influenzae makes use of parallel molybdate transport systems (MolBC-A and ModBC-A) to take up a greater amount of molybdate than a strain with ModBC-A alone. In addition, the movement of the translocation pathway in response to nucleotide binding and hydrolysis in a lipid environment is conserved when compared with in-detergent analysis. However, electron paramagnetic resonance spectroscopy indicates that a lipid environment restricts the flexibility of the MolBC translocation pathway. By combining continuous wave-electron paramagnetic resonance spectroscopy and substrate uptake studies, we reveal details of molybdate transport and the logistics of uptake systems that employ multiple transporters for the same substrate, offering insight into the mechanisms of nutrient uptake in bacteria.	[Rice, Austin J.; Pinkett, Heather W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Harrison, Alistair] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Alvarez, Frances J. D.; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Northwestern University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pinkett, HW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	h-pinkett@northwestern.edu	Pinkett, Heather Wendy/M-9235-2014	Alvarez, Frances/0000-0001-9742-6064	National Science Foundation [MCB1121872]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant MCB1121872.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Dairies D. A., 2003, J MED MICROBIOL, V52, P277; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gil T, 1998, BBA-REV BIOMEMBRANES, V1376, P245, DOI 10.1016/S0304-4157(98)00022-7; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Grunden AM, 1996, J BACTERIOL, V178, P735, DOI 10.1128/jb.178.3.735-744.1996; Grunden AM, 1997, ARCH MICROBIOL, V168, P345, DOI 10.1007/s002030050508; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Neidhardt FC., 1987, ESCHERICHIA COLI SAL, V2nd ed, P3; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pau RN, 2002, MET IONS BIOL SYST, V39, P31; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; ROSENTEL JK, 1995, J BACTERIOL, V177, P4857, DOI 10.1128/jb.177.17.4857-4864.1995; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT D, 1989, J BACTERIOL, V171, P1284, DOI 10.1128/jb.171.3.1284-1287.1989; Singleton P., 1978, DICT MICROBIOLOGY, P145; SPENCER HT, 1965, J BACTERIOL, V90, P911, DOI 10.1128/JB.90.4.911-920.1965; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110	45	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15005	15013		10.1074/jbc.M114.563783	http://dx.doi.org/10.1074/jbc.M114.563783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722984	hybrid, Green Published			2022-12-25	WOS:000337248100052
J	Li, SJ; Chen, HP; Chen, YH; Zhang, LH; Tu, YM; Liu, ZH				Li, Shi-Jun; Chen, Hui-Ping; Chen, Ying-Hua; Zhang, Li-Hua; Tu, Yuan-Mao; Liu, Zhi-hong			Renal Involvement in Non-Hodgkin Lymphoma: Proven by Renal Biopsy	PLOS ONE			English	Article							B-CELL LYMPHOMA; LYMPHOCYTIC-LEUKEMIA; KIDNEY INVOLVEMENT; GLOMERULONEPHRITIS	Aims: To determine the spectrum of renal lesions in patients with kidney involvement in non-Hodgkin's lymphoma (NHL) by renal biopsy. Methods: The clinical features and histological findings at the time of the renal biopsy were assessed for each patient. Results: We identified 20 patients with NHL and renal involvement, and the diagnosis of NHL was established following the kidney biopsy in 18 (90%) patients. The types of NHL include the following: chronic lymphocytic leukemia/small lymphocytic lymphoma (n = 8), diffuse large B-cell lymphoma (n = 4), T/NK cell lymphoma (n = 3), lymphoplasmacytic lymphoma (n = 2), cutaneous T-cell lymphoma (n = 1), mucosa-associated lymphoid tissue lymphoma (n = 1) and mantle cell lymphoma (n = 1). All presented with proteinuria, and 15 patients had impaired renal function. The pathological findings included (1) membranoproliferative glomerulonephritis-like pattern in seven patients; (2) crescent glomerulonephritis in four; (3) minimal-change disease in three, and glomeruli without specific pathological abnormalities in three; (4) intraglomerular large B-cell lymphoma in one; (5) intracapillary monoclonal IgM deposits in one; (6) primary diffuse large B-cell lymphoma of the kidneys in one; and (7) lymphoma infiltration of the kidney in eight patients. Conclusion: A wide spectrum of renal lesions can be observed in patients with NHL, and NHL may be first proven by renal biopsies for evaluation of kidney injury or proteinuria. Renal biopsy is necessary to establish the underlying cause of renal involvement in NHL.	[Li, Shi-Jun; Chen, Hui-Ping; Chen, Ying-Hua; Zhang, Li-Hua; Tu, Yuan-Mao; Liu, Zhi-hong] Nanjing Univ Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China		Liu, ZH (corresponding author), Nanjing Univ Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	zhihong-liu@hotmail.com	Liu, Zhihong/ABB-6918-2021; chen, ying/HHS-8254-2022	Liu, Zhihong/0000-0001-6093-0726; 				Audard V, 2006, KIDNEY INT, V69, P2251, DOI 10.1038/sj.ki.5000341; Audard V, 2008, CLIN J AM SOC NEPHRO, V3, P1339, DOI 10.2215/CJN.01600408; Bai XY, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-86; Cohen LJ, 2010, AM J KIDNEY DIS, V56, P1191, DOI 10.1053/j.ajkd.2010.07.009; Da'as N, 2001, EUR J HAEMATOL, V67, P158, DOI 10.1034/j.1600-0609.2001.5790493.x; Dussol B, 1997, NEPHROL DIAL TRANSPL, V12, P785, DOI 10.1093/ndt/12.4.785; Harper L, 1997, NEPHROL DIAL TRANSPL, V12, P1520, DOI 10.1093/ndt/12.7.1520; Henriksen KJ, 2011, AM J KIDNEY DIS, V57, P170, DOI 10.1053/j.ajkd.2010.08.011; Kameoka Y, 2009, INT J HEMATOL, V89, P533, DOI 10.1007/s12185-009-0294-5; Kowalewska J, 2011, HUM PATHOL, V42, P896, DOI 10.1016/j.humpath.2010.09.009; MOULIN B, 1992, KIDNEY INT, V42, P127, DOI 10.1038/ki.1992.270; RAULT R, 1992, AM J KIDNEY DIS, V20, P84, DOI 10.1016/S0272-6386(12)80323-4; Ronco PM, 1999, KIDNEY INT, V56, P355, DOI 10.1046/j.1523-1755.1999.00548.x; Shi SF, 2012, AM J KIDNEY DIS, V60, P1044, DOI 10.1053/j.ajkd.2012.05.023; Stokes MB, 2002, CLIN NEPHROL, V57, P303; Sun J, 2012, AM J CLIN PATHOL, V138, P429, DOI 10.1309/AJCP7YLTQPUSDQ5C; Swerdlow E., 2008, WHO CLASSIFICATION T; Villa D, 2011, HAEMATOL-HEMATOL J, V96, P1002, DOI 10.3324/haematol.2011.041277; Wood SM, 1996, NEPHROL DIAL TRANSPL, V11, P535; Yeo SC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-158	20	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95190	10.1371/journal.pone.0095190	http://dx.doi.org/10.1371/journal.pone.0095190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733356	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400162
J	Wang, J; Li, BZ; Yu, W; Yang, Q; Wang, H; Huang, DC; Sundell, J; Norback, D				Wang, Juan; Li, Baizhan; Yu, Wei; Yang, Qin; Wang, Han; Huang, Duchai; Sundell, Jan; Norback, Dan			Rhinitis Symptoms and Asthma among Parents of Preschool Children in Relation to the Home Environment in Chongqing, China	PLOS ONE			English	Article							REPORTED ALLERGIC RHINITIS; QUALITY-OF-LIFE; RISK-FACTOR; SURFACE MATERIALS; AND/OR RHINITIS; AIR-POLLUTION; PREVALENCE; HEALTH; EXPOSURE; DAMPNESS	Risk factors for rhinitis and asthma in the home environment were studied by a questionnaire survey. Parents of 4530 1-8 year old children (one parent per child) from randomly selected kindergartens in Chongqing, China participated. 70.4% were females; 47.1% had rhinitis symptoms in the last three months (current rhinitis, CR); 1.6% reported a history of allergic asthma (AA); 2.7% reported a history of allergic rhinitis (AR); 16.4% were current smokers; 50.8% males and 2.4% females were current smokers. Stuffy odor, unpleasant odor, tobacco smoke odor and dry air were associated with CR (adjustment for gender, current smoking and other perceptions of odor or humidity). Associations between home environment and CR, AR, and AA were studied by multiple logistic regression analyses, adjusting for gender, current smoking and other significant home factors. Living near a main road or highway was a risk factor for both CR (OR(95% CI): 1.31(1.13,1.52)) and AR (OR(95% CI): 2.44(1.48,4.03)). Other risk factors for CR included living in rural areas (OR(95% CI): 1.43(1.10,1.85)), new furniture (OR(95% CI): 1.28(1.11,1.49)), water damage (OR(95% CI): 1.68(1.29,2.18)), cockroaches (OR(95% CI): 1.46(1.23,1.73)), and keeping pets (OR(95% CI): 1.24(1.04,1.49)). Other risk factors for AR included redecoration (OR(95% CI): 2.14(1.34,3.41)), mold spots (OR(95% CI): 2.23(1.06,4.68)), window pane condensation (OR(95% CI): 2.04(1.28,3.26)). Water damage was the only home factor associated with AA (2.56(1.34,4.86)). Frequently put bedding to sunshine was protective for CR (OR(95% CI): 0.79(0.68,0.92); cleaning every day was protective for AR (OR(95% CI): 0.40(0.22,0.71)). In conclusion, parents' CR and AR were related to a number of factors of the home environment.	[Wang, Juan; Norback, Dan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Wang, Juan; Norback, Dan] Univ Uppsala Hosp, Uppsala, Sweden; [Wang, Juan; Li, Baizhan; Yu, Wei; Yang, Qin; Wang, Han; Huang, Duchai; Sundell, Jan] Chongqing Univ, Minist Educ, Key Lab Gorges Reservoir Regions Ecoenvironm 3, Chongqing 630044, Peoples R China; [Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China	Uppsala University; Uppsala University; Uppsala University Hospital; Chongqing University; Tsinghua University	Li, BZ (corresponding author), Chongqing Univ, Minist Educ, Key Lab Gorges Reservoir Regions Ecoenvironm 3, Chongqing 630044, Peoples R China.	baizhanli@cqu.edu.cn	li, bz/GVR-7133-2022; li, bing/GWQ-9617-2022	Li, Baizhan/0000-0001-7526-1748; Norback, Dan/0000-0002-5174-6668	Key National Project of Physical Science (Theory and Method for Control and Dynamic Regulation of Building Thermal Environment) [50838009]; National Technology Support Project (Technology for Monitoring and Operation of Building Indoor Air Pollution) [2012BAJ02B06]	Key National Project of Physical Science (Theory and Method for Control and Dynamic Regulation of Building Thermal Environment); National Technology Support Project (Technology for Monitoring and Operation of Building Indoor Air Pollution)	This study was supported by the Key National Project of Physical Science (Theory and Method for Control and Dynamic Regulation of Building Thermal Environment, 50838009) and National Technology Support Project (Technology for Monitoring and Operation of Building Indoor Air Pollution, 2012BAJ02B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki A, 2012, SCI TOTAL ENVIRON, V423, P18, DOI 10.1016/j.scitotenv.2012.02.026; Baena-Cagnani CE, 2009, CURR OPIN ALLERGY CL, V9, P136, DOI 10.1097/ACI.0b013e3283294038; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bener A, 2004, Eur Ann Allergy Clin Immunol, V36, P306; Billionnet C, 2011, ENVIRON RES, V111, P425, DOI 10.1016/j.envres.2011.02.008; Bjerg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016082; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2001, INDOOR AIR, V11, P72; Bornehag CG, 2004, INDOOR AIR, V14, P243, DOI 10.1111/j.1600-0668.2004.00240.x; Boulay ME, 2012, CURR OPIN ALLERGY CL, V12, P449, DOI 10.1097/ACI.0b013e328357cc32; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Brandt D, 2006, ANN ALLERG ASTHMA IM, V96, P526, DOI 10.1016/S1081-1206(10)63546-6; Bugiani M, 2005, ALLERGY, V60, P165, DOI 10.1111/j.1398-9995.2005.00659.x; Chen Ke-jun, 2007, Huanjing Kexue, V28, P1847; Choi H, 2010, INT J ENV RES PUB HE, V7, P4213, DOI 10.3390/ijerph7124213; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; de Marco R, 2002, CLIN EXP ALLERGY, V32, P1405, DOI 10.1046/j.1365-2745.2002.01466.x; Eriksson J, 2012, CLIN RESPIR J, V6, P159, DOI 10.1111/j.1752-699X.2011.00269.x; Eriksson J, 2011, RESP MED, V105, P1611, DOI 10.1016/j.rmed.2011.06.004; Fang Mingjian, 2011, Proceedings 2011 International Conference on Computer Distributed Control and Intelligent Environmental Monitoring (CDCIEM 2011), P1346, DOI 10.1109/CDCIEM.2011.431; Garrett MH, 1999, ALLERGY, V54, P330, DOI 10.1034/j.1398-9995.1999.00763.x; Gislason David, 2002, Laeknabladid, V88, P891; Hancox RJ, 2008, J ALLERGY CLIN IMMUN, V121, P38, DOI 10.1016/j.jaci.2007.09.052; Heseltine E., 2009, WHO GUID IND AIR QUA; Hisamitsu Minako, 2011, Allergology International, V60, P373, DOI 10.2332/allergolint.10-OA-0210; Hong S, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P558; Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jaakkola MS, 2013, J ALLERGY CLIN IMMUN, V132, P1099, DOI 10.1016/j.jaci.2013.07.028; Ke Xia, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P200; Kilpelainen M, 2001, THORAX, V56, P462, DOI 10.1136/thorax.56.6.462; Koskinen OM, 1999, EUR RESPIR J, V14, P1363, DOI 10.1183/09031936.99.14613639; Kurt E, 2009, EUR RESPIR J, V33, P724, DOI 10.1183/09031936.00082207; Li J, 2009, ALLERGY, V64, P1083, DOI 10.1111/j.1398-9995.2009.01967.x; Li J, 2012, AM J RHINOL ALLERGY, V26, P85, DOI 10.2500/ajra.2012.26.3751; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-25; Linneberg A, 2001, ALLERGY, V56, P328, DOI 10.1034/j.1398-9995.2000.00509.x-i1; Lu Yunxia, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P491; Mahesh PA, 2009, LUNG, V187, P393, DOI 10.1007/s00408-009-9179-x; Maspero J, 2012, CLIN EXP ALLERGY, V42, P1684, DOI 10.1111/j.1365-2222.2012.04025.x; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; NG TP, 1994, INT J EPIDEMIOL, V23, P553, DOI 10.1093/ije/23.3.553; Nihlen U, 2006, ALLERGY, V61, P1299, DOI 10.1111/j.1398-9995.2006.01166.x; Nyembue TD, 2012, INT FORUM ALLERGY RH, V2, P285, DOI 10.1002/alr.21017; Park JH, 2004, INDOOR AIR, V14, P425, DOI 10.1111/j.1600-0668.2004.00291.x; PAZDRAK K, 1993, INT ARCH OCC ENV HEA, V64, P515, DOI 10.1007/BF00381101; Qian Di (et al), 2008, Journal of Chongqing Medical University, V33, P531; Radon K, 2008, OCCUP ENVIRON MED, V65, P38, DOI 10.1136/oem.2006.031542; Reitzig M, 1998, INDOOR AIR, V8, P91, DOI 10.1111/j.1600-0668.1998.t01-2-00004.x; Salo PM, 2004, ANN EPIDEMIOL, V14, P543, DOI 10.1016/j.annepidem.2003.09.015; Salvi S, 2001, CURR OPIN ALLERGY CL, V1, P35; Settipane RA, 2001, ANN ALLERG ASTHMA IM, V86, P494, DOI 10.1016/S1081-1206(10)62896-7; Settipane Russell A, 2007, Clin Allergy Immunol, V19, P23; Shariat M, 2012, IRAN J ALLERGY ASTHM, V11, P324, DOI 011.04/ijaai.324328; Shen J, 2011, J HUAZHONG U SCI-MED, V31, P433, DOI 10.1007/s11596-011-0469-1; Shusterman D, 2007, INDOOR AIR, V17, P328, DOI 10.1111/j.1600-0668.2007.00482.x; Shusterman Dennis, 2007, Clin Allergy Immunol, V19, P249; Skulberg KR, 2004, EPIDEMIOLOGY, V15, P71, DOI 10.1097/01.ede.0000101020.72399.37; Sun BQ, 2010, CHINESE MED J-PEKING, V123, P3540, DOI 10.3760/cma.j.issn.0366-6999.2010.24.007; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; SUNDELL J, 1994, INDOOR AIR, V4, P83, DOI 10.1111/j.1600-0668.1994.t01-2-00003.x; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Trevillian LF, 2005, AM J PUBLIC HEALTH, V95, P2238, DOI 10.2105/AJPH.2004.047191; Wang De-Yun, 2005, Ther Clin Risk Manag, V1, P115, DOI 10.2147/tcrm.1.2.115.62907; Wang J, 2013, CHINESE SCI BULL, V58, P4267, DOI 10.1007/s11434-013-5814-2; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072385; Wang Ze-hai, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P225; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Zhang C, 2011, ALLERGY, V66, P186, DOI 10.1111/j.1398-9995.2010.02465.x; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhu Lu-ping, 2010, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V45, P993	74	36	37	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94731	10.1371/journal.pone.0094731	http://dx.doi.org/10.1371/journal.pone.0094731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6GP	24733290	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400086
J	Wang, M; Su, YZ; Yang, X				Wang, Min; Su, Yongzhong; Yang, Xiao			Spatial Distribution of Soil Organic Carbon and Its Influencing Factors in Desert Grasslands of the Hexi Corridor, Northwest China	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; STORAGE; CLIMATE; PATTERNS; BIOMASS; MATTER; SEQUESTRATION; DYNAMICS; TEXTURE; POOL	Knowledge of the distribution patterns of soil organic carbon (SOC) and factors that influence these patterns is crucial for understanding the carbon cycle. The objectives of this study were to determine the spatial distribution pattern of soil organic carbon density (SOCD) and the controlling factors in arid desert grasslands of northwest China. The above-and belowground biomass and SOCD in 260 soil profiles from 52 sites over 2.7x10(4) km(2) were investigated. Combined with a satellite-based dataset of an enhanced vegetation index during 2011-2012 and climatic factors at different sites, the relationships between SOCD and biotic and abiotic factors were identified. The results indicated that the mean SOCD was 1.20 (SD:+/- 0.85), 1.73 (SD:+/- 1.20), and 2.69 (SD:+/- 1.91) kg m(-2) at soil depths of 0-30 cm, 0-50 cm, and 0-100 cm, respectively, which was smaller than other estimates in temperate grassland, steppe, and desert-grassland ecosystems. The spatial distribution of SOCD gradually decreased from the southeast to the northwest, corresponding to the precipitation gradient. SOCD increased significantly with vegetation biomass, annual precipitation, soil moisture, clay and silt content, and decreased with mean annual temperature and sand content. The correlation between BGB and SOCD was closer than the correlation between AGB and SOCD. Variables could together explain about 69.8%, 74.4%, and 78.9% of total variation in SOCD at 0-30 cm, 0-50 cm, and 0-100 cm, respectively. In addition, we found that mean annual temperature is more important than other abiotic factors in determining SOCD in arid desert grasslands in our study area. The information obtained in this study provides a basis for accurately estimating SOC stocks and assessing carbon (C) sequestration potential in the desert grasslands of northwest China.	[Wang, Min; Su, Yongzhong; Yang, Xiao] Chinese Acad Sci, Linze Inland River Basin Res Stn, Chinese Ecosyst Network Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Wang, Min] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, M (corresponding author), Chinese Acad Sci, Linze Inland River Basin Res Stn, Chinese Ecosyst Network Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China.	wmin85@126.com			Chinese Academy of Sciences [XDA05050406-3]; National Natural Science Foundation of China [91125022]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences, grant number XDA05050406-3. (2) National Natural Science Foundation of China (91125022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo J, 2013, J SOIL SEDIMENT, V13, P265, DOI 10.1007/s11368-012-0617-7; Bastida F, 2007, APPL SOIL ECOL, V37, P53, DOI 10.1016/j.apsoil.2007.03.010; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Callesen I, 2003, GLOBAL CHANGE BIOL, V9, P358, DOI 10.1046/j.1365-2486.2003.00587.x; Canadell JG, 2007, ENVIRON SCI POLICY, V10, P370, DOI 10.1016/j.envsci.2007.01.009; Chaudhari SK, 2008, SOIL SCI SOC AM J, V72, P431, DOI 10.2136/sssaj2006.0117N; Conant RT, 2002, ENVIRON POLLUT, V116, pS127, DOI 10.1016/S0269-7491(01)00265-2; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P757, DOI 10.1007/s11427-010-4029-x; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P231; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Liu WJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035401; Ma WH, 2006, CARBON STORAGE TEMPE; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; PAUL EA, 1984, PLANT SOIL, V76, P275, DOI 10.1007/BF02205586; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; SCHIMEL DS, 1986, PLANT SOIL, V93, P347, DOI 10.1007/BF02374285; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Su YZ, 2010, J ENVIRON MANAGE, V91, P2109, DOI 10.1016/j.jenvman.2009.12.014; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang Min, 2013, Chinese Journal of Plant Ecology, V37, P209, DOI 10.3724/SP.J.1258.2013.00021; Wang QB, 1998, ACTA PHYTOECOLOGICA, V22, P409; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Wu HB, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001844; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Wynn JG, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002576; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Zhong L, 2001, PLANT SOIL, V231, P175, DOI 10.1023/A:1010350020951; Zinke PJ, 1984, WORLDWIDE ORGANIC SO	41	37	38	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94652	10.1371/journal.pone.0094652	http://dx.doi.org/10.1371/journal.pone.0094652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732375	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400063
J	Hammerling, D; Cefalu, M; Cisewski, J; Dominici, F; Parmigiani, G; Paulson, C; Smith, RL				Hammerling, Dorit; Cefalu, Matthew; Cisewski, Jessi; Dominici, Francesca; Parmigiani, Giovanni; Paulson, Charles; Smith, Richard L.			Completing the Results of the 2013 Boston Marathon	PLOS ONE			English	Article								The 2013 Boston marathon was disrupted by two bombs placed near the finish line. The bombs resulted in three deaths and several hundred injuries. Of lesser concern, in the immediate aftermath, was the fact that nearly 6,000 runners failed to finish the race. We were approached by the marathon's organizers, the Boston Athletic Association (BAA), and asked to recommend a procedure for projecting finish times for the runners who could not complete the race. With assistance from the BAA, we created a dataset consisting of all the runners in the 2013 race who reached the halfway point but failed to finish, as well as all runners from the 2010 and 2011 Boston marathons. The data consist of split times from each of the 5 km sections of the course, as well as the final 2.2 km (from 40 km to the finish). The statistical objective is to predict the missing split times for the runners who failed to finish in 2013. We set this problem in the context of the matrix completion problem, examples of which include imputing missing data in DNA microarray experiments, and the Netflix prize problem. We propose five prediction methods and create a validation dataset to measure their performance by mean squared error and other measures. The best method used local regression based on a K-nearest-neighbors algorithm (KNN method), though several other methods produced results of similar quality. We show how the results were used to create projected times for the 2013 runners and discuss potential for future application of the same methodology. We present the whole project as an example of reproducible research, in that we are able to make the full data and all the algorithms we have used publicly available, which may facilitate future research extending the methods or proposing completely different approaches.	[Hammerling, Dorit; Smith, Richard L.] Stat & Appl Math Sci Inst, Res Triangle Pk, NC 27709 USA; [Cefalu, Matthew; Dominici, Francesca; Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cisewski, Jessi] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Boston, MA 02115 USA; [Paulson, Charles] Puffinware LLC, State Coll, PA USA; [Smith, Richard L.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC USA	Harvard University; Harvard T.H. Chan School of Public Health; Carnegie Mellon University; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill	Smith, RL (corresponding author), Stat & Appl Math Sci Inst, Res Triangle Pk, NC 27709 USA.	rls@email.unc.edu		Cisewski, Jessi/0000-0002-9656-2272; Hammerling, Dorit/0000-0003-3583-3611	National Science Foundation [DMS-1127914, DMS-1043903]; Division Of Mathematical Sciences [1106862] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Dorit Hammerling and Richard Smith were partially supported by the National Science Foundation under Grant DMS-1127914 to the Statistical and Applied Mathematical Sciences Institute, and Jessi Cisewski was partially supported by the National Science Foundation under Grant DMS-1043903. The National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett J., 2007, P KDD CUP WORKSH NEW, P3; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chambers JM, 1992, STAT MODELS S LONDON; Christensen R, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-9816-3; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520	7	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93800	10.1371/journal.pone.0093800	http://dx.doi.org/10.1371/journal.pone.0093800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727904	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200027
J	Li, Y; Gu, F; Zhang, XL; Yang, LZ; Chen, LJ; Wei, ZD; Zha, RJ; Wang, Y; Li, XM; Zhou, YF; Zhang, XC				Li, Ya; Gu, Feng; Zhang, Xiliang; Yang, Lizhuang; Chen, Lijun; Wei, Zhengde; Zha, Rujing; Wang, Ying; Li, Xiaoming; Zhou, Yifeng; Zhang, Xiaochu			Cerebral Activity to Opposite-Sex Voices Reflected by Event-Related Potentials	PLOS ONE			English	Article							SMOKING CUE-REACTIVITY; BRAIN POTENTIALS; PERCEPTION; PITCH; RECOGNITION; ERP; EXPRESSIONS; PREFERENCES; PICTURES; STIMULI	Human voice is a gender discriminating cue and is important to mate selection. This study employed electrophysiological recordings to examine whether there is specific cerebral activity when presented with opposite-sex voices as compared to same-sex voices. Male voices and female voices were pseudo-randomly presented to male and female participants. In Experiment 1, participants were instructed to determine the gender of each voice. A late positivity (LP) response around 750 ms after voice onset was elicited by opposite-sex voices, as reflected by a positive deflection of the ERP to opposite-sex voices than that to same-sex voices. This LP response was prominent around parieto-occipital recording sites, and it suggests an opposite-sex specific process, which may reflect emotion-and/or reward-related cerebral activity. In Experiment 2, participants were instructed to press a key when hearing a non-voice pure tone and not give any response when they heard voice stimuli. In this task, no difference were found between the ERP to same-sex voices and that to opposite-sex voices, suggesting that the cerebral activity to opposite-sex voices may disappear without gender-related attention. These results provide significant implications on cognitive mechanisms with regard to opposite-sex specific voice processing.	[Li, Ya; Gu, Feng; Zhang, Xiliang; Yang, Lizhuang; Chen, Lijun; Wei, Zhengde; Zha, Rujing; Wang, Ying; Li, Xiaoming; Zhou, Yifeng; Zhang, Xiaochu] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Zhang, Xiaochu] Univ Sci & Technol China, Sch Humanities & Social Sci, Hefei 230026, Anhui, Peoples R China; [Li, Xiaoming] Anhui Med Univ, Dept Med Psychol, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University	Gu, F (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	fgu@ustc.edu.cn; zxcustc@ustc.edu.cn	Yang, Li-Zhuang/F-3648-2016; zha, rujing/AAE-4602-2020; Zhang, Xiaochu/AAG-8768-2022; Yang, Li-Zhuang/AAJ-3623-2020; Zhang, Xiaochu/AEW-0582-2022; Zhang, Xiaochu/O-9592-2014	Yang, Li-Zhuang/0000-0002-0192-4323; Yang, Li-Zhuang/0000-0002-0192-4323; Zhang, Xiaochu/0000-0002-7541-0130; Gu, Feng/0000-0002-5954-5596; Wei, Zhengde/0000-0003-4586-0170; Zha, Rujing/0000-0003-0457-096X	National Natural Science Foundation of China [31171083, 31230032]; Fundamental Research Funds for the Central Universities of China [WK2070000033]; 100 Talents Programme of The Chinese Academy of Sciences [BJ2070000047]; China Postdoctoral Science Foundation [2013M541834]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); 100 Talents Programme of The Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31171083, 31230032), and the Fundamental Research Funds for the Central Universities of China (WK2070000033), and 100 Talents Programme of The Chinese Academy of Sciences (BJ2070000047), and China Postdoctoral Science Foundation (2013M541834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Charest I, 2013, CEREB CORTEX, V23, P958, DOI 10.1093/cercor/bhs090; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; de Gelder B, 2002, P NATL ACAD SCI USA, V99, P4121, DOI 10.1073/pnas.062018499; Dolcos F, 2000, J COGNITIVE NEUROSCI, P55; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ethofer T, 2007, SOC COGN AFFECT NEUR, V2, P334, DOI 10.1093/scan/nsm028; Franken IHA, 2003, PSYCHOPHARMACOLOGY, V170, P205, DOI 10.1007/s00213-003-1542-7; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hofmann SG, 2006, PERS INDIV DIFFER, V40, P1683, DOI 10.1016/j.paid.2005.12.014; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Junger J, 2013, NEUROIMAGE, V79, P275, DOI 10.1016/j.neuroimage.2013.04.105; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Latinus M, 2012, BRAIN TOPOGR, V25, P194, DOI 10.1007/s10548-011-0207-9; Latinus M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-36; Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Littel M, 2007, J PSYCHOPHARMACOL, V21, P873, DOI 10.1177/0269881107078494; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pernet CR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00023; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sokhi DS, 2005, NEUROIMAGE, V27, P572, DOI 10.1016/j.neuroimage.2005.04.023; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Warren CA, 1999, CLIN NEUROPHYSIOL, V110, P1570, DOI 10.1016/S1388-2457(99)00089-9; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; WU K, 1991, J ACOUST SOC AM, V90, P1828, DOI 10.1121/1.401663; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063	34	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94976	10.1371/journal.pone.0094976	http://dx.doi.org/10.1371/journal.pone.0094976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727971	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200143
J	Wang, L; Ma, XY; Zhang, Y; Feng, YF; Li, X; Hu, YY; Wang, Z; Ma, ZS; Lei, W				Wang, Lin; Ma, Xiang-Yu; Zhang, Yang; Feng, Ya-Fei; Li, Xiang; Hu, Yun-Yu; Wang, Zhen; Ma, Zhen-Sheng; Lei, Wei			Repair of Segmental Bone Defect Using Totally Vitalized Tissue Engineered Bone Graft by a Combined Perfusion Seeding and Culture System	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; TRICALCIUM PHOSPHATE SCAFFOLD; FIBER MESH SCAFFOLDS; FLOW PERFUSION; 3-DIMENSIONAL FABRICATION; INTERNAL ARCHITECTURE; OSTEOBLASTIC CELLS; MATRIX DEPOSITION; POLYMER SCAFFOLDS	Background: The basic strategy to construct tissue engineered bone graft (TEBG) is to combine osteoblastic cells with three dimensional (3D) scaffold. Based on this strategy, we proposed the "Totally Vitalized TEBG" (TV-TEBG) which was characterized by abundant and homogenously distributed cells with enhanced cell proliferation and differentiation and further investigated its biological performance in repairing segmental bone defect. Methods: In this study, we constructed the TV-TEBG with the combination of customized flow perfusion seeding/culture system and beta-tricalcium phosphate (beta-TCP) scaffold fabricated by Rapid Prototyping (RP) technique. We systemically compared three kinds of TEBG constructed by perfusion seeding and perfusion culture (PSPC) method, static seeding and perfusion culture (SSPC) method, and static seeding and static culture (SSSC) method for their in vitro performance and bone defect healing efficacy with a rabbit model. Results: Our study has demonstrated that TEBG constructed by PSPC method exhibited better biological properties with higher daily D-glucose consumption, increased cell proliferation and differentiation, and better cell distribution, indicating the successful construction of TV-TEBG. After implanted into rabbit radius defects for 12 weeks, PSPC group exerted higher X-ray score close to autograft, much greater mechanical property evidenced by the biomechanical testing and significantly higher new bone formation as shown by histological analysis compared with the other two groups, and eventually obtained favorable healing efficacy of the segmental bone defect that was the closest to autograft transplantation. Conclusion: This study demonstrated the feasibility of TV-TEBG construction with combination of perfusion seeding, perfusion culture and RP technique which exerted excellent biological properties. The application of TV-TEBG may become a preferred candidate for segmental bone defect repair in orthopedic and maxillofacial fields.	[Wang, Lin; Ma, Xiang-Yu; Zhang, Yang; Feng, Ya-Fei; Hu, Yun-Yu; Wang, Zhen; Ma, Zhen-Sheng; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi, Peoples R China; [Li, Xiang] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China	Air Force Military Medical University; Shanghai Jiao Tong University	Ma, ZS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi, Peoples R China.	bonefour@fmmu.edu.cn; leiwei@fmmu.edu.cn	; Wang, Lin/J-8805-2018	Lei, Wei/0000-0002-7346-6915; Wang, Lin/0000-0001-5937-6318	Research Fund for the National Natural Science Foundation of China [81371933]; National Natural Science Foundation of China [31170913/C1002]	Research Fund for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Research Fund for the National Natural Science Foundation of China (No. 81371933) to Lin Wang and the National Natural Science Foundation of China (No. 31170913/C1002) to Wei Lei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Barreto JF, 2007, MACROMOL BIOSCI, V7, P579, DOI 10.1002/mabi.200600280; Alvarez-Barreto JF, 2007, ANN BIOMED ENG, V35, P429, DOI 10.1007/s10439-006-9244-z; Burg KJL, 2002, J BIOMED MATER RES, V61, P380, DOI 10.1002/jbm.10146; Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053; Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5; Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4; Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5; Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y; Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330; Janssen FW, 2006, J BIOMED MATER RES A, V79A, P338, DOI 10.1002/jbm.a.30794; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260; Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792; Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6; McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje; Minamide A, 2005, SPINE, V30, P1134, DOI 10.1097/01.brs.0000162394.75425.04; Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045; Nair MB, 2009, J BIOMED MATER RES A, V91A, P855, DOI 10.1002/jbm.a.32239; Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041; Pieri F, 2010, BIOMATERIALS, V31, P3527, DOI 10.1016/j.biomaterials.2010.01.066; Pountos I, 2006, J BONE JOINT SURG BR, V88B, P421, DOI 10.1302/0301-620x.88B4.17060; Raimondi MT, 2002, BIOMECH MODEL MECHAN, V1, P69, DOI 10.1007/s10237-002-0007-y; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Roy TD, 2003, J BIOMED MATER RES A, V67A, P1228, DOI 10.1002/jbm.a.20034; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Schumacher M, 2010, J MATER SCI-MATER M, V21, P3039, DOI 10.1007/s10856-010-4153-y; Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550; Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3; Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569; Song KD, 2013, CELL STRESS CHAPERON, V18, P193, DOI 10.1007/s12192-012-0370-2; Tan HB, 2009, BIOMATERIALS, V30, P3560, DOI 10.1016/j.biomaterials.2009.03.029; van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365; van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783; Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j; Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036; Wang L, 2009, J BIOMED MATER RES A, V91A, P102, DOI 10.1002/jbm.a.32189; Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200; YANG CY, 1994, CLIN ORTHOP RELAT R, P286; Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101; Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025; Zhao F, 2005, BIOTECHNOL BIOENG, V91, P482, DOI 10.1002/bit.20532	49	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94276	10.1371/journal.pone.0094276	http://dx.doi.org/10.1371/journal.pone.0094276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728277	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200054
J	Alves, ER; Gomes, LT; Ribatski-Silva, D; Mendes, CRJ; Leal-Santos, FA; Simoes, LR; Mello, MBC; Fontes, CJF				Alves-Junior, Eduardo R.; Gomes, Luciano T.; Ribatski-Silva, Daniele; Mendes, Clebson Rodrigues J.; Leal-Santos, Fabio A.; Simoes, Luciano R.; Mello, Marcia Beatriz C.; Fontes, Cor Jesus F.			Assumed White Blood Cell Count of 8,000 Cells/mu L Overestimates Malaria Parasite Density in the Brazilian Amazon	PLOS ONE			English	Article							THICK	Quantification of parasite density is an important component in the diagnosis of malaria infection. The accuracy of this estimation varies according to the method used. The aim of this study was to assess the agreement between the parasite density values obtained with the assumed value of 8,000 cells/mu L and the automated WBC count. Moreover, the same comparative analysis was carried out for other assumed values of WBCs. The study was carried out in Brazil with 403 malaria patients who were infected in different endemic areas of the Brazilian Amazon. The use of a fixed WBC count of 8,000 cells/mu L to quantify parasite density in malaria patients led to overestimated parasitemia and resulted in low reliability when compared to the automated WBC count. Assumed values ranging between 5,000 and 6,000 cells/mu L, and 5,500 cells/mu L in particular, showed higher reliability and more similar values of parasite density when compared between the 2 methods. The findings show that assumed WBC count of 5,500 cells/mu L could lead to a more accurate estimation of parasite density for malaria patients in this endemic region.	[Alves-Junior, Eduardo R.; Gomes, Luciano T.; Ribatski-Silva, Daniele; Mendes, Clebson Rodrigues J.; Leal-Santos, Fabio A.; Simoes, Luciano R.; Mello, Marcia Beatriz C.; Fontes, Cor Jesus F.] Fed Univ Mato Grosso Cuiaba, Julio Muller Hosp, Cuiaba, Mato Grosso, Brazil; [Alves-Junior, Eduardo R.; Gomes, Luciano T.] Univ Univ Ctr, Biomed Dept, Varzea Grande, Mato Grosso, Brazil; [Gomes, Luciano T.; Fontes, Cor Jesus F.] Facimed Course Med, Dept Med, Cacoal, Rondonia, Brazil	Universidade Federal de Mato Grosso do Sul	Fontes, CJF (corresponding author), Fed Univ Mato Grosso Cuiaba, Julio Muller Hosp, Cuiaba, Mato Grosso, Brazil.	corfontes@gmail.com	Alves, Eduardo Rodrigues/B-8148-2016; Santos, Fabio/C-2708-2012; Fontes, Cor JF/G-7331-2018; Gomes, Luciano/E-9090-2018	Alves, Eduardo Rodrigues/0000-0002-4785-0008; Fontes, Cor JF/0000-0003-2756-0588; Gomes, Luciano/0000-0002-4036-3688; Santos, Fabio/0000-0002-3261-4379	Brazilian National Council for Scientific and Technological Development; State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network)	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network)	Financial support was provided by the Brazilian National Council for Scientific and Technological Development and State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyasi D, 2012, MALARIA J, V11, P1; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gonzalez B, 2009, INVEST CLIN, V50, P187; Haggaz AD, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-6; HIDEMI E, 1989, REV SAUDE PUBL, V23, P58; Jeremiah ZA, 2007, ANN TROP PAEDIATR, V27, P75, DOI 10.1179/146532807X170547; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Limaye Charulata S, 2012, J Assoc Physicians India, V60, P15; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Olliaro P, 2011, TROP MED INT HEALTH, V16, P551, DOI 10.1111/j.1365-3156.2011.02738.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; World Health Organisation, 2010, BAS MAL MICR LEARN G, P69	16	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94193	10.1371/journal.pone.0094193	http://dx.doi.org/10.1371/journal.pone.0094193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721983	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100043
J	Blagodatskaya, E; Blagodatsky, S; Anderson, TH; Kuzyakov, Y				Blagodatskaya, Evgenia; Blagodatsky, Sergey; Anderson, Traute-Heidi; Kuzyakov, Yakov			Microbial Growth and Carbon Use Efficiency in the Rhizosphere and Root-Free Soil	PLOS ONE			English	Article							BACTERIAL-GROWTH; DNA CONTENTS; BIOMASS; RESPIRATION; COMMUNITIES; NITROGEN; DIVERSITY; TURNOVER; FUNGAL; MINERALIZATION	Plant-microbial interactions alter C and N balance in the rhizosphere and affect the microbial carbon use efficiency (CUE)the fundamental characteristic of microbial metabolism. Estimation of CUE in microbial hotspots with high dynamics of activity and changes of microbial physiological state from dormancy to activity is a challenge in soil microbiology. We analyzed respiratory activity, microbial DNA content and CUE by manipulation the C and nutrients availability in the soil under Beta vulgaris. All measurements were done in root-free and rhizosphere soil under steady-state conditions and during microbial growth induced by addition of glucose. Microorganisms in the rhizosphere and root-free soil differed in their CUE dynamics due to varying time delays between respiration burst and DNA increase. Constant CUE in an exponentially-growing microbial community in rhizosphere demonstrated the balanced growth. In contrast, the CUE in the root-free soil increased more than three times at the end of exponential growth and was 1.5 times higher than in the rhizosphere. Plants alter the dynamics of microbial CUE by balancing the catabolic and anabolic processes, which were decoupled in the root-free soil. The effects of N and C availability on CUE in rhizosphere and root-free soil are discussed.	[Blagodatskaya, Evgenia; Kuzyakov, Yakov] Univ Gottingen, Busgen Inst, D-37073 Gottingen, Germany; [Blagodatskaya, Evgenia; Blagodatsky, Sergey] Russian Acad Sci, Inst Physicochem & Biol Problems Soil Sci, Pushchino 142292, Russia; [Blagodatsky, Sergey] Univ Hohenheim, Inst Plant Prod & Agroecol Trop & Subtrop, Stuttgart, Germany; [Anderson, Traute-Heidi] Thunen Inst Climate Smart Agr vTI, Braunschweig, Germany	University of Gottingen; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Physicohemical & Biological Problems of Soil Science; University Hohenheim; Johann Heinrich von Thunen Institute	Blagodatskaya, E (corresponding author), Univ Gottingen, Busgen Inst, D-37073 Gottingen, Germany.	janeblag@mail.ru	Kuzyakov, Yakov/D-1605-2010; Blagodatsky, Sergey/F-2734-2010; Blagodatskaya, Evgenia/L-7177-2017	Kuzyakov, Yakov/0000-0002-9863-8461; Blagodatsky, Sergey/0000-0003-1428-6014; Blagodatskaya, Evgenia/0000-0002-8284-4017	European Commission [IIF 039907-MICROSOM]; Alexander von Humboldt Foundation; Russian Academy of Sciences [6123.2014.4]; Russian Foundation for Basic Research [12-04-01170]; German Research Foundation (DFG) [KU 1184/13-1/2]	European Commission(European CommissionEuropean Commission Joint Research Centre); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); German Research Foundation (DFG)(German Research Foundation (DFG))	This authors acknowledge the following: the European Commission (Marie Curie IIF program, project IIF 039907-MICROSOM) for supporting EB (http://ec.europa.eu/research/mariecurieactions/); the Alexander von Humboldt Foundation for supporting SB (http://www.humboldt-foundation.de/web/start.html); Russian Academy of Sciences (Scientific School Program 6123.2014.4, https://grants.extech.ru/grants/res/winners.php?OZ = 4&TZ = S&year = 2014); Russian Foundation for Basic Research (grant No 12-04-01170, http://www.rfbr.ru/rffi/ru/); and German Research Foundation (DFG) within project KU 1184/13-1/2 (http://www.dfg.de/en/). The funders had no role in study, design, data collection and analysis, decision to manuscript, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; ANDERSON TH, 1986, Z PFLANZ BODENKUNDE, V149, P457, DOI 10.1002/jpln.19861490409; Anderson TH, 2008, LANDBAUFORSCH VOLK, V58, P19; Anderson TH, 2013, SOIL BIOL BIOCHEM, V57, P487, DOI 10.1016/j.soilbio.2012.09.031; ANDREWS JH, 1986, ADV MICROB ECOL, V9, P99; [Anonymous], 1975, PRINCIPLES MICROBIAL; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blagodatskaya EV, 2007, APPL SOIL ECOL, V37, P95, DOI 10.1016/j.apsoil.2007.05.002; Blagodatskaya E. V., 2003, Mikrobiologiya, V72, P840; Blagodatskaya EV, 2009, EUROP J SOIL SCI, V60; BLAGODATSKIY SA, 1993, EURASIAN SOIL SCI+, V25, P85; Blagodatsky SA, 2006, EURASIAN SOIL SCI+, V39, P290, DOI 10.1134/S1064229306030082; Blagodatsky SA, 2000, BIOL FERT SOILS, V32, P73, DOI 10.1007/s003740000219; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1757, DOI 10.1016/S0038-0717(98)00029-7; Blagodatsky SA, 2002, EURASIAN SOIL SCI+, V35, P874; Bradford MA, 2013, BIOGEOCHEMISTRY, V113, P271, DOI 10.1007/s10533-012-9822-0; Cheng WX, 2009, SOIL BIOL BIOCHEM, V41, P1795, DOI 10.1016/j.soilbio.2008.04.018; CHRISTENSEN H, 1993, FEMS MICROBIOL ECOL, V102, P129, DOI 10.1111/j.1574-6968.1993.tb05804.x; CHRISTENSEN H, 1995, MICROBIAL ECOL, V29, P49, DOI 10.1007/BF00217422; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dorodnikov M, 2009, FEMS MICROBIOL ECOL, V69, P43, DOI 10.1111/j.1574-6941.2009.00697.x; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Goddard VJ, 2001, PLANT SOIL, V232, P181, DOI 10.1023/A:1010302607616; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; Herron PM, 2009, SOIL BIOL BIOCHEM, V41, P1262, DOI 10.1016/j.soilbio.2009.03.010; Hill PW, 2008, SOIL BIOL BIOCHEM, V40, P616, DOI 10.1016/j.soilbio.2007.09.008; Joergensen RG, 2006, J PLANT NUTR SOIL SC, V169, P295, DOI 10.1002/jpln.200521941; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leckie SE, 2004, SOIL BIOL BIOCHEM, V36, P529, DOI 10.1016/j.soilbio.2003.10.014; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Marstorp H, 1999, SOIL BIOL BIOCHEM, V31, P1443, DOI 10.1016/S0038-0717(99)00065-6; Marstorp H, 2000, SOIL BIOL BIOCHEM, V32, P879, DOI 10.1016/S0038-0717(99)00210-2; ModelMaker, 1997, MODELMAKER VERS 3 0; Panikov NS, 2010, HANDB ENVIRON ENG, V10, P121, DOI 10.1007/978-1-60327-140-0_4; Panikov NS, 1996, J MICROBIOL METH, V24, P219, DOI 10.1016/0167-7012(95)00074-7; Panikov NS, 1995, MICROBIAL GROWTH KIN; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; Paterson E, 2009, SOIL BIOL BIOCHEM, V41, P1352, DOI 10.1016/j.soilbio.2009.02.012; PAYNE WJ, 1970, ANNU REV MICROBIOL, V24, P17, DOI 10.1146/annurev.mi.24.100170.000313; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rousk J, 2007, FEMS MICROBIOL ECOL, V62, P258, DOI 10.1111/j.1574-6941.2007.00398.x; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; Thiet RK, 2006, SOIL BIOL BIOCHEM, V38, P837, DOI 10.1016/j.soilbio.2005.07.010; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Weigel HJ, 2005, PEDOSPHERE, V15, P728; Wutzler T, 2012, SOIL BIOL BIOCHEM, V45, P102, DOI 10.1016/j.soilbio.2011.10.004; Zachow C, 2008, MICROB ECOL, V55, P119, DOI 10.1007/s00248-007-9257-7	54	138	147	9	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93282	10.1371/journal.pone.0093282	http://dx.doi.org/10.1371/journal.pone.0093282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722409	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100015
J	Shibahara, H; Higashi, M; Koriyama, C; Yokoyama, S; Kitazono, I; Kurumiya, Y; Narita, M; Kuze, S; Kyokane, T; Mita, S; Arai, T; Kato, T; Yuasa, N; Yamaguchi, R; Kubota, H; Suzuki, H; Baba, S; Rousseau, K; Batra, SK; Yonezawa, S				Shibahara, Hiroaki; Higashi, Michiyo; Koriyama, Chihaya; Yokoyama, Seiya; Kitazono, Iwao; Kurumiya, Yasuhiro; Narita, Michihiko; Kuze, Shingo; Kyokane, Takanori; Mita, Saburo; Arai, Toshiyuki; Kato, Takehito; Yuasa, Norihiro; Yamaguchi, Ryuzo; Kubota, Hitoshi; Suzuki, Hideaki; Baba, Satoshi; Rousseau, Karine; Batra, Surinder K.; Yonezawa, Suguru			Pathobiological Implications of Mucin (MUC) Expression in the Outcome of Small Bowel Cancer	PLOS ONE			English	Article							BILE-DUCT CARCINOMAS; ABERRANT EXPRESSION; PROGNOSTIC-FACTOR; HUMAN NEOPLASMS; ADENOCARCINOMA; ANTIGENS; TUMORS; CELLS	Mucins have been associated with survival in various cancer patients, but there have been no studies of mucins in small bowel carcinoma (SBC). In this study, we investigated the relationships between mucin expression and clinicopathologic factors in 60 SBC cases, in which expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6 and MUC16 in cancer and normal tissues were examined by immunohistochemistry. MUC1, MUC5AC and MUC16 expression was increased in SBC lesions compared to the normal epithelium, and expression of these mucins was related to clinicopathologic factors, as follows: MUC1 [tumor location (p = 0.019), depth (p = 0.017) and curability (p = 0.007)], MUC5AC [tumor location (p = 0.063) and lymph node metastasis (p = 0.059)], and MUC16 [venous invasion (p = 0.016) and curability (p = 0.016)]. Analysis of 58 cases with survival data revealed five factors associated with a poor prognosis: poorly-differentiated or neuroendocrine histological type (p<0.001), lymph node metastasis (p<0.001), lymphatic invasion (p = 0.026), venous invasion (p<0.001) and curative resection (p<0.001), in addition to expression of MUC1 (p = 0.042), MUC5AC (p = 0.007) and MUC16 (p<0.001). In subsequent multivariate analysis with curability as the covariate, lymph node metastasis, venous invasion, and MUC5AC and/or MUC16 expression were significantly related to the prognosis. Multivariate analysis in curative cases (n = 45) showed that SBC with MUC5AC and/or MUC16 expression had a significantly independent high hazard risk after adjusting for the effects of venous invasion (hazard ratio: 5.6, 95% confidence interval: 1.8-17). In conclusion, the study shows that a MUC5AC-positive and/or MUC16-positive status is useful as a predictor of a poor outcome in patients with SBC.	[Shibahara, Hiroaki] Toyota Kosei Hosp, Dept Palliat Care, Toyota, Japan; [Higashi, Michiyo; Yokoyama, Seiya; Kitazono, Iwao; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 890, Japan; [Koriyama, Chihaya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 890, Japan; [Kurumiya, Yasuhiro] Toyota Kosei Hosp, Dept Surg, Toyota, Japan; [Narita, Michihiko] Toyota Kosei Hosp, Dept Pathol, Toyota, Japan; [Kuze, Shingo; Kyokane, Takanori] Chutoen Gen Med Ctr, Dept Surg, Kakegawa, Japan; [Mita, Saburo] Chita City Hosp, Dept Surg, Chita, Japan; [Arai, Toshiyuki] Anjo Kosei Hosp, Dept Surg, Anjo, Japan; [Kato, Takehito] Toyohashi Municipal Hosp, Dept Surg, Toyohashi, Aichi, Japan; [Yuasa, Norihiro] Japanese Red Cross Nagoya Daiichi Hosp, Dept Surg, Nagoya, Aichi, Japan; [Yamaguchi, Ryuzo] Kasugai Municipal Hosp, Dept Surg, Kasugai, Aichi, Japan; [Kubota, Hitoshi; Suzuki, Hideaki] Handa City Hosp, Dept Surg, Handa, Japan; [Baba, Satoshi] Hamamatsu Univ Sch Med, Univ Hosp, Dept Diagnost Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Rousseau, Karine] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Mol Biol, Omaha, NE USA	Kagoshima University; Kagoshima University; Red Cross Nagoya Daiichi Hospital; Hamamatsu University School of Medicine; University of Manchester; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Higashi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 890, Japan.	east@m2.kufm.kagoshima-u.ac.jp			Princess Takamatsu Cancer Research Fund [11-24319]; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 24590447, 24701008]; Kodama Memorial Foundation, Japan; National Institutes of Health [CA78590]; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA078590] Funding Source: NIH RePORTER	Princess Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kodama Memorial Foundation, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Princess Takamatsu Cancer Research Fund (11-24319) to S. Yonezawa; Grants-in-Aid for Scientific Research (B) 23390085 to S. Yonezawa; Scientific Research (C) 24590447 to M. Higashi; and Young Scientists (B) 24701008 to S. Yokoyama from the Ministry of Education, Science, Sports, Culture and Technology, Japan; by the Kodama Memorial Foundation, Japan (S. Yokoyama & M. Higashi); and by USPHS grant CA78590 from the National Institutes of Health to S. K. Batra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, ANN SURG ONCOL, V14, P2263, DOI 10.1245/s10434-007-9428-2; Boonla C, 2003, CANCER, V98, P1438, DOI 10.1002/cncr.11652; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Dabaja BS, 2004, CANCER, V101, P518, DOI 10.1002/cncr.20404; Goto M, 2005, PATHOL INT, V55, P464, DOI 10.1111/j.1440-1827.2005.01854.x; Hamada T, 2012, CANCER; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; Higashi M, 1999, HEPATOLOGY, V30, P1347, DOI 10.1002/hep.510300609; Higashi M, 2012, PATHOBIOLOGY, V79, P101, DOI 10.1159/000335164; Higashi M, 2010, J HEPATO-BIL-PAN SCI, V17, P275, DOI 10.1007/s00534-009-0176-5; Hoshi H, 2013, INT J ONCOL, V42, P887, DOI 10.3892/ijo.2013.1760; Hoshi H, 2011, INT J ONCOL, V38, P619, DOI 10.3892/ijo.2011.911; Inaguma S, 2011, ONCOGENE, V30, P714, DOI 10.1038/onc.2010.459; Ito H, 2003, J GASTROINTEST SURG, V7, P925, DOI 10.1016/j.gassur.2003.07.003; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Lee MJ, 2003, MODERN PATHOL, V16, P403, DOI 10.1097/01.MP.0000067683.84284.66; OURIEL K, 1984, AM J SURG, V147, P66, DOI 10.1016/0002-9610(84)90036-9; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Shibahara H, 2004, AM J SURG PATHOL, V28, P327, DOI 10.1097/00000478-200403000-00005; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tamada S, 2002, PATHOL INT, V52, P713, DOI 10.1046/j.1440-1827.2002.01414.x; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Ugurlu MM, 2005, J GASTROINTEST SURG, V9, P1182, DOI 10.1016/j.gassur.2005.08.027; Wang RQ, 2003, J CLIN PATHOL, V56, P378, DOI 10.1136/jcp.56.5.378; Wu TJ, 2006, WORLD J SURG, V30, P391, DOI 10.1007/s00268-005-7898-6; Yamazoe S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-53; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Yu CJ, 2005, LUNG CANCER, V47, P59, DOI 10.1016/j.lungcan.2004.05.018; Zhang MQ, 2007, AM J CLIN PATHOL, V128, P808, DOI 10.1309/JAF3KVGJHQCJ1QF9	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e86111	10.1371/journal.pone.0086111	http://dx.doi.org/10.1371/journal.pone.0086111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722639	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100001
J	Franchini, P; Fruciano, C; Frickey, T; Jones, JC; Meyer, A				Franchini, Paolo; Fruciano, Carmelo; Frickey, Tancred; Jones, Julia C.; Meyer, Axel			The Gut Microbial Community of Midas Cichlid Fish in Repeatedly Evolved Limnetic-Benthic Species Pairs	PLOS ONE			English	Article							CICHLASOMA-CITRINELLUM; GASTEROSTEUS-ACULEATUS; THREESPINE STICKLEBACK; TROPHIC POLYMORPHISM; PARALLEL EVOLUTION; MOLECULAR ANALYSIS; LAKE; SPECIATION; DIVERSITY; ZEBRAFISH	Gut bacterial communities are now known to influence a range of fitness related aspects of organisms. But how different the microbial community is in closely related species, and if these differences can be interpreted as adaptive is still unclear. In this study we compared microbial communities in two sets of closely related sympatric crater lake cichlid fish species pairs that show similar adaptations along the limnetic-benthic axis. The gut microbial community composition differs in the species pair inhabiting the older of two crater lakes. One major difference, relative to other fish, is that in these cichlids that live in hypersaline crater lakes, the microbial community is largely made up of Oceanospirillales (52.28%) which are halotolerant or halophilic bacteria. This analysis opens up further avenues to identify candidate symbiotic or co-evolved bacteria playing a role in adaptation to similar diets and life-styles or even have a role in speciation. Future functional and phylosymbiotic analyses might help to address these issues.	[Franchini, Paolo; Fruciano, Carmelo; Frickey, Tancred; Jones, Julia C.; Meyer, Axel] Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, Constance, Germany; [Jones, Julia C.] Univ Konstanz, Zukunftskolleg, Constance, Germany	University of Konstanz; University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, Constance, Germany.	axel.meyer@uni-konstanz.de	Fruciano, Carmelo/O-5175-2018; Jones, Julia/P-2339-2016; Fruciano, Carmelo/HHM-5130-2022; Meyer, Axel/C-9826-2009; Franchini, Paolo/M-6581-2016	Fruciano, Carmelo/0000-0002-1659-9746; Jones, Julia/0000-0002-3557-1941; Fruciano, Carmelo/0000-0002-1659-9746; Meyer, Axel/0000-0002-0888-8193; Franchini, Paolo/0000-0002-8184-1463	ERC [293700]; The European Commission; The University of Konstanz	ERC(European Research Council (ERC)European Commission); The European Commission(European CommissionEuropean Commission Joint Research Centre); The University of Konstanz	ERC Advanced Grant "GenAdap'' 293700 to A. M. The European Commission (Marie Curie IEF Fellowship PlasticitySpeciation to C. F.). The University of Konstanz (Zukunftskolleg Fellowship to J.C.J., Zukunftskolleg Independent Research Start up Grant to C. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Arahal DR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P811, DOI 10.1007/0-387-30746-x_28; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barlow GW, 1976, CHEM ANAL SOME CRATE; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bertrand M, 2008, J FISH BIOL, V72, P555, DOI 10.1111/j.1095-8649.2007.01720.x; Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvajal-Rodriguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024700; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Douglas A.E., 2010, SYMBIOTIC HABIT; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elmer KR, 2010, PHILOS T R SOC B, V365, P1763, DOI 10.1098/rstb.2009.0271; FENDERSON OWEN, 1964, TRANS AMER FISH SOC, V93, P77, DOI 10.1577/1548-8659(1964)93[77:EOSOLW]2.0.CO;2; Franchini P, 2014, MOL ECOL, V23, P1828, DOI 10.1111/mec.12590; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Hulsey C, 2013, ECOLOGY EVOLUTION; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kautt AF, 2012, MOL ECOL, V21, P4770, DOI 10.1111/j.1365-294X.2012.05738.x; Kekalainen J, 2010, J FISH BIOL, V76, P787, DOI 10.1111/j.1095-8649.2009.02475.x; Kim H, 2007, INT J SYST EVOL MICR, V57, P1793, DOI 10.1099/ijs.0.65059-0; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kutterolf S, 2007, J VOLCANOL GEOTH RES, V163, P55, DOI 10.1016/j.jvolgeores.2007.02.006; Landry L, 2007, J EVOLUTION BIOL, V20, P971, DOI 10.1111/j.1420-9101.2007.01304.x; LARSON GL, 1976, CAN J ZOOL, V54, P107, DOI 10.1139/z76-012; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; Merrifield DL, 2009, AQUAC RES, V40, P1064, DOI 10.1111/j.1365-2109.2009.02200.x; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; MEYER A, 1990, J ZOOL, V221, P237, DOI 10.1111/j.1469-7998.1990.tb03994.x; MEYER A, 1993, TRENDS ECOL EVOL, V8, P279, DOI 10.1016/0169-5347(93)90255-N; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michel AP, 2010, P NATL ACAD SCI USA, V107, P9724, DOI 10.1073/pnas.1000939107; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oren A, 2008, SALINE SYSTEMS, V4, P13; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Recknagel Hans, 2013, Aqua, V19, P207; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rogers SM, 2005, MOL ECOL, V14, P351, DOI 10.1111/j.1365-294X.2004.02396.x; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Siwertsson A, 2013, ECOLOGY EVOLUTION; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willacker JJ, 2010, BIOL J LINN SOC, V101, P595, DOI 10.1111/j.1095-8312.2010.01531.x; WILLIAMS EE, 1977, AM ZOOL, V17, P261; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260; Wootton RJ, 2009, J FISH BIOL, V75, P1919, DOI 10.1111/j.1095-8649.2009.02412.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	74	42	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95027	10.1371/journal.pone.0095027	http://dx.doi.org/10.1371/journal.pone.0095027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733403	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400145
J	Romo-Vaquero, M; Selma, MV; Larrosa, M; Obiol, M; Garcia-Villalba, R; Gonzalez-Barrio, R; Issaly, N; Flanagan, J; Roller, M; Tomas-Barberan, FA; Garcia-Conesa, MT				Romo-Vaquero, Maria; Selma, Maria-Victoria; Larrosa, Mar; Obiol, Maria; Garcia-Villalba, Rocio; Gonzalez-Barrio, Rocio; Issaly, Nicolas; Flanagan, John; Roller, Marc; Tomas-Barberan, Francisco A.; Garcia-Conesa, Maria-Teresa			A Rosemary Extract Rich in Carnosic Acid Selectively Modulates Caecum Microbiota and Inhibits beta-Glucosidase Activity, Altering Fiber and Short Chain Fatty Acids Fecal Excretion in Lean and Obese Female Rats	PLOS ONE			English	Article							GUT MICROBIOTA; IN-VITRO; DIET; INFLAMMATION; PREBIOTICS; MICE; POPULATIONS; POLYPHENOLS; METABOLISM; INULIN	Background: Carnosic acid (CA) and rosemary extracts (RE) show body-weight, energy metabolism and inflammation regulatory properties in animal models but the mechanisms are not yet understood. Gut microbiota plays an important role in the host metabolism and inflammatory status and is modulated by the diet. The aim of this research was to investigate whether a RE enriched in CA affected caecum microbiota composition and activity in a rat model of genetic obesity. Methods and Principal Findings: A RE (40% CA) was administered with the diet (0.5% w/w) to lean (fa/+) and obese (fa/fa) female Zucker rats for 64 days. Changes in the microbiota composition and beta-glucosidase activity in the caecum and in the levels of macronutrients and short chain fatty acids (SCFA) in feces were examined. The RE increased the Blautia coccoides and Bacteroides/Prevotella groups and reduced the Lactobacillus/Leuconostoc/Pediococccus group in both types of animals. Clostridium leptum was significantly decreased and Bifidobacterium increased only in the lean rats. beta-Glucosidase activity was significantly reduced and fecal fiber excretion increased in the two genotypes. The RE also increased the main SCFA excreted in the feces of the obese rats but decreased them in the lean rats reflecting important differences in the uptake and metabolism of these molecules between the two genotypes. Conclusions: Our results indicate that the consumption of a RE enriched in CA modifies microbiota composition and decreases beta-glucosidase activity in the caecum of female Zucker rats while it increases fiber fecal elimination. These results may contribute to explain the body weight gain reducing effects of the RE. The mutated leptin receptor of the obese animals significantly affects the microbiota composition, the SCFA fecal excretion and the host response to the RE intake.	[Romo-Vaquero, Maria; Selma, Maria-Victoria; Larrosa, Mar; Obiol, Maria; Garcia-Villalba, Rocio; Tomas-Barberan, Francisco A.; Garcia-Conesa, Maria-Teresa] CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain; [Garcia-Villalba, Rocio] Univ Murcia, Fac Vet Sci, Dept Human Nutr & Food Sci, Murcia, Spain; [Issaly, Nicolas] Naturex SL, Valencia, Spain; [Flanagan, John; Roller, Marc] Naturex SA, Avignon, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia	Garcia-Conesa, MT (corresponding author), CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain.	mtconesa@cebas.csic.es	Gonzalez-Barrio, Rocío/F-2180-2018; Selma, Maria Victoria/N-3997-2014; LARROSA, MAR/H-6012-2012; Villalba, Rocio Garcia/G-7217-2015; Tomás-Barberán, Francisco/D-6686-2011; García-Conesa, María-Teresa/N-4032-2014; Vaquero, María Romo/G-6883-2015	Gonzalez-Barrio, Rocío/0000-0002-6648-5229; Selma, Maria Victoria/0000-0002-6780-974X; LARROSA, MAR/0000-0002-8863-4686; Tomás-Barberán, Francisco/0000-0002-0790-1739; García-Conesa, María-Teresa/0000-0002-4125-853X; Vaquero, María Romo/0000-0002-0084-6060; Garcia Villalba, Rocio/0000-0003-1883-1673	Spanish Centre for the Development of Industrial Technology (CDTI) as part of the project SENIFOOD [CEN-20091006]; Project Consolider Ingenio [CSD2007-00063]; Seneca Foundation of the Region of Murcia, Spain [GERM 06 04486, 05556/PI/04]	Spanish Centre for the Development of Industrial Technology (CDTI) as part of the project SENIFOOD; Project Consolider Ingenio(Spanish Government); Seneca Foundation of the Region of Murcia, Spain	This project was financed by the Spanish Centre for the Development of Industrial Technology (CDTI) as part of the project SENIFOOD, which belongs to the CENIT subvention program (Ref: CEN-20091006). This work was also supported by the Project Consolider Ingenio 2010, CSD2007-00063 (Fun-C-Food) and by the Seneca Foundation of the Region of Murcia, Spain (Group of Excellence GERM 06 04486 and 05556/PI/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1999, OFF METH ASS OFF AGR; Bailey D. T., 1999, US Patent, Patent No. [5,859,293, 5859293, 5.859.293]; Blaut Michael, 2012, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-24716-3_11; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; den Besten G, 2013, AM J PHYSL GASTROINT; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; FAO, 2008, FATS FATT AC HUM NUT, P1; FAVIER ML, 1995, METABOLISM, V44, P200, DOI 10.1016/0026-0495(95)90265-1; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Gibson GR, 1996, P NUTR SOC, V55, P899, DOI 10.1079/PNS19960087; GREENWOOD MRC, 1993, ANN NY ACAD SCI, V676, P253; Grootaert C, 2011, BENEF MICROBES, V2, P305, DOI 10.3920/BM2011.0020; Guglielmetti S, 2013, J AGR FOOD CHEM, V61, P8134, DOI 10.1021/jf402495k; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Kovatcheva-Datchary P, 2013, BEST PRACT RES CL GA, V27, P59, DOI 10.1016/j.bpg.2013.03.017; Larrosa M, 2010, J NUTR BIOCHEM, V21, P717, DOI 10.1016/j.jnutbio.2009.04.012; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Lecerf JM, 2012, BRIT J NUTR, V108, P1847, DOI 10.1017/S0007114511007252; Lee H, 2013, PEDIATR GASTROENTERO, V16, P143, DOI 10.5223/pghn.2013.16.3.143; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Molan AL, 2010, PHYTOTHER RES, V24, P1614, DOI 10.1002/ptr.3145; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Neyrinck AM, 2013, BRIT J NUTR, V109, P802, DOI 10.1017/S0007114512002206; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Puhl NJ, 2012, ANAEROBE, V18, P67, DOI 10.1016/j.anaerobe.2011.12.007; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Vaquero MR, 2013, MOL NUTR FOOD RES, V57, P1834, DOI 10.1002/mnfr.201300052; Romo-Vaquero M, 2013, MOL NUTR FOOD RES, DOI [10.1002/mnfr.2013005241, DOI 10.1002/MNFR.2013005241]; Romo-Vaquero M, 2012, PLOS ONE, V7; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Tagliabue A, 2013, NUTR METAB CARDIOVAS, V23, P160, DOI 10.1016/j.numecd.2012.09.002; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang Y, 2010, NUTRITION, V26, P305, DOI 10.1016/j.nut.2009.04.014; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Zdunczyk Z, 2006, NUTRITION, V22, P898, DOI 10.1016/j.nut.2006.05.010	53	44	46	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94687	10.1371/journal.pone.0094687	http://dx.doi.org/10.1371/journal.pone.0094687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733124	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400073
J	Shkumatov, A; Baek, K; Kong, H				Shkumatov, Artem; Baek, Kwanghyun; Kong, Hyunjoon			Matrix Rigidity-Modulated Cardiovascular Organoid Formation from Embryoid Bodies	PLOS ONE			English	Article							STEM-CELLS; SELF-ORGANIZATION; AXIS FORMATION; IN-VITRO; DIFFERENTIATION; CARDIOMYOCYTES; MUSCLE; REGENERATION; PROGENITORS; EFFICIENCY	Stem cell clusters, such as embryoid bodies (EBs) derived from embryonic stem cells, are extensively studied for creation of multicellular clusters and complex functional tissues. It is common to control phenotypes of ES cells with varying molecular compounds; however, there is still a need to improve the controllability of cell differentiation, and thus, the quality of created tissue. This study demonstrates a simple but effective strategy to promote formation of vascularized cardiac muscle-like tissue in EBs and form contracting cardiovascular organoids by modulating the stiffness of a cell adherent hydrogel. Using collagen-conjugated polyacrylamide hydrogels with controlled elastic moduli, we discovered that cellular organization in a form of vascularized cardiac muscle sheet was maximal on the gel with the stiffness similar to cardiac muscle. We envisage that the results of this study will greatly contribute to better understanding of emergent behavior of stem cells in developmental and regeneration process and will also expedite translation of EB studies to drug-screening device assembly and clinical treatments.	[Shkumatov, Artem] Univ Illinois, Dept Pathobiol, Coll Vet Med, Urbana, IL 61801 USA; [Baek, Kwanghyun] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Kong, Hyunjoon] Univ Illinois, Dept Chem & Biomol Engn, Dept Pathobiol, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kong, H (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Dept Pathobiol, Inst Genom Biol, Urbana, IL 61801 USA.	hjkong06@illinois.edu			National Science Foundation [CAREER: DMR-0847253, CBET-0939511]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (CAREER: DMR-0847253 and STC-EBICS Grant CBET-0939511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Fuchs C, 2012, CELLS TISSUES ORGANS, V195, P377, DOI 10.1159/000328712; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; HSU YC, 1972, NATURE, V239, P200, DOI 10.1038/239200a0; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Nieto A, 2007, CELL BIOL INT, V31, P269, DOI 10.1016/j.cellbi.2006.11.006; Rust WL, 2006, STEM CELLS DEV, V15, P889, DOI 10.1089/scd.2006.15.889; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; TUCKWELL DS, 1993, CRIT REV ONCOL HEMAT, V15, P149, DOI 10.1016/1040-8428(93)90053-7; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; WOBUS AM, 1995, TOXICOL IN VITRO, V9, P477, DOI 10.1016/0887-2333(95)00023-2; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	25	43	46	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94764	10.1371/journal.pone.0094764	http://dx.doi.org/10.1371/journal.pone.0094764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732893	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400095
J	El Refaey, M; Zhong, Q; Hill, WD; Shi, XM; Hamrick, MW; Bailey, L; Johnson, M; Xu, JR; Bollag, WB; Chutkan, N; Isales, CM				El Refaey, Mona; Zhong, Qing; Hill, William D.; Shi, Xing-Ming; Hamrick, Mark W.; Bailey, Lakiea; Johnson, Maribeth; Xu, Jianrui; Bollag, Wendy B.; Chutkan, Norman; Isales, Carlos M.			Aromatic Amino Acid Activation of Signaling Pathways in Bone Marrow Mesenchymal Stem Cells Depends on Oxygen Tension	PLOS ONE			English	Article							PROGENITOR CELLS; DIETARY-PROTEIN; CALCIUM	The physiologic oxygen pressures inside the bone marrow environment are much lower than what is present in the peripheral circulation, ranging from 1-7%, compared to values as high as 10-13% in the arteries, lungs and liver. Thus, experiments done with bone marrow mesenchymal stem cells (BMMSCs) using standard culture conditions may not accurately reflect the true hypoxic bone marrow microenvironment. However, since aging is associated with an increased generation of reactive oxygen species, experiments done under 21%O-2 conditions may actually more closely resemble that of the aging bone marrow environment. Aromatic amino acids are known to be natural anti-oxidants. We have previously reported that aromatic amino acids are potent agonists for stimulating increases in intracellular calcium and phospho-c-Raf and in promoting BMMSC differentiation down the osteogenic pathway. Our previous experiments were performed under normoxic conditions. Thus, we next decided to compare a normoxic (21% O-2) vs. a hypoxic environment (3% O-2) alone or after treatment with aromatic amino acids. Reverse-phase protein arrays showed that 3% O-2 itself up-regulated proliferative pathways. Aromatic amino acids had no additional effect on signaling pathways under these conditions. However, under 21%O-2 conditions, aromatic amino acids could now significantly increase these proliferative pathways over this "normoxic'' baseline. Pharmacologic studies are consistent with the aromatic amino acids activating the extracellular calcium-sensing receptor. The effects of aromatic amino acids on BMMSC function in the 21% O-2 environment is consistent with a potential role for these amino acids in an aging environment as functional anti oxidants.	[El Refaey, Mona; Zhong, Qing; Hill, William D.; Shi, Xing-Ming; Hamrick, Mark W.; Bailey, Lakiea; Xu, Jianrui; Bollag, Wendy B.; Chutkan, Norman; Isales, Carlos M.] Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA 30912 USA; [Zhong, Qing; Isales, Carlos M.] Georgia Regents Univ, Dept Med, Med Coll Georgia, Augusta, GA USA; [Hill, William D.; Shi, Xing-Ming; Hamrick, Mark W.; Xu, Jianrui; Chutkan, Norman; Isales, Carlos M.] Georgia Regents Univ, Dept Orthopaed Surg, Med Coll Georgia, Augusta, GA USA; [Hill, William D.; Hamrick, Mark W.; Isales, Carlos M.] Georgia Regents Univ, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA USA; [Shi, Xing-Ming] Georgia Regents Univ, Dept Pathol, Med Coll Georgia, Augusta, GA USA; [Bollag, Wendy B.] Georgia Regents Univ, Dept Physiol, Med Coll Georgia, Augusta, GA USA; [Johnson, Maribeth] Georgia Regents Univ, Dept Biostat, Med Coll Georgia, Augusta, GA USA; [Bollag, Wendy B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Isales, CM (corresponding author), Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA 30912 USA.	cisales@gru.edu	; Isales, Carlos/J-9902-2013	Bollag, Wendy/0000-0003-3146-162X; Isales, Carlos/0000-0002-4480-3484; El Refaey, Mona/0000-0003-3989-0920	National Institute on Aging [P01 AG036675]; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute on Aging P01 AG036675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LH, 1979, AM J CLIN NUTR, V32, P741, DOI 10.1093/ajcn/32.4.741; Arounleut P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072330; Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1; Bonjour JP, 2005, J AM COLL NUTR, V24, p526S, DOI 10.1080/07315724.2005.10719501; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; Ding KH, 2008, J BONE MINER RES, V23, P536, DOI 10.1359/JBMR.071202; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Herberg S, 2013, TISSUE ENG PT A, V19, P1, DOI [10.1089/ten.tea.2012.0085, 10.1089/ten.TEA.2012.0085]; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Ivanovic Z, 2000, BRIT J HAEMATOL, V108, P424; JOHNSON NE, 1970, J NUTR, V100, P1425, DOI 10.1093/jn/100.12.1425; Kerstetter JE, 1997, AM J CLIN NUTR, V66, P1188, DOI 10.1093/ajcn/66.5.1188; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Meucci E, 1997, AMINO ACIDS, V12, P373, DOI 10.1007/BF01373017; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wengreen HJ, 2004, J BONE MINER RES, V19, P537, DOI 10.1359/JBMR.040208; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304	21	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e91108	10.1371/journal.pone.0091108	http://dx.doi.org/10.1371/journal.pone.0091108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727733	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200005
J	Brazaitis, M; Eimantas, N; Daniuseviciute, L; Baranauskiene, N; Skrodeniene, E; Skurvydas, A				Brazaitis, Marius; Eimantas, Nerijus; Daniuseviciute, Laura; Baranauskiene, Neringa; Skrodeniene, Erika; Skurvydas, Albertas			Time Course of Physiological and Psychological Responses in Humans during a 20-Day Severe-Cold-Acclimation Programme	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; THERMOREGULATORY RESPONSES; SKELETAL-MUSCLE; TEMPERATURE; ADAPTATION; STRESS; IMMERSION; THERMOGENESIS; PREDICTION; EPHEDRINE	The time course of physiological and psychological markers during cold acclimation (CA) was explored. The experiment included 17 controlled (i.e., until the rectal temperature reached 35.5 degrees C or 170 min had elapsed; for the CA-17 session, the subjects (n = 14) were immersed in water for the same amount of time as that used in the CA-1 session) head-out water immersions at a temperature of 14 degrees C over 20 days. The data obtained in this study suggest that the subjects exhibited a thermoregulatory shift from peripheral-to-central to solely central input thermoregulation, as well as from shivering to non-shivering thermogenesis throughout the CA. In the first six CA sessions, a hypothermic type of acclimation was found; further CA (CA-7 to CA-16) led to a transitional shift to a hypothermic-insulative type of acclimation. Interestingly, when the subjects were immersed in water for the same time as that used in the CA-1 session (CA-17), the CA led to a hypothermic type of acclimation. The presence of a metabolic type of thermogenesis was evident only under thermoneutral conditions. Cold-water immersion decreased the concentration of cold-stress markers, reduced the activity of the innate immune system, suppressed specific immunity to a lesser degree and yielded less discomfort and cold sensation. We found a negative correlation between body mass index and D metabolic heat production before and after CA.	[Brazaitis, Marius; Eimantas, Nerijus; Baranauskiene, Neringa; Skurvydas, Albertas] Lithuanian Sports Univ, Sports Sci & Innovat Inst, Kaunas, Lithuania; [Daniuseviciute, Laura] Kaunas Univ Technol, Dept Educ Studies, Kaunas, Lithuania; [Skrodeniene, Erika] Lithuanian Univ Hlth Sci, Med Acad, Dept Lab Med, Kaunas, Lithuania	Lithuanian Sports University; Kaunas University of Technology; Lithuanian University of Health Sciences	Brazaitis, M (corresponding author), Lithuanian Sports Univ, Sports Sci & Innovat Inst, Kaunas, Lithuania.	marius_brazaitis@yahoo.com						ALLEN TH, 1956, METABOLISM, V5, P346; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; ASTRUP A, 1985, AM J CLIN NUTR, V42, P83, DOI 10.1093/ajcn/42.1.83; BITTEL J, 1992, INT J SPORTS MED, V13, pS172, DOI 10.1055/s-2007-1024630; BITTEL JHM, 1987, J APPL PHYSIOL, V62, P1627, DOI 10.1152/jappl.1987.62.4.1627; Brazaitis M, 2012, MUSCLE NERVE, V46, P799, DOI 10.1002/mus.23397; Brazaitis M, 2010, J THERM BIOL, V35, P386, DOI 10.1016/j.jtherbio.2010.08.002; Brazaitis M, 2010, APPL ERGON, V42, P46, DOI 10.1016/j.apergo.2010.04.001; Burton AC, 1935, J NUTR, V9, P261, DOI 10.1093/jn/9.3.261; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castellani JW, 1998, J APPL PHYSIOL, V85, P204, DOI 10.1152/jappl.1998.85.1.204; Drinkwater Eric, 2008, V53, P74, DOI 10.1159/000151551; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; GALBO H, 1979, ACTA PHYSIOL SCAND, V105, P326, DOI 10.1111/j.1748-1716.1979.tb06348.x; Golden FS, 1997, BRIT J ANAESTH, V79, P214, DOI 10.1093/bja/79.2.214; GOLDEN FSC, 1988, J PHYSIOL-LONDON, V396, P349, DOI 10.1113/jphysiol.1988.sp016965; Ha Minja, 1996, Applied Human Science, V15, P33, DOI 10.2114/jpa.15.33; HAMMEL H. T., 1963, FED PROC, V22, P846; Hoehn K., 2010, HUMAN ANATOMY PHYSL; HONG SK, 1973, FED PROC, V32, P1614; Jansky L, 1996, PFLUG ARCH EUR J PHY, V432, P368, DOI 10.1007/s004240050146; Lagerspetz KYH, 2006, J THERM BIOL, V31, P332, DOI 10.1016/j.jtherbio.2006.01.003; Launay JC, 2009, IND HEALTH, V47, P221, DOI 10.2486/indhealth.47.221; LEBLANC J, 1979, J APPL PHYSIOL, V47, P1207, DOI 10.1152/jappl.1979.47.6.1207; Leon Lisa R, 2010, Front Biosci (Schol Ed), V2, P916; Lesna I, 1999, J THERM BIOL, V24, P63, DOI 10.1016/S0306-4565(98)00041-2; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lieberman HR, 2009, AVIAT SPACE ENVIR MD, V80, P629, DOI 10.3357/ASEM.2431.2009; Makinen Tiina Maria, 2010, Front Biosci (Schol Ed), V2, P1047; Mantoni T, 2008, AVIAT SPACE ENVIR MD, V79, P765, DOI 10.3357/ASEM.2216.2008; MCARDLE WD, 1984, J APPL PHYSIOL, V56, P1572, DOI 10.1152/jappl.1984.56.6.1572; Moran DS, 1999, J APPL PHYSIOL, V86, P895, DOI 10.1152/jappl.1999.86.3.895; Nater UM, 2013, CURR OPIN PSYCHIATR, V26, P440, DOI 10.1097/YCO.0b013e328363b4ed; O'Brien C, 2000, J APPL PHYSIOL, V89, P242, DOI 10.1152/jappl.2000.89.1.242; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PALACIOS R, 1982, SCAND J IMMUNOL, V15, P25, DOI 10.1111/j.1365-3083.1982.tb00618.x; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; RADOMSKI MW, 1982, J APPL PHYSIOL, V53, P610, DOI 10.1152/jappl.1982.53.3.610; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; SCHOLANDER PF, 1958, J APPL PHYSIOL, V12, P1; SIMONSEN L, 1993, INT J OBESITY, V17, pS47; SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850; SKRESLET S, 1968, J APPL PHYSIOL, V24, P177, DOI 10.1152/jappl.1968.24.2.177; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; Stocks Jodie M., 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P263, DOI 10.2114/jpa.20.263; Taylor NAS, 2006, J THERM BIOL, V31, P90, DOI 10.1016/j.jtherbio.2005.11.007; Tikuisis P, 2000, J APPL PHYSIOL, V89, P1403, DOI 10.1152/jappl.2000.89.4.1403; Tikuisis P, 2001, EUR J APPL PHYSIOL, V85, P264, DOI 10.1007/s004210100484; TIPTON MJ, 1989, CLIN SCI, V77, P581, DOI 10.1042/cs0770581; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vybiral S, 2000, EXP PHYSIOL, V85, P321, DOI 10.1017/S0958067000019096; Wang QD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021006, 10.1371/journal.pone.0028114]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; YOUNG AJ, 1986, J APPL PHYSIOL, V60, P1542, DOI 10.1152/jappl.1986.60.5.1542	56	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94698	10.1371/journal.pone.0094698	http://dx.doi.org/10.1371/journal.pone.0094698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722189	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100123
J	Huet, T; Miannay, FA; Patton, JR; Thore, S				Huet, Tiphaine; Miannay, Francois-Alexandre; Patton, Jeffrey R.; Thore, Stephane			Steroid Receptor RNA Activator (SRA) Modification by the Human Pseudouridine Synthase 1 (hPus1p): RNA Binding, Activity, and Atomic Model	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; TRUD REVEALS; RECOGNITION; COMPLEX; DOMAIN; PUS1P; YEAST; SITE; PROTEINS	The most abundant of the modified nucleosides, and once considered as the "fifth'' nucleotide in RNA, is pseudouridine, which results from the action of pseudouridine synthases. Recently, the mammalian pseudouridine synthase 1 (hPus1p) has been reported to modulate class I and class II nuclear receptor responses through its ability to modify the Steroid receptor RNA Activator (SRA). These findings highlight a new level of regulation in nuclear receptor (NR)-mediated transcriptional responses. We have characterised the RNA association and activity of the human Pus1p enzyme with its unusual SRA substrate. We validate that the minimal RNA fragment within SRA, named H7, is necessary for both the association and modification by hPus1p. Furthermore, we have determined the crystal structure of the catalytic domain of hPus1p at 2.0 angstrom resolution, alone and in a complex with several molecules present during crystallisation. This model shows an extended C-terminal helix specifically found in the eukaryotic protein, which may prevent the enzyme from forming a homodimer, both in the crystal lattice and in solution. Our biochemical and structural data help to understand the hPus1p active site architecture, and detail its particular requirements with regard to one of its nuclear substrates, the non-coding RNA SRA.	[Huet, Tiphaine; Thore, Stephane] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Miannay, Francois-Alexandre] Univ Geneva, Dept Phys Chem, Geneva, Switzerland; [Patton, Jeffrey R.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	University of Geneva; University of Geneva; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Thore, S (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	stephane.thore@unige.ch	Thore, stéphane/M-7759-2014; Thore, Stephane/AAW-6482-2020	Thore, stéphane/0000-0001-7058-3887; Thore, Stephane/0000-0001-7058-3887	Swiss National Science Foundation [31003A_140924, 31003A_124909]; Ligue Genevoise contre le Cancer [1011]; foundation E. Boninchi; foundation E L. Schmidheiny; Swiss National Science Foundation R'equip grant [316030-128787]; University of Geneva; University of South Carolina, School of Medicine; South Carolina INBRE; Worldwide Cancer Research [14-0346] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ligue Genevoise contre le Cancer; foundation E. Boninchi; foundation E L. Schmidheiny; Swiss National Science Foundation R'equip grant(Swiss National Science Foundation (SNSF)); University of Geneva; University of South Carolina, School of Medicine; South Carolina INBRE; Worldwide Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Swiss National Science Foundation (No31003A_140924 and 31003A_124909 to S. T.), and the Ligue Genevoise contre le Cancer (No1011 to S. T.). This study would not have been possible without the establishment of the Biostructural platform that was possible due to the generous support of the foundation E. Boninchi, the foundation E & L. Schmidheiny, the Swiss National Science Foundation R'equip grant (No316030-128787) and the University of Geneva. The work was possible thanks to a Research Development Fund grant from the University of South Carolina, School of Medicine (to J.R.P.) and a grant from South Carolina INBRE (to J.R.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alian A, 2009, J MOL BIOL, V388, P785, DOI 10.1016/j.jmb.2009.03.029; Arluison V, 1999, BIOCHIMIE, V81, P751, DOI 10.1016/S0300-9084(99)80133-3; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Behm-Ansmant I, 2006, RNA, V12, P1583, DOI 10.1261/rna.100806; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chen JG, 1999, RNA, V5, P409, DOI 10.1017/S1355838299981591; CORTESE R, 1974, J BIOL CHEM, V249, P1103; Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014; Dong Xuesong, 2006, RNA Biol, V3, P115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2004, FEBS LETT, V565, P59, DOI 10.1016/j.febslet.2004.03.085; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Ghosh SK, 2012, BIOCHEMISTRY-US, V51, P8163, DOI 10.1021/bi300602r; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hoang C, 2004, RNA, V10, P1026, DOI 10.1261/rna.7240504; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Massenet S, 1999, MOL CELL BIOL, V19, P2142; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizutani K, 2004, BIOCHEMISTRY-US, V43, P4454, DOI 10.1021/bi036079c; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Pan H, 2007, J MOL BIOL, V367, P1459, DOI 10.1016/j.jmb.2007.01.084; PATTON JR, 1991, MOL CELL BIOL, V11, P5998, DOI 10.1128/MCB.11.12.5998; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; SAMUELSSON T, 1990, J BIOL CHEM, V265, P8782; Sibert BS, 2008, RNA, V14, P1895, DOI 10.1261/rna.984508; Sibert BS, 2012, NUCLEIC ACIDS RES, V40, P2107, DOI 10.1093/nar/gkr1017; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Sivaraman J, 2002, NAT STRUCT BIOL, V9, P353, DOI 10.1038/nsb788; Sunita S, 2006, J MOL BIOL, V359, P998, DOI 10.1016/j.jmb.2006.04.019; Zhao XS, 2007, MOL ENDOCRINOL, V21, P686, DOI 10.1210/me.2006-0414; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	43	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94610	10.1371/journal.pone.0094610	http://dx.doi.org/10.1371/journal.pone.0094610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722331	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100107
J	Villarino, GH; Bombarely, A; Giovannoni, JJ; Scanlon, MJ; Mattson, NS				Villarino, Gonzalo H.; Bombarely, Aureliano; Giovannoni, James J.; Scanlon, Michael J.; Mattson, Neil S.			Transcriptomic Analysis of Petunia hybrida in Response to Salt Stress Using High Throughput RNA Sequencing	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; ROOT TRANSCRIPTOME; ABIOTIC STRESS; SEQ DATA; TOMATO; IDENTIFICATION; TOLERANCE; GENES; OVEREXPRESSION; INSIGHTS	Salinity and drought stress are the primary cause of crop losses worldwide. In sodic saline soils sodium chloride (NaCl) disrupts normal plant growth and development. The complex interactions of plant systems with abiotic stress have made RNA sequencing a more holistic and appealing approach to study transcriptome level responses in a single cell and/or tissue. In this work, we determined the Petunia transcriptome response to NaCl stress by sequencing leaf samples and assembling 196 million Illumina reads with Trinity software. Using our reference transcriptome we identified more than 7,000 genes that were differentially expressed within 24 h of acute NaCl stress. The proposed transcriptome can also be used as an excellent tool for biological and bioinformatics in the absence of an available Petunia genome and it is available at the SOL Genomics Network (SGN) http://solgenomics.net. Genes related to regulation of reactive oxygen species, transport, and signal transductions as well as novel and undescribed transcripts were among those differentially expressed in response to salt stress. The candidate genes identified in this study can be applied as markers for breeding or to genetically engineer plants to enhance salt tolerance. Gene Ontology analyses indicated that most of the NaCl damage happened at 24 h inducing genotoxicity, affecting transport and organelles due to the high concentration of Na+ ions. Finally, we report a modification to the library preparation protocol whereby cDNA samples were bar-coded with non-HPLC purified primers, without affecting the quality and quantity of the RNA-seq data. The methodological improvement presented here could substantially reduce the cost of sample preparation for future high-throughput RNA sequencing experiments.	[Villarino, Gonzalo H.; Mattson, Neil S.] Cornell Univ, Dept Hort, Ithaca, NY 14853 USA; [Bombarely, Aureliano; Scanlon, Michael J.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Bombarely, Aureliano; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Giovannoni, James J.] USDA ARS, Robert W Holley Res Ctr Agr & Hlth, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Villarino, GH (corresponding author), Cornell Univ, Dept Hort, Ithaca, NY 14853 USA.	ghv8@cornell.edu	Bombarely, Aureliano/C-6580-2009	Bombarely, Aureliano/0000-0001-6257-8914; Mattson, Neil/0000-0003-3076-7336	Post Schenkel Foundation	Post Schenkel Foundation	This study was funded by an internal grant (Post Schenkel Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Chu HT, 2013, BIOINFORMATICS, V29, P1004, DOI 10.1093/bioinformatics/btt092; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ekblom R, 2012, COMP FUNCTIONAL GENO, V2012, P8; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goldfeder RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023683; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169, DOI 10.1093/oxfordjournals.pcp.a028928; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Manaa A, 2011, J EXP BOT, V62, P2797, DOI 10.1093/jxb/erq460; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Ulm R, 2003, TOP CURR GENET, V4, P217; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zenoni S, 2011, PLANT J, V68, P11, DOI 10.1111/j.1365-313X.2011.04661.x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhong S., 2011, COLD SPRING HARB PRO, V2011	46	38	38	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94651	10.1371/journal.pone.0094651	http://dx.doi.org/10.1371/journal.pone.0094651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722556	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100116
J	Yoshida, Y; Miki, T; Ono, S; Haneda, T; Ito, M; Okada, N				Yoshida, Yukie; Miki, Tsuyoshi; Ono, Sayaka; Haneda, Takeshi; Ito, Masahiro; Okada, Nobuhiko			Functional Characterization of the Type III Secretion ATPase SsaN Encoded by Salmonella Pathogenicity Island 2	PLOS ONE			English	Article							FLII ATPASE; ENZYMATIC CHARACTERIZATION; PROTEOMIC ANALYSIS; SHIGELLA-FLEXNERI; EXPORT APPARATUS; CHAPERONE; TYPHIMURIUM; COMPONENTS; SYSTEM; GENES	A type III secretion system (T3SS) is utilized by a large number of gram-negative bacteria to deliver effectors directly into the cytosol of eukaryotic host cells. One essential component of a T3SS is an ATPase that catalyzes the unfolding of proteins, which is followed by the translocation of effectors through an injectisome. Here we demonstrate a functional role of the ATPase SsaN, a component of Salmonella pathogenicity island 2 T3SS (T3SS-2) in Salmonella enterica serovar Typhimurium. SsaN hydrolyzed ATP in vitro and was essential for T3SS function and Salmonella virulence in vivo. Protein-protein interaction analyses revealed that SsaN interacted with SsaK and SsaQ to form the C ring complex. SsaN and its complex colocalized to the membrane fraction under T3SS-2 inducing conditions. In addition, SsaN bound to Salmonella pathogenicity island 2 (SPI-2) specific chaperones, including SsaE, SseA, SscA, and SscB that facilitated translocator/effector secretion. Using an in vitro chaperone release assay, we demonstrated that SsaN dissociated a chaperone-effector complex, SsaE and SseB, in an ATP-dependent manner. Effector release was dependent on a conserved arginine residue at position 192 of SsaN, and this was essential for its enzymatic activity. These results strongly suggest that the T3SS-2-associated ATPase SsaN contributes to T3SS-2 effector translocation efficiency.	[Yoshida, Yukie; Miki, Tsuyoshi; Ono, Sayaka; Haneda, Takeshi; Ito, Masahiro; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Dept Microbiol, Tokyo, Japan	Kitasato University	Okada, N (corresponding author), Kitasato Univ, Sch Pharm, Dept Microbiol, Tokyo, Japan.	okadan@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293106, 24590534, 25460547]; Kitasato University; Grants-in-Aid for Scientific Research [24590534] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded in part by Grants-in-Aid for Scientific Research (B) (25293106 to NO) and (C) (24590534 to TH and 25460547 to TM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Kitasato University Research Grant for Young Researchers (2013 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Chatterjee R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075028; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Cherradi Y, 2014, MICROBIOL-SGM, V160, P130, DOI 10.1099/mic.0.071712-0; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Galan JE, 1996, CURR TOP MICROBIOL, V209, P43; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2012, MOL MICROBIOL, V83, P168, DOI 10.1111/j.1365-2958.2011.07924.x; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Yu XJ, 2011, J BIOL CHEM, V286, P36098, DOI 10.1074/jbc.M111.278663; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; Zurawski DV, 2003, MOL MICROBIOL, V47, P1341, DOI 10.1046/j.1365-2958.2003.03373.x	54	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94347	10.1371/journal.pone.0094347	http://dx.doi.org/10.1371/journal.pone.0094347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722491	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100056
J	Faria, MS; Calegari-Silva, TC; Vivarini, AD; Mottram, JC; Lopes, UG; Lima, APCA				Faria, Marilia S.; Calegari-Silva, Tereza C.; Vivarini, Aislan de Carvalho; Mottram, Jeremy C.; Lopes, Ulisses Gazos; Lima, Ana Paula C. A.			Role of protein kinase R in the killing of Leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNF alpha and IFN beta	FASEB JOURNAL			English	Article						ecotin; Toll; interferon; ISP2	INNATE IMMUNE-RESPONSE; NITRIC-OXIDE SYNTHASE; PKR; PEPTIDASES; ACTIVATION; EXPRESSION; INFECTION	In cutaneous leishmaniasis, Leishmania amazonensis activates macrophage double-stranded, RNA-activated protein kinase R (PKR) to promote parasite growth. In our study, Leishmania major grew normally in RAW cells, RAW-expressing dominant-negative PKR (PKR-DN) cells, and macrophages of PKR-knockout mice, revealing that PKR is dispensable for L. major growth in macrophages. PKR activation in infected macrophages with poly I: C resulted in parasite death. Fifty percent of L. major-knockout lines for the ecotin-like serine peptidase inhibitor (ISP2; Delta isp2/isp3), an inhibitor of neutrophil elastase (NE), died in RAW cells or macrophages from 129Sv mice, as a result of PKR activation. Inhibition of PKR or NE or neutralization of Toll-like receptor 4 or 2(TLR4 or TLR2) prevented the death of Delta isp2/isp3. Delta isp2/isp3 grew normally in RAW-PKR-DN cells or macrophages from 129Sv pkr(-/-), tlr2(-/-), trif(-/-), and myd88(-/-) mice, associating NE activity, PKR, and TLR responses with parasite death. Delta isp2/isp3 increased the expression of mRNA for TNF-alpha by 2-fold and of interferon beta (IFN beta) in a PKR-dependent manner. Antibodies to TNF-alpha reversed the 95% killing by Delta isp2/isp3, whereas they grew normally in macrophages from IFN receptor-knockout mice. We propose that ISP2 prevents the activation of PKR via an NE-TLR4-TLR2 axis to control innate responses that contribute to the killing of L. major.	[Faria, Marilia S.; Calegari-Silva, Tereza C.; Vivarini, Aislan de Carvalho; Lopes, Ulisses Gazos; Lima, Ana Paula C. A.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949902 Rio De Janeiro, RJ, Brazil; [Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Universidade Federal do Rio de Janeiro; University of Glasgow	Lima, APCA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Ilha Fundao, Av Carlos Chagas Filho 373,Bloco G,Cidade Univ, BR-21949902 Rio De Janeiro, RJ, Brazil.	anapaula@biof.ufrj.br	Lopes, Ulisses Gazos/T-6634-2019; Vivarini, Áislan/G-3249-2015; Lima, Ana Paula CA/G-4122-2012; Vivarini, Aislan/ABC-9774-2021	Vivarini, Áislan/0000-0002-2629-257X; Calegari Silva, Teresa Cristina/0000-0002-1656-3460; Mottram, Jeremy/0000-0001-5574-3766	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Portuguese Research Foundation of Rio de Janeiro); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Technological and Scientific Development); Wellcome Trust [085349]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Portuguese Research Foundation of Rio de Janeiro); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank E. Lopes for technical assistance and Prof. S. Oliveira [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil], Dr. M. Bellio [Universidade Federal do Rio de Janeiro (UFRJ)], and Dr. M. Bozza (UFRJ) for the donation of bone marrow from knockout mice. This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Portuguese Research Foundation of Rio de Janeiro) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Technological and Scientific Development). A.P.C.A.L. and U.G.L. are CNPq fellows. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (grant 085349).	Abu-Dayyeh I, 2010, INFECT IMMUN, V78, P2438, DOI 10.1128/IAI.00812-09; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Danelli MGM, 2009, PHYTOCHEMISTRY, V70, P608, DOI 10.1016/j.phytochem.2009.03.009; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Faria MS, 2011, J IMMUNOL, V186, P411, DOI 10.4049/jimmunol.1002175; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Lee JH, 2005, GLIA, V50, P66, DOI 10.1002/glia.20156; Mattner J, 2004, J IMMUNOL, V172, P7574, DOI 10.4049/jimmunol.172.12.7574; Mattner J, 2000, EUR J IMMUNOL, V30, P2257, DOI 10.1002/1521-4141(2000)30:8&lt;2257::AID-IMMU2257&gt;3.0.CO;2-U; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nylen S, 2012, PARASITE IMMUNOL, V34, P551, DOI 10.1111/pim.12007; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127	28	29	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3050	3063		10.1096/fj.13-245126	http://dx.doi.org/10.1096/fj.13-245126			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24732131	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000337949400027
J	Beilhartz, GL; Ngure, M; Johns, BA; DeAnda, F; Gerondelis, P; Gotte, M				Beilhartz, Greg L.; Ngure, Marianne; Johns, Brian A.; DeAnda, Felix; Gerondelis, Peter; Goette, Matthias			Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNASE-H; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; DRUG-RESISTANCE; DNA-POLYMERASE; PRIMER; SITE; SPECIFICITY; MECHANISM	Compounds that efficiently inhibit the ribonuclease (RNase) H activity of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have yet to be developed. Here, we demonstrate that GSK5750, a 1-hydroxy-pyridopyrimidinone analog, binds to the enzyme with an equilibrium dissociation constant (K-d) of similar to 400 nM. Inhibition of HIV-1 RNase H is specific, as DNA synthesis is not affected. Moreover, GSK5750 does not inhibit the activity of Escherichia coli RNase H. Order-of-addition experiments show that GSK5750 binds to the free enzyme in an Mg2+-dependent fashion. However, as reported for other active site inhibitors, binding of GSK5750 to a preformed enzyme-substrate complex is severely compromised. The bound nucleic acid prevents access to the RNase H active site, which represents a possible biochemical hurdle in the development of potent RNase H inhibitors. Previous studies suggested that formation of a complex with the prototypic RNase H inhibitor beta-thujaplicinol is slow, and, once formed, it dissociates rapidly. This unfavorable kinetic behavior can limit the potency of RNase H active site inhibitors. Although the association kinetics of GSK5750 remains slow, our data show that this compound forms a long lasting complex with HIV-1 RT. We conclude that slow dissociation of the inhibitor and HIV-1 RT improves RNase H active site inhibitors and may circumvent the obstacle posed by the inability of these compounds to bind to a preformed enzyme-substrate complex.	[Beilhartz, Greg L.; Ngure, Marianne; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Johns, Brian A.] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA; [DeAnda, Felix] GlaxoSmithKline, Dept Computat Chem, Res Triangle Pk, NC 27709 USA; [Gerondelis, Peter] GlaxoSmithKline, Dept Virol, Infect Dis Therapeut Area Unit, Res Triangle Pk, NC 27709 USA; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Goette, Matthias] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada	McGill University; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; McGill University; McGill University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			Canadian Foundation for AIDS Research (CANFAR); GlaxoSmithKline (GSK); Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec	Canadian Foundation for AIDS Research (CANFAR); GlaxoSmithKline (GSK)(GlaxoSmithKline); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by the Canadian Foundation for AIDS Research (CANFAR) and by GlaxoSmithKline (GSK).; Recipient of a Banting and Best Canada Graduate Scholarship from the Canadian Institutes of Health Research.; Recipient of a Chercheur National career award from the Fonds de la Recherche en Sante du Quebec. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, McGill University, Duff Medical Bldg., 3775 University St., Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1365; Fax: 514-398-7052; E-mail: matthias.gotte@mcgill.ca.	Arion D, 2002, J BIOL CHEM, V277, P1370, DOI 10.1074/jbc.M110254200; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Burney T, 2011, EXPERT REV ANTI-INFE, V9, P151, DOI [10.1586/eri.10.153, 10.1586/ERI.10.153]; Chung SM, 2010, ANTIMICROB AGENTS CH, V54, P3913, DOI 10.1128/AAC.00434-10; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Foote BS, 2011, ANN PHARMACOTHER, V45, P1085, DOI 10.1345/aph.1P744; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Garvey E. P., 2003, AIDS OTHER MANIFESTA, P855; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Herman BD, 2013, BIOCHEM J, V455, P179, DOI 10.1042/BJ20130850; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1990, J BIOL CHEM, V265, P10565; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kirschberg TA, 2009, J MED CHEM, V52, P5781, DOI 10.1021/jm900597q; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; PALANIAPPAN C, 1995, J BIOL CHEM, V270, P4861, DOI 10.1074/jbc.270.9.4861; PULLEN KA, 1990, J VIROL, V64, P6274, DOI 10.1128/JVI.64.12.6274-6277.1990; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; SMITH JS, 1992, J BIOL CHEM, V267, P15071; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tan S. L, 2006, HEPATITIS C VIRUSES, P163; Telesnitsky A., 1997, P121; Tramontano E, 2010, CURR MED CHEM, V17, P2837, DOI 10.2174/092986710792065045; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039	36	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16270	16277		10.1074/jbc.M114.569707	http://dx.doi.org/10.1074/jbc.M114.569707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719329	hybrid, Green Published			2022-12-25	WOS:000337965700031
J	Hamid, MSA; Jaafar, Z; Ali, ASM				Hamid, Mohamad Shariff A.; Jaafar, Zulkarnain; Ali, Azril Syazwan Mohd			Incidence and Characteristics of Injuries during the 2010 FELDA/FAM National Futsal League in Malaysia	PLOS ONE			English	Article							MECHANISMS; FOOTBALL; SOCCER	Objective: In Malaysia, futsal is a popular sport played by individuals across all ages and genders. Despite its popularity, information on futsal related injury in Malaysia is not available. The purpose of this study is to examine the injury incidence and injury patterns among amateur men and women futsal players in Malaysia. Methods: Players reported injury to the tournament medical team during the FELDA/FAM National Futsal League 2010 were interviewed and assessed by a Sports Medicine registrar. Player's socio-demographic profiles and information about the injury were documented in the injury report form adapted from medical report form used by FIFA: Medical Assessment and Research Centre (F-Marc). Results: A total of 86 injuries were reported from 141 matches, equivalent to an incidence of 91.5 injuries per 1000 player hours (95% CI 72.2 to 110.8), or 61.0 injuries per 1000 player matches (95% CI 48.1 to 73.9). Most were minor injuries resulted from contact with another player. Injuries often involved the lower extremity (44%) followed by the trunk (14%) and the upper limb (13%). Ankle (n = 7; 39%) and knee (n = 6; 33%) sprains were the most prevalent diagnoses of time-loss injuries. A significant association between time-loss and type of injury was found chi(2) (1,N = 86) = 3.99, p = 0.04. In addition, time-loss injury was significantly associated with playing surface chi(2) (1, N = 86) = 10.11, p = 0.018. Conclusion: The injury rate during the FELDA/FAM National Amateur Futsal Men's League in Malaysia was lower compared with previous Futsal World Cups competition. Most injuries resulted from contact with another player were minor and did not lead to time-loss from participation. Time-loss injury was significantly associated with type of injury and playing surface.	[Hamid, Mohamad Shariff A.; Jaafar, Zulkarnain] Univ Malaya, Fac Med, Unit Sports Med, Kuala Lumpur, Malaysia; [Ali, Azril Syazwan Mohd] Jalan Hosp, Hosp Raja Perempuan Zainab II, Dept Orthopaed, Kota Bahru, Kelantan, Malaysia	Universiti Malaya	Hamid, MSA (corresponding author), Univ Malaya, Fac Med, Unit Sports Med, Kuala Lumpur, Malaysia.	ayip@um.edu.my	HAMID, MOHAMAD SHARIFF A/B-9029-2010; JAAFAR, ZULKARNAIN/C-1155-2010	HAMID, MOHAMAD SHARIFF A/0000-0001-9196-0442; JAAFAR, ZULKARNAIN/0000-0002-4331-788X	Institute of Research Management and Monitoring University Malaya; Football Association of Malaysia; National Institute of Sports of Malaysia	Institute of Research Management and Monitoring University Malaya; Football Association of Malaysia; National Institute of Sports of Malaysia	We would like to thank the Institute of Research Management and Monitoring University Malaya, the Football Association of Malaysia and the National Institute of Sports of Malaysia for their support in conducting this study.	Alvarez JCB, 2009, J STRENGTH COND RES, V23, P2163, DOI 10.1519/JSC.0b013e3181b7f8ad; Castagna C, 2009, J SCI MED SPORT, V12, P490, DOI 10.1016/j.jsams.2008.02.001; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; Federation International de Football Association, 2008, FUTS LAWS GAM 2008; FIFA Communications Division. Big Count, 2006, STAT SUMM REP GEND C; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2010, BRIT J SPORT MED, V44, P1089, DOI 10.1136/bjsm.2010.076752; Laoruengthana Artit, 2009, J Med Assoc Thai, V92 Suppl 6, pS204; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Putukian M, 1996, AM J SPORT MED, V24, P317, DOI 10.1177/036354659602400312; Ribeiro Rodrigo Nogueira, 2006, Rev Bras Med Esporte, V12, P1; van Beijsterveldt AMC, 2014, J SCI MED SPORT, DOI 10./1016/j.jsams.2014.02.004	14	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95158	10.1371/journal.pone.0095158	http://dx.doi.org/10.1371/journal.pone.0095158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733140	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400157
J	Schafer, I; Pawels, M; Kuver, C; Pohontsch, NJ; Scherer, M; van den Bussche, H; Kaduszkiewicz, H				Schaefer, Ingmar; Pawels, Marc; Kuever, Claudia; Pohontsch, Nadine Janis; Scherer, Martin; van den Bussche, Hendrik; Kaduszkiewicz, Hanna			Strategies for Improving Participation in Diabetes Education. A Qualitative Study	PLOS ONE			English	Article							SELF-MANAGEMENT; MELLITUS; PREVALENCE; EDUCATORS; ADULTS	Objective: Diabetes mellitus is highly prevalent and can lead to serious complications and mortality. Patient education can help to avoid negative outcomes, but up to half of the patients do not participate. The aim of this study was to analyze patients' attitudes towards diabetes education in order to identify barriers to participation and develop strategies for better patient education. Methods: We conducted a qualitative study. Seven GP practices were purposively selected based on socio-demographic data of city districts in Hamburg, Germany. Study participants were selected by their GPs in order to increase participation. Semi-structured face-to-face interviews were conducted with 14 patients. Interviews were audiotaped and transcribed verbatim. The sample size was determined by data saturation. Data were analysed by qualitative content analysis. Categories were determined deductively and inductively. Results: The interviews yielded four types of barriers: 1) Statements and behaviour of the attending physician influence the patients' decisions about diabetes education. 2) Both, a good state of health related to diabetes and physical/psychosocial comorbidity can be reasons for non-participation. 3) Manifold motivational factors were discussed. They ranged from giving low priority to diabetes to avoidance of implications of diabetes education as being confronted with illness narratives of others. 4) Barriers also include aspects of the patients' knowledge and activity. Conclusions: First, physicians should encourage patients to participate in diabetes education and argue that they can profit even if actual treatment and examination results are promising. Second, patients with other priorities, psychic comorbidity or functional limitations might profit more from continuous individualized education adapted to their specific situation instead of group education. Third, it might be justified that patients do not participate in diabetes education if they have slightly increased blood sugar values only and no risk for harmful consequences or if they already have sufficient knowledge on diabetes.	[Schaefer, Ingmar; Pawels, Marc; Kuever, Claudia; Pohontsch, Nadine Janis; Scherer, Martin; van den Bussche, Hendrik; Kaduszkiewicz, Hanna] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Kaduszkiewicz, Hanna] Univ Kiel, Fac Med, Inst Gen Practice, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel	Schafer, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany.	in.schaefer@uke.uni-hamburg.de	Pohontsch, Nadine/AAK-6573-2020	Pohontsch, Nadine/0000-0002-0966-4087	German Federal Ministry of Education and Research [01GK0714]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was funded by the German Federal Ministry of Education and Research (grant number 01GK0714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhofen L, 2004, QUALITY ASSURANCE RE; CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204; COONROD BA, 1994, DIABETES CARE, V17, P852, DOI 10.2337/diacare.17.8.852; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Graziani C, 1999, Fam Med, V31, P358; Hall PA, 2009, J PSYCHOSOM RES, V67, P297, DOI 10.1016/j.jpsychores.2009.05.015; Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5; Icks A, 2006, DEUT MED WOCHENSCHR, V131, P73, DOI 10.1055/s-2006-924927; Koster I, 2012, DEUT MED WOCHENSCHR, V137, P1013, DOI 10.1055/s-0032-1304891; Kuver Claudia, 2004, Z Arztl Fortbild Qualitatssich, V98, P393; Mayring P., 2010, HDB QUALITATIVE FORS, P601, DOI [DOI 10.1007/978-3-531-92052-8_42, 10.1007/978-3-531-92052-8_42]; MURPHY E, 1995, FAM PRACT, V12, P184, DOI 10.1093/fampra/12.2.184; Ockleford E, 2008, CHRONIC ILLN, V4, P28, DOI 10.1177/1742395307086673; Peyrot M, 2009, DIABETES EDUCATOR, V35, P246, DOI 10.1177/0145721708329546; Rafique Ghazala, 2006, J Pak Med Assoc, V56, P347; Ruppert K, 2010, DIABETES EDUCATOR, V36, P603, DOI 10.1177/0145721710369705; Rygg LO, 2010, SCAND J PUBLIC HEALT, V38, P788, DOI 10.1177/1403494810382475; Schafer I, 2013, AM J MANAG CARE, V19, P499; Schafer I, 2010, BMC HEALTH SERV RES, V10, DOI [10.1186/1472-6963-10-351, 10.1186/1472-6963-10-55]; Sprague MA, 1999, DIABETES EDUCATOR, V25, P907, DOI 10.1177/014572179902500608; Wens Johan, 2007, Prim Care Diabetes, V1, P17, DOI 10.1016/j.pcd.2006.07.001	21	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95035	10.1371/journal.pone.0095035	http://dx.doi.org/10.1371/journal.pone.0095035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733428	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400146
J	Shih, YP; Chou, CC; Chen, YL; Huang, KF; Wang, AHJ				Shih, Yan-Ping; Chou, Chi-Chi; Chen, Yi-Ling; Huang, Kai-Fa; Wang, Andrew H. -J.			Linked Production of Pyroglutamate-Modified Proteins via Self-Cleavage of Fusion Tags with TEV Protease and Autonomous N-Terminal Cyclization with Glutaminyl Cyclase In Vivo	PLOS ONE			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-2; BONE-MINERAL DENSITY; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; STRUCTURAL INTEGRITY; RIBONUCLEASE; PEPTIDES; ENZYME; BETA; ASSOCIATION	Overproduction of N-terminal pyroglutamate (pGlu)-modified proteins utilizing Escherichia coli or eukaryotic cells is a challenging work owing to the fact that the recombinant proteins need to be recovered by proteolytic removal of fusion tags to expose the N-terminal glutaminyl or glutamyl residue, which is then converted into pGlu catalyzed by the enzyme glutaminyl cyclase. Herein we describe a new method for production of N-terminal pGlu-containing proteins in vivo via intracellular self-cleavage of fusion tags by tobacco etch virus (TEV) protease and then immediate N-terminal cyclization of passenger target proteins by a bacterial glutaminyl cyclase. To combine with the sticky-end PCR cloning strategy, this design allows the gene of target proteins to be efficiently inserted into the expression vector using two unique cloning sites (i.e., SnaB I and Xho I), and the soluble and N-terminal pGlu-containing proteins are then produced in vivo. Our method has been successfully applied to the production of pGlu-modified enhanced green fluorescence protein and monocyte chemoattractant proteins. This design will facilitate the production of protein drugs and drug target proteins that possess an N-terminal pGlu residue required for their physiological activities.	[Shih, Yan-Ping; Chou, Chi-Chi; Chen, Yi-Ling; Huang, Kai-Fa; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem & Core Facil Prot Struct Anal, Taipei 115, Taiwan	Academia Sinica - Taiwan	Huang, KF (corresponding author), Acad Sinica, Inst Biol Chem & Core Facil Prot Struct Anal, Taipei 115, Taiwan.	huangkf@gate.sinica.edu.tw; ahjwang@gate.sinica.edu.tw	Chou, Chi-Chi/X-6053-2019	Chou, Chi-Chi/0000-0002-7862-7757	Academia Sinica; National Science Council, Taiwan [NSC-101-2319-B-001-003]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and the National Science Council, Taiwan (NSC-101-2319-B-001-003 to A.H.-J. Wang for the National Core Facilities for Protein Structural Analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardelt W, 2008, CURR PHARM BIOTECHNO, V9, P215, DOI 10.2174/138920108784567245; Ardelt W, 2009, EUR J PHARMACOL, V625, P181, DOI 10.1016/j.ejphar.2009.06.067; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; Becker A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-108; Blaszczyk J, 2000, BIOCHEMISTRY-US, V39, P14075, DOI 10.1021/bi0009340; BOCKERS TM, 1995, J NEUROENDOCRINOL, V7, P445, DOI 10.1111/j.1365-2826.1995.tb00780.x; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Chang CF, 1998, J MOL BIOL, V283, P231, DOI 10.1006/jmbi.1998.2082; Chen YL, 2012, BIOCHEM J, V442, P403, DOI 10.1042/BJ20110535; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Cynis H, 2013, INT J EXP PATHOL, V94, P217, DOI 10.1111/iep.12020; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Ezura Y, 2004, J BONE MINER RES, V19, P1296, DOI 10.1359/JBMR.040324; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; FLANAGAN T, 1990, CELL MOL NEUROBIOL, V10, P507, DOI 10.1007/BF00712845; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Guevara T, 2006, BIOL CHEM, V387, P1479, DOI 10.1515/BC.2006.185; Hoist JJ, 1994, GUT PEPTIDES BIOCH P, P305; Huang KF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208595; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang QY, 2007, J HUM GENET, V52, P757, DOI 10.1007/s10038-007-0178-6; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; INGROSSO D, 1989, BIOCHEM BIOPH RES CO, V162, P1528, DOI 10.1016/0006-291X(89)90848-6; Iwasaki H, 2003, BONE, V32, P185, DOI 10.1016/S8756-3282(02)00949-3; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KITABGI P, 1992, ANN NY ACAD SCI, V668, P30, DOI 10.1111/j.1749-6632.1992.tb27337.x; Kuhlmann MT, 2007, VASA-J VASCULAR DIS, V36, P253, DOI 10.1024/0301-1526.36.4.253; Lee JY, 2007, J BIOL CHEM, V282, P24928, DOI 10.1074/jbc.M701551200; Liao YD, 2000, NUCLEIC ACIDS RES, V28, P4097, DOI 10.1093/nar/28.21.4097; Liao YD, 2003, NUCLEIC ACIDS RES, V31, P5247, DOI 10.1093/nar/gkg746; Lou YC, 2006, J MOL BIOL, V355, P409, DOI 10.1016/j.jmb.2005.10.069; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; MOSIMANN SC, 1994, J MOL BIOL, V236, P1141, DOI 10.1016/0022-2836(94)90017-5; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Oberg KA, 1998, EUR J BIOCHEM, V258, P214, DOI 10.1046/j.1432-1327.1998.2580214.x; Oppenheim Joost, 1996, Cytokine and Growth Factor Reviews, V7, P279, DOI 10.1016/S1359-6101(96)00025-1; Pavlakis N, 2006, EXPERT OPIN BIOL TH, V6, P391, DOI 10.1517/14712598.6.4.391; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Schilling S, 2003, BIOL CHEM, V384, P1583, DOI 10.1515/BC.2003.175; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Smith AM, 2000, ALIMENT PHARM THERAP, V14, P1231, DOI 10.1046/j.1365-2036.2000.00842.x; Sozzani S, 1996, INT J CLIN LAB RES, V26, P69, DOI 10.1007/BF02592349; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; WANG TF, 2004, PURIFYING PROTEINS P, P111; Welker E, 2007, BIOCHEMISTRY-US, V46, P5485, DOI 10.1021/bi602495a; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05	57	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94812	10.1371/journal.pone.0094812	http://dx.doi.org/10.1371/journal.pone.0094812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733552	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400110
J	Wong, G; Trevillyan, JM; Fatou, B; Cinel, M; Weir, JM; Hoy, JF; Meikle, PJ				Wong, Gerard; Trevillyan, Janine M.; Fatou, Benoit; Cinel, Michelle; Weir, Jacquelyn M.; Hoy, Jennifer F.; Meikle, Peter J.			Plasma Lipidomic Profiling of Treated HIV-Positive Individuals and the Implications for Cardiovascular Risk Prediction	PLOS ONE			English	Article							FREE FATTY-ACIDS; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; PROTEASE INHIBITORS; DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; HYPERLIPIDEMIA; DISEASE; RATES	Background: The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patients is collectively contributed to by the human immunodeficiency virus and antiretroviral-associated dyslipidaemia. In this study, we investigate the characterisation of the plasma lipid profiles of treated HIV patients and the relationship of 316 plasma lipid species across multiple lipid classes with the risk of future cardiovascular events in HIV-positive patients. Methods: In a retrospective case-control study, we analysed plasma lipid profiles of 113 subjects. Cases (n = 23) were HIV-positive individuals with a stored blood sample available 12 months prior to their diagnosis of coronary artery disease (CAD). They were age and sex matched to HIV-positive individuals without a diagnosis of CAD (n = 45) and with healthy HIV-negative volunteers (n = 45). Results: Association of plasma lipid species and classes with HIV infection and cardiovascular risk in HIV were determined. In multiple logistic regression, we identified 83 lipids species and 7 lipid classes significantly associated with HIV infection and a further identified 74 lipid species and 8 lipid classes significantly associated with future cardiovascular events in HIV-positive subjects. Risk prediction models incorporating lipid species attained an area under the receiver operator characteristic curve (AUC) of 0.78 (0.775, 0.785)) and outperformed all other tested markers and risk scores in the identification of HIV-positive subjects with increased risk of cardiovascular events. Conclusions: Our results demonstrate that HIV-positive patients have significant differences in their plasma lipid profiles compared with healthy HIV-negative controls and that numerous lipid species were significantly associated with elevated cardiovascular risk. This suggests a potential novel application for plasma lipids in cardiovascular risk screening of HIV-positive patients.	[Wong, Gerard; Fatou, Benoit; Cinel, Michelle; Weir, Jacquelyn M.; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Trevillyan, Janine M.; Hoy, Jennifer F.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Trevillyan, Janine M.; Hoy, Jennifer F.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Clayton, Vic 3800, Australia; [Fatou, Benoit] Univ Sci & Technol Lille, Lille, France	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Universite de Lille - ISITE; Universite de Lille	Meikle, PJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	peter.meikle@bakeridi.edu.au	Hoy, Jennifer/AAK-7968-2020; Trevillyan, Janine/AAD-1631-2019; Meikle, Peter J/B-4023-2009	Hoy, Jennifer/0000-0002-6948-7086; Meikle, Peter/0000-0002-2593-4665; Fatou, Benoit/0000-0003-0317-0243; Trevillyan, Janine/0000-0002-8660-5558	National Heart Foundation of Australia; National Health and Medical Research Council of Australia [APP1029754, APP472672]; OIS Program of the Victorian Government, Australia; Merck Sharp Dohme; Gilead	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OIS Program of the Victorian Government, Australia; Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences)	This work was supported by the National Heart Foundation of Australia, the National Health and Medical Research Council of Australia [APP1029754 and APP472672] and the OIS Program of the Victorian Government, Australia. The Alfred Hospital received funding for Professor Hoy to perform research unrelated to the current manuscript from Merck Sharp & Dohme and Gilead in 2009. No funding was received from commercial funders for this research project. Jennifer F. Hoy has no financial or non-financial competing interests related to the research described in this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BARUCHEL S, 1992, J LEUKOCYTE BIOL, V52, P111, DOI 10.1002/jlb.52.1.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carpentier A, 2005, ATHEROSCLEROSIS, V178, P165, DOI 10.1016/j.atherosclerosis.2004.07.035; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crane HM, 2011, AIDS, V25, P185, DOI 10.1097/QAD.0b013e328341f925; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Francisci D, 2009, AIDS, V23, P589, DOI 10.1097/QAD.0b013e328325a87c; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Grunfeld Carl, 2010, Top HIV Med, V18, P112; Haugaard SB, 2006, METABOLISM, V55, P175, DOI 10.1016/j.metabol.2005.08.018; HELLERSTEIN MK, 1993, J CLIN ENDOCR METAB, V76, P559, DOI 10.1210/jc.76.3.559; Lee Grace A, 2004, Curr Infect Dis Rep, V6, P471, DOI 10.1007/s11908-004-0067-5; Lenhard JM, 2000, ANTIVIR RES, V47, P121, DOI 10.1016/S0166-3542(00)00102-9; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Moxon JV, 2014, CIRC-CARDIOVASC GENE, V7, P71, DOI 10.1161/CIRCGENETICS.113.000343; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Penzak SR, 2000, SCAND J INFECT DIS, V32, P111; Rasheed S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003003; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Shahmanesh M, 2005, J CLIN ENDOCR METAB, V90, P755, DOI 10.1210/jc.2004-1273; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Trevillyan JM, 2012, SEXUAL HLTH; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577; Young J, 2005, ANTIVIR THER, V10, P585	33	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94810	10.1371/journal.pone.0094810	http://dx.doi.org/10.1371/journal.pone.0094810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733512	Green Published, gold			2022-12-25	WOS:000336970400109
J	Xie, ZX; Huang, JL; Luo, SS; Xie, ZQ; Xie, LJ; Liu, JB; Pang, YS; Deng, XW; Fan, Q				Xie, Zhixun; Huang, Jiaoling; Luo, Sisi; Xie, Zhiqin; Xie, Liji; Liu, Jiabo; Pang, Yaoshan; Deng, Xianwen; Fan, Qing			Ultrasensitive Electrochemical Immunoassay for Avian Influenza Subtype H5 Using Nanocomposite	PLOS ONE			English	Article							GOLD NANOPARTICLES; HUMAN SERUM; VIRUS H5N1; A VIRUSES; RT-PCR; ANTIGEN; IMMUNOSENSOR; H7; AMPLIFICATION; ANTIBODY	We report a novel electrochemical immunosensor that can sensitively detect avian influenza virus H5 subtype (AIV H5) captured by graphene oxide-H5-polychonal antibodies-bovine serum albumin (GO-PAb-BSA) nanocomposite. The graphene oxide (GO) carried H5-polychonal antibody (PAb) were used as signal amplification materials. Upon signal amplification, the immunosensor showed a 256-fold increase in detection sensitivity compared to the immunosensor without GO-PAb-BSA. We designed a PAb labeling GO strategy and signal amplification procedure that allow ultrasensitive and selective detection of AIV H5. The established method responded to 2(-15) HA unit/50 mu L H5, with a linear calibration range from 2(-15) to 2(-8) HA unit/50 mu L. In summary, we demonstrated that the immunosenser has a high specificity and sensitivity for AIV H5, and the established assay could be potentially applied in the rapid detection of other pathogenic microorganisms.	[Xie, Zhixun; Huang, Jiaoling; Luo, Sisi; Xie, Zhiqin; Xie, Liji; Liu, Jiabo; Pang, Yaoshan; Deng, Xianwen; Fan, Qing] Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China	Guangxi Veterinary Research Institute	Xie, ZX (corresponding author), Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China.	xiezhixun@126.com			Guangxi Science and Technology Bureau [1222003-2-4, 13-051-27-A-1]; Guangxi Government Senior Scientist Foundation (Guangxi, China) [2011B020]	Guangxi Science and Technology Bureau; Guangxi Government Senior Scientist Foundation (Guangxi, China)	This work was supported by the Guangxi Science and Technology Bureau (1222003-2-4 and 13-051-27-A-1) and by the Guangxi Government Senior Scientist Foundation (2011B020) (Guangxi, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 2005, ANAL BIOANAL CHEM, V381, P156, DOI 10.1007/s00216-004-2927-0; [Anonymous], WHO CUM NUMB CONF HU; Bai H, 2012, SENSORS-BASEL, V12, P12506, DOI 10.3390/s120912506; Chantratita W, 2008, MOL CELL PROBE, V22, P287, DOI 10.1016/j.mcp.2008.06.005; Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g; Chen YX, 2008, J VIROL METHODS, V154, P213, DOI 10.1016/j.jviromet.2008.08.013; Du D, 2011, ANAL CHEM, V83, P746, DOI 10.1021/ac101715s; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; FREY ML, 1968, AM J VET RES, V29, P2163; Haque AMJ, 2012, ANAL CHEM, V84, P1871, DOI 10.1021/ac202562v; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Li QF, 2011, ACS APPL MATER INTER, V3, P1366, DOI 10.1021/am200228k; Li T, 2011, J ELECTROANAL CHEM, V655, P50, DOI 10.1016/j.jelechem.2011.02.009; Liu GD, 2007, TALANTA, V74, P308, DOI 10.1016/j.talanta.2007.10.014; Liu XQ, 2011, ANALYST, V136, P5204, DOI 10.1039/c1an15411g; Muszynski R, 2008, J PHYS CHEM C, V112, P5263, DOI 10.1021/jp800977b; Qi X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004682; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Su BL, 2010, ANAL METHODS-UK, V2, P1702, DOI 10.1039/c0ay00468e; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Tian JN, 2012, MICROCHIM ACTA, V178, P81, DOI 10.1007/s00604-012-0816-3; Vashist SK, 2011, BIOTECHNOL ADV, V29, P169, DOI 10.1016/j.biotechadv.2010.10.002; Velumani S, 2008, J VIROL METHODS, V147, P219, DOI 10.1016/j.jviromet.2007.09.004; Wang GF, 2011, ANAL METHODS-UK, V3, P2082, DOI 10.1039/c1ay05294b; Wang RH, 2009, TALANTA, V79, P159, DOI 10.1016/j.talanta.2009.03.017; Xie ZX, 2006, MOL CELL PROBE, V20, P245, DOI 10.1016/j.mcp.2006.01.003; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhuo Y, 2009, J ELECTROANAL CHEM, V628, P90, DOI 10.1016/j.jelechem.2009.01.016	28	17	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94685	10.1371/journal.pone.0094685	http://dx.doi.org/10.1371/journal.pone.0094685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733043	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400071
J	Castellanos-Rizaldos, E; Milbury, CA; Karatza, E; Chen, CC; Makrigiorgos, GM; Merewood, A				Castellanos-Rizaldos, Elena; Milbury, Coren A.; Karatza, Elli; Chen, Clark C.; Makrigiorgos, G. Mike; Merewood, Anne			COLD-PCR Amplification of Bisulfite-Converted DNA Allows the Enrichment and Sequencing of Rare Un-Methylated Genomic Regions	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; PROMOTER METHYLATION; MUTATION DETECTION; CANCER; SENSITIVITY; ASSAY; IDENTIFICATION; GLIOBLASTOMA; KRAS	Aberrant hypo-methylation of DNA is evident in a range of human diseases including cancer and diabetes. Development of sensitive assays capable of detecting traces of un-methylated DNA within methylated samples can be useful in several situations. Here we describe a new approach, fast-COLD-MS-PCR, which amplifies preferentially un-methylated DNA sequences. By employing an appropriate denaturation temperature during PCR of bi-sulfite converted DNA, fast-COLD-MS-PCR enriches un-methylated DNA and enables differential melting analysis or bisulfite sequencing. Using methylation on the MGMT gene promoter as a model, it is shown that serial dilutions of controlled methylation samples lead to the reliable sequencing of un-methylated sequences down to 0.05% un-methylated-to-methylated DNA. Screening of clinical glioma tumor and infant blood samples demonstrated that the degree of enrichment of un-methylated over methylated DNA can be modulated by the choice of denaturation temperature, providing a convenient method for analysis of partially methylated DNA or for revealing and sequencing traces of un-methylated DNA. Fast-COLD-MS-PCR can be useful for the detection of loss of methylation/imprinting in cancer, diabetes or diet-related methylation changes.	[Castellanos-Rizaldos, Elena; Milbury, Coren A.; Karatza, Elli; Makrigiorgos, G. Mike] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, Boston, MA 02115 USA; [Chen, Clark C.] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA; [Makrigiorgos, G. Mike] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Med Phys & Biophys,Dept Radiat Oncol,Brigham, Boston, MA 02115 USA; [Merewood, Anne] Boston Med Ctr, Div Gen Pediat, Boston, MA USA; [Merewood, Anne] Boston Univ, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Harvard University; Boston Medical Center; Boston University	Makrigiorgos, GM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	mmakrigiorgos@lroc.harvard.edu	Makrigiorgos, Mike/AFC-4575-2022		NCI [1R03CA139406, R21CA-155615, R21CA-175542]; NATIONAL CANCER INSTITUTE [R03CA139406, R21CA155615, R21CA175542] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grants 1R03CA139406 (AM); R21CA-155615 and R21CA-175542 (GMM). The contents of this manuscript do not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonanno C, 2007, CLIN CHEM, V53, P2119, DOI 10.1373/clinchem.2007.094011; Chen Y, 2013, ARCH MED RES, V44, P281, DOI 10.1016/j.arcmed.2013.04.004; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kristensen LS, 2010, HUM MUTAT, V31, P1366, DOI 10.1002/humu.21358; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Mancini I, 2010, J MOL DIAGN, V12, P705, DOI 10.2353/jmoldx.2010.100018; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; Milbury CA, 2011, J MOL DIAGN, V13, P220, DOI 10.1016/j.jmoldx.2010.10.008; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Palmisano WA, 2000, CANCER RES, V60, P5954; Pritchard CC, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-6; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zerilli F, 2010, CLIN CHEM, V56, P1287, DOI 10.1373/clinchem.2010.143545	27	10	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94103	10.1371/journal.pone.0094103	http://dx.doi.org/10.1371/journal.pone.0094103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728321	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200037
J	Huang, R; Faratian, D; Sims, AH; Wilson, D; Thomas, JS; Harrison, DJ; Langdon, SP				Huang, Rui; Faratian, Dana; Sims, Andrew H.; Wilson, Danielle; Thomas, Jeremy S.; Harrison, David J.; Langdon, Simon P.			Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTIONAL CONTROL; EXPRESSION; TRANSDUCERS; ACTIVATION; INHIBITOR; TAMOXIFEN; GROWTH; PHOSPHORYLATION	Proteomic profiling of the estrogen/tamoxifen-sensitive MCF-7 cell line and its partially sensitive (MCF-7/LCC1) and fully resistant (MCF-7/LCC9) variants was performed to identify modifiers of endocrine sensitivity in breast cancer. Analysis of the expression of 120 paired phosphorylated and non-phosphorylated epitopes in key oncogenic and tumor suppressor pathways revealed that STAT1 and several phosphorylated epitopes (phospho-STAT1(Tyr701) and phospho-STAT3(Ser727)) were differentially expressed between endocrine resistant and parental controls, confirmed by qRT-PCR and western blotting. The STAT1 inhibitor EGCG was a more effective inhibitor of the endocrine resistant MCF-7/LCC1 and MCF-7/LCC9 lines than parental MCF-7 cells, while STAT3 inhibitors Stattic and WP1066 were equally effective in endocrine-resistant and parental lines. The effects of the STAT inhibitors were additive, rather than synergistic, when tested in combination with tamoxifen in vitro. Expression of STAT1 and STAT3 were measured by quantitative immunofluorescence in invasive breast cancers and matched lymph nodes. When lymph node expression was compared to its paired primary breast cancer expression, there was greater expression of cytoplasmic STAT1 (similar to 3.1 fold), phospho-STAT3(Ser727) (similar to 1.8 fold), and STAT5 (similar to 1.5 fold) and nuclear phospho-STAT3(Ser727) (similar to 1.5 fold) in the nodes. Expression levels of STAT1 and STAT3 transcript were analysed in 550 breast cancers from publicly available gene expression datasets (GSE2990, GSE12093, GSE6532). When treatment with tamoxifen was considered, STAT1 gene expression was nearly predictive of distant metastasis-free survival (DMFS, log-rank p = 0.067), while STAT3 gene expression was predictive of DMFS (log-rank p<0.0001). Analysis of STAT1 and STAT3 protein expression in a series of 546 breast cancers also indicated that high expression of STAT3 protein was associated with improved survival (DMFS, p = 0.006). These results suggest that STAT signaling is important in endocrine resistance, and that STAT inhibitors may represent potential therapies in breast cancer, even in the resistant setting.	[Huang, Rui; Faratian, Dana; Sims, Andrew H.; Wilson, Danielle; Langdon, Simon P.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Thomas, Jeremy S.] Western Gen Hosp, Dept Pathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Harrison, David J.] Univ St Andrews, St Andrews, Fife, Scotland	University of Edinburgh; University of Edinburgh; University of St Andrews	Langdon, SP (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	simon.langdon@ed.ac.uk	Huang, Rui/Y-7557-2019; Sims, Andrew/E-4819-2012	Huang, Rui/0000-0002-4103-8537; Sims, Andrew/0000-0001-9082-3665; harrison, david/0000-0001-9041-9988	China Scholarship Council; University of Edinburgh; Scottish Funding Council; Breakthrough Breast Cancer; Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); University of Edinburgh; Scottish Funding Council; Breakthrough Breast Cancer; Breast Cancer Now	This work was supported by the China Scholarship Council, University of Edinburgh, Scottish Funding Council and Breakthrough Breast Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Becker M, 2005, MOL CANCER THER, V4, P151; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Chisholm K, 2004, ANTI-CANCER DRUG, V15, P889, DOI 10.1097/00001813-200410000-00010; Choi J, 2013, BREAST CANCER RES TR, V137, P417, DOI 10.1007/s10549-012-2383-z; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Englert NA, 2011, J STEROID BIOCHEM, V123, P140, DOI 10.1016/j.jsbmb.2010.12.010; Farabegoli F, 2011, BIOSCIENCE REP, V31, P99, DOI 10.1042/BSR20090143; Furth PA, 2014, MOL CELL ENDOCRINOL, V382, P612, DOI 10.1016/j.mce.2013.03.023; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Magkou C, 2012, HISTOPATHOLOGY, V60, P1125, DOI 10.1111/j.1365-2559.2011.04143.x; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Mohr A, 2012, EUR J CELL BIOL, V91, P524, DOI 10.1016/j.ejcb.2011.09.005; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Scandlyn MJ, 2008, BRIT J CANCER, V99, P1056, DOI 10.1038/sj.bjc.6604634; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sheen-Chen SM, 2008, CANCER EPIDEM BIOMAR, V17, P2286, DOI 10.1158/1055-9965.EPI-08-0089; Sheen-Chen SM, 2007, ANTICANCER RES, V27, P2481; Silva CM, 2007, MOL ENDOCRINOL, V21, P1499, DOI 10.1210/me.2007-0109; Sonnenblick A, 2012, CLIN TRANSL ONCOL, V14, P232, DOI 10.1007/s12094-012-0789-z; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stuart EC, 2008, LIFE SCI, V82, P943, DOI 10.1016/j.lfs.2008.02.009; Szelag M, 2013, EUR J PHARMACOL, V720, P38, DOI 10.1016/j.ejphar.2013.10.055; Tedeschi E, 2002, ANN NY ACAD SCI, V973, P435, DOI 10.1111/j.1749-6632.2002.tb04678.x; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Widschwendter A, 2002, CLIN CANCER RES, V8, P3065; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yeh YT, 2006, INT J CANCER, V118, P2943, DOI 10.1002/ijc.21771; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	46	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94226	10.1371/journal.pone.0094226	http://dx.doi.org/10.1371/journal.pone.0094226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728078	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200048
J	Kawano, Y; Ishikawa, N; Aida, J; Sanada, Y; Izumiyama-Shimomura, N; Nakamura, K; Poon, SSS; Matsumoto, K; Mizuta, K; Uchida, E; Tajiri, T; Kawarasaki, H; Takubo, K				Kawano, Youichi; Ishikawa, Naoshi; Aida, Junko; Sanada, Yukihiro; Izumiyama-Shimomura, Naotaka; Nakamura, Ken-ichi; Poon, Steven S. S.; Matsumoto, Koshi; Mizuta, Koichi; Uchida, Eiji; Tajiri, Takashi; Kawarasaki, Hideo; Takubo, Kaiyo			Q-FISH Measurement of Hepatocyte Telomere Lengths in Donor Liver and Graft after Pediatric Living-Donor Liver Transplantation: Donor Age Affects Telomere Length Sustainability	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; REPLICATIVE SENESCENCE; CHROMOSOMAL INSTABILITY; CELLULAR SENESCENCE; LINGUAL EPITHELIUM; HUMAN FIBROBLASTS; ALLOGRAFTS; OUTCOMES; CELLS; LIFE	Along with the increasing need for living-donor liver transplantation (LDLT), the issue of organ shortage has become a serious problem. Therefore, the use of organs from elderly donors has been increasing. While the short-term results of LDLT have greatly improved, problems affecting the long-term outcome of transplant patients remain unsolved. Furthermore, since contradictory data have been reported with regard to the relationship between donor age and LT/LDLT outcome, the question of whether the use of elderly donors influences the long-term outcome of a graft after LT/LDLT remains unsettled. To address whether hepatocyte telomere length reflects the outcome of LDLT, we analyzed the telomere lengths of hepatocytes in informative biopsy samples from 12 paired donors and recipients (grafts) of pediatric LDLT more than 5 years after adult-to-child LDLT because of primary biliary atresia, using quantitative fluorescence in situ hybridization (Q-FISH). The telomere lengths in the paired samples showed a robust relationship between the donor and grafted hepatocytes (r = 0.765, p = 0.0038), demonstrating the feasibility of our Q-FISH method for cell-specific evaluation. While 8 pairs showed no significant difference between the telomere lengths for the donor and the recipient, the other 4 pairs showed significantly shorter telomeres in the recipient than in the donor. Multiple regression analysis revealed that the donors in the latter group were older than those in the former (p = 0.001). Despite the small number of subjects, this pilot study indicates that donor age is a crucial factor affecting telomere length sustainability in hepatocytes after pediatric LDLT, and that the telomeres in grafted livers may be elongated somewhat longer when the grafts are immunologically well controlled.	[Kawano, Youichi; Uchida, Eiji; Tajiri, Takashi] Nippon Med Sch, Dept Surg, Tokyo 113, Japan; [Kawano, Youichi; Ishikawa, Naoshi; Aida, Junko; Izumiyama-Shimomura, Naotaka; Nakamura, Ken-ichi; Takubo, Kaiyo] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Sanada, Yukihiro; Mizuta, Koichi; Kawarasaki, Hideo] Jichi Med Univ, Dept Transplant Surg, Shimotsuke, Tochigi, Japan; [Poon, Steven S. S.] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Matsumoto, Koshi] Ebina Gen Hosp, Dept Clin Pathol, Ebina, Kanagawa, Japan	Nippon Medical School; Tokyo Metropolitan Institute of Gerontology; Jichi Medical University; British Columbia Cancer Agency	Kawano, Y (corresponding author), Nippon Med Sch, Dept Surg, 1-1-5 Sendagi, Tokyo 113, Japan.	y-kawano@nms.ac.jp; naoshi@tmig.or.jp	Aida, Junko/Q-5697-2019	Aida, Junko/0000-0003-4923-5540	Japan Society for the Promotion of Science (JSPS) KAKENHI [19790926, 24592013, 24590468]; Grants-in-Aid for Scientific Research [23659193] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI, 19790926 and 24592013 (to Y.K.), 24590468 (to N.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasoglu O, 2008, WORLD J GASTROENTERO, V14, P3117, DOI 10.3748/wjg.14.3117; Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; Aida J, 2011, J PATHOL, V223, P410, DOI 10.1002/path.2817; Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Attia M, 2008, TRANSPL INT, V21, P713, DOI 10.1111/j.1432-2277.2008.00696.x; Baerlocher GM, 2009, BLOOD, V114, P219, DOI 10.1182/blood-2009-03-209833; Barber K, 2007, GUT, V56, P279, DOI 10.1136/gut.2006.093195; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Borchert D, 2005, TRANSPL INT, V18, P709, DOI 10.1111/j.1432-2277.2005.00128.x; CALNE RY, 1979, LANCET, V2, P1033; Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8; Chkhotua A, 2002, TRANSPL IMMUNOL, V9, P165, DOI 10.1016/S0966-3274(02)00003-5; Cowles RA, 2008, J PEDIATR SURG, V43, P1605, DOI 10.1016/j.jpedsurg.2008.04.012; Demetris AJ, 2006, HEPATOLOGY, V44, P489, DOI 10.1002/hep.21280; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans HM, 2006, HEPATOLOGY, V43, P1109, DOI 10.1002/hep.21152; Ferlicot S, 2003, J PATHOL, V200, P661, DOI 10.1002/path.1392; Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251; Ishikawa N, 2012, AGE, V34, P795, DOI 10.1007/s11357-011-9280-y; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; MARKUS BH, 1988, TRANSPLANTATION, V46, P372; McDiarmid SV, 2004, LIVER TRANSPLANT, V10, pS23, DOI 10.1002/lt.20272; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Mehrabi A, 2008, LANGENBECK ARCH SURG, V393, P245, DOI 10.1007/s00423-007-0262-6; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x; Nakamura KI, 2002, J INVEST DERMATOL, V119, P1014, DOI 10.1046/j.1523-1747.2002.19523.x; Navarro V, 2006, LIVER TRANSPLANT, V12, P652, DOI 10.1002/lt.20680; Nobori S, 2006, P NATL ACAD SCI USA, V103, P19081, DOI 10.1073/pnas.0605159103; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Ohe H, 2011, TRANSPLANTATION, V91, P808, DOI 10.1097/TP.0b013e31820f07de; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Sanada Y, 2014, TRANSPL INT, V27, P383, DOI 10.1111/tri.12273; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196; STARZL TE, 1989, LANCET, V2, P1000; STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Sugawara Y, 1999, J Hepatobiliary Pancreat Surg, V6, P245, DOI 10.1007/s005340050114; Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Takubo K, 2010, MECH AGEING DEV, V131, P614, DOI 10.1016/j.mad.2010.08.007; Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704; Veldhuis JD, 2008, AGEING RES REV, V7, P189, DOI 10.1016/j.arr.2007.12.005; Wege Henning, 2007, Curr Stem Cell Res Ther, V2, P31, DOI 10.2174/157488807779317062; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Yoshiya S, 2012, TRANSPLANTATION, V94, P947, DOI 10.1097/TP.0b013e31826969e6	54	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93749	10.1371/journal.pone.0093749	http://dx.doi.org/10.1371/journal.pone.0093749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727734	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200024
J	Miller, CJ; Baker, JV; Bormann, AM; Erlandson, KM; Hullsiek, KH; Justice, AC; Neuhaus, J; Paredes, R; Petoumenos, K; Wentworth, D; Winston, A; Wolfson, J; Neaton, JD				Miller, Christopher J.; Baker, Jason V.; Bormann, Alison M.; Erlandson, Kristine M.; Hullsiek, Katherine Huppler; Justice, Amy C.; Neuhaus, Jacqueline; Paredes, Roger; Petoumenos, Kathy; Wentworth, Deborah; Winston, Alan; Wolfson, Julian; Neaton, James D.		INSIGHT SMART Study Grp; ESPRIT Study Grp	Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEART-DISEASE; AIDS EVENTS; RISK; DEATH; POPULATION; PREVENTION; HEALTH; CANCER; ERA	Background: Non-AIDS conditions such as cardiovascular disease and non-AIDS defining cancers dominate causes of morbidity and mortality among persons with HIV on suppressive combination antiretroviral therapy. Accurate estimates of disease incidence and of risk factors for these conditions are important in planning preventative efforts. Methods: With use of medical records, serious non-AIDS events, AIDS events, and causes of death were adjudicated using pre-specified criteria by an Endpoint Review Committee in two large international trials. Rates of serious non-AIDS which include cardiovascular disease, end-stage renal disease, decompensated liver disease, and non-AIDS cancer, and other serious (grade 4) adverse events were determined, overall and by age, over a median follow-up of 4.3 years for 3,570 participants with CD4(+) cell count >= 300 cells/mm(3) who were taking antiretroviral therapy and had an HIV RNA level <= 500 copies/mL. Cox models were used to examine the effect of age and other baseline factors on risk of a composite outcome of all-cause mortality, AIDS, or serious non-AIDS. Results: Five-year Kaplan-Meier estimates of the composite outcome, overall and by age were 8.3% (overall), 3.6% (<40), 8.7% (40-49) and 16.1% (>= 50), respectively (p<0.001). In addition to age, smoking and higher levels of interleukin-6 and D-dimer were significant predictors of the composite outcome. The composite outcome was dominated by serious non-AIDS events (overall 65% of 277 participants with a composite event). Most serious non-AIDS events were due to cardiovascular disease and non-AIDS cancers. Conclusions: To date, few large studies have carefully collected data on serious non-AIDS outcomes. Thus, reliable estimates of event rates are scarce. Data cited here, from a geographically diverse cohort, will be useful for planning studies of interventions aimed at reducing rates of serious non-AIDS events among people with HIV.	[Miller, Christopher J.; Hullsiek, Katherine Huppler; Neuhaus, Jacqueline; Wentworth, Deborah; Wolfson, Julian; Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Baker, Jason V.; Bormann, Alison M.] Univ Minnesota, Div Infect Dis, Minneapolis, MN USA; [Baker, Jason V.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Erlandson, Kristine M.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Justice, Amy C.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Justice, Amy C.] Yale Univ, Sch Med & Publ Hlth, New Haven, CT USA; [Paredes, Roger] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, irsiCaixa Fdn, Badalona, Spain; [Paredes, Roger] Lluita SIDA Fdn, Badalona, Spain; [Petoumenos, Kathy] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; University of New South Wales Sydney; Kirby Institute; Imperial College London	Neaton, JD (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.	jim@ccbr.umn.edu	Winston, Alan/AGZ-3015-2022; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017	Winston, Alan/0000-0002-5847-8416; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309	National Institute of Allergy and Infectious Diseases (NIAID) [AI007432-15]; NIAID [U01AI042170, U01AI46362, U01AI46957, U01AI068641]; MRC [MC_U122886352, MC_UU_12023/16] Funding Source: UKRI; Medical Research Council [MC_UU_12023/16, MC_U122886352] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI042170, T32AI007432, U01AI068641, U01AI046362] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CJM was supported by the National Institute of Allergy and Infectious Diseases (NIAID) [grant number AI007432-15]. The SMART and ESPRIT studies were funded by NIAID [grant numbers U01AI042170 and U01AI46362 (SMART); U01AI46957 and U01AI068641 (ESPRIT)]. Funding source staff members participated in non-binding manuscript review as members of the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), but were not part of the writing group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Butt AA, 2011, ARCH INTERN MED, V171, P737, DOI 10.1001/archinternmed.2011.151; *CDC, 2008, HIV SURV REP, V20; CDC, 2009, HIV SURV REP, V21; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; *COP HIV PROGR, 2005, COD CAUS DEATH HIV P; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; GRUND B, 2013, COMBINED EFFECT INTE; *HLTH PROT AG, 2010, 4 HLTH PROT AG; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; LANE HC, 2010, 18 C RETR OPP INF BO; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lifson AR, 2008, HIV CLIN TRIALS, V9, P177, DOI 10.1310/hct0903-177; Lifson AR, 2006, HIV CLIN TRIALS, V7, P125, DOI 10.1310/7MER-XFA7-1762-E2WR; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; McGinnis KA, 2006, J CLIN ONCOL, V24, P5005, DOI 10.1200/JCO.2006.05.7984; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Psaty BM, 2010, CIRCULATION, V121, P940, DOI 10.1161/CIRCULATIONAHA.109.933705; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190	33	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e95061	10.1371/journal.pone.0095061	http://dx.doi.org/10.1371/journal.pone.0095061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728071	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200145
J	Plessa, E; Tansarli, GS; Xanthopoulos, D; Falagas, ME				Plessa, Eleni; Tansarli, Giannoula S.; Xanthopoulos, Dimitrios; Falagas, Matthew E.			Morbidity and Outcomes of Foreign Travelers in Zakynthos Island, Greece: A Retrospective Study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; EXPOSURE; ATTICA	Background: Although there is satisfactory recording of diseases affecting travelers visiting developing countries, little is known regarding morbidity of travelers when visiting developed countries. We sought to evaluate the morbidity of foreign travelers in Zakynthos, a popular Greek island attracting large number of foreign tourists every summer. Methods: Data from foreign travelers that accommodated in Zakynthos and sought medical services from the private offices of Zante Medical Care from May 1 to October 30 2012 were retrospectively analyzed. Results: Two thousand six hundred and eighty-eight patients were included in the study. The mean age (+/- SD) of the patients whom the age was recorded was 29.6 (+/- 18.3) and 51.5% of them were from 18 to 40 years old. Disorders of the respiratory tract (32.7%), dermatologic conditions (21.1%), musculoskeletal injuries (16.4%), and gastrointestinal disorders (16.3%) were the four most prevalent clinical categories among patients. Ear disorder was the most common syndromic description (14.5%) among which 81.2% were ear infections; otitis externa and otitis media were diagnosed in 8.5% and 3.3% patients in total. The most common specific diagnosis was gastroenteritis (14.3%). Insect bite and sunburn were the most common diagnosis (6.5% and 3.8%, respectively) among patients with a dermatologic condition. Ear infection was the most common diagnosis in pediatric patients. Conclusion: Disorders mainly of the upper respiratory tract were the predominant causes of illness among foreign travelers in Zakynthos. Traveler's diarrhea was the most common specific diagnosis but the prevalence within the total population was not very high.	[Plessa, Eleni; Xanthopoulos, Dimitrios] Zante Med Care ZanteMed, Zakynthos, Greece; [Plessa, Eleni; Tansarli, Giannoula S.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Iaso Hosp, Iaso Grp, Dept Internal Med Infect Dis, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr						[Anonymous], 2010, UNWTO WORLD TOURISM; Center for Disease Control and Prevention, VIR GASTR; Falagas ME, 2008, RESP MED, V102, P733, DOI 10.1016/j.rmed.2007.12.010; Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gautret P, 2009, EMERG INFECT DIS, V15, P1783, DOI 10.3201/eid1511.091147; Hagmann S, 2010, PEDIATRICS, V125, pE1072, DOI 10.1542/peds.2009-1951; Hajjartabar M, 2004, WATER SCI TECHNOL, V50, P63, DOI 10.2166/wst.2004.0020; Mourtzoukou EG, 2007, INT J TUBERC LUNG D, V11, P938; OpenEpi, OPENEPI OPEN SOURCE; Peppas G, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-112; Theocharis G, 2012, EUR J CLIN MICROBIOL, V31, P2141, DOI 10.1007/s10096-012-1548-3; Wang Mao-Che, 2005, J Chin Med Assoc, V68, P347, DOI 10.1016/S1726-4901(09)70174-1; World Tourism Organization UNWTO, ANN REP 2012	14	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94416	10.1371/journal.pone.0094416	http://dx.doi.org/10.1371/journal.pone.0094416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728297	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200072
J	Bogebo, R; Horn, H; Olsen, JV; Gammeltoft, S; Jensen, LJ; Hansen, JL; Christensen, GL				Bogebo, Rikke; Horn, Heiko; Olsen, Jesper V.; Gammeltoft, Steen; Jensen, Lars J.; Hansen, Jakob L.; Christensen, Gitte L.			Predicting Kinase Activity in Angiotensin Receptor Phosphoproteomes Based on Sequence-Motifs and Interactions	PLOS ONE			English	Article							FUNCTIONAL SELECTIVITY; BETA-ARRESTIN; AT(1) RECEPTOR; PHOSPHORYLATION; ACTIVATION; REVEALS; PATHWAY; INSULIN; EXTRACELLULAR-SIGNAL-REGULATED-KINASE-1; DISTINCT	Recent progress in the understanding of seven-transmembrane receptor (7TMR) signalling has promoted the development of a new generation of pathway selective ligands. The angiotensin II type I receptor (AT(1a)R) is one of the most studied 7TMRs with respect to selective activation of the beta-arrestin dependent signalling. Two complimentary global phosphoproteomics studies have analyzed the complex signalling induced by the AT(1a)R. Here we integrate the data sets from these studies and perform a joint analysis using a novel method for prediction of differential kinase activity from phosphoproteomics data. The method builds upon NetworKIN, which applies sophisticated linear motif analysis in combination with contextual network modelling to predict kinase-substrate associations with high accuracy and sensitivity. These predictions form the basis for subsequently nonparametric statistical analysis to identify likely activated kinases. This suggested that AT(1a)R-dependent signalling activates 48 of the 285 kinases detected in HEK293 cells. Of these, Aurora B, CLK3 and PKG1 have not previously been described in the pathway whereas others, such as PKA, PKB and PKC, are well known. In summary, we have developed a new method for kinase-centric analysis of phosphoproteomes to pinpoint differential kinase activity in large-scale data sets.	[Bogebo, Rikke; Gammeltoft, Steen; Christensen, Gitte L.] Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Biochem, Glostrup, Denmark; [Horn, Heiko; Jensen, Lars J.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Dept Dis Syst Biol, Copenhagen, Denmark; [Olsen, Jesper V.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Dept Prote, Copenhagen, Denmark; [Hansen, Jakob L.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Hansen, Jakob L.] Univ Copenhagen, Fac Hlth Sci, Ctr Cardiac Arrhythmia, Danish Natl Res Fdn, Copenhagen, Denmark; [Christensen, Gitte L.] Univ Copenhagen, Dept Biomed Sci, Cellular & Metab Res Sect, Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen	Hansen, JL (corresponding author), Novo Nordisk AS, Diabet NBEs & Obes Biol, Malov, Denmark.	jlhh@novonordisk.com; gilc@sund.ku.dk	Jensen, Lars Juhl/C-6492-2008; Olsen, Jesper/ABH-4638-2020; Christensen, Gitte Lund/AAY-1444-2020	Jensen, Lars Juhl/0000-0001-7885-715X; Olsen, Jesper/0000-0002-4747-4938; Horn, Heiko/0000-0003-4898-0557; Lund Christensen, Gitte/0000-0002-3272-632X	Danish Heart Association; Danish Council for Independent Research \ Medical Sciences; Danish National Research Foundation; Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen, PI Lars Juhl Jensen] Funding Source: researchfish	Danish Heart Association; Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation Center for Protein Research	We thank the following for financial support: The Danish Heart Association, The Danish Council for Independent Research vertical bar Medical Sciences, the Danish National Research Foundation and The Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ali MS, 1997, J BIOL CHEM, V272, P12373, DOI 10.1074/jbc.272.19.12373; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Aplin M, 2008, TRENDS CARDIOVAS MED, V18, P305, DOI 10.1016/j.tcm.2009.01.003; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Butt E GS, 2003, J BIOL CHEM, P6; Christensen GL, 2011, MOL CELL ENDOCRINOL, V331, P49, DOI 10.1016/j.mce.2010.08.004; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Christensen GL, 2010, TRENDS CARDIOVAS MED, V20, P221, DOI 10.1016/j.tcm.2011.11.005; Clevers H NR, 2012, CELL, V149, P13, DOI DOI 10.1016/J.CE11.2012.05.012; Guise AJ, 2012, MOL CELL PROTEOMICS, V11, P1220, DOI 10.1074/mcp.M112.021030; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lachmann A MaA, 2009, BIOINFORMATICS, V25, P3; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Linding R JL, 2008, NUCLEIC ACIDS RES, V36, P4; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Olsen JV BB, 2006, CELL, V127, P13; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Seta K, 2003, J BIOL CHEM, V278, P9019, DOI 10.1074/jbc.M208017200; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shah BH CK, 2003, TRENDS PHARMACOL SCI, V24, P5; Thomas WG BY, 2002, CIRC RES, V90, P7; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Xiao K SJ, 2010, P NATL ACAD SCI USA, V107, P35; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94672	10.1371/journal.pone.0094672	http://dx.doi.org/10.1371/journal.pone.0094672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722691	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100120
J	Chang, CB; Lai, HY; Yang, SY; Wu, RS; Liu, HC; Hsu, HY; Hwang, SJ; Chan, DC				Chang, Chirn-Bin; Lai, Hsiu-Yun; Yang, Shu-Yu; Wu, Ru-Shu; Liu, Hsing-Cheng; Hsu, Hsiu-Ying; Hwang, Shinn-Jang; Chan, Ding-Cheng			Patient- and Clinic Visit-Related Factors Associated with Potentially Inappropriate Medication Use among Older Home Healthcare Service Recipients	PLOS ONE			English	Article							DRUG; OUTCOMES; OUTPATIENTS; PREVALENCE; RESIDENTS; CRITERIA; GERMANY	Objectives: Taiwanese National Health Insurance (TNHI) provides home healthcare services to patients with skilled nursing needs who were homebound or lived in nursing homes. Studies on potentially inappropriate medications (PIMs) for older home healthcare service recipients (HHSRs) are growing, but comparisons among newer criteria of PIMs have not been applied. The aim of this study was to explore the prevalence and correlates of PIMs based on three different instruments published after 2010 among older HHSRs. Materials and Methods: We performed cross-sectional analysis of the TNHI Research Database. A total of 25,187 HHSRs aged more than 65 years in 2009 were included. Medication lists independent of chronic conditions from the 2012 Beers criteria, PIM-Taiwan criteria, and the PRISCUS (Latin for "old and venerable') criteria were used. Analysis was performed separately at patient and clinic-visit level. T-tests, chi-square analysis, and multivariate logistic regressions were used where appropriate. Results: The prevalence of having at least one PIM at patient and clinic-visit level was highest with the Beers (82.67%, 36.14% respectively), followed by the PRISCUS (68.49%, 25.13%) and PIM-Taiwan (63.04%, 19.21%) criteria. At patient level, polypharmacy (odds ratio (OR) 2.53 to 4.90), higher number of clinic (OR 1.15 to 1.41), hospital (OR 1.24 to 1.64), and physician (OR 1.15 to 1.41) visits were associated with PIM use for all 3 sets of criteria. At clinic-visit level, internist/family physicians (OR 1.26 to 1.72) and neurologists/psychiatrists (OR 1.73 to 5.87) were more likely to prescribe PIMs than others. Psychotropic drugs and first generation antihistamines accounted for most of the top ten PIMs. Conclusion: The prevalence of PIMs was high among older Taiwanese HHSRs. Polypharmacy and certain medical specialties were associated with a higher likelihood of PIM prescriptions. Provider education and medication review and reconciliation should be considered.	[Chang, Chirn-Bin] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Chang, Chirn-Bin] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chang, Chirn-Bin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lai, Hsiu-Yun] Natl Taiwan Univ Hosp, Dept Family Med, Hsinchu, Taiwan; [Yang, Shu-Yu; Wu, Ru-Shu; Hsu, Hsiu-Ying] Taipei City Hosp, Dept Pharm, Taipei, Taiwan; [Liu, Hsing-Cheng] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Hwang, Shinn-Jang] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; Taipei City Hospital; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hwang, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan.	sjhwang@vghtpe.gov.tw; doctord6226@yahoo.com	Bin Chang, Chirn/E-8605-2010	CHAN, DING-CHENG/0000-0003-2215-2243; Chang, Chirn-Bin/0000-0001-9423-7655				Baldoni AD, 2013, INT J CLIN PHARM; Bao YH, 2012, J GEN INTERN MED, V27, P304, DOI 10.1007/s11606-011-1905-4; Cannon Katrina T, 2006, Am J Geriatr Pharmacother, V4, P134, DOI 10.1016/j.amjopharm.2006.06.010; CHANG C, 2011, FILM COMMENT, V47, P72; Chang CB, 2012, PHARMACOEPIDEM DR S, V21, P1269, DOI 10.1002/pds.3274; Chang HT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-274; Chen LL, 2012, INT J CLIN PHARM-NET, V34, P596, DOI 10.1007/s11096-012-9651-1; Chiatti C, 2012, DRUG SAFETY, V35, P73, DOI 10.1007/BF03319105; Chu HY, 2012, MED CARE, V50, P1002, DOI 10.1097/MLR.0b013e31826c870f; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Garcia-Gollarte F, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.02.009; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Kolzsch M, 2011, PHARMACOEPIDEM DR S, V20, P12, DOI 10.1002/pds.2005; Lai HY, 2009, CLIN THER, V31, P1859, DOI 10.1016/j.clinthera.2009.08.023; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Maio V, 2010, J CLIN PHARM THER, V35, P219, DOI 10.1111/j.1365-2710.2009.01094.x; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; Murtaugh Christopher, 2009, J Healthc Qual, V31, P34; O'Sullivan DP, 2013, DRUG AGING, V30, P39, DOI 10.1007/s40266-012-0039-7; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Perri M, 2005, ANN PHARMACOTHER, V39, P405, DOI 10.1345/aph.1E230; Pugh MJV, 2005, J AM GERIATR SOC, V53, P1282, DOI 10.1111/j.1532-5415.2005.53402.x; Pugh MJV, 2008, MED CARE, V46, P167, DOI 10.1097/MLR.0b013e318158aec2; Raivio MM, 2006, DRUG AGING, V23, P333, DOI 10.2165/00002512-200623040-00006; Riker GI, 2012, HOME HEALTHC NURSE, V30, P486; Riker Gretchen I, 2013, Home Healthc Nurse, V31, P65, DOI 10.1097/NHH.0b013e31827f43b2; Riker Gretchen I, 2012, Home Healthc Nurse, V30, P474, DOI 10.1097/NHH.0b013e31826502dd; Schubert I, 2013, PHARMACOEPIDEM DR S, V22, P719, DOI 10.1002/pds.3429; de Lima TJV, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-52; Weng MC, 2013, QJM-INT J MED, V106, P1009, DOI 10.1093/qjmed/hct141	33	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94350	10.1371/journal.pone.0094350	http://dx.doi.org/10.1371/journal.pone.0094350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722537	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100057
J	Dunmyre, JR; Mashour, GA; Booth, V				Dunmyre, Justin R.; Mashour, George A.; Booth, Victoria			Coupled Flip-Flop Model for REM Sleep Regulation in the Rat	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; BRAIN-STEM; MATHEMATICAL-MODEL; HYPOTHALAMIC CONTROL; WAKE BEHAVIOR; NEURONS; DYNAMICS; WAKEFULNESS; ADENOSINE; SYSTEM	Recent experimental studies investigating the neuronal regulation of rapid eye movement (REM) sleep have identified mutually inhibitory synaptic projections among REM sleep-promoting (REM-on) and REM sleep-inhibiting (REM-off) neuronal populations that act to maintain the REM sleep state and control its onset and offset. The control mechanism of mutually inhibitory synaptic interactions mirrors the proposed flip-flop switch for sleep-wake regulation consisting of mutually inhibitory synaptic projections between wake-and sleep-promoting neuronal populations. While a number of synaptic projections have been identified between these REM-on/REM-off populations and wake/sleep-promoting populations, the specific interactions that govern behavioral state transitions have not been completely determined. Using a minimal mathematical model, we investigated behavioral state transition dynamics dictated by a system of coupled flip-flops, one to control transitions between wake and sleep states, and another to control transitions into and out of REM sleep. The model describes the neurotransmitter-mediated inhibitory interactions between a wake-and sleep-promoting population, and between a REM-on and REM-off population. We proposed interactions between the wake/sleep and REMon/REM-off flip-flops to replicate the behavioral state statistics and probabilities of behavioral state transitions measured from experimental recordings of rat sleep under ad libitum conditions and after 24 h of REM sleep deprivation. Reliable transitions from REM sleep to wake, as dictated by the data, indicated the necessity of an excitatory projection from the REM-on population to the wake-promoting population. To replicate the increase in REM-wake-REM transitions observed after 24 h REM sleep deprivation required that this excitatory projection promote transient activation of the wake-promoting population. Obtaining the reliable wake-nonREM sleep transitions observed in the data required that activity of the wake-promoting population modulated the interaction between the REM-on and REM-off populations. This analysis suggests neuronal processes to be targeted in further experimental studies of the regulatory mechanisms of REM sleep.	[Dunmyre, Justin R.; Booth, Victoria] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Mashour, George A.; Booth, Victoria] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA; [Mashour, George A.; Booth, Victoria] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Dunmyre, Justin R.] Frostburg State Univ, Dept Math, Frostburg, MD 21532 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; Frostburg State University	Booth, V (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	vbooth@umich.edu			NSF [DMS-1121361]; NIH [RO1GM098578]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation	This work was supported by NSF DMS-1121361 (JRD, VB), NIH RO1GM098578 (GAM) and the James S. McDonnell Foundation (GAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici R, 2008, SLEEP, V31, P708, DOI 10.1093/sleep/31.5.708; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Behn CGD, 2013, SIAM J APPL DYN SYST, V12, P279, DOI 10.1137/120876939; Behn CGD, 2012, SIAM J APPL DYN SYST, V11, P212, DOI 10.1137/110832823; Behn CGD, 2010, J NEUROPHYSIOL, V103, P1937, DOI 10.1152/jn.00795.2009; BENINGTON JH, 1994, PROG NEUROBIOL, V44, P433, DOI 10.1016/0301-0082(94)90005-1; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; Borbely A A, 1982, Hum Neurobiol, V1, P195; Chamberlin NL, 2003, NEUROSCIENCE, V119, P913, DOI 10.1016/S0306-4522(03)00246-X; Chervin RD, 2009, SLEEP, V32, P1325, DOI 10.1093/sleep/32.10.1325; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; de Andres I, 2003, SLEEP, V26, P419, DOI 10.1093/sleep/26.4.419; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; DOKSUM KA, 1976, BIOMETRIKA, V63, P421, DOI 10.2307/2335720; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Fleshner M, 2011, PHILOS T R SOC A, V369, P3855, DOI 10.1098/rsta.2011.0085; Franken P, 2002, J SLEEP RES, V11, P17, DOI 10.1046/j.1365-2869.2002.00275.x; Fuller PM, 2007, J PHYSIOL-LONDON, V584, P735, DOI 10.1113/jphysiol.2007.140160; Gallopin T, 2005, NEUROSCIENCE, V134, P1377, DOI 10.1016/j.neuroscience.2005.05.045; Gross BA, 2009, J NEUROSCI METH, V184, P10, DOI 10.1016/j.jneumeth.2009.07.009; Gvilia I, 2006, J NEUROSCI, V26, P3037, DOI 10.1523/JNEUROSCI.4827-05.2006; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jego S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052525; JOUVET D, 1964, CR SOC BIOL, V158, P756; Klerman EB, 2013, NEUROBIOL AGING, V34, P309, DOI 10.1016/j.neurobiolaging.2012.05.018; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042059; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2013, CURR OPIN NEUROBIOL, V23, P786, DOI 10.1016/j.conb.2013.02.006; Luppi PH, 2012, PFLUG ARCH EUR J PHY, V463, P43, DOI 10.1007/s00424-011-1054-y; Mashour GA, 2010, ANESTH ANALG, V110, P1283, DOI 10.1213/ANE.0b013e3181d3e861; McCarley RW, 2004, ARCH ITAL BIOL, V142, P429; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCCARLEY RW, 1986, AM J PHYSIOL, V251, pR1011, DOI 10.1152/ajpregu.1986.251.6.R1011; Monti JM, 2013, SLEEP MED REV, V17; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Pal D, 2011, ANESTHESIOLOGY, V114, P302, DOI 10.1097/ALN.0b013e318204e064; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Porkka-Heiskanen T, 2013, CURR OPIN NEUROBIOL, V23, P799, DOI 10.1016/j.conb.2013.02.010; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; RINZEL J, 1985, LECT NOTES MATH, V1151, P304; Robinson PA, 2011, PHILOS T R SOC A, V369, P3840, DOI 10.1098/rsta.2011.0120; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Shea JL, 2008, BRAIN RES, V1213, P48, DOI 10.1016/j.brainres.2008.03.062; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	57	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94481	10.1371/journal.pone.0094481	http://dx.doi.org/10.1371/journal.pone.0094481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722577	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100078
J	Fernandez-Soto, P; Mvoulouga, PO; Akue, JP; Aban, JL; Santiago, BV; Sanchez, MC; Muro, A				Fernandez-Soto, Pedro; Obolo Mvoulouga, Prosper; Akue, Jean Paul; Lopez Aban, Julio; Vicente Santiago, Belen; Cordero Sanchez, Miguel; Muro, Antonio			Development of a Highly Sensitive Loop-Mediated Isothermal Amplification (LAMP) Method for the Detection of Loa loa	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI DNA; CHAIN-REACTION ASSAY; HUMAN OCCULT LOIASIS; HUMAN BLOOD; DIAGNOSIS; FILARIASIS; IGG4; PCR	The filarial parasite Loa loa, the causative agent of loiasis, is endemic in Central and Western Africa infecting 3-13 million people. L. loa has been associated with fatal encephalopathic reactions in high Loa-infected individuals receiving ivermectin during mass drug administration programs for the control of onchocerciasis and lymphatic filariasis. In endemic areas, the only diagnostic method routinely used is the microscopic examination of mid-day blood samples by thick blood film. Improved methods for detection of L. loa are needed in endemic regions with limited resources, where delayed diagnosis results in high mortality. We have investigated the use of a loop-mediated isothermal amplification (LAMP) assay to facilitate rapid, inexpensive, molecular diagnosis of loiasis. Primers for LAMP were designed from a species-specific repetitive DNA sequence from L. loa retrieved from GenBank. Genomic DNA of a L. loa adult worm was used to optimize the LAMP conditions using a thermocycler or a conventional heating block. Amplification of DNA in the LAMP mixture was visually inspected for turbidity as well as addition of fluorescent dye. LAMP specificity was evaluated using DNA from other parasites; sensitivity was evaluated using DNA from L. loa 10-fold serially diluted. Simulated human blood samples spiked with DNA from L. loa were also tested for sensitivity. Upon addition of fluorescent dye, all positive reactions turned green while the negative controls remained orange under ambient light. After electrophoresis on agarose gels, a ladder of multiple bands of different sizes could be observed in positive samples. The detection limit of the assay was found to be as little as 0.5 ag of L. loa genomic DNA when using a heating block. We have designed, for the first time, a highly sensitive LAMP assay for the detection of L. loa which is potentially adaptable for field diagnosis and disease surveillance in loiasisendemic areas.	[Fernandez-Soto, Pedro; Obolo Mvoulouga, Prosper; Lopez Aban, Julio; Vicente Santiago, Belen; Muro, Antonio] Univ Salamanca, Fac Farm, CIETUS, IBSAL,Inst Invest Biomed Salamanca, E-37007 Salamanca, Spain; [Akue, Jean Paul] CIRMF, Deparment Med Parasitol, Franceville, Gabon; [Cordero Sanchez, Miguel] Univ Hosp Salamanca, Serv Internal Med, Dept Infect Dis, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Fernandez-Soto, P (corresponding author), Univ Salamanca, Fac Farm, CIETUS, IBSAL,Inst Invest Biomed Salamanca, E-37007 Salamanca, Spain.	pfsoto@usal.es	López-Abán, Julio/B-3557-2015	López-Abán, Julio/0000-0001-8509-0727; OBOLO-MVOULOUGA, Proper/0000-0003-1004-9521; Muro, Antonio/0000-0003-0244-4740	Real Federacion Espanola de Futbol-Sociedad Espanola de Medicina Tropical y Salud Internacional (RFEF-SEMTSI); Junta de Castilla y Leon [SA342U13]	Real Federacion Espanola de Futbol-Sociedad Espanola de Medicina Tropical y Salud Internacional (RFEF-SEMTSI); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Real Federacion Espanola de Futbol-Sociedad Espanola de Medicina Tropical y Salud Internacional, 2013 (RFEF-SEMTSI, 2013) and by Junta de Castilla y Leon (Ref. no. SA342U13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addiss David G, 2003, Filaria J, V2 Suppl 1, pS9, DOI 10.1186/1475-2883-2-S1-S9; AKUE JP, 1994, TROP MED PARASITOL, V45, P246; Aonuma H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-15; Bain O, 1997, EXP PARASITOL, V86, P163, DOI 10.1006/expr.1997.4168; Boussinesq M, 2006, ANN TROP MED PARASIT, V100, P715, DOI 10.1179/136485906X112194; Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08; Fink DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001299; Fong MY, 2008, TROP BIOMED, V25, P87; Jimenez M, 2011, EXP PARASITOL, V127, P282, DOI 10.1016/j.exppara.2010.06.019; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Klion AD, 2003, J INFECT DIS, V187, P128, DOI 10.1086/345873; KLION AD, 1991, MOL BIOCHEM PARASIT, V45, P297, DOI 10.1016/0166-6851(91)90098-Q; LAL RB, 1988, J INFECT DIS, V158, P1034, DOI 10.1093/infdis/158.5.1034; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Mackenzie C, 2007, TRENDS PARASITOL, V23, P237, DOI 10.1016/j.pt.2007.04.007; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Pion SDS, 2004, PARASITOLOGY, V129, P613, DOI 10.1017/S0031182004005694; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Rao RU, 2006, J CLIN MICROBIOL, V44, P3887, DOI 10.1128/JCM.00969-06; Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Toure FS, 1998, AM J TROP MED HYG, V59, P144, DOI 10.4269/ajtmh.1998.59.144; Toure FS, 1998, TROP MED INT HEALTH, V3, P505, DOI 10.1046/j.1365-3156.1998.00260.x; Twum-Danso Nana AY, 2003, Filaria J, V2 Suppl 1, pS7, DOI 10.1186/1475-2883-2-S1-S7	27	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94664	10.1371/journal.pone.0094664	http://dx.doi.org/10.1371/journal.pone.0094664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722638	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100118
J	Hauser, DN; Dillman, AA; Ding, JH; Li, Y; Cookson, MR				Hauser, David N.; Dillman, Allissa A.; Ding, Jinhui; Li, Yan; Cookson, Mark R.			Post-Translational Decrease in Respiratory Chain Proteins in the Polg Mutator Mouse Brain	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; POINT MUTATIONS; MTDNA DELETIONS; MICE; PHENOTYPES; EXPRESSION; DISEASE	Mitochondrial DNA damage is thought to be a causal contributor to aging as mice with inactivating mutations in polymerase gamma (Polg) develop a progeroid phenotype. To further understand the molecular mechanisms underlying this phenotype, we used iTRAQ and RNA-Seq to determine differences in protein and mRNA abundance respectively in the brains of one year old Polg mutator mice compared to control animals. We found that mitochondrial respiratory chain proteins are specifically decreased in abundance in the brains of the mutator mice, including several nuclear encoded mitochondrial components. However, we found no evidence that the changes we observed in protein levels were the result of decreases in mRNA expression. These results show that there are post-translational effects associated with mutations in Polg.	[Hauser, David N.; Dillman, Allissa A.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Hauser, David N.] Brown Univ, Dept Neurosci, Brown Univ Natl Inst Hlth Grad Partnership Progra, Providence, RI 02912 USA; [Dillman, Allissa A.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Ding, Jinhui] NIA, Computat Biol Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Brown University; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	Cookson@mail.nih.gov	Hauser, David/I-4933-2012; Hauser, David/AAJ-1536-2020; Cookson, Mark/AAW-2516-2021	Hauser, David/0000-0002-9500-5255; Cookson, Mark/0000-0002-1058-3831	US National Institutes of Health, National Institute on Aging; US National Institutes of Health, National Institute of Neurological Disease and Stroke; NATIONAL INSTITUTE ON AGING [ZIAAG000953, ZIAAG000940] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institutes of Health, National Institute of Neurological Disease and Stroke; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D.N.H., A. A. D., J.D., and M. R. C. are supported by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging. Y.L. is supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Neurological Disease and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223	20	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94646	10.1371/journal.pone.0094646	http://dx.doi.org/10.1371/journal.pone.0094646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722488	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100114
J	Meng, XY; Yu, HL; Zhang, WC; Wang, TH; Mai, X; Liu, HT; Xu, RC				Meng, Xiang-yan; Yu, Hai-long; Zhang, Wen-cheng; Wang, Tian-hui; Mai, Xia; Liu, Hong-tao; Xu, Rui-cheng			ZFP580, a Novel Zinc-Finger Transcription Factor, Is Involved in Cardioprotection of Intermittent High-Altitude Hypoxia against Myocardial Ischemia-Reperfusion Injury	PLOS ONE			English	Article							PROTEIN-KINASES; INFARCT SIZE; HEART; APOPTOSIS; INHIBITION; ADAPTATION; ACTIVATION; EXPRESSION; PROTECTION; GENES	Background: ZFP580 is a novel C2H2 type zinc-finger transcription factor recently identified by our laboratory. We previously showed that ZFP580 may be involved in cell survival and growth. The aim of this study was to elucidate whether ZFP580 is involved in the cardioprotective effects of intermittent high-altitude (IHA) hypoxia against myocardial ischemia-reperfusion (I/R) injury. Methods and Results: After rats were subjected to myocardial ischemia for 30 min followed by reperfusion, ZFP580 expression in the left ventricle was measured. ZFP580 protein expression was found to be up-regulated within 1 h and decreased at 2 h after reperfusion. Comparing normoxic and IHA hypoxia-adapted rats (5000 m, 6 h day(-1), 6 weeks) following I/R injury (30 min ischemia and 2 h reperfusion), we found that adaptation to IHA hypoxia attenuated infarct size and plasma leakage of lactate dehydrogenase and creatine kinase-MB. In addition, ZFP580 expression in the myocardium was up-regulated by IHA hypoxia. Consistent with this result, ZFP580 expression was found to be significantly increased in cultured H9c2 myocardial cells in the hypoxic preconditioning group compared with those in the control group following simulated I/R injury (3 h simulated ischemic hypoxia and 2 h reoxygenation). To determine the role of ZFP580 in apoptosis, lentivirus-mediated gene transfection was performed in H9c2 cells 72 h prior to simulated I/R exposure. The results showed that ZFP580 overexpression significantly inhibited I/R-induced apoptosis and caspase-3 activation. H9c2 cells were pretreated with or without PD98059, an inhibitor of ERK1/2 phosphorylation, and Western blot results showed that PD98059 (10 mu M) markedly suppressed I/R-induced up-regulation of ZFP580 expression. Conclusions: Our findings demonstrate that the cardioprotective effect of IHA hypoxia against I/R injury is mediated via ZFP580, a downstream target of ERK1/2 signaling with anti-apoptotic roles in myocardial cells.	[Meng, Xiang-yan; Wang, Tian-hui; Liu, Hong-tao] Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China; [Meng, Xiang-yan; Yu, Hai-long; Zhang, Wen-cheng; Mai, Xia] Logist Univ Chinese Peoples Armed Police Force, Dept Physiol & Pathophysiol, Tianjin, Peoples R China; [Xu, Rui-cheng] Logist Univ Chinese Peoples Armed Police Force, Tianjin Key Lab Biomarkers Occupat & Environm Haz, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Liu, HT (corresponding author), Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China.	liuhongt@sina.com; xu_rc@sohu.com			Tianjin Natural Science Foundation [12JCYBJC15900]; Science Foundation of CAPF logistics university [WYM201108]; National Natural Science Foundation of China [81170106, 81370439, 81373108]	Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); Science Foundation of CAPF logistics university; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Tianjin Natural Science Foundation 12JCYBJC15900 (http://www.tstc.gov.cn) and the Science Foundation of CAPF logistics university WYM201108 (http://www.wjyxy.com). This work was also supported in part by National Natural Science Foundation of China (No. 81170106; No. 81370439; No. 81373108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemu G, 1999, J MOL CELL CARDIOL, V31, P1821, DOI 10.1006/jmcc.1999.1013; Baxter GF, 1997, ANN MED, V29, P345, DOI 10.3109/07853899708999359; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Kolar F, 2004, PHYSIOL RES, V53, pS3; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; [孟祥艳 MENG Xiangyan], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1127; Neckar J, 2004, PHYSIOL RES, V53, P621; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Plumier JCL, 1996, J MOL CELL CARDIOL, V28, P1251, DOI 10.1006/jmcc.1996.0115; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Strniskova M, 2006, GEN PHYSIOL BIOPHYS, V25, P25; Sun HY, 2010, BIOCHEM BIOPH RES CO, V395, P361, DOI 10.1016/j.bbrc.2010.04.019; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Vassalli G, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/928954; Wang ZH, 2012, EXP PHYSIOL, V97, P1105, DOI 10.1113/expphysiol.2012.065102; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang WC, 2008, ACTA ACAD MED CPAF, V17, P161; [张文成 Zhang Wencheng], 2003, [基础医学与临床, Basic Medical Sciences and Clinics], V23, P279; Zhao ZQ, 2003, CARDIOVASC RES, V59, P132, DOI 10.1016/S0008-6363(03)00344-4; Zhu YB, 2008, LIFE SCI J, V5, P11	28	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94635	10.1371/journal.pone.0094635	http://dx.doi.org/10.1371/journal.pone.0094635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722354	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100109
J	Zhang, H; Li, JC; Sun, WJ; Hu, Y; Zhang, GF; Shen, MW; Shi, XY				Zhang, He; Li, Jingchao; Sun, Wenjie; Hu, Yong; Zhang, Guofu; Shen, Mingwu; Shi, Xiangyang			Hyaluronic Acid-Modified Magnetic Iron Oxide Nanoparticles for MR Imaging of Surgically Induced Endometriosis Model in Rats	PLOS ONE			English	Article							DEEP PELVIC ENDOMETRIOSIS; BIOMEDICAL APPLICATIONS; CONTRAST AGENTS; ADNEXAL MASSES; TUMORS; DIAGNOSIS; DELIVERY; FABRICATION; STRATEGIES	Endometriosis is defined as the presence of endometrial tissue outside the uterine, which may affect nearly 60% of women in reproductive age. Deep infiltrating endometriosis (DIE) defined as an endometriotic lesion penetrating into the retroperitoneal space or the wall of the pelvic organs to a depth of at least 5 mm represents the most diagnostic challenge. Herein, we reported the use of hyaluronic acid (HA)-modified magnetic iron oxide nanoparticles (HA-Fe3O4 NPs) for magnetic resonance (MR) imaging of endometriotic lesions in the rodent model. Sixteen endometriotic lesions were surgically induced in eight rats by autologous transplantation. Four weeks after lesion induction, three rats were scanned via MR imaging after tail vein injection of the HA-Fe3O4 NPs. Accordingly, the remaining five mice were sacrificed in the corresponding time points. The ectopic uterine tissues (EUTs) were confirmed by histological analysis. Quantification of Fe in the EUT was also performed by inductively coupled plasma-optical emission spectroscopy. Our results showed that by using the HA-Fe3O4 NPs, the EUTs were able to be visualized via T-2-weighted MR imaging at 2 hours post injection, corroborating the Prussian blue staining results. The developed HA-Fe3O4 NPs could be used as negative contrast agents for sensitively detecting endometriosis in a mouse model and may be applied for future hyperthermia treatment of endometriosis.	[Zhang, He; Zhang, Guofu] Fudan Univ, Obstet & Gynecol Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Li, Jingchao; Sun, Wenjie; Hu, Yong; Shen, Mingwu; Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China	Fudan University; Donghua University	Zhang, GF (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	guofuzh@msn.com; mwshen@dhu.edu.cn; xshi@dhu.edu.cn	Hu, Yong/A-9308-2018; Shi, Xiangyang/A-1289-2007; shen, mingwu/B-2534-2012; Li, Jingchao/AAK-6909-2021	Hu, Yong/0000-0003-1425-6093; Shi, Xiangyang/0000-0001-6785-6645; 				Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b; Bazot M, 2004, RADIOLOGY, V232, P379, DOI 10.1148/radiol.2322030762; Bazot M, 2011, EUR J RADIOL, V80, pE331, DOI 10.1016/j.ejrad.2010.12.006; Benagiano G, 2014, HUM REPROD UPDATE, V20, P386, DOI 10.1093/humupd/dmt052; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Busard MPH, 2010, J MAGN RESON IMAGING, V31, P1117, DOI 10.1002/jmri.22139; Cai HD, 2013, ACS APPL MATER INTER, V5, P1722, DOI 10.1021/am302883m; Chen Y, 2010, ACS NANO, V4, P6001, DOI 10.1021/nn1015117; Chertok B, 2010, BIOMATERIALS, V31, P6317, DOI 10.1016/j.biomaterials.2010.04.043; CORNILLIE FJ, 1990, FERTIL STERIL, V53, P978; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; Dilks P, 2010, EUR RADIOL, V20, P2176, DOI 10.1007/s00330-010-1795-6; Griffin N, 2010, SEMIN ULTRASOUND CT, V31, P330, DOI 10.1053/j.sult.2010.07.002; Grummer R, 2006, HUM REPROD UPDATE, V12, P641, DOI 10.1093/humupd/dml026; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Jiang G, 2008, BIOPOLYMERS, V89, P635, DOI 10.1002/bip.20978; Kamat M, 2010, BIOCONJUGATE CHEM, V21, P2128, DOI 10.1021/bc100354m; Kinkel K, 2006, EUR RADIOL, V16, P285, DOI 10.1007/s00330-005-2882-y; Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y; Kyriazi S, 2011, RADIOLOGY, V261, P182, DOI 10.1148/radiol.11110577; Larsen EKU, 2009, ACS NANO, V3, P1947, DOI 10.1021/nn900330m; Lebovic DI, 2004, FERTIL STERIL, V82, P1008, DOI 10.1016/j.fertnstert.2004.02.148; Lee HJ, 2012, MAGN RESON IMAGING, V30, P860, DOI 10.1016/j.mri.2012.02.020; Lee N, 2012, NANO LETT, V12, P3127, DOI 10.1021/nl3010308; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Li JC, 2014, BIOMATERIALS, V35, P3666, DOI 10.1016/j.biomaterials.2014.01.011; Li JC, 2013, ACS APPL MATER INTER, V5, P10357, DOI 10.1021/am4034526; Li JC, 2013, BIOMATERIALS, V34, P8382, DOI 10.1016/j.biomaterials.2013.07.070; Liu HL, 2008, BIOMATERIALS, V29, P4003, DOI 10.1016/j.biomaterials.2008.06.031; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; Pan BF, 2007, CANCER RES, V67, P8156, DOI 10.1158/0008-5472.CAN-06-4762; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Schreinemacher MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033241; Shi XY, 2008, ADV MATER, V20, P1671, DOI 10.1002/adma.200702770; Thomassin-Naggara I, 2009, EUR RADIOL, V19, P1544, DOI 10.1007/s00330-009-1299-4; TOGASHI K, 1991, RADIOLOGY, V180, P73, DOI 10.1148/radiology.180.1.2052726; Turcheniuk K, 2013, NANOSCALE, V5, P10729, DOI 10.1039/c3nr04131j; Wang ZJ, 2008, PEDIATR RADIOL, V38, P529, DOI 10.1007/s00247-008-0764-6; Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975; Xu CJ, 2013, ADV DRUG DELIVER REV, V65, P732, DOI 10.1016/j.addr.2012.10.008; Xu CJ, 2009, DALTON T, P5583, DOI 10.1039/b900272n	41	34	35	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94718	10.1371/journal.pone.0094718	http://dx.doi.org/10.1371/journal.pone.0094718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722347	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100127
J	Pastore, F; Pastore, A; Wittmann, G; Hiddemann, W; Spiekermann, K				Pastore, Friederike; Pastore, Alessandro; Wittmann, Georg; Hiddemann, Wolfgang; Spiekermann, Karsten			The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; EARLY MORTALITY; PROGNOSTIC-SIGNIFICANCE; TANDEM DUPLICATION; LEUKOSTASIS; MUTATIONS; INDUCTION; SURVIVAL; MANAGEMENT	Purpose: Hyperleukocytosis in AML with leukostasis is a serious life-threatening condition leading to a high early mortality which requires immediate cytoreductive therapy. Therapeutic leukapheresis is currently recommended by the American Society of Apheresis in patients with a WBC>100 G/l with signs of leukostasis, but the role of prophylactic leukapheresis before clinical signs of leukostasis occur is unclear. Patients: We retrospectively analyzed the role of leukapheresis in 52 patients (median age 60 years) with hyperleukocytotic AML with and without clinical signs of leukostasis. Since leukapheresis was performed more frequently in patients with signs of leukostasis due to the therapeutic policy in our hospital, we developed a risk score for early death within seven days after start of therapy (EDd7) to account for this selection bias and to independently measure the effect of leukapheresis on EDd7. Results: 20 patients received leukapheresis in combination to chemotherapy compared to 32 patients who received chemotherapy only. In a multivariate logistic regression model for the estimation of the probability of EDd7 thromboplastin time and creatinine remained as independent significant parameters and were combined to create an EDd7 risk score. The effect of leukapheresis on EDd7 was evaluated in a bivariate logistic regression together with the risk score. Leukapheresis did not significantly change early mortality in all patients with a WBC >= 100 G/l. Discussion: Prophylactic leukapheresis in hyperleukocytotic patients with and without leukostasis did not improve early mortality in our retrospective study. Larger and prospective clinical trials are needed to validate the risk score and to further explore the role of leukapheresis in AML with hyperleukocytosis.	[Pastore, Friederike; Pastore, Alessandro; Hiddemann, Wolfgang; Spiekermann, Karsten] Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Munich, Germany; [Wittmann, Georg] Univ Munich, Univ Hosp Munich, Dept Transfus Med, Munich, Germany; [Pastore, Friederike; Hiddemann, Wolfgang; Spiekermann, Karsten] German Canc Consortium DKTK, Heidelberg, Germany; [Pastore, Friederike; Hiddemann, Wolfgang; Spiekermann, Karsten] German Canc Res Ctr, Heidelberg, Germany	University of Munich; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Pastore, F (corresponding author), Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Campus Grosshadern, Munich, Germany.	Friederike.Pastore@med.uni-muenchen.de	/AAR-7818-2021; /AGZ-3814-2022	/0000-0002-3621-4807; /0000-0002-3621-4807				Benthaus T, 2008, BRIT J HAEMATOL, V143, P230, DOI 10.1111/j.1365-2141.2008.07328.x; Blum W, 2007, SEMIN THROMB HEMOST, V33, P350, DOI 10.1055/s-2007-976170; Braess J, 2009, BLOOD, V113, P3903, DOI 10.1182/blood-2008-07-162842; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Bug G, 2007, TRANSFUSION, V47, P1843, DOI 10.1111/j.1537-2995.2007.01406.x; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; De Santis GC, 2011, J CLIN APHERESIS, V26, P181, DOI 10.1002/jca.20290; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; DUTCHER JP, 1987, J CLIN ONCOL, V5, P1364, DOI 10.1200/JCO.1987.5.9.1364; Efron B., 1994, INTRO BOOTSTRAP MONO, P57; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Giles FJ, 2001, LEUKEMIA LYMPHOMA, V42, P67, DOI 10.3109/10428190109097677; Holig K, 2012, TRANSFUS MED HEMOTH, V39, P241, DOI 10.1159/000341805; Inaba H, 2008, CANCER, V113, P522, DOI 10.1002/cncr.23581; Lillo-de Louet A, 2004, J THROMB HAEMOST, V2, P1882, DOI 10.1111/j.1538-7836.2004.00949.x; Oliveira LCO, 2010, MED ONCOL, V27, P1254, DOI 10.1007/s12032-009-9367-9; Porcu P, 1997, BRIT J HAEMATOL, V98, P433, DOI 10.1046/j.1365-2141.1997.1943011.x; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Stemmler J, 2002, LEUKEMIA LYMPHOMA, V43, P1427, DOI 10.1080/1042819022386671; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Szczepiorkowski ZM, 2010, J CLIN APHERESIS, V25, P83, DOI 10.1002/jca.20240; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; VENTURA GJ, 1988, AM J HEMATOL, V27, P34, DOI 10.1002/ajh.2830270109; Whitman SP, 2005, BLOOD, V106, P345, DOI 10.1182/blood-2005-01-0204; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838	28	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95062	10.1371/journal.pone.0095062	http://dx.doi.org/10.1371/journal.pone.0095062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733550	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400150
J	Wang, DF; He, J; Qiao, HT; Song, XL; Fan, YB; Li, DY				Wang, Daifa; He, Jin; Qiao, Huiting; Song, Xiaolei; Fan, Yubo; Li, Deyu			High-Performance Fluorescence Molecular Tomography through Shape-Based Reconstruction Using Spherical Harmonics Parameterization	PLOS ONE			English	Article							TOTAL VARIATION REGULARIZATION; DIFFUSE OPTICAL TOMOGRAPHY; SYSTEM; BOUNDARY	Fluorescence molecular tomography in the near-infrared region is becoming a powerful modality for mapping the three-dimensional quantitative distributions of fluorochromes in live small animals. However, wider application of fluorescence molecular tomography still requires more accurate and stable reconstruction tools. We propose a shape-based reconstruction method that uses spherical harmonics parameterization, where fluorophores are assumed to be distributed as piecewise constants inside disjointed subdomains and the remaining background. The inverse problem is then formulated as a constrained nonlinear least-squares problem with respect to shape parameters, which decreases ill-posedness because of the significantly reduced number of unknowns. Since different shape parameters contribute differently to the boundary measurements, a two-step and modified block coordinate descent optimization algorithm is introduced to stabilize the reconstruction. We first evaluated our method using numerical simulations under various conditions for the noise level and fluorescent background; it showed significant superiority over conventional voxel-based methods in terms of the spatial resolution, reconstruction accuracy with regard to the morphology and intensity, and robustness against the initial estimated distribution. In our phantom experiment, our method again showed better spatial resolution and more accurate intensity reconstruction. Finally, the results of an in vivo experiment demonstrated its applicability to the imaging of mice.	[Wang, Daifa] Beihang Univ, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Wang, Daifa; He, Jin; Qiao, Huiting; Fan, Yubo; Li, Deyu] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China; [Song, Xiaolei] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div MR Res, Baltimore, MD USA	Beihang University; Beihang University; Johns Hopkins University	Li, DY (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China.	deyuli@buaa.edu.cn	Song, Xiaolei/B-3000-2014		State Key Laboratory of Software Development Environment [SKLSDE-2011ZX-12]; National Natural Science Foundation of China [61108084, 81101123]; Research Fund for the Doctoral Program of Higher Education of China [20111102120039]; Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education	State Key Laboratory of Software Development Environment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education	This study was funded by the State Key Laboratory of Software Development Environment (No. SKLSDE-2011ZX-12), the National Natural Science Foundation of China (Nos. 61108084, 81101123), Research Fund for the Doctoral Program of Higher Education of China (No. 20111102120039), Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2009, OPT EXPRESS, V17, P8843, DOI 10.1364/OE.17.008843; Babaeizadeh S, 2007, IEEE T MED IMAGING, V26, P637, DOI 10.1109/TMI.2006.887367; Beck A, 2013, SIAM J OPTIMIZ, V23, P2037, DOI 10.1137/120887679; Behrooz A, 2012, APPL OPTICS, V51, P8216, DOI 10.1364/AO.51.008216; Chamorro-Servent J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076016; Davis SC, 2013, P NATL ACAD SCI USA, V110, P9025, DOI 10.1073/pnas.1213490110; Deliolanis N, 2007, OPT LETT, V32, P382, DOI 10.1364/OL.32.000382; Dutta J, 2012, PHYS MED BIOL, V57, P1459, DOI 10.1088/0031-9155/57/6/1459; Freiberger M, 2010, APPL OPTICS, V49, P3741, DOI 10.1364/AO.49.003741; Graves EE, 2003, MED PHYS, V30, P901, DOI 10.1118/1.1568977; Guo XL, 2010, IEEE T BIO-MED ENG, V57, P2876, DOI 10.1109/TBME.2010.2073468; Han D, 2010, OPT EXPRESS, V18, P8630, DOI 10.1364/OE.18.008630; Hyde D, 2010, IEEE T MED IMAGING, V29, P365, DOI 10.1109/TMI.2009.2031112; Koenig A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2884505; Lasser T, 2007, MED IMAGE ANAL, V11, P389, DOI 10.1016/j.media.2007.04.003; Laurain A, 2013, INVERSE PROBL, V29, DOI 10.1088/0266-5611/29/2/025003; Li MZ, 2012, IEEE T BIO-MED ENG, V59, P1799, DOI 10.1109/TBME.2012.2194490; Lin YT, 2009, APPL OPTICS, V48, P1328, DOI 10.1364/AO.48.001328; Liu K, 2010, J OPT SOC AM A, V27, P1413, DOI 10.1364/JOSAA.27.001413; Mohajerani P, 2007, APPL OPTICS, V46, P1679, DOI 10.1364/AO.46.001679; Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382; Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Nvidia, 2011, NVIDIA CUDA C PROGR; NVIDIA Corporation, 2010, NVIDIAS NEXT GEN CUD; Schulz RB, 2010, IEEE T MED IMAGING, V29, P465, DOI 10.1109/TMI.2009.2035310; Schweiger M, 2010, OPT EXPRESS, V18, P150, DOI 10.1364/OE.18.000150; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Song XL, 2007, OPT EXPRESS, V15, P18300, DOI 10.1364/OE.15.018300; Soubret A, 2005, IEEE T MED IMAGING, V24, P1377, DOI 10.1109/TMI.2005.857213; Vasquez KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020594; Wang DF, 2012, APPL OPTICS, V51, P8731, DOI 10.1364/AO.51.008731; Wang DF, 2010, IEEE T INF TECHNOL B, V14, P1346, DOI 10.1109/TITB.2010.2077306; Wang DF, 2010, CHIN OPT LETT, V8, P82, DOI 10.3788/COL20100801.0082; Zacharopoulos AD, 2004, THESIS U LONDON; Zacharopoulos A, 2009, OPT EXPRESS, V17, P18940, DOI 10.1364/OE.17.018940	36	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94317	10.1371/journal.pone.0094317	http://dx.doi.org/10.1371/journal.pone.0094317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732826	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400030
J	Zhang, HW; Chin, AI				Zhang, Hanwei; Chin, Arnold I.			Role of Rip2 in Development of Tumor-Infiltrating MDSCs and Bladder Cancer Metastasis	PLOS ONE			English	Article							SUPPRESSOR-CELLS; KINASE-ACTIVITY; INNATE; EXPRESSION; PROTEIN; INVOLVEMENT; ACTIVATION; IMMUNITY; SUBSETS; NOD2	Tumor invasion and metastases represent a complex series of molecular events that portends a poor prognosis. The contribution of inflammatory pathways mediating this process is not well understood. Nod-like receptors (NLRs) of innate immunity function as intracellular sensors of pathogen motifs and danger molecules. We propose a role of NLRs in tumor surveillance and in programming tumor-infiltrating lymphocytes (TILs). In this study, we examined the downstream serine/threonine and tyrosine kinase Rip2 in a murine model of bladder cancer. In Rip2-deficient C57Bl6 mice, larger orthotopic MB49 tumors developed with more numerous and higher incidence of metastases compared to wild-type controls. As such, increased tumor infiltration of CD11b(+)Gr1(hi) myeloid-derived suppressor cells (MDSCs) with concomitant decrease in T cells and NK cells were observed in Rip2-deficient tumor bearing animals using orthotopic and subcutaneous tumor models. Rip2-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zeb1, zeb2, twist, and snail in the tumor microenvironment. We found that the absence of Rip2 plays an intrinsic role in fostering the development of granulocytic MDSCs by an autocrine and paracrine effect of granulocytic colony stimulating factor (G-CSF) expression. Our findings suggest that NLR pathways may be a novel modality to program TILs and influence tumor metastases.	[Zhang, Hanwei; Chin, Arnold I.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Urol, Broad Stem Cell Res Ctr, Los Angeles, CA 90024 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Chin, AI (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Urol, Broad Stem Cell Res Ctr, Los Angeles, CA 90024 USA.	aichin@ucla.edu			American Association of Cancer Research Career Development Award [10-20-14]; Broad Stem Cell Research Center Scholars in Translational Medicine Program; STOP Cancer Research Career Development Award; Becton Dickinson Biosciences Research Grant; Perkins Foundation; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	American Association of Cancer Research Career Development Award; Broad Stem Cell Research Center Scholars in Translational Medicine Program; STOP Cancer Research Career Development Award; Becton Dickinson Biosciences Research Grant; Perkins Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Association of Cancer Research Career Development Award 10-20-14, Broad Stem Cell Research Center Scholars in Translational Medicine Program, STOP Cancer Research Career Development Award, Becton Dickinson Biosciences Research Grant (A. I. Chin) & Perkins Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Chiu HY, 2012, CYTOKINE, V59, P423, DOI 10.1016/j.cyto.2012.04.017; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Eruslanov E, 2012, INT J CANCER, V130, P1109, DOI 10.1002/ijc.26123; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Glass WG, 2006, J INTERF CYTOK RES, V26, P511, DOI 10.1089/jir.2006.26.511; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; HUDSON MA, 1990, CANCER RES, V50, P3843; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jessen KA, 2004, BREAST CANCER RES, V6, pR157, DOI 10.1186/bcr768; Jung YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038773; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Li J, 2012, MUTAGENESIS, V27, P319, DOI 10.1093/mutage/ger081; Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841; Magalhaes JG, 2011, EUR J IMMUNOL, V41, P1445, DOI 10.1002/eji.201040827; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Ribas A, 2012, CLIN CANCER RES, V18, P336, DOI 10.1158/1078-0432.CCR-11-2323; Sevko A, 2013, J CANCER, V4, P3, DOI 10.7150/jca.5047; SHAPIRO A, 1984, CANCER RES, V44, P3051; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Simons MP, 2008, UROL ONCOL-SEMIN ORI, V26, P341, DOI 10.1016/j.urolonc.2007.11.031; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; SOLOWAY MS, 1977, CANCER RES, V37, P2918; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Toh B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001162; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wu S, 2012, ANTICANCER RES, V32, P3775; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zanzinger K, 2009, IMMUNOLOGY, V128, P185, DOI 10.1111/j.1365-2567.2009.03091.x	50	16	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94793	10.1371/journal.pone.0094793	http://dx.doi.org/10.1371/journal.pone.0094793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733360	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400104
J	Luo, YJ; Zhang, XQ; Wang, XK; Ren, Y				Luo, Yunjian; Zhang, Xiaoquan; Wang, Xiaoke; Ren, Yin			Dissecting Variation in Biomass Conversion Factors across China's Forests: Implications for Biomass and Carbon Accounting	PLOS ONE			English	Article							EXPANSION FACTORS; NORWAY SPRUCE; STORAGE; PINE	Biomass conversion factors (BCFs, defined as the ratios of tree components (i.e. stem, branch, foliage and root), as well as aboveground and whole biomass of trees to growing stock volume, Mg m(-3)) are considered as important parameters in large-scale forest biomass carbon estimation. To date, knowledge of possible sources of the variation in BCFs is still limited at large scales. Using our compiled forest biomass dataset of China, we presented forest type-specific values of BCFs, and examined the variation in BCFs in relation to forest type, stand development and environmental factors (climate and soil fertility). BCFs exhibited remarkable variation across forest types, and also were significantly related to stand development (especially growing stock volume). BCFs (except Stem BCF) had significant relationships with mean annual temperature (MAT) and mean annual precipitation (MAP) (P<0.001). Climatic data (MAT and MAP) collectively explained 10.0-25.0% of the variation in BCFs (except Stem BCFs). Moreover, stronger climatic effects were found on BCFs for functional components (i.e. branch, foliage and root) than BCFs for combined components (i.e. aboveground section and whole trees). A general trend for BCFs was observed to decrease and then increase from low to high soil fertility. When qualitative soil fertility and climatic data (MAT and MAP) were combined, they explained 14.1-29.7% of the variation in in BCFs (except Stem BCFs), adding only 4.1-4.9% than climatic data used. Therefore, to reduce the uncertainty induced by BCFs in forest carbon estimates, we should apply values of BCFs for a specified forest type, and also consider climatic and edaphic effects, especially climatic effect, in developing predictive models of BCFs (except Stem BCF).	[Luo, Yunjian; Ren, Yin] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Zhang, Xiaoquan] Nat Conservancy China Program, Beijing, Peoples R China; [Wang, Xiaoke] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Luo, YJ (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	yunjianluo@gmail.com; wangxk@rcees.ac.cn	Luo, Yunjian/H-4038-2014; yin, ren/AAC-2333-2022; Luo, Yunjian/C-5366-2019; CAS, KLUEH/T-5743-2019	Luo, Yunjian/0000-0002-7358-5797; Ren, Yin/0000-0003-4026-3086; wang, xiao ke/0000-0002-2421-3970	Forestry Public Welfare Programme of China [201304205]; Strategic Priority Programme of Chinese Academy of Sciences [XDA05060102, XDA05050602]; Fujian Provincial ST Programme [2013Y0083, 2011Y0052]; National Natural Science Foundation of China [31200363, 31270588]; International Partnership Programme for Creative Research Teams [KZCX2-YW-T08]	Forestry Public Welfare Programme of China; Strategic Priority Programme of Chinese Academy of Sciences; Fujian Provincial ST Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Partnership Programme for Creative Research Teams	This study was funded by Forestry Public Welfare Programme of China (201304205), Strategic Priority Programme of Chinese Academy of Sciences (XDA05060102 and XDA05050602) and Fujian Provincial S&T Programme (2013Y0083 and 2011Y0052), and partly by National Natural Science Foundation of China (31200363 and 31270588) and International Partnership Programme for Creative Research Teams (KZCX2-YW-T08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh TJ, 2009, FOREST ECOL MANAG, V258, P2628, DOI 10.1016/j.foreco.2009.09.021; ALEXEYEV V, 1995, WATER AIR SOIL POLL, V82, P271, DOI 10.1007/BF01182840; Antunez I, 2001, OECOLOGIA, V128, P172, DOI 10.1007/s004420100645; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; BROWN S, 1984, SCIENCE, V223, P1290, DOI 10.1126/science.223.4642.1290; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Cornelissen JHC, 1998, INHERENT VARIATION IN PLANT GROWTH, P363; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Feng Z. W., 1999, BIOMASS PRODUCTIVITY; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; IPCC, 2006, 2006 IPCC GUID NAT G, V4; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Lehtonen A, 2004, FOREST ECOL MANAG, V188, P211, DOI 10.1016/j.foreco.2003.07.008; Li X, 2010, J PLANT BIOL, V53, P381, DOI 10.1007/s12374-010-9134-7; Lindner M, 2007, EUR J FOREST RES, V126, P149, DOI 10.1007/s10342-006-0161-3; Luo T. X., 1996, THESIS CHINESE ACAD; Luo Yun-Jian, 2007, Zhiwu Shengtai Xuebao, V31, P1111; Luo YJ, 2013, ANN FOREST SCI, V70, P589, DOI 10.1007/s13595-013-0296-6; Luo YJ, 2012, FOREST ECOL MANAG, V269, P19, DOI 10.1016/j.foreco.2012.01.005; Luo YunJian, 2009, Scientia Silvae Sinicae, V45, P129; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Pajtik J, 2008, FOREST ECOL MANAG, V256, P1096, DOI 10.1016/j.foreco.2008.06.013; Pajtik J, 2011, TREES-STRUCT FUNCT, V25, P277, DOI 10.1007/s00468-010-0504-z; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Reich PB, 1998, INHERENT VARIATION IN PLANT GROWTH, P467; Ren Y, 2013, FOREST ECOL MANAG, V293, P122, DOI 10.1016/j.foreco.2012.12.043; Ren Y, 2012, J ENVIRON MANAGE, V113, P447, DOI 10.1016/j.jenvman.2012.09.011; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Sands P., 2011, PHYSL ECOLOGY FOREST, V1st ed.; Schroeder P, 1997, FOREST SCI, V43, P424; Somogyi Z, 2007, EUR J FOREST RES, V126, P197, DOI 10.1007/s10342-006-0125-7; Stinson G, 2011, GLOBAL CHANGE BIOL, V17, P2227, DOI 10.1111/j.1365-2486.2010.02369.x; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Xiao X.W., 2005, FOREST RESOURCE INVE; Zhang X. S., 2007, VEGETATION MAP CHINA, P91; Zhang XQ, 2010, FOREST CARBON MITIGA	41	17	19	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94777	10.1371/journal.pone.0094777	http://dx.doi.org/10.1371/journal.pone.0094777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728222	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200130
J	Andre, ED; Grinberg, F; Farrher, E; Maximov, II; Shah, NJ; Meyer, C; Jaspar, M; Muto, V; Phillips, C; Balteau, E				Andre, Elodie D.; Grinberg, Farida; Farrher, Ezequiel; Maximov, Ivan I.; Shah, N. Jon; Meyer, Christelle; Jaspar, Mathieu; Muto, Vincenzo; Phillips, Christophe; Balteau, Evelyne			Influence of Noise Correction on Intra- and Inter-Subject Variability of Quantitative Metrics in Diffusion Kurtosis Imaging	PLOS ONE			English	Article							NON-GAUSSIAN DIFFUSION; RICIAN NOISE; BRAIN-TISSUE; WATER DIFFUSION; MR-IMAGES; SPIN-ECHO; TENSOR; MODEL; RECONSTRUCTION; PARAMETERS	Diffusion kurtosis imaging (DKI) is a promising extension of diffusion tensor imaging, giving new insights into the white matter microstructure and providing new biomarkers. Given the rapidly increasing number of studies, DKI has a potential to establish itself as a valuable tool in brain diagnostics. However, to become a routine procedure, DKI still needs to be improved in terms of robustness, reliability, and reproducibility. As it requires acquisitions at higher diffusion weightings, results are more affected by noise than in diffusion tensor imaging. The lack of standard procedures for post-processing, especially for noise correction, might become a significant obstacle for the use of DKI in clinical routine limiting its application. We considered two noise correction schemes accounting for the noise properties of multichannel phased-array coils, in order to improve the data quality at signal-to-noise ratio (SNR) typical for DKI. The SNR dependence of estimated DKI metrics such as mean kurtosis (MK), mean diffusivity (MD) and fractional anisotropy (FA) is investigated for these noise correction approaches in Monte Carlo simulations and in in vivo human studies. The intra-subject reproducibility is investigated in a single subject study by varying the SNR level and SNR spatial distribution. Then the impact of the noise correction on inter-subject variability is evaluated in a homogeneous sample of 25 healthy volunteers. Results show a strong impact of noise correction on the MK estimate, while the estimation of FA and MD was affected to a lesser extent. Both intra-and inter-subject SNR-related variability of the MK estimate is considerably reduced after correction for the noise bias, providing more accurate and reproducible measures. In this work, we have proposed a straightforward method that improves accuracy of DKI metrics. This should contribute to standardization of DKI applications in clinical studies making valuable inferences in group analysis and longitudinal studies.	[Andre, Elodie D.; Meyer, Christelle; Jaspar, Mathieu; Muto, Vincenzo; Phillips, Christophe; Balteau, Evelyne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Grinberg, Farida; Farrher, Ezequiel; Maximov, Ivan I.; Shah, N. Jon] Inst Neurosci & Med 4, Julich, Germany; [Grinberg, Farida; Shah, N. Jon] Rhein Westfal TH Aachen, Julich Aachen Res Alliance, Dept Neurol, Fac Med, Aachen, Germany; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; RWTH Aachen University; University of Liege	Grinberg, F (corresponding author), Inst Neurosci & Med 4, Julich, Germany.	f.grinberg@fz-juelich.de	Maximov, Ivan I./A-8242-2012; Muto, Vincenzo/AAS-5220-2020; Shah, N. Jon/H-5849-2013; Phillips, Christophe/M-3025-2017	Muto, Vincenzo/0000-0001-5100-9927; Shah, N. Jon/0000-0002-8151-6169; Maximov, Ivan I./0000-0001-6319-6774; Farrher, Ezequiel/0000-0003-2902-8667; Phillips, Christophe/0000-0002-4990-425X	EU; Belgian National Funds of Scientific Research (FNRS); les Actions de Recherche Concertees (ARC, ULg); la Fondation Medicale Reine Elisabeth (FMRE); Walloon Excellence in Lifesciences and Biotechnology (WELBIO); Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC); FEDER - RW; European Regional Development Fund; Belgian Walloon Government	EU(European Commission); Belgian National Funds of Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); les Actions de Recherche Concertees (ARC, ULg); la Fondation Medicale Reine Elisabeth (FMRE); Walloon Excellence in Lifesciences and Biotechnology (WELBIO)(WELBIO); Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FEDER - RW; European Regional Development Fund(European Commission); Belgian Walloon Government	This work was funded by the EU within the PEOPLE Programme (FP7): Initial Training Networks (FP7-PEOPLE-ITN-2008), the Belgian National Funds of Scientific Research (FNRS), les Actions de Recherche Concertees (ARC, ULg), la Fondation Medicale Reine Elisabeth (FMRE), the Walloon Excellence in Lifesciences and Biotechnology (WELBIO), the Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC), FEDER - RW, the European Regional Development Fund and the Belgian Walloon Government (Project FEDER/RADIOMED 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja-Fernandez S, 2012, MAGN RESON MED, V67, P580, DOI 10.1002/mrm.23020; Aja-Fernandez S, 2009, MAGN RESON IMAGING, V27, P1397, DOI 10.1016/j.mri.2009.05.025; Andersson JLR, 2008, NEUROIMAGE, V42, P1340, DOI 10.1016/j.neuroimage.2008.05.053; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Blockx I, 2012, NEUROIMAGE, V63, P653, DOI 10.1016/j.neuroimage.2012.06.032; Chung S, 2010, NEUROIMAGE, V49, P631, DOI 10.1016/j.neuroimage.2009.06.067; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; De Santis S., 2011, MAGMA, V25, P267; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hutton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052075; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kang XJ, 2012, MAGN RESON IMAGING, V30, P1111, DOI 10.1016/j.mri.2012.04.004; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Kristoffersen A, 2012, J MAGN RESON IMAGING, V35, P181, DOI 10.1002/jmri.22826; Landman BA, 2009, MAGN RESON MED, V62, P500, DOI 10.1002/mrm.22013; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Maggioni M., 2012, IEEE T IMAGE PROCESS; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Maximov II, 2012, MED IMAGE ANAL, V16, P536, DOI 10.1016/j.media.2011.12.002; Maximov II, 2011, J MAGN RESON, V213, P136, DOI 10.1016/j.jmr.2011.09.035; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nowak RD, 1999, IEEE T IMAGE PROCESS, V8, P1408, DOI 10.1109/83.791966; Nunes RG, 2005, J MAGN RESON, V177, P102, DOI 10.1016/j.jmr.2005.07.005; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Prah DE, 2010, MAGN RESON MED, V64, P418, DOI 10.1002/mrm.22407; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Thompson MR, 1999, RADIOLOGY, V210, P253, DOI 10.1148/radiology.210.1.r99ja25253; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Veraart J, 2013, MAGN RESON MED, V70, P972, DOI 10.1002/mrm.24529; Veraart J, 2011, MAGN RESON MED, V66, P678, DOI 10.1002/mrm.22835; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wirestam R, 2006, MAGN RESON MED, V56, P1114, DOI 10.1002/mrm.21036	66	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94531	10.1371/journal.pone.0094531	http://dx.doi.org/10.1371/journal.pone.0094531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722363	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100091
J	Faller, N; Gautschi, I; Schild, L				Faller, Nicolas; Gautschi, Ivan; Schild, Laurent			Functional Analysis of a Missense Mutation in the Serine Protease Inhibitor SPINT2 Associated with Congenital Sodium Diarrhea	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; XENOPUS-OOCYTES; TRANSMEMBRANE DOMAIN; IRON-DEFICIENCY; HUMAN TISSUES; CHANNEL ENAC; IN-VITRO; MATRIPTASE; EXPRESSION	Membrane-bound serine proteases play important roles in different biological processes. Their regulation by endogenous inhibitors is poorly understood. A Y163C mutation in the SPINT2 gene encoding the serine protease inhibitor Hepatocyte Growth Factor Inhibitor HAI-2 is associated with a congenital sodium diarrhea. The functional consequences of this mutation on HAI-2 activity and its physiological targets are unknown. We established a cellular assay in Xenopus laevis oocytes to study functional interactions between HAI-2 and candidate membrane-bound serine proteases expressed in the gastro-intestinal tract. We found that the wild-type form of HAI-2 is a potent inhibitor of nine gastro-intestinal serine proteases. The Y163C mutation in the second Kunitz domain of HAI-2 resulted in a complete loss of inhibitory activity on two intestinal proteases, prostasin and tmprss13. The effect of the mutation of the homologous Y68C in the first Kunitz domain of HAI-2 is consistent with a differential contribution of the two Kunitz domains of HAI-2 in the inhibition of serine proteases. By contrast to the Tyr to Cys, the Tyr to Ser substitution did not change the inhibitory potency of HAI-2, indicating that the thiol-group of the cysteine rather than the Tyr deletion is responsible for the HAI-2 loss of function. Our functional assay allowed us to identify membrane-bound serine proteases as cellular target for inhibition by HAI-2 wild type and mutants, and to better define the role of the Tyr in the second Kunitz domain in the inhibitory activity of HAI-2.	[Faller, Nicolas; Gautschi, Ivan; Schild, Laurent] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Laurent.Schild@unil.ch		, Nicolas/0000-0003-1647-9311	Swiss National Science Foundation [323530-128871]; Swiss Academy of Medical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Medical Sciences	The work was supported by a grant from the Swiss National Science Foundation 323530-128871, MD-PhD Program of the Swiss Academy of Medical Sciences (to NF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DR, 2001, BBA-GENE STRUCT EXPR, V1518, P204, DOI 10.1016/S0167-4781(01)00184-1; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Malsure S, 2014, J AM SOC NEPHROL; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; TSUJI A, 1991, J BIOL CHEM, V266, P16948; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Yuan X, 1998, AM J PHYSIOL-GASTR L, V274, pG342, DOI 10.1152/ajpgi.1998.274.2.G342; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	53	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94267	10.1371/journal.pone.0094267	http://dx.doi.org/10.1371/journal.pone.0094267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722141	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100046
J	Papa, M; Boccardi, V; Prestano, R; Angellotti, E; Desiderio, M; Marano, L; Rizzo, MR; Paolisso, G				Papa, Michela; Boccardi, Virginia; Prestano, Raffaele; Angellotti, Edith; Desiderio, Manuela; Marano, Luigi; Rizzo, Maria Rosaria; Paolisso, Giuseppe			Comorbidities and Crash Involvement among Younger and Older Drivers	PLOS ONE			English	Article							ILLNESS RATING-SCALE; LOW-MILEAGE BIAS; AUTOMOBILE CRASHES; MEDICAL CONDITIONS; POPULATION; VALIDATION; DISEASE; RISK; DEATH	Previous studies identified comorbidities as predictors of older driver performance and driving pattern, while the direct impact of comorbidities on road crash risk in elderly drivers is still unknown. The present study is a cross-sectional aimed at investigating the association between levels of comorbidity and crash involvement in adult and elderly drivers. 327 drivers were stratified according to age range in two groups: elderly drivers (age >= 70 years old, referred as older) and adult drivers (age <70 years old, referred as younger). Driving information was obtained through a driving questionnaire. Distance traveled was categorized into low, medium and high on the basis of kilometers driven in a year. CIRS-illness severity (IS) and CIRS-comorbidity indices (CI) in all populations were calculated. Older drivers had a significantly higher crash involvements rate (p = .045) compared with the younger group based on the number of licensed drivers. Dividing comorbidity indices into tertiles among all licensed subjects, the number of current drivers significantly decreased (p < .0001) with increasing level of comorbidity. The number of current drivers among older subjects significantly decreased with increasing comorbidity level (p = .026) while no difference among younger group was found (p = .462). Among younger drivers with increasing comorbidity level, the number of road accidents significantly increased (p = .048) and the logistic regression analysis showed that comorbidity level significantly associated with crash involvement independent of gender and driving exposure. Older subjects with high level of comorbidity are able to self-regulate driving while comorbidity burden represents a significant risk factor for crash involvements among younger drivers.	[Papa, Michela; Boccardi, Virginia; Prestano, Raffaele; Angellotti, Edith; Desiderio, Manuela; Marano, Luigi; Rizzo, Maria Rosaria; Paolisso, Giuseppe] Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, Naples, Italy	Universita della Campania Vanvitelli	Boccardi, V (corresponding author), Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, Naples, Italy.	virginia.boccardi@email.it	Boccardi, Virginia/K-2630-2016; Rizzo, Maria Rosaria/AHH-3649-2022; paolisso, giuseppe/AAP-8516-2020; Rizzo, Maria/HGD-6576-2022; Marano, Luigi/K-4944-2013; rizzo, maria rosaria R/J-1968-2016	Boccardi, Virginia/0000-0003-2134-1122; Rizzo, Maria Rosaria/0000-0002-1023-4260; paolisso, giuseppe/0000-0002-2137-455X; Marano, Luigi/0000-0002-9777-9588; rizzo, maria rosaria R/0000-0002-1023-4260				Bo M, 2007, ARCH GERONTOL GERIAT, V44, P215, DOI 10.1016/j.archger.2006.05.007; Boulos DL, 2006, CANCER-AM CANCER SOC, V106, P1804, DOI 10.1002/cncr.21813; Cerrelli EC, 1998, CRASH DATA RATES AGE, P1; Cheung I, 2011, ACCIDENT ANAL PREV, V43, P666, DOI 10.1016/j.aap.2010.10.010; Cheung Ivan, 2008, Ann Adv Automot Med, V52, P255; Choi M, 2012, J GERONTOL SOC WORK, V55, P367, DOI 10.1080/01634372.2011.642473; Classen S, 2008, TRAFFIC INJ PREV, V9, P456, DOI 10.1080/15389580802260026; CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x; Dewar R. E., 2002, HUMAN FACTORS TRAFFI; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Forrest KYZ, 1997, J AM GERIATR SOC, V45, P1214, DOI 10.1111/j.1532-5415.1997.tb03772.x; Giaquinto S, 2001, DISABIL REHABIL, V23, P296; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; Holland C.A., 2002, 25 DEP TRANSP; Koppel S, 2011, TRAFFIC INJ PREV, V12, P459, DOI 10.1080/15389588.2011.580802; Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; Langford J, 2008, ACCIDENT ANAL PREV, V40, P1996, DOI 10.1016/j.aap.2008.08.027; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Lyman S, 2002, INJ PREV, V8, P116, DOI 10.1136/ip.8.2.116; MacDonald L, 2008, TOP GERIATR REHABIL, V24, P239; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; McGwin G, 1999, DIABETES CARE, V22, P220, DOI 10.2337/diacare.22.2.220; McGwin G, 1998, ACCIDENT ANAL PREV, V30, P781, DOI 10.1016/S0001-4575(98)00031-1; McGwin G, 2000, AM J EPIDEMIOL, V152, P424, DOI 10.1093/aje/152.5.424; Murakami E, 1997, COMP COMPUTER ASSIST; Nagaratnam N, 2007, ARCH GERONTOL GERIAT, V44, P29, DOI 10.1016/j.archger.2006.02.002; Owsley C, 2013, J GERONTOL A-BIOL, V68, P567, DOI 10.1093/gerona/gls185; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Popescu ML, 2011, INVEST OPHTH VIS SCI, V52, P7168, DOI 10.1167/iovs.11-7564; Sims RV, 2007, J GERONTOL A-BIOL, V62, P789, DOI 10.1093/gerona/62.7.789; Sims RV, 2001, J AGING HEALTH, V13, P430, DOI 10.1177/089826430101300306; Tervo T, 2013, TRAFFIC INJ PREV, V14, P138, DOI 10.1080/15389588.2012.695827; Uc EY, 2008, CURR NEUROL NEUROSCI, V8, P377, DOI 10.1007/s11910-008-0059-1	34	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94564	10.1371/journal.pone.0094564	http://dx.doi.org/10.1371/journal.pone.0094564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722619	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100098
J	Shin, H; Kwon, S; Song, H; Lim, HJ				Shin, Hyejin; Kwon, Sojung; Song, Haengseok; Lim, Hyunjung Jade			The Transcription Factor Egr3 Is a Putative Component of the Microtubule Organizing Center in Mouse Oocytes	PLOS ONE			English	Article							MITOTIC SPINDLE; MEIOTIC SPINDLE; GAMMA-TUBULIN; MICE LACKING; MATURATION; PROTEIN; CELLS; MORPHOGENESIS; ORGANIZATION; CYTOSKELETON	The early growth response (Egr) family of zinc finger transcription factors consists of 4 members. During an investigation of Egr factor localization in mouse ovaries, we noted that Egr3 exhibits a subcellular localization that overlaps with the meiotic spindle in oocytes. Using Egr3-specific antibodies, we establish that Egr3 co-localizes with the spindle and cytosolic microtubule organizing centers (MTOCs) in oocytes during meiotic maturation. Notably, the Egr3 protein appears to accumulate around c-tubulin in MTOCs. Nocodazole treatment, which induces microtubule depolymerization, resulted in the disruption of spindle formation and Egr3 localization, suggesting that Egr3 localization is dependent on the correct configuration of the spindle. Shortly after warming of vitrified oocytes, growing arrays of microtubules were observed near large clusters of Egr3. An in vitro microtubule interaction assay showed that Egr3 does not directly interact with polymerized microtubules. Egr3 localization on the spindle was sustained in early preimplantation mouse embryos, but this pattern did not persist until the blastocyst stage. Collectively, our result shows for the first time that the Egr3 a transcription factor may play a novel non-transcriptional function during microtubule organization in mouse oocytes.	[Shin, Hyejin; Kwon, Sojung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Song, Haengseok] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Konkuk University; Pochon Cha University	Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.	hlim@konkuk.ac.kr	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X; Song, Haengseok/0000-0002-5027-7310	Konkuk University	Konkuk University	This paper resulted from the Konkuk University research support program in 2011 (www.konkuk.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Clary LM, 2010, DEVELOPMENT, V137, P3129, DOI 10.1242/dev.041616; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Hogarth CA, 2010, DEV DYNAM, V239, P3106, DOI 10.1002/dvdy.22442; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Katche C, 2012, NEUROBIOL LEARN MEM, V98, P220, DOI 10.1016/j.nlm.2012.08.001; Kwon Sojung, 2011, Clin Exp Reprod Med, V38, P1, DOI 10.5653/cerm.2011.38.1.1; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Ma W, 2010, DEV BIOL, V339, P439, DOI 10.1016/j.ydbio.2010.01.009; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Mora GR, 2004, MOL CANCER RES, V2, P115; O'Donovan KJ, 1999, MOL CELL BIOL, V19, P4711; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Quach DH, 2013, J NEUROSCI, V33, P4570, DOI 10.1523/JNEUROSCI.5481-12.2013; Schatten H, 2011, MOL REPROD DEV, V78, P757, DOI 10.1002/mrd.21380; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Soubry A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009203; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94708	10.1371/journal.pone.0094708	http://dx.doi.org/10.1371/journal.pone.0094708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722338	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100126
J	Wen, K; Tin, C; Wang, HF; Yang, XD; Li, GH; Giri-Rachman, E; Kocher, J; Bui, T; Clark-Deener, S; Yuan, LJ				Wen, Ke; Tin, Christine; Wang, Haifeng; Yang, Xingdong; Li, Guohua; Giri-Rachman, Ernawati; Kocher, Jacob; Bui, Tammy; Clark-Deener, Sherrie; Yuan, Lijuan			Probiotic Lactobacillus rhamnosus GG Enhanced Th1 Cellular Immunity but Did Not Affect Antibody Responses in a Human Gut Microbiota Transplanted Neonatal Gnotobiotic Pig Model	PLOS ONE			English	Article							HUMAN ROTAVIRUS INFECTION; FLORA-ASSOCIATED PIGLETS; WA HUMAN ROTAVIRUS; GERM-FREE; PROTECTIVE IMMUNITY; VACCINE; BACTERIA; DIARRHEA; DISEASE; IMMUNOGENICITY	This study aims to establish a human gut microbiota (HGM) transplanted gnotobiotic (Gn) pig model of human rotavirus (HRV) infection and diarrhea, and to verify the dose-effects of probiotics on HRV vaccine-induced immune responses. Our previous studies using the Gn pig model found that probiotics dose-dependently regulated both T cell and B cell immune responses induced by rotavirus vaccines. We generated the HGM transplanted neonatal Gn pigs through daily feeding of neonatal human fecal suspension to germ-free pigs for 3 days starting at 12 hours after birth. We found that attenuated HRV (AttHRV) vaccination conferred similar overall protection against rotavirus diarrhea and virus shedding in Gn pigs and HGM transplanted Gn pigs. HGM promoted the development of the neonatal immune system, as evidenced by the significantly enhanced IFN-gamma producing T cell responses and reduction of regulatory T cells and their cytokine production in the AttHRV-vaccinated pigs. The higher dose Lactobacillus rhamnosus GG (LGG) feeding (14 doses, up to 10(9) colony-forming-unit [CFU]/dose) effectively increased the LGG counts in the HGM Gn pig intestinal contents and significantly enhanced HRV-specific IFN-gamma producing T cell responses to the AttHRV vaccine. Lower dose LGG (9 doses, up to 10(6) CFU/dose) was ineffective. Neither doses of LGG significantly improved the protection rate, HRV-specific IgA and IgG antibody titers in serum, or IgA antibody titers in intestinal contents compared to the AttHRV vaccine alone, suggesting that an even higher dose of LGG is needed to overcome the influence of the microbiota to achieve the immunostimulatory effect in the HGM pigs. This study demonstrated that HGM Gn pig is an applicable animal model for studying immune responses to rotavirus vaccines and can be used for studying interventions (i.e., probiotics and prebiotics) that may enhance the immunogenicity and protective efficacy of vaccines through improving the gut microbiota.	[Wen, Ke; Tin, Christine; Wang, Haifeng; Yang, Xingdong; Li, Guohua; Giri-Rachman, Ernawati; Kocher, Jacob; Bui, Tammy; Yuan, Lijuan] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Clark-Deener, Sherrie] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Yuan, LJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	lyuan@vt.edu	Clark-Deener, Sherrie G/K-8181-2016; Yuan, Lijuan/A-2468-2008	Yuan, Lijuan/0000-0003-0709-5228; Giri-Rachman, Ernawati/0000-0002-1661-9073; Tin, Christine/0000-0002-2353-2582; Tin, Christine/0000-0003-0190-0636	National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD [R01AT004789]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004789] Funding Source: NIH RePORTER	National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant (R01AT004789) to Lijuan Yuan from the National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avershina E, 2013, FEMS MICROBIOL ECOL; Azevedo AS, 2005, J VIROL, V79, P5428, DOI 10.1128/JVI.79.9.5428-5436.2005; Che C, 2009, SCAND J IMMUNOL, V69, P223, DOI 10.1111/j.1365-3083.2008.02211.x; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hirayama K, 1999, EXP ANIM TOKYO, V48, P219, DOI 10.1538/expanim.48.219; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kunisawa J, 2011, CELL HOST MICROBE, V9, P83, DOI 10.1016/j.chom.2011.01.012; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Levast B, 2013, VACCINE, V31, P2489, DOI 10.1016/j.vaccine.2012.11.089; Licciardi PV, 2011, DISCOV MED, V12, P525; Liu FN, 2014, J PEDIATR GASTR NUTR, V58, P169, DOI 10.1097/MPG.0000000000000197; Liu FN, 2013, J PEDIATR GASTR NUTR, V57, P750, DOI 10.1097/MPG.0b013e3182a356e1; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; PLEASANTS JR, 1986, J NUTR, V116, P1949, DOI 10.1093/jn/116.10.1949; Saif LJ, 1996, ARCH VIROL, P153; Shen JA, 2010, ARCH MICROBIOL, V192, P959, DOI 10.1007/s00203-010-0628-y; Stepankova R, 1998, FOLIA MICROBIOL, V43, P531, DOI 10.1007/BF02820814; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; TLASKALOVAHOGENOVA H, 1983, ANN NY ACAD SCI, V409, P96, DOI 10.1111/j.1749-6632.1983.tb26862.x; To TL, 1998, J GEN VIROL, V79, P2661; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; Wei H, 2008, J VET MED SCI, V70, P715, DOI 10.1292/jvms.70.715; Wen K, 2012, VACCINE, V30, P1198, DOI 10.1016/j.vaccine.2011.11.107; Yuan L, 2003, PERSP MED V, V9, P357; Yuan L, 2013, DOSE EFFECTS LAB MOD; Yuan LJ, 2008, VACCINE, V26, P3322, DOI 10.1016/j.vaccine.2008.03.085; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001; Zhu YH, 2014, APPL ENV MICROBIOL	40	54	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94504	10.1371/journal.pone.0094504	http://dx.doi.org/10.1371/journal.pone.0094504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722168	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100085
J	Nita, II; Hershfinkel, M; Kantor, C; Rutter, GA; Lewis, EC; Sekler, I				Nita, Iulia I.; Hershfinkel, Michal; Kantor, Chase; Rutter, Guy A.; Lewis, Eli C.; Sekler, Israel			Pancreatic beta-cell Na+ channels control global Ca2+ signaling and oxidative metabolism by inducing Na+ and Ca2+ responses that are propagated into mitochondria	FASEB JOURNAL			English	Article						TTX; NCLX; MCU	STIMULATED INSULIN-SECRETION; NA+/CA2+ EXCHANGE; B-CELLS; ESSENTIAL COMPONENT; NA+-CA2+ EXCHANGER; CALCIUM UNIPORTER; CYTOPLASMIC CA2+; IMAGING REVEALS; SODIUM-CHANNEL; CYTOSOLIC CA2+	Communication between the plasma membrane and mitochondria is essential for initiating the Ca2+ and metabolic signals required for secretion in beta cells. Although voltage-dependent Na+ channels are abundantly expressed in beta cells and activated by glucose, their role in communicating with mitochondria is unresolved. Here, we combined fluorescent Na+, Ca2+, and ATP imaging, electrophysiological analysis with tetrodotoxin (TTX)-dependent block of the Na+ channel, and molecular manipulation of mitochondrial Ca2+ transporters to study the communication between Na+ channels and mitochondria. We show that TTX inhibits glucose-dependent depolarization and blocks cytosolic Na+ and Ca2+ responses and their propagation into mitochondria. TTX-sensitive mitochondrial Ca2+ influx was largely blocked by knockdown of the mitochondrial Ca2+ uniporter (MCU) expression. Knockdown of the mitochondrial Na+/Ca2+ exchanger (NCLX) and Na+ dose response analysis demonstrated that NCLX mediates the mitochondrial Na+ influx and is tuned to sense the TTX-sensitive cytosolic Na+ responses. Finally, TTX blocked glucose-dependent mitochondrial Ca2+ rise, mitochondrial metabolic activity, and ATP production. Our results show that communication of the Na+ channels with mitochondria shape both global Ca2+ and metabolism signals linked to insulin secretion in beta cells.	[Nita, Iulia I.; Hershfinkel, Michal; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel; [Lewis, Eli C.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel; [Kantor, Chase; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Cell Biol,Div Diabet Endocrinol & Metab, London, England	Ben Gurion University; Ben Gurion University; Imperial College London	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, POB 653, IL-84105 Beer Sheva, Israel.	sekler@bgu.ac.il	LEWIS, ELI C/F-1552-2012; Nita, Iulia/AAF-6887-2021	LEWIS, ELI C/0000-0002-4189-2207; Rutter, Guy/0000-0001-6360-0343; Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation (ISF) [985/05]; German Israeli Foundation (GIF) [485/11]; ISF [513/09]; Biotechnology and Biological Sciences Research Council (UK); Welcome Trust Senior Investigator Award; UK Medical Research Council program grant; Royal Society Research Merit Award; BBSRC [BB/J015873/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish	Israel Science Foundation (ISF)(Israel Science Foundation); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); ISF(Israel Science Foundation); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welcome Trust Senior Investigator Award; UK Medical Research Council program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Research Merit Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dr. Atsushi Miyawaki (RIKEN, Wako, Japan) for the mitopericam and Dr. Hiroyuki Noji (Osaka University, Ibaraki, Osaka, Japan) for the generous gift of AT 1.03 plasmid, as well as Dr. Ilya Fleidervish (Ben-Gurion University, Beer-Sheva, Israel) for his critical comments. I.S. was supported by Israel Science Foundation (ISF) grant 985/05 and German Israeli Foundation (GIF) grant 485/11, M.H. was supported by ISF grant 513/09, G.A.R. was supported by a project grant from the Biotechnology and Biological Sciences Research Council (UK), a Welcome Trust Senior Investigator Award, a UK Medical Research Council program grant, and a Royal Society Research Merit Award.	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223, DOI 10.1042/bj1320223; Barnett DW, 1995, PFLUG ARCH EUR J PHY, V431, P272, DOI 10.1007/BF00410201; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P788, DOI 10.1113/jphysiol.1965.sp007732; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; DUNNE MJ, 1990, J MEMBRANE BIOL, V113, P131, DOI 10.1007/BF01872887; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Gall D, 1999, BIOPHYS J, V77, P45, DOI 10.1016/S0006-3495(99)76871-2; Grapengiesser E, 1998, ENDOCRINOLOGY, V139, P3227, DOI 10.1210/en.139.7.3227; Herchuelz A, 2013, ADV EXP MED BIOL, V961, P385, DOI 10.1007/978-1-4614-4756-6_33; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; HIRIART M, 1988, J GEN PHYSIOL, V91, P617, DOI 10.1085/jgp.91.5.617; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jonkers FC, 2001, DIABETES, V50, P540, DOI 10.2337/diabetes.50.3.540; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; KAWAZU S, 1978, PFLUG ARCH EUR J PHY, V375, P197, DOI 10.1007/BF00584244; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lindskog C, 2012, J PROTEOMICS, V75, P2611, DOI 10.1016/j.jprot.2012.03.008; Luciani DS, 2007, EUR J PHARMACOL, V576, P18, DOI 10.1016/j.ejphar.2007.07.055; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Meyer-Hermann ME, 2007, BIOPHYS J, V93, P2952, DOI 10.1529/biophysj.107.106096; MOORE JW, 1967, J GEN PHYSIOL, V50, P1401, DOI 10.1085/jgp.50.5.1401; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Paucek P, 2004, BBA-BIOENERGETICS, V1659, P83, DOI 10.1016/j.bbabio.2004.03.019; PLANT TD, 1988, PFLUG ARCH EUR J PHY, V411, P429, DOI 10.1007/BF00587723; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; PRENTKI M, 1983, J BIOL CHEM, V258, P7597; PRESSEL DM, 1990, J MEMBRANE BIOL, V116, P273, DOI 10.1007/BF01868466; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; RUTTER GA, 1990, INT J BIOCHEM, V22, P1081, DOI 10.1016/0020-711X(90)90105-C; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Tarasov AI, 2006, DIABETES, V55, P3075, DOI 10.2337/db06-0637; Tarasov AI, 2013, PFLUG ARCH EUR J PHY, V465, P543, DOI 10.1007/s00424-012-1177-9; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Van Eylen F, 2002, DIABETES, V51, P366, DOI 10.2337/diabetes.51.2.366; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Vidaltamayo R, 2002, FASEB J, V16, P891, DOI 10.1096/fj.01-0934fje; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027	60	40	42	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3301	3312		10.1096/fj.13-248161	http://dx.doi.org/10.1096/fj.13-248161			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24719357	Green Accepted			2022-12-25	WOS:000340265400003
J	Ansari, SA; Paul, E; Sommer, S; Lieleg, C; He, QY; Daly, AZ; Rode, KA; Barber, WT; Ellis, LC; LaPorta, E; Orzechowski, AM; Taylor, E; Reeb, T; Wong, J; Korber, P; Morse, RH				Ansari, Suraiya A.; Paul, Emily; Sommer, Sebastian; Lieleg, Corinna; He, Qiye; Daly, Alexandre Z.; Rode, Kara A.; Barber, Wesley T.; Ellis, Laura C.; LaPorta, Erika; Orzechowski, Amanda M.; Taylor, Emily; Reeb, Tanner; Wong, Jason; Korber, Philipp; Morse, Randall H.			Mediator, TATA-binding Protein, and RNA Polymerase II Contribute to Low Histone Occupancy at Active Gene Promoters in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; PHO5 PROMOTER; SRB MEDIATOR; DISASSEMBLY RATHER; CHAPERONE ASF1; CHROMATIN; COMPLEX; SWI/SNF	Transcription by RNA polymerase II (Pol II) in eukaryotes requires the Mediator complex, and often involves chromatin remodeling and histone eviction at active promoters. Here we address the role of Mediator in recruitment of the Swi/Snf chromatin remodeling complex and its role, along with components of the preinitiation complex (PIC), in histone eviction at inducible and constitutively active promoters in the budding yeast Saccharomyces cerevisiae. We show that recruitment of the Swi/Snf chromatin remodeling complex to the induced CHA1 promoter, as well as its association with several constitutively active promoters, depends on the Mediator complex but is independent of Mediator at the induced MET2 and MET6 genes. Although transcriptional activation and histone eviction at CHA1 depends on Swi/Snf, Swi/Snf recruitment is not sufficient for histone eviction at the induced CHA1 promoter. Loss of Swi/ Snf activity does not affect histone occupancy of several constitutively active promoters; in contrast, higher histone occupancy is seen at these promoters in Mediator and PIC component mutants. We propose that an initial activator-dependent, nucleosome remodeling step allows PIC components to outcompete histones for occupancy of promoter sequences. We also observe reduced promoter association of Mediator and TATA-binding protein in a Pol II (rpb1-1) mutant, indicating mutually cooperative binding of these components of the transcription machinery and indicating that it is the PIC as a whole whose binding results in stable histone eviction.	[Ansari, Suraiya A.; Paul, Emily; He, Qiye; Daly, Alexandre Z.; Rode, Kara A.; Barber, Wesley T.; Ellis, Laura C.; LaPorta, Erika; Orzechowski, Amanda M.; Taylor, Emily; Reeb, Tanner; Wong, Jason; Morse, Randall H.] New York State Dept Hlth, Mol Genet Lab, Wadsworth Ctr, Albany, NY 12201 USA; [He, Qiye; LaPorta, Erika; Morse, Randall H.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Sommer, Sebastian; Lieleg, Corinna; Korber, Philipp] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Munich	Morse, RH (corresponding author), New York State Dept Hlth, Mol Genet Lab, Wadsworth Ctr, Albany, NY 12201 USA.	randall.morse@wadsworth.org	Korber, Philipp/AAN-7633-2021	Korber, Philipp/0000-0001-7526-6549; Morse, Randall/0000-0003-0000-8718; Wong, Jason/0000-0002-0710-3112; Daly, Alexandre/0000-0002-1924-0755; Ansari, Suraiya/0000-0002-0483-4235	National Science Foundation [MCB0517825, MCB0949722]; German Research Community [DFG KO2945/1-1]; program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich; National Science Foundation REU [DBI1062963]; Wadsworth Center; Direct For Biological Sciences [0949722, 1359413] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062963] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); German Research Community(German Research Foundation (DFG)); program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich; National Science Foundation REU(National Science Foundation (NSF)); Wadsworth Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Science Foundation Grants MCB0517825 and MCB0949722 (to R. H. M.), German Research Community Grant DFG KO2945/1-1 (to P. K.), a scholarship within the program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich (to S. S.), National Science Foundation REU Program Grant DBI1062963, and the Wadsworth Center.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; BORNAES C, 1992, GENETICS, V131, P531; Brachmann CB, 1998, YEAST, V14, P115; Brown CR, 2011, J BIOL CHEM, V286, P40556, DOI 10.1074/jbc.M111.289918; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Cormier L, 2010, NUCLEIC ACIDS RES, V38, P4998, DOI 10.1093/nar/gkq257; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Gregory PD, 1999, METH MOL B, V119, P417; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lacombe T, 2013, NUCLEIC ACIDS RES, V41, P9651, DOI 10.1093/nar/gkt701; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Mukundan B, 2013, J BIOL CHEM, V288, P11384, DOI 10.1074/jbc.M112.446773; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; PINTO I, 1994, J BIOL CHEM, V269, P30569; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TSANG SS, 1993, BIOTECHNIQUES, V14, P380; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Wippo CJ, 2009, MOL CELL BIOL, V29, P2960, DOI 10.1128/MCB.01054-08; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200	75	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14981	14995		10.1074/jbc.M113.529354	http://dx.doi.org/10.1074/jbc.M113.529354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727477	hybrid, Green Published			2022-12-25	WOS:000337248100050
J	Dziewanowska, K; Settles, M; Hunter, S; Linquist, I; Schilkey, F; Hartzell, PL				Dziewanowska, Katarzyna; Settles, Matthew; Hunter, Samuel; Linquist, Ingrid; Schilkey, Faye; Hartzell, Patricia L.			Phase Variation in Myxococcus xanthus Yields Cells Specialized for Iron Sequestration	PLOS ONE			English	Article							SOCIAL MOTILITY; GLOBAL ANALYSIS; ASGB; PROMOTER; COHESION; ENCODES; GENES	Myxococcus xanthus undergoes phase variation during growth to produce predominantly two colony phenotypes. The majority are yellow colonies containing swarm-proficient cells and a minority are tan colonies containing swarm-deficient cells. Comparison of the transcriptomes of a yellow variant, a tan variant, and three tan mutants led to the identification of differentially-regulated genes that define key segments of the phase variation pathway. For example, expression of genes for the yellow pigment DKxanthene and the antibiotic myxovirescin was increased significantly in yellow variants. In contrast, expression of the siderophore myxochelin, hemin binding proteins, and iron transport proteins was increased specifically in tan strains. Thus, a consequence of phase variation is that yellow cells shift from producing antibiotic and pigment to producing components involved in acquisition of iron, which may increase fitness during periods of iron limitation. Multiple protein kinases and HTH-Xre DNA-binding proteins identified in this study may be involved in the regulatory hierarchy that governs phase variation.	[Dziewanowska, Katarzyna; Hartzell, Patricia L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Settles, Matthew] Univ Idaho, Inst Bioinformat & Evolutionary Sci, Moscow, ID 83843 USA; [Hunter, Samuel] Univ Idaho, Bioinformat & Computat Biol, Moscow, ID 83843 USA; [Linquist, Ingrid; Schilkey, Faye] Natl Ctr Genome Resources, Santa Fe, NM USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; National Center for Genome Resources (NCGR)	Hartzell, PL (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	hartzell@uidaho.edu	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	National Science Foundation [MCB1052525]; NM-INBRE/NCGR pilot award (National Center for Research Resources) [P20RR016480]; NM-INBRE/NCGR pilot award (National Institute of General Medical Sciences) [P20 GM103451]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NM-INBRE/NCGR pilot award (National Center for Research Resources); NM-INBRE/NCGR pilot award (National Institute of General Medical Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following granting agencies: the National Science Foundation (MCB1052525 to PLH) and NM-INBRE/NCGR pilot award (National Center for Research Resources award P20RR016480 and National Institute of General Medical Sciences award P20 GM103451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Black WP, 2006, MOL MICROBIOL, V61, P447, DOI 10.1111/j.1365-2958.2006.05230.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowden MG, 1996, J BACTERIOL, V178, P6628, DOI 10.1128/jb.178.22.6628-6631.1996; BURCHARD RP, 1977, CAN J MICROBIOL, V23, P1657, DOI 10.1139/m77-238; BURCHARD RP, 1966, J BACTERIOL, V91, P535, DOI 10.1128/JB.91.2.535-545.1966; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Dahl JL, 2011, J BACTERIOL, V193, P5081, DOI 10.1128/JB.05383-11; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; Ducey TF, 2009, MICROB PATHOGENESIS, V46, P166, DOI 10.1016/j.micpath.2008.12.003; Furusawa G, 2011, MOL MICROBIOL, V81, P784, DOI 10.1111/j.1365-2958.2011.07732.x; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Inouye Sumiko, 2000, Microbial and Comparative Genomics, V5, P103, DOI 10.1089/10906590050179783; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Konovalova A, 2010, FEMS MICROBIOL REV, V34, P89, DOI 10.1111/j.1574-6976.2009.00194.x; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; KUNZE B, 1989, J ANTIBIOT, V42, P14, DOI 10.7164/antibiotics.42.14; LAUE BE, 1995, J BACTERIOL, V177, P4089, DOI 10.1128/jb.177.14.4089-4096.1995; LAUE BE, 1994, J BACTERIOL, V176, P5341, DOI 10.1128/JB.176.17.5341-5349.1994; MAYO KA, 1989, MOL GEN GENET, V218, P409, DOI 10.1007/BF00332403; Meiser P, 2006, P NATL ACAD SCI USA, V103, P19128, DOI 10.1073/pnas.0606039103; MUNOZDORADO J, 1993, J CELL BIOCHEM, V51, P29, DOI 10.1002/jcb.240510107; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Piggot P, 2010, CURR BIOL, V20, pR480, DOI 10.1016/j.cub.2010.04.020; PLAMANN L, 1994, J BACTERIOL, V176, P2013, DOI 10.1128/jb.176.7.2013-2020.1994; Raman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014377; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; Silakowski B, 2000, EUR J BIOCHEM, V267, P6476, DOI 10.1046/j.1432-1327.2000.01740.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Team RDC, 2010, R LANG ENV STAT COMP; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; van der Woude MW, 2006, FEMS MICROBIOL LETT, V254, P190, DOI 10.1111/j.1574-6968.2005.00038.x; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Xiao Y, 2012, ANTIMICROB AGENTS CH, V56, P2014, DOI 10.1128/AAC.06148-11; Xiao Y, 2011, J BACTERIOL, V193, P4626, DOI 10.1128/JB.05052-11	43	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95189	10.1371/journal.pone.0095189	http://dx.doi.org/10.1371/journal.pone.0095189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733297	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400161
J	Hartman, ML; Talar, B; Noman, MZ; Gajos-Michniewicz, A; Chouaib, S; Czyz, M				Hartman, Mariusz L.; Talar, Beata; Noman, Muhammad Zaeem; Gajos-Michniewicz, Anna; Chouaib, Salem; Czyz, Malgorzata			Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; MALIGNANT-MELANOMA; INITIATING CELLS; BETA-CATENIN; METASTASIS; CANCER; GROWTH; XENOGRAFTS; INHIBITION	Background: The diversity of functional phenotypes observed within a tumor does not exclusively result from intratumoral genetic heterogeneity but also from the response of cancer cells to the microenvironment. We have previously demonstrated that the morphological and functional phenotypes of melanoma can be dynamically altered upon external stimuli. Findings: In the present study, transcriptome profiles were generated to explore the molecules governing phenotypes of melanospheres grown in the bFGF(+)EGF(+) serum-free cultures and monolayers maintained in the serum-containing medium. Higher expression levels of MITF-dependent genes that are responsible for differentiation, e. g., TYR and MLANA, and stemness-related genes, e.g., ALDH1A1, were detected in melanospheres. These results were supported by the observation that the melanospheres contained more pigmented cells and cells exerting the self-renewal capacity than the monolayers. In addition, the expression of the anti-apoptotic, MITF-dependent genes e. g., BCL2A1 was also higher in the melanospheres. The enhanced activity of MITF in melanospheres, as illustrated by the increased expression of 74 MITF-dependent genes, identified MITF as a central transcriptional regulator in melanospheres. Importantly, several genes including MITF-dependent ones were expressed in melanospheres and original tumors at similar levels. The reduced MITF level in monolayers might be partially explained by suppression of the Wnt/ beta-catenin pathway, and DKK1, a secreted inhibitor of this pathway, was highly up-regulated in monolayers in comparison to melanospheres and original tumors. Furthermore, the silencing of DKK1 in monolayers increased the percentage of cells with self-renewing capacity. Conclusions: Our study indicates that melanospheres can be used to unravel the molecular pathways that sustain intratumoral phenotypic heterogeneity. Melanospheres directly derived from tumor specimens more accurately mirrored the morphology and gene expression profiles of the original tumors compared to monolayers. Therefore, melanospheres represent a relevant preclinical tool to study new anticancer treatment strategies.	[Hartman, Mariusz L.; Talar, Beata; Gajos-Michniewicz, Anna; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland; [Noman, Muhammad Zaeem; Chouaib, Salem] Inst Canc Gustave Roussy, Unite INSERM U753, Villejuif, France	Medical University Lodz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	/S-9995-2016; Czyz, Malgorzata/AAD-1869-2020; NOMAN, Muhammmad Zaeem/AAJ-1466-2021; Chouaib, Salem/F-7939-2016; NOMAN, Muhammmad Zaeem/AAJ-1465-2021; Noman, Muhammad zaeem/AAF-8483-2020	Czyz, Malgorzata/0000-0002-8279-4742; NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; Hartman, Mariusz/0000-0002-2231-3740	National Science Centre (Poland) [2012/06/M/NZ2/00109]; ARC (Association pour la Recherche sur le Cancer) [SFI20121205624]; Ligue contre le Cancer (France)	National Science Centre (Poland); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer (France)	This work was supported by grants 2012/06/M/NZ2/00109 from National Science Centre (Poland) and by the ARC (Association pour la Recherche sur le Cancer) 2012-2013: No SFI20121205624 and Ligue contre le Cancer (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Anaka M, 2012, STEM CELLS, V30, P336, DOI 10.1002/stem.786; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Feldmann R, 2011, DERMATOLOGY, V222, P171, DOI 10.1159/000324516; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Fukamachi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072438; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Ghislin S, 2012, MELANOMA RES, V22, P184, DOI 10.1097/CMR.0b013e328351e7c4; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; Kopetz S, 2012, CLIN CANCER RES, V18, P5160, DOI 10.1158/1078-0432.CCR-12-2408; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kuch V, 2013, INT J CANCER, V132, pE94, DOI 10.1002/ijc.27785; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu F, 2013, PIGM CELL MELANOMA R, V26, P67, DOI 10.1111/pcmr.12029; Hernandez JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072480; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mo J, 2013, MELANOMA RES, V23, P254, DOI 10.1097/CMR.0b013e32836314e3; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Morrison BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049752; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sette G, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-91; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Smart CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064388; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Sztiller-Sikorska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090783; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Wang X, 2013, CANCER LETT, V331, P211, DOI 10.1016/j.canlet.2013.01.005; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384	59	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95157	10.1371/journal.pone.0095157	http://dx.doi.org/10.1371/journal.pone.0095157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733089	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400156
J	Wang, Y; Gehringer, R; Mousa, SA; Hackel, D; Brack, A; Rittner, HL				Wang, Ying; Gehringer, Rebekka; Mousa, Shaaban A.; Hackel, Dagmar; Brack, Alexander; Rittner, Heike L.			CXCL10 Controls Inflammatory Pain via Opioid Peptide-Containing Macrophages in Electroacupuncture	PLOS ONE			English	Article							CONTAINING POLYMORPHONUCLEAR CELLS; CANNABINOID CB2 RECEPTORS; INFLAMED SKIN TISSUES; DORSAL-ROOT GANGLION; LOW-BACK-PAIN; ANTI-HYPERALGESIA; DENDRITIC CELLS; BETA-ENDORPHIN; RAT MODEL; ACUPUNCTURE	Acupuncture is widely used for pain treatment in patients with osteoarthritis or low back pain, but molecular mechanisms remain largely enigmatic. In the early phase of inflammation neutrophilic chemokines direct opioid-containing neutrophils in the inflamed tissue and stimulate opioid peptide release and antinociception. In this study the molecular pathway and neuroimmune connections in complete Freund's adjuvant (CFA)-induced hind paw inflammation and electroacupuncture for peripheral pain control were analyzed. Free moving Wistar rats with hind paw inflammation were treated twice with electroacupuncture at GB30 (Huan Tiao - gall bladder meridian) (day 0 and 1) and analyzed for mechanical and thermal nociceptive thresholds. The cytokine profiles as well as the expression of opioid peptides were quantified in the inflamed paw. Electroacupuncture elicited long-term antinociception blocked by local injection of anti-opioid peptide antibodies (beta-endorphin, met-enkephalin, dynorphin A). The treatment altered the cytokine profile towards an anti-inflammatory pattern but augmented interferon (IFN)-gamma and the chemokine CXCL10 (IP-10: interferon gamma-inducible protein) protein and mRNA expression with concomitant increased numbers of opioid peptide-containing CXCR3(+) macrophages. In rats with CFA hind paw inflammation without acupuncture repeated injection of CXCL10 triggered opioid-mediated antinociception and increase opioid-containing macrophages. Conversely, neutralization of CXCL10 time-dependently decreased electroacupuncture-induced antinociception and the number of infiltrating opioid peptide-expressing CXCR3(+) macrophages. In summary, we describe a novel function of the chemokine CXCL10 - as a regulator for an increase of opioid-containing macrophages and antinociceptive mediator in inflammatory pain and as a key chemokine regulated by electroacupuncture.	[Wang, Ying; Gehringer, Rebekka; Hackel, Dagmar; Brack, Alexander; Rittner, Heike L.] Univ Hosp Wurzburg, Dept Anesthesiol, Wurzburg, Germany; [Mousa, Shaaban A.] Charite, Dept Anesthesiol & Crit Care, D-13353 Berlin, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wang, Y (corresponding author), Univ Hosp Wurzburg, Dept Anesthesiol, Wurzburg, Germany.	e_wang_y@ukw.de; rittner_h@ukw.de	RIttner, Heike/AAC-6523-2019	RIttner, Heike/0000-0003-4867-0188	German medical acupuncture association (DAgfA); China scholarship council; University Hospitals of Wuerzburg	German medical acupuncture association (DAgfA); China scholarship council(China Scholarship Council); University Hospitals of Wuerzburg	This study was supported by a grant of the German medical acupuncture association (DAgfA), China scholarship council and University Funds from the University Hospitals of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Brack A, 2004, PAIN, V108, P67, DOI 10.1016/j.pain.2003.12.008; Brack A, 2004, ANESTHESIOLOGY, V100, P149, DOI 10.1097/00000542-200401000-00024; Brack A, 2004, PAIN, V112, P229, DOI 10.1016/j.pain.2004.08.029; Carneiro ER, 2010, CYTOKINE, V50, P335, DOI 10.1016/j.cyto.2010.01.005; CHUNG SH, 1980, NATURE, V283, P243, DOI 10.1038/283243a0; CLEMENTJONES V, 1980, LANCET, V2, P946; CZLONKOWSKI A, 1993, EUR J PHARMACOL, V242, P229, DOI 10.1016/0014-2999(93)90246-E; Gaffal E, 2013, J IMMUNOL, V190, P4929, DOI 10.4049/jimmunol.1201777; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Gondim DV, 2012, CAN J PHYSIOL PHARM, V90, P395, DOI 10.1139/Y2012-003; Hackel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063564; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang C, 2004, BRAIN RES BULL, V63, P99, DOI 10.1016/j.brainresbull.2004.01.006; Jang S, 2008, J LEUKOCYTE BIOL, V84, P1264, DOI 10.1189/jlb.1107742; Kim JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-22; Lao LX, 2004, BRAIN RES, V1020, P18, DOI 10.1016/j.brainres.2004.01.092; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Machelska H, 2003, NAT MED, V9, P1353, DOI 10.1038/nm1103-1353; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Mavrommatis CI, 2012, PAIN, V153, P1720, DOI 10.1016/j.pain.2012.05.005; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Park MB, 2004, J NEUROIMMUNOL, V151, P40, DOI 10.1016/j.jneuroim.2004.02.003; Pflucke D, 2013, J PAIN, V14, P897, DOI 10.1016/j.jpain.2013.02.012; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Rittner HL, 2006, FASEB J, V20, P2627, DOI 10.1096/fj.06-6077fje; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; Su TF, 2012, EUR J PAIN, V16, P624, DOI 10.1002/j.1532-2149.2011.00055.x; Su TF, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-98; Taguchi R, 2010, BRAIN RES, V1355, P97, DOI 10.1016/j.brainres.2010.08.014; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Wang K, 2009, ANESTH ANALG, V109, P1666, DOI 10.1213/ANE.0b013e3181b5a234; Wang Y, 2013, EUR J PAIN, V17, P1447, DOI 10.1002/j.1532-2149.2013.00325.x; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Yao HH, 2010, J NEUROIMMUNE PHARM, V5, P489, DOI 10.1007/s11481-010-9211-1; Yu Min, 2011, Zhen Ci Yan Jiu, V36, P79; Zhang GG, 2005, EXPLORE-NY, V1, P365, DOI 10.1016/j.explore.2005.06.006; Zhang N, 2005, J LEUKOCYTE BIOL, V78, P1210, DOI 10.1189/jlb.0405224; Zhang RX, 2005, BRAIN RES, V1048, P235, DOI 10.1016/j.brainres.2005.05.008; Zhang RX, 2004, BRAIN RES, V1020, P12, DOI 10.1016/j.brainres.2004.05.067; Zhang Y, 2011, BRAIN RES, V1395, P38, DOI 10.1016/j.brainres.2011.04.037; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	41	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94696	10.1371/journal.pone.0094696	http://dx.doi.org/10.1371/journal.pone.0094696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732949	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400078
J	Bodian, DL; McCutcheon, JN; Kothiyal, P; Huddleston, KC; Iyer, RK; Vockley, JG; Niederhuber, JE				Bodian, Dale L.; McCutcheon, Justine N.; Kothiyal, Prachi; Huddleston, Kathi C.; Iyer, Ramaswamy K.; Vockley, Joseph G.; Niederhuber, John E.			Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing	PLOS ONE			English	Article							RISK PREDICTION MODELS; BREAST-CANCER; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; BRCA2 MUTATIONS; DNA-BINDING; VARIANTS; COMPLEX; DOMAIN; EXOME	Technological advances coupled with decreasing costs are bringing whole genome and whole exome sequencing closer to routine clinical use. One of the hurdles to clinical implementation is the high number of variants of unknown significance. For cancer-susceptibility genes, the difficulty in interpreting the clinical relevance of the genomic variants is compounded by the fact that most of what is known about these variants comes from the study of highly selected populations, such as cancer patients or individuals with a family history of cancer. The genetic variation in known cancer-susceptibility genes in the general population has not been well characterized to date. To address this gap, we profiled the nonsynonymous genomic variation in 158 genes causally implicated in carcinogenesis using high-quality whole genome sequences from an ancestrally diverse cohort of 681 healthy individuals. We found that all individuals carry multiple variants that may impact cancer susceptibility, with an average of 68 variants per individual. Of the 2,688 allelic variants identified within the cohort, most are very rare, with 75% found in only 1 or 2 individuals in our population. Allele frequencies vary between ancestral groups, and there are 21 variants for which the minor allele in one population is the major allele in another. Detailed analysis of a selected subset of 5 clinically important cancer genes, BRCA1, BRCA2, KRAS, TP53, and PTEN, highlights differences between germline variants and reported somatic mutations. The dataset can serve a resource of genetic variation in cancer-susceptibility genes in 6 ancestry groups, an important foundation for the interpretation of cancer risk from personal genome sequences.	[Bodian, Dale L.; McCutcheon, Justine N.; Kothiyal, Prachi; Huddleston, Kathi C.; Iyer, Ramaswamy K.; Vockley, Joseph G.; Niederhuber, John E.] Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA 22042 USA	Inova Health System	Vockley, JG (corresponding author), Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA 22042 USA.	joe.vockley@inova.org		Kothiyal, Prachi/0000-0002-5457-3029	Inova Health System	Inova Health System	This research was funded entirely by the Inova Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], DAT SINGL NUCL POL D; Anothaisintawee T, 2012, BREAST CANCER RES TR, V133, P1, DOI 10.1007/s10549-011-1853-z; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bodmer W, 2010, CURR OPIN GENET DEV, V20, P262, DOI 10.1016/j.gde.2010.04.016; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Burke W, 2013, GENET MED; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Chen J, 2008, INT J CANCER, V122, P2249, DOI 10.1002/ijc.23397; Chen XW, 2006, HUM MUTAT, V27, P427, DOI 10.1002/humu.20319; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Coate L, 2010, J CLIN ONCOL, V28, P4029, DOI 10.1200/JCO.2009.27.2336; Coquelle N, 2011, BIOCHEMISTRY-US, V50, P4579, DOI 10.1021/bi2003795; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Denisov EV, 2012, TUMOR SUPPRESSOR GEN; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall MJ, 2009, CANCER-AM CANCER SOC, V115, P2222, DOI 10.1002/cncr.24200; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hayden EC, 2013, NATURE, V498, P16, DOI 10.1038/498017a; Howlader N, 2013, SEER CANC STAT REV; Huddleston K, 2013, CLEV CLIN 9 ANN NURS; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kilpivaara O, 2013, SCIENCE, V339, P1559, DOI 10.1126/science.1233899; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Kurian AW, 2010, CURR OPIN OBSTET GYN, V22, P72, DOI 10.1097/GCO.0b013e328332dca3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Libiger Ondrej, 2013, Frontiers in Genetics, V3, P322, DOI 10.3389/fgene.2012.00322; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Neuhausen SL, 1999, CANCER-AM CANCER SOC, V86, P2575, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2575::AID-CNCR15>3.0.CO;2-F; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Olivier M, 2010, MOL BIOL INTELL UNIT, P1; Ostrow KL, 2004, CANCER GENET CYTOGEN, V153, P177, DOI 10.1016/j.cancergencyto.2004.01.020; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Pilato B, 2011, BREAST CANCER RES TR, V125, P651, DOI 10.1007/s10549-010-0861-8; Plon SE, 2011, GENET MED, V13, P148, DOI 10.1097/GIM.0b013e318207f564; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quiles F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061302; R Core Team, 2021, R LANG ENV STAT COMP; Rosenfeld JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040294; Savas Sevtap, 2006, Human Genomics, V2, P287; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; TRAINOR KJ, 1984, MECH AGEING DEV, V27, P83, DOI 10.1016/0047-6374(84)90084-8; van Erp NP, 2010, BRIT J CANCER, V103, P757, DOI 10.1038/sj.bjc.6605813; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; Vazquez AI, 2012, GENETICS, V192, P1493, DOI 10.1534/genetics.112.141705; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wenham RM, 2003, CLIN CANCER RES, V9, P4396; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Win AK, 2012, CANCER EPIDEM BIOMAR, V21, P398, DOI 10.1158/1055-9965.EPI-11-0771; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	82	66	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94554	10.1371/journal.pone.0094554	http://dx.doi.org/10.1371/journal.pone.0094554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728327	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200094
J	Kang, M; Han, YM				Kang, Minyong; Han, Yong-Mahn			Differentiation of Human Pluripotent Stem Cells into Nephron Progenitor Cells in a Serum and Feeder Free System	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-FAILURE; DIRECTED DIFFERENTIATION; IN-VITRO; REGENERATION; ORGANOGENESIS; ADULT; WT1; PRONEPHROS; LINEAGE	Objectives: Kidney disease is emerging as a critical medical problem worldwide. Because of limited treatment options for the damaged kidney, stem cell treatment is becoming an alternative therapeutic approach. Of many possible human stem cell sources, pluripotent stem cells are most attractive due to their self-renewal and pluripotent capacity. However, little is known about the derivation of renal lineage cells from human pluripotent stem cells (hPSCs). In this study, we developed a novel protocol for differentiation of nephron progenitor cells (NPCs) from hPSCs in a serum-and feeder-free system. Materials and Methods: We designed step-wise protocols for differentiation of human pluripotent stem cells toward primitive streak, intermediate mesoderm and NPCs by recapitulating normal nephrogenesis. Expression of key marker genes was examined by RT-PCR, real time RT-PCR and immunocytochemistry. Each experiment was independently performed three times to confirm its reproducibility. Results: After modification of culture period and concentration of exogenous factors, hPSCs can differentiate into NPCs that markedly express specific marker genes such as SIX2, GDNF, HOXD11, WT1 and CITED1 in addition to OSR1, PAX2, SALL1 and EYA1. Moreover, NPCs possess the potential of bidirectional differentiation into both renal tubular epithelial cells and glomerular podocytes in defined culture conditions. In particular, approximately 70% of SYN-positive cells were obtained from hPSC-derived NPCs after podocytes induction. NPCs can also form in vitro tubule-like structures in three dimensional culture systems. Conclusions: Our novel protocol for hPSCs differentiation into NPCs can be useful for producing alternative sources of cell replacement therapy and disease modeling for human kidney diseases.	[Kang, Minyong; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Grad Sch Med Sci, Taejon 305701, South Korea; [Kang, Minyong; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Grad Sch Engn, Taejon 305701, South Korea; [Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Han, YM (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci, Taejon 305701, South Korea.	ymhan57@kaist.ac.kr	Kang, Minyong/AAO-6484-2020		NRF Stem Cell Program, Republic of Korea [2011-0019509]	NRF Stem Cell Program, Republic of Korea	This research was supported by NRF Stem Cell Program (2011-0019509), Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Brodie JC, 2005, PHARMACOL REV, V57, P299, DOI 10.1124/pr.57.3.3; Bruce SJ, 2007, DIFFERENTIATION, V75, P337, DOI 10.1111/j.1432-0436.2006.00149.x; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davies Jamie A, 2002, ScientificWorldJournal, V2, P1937; DRESSLER GR, 1995, SEMIN NEPHROL, V15, P263; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Faa G, 2012, J CELL PHYSIOL, V227, P1257, DOI 10.1002/jcp.22985; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Harari-Steinberg O, 2011, ORGANOGENESIS, V7, P123, DOI 10.4161/org.7.2.15783; Hopkins C, 2009, J PATHOL, V217, P265, DOI 10.1002/path.2477; Hsu HJ, 2004, ENDOCR RES, V30, P803, DOI 10.1081/ERC-200044044; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Little MH, 2012, COLD SPRING HARB PER, V4; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Nishikawa M, 2012, BIOCHEM BIOPH RES CO, V417, P897, DOI 10.1016/j.bbrc.2011.12.071; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Ren XH, 2010, ACTA BIOCH BIOPH SIN, V42, P464, DOI 10.1093/abbs/gmq046; Romagnani P, 2013, NAT REV NEPHROL, V9, P137, DOI 10.1038/nrneph.2012.290; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yokoo T, 2008, CLIN EXP NEPHROL, V12, P326, DOI 10.1007/s10157-008-0062-5; Yokoo T, 2008, FRONT BIOSCI-LANDMRK, V13, P2814, DOI 10.2741/2888; Yokote S, 2013, CURR OPIN ORGAN TRAN, V18, P186, DOI 10.1097/MOT.0b013e32835f070d; Yokote S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/453519	47	50	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94888	10.1371/journal.pone.0094888	http://dx.doi.org/10.1371/journal.pone.0094888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728509	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200138
J	Sanoff, HK; Renfro, LA; Poonnen, P; Ambadwar, P; Sargent, DJ; Goldberg, RM; McLeod, H				Sanoff, Hanna K.; Renfro, Lindsay A.; Poonnen, Pradeep; Ambadwar, Pratibha; Sargent, Daniel J.; Goldberg, Richard M.; McLeod, Howard			Germline Variation in Colorectal Risk Loci Does Not Influence Treatment Effect or Survival in Metastatic Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; VARIANTS; PROSTATE; TRIAL; SMAD7; 8Q24	Background: Colorectal cancer (CRC) risk is partly conferred by common, low-penetrance single nucleotide polymorphisms (SNPs). We hypothesized that these SNPs are associated with outcomes in metastatic CRC. Methods: Six candidate SNPs from 8q24, 10p14, 15q13, 18q21 were investigated for their association with response rate (RR), time to progression (TTP) and overall survival (OS) among 524 patients treated on a phase III clinical trial of first-line chemotherapy for metastatic CRC. Results: rs10795668 was weakly associated with TTP (p = 0.02), but not RR or OS. No other SNPs carried statistically significant HRs for any of the primary outcomes (RR, TTP or OS). Conclusion: Common low-penetrance CRC risk SNPs were not associated with outcomes among patients with metastatic CRC.	[Sanoff, Hanna K.] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27514 USA; [Poonnen, Pradeep] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [McLeod, Howard] Univ S Florida, H Lee Moffitt Canc Ctr, DeBartolo Family Personalized Med Inst, Div Populat Sci, Tampa, FL 33682 USA; [Renfro, Lindsay A.; Ambadwar, Pratibha; Sargent, Daniel J.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Goldberg, Richard M.] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic; University System of Ohio; Ohio State University	Sanoff, HK (corresponding author), Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27514 USA.	Hanna_sanoff@med.unc.edu	Goldberg, Richard/O-1871-2017; McLeod, Howard/ABD-8364-2021	Goldberg, Richard/0000-0003-3713-6895; McLeod, Howard/0000-0002-9004-9232; Sargent, Daniel/0000-0002-2684-4741	NATIONAL CANCER INSTITUTE [P30CA016086, P30CA015083, U10CA180850, P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30 CA015083, P30 CA016086, U10 CA180850] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Goldberg RM, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.1220; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Haerian MS, 2011, J GASTROEN HEPATOL, V26, P1475, DOI 10.1111/j.1440-1746.2011.06831.x; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hoskins JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041954; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; McLeod HL, 2010, J CLIN ONCOL, V28, P3227, DOI 10.1200/JCO.2009.21.7943; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Passarelli MN, 2011, GENE CHROMOSOME CANC, V50, P875, DOI 10.1002/gcc.20913; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94727	10.1371/journal.pone.0094727	http://dx.doi.org/10.1371/journal.pone.0094727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727911	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200123
J	Ziolkowska, N; Lewczuk, B; Petrynski, W; Palkowska, K; Prusik, M; Targonska, K; Gizejewski, Z; Przybylska-Gornowicz, B				Ziolkowska, Natalia; Lewczuk, Bogdan; Petrynski, Wojciech; Palkowska, Katarzyna; Prusik, Magdalena; Targonska, Krystyna; Gizejewski, Zygmunt; Przybylska-Gornowicz, Barbara			Light and Electron Microscopy of the European Beaver (Castor fiber) Stomach Reveal Unique Morphological Features with Possible General Biological Significance	PLOS ONE			English	Article							GASTRIC ENDOCRINE-CELLS; GASTROINTESTINAL-TRACT; GLAND PATCH; MALAYAN PANGOLIN; EPITHELIAL-CELLS; MUCUS THICKNESS; ZYMOGENIC CELLS; MOUSE STOMACH; CHIEF CELLS; NECK CELLS	Anatomical, histological, and ultrastructural studies of the European beaver stomach revealed several unique morphological features. The prominent attribute of its gross morphology was the cardiogastric gland (CGG), located near the oesophageal entrance. Light microscopy showed that the CGG was formed by invaginations of the mucosa into the submucosa, which contained densely packed proper gastric glands comprised primarily of parietal and chief cells. Mucous neck cells represented <0.1% of cells in the CGG gastric glands and 22-32% of cells in the proper gastric glands of the mucosa lining the stomach lumen. These data suggest that chief cells in the CGG develop from undifferentiated cells that migrate through the gastric gland neck rather than from mucous neck cells. Classical chief cell formation (i.e., arising from mucous neck cells) occurred in the mucosa lining the stomach lumen, however. The muscularis around the CGG consisted primarily of skeletal muscle tissue. The cardiac region was rudimentary while the fundus/corpus and pyloric regions were equally developed. Another unusual feature of the beaver stomach was the presence of specific mucus with a thickness up to 950 mm (in frozen, unfixed sections) that coated the mucosa. Our observations suggest that the formation of this mucus is complex and includes the secretory granule accumulation in the cytoplasm of pit cells, the granule aggregation inside cells, and the incorporation of degenerating cells into the mucus.	[Ziolkowska, Natalia; Lewczuk, Bogdan; Petrynski, Wojciech; Palkowska, Katarzyna; Prusik, Magdalena; Targonska, Krystyna; Przybylska-Gornowicz, Barbara] Univ Warmia & Mazury, Fac Vet Med, Dept Histol & Embryol, Olsztyn, Poland; [Gizejewski, Zygmunt] Polish Acad Sci, Anim Reprod & Food Res 2Inst, Olsztyn, Poland	University of Warmia & Mazury; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Ziolkowska, N (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Histol & Embryol, Olsztyn, Poland.	ntrzaska@o2.pl	Giżejewski, Zygmunt/H-7174-2017	Giżejewski, Zygmunt/0000-0001-7627-3222; Ziolkowska, Natalia/0000-0002-0748-7777; Lewczuk, Bogdan/0000-0003-2604-926X; Prusik, Magdalena/0000-0001-6456-2502	University of Warmia and Mazury in Olsztyn [0522-0806]	University of Warmia and Mazury in Olsztyn	The study was supported by the University of Warmia and Mazury in Olsztyn (statutory research grant No 0522-0806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Allen A, 1989, HDB PHYSL, VIII, P359; Carson F., 2009, HISTOTECHNOLOGY SELF, P114; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Ford P, 1956, P 14 INT C ZOOL COP; Ge YB, 1998, CELL TISSUE RES, V293, P121, DOI 10.1007/s004410051104; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Higson DJ, 1968, P LINN SCO N S W, P69; Horner E., 1965, J MAMMAL, V45, P513; HOSHI H, 1990, Z MIKROSK ANAT FORSC, V104, P298; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KERSS S, 1982, CLIN SCI, V63, P187, DOI 10.1042/cs0630187; KRAUSE WJ, 1974, ACTA ANAT, V88, P1; KRAUSE WJ, 1973, ANAT RECORD, V176, P475, DOI 10.1002/ar.1091760410; Kressin M, 1997, ANAT HISTOL EMBRYOL, V26, P217, DOI 10.1111/j.1439-0264.1997.tb00129.x; LANGER P, 1984, Q J EXP PHYSIOL CMS, V69, P615, DOI 10.1113/expphysiol.1984.sp002848; Leus K, 1999, CR ACAD SCI III-VIE, V322, P1081, DOI 10.1016/S0764-4469(99)00107-9; Macdonald AA, 2008, CR BIOL, V331, P32, DOI 10.1016/j.crvi.2007.10.007; Marsh H, 1977, P271; Morgan LH, 1868, AM BEAVER HIS WORKS, P71; NASSET ES, 1953, J MAMMAL, V34, P204, DOI 10.2307/1375621; Nisa C, 2005, ANAT HISTOL EMBRYOL, V34, P373, DOI 10.1111/j.1439-0264.2005.00626.x; Nisa C, 2010, ANAT HISTOL EMBRYOL, V39, P432, DOI 10.1111/j.1439-0264.2010.01015.x; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Reynolds JE, 1996, ANAT REC, V245, P539, DOI 10.1002/(SICI)1097-0185(199607)245:3<539::AID-AR11>3.0.CO;2-Q; RICHARDSON KC, 1987, ACTA ZOOL-STOCKHOLM, V68, P65, DOI 10.1111/j.1463-6395.1987.tb00877.x; Smith JR, 1942, THESIS WYOMING, P1; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211; SUZUKI S, 1983, CELL TISSUE RES, V233, P475; TESIK I, 1992, ACTA VET BRNO, V61, P11, DOI 10.2754/avb199261010011; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Varum FJO, 2010, EUR J PHARM SCI, V40, P335, DOI 10.1016/j.ejps.2010.04.007; YAMADA J, 1987, ANAT ANZEIGER, V163, P311	36	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94590	10.1371/journal.pone.0094590	http://dx.doi.org/10.1371/journal.pone.0094590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727802	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200101
J	Clark, CJ				Clark, Christopher James			Harmonic Hopping, and Both Punctuated and Gradual Evolution of Acoustic Characters in Selasphorus Hummingbird Tail-Feathers	PLOS ONE			English	Article							BLACK-CHINNED HUMMINGBIRD; AEROELASTIC FLUTTER; COURTSHIP DISPLAYS; SOUND PRODUCTION; WING FEATHERS; BIRD; TROCHILIDAE; SYSTEMATICS; PHONATION; SONATIONS	Models of character evolution often assume a single mode of evolutionary change, such as continuous, or discrete. Here I provide an example in which a character exhibits both types of change. Hummingbirds in the genus Selasphorus produce sound with fluttering tail-feathers during courtship. The ancestral character state within Selasphorus is production of sound with an inner tail-feather, R2, in which the sound usually evolves gradually. Calliope and Allen's Hummingbirds have evolved autapomorphic acoustic mechanisms that involve feather-feather interactions. I develop a source-filter model of these interactions. The 'source' comprises feather(s) that are both necessary and sufficient for sound production, and are aerodynamically coupled to neighboring feathers, which act as filters. Filters are unnecessary or insufficient for sound production, but may evolve to become sources. Allen's Hummingbird has evolved to produce sound with two sources, one with feather R3, another frequency-modulated sound with R4, and their interaction frequencies. Allen's R2 retains the ancestral character state, a similar to 1 kHz "ghost'' fundamental frequency masked by R3, which is revealed when R3 is experimentally removed. In the ancestor to Allen's Hummingbird, the dominant frequency has 'hopped' to the second harmonic without passing through intermediate frequencies. This demonstrates that although the fundamental frequency of a communication sound may usually evolve gradually, occasional jumps from one character state to another can occur in a discrete fashion. Accordingly, mapping acoustic characters on a phylogeny may produce misleading results if the physical mechanism of production is not known.	[Clark, Christopher James] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Clark, Christopher James] Yale Univ, Peabody Museum Nat Hist, New Haven, CT USA	University of California System; University of California Berkeley; Yale University	Clark, CJ (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	cclark@ucr.edu			Museum of Vertebrate Zoology; NSF [IOS-0920353]	Museum of Vertebrate Zoology; NSF(National Science Foundation (NSF))	Field work was funded by the Museum of Vertebrate Zoology, and by the author's personal funds. Funding during manuscript preparation was provided by NSF IOS-0920353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr PH, 1907, P ZOOL SOC LOND, V1907, P12; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bostwick K., 2009, P ROYAL SOC BIOL S B, V227, P835; Bostwick KS, 2005, SCIENCE, V309, P736, DOI 10.1126/science.1111701; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; Clark CJ, 2013, J EXP BIOL, V216, P3395, DOI 10.1242/jeb.080317; Clark CJ, 2013, J EXP BIOL, V216, P3404, DOI 10.1242/jeb.085993; Clark CJ, 2012, CONDOR, V114, P329, DOI 10.1525/cond.2012.110058; Clark CJ, 2011, SCIENCE, V333, P1430, DOI 10.1126/science.1205222; Clark CJ, 2011, WILSON J ORNITHOL, V123, P218, DOI 10.1676/10-076.1; Clark CJ, 2010, AM NAT, V175, P27, DOI 10.1086/648560; Clark CJ, 2008, BIOL LETTERS, V4, P341, DOI 10.1098/rsbl.2008.0252; Clark CJ, 2008, P R SOC B, V275, P955, DOI 10.1098/rspb.2007.1619; Clark CJ, 2011, CURR ZOOL, V57, P187, DOI 10.1093/czoolo/57.2.187; Clark CJ, 2013, BIRS N AM ONLINE; Darwin G., 1871, P423; De Kort SR, 2004, ANIM BEHAV, V67, P549, DOI 10.1016/j.anbehav.2003.07.004; Delacour J., 1973, CURASSOWS RELATED BI; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Felsenstein J, 2012, AM NAT, V179, P145, DOI 10.1086/663681; Feo TJ, 2010, AUK, V127, P787, DOI 10.1525/auk.2010.09263; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Gaunt AS, 1999, GUIDELINES USE WILD, P1; Hingee M, 2009, P ROY SOC B-BIOL SCI, V276, P4173, DOI 10.1098/rspb.2009.1110; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Lane DF, 2007, AUK, V124, P762, DOI 10.1642/0004-8038(2007)124[762:ADNSOT]2.0.CO;2; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2009, J ORNITHOL, V150, P155, DOI 10.1007/s10336-008-0330-x; NOWICKI S, 1986, J NEUROSCI, V6, P3595; Pearson OP, 1960, SPEED ALLEN HUMMINGB, P403; Peterson Roger, 2001, FIELD GUIDE BIRDS BR; Price JJ, 2002, EVOLUTION, V56, P1514; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Reddig V. E., 1978, J ORNITHOL, V119, P357; Robillard T, 2013, J EXP BIOL, V216, P2001, DOI 10.1242/jeb.083964; STILES FG, 1983, AUK, V100, P311, DOI 10.1093/auk/100.2.311; Suthers RA, 2004, NATURES MUSIC; ten Cate C, 2004, NATURES MUSIC SCI BI; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; TRAIL PW, 1991, WILSON BULL, V103, P539; Tuck L.M., 1972, SNIPES STUDY GENUS C, V5; Zyskowski Kristof, 1998, Bulletin of the British Ornithologists' Club, V118, P82	42	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93829	10.1371/journal.pone.0093829	http://dx.doi.org/10.1371/journal.pone.0093829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722049	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100025
J	Gianola, D; Weigel, KA; Kramer, N; Stella, A; Schon, CC				Gianola, Daniel; Weigel, Kent A.; Kraemer, Nicole; Stella, Alessandra; Schoen, Chris-Carolin			Enhancing Genome-Enabled Prediction by Bagging Genomic BLUP	PLOS ONE			English	Article							HILBERT-SPACES REGRESSION; QUANTITATIVE TRAITS; ASSISTED PREDICTION; BREEDING VALUES; GENETIC VALUE; ACCURACY; PEDIGREE; INFORMATION; SELECTION	We examined whether or not the predictive ability of genomic best linear unbiased prediction (GBLUP) could be improved via a resampling method used in machine learning: bootstrap aggregating sampling ("bagging''). In theory, bagging can be useful when the predictor has large variance or when the number of markers is much larger than sample size, preventing effective regularization. After presenting a brief review of GBLUP, bagging was adapted to the context of GBLUP, both at the level of the genetic signal and of marker effects. The performance of bagging was evaluated with four simulated case studies including known or unknown quantitative trait loci, and an application was made to real data on grain yield in wheat planted in four environments. A metric aimed to quantify candidate-specific cross-validation uncertainty was proposed and assessed; as expected, model derived theoretical reliabilities bore no relationship with cross-validation accuracy. It was found that bagging can ameliorate predictive performance of GBLUP and make it more robust against over-fitting. Seemingly, 25-50 bootstrap samples was enough to attain reasonable predictions as well as stable measures of individual predictive mean squared errors.	[Gianola, Daniel] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Gianola, Daniel; Weigel, Kent A.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Gianola, Daniel] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Kraemer, Nicole; Schoen, Chris-Carolin] Tech Univ Munich, Weihenstephan Ctr, Dept Plant Breeding, D-80290 Munich, Germany; [Stella, Alessandra] Parco Tecnol Padano, Bioinformat & Stat Unit, Lodi, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Munich	Gianola, D (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	gianola@ansci.wisc.edu	stella, Alessandra/AAG-6401-2021; Guntinas-Lichius, Orlando/L-1871-2016; Schoen, Chris/G-1867-2011; stella, Alessandra/ABB-1952-2021; Stella, Alessandra/AAY-7322-2020	stella, Alessandra/0000-0003-2850-3964; Guntinas-Lichius, Orlando/0000-0001-9671-0784; Schoen, Chris/0000-0001-6067-7900; stella, Alessandra/0000-0003-2850-3964; Kramer, Nicole/0000-0002-8209-9141	Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding" [FKZ 03115528A]; U.S. Department of Agriculture Hatch Grant [142-PRJ63CV]; Wisconsin Agriculture Experiment Station	Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding"(Federal Ministry of Education & Research (BMBF)); U.S. Department of Agriculture Hatch Grant; Wisconsin Agriculture Experiment Station	Research was partially supported by the Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding" (FKZ 03115528A), by a U.S. Department of Agriculture Hatch Grant (142-PRJ63CV) to DG, and by the Wisconsin Agriculture Experiment Station. The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, MACH LEARN, V45, P261, DOI 10.1023/A:1017934522171; Bulmer MG, 1980, MATH THEORY QUANTITA; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, ANIM PROD SCI, V50, P1004, DOI 10.1071/AN10096; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Erbe M., 2010, 9 WORLD C GEN APPL L, P129; Erbe M, 2013, THESIS GEORGE AUGUST; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNANDO RL, 1986, THEOR APPL GENET, V72, P822, DOI 10.1007/BF00266552; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gianola D, 1999, GENET SEL EVOL, V22, P403; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Gianola D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-87; Goddard ME, 2008, GENETICA; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Henderson C. R., 1973, Proceedings of the Animal Breeding and Genetics Symposium in honor of Dr. Jay L. Lush, held July 29, 1972, at Virginia Polytechnic Institute and State University, Blacksburg, Virginia., P10; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; HENDERSON CR, 1977, J DAIRY SCI, V60, P783, DOI 10.3168/jds.S0022-0302(77)83935-0; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Janss L, 2012, GENETICS, V192, P693, DOI 10.1534/genetics.112.141143; Lehermeier C, 2013, STAT APPL GENET MOL, V12, P375, DOI 10.1515/sagmb-2012-0042; Long NY, 2011, GENETICA, V139, P843, DOI 10.1007/s10709-011-9588-7; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Meuwissen THE, 2001, GENETICS, V157, P1819; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; Suen YL, 2005, LECT NOTES ARTIF INT, V3720, P741, DOI 10.1007/11564096_76; Takezawa K, 2006, INTRODUCTION TO NONPARAMETRIC REGRESSION, P1; Valle C, 2007, LECT NOTES COMPUT SC, V4723, P130; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078	45	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91693	10.1371/journal.pone.0091693	http://dx.doi.org/10.1371/journal.pone.0091693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722227	Green Published, gold			2022-12-25	WOS:000336909100009
J	Li, Q; Pogwizd, SM; Prabhu, SD; Zhou, LF				Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang			Inhibiting Na+/K+ ATPase Can Impair Mitochondrial Energetics and Induce Abnormal Ca2+ Cycling and Automaticity in Guinea Pig Cardiomyocytes	PLOS ONE			English	Article							COMPUTATIONAL MODEL; ELECTRICAL-ACTIVITY; INTRACELLULAR CA2+; REDOX BALANCE; CALCIUM; CONTRACTION; TRANSPORT; OSCILLATIONS; MICRODOMAINS; MECHANISMS	Cardiac glycosides have been used for the treatment of heart failure because of their capabilities of inhibiting Na+/K+ ATPase (NKA), which raises [Na+](i) and attenuates Ca2+ extrusion via the Na+/Ca2+ exchanger (NCX), causing [Ca2+](i) elevation. The resulting [Ca2+](i) accumulation further enhances Ca2+-induced Ca2+ release, generating the positive inotropic effect. However, cardiac glycosides have some toxic and side effects such as arrhythmogenesis, confining their extensive clinical applications. The mechanisms underlying the proarrhythmic effect of glycosides are not fully understood. Here we investigated the mechanisms by which glycosides could cause cardiac arrhythmias via impairing mitochondrial energetics using an integrative computational cardiomyocyte model. In the simulations, the effect of glycosides was mimicked by blocking NKA activity. Results showed that inhibiting NKA not only impaired mitochondrial Ca2+ retention (thus suppressed reactive oxygen species (ROS) scavenging) but also enhanced oxidative phosphorylation (thus increased ROS production) during the transition of increasing workload, causing oxidative stress. Moreover, concurrent blocking of mitochondrial Na+/Ca2+ exchanger, but not enhancing of Ca2+ uniporter, alleviated the adverse effects of NKA inhibition. Intriguingly, NKA inhibition elicited Ca2+ transient and action potential alternans under more stressed conditions such as severe ATP depletion, augmenting its proarrhythmic effect. This computational study provides new insights into the mechanisms underlying cardiac glycoside-induced arrhythmogenesis. The findings suggest that targeting both ion handling and mitochondria could be a very promising strategy to develop new glycoside-based therapies in the treatment of heart failure.	[Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Pogwizd, Steven M.; Zhou, Lufang] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang] Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, LF (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	lfzhou@uab.edu		Zhou, Lufang/0000-0002-1321-8442	NIH/NHLBI [R00HL095648]; University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095648, R01HL121206] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH/NHLBI R00HL095648 and University of Alabama at Birmingham Comprehensive Cardiovascular Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; BARRINGTON PL, 1988, J MOL CELL CARDIOL, V20, P1163, DOI 10.1016/0022-2828(88)90596-2; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bers DM, 2009, IUBMB LIFE, V61, P215, DOI 10.1002/iub.163; Brandes R, 2002, BIOPHYS J, V83, P587, DOI 10.1016/S0006-3495(02)75194-1; Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82; Brandes R, 1999, BIOPHYS J, V77, P1666, DOI 10.1016/S0006-3495(99)77014-1; Campia I, 2012, BIOCHEM J, V447, P301, DOI 10.1042/BJ20120200; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; FEDIDA D, 1987, J PHYSIOL-LONDON, V392, P523, DOI 10.1113/jphysiol.1987.sp016795; FERRIER GR, 1977, PROG CARDIOVASC DIS, V19, P459, DOI 10.1016/0033-0620(77)90010-X; Florea SM, 2012, AM J PHYSIOL-HEART C, V303, pH1047, DOI 10.1152/ajpheart.00384.2012; Florea SM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00141; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Gauthier LD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00244; Gonano LA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P947, DOI 10.1161/CIRCEP.111.964908; Greenstein JL, 2006, BIOPHYS J, V90, P77, DOI 10.1529/biophysj.105.065169; Hashim T, 2013, AM J MED; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Huser J, 2000, J BIOENERG BIOMEMBR, V32, P27, DOI 10.1023/A:1005556227425; ISHIDA H, 1988, J CLIN INVEST, V81, P1173, DOI 10.1172/JCI113432; Kajikawa M, 2002, DIABETES, V51, P2522, DOI 10.2337/diabetes.51.8.2522; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Li QC, 2012, BIOPHYS J, V102, P1471, DOI 10.1016/j.bpj.2012.03.007; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Liu T, 2010, J MOL CELL CARDIOL, V49, P728, DOI 10.1016/j.yjmcc.2010.06.012; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; Matsuoka S, 2004, PROG BIOPHYS MOL BIO, V85, P279, DOI 10.1016/j.pbiomolbio.2004.01.006; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Rahimtoola SH, 2004, CIRCULATION, V109, P2942, DOI 10.1161/01.CIR.0000132477.32438.03; Ramesh V, 1998, ANN NY ACAD SCI, V853, P341, DOI 10.1111/j.1749-6632.1998.tb08295.x; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; RIZZUTO R, 2004, SCI STKE; Roberts BN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002241; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Smith RM, 2013, AM J PHYSIOL-HEART C, V305, pH9, DOI 10.1152/ajpheart.00915.2012; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Zhou LF, 2011, J MOL CELL CARDIOL, V51, P632, DOI 10.1016/j.yjmcc.2011.05.007; Zhou L, 2009, BIOPHYS J, V97, P1843, DOI 10.1016/j.bpj.2009.07.029	55	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93928	10.1371/journal.pone.0093928	http://dx.doi.org/10.1371/journal.pone.0093928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722410	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100029
J	Li, R; Xu, W; Chen, Y; Qiu, W; Shu, YQ; Wu, AM; Dai, YQ; Bao, J; Lu, ZQ; Hu, XQ				Li, Rui; Xu, Wen; Chen, Ying; Qiu, Wei; Shu, Yaqing; Wu, Aimin; Dai, Yongqiang; Bao, Jian; Lu, Zhengqi; Hu, Xueqiang			Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-kappa B-Dependent CCL20 Expression in Reactive Astrocytes	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PREGNANCY HORMONE ESTRIOL; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; SPINAL-CORD; IN-VITRO; T-CELLS; INHIBITION; MODULATORS	Recent clinical data have led to the consideration of sexual steroids as new potential therapeutic tools for multiple sclerosis. Selective estrogen receptor modulators can exhibit neuroprotective effects like estrogen, with fewer systemic estrogen side effects than estrogen, offering a more promising therapeutic modality for multiple sclerosis. The important role of astrocytes in a proinflammatory effect mediated by CCL20 signaling on inflammatory cells has been documented. Their potential contribution to selective estrogen receptor modulator-mediated protection is still unknown. Using a mouse model of chronic neuroinflammation, we report that raloxifene, a selective estrogen receptor modulator, alleviated experimental autoimmune encephalomyelitis-an animal model of multiple sclerosis-and decreased astrocytic production of CCL20. Enzyme-linked immunosorbent assay, immunohistochemistry imaging and transwell migration assays revealed that reactive astrocytes express CCL20, which promotes Th17 cell migration. In cultured rodent astrocytes, raloxifene inhibited IL-1 beta-induced CCL20 expression and chemotaxis ability for Th17 migration, whereas the estrogen receptor antagonist ICI 182,780 blocked this effect. Western blotting further indicated that raloxifene suppresses IL-1 beta-induced NF-kappa B activation (phosphorylation of p65) and translocation but does not affect phosphorylation of I kappa B. In conclusion, these data demonstrate that raloxifene provides robust neuroprotection against experimental autoimmune encephalomyelitis, partially via an inhibitory action on CCL20 expression and NF-kappa B pathways in reactive astrocytes. Our results contribute to a better understanding of the critical roles of raloxifene in treating experimental autoimmune encephalomyelitis and uncover reactive astrocytes as a new target for the inhibitory action of estrogen receptors on chemokine CCL20 expression.	[Li, Rui; Xu, Wen; Chen, Ying; Qiu, Wei; Shu, Yaqing; Wu, Aimin; Dai, Yongqiang; Bao, Jian; Lu, Zhengqi; Hu, Xueqiang] Sun Yat Sen Univ, Affiliated Hosp 3, Multiple Sclerosis Ctr, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Hu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Multiple Sclerosis Ctr, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	huxueqiangzssy@qq.com	wei, qiu/M-7363-2015		National Science Foundation of China [81171126]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation of China (No. 81171126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Bebo BF, 2009, GLIA, V57, P777, DOI 10.1002/glia.20805; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Garidou L, 2004, J IMMUNOL, V173, P2435, DOI 10.4049/jimmunol.173.4.2435; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hosokawa Y, 2013, CELL IMMUNOL, V283, P8, DOI 10.1016/j.cellimm.2013.05.005; Islander U, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3371; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu HB, 2003, J IMMUNOL, V171, P6936, DOI 10.4049/jimmunol.171.12.6936; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nicot A, 2005, EUR J NEUROSCI, V21, P2660, DOI 10.1111/j.1460-9568.2005.04086.x; Nicot A, 2009, FRONT BIOSCI-LANDMRK, V14, P4477, DOI 10.2741/3543; Niino Masaaki, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P87; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; RUNMARKER B, 1995, BRAIN, V118, P253, DOI 10.1093/brain/118.1.253; Serafini B, 2000, AM J PATHOL, V157, P1991, DOI 10.1016/S0002-9440(10)64838-9; Sharma RV, 2001, J APPL PHYSIOL, V91, P2400, DOI 10.1152/jappl.2001.91.5.2400; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	43	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94320	10.1371/journal.pone.0094320	http://dx.doi.org/10.1371/journal.pone.0094320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722370	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100053
J	Li, W; Zhao, QJ; Deng, WY; Chen, T; Liu, MQ; Xie, JP				Li, Wu; Zhao, Quanju; Deng, Wanyan; Chen, Tian; Liu, Minqiang; Xie, Jianping			Mycobacterium tuberculosis Rv3402c Enhances Mycobacterial Survival within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production via NF-Kappa B/ERK/p38 Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE-PHOSPHATASE PTPA; FACTOR-ALPHA; PROINFLAMMATORY CYTOKINES; SUPEROXIDE-DISMUTASE; PROMOTES SURVIVAL; HUMAN MONOCYTES; TNF-ALPHA; PROTEIN; GROWTH	Intracellular survival plays a central role in the pathogenesis of Mycobacterium tuberculosis, a process which depends on an array of virulence factors to colonize and replicate within the host. The M. tuberculosis iron regulated open reading frame (ORF) rv3402c, encoding a conserved hypothetical protein, was shown to be up-regulated upon infection in both human and mice macrophages. To explore the function of this ORF, we heterologously expressed the rv3402c gene in the nonpathogenic fast-growing Mycobacterium smegmatis strain, and demonstrated that Rv3402c, a cell envelope-associated protein, was able to enhance the intracellular survival of recombinant M. smegmatis. Enhanced growth was not found to be the result of an increased resistance to intracellular stresses, as growth of the Rv3402c expressing strain was unaffected by iron depletion, H2O2 exposure, or acidic conditions. Colonization of macrophages by M. smegmatis expressing Rv3402c was associated with substantial cell death and significantly greater amount of TNF-alpha and IL-1 beta compared with controls. Rv3402c-induced TNF-alpha and IL-1 beta production was found to be mediated by NF-kappa B, ERK and p38 pathway in macrophages. In summary, our study suggests that Rv3402c delivered in a live M. smegmatis vehicle can modify the cytokines profile of macrophage, promote host cell death and enhance the persistence of mycobacterium within host cells.	[Li, Wu; Zhao, Quanju; Deng, Wanyan; Chen, Tian; Liu, Minqiang; Xie, Jianping] Southwest Univ, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Minist Educ Ecoenvironm Gorges Reservoir, Inst Modern Biopharmaceut,Sch Life Sci, Chongqing, Peoples R China	Southwest University - China	Xie, JP (corresponding author), Southwest Univ, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Minist Educ Ecoenvironm Gorges Reservoir, Inst Modern Biopharmaceut,Sch Life Sci, Chongqing, Peoples R China.	georgex@swu.edu.cn	xu, li/AAO-4684-2021; Li, Wu/K-3792-2019; xu, li/GNH-3667-2022	Li, Wu/0000-0002-0336-1843	National Natural Science Foundation [81371851, 81071316, 81271882]; National Megaprojects for Key Infectious Diseases [2008ZX10003-006, 2012ZX10003-003]; New Century Excellent Talents in Universities [NCET-11-0703]; Southwest University [kb2010017, ky2011003]; Fundamental Research Funds for the Central Universities [XDJK2011D006, XDJK2012D011, XDJK2012D007, XDJK2013D003]; Natural Science Foundation Project of CQ CSTC [CSTC 2010BB5002]; Chongqing Municipal Committee of Education for postgraduates excellence program [YJG123104]; undergraduates teaching reform program [2011JY052]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Megaprojects for Key Infectious Diseases; New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Southwest University(Southwest University - China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Chongqing Municipal Committee of Education for postgraduates excellence program; undergraduates teaching reform program	This work was supported by National Natural Science Foundation (grant numbers 81371851, 81071316, 81271882), National Megaprojects for Key Infectious Diseases (grant numbers 2008ZX10003-006, 2012ZX10003-003), New Century Excellent Talents in Universities (grant number NCET-11-0703), Excellent PhD thesis fellowship of Southwest University (grant numbers kb2010017, ky2011003), the Fundamental Research Funds for the Central Universities (Nos. XDJK2011D006, XDJK2012D011, XDJK2012D007 and XDJK2013D003), Natural Science Foundation Project of CQ CSTC (grant number CSTC 2010BB5002), the Chongqing Municipal Committee of Education for postgraduates excellence program (No. YJG123104), the undergraduates teaching reform program (No. 2011JY052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Daim S, 2011, J MED MICROBIOL, V60, P582, DOI 10.1099/jmm.0.026047-0; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jacobs M, 2007, MICROBES INFECT, V9, P623, DOI 10.1016/j.micinf.2007.02.002; Ji L, 2011, INT J BIOL SCI, V7, P376, DOI 10.7150/ijbs.7.376; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Kim KH, 2011, IMMUNE NETW, V11, P123, DOI DOI 10.4110/IN.2011.11.2.123; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Kuprash DV, 1999, J IMMUNOL, V163, P6575; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lagier B, 1998, MOL MICROBIOL, V29, P465, DOI 10.1046/j.1365-2958.1998.00933.x; Lee JS, 2003, CLIN EXP IMMUNOL, V132, P443, DOI 10.1046/j.1365-2249.2003.02172.x; Li JM, 2008, CHINESE MED J-PEKING, V121, P1114, DOI 10.1097/00029330-200806020-00015; Li W, 2013, CELL PHYSIOL BIOCHEM, V31, P1, DOI 10.1159/000343343; Li W, 2011, J CELL BIOCHEM, V112, P2688, DOI 10.1002/jcb.23218; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Miller J, 2010, NY TIMES BK REV, P6; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pelosi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031788; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Rengarajan J, 2008, P NATL ACAD SCI USA, V105, P264, DOI 10.1073/pnas.0710601105; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Silver RF, 1998, J IMMUNOL, V160, P2408; Singh A, 2006, TUBERCULOSIS, V86, P28, DOI 10.1016/j.tube.2005.04.002; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wilson T, 1998, MICROBIOL-UK, V144, P2687, DOI 10.1099/00221287-144-10-2687; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	61	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94418	10.1371/journal.pone.0094418	http://dx.doi.org/10.1371/journal.pone.0094418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722253	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100068
J	Medina, DJ; Abass-Shereef, J; Walton, K; Goodell, L; Aviv, H; Strair, RK; Budak-Alpdogan, T				Medina, Daniel J.; Abass-Shereef, Jeneba; Walton, Kelly; Goodell, Lauri; Aviv, Hana; Strair, Roger K.; Budak-Alpdogan, Tulin			Cobblestone-Area Forming Cells Derived from Patients with Mantle Cell Lymphoma Are Enriched for CD133(+) Tumor-Initiating Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; STROMAL CELLS; NOD/SCID MICE; TRANSCRIPTION FACTORS; FREQUENCY-ANALYSIS; PROGENITOR CELLS; ENGRAFTMENT; SOX11; EXPRESSION	Mantle cell lymphoma (MCL) is associated with a significant risk of therapeutic failure and disease relapse, but the biological origin of relapse is poorly understood. Here, we prospectively identify subpopulations of primary MCL cells with different biologic and immunophenotypic features. Using a simple culture system, we demonstrate that a subset of primary MCL cells co-cultured with either primary human mesenchymal stromal cells (hMSC) or murine MS-5 cells form in cobblestone-areas consisting of cells with a primitive immunophenotype (CD19-CD133(+)) containing the chromosomal translocation t (11;14)(q13;q32) characteristic of MCL. Limiting dilution serial transplantation experiments utilizing immunodeficient mice revealed that primary MCL engraftment was only observed when either unsorted or CD19-CD133(+) cells were utilized. No engraftment was seen using the CD19(+)CD133(-) subpopulation. Our results establish that primary CD19-CD133(+) MCL cells are a functionally distinct subpopulation of primary MCL cells enriched for MCL-initiating activity in immunodeficient mice. This rare subpopulation of MCL-initiating cells may play an important role in the pathogenesis of MCL.	[Medina, Daniel J.; Abass-Shereef, Jeneba; Walton, Kelly; Strair, Roger K.; Budak-Alpdogan, Tulin] Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Goodell, Lauri; Aviv, Hana] Rutgers State Univ, Dept Pathol, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Medina, DJ (corresponding author), Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	medinadj@cinj.rutgers.edu			New Jersey Commission on Science and Technology; Two Guys Charity Golf Outing; The Century For The CURE; The Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	New Jersey Commission on Science and Technology; Two Guys Charity Golf Outing; The Century For The CURE; The Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the New Jersey Commission on Science and Technology, Two Guys Charity Golf Outing and The Century For The CURE. This research was also supported by the Laboratory Support Services, Tissue Analytic Services and the Flow Cytometry Shared Resource(s) of The Cancer Institute of New Jersey (P30CA072720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bilwani FA, 2012, J IMMUNOL, V189, P4379, DOI 10.4049/jimmunol.1201176; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Brennan SK, 2010, BLOOD, V116, P4185, DOI 10.1182/blood-2010-02-268375; Brouard N, 1998, LEUKEMIA, V12, P1128, DOI 10.1038/sj.leu.2401081; Bruns I, 2009, LEUKEMIA, V23, P892, DOI 10.1038/leu.2008.392; Campo E, 1999, SEMIN HEMATOL, V36, P115; Carfi' M, 2010, TOXICOLOGY, V276, P33, DOI 10.1016/j.tox.2010.06.012; Chen Z, 2010, STEM CELL RES, V5, P212, DOI 10.1016/j.scr.2010.07.003; Choong ML, 2004, ANN HEMATOL, V83, P160, DOI 10.1007/s00277-003-0797-8; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Daibata M, 1996, J VIROL, V70, P9003, DOI 10.1128/JVI.70.12.9003-9007.1996; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Durand C, 2006, HAEMATOLOGICA, V91, P1172; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Ferrando AA, 2013, BLOOD, V121, P2169, DOI 10.1182/blood-2013-02-480418; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Hielscher A, 2013, STEM CELLS, V3, P167; Hielscher AC, 2009, THESIS U NEBRASKA; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hubin F, 2005, STEM CELLS, V23, P1626, DOI 10.1634/stemcells.2005-0041; ITOH K, 1989, EXP HEMATOL, V17, P145; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Kvinlaug BT, 2007, EXPERT OPIN THER TAR, V11, P915, DOI 10.1517/14728222.11.7.915; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee MR, 2013, ACTA HAEMATOL-BASEL, V129, P10, DOI 10.1159/000341284; Leonard JP, 2009, CLIN LYMPHOMA MYELOM, V9, P267, DOI 10.3816/CLM.2009.n.055; Li ZM, 2013, CANC TREAT REV; Lu TX, 2013, LEUKEMIA RES, V37, P1412, DOI 10.1016/j.leukres.2013.07.039; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Nygren L, 2012, BLOOD, V119, P4215, DOI 10.1182/blood-2011-12-400580; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pileri SA, 2009, HAEMATOL-HEMATOL J, V94, P1488, DOI 10.3324/haematol.2009.013359; Ploemacher RE, 1997, BAILLIERE CLIN HAEM, V10, P429, DOI 10.1016/S0950-3536(97)80019-4; PLOEMACHER RE, 1989, BLOOD, V74, P2755; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Rasheed Z, 2010, J VIS EXP; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rehe K, 2013, EMBO MOL MED, V5, P38, DOI 10.1002/emmm.201201703; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schaumann DHS, 2007, MOL IMMUNOL, V44, P1606, DOI 10.1016/j.molimm.2006.08.021; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; SUTHERLAND HJ, 1991, BLOOD, V78, P666, DOI 10.1182/blood.V78.3.666.bloodjournal783666; Teshima K, 2013, ONCOGENE; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; Vegliante MC, 2013, BLOOD; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang XM, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/465915; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xu WR, 2011, J TRADIT CHIN MED, V31, P158, DOI 10.1016/S0254-6272(11)60032-0; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhang XB, 2002, BONE MARROW TRANSPL, V30, P557, DOI 10.1038/sj.bmt.1703714	67	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91042	10.1371/journal.pone.0091042	http://dx.doi.org/10.1371/journal.pone.0091042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722054	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100006
J	Xu, S; Wen, Z; Jiang, Q; Zhu, L; Feng, S; Zhao, Y; Wu, J; Dong, Q; Mao, J; Zhu, Y				Xu, S.; Wen, Z.; Jiang, Q.; Zhu, L.; Feng, S.; Zhao, Y.; Wu, J.; Dong, Q.; Mao, J.; Zhu, Y.			CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer	ONCOGENE			English	Article							STEM-CELLS; PROSPECTIVE IDENTIFICATION; METASTATIC CAPACITY; ADHESION MOLECULES; DRUG-RESISTANCE; COLON; EXPRESSION; DIFFERENTIATION; SUBPOPULATION; CONTRIBUTE	Colorectal tumor-initiating cells (CT-ICs) have self-renewal capabilities and have an important role in tumorigenesis, metastasis, recurrence and treatment resistance in colorectal cancer. Multiple cell-surface molecules targeting CT-ICs, possibly representing different CT-IC subpopulations, have been reported. However, whether new surface markers exist, as well as the mechanisms by which the markers regulate self-renewal, remain unclear. In this study, we enriched a CT-IC population through a serum-free low-adhesion system in vitro. Within this population, we found that CD58 and CD44 were upregulated using a cDNA GeneChip, and CD44(high)CD58(high) cancer cells, the common existence of which was demonstrated by flow cytometry in multiple colon cancer cell lines and primary specimens, exhibited enhanced self-renewal ability, epithelial-mesenchymal transition ability and tumorigenicity, both in vitro and in vivo. Furthermore, activated CD58 upregulated the Wnt/beta-catenin pathway and thus promoted self-renewal of CT-ICs; conversely, knockdown of CD58 significantly impaired sphere formation and tumor growth. With immunoprecipitation and western blotting approaches, CD58 was found to upregulate the Wnt pathway by degradation of Dickkopf 3. These results indicate that CD58 is a novel cell-surface marker that functionally regulates self-renewal of CT-ICs, which may provide an intriguing therapeutic target for the efficient killing and elimination of CT-ICs.	[Xu, S.; Wen, Z.; Zhu, L.; Feng, S.; Zhao, Y.; Wu, J.; Mao, J.; Zhu, Y.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Lab Gastroenterol, Hangzhou 310009, Zhejiang, Peoples R China; [Jiang, Q.] Tongde Hosp Zhejiang Prov, Dept Gastroenterol, Hangzhou 310012, Zhejiang, Peoples R China; [Dong, Q.; Zhu, Y.] Zhejiang Univ, Sch Med, Inst Canc, Hangzhou 310009, Zhejiang, Peoples R China; [Dong, Q.; Zhu, Y.] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent, Educ Minist, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, Y (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Lab Gastroenterol, Hangzhou 310009, Zhejiang, Peoples R China.	zhuyongliangch@gmail.com			National Science of Foundation Committee of China [81071768, 81071619, 31090361, 81372348]; Natural Science of Foundation of Zhejiang Province [R2090074, Y2110246]; Foundation of Scientific Technology Bureau of Zhejiang Province [2010C33118, 2011C23091, 2013C33129]	National Science of Foundation Committee of China; Natural Science of Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Foundation of Scientific Technology Bureau of Zhejiang Province	We thank Mr Qinghua Lu (Cancer Institute and Education Ministry Key Laboratory of Cancer Prevention and Intervention, Zhejiang University School of Medicine) for FCM analysis. This work was supported by grants from the National Science of Foundation Committee of China (81071768, 81071619, 31090361, 81372348), the Natural Science of Foundation of Zhejiang Province (R2090074, Y2110246) and the Foundation of Scientific Technology Bureau of Zhejiang Province (2010C33118, 2011C23091, 2013C33129).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ariel O, 2009, CELL SIGNAL, V21, P1100, DOI 10.1016/j.cellsig.2009.02.022; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Du L, 2013, CANCER RES, V73, P2682, DOI 10.1158/0008-5472.CAN-12-3759; DUSTIN ML, 1987, NATURE, V329, P846, DOI 10.1038/329846a0; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG671, DOI 10.1152/ajpgi.90497.2008; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; KVALE D, 1992, SCAND J IMMUNOL, V35, P669, DOI 10.1111/j.1365-3083.1992.tb02973.x; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lee RV, 2005, AM J CLIN PATHOL, V123, P119, DOI 10.1309/X5VV-6FKJ-Q6MU-BLPX; Li DW, 2011, ANN SURG ONCOL, V18, P2074, DOI 10.1245/s10434-011-1567-9; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Mayer B, 1995, INT J CANCER, V64, P415, DOI 10.1002/ijc.2910640611; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Shenoy AK, 2012, CANCER RES, V72, P5091, DOI 10.1158/0008-5472.CAN-12-1806; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2003, CANCER RES, V63, P5821; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	55	23	24	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1520	1531		10.1038/onc.2014.95	http://dx.doi.org/10.1038/onc.2014.95			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24727892				2022-12-25	WOS:000351416800005
J	Gelabert-Baldrich, M; Soriano-Castell, D; Calvo, M; Lu, A; Vina-Vilaseca, A; Rentero, C; Pol, A; Grinstein, S; Enrich, C; Tebar, F				Gelabert-Baldrich, Mariona; Soriano-Castell, David; Calvo, Maria; Lu, Albert; Vina-Vilaseca, Arnau; Rentero, Carles; Pol, Albert; Grinstein, Sergio; Enrich, Carlos; Tebar, Francesc			Dynamics of KRas on endosomes: involvement of acidic phospholipids in its association	FASEB JOURNAL			English	Article						EGFR; PI3P; PS	RAS MEMBRANE ORIENTATION; K-RAS; PLASMA-MEMBRANE; H-RAS; CELLULAR MEMBRANES; MAMMALIAN-CELLS; CAAX MOTIF; PROTEINS; LOCALIZATION; RECEPTOR	The endocytic compartment is emerging as a functional platform for controlling important cellular processes. We have found that similar to 10 to 15% of total KRas, a protein that is frequently mutated in cancer, is present on endosomes, independent of its activation state. The dynamics of GFP-KRas wild-type (WT) and constitutively active or inactive mutants on endosomes were analyzed by fluorescence recovery after photobleaching (FRAP) microscopy. The measurements revealed an extraordinarily fast recovery of KRas WT [half-time (HT), similar to 1.3 s] compared to HRas, Rab5, and EGFR, with the active KRasG12V mutant being significantly faster and more mobile (HT, similar to 1 s, and similar to 82% of exchangeable fraction) than the inactive KRasS17N (HT, similar to 1.6 s, and similar to 60% of exchangeable fraction). KRas rapidly switches from the cytoplasm to the endosomal membranes by an electrostatic interaction between its polybasic region and the endosomal acidic phospholipids, mainly phosphatidylserine.	[Gelabert-Baldrich, Mariona; Soriano-Castell, David; Vina-Vilaseca, Arnau; Rentero, Carles; Pol, Albert; Enrich, Carlos; Tebar, Francesc] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, IDIBAPS, Barcelona 08036, Spain; [Calvo, Maria] Univ Barcelona, Unitat Microscopia Opt Avancada, Fac Med, Ctr Cient, E-08036 Barcelona, Spain; [Calvo, Maria] Univ Barcelona, Unitat Microscopia Opt Avancada, Fac Med, Ctr Tecnol, E-08036 Barcelona, Spain; [Lu, Albert] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Pol, Albert] ICREA, Barcelona, Spain; [Grinstein, Sergio] Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Stanford University; ICREA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tebar, F (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, C Casanova 143, Barcelona 08036, Spain.	tebar@ub.edu	Rentero Alfonso, Carles/L-4430-2017; Pol, Albert/M-1865-2014; Vina-Vilaseca, Arnau/O-1779-2015; LU, ALBERT/AAB-6134-2019; Tebar, Francesc/H-1498-2015; Calvo, Maria/I-1872-2015	Rentero Alfonso, Carles/0000-0003-4684-0278; Pol, Albert/0000-0002-1750-1085; Vina-Vilaseca, Arnau/0000-0003-0447-5268; LU, ALBERT/0000-0002-7507-3330; Tebar, Francesc/0000-0002-9522-9726; Calvo, Maria/0000-0002-7473-0474; Enrich, Carlos/0000-0003-0382-2993; SORIANO-CASTELL, DAVID/0000-0002-1235-1671	Ministerio de Economia y Competitividad of Spain [BFU2012-38259]; Consolider-Ingenio from Ministerio de Innovacion, Ciencia y Tecnologia of Spain; FPI from Ministerio de Ciencia et Innovacion (MICINN) [BES2009-016850]; Generalitat de Catalunya;  [BFU2011-23745]; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad of Spain(Spanish Government); Consolider-Ingenio from Ministerio de Innovacion, Ciencia y Tecnologia of Spain; FPI from Ministerio de Ciencia et Innovacion (MICINN); Generalitat de Catalunya(Generalitat de Catalunya); ; ICREA(ICREA)	The authors thank A. Bosch and E. Coll (Unitat Microscopia Optica Avancada, Centres Cientifics i Tecnologics, Universitat de Barcelona) for assistance with the confocal imaging and M. Molinos for technical assistance. This research was supported by grants BFU2012-38259 from Ministerio de Economia y Competitividad of Spain (to F. T.), Consolider-Ingenio from Ministerio de Innovacion, Ciencia y Tecnologia of Spain (to C. E. and A. P.), and BFU2011-23745 (to A. P.). M. G. is the recipient of FPI fellowship BES2009-016850 from Ministerio de Ciencia et Innovacion (MICINN). D. S. is the recipient of an FI fellowship from Generalitat de Catalunya. The authors declare no conflicts of interest.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Alvarez-Moya Blanca, 2011, Small GTPases, V2, P99; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Eisenberg S, 2008, J BIOL CHEM, V283, P27279, DOI 10.1074/jbc.M804589200; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Flores-Rodriguez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024479; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Lobert VH, 2011, PHYSIOLOGY, V26, P171, DOI 10.1152/physiol.00054.2010; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Niv H, 1999, J BIOL CHEM, V274, P1606, DOI 10.1074/jbc.274.3.1606; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pattni K, 2001, CURR BIOL, V11, P1636, DOI 10.1016/S0960-9822(01)00486-9; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Philips MR, 2012, NAT CELL BIOL, V14, P128, DOI 10.1038/ncb2429; Prior I A, 1999, Mol Cell Biol Res Commun, V1, P162, DOI 10.1006/mcbr.1999.0126; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	68	12	12	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3023	3037		10.1096/fj.13-241158	http://dx.doi.org/10.1096/fj.13-241158			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24719356				2022-12-25	WOS:000337949400025
J	Hong, IK; Byun, HJ; Lee, J; Jin, YJ; Wang, SJ; Jeoung, DI; Kim, YM; Lee, H				Hong, In-Kee; Byun, Hee-Jung; Lee, Jaeseob; Jin, Young-June; Wang, Sun-Ju; Jeoung, Doo-Il; Kim, Young-Myeong; Lee, Hansoo			The Tetraspanin CD81 Protein Increases Melanoma Cell Motility by Up-regulating Metalloproteinase MT1-MMP Expression through the Pro-oncogenic Akt-dependent Sp1 Activation Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Motility; Cell Signaling; Invasion; Melanoma; Sp1; Tetraspanins	MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; HEPATOCELLULAR-CARCINOMA; GENE-TRANSCRIPTION; BETA(1) INTEGRINS; CANCER CELLS; TUMOR-CELLS; IN-VIVO; MIGRATION; CD151; PHOSPHORYLATION	Despite the importance of multiple tetraspanin proteins in cancer invasion and metastasis, little is known about the role and significance of tetraspanin CD81 in these processes. In the present study, we examined CD81 effects on melanoma cell invasiveness and metastasis. Transfection of CD81 into melanoma cells lacking endogenous CD81 expression significantly enhanced the migrating, invasive, and metastatic abilities of melanoma cells. Interestingly, membrane type 1 matrix metalloproteinase (MT1-MMP) expression was found in CD81-expressing melanoma cells but not in CD81-deficient cells. siRNA knockdown of CD81 in melanoma cells with endogenous CD81 demonstrated decreased MT1-MMP levels and cell motility. Notably, CD81-induced cell migration was abrogated by antibody blocking and siRNA knockdown of MT1-MMP, indicating that MT1-MMP is responsible for CD81-stimulated melanoma cell migration. Promoter analysis revealed an essential role of the Sp1 transcription factor in CD81-induced MT1-MMP transcription. We also demonstrate that the Sp1-activating Akt pathway is involved in adhesion-dependent CD81 signaling to induce MT1-MMP expression and cell motility. Importantly, human skin cancer tissue specimens displayed a positive correlation of CD81 with MT1-MMP expression levels and a close association of CD81 with malignant melanomas. Taken together, these results strongly suggest that CD81 stimulates melanoma cell motility by inducing MT1-MMP expression through the Akt-dependent Sp1 activation signaling pathway, leading to increased melanoma invasion and metastasis.	[Hong, In-Kee; Byun, Hee-Jung; Jin, Young-June; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Lee, Jaeseob; Lee, Hansoo] Kangwon Natl Univ, Brain Korea Grad Program 21, Chunchon 200701, Kangwon Do, South Korea; [Lee, Jaeseob; Wang, Sun-Ju; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr			National Research Foundation of Korea - Ministry of Education [2011-0024380]; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI13C1819]	National Research Foundation of Korea - Ministry of Education; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program Grant 2011-0024380 through the National Research Foundation of Korea funded by the Ministry of Education and by Grant HI13C1819 of the Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea.	Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Choi NS, 2000, ANAL BIOCHEM, V281, P236, DOI 10.1006/abio.2000.4572; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; Inoue G, 2001, INT J MOL MED, V7, P67; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mou LY, 2013, J BIOL CHEM, V288, P306, DOI 10.1074/jbc.M112.389783; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Schroder HM, 2013, INT J BIOCHEM CELL B, V45, P1133, DOI 10.1016/j.biocel.2013.02.020; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	42	49	52	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15691	15704		10.1074/jbc.M113.534206	http://dx.doi.org/10.1074/jbc.M113.534206			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733393	Green Published, hybrid			2022-12-25	WOS:000337465400050
J	Kang, I; Yoon, DW; Braun, KR; Wight, TN				Kang, Inkyung; Yoon, Dong Won; Braun, Kathleen R.; Wight, Thomas N.			Expression of Versican V3 by Arterial Smooth Muscle Cells Alters Tumor Growth Factor beta (TGF beta)-, Epidermal Growth Factor (EGF)-, and Nuclear Factor kappa B (NF kappa B)-dependent Signaling Pathways, Creating a Microenvironment That Resists Monocyte Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Elastin; Epidermal Growth Factor Receptor (EGFR); Extracellular Matrix; Hyaluronate; Monocytes; NFkappaB; Transforming Growth Factor Beta (TGFbeta); Vascular Smooth Muscle Cells; Versican	RETROVIRALLY MEDIATED OVEREXPRESSION; ACTIVATES LATENT TGF-BETA-1; ELASTIN-BINDING PROTEIN; EXTRACELLULAR-MATRIX; HYALURONAN SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; POLYCYTIDYLIC ACID; VCAM-1 EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION	Background: Monocyte accumulation contributes to inflammatory disease progression. Results: ASMCs overexpressing V3 resist monocyte adhesion by promoting elastogenesis, depleting hyaluronan, and reducing VCAM1, via differentially regulating TGF-, EGF-, and NFB-signaling pathways. Conclusion: V3 expression by ASMCs generates a microenvironment resistant to monocyte adhesion. Significance: Modifying ECM components via V3 expression alters monocyte adhesion, which suggests therapeutic possibilities to treat inflammation. Monocyte/macrophage accumulation plays a critical role during progression of cardiovascular diseases, such as atherosclerosis. Our previous studies demonstrated that retrovirally mediated expression of the versican V3 splice variant (V3) by arterial smooth muscle cells (ASMCs) decreases monocyte adhesion in vitro and macrophage accumulation in a model of lipid-induced neointimal formation in vivo. We now demonstrate that V3-expressing ASMCs resist monocyte adhesion by altering the composition of the microenvironment surrounding the cells by affecting multiple signaling pathways. Reduction of monocyte adhesion to V3-expressing ASMCs is due to the generation of an extracellular matrix enriched in elastic fibers and depleted in hyaluronan, and reduction of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1). Blocking these changes reverses the protective effect of V3 on monocyte adhesion. The enhanced elastogenesis induced by V3 expression is mediated by TGF signaling, whereas the reduction in hyaluronan cable formation induced by V3 expression is mediated by the blockade of epidermal growth factor receptor and NFB activation pathways. In addition, expression of V3 by ASMCs induced a marked decrease in NFB-responsive proinflammatory cell surface molecules that mediate monocyte adhesion, such as VCAM1. Overall, these results indicate that V3 expression by ASMCs creates a microenvironment resistant to monocyte adhesion via differentially regulating multiple signaling pathways.	[Kang, Inkyung; Yoon, Dong Won; Braun, Kathleen R.; Wight, Thomas N.] Virginia Mason, Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center	Wight, TN (corresponding author), Virginia Mason, Benaroya Res Inst, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org			National Institutes of Health [EB012558, HL098067, HL106967, HL018645]; American Heart Association [09POST2050065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL106967, P01HL018645, P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB012558, HL098067, HL106967, and HL018645 (to T. N. W.). This work was also supported by American Heart Association Grant 09POST2050065 (to I. K.).	Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Bandyopadhyay SK, 2008, AM J PATHOL, V173, P1361, DOI 10.2353/ajpath.2008.080444; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hinek A, 1996, BIOL CHEM, V377, P471; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kothapalli CR, 2008, J TISSUE ENG REGEN M, V2, P106, DOI 10.1002/term.70; Landry DB, 1997, AM J PATHOL, V151, P1085; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Leask A., 2014, J CELL COMM IN PRESS; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McGowan SE, 1997, AM J RESP CELL MOL, V17, P25, DOI 10.1165/ajrcmb.17.1.2686; MCGOWAN SE, 1990, AM J RESP CELL MOL, V3, P369, DOI 10.1165/ajrcmb/3.4.369; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; NEEDHAM LA, 1994, CELL ADHES COMMUN, V2, P87, DOI 10.3109/15419069409004429; Oertli B, 1998, J IMMUNOL, V161, P3431; Ohkawa T, 1999, BBA-MOL CELL RES, V1448, P416, DOI 10.1016/S0167-4889(98)00155-4; Parks WC, 1997, AM J RESP CELL MOL, V17, P1; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schawalder A, 1999, NEPHROL DIAL TRANSPL, V14, P2130, DOI 10.1093/ndt/14.9.2130; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhang MC, 1999, MOL CELL BIOL, V19, P7314; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	85	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15393	15404		10.1074/jbc.M113.544338	http://dx.doi.org/10.1074/jbc.M113.544338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719328	Green Published, hybrid			2022-12-25	WOS:000337465400023
J	Luz, S; Cihil, KM; Brautigan, DL; Amaral, MD; Farinha, CM; Swiatecka-Urban, A				Luz, Simao; Cihil, Kristine M.; Brautigan, David L.; Amaral, Margarida D.; Farinha, Carlos M.; Swiatecka-Urban, Agnieszka			LMTK2-mediated Phosphorylation Regulates CFTR Endocytosis in Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; DARBY CANINE KIDNEY; TYROSINE KINASE; MYOSIN-VI; ION-TRANSPORT; CL-SECRETION; HALF-LIFE; PROTEIN; TRAFFICKING	Cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- -selective ion channel expressed in fluid-transporting epithelia. Lemur tyrosine kinase 2 (LMTK2) is a transmembrane protein with serine and threonine but not tyrosine kinase activity. Previous work identified CFTR as an in vitro substrate of LMTK2, suggesting a functional link. Here we demonstrate that LMTK2 co-immunoprecipitates with CFTR and phosphorylates CFTR-Ser737 inhumanairway epithelial cells. LMTK2knockdown or expression of inactive LMTK2 kinase domain increases cell surface density of CFTR by attenuating its endocytosis in human airway epithelial cells. Moreover, LMTK2 knockdown increases Cl- secretion mediated by the wild-type and rescued Delta F508-CFTR. Compared with the wild-type CFTR, the phosphorylation-deficient mutant CFTR-S737A shows increased cell surface density and decreased endocytosis. These results demonstrate a novel mechanism of the phospho-dependent inhibitory effect of CFTR-Ser(737) mediated by LMTK2 via endocytosis and inhibition of the cell surface density of CFTRCl- channels. These data indicate that targeting LMTK2 may increase the cell surface density of CFTR Cl- channels and improve stability of pharmacologically rescued Delta F508-CFTR in patients with cystic fibrosis.	[Luz, Simao; Amaral, Margarida D.; Farinha, Carlos M.] Univ Lisbon, Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Cihil, Kristine M.; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15201 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Universidade de Lisboa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Amaral, Margarida D/E-5748-2012; Cunha da Luz, Simao/U-5699-2017; Swiatecka-Urban, Agnieszka/AAP-6041-2020; Farinha, Carlos/A-7110-2010	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; Amaral, Margarida D/0000-0002-0828-8630; Cunha da Luz, Simao/0000-0001-5649-583X; Farinha, Carlos/0000-0002-5467-1710	National Institutes of Health [R01HL090767, R01HL090767-02S1, P30DK072506]; Cystic Fibrosis Foundation [SWIATE14P0]; University of Pittsburgh Bridge Founding; Portuguese FCT [PEst-OE/BIA/UI4046/2011, MCTES PTDC/BIA-BCM/112635/2009, EXPL/BIM-MEC/1451/2013]; Romain Pauwels Research Award;  [SFRH/BD/47445/2008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Pittsburgh Bridge Founding; Portuguese FCT(Portuguese Foundation for Science and Technology); Romain Pauwels Research Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01HL090767, R01HL090767-02S1, the Cystic Fibrosis Foundation SWIATE14P0, and the University of Pittsburgh Bridge Founding (to A. S-U.), the National Institutes of Health Grant P30DK072506 (to J. M. P., Cystic Fibrosis Research Center Epithelial Cell Core at the University of Pittsburgh School of Medicine, Pittsburgh, PA), the Portuguese FCT grants PEst-OE/BIA/UI4046/2011, MCTES PTDC/BIA-BCM/112635/2009, EXPL/BIM-MEC/1451/2013, and Romain Pauwels Research Award (to C. M. F.), and the Fellowship Grant SFRH/BD/47445/2008 (to S. L.).	Alzamora R, 2011, METHODS MOL BIOL, V741, P471, DOI 10.1007/978-1-61779-117-8_29; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chang CW, 1997, J NEUROCHEM, V69, P859; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cihil KM, 2013, JOVE-J VIS EXP, DOI 10.3791/50867; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Guggino WB, 2004, AM J RESP CRIT CARE, V170, P815, DOI 10.1164/rccm.200403-381WS; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Holy M, 2012, TOXINS, V4, P940, DOI 10.3390/toxins4100940; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Kesavapany S, 2003, J NEUROSCI, V23, P4975; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Lukacs GL, 1997, BIOCHEM J, V328, P353; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Madden Dean R, 2012, Commun Integr Biol, V5, P473, DOI 10.4161/cib.21375; Manser C, 2012, ONCOGENE, V31, P2773, DOI 10.1038/onc.2011.437; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mendes AI, 2011, MOL CELL BIOL, V31, P4076, DOI 10.1128/MCB.05152-11; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Nixon A, 2013, AM J PHYSIOL-CELL PH, V304, pC164, DOI 10.1152/ajpcell.00288.2012; Peter K, 2002, J BIOL CHEM, V277, P49952, DOI 10.1074/jbc.M209275200; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Rattray M, 2012, J NEUROCHEM, V121, P327, DOI 10.1111/j.1471-4159.2012.07654.x; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Snodgrass SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063167; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Wang H, 2006, MOL CELL PROTEOMICS, V5, P2124, DOI 10.1074/mcp.M600188-MCP200; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881	71	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15080	15093		10.1074/jbc.M114.563742	http://dx.doi.org/10.1074/jbc.M114.563742			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727471	Green Published, hybrid			2022-12-25	WOS:000337248100059
J	Matsui, T; Noguchi, K; Fukuda, M				Matsui, Takahide; Noguchi, Kenta; Fukuda, Mitsunori			Dennd3 Functions as a Guanine Nucleotide Exchange Factor for Small GTPase Rab12 in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acids Transport; Autophagy; Endosomes; G Proteins; Guanine Nucleotide Exchange Factor (GEF); Low Molecular Weight G Proteins; Membrane Trafficking; mTOR Complex (mTORC); Rab Proteins	BINDING-SPECIFICITY; AUTOPHAGY; COMPLEX; MTOR; INSULIN; PROTEINS; PHOSPHORYLATION; DEGRADATION; ACTIVATION; MEMBRANE	Background: The physiological function of Dennd3, a putative Rab12-GEF, was unknown. Results: Dennd3 regulates degradation of the amino acid transporter PAT4 through Rab12 activation and also modulates Akt activity. Conclusion: Dennd3 functions as a Rab12-GEF in MEF cells. Significance: Our findings provide a novel insight into the cross-talk between an amino acid signaling pathway and a growth factor signaling pathway through Dennd3. Small GTPase Rab12 regulates mTORC1 (mammalian target of rapamycin complex 1) activity and autophagy through controlling PAT4 (proton/amino acid transporter 4) trafficking from recycling endosomes to lysosomes, where PAT4 is degraded. However, the precise regulatory mechanism of the Rab12-mediated membrane trafficking pathway remained to be determined because a physiological Rab12-GEF (guanine nucleotide exchange factor) had yet to be identified. In this study we performed functional analyses of Dennd3, which has recently been shown to possess a GEF activity toward Rab12 in vitro. The results showed that knockdown of Dennd3 in mouse embryonic fibroblast cells caused an increase in the amount of PAT4 protein, the same as Rab12 knockdown did, and knockdown of Dennd3 and overexpression of Dennd3 were found to result in an increase and a decrease, respectively, in the intracellular amino acid concentration. Dennd3 overexpression was also found to reduce mTORC1 activity and promoted autophagy in a Rab12-dependent manner. Unexpectedly, however, Dennd3 knockdown had no effect on mTORC1 activity or autophagy despite increasing the intracellular amino acid concentration. Further study showed that Dennd3 knockdown reduced Akt activity, and the reduction in Akt activity is likely to have canceled out amino acid-induced mTORC1 activation through PAT4. These findings indicated that Dennd3 not only functions as a Rab12-GEF but also modulates Akt signaling in mouse embryonic fibroblast cells.	[Matsui, Takahide; Noguchi, Kenta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Matsui, Takahide/S-4986-2018; Fukuda, MItsunori/I-1511-2015	Matsui, Takahide/0000-0002-3342-0170; Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26111501] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to M. F.).; Supported by the Japan Society for the Promotion of Science.	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Matsui T, 2013, EMBO REP, V14, P450, DOI 10.1038/embor.2013.32; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13986	13995		10.1074/jbc.M113.546689	http://dx.doi.org/10.1074/jbc.M113.546689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719330	Green Published, hybrid			2022-12-25	WOS:000335984600029
J	Anjum, MAR; Ahmed, MM				Anjum, Muhammad Ali Raza; Ahmed, Muhammad Mansoor			A New Approach for Inversion of Large Random Matrices in Massive MIMO Systems	PLOS ONE			English	Article								We report a novel approach for inversion of large random matrices in massive Multiple-Input Multiple Output (MIMO) systems. It is based on the concept of inverse vectors in which an inverse vector is defined for each column of the principal matrix. Such an inverse vector has to satisfy two constraints. Firstly, it has to be in the null-space of all the remaining columns. We call it the null-space problem. Secondly, it has to form a projection of value equal to one in the direction of selected column. We term it as the normalization problem. The process essentially decomposes the inversion problem and distributes it over columns. Each column can be thought of as a node in the network or a particle in a swarm seeking its own solution, the inverse vector, which lightens the computational load on it. Another benefit of this approach is its applicability to all three cases pertaining to a linear system: the fully-determined, the over-determined, and the under-determined case. It eliminates the need of forming the generalized inverse for the last two cases by providing a new way to solve the least squares problem and the Moore and Penrose's pseudoinverse problem. The approach makes no assumption regarding the size, structure or sparsity of the matrix. This makes it fully applicable to much in vogue large random matrices arising in massive MIMO systems. Also, the null-space problem opens the door for a plethora of methods available in literature for null-space computation to enter the realm of matrix inversion. There is even a flexibility of finding an exact or approximate inverse depending on the null-space method employed. We employ the Householder's null-space method for exact solution and present a complete exposition of the new approach. A detailed comparison with well-established matrix inversion methods in literature is also given.	[Anjum, Muhammad Ali Raza; Ahmed, Muhammad Mansoor] Mohammad Ali Jinnah Univ, Dept Elect Engn, Islamabad, Pakistan	Mohammad Ali Jinnah University	Anjum, MAR (corresponding author), Mohammad Ali Jinnah Univ, Dept Elect Engn, Islamabad, Pakistan.	ali.raza.anjum@gmail.com		Ahmed, Muhammad Mansoor/0000-0001-6538-2183				Chaufray JM, 2004, IEEE T INFORM THEORY, V50, P2620, DOI 10.1109/TIT.2004.836929; Chong Edwin K.P., 2013, INTRO OPTIMIZATION, V4th; Couillet R., 2011, RANDOM MATRIX METHOD; Edman F, 2003, PIMRC 2003: 14TH IEEE 2003 INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR AND MOBILE RADIO COMMUNICATIONS PROCEEDINGS, VOLS 1-3 2003, P2558, DOI 10.1109/PIMRC.2003.1259188; Fong DC-L, 2011, SIAM J SCI COMPUTING; Golub GH., 2013, MATRIX COMPUTATIONS; Hochwald BM, 2003, IEEE T COMMUN, V51, P389, DOI 10.1109/TCOMM.2003.809789; Honig ML, 2001, IEEE T INFORM THEORY, V47, P1928, DOI 10.1109/18.930928; Karkooti M, 2005, 2005 39TH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND COMPUTERS, VOLS 1 AND 2, P1625; Ma L, 2011, IEEE T SIGNAL PROCES, V59, P1858, DOI 10.1109/TSP.2011.2105485; Moshavi S., 1996, INT J WIRELESS INFOR; Muller RR, 2001, IEEE J SEL AREA COMM, V19, P1429, DOI 10.1109/49.942506; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; Paulraj AJ, 2004, P IEEE, V92, P198, DOI 10.1109/JPROC.2003.821915; Rusek F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2011.2178495; Stewart GW., 2001, MATRIX ALGORITHMS EI, DOI [10.1137/1.9780898718058, DOI 10.1137/1.9780898718058]; Strang G., 2007, COMPUTATIONAL SCI EN; Strang G., 1986, INTRO APPL MATH; Tse D., 2005, FUNDAMENTALS WIRELES, P290, DOI [10.1017/CBO9780511807213.008, DOI 10.1017/CBO9780511807213.008]; Vardhan KV, 2008, IEEE J SEL AREA COMM, V26, P473, DOI 10.1109/JSAC.2008.080406; Wang Y, 2013, IEEE COMMUN LETT, V17, P389, DOI 10.1109/LCOMM.2013.010313.121837; Wu D, 2007, IEEE COMP SOC ANN, P325, DOI 10.1109/ISVLSI.2007.45	22	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94958	10.1371/journal.pone.0094958	http://dx.doi.org/10.1371/journal.pone.0094958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733148	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400138
J	Brodsky, AS; Fischer, A; Miller, DH; Vang, S; MacLaughlan, S; Wu, HT; Yu, J; Steinhoff, M; Collins, C; Smith, PJS; Raphael, BJ; Brard, L				Brodsky, Alexander S.; Fischer, Andrew; Miller, Daniel H.; Vang, Souriya; MacLaughlan, Shannon; Wu, Hsin-Ta; Yu, Jovian; Steinhoff, Margaret; Collins, Colin; Smith, Peter J. S.; Raphael, Benjamin J.; Brard, Laurent			Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease	PLOS ONE			English	Article							CANCER METASTASIS; GENE-EXPRESSION; THERAPEUTIC TARGET; CARCINOMA; IDENTIFICATION; EVOLUTION; BETA; BIOMARKERS; ALGORITHM; SURVIVAL	The behavior and genetics of serous epithelial ovarian cancer (EOC) metastasis, the form of the disease lethal to patients, is poorly understood. The unique properties of metastases are critical to understand to improve treatments of the disease that remains in patients after debulking surgery. We sought to identify the genetic and phenotypic landscape of metastatic progression of EOC to understand how metastases compare to primary tumors. DNA copy number and mRNA expression differences between matched primary human tumors and omental metastases, collected at the same time during debulking surgery before chemotherapy, were measured using microarrays. qPCR and immunohistochemistry validated findings. Pathway analysis of mRNA expression revealed metastatic cancer cells are more proliferative and less apoptotic than primary tumors, perhaps explaining the aggressive nature of these lesions. Most cases had copy number aberrations (CNAs) that differed between primary and metastatic tumors, but we did not detect CNAs that are recurrent across cases. A six gene expression signature distinguishes primary from metastatic tumors and predicts overall survival in independent datasets. The genetic differences between primary and metastatic tumors, yet common expression changes, suggest that the major clone in metastases is not the same as in primary tumors, but the cancer cells adapt to the omentum similarly. Together, these data highlight how ovarian tumors develop into a distinct, more aggressive metastatic state that should be considered for therapy development.	[Brodsky, Alexander S.; Fischer, Andrew; Miller, Daniel H.; Vang, Souriya; Wu, Hsin-Ta] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Brodsky, Alexander S.; Wu, Hsin-Ta; Yu, Jovian; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Brodsky, Alexander S.] Brown Univ, Ctr Genom & Prote, Providence, RI 02912 USA; [Wu, Hsin-Ta; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [MacLaughlan, Shannon] Brown Univ, Program Womens Oncol, Dept Obstet & Gynecol, Women & Infants Hosp,Alpert Med Sch, Providence, RI USA; [Steinhoff, Margaret] Brown Univ, Women & Infants Hosp, Dept Pathol, Alpert Med Sch, Providence, RI USA; [Collins, Colin] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Smith, Peter J. S.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Brard, Laurent] So Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA	Brown University; Brown University; Brown University; Brown University; Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; University of Southampton; Southern Illinois University System; Southern Illinois University	Brodsky, AS (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Alex_brodsky@brown.edu		Brard, Laurent/0000-0003-0065-1826; Smith, Peter/0000-0003-4400-6853; Yu, Jovian/0000-0001-9214-7576; /0000-0002-4866-1145	Brown University Center for Computational Molecular Biology; Brown University National Center of Excellence in Women's Health; AARA supplement [5P41RR001395, NIH2674-4/OHGB1623]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031153, P41RR001395, S10RR027634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007069] Funding Source: NIH RePORTER	Brown University Center for Computational Molecular Biology; Brown University National Center of Excellence in Women's Health; AARA supplement; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Brown University Center for Computational Molecular Biology (ASB), a seed award from the Brown University National Center of Excellence in Women's Health (ASB), an AARA supplement to NIH/NCRR grant 5P41RR001395 (PJSS), NIH2674-4/OHGB1623 LRP (LB), and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (BJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Barnett JC, 2010, GYNECOL ONCOL, V116, P556, DOI 10.1016/j.ygyno.2009.11.020; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bronson MW, 2010, MOL ENDOCRINOL, V24, P1120, DOI 10.1210/me.2009-0436; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; DeRycke MS, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24535; Fernald K, 2013, TRENDS CELL BIOL, V23, P620, DOI 10.1016/j.tcb.2013.07.006; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Khalique L, 2009, INT J CANCER, V124, P1579, DOI 10.1002/ijc.24148; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Malek JA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-121; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Paris PL, 2006, NEOPLASIA, V8, P1083, DOI 10.1593/neo.06421; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tuefferd M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001138; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wimberger P, 2010, ANN SURG ONCOL, V17, P1642, DOI 10.1245/s10434-010-0964-9; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961	37	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94476	10.1371/journal.pone.0094476	http://dx.doi.org/10.1371/journal.pone.0094476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732363	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000336970400042
J	Jain, R; Rajashankar, KR; Buku, A; Johnson, RE; Prakash, L; Prakash, S; Aggarwal, AK				Jain, Rinku; Rajashankar, Kanagalaghatta R.; Buku, Angeliki; Johnson, Robert E.; Prakash, Louise; Prakash, Satya; Aggarwal, Aneel K.			Crystal Structure of Yeast DNA Polymerase e Catalytic Domain	PLOS ONE			English	Article							HIGH-FIDELITY; REPLICATION; COMPLEX; BASE; MECHANISM; GERMLINE; DYNAMICS; FRAGMENT; DELTA	DNA polymerase epsilon (Pol epsilon) is a multi-subunit polymerase that contributes to genomic stability via its roles in leading strand replication and the repair of damaged DNA. Here we report the ternary structure of the Pol epsilon catalytic subunit (Pol2) bound to a nascent G:C base pair (Pol2(G:C)). Pol2(G:C) has a typical B-family polymerase fold and embraces the template-primer duplex with the palm, fingers, thumb and exonuclease domains. The overall arrangement of domains is similar to the structure of Pol2(T:A) reported recently, but there are notable differences in their polymerase and exonuclease active sites. In particular, we observe Ca2+ ions at both positions A and B in the polymerase active site and also observe a Ca2+ at position B of the exonuclease site. We find that the contacts to the nascent G:C base pair in the Pol2(G:C) structure are maintained in the Pol2(T:A) structure and reflect the comparable fidelity of Pol2 for nascent purine-pyrimidine and pyrimidine-purine base pairs. We note that unlike that of Pol3, the shape of the nascent base pair binding pocket in Pol2 is modulated from the major grove side by the presence of Tyr431. Together with Pol2(T:A), our results provide a framework for understanding the structural basis of high fidelity DNA synthesis by Pol2.	[Jain, Rinku; Buku, Angeliki; Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne, IL USA; [Rajashankar, Kanagalaghatta R.] NE CAT, Adv Photon Source, Argonne, IL USA; [Johnson, Robert E.; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Icahn School of Medicine at Mount Sinai; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	Aneel.Aggarwal@mssm.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	U.S. National Institutes of Health [R01 CA138546, R01 CA107650, P41 GM103403]; NATIONAL CANCER INSTITUTE [R01CA107650, R01CA138546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R01 CA138546, R01 CA107650, and P41 GM103403 from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Jain R, 2014, J MOL BIOL, V426, P301, DOI 10.1016/j.jmb.2013.10.015; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Reha-Krantz LJ, 1998, J BIOL CHEM, V273, P22969, DOI 10.1074/jbc.273.36.22969; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	36	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94835	10.1371/journal.pone.0094835	http://dx.doi.org/10.1371/journal.pone.0094835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733111	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400119
J	Liu, ZW; Li, Y; Qian, JY; Cui, YS; Chopp, M				Liu, Zhongwu; Li, Yi; Qian, Jianyong; Cui, Yisheng; Chopp, Michael			Plasminogen Deficiency Causes Reduced Corticospinal Axonal Plasticity and Functional Recovery after Stroke in Mice	PLOS ONE			English	Article							SCIATIC-NERVE CRUSH; MOTOR CORTEX STROKE; MARROW STROMAL CELL; ISCHEMIC BRAIN; GROWTH-FACTOR; SPINAL-CORD; ADULT MICE; WILD-TYPE; ACTIVATOR; SYSTEM	Tissue plasminogen activator (tPA) has been implicated in neurite outgrowth and neurological recovery post stroke. tPA converts the zymogen plasminogen (Plg) into plasmin. In this study, using plasminogen knockout (Plg(-/-)) mice and their Plg-native littermates (Plg(+/+)), we investigated the role of Plg in axonal remodeling and neurological recovery after stroke. Plg(+/+) and Plg(-/-) mice (n = 10/group) were subjected to permanent intraluminal monofilament middle cerebral artery occlusion (MCAo). A foot-fault test and a single pellet reaching test were performed prior to and on day 3 after stroke, and weekly thereafter to monitor functional deficit and recovery. Biotinylated dextran amine (BDA) was injected into the left motor cortex to anterogradely label the corticospinal tract (CST). Animals were euthanized 4 weeks after stroke. Neurite outgrowth was also measured in primary cultured cortical neurons harvested from Plg(+/+) and Plg(-/-) embryos. In Plg(+/+) mice, the motor functional deficiency after stroke progressively recovered with time. In contrast, recovery in Plg(-/-) mice was significantly impaired compared to Plg(+/+) mice (p<0.01). BDA-positive axonal density of the CST originating from the contralesional cortex in the denervated side of the cervical gray matter was significantly reduced in Plg(-/-) mice compared with Plg(+/+) mice (p<0.05). The behavioral outcome was highly correlated with the midline-crossing CST axonal density (R-2>0.82, p<0.01). Plg(-/-) neurons exhibited significantly reduced neurite outgrowth. Our data suggest that plasminogen-dependent proteolysis has a beneficial effect during neurological recovery after stroke, at least in part, by promoting axonal remodeling in the denervated spinal cord.	[Liu, Zhongwu; Li, Yi; Qian, Jianyong; Cui, Yisheng; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, ZW (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zwliu@neuro.hfh.edu			NIH [R01AG037506, R01NS066041]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088656, R01NS066041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH R01AG037506 (MC) and R01NS066041 (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann LC, 2014, J NEUROSCI, V34, P3378, DOI 10.1523/JNEUROSCI.4384-13.2014; Baron A, 2010, CELL DEATH DIFFER, V17, P860, DOI 10.1038/cdd.2009.172; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Butefisch CM, 2005, NEUROLOGY, V64, P1067, DOI 10.1212/01.WNL.0000154603.48446.36; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Fanardjian V. V., 2000, Neural Plasticity, V7, P261, DOI 10.1155/NP.2000.261; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; Gutierrez-Fernandez A, 2009, J NEUROSCI, V29, P12393, DOI 10.1523/JNEUROSCI.3553-09.2009; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hoover-Plow J, 1999, GROWTH DEVELOP AGING, V63, P13; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kollins KM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-26; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2013, STROKE, V44, P1951, DOI 10.1161/STROKEAHA.113.001162; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Liu ZW, 2009, STROKE, V40, P2546, DOI 10.1161/STROKEAHA.109.547265; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MATSUMOTO RR, 1991, BRAIN RES, V556, P78, DOI 10.1016/0006-8993(91)90549-B; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PITTMAN RN, 1995, J NEUROCHEM, V64, P566; Reitmeir R, 2012, ACTA NEUROPATHOL, V123, P273, DOI 10.1007/s00401-011-0914-z; Ruigrok TJH, 1996, NEUROSCI LETT, V214, P119, DOI 10.1016/0304-3940(96)12898-6; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Schott D, 1998, NEW ENGL J MED, V339, P1679, DOI 10.1056/NEJM199812033392305; Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Siconolfi LB, 2001, J NEUROSCI, V21, P4348, DOI 10.1523/JNEUROSCI.21-12-04348.2001; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/BST0300222; Tsirka SE, 1997, J NEUROSCI, V17, P543; Van Kan PLE, 2001, J NEUROPHYSIOL, V85, P1461, DOI 10.1152/jn.2001.85.4.1461; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Ye B, 2011, J NEUROSCI, V31, P3309, DOI 10.1523/JNEUROSCI.6307-10.2011	51	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94505	10.1371/journal.pone.0094505	http://dx.doi.org/10.1371/journal.pone.0094505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732409	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400043
J	Nishigori, K; Temma, T; Onoe, S; Sampei, S; Kimura, I; Ono, M; Saji, H				Nishigori, Kantaro; Temma, Takashi; Onoe, Satoru; Sampei, Sotaro; Kimura, Ikuo; Ono, Masahiro; Saji, Hideo			Development of a Radioiodinated Triazolopyrimidine Probe for Nuclear Medical Imaging of Fatty Acid Binding Protein 4	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TC-99M-ANNEXIN A5; EXPRESSION; INHIBITORS; FABP; ATHEROSCLEROSIS; BLADDER; AP2	Fatty acid binding protein 4 (FABP4) is the most well-characterized FABP isoform. FABP4 regulates inflammatory pathways in adipocytes and macrophages and is involved in both inflammatory diseases and tumor formation. FABP4 expression was recently reported for glioblastoma, where it may participate in disease malignancy. While FABP4 is a potential molecular imaging target, with the exception of a tritium labeled probe there are no reports of other nuclear imaging probes that target this protein. Here we designed and synthesized a nuclear imaging probe, [I-123] TAP1, and evaluated its potential as a FABP4 targeting probe in in vitro and in vivo assays. We focused on the unique structure of a triazolopyrimidine scaffold that lacks a carboxylic acid to design the TAP1 probe that can undergo facilitated delivery across cell membranes. The affinity of synthesized TAP1 was measured using FABP4 and 8-anilino-1-naphthalene sulfonic acid. [I-125] TAP1 was synthesized by iododestannylation of a precursor, followed by affinity and selectivity measurements using immobilized FABPs. Biodistributions in normal and C6 glioblastoma-bearing mice were evaluated, and excised tumors were subjected to autoradiography and immunohistochemistry. TAP1 and [I-125] TAP1 showed high affinity for FABP4 (K-i = 44.5 +/- 9.8 nM, K-d = 69.1612.3 nM). The FABP4 binding affinity of [I-125] TAP1 was 11.5- and 35.5-fold higher than for FABP3 and FABP5, respectively. In an in vivo study [I-125] TAP1 displayed high stability against deiodination and degradation, and moderate radioactivity accumulation in C6 tumors (1.37 +/- 0.24% dose/g 3 hr after injection). The radioactivity distribution profile in tumors partially corresponded to the FABP4 positive area and was also affected by perfusion. The results indicate that [I-125] TAP1 could detect FABP4 in vitro and partly in vivo. As such, [I-125] TAP1 is a promising lead compound for further refinement for use in in vivo FABP4 imaging.	[Nishigori, Kantaro; Temma, Takashi; Onoe, Satoru; Sampei, Sotaro; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Grad Sch Agr, Fuchu, Tokyo, Japan; [Kimura, Ikuo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacogen, Sakyo Ku, Kyoto, Japan	Kyoto University; Tokyo University of Agriculture & Technology; Kyoto University	Saji, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan.	hsaji@pharm.kyoto-u.ac.jp	Onoe, Satoru/S-7701-2019; Temma, Takashi/AAG-6809-2019; Kimura, Ikuo/B-4193-2015	Temma, Takashi/0000-0002-7345-6004; 	Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [24591813]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health and Labour Science Research Grant "Research on Noninvasive and Minimally Invasive Medical Devices" from the Ministry of Health, Labour and Welfare of Japan and JSPS KAKENHI Grant Number 24591813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Cai HY, 2010, BIOORG MED CHEM LETT, V20, P3675, DOI 10.1016/j.bmcl.2010.04.095; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Coe NR, 1999, J LIPID RES, V40, P967; Fu YC, 2000, J LIPID RES, V41, P2017; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Haukkala J, 2009, EUR J NUCL MED MOL I, V36, P2058, DOI 10.1007/s00259-009-1220-z; Herholz K, 2012, SEMIN NUCL MED, V42, P356, DOI 10.1053/j.semnuclmed.2012.06.001; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Ishino S, 2008, J NUCL MED, V49, P1677, DOI 10.2967/jnumed.107.049536; Ishino S, 2007, EUR J NUCL MED MOL I, V34, P889, DOI 10.1007/s00259-006-0289-x; Kakwani MD, 2011, BIOORG MED CHEM LETT, V21, P6523, DOI 10.1016/j.bmcl.2011.08.076; Kuge Y, 2010, EUR J NUCL MED MOL I, V37, P2093, DOI 10.1007/s00259-010-1521-2; Lan H, 2011, J LIPID RES, V52, P646, DOI 10.1194/jlr.M012757; Lehmann F, 2004, BIOORG MED CHEM LETT, V14, P4445, DOI 10.1016/j.bmcl.2004.06.057; Liu X, 2011, BIOORG MED CHEM LETT, V21, P2949, DOI 10.1016/j.bmcl.2011.03.063; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nishigori K, 2013, NUCL MED BIOL, V40, P97, DOI 10.1016/j.nucmedbio.2012.08.002; Ogawa K, 2013, NUCL MED BIOL, V40, P445, DOI 10.1016/j.nucmedbio.2013.02.008; Okada T, 2012, CHEM PHARM BULL, V60, P164, DOI 10.1248/cpb.60.164; Ringom R, 2004, BIOORG MED CHEM LETT, V14, P4449, DOI 10.1016/j.bmcl.2004.06.058; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shipps G. W., 2010, World Pat, Patent No. [2010,056,631, 2010056631, WO2010056631A1]; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Temma T, 2012, AM J NUCL MED MOLEC, V2, P432; Temma T, 2010, J NUCL MED, V51, P1979, DOI 10.2967/jnumed.110.081216; Tolle A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-302; Zhao Y, 2007, EUR J NUCL MED MOL I, V34, P1747, DOI 10.1007/s00259-007-0433-2	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94668	10.1371/journal.pone.0094668	http://dx.doi.org/10.1371/journal.pone.0094668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732569	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400065
J	Sun, YG; Hills, MD; Ye, WG; Tong, XL; Bai, DL				Sun, Yiguo; Hills, Matthew D.; Ye, Willy G.; Tong, Xiaoling; Bai, Donglin			Atrial Fibrillation-Linked Germline GJA5/Connexin40 Mutants Showed an Increased Hemichannel Function	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; OCULODENTODIGITAL DYSPLASIA; INTERCELLULAR COMMUNICATION; CONNEXIN HEMICHANNELS; MUTATIONS; DISEASE; DEAFNESS; CONDUCTION; MECHANISM; CHANNELS	Mutations in GJA5 encoding the gap junction protein connexin40 (Cx40) have been linked to lone atrial fibrillation. Some of these mutants result in impaired gap junction function due to either abnormal connexin localization or impaired gap junction channels, which may play a role in promoting atrial fibrillation. However, the effects of the atrial fibrillation-linked Cx40 mutants on hemichannel function have not been studied. Here we investigated two atrial fibrillation-linked germline Cx40 mutants, V85I and L221I. These two mutants formed putative gap junction plaques at cell-cell interfaces, with similar gap junction coupling conductance as that of wild-type Cx40. Connexin deficient HeLa cells expressing either one of these two mutants displayed prominent propidium iodide-uptake distinct from cells expressing wild-type Cx40 or other atrial fibrillation-linked Cx40 mutants, I75F, L229M, and Q49X. Propidium iodide-uptake was sensitive to [Ca2+](o) and the hemichannel blockers, carbenoxolone, flufenamic acid and mefloquine, but was not affected by the pannexin 1 channel blocking agent, probenecid, indicating that uptake is most likely mediated via connexin hemichannels. A gain-of-hemichannel function in these two atrial fibrillation-linked Cx40 mutants may provide a novel mechanism underlying the etiology of atrial fibrillation.	[Sun, Yiguo; Hills, Matthew D.; Ye, Willy G.; Tong, Xiaoling; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario)	Bai, DL (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	donglin.bai@schulich.uwo.ca	Bai, Donglin/ABB-9924-2021; Bai, Donglin/A-5799-2008	Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947	Canadian Institutes of Health Research [MOP86649]; Heart and Stroke Foundation of Canada [G-13-0003066]; Early Researcher Award from Ontario government	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Early Researcher Award from Ontario government	This work was supported by the Canadian Institutes of Health Research (MOP86649 to D. B.); Heart and Stroke Foundation of Canada (G-13-0003066 to D. B.); and an Early Researcher Award from Ontario government (to D. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; Allen MJ, 2011, J BIOL CHEM, V286, P22139, DOI 10.1074/jbc.M111.240002; Bruzzone S, 2001, FASEB J, V15, P10; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Chaldoupi SM, 2009, CARDIOVASC RES, V84, P15, DOI 10.1093/cvr/cvp203; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Dale N, 2008, J PHYSIOL-LONDON, V586, P2429, DOI 10.1113/jphysiol.2008.152207; DAVIS LM, 1995, J CARDIOVASC ELECTR, V6, P813, DOI 10.1111/j.1540-8167.1995.tb00357.x; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Essenfelder GM, 2004, HUM MOL GENET, V13, P1703, DOI 10.1093/hmg/ddh191; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Manias JL, 2008, CARDIOVASC RES, V80, P385, DOI 10.1093/cvr/cvn203; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Rudy Y, 2008, ANN NY ACAD SCI, V1123, P113, DOI 10.1196/annals.1420.013; Saffitz JE, 2006, NEW ENGL J MED, V354, P2712, DOI 10.1056/NEJMe068088; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Sun Y, 2014, ENDOPLASMIC RETICULU; Sun YG, 2013, HUM MUTAT, V34, P603, DOI 10.1002/humu.22278; Thibodeau IL, 2010, CIRCULATION, V122, P236, DOI 10.1161/CIRCULATIONAHA.110.961227; Thomas T, 2004, J BIOL CHEM, V279, P19157, DOI 10.1074/jbc.M314117200; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Yang YQ, 2010, INT J MOL MED, V26, P605, DOI 10.3892/ijmm_00000505; Yang YQ, 2010, EUROPACE, V12, P1421, DOI 10.1093/europace/euq274	35	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95125	10.1371/journal.pone.0095125	http://dx.doi.org/10.1371/journal.pone.0095125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733048	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400155
J	Wu, B; Zhong, GY; Yue, JQ; Yang, RT; Li, C; Li, YJ; Zhong, Y; Wang, X; Jiang, B; Zeng, JW; Zhang, L; Yan, ST; Bei, XJ; Zhou, DG				Wu, Bo; Zhong, Guang-yan; Yue, Jian-qiang; Yang, Run-ting; Li, Chong; Li, Yue-jia; Zhong, Yun; Wang, Xuan; Jiang, Bo; Zeng, Ji-wu; Zhang, Li; Yan, Shu-tang; Bei, Xue-jun; Zhou, Dong-guo			Identification of Pummelo Cultivars by Using a Panel of 25 Selected SNPs and 12 DNA Segments	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SIMPLE SEQUENCE REPEAT; POPULATION-STRUCTURE; ASCERTAINMENT BIAS; GENETIC DIVERSITY; MARK-RECAPTURE; PARENTAGE; IDENTITY; ORIGIN; MICROSATELLITE	Pummelo cultivars are usually difficult to identify morphologically, especially when fruits are unavailable. The problem was addressed in this study with the use of two methods: high resolution melting analysis of SNPs and sequencing of DNA segments. In the first method, a set of 25 SNPs with high polymorphic information content were selected from SNPs predicted by analyzing ESTs and sequenced DNA segments. High resolution melting analysis was then used to genotype 260 accessions including 55 from Myanmar, and 178 different genotypes were thus identified. A total of 99 cultivars were assigned to 86 different genotypes since the known somatic mutants were identical to their original genotypes at the analyzed SNP loci. The Myanmar samples were genotypically different from each other and from all other samples, indicating they were derived from sexual propagation. Statistical analysis showed that the set of SNPs was powerful enough for identifying at least 1000 pummelo genotypes, though the discrimination power varied in different pummelo groups and populations. In the second method, 12 genomic DNA segments of 24 representative pummelo accessions were sequenced. Analysis of the sequences revealed the existence of a high haplotype polymorphism in pummelo, and statistical analysis showed that the segments could be used as genetic barcodes that should be informative enough to allow reliable identification of 1200 pummelo cultivars. The high level of haplotype diversity and an apparent population structure shown by DNA segments and by SNP genotypes, respectively, were discussed in relation to the origin and domestication of the pummelo species.	[Wu, Bo; Yang, Run-ting; Li, Chong; Wang, Xuan; Yan, Shu-tang; Bei, Xue-jun] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Wu, Bo; Zhong, Guang-yan; Li, Yue-jia; Zhong, Yun; Jiang, Bo; Zeng, Ji-wu; Zhang, Li] Minist Agr, Key Lab South Subtrop Fruit Biol & Genet Resource, Guangzhou, Guangdong, Peoples R China; [Yue, Jian-qiang; Zhou, Dong-guo] Yunnan Acad Agr Sci, Inst Trop & Subtrop Cash Crops, Dehong, Yunnan, Peoples R China; [Wu, Bo; Li, Yue-jia; Zhong, Yun; Jiang, Bo; Zeng, Ji-wu; Zhang, Li] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Yunnan Academy of Agricultural Sciences; Guangdong Academy of Agricultural Sciences	Zhong, GY (corresponding author), Minist Agr, Key Lab South Subtrop Fruit Biol & Genet Resource, Guangzhou, Guangdong, Peoples R China.	gy_zhong@163.com	Zhong, Yun/HCH-6868-2022	Wu, Bo/0000-0003-2027-8651	International Science & Technology Cooperation Program of China [2012DFA30610]; National Program on Key Basic Research Project [2011CB100600]; National Natural Science Foundation of China [30971992]	International Science & Technology Cooperation Program of China; National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was Supported by the International Science & Technology Cooperation Program of China (Grant No: 2012DFA30610), the National Program on Key Basic Research Project (Grant No: 2011CB100600), and the National Natural Science Foundation of China (Grant No: 30971992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Breto MP, 2001, MOL PHYLOGENET EVOL, V21, P285, DOI 10.1006/mpev.2001.1008; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Candolle AD, 1886, ORIGIN CULTIVATED PL; Chomchalow N, 1984, IBPGR NEW LETT, V8, P3; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Corazza-Nunes MJ, 2002, EUPHYTICA, V126, P169, DOI 10.1023/A:1016332030738; Correia L., 2011, BMC P, V5, P41; Curtu AL, 2004, PLANT MOL BIOL REP, V22, P339, DOI 10.1007/BF02772677; Dass H, 1990, P INT CITR S GUANGZH, P65; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Distefano G, 2013, TREE GENET GENOMES, V9, P1271, DOI 10.1007/s11295-013-0636-6; Distefano G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044202; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Gupta PK, 2001, CURR SCI INDIA, V80, P524; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hodgson RW, 1967, CITRUS IND, V1, P431, DOI DOI 10.1016/J.FOODCHEM.2006.02.05910.1039/; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones B, 2009, MOL ECOL RESOUR, V9, P487, DOI 10.1111/j.1755-0998.2008.02444.x; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Jung JK, 2010, EUPHYTICA, V175, P91, DOI 10.1007/s10681-010-0191-2; Korir NK, 2013, CRIT REV BIOTECHNOL, V33, P111, DOI 10.3109/07388551.2012.675314; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HY, 2005, FORENSIC SCI INT, V148, P107, DOI 10.1016/j.forsciint.2004.04.073; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Yong, 2005, Scientia Agricultura Sinica, V38, P2308; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Moriya S, 2011, EUPHYTICA, V177, P135, DOI 10.1007/s10681-010-0295-8; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Pakstis AJ, 2010, HUM GENET, V127, P315, DOI 10.1007/s00439-009-0771-1; Pattemore JA, 2010, J CEREAL SCI, V52, P356, DOI 10.1016/j.jcs.2010.06.004; Peakall R, 2006, J ZOOL, V268, P207, DOI 10.1111/j.1469-7998.2005.00011.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x; Spiegel-Roy P, 1996, BIOL CITRUS; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tan WQ, 2011, FUJIAN FRUITS, V1, P7; Tanaka T, 1961, CITROLOGIA, P1; Tokarska M, 2009, HEREDITY, V103, P326, DOI 10.1038/hdy.2009.73; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Webber HJ, 1943, CITRUS IND, V1, P475; Werner FAO, 2004, ANIM GENET, V35, P44, DOI 10.1046/j.1365-2052.2003.01071.x; Wu Bo, 2012, Acta Horticulturae Sinica, V39, P777; Xie RJ, 2011, PLANT MOL BIOL REP, V29, P554, DOI 10.1007/s11105-010-0261-6; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; [杨润婷 Yang Runting], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1061; Ye YinMin, 1997, South China Fruits, V26, P3; Yoon MS, 2007, THEOR APPL GENET, V114, P885, DOI 10.1007/s00122-006-0487-8	70	17	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94506	10.1371/journal.pone.0094506	http://dx.doi.org/10.1371/journal.pone.0094506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732455	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400044
J	Huang, JH; Sun, W; Huang, H; Ye, J; Pan, W; Zhong, Y; Cheng, CF; You, XY; Liu, BR; Xiong, LG; Liu, SM				Huang, Jionghua; Sun, Wen; Huang, He; Ye, Jing; Pan, Wei; Zhong, Yun; Cheng, Chuanfang; You, Xiangyu; Liu, Benrong; Xiong, Longgen; Liu, Shiming			miR-34a Modulates Angiotensin II-Induced Myocardial Hypertrophy by Direct Inhibition of ATG9A Expression and Autophagic Activity	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CARDIOMYOCYTE AUTOPHAGY; DOWN-REGULATION; MICRORNAS; HEART; MECHANISMS; GROWTH; BCL-2; PLAY	Cardiac hypertrophy is characterized by thickening myocardium and decreasing in heart chamber volume in response to mechanical or pathological stress, but the underlying molecular mechanisms remain to be defined. This study investigated altered miRNA expression and autophagic activity in pathogenesis of cardiac hypertrophy. A rat model of myocardial hypertrophy was used and confirmed by heart morphology, induction of cardiomyocyte autophagy, altered expression of autophagy-related ATG9A, LC3 II/I and p62 proteins, and decrease in miR-34a expression. The in vitro data showed that in hypertrophic cardiomyocytes induced by Ang II, miR-34a expression was downregulated, whereas ATG9A expression was up-regulated. Moreover, miR-34a was able to bind to ATG9A 3'-UTR, but not to the mutated 3'-UTR and inhibited ATG9A protein expression and autophagic activity. The latter was evaluated by autophagy-related LC3 II/I and p62 levels, TEM, and flow cytometry in rat cardiomyocytes. In addition, ATG9A expression induced either by treatment of rat cardiomyocytes with Ang II or ATG9A cDNA transfection upregulated autophagic activity and cardiomyocyte hypertrophy in both morphology and expression of hypertrophy-related genes (i.e., ANP and beta-MHC), whereas knockdown of ATG9A expression downregulated autophagic activity and cardiomyocyte hypertrophy. However, miR-34a antagonized Ang II-stimulated myocardial hypertrophy, whereas inhibition of miR-34a expression aggravated Ang II-stimulated myocardial hypertrophy (such as cardiomyocyte hypertrophy-related ANP and beta-MHC expression and cardiomyocyte morphology). This study indicates that miR-34a plays a role in regulation of Ang II-induced cardiomyocyte hypertrophy by inhibition of ATG9A expression and autophagic activity.	[Huang, Jionghua; Sun, Wen; Huang, He; Ye, Jing; Pan, Wei; Zhong, Yun; Cheng, Chuanfang; You, Xiangyu; Liu, Benrong; Xiong, Longgen; Liu, Shiming] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Xiong, LG (corresponding author), Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	xionglg66@126.com; gzliushiming@126.com	Zhong, Yun/HCH-6868-2022	Liu, Bin/0000-0003-2184-4723	Bureau of Science and Information Technology of Guangzhou Municipality [2011J4300057, 2012Y2-00027]; Bureau of Education of Guangzhou Municipality [2012C230]	Bureau of Science and Information Technology of Guangzhou Municipality; Bureau of Education of Guangzhou Municipality	Funding was supported by the Bureau of Science and Information Technology of Guangzhou Municipality (Grants Number: 2011J4300057 and 2012Y2-00027) and Bureau of Education of Guangzhou Municipality (Grants Number: 2012C230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Barbosa ME, 2005, METH MOLEC MED, V112, P339; Basak SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073195; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Han JJ, 2009, J VET MED SCI, V71, P737, DOI 10.1292/jvms.71.737; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Perrotta I, 2013, MICRON, V50, P7, DOI 10.1016/j.micron.2013.03.007; Porrello ER, 2009, AUTOPHAGY, V5, P1215, DOI 10.4161/auto.5.8.10153; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Rifki OF, 2013, J MOL CELL CARDIOL, V59, P128, DOI 10.1016/j.yjmcc.2013.02.015; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Su HB, 2011, CIRC RES, V108, P40, DOI 10.1161/CIRCRESAHA.110.230607; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Wang W, 2013, INDIAN J BIOCHEM BIO, V50, P87; Xiao JA, 2011, INT J CARDIOL, V148, P110, DOI 10.1016/j.ijcard.2011.01.029; Yang JR, 2013, AGE, V35, P11, DOI 10.1007/s11357-011-9324-3; Yen WL, 2007, AUTOPHAGY, V3, P254, DOI 10.4161/auto.3823; Yin XS, 2013, MOL CELL BIOCHEM, V379, P1, DOI 10.1007/s11010-012-1552-z; Zahabi A, 2003, J BIOL CHEM, V278, P47694, DOI 10.1074/jbc.M309661200; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152; Zhang ZH, 2013, J CARDIOVASC PHARM; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zou YZ, 2001, CIRCULATION, V104, P97, DOI 10.1161/01.CIR.104.1.97	47	44	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94382	10.1371/journal.pone.0094382	http://dx.doi.org/10.1371/journal.pone.0094382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728149	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200069
J	Langewisch, T; Zhang, HX; Vincent, R; Joshi, T; Xu, D; Bilyeu, K				Langewisch, Tiffany; Zhang, Hongxin; Vincent, Ryan; Joshi, Trupti; Xu, Dong; Bilyeu, Kristin			Major Soybean Maturity Gene Haplotypes Revealed by SNPViz Analysis of 72 Sequenced Soybean Genomes	PLOS ONE			English	Article							MAP-BASED CLONING; GROWTH HABIT; SENSITIVITY; SELECTION	In this Genomics Era, vast amounts of next-generation sequencing data have become publicly available for multiple genomes across hundreds of species. Analyses of these large-scale datasets can become cumbersome, especially when comparing nucleotide polymorphisms across many samples within a dataset and among different datasets or organisms. To facilitate the exploration of allelic variation and diversity, we have developed and deployed an in-house computer software to categorize and visualize these haplotypes. The SNPViz software enables users to analyze region-specific haplotypes from single nucleotide polymorphism (SNP) datasets for different sequenced genomes. The examination of allelic variation and diversity of important soybean [Glycine max (L.) Merr.] flowering time and maturity genes may provide additional insight into flowering time regulation and enhance researchers' ability to target soybean breeding for particular environments. For this study, we utilized two available soybean genomic datasets for a total of 72 soybean genotypes encompassing cultivars, landraces, and the wild species Glycine soja. The major soybean maturity genes E1, E2, E3, and E4 along with the Dt1 gene for plant growth architecture were analyzed in an effort to determine the number of major haplotypes for each gene, to evaluate the consistency of the haplotypes with characterized variant alleles, and to identify evidence of artificial selection. The results indicated classification of a small number of predominant haplogroups for each gene and important insights into possible allelic diversity for each gene within the context of known causative mutations. The software has both a stand-alone and web-based version and can be used to analyze other genes, examine additional soybean datasets, and view similar genome sequence and SNP datasets from other species.	[Langewisch, Tiffany; Bilyeu, Kristin] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA; [Zhang, Hongxin; Joshi, Trupti; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Vincent, Ryan] McKendree Univ, Div Comp, Lebanon, IL USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Inst Informat, Columbia, MO USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bilyeu, K (corresponding author), Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA.	Kristin.Bilyeu@ars.usda.gov		Joshi, Trupti/0000-0001-8944-4924	United Soybean Board; Missouri Soybean Merchandising Council; ARS [ARS-0424526] Funding Source: Federal RePORTER	United Soybean Board; Missouri Soybean Merchandising Council; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research was supported by a grant to KB by The United Soybean Board, and a grant to DX from the Missouri Soybean Merchandising Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD RL, 1972, CROP SCI, V12, P235, DOI 10.2135/cropsci1972.0011183X001200020028x; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; BERNARD RL, 1982, CROP SCI, V22, P688, DOI 10.2135/cropsci1982.0011183X002200030073x; BERNARD RL, 1988, CROP SCI, V28, P1027; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Durbin R, 1998, BIOL SEQUENCE ANAL, P160; Joshi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S15; Kanazawa A, 2009, J MOL EVOL, V69, P164, DOI 10.1007/s00239-009-9262-1; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Liebecq C, 1992, BIOCH NOMENCLATURE R; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tsubokura Y, 2013, ANN BOT; Tsubokura Y, 2013, AGRONOMY-BASEL, V3, P117, DOI 10.3390/agronomy3010117; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Woodworth C.M., 1932, ILLINOIS AGR EXP STA, V384, P297; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109	25	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94150	10.1371/journal.pone.0094150	http://dx.doi.org/10.1371/journal.pone.0094150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727730	Green Published, gold			2022-12-25	WOS:000336736200041
J	Li, M; Guo, J; Gao, WH; Yu, JL; Han, XY; Zhang, J; Shao, B				Li, Ming; Guo, Jing; Gao, Wenhui; Yu, Jianlong; Han, Xiaoyu; Zhang, Jing; Shao, Bing			Bisphenol AF-Induced Endogenous Transcription Is Mediated by ER alpha and ERK1/2 Activation in Human Breast Cancer Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GENE-EXPRESSION CHANGES; GROWTH-FACTOR RECEPTOR; IN-VITRO; ESTROGEN; GPR30; BETA; TRANSACTIVATION; MECHANISMS; 17-BETA-ESTRADIOL	Bisphenol AF (BPAF)-induced transcriptional activity has been evaluated by luciferase reporter assay. However, the molecular mechanism of BPAF-induced endogenous transcription in human breast cancer cells has not been fully elucidated. In the present study, we investigated the effect and mechanism of BPAF-induced endogenous transcription detected by real-time PCR in human breast cancer cells. We found that BPAF stimulated transcription of estrogen responsive genes, such as trefoil factor 1 (TFF1), growth regulation by estrogen in breast cancer 1 (GREB1) and cathepsin D (CTSD), through dose-dependent and time-dependent manners in T47D and MCF7 cells. Gene-silencing of ER alpha, ER beta and G protein-coupled estrogen receptor 1 (GPER) by small interfering RNA revealed that BPAF-induced endogenous transcription was dependent on ER alpha and GPER, implying both genomic and nongenomic pathways might be involved in the endogenous transcription induced by BPAF. ER alpha-mediated gene transcription was further confirmed by inhibition of ER activity using ICI 182780 in ER alpha-positive T47D and MCF7 cells as well as overexpression of ER alpha in ER alpha-negative MDA-MB-231 breast cancer cells. Moreover, we utilized Src tyrosine kinase inhibitor PP2 and two MEK inhibitors PD98059 and U0126 to elucidate the rapid nongenomic activation of Src/MEK/ERK1/2 cascade on endogenous transcription. Our data showed that BPAF-induced transcription could be significantly blocked by PP2, PD98059 and U0126, suggesting activation of ERK1/2 was also required to regulate endogenous transcription. Taken together, these results indicate that BPAF-induced endogenous transcription of estrogen responsive genes is mediated through both genomic and nongenomic pathways involving the ER alpha and ERK1/2 activation in human breast cancer cells.	[Li, Ming; Gao, Wenhui; Yu, Jianlong; Han, Xiaoyu; Zhang, Jing; Shao, Bing] Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China; [Guo, Jing] Beijing Mentougou Dist Hosp, Dept Emergency, Beijing, Peoples R China; [Yu, Jianlong; Han, Xiaoyu; Shao, Bing] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China	Capital Medical University	Shao, B (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China.	shaobingch@sina.com	han, xiao/HDN-9782-2022; shao, bing/L-8793-2019		National Natural Science Foundation of China [41273132, 21207008]; Beijing Municipal Senior Technical Training Plan for the Health System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Senior Technical Training Plan for the Health System	This work was supported by National Natural Science Foundation of China (grant number 41273132 and 21207008) and the Beijing Municipal Senior Technical Training Plan for the Health System. URL of National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alexaki VI, 2006, J STEROID BIOCHEM, V98, P97, DOI 10.1016/j.jsbmb.2005.08.017; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; Bermudez DS, 2010, TOXICOL SCI, V116, P477, DOI 10.1093/toxsci/kfq156; Cantwell MJ, 1996, BLOOD, V88, P4676, DOI 10.1182/blood.V88.12.4676.bloodjournal88124676; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Feng YX, 2012, TOXICOL LETT, V211, P201, DOI 10.1016/j.toxlet.2012.03.802; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Geffroy N, 2005, MOL CELL ENDOCRINOL, V237, P11, DOI 10.1016/j.mce.2005.04.003; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; LaFleur AD, 2011, ANAL CHIM ACTA, V696, P6, DOI 10.1016/j.aca.2011.03.054; Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083170; Li Y, 2013, ENVIRON HEALTH PERSP, V121, P459, DOI 10.1289/ehp.1205951; Li Y, 2012, ENVIRON HEALTH PERSP, V120, P1029, DOI 10.1289/ehp.1104689; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Matsushima A, 2010, ENVIRON HEALTH PERSP, V118, P1267, DOI 10.1289/ehp.0901819; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Shimizu M, 2002, TOXICOL IN VITRO, V16, P549, DOI 10.1016/S0887-2333(02)00055-3; Song SJ, 2012, ENVIRON SCI TECHNOL, V46, P13136, DOI 10.1021/es303960k; Sui YP, 2012, ENVIRON HEALTH PERSP, V120, P399, DOI 10.1289/ehp.1104426; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	35	17	22	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94725	10.1371/journal.pone.0094725	http://dx.doi.org/10.1371/journal.pone.0094725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727858	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200122
J	Ma, LC; Shen, ZQ; Naren, GW; Li, H; Xia, X; Wu, CM; Shen, JZ; Zhang, QJ; Wang, Y				Ma, Licai; Shen, Zhangqi; Naren, Gaowa; Li, Hui; Xia, Xi; Wu, Congming; Shen, Jianzhong; Zhang, Qijing; Wang, Yang			Identification of a Novel G2073A Mutation in 23S rRNA in Amphenicol-Selected Mutants of Campylobacter jejuni	PLOS ONE			English	Article							FLORFENICOL RESISTANCE GENE; FOOD-PRODUCING ANIMALS; ANTIMICROBIAL RESISTANCE; CHLORAMPHENICOL RESISTANCE; ANTIBIOTIC-RESISTANCE; MACROLIDE RESISTANCE; CHICKEN CARCASSES; UNITED-STATES; EFFLUX PUMP; COLI	Objectives: This study was conducted to examine the development and molecular mechanisms of amphenicol resistance in Campylobacter jejuni by using in vitro selection with chloramphenicol and florfenicol. The impact of the resistance development on growth rates was also determined using in vitro culture. Methods: Chloramphenicol and florfenicol were used as selection agents to perform in vitro stepwise selection. Mutants resistant to the selective agents were obtained from the selection process. The mutant strains were compared with the parent strain for changes in MICs and growth rates. The 23S rRNA gene and the L4 and L22 ribosomal protein genes in the mutant strains and the parent strain were amplified and sequenced to identify potential resistance-associated mutations. Results: C. jejuni strains that were highly resistant to chloramphenicol and florfenicol were obtained from in vitro selection. A novel G2073A mutation in all three copies of the 23S rRNA gene was identified in all the resistant mutants examined, which showed resistance to both chloramphenicol and florfenicol. In addition, all the mutants selected by chloramphenicol also exhibited the G74D modification in ribosomal protein L4, which was previously shown to confer a low-level erythromycin resistance in Campylobacter species. The mutants selected by florfenicol did not have the G74D mutation in L4. Notably, the amphenicol-resistant mutants also exhibited reduced susceptibility to erythromycin, suggesting that the selection resulted in cross resistance to macrolides. Conclusions: This study identifies a novel point mutation (G2073A) in 23S rRNA in amphenicol-selected mutants of C. jejuni. Development of amphenicol resistance in Campylobacter likely incurs a fitness cost as the mutant strains showed slower growth rates in antibiotic-free media.	[Ma, Licai; Naren, Gaowa; Li, Hui; Xia, Xi; Wu, Congming; Shen, Jianzhong; Wang, Yang] China Agr Univ, Coll Vet Med, Key Lab Dev & Evaluat Chem & Herbal Drugs Anim Us, Beijing 100094, Peoples R China; [Shen, Zhangqi; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	China Agricultural University; Iowa State University	Zhang, QJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu; wangyang@cau.edu.cn	Shen, Zhangqi/HCI-5736-2022; Wang, Yang/ABD-5983-2021; Shen, Jianzhong/AAH-8184-2019	Shen, Zhangqi/0000-0003-4789-7540; Wang, Yang/0000-0002-5928-9377; 	National Natural Science Foundation of China [U1031004]; Key Projects in the National Science & Technology Pillar Program [2012BAK01B02]; Special Fund for Agro-scientific Research in the Public Interest [201203040]; Specialized Research Fund for the Doctoral Program of Higher Education (SEFDP) [20100008120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Special Fund for Agro-scientific Research in the Public Interest; Specialized Research Fund for the Doctoral Program of Higher Education (SEFDP)	This work was supported by the National Natural Science Foundation of China (U1031004), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAK01B02), Special Fund for Agro-scientific Research in the Public Interest (201203040), and Specialized Research Fund for the Doctoral Program of Higher Education (SEFDP, 20100008120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzitey F, 2012, INT J FOOD MICROBIOL, V154, P197, DOI 10.1016/j.ijfoodmicro.2012.01.006; Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Arcangioli MA, 2000, J MED MICROBIOL, V49, P103, DOI 10.1099/0022-1317-49-1-103; Asai T, 2007, JPN J INFECT DIS, V60, P290; Barreto F, 2012, FOOD ADDIT CONTAM A, V29, P550, DOI 10.1080/19440049.2011.641160; Bester LA, 2008, J ANTIMICROB CHEMOTH, V62, P1298, DOI 10.1093/jac/dkn408; Bischoff KM, 2005, FEMS MICROBIOL LETT, V243, P285, DOI 10.1016/j.femsle.2004.12.017; Bostan K, 2009, MICROB DRUG RESIST, V15, P143, DOI 10.1089/mdr.2009.0894; Cagliero C, 2006, ANTIMICROB AGENTS CH, V50, P3893, DOI 10.1128/AAC.00616-06; Caldwell DB, 2008, ANTIMICROB AGENTS CH, V52, P3947, DOI 10.1128/AAC.00450-08; Chakeri A, 2012, J PURE APPL MICROBIO, V6, P1823; Chen X, 2010, VET MICROBIOL, V144, P133, DOI 10.1016/j.vetmic.2009.12.035; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; de Moura HM, 2013, J FOOD PROTECT, V76, P691, DOI 10.4315/0362-028X.JFP-12-485; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; DOUTHWAITE S, 1992, J BACTERIOL, V174, P1333, DOI 10.1128/jb.174.4.1333-1338.1992; Englen MD, 2007, J APPL MICROBIOL, V102, P1570, DOI 10.1111/j.1365-2672.2006.03189.x; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; Food and Drug Administration, 2010, NAT ANT RES MON SYST; Gibreel A, 2005, ANTIMICROB AGENTS CH, V49, P2753, DOI 10.1128/AAC.49.7.2753-2759.2005; Gibreel A, 2007, ANTIMICROB AGENTS CH, V51, P3212, DOI 10.1128/AAC.01592-06; Gupta A, 2004, EMERG INFECT DIS, V10, P1102, DOI 10.3201/eid1006.030635; Hanninen ML, 2007, J ANTIMICROB CHEMOTH, V60, P1251, DOI 10.1093/jac/dkm345; Hao HH, 2009, MICROB DRUG RESIST, V15, P239, DOI 10.1089/mdr.2009.0008; Harada K, 2006, AM J VET RES, V67, P230, DOI 10.2460/ajvr.67.2.230; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Kehrenberg C, 2004, ANTIMICROB AGENTS CH, V48, P615, DOI 10.1128/AAC.48.2.615-618.2004; Kim EH, 1996, MICROBIOL IMMUNOL, V40, P665, DOI 10.1111/j.1348-0421.1996.tb01125.x; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Li XS, 2007, J VET SCI, V8, P243, DOI 10.4142/jvs.2007.8.3.243; Liu HB, 2012, J ANTIMICROB CHEMOTH, V67, P322, DOI 10.1093/jac/dkr481; Luangtongkum T, 2012, ANTIMICROB AGENTS CH, V56, P1300, DOI 10.1128/AAC.05516-11; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Mascaretti O.A., 2003, BACTERIA VERSUS ANTI; McDermott PF, 2004, MICROB DRUG RESIST, V10, P124, DOI 10.1089/1076629041310064; McGill K, 2009, J MICROBIOL METH, V79, P238, DOI 10.1016/j.mimet.2009.09.020; MoAo China, 2002, B MIN AGR PEOPL REP; Nagshetty K, 2010, J INFECT DEV COUNTR, V4, P70, DOI 10.3855/jidc.109; Noormohamed A, 2012, FOODBORNE PATHOG DIS, V9, P617, DOI 10.1089/fpd.2011.1074; Oporto Beatriz, 2009, Int J Microbiol, V2009, P456573, DOI 10.1155/2009/456573; Ozawa M, 2012, PREV VET MED, V106, P295, DOI 10.1016/j.prevetmed.2012.03.013; Perez-Boto D, 2013, MICROB DRUG RESIST, V19, P323, DOI 10.1089/mdr.2012.0160; Rzewuska Katarzyna, 2010, Przegl Epidemiol, V64, P63; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Serraino A, 2013, J DAIRY SCI, V96, P2801, DOI 10.3168/jds.2012-6249; Shi XZ, 2007, J CHROMATOGR B, V850, P24, DOI 10.1016/j.jchromb.2006.10.057; Shin E, 2013, MICROB DRUG RESIST, V19, P110, DOI 10.1089/mdr.2012.0099; Stolker AAM, 2005, J CHROMATOGR A, V1067, P15, DOI 10.1016/j.chroma.2005.02.037; Switala M, 2007, J VET PHARMACOL THER, V30, P145, DOI 10.1111/j.1365-2885.2007.00827.x; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Wierzba TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003674; Xie Yong-Qiang, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P422; Zhang QJ, 2006, MICROBES INFECT, V8, P1972, DOI 10.1016/j.micinf.2005.12.031	58	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94503	10.1371/journal.pone.0094503	http://dx.doi.org/10.1371/journal.pone.0094503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728007	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200085
J	Xue, NN; Li, X; Bertulli, C; Li, ZY; Patharagulpong, A; Sadok, A; Huang, YYS				Xue, Niannan; Li, Xia; Bertulli, Cristina; Li, Zhaoying; Patharagulpong, Atipat; Sadok, Amine; Huang, Yan Yan Shery			Rapid Patterning of 1-D Collagenous Topography as an ECM Protein Fibril Platform for Image Cytometry	PLOS ONE			English	Article							PERMANENT CELL-LINE; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; GELATIN; MORPHOGENESIS; KINASES; RHO	Cellular behavior is strongly influenced by the architecture and pattern of its interfacing extracellular matrix (ECM). For an artificial culture system which could eventually benefit the translation of scientific findings into therapeutic development, the system should capture the key characteristics of a physiological microenvironment. At the same time, it should also enable standardized, high throughput data acquisition. Since an ECM is composed of different fibrous proteins, studying cellular interaction with individual fibrils will be of physiological relevance. In this study, we employ near-field electrospinning to create ordered patterns of collagenous fibrils of gelatin, based on an acetic acid and ethyl acetate aqueous co-solvent system. Tunable conformations of micro-fibrils were directly deposited onto soft polymeric substrates in a single step. We observe that global topographical features of straight lines, beads-on-strings, and curls are dictated by solution conductivity; whereas the finer details such as the fiber cross-sectional profile are tuned by solution viscosity. Using these fibril constructs as cellular assays, we study EA.hy926 endothelial cells' response to ROCK inhibition, because of ROCK's key role in the regulation of cell shape. The fibril array was shown to modulate the cellular morphology towards a precapillary cord-like phenotype, which was otherwise not observed on a flat 2-D substrate. Further facilitated by quantitative analysis of morphological parameters, the fibril platform also provides better dissection in the cells' response to a H1152 ROCK inhibitor. In conclusion, the near-field electrospun fibril constructs provide a more physiologically-relevant platform compared to a featureless 2-D surface, and simultaneously permit statistical single-cell image cytometry using conventional microscopy systems. The patterning approach described here is also expected to form the basics for depositing other protein fibrils, seen among potential applications as culture platforms for drug screening.	[Xue, Niannan; Li, Xia; Bertulli, Cristina; Patharagulpong, Atipat] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Li, Zhaoying; Huang, Yan Yan Shery] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Sadok, Amine] Inst Canc Res, London SW3 6JB, England	University of Cambridge; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Huang, YYS (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	yysh2@cam.ac.uk	Huang, Yan Yan Shery/A-6177-2015; Huang, Yan Yan/A-6596-2012	Huang, Yan Yan Shery/0000-0003-2619-730X; Huang, Yan Yan/0000-0003-2619-730X	Oppenheimer Research Fellowship; Department of Engineering Starting Grant (Cambridge); Chinese Scholarship Council; Fondazione Angelo Della Riccia; Royal Thai Scholarship Council	Oppenheimer Research Fellowship; Department of Engineering Starting Grant (Cambridge); Chinese Scholarship Council(China Scholarship Council); Fondazione Angelo Della Riccia; Royal Thai Scholarship Council	This research is funded by an Oppenheimer Research Fellowship and a Department of Engineering Starting Grant (Cambridge). X. Li is supported by the Chinese Scholarship Council (http://en.csc.edu.cn/), C. Bertulli is supported by Fondazione Angelo Della Riccia (http://theory.fi.infn.it/casalbuoni/dellariccia/) and A. Patharagulpong is supported by the Royal Thai Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Bisht GS, 2011, NANO LETT, V11, P1831, DOI 10.1021/nl2006164; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2975834; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Daerr A., 2011, IMAGEJ PLUG IN SURFA; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040; Di Camillo D, 2013, NANOSCALE, V5, P11637, DOI 10.1039/c3nr03094f; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Gioffre M, 2012, J BIOACT COMPAT POL, V27, P67, DOI 10.1177/0883911511431484; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Huang YYS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/10/105305; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Ko CL, 2012, J MECH BEHAV BIOMED, V14, P227, DOI 10.1016/j.jmbbm.2012.06.019; Kunitz M, 1927, J GEN PHYSIOL, V10, P811, DOI 10.1085/jgp.10.5.811; Larkin PJ, 2011, INFRARED AND RAMAN SPECTROSCOPY: PRINCIPLES AND SPECTRAL INTERPRETATION, P1; Liu ZH, 2013, SENSOR ACTUAT A-PHYS, V193, P13, DOI 10.1016/j.sna.2013.01.007; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115; Neves NM, 2007, INT J NANOMED, V2, P433; Nezarati RM, 2013, TISSUE ENG PART C-ME, V19, P810, DOI [10.1089/ten.tec.2012.0671, 10.1089/ten.TEC.2012.0671]; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Pritchard RH, 2013, POLYMER, V54, P6954, DOI 10.1016/j.polymer.2013.11.006; Pu JA, 2010, SENSOR ACTUAT A-PHYS, V164, P131, DOI 10.1016/j.sna.2010.09.019; Richards Jr R, 1966, EXP MECH, V6, P30, DOI DOI 10.1007/BF02327111; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Scatchard G, 1944, J AM CHEM SOC, V66, P1980, DOI 10.1021/ja01239a058; Sharma Ved P, 2012, Intravital, V1, P77; SHEDLOVSKY T, 1956, J PHYS CHEM-US, V60, P151, DOI 10.1021/j150536a003; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Sun DH, 2006, NANO LETT, V6, P839, DOI 10.1021/nl0602701; TAKAHASHI Y, 1973, J POLYM SCI POL PHYS, V11, P2113, DOI 10.1002/pol.1973.180111103; Vieira DF, 2007, ELECTROCHIM ACTA, V53, P1404, DOI 10.1016/j.electacta.2007.04.034; von Szyszkowski B, 1908, Z PHYS CHEM-STOCH VE, V64, P385; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; Xue NN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0060; Zemaitis J. F., 1986, HDB AQUEOUS ELECTROL; Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128; Zheng JF, 2006, POLYMER, V47, P7095, DOI 10.1016/j.polymer.2006.08.019	58	20	20	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93590	10.1371/journal.pone.0093590	http://dx.doi.org/10.1371/journal.pone.0093590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727667	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200021
J	De Rui, M; Toffanello, ED; Veronese, N; Zambon, S; Bolzetta, F; Sartori, L; Musacchio, E; Corti, MC; Baggio, G; Crepaldi, G; Perissinotto, E; Manzato, E; Sergi, G				De Rui, Marina; Toffanello, Elena Debora; Veronese, Nicola; Zambon, Sabina; Bolzetta, Francesco; Sartori, Leonardo; Musacchio, Estella; Corti, Maria Chiara; Baggio, Giovannella; Crepaldi, Gaetano; Perissinotto, Egle; Manzato, Enzo; Sergi, Giuseppe			Vitamin D Deficiency and Leisure Time Activities in the Elderly: Are All Pastimes the Same?	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL-ACTIVITY; WOMEN; POPULATION; CALCIUM; SUPPLEMENTATION; HEALTH; RISK; AGE	Background: Optimal vitamin D status is important for overall health and well-being, particularly in the elderly. Although vitamin D synthesis in the skin declines with age, exposure to sunlight still seems to help older-aged adults to achieve adequate serum 25-hydroxyvitamin D (25OHD) levels. Elderly people would therefore benefit from outdoor leisure activities, but the effects of different types of pastime on serum 25OHD levels have yet to be thoroughly investigated. Aims: To assess the association of different pastimes with 25OHD deficiency in elderly subjects. Methods: A sample of 2,349 community-dwelling elderly individuals (1,389 females and 960 males) enrolled in the Progetto Veneto Anziani was analyzed. Brisk walking, cycling, gardening and fishing were classed as outdoor activities, and dancing and gym workouts as indoor pastimes. Any activities undertaken for at least 1 hour/week during the previous month were considered as being practiced regularly. Logistic regression models were used to estimate the association between different pastimes and 25OHD deficiency. Results: Serum 25OHD levels were significantly higher in individuals who engaged in outdoor pastimes (+25% in women, + 27.7% in men) compared to those who did not. In particular, subjects regularly practicing gardening or cycling had higher serum 25OHD levels than those who did not, whereas 25OHD levels differed little between subjects who did or did not undertake indoor activities. Among the outdoor pastimes considered, logistic regression analysis confirmed a lower likelihood of vitamin D deficiency (25OHD, 50 nmol/L) for cyclists (OR 0.51, 95% CI 0.37-0.69 in women; OR 0.50, 95% CI 0.29-0.87 in men) and gardeners (OR 0.62, 95% CI 0.47-0.83 in women; OR 0.46, 95% CI 0.26-0.80), but not for brisk walkers. Conclusions: Regular cycling and gardening reduce the likelihood of inadequate vitamin D status in Caucasian elderly people, irrespective of their age, BMI and comorbidities, and of the season of the year.	[De Rui, Marina; Toffanello, Elena Debora; Veronese, Nicola; Bolzetta, Francesco; Manzato, Enzo; Sergi, Giuseppe] Univ Padua, Dept Med, Div Geriatr, Padua, Italy; [Zambon, Sabina; Sartori, Leonardo; Musacchio, Estella] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Corti, Maria Chiara] Azienda Unita Locale Socio Sanitaria 16, Padua, Italy; [Baggio, Giovannella] Azienda Osped, Div Internal Med, Dept Med, Padua, Italy; [Crepaldi, Gaetano; Manzato, Enzo] Inst Neurosci, Natl Res Council, Aging Branch, Padua, Italy; [Perissinotto, Egle] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostatist Epidemiol & Publ Hlth Unit, Padua, Italy	University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua	De Rui, M (corresponding author), Univ Padua, Dept Med, Div Geriatr, Padua, Italy.	marinaderui@gmail.com	SERGI, GIUSEPPE/J-9396-2018; De Rui, Marina/AAA-6029-2022; Veronese, Nicola/K-4343-2018	SERGI, GIUSEPPE/0000-0001-9757-856X; De Rui, Marina/0000-0003-4966-1312; Veronese, Nicola/0000-0002-9328-289X; Musacchio, Estella/0000-0001-9811-9103	Fondazione Cassa di Risparmio di Padova e Rovigo; University of Padova; Azienda Unita Locale Socio Sanitaria 15 and 18 of the Veneto region; National Institute on Aging, National Institutes of Health; Veneto Region Research Project [104/02]	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); University of Padova; Azienda Unita Locale Socio Sanitaria 15 and 18 of the Veneto region(Regione Veneto); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veneto Region Research Project	This study was funded by Fondazione Cassa di Risparmio di Padova e Rovigo, University of Padova, Azienda Unita Locale Socio Sanitaria 15 and 18 of the Veneto region; by the Intramural Research Program of the National Institute on Aging, National Institutes of Health; and by Veneto Region Research Project 104/02 (GC). The funding institutes had no role in the design, methods, subject recruitment, data collection, analysis, or preparation of the manuscript or in the decision to submit the manuscript for publication.	Barry DW, 2007, CALCIFIED TISSUE INT, V80, P359, DOI 10.1007/s00223-007-9028-y; Chel VGM, 1998, J BONE MINER RES, V13, P1238, DOI 10.1359/jbmr.1998.13.8.1238; Coin A, 2008, CLIN NUTR, V27, P87, DOI 10.1016/j.clnu.2007.10.008; Corti MC, 2002, J AM GERIATR SOC, V50, P1535, DOI 10.1046/j.1532-5415.2002.50409.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher JC, 2013, J STEROID BIOCHEM, V136, P195, DOI 10.1016/j.jsbmb.2012.12.003; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Kluczynski MA, 2011, ANN EPIDEMIOL, V21, P440, DOI 10.1016/j.annepidem.2010.11.011; Lindqvist PG, 2010, DIABETES RES CLIN PR, V90, P109, DOI 10.1016/j.diabres.2010.06.007; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Maeda SS, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-14; Gomez JM, 2006, CURR PHARM BIOTECHNO, V7, P125; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Parmelee P.A., 1989, J CONSULT CLIN PSYCH, V1, P331; Robinson PJ, 2013, AUSTRALAS J AGEING, V32, P177, DOI 10.1111/j.1741-6612.2011.00553.x; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; Toffanello ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034950; van Dam RM, 2007, AM J CLIN NUTR, V85, P755, DOI 10.1093/ajcn/85.3.755; Vernay M., 2012, BEH, V16-17, P189; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Zittermann A, 2000, CALCIFIED TISSUE INT, V67, P215, DOI 10.1007/s002230001132	22	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94805	10.1371/journal.pone.0094805	http://dx.doi.org/10.1371/journal.pone.0094805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722592	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100135
J	Muller, S; Kaiser, H; Kruger, B; Fitzner, B; Lange, F; Bock, CN; Nizze, H; Ibrahim, SM; Fuellen, G; Wolkenhauer, O; Jaster, R				Mueller, Sarah; Kaiser, Hannah; Krueger, Burkhard; Fitzner, Brit; Lange, Falko; Bock, Cristin N.; Nizze, Horst; Ibrahim, Saleh M.; Fuellen, Georg; Wolkenhauer, Olaf; Jaster, Robert			Age-Dependent Effects of UCP2 Deficiency on Experimental Acute Pancreatitis in Mice	PLOS ONE			English	Article							ACUTE NECROTIZING PANCREATITIS; OXYGEN SPECIES PRODUCTION; UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; FREE-RADICALS; CONTROLLED-TRIAL; ACINAR-CELLS; INFLAMMATION; ACTIVATION; PATHOGENESIS	Reactive oxygen species (ROS) have been implicated in the pathogenesis of acute pancreatitis (AP) for many years but experimental evidence is still limited. Uncoupling protein 2 (UCP2)-deficient mice are an accepted model of age-related oxidative stress. Here, we have analysed how UCP2 deficiency affects the severity of experimental AP in young and older mice (3 and 12 months old, respectively) triggered by up to 7 injections of the secretagogue cerulein (50 mu g/kg body weight) at hourly intervals. Disease severity was assessed at time points from 3 hours to 7 days based on pancreatic histopathology, serum levels of alpha-amylase, intrapancreatic trypsin activation and levels of myeloperoxidase (MPO) in lung and pancreatic tissue. Furthermore, in vitro studies with pancreatic acini were performed. At an age of 3 months, UCP2(-/-) mice and wild-type (WT) C57BL/6 mice were virtually indistinguishable with respect to disease severity. In contrast, 12 months old UCP2(-/-) mice developed a more severe pancreatic damage than WT mice at late time points after the induction of AP (24 h and 7 days, respectively), suggesting retarded regeneration. Furthermore, a higher peak level of alpha-amylase activity and gradually increased MPO levels in pancreatic and lung tissue were observed in UCP2(-/-) mice. Interestingly, intrapancreatic trypsin activities (in vivo studies) and intraacinar trypsin and elastase activation in response to cerulein treatment (in vitro studies) were not enhanced but even diminished in the knockout strain. Finally, UCP2(-/-) mice displayed a diminished ratio of reduced and oxidized glutathione in serum but no increased ROS levels in pancreatic acini. Together, our data indicate an aggravating effect of UCP2 deficiency on the severity of experimental AP in older but not in young mice. We suggest that increased severity of AP in 12 months old UCP2(-/-) is caused by an imbalanced inflammatory response but is unrelated to acinar cell functions.	[Mueller, Sarah; Kaiser, Hannah; Fitzner, Brit; Lange, Falko; Bock, Cristin N.; Jaster, Robert] Univ Med Rostock, Dept Med 2, Div Gastroenterol, Rostock, Germany; [Krueger, Burkhard] Univ Med Rostock, Div Med Biol, Rostock, Germany; [Fitzner, Brit] Univ Med Rostock, Dept Neurol, Rostock, Germany; [Lange, Falko] Univ Med Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany; [Nizze, Horst] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Fuellen, Georg] Univ Med Rostock, Inst Biostatist & Informat Med & Ageing Res, Rostock, Germany; [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Wolkenhauer, Olaf] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study, ZA-7600 Stellenbosch, South Africa	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Lubeck; University of Rostock; University of Rostock; Stellenbosch University	Jaster, R (corresponding author), Univ Med Rostock, Dept Med 2, Div Gastroenterol, Rostock, Germany.	jaster@med.uni-rostock.de	Ibrahim, Saleh/AAO-9541-2020	Lange, Falko/0000-0001-8782-5205; Fitzner, Brit/0000-0003-3077-1351; Ibrahim, Saleh/0000-0001-7827-2290; Wolkenhauer, Olaf/0000-0001-6105-2937	Bundesministerium fur Bildung und Forschung [0315892A]; Bundesministerium fur Bildung und Forschung (GERONTOSYS program)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (GERONTOSYS program)	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (0315892A, GERONTOSYS program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bai Y, 2008, ALIMENT PHARM THER, V28, P557, DOI 10.1111/j.1365-2036.2008.03756.x; Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120; Kruger B, 1998, LAB INVEST, V78, P763; Kuhla A, 2011, EXP GERONTOL, V46, P868, DOI 10.1016/j.exger.2011.07.008; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lorentz K, 1998, CLIN CHEM LAB MED, V36, P185, DOI 10.1515/CCLM.1998.034; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Park BK, 2003, WORLD J GASTROENTERO, V9, P2266; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; RUTLEDGE PL, 1987, GASTROENTEROLOGY, V93, P41, DOI 10.1016/0016-5085(87)90311-8; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Segersvard R, 2005, CELL TISSUE RES, V320, P251, DOI 10.1007/s00441-004-1024-1; Siriwardena AK, 2007, GUT, V56, P1439, DOI 10.1136/gut.2006.115873; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Telek G, 1999, J HISTOCHEM CYTOCHEM, V47, P1201, DOI 10.1177/002215549904700912; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Verlaan M, 2006, WORLD J GASTROENTERO, V12, P5705, DOI 10.3748/wjg.v12.i35.5705; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yasar M, 2002, HEPATO-GASTROENTEROL, V49, P1692; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; ZHOU WG, 1993, AM J PATHOL, V142, P1504	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94494	10.1371/journal.pone.0094494	http://dx.doi.org/10.1371/journal.pone.0094494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721982	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100082
J	Pan, JH; Xue, W; Sha, JJ; Yang, H; Xu, F; Xuan, HQ; Li, D; Huang, YR				Pan, Jiahua; Xue, Wei; Sha, Jianjun; Yang, Hu; Xu, Fan; Xuan, Hanqing; Li, Dong; Huang, Yiran			Incidental Prostate Cancer at the Time of Cystectomy: The Incidence and Clinicopathological Features in Chinese Patients	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; INVASIVE BLADDER-CANCER; RADICAL CYSTOPROSTATECTOMY; ADENOCARCINOMA; SPECIMENS; PREVALENCE	Objectives: To evaluate the incidence and the clinicopathological features of incidental prostate cancer detected in radical cystoprostatectomy (RCP) specimens in Chinese men and to estimate the oncological risk of prostate apex-sparing surgery for such patients. Methods: The clinical data and pathological feature of 504 patients who underwent RCP for bladder cancer from January 1999 to March 2013 were retrospectively reviewed. Whole mount serial section of the RCP specimens were cut transversely at 3-4 mm intervals and examined in same pathological institution. Results: Thirty-four out of 504 patients (6.8%) had incidental prostate cancer with a mean age of 70.3 years. 12 cases (35.2%) were diagnosed as significant disease. 4 cases were found to have apex involvement of adenocarcinoma of the prostate while in 5 cases the prostate stroma invasion by urothelial carcinoma were identified (one involved prostate apex). The mean follow-up time was 46.4 +/- 33.8 months. Biochemical recurrence occurred in 3 patients but no prostate cancer-related death during the follow-up. There was no statistical significance in cancer specific survival between the clinically significant and insignificant cancer group. Conclusions: The prevalence of incidental prostate cancer in RCP specimens in Chinese patients was remarkably lower than in western people. Most of the incidental prostate cancer was clinically insignificant and patient's prognosis was mainly related to the bladder cancer. Sparing the prostate apex was potentially associated with a 1.0% risk of leaving significant cancer of the prostate or urothelial carcinoma.	[Pan, Jiahua; Xue, Wei; Sha, Jianjun; Yang, Hu; Xu, Fan; Xuan, Hanqing; Li, Dong; Huang, Yiran] Shanghai Jiao Tong Univ, Renji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, YR (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China.	viovilla@163.com			National Natural Science Foundation of China [91129725]; Renji Medical Research Seed Project [RJZZ13-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Renji Medical Research Seed Project	The study was supported by National Natural Science Foundation of China (91129725) and Renji Medical Research Seed Project (RJZZ13-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 1996, EUR UROL, V30, P322; Abdelhady M, 2007, BJU INT, V99, P326, DOI 10.1111/j.1464-410X.2006.06558.x; Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Alsinnawi M, 2012, INT UROL NEPHROL, V44, P1705, DOI 10.1007/s11255-012-0224-y; [Anonymous], 2000, ONCOLOGY, V14, P267; Boehm K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005004.pub2; CARTER BS, 1991, CANCER SURV, V11, P5; Chen WQ, 2012, CHINESE J CANCER RES, V24, P1, DOI 10.1007/s11670-012-0001-6; Coen JJ, 2013, INT J RADIAT ONCOL, V86, P311, DOI 10.1016/j.ijrobp.2013.01.020; Colombo R, 2001, J UROLOGY, V165, P51, DOI 10.1097/00005392-200101000-00013; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Cussenot O, 2001, Eur J Intern Med, V12, P11, DOI 10.1016/S0953-6205(00)00136-9; Damiano R, 2007, EUR UROL, V52, P648, DOI 10.1016/j.eururo.2007.06.016; Davila HH, 2007, BJU INT, V100, P1026, DOI 10.1111/j.1464-410X.2007.07169.x; Delongchamps NB, 2005, EUR UROL, V48, P946, DOI 10.1016/j.eururo.2005.07.008; Desai SB, 2002, CANCER, V94, P2350, DOI 10.1002/cncr.10495; Deschasaux M, 2014, J NUTR, V144, P504, DOI 10.3945/jn.113.189670; Gakis G, 2013, SCAND J UROL, V47, P358, DOI 10.3109/00365599.2012.723045; Gakis G, 2010, BJU INT, V105, P468, DOI 10.1111/j.1464-410X.2009.08739.x; Gunderson K, 2011, CANCER EPIDEMIOL, V35, P320, DOI 10.1016/j.canep.2010.11.007; Hosseini S.Y., 2007, Int. braz j urol., V33, P167, DOI 10.1590/S1677-55382007000200006; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joung JY, 2009, UROLOGY, V73, P153, DOI 10.1016/j.urology.2008.02.040; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Kim SJ, 2014, CANCER PREV RES, V7, P435, DOI 10.1158/1940-6207.CAPR-13-0427-T; KONSKI A, 1991, UROLOGY, V37, P202, DOI 10.1016/0090-4295(91)80285-F; Kouriefs C, 2005, UROL INT, V75, P213, DOI 10.1159/000087796; Kurahashi T, 2010, INT UROL NEPHROL, V42, P73, DOI 10.1007/s11255-009-9578-1; Liu R, 1996, CHIN J UROL, V17, P738; Mazzucchelli R, 2010, ANAL QUANT CYTOL, V32, P151; Mazzucchelli R, 2009, AM J CLIN PATHOL, V131, P279, DOI 10.1309/AJCP4OCYZBAN9TJU; Mertens LS, 2014, J UROLOGY, V191, P1250, DOI 10.1016/j.juro.2013.11.031; MONTIE JE, 1989, CANCER, V63, P381, DOI 10.1002/1097-0142(19890115)63:2<381::AID-CNCR2820630230>3.0.CO;2-O; Mosli HA, 2009, SAUDI MED J, V30, P1439; Moutzouris G, 1999, SCAND J UROL NEPHROL, V33, P27; Novara G, 2010, EUR UROL, V57, P1045, DOI 10.1016/j.eururo.2010.01.007; Ogunbiyi JO, 1999, J NATL MED ASSOC, V91, P159; Pettus JA, 2006, 2006 ANN M AM UR ASS; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Shen SS, 2006, HUM PATHOL, V37, P726, DOI 10.1016/j.humpath.2006.01.027; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Sivalingam S, 2013, CUAJ-CAN UROL ASSOC, V7, P35, DOI 10.5489/cuaj.212; Walker ARP, 2003, SAMJ S AFR MED J, V93, P773; Wunderlich H, 2006, UROLOGY, V68, P554, DOI 10.1016/j.urology.2006.03.047; Yumura Yasushi, 2006, Hinyokika Kiyo, V52, P255; Zapatero A, 2012, UROLOGY, V80, P1056, DOI 10.1016/j.urology.2012.07.045; Zhu YP, 2009, ASIAN J ANDROL, V11, P104, DOI [10.1038/aja.2008.15, 10.1038/aja.2009.15]; Zietman AL, 2000, ANN MED, V32, P34, DOI 10.3109/07853890008995908	48	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94490	10.1371/journal.pone.0094490	http://dx.doi.org/10.1371/journal.pone.0094490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722643	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100080
J	Rothan, HA; Bahrani, H; Mohamed, Z; Abd Rahman, N; Yusof, R				Rothan, Hussin A.; Bahrani, Hirbod; Mohamed, Zulqarnain; Abd Rahman, Noorsaadah; Yusof, Rohana			Fusion of Protegrin-1 and Plectasin to MAP30 Shows Significant Inhibition Activity against Dengue Virus Replication	PLOS ONE			English	Article							ANTI-HIV; ANTIMICROBIAL PEPTIDES; SERINE-PROTEASE; PROTEINS MAP30; EXPRESSION; CLEAVAGE; CELLS; NS3; DEPENDENCE; INFECTION	Dengue virus (DENV) broadly disseminates in tropical and sub-tropical countries and there are no vaccine or anti-dengue drugs available. DENV outbreaks cause serious economic burden due to infection complications that requires special medical care and hospitalization. This study presents a new strategy for inexpensive production of anti-DENV peptide-fusion protein to prevent and/or treat DENV infection. Antiviral cationic peptides protegrin-1 (PG1) and plectasin (PLSN) were fused with MAP30 protein to produce recombinant antiviral peptide-fusion protein (PG1-MAP30-PLSN) as inclusion bodies in E. coli. High yield production of PG1-MAP30-PLSN protein was achieved by solubilization of inclusion bodies in alkaline buffer followed by the application of appropriate refolding techniques. Antiviral PG1-MAP30-PLSN protein considerably inhibited DENV protease (NS2B-NS3pro) with half-maximal inhibitory concentration (IC50) 0.5 +/- 0.1 mu M. The real-time proliferation assay (RTCA) and the end-point proliferation assay (MTT assay) showed that the maximal-nontoxic dose of the peptide-fusion protein against Vero cells is approximately 0.67 +/- 0.2 mu M. The cell-based assays showed considerable inhibition of the peptide-fusion protein against binding and proliferating stages of DENV2 into the target cells. The peptide-fusion protein protected DENV2-challeged mice with 100% of survival at the dose of 50 mg/kg. In conclusion, producing recombinant antiviral peptide-fusion protein by combining short antiviral peptide with a central protein owning similar activity could be useful to minimize the overall cost of short peptide production and take advantage of its synergistic antiviral activities.	[Rothan, Hussin A.; Bahrani, Hirbod; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Mohamed, Zulqarnain] Univ Malaya, Inst Biol Sci, Fac Sci, Genet & Mol Biol Unit, Kuala Lumpur, Malaysia; [Abd Rahman, Noorsaadah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Rothan, HA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	rothan@um.edu.my	ROTHAN, HUSSIN/D-5490-2016; Rahman, Noorsaadah Abd./B-9291-2010; MOHAMED, ZULQARNAIN/C-1158-2010; YUSOF, ROHANA/B-9589-2010	Rahman, Noorsaadah Abd./0000-0001-5847-8961; MOHAMED, ZULQARNAIN/0000-0001-7311-0356; YUSOF, ROHANA/0000-0002-6591-3236; ROTHAN, HUSSIN/0000-0002-7300-6388	University of Malaya; Ministry of Science, Technology and Innovation (ERGS) [ER016-2013A]	University of Malaya(Universiti Malaya); Ministry of Science, Technology and Innovation (ERGS)	This project was funded by the University of Malaya and Ministry of Science, Technology and Innovation (ERGS Grant ER016-2013A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienzar FA, 2011, J BIOMOL SCREEN, V16, P575, DOI 10.1177/1087057111402825; Botting C, 2012, EXPERT OPIN DRUG DIS, V7, P417, DOI 10.1517/17460441.2012.673579; Bourinbaiar AS, 1996, BIOCHEM BIOPH RES CO, V219, P923, DOI 10.1006/bbrc.1996.0334; CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; David JC, 2013, DRUGS CHEM BIOL DRUG, V81, P136; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fang EF, 2012, CANCER LETT, V324, P66, DOI 10.1016/j.canlet.2012.05.005; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Heiker JT, 2010, BIOCHEM BIOPH RES CO, V398, P32, DOI 10.1016/j.bbrc.2010.06.020; HOLOWACHUK EW, 1995, PCR METH APPL, V4, P299; Hotez PJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001133; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; LEEHUANG S, 1995, GENE, V161, P151, DOI 10.1016/0378-1119(95)00186-A; LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O; LEEHUANG S, 1995, P NATL ACAD SCI USA, V92, P8818, DOI 10.1073/pnas.92.19.8818; Miyasaki KT, 1998, INT J ANTIMICROB AG, V9, P269, DOI 10.1016/S0924-8579(98)00006-5; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Puigbo P, 2008, NUCLEIC ACIDS RES, V36, pD524, DOI 10.1093/nar/gkm831; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rothan HA, 2013, OMICS, V17, P560, DOI 10.1089/omi.2013.0056; Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314; Rothan HA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251482; Saida F, 2006, CURR PROTEIN PEPT SC, V7, P47, DOI 10.2174/138920306775474095; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Schmitz Jens, 2010, Pharm Unserer Zeit, V39, P336, DOI 10.1002/pauz.201090076; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; Sun YT, 2001, BIOCHEM BIOPH RES CO, V287, P983, DOI 10.1006/bbrc.2001.5689; TAMAMURA H, 1995, CHEM PHARM BULL, V43, P853; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Wang YX, 1999, CELL, V99, P433, DOI 10.1016/S0092-8674(00)81529-9; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28	42	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94561	10.1371/journal.pone.0094561	http://dx.doi.org/10.1371/journal.pone.0094561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722532	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100096
J	Wang, XX; Gao, Y; Feng, Y; Li, X; Wei, Q; Sheng, XY				Wang, Xiaoxia; Gao, Yuan; Feng, Yu; Li, Xue; Wei, Qian; Sheng, Xianyong			Cadmium Stress Disrupts the Endomembrane Organelles and Endocytosis during Picea wilsonii Pollen Germination and Tube Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; METAL ACCUMULATION; HEAVY-METALS; ROOT-CELLS; TOXICITY; DYNAMICS; CHINA; CD; ULTRASTRUCTURE; BREFELDIN	As one of the most severe pollutants, cadmium has been reported to be harmful to plant cells, but the effects of cadmium on gymnosperm pollen germination and tube growth and the mechanism of this involvement are still unclear. Here, we report that cadmium not only strongly inhibited P. wilsonii pollen germination and tube growth, but also significantly altered tube morphology in a dose-dependent manner. Time-lapse images obtained with a laser scanning confocal microscope revealed that endocytosis was dramatically inhibited by cadmium stress. Further investigation with ER-Tracker dye indicated that cadmium stress reduced the number of the Golgi apparatus, and induced dilation of ER. Additionally, Lyso-Tracker staining showed that cadmium distinctly promoted the formation of acidic organelles in pollen tubes, likely derived from the dilated ER. Taken together, our studies indicated that P. wilsonii pollens were highly susceptible to cadmium stress, and that cadmium stress strongly inhibited pollen germination and tube growth by disrupting the endomembrane organelles, inhibiting endo/exocytosis, and forming acidic vacuoles, resulting in swollen tube tips and irregularly broadened tube diameters. These findings provide a new insight into the effects of cadmium toxicity on the tip growth of pollen tubes.	[Wang, Xiaoxia; Gao, Yuan; Feng, Yu; Li, Xue; Wei, Qian; Sheng, Xianyong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Capital Normal University	Sheng, XY (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	xianyong.sheng@163.com			Natural Science Foundation of China [31371387]; Scientific Research Project of Beijing Educational Committee [KM201210028017]; Excellent Talent Training Project of Beijing [2012D005016000006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Beijing Educational Committee; Excellent Talent Training Project of Beijing	This work was supported by Natural Science Foundation of China (Grant No. 31371387), Scientific Research Project of Beijing Educational Committee (Grant No. KM201210028017), and Excellent Talent Training Project of Beijing (Grant No. 2012D005016000006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CHINA DAILY; Caijing, 2013, CHIN HAZ MOR HORR SA; Calzoni GL, 2007, ENVIRON POLLUT, V149, P239, DOI 10.1016/j.envpol.2006.12.023; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Cole L, 2000, J MICROSC-OXFORD, V197, P239, DOI 10.1046/j.1365-2818.2000.00664.x; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Gan HY, 2013, MAR POLLUT BULL, V66, P252, DOI 10.1016/j.marpolbul.2012.09.020; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; HOLUB Z, 1983, BIOLOGIA, V38, P393; Kalbande DM, 2008, ENVIRON MONIT ASSESS, V138, P233, DOI 10.1007/s10661-007-9793-0; Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2; Kutik J, 2014, PHYSIOL PLANTARUM, V151, P423, DOI 10.1111/ppl.12124; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Liu DH, 2003, J BIOSCIENCES, V28, P471, DOI 10.1007/BF02705121; Liu N, 2012, ECOTOXICOLOGY, V21, P2004, DOI 10.1007/s10646-012-0935-y; Luo L, 2009, J ENVIRON MANAGE, V90, P2524, DOI 10.1016/j.jenvman.2009.01.011; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; Niu LL, 2013, ENVIRON POLLUT, V176, P55, DOI 10.1016/j.envpol.2013.01.019; Oleksyn J, 1999, WATER AIR SOIL POLL, V110, P195, DOI 10.1023/A:1005064218004; Parton RM, 2001, J CELL SCI, V114, P2685; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; Sabrine H, 2010, SCI HORTIC-AMSTERDAM, V125, P551, DOI 10.1016/j.scienta.2010.05.031; Sawidis T, 2008, PROTOPLASMA, V233, P95, DOI 10.1007/s00709-008-0306-y; SAWIDIS T, 1995, PROTOPLASMA, V185, P113, DOI 10.1007/BF01272851; Sheng XY, 2010, CELL BIOCHEM FUNCT, V28, P420, DOI 10.1002/cbf.1672; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Sheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045673; Sheng XY, 2012, BIOL TRACE ELEM RES, V146, P86, DOI 10.1007/s12011-011-9212-9; Tuna A. Levent, 2002, Turkish Journal of Biology, V26, P109; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Xiong ZT, 2001, ECOTOX ENVIRON SAFE, V48, P51, DOI 10.1006/eesa.2000.2002; Zhang ZS, 2012, BIOL TRACE ELEM RES, V145, P403, DOI 10.1007/s12011-011-9199-2; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008; 王崇臣, 2009, [环境化学, Environmental Chemistry], V28, P604	36	13	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94721	10.1371/journal.pone.0094721	http://dx.doi.org/10.1371/journal.pone.0094721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722362	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100128
J	Ximerakis, M; Pampalakis, G; Roumeliotis, TI; Sykioti, VS; Garbis, SD; Stefanis, L; Sotiropoulou, G; Vekrellis, K				Ximerakis, Methodios; Pampalakis, Georgios; Roumeliotis, Theodoros I.; Sykioti, Vasia-Samantha; Garbis, Spiros D.; Stefanis, Leonidas; Sotiropoulou, Georgia; Vekrellis, Kostas			Resistance of naturally secreted alpha-synuclein to proteolysis	FASEB JOURNAL			English	Article						KLK6; metalloprotease; lipidation; clearance; Parkinson's disease	SERINE-PROTEASE NEUROSIN; CLEAVAGE; FORMS; DEGRADATION; AGGREGATION; MECHANISM; DISEASE; BINDING; BREAST; OCCURS	Recent evidence suggests that specific extracellular alpha-synuclein (alpha-syn) strains are implicated in the progression of Parkinson's disease (PD) pathology. It is plausible that deregulation in the normal processing of secreted alpha-syn may be a causative risk factor for PD. To date, the degradation mechanisms involved have received very little attention. Here, we sought to investigate factors that regulate extracellular alpha-syn levels. We show, for the first time, that cell-secreted alpha-syn forms are resistant to direct proteolysis by kallikrein-related peptidase 6 (KLK6), an extracellular enzyme known to cleave recombinant alpha-syn. This differential susceptibility appears to be partially due to the association of secreted alpha-syn with lipids. We further provide evidence that secreted alpha-syn can be cleaved by KLK6 indirectly through activation of a secreted metalloprotease, suggestive of the involvement of a proteolytic cascade in the catabolism of secreted alpha-syn. Our results clearly suggest that physiological modifications affect the biochemical behavior of secreted alpha-syn and provide novel insights into mechanisms and potential targets for therapeutic interventions.	[Ximerakis, Methodios; Sykioti, Vasia-Samantha; Stefanis, Leonidas; Vekrellis, Kostas] Acad Athens, Biomed Res Fdn, Ctr Neurosci, Athens 11527, Greece; [Pampalakis, Georgios; Sotiropoulou, Georgia] Univ Patras, Sch Hlth Sci, Dept Pharm, Rion, Greece; [Roumeliotis, Theodoros I.; Garbis, Spiros D.] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England; [Stefanis, Leonidas] Univ Athens, Sch Med, Dept Neurol 2, GR-11527 Athens, Greece	Academy of Athens; University of Patras; University of Southampton; Athens Medical School; National & Kapodistrian University of Athens	Vekrellis, K (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Neurosci, 4 Soranou Ephessiou, Athens 11527, Greece.	vekrellis@bioacademy.gr	Ximerakis, Methodios/AAE-7642-2020; Stefanis, Leonidas/AAD-7192-2019; Garbis, Spiros D/L-3099-2013	Ximerakis, Methodios/0000-0002-2815-7558; Garbis, Spiros D/0000-0002-1050-0805	Michael J. Fox Foundation; EU FP7-MEFOPA project; Fondation Sante grant; EU FP7-REGPOT TranSMed grant	Michael J. Fox Foundation; EU FP7-MEFOPA project; Fondation Sante grant; EU FP7-REGPOT TranSMed grant	The authors thank N. Paschalidis for his assistance in cell survival assays and G. Arianoglou for ELISA measurements. Funding for this work was obtained from the Michael J. Fox Foundation (to K. V.), the EU FP7-MEFOPA project, and a 2013 Fondation Sante grant (to G. S). Additional funds were obtained from an EU FP7-REGPOT TranSMed grant.	Alvarez-Castelao B, 2014, BBA-MOL CELL RES, V1843, P352, DOI 10.1016/j.bbamcr.2013.11.018; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; Blaber SI, 2007, BIOCHEMISTRY-US, V46, P5209, DOI 10.1021/bi6025006; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Diamandis EP, 2000, CLIN BIOCHEM, V33, P369, DOI 10.1016/S0009-9120(00)00145-4; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Merlo S, 2012, MOL CELL NEUROSCI, V49, P423, DOI 10.1016/j.mcn.2012.02.005; Ogawa K, 2000, PSYCHIAT CLIN NEUROS, V54, P419, DOI 10.1046/j.1440-1819.2000.00731.x; Oikonomopoulou K, 2008, BIOL CHEM, V389, P747, DOI 10.1515/BC.2008.086; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pampalakis G, 2009, CANCER RES, V69, P3779, DOI 10.1158/0008-5472.CAN-08-1976; Papachristou EK, 2013, J PROTEOME RES, V12, P2078, DOI 10.1021/pr301067r; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sotiropoulou G, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-148; Spencer B, 2013, MOL THER, V21, P31, DOI 10.1038/mt.2012.66; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	43	16	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3146	3158		10.1096/fj.13-245852	http://dx.doi.org/10.1096/fj.13-245852			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24723692				2022-12-25	WOS:000337949400035
J	Hattori, Y; Morita, D; Fujiwara, N; Mori, D; Nakamura, T; Harashima, H; Yamasaki, S; Sugita, M				Hattori, Yuki; Morita, Daisuke; Fujiwara, Nagatoshi; Mori, Daiki; Nakamura, Takashi; Harashima, Hideyoshi; Yamasaki, Sho; Sugita, Masahiko			Glycerol Monomycolate Is a Novel Ligand for the Human, but Not Mouse Macrophage Inducible C-type Lectin, Mincle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Innate Immunity; Lipids; Macrophages; Mycobacteria; Transgenic Mice; Glycerol Monomycolate; Mincle	MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIGS; DC-SIGN; ACTIVATING RECEPTOR; CELLS; RECOGNITION; HYPERSENSITIVITY; EXPRESSION; GRANULOMAS; ANTIGENS	Background: A host receptor has not yet been identified for glycerol monomycolate (GroMM), an immunostimulatory lipid of mycobacteria. Results: GroMM recognition occurred in cell transfectants expressing human, but not mouse Mincle. Human Mincle transgenic mice acquired the ability to respond to GroMM. Conclusion: GroMM is a ligand for human Mincle. Significance: The molecular basis underlying the innate immune recognition of GroMM has been elucidated. An array of lipidic compounds that constitute the cell wall of mycobacteria is recognized by host receptors. Examples include trehalose dimycolate (TDM), which is a major surface-exposed glycolipid of mycobacteria, that interacts with the macrophage inducible C-type lectin, Mincle, and exerts its highly potent adjuvant functions. Recent evidence has suggested that glycerol monomycolate (GroMM), another mycolate-containing lipid species produced by mycobacteria, can stimulate innate immune cells; however, its specific host receptors have yet to be identified. We here demonstrated that cell transfectants expressing human Mincle (hMincle) reacted to both TDM and GroMM, while those expressing mouse Mincle (mMincle) only reacted to TDM and failed to recognize GroMM. Studies using domain swap chimeras confirmed that the ectodomain of hMincle, but not that of mMincle, interacted with GroMM, and site-directed mutagenesis analyses revealed that short stretches of amino acid residues at positions 174-176 and 195-196 were involved in GroMM recognition. To further substantiate the differential recognition of GroMM by hMincle and mMincle, hMincle transgenic/mMincle knock-out mice (i.e. hMincle(+) mice) were established and compared with non-transgenic mice (i.e. mMincle(+) mice). We showed that macrophages derived from hMincle(+) mice were activated by GroMM and produced inflammatory cytokines, whereas those derived from mMincle(+) mice did not exhibit any reactivity to GroMM. Furthermore, local inflammatory responses were elicited in the GroMM-injected skin of hMincle(+), but not mMincle(+) mice. These results demonstrated that GroMM is a unique ligand for hMincle that is not recognized by mMincle.	[Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Lab Cell Regulat, Kyoto 6068507, Japan; [Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Mol Network, Kyoto 6068507, Japan; [Fujiwara, Nagatoshi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara 6318585, Japan; [Mori, Daiki; Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Nakamura, Takashi; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Kyoto University; Kyoto University; Kyoto University; Kyushu University; Hokkaido University	Yamasaki, S (corresponding author), Kyushu Univ, Div Mol Immunol, Res Ctr Infect Dis, Med Inst Bioregulat,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp; msugita@virus.kyoto-u.ac.jp	Nakamura, Takashi/F-4419-2016; Hattori, Yuki/AAW-2061-2021	Nakamura, Takashi/0000-0001-9019-1426; Sugita, Masahiko/0000-0001-5511-1304; MORI, Daiki/0000-0002-3596-0840; Hattori, Yuki/0000-0001-6576-0121	Japan Society for the Promotion of Science [24390255]; Ministry of Health, Labor and Welfare; Institute for Virus Research, Kyoto University; Grants-in-Aid for Scientific Research [12J04754] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Institute for Virus Research, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science (grant-in-aid for Scientific Research (B); grant number 24390255). This work was also supported by a grant from the Ministry of Health, Labor and Welfare, and by Joint Usage/Research Center program of Institute for Virus Research, Kyoto University.	Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Dascher CC, 2003, INT IMMUNOL, V15, P915, DOI 10.1093/intimm/dxg091; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Miyake Yasunobu, 2010, Self Nonself, V1, P310, DOI 10.4161/self.1.4.13736; Otsuka A, 2008, J IMMUNOL, V181, P8528, DOI 10.4049/jimmunol.181.12.8528; Pirson C, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-54; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Sakamoto K, 2013, INFECT IMMUN, V81, P764, DOI 10.1128/IAI.00906-12; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang Y., 2014, HYDROLASE TREHALOSE	35	61	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15405	15412		10.1074/jbc.M114.566489	http://dx.doi.org/10.1074/jbc.M114.566489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733387	hybrid, Green Published			2022-12-25	WOS:000337465400024
J	Shearn, CT; Backos, DS; Orlicky, DJ; Smathers-McCullough, RL; Petersen, DR				Shearn, Colin T.; Backos, Donald S.; Orlicky, David J.; Smathers-McCullough, Rebecca L.; Petersen, Dennis R.			Identification of 5 ' AMP-activated Kinase as a Target of Reactive Aldehydes during Chronic Ingestion of High Concentrations of Ethanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alcohol; AMP-activated Kinase (AMPK); Lipid Peroxidation; Liver; Oxidative Stress	BLOOD-ALCOHOL CONCENTRATIONS; IN-SITU DETECTION; PROTEIN-KINASE; MURINE MODEL; FATTY LIVER; LIPID-PEROXIDATION; PROTECTIVE ACTION; OXIDATIVE STRESS; EXPOSURE OCCURS; PEROXIREDOXIN 6	The production of reactive aldehydes including 4-hydroxy-2-nonenal (4-HNE) is a key component of the pathogenesis in a spectrum of chronic inflammatory hepatic diseases including alcoholic liver disease (ALD). One consequence of ALD is increased oxidative stress and altered -oxidation in hepatocytes. A major regulator of -oxidation is 5 AMP protein kinase (AMPK). In an in vitro cellular model, we identified AMPK as a direct target of 4-HNE adduction resulting in inhibition of both H2O2 and 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced downstream signaling. By employing biotin hydrazide capture, it was confirmed that 4-HNE treatment of cells resulted in carbonylation of AMPK/, which was not observed in untreated cells. Using a murine model of alcoholic liver disease, treatment with high concentrations of ethanol resulted in an increase in phosphorylated as well as carbonylated AMPK. Despite increased AMPK phosphorylation, there was no significant change in phosphorylation of acetyl CoA carboxylase. Mass spectrometry identified Michael addition adducts of 4-HNE on Cys(130), Cys(174), Cys(227), and Cys(304) on recombinant AMPK and Cys(225) on recombinant AMPK. Molecular modeling analysis of identified 4-HNE adducts on AMPK suggest that inhibition of AMPK occurs by steric hindrance of the active site pocket and by inhibition of hydrogen peroxide induced oxidation. The observed inhibition of AMPK by 4-HNE provides a novel mechanism for altered -oxidation in ALD, and these data demonstrate for the first time that AMPK is subject to regulation by reactive aldehydes in vivo.	[Shearn, Colin T.; Backos, Donald S.; Petersen, Dennis R.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Smathers-McCullough, Rebecca L.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cleveland Clinic Foundation	Petersen, DR (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Sch Pharm, Anschutz Med Campus,12850 East Montview Blvd Box, Denver, CO 80217 USA.	Dennis.Petersen@ucdenver.edu	Backos, Donald/N-5265-2019; Backos, Donald/Q-4791-2018	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210	Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility; Colorado Clinical Translational Science Institute; University of Colorado Cancer Center Grants Clinical and Translational Science Award [UL1 RR025780]; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018613, R56AA009300, R37AA009300] Funding Source: NIH RePORTER	Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute; University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility; Colorado Clinical Translational Science Institute; University of Colorado Cancer Center Grants Clinical and Translational Science Award; University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the Computational Chemistry and Biology Core Facility at the University of Colorado Anschutz Medical Campus and the University of Colorado Denver Cancer Center Research Histology Core (E. Erin Smith, April Otero, and Kathy Lux). The mass spectrometry and histology experiments were supported in part by Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute Grant UL1 RR025780 and the University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility, by the Colorado Clinical Translational Science Institute, and University of Colorado Cancer Center Grants Clinical and Translational Science Award UL1 RR025780 and the University of Colorado Cancer Center Grant P30 CA046934.	Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; BADGER TM, 1993, BIOCHEM BIOPH RES CO, V190, P780, DOI 10.1006/bbrc.1993.1117; Baio DL, 1998, ARCH BIOCHEM BIOPHYS, V350, P193, DOI 10.1006/abbi.1997.0514; BENEDETTI A, 1982, BIOCHIM BIOPHYS ACTA, V712, P628, DOI 10.1016/0005-2760(82)90292-2; BENEDETTI A, 1984, BIOCHIM BIOPHYS ACTA, V792, P172, DOI 10.1016/0005-2760(84)90219-4; BENEDETTI A, 1982, BIOCHIM BIOPHYS ACTA, V711, P345, DOI 10.1016/0005-2760(82)90044-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaudhary P, 2010, BIOCHEMISTRY-US, V49, P6263, DOI 10.1021/bi100517x; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Deguchi JO, 2009, LAB INVEST, V89, P315, DOI 10.1038/labinvest.2008.167; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Everitt H, 2013, AM J PHYSIOL-GASTR L, V304, pG38, DOI 10.1152/ajpgi.00309.2012; FRENCH SW, 1989, CLIN BIOCHEM, V22, P41, DOI 10.1016/S0009-9120(89)80067-0; Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; Gao XX, 2005, PROTEIN EXPRES PURIF, V43, P44, DOI 10.1016/j.pep.2005.03.017; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARRIS RA, 1978, ARCH BIOCHEM BIOPHYS, V189, P364, DOI 10.1016/0003-9861(78)90223-0; Jones AW, 2003, J FORENSIC SCI, V48, P874; JONES AW, 1992, ALCOHOL ALCOHOLISM, V27, P641; Kohjima M, 2008, INT J MOL MED, V21, P507; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Liangpunsakul S, 2008, AM J PHYSIOL-GASTR L, V295, pG1173, DOI 10.1152/ajpgi.90349.2008; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Paradis V, 1997, HEPATOLOGY, V26, P135; Paradis V, 1997, J CLIN PATHOL, V50, P401, DOI 10.1136/jcp.50.5.401; Qin SF, 2010, EXP EYE RES, V91, P818, DOI 10.1016/j.exer.2010.10.007; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Roede JR, 2009, J PHARMACOL EXP THER, V330, P79, DOI 10.1124/jpet.109.152983; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; RONIS MJJ, 1993, J PHARMACOL EXP THER, V264, P944; Sampey BP, 2003, ALCOHOL CLIN EXP RES, V27, P1015, DOI 10.1097/01.ALC.0000071928.16732.26; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Setshedi M, 2011, ALCOHOL CLIN EXP RES, V35, P2139, DOI 10.1111/j.1530-0277.2011.01569.x; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Shearn CT, 2011, BIOCHEMISTRY-US, V50, P3984, DOI 10.1021/bi200029w; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shearn CT, 2012, FREE RADICAL BIO MED, V53, P1, DOI 10.1016/j.freeradbiomed.2012.04.021; Shearn CT, 2011, MOL PHARMACOL, V79, P941, DOI 10.1124/mol.110.069534; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Smathers RL, 2013, J LIPID RES, V54, P1335, DOI 10.1194/jlr.M034892; Smathers RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038459; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; WILLIAMS SP, 1987, INT J BIOCHEM, V19, P879, DOI 10.1016/0020-711X(87)90249-7; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu J, 2011, J HEPATOL, V55, P673, DOI 10.1016/j.jhep.2010.12.034; Ye Qinyuan, 2012, Hepatobiliary Surg Nutr, V1, P5; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	63	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15449	15462		10.1074/jbc.M113.543942	http://dx.doi.org/10.1074/jbc.M113.543942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722988	Green Published, hybrid			2022-12-25	WOS:000337465400028
J	Gao, HF; Bai, JH; He, XH; Zhao, QQ; Lu, QQ; Wang, JJ				Gao, Haifeng; Bai, Junhong; He, Xinhua; Zhao, Qingqing; Lu, Qiongqiong; Wang, Junjing			High Temperature and Salinity Enhance Soil Nitrogen Mineralization in a Tidal Freshwater Marsh	PLOS ONE			English	Article							YELLOW-RIVER DELTA; LAND-USE; NET NITRIFICATION; N-MINERALIZATION; ORGANIC-MATTER; DYNAMICS; GRASSLAND; MOISTURE; WETLANDS; CARBON	Soil nitrogen (N) mineralization in wetlands is sensitive to various environmental factors. To compare the effects of salinity and temperature on N mineralization, wetland soils from a tidal freshwater marsh locating in the Yellow River Delta was incubated over a 48-d anaerobic incubation period under four salinity concentrations (0, 10, 20 and 35 parts per thousand) and four temperature levels (10, 20, 30 and 40 degrees C). The results suggested that accumulated ammonium nitrogen (NH4+-N) increased with increasing incubation time under all salinity concentrations. Higher temperatures and salinities significantly enhanced soil N mineralization except for a short-term (approximate to 10 days) inhibiting effect found under 35 parts per thousand salinity. The incubation time, temperature, salinity and their interactions exhibited significant effects on N mineralization (P < 0.001) except the interactive effect of salinity and temperature (P > 0.05), while temperature exhibited the greatest effect (P < 0.001). Meanwhile, N mineralization processes were simulated using both an effective accumulated temperature model and a one-pool model. Both models fit well with the simulation of soil N mineralization process in the coastal freshwater wetlands under a range of 30 to 40 degrees C (R-2 = 0.88-0.99, P < 0.01). Our results indicated that an enhanced NH4+-N release with increasing temperature and salinity deriving from the projected global warming could have profound effects on nutrient cycling in coastal wetland ecosystems.	[Gao, Haifeng; Bai, Junhong; Zhao, Qingqing; Lu, Qiongqiong; Wang, Junjing] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China; [He, Xinhua] NSW Dept Primary Ind, West Pennant Hills, NSW, Australia	Beijing Normal University; NSW Department of Primary Industries	Bai, JH (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	junhongbai@163.com	Bai, Junhong/V-1993-2019; He, Xinhua/B-8047-2015	Bai, Junhong/0000-0003-2613-2143; He, Xinhua/0000-0002-5570-3454	National Science Foundation for Innovative Research Group [51121003]; National Basic Research Program Cover Letter [2013CB430406]; National Natural Science Foundation of China [51179006]; Program for New Century Excellent Talents in University [NECT-10-0235]; Fok Ying Tung Foundation [132009]	National Science Foundation for Innovative Research Group; National Basic Research Program Cover Letter(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying Tung Foundation(Fok Ying Tung Education Foundation)	This work was financially supported by the National Science Foundation for Innovative Research Group (51121003), the National Basic Research Program Cover Letter (2013CB430406), National Natural Science Foundation of China (51179006), the Program for New Century Excellent Talents in University (NECT-10-0235) and the Fok Ying Tung Foundation (132009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BIOGEOCHEMISTRY WETL; Bagherzadeh Ali, 2008, Journal of Forestry Research (Harbin), V19, P37, DOI 10.1007/s11676-008-0006-7; Bai JH, 2005, CAN J SOIL SCI, V85, P359, DOI 10.4141/S04-016; Bai JH, 2012, CLEAN-SOIL AIR WATER, V40, P1099, DOI 10.1002/clen.201200055; Bai JH, 2010, BIOL FERT SOILS, V46, P525, DOI 10.1007/s00374-010-0441-4; Carlson AE, 2008, NAT GEOSCI, V1, P620, DOI 10.1038/ngeo285; Chen RH, 1999, ESTUARIES, V22, P955, DOI 10.2307/1353075; Chen YT, 2012, WETLANDS, V32, P579, DOI 10.1007/s13157-012-0295-7; Cordovil CMDS, 2005, SOIL USE MANAGE, V21, P65, DOI 10.1079/SUM2005294; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Deng W, 2012, TYPICAL WETLAND SYST; Dou ZX, 1996, SOIL BIOL BIOCHEM, V28, P625, DOI 10.1016/0038-0717(95)00184-0; Downing JA, 1999, BIOGEOCHEMISTRY, V46, P109, DOI 10.1007/BF01007576; Ehrenfeld JG, 2012, AM MIDL NAT, V167, P322, DOI 10.1674/0003-0031-167.2.322; Fang HL, 2005, ENVIRON MANAGE, V35, P72, DOI 10.1007/s00267-004-3066-2; Fujita Y, 2013, SOIL BIOL BIOCHEM, V58, P302, DOI 10.1016/j.soilbio.2012.12.013; Gao HF, 2012, CLEAN-SOIL AIR WATER, V40, P1111, DOI 10.1002/clen.201200031; Gao JQ, 2009, PEDOSPHERE, V19, P71, DOI 10.1016/S1002-0160(08)60085-5; Gilliam FS, 2010, CAN J FOREST RES, V40, P436, DOI 10.1139/X09-202; Grenon F, 2004, SOIL BIOL BIOCHEM, V36, P1465, DOI 10.1016/j.soilbio.2004.04.021; Haddad SA, 2013, SOIL SCI SOC AM J, V77, P809, DOI 10.2136/sssaj2012.0231; IUSS-ISRIC-FAO, 2006, WORLD REF BAS SOIL R; Khoi CM, 2006, AQUACULTURE, V257, P221, DOI 10.1016/j.aquaculture.2006.02.075; Koch O, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002983; Li HL, 2003, GEODERMA, V115, P161, DOI 10.1016/S0016-7061(02)00358-0; Li SQ, 2013, COMMUN SOIL SCI PLAN, V44, P1659, DOI 10.1080/00103624.2013.783056; Li SX, 2008, SOIL PLANT NITROGEN; Lodhi A, 2009, PAK J BOT, V41, P967; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027645; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Muhammad S, 2006, BIOL FERT SOILS, V43, P93, DOI 10.1007/s00374-005-0068-z; Noe GB, 2013, BIOGEOCHEMISTRY, V114, P225, DOI 10.1007/s10533-012-9805-1; Pathak H, 1998, SOIL BIOL BIOCHEM, V30, P695, DOI 10.1016/S0038-0717(97)00208-3; Pidwirny M, 2006, SEAWATER; Prusty BAK, 2009, AUST J SOIL RES, V47, P177, DOI 10.1071/SR08087; RICHTER J, 1982, PLANT SOIL, V68, P379, DOI 10.1007/BF02197943; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Rysgaard S, 1999, ESTUARIES, V22, P21, DOI 10.2307/1352923; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Solomon S., 2007, CLIMATE CHANGE 2007, V4; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Tripathi S, BIOL FERTIL, V42, P273; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Wang WJ, 2003, BIOL FERT SOILS, V37, P362, DOI 10.1007/s00374-003-0604-7; WARING SA, 1964, NATURE, V201, P951, DOI 10.1038/201951a0; Whigham DF, 2009, COASTAL WETLANDS INT, P515; Wong VNL, 2008, BIOL FERT SOILS, V44, P943, DOI 10.1007/s00374-008-0279-1; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zhang X, 2011, GRASS FORAGE SCI, V66, P391, DOI 10.1111/j.1365-2494.2011.00789.x; Zhang XL, 2008, ACTA OECOL, V34, P322, DOI 10.1016/j.actao.2008.06.004; Zhu ZL, 1982, ACTA PEDOL SIN, V21, P29	52	31	35	7	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95011	10.1371/journal.pone.0095011	http://dx.doi.org/10.1371/journal.pone.0095011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733366	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400144
J	Henderson, J; Michailidis, G				Henderson, James; Michailidis, George			Network Reconstruction Using Nonparametric Additive ODE Models	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; TIME-SERIES DATA; PARAMETER-ESTIMATION; DIFFERENTIAL-EQUATIONS; SYSTEMS; INFERENCE; LIKELIHOOD	Network representations of biological systems are widespread and reconstructing unknown networks from data is a focal problem for computational biologists. For example, the series of biochemical reactions in a metabolic pathway can be represented as a network, with nodes corresponding to metabolites and edges linking reactants to products. In a different context, regulatory relationships among genes are commonly represented as directed networks with edges pointing from influential genes to their targets. Reconstructing such networks from data is a challenging problem receiving much attention in the literature. There is a particular need for approaches tailored to time-series data and not reliant on direct intervention experiments, as the former are often more readily available. In this paper, we introduce an approach to reconstructing directed networks based on dynamic systems models. Our approach generalizes commonly used ODE models based on linear or nonlinear dynamics by extending the functional class for the functions involved from parametric to nonparametric models. Concomitantly we limit the complexity by imposing an additive structure on the estimated slope functions. Thus the submodel associated with each node is a sum of univariate functions. These univariate component functions form the basis for a novel coupling metric that we define in order to quantify the strength of proposed relationships and hence rank potential edges. We show the utility of the method by reconstructing networks using simulated data from computational models for the glycolytic pathway of Lactocaccus Lactis and a gene network regulating the pluripotency of mouse embryonic stem cells. For purposes of comparison, we also assess reconstruction performance using gene networks from the DREAM challenges. We compare our method to those that similarly rely on dynamic systems models and use the results to attempt to disentangle the distinct roles of linearity, sparsity, and derivative estimation.	[Henderson, James; Michailidis, George] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Henderson, J (corresponding author), Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA.	jbhender@umich.edu		Henderson, James/0000-0002-3879-2942	National Science Foundation [F032335, F031344]; National Institute of Health [1R21GM101719-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101719] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation under grant No. F032335 and No. F031344. The work of GM was funded in part by the National Institute of Health grant 1R21GM101719-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Bard Y., 1974, NONLINEAR PARAMETER; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Brunel NJB, 2008, ELECTRON J STAT, V2, P1242, DOI 10.1214/07-EJS132; BUJA A, 1989, ANN STAT, V17, P453, DOI 10.1214/aos/1176347115; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Ellner SP, 2002, ECOLOGY, V83, P2256, DOI 10.1890/0012-9658(2002)083[2256:FPDMTT]2.0.CO;2; Fujita Andre, 2008, Journal of Bioinformatics and Computational Biology, V6, P961, DOI 10.1142/S0219720008003746; Green P. J., 1994, MONOGRAPHS STAT APPL, V58; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Guckenheimer J., 1997, APPL MATH SCI, V42; Gugushvili S, 2012, BERNOULLI, V18, P1061, DOI 10.3150/11-BEJ362; Gustafsson M, 2009, HDB RES COMPUTATIONA, P476; Hastie T., 2012, LARS LEAST ANGLE REG; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Madar A, 2009, IEEE ENG MED BIO, P5448, DOI 10.1109/IEMBS.2009.5334018; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meister A, 2013, ANN APPL STAT, V7, P1311, DOI 10.1214/13-AOAS645; Michailidis G, 2012, J COMPUT GRAPH STAT, V21, P840, DOI 10.1080/10618600.2012.738614; Nakatsui M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S9; Oates CJ, 2012, ANN APPL STAT, V6, P1209, DOI 10.1214/11-AOAS532; Ong Irene M, 2002, Bioinformatics, V18 Suppl 1, pS241; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Qi X, 2010, ANN STAT, V38, P435, DOI 10.1214/09-AOS724; R Core Team, 2012, R LANG ENV STAT COMP; Ramsay JO, 2007, J ROY STAT SOC B, V69, P741, DOI 10.1111/j.1467-9868.2007.00610.x; Ravikumar P, 2009, J R STAT SOC B, V71, P1009, DOI 10.1111/j.1467-9868.2009.00718.x; Shimamura T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-41; Shojaie A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082393; Shojaie A, 2010, BIOMETRIKA, V97, P519, DOI 10.1093/biomet/asq038; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; Voit E., 1991, CANONICAL NONLINEAR; Wang Y, 2010, COMPUTATIONAL METHOD, P450; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yamaguchi R, 2007, IEEE SIGNAL PROC MAG, V24, P37, DOI 10.1109/MSP.2007.273053; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121	46	25	25	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94003	10.1371/journal.pone.0094003	http://dx.doi.org/10.1371/journal.pone.0094003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732037	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400014
J	Highcock, L; Carter, AJ				Highcock, Laura; Carter, Alecia J.			Intraindividual Variability of Boldness Is Repeatable across Contexts in a Wild Lizard	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; MODEL SELECTION; OLDER-ADULTS; PERSONALITY; INFORMATION; VIGILANCE; PREDATION; INFERENCE; GUIDE; RISK	Animals do not behave in exactly the same way when repeatedly tested in the same context or situation, even once systematic variation, such as habituation, has been controlled for. This unpredictability is called intraindividual variability (IIV) and has been little studied in animals. Here we investigated how IIV in boldness (estimated by flight initiation distances) changed across two seasons-the dry, non-breeding season and the wet, breeding season-in a wild population of the Namibian rock agama, Agama planiceps. We found significant differences in IIV both between individuals and seasons, and IIV was higher in the wet season, suggesting plasticity in IIV. Further, IIV was highly repeatable (r = 0.61) between seasons and we found strong negative correlations between consistent individual differences in flight initiation distances, i.e. their boldness, and individuals' IIVs. We suggest that to understand personality in animals, researchers should generate a personality 'profile' that includes not only the relative level of a trait (i.e. its personality), but also its plasticity and variability under natural conditions.	[Highcock, Laura; Carter, Alecia J.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Carter, AJ (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ac854@cam.ac.uk		Carter, Alecia/0000-0001-5550-9312	Chicago Herpetological Society; Fenner School of Environment and Society	Chicago Herpetological Society; Fenner School of Environment and Society	This project received funding from Chicago Herpetological Society (chicagoherp.org). AJC was supported by a Fenner School of Environment and Society studentship, which also supported the majority of the costs of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503; Biro PA, 2013, AM NAT, V182, P621, DOI 10.1086/673213; Biro PA, 2012, ANIM BEHAV, V83, P1295, DOI 10.1016/j.anbehav.2012.01.036; Briffa M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0592; Caro T., 2005, ANTIPREDATOR DEFENCE; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Carter A, 2012, ANIM BEHAV, V84, P471, DOI 10.1016/j.anbehav.2012.06.001; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Carter AJ, 2010, BEHAV ECOL, V21, P655, DOI 10.1093/beheco/arq036; Cooper WE, 1999, BEHAV ECOL SOCIOBIOL, V47, P54, DOI 10.1007/s002650050649; Cooper WE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1765, DOI 10.1007/s00265-009-0799-1; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; Edwards AM, 2013, AUST J ZOOL, V61, P332, DOI 10.1071/ZO13025; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fleeson W, 2004, CURR DIR PSYCHOL SCI, V13, P83, DOI 10.1111/j.0963-7214.2004.00280.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hadfield J.D, 2012, MCMCGLMM COURSE NOTE; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; JENSEN AR, 1992, PERS INDIV DIFFER, V13, P869, DOI 10.1016/0191-8869(92)90004-9; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; Martin M, 2004, GERONTOLOGY, V50, P7, DOI 10.1159/000074382; McElreath R, 2006, ANIM BEHAV, V72, P1135, DOI 10.1016/j.anbehav.2006.04.001; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pays O, 2010, BEHAV ECOL SOCIOBIOL, V64, P443, DOI 10.1007/s00265-009-0860-0; Ram N, 2009, PSYCHOL AGING, V24, P778, DOI 10.1037/a0017915; Sanderson J, 2012, CONFLICT COOPERATION; Siegler RS, 2007, DEVELOPMENTAL SCI, V10, P104, DOI 10.1111/j.1467-7687.2007.00571.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Team R. D. C, 2011, R LANG ENV STAT COMP; Westneat DF, 2013, BEHAV ECOL, V24, P598, DOI 10.1093/beheco/ars207	38	31	31	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95179	10.1371/journal.pone.0095179	http://dx.doi.org/10.1371/journal.pone.0095179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733271	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400160
J	Shogen, Y; Isomura, ET; Kogo, M				Shogen, Yosuke; Isomura, Emiko Tanaka; Kogo, Mikihiko			Evaluation of Inferior Alveolar Nerve Regeneration by Bifocal Distraction Osteogenesis with Retrograde Transportation of Horseradish Peroxidase in Dogs	PLOS ONE			English	Article							SEGMENTAL MANDIBULAR DEFECTS; TRIGEMINAL GANGLION; RECONSTRUCTION; DEVICE; CAT	Background: Bifocal distraction osteogenesis has been shown to be a reliable method for reconstructing segmental mandibular defects. However, there are few reports regarding the occurrence of inferior alveolar nerve regeneration during the process of distraction. Previously, we reported inferior alveolar nerve regeneration after distraction, and evaluated the regenerated nerve using histological and electrophysiological methods. In the present study, we investigated axons regenerated by bifocal distraction osteogenesis using retrograde transportation of horseradish peroxidase in the mandibles of dogs to determine their type and function. Methods and Findings: Using a bifocal distraction osteogenesis method, we produced a 10-mm mandibular defect, including a nerve defect, in 11 dogs and distracted using a transport disk at a rate of 1 mm/day. The regenerated inferior alveolar nerve was evaluated by retrograde transportation of HRP in all dogs at 3 and 6 months after the first operation. At 3 and 6 months, HRP-labeled neurons were observed in the trigeminal ganglion. The number of HRP-labeled neurons in each section increased, while the cell body diameter of HRP-labeled neurons was reduced over time. Conclusions: We found that the inferior alveolar nerve after bifocal distraction osteogenesis successfully recovered until peripheral tissue began to function. Although our research is still at the stage of animal experiments, it is considered that it will be possible to apply this method in the future to humans who have the mandibular defects.	[Shogen, Yosuke; Isomura, Emiko Tanaka; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Isomura, Emiko Tanaka] Osaka Univ Hosp, Unit Dent, Suita, Osaka, Japan	Osaka University; Osaka University	Isomura, ET (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan.	tanaemi@dent.osaka-u.ac.jp	Isomura, Emiko/AAG-7594-2021; Isomura, Emiko Tanaka/GPP-3788-2022; Kogo, Mikihiko/ABD-7080-2020	Isomura, Emiko Tanaka/0000-0002-7855-9600; Kogo, Mikihiko/0000-0002-4556-2491	Japan Society for the Promotion of Science [23792332]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-aid for Scientific Research (23792332) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO N, 1987, NEUROSCI LETT, V82, P127, DOI 10.1016/0304-3940(87)90116-9; ARVIDSSON J, 1981, BRAIN RES, V210, P1, DOI 10.1016/0006-8993(81)90880-5; Block MS, 1996, J ORAL MAXIL SURG, V54, P1365, DOI 10.1016/S0278-2391(96)90499-1; BLOCK MS, 1993, J ORAL MAXIL SURG, V51, P652, DOI 10.1016/S0278-2391(10)80265-4; Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P1074, DOI 10.1097/00006534-200203000-00046; Cai M, 2011, J CRANIOFAC SURG, V22, P562, DOI 10.1097/SCS.0b013e318207b539; Carter LC, 1999, ORAL SURG ORAL MED O, V87, P477, DOI 10.1016/S1079-2104(99)70248-9; COSTANTINO PD, 1993, ARCH OTOLARYNGOL, V119, P511; COSTANTINO PD, 1990, ARCH OTOLARYNGOL, V116, P535; GANEY TM, 1994, CLIN ORTHOP RELAT R, P132; GANEY TM, 1994, OTOLARYNG HEAD NECK, V111, P265, DOI 10.1016/S0194-5998(94)70601-8; GANTOUS A, 1994, PLAST RECONSTR SURG, V93, P164, DOI 10.1097/00006534-199401000-00025; Gonzalez-Garcia R, 2010, ARCH OTOLARYNGOL, V136, P243, DOI 10.1001/archoto.2010.2; Hayashi Y, 2006, OHU U DENT J, V33, P195; Herford AS, 2004, J ORAL MAXIL SURG, V62, P412, DOI 10.1016/j.joms.2003.06.010; HOLLAND GR, 1990, J ANAT, V171, P179; Hu J, 2003, INT J ORAL MAX SURG, V32, P318, DOI 10.1054/ijom.2002.0356; Isomura ET, 2013, PLAST RECONSTR SURG, V132, P877, DOI 10.1097/PRS.0b013e31829fe49a; Isomura ET, 2013, J ORAL MAXIL SURG, V71, DOI 10.1016/j.joms.2013.04.037; Krishnan S, 2010, CRANIOMAX TRAUM REC, V3, P97, DOI 10.1055/s-0030-1254382; Kuriakose MA, 2003, HEAD NECK-J SCI SPEC, V25, P816, DOI 10.1002/hed.10294; Makarov MR, 1998, J ORAL MAXIL SURG, V56, P1417, DOI 10.1016/S0278-2391(98)90407-4; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Sacco AG, 2007, LANCET ONCOL, V8, P323, DOI 10.1016/S1470-2045(07)70102-X; Seitz O, 2010, J CRANIOFAC SURG, V21, P59, DOI 10.1097/SCS.0b013e3181c3b560; Takeda M, 2010, BRAIN BEHAV IMMUN, V24, P72, DOI 10.1016/j.bbi.2009.08.002; Tanimoto T, 2005, BRAIN RES, V1044, P262, DOI 10.1016/j.brainres.2005.02.082; Whitesides LM, 2004, J ORAL MAXIL SURG, V62, P292, DOI 10.1016/j.joms.2003.06.008; Zapata U, 2011, CALCIFIED TISSUE INT, V89, P379, DOI 10.1007/s00223-011-9529-6; Zuniga JR, 1999, J ORAL MAXILLOFAC SU, V57, P327	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94365	10.1371/journal.pone.0094365	http://dx.doi.org/10.1371/journal.pone.0094365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732938	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400032
J	Siervo, M; Riley, HL; Fernandez, BO; Leckstrom, CA; Martin, DS; Mitchell, K; Levett, DZH; Montgomery, HE; Mythen, MG; Grocott, MPW; Feelisch, M				Siervo, Mario; Riley, Heather L.; Fernandez, Bernadette O.; Leckstrom, Carl A.; Martin, Daniel S.; Mitchell, Kay; Levett, Denny Z. H.; Montgomery, Hugh E.; Mythen, Monty G.; Grocott, Michael P. W.; Feelisch, Martin		Caudwell Xtreme Everest Res Grp	Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress, Inflammation and Gluco-Insular Regulation: The Not-So-Sweet Price for Good Regulation	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; HIGH-ALTITUDE; ADIPOSE-TISSUE; OPERATION-EVEREST; HUMAN ADAPTATION; C-PEPTIDE; RESISTANCE; INTERLEUKIN-6; HOMEOSTASIS; METABOLISM	Objectives: The mechanisms by which low oxygen availability are associated with the development of insulin resistance remain obscure. We thus investigated the relationship between such gluco-insular derangements in response to sustained (hypobaric) hypoxemia, and changes in biomarkers of oxidative stress, inflammation and counter-regulatory hormone responses. Methods: After baseline testing in London (75 m), 24 subjects ascended from Kathmandu (1,300 m) to Everest Base Camp (EBC; 5,300 m) over 13 days. Of these, 14 ascended higher, with 8 reaching the summit (8,848 m). Assessments were conducted at baseline, during ascent to EBC, and 1, 6 and 8 week(s) thereafter. Changes in body weight and indices of gluco-insular control were measured (glucose, insulin, C-Peptide, homeostasis model assessment of insulin resistance [HOMA-IR]) along with biomarkers of oxidative stress (4-hydroxy-2-nonenal-HNE), inflammation (Interleukin-6 [IL-6]) and counter-regulatory hormones (glucagon, adrenalin, noradrenalin). In addition, peripheral oxygen saturation (SpO(2)) and venous blood lactate concentrations were determined. Results: SpO(2) fell significantly from 98.0% at sea level to 82.0% on arrival at 5,300 m. Whilst glucose levels remained stable, insulin and C-Peptide concentrations increased by >200% during the last 2 weeks. Increases in fasting insulin, HOMA-IR and glucagon correlated with increases in markers of oxidative stress (4-HNE) and inflammation (IL-6). Lactate levels progressively increased during ascent and remained significantly elevated until week 8. Subjects lost on average 7.3 kg in body weight. Conclusions: Sustained hypoxemia is associated with insulin resistance, whose magnitude correlates with the degree of oxidative stress and inflammation. The role of 4-HNE and IL-6 as key players in modifying the association between sustained hypoxia and insulin resistance merits further investigation.	[Siervo, Mario] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne, England; [Riley, Heather L.; Feelisch, Martin] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Fernandez, Bernadette O.; Leckstrom, Carl A.; Feelisch, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Fernandez, Bernadette O.; Grocott, Michael P. W.; Feelisch, Martin] Univ Southampton, Fac Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Martin, Daniel S.; Mitchell, Kay; Levett, Denny Z. H.; Montgomery, Hugh E.; Mythen, Monty G.; Grocott, Michael P. W.] UCL Inst Child Hlth, Ctr Altitude Space & Extreme Environm Med, Portex Unit, London, England; [Martin, Daniel S.] UCL, Royal Free Hosp, Div Surg & Intervent Sci, London, England; [Mitchell, Kay; Levett, Denny Z. H.; Grocott, Michael P. W.] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Southampton, Hants, England; [Levett, Denny Z. H.; Grocott, Michael P. W.; Feelisch, Martin] Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England	Newcastle University - UK; University of Warwick; University of Warwick; University of Southampton; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Feelisch, M (corresponding author), Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	m.feelisch@soton.ac.uk	Mitchell, Kay/ABC-2981-2020; Siervo, Mario/AAB-9302-2019; Fernandez, Bernadette/AAG-7202-2020; Montgomery, Hugh/L-1229-2019; Martin, Daniel S/F-7997-2010; Levett, Denny/F-4474-2011; Levett, Denny Zelda Hope/AAY-4627-2021; Feelisch, Martin/C-3042-2008; Levett, Denny/D-2239-2017; Murray, Andrew/B-3130-2010; Grocott, Michael/C-4394-2008; Mitchell, Kay/F-8974-2012; Montgomery, Hugh/C-2592-2008	Fernandez, Bernadette/0000-0001-6337-0381; Levett, Denny/0000-0002-8418-1675; Levett, Denny Zelda Hope/0000-0002-8418-1675; Feelisch, Martin/0000-0003-2320-1158; Levett, Denny/0000-0002-8418-1675; Murray, Andrew/0000-0002-0929-9315; Grocott, Michael/0000-0002-9484-7581; Mitchell, Kay/0000-0001-6393-8475; Siervo, Mario/0000-0001-5515-0944; imray, chris/0000-0001-8451-4102; Montgomery, Hugh/0000-0001-8797-5019; Holloway, Courtney Jean/0000-0003-3661-1957; Martin, Daniel/0000-0001-6220-8235; O'Dwyer, Michael J/0000-0003-4038-5745	Mr. John Caudwell; BOC Medical (now part of Linde Gas therapeutics); Eli Lilly Critical Care; The London Clinic; Smiths Medical; Deltex Medical; The Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland (AAGBI); UK Intensive Care Foundation; Sir Halley Stewart Trust; UK Department of Health Research Biomedical Research Centres funding scheme; Medical Research Council; Faculty of Medicine, University of Southampton	Mr. John Caudwell; BOC Medical (now part of Linde Gas therapeutics); Eli Lilly Critical Care(Eli Lilly); The London Clinic; Smiths Medical; Deltex Medical; The Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland (AAGBI); UK Intensive Care Foundation; Sir Halley Stewart Trust; UK Department of Health Research Biomedical Research Centres funding scheme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Medicine, University of Southampton	The research was funded from a variety of sources, including Mr. John Caudwell, BOC Medical (now part of Linde Gas therapeutics), Eli Lilly Critical Care, The London Clinic, Smiths Medical, Deltex Medical, and The Rolex Foundation (unrestricted grants). Peer reviewed research grants were awarded by the Association of Anaesthetists of Great Britain and Ireland (AAGBI), the UK Intensive Care Foundation, and the Sir Halley Stewart Trust. The CXE volunteers who trekked to Everest base camp also kindly donated to support the research. Some of this work was undertaken at University College Hospitals-University College London Comprehensive Biomedical Research Centre, which received a portion of funding from the UK Department of Health Research Biomedical Research Centres funding scheme. All funding was unrestricted. Part of the biomarker work was supported by the Medical Research Council (Strategic Appointment Scheme, to MF) and funds from the Faculty of Medicine, University of Southampton (to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benso A, 2007, EUR J ENDOCRINOL, V157, P733, DOI 10.1530/EJE-07-0355; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Braun B, 2001, J APPL PHYSIOL, V91, P623; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Chen MT, 2010, RES Q EXERCISE SPORT, V81, P472; Cizza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065400; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; FABER O K, 1986, Diabetes Metabolism Reviews, V2, P331; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Joanny P, 2001, RESUSCITATION, V49, P307, DOI 10.1016/S0300-9572(00)00373-7; Kelly KR, 2010, METABOLISM, V59, P200, DOI 10.1016/j.metabol.2009.07.014; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Larsen JJ, 1997, J PHYSIOL-LONDON, V504, P241, DOI 10.1111/j.1469-7793.1997.241bf.x; Levett DZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00109; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Louis M, 2009, J APPL PHYSIOL, V106, P1538, DOI 10.1152/japplphysiol.91523.2008; Mackenzie R, 2012, J CLIN ENDOCR METAB, V97, pE546, DOI 10.1210/jc.2011-2829; Mackenzie R, 2011, DIABETES-METAB RES, V27, P94, DOI 10.1002/dmrr.1156; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Oltmanns KM, 2004, AM J RESP CRIT CARE, V169, P1231, DOI 10.1164/rccm.200308-1200OC; Ouiddir A, 1999, AM J RESP CELL MOL, V21, P710, DOI 10.1165/ajrcmb.21.6.3751; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Peng YJ, 2003, ADV EXP MED BIOL, V536, P559; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Rafacho A, 2013, ACTA PHYSL; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; SAWHNEY RC, 1986, INT J BIOMETEOROL, V30, P231, DOI 10.1007/BF02189466; SAWHNEY RC, 1991, EUR J APPL PHYSIOL O, V62, P286, DOI 10.1007/BF00571554; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; UNGER RJ, 1971, DIABETES, V20, P834, DOI 10.2337/diab.20.12.834; Vij AG, 2005, HIGH ALT MED BIOL, V6, P301, DOI 10.1089/ham.2005.6.301; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wang N, 2013, EXP PHYSL; Wang X, 2013, RESPIROLOGY, V18, P140, DOI 10.1111/j.1440-1843.2012.02267.x; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; YOUNG PM, 1989, J APPL PHYSIOL, V66, P1430, DOI 10.1152/jappl.1989.66.3.1430	49	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94915	10.1371/journal.pone.0094915	http://dx.doi.org/10.1371/journal.pone.0094915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733551	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336970400130
J	Zeng, XW; Liu, LL; Hao, RJ; Han, CY				Zeng, Xiangwei; Liu, Lanlan; Hao, Ruijun; Han, Chunyan			Detection and Molecular Characterization of J Subgroup Avian Leukosis Virus in Wild Ducks in China	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; CHICKENS; SARCOMA; EPIDEMIOLOGY; RECOMBINANTS; INFECTION; GENOME; FLOCKS; GENES	To assess the status of avian leukosis virus subgroup J (ALV-J) in wild ducks in China, we examined samples from 528 wild ducks, representing 17 species, which were collected in China over the past 3 years. Virus isolation and PCR showed that 7 ALV-J strains were isolated from wild ducks. The env genes and the 3'UTRs from these isolates were cloned and sequenced. The env genes of all 7 wild duck isolates were significantly different from those in the prototype strain HPRS-103, American strains, broiler ALV-J isolates and Chinese local chicken isolates, but showed close homology with those found in some layer chicken ALV-J isolates and belonged to the same group. The 3'UTRs of 7 ALV-J wild ducks isolates showed close homology with the prototype strain HPRS-103 and no obvious deletion was found in the 3'UTR except for a 1 bp deletion in the E element that introduced a binding site for c-Ets-1. Our study demonstrated the presence of ALV-J in wild ducks and investigated the molecular characterization of ALV-J in wild ducks isolates.	[Zeng, Xiangwei; Hao, Ruijun; Han, Chunyan] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China; [Liu, Lanlan] Heilongjiang Univ Chinese Med, Coll Basic Med Sci, Harbin, Peoples R China	Northeast Forestry University - China; Heilongjiang University of Chinese Medicine	Zeng, XW (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China.	xiangwei_zeng@163.com			Fundamental Research Funds for the Central Universities [DL12CA14]; Natural Science Foundation of Heilongjiang Province of China [C201223]; State Forestry Administration of wildlife protection program; Nature Reserve Management Division	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); State Forestry Administration of wildlife protection program; Nature Reserve Management Division	The study was supported by the Fundamental Research Funds for the Central Universities (DL12CA14) (http://kjc.nefu.edu.cn/), the Natural Science Foundation of Heilongjiang Province of China (C201223) (http://nsf.hljkj.cn/zrjj/), and the State Forestry Administration of wildlife protection and Nature Reserve Management Division programs (2013)(http://bhs.forestry.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2000, VIROLOGY, V276, P161, DOI 10.1006/viro.2000.0550; Bagust TJ, 2004, AUST VET J, V82, P701, DOI 10.1111/j.1751-0813.2004.tb12163.x; Bai J.H.K., 1998, AVIAN DIS, V27, pS92; BOVA CA, 1986, VIROLOGY, V152, P343, DOI 10.1016/0042-6822(86)90137-6; Chesters PM, 2006, J GEN VIROL, V87, P2685, DOI 10.1099/vir.0.81884-0; Cui ZZ, 2003, AVIAN DIS, V47, P1321, DOI 10.1637/6085; Dimcheff DE, 2000, J VIROL, V74, P3984, DOI 10.1128/JVI.74.9.3984-3995.2000; DORNER AJ, 1986, CELL, V45, P365, DOI 10.1016/0092-8674(86)90322-3; Fadly AM, 1999, AVIAN DIS, V43, P391, DOI 10.2307/1592636; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Guo W, 2000, J VIROL, V74, P8513, DOI 10.1128/JVI.74.18.8513-8523.2000; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai H., 2011, VET MICROBIOL, V3, P1, DOI DOI 10.4018/JIIT.2011070101; Li DL, 2013, VET MICROBIOL, V163, P257, DOI 10.1016/j.vetmic.2013.01.020; Liu CN, 2011, AVIAN PATHOL, V40, P269, DOI 10.1080/03079457.2011.560932; Malkinson M, 2004, AVIAN PATHOL, V33, P281, DOI 10.1080/0307945042000203380; NEUMANN U, 1983, AVIAN PATHOL, V12, P353, DOI 10.1080/03079458308436178; Pan W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-552; Payne LN, 1998, AVIAN PATHOL, V27, pS36, DOI 10.1080/03079459808419291; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; Payne LN, 1992, RETROVIRIDAE, V1, P299, DOI DOI 10.1007/978-1-4615-3372-6_; ROBINSON HL, 1982, P NATL ACAD SCI-BIOL, V79, P1225, DOI 10.1073/pnas.79.4.1225; RUDDELL A, 1995, VIROLOGY, V206, P1, DOI 10.1016/S0042-6822(95)80013-1; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; Smith LM, 1998, VIRUS RES, V54, P87, DOI 10.1016/S0168-1702(98)00022-7; Sun SH, 2007, AVIAN PATHOL, V36, P221, DOI 10.1080/03079450701332345; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSICHLIS PN, 1980, J VIROL, V33, P238, DOI 10.1128/JVI.33.1.238-249.1980; Venugopal K, 1997, AVIAN DIS, V41, P283, DOI 10.2307/1592179; Wu XP, 2010, VET RES COMMUN, V34, P619, DOI 10.1007/s11259-010-9436-8; Zavala G, 2007, AVIAN DIS, V51, P942, DOI 10.1637/0005-2086(2007)51[942:MEOALV]2.0.CO;2	32	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94980	10.1371/journal.pone.0094980	http://dx.doi.org/10.1371/journal.pone.0094980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733260	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400141
J	Biec, E; Zima, J; Wojtowicz, D; Wojciechowska-Maszkowska, B; Krecisz, K; Kuczynski, M				Biec, Ewa; Zima, Joanna; Wojtowicz, Dorota; Wojciechowska-Maszkowska, Bozena; Krecisz, Krzysztof; Kuczynski, Michal			Postural Stability in Young Adults with Down Syndrome in Challenging Conditions	PLOS ONE			English	Article							TEENAGERS; MOVEMENTS; BALANCE; TIME	To evaluate postural control and performance in subjects with Down syndrome (SwDS), we measured postural sway (COP) in quiet stance in four 20-second tests: with eyes open or closed and on hard or foam surface. Ten SwDS and eleven healthy subjects participated, aged 29.8 (4.8) and 28.4 (3.9), respectively. The time-series recorded with the sampling rate of 100 Hz were used to evaluate postural performance (COP amplitude and mean velocity) and strategies (COP frequency, fractal dimension and entropy). There were no intergroup differences in the amplitude except the stance on foam pad with eyes open when SwDS had larger sway. The COP velocity and frequency were larger in SwDS than controls in all trials on foam pad. During stances on the foam pad SwDS increased fractal dimension showing higher complexity of their equilibrium system, while controls decreased sample entropy exhibiting more conscious control of posture in comparison to the stances on hard support surface. This indicated that each group used entirely different adjustments of postural strategies to the somatosensory challenge. It is proposed that the inferior postural control of SwDS results mainly from insufficient experience in dealing with unpredictable postural stimuli and deficit in motor learning.	[Biec, Ewa; Zima, Joanna; Wojtowicz, Dorota; Kuczynski, Michal] Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Wroclaw, Poland; [Wojciechowska-Maszkowska, Bozena; Krecisz, Krzysztof; Kuczynski, Michal] Opole Univ Technol, Dept Biomech, Opole, Poland	Opole University of Technology	Zima, J (corresponding author), Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Wroclaw, Poland.	joannazima@gmail.com	Krecisz, Krzysztof/A-6093-2012	Krecisz, Krzysztof/0000-0003-2802-981X; Biec, Ewa/0000-0002-6749-8267; Wojtowicz, Dorota/0000-0002-9794-5400; Kuczynski, Michal/0000-0003-0260-8733				ALMEIDA GL, 1994, PHYS THER, V74, P1000, DOI 10.1093/ptj/74.11.1000; Aruin A.S., 1997, MOTOR CONTROL, V1, P178, DOI [10.1123/mcj.1.2.178., DOI 10.1123/MCJ.1.2.178]; Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Cabeza-Ruiz R, 2011, GAIT POSTURE, V33, P23, DOI 10.1016/j.gaitpost.2010.09.014; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cimolin V, 2011, RES DEV DISABIL, V32, P669, DOI 10.1016/j.ridd.2010.11.017; COLE KJ, 1988, DEV MED CHILD NEUROL, V30, P752; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Doyle Tim L A, 2004, Int J Med Sci, V1, P11; FURMAN JM, 1995, OTOLARYNG HEAD NECK, V112, P8, DOI 10.1016/S0194-5998(95)70300-4; Galli M, 2008, DISABIL REHABIL, V30, P1274, DOI 10.1080/09638280701610353; Galli M, 2011, RES DEV DISABIL, V32, P1117, DOI 10.1016/j.ridd.2011.01.015; Gomes MM, 2007, MOTOR CONTROL, V11, P224, DOI 10.1123/mcj.11.3.224; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; Kuczynski M, 1999, GAIT POSTURE, V9, P50, DOI 10.1016/S0966-6362(99)00003-X; Lake DE, 2003, AM J PHYSIOL-REG I, V283, pR798; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Latash M., 2008, DOWNS SYNDROME RES P, V21, DOI [10.3104/reviews.2074, DOI 10.3104/REVIEWS.2074]; Latash M.L., 1992, J DEV PHYS DISABIL, V4, P227, DOI [DOI 10.1007/BF01046967, 10.1007/BF01046967]; Latash ML, 1996, BEHAV BRAIN SCI, V19, P55, DOI 10.1017/S0140525X00041467; Liu JZ, 2005, BIOL CYBERN, V93, P131, DOI 10.1007/s00422-005-0561-3; Patel M, 2011, EXP BRAIN RES, V208, P519, DOI 10.1007/s00221-010-2498-6; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Querner V, 2000, NEUROSCI LETT, V285, P21, DOI 10.1016/S0304-3940(00)01008-9; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rigoldi Ch, 2012, COMPUTER METHODS BIO, P1; Rigoldi C, 2011, RES DEV DISABIL, V32, P170, DOI 10.1016/j.ridd.2010.09.007; Roerdink M, 2011, HUM MOVEMENT SCI, V30, P203, DOI 10.1016/j.humov.2010.04.005; SHUMWAYCOOK A, 1985, PHYS THER, V65, P1315, DOI 10.1093/ptj/65.9.1315; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Ulrich BD, 2004, HUM MOVEMENT SCI, V23, P133, DOI 10.1016/j.humov.2004.06.002; Vuillerme N, 2001, ADAPT PHYS ACT Q, V18, P417, DOI 10.1123/apaq.18.4.417; Webber A, 2004, EXP BRAIN RES, V155, P450, DOI 10.1007/s00221-003-1743-7	33	25	26	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94247	10.1371/journal.pone.0094247	http://dx.doi.org/10.1371/journal.pone.0094247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728178	Green Published, gold			2022-12-25	WOS:000336736200052
J	Denis, B; Guiguet, M; de Castro, N; Mechai, F; Revest, M; Mahamat, A; Gregoire, GM; Lortholary, O; Costagliola, D				Denis, Blandine; Guiguet, Marguerite; de Castro, Nathalie; Mechai, Frederic; Revest, Matthieu; Mahamat, Aba; Gregoire, Giovanna Melica; Lortholary, Olivier; Costagliola, Dominique			Critical Importance of Long-Term Adherence to Care in HIV Infected Patients in the cART Era: New Insights from Pneumocystis jirovecii Pneumonia Cases over 2004-2011 in the FHDH-ANRS CO4 Cohort	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL COUNT; UNITED-STATES; MORTALITY; AIDS; EPIDEMIOLOGY; RECOVERY	Objective: To describe characteristics and outcomes of HIV-infected patients with Pneumocystis jirovecii pneumonia (PCP) over 2004-2011 in France, in particular in those previously enrolled (PE) in the French Hospital Database on HIV (FHDH). Methods: PE patients with an incident PCP were compared with patients with an inaugural PCP revealing HIV infection (reference). Adequate adherence to care was defined as a CD4 measurement at least every 6 months. Immune reconstitution (CD4 >= 200/mm(3)) and risk of death were studied using Kaplan-Meier estimates and multivariable Cox proportional hazards models. Results: In a context of a decreasing incidence of PCP, 1259 HIV-infected patients had a PCP diagnosis, and 593 (47%) were PE patients of whom 161 (27%) have had a prior history of AIDS-defining clinical illness (prior ADI). Median time since enrolment was 8 years for PE patients; 74% had received cART. Median proportion of time with adequate adherence to care was 85% (IQR, 66-96) for all FHDH enrollees, but only 45% (IQR, 1-81) for PE patients during the 2 years before PCP. Median CD4 cell count (38/mm(3)) and HIV viral load (5.2 log10 copies/ml) at PCP diagnosis did not differ between PE patients and the reference group. Three year mortality rate of 25% was observed for PE prior ADI group, higher than in PE non-prior ADI group (8%) and the reference group (9%) (p<0.0001). In the PE prior ADI group, poor prognosis remained even after adjustment for virological control and immune reconstitution (HR, 2.4 [95% CI, 1.5-3.7]). Conclusion: Almost 50% of PCP diagnoses in HIV-infected patients occurred presently in patients already in care, mainly with a previous cART prescription but with waning adherence to care. Having repeated ADI is contributing to the risk of death beyond its impact on immune reconstitution and viral suppression: special efforts must be undertaken to maintain those patients in care.	[Denis, Blandine; Guiguet, Marguerite; Costagliola, Dominique] INSERM, UMRS 1136, Paris, France; [Denis, Blandine; Guiguet, Marguerite; Costagliola, Dominique] Univ Paris 06, UMRS 1136, Paris, France; [de Castro, Nathalie; Gregoire, Giovanna Melica] CHU St Louis, AP HP, Serv Malad Infect & Trop, Paris, France; [de Castro, Nathalie; Gregoire, Giovanna Melica] Univ Paris Diderot, Paris, France; [Mechai, Frederic] CHU Avicenne, AP HP, Serv Malad Infect & Trop, Bobigny, France; [Revest, Matthieu] CHU Rennes, Serv Malad Infect & Trop, Rennes, France; [Mahamat, Aba] CHU Cayenne, Serv Malad Infect & Trop, Cayenne, France; [Mahamat, Aba] Univ Antilles Guyane, EA 3595, Cayenne, France; [Lortholary, Olivier] CHU Necker Enfants Malad, AP HP, Ctr Infectiol Necker Pasteur, Paris, France; [Lortholary, Olivier] Univ Paris 05, Inst Imagine, Paris, France; [Lortholary, Olivier] Inst Pasteur, Ctr Natl Reference Mycoses Invas & Antifong, Paris, France; [Lortholary, Olivier] CNRS, URA 3012, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Denis, B (corresponding author), INSERM, UMRS 1136, Paris, France.	bdenis@ccde.chups.jussieu.fr	Revest, Matthieu/L-9533-2015; Mahamat, Aba/V-7888-2019; De Castro, Nathalie/AFQ-4610-2022; Costagliola, Dominique/H-5849-2011; Guiguet, Marguerite/L-8480-2018	Mahamat, Aba/0000-0001-8755-0424; Costagliola, Dominique/0000-0003-0765-0869; 	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS, France)	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS, France)(ANRS)	This work was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS, France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2001, J ACQ IMMUN DEF SYND, V26, P151, DOI 10.1097/00126334-200102010-00007; Boulassel MR, 2012, J CLIN VIROL, V53, P29, DOI 10.1016/j.jcv.2011.09.018; Delaugerre C, 2011, TREND CALENDAR TIME; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Grabar S, 2008, HIV MED, V9, P246, DOI 10.1111/j.1468-1293.2008.00554.x; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Lee MJ, 2013, SEX TRANSM INFECT, V89, P553, DOI 10.1136/sextrans-2012-050966; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Llibre JM, 2013, SCAND J INFECT DIS, V45, P635, DOI 10.3109/00365548.2013.777778; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mary-Krause M, 2014, INT J EPIDE IN PRESS; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Radhi S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-118; Trotta MP, 2010, CLIN INFECT DIS, V51, P456, DOI 10.1086/655151; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778	19	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94183	10.1371/journal.pone.0094183	http://dx.doi.org/10.1371/journal.pone.0094183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727746	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200042
J	Ma, Y; Ambannavar, R; Stephans, J; Jeong, J; Rossi, AD; Liu, ML; Friedman, AJ; Londry, JJ; Abramson, R; Beasley, EM; Baker, J; Levy, S; Qu, KB				Ma, Yan; Ambannavar, Ranjana; Stephans, James; Jeong, Jennie; Rossi, Andrew Dei; Liu, Mei-Lan; Friedman, Adam J.; Londry, Jason J.; Abramson, Richard; Beasley, Ellen M.; Baker, Joffre; Levy, Samuel; Qu, Kunbin			Fusion Transcript Discovery in Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissues Reveals a Link to Tumor Progression	PLOS ONE			English	Article							GENE FUSIONS; EXPRESSION; IDENTIFICATION; KINASE; RET; ALK	The identification of gene fusions promises to play an important role in personalized cancer treatment decisions. Many rare gene fusion events have been identified in fresh frozen solid tumors from common cancers employing next-generation sequencing technology. However the ability to detect transcripts from gene fusions in RNA isolated from formalin-fixed paraffin-embedded (FFPE) tumor tissues, which exist in very large sample repositories for which disease outcome is known, is still limited due to the low complexity of FFPE libraries and the lack of appropriate bioinformatics methods. We sought to develop a bioinformatics method, named gFuse, to detect fusion transcripts in FFPE tumor tissues. An integrated, cohort based strategy has been used in gFuse to examine single-end 50 base pair (bp) reads generated from FFPE RNA-Sequencing (RNA-Seq) datasets employing two breast cancer cohorts of 136 and 76 patients. In total, 118 fusion events were detected transcriptome-wide at base-pair resolution across the 212 samples. We selected 77 candidate fusions based on their biological relevance to cancer and supported 61% of these using TaqMan assays. Direct sequencing of 19 of the fusion sequences identified by TaqMan confirmed them. Three unique fused gene pairs were recurrent across the 212 patients with 6, 3, 2 individuals harboring these fusions respectively. We show here that a high frequency of fusion transcripts detected at the whole transcriptome level correlates with poor outcome (P<0.0005) in human breast cancer patients. This study demonstrates the ability to detect fusion transcripts as biomarkers from archival FFPE tissues, and the potential prognostic value of the fusion transcripts detected.	[Ma, Yan; Ambannavar, Ranjana; Stephans, James; Jeong, Jennie; Rossi, Andrew Dei; Liu, Mei-Lan; Friedman, Adam J.; Londry, Jason J.; Abramson, Richard; Beasley, Ellen M.; Baker, Joffre; Levy, Samuel; Qu, Kunbin] Genom Hlth Inc, Redwood City, CA 94063 USA	Genomic Health	Qu, KB (corresponding author), Genom Hlth Inc, Redwood City, CA 94063 USA.	kqu@genomichealth.com		Abramson, Richard/0000-0002-1200-0281	Genomic Health Inc	Genomic Health Inc	The funder Genomic Health Inc provided support in the form of salaries for authors, YM, RA, JS, JJ, ADR, ML, AJF, JJL, RA, EMB, JB, SL, KQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mitelman F, 2012, MITELMAN DATABASE CH; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NOWELL PC, 1960, SCIENCE, V132, P1497; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sharon D, 2013, NAT BIOTECH; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	39	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94202	10.1371/journal.pone.0094202	http://dx.doi.org/10.1371/journal.pone.0094202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727804	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200043
J	Muller, N; Schulte, DM; Hillebrand, S; Turk, K; Hampe, J; Schafmayer, C; Brosch, M; von Schonfels, W; Ahrens, M; Zeuner, R; Schroder, JO; Bluher, M; Gutschow, C; Freitag-Wolf, S; Stelmach-Mardas, M; Saggau, C; Schreiber, S; Laudes, M				Mueller, Nike; Schulte, Dominik M.; Hillebrand, Susann; Tuerk, Kathrin; Hampe, Jochen; Schafmayer, Clemens; Brosch, Mario; von Schoenfels, Witigo; Ahrens, Markus; Zeuner, Rainald; Schroeder, Johann O.; Blueher, Matthias; Gutschow, Christian; Freitag-Wolf, Sandra; Stelmach-Mardas, Marta; Saggau, Carina; Schreiber, Stefan; Laudes, Matthias			B Lymphocyte Stimulator (BLyS) Is Expressed in Human Adipocytes In Vivo and Is Related to Obesity but Not to Insulin Resistance	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; ADIPOSE-TISSUE; METABOLIC SYNDROME; CELLS; BAFF; ASSOCIATION; MECHANISMS; OVERWEIGHT; IMPACT; WNT-5A	Inflammation and metabolism have been shown to be evolutionary linked and increasing evidence exists that pro-inflammatory factors are involved in the pathogenesis of obesity and type 2 diabetes. Until now, most data suggest that within adipose tissue these factors are secreted by cells of the innate immune system, e. g. macrophages. In the present study we demonstrate that B lymphocyte stimulator (BLyS) is increased in human obesity. In contrast to several pro-inflammatory factors, we found the source of BLyS in human adipose tissue to be the adipocytes rather than immune cells. In grade 3 obese human subjects, expression of BLyS in vivo in adipose tissue is significantly increased (p<0.001). Furthermore, BLyS serum levels are elevated in grade 3 human obesity (862.5+222.0 pg/ml vs. 543.7+60.7 pg/ml in lean controls, p<0.001) and are positively correlated to the BMI (r = 0.43, p<0.0002). In the present study, bariatric surgery significantly altered serum BLyS concentrations. In contrast, weight loss due to a very-low-calorie-formula-diet (800 kcal/d) had no such effect. To examine metabolic activity of BLyS, in a translational research approach, insulin sensitivity was measured in human subjects in vivo before and after treatment with the human recombinant anti-BLyS antibody belimumab. Since BLyS is known to promote B-cell proliferation and immunoglobulin secretion, the present data suggest that adipocytes of grade 3 obese human subjects are able to activate the adaptive immune system, suggesting that in metabolic inflammation in humans both, innate and adaptive immunity, are of pathophysiological relevance.	[Mueller, Nike; Schulte, Dominik M.; Hillebrand, Susann; Tuerk, Kathrin; Hampe, Jochen; Brosch, Mario; Zeuner, Rainald; Schroeder, Johann O.; Stelmach-Mardas, Marta; Saggau, Carina; Schreiber, Stefan; Laudes, Matthias] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Schafmayer, Clemens; von Schoenfels, Witigo; Ahrens, Markus] Univ Kiel, Dept Gen Abdominal Thorac & Transplantat Surg, Kiel, Germany; [Blueher, Matthias] Univ Leipzig, Clin Endocrinol & Nephrol, Dept Internal Med, D-04109 Leipzig, Germany; [Gutschow, Christian] Univ Cologne, Dept Gen Visceral & Canc Surg, D-50931 Cologne, Germany; [Freitag-Wolf, Sandra] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; University of Kiel; Leipzig University; University of Cologne; University of Kiel	Laudes, M (corresponding author), Univ Kiel, Dept Internal Med 1, Kiel, Germany.	matthias.laudes@uk-sh.de	Schulte, Dominik M/G-8653-2013; Hampe, Jochen/A-2555-2010; Laudes, Matthias/C-8885-2011; Ahrens, Markus/AAA-2615-2022	Schulte, Dominik M/0000-0002-4622-6051; Hampe, Jochen/0000-0002-2421-6127; Brosch, Mario/0000-0001-8983-6557	Deutsche Diabetes Stiftung [319/06/12]	Deutsche Diabetes Stiftung	This work was supported by Deutsche Diabetes Stiftung (319/06/12 to Dominik M. Schulte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Hamada M, 2011, OBESITY, V19, P1915, DOI 10.1038/oby.2011.165; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kim YH, 2009, EXP MOL MED, V41, P208, DOI 10.3858/emm.2009.41.3.024; Kopp HP, 2003, ARTERIOSCL THROM VAS, V23, P1042, DOI 10.1161/01.ATV.0000073313.16135.21; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Pelekanou V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-76; Reaven GM, 2003, ANN INTERN MED, V138, P420, DOI 10.7326/0003-4819-138-5-200303040-00012; Schaffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003; Schaffler A, 2006, ENDOCR REV, V27, P449, DOI 10.1210/er.2005-0022; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Viana EC, 2013, OBES SURG, V23, P1252, DOI 10.1007/s11695-013-0894-2; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang Chao-Ping, 2007, Rev Diabet Stud, V4, P77, DOI 10.1900/RDS.2007.4.77; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188	26	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94282	10.1371/journal.pone.0094282	http://dx.doi.org/10.1371/journal.pone.0094282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728308	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200055
J	Mulley, G; Jenkins, ATA; Waterfield, NR				Mulley, Geraldine; Jenkins, A. Tobias A.; Waterfield, Nicholas R.			Inactivation of the Antibacterial and Cytotoxic Properties of Silver Ions by Biologically Relevant Compounds	PLOS ONE			English	Article							NANOPARTICLES; GLUTATHIONE; RESISTANCE; TOXICITY; CELLS; THIOL; METALLOTHIONEINS; MECHANISMS; GENERATION; EXPOSURE	There has been a recent surge in the use of silver as an antimicrobial agent in a wide range of domestic and clinical products, intended to prevent or treat bacterial infections and reduce bacterial colonization of surfaces. It has been reported that the antibacterial and cytotoxic properties of silver are affected by the assay conditions, particularly the type of growth media used in vitro. The toxicity of Ag+ to bacterial cells is comparable to that of human cells. We demonstrate that biologically relevant compounds such as glutathione, cysteine and human blood components significantly reduce the toxicity of silver ions to clinically relevant pathogenic bacteria and primary human dermal fibroblasts (skin cells). Bacteria are able to grow normally in the presence of silver nitrate at >20-fold the minimum inhibitory concentration (MIC) if Ag+ and thiols are added in a 1: 1 ratio because the reaction of Ag+ with extracellular thiols prevents silver ions from interacting with cells. Extracellular thiols and human serum also significantly reduce the antimicrobial activity of silver wound dressings Aquacel-Ag (Convatec) and Acticoat (Smith & Nephew) to Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in vitro. These results have important implications for the deployment of silver as an antimicrobial agent in environments exposed to biological tissue or secretions. Significant amounts of money and effort have been directed at the development of silver-coated medical devices (e. g. dressings, catheters, implants). We believe our findings are essential for the effective design and testing of antimicrobial silver coatings.	[Mulley, Geraldine] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Jenkins, A. Tobias A.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Waterfield, Nicholas R.] Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England	University of Reading; University of Bath; University of Warwick	Mulley, G (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	G.Mulley@reading.ac.uk	Jenkins, Toby/C-2124-2009; Mulley, Geraldine/D-6642-2012	Jenkins, Toby/0000-0002-8981-3029; Waterfield, Nicholas/0000-0002-8044-7763	European Commission via the consortium EMBEK1-FP7 project [211436]	European Commission via the consortium EMBEK1-FP7 project	All authors would like to thank the European Commission's 7th Framework programme for funding via the consortium EMBEK1-FP7 project #211436 (Website: http://www2.mpip-mainz.mpg.de/eu-projekte/embek1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Babula P, 2012, METALLOMICS, V4, P739, DOI 10.1039/c2mt20081c; Bayston R, 2010, J ANTIMICROB CHEMOTH, V65, P258, DOI 10.1093/jac/dkp420; Beam JW, 2009, J ATHL TRAINING, V44, P531, DOI 10.4085/1062-6050-44.5.531; Burrell RE, 2003, OSTOMY WOUND MANAG, V49; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002; Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gallant-Behm CL, 2005, WOUND REPAIR REGEN, V13, P412, DOI 10.1111/j.1067-1927.2005.130409.x; Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09; Grade S, 2012, RSC ADV, V2, P7190, DOI 10.1039/c2ra20546g; Greulich C, 2012, RSC ADV, V2, P6981, DOI 10.1039/c2ra20684f; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Iwasaki Y, 2009, J CHROMATOGR B, V877, P3309, DOI 10.1016/j.jchromb.2009.07.001; Lansdown ABG, 2010, ISSUES TOXICOL, V6, P1; Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/JB.179.19.6127-6132.1997; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Luther EM, 2012, NEUROCHEM RES, V37, P1639, DOI 10.1007/s11064-012-0767-4; MCCAULEY RL, 1989, J SURG RES, V46, P267, DOI 10.1016/0022-4804(89)90069-3; Miyayama T, 2013, TOXICOLOGY, V305, P20, DOI 10.1016/j.tox.2013.01.004; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Richie JP, 1996, CLIN CHEM, V42, P64; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Samberg ME, 2011, NANOTOXICOLOGY, V5, P244, DOI 10.3109/17435390.2010.525669; Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Teodoro JS, 2011, TOXICOL IN VITRO, V25, P664, DOI 10.1016/j.tiv.2011.01.004; Toy LW, 2011, J AM ACAD NURSE PRAC, V23, P183, DOI 10.1111/j.1745-7599.2011.00600.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023	45	54	55	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94409	10.1371/journal.pone.0094409	http://dx.doi.org/10.1371/journal.pone.0094409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728271	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200071
J	Nho, RS; Hergert, P				Nho, Richard Seonghun; Hergert, Polla			IPF Fibroblasts Are Desensitized to Type I Collagen Matrix-Induced Cell Death by Suppressing Low Autophagy via Aberrant Akt/mTOR Kinases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FOCAL ADHESION KINASE; MAMMALIAN TARGET; ER STRESS; PATHWAY; INHIBITION; PROLIFERATION; DEGRADATION; RAPAMYCIN; SURVIVAL	Idiopathic pulmonary fibrosis (IPF) is a chronic, lethal interstitial lung disease in which the aberrant PTEN/Akt axis plays a major role in conferring a survival phenotype in response to the cell death inducing properties of type I collagen matrix. The underlying mechanism by which IPF fibroblasts become desensitized to polymerized collagen, thereby eluding collagen matrix-induced cell death has not been fully elucidated. We hypothesized that the pathologically altered PTEN/Akt axis suppresses autophagy via high mTOR kinase activity, which subsequently desensitizes IPF fibroblasts to collagen matrix induced cell death. We found that the autophagosome marker LC3-2 expression is suppressed, while mTOR activity remains high when IPF fibroblasts are cultured on collagen. However, LC3-2 expression increased in response to IPF fibroblast attachment to collagen in the presence of rapamycin. In addition, PTEN over-expression or Akt inhibition suppressed mTOR activity, thereby increasing LC3-2 expression in IPF fibroblasts. Furthermore, the treatment of IPF fibroblasts over-expressing PTEN or dominant negative Akt with autophagy inhibitors increased IPF fibroblast cell death. Enhanced p-mTOR expression along with low LC3-2 expression was also found in myofibroblasts within the fibroblastic foci from IPF patients. Our data show that the aberrant PTEN/Akt/mTOR axis desensitizes IPF fibroblasts from polymerized collagen driven stress by suppressing autophagic activity, which produces a viable IPF fibroblast phenotype on collagen. This suggests that the aberrantly regulated autophagic pathway may play an important role in maintaining a pathological IPF fibroblast phenotype in response to collagen rich environment.	[Nho, Richard Seonghun; Hergert, Polla] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			American Lung Association; American Heart Association NIH [R01 HL114662-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114662] Funding Source: NIH RePORTER	American Lung Association; American Heart Association NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Pulmonary Fibrosis Research Grant from the American Lung Association, Scientist Development Grant from the American Heart Association NIH R01 HL114662-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beau I, 2011, INT J BIOCHEM CELL B, V43, P460, DOI 10.1016/j.biocel.2011.01.006; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Gharaee-Kermani M, 2007, PHARM RES-DORDR, V24, P819, DOI 10.1007/s11095-006-9216-x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; KUHN C, 1991, AM J PATHOL, V138, P1257; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Lamoureux F, 2013, AUTOPHAGY, V9, P1119, DOI 10.4161/auto.24921; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nho RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061017; Nho RS, 2011, AM J PATHOL, V179, P2420, DOI 10.1016/j.ajpath.2011.07.020; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ricci A, 2013, J CELL PHYSIOL, V228, P1516, DOI 10.1002/jcp.24307; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Ryter Stefan W, 2010, Expert Rev Respir Med, V4, P573, DOI 10.1586/ers.10.61; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Ryu JH, 1998, MAYO CLIN PROC, V73, P1085, DOI 10.4065/73.11.1085; SCHWARTZ AL, 1992, AM J PHYSIOL, V262, pC1031, DOI 10.1152/ajpcell.1992.262.4.C1031; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sishi BJN, 2013, BIOCHEM PHARMACOL, V85, P124, DOI 10.1016/j.bcp.2012.10.005; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Wallach-Dayan SB, 2007, P NATL ACAD SCI USA, V104, P20460, DOI 10.1073/pnas.0705582104; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xia H, 2012, AM J PATHOL, V181, P222, DOI 10.1016/j.ajpath.2012.03.034; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yamashita M, 2009, HUM PATHOL, V40, P1278, DOI 10.1016/j.humpath.2009.01.014	46	64	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94616	10.1371/journal.pone.0094616	http://dx.doi.org/10.1371/journal.pone.0094616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728102	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200109
J	Regos, A; Aquilue, N; Retana, J; De Caceres, M; Brotons, L				Regos, Adrian; Aquilue, Nuria; Retana, Javier; De Caceres, Miquel; Brotons, Lluis			Using Unplanned Fires to Help Suppressing Future Large Fires in Mediterranean Forests	PLOS ONE			English	Article							SOUTHERN-CALIFORNIA; PRESCRIBED FIRE; WILDFIRE OCCURRENCE; FUEL TREATMENT; MEGA-FIRES; LANDSCAPE; LAND; MANAGEMENT; IMPACT; PATTERNS	Despite the huge resources invested in fire suppression, the impact of wildfires has considerably increased across the Mediterranean region since the second half of the 20th century. Modulating fire suppression efforts in mild weather conditions is an appealing but hotly-debated strategy to use unplanned fires and associated fuel reduction to create opportunities for suppression of large fires in future adverse weather conditions. Using a spatially-explicit fire-succession model developed for Catalonia (Spain), we assessed this opportunistic policy by using two fire suppression strategies that reproduce how firefighters in extreme weather conditions exploit previous fire scars as firefighting opportunities. We designed scenarios by combining different levels of fire suppression efficiency and climatic severity for a 50-year period (2000-2050). An opportunistic fire suppression policy induced large-scale changes in fire regimes and decreased the area burnt under extreme climate conditions, but only accounted for up to 18-22% of the area to be burnt in reference scenarios. The area suppressed in adverse years tended to increase in scenarios with increasing amounts of area burnt during years dominated by mild weather. Climate change had counterintuitive effects on opportunistic fire suppression strategies. Climate warming increased the incidence of large fires under uncontrolled conditions but also indirectly increased opportunities for enhanced fire suppression. Therefore, to shift fire suppression opportunities from adverse to mild years, we would require a disproportionately large amount of area burnt in mild years. We conclude that the strategic planning of fire suppression resources has the potential to become an important cost-effective fuel-reduction strategy at large spatial scale. We do however suggest that this strategy should probably be accompanied by other fuel-reduction treatments applied at broad scales if large-scale changes in fire regimes are to be achieved, especially in the wider context of climate change.	[Regos, Adrian; Aquilue, Nuria; De Caceres, Miquel; Brotons, Lluis] CTFC, CEMFOR, Solsona, Spain; [Regos, Adrian; Aquilue, Nuria; Retana, Javier; De Caceres, Miquel; Brotons, Lluis] CREAF, Bellaterra, Spain; [Retana, Javier] Univ Autonoma Barcelona, Bellaterra, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Regos, A (corresponding author), CTFC, CEMFOR, Solsona, Spain.	adrian.regos@ctfc.es	De Caceres, Miquel/I-1279-2016; Aquilué, Núria/AAA-6149-2020; Regos, Adrian/M-5207-2014; Brotons, Lluís/D-1570-2009; Retana, Javier/L-1214-2014	De Caceres, Miquel/0000-0001-7132-2080; Aquilué, Núria/0000-0001-7911-3144; Regos, Adrian/0000-0003-1983-936X; Brotons, Lluís/0000-0002-4826-4457; Retana, Javier/0000-0002-7505-9467	BIONOVEL - Spanish Ministry of Education and Science [CGL2011-29539/BOS]; MONTES - Spanish Ministry of Education and Science [CSD2008-00040]	BIONOVEL - Spanish Ministry of Education and Science; MONTES - Spanish Ministry of Education and Science	This study was supported by the research projects BIONOVEL (CGL2011-29539/BOS) and MONTES (CSD2008-00040) funded by the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Alcamo J, 2007, CLIMATE CHANGE 2007, P543; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2009, 5 C FOR ESP AV; Bielsa I., 2005, Journal of Environmental Planning and Management, V48, P85, DOI 10.1080/0964056042000308166; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Costa P, 2011, PREVENCIO GRANS INCE; DARP, 1999, FOC VERD; De Caceres M, 2013, J BIOGEOGR, V40, P1535, DOI 10.1111/jbi.12111; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Diaz-Delgado R, 2004, LANDSCAPE ECOL, V19, P731, DOI 10.1007/s10980-005-0183-1; Fall A, 2001, ECOL MODEL, V141, P1, DOI 10.1016/S0304-3800(01)00334-9; Finney MA, 2007, INT J WILDLAND FIRE, V16, P712, DOI 10.1071/WF06064; Gracia C, 2000, INVENTARI ECOLOGIC F; Houtman RM, 2013, INT J WILDLAND FIRE; Houtman RM, 2011, THESIS OREGON STATE; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 1999, SCIENCE, V284, P1829, DOI 10.1126/science.284.5421.1829; Liang JJ, 2008, INT J WILDLAND FIRE, V17, P650, DOI 10.1071/WF07010; Liu YQ, 2010, FOREST ECOL MANAG, V259, P685, DOI 10.1016/j.foreco.2009.09.002; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; Lloret F, 2009, PHYS GEOGRAPHY MEDIT, P541; Loepfe L, 2012, CLIMATIC CHANGE, V115, P693, DOI 10.1007/s10584-012-0488-3; Loepfe L, 2010, FOREST ECOL MANAG, V259, P2366, DOI 10.1016/j.foreco.2010.03.009; McCaw WL, 2013, FOREST ECOL MANAG, V294, P217, DOI 10.1016/j.foreco.2012.09.012; McIver J, 2012, PNWGTR860 USDA FOR S; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; MINNICH RA, 1983, SCIENCE, V219, P1287, DOI 10.1126/science.219.4590.1287; Minnich RA, 2001, CONSERV BIOL, V15, P1549, DOI 10.1046/j.1523-1739.2001.01067.x; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moritz MA, 2004, FRONT ECOL ENVIRON, V2, P67, DOI 10.1890/1540-9295(2004)002[0067:TABAOS]2.0.CO;2; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Pinol J, 2005, ECOL MODEL, V183, P397, DOI 10.1016/j.ecolmodel.2004.09.001; Pinol J, 2007, ECOL MODEL, V207, P34, DOI 10.1016/j.ecolmodel.2007.03.020; Price OE, 2012, J ENVIRON MANAGE, V113, P301, DOI 10.1016/j.jenvman.2012.08.042; Price OF, 2012, INT J WILDLAND FIRE, V21, P297, DOI 10.1071/WF10079; Price F, 2011, INT J WILDLAND FIRE, V20, P142, DOI 10.1071/WF10016; Gonzalez-Olabarria JR, 2012, INT J WILDLAND FIRE, V21, P905, DOI 10.1071/WF11039; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; San-Miguel-Ayanz J, 2013, FOREST ECOL MANAG, V294, P11, DOI 10.1016/j.foreco.2012.10.050; Stellmes M, 2013, LAND USE POLICY, V30, P685, DOI 10.1016/j.landusepol.2012.05.007; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Terradas J, 1996, ECOLOGIA FOC, P63; Vega-Garcia C, 2006, LANDSCAPE ECOL, V21, P595, DOI 10.1007/s10980-005-4119-5; Roman MV, 2013, FOREST ECOL MANAG, V294, P158, DOI 10.1016/j.foreco.2012.07.001; Vilen T, 2011, ENVIRON MANAGE, V48, P558, DOI 10.1007/s00267-011-9681-9; Williams J, 2013, FOREST ECOL MANAG, V294, P4, DOI 10.1016/j.foreco.2012.06.030	52	42	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94906	10.1371/journal.pone.0094906	http://dx.doi.org/10.1371/journal.pone.0094906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727853	gold, Green Published			2022-12-25	WOS:000336736200141
J	Chang, H; Yanachkov, IB; Dix, EJ; Yanachkova, M; Li, YF; Barnard, MR; Wright, GE; Michelson, AD; Frelinger, AL				Chang, Hung; Yanachkov, Ivan B.; Dix, Edward J.; Yanachkova, Milka; Li, YouFu; Barnard, Marc R.; Wright, George E.; Michelson, Alan D.; Frelinger, Andrew L., III			Antiplatelet Activity, P2Y(1) and P2Y(12) Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5 ',5 '''-P-1, P-4-dithio-P-2,P-3-chloromethylenetetraphosphate	PLOS ONE			English	Article							PLATELET-AGGREGATION; PURINERGIC RECEPTORS; MICROPLATE READER; POLYPHOSPHATES; ADP; DIASTEREOSELECTIVITY; OLIGONUCLEOTIDES; RECOGNITION; ANTAGONISTS; ANALOGS	Background: Diadenosine tetraphosphate (Ap(4)A), a constituent of platelet dense granules, and its P-1, P-4-dithio and/or P-2, P-3-chloromethylene analogs, inhibit adenosine diphosphate (ADP)-induced platelet aggregation. We recently reported that these compounds antagonize both platelet ADP receptors, P2Y(1) and P2Y(12). The most active of those analogs, diadenosine 5',5''''-P-1, P-4-dithio-P-2, P-3-chloromethylenetetraphosphate, (compound 1), exists as a mixture of 4 stereoisomers. Objective: To separate the stereoisomers of compound 1 and determine their effects on platelet aggregation, platelet P2Y1 and P2Y12 receptor antagonism, and their metabolism in human plasma. Methods: We separated the 4 diastereomers of compound 1 by preparative reversed-phase chromatography, and studied their effect on ADP-induced platelet aggregation, P2Y(1)-mediated changes in cytosolic Ca2+, P2Y(12)-mediated changes in VASP phosphorylation, and metabolism in human plasma. Results: The inhibition of ADP-induced human platelet aggregation and human platelet P2Y12 receptor, and stability in human plasma strongly depended on the stereo-configuration of the chiral P-1 - and P-4-phosphorothioate groups, the SPSP diastereomer being the most potent inhibitor and completely resistant to degradation in plasma, and the RPRP diastereomer being the least potent inhibitor and with the lowest plasma stability. The inhibitory activity of SPRP diastereomers depended on the configuration of the pseudo-asymmetric carbon of the P-2,P-3-chloromethylene group, one of the configurations being significantly more active than the other. Their plasma stability did not differ significantly, being intermediate to that of the SPSP and the RPRP diastereomers. Conclusions: The presently-described stereoisomers have utility for structural, mechanistic, and drug development studies of dual antagonists of platelet P2Y(1) and P2Y(12) receptors.	[Chang, Hung; Li, YouFu; Barnard, Marc R.; Michelson, Alan D.; Frelinger, Andrew L., III] Univ Massachusetts, Sch Med, Dept Pediat, Ctr Platelet Funct Studies, Worcester, MA 01605 USA; [Chang, Hung] Chang Gung Univ, Chang Gung Mem Hosp, Div Hematol, Taipei, Taiwan; [Yanachkov, Ivan B.; Dix, Edward J.; Yanachkova, Milka; Wright, George E.] GLSynthesis Inc, Worcester, MA USA; [Michelson, Alan D.; Frelinger, Andrew L., III] Harvard Univ, Sch Med, Dana Farber Canc Inst,Boston Childrens Hosp, Ctr Platelet Res Studies,Div Hematol Oncol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Chang Gung Memorial Hospital; Chang Gung University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Frelinger, AL (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Ctr Platelet Funct Studies, Worcester, MA 01605 USA.	Andrew.Frelinger@childrens.harvard.edu	Michelson, Alan/ABE-8487-2021	Michelson, Alan/0000-0002-1746-4819; Yanachkova, Milka/0000-0002-9621-6206; Frelinger, Andrew/0000-0002-6871-7441; Yanachkov, Ivan/0000-0001-9358-1905	SBIR from the National Heart, Lung and Blood Institute [HL081992, HL088828]; CMRP by Chang Gung Memorial Hospital [G380211]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [R44TR000983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL081992, R44HL088828, R43HL088828] Funding Source: NIH RePORTER	SBIR from the National Heart, Lung and Blood Institute; CMRP by Chang Gung Memorial Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by SBIR grants HL081992 and HL088828 (to I.B. Yanachkov) from the National Heart, Lung and Blood Institute. Support for H. Chang was provided by grant CMRP G380211, provided by Chang Gung Memorial Hospital. There were no other funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; BLACKBURN GM, 1990, TETRAHEDRON LETT, V31, P4371, DOI 10.1016/S0040-4039(00)97625-1; BRYANT FR, 1981, J BIOL CHEM, V256, P5965; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Cattaneo M, 2013, PLATELETS, P261; Chan SW, 1997, P NATL ACAD SCI USA, V94, P4034, DOI 10.1073/pnas.94.8.4034; Chang H, 2012, J THROMB HAEMOST, V10, P2573, DOI 10.1111/jth.12035; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; CONNOLLY BA, 1982, BIOCHEMISTRY-US, V21, P1983, DOI 10.1021/bi00538a002; Deflorian F, 2011, J COMPUT AID MOL DES, V25, P329, DOI 10.1007/s10822-011-9423-3; ECKSTEIN F, 1975, ANGEW CHEM INT EDIT, V14, P160, DOI 10.1002/anie.197501601; FRATANTONI JC, 1990, AM J CLIN PATHOL, V94, P613, DOI 10.1093/ajcp/94.5.613; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Guga P, 2007, CURR TOP MED CHEM, V7, P695, DOI 10.2174/156802607780487786; Hoyle CHV, 2001, DRUG DEVELOP RES, V52, P260, DOI 10.1002/ddr.1123; Jacobson KA, 2011, PURINERG SIGNAL, V7, P305, DOI 10.1007/s11302-011-9216-0; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; KIM BK, 1992, P NATL ACAD SCI USA, V89, P11056, DOI 10.1073/pnas.89.22.11056; Koziolkiewicz M, 1997, ANTISENSE NUCLEIC A, V7, P43, DOI 10.1089/oli.1.1997.7.43; LOUIE S, 1988, THROMB RES, V49, P557, DOI 10.1016/0049-3848(88)90253-8; LUTHJE J, 1983, BIOCHEM BIOPH RES CO, V115, P253, DOI 10.1016/0006-291X(83)90997-X; LUTHJE J, 1984, BIOCHEM BIOPH RES CO, V118, P704, DOI 10.1016/0006-291X(84)91451-7; Major DT, 2004, J MED CHEM, V47, P4405, DOI 10.1021/jm049771u; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; Moss GP, 1996, PURE APPL CHEM, V68, P2193, DOI 10.1351/pac199668122193; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stivers JT, 2006, CHEM REV, V106, P3443, DOI 10.1021/cr050317n; Verspohl EJ, 2003, J MED CHEM, V46, P1554, DOI 10.1021/jm011070z; Wojcik M, 2007, OLIGONUCLEOTIDES, V17, P134, DOI 10.1089/oli.2007.0021; Yanachkov IB, 2011, ORG BIOMOL CHEM, V9, P730, DOI 10.1039/c0ob00542h; ZAMECNIK PC, 1992, P NATL ACAD SCI USA, V89, P2370, DOI 10.1073/pnas.89.6.2370; Zerr M, 2011, CIRCULATION, V123, P2404, DOI 10.1161/CIRCULATIONAHA.110.002139; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94780	10.1371/journal.pone.0094780	http://dx.doi.org/10.1371/journal.pone.0094780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722456	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100131
J	Li, W; Liu, W; Wei, HL; He, QL; Chen, JH; Zhang, BH; Zhu, SJ				Li, Wei; Liu, Wei; Wei, Hengling; He, Qiuling; Chen, Jinhong; Zhang, Baohong; Zhu, Shuijin			Species-Specific Expansion and Molecular Evolution of the 3-hydroxy-3-methylglutaryl Coenzyme A Reductase (HMGR) Gene Family in Plants	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; EXPRESSION; CLONING; PATHWAYS; GENOME; ACCUMULATION; VOLATILES; DISTINCT; DEFENSE	The terpene compounds represent the largest and most diverse class of plant secondary metabolites which are important in plant growth and development. The 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR; EC 1.1.1.34) is one of the key enzymes contributed to terpene biosynthesis. To better understand the basic characteristics and evolutionary history of the HMGR gene family in plants, a genome-wide analysis of HMGR genes from 20 representative species was carried out. A total of 56 HMGR genes in the 14 land plant genomes were identified, but no genes were found in all 6 algal genomes. The gene structure and protein architecture of all plant HMGR genes were highly conserved. The phylogenetic analysis revealed that the plant HMGRs were derived from one ancestor gene and finally developed into four distinct groups, two in the monocot plants and two in dicot plants. Species-specific gene duplications, caused mainly by segmental duplication, led to the limited expansion of HMGR genes in Zea mays, Gossypium raimondii, Populus trichocarpa and Glycine max after the species diverged. The analysis of Ka/Ks ratios and expression profiles indicated that functional divergence after the gene duplications was restricted. The results suggested that the function and evolution of HMGR gene family were dramatically conserved throughout the plant kingdom.	[Li, Wei; Liu, Wei; He, Qiuling; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Hengling] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC USA	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; University of North Carolina; East Carolina University	Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	shjzhu@zju.edu.cn			National Basic Research Program (973 program) [2010CB126006]; National High Technology Research and Development Program of China [2011AA10A102, 2013AA102601]	National Basic Research Program (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The works are support by the National Basic Research Program (973 program, No: 2010CB126006) and the National High Technology Research and Development Program of China (2011AA10A102, 2013AA102601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; AOYAGI K, 1993, PLANT PHYSIOL, V102, P623, DOI 10.1104/pp.102.2.623; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BACH TJ, 1995, LIPIDS, V30, P191, DOI 10.1007/BF02537822; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; Campos N, 1995, PLANT CELL, V7, P2163, DOI 10.1105/tpc.7.12.2163; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Dai ZB, 2011, J PLANT PHYSIOL, V168, P148, DOI 10.1016/j.jplph.2010.06.008; Darabi M, 2012, MOL BIOL REP, V39, P8925, DOI 10.1007/s11033-012-1761-2; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; ENJUTO M, 1995, PLANT CELL, V7, P517, DOI 10.1105/tpc.7.5.517; ENJUTO M, 1994, P NATL ACAD SCI USA, V91, P927, DOI 10.1073/pnas.91.3.927; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Grauvogel C, 2007, GENE, V396, P125, DOI 10.1016/j.gene.2007.02.020; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Ha SH, 2001, MOL CELLS, V11, P295; Harker M, 2003, PLANT BIOTECHNOL J, V1, P113, DOI 10.1046/j.1467-7652.2003.00011.x; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Hey SJ, 2006, PLANT BIOTECHNOL J, V4, P219, DOI 10.1111/j.1467-7652.2005.00174.x; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; Jiang HY, 2013, DEV GENES EVOL, V223, P303, DOI 10.1007/s00427-013-0447-7; Kato-Emori S, 2001, MOL GENET GENOMICS, V265, P135, DOI 10.1007/s004380000401; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Korth KL, 1997, PLANT MOL BIOL, V33, P545, DOI 10.1023/A:1005743011651; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEARNED RM, 1989, P NATL ACAD SCI USA, V86, P2779, DOI 10.1073/pnas.86.8.2779; Leivar P, 2005, PLANT PHYSIOL, V137, P57, DOI 10.1104/pp.104.050245; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Loguercio LL, 1999, PLANT CELL PHYSIOL, V40, P750, DOI 10.1093/oxfordjournals.pcp.a029602; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Munoz-Bertomeu J, 2007, PLANT BIOTECHNOL J, V5, P746, DOI 10.1111/j.1467-7652.2007.00286.x; Ober D, 2010, PLANT BIOLOGY, V12, P570, DOI 10.1111/j.1438-8677.2009.00317.x; Omura T, 2007, PLANT BIOTECHNOL-NAR, V24, P107, DOI 10.5511/plantbiotechnology.24.107; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shen GA, 2006, MOL BIOL REP, V33, P117, DOI 10.1007/s11033-006-0014-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Venkatachalam P., 2009, Physiology and Molecular Biology of Plants, V15, P133, DOI 10.1007/s12298-009-0015-9; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wei HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068435; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	59	25	31	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94172	10.1371/journal.pone.0094172	http://dx.doi.org/10.1371/journal.pone.0094172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722776	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100041
J	Schneikert, J; Ruppert, JG; Behrens, J; Wenzel, EM				Schneikert, Jean; Ruppert, Jan Gustav; Behrens, Juergen; Wenzel, Eva Maria			Different Roles for the Axin Interactions with the SAMP versus the Second Twenty Amino Acid Repeat of Adenomatous Polyposis Coli	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; APC TUMOR-SUPPRESSOR; BETA-CATENIN PHOSPHORYLATION; MUTATION CLUSTER REGION; COLORECTAL TUMORS; GENE-PRODUCT; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; SOMATIC MUTATIONS; CRYSTAL-STRUCTURE	Wnt signalling is prevented by the proteosomal degradation of beta-catenin, which occurs in a destruction complex containing adenomatous polyposis coli (APC), APC-like (APCL), Axin and Axin2. Truncating mutations of the APC gene result in the constitutive stabilisation of beta-catenin and the initiation of colon cancer, although tumour cells tolerate the expression of wild-type APCL. Using the colocalisation of overexpressed Axin, APC and APCL constructs as a readout of interaction, we found that Axin interacted with the second twenty amino acid repeat (20R2) of APC and APCL. This interaction involved a domain adjacent to the C-terminal DIX domain of Axin. We identified serine residues within the 20R2 of APCL that were involved in Axin colocalisation, the phosphorylation of truncated APCL and the down-regulation of beta-catenin. Our results indicated that Axin, but not Axin2, displaced APC, but not APCL, from the cytoskeleton and stimulated its incorporation into bright cytoplasmic dots that others have recognised as beta-catenin destruction complexes. The SAMP repeats in APC interact with the N-terminal RGS domain of Axin. Our data showed that a short domain containing the first SAMP repeat in truncated APC was required to stimulate Axin oligomerisation. This was independent of Axin colocalisation with 20R2. Our data also suggested that the RGS domain exerted an internal inhibitory constraint on Axin oligomerisation. Considering our data and those from others, we discuss a working model whereby beta-catenin phosphorylation involves Axin and the 20R2 of APC or APCL and further processing of phospho-beta-catenin occurs upon the oligomerisation of Axin that is induced by binding the SAMP repeats in APC.	[Schneikert, Jean; Ruppert, Jan Gustav; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Wenzel, Eva Maria] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of Erlangen Nuremberg; University of Oslo	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Wenzel, Eva Maria/0000-0002-5561-3344	Deutsche Forschungsgemeinschaft [SCHN 1189/1-2]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to JS [SCHN 1189/1-2]. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jarrett CR, 2001, CANCER RES, V61, P7978; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kohler EM, 2010, ONCOGENE, V29, P1663, DOI 10.1038/onc.2009.447; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li ZY, 2008, J CELL SCI, V121, P1916, DOI 10.1242/jcs.029470; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schneikert J, 2013, PLOS ONE IN PRESS; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Schneikert J, 2011, HUM MOL GENET, V20, P3554, DOI 10.1093/hmg/ddr273; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vijaya-Chandra SH, 2012, PLOS ONE, V7; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94413	10.1371/journal.pone.0094413	http://dx.doi.org/10.1371/journal.pone.0094413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722208	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100067
J	Wang, GC; Li, TT; Zhang, W; Yu, YQ				Wang, Guocheng; Li, Tingting; Zhang, Wen; Yu, Yongqiang			Impacts of Agricultural Management and Climate Change on Future Soil Organic Carbon Dynamics in North China Plain	PLOS ONE			English	Article							PROJECTED CHANGES; WINTER-WHEAT; MINERAL SOIL; CROPLANDS; NITROGEN; MATTER; DECOMPOSITION; CULTIVATION; LANDSCAPE; TURNOVER	Dynamics of cropland soil organic carbon (SOC) in response to different management practices and environmental conditions across North China Plain (NCP) were studied using a modeling approach. We identified the key variables driving SOC changes at a high spatial resolution (10 kmx10 km) and long time scale (90 years). The model used future climatic data from the FGOALS model based on four future greenhouse gas (GHG) concentration scenarios. Agricultural practices included different rates of nitrogen (N) fertilization, manure application, and stubble retention. We found that SOC change was significantly influenced by the management practices of stubble retention (linearly positive), manure application (linearly positive) and nitrogen fertilization (nonlinearly positive) - and the edaphic variable of initial SOC content (linearly negative). Temperature had weakly positive effects, while precipitation had negligible impacts on SOC dynamics under current irrigation management. The effects of increased N fertilization on SOC changes were most significant between the rates of 0 and 300 kg ha(-1) yr(-1). With a moderate rate of manure application (i.e., 2000 kg ha(-1) yr(-1)), stubble retention (i.e., 50%), and an optimal rate of nitrogen fertilization (i.e., 300 kg ha(-1) yr(-1)), more than 60% of the study area showed an increase in SOC, and the average SOC density across NCP was relatively steady during the study period. If the rates of manure application and stubble retention doubled (i.e., manure application rate of 4000 kg ha(-1) yr(-1) and stubble retention rate of 100%), soils across more than 90% of the study area would act as a net C sink, and the average SOC density kept increasing from 40 Mg ha(-1) during 2010s to the current worldwide average of similar to 55 Mg ha(-1) during 2060s. The results can help target agricultural management practices for effectively mitigating climate change through soil C sequestration.	[Wang, Guocheng; Li, Tingting; Zhang, Wen; Yu, Yongqiang] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Li, TT (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing, Peoples R China.	litingting@mail.iap.ac.cn	Wang, Yuesi/AAF-3186-2019; Wang, Guocheng/AAJ-6674-2020; WANG, YUE/GWQ-9256-2022; Wang, Guocheng/M-3857-2013; Li, Tingting/AAJ-7797-2020; Yu, Yongqiang/C-9661-2011; Zhang, Wen/AAH-6060-2020; LAPC, IAP/AAI-6991-2020	Wang, Guocheng/0000-0002-4141-4395; Yu, Yongqiang/0000-0002-9345-2211; Zhang, Wen/0000-0001-6670-3057; LAPC, IAP/0000-0002-0025-3484; Li, Tingting/0000-0002-6338-2769	Ministry of Science and Technology of China [2010CB950603]; CAS Strategic Priority Research Program [XDA05050507]; National Natural Science Foundation of China [41021004]; State Key Program of National Natural Science of China [41130104]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the Ministry of Science and Technology of China (Grant No. 2010CB950603), the CAS Strategic Priority Research Program (Grant No. XDA05050507), the National Natural Science Foundation of China (Grant No. 41021004), and the State Key Program of National Natural Science of China (Grant No. 41130104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATO M, 1992, SOIL BIOL BIOCHEM, V24, P455, DOI 10.1016/0038-0717(92)90208-F; Batjes NH, 1999, MANAGEMENT OPTIONS R; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Brady N.C, 2000, NATURE PROPERTIES SO; Bryan BA, 2003, LANDSCAPE URBAN PLAN, V65, P237, DOI 10.1016/S0169-2046(03)00059-8; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; Ding Y, 2006, ADV CLIM CHANG RES, V2, P3, DOI DOI 10.3969/J.ISSN.1673-1719.2006.01.001; Falloon P, 2006, SOIL USE MANAGE, V22, P274, DOI 10.1111/j.1475-2743.2006.00028.x; Gao L.W., 2009, CHINESE AGR SCI B, V25, P186; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Goidts E, 2009, GLOBAL CHANGE BIOL, V15, P2981, DOI 10.1111/j.1365-2486.2009.01940.x; Huang Y, 2009, AGR FOREST METEOROL, V149, P106, DOI 10.1016/j.agrformet.2008.07.013; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P2958, DOI 10.1111/j.1365-2486.2010.02187.x; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI DOI 10.1098/rstb.1990.0177; Kidson JW, 1998, J CLIMATE, V11, P735, DOI 10.1175/1520-0442(1998)011<0735:ACOSAM>2.0.CO;2; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li CS, 2003, ECOL APPL, V13, P327, DOI 10.1890/1051-0761(2003)013[0327:MSOCCI]2.0.CO;2; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Luo ZK, 2011, AGR FOREST METEOROL, V151, P1529, DOI 10.1016/j.agrformet.2011.06.011; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; National Development and Reform Commission, 2007, PEOPL REP CHIN IN NA; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Ogle SM, 2010, GLOBAL CHANGE BIOL, V16, P810, DOI 10.1111/j.1365-2486.2009.01951.x; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Powlson DS, 2011, AGRON J, V103, P279, DOI 10.2134/agronj2010.0146s; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Saby NPA, 2008, SOIL USE MANAGE, V24, P254, DOI 10.1111/j.1475-2743.2008.00159.x; Sanderman J, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034003; Smith J, 2005, GLOBAL CHANGE BIOL, V11, P2141, DOI 10.1111/j.1365-2486.2005.001075.x; Uvo CB, 2001, HYDROL EARTH SYST SC, V5, P259; van Wesemael B, 2010, P NATL ACAD SCI USA, V107, P14926, DOI 10.1073/pnas.1002592107; Wang EL, 2008, INT J CLIMATOL, V28, P1959, DOI 10.1002/joc.1677; Wang GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063324; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Wu D, 2008, INT J PLANT PROD, V2, P71; Wu DR, 2006, EUR J AGRON, V24, P226, DOI 10.1016/j.eja.2005.06.001; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020; Yu YQ, 2013, AGR ECOSYST ENVIRON, V178, P109, DOI 10.1016/j.agee.2013.06.008; Yu YQ, 2012, GLOBAL PLANET CHANGE, V82-83, P115, DOI 10.1016/j.gloplacha.2011.12.005; Zhang TY, 2012, J SCI FOOD AGR, V92, P1643, DOI 10.1002/jsfa.5523; Zhang W, 2011, GLOBAL CHANGE BIOL, V17, P3511, DOI 10.1111/j.1365-2486.2011.02495.x; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145	51	15	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94827	10.1371/journal.pone.0094827	http://dx.doi.org/10.1371/journal.pone.0094827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722689	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100138
J	Yao, HM; Sun, TW; Zhang, XJ; Shen, DL; Du, YY; Wan, YD; Zhang, JY; Li, L; Zhao, LS				Yao, Hai-Mu; Sun, Tong-Wen; Zhang, Xiao-Juan; Shen, De-Liang; Du, You-You; Wan, You-Dong; Zhang, Jin-Ying; Li, Ling; Zhao, Luo-Sha			Red Blood Cell Distribution Width and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stenting Era: A Two-Year Cohort Study	PLOS ONE			English	Article							PROGNOSTIC MARKER; MORTALITY; PREDICTOR; FRAILTY; ANEMIA; RISK	Background: Previous studies suggest the higher the red blood cell distribution width (RDW) the greater the risk of mortality in patients with coronary artery disease (CAD). However, the relationship between RDW and long-term outcome in CAD patients undergoing percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) remains unclear. This study was designed to evaluate the long-term effect of RDW in patients treated with drug-eluting stent for CAD. Methods: In total of 2169 non-anemic patients (1468 men, mean age 60.2 +/- 10.9 years) with CAD who had undergone successful PCI and had at least one drug-eluting stent were included in this study. Patients were grouped according to their baseline RDW: Quartile 1 (RDW<12.27%), Quartile 2 (12.27%<= RDW<13%), Quartile 3 (13%<= RDW<13.5%), and Quartile 4 (RDW >= 13.5). Results: The incidence of in-hospital mortality and death or myocardial infarction was significantly higher in Quartiles 3 and 4 compared with Quartile 1 (P<0.05). After a follow-up of 29 months, the incidence of all-cause death and stent thrombosis in Quartile 4 was higher than in Quartiles 1, 2, and 3 (P<0.05). The incidence of death/ myocardial infarction/ stroke and cardiac death in Quartile 4 was higher than in Quartiles 1 and 2 (P<0.05). Multivariate Cox regression analysis showed that RDW was an independent predictor of all-cause death (hazard ratio (HR) = 1.37, 95% confidence interval (CI) = 1.15-1.62, P<0.001) and outcomes of death/ myocardial infarction/ stroke (HR = 1.21, 95% CI = 1.04-1.39, P = 0.013). The cumulative survival rate of Quartile 4 was lower than that of Quartiles 1, 2, and 3 (P<0.05). Conclusion: High RDW is an independent predictor of long-term adverse clinical outcomes in non-anemic patients with CAD treated with DES.	[Yao, Hai-Mu; Shen, De-Liang; Du, You-You; Zhang, Jin-Ying; Li, Ling; Zhao, Luo-Sha] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China; [Sun, Tong-Wen; Zhang, Xiao-Juan; Wan, You-Dong] Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University	Sun, TW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China.	suntongwen@163.com	LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; Sun, Tongwen/AAQ-7741-2020; li, li/AAT-2097-2020; li, li/GPX-3938-2022	zhao, luosha/0000-0002-5785-3923	National Natural Science Foundation of China [81370364]; Program for Science and Technology Innovation of Henan Province [201203035]; Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province [2012HASTIT001]; Henan Provincial Science and Technology Achievement Transformation Project [122102310581]; Henan Province of Medical Scientific Province & Ministry Research Project [201301005]; Henan Province of Medical Scientific Research Project, China [201203027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science and Technology Innovation of Henan Province; Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province; Henan Provincial Science and Technology Achievement Transformation Project; Henan Province of Medical Scientific Province & Ministry Research Project; Henan Province of Medical Scientific Research Project, China	This study was supported by the National Natural Science Foundation of China (Grant No. 81370364), Program for Science and Technology Innovation of Henan Province (NO. 201203035), Innovative investigators project grant from the Health Bureau of Henan Province, Program Grant for Science & Technology Innovation Talents in Universities of Henan Province (2012HASTIT001), Henan Provincial Science and Technology Achievement Transformation Project (122102310581), Henan Province of Medical Scientific Province & Ministry Research Project (201301005), Henan Province of Medical Scientific Research Project (201203027), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Saleh H, 2009, CIRCULATION, V120, P2230, DOI 10.1161/CIRCULATIONAHA.109.894642; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Arbel Y, 2013, J THROMB THROMBOLYSI; Arbel Y, 2014, THROMB HAEMOSTASIS, V111, P300, DOI 10.1160/TH13-07-0567; Cavusoglu E, 2010, INT J CARDIOL, V141, P141, DOI 10.1016/j.ijcard.2008.11.187; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Fatemi O, 2013, AM HEART J, V166, P104, DOI 10.1016/j.ahj.2013.04.006; Fatemi O, 2013, J THROMB THROMBOLYS, V35, P57, DOI 10.1007/s11239-012-0767-x; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Klein LW, 2012, J AM COLL CARDIOL, V59, P1760, DOI 10.1016/j.jacc.2012.01.042; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Lippi G, 2009, CLIN CHEM LAB MED, V47, P353, DOI 10.1515/CCLM.2009.066; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Moses JW, 2008, NEW ENGL J MED, V349, P1315; Nabais Sergio, 2009, Rev Port Cardiol, V28, P905; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Poludasu S, 2009, THROMB HAEMOSTASIS, V102, P581, DOI 10.1160/TH09-02-0127; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Veeranna V, 2013, INT J CARDIOL, V168, P5156, DOI 10.1016/j.ijcard.2013.07.109; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Wang YL, 2011, INTERNAL MED, V50, P2941, DOI 10.2169/internalmedicine.50.6407; Ward MJ, 2012, WORLD J EMERG MED, V3, P102, DOI 10.5847/wjem.j.issn.1920-8642.2012.02.004; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	32	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94887	10.1371/journal.pone.0094887	http://dx.doi.org/10.1371/journal.pone.0094887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722190	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100143
J	Ghosh, A; Stasch, JP; Papapetropoulos, A; Stuehr, DJ				Ghosh, Arnab; Stasch, Johannes-Peter; Papapetropoulos, Andreas; Stuehr, Dennis J.			Nitric Oxide and Heat Shock Protein 90 Activate Soluble Guanylate Cyclase by Driving Rapid Change in Its Subunit Interactions and Heme Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Guanylate Cyclase (Guanylyl Cyclase); Heme; Hsp90; Nitric Oxide; Nitrosative Stress; Signal Transduction	THERAPEUTIC TARGET; S-NITROSYLATION; HSP90; RECEPTOR; OXIDATION; DESENSITIZATION; STABILIZATION; INSERTION; INSIGHTS; REVEALS	Background: Heme insertion into souble guanylate cyclase (sGC) enables it to bind nitric oxide (NO) for cell signaling. Results: NO triggered a rapid, reversible, and hsp90-dependent heme insertion into sGC-1 and an association with sGC-1 subunit. sGC activator BAY 60-2770 did the same. Conclusion: NO dynamically impacts the maturation and stability of active sGC heterodimer. Significance: The data uncover new mechanisms that regulate cellular NO signaling cascades. The chaperone heat shock protein 90 (hsp90) associates with signaling proteins in cells including soluble guanylate cyclase (sGC). hsp90 associates with the heme-free (apo) sGC-1 subunit and helps to drive heme insertion during maturation of sGC to its NO-responsive active form. Here, we found that NO caused apo-sGC-1 to rapidly and transiently dissociate from hsp90 and associate with sGC-1 in cells. This NO response (i) required that hsp90 be active and that cellular heme be available and be capable of inserting into apo-sGC-1; (ii) was associated with an increase in sGC-1 heme content; (iii) could be mimicked by the heme-independent sGC activator BAY 60-2770; and (iv) was followed by desensitization of sGC toward NO, sGC-1 disassociation, and reassociation with hsp90. Thus, NO promoted a rapid, transient, and hsp90-dependent heme insertion into the apo-sGC-1 subpopulation in cells, which enabled it to combine with the sGC-1 subunit to form the mature enzyme. The driving mechanism likely involves conformational changes near the heme site in sGC-1 that can be mimicked by the pharmacologic sGC activator. Such dynamic interplay between hsp90, apo-sGC-1, and sGC-1 in response to NO is unprecedented and represent new steps by which cells can modulate the heme content and activity of sGC for signaling cascades.	[Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Stasch, Johannes-Peter] Bayer Pharma AG, D-42096 Wuppertal, Germany; [Papapetropoulos, Andreas] Univ Patras, Dept Pharm, Patras 26504, Greece	Cleveland Clinic Foundation; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Patras	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol NC22, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Andreas, Papapetropoulos/AAJ-3089-2020	GHOSH, ARNAB/0000-0002-7498-1994; Papapetropoulos, Andreas/0000-0002-4253-5930	National Institutes of Health [GM51491, HL076491, GM 097041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM097041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, HL076491, and GM 097041 (to D. J. S.).	Becker E M, 2001, BMC Pharmacol, V1, P13, DOI 10.1186/1471-2210-1-13; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fernhoff NB, 2012, J BIOL CHEM, V287, P43053, DOI 10.1074/jbc.M112.393892; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Fritz BG, 2011, BIOCHEMISTRY-US, V50, P5813, DOI 10.1021/bi200794c; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hu XH, 2008, J AM CHEM SOC, V130, P15748, DOI 10.1021/ja804103y; Ibrahim M, 2010, BIOCHEMISTRY-US, V49, P4864, DOI 10.1021/bi100506j; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kots AY, 2011, CURR MED CHEM, V18, P3299, DOI 10.2174/092986711796504646; Kumar V, 2013, BIOCHEMISTRY-US, V52, P3601, DOI 10.1021/bi301657w; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lucas KA, 2000, PHARMACOL REV, V52, P375; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Miller TW, 2010, BRIT J PHARMACOL, V159, P1542, DOI 10.1111/j.1476-5381.2009.00631.x; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Pal B, 2010, BIOCHEM BIOPH RES CO, V397, P375, DOI 10.1016/j.bbrc.2010.05.122; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Sharina IG, 2011, NITRIC OXIDE-BIOL CH, V25, P265, DOI 10.1016/j.niox.2011.08.001; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Torregrossa AC, 2011, J GERIATR CARDIOL, V8, P230, DOI 10.3724/SP.J.1263.2011.00230; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539	41	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15259	15271		10.1074/jbc.M114.559393	http://dx.doi.org/10.1074/jbc.M114.559393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733395	Green Published, hybrid			2022-12-25	WOS:000337465400011
J	Nomura, Y; Izumi, A; Fukunaga, Y; Kusumi, K; Iba, K; Watanabe, S; Nakahira, Y; Weber, APM; Nozawa, A; Tozawa, Y				Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Kusumi, Kensuke; Iba, Koh; Watanabe, Seiya; Nakahira, Yoichi; Weber, Andreas P. M.; Nozawa, Akira; Tozawa, Yuzuru			Diversity in Guanosine 3 ',5 '-Bisdiphosphate (ppGpp) Sensitivity among Guanylate Kinases of Bacteria and Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chloroplast; Enzymes; Metabolism; Nucleoside Nucleotide Biosynthesis; Plant; Oryza Sativa; Guanylate Kinase; ppGpp; Stringent Response	5'-DIPHOSPHATE 3'-DIPHOSPHATE PPGPP; BACILLUS-SUBTILIS; ARABIDOPSIS-THALIANA; STRINGENT RESPONSE; ESCHERICHIA-COLI; RNA-POLYMERASE; AMP-DEAMINASE; LAND PLANTS; TRANSCRIPTION; CHLOROPLASTS	The guanosine 3,5-bisdiphosphate (ppGpp) signaling system is shared by bacteria and plant chloroplasts, but its role in plants has remained unclear. Here we show that guanylate kinase (GK), a key enzyme in guanine nucleotide biosynthesis that catalyzes the conversion of GMP to GDP, is a target of regulation by ppGpp in chloroplasts of rice, pea, and Arabidopsis. Plants have two distinct types of GK that are localized to organelles (GKpm) or to the cytosol (GKc), with both enzymes being essential for growth and development. We found that the activity of rice GKpm in vitro was inhibited by ppGpp with a K-i of 2.8 m relative to the substrate GMP, whereas the K-m of this enzyme for GMP was 73 m. The IC50 of ppGpp for GKpm was approximate to 10 m. In contrast, the activity of rice GKc was insensitive to ppGpp, as was that of GK from bakers' yeast, which is also a cytosolic enzyme. These observations suggest that ppGpp plays a pivotal role in the regulation of GTP biosynthesis in chloroplasts through specific inhibition of GKpm activity, with the regulation of GTP biosynthesis in chloroplasts thus being independent of that in the cytosol. We also found that GKs of Escherichia coli and Synechococcus elongatus PCC 7942 are insensitive to ppGpp, in contrast to the ppGpp sensitivity of the Bacillus subtilis enzyme. Our biochemical characterization of GK enzymes has thus revealed a novel target of ppGpp in chloroplasts and has uncovered diversity among bacterial GKs with regard to regulation by ppGpp.	[Nomura, Yuhta; Fukunaga, Yoshinori] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Nakahira, Yoichi; Nozawa, Akira; Tozawa, Yuzuru] Ehime Univ, Proteo Sci Ctr, Matsuyama, Ehime 7908577, Japan; [Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Nakahira, Yoichi; Nozawa, Akira; Tozawa, Yuzuru] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Kusumi, Kensuke; Iba, Koh] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Watanabe, Seiya] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, Cluster Excellence Plant Sci, D-40225 Dusseldorf, Germany	Ehime University; Ehime University; Ehime University; Kyushu University; Ehime University; Heinrich Heine University Dusseldorf	Tozawa, Y (corresponding author), 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	tozawa.yuzuru.mx@ehime-u.ac.jp	Tozawa, Yuzuru/AAM-9620-2020; Nomura, Yuhta/F-4362-2018; Weber, Andreas PM/A-6250-2011; Weber, Andreas Paul Michael/O-3043-2019	Nomura, Yuhta/0000-0002-4954-4653; Weber, Andreas PM/0000-0003-0970-4672; Weber, Andreas Paul Michael/0000-0003-0970-4672; Nozawa, Akira/0000-0003-4886-0213	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24570054]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24570054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research 24570054 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant-in-Aid for JSPS Fellows (to Y. Nomura) from the Japan Society for the Promotion of Science.	Agarwal K C, 1978, Methods Enzymol, V51, P483; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Cao YJ, 2001, BBA-GENE STRUCT EXPR, V1520, P242, DOI 10.1016/S0167-4781(01)00269-X; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Collart FR, 1996, GENE, V174, P217, DOI 10.1016/0378-1119(96)00045-5; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; GENTRY D, 1993, J BIOL CHEM, V268, P14316; Kasai K, 2004, NUCLEIC ACIDS RES, V32, P5732, DOI 10.1093/nar/gkh916; Kihara A, 2011, BIOSCI BIOTECH BIOCH, V75, P1740, DOI 10.1271/bbb.110285; KONRAD M, 1992, J BIOL CHEM, V267, P25652; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Kumar V, 2000, EUR J BIOCHEM, V267, P606, DOI 10.1046/j.1432-1327.2000.01045.x; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Masuda S, 2008, PLANT CELL PHYSIOL, V49, P135, DOI 10.1093/pcp/pcm177; Mizusawa K, 2008, PLANTA, V228, P553, DOI 10.1007/s00425-008-0758-5; Nomura Y, 2012, PLANT MOL BIOL, V78, P185, DOI 10.1007/s11103-011-9858-x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Sabina RL, 2007, PLANT PHYSIOL, V143, P1752, DOI 10.1104/pp.107.096487; Sato M, 2009, CHEMBIOCHEM, V10, P1227, DOI 10.1002/cbic.200800737; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tojo S, 2008, J BACTERIOL, V190, P6134, DOI 10.1128/JB.00606-08; Tojo S, 2013, J BACTERIOL, V195, P1656, DOI 10.1128/JB.02131-12; Tozawa Y, 2011, PLANT BIOLOGY, V13, P699, DOI 10.1111/j.1438-8677.2011.00484.x; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Xu J, 2005, PLANT J, V42, P743, DOI 10.1111/j.1365-313X.2005.02411.x; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	36	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15631	15641		10.1074/jbc.M113.534768	http://dx.doi.org/10.1074/jbc.M113.534768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722991	hybrid, Green Published			2022-12-25	WOS:000337465400045
J	Pereira, NA; Pu, HX; Goh, H; Song, ZW				Pereira, Natasha A.; Pu, Helen X.; Goh, Hazel; Song, Zhiwei			Golgi Phosphoprotein 3 Mediates the Golgi Localization and Function of Protein O-Linked Mannose beta-1,2-N-Acetlyglucosaminyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; DYSTROGLYCAN FUNCTION; PHAGE DISPLAY; GLYCOPROTEIN COMPLEX; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; GLYCOSYLATION; DISEASE; MUSCLE; GLYCOSYLTRANSFERASES	GOLPH3 is a highly conserved protein found across the eukaryotic lineage. The yeast homolog, Vps74p, interacts with and maintains the Golgi localization of several mannosyltransferases, which is subsequently critical for N- and O-glycosylation in yeast. Through the use of a T7 phage display, we discovered a novel interaction between GOLPH3 and a mammalian glycosyltransferase, POMGnT1, which is involved in the O-mannosylation of alpha-dystroglycan. The cytoplasmic tail of POMGnT1 was found to be critical for mediating its interaction with GOLPH3. Loss of this interaction resulted in the inability of POMGnT1 to localize to the Golgi and reduced the functional glycosylation of alpha-dystroglycan. In addition, we showed that three clinically relevant mutations present in the stem domain of POMGnT1 mislocalized to the endoplasmic reticulum, high-lighting the importance of identifying the molecular mechanisms responsible for Golgi localization of glycosyltransferases. Our findings reveal a novel role for GOLPH3 in mediating the Golgi localization of POMGnT1.	[Pereira, Natasha A.; Pu, Helen X.; Goh, Hazel; Song, Zhiwei] ASTAR, Bioproc Technol Inst, Singapore 138668, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Song, ZW (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	song_zhiwei@bti.a-star.edu.sg			Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Danner S, 2001, P NATL ACAD SCI USA, V98, P12954, DOI 10.1073/pnas.211439598; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kuga A, 2012, J BIOL CHEM, V287, P9560, DOI 10.1074/jbc.M111.271767; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Nagano-Ito M, 2007, GENE, V400, P82, DOI 10.1016/j.gene.2007.06.007; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Taniguchi K, 2003, HUM MOL GENET, V12, P527, DOI 10.1093/hmg/ddg043; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Vervoort VS, 2004, ANN NEUROL, V56, P143, DOI 10.1002/ana.20172; Voglmeir J, 2011, BIOCHEM J, V436, P447, DOI 10.1042/BJ20101059; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto M, 1999, BIOCHEM BIOPH RES CO, V255, P194, DOI 10.1006/bbrc.1999.0175; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	39	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14762	14770		10.1074/jbc.M114.548305	http://dx.doi.org/10.1074/jbc.M114.548305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733390	hybrid, Green Published			2022-12-25	WOS:000337248100032
J	Chien, AJ; Haydu, LE; Biechele, TL; Kulikauskas, RM; Rizos, H; Kefford, RF; Scolyer, RA; Moon, RT; Long, GV				Chien, Andy J.; Haydu, Lauren E.; Biechele, Travis L.; Kulikauskas, Rima M.; Rizos, Helen; Kefford, Richard F.; Scolyer, Richard A.; Moon, Randall T.; Long, Georgina V.			Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BETA-CATENIN; METASTATIC MELANOMA; MELANOCYTIC TUMORS; RAS MUTATIONS; SOLID TUMORS; OPEN-LABEL; KINASE; RESISTANCE; DABRAFENIB; APOPTOSIS	Unprecedented clinical responses have been reported in advanced stage metastatic melanoma patients treated with targeted inhibitors of constitutively activated mutant BRAF, which is present in approximately half of all melanomas. We and others have previously observed an association of elevated nuclear beta-catenin with improved survival in molecularly-unselected melanoma patients. This study sought to determine whether levels of Wnt/beta-catenin signaling in melanoma tumors prior to treatment might predict patient responses to BRAF inhibitors (BRAFi). We performed automated quantification of beta-catenin immunohistochemical expression in pretreatment BRAF-mutant tumors from 32 BRAFi-treated melanoma patients. Unexpectedly, patients with higher nuclear beta-catenin in their tumors did not exhibit the survival advantage previously observed in molecularly-unselected melanoma patients who did not receive BRAFi. In cultured melanoma cells treated with long-term BRAFi, activation of Wnt/beta-catenin signaling is markedly inhibited, coinciding with a loss of the enhancement of BRAFi-induced apoptosis by WNT3A observed in BRAFi-naive cells. Together, these observations suggest that long-term treatment with BRAFi can impact the interaction between BRAF/MAPK and Wnt/beta-catenin signaling to affect patient outcomes. Studies with larger patient cohorts are required to determine whether nuclear beta-catenin expression correlates with clinical responses to BRAFi and to specific mechanisms of acquired resistance to BRAFi. Understanding these pathway interactions will be necessary to facilitate efforts to individualize therapies for melanoma patients.	[Chien, Andy J.; Biechele, Travis L.; Kulikauskas, Rima M.] Univ Washington, Div Dermatol, Dept Med, Seattle, WA 98195 USA; [Chien, Andy J.] Grp Hlth Res Inst, Seattle, WA USA; [Haydu, Lauren E.; Rizos, Helen; Kefford, Richard F.; Scolyer, Richard A.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Haydu, Lauren E.; Rizos, Helen; Kefford, Richard F.; Scolyer, Richard A.; Long, Georgina V.] Univ Sydney, Sydney, NSW 2006, Australia; [Rizos, Helen; Kefford, Richard F.; Long, Georgina V.] Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW, Australia; [Kefford, Richard F.; Long, Georgina V.] Westmead Hosp, Sydney, NSW, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Moon, Randall T.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Melanoma Institute Australia; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; Howard Hughes Medical Institute	Chien, AJ (corresponding author), Univ Washington, Div Dermatol, Dept Med, Seattle, WA 98195 USA.	chien.a@ghc.org; georgina.long@sydney.edu.au	Moon, Randall/M-5605-2019; Rizos, Helen/AAE-5010-2020; Scolyer, Richard/AAE-8511-2019; Long, Georgina V/C-1771-2013; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Rizos, Helen/0000-0002-2094-9198; Scolyer, Richard/0000-0002-8991-0013; Long, Georgina V/0000-0001-8894-3545; Moon, Randall T/0000-0002-9352-1408; Kefford, Richard/0000-0001-9251-9229	National Health and Medical Research Council of Australia (NHMRC); Cancer Institute New South Wales (NSW); Cancer Institute NSW Fellowship program; NHMRC; University of Washington Division of Dermatology; University of Washington's Office of the Provost; NIH/NIAMS T32 training grant through the University of Washington Division of Dermatology	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales (NSW); Cancer Institute NSW Fellowship program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Washington Division of Dermatology; University of Washington's Office of the Provost; NIH/NIAMS T32 training grant through the University of Washington Division of Dermatology	This work is supported by Program Grants of the National Health and Medical Research Council of Australia (NHMRC) and the Cancer Institute New South Wales (NSW). G. V. L., H. R. and R. A. S. are supported by the Cancer Institute NSW Fellowship program. H. R. and R. A. S. are also supported by the NHMRC Fellowship program. A.J.C. is supported through endowed research funds in the University of Washington Division of Dermatology. R. M. K. is supported through bridge funding from the University of Washington's Office of the Provost. T. L. B. was supported through a NIH/NIAMS T32 training grant through the University of Washington Division of Dermatology. R. T. M. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Brose MS, 2002, CANCER RES, V62, P6997; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Chapman PB, 2011, NEW ENGL J MED, V364, P9; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Conrad WH, 2012, CELL CYCLE, V11, P3724, DOI 10.4161/cc.21645; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Gallagher SJ, 2012, ONCOGENE; Gorden A, 2003, CANCER RES, V63, P3955; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Libra M, 2005, CELL CYCLE, V4, P1382, DOI 10.4161/cc.4.10.2026; Loewe R, 2004, J INVEST DERMATOL, V123, P733, DOI 10.1111/j.0022-202X.2004.23402.x; Long GV, 2012, LANCET ONCOL, V13, P1087, DOI 10.1016/S1470-2045(12)70431-X; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Poynter JN, 2006, MELANOMA RES, V16, P267, DOI 10.1097/01.cmr.0000222600.73179.f3; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Scolyer RA, 2010, ARCH PATHOL LAB MED, V134, P1770, DOI 10.1043/2009-0612-RAR.1; Shi HB, 2012, CANCER DISCOV, V2, P414, DOI 10.1158/2159-8290.CD-12-0022; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trefzer U, 2010, PIGM CELL MELANOMA R, V24, P1020; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yaguchi T, 2012, J IMMUNOL, V189, P2110, DOI 10.4049/jimmunol.1102282; Yazdi AS, 2003, J INVEST DERMATOL, V121, P1160, DOI 10.1046/j.1523-1747.2003.12559.x; Zalaudek I, 2011, J INVEST DERMATOL, V131, P542, DOI 10.1038/jid.2010.332	40	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94748	10.1371/journal.pone.0094748	http://dx.doi.org/10.1371/journal.pone.0094748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733413	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400089
J	Dorheim, SK; Bjorvatn, B; Eberhard-Gran, M				Dorheim, Signe K.; Bjorvatn, Bjorn; Eberhard-Gran, Malin			Can Insomnia in Pregnancy Predict Postpartum Depression? A Longitudinal, Population-Based Study	PLOS ONE			English	Article							EDINBURGH POSTNATAL DEPRESSION; RISK-FACTORS; SLEEP DISTURBANCES; PROSPECTIVE COHORT; MAJOR DEPRESSION; MATERNAL SLEEP; WOMEN; QUALITY; SCALE; SYMPTOMS	Background: Insomnia and depression are strongly interrelated. This study aimed to describe changes in sleep across childbirth, and to evaluate whether insomnia in pregnancy is a predictor of postpartum depression. Methods: A longitudinal, population-based study was conducted among perinatal women giving birth at Akershus University Hospital, Norway. Women received questionnaires in weeks 17 and 32 of pregnancy and eight weeks postpartum. This paper presents data from 2,088 of 4,662 women with complete data for insomnia and depression in week 32 of pregnancy and eight weeks postpartum. Sleep times, wake-up times and average sleep durations were self-reported. The Bergen Insomnia Scale (BIS) was used to measure insomnia. The Edinburgh Postnatal Depression Scale (EPDS) was used to measure depressive symptoms. Results: After delivery, sleep duration was reduced by 49 minutes (to 6.5 hours), and mean sleep efficiency was reduced from 84% to 75%. However, self-reported insomnia scores (BIS) improved from 17.2 to 15.4, and the reported prevalence of insomnia decreased from 61.6% to 53.8%. High EPDS scores and anxiety in pregnancy, fear of delivery, previous depression, primiparity, and higher educational level were risk factors for both postpartum insomnia and depression. Insomnia did not predict postpartum depression in women with no prior history of depression, whereas women who recovered from depression had residual insomnia. Limitations: Depression and insomnia were not verified by clinical interviews. Women with depressive symptoms were less likely to remain in the study. Conclusions: Although women slept fewer hours at night after delivery compared to during late pregnancy, and reported more nights with nighttime awakenings, their self-reported insomnia scores improved, and the prevalence of insomnia according to the DSM-IV criteria decreased. Insomnia in pregnancy may be a marker for postpartum recurrence of depression among women with previous depression.	[Dorheim, Signe K.] Stavanger Univ Hosp, Div Psychiat, MoodNet Res Grp, Stavanger, Norway; [Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Bjorvatn, Bjorn] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway; [Eberhard-Gran, Malin] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway; [Eberhard-Gran, Malin] Univ Oslo, Inst Clin Med, Oslo, Norway	Stavanger University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Dorheim, SK (corresponding author), Stavanger Univ Hosp, Div Psychiat, MoodNet Res Grp, Stavanger, Norway.	sdhy@sus.no			Norwegian Research Council [191098]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was supported by the Norwegian Research Council, project number 191098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASM AAoSM, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; Baglioni C, 2012, CURR PSYCHIAT REP, V14, P511, DOI 10.1007/s11920-012-0308-5; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Bei B, 2010, SLEEP, V33, P531, DOI 10.1093/sleep/33.4.531; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4; Britton WB, 2010, PSYCHOSOM MED, V72, P539, DOI 10.1097/PSY.0b013e3181dc1bad; Bunevicius A, 2009, J PSYCHOSOM OBST GYN, V30, P238, DOI 10.3109/01674820903230708; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calcagni SC, 2012, BEHAV SLEEP MED, V10, P167, DOI 10.1080/15402002.2012.668147; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Diego MA, 2004, PSYCHIATRY, V67, P63, DOI 10.1521/psyc.67.1.63.31251; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Dorheim SK, 2013, BJOG-INT J OBSTET GY, V120, P521, DOI 10.1111/1471-0528.12035; Dorheim SK, 2012, BEHAV SLEEP MED, V10, P152, DOI 10.1080/15402002.2012.660588; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Eberhard-Gran M, 2004, J PSYCHOSOM OBST GYN, V25, P15, DOI 10.1080/01674820410001737405; Eberhard-Gran M, 2002, ACTA PSYCHIAT SCAND, V106, P426, DOI 10.1034/j.1600-0447.2002.02408.x; Eberhard-Gran M, 2001, NORD J PSYCHIAT, V55, P113, DOI 10.1080/08039480151108525; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Evans J, 2012, J CHILD PSYCHOL PSYC, V53, P632, DOI 10.1111/j.1469-7610.2011.02513.x; Field T, 2007, INFANT BEHAV DEV, V30, P127, DOI 10.1016/j.infbeh.2006.08.002; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Garthus-Niegel S, 2011, J PSYCHOSOM OBSTET G; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Green JM, 2005, SCREENING PERINATAL, P141; Insana S. P., 2012, DEV PSYCHOBIOL; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kizilirmak A, 2012, SCI WORLD J, DOI 10.1100/2012/197093; Ko H, 2012, J PSYCHOSOM OBST GYN, V33, P85, DOI 10.3109/0167482X.2012.658465; Lampio L, 2013, MENOPAUSE; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Lee KA, 2011, RES NURS HEALTH, V34, P7, DOI 10.1002/nur.20413; Li SX, 2012, SLEEP, V35, P1153, DOI 10.5665/sleep.2008; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; Marques M, 2011, PSYCHIAT RES, V186, P272, DOI 10.1016/j.psychres.2010.06.029; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Montgomery-Downs HE, 2010, PEDIATRICS, V126, pE1562, DOI 10.1542/peds.2010-1269; Montgomery-Downs HE, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.057; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Murray L, 2010, J CHILD PSYCHOL PSYC, V51, P1150, DOI 10.1111/j.1469-7610.2010.02259.x; O'Hara MW, 2009, J CLIN PSYCHOL, V65, P1258, DOI 10.1002/jclp.20644; Okun ML, 2011, J AFFECT DISORDERS, V130, P378, DOI 10.1016/j.jad.2010.07.015; Okun ML, 2009, BEHAV SLEEP MED, V7, P106, DOI 10.1080/15402000902762394; Pallesen S, 2005, TIDSSKR NOR PSYKOL, V42, P714; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Park EM, 2013, ARCH WOMEN MENT HLTH, V16, P539, DOI 10.1007/s00737-013-0356-9; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Ryding EL, 1998, ACTA OBSTET GYN SCAN, V77, P542; Salo P, 2012, SLEEP MED, V13, P278, DOI 10.1016/j.sleep.2011.06.022; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Signal TL, 2007, AUST NZ J OBSTET GYN, V47, P16, DOI 10.1111/j.1479-828X.2006.00672.x; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; Swanson LM, 2012, BEHAV SLEEP MED; Pinheiro KAT, 2011, INFANT BEHAV DEV, V34, P371, DOI 10.1016/j.infbeh.2010.12.006; Tikotzky L, 2010, INFANT BEHAV DEV, V33, P605, DOI 10.1016/j.infbeh.2010.07.012; Tsai SY, 2013, NURS RES, V62, P99, DOI 10.1097/NNR.0b013e3182830d87; Wijma K, 1998, J PSYCHOSOM OBST GYN, V19, P84, DOI 10.3109/01674829809048501; Zhang JH, 2012, SLEEP MED, V13, P1113, DOI 10.1016/j.sleep.2012.08.006	67	56	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94674	10.1371/journal.pone.0094674	http://dx.doi.org/10.1371/journal.pone.0094674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6GP	24732691	Green Published, gold			2022-12-25	WOS:000336970400066
J	Minniear, TD; Girde, S; Angira, F; Mills, LA; Zeh, C; Peters, PJ; Masaba, R; Lando, R; Thomas, TK; Taylor, AW				Minniear, Timothy D.; Girde, Sonali; Angira, Frank; Mills, Lisa A.; Zeh, Clement; Peters, Philip J.; Masaba, Rose; Lando, Richard; Thomas, Timothy K.; Taylor, Allan W.		Kisumu Breastfeeding Study Team	Outcomes in a Cohort of Women Who Discontinued Maternal Triple-Antiretroviral Regimens Initially Used to Prevent Mother-to-Child Transmission during Pregnancy and Breastfeeding-Kenya, 2003-2009	PLOS ONE			English	Article							HIV-1 INFECTION; SURVIVAL	Background: In 2012, the World Health Organization (WHO) amended their 2010 guidelines for women receiving limited duration, triple-antiretroviral drug regimens during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV (tARV-PMTCT) (Option B) to include the option to continue lifelong combination antiretroviral therapy (cART) (Option B+). We evaluated clinical and CD4 outcomes in women who had received antiretrovirals for prevention of mother-to-child transmission and then discontinued antiretrovirals 6-months postpartum. Methods and Findings: The Kisumu Breastfeeding Study, 2003-2009, was a prospective, non-randomized, open-label clinical trial of tARV-PMTCT in ARV-naive, Kenyan women. Women received tARV-PMTCT from 34 weeks' gestation until 6-months postpartum when women were instructed to discontinue breastfeeding. Women with CD4 count (CD4) <250cells/mm3 or WHO stage III/IV prior to 6-months postpartum continued cART indefinitely. We estimated the change in CD4 after discontinuing tARV-PMTCT and the adjusted relative risk [aRR] for factors associated with declines in maternal CD4. We compared maternal and infant outcomes following weaning-when tARV-PMTCT discontinued-by maternal ARV status through 24-months postpartum. Compared with women who continued cART, discontinuing antiretrovirals was associated with infant HIV transmission and death (10.1% vs. 2.4%; P = 0.03). Among women who discontinued antiretrovirals, CD4,500 cells/mm3 at either initiation (21.8% vs. 1.5%; P = 0.002; aRR: 9.8; 95%-confidence interval [CI]: 2.4-40.6) or discontinuation (36.9% vs. 8.3%; P<0.0001; aRR: 4.4; 95%-CI: 1.9-5.0) were each associated with increased risk of women requiring cART for their own health within 6 months after discontinuing. Conclusions: Considering the serious health risks to the woman's infant and the brief reprieve from cART gained by stopping, every country should evaluate the need for and feasibility to implement WHO Option B+ for PMTCT. Evaluating CD4 at antiretroviral initiation or 6-months postpartum can identify pregnant women who would most benefit from continuing cART in settings unable to implement WHO Option B+.	[Minniear, Timothy D.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Minniear, Timothy D.; Mills, Lisa A.; Zeh, Clement; Peters, Philip J.; Thomas, Timothy K.; Taylor, Allan W.] CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Minniear, Timothy D.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Girde, Sonali] ICF Int, CDC Informat Management Serv, Atlanta, GA USA; [Angira, Frank; Mills, Lisa A.; Zeh, Clement; Masaba, Rose; Lando, Richard] CDC Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; St Jude Children's Research Hospital; Kenya Medical Research Institute	Taylor, AW (corresponding author), CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	avt0@cdc.gov		Taylor, Allan/0000-0001-7496-8768	Kenya Medical Research Institute (KEMRI) through US Centers for Disease Control and Prevention (CDC)	Kenya Medical Research Institute (KEMRI) through US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the study was provided by the Kenya Medical Research Institute (KEMRI) through a cooperative agreement with the US Centers for Disease Control and Prevention (CDC). The study design, data collection instruments, data collection, data analysis, decision to publish, and preparation of the manuscript were led by CDC and KEMRI staff based in Atlanta and at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, Kenya. This publication has been approved by the Director of the Kenya Medical Research Institute.	Cames C, 2010, MATERN CHILD NUTR, V6, P253, DOI 10.1111/j.1740-8709.2009.00201.x; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Johansson KA, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-3; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; WHO, 2010, ANT THER HIV INF AD; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2010, T PRIC ANT MED HIV D	13	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93556	10.1371/journal.pone.0093556	http://dx.doi.org/10.1371/journal.pone.0093556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733021	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400008
J	Ni, WH; Xiao, SQ; Qiu, XF; Jin, JY; Pan, CS; Li, Y; Fei, QJ; Yang, X; Zhang, LY; Huang, XF				Ni, Wuhua; Xiao, Shiquan; Qiu, Xiufang; Jin, Jianyuan; Pan, Chengshuang; Li, Yan; Fei, Qianjin; Yang, Xu; Zhang, Liya; Huang, Xuefeng			Effect of Sperm DNA Fragmentation on Clinical Outcome of Frozen-Thawed Embryo Transfer and on Blastocyst Formation	PLOS ONE			English	Article							CHROMATIN-STRUCTURE ASSAY; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNIQUES; HYALURONIC-ACID BINDING; DISPERSION-TEST; INTRAUTERINE INSEMINATION; DAMAGED SPERMATOZOA; PREGNANCY RATES; HUMAN-FERTILITY; COMET ASSAY	During the last decades, many studies have shown the possible influence of sperm DNA fragmentation on assisted reproductive technique outcomes. However, little is known about the impact of sperm DNA fragmentation on the clinical outcome of frozen-thawed embryo transfer (FET) from cycles of conventional in vitro fertilization (IVF) and intra-cytoplasmic sperm injection (ICSI). In the present study, the relationship between sperm DNA fragmentation (SDF) and FET clinical outcomes in IVF and ICSI cycles was analyzed. A total of 1082 FET cycles with cleavage stage embryos (C-FET) (855 from IVF and 227 from ICSI) and 653 frozen-thawed blastocyst transfer cycles (B-FET) (525 from IVF and 128 from ICSI) were included. There was no significant change in clinical pregnancy, biochemical pregnancy and miscarriage rates in the group with a SDF >30% compared with the group with a SDF <= 30% in IVF and ICSI cycles with C-FET or B-FET. Also, there was no significant impact on the FET clinic outcome in IVF and ICSI when different values of SDF (such as 10%, 20%, 25%, 35%, and 40%) were taken as proposed threshold levels. However, the blastulation rates were significantly higher in the SDF <= 30% group in ICSI cycle. Taken together, our data show that sperm DNA fragmentation measured by Sperm Chromatin Dispersion (SCD) test is not associated with clinical outcome of FET in IVF and ICSI. Nonetheless, SDF is related to the blastocyst formation in ICSI cycles.	[Ni, Wuhua; Xiao, Shiquan; Qiu, Xiufang; Jin, Jianyuan; Pan, Chengshuang; Li, Yan; Fei, Qianjin; Yang, Xu; Zhang, Liya; Huang, Xuefeng] Wenzhou Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Huang, XF (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Zhejiang, Peoples R China.	xuefhuang@hotmail.com		Ni, Wuhua/0000-0001-9611-8537				Ahmadi A, 1999, HUM REPROD, V14, P2279, DOI 10.1093/humrep/14.9.2279; Ahmadi A, 1999, J EXP ZOOL, V284, P696, DOI 10.1002/(SICI)1097-010X(19991101)284:6&lt;696::AID-JEZ11&gt;3.0.CO;2-E; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Al-Inany H, 2010, INT J WOMENS HEALTH, V2, P89; Oliveira JBA, 2010, FERTIL STERIL, V94, P1937, DOI 10.1016/j.fertnstert.2010.01.042; Aziz N, 2008, FERTIL STERIL, V90, P484, DOI 10.1016/j.fertnstert.2007.07.1287; Bakos HW, 2008, INT J ANDROL, V31, P518, DOI 10.1111/j.1365-2605.2007.00803.x; Benchaib M, 2003, HUM REPROD, V18, P1023, DOI 10.1093/humrep/deg228; Bungum M, 2004, HUM REPROD, V19, P1401, DOI 10.1093/humrep/deh280; Cohen-Bacrie P, 2009, FERTIL STERIL, V91, P1801, DOI 10.1016/j.fertnstert.2008.01.086; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Evenson DP, 2005, FERTIL STERIL, V84, P846, DOI 10.1016/j.fertnstert.2005.08.009; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fernandez JL, 2005, FERTIL STERIL, V84, P833, DOI 10.1016/j.fertnstert.2004.11.089; Fernandez JL, 2003, J ANDROL, V24, P59; Gandini L, 2004, HUM REPROD, V19, P1409, DOI 10.1093/humrep/deh233; Ghobara T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003414.pub2; Hammadeh ME, 2001, ASIAN J ANDROL, V3, P125; Han Ae Ra, 2012, Clin Exp Reprod Med, V39, P114, DOI 10.5653/cerm.2012.39.3.114; Huang CC, 2005, FERTIL STERIL, V84, P130, DOI 10.1016/j.fertnstert.2004.08.042; Huszar G, 2007, REPROD BIOMED ONLINE, V14, P650, DOI 10.1016/S1472-6483(10)61060-7; Huszar G, 2006, CURR OPIN OBSTET GYN, V18, P260, DOI 10.1097/01.gco.0000193018.98061.2f; Karlstrom PO, 1997, HUM REPROD, V12, P1263; Kondo I, 1996, J ASSIST REPROD GEN, V13, P201, DOI 10.1007/BF02065936; Larson-Cook KL, 2003, FERTIL STERIL, V80, P895, DOI 10.1016/S0015-0282(03)01116-6; Lee SH, 2009, FERTIL STERIL, V91, P798, DOI 10.1016/j.fertnstert.2007.12.061; Lewis SE, 2013, REPROD BIOMED ONLINE; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Liu DY, 2007, HUM REPROD, V22, P1597, DOI 10.1093/humrep/dem044; Martinez-Pastor F, 2009, REPROD DOMEST ANIM, V44, P424, DOI 10.1111/j.1439-0531.2008.01098.x; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Muriel L, 2006, HUM REPROD, V21, P738, DOI 10.1093/humrep/dei403; Nasr-Esfahani M, 2005, REPROD BIOMED ONLINE, V11, P198; Nicopoullos JDM, 2004, J ASSIST REPROD GEN, V21, P401, DOI 10.1007/s10815-004-7528-5; Papanikolaou EG, 2008, HUM REPROD, V23, P91, DOI 10.1093/humrep/dem339; Payne JF, 2005, FERTIL STERIL, V84, P356, DOI 10.1016/j.fertnstert.2005.02.032; Sadeghi Mohamad Reza, 2009, Avicenna Journal of Medical Biotechnology, V1, P173; Sakkas D, 1998, HUM REPROD, V13, P11, DOI 10.1093/humrep/13.suppl_4.11; Sakkas Denny, 2000, Hum Fertil (Camb), V3, P26, DOI 10.1080/1464727002000198651; Figueira RDS, 2009, FERTIL STERIL, V91, P727, DOI 10.1016/j.fertnstert.2007.12.063; SCHALKOFF ME, 1993, FERTIL STERIL, V59, P1070; Sergerie M, 2005, HUM REPROD, V20, P1921, DOI 10.1093/humrep/deh885; Shamsi MB, 2008, INDIAN J MED RES, V127, P115; Sharbatoghli M, 2012, ARCH GYNECOL OBSTET, V286, P1315, DOI 10.1007/s00404-012-2440-1; Sharma RK, 2004, ASIAN J ANDROL, V6, P139; Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Tesarik J, 2005, REPROD BIOMED ONLINE, V10, P370, DOI 10.1016/S1472-6483(10)61798-1; Tomsu M, 2002, HUM REPROD, V17, P1856, DOI 10.1093/humrep/17.7.1856; Virro MR, 2004, FERTIL STERIL, V81, P1289, DOI 10.1016/j.fertnstert.2003.09.063; WANG XJ, 1994, HUM REPROD, V9, P103, DOI 10.1093/oxfordjournals.humrep.a138296; Zini A, 2005, HUM REPROD, V20, P3476, DOI 10.1093/humrep/dei266; Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218; Zini A, 2006, CURR OPIN UROL, V16, P428, DOI 10.1097/01.mou.0000250283.75484.dd; Zini A, 2011, J ASSIST REPROD GEN, V28, P391, DOI 10.1007/s10815-011-9544-6; Zini A, 2009, J ANDROL, V30, P219, DOI 10.2164/jandrol.108.006908; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	59	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94956	10.1371/journal.pone.0094956	http://dx.doi.org/10.1371/journal.pone.0094956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733108	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400137
J	Park, SM; Angel, CE; McIntosh, JD; Mansell, CM; Chen, CJJ; Cebon, J; Dunbar, PR				Park, Saem Mul; Angel, Catherine E.; McIntosh, Julie D.; Mansell, Claudia M.; Chen, Chun-Jen J.; Cebon, Jonathon; Dunbar, P. Rod			Mapping the Distinctive Populations of Lymphatic Endothelial Cells in Different Zones of Human Lymph Nodes	PLOS ONE			English	Article							HYALURONAN RECEPTOR LYVE-1; DENDRITIC CELLS; DC-SIGN; LYMPHANGIOGENESIS; EXPRESSION; MARKER; INFECTION; JUNCTIONS; ADHESION; AFFERENT	The lymphatic sinuses in human lymph nodes (LNs) are crucial to LN function yet their structure remains poorly defined. Much of our current knowledge of lymphatic sinuses derives from rodent models, however human LNs differ substantially in their sinus structure, most notably due to the presence of trabeculae and trabecular lymphatic sinuses that rodent LNs lack. Lymphatic sinuses are bounded and traversed by lymphatic endothelial cells (LECs). A better understanding of LECs in human LNs is likely to improve our understanding of the regulation of cell trafficking within LNs, now an important therapeutic target, as well as disease processes that involve lymphatic sinuses. We therefore sought to map all the LECs within human LNs using multicolor immunofluorescence microscopy to visualize the distribution of a range of putative markers. PROX1 was the only marker that uniquely identified the LECs lining and traversing all the sinuses in human LNs. In contrast, LYVE1 and STAB2 were only expressed by LECs in the paracortical and medullary sinuses in the vast majority of LNs studied, whilst the subcapsular and trabecular sinuses lacked these molecules. These data highlight the existence of at least two distinctive populations of LECs within human LNs. Of the other LEC markers, we confirmed VEGFR3 was not specific for LECs, and CD144 and CD31 stained both LECs and blood vascular endothelial cells (BECs); in contrast, CD59 and CD105 stained BECs but not LECs. We also showed that antigen-presenting cells (APCs) in the sinuses could be clearly distinguished from LECs by their expression of CD169, and their lack of expression of PROX1 and STAB2, or endothelial markers such as CD144. However, both LECs and sinus APCs were stained with DCN46, an antibody commonly used to detect CD209.	[Park, Saem Mul; Angel, Catherine E.; McIntosh, Julie D.; Mansell, Claudia M.; Chen, Chun-Jen J.; Dunbar, P. Rod] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Park, Saem Mul; Angel, Catherine E.; McIntosh, Julie D.; Mansell, Claudia M.; Dunbar, P. Rod] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Cebon, Jonathon] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia	University of Auckland; University of Auckland; Ludwig Institute for Cancer Research	Dunbar, PR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	r.dunbar@auckland.ac.nz	Dunbar, Rod/C-2570-2012	Dunbar, Rod/0000-0001-9626-2600; Cebon, Jonathan/0000-0002-3898-950X; Angel, Catherine/0000-0003-1737-8539	Health Research Council of New Zealand; Maurice Wilkins Centre; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); Maurice Wilkins Centre; University of Auckland	This study is supported by grants from the Health Research Council of New Zealand, the Maurice Wilkins Centre and the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Angel CE, 2009, BLOOD, V113, P1257, DOI 10.1182/blood-2008-06-165266; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Canard B, 2011, IMMUNOL LETT, V135, P165, DOI 10.1016/j.imlet.2010.11.002; Carreira CM, 2001, CANCER RES, V61, P8079; Clarijs R, 2002, CANCER RES, V62, P7059; Engering A, 2004, AM J PATHOL, V164, P1587, DOI 10.1016/S0002-9440(10)63717-0; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gijzen K, 2008, EXP HEMATOL, V36, P860, DOI 10.1016/j.exphem.2008.02.003; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Moll R, 2009, CELL TISSUE RES, V335, P109, DOI 10.1007/s00441-008-0700-y; Ohtani O, 2008, ARCH HISTOL CYTOL, V71, P69, DOI 10.1679/aohc.71.69; Pegu Amarendra, 2007, Lymphatic Research and Biology, V5, P91, DOI 10.1089/lrb.2007.1006; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje	26	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94781	10.1371/journal.pone.0094781	http://dx.doi.org/10.1371/journal.pone.0094781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733110	Green Published, gold			2022-12-25	WOS:000336970400099
J	Scanes, E; Parker, LM; O'Connor, WA; Ross, PM				Scanes, Elliot; Parker, Laura M.; O'Connor, Wayne A.; Ross, Pauline M.			Mixed Effects of Elevated pCO(2) on Fertilisation, Larval and Juvenile Development and Adult Responses in the Mobile Subtidal Scallop Mimachlamys asperrima (Lamarck, 1819)	PLOS ONE			English	Article							CO2-DRIVEN OCEAN ACIDIFICATION; OYSTER SACCOSTREA-GLOMERATA; INCREASED ATMOSPHERIC CO2; REDUCED SEAWATER PH; NEAR-FUTURE LEVELS; DOUGHBOY SCALLOP; TEMPERATURE TOLERANCE; MARINE CALCIFIERS; ANIMAL PHYSIOLOGY; CLIMATE-CHANGE	Ocean acidification is predicted to have severe consequences for calcifying marine organisms especially molluscs. Recent studies, however, have found that molluscs in marine environments with naturally elevated or fluctuating CO2 or with an active, high metabolic rate lifestyle may have a capacity to acclimate and be resilient to exposures of elevated environmental pCO(2). The aim of this study was to determine the effects of near future concentrations of elevated pCO(2) on the larval and adult stages of the mobile doughboy scallop, Mimachlamys asperrima from a subtidal and stable physiochemical environment. It was found that fertilisation and the shell length of early larval stages of M. asperrima decreased as pCO(2) increased, however, there were less pronounced effects of elevated pCO(2) on the shell length of later larval stages, with high pCO(2) enhancing growth in some instances. Byssal attachment and condition index of adult M. asperrima decreased with elevated pCO(2), while in contrast there was no effect on standard metabolic rate or pH(e). The responses of larval and adult M. asperrima to elevated pCO(2) measured in this study were more moderate than responses previously reported for intertidal oysters and mussels. Even this more moderate set of responses are still likely to reduce the abundance of M. asperrima and potentially other scallop species in the world's oceans at predicted future pCO(2) levels.	[Scanes, Elliot; Parker, Laura M.; Ross, Pauline M.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [O'Connor, Wayne A.] Port Stephens Fisheries Inst, Ind & Investment NSW, Taylors Beach, NSW, Australia	Western Sydney University; NSW Department of Primary Industries	Ross, PM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	pm.ross@uws.edu.au	O'Connor, Wayne/AAL-8097-2020; Scanes, Elliot/W-1244-2018	Parker, Laura/0000-0003-3139-1844; Scanes, Elliot/0000-0001-7520-3804; Ross, Pauline/0000-0002-8714-5194; O'Connor, Wayne/0000-0002-0972-4668	Australian National Climate Change Adaption Research Facility, Marine Adaption Network for Marine Biodiversity and Resources	Australian National Climate Change Adaption Research Facility, Marine Adaption Network for Marine Biodiversity and Resources	This work was funded via a grant from the Australian National Climate Change Adaption Research Facility (www.nccarf.edu.au) Marine Adaption Network for Marine Biodiversity and Resources. This work would not have been possible without their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2013, BIOGEOSCIENCES DISCU, V10, P3281, DOI [10.5194/bgd-10-3281-2013, DOI 10.5194/BGD-10-3281-2013]; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Brand AR, 1991, SCALLOPS BIOL ECOLOG; Butler J. N., 1982, CARBON DIOXIDE EQUIL, DOI 10.1016/0146-6380(83)90006-2; Byrne M, 2012, MAR ENVIRON RES, V76, P3, DOI 10.1016/j.marenvres.2011.10.004; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; CADDY J F, 1972, Journal of Experimental Marine Biology and Ecology, V9, P179, DOI 10.1016/0022-0981(72)90047-0; Cai WJ, 1999, LIMNOL OCEANOGR, V44, P639, DOI 10.4319/lo.1999.44.3.0639; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Christophersen G, 2003, AQUACULTURE, V215, P79, DOI 10.1016/S0044-8486(02)00094-7; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Cragg SM, 1991, SCALLOPS BIOL ECOLOG; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; Gazeau F, 2010, BIOGEOSCI DISCUSS, V7, P2061; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Krassoi Rick, 1997, Australasian Journal of Ecotoxicology, V3, P65; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2004, J OCEANOGR, V60, P743, DOI 10.1007/s10872-004-5766-x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; LAMPRELL K, 1992, BIVALVES AUSTR; Langenbuch M, 2006, COMP BIOCHEM PHYS A, V144, P479, DOI 10.1016/j.cbpa.2006.04.017; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Loosanoff V. L., 1963, Advances in Marine Biology, V1, P1, DOI 10.1016/S0065-2881(08)60257-6; Marshall DJ, 2002, ECOL LETT, V5, P173, DOI 10.1046/j.1461-0248.2002.00257.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Morton B, 1998, MOLLUSCA SO SYNTHESI, V5; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Neuberger-Cywiak L, 2007, B ENVIRON CONTAM TOX, V79, P622, DOI 10.1007/s00128-007-9306-4; Nilsson GE, 2009, GLOBAL CHANGE BIOL, V15, P1405, DOI 10.1111/j.1365-2486.2008.01767.x; O'Connor W. A., 1994, Memoirs of the Queensland Museum, V36, P357; O'Connor WA, 1998, J SHELLFISH RES, V17, P89; O'Connor WA, 2000, AQUAC RES, V31, P627; O'Connor WA, 1997, REPROD BIOL HATCHERY; OConnor WA, 1995, AQUACULTURE, V136, P117, DOI 10.1016/0044-8486(95)01040-8; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; PAUL JD, 1980, J EXP MAR BIOL ECOL, V46, P41, DOI 10.1016/0022-0981(80)90089-1; PEREZ FF, 1987, MAR CHEM, V21, P315, DOI 10.1016/0304-4203(87)90054-5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; PORTNER HO, 1991, AM J PHYSIOL, V261, pR239, DOI 10.1152/ajpregu.1991.261.1.R239; Range P, 2011, J EXP MAR BIOL ECOL, V396, P177, DOI 10.1016/j.jembe.2010.10.020; Raven J.A., 2005, 1205 ROYAL SOC, DOI DOI 10.1080/02688690801911598; Reipschlager A, 1996, J EXP BIOL, V199, P1801; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roberts D, 1973, THESIS U LIVERPOOL; ROSE RA, 1984, AUST J MAR FRESH RES, V35, P315; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Rupp GS, 2004, J EXP MAR BIOL ECOL, V309, P173, DOI 10.1016/j.jembe.2004.03.018; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Shirayama Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002618; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; THOMPSON RJ, 1980, J COMP PHYSIOL, V137, P97, DOI 10.1007/BF00689207; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Underwood, 1996, EXPT ECOLOGY THEIR L; VAHL O, 1981, J EXP MAR BIOL ECOL, V53, P281, DOI 10.1016/0022-0981(81)90026-5; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065	98	31	31	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93649	10.1371/journal.pone.0093649	http://dx.doi.org/10.1371/journal.pone.0093649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733125	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400010
J	Shannon, CP; Balshaw, R; Ng, RT; Wilson-McManus, JE; Keown, P; McMaster, R; McManus, BM; Landsberg, D; Isbel, NM; Knoll, G; Tebbutt, SJ				Shannon, Casey P.; Balshaw, Robert; Ng, Raymond T.; Wilson-McManus, Janet E.; Keown, Paul; McMaster, Robert; McManus, Bruce M.; Landsberg, David; Isbel, Nicole M.; Knoll, Greg; Tebbutt, Scott J.			Two-Stage, In Silico Deconvolution of the Lymphocyte Compartment of the Peripheral Whole Blood Transcriptome in the Context of Acute Kidney Allograft Rejection	PLOS ONE			English	Article							IMMUNE-SYSTEM; EXPRESSION; CELLS; RATIO; REGULARIZATION; RESPONSES; INNATE; COUNT	Acute rejection is a major complication of solid organ transplantation that prevents the long-term assimilation of the allograft. Various populations of lymphocytes are principal mediators of this process, infiltrating graft tissues and driving cell-mediated cytotoxicity. Understanding the lymphocyte-specific biology associated with rejection is therefore critical. Measuring genome-wide changes in transcript abundance in peripheral whole blood cells can deliver a comprehensive view of the status of the immune system. The heterogeneous nature of the tissue significantly affects the sensitivity and interpretability of traditional analyses, however. Experimental separation of cell types is an obvious solution, but is often impractical and, more worrying, may affect expression, leading to spurious results. Statistical deconvolution of the cell type-specific signal is an attractive alternative, but existing approaches still present some challenges, particularly in a clinical research setting. Obtaining time-matched sample composition to biologically interesting, phenotypically homogeneous cell sub-populations is costly and adds significant complexity to study design. We used a two-stage, in silico deconvolution approach that first predicts sample composition to biologically meaningful and homogeneous leukocyte sub-populations, and then performs cell type-specific differential expression analysis in these same sub-populations, from peripheral whole blood expression data. We applied this approach to a peripheral whole blood expression study of kidney allograft rejection. The patterns of differential composition uncovered are consistent with previous studies carried out using flow cytometry and provide a relevant biological context when interpreting cell type-specific differential expression results. We identified cell type-specific differential expression in a variety of leukocyte sub-populations at the time of rejection. The tissue-specificity of these differentially expressed probe-set lists is consistent with the originating tissue and their functional enrichment consistent with allograft rejection. Finally, we demonstrate that the strategy described here can be used to derive useful hypotheses by validating a cell type-specific ratio in an independent cohort using the nanoString nCounter assay.	[Shannon, Casey P.; Balshaw, Robert; Ng, Raymond T.; Wilson-McManus, Janet E.; Keown, Paul; McMaster, Robert; McManus, Bruce M.; Tebbutt, Scott J.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Balshaw, Robert] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Ng, Raymond T.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1W5, Canada; [Keown, Paul] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada; [McMaster, Robert] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [McManus, Bruce M.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [McManus, Bruce M.] Univ British Columbia, Lab Med, Vancouver, BC V5Z 1M9, Canada; [Tebbutt, Scott J.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [Shannon, Casey P.; Ng, Raymond T.; Wilson-McManus, Janet E.; McManus, Bruce M.; Tebbutt, Scott J.] UBC James Hogg Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Landsberg, David] St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada; [Landsberg, David] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Isbel, Nicole M.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia; [Isbel, Nicole M.] Univ Queensland, Brisbane, Qld, Australia; [Knoll, Greg] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Queensland; University of Ottawa; Ottawa Hospital Research Institute	Tebbutt, SJ (corresponding author), PROOF Ctr Excellence, Vancouver, BC, Canada.	scott.tebbutt@hli.ubc.camailto	Isbel, Nicole M/G-5604-2011	Shannon, Casey/0000-0002-5687-3156; Tebbutt, Scott/0000-0002-7908-1581; Knoll, Greg/0000-0001-5442-9310; Balshaw, Robert/0000-0002-2455-8792	Genome Canada; Novartis Pharma AG; IBM; Genome British Columbia; NCE CECR PROOF Centre of Excellence	Genome Canada(Genome Canada); Novartis Pharma AG; IBM(International Business Machines (IBM)); Genome British Columbia; NCE CECR PROOF Centre of Excellence	Funding for this work was provided by Genome Canada, Novartis Pharma AG, IBM, Genome British Columbia, and the NCE CECR PROOF Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buttarello M, 2008, AM J CLIN PATHOL, V130, P104, DOI 10.1309/EK3C7CTDKNVPXVTN; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Etminan M, 2004, PHARMACOTHERAPY, V24, P964, DOI 10.1592/phco.24.11.964.36143; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Freue GVC, 2007, BIOINFORMATICS, V23, P3162, DOI 10.1093/bioinformatics/btm487; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong T, 2013, BIOINFORMATICS; Gong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027156; Gunther OP, 2009, TRANSPLANTATION, V88, P942, DOI 10.1097/TP.0b013e3181b7ccc6; He HZ, 2003, IMMUNOLOGY, V109, P185, DOI 10.1046/j.1365-2567.2003.01641.x; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hollander Z, 2010, TRANSPLANTATION, V90, P1388, DOI 10.1097/TP.0b013e3182003df6; Hwang K, 2011, ANN CLIN LAB SCI, V41, P144; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kitchens WH, 2006, TRANSPLANTATION, V81, P811, DOI 10.1097/01.tp.0000202844.33794.0e; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Puttarajappa C, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/193724; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Shannon CP, 2012, BIOINFORM BIOL INSIG, V6, P49, DOI 10.4137/BBI.S9197; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Shin H, 2014, BIOINFORM BIOL INSIG, V8, P17, DOI [10.4137/BBi.s13376, 10.4137/BBI.S13376.]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swaim AF, 2010, J IMMUNOL, V185, P6999, DOI 10.4049/jimmunol.1000929; Team RC, 2012, R LANG ENV STAT COMP; Tebbutt SJ, 2012, GENOM INSIGHTS, V5, P1, DOI 10.4137/GEI.S9125; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood BL, 1999, AM J CLIN PATHOL, V112, P687; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89; Zhong Y, 2012, NAT METHODS, V9, P8, DOI 10.1038/nmeth.1830; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zuckerman NS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003189	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95224	10.1371/journal.pone.0095224	http://dx.doi.org/10.1371/journal.pone.0095224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733377	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400163
J	van Dommelen, P; Schonbeck, Y; van Buuren, S; HiraSing, RA				van Dommelen, Paula; Schonbeck, Yvonne; van Buuren, Stef; HiraSing, Remy A.			Trends in a Life Threatening Condition: Morbid Obesity in Dutch, Turkish and Moroccan Children in The Netherlands	PLOS ONE			English	Article							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; ETHNIC-DIFFERENCES; HEALTH-RISK; OVERWEIGHT; PREVALENCE; PREVENTION; MANAGEMENT; ORIGIN	Background: Morbid obesity can be a life threatening condition. The aim of our study is to assess the trend in morbid obesity in The Netherlands among children of Dutch origin since 1980, and among children of Turkish and Moroccan origin since 1997. Methods and Findings: Cross-sectional height and weight data of children of Dutch, Turkish and Moroccan origin aged 2-18 years were selected from three national Dutch Growth Studies performed in 1980, 1997 and 2009 (n = 54,814). Extended international (IOTF) cut-offs in childhood were used to define morbid obesity (obesity class II and III combined). The morbidity index for overweight was calculated as the prevalence of morbid obesity divided by the prevalence of overweight. Our study showed that the prevalence of morbid obesity in children of Dutch origin was 0.59% in boys and 0.53% in girls in 2009. Significant upward trends occurred since 1980 and 1997. The prevalence was three to four fold higher in Turkish children compared to Dutch children. The Turkish children also had an upward trend since 1997, but this was only statistically significant in boys. The prevalence of morbid obesity in Moroccan children was two to three fold higher than in Dutch children, but it remained almost stable between 1997 and 2009. The Dutch and Turkish children showed an upward trend in morbidity index for overweight since respectively 1980 and 1997, while the Moroccan children showed a downward trend since 1997. In 2009, children of low educated parents had the highest prevalence rates of morbid obesity; 1.06% in Dutch, 2.11% in Turkish and 1.41% in Moroccan children. Conclusions and Significance: An upward trend of morbid obesity in Dutch and Turkish children in The Netherlands occurred. Monitoring and reducing the prevalence of childhood morbid obesity is of high importance for these children, health care and the community.	[van Dommelen, Paula; van Buuren, Stef] TNO, Dept Life Style, Leiden, Netherlands; [Schonbeck, Yvonne] TNO, Dept Child Hlth, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands; [HiraSing, Remy A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, EMGO Inst Hlth Care Res, Amsterdam, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Utrecht University; Vrije Universiteit Amsterdam	van Dommelen, P (corresponding author), TNO, Dept Life Style, Leiden, Netherlands.	Paula.vanDommelen@tno.nl		Schonbeck, Yvonne/0000-0002-4998-5117; van Buuren, Stef/0000-0003-1098-2119				Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Dijkshoorn H, 2008, PUBLIC HEALTH, V122, P625, DOI 10.1016/j.puhe.2007.08.016; Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x; Farrant B, 2013, J PEDIATR-US, V163, P143, DOI 10.1016/j.jpeds.2012.12.043; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Goulding A, 2007, J PEDIATR-US, V151, P542, DOI 10.1016/j.jpeds.2007.07.011; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hosper K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-105; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Kocken PL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-867; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Livingstone M B, 2001, Public Health Nutr, V4, P109; Lo JC, 2013, PEDIAT OBES     0515; Marcus MD, 2010, J ADOLESCENT HEALTH, V47, P604, DOI 10.1016/j.jadohealth.2010.04.017; Molnar D, 2008, INT J PEDIATR OBES, V3, P9, DOI 10.1080/17477160802404608; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; ROEDE MJ, 1985, TIJDSCHR SOC GEZON S, V63, P1, DOI DOI 10.1007/978-1-4471-1721-6_10; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Seidell JC, 2012, FAM PRACT, V29, pi153, DOI 10.1093/fampra/cmr057; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; van Emmerik NMA, 2012, ARCH DIS CHILD, V97, P818, DOI 10.1136/archdischild-2012-301877; Veldhuis L, 2013, ISRN PEDIAT, V2013; Verweij A, 2008, DUTCH 2008 PUBLIC HL; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Young-Hyman D, 2000, OBES RES, V8, P241, DOI 10.1038/oby.2000.28	31	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94299	10.1371/journal.pone.0094299	http://dx.doi.org/10.1371/journal.pone.0094299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732729	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400029
J	Tonge, DP; Pashley, CH; Gant, TW				Tonge, Daniel P.; Pashley, Catherine H.; Gant, Timothy W.			Amplicon -Based Metagenomic Analysis of Mixed Fungal Samples Using Proton Release Amplicon Sequencing	PLOS ONE			English	Article							DNA BARCODE; DIVERSITY; MAGNITUDE; REVEALS; COMMUNITIES; NUMBERS; REGION; FOREST	Next generation sequencing technology has revolutionised microbiology by allowing concurrent analysis of whole microbial communities. Here we developed and verified similar methods for the analysis of fungal communities using a proton release sequencing platform with the ability to sequence reads of up to 400 bp in length at significant depth. This read length permits the sequencing of amplicons from commonly used fungal identification regions and thereby taxonomic classification. Using the 400 bp sequencing capability, we have sequenced amplicons from the ITS1, ITS2 and LSU fungal regions to a depth of approximately 700,000 raw reads per sample. Representative operational taxonomic units (OTUs) were chosen by the USEARCH algorithm, and identified taxonomically through nucleotide blast (BLASTn). Combination of this sequencing technology with the bioinformatics pipeline allowed species recognition in two controlled fungal spore populations containing members of known identity and concentration. Each species included within the two controlled populations was found to correspond to a representative OTU, and these OTUs were found to be highly accurate representations of true biological sequences. However, the absolute number of reads attributed to each OTU differed among species. The majority of species were represented by an OTU derived from all three genomic regions although in some cases, species were only represented in two of the regions due to the absence of conserved primer binding sites or due to sequence composition. It is apparent from our data that proton release sequencing technologies can deliver a qualitative assessment of the fungal members comprising a sample. The fact that some fungi cannot be amplified by specific "conserved'' primer pairs confirms our recommendation that a multi-region approach be taken for other amplicon-based metagenomic studies.	[Gant, Timothy W.] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England; [Pashley, Catherine H.] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Tonge, Daniel P.] Staffordshire Univ, Fac Comp Engn & Sci, Stoke On Trent ST4 2DE, Staffs, England	Public Health England; University of Leicester; Staffordshire University	Tonge, DP (corresponding author), Staffordshire Univ, Fac Comp Engn & Sci, Stoke On Trent ST4 2DE, Staffs, England.	daniel.tonge@staffs.ac.uk	Pashley, Catherine/M-9002-2015	Pashley, Catherine/0000-0003-4023-3610; Tonge, Daniel/0000-0002-3499-2752; Gant, Timothy/0000-0001-9057-4937	Centre for Radiation, Chemical and Environmental Hazards, Public Health England [108539]; Midlands Asthma and Allergy Research Association (MAARA); National Institute for Health Research Leicester Respiratory Biomedical Research Unit	Centre for Radiation, Chemical and Environmental Hazards, Public Health England; Midlands Asthma and Allergy Research Association (MAARA); National Institute for Health Research Leicester Respiratory Biomedical Research Unit	DPT and TWG are supported by Centre for Radiation, Chemical and Environmental Hazards, Public Health England (Development Grant 108539). CHP is supported by the Midlands Asthma and Allergy Research Association (MAARA) and the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Black Jonathan, 2013, J Biomol Tech, V24, P32, DOI 10.7171/jbt.13-2401-004; Boreson J, 2004, ATMOS ENVIRON, V38, P6029, DOI 10.1016/j.atmosenv.2004.06.040; Brown SP, 2013, FEMS MICROBIOLOGY EC; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Houbraken J, 2012, PERSOONIA, V29, P78, DOI 10.3767/003158512X660571; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Issakainen J, 1999, MYCOL RES, V103, P1179, DOI 10.1017/S0953756299008333; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Lacey J, 1996, MYCOL RES, V100, P641, DOI 10.1016/S0953-7562(96)80194-8; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Samson RA, 2011, STUD MYCOL, P81, DOI 10.3114/sim.2011.69.06; Samson R. A., 2000, INTEGRATION MODERN T; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	32	34	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93849	10.1371/journal.pone.0093849	http://dx.doi.org/10.1371/journal.pone.0093849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728005	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336736200029
J	Vukasinovic, N; Cvrckova, F; Elias, M; Cole, R; Fowler, JE; Zarsky, V; Synek, L				Vukasinovic, Nemanja; Cvrckova, Fatima; Elias, Marek; Cole, Rex; Fowler, John E.; Zarsky, Viktor; Synek, Lukas			Dissecting a Hidden Gene Duplication: The Arabidopsis thaliana SEC10 Locus	PLOS ONE			English	Article							RECENT SEGMENTAL DUPLICATIONS; WHOLE-GENOME; ARABIDOPSIS-THALIANA; EXOCYST COMPLEX; INSERTIONAL MUTAGENESIS; SEQUENCE; EVOLUTION; FAMILIES; SUBUNIT; CDNA	Repetitive sequences present a challenge for genome sequence assembly, and highly similar segmental duplications may disappear from assembled genome sequences. Having found a surprising lack of observable phenotypic deviations and non-Mendelian segregation in Arabidopsis thaliana mutants in SEC10, a gene encoding a core subunit of the exocyst tethering complex, we examined whether this could be explained by a hidden gene duplication. Re-sequencing and manual assembly of the Arabidopsis thaliana SEC10 (At5g12370) locus revealed that this locus, comprising a single gene in the reference genome assembly, indeed contains two paralogous genes in tandem, SEC10a and SEC10b, and that a sequence segment of 7 kb in length is missing from the reference genome sequence. Differences between the two paralogs are concentrated in non-coding regions, while the predicted protein sequences exhibit 99% identity, differing only by substitution of five amino acid residues and an indel of four residues. Both SEC10 genes are expressed, although varying transcript levels suggest differential regulation. Homozygous T-DNA insertion mutants in either paralog exhibit a wild-type phenotype, consistent with proposed extensive functional redundancy of the two genes. By these observations we demonstrate that recently duplicated genes may remain hidden even in well-characterized genomes, such as that of A. thaliana. Moreover, we show that the use of the existing A. thaliana reference genome sequence as a guide for sequence assembly of new Arabidopsis accessions or related species has at least in some cases led to error propagation.	[Vukasinovic, Nemanja; Zarsky, Viktor; Synek, Lukas] Acad Sci Czech Republ, Inst Expt Bot, Prague, Czech Republic; [Vukasinovic, Nemanja; Cvrckova, Fatima; Zarsky, Viktor] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Elias, Marek] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [Cole, Rex; Fowler, John E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Cole, Rex; Fowler, John E.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; University of Ostrava; Oregon State University; Oregon State University	Synek, L (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, Prague, Czech Republic.	synek@ueb.cas.cz	Elias, Marek/D-6851-2014; Zarsky, Viktor/G-7352-2014; Fowler, John E/U-4529-2017; Žárský, Viktor/P-3673-2018; Synek, Lukas/H-4840-2014; Vukašinović, Nemanja/H-4727-2014	Elias, Marek/0000-0003-0066-6542; Zarsky, Viktor/0000-0002-5301-0339; Fowler, John E/0000-0002-9254-5934; Žárský, Viktor/0000-0002-5301-0339; Vukasinovic, Nemanja/0000-0003-2740-7874; Cvrckova, Fatima/0000-0002-5560-8473	Czech Science Foundation [GPP501/11/P853, P305/11/1629]; Europe Union [CZ.1.05/2.1.00/03.0M.100 IET]; Ministry of Education, Youth and Sports of the Czech Republic [KONTAKT ME10033, MSM0021620858];  [EU-ITN-PLANTORIGINS 238 640]; Div Of Molecular and Cellular Bioscience [1244633] Funding Source: National Science Foundation	Czech Science Foundation(Grant Agency of the Czech Republic); Europe Union; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Czech Science Foundation (projects GPP501/11/P853 and P305/11/1629), the Structural Funds of the Europe Union (project CZ.1.05/2.1.00/03.0M.100 IET), Ministry of Education, Youth and Sports of the Czech Republic grant (KONTAKT ME10033, MSM0021620858) and by the project EU-ITN-PLANTORIGINS 238 640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Cole RA, 2005, PLANT PHYSIOL, V138, P2005, DOI 10.1104/pp.105.062273; Cvrckova F, 2001, NATO SCI SER I LIFE, V328, P105; Cvrckova F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00159; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; Deng Y, 2014, PLANT BIOLOGY, V16, P643, DOI 10.1111/plb.12090; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Elias M, 2003, CELL BIOL INT, V27, P199, DOI 10.1016/S1065-6995(02)00349-9; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hanada K, 2009, GENOME BIOL EVOL, V1, P409, DOI 10.1093/gbe/evp043; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lehti-Shiu MD, 2005, PLANT MOL BIOL, V58, P89, DOI 10.1007/s11103-005-4546-3; Liu JL, 2012, PROTOPLASMA, V249, P587, DOI 10.1007/s00709-011-0330-1; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; NASMYTH K, 1991, COLD SPRING HARB SYM, V56, P9; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Ohno S., 1970, EVOLUTION GENE DUPLI; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Wang YH, 2008, J BIOTECHNOL TECHNOL, V1, P11; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	57	22	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94077	10.1371/journal.pone.0094077	http://dx.doi.org/10.1371/journal.pone.0094077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728280	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200036
J	Yang, DR; Meng, XH; Xue, BB; Liu, NL; Wang, XH; Zhu, HZ				Yang, Darong; Meng, Xianghe; Xue, Binbin; Liu, Nianli; Wang, Xiaohong; Zhu, Haizhen			MiR-942 Mediates Hepatitis C Virus-Induced Apoptosis via Regulation of ISG12a	PLOS ONE			English	Article							I-LIKE RECEPTORS; RIG-I; RNA REPLICATION; INNATE IMMUNITY; STRANDED-RNA; CELL-LINE; INFECTION; INTERFERON; PROTEIN; RECOGNITION	The interaction between hepatitis C virus (HCV) and human hepatic innate antiviral responses is unclear. The aim of this study was to examine how human hepatocytes respond to HCV infection. An infectious HCV isolate, JFH1, was used to infect a newly established human hepatoma cell line HLCZ01. Viral RNA or NS5A protein was examined by real-time PCR or immunofluorescence respectively. The mechanisms of HCV-induced IFN-beta and apoptosis were explored. Our data showed that HLCZ01 cells supported the entire HCV lifecycle and IFN-beta and interferon-stimulated genes (ISGs) were induced in HCV-infected cells. Viral infection caused apoptosis of HLCZ01 cells. Silencing of RIG-I, IRF3 or TRAIL inhibited ISG12a expression and blocked apoptosis of viral-infected HLCZ01 cells. Knockdown ISG12a blocked apoptosis of viral-infected cells. MiR-942 is a candidate negative regulator of ISG12a predicted by bioinformatics search. Moreover, HCV infection decreased miR-942 expression in HLCZ01 cells and miR-942 was inversely correlated with ISG12a expression in both HCV-infected cells and liver biopsies. MiR-942 forced expression in HLCZ01 cells decreased ISG12a expression and subsequently suppressed apoptosis triggered by HCV infection. Conversely, silencing of miR-942 expression by anti-miR-942 increased ISG12a expression and enhanced apoptosis in HCV-infected cells. Induction of Noxa by HCV infection contributed to ISG12a-mediated apoptosis. All the data indicated that innate host response is intact in HCV-infected hepatocytes. MiR-942 regulates HCV-induced apoptosis of human hepatocytes by targeting ISG12a. Our study provides a novel mechanism by which human hepatocytes respond to HCV infection.	[Yang, Darong; Meng, Xianghe; Xue, Binbin; Liu, Nianli; Wang, Xiaohong; Zhu, Haizhen] Hunan Univ, Dept Mol Med, State Key Lab Chemobiosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Zhu, Haizhen] Cent S Univ, Xiangya Med Sch, Affiliated Tumor Hosp,Hunan Prov Tumor Hosp, Res Ctr Canc Prevent & Treatment,Translat Med Res, Changsha, Hunan, Peoples R China	Hunan University; Central South University	Zhu, HZ (corresponding author), Hunan Univ, Dept Mol Med, State Key Lab Chemobiosensing & Chemometr, Changsha 410082, Hunan, Peoples R China.	zhuhaizhen69@yahoo.com	Yang, Darong/HHZ-5465-2022; wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Yang, Darong/0000-0002-5343-9047	National Science and Technology Major Project of the Ministry of Science and Technology of China [2009ZX10004-312]; National Natural Science Foundation of China [81271885]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science and Technology Major Project of the Ministry of Science and Technology of China (2009ZX10004-312), and National Natural Science Foundation of China (81271885) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chien H, 2012, J VIROL, V86, P10961, DOI 10.1128/JVI.01275-12; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Leung DW, 2012, TRENDS MICROBIOL, V20, P139, DOI 10.1016/j.tim.2011.12.005; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Smith W, 2013, CELL HOST MICROBE, V13, P324, DOI 10.1016/j.chom.2013.02.003; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang DR, 2013, ANTIMICROB AGENTS CH, V57, P4937, DOI 10.1128/AAC.00897-13; Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	34	29	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94501	10.1371/journal.pone.0094501	http://dx.doi.org/10.1371/journal.pone.0094501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727952	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200084
J	Yeo, ASL; Azhar, NA; Yeow, W; Talbot, CC; Khan, MA; Shankar, EM; Rathakrishnan, A; Azizan, A; Wang, SM; Lee, SK; Fong, MY; Manikam, R; Sekaran, SD				Yeo, Adeline S. L.; Azhar, Nur Atiqah; Yeow, Wanyi; Talbot, C. Conover, Jr.; Khan, Mohammad Asif; Shankar, Esaki M.; Rathakrishnan, Anusyah; Azizan, Azliyati; Wang, Seok Mui; Lee, Siew Kim; Fong, Mun Yik; Manikam, Rishya; Sekaran, Shamala Devi			Lack of Clinical Manifestations in Asymptomatic Dengue Infection Is Attributed to Broad Down-Regulation and Selective Up-Regulation of Host Defence Response Genes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; VIRUS-INFECTION; DENDRITIC CELLS; ELEVATED LEVELS; HEMORRHAGIC-FEVER; FEEDING-BEHAVIOR; VASCULAR LEAKAGE; INTERFERON-GAMMA; CHILDREN; IMMUNITY	Objectives: Dengue represents one of the most serious life-threatening vector-borne infectious diseases that afflicts approximately 50 million people across the globe annually. Whilst symptomatic infections are frequently reported, asymptomatic dengue remains largely unnoticed. Therefore, we sought to investigate the immune correlates conferring protection to individuals that remain clinically asymptomatic. Methods: We determined the levels of neutralizing antibodies (nAbs) and gene expression profiles of host immune factors in individuals with asymptomatic infections, and whose cognate household members showed symptoms consistent to clinical dengue infection. Results: We observed broad down-regulation of host defense response (innate, adaptive and matrix metalloprotease) genes in asymptomatic individuals as against symptomatic patients, with selective up-regulation of distinct genes that have been associated with protection. Selected down-regulated genes include: TNF alpha (TNF), IL8, C1S, factor B (CFB), IL2, IL3, IL4, IL5, IL8, IL9, IL10 and IL13, CD80, CD28, and IL18, MMP8, MMP10, MMP12, MMP15, MMP16, and MMP24. Selected up-regulated genes include: RANTES (CCL5), MIP-1 alpha (CCL3L1/CCL3L3), MIP-1 beta (CCL4L1), TGF beta (TGF beta), and TIMP1. Conclusion: Our findings highlight the potential association of certain host genes conferring protection against clinical dengue. These data are valuable to better explore the mysteries behind the hitherto poorly understood immunopathogenesis of subclinical dengue infection.	[Yeo, Adeline S. L.; Azhar, Nur Atiqah; Shankar, Esaki M.; Rathakrishnan, Anusyah; Lee, Siew Kim; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Azhar, Nur Atiqah; Yeow, Wanyi; Khan, Mohammad Asif] Perdana Univ, Grad Sch Med, Serdang, Selangor Darul, Malaysia; [Azhar, Nur Atiqah; Yeow, Wanyi; Khan, Mohammad Asif] Jalan MAEPS Perdana, Ctr Bioinformat, Serdang, Selangor Darul, Malaysia; [Talbot, C. Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Khan, Mohammad Asif] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Azizan, Azliyati] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA; [Wang, Seok Mui] Univ Teknol MARA, Inst Med Mol Biotechnol, Jalan Hosp, Sungai Buloh, Selangor, Malaysia; [Fong, Mun Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia	Universiti Malaya; Perdana University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of South Florida; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamala@ummc.edu.my	Manikam, Rishya/F-5908-2014; Shankar, EM/G-6444-2011; Muthu, Shankar Esaki/B-3132-2019; Khan, Mohammad Asif/F-4663-2010; Khan, M. Asif/ABE-7839-2021; Devi, Shamala Devi/B-9735-2010; FONG, MUN YIK/B-5443-2010; Wang, Seok Mui/X-5856-2019; Sekaran, Shamala Devi/B-8482-2008	Muthu, Shankar Esaki/0000-0002-7866-9818; Khan, Mohammad Asif/0000-0001-9202-279X; Khan, M. Asif/0000-0001-9202-279X; Devi, Shamala Devi/0000-0002-0478-0425; Wang, Seok Mui/0000-0002-3631-6504; Sekaran, Shamala Devi/0000-0002-0478-0425	High Impact Research Grant UM-MOHE [UM.C/625/1/HIR/MOHE/H-20001-00-E000053]; Science Fund of the Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2049]; UM Postgraduate Research Fund [PV039/2012A]	High Impact Research Grant UM-MOHE; Science Fund of the Ministry of Science, Technology and Innovation, Malaysia; UM Postgraduate Research Fund	This study was supported by High Impact Research Grant UM-MOHE; UM.C/625/1/HIR/MOHE/H-20001-00-E000053, Science Fund (No. 12-02-03-2049) of the Ministry of Science, Technology and Innovation, Malaysia, and UM Postgraduate Research Fund (PV039/2012A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, INT J EXP PATHOL, V80, P143, DOI 10.1046/j.1365-2613.1999.00107.x; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Bhatt S, 2013, NATURE; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1; CARDOSA MJ, 1983, J EXP MED, V158, P258, DOI 10.1084/jem.158.1.258; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E; Chaturvedi UC, 1999, CURR SCI INDIA, V76, P63; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527; Dengue W., 2009, GUIDELINES DIAGNOSIS; Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353; Gomes ALV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011267; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318; Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649; HARRIS R, 1969, LANCET, V2, P327; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Jain A, 2013, J CLIN IMMUNOL, V33, P613, DOI 10.1007/s10875-012-9855-0; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kurane I, 1994, CYTOKINES DENGUE VIR, P443; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Laur F, 1998, T ROY SOC TROP MED H, V92, P654, DOI 10.1016/S0035-9203(98)90800-8; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Liang Z, 2011, PLOS ONE, V6; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Luplertlop N, 2008, JPN J INFECT DIS, V61, P298; MALASIT P, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P316; Mathew A, 1999, J IMMUNOL, V162, P5609; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rogers KA, 2006, J IMMUNOL, V177, P3848, DOI 10.4049/jimmunol.177.6.3848; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Royall J, 1989, AM J PHYSIOL, V257, P410; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12; Siler JF, 1925, J AMER MED ASSOC, V84, P1163, DOI 10.1001/jama.1925.02660420001001; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Thomas SJ, 2009, VACCINE, V27, P355, DOI 10.1016/j.vaccine.2008.10.086; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wright H, 2005, DIGEST DIS SCI, V50, P1793, DOI 10.1007/s10620-005-2940-y; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zola H., 2007, LEUKOCYTE STROMAL CE	78	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92240	10.1371/journal.pone.0092240	http://dx.doi.org/10.1371/journal.pone.0092240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727912	gold, Green Submitted, Green Published			2022-12-25	WOS:000336736200009
J	Calbet, A; Sazhin, AF; Nejstgaard, JC; Berger, SA; Tait, ZS; Olmos, L; Sousoni, D; Isari, S; Martinez, RA; Bouquet, JM; Thompson, EM; Bamstedt, U; Jakobsen, HH				Calbet, Albert; Sazhin, Andrey F.; Nejstgaard, Jens C.; Berger, Stella A.; Tait, Zachary S.; Olmos, Lorena; Sousoni, Despoina; Isari, Stamatina; Martinez, Rodrigo A.; Bouquet, Jean-Marie; Thompson, Eric M.; Bamstedt, Ulf; Jakobsen, Hans H.			Future Climate Scenarios for a Coastal Productive Planktonic Food Web Resulting in Microplankton Phenology Changes and Decreased Trophic Transfer Efficiency	PLOS ONE			English	Article							OCEAN ACIDIFICATION; MARINE-PHYTOPLANKTON; INCREASED TEMPERATURE; NUTRIENT ENRICHMENT; COMMUNITY STRUCTURE; INCREASED PCO(2); GRAZING IMPACT; SPRING BLOOM; GROWTH; CO2	We studied the effects of future climate change scenarios on plankton communities of a Norwegian fjord using a mesocosm approach. After the spring bloom, natural plankton were enclosed and treated in duplicates with inorganic nutrients elevated to pre-bloom conditions (N, P, Si; eutrophication), lowering of 0.4 pH units (acidification), and rising 3 degrees C temperature (warming). All nutrient-amended treatments resulted in phytoplankton blooms dominated by chain-forming diatoms, and reached 13-16 mu g chlorophyll (chl) a l(-1). In the control mesocosms, chl a remained below 1 mu g l(-1). Acidification and warming had contrasting effects on the phenology and bloom-dynamics of autotrophic and heterotrophic microplankton. Bacillariophyceae, prymnesiophyceae, cryptophyta, and Protoperidinium spp. peaked earlier at higher temperature and lower pH. Chlorophyta showed lower peak abundances with acidification, but higher peak abundances with increased temperature. The peak magnitude of autotrophic dinophyceae and ciliates was, on the other hand, lowered with combined warming and acidification. Over time, the plankton communities shifted from autotrophic phytoplankton blooms to a more heterotrophic system in all mesocosms, especially in the control unaltered mesocosms. The development of mass balance and proportion of heterotrophic/autotrophic biomass predict a shift towards a more autotrophic community and less-efficient food web transfer when temperature, nutrients and acidification are combined in a future climate-change scenario. We suggest that this result may be related to a lower food quality for microzooplankton under acidification and warming scenarios and to an increase of catabolic processes compared to anabolic ones at higher temperatures.	[Calbet, Albert; Olmos, Lorena; Isari, Stamatina; Martinez, Rodrigo A.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Sazhin, Andrey F.] PP Shirshov Inst Oceanol RAS, Moscow, Russia; [Nejstgaard, Jens C.; Berger, Stella A.; Tait, Zachary S.] Univ Georgia, Skidaway Inst Oceanog, Savannah, GA USA; [Berger, Stella A.; Bouquet, Jean-Marie; Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway; [Olmos, Lorena] CSIC, Inst Invest Marinas, Vigo, Spain; [Sousoni, Despoina] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Isari, Stamatina] Hellen Ctr Marine Res, Inst Oceanog, Athens, Greece; [Bouquet, Jean-Marie; Thompson, Eric M.] Univ Bergen, Sars Int Ctr, Uni Res, Bergen, Norway; [Bamstedt, Ulf] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Jakobsen, Hans H.] Aarhus Univ, Dept Biosci, Roskilde, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Russian Academy of Sciences; Shirshov Institute of Oceanology; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; University of Bergen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Crete; Hellenic Centre for Marine Research; University of Bergen; Umea University; Aarhus University	Calbet, A (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	acalbet@icm.csic.es	Isari, Stamatina/J-6987-2014; Nejstgaard, Jens/ABB-8903-2020; Jakobsen, Hans/I-7200-2013; Calbet, Albert/A-7779-2008	Isari, Stamatina/0000-0003-3457-0274; Nejstgaard, Jens/0000-0003-1236-0647; Jakobsen, Hans/0000-0001-9590-2362; Calbet, Albert/0000-0003-1069-212X; Sousoni, Despoina/0000-0002-5426-7881	MESOAQUA -EU [FP7-INFRA-2008-1, 228224]; Norwegian Research Council [NFR-HK 2024040/E40]; Ministry of Science and Innovation [CTM2009-08783, CTM2011-23480]; VELUX foundation [VKR022608]	MESOAQUA -EU; Norwegian Research Council(Research Council of NorwayEuropean Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); VELUX foundation(Velux Fonden)	This research was funded through the projects BIOPUMP (EMT) and CYCLE from MESOAQUA -EU FP7-INFRA-2008-1, 228224 to (M. Winder & group members), the Norwegian Research Council grant NFR-HK 2024040/E40 (EMT), the project PROTOS (CTM2009-08783), and TopCop (CTM2011-23480) from the Ministry of Science and Innovation (AC). HHJ received financial support from the VELUX foundation (grant VKR022608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2007, OECOLOGIA, V150, P668, DOI 10.1007/s00442-006-0540-y; Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; Aberle N, 2012, MAR BIOL, V159, P2441, DOI 10.1007/s00227-012-1947-0; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Berger SA, 2010, GLOBAL CHANGE BIOL, V16, P1954, DOI 10.1111/j.1365-2486.2009.02134.x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Calbet A, 1996, J PLANKTON RES, V18, P2329, DOI 10.1093/plankt/18.12.2329; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; CARON DA, 1986, APPL ENVIRON MICROB, V52, P1340, DOI 10.1128/AEM.52.6.1340-1347.1986; Chen BZ, 2012, LIMNOL OCEANOGR, V57, P519, DOI 10.4319/lo.2012.57.2.0519; Chi YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056482; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Grasshoff K., 1983, METHODS SEA WATER AN, V2nd; GREBECKI A., 1962, BULL ACAD POLON SCI SER SCI BIOL, V10, P483; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hutchins DA, 2003, LIMNOL OCEANOGR-METH, V1, P82; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jakobsen HH, 2011, AQUAT MICROB ECOL, V65, P75, DOI 10.3354/ame01539; Kemp WM, 2001, MAR ECOL PROG SER, V223, P73, DOI 10.3354/meps223073; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Lewandowska A, 2010, MAR ECOL PROG SER, V405, P101, DOI 10.3354/meps08520; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; Mackas DL, 1998, CAN J FISH AQUAT SCI, V55, P1878, DOI 10.1139/cjfas-55-8-1878; Meakin NG, 2011, ISME J, V5, P1397, DOI 10.1038/ismej.2011.18; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mitchell JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059548; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Paulino AI, 2008, BIOGEOSCIENCES, V5, P739, DOI 10.5194/bg-5-739-2008; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P33, DOI 10.3354/meps260033; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riegman R, 1995, WATER SCI TECHNOL, V32, P63, DOI 10.1016/0273-1223(95)00682-6; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sazhin AF, 2007, BIOGEOCHEMISTRY, V83, P137, DOI 10.1007/s10533-007-9086-2; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Smith WO, 2003, DEEP-SEA RES PT II, V50, P605, DOI 10.1016/S0967-0645(02)00586-6; Sommer U, 2007, OECOLOGIA, V150, P655, DOI 10.1007/s00442-006-0539-4; Sommer U, 2012, MAR BIOL, V159, P2479, DOI [10.1007/s00227-012-2085-4, 10.1007/s00227-012-1897-6]; STOECKER DK, 1994, MAR ECOL PROG SER, V110, P293, DOI 10.3354/meps110293; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Taraldsvik M, 2000, EUR J PHYCOL, V35, P189, DOI 10.1017/S0967026200002687; THORESEN SS, 1984, J EXP MAR BIOL ECOL, V83, P149, DOI 10.1016/0022-0981(84)90042-X; Troedsson C, 2013, MAR BIOL, V160, P2175, DOI 10.1007/s00227-012-2137-9; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; WEISSE T, 1990, LIMNOL OCEANOGR, V35, P781, DOI 10.4319/lo.1990.35.4.0781; Winder M, 2012, MAR BIOL, V159, P2491, DOI 10.1007/s00227-012-1964-z; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222	73	43	44	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94388	10.1371/journal.pone.0094388	http://dx.doi.org/10.1371/journal.pone.0094388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721992	Green Published, gold			2022-12-25	WOS:000336909100063
J	Law, C; Paquet, M; Kania, A				Law, Chris; Paquet, Michel; Kania, Artur			Emergence of Motor Circuit Activity	PLOS ONE			English	Article							ISOLATED SPINAL-CORD; METHYL-D-ASPARTATE; CHICK-EMBRYO; ACTIVATION PATTERNS; ELECTRICAL-ACTIVITY; NETWORK ACTIVITY; SYNAPTIC DRIVE; CALCIUM WAVES; HIND-LIMB; MOTONEURONS	In the developing nervous system, ordered neuronal activity patterns can occur even in the absence of sensory input and to investigate how these arise, we have used the model system of the embryonic chicken spinal motor circuit, focusing on motor neurons of the lateral motor column (LMC). At the earliest stages of their molecular differentiation, we can detect differences between medial and lateral LMC neurons in terms of expression of neurotransmitter receptor subunits, including CHRNA5, CHRNA7, GRIN2A, GRIK1, HTR1A and HTR1B, as well as the KCC2 transporter. Using patch-clamp recordings we also demonstrate that medial and lateral LMC motor neurons have subtly different activity patterns that reflect the differential expression of neurotransmitter receptor subunits. Using a combination of patch-clamp recordings in single neurons and calcium-imaging of motor neuron populations, we demonstrate that inhibition of nicotinic, muscarinic or GABA-ergic activity, has profound effects of motor circuit activity during the initial stages of neuromuscular junction formation. Finally, by analysing the activity of large populations of motor neurons at different developmental stages, we show that the asynchronous, disordered neuronal activity that occurs at early stages of circuit formation develops into organised, synchronous activity evident at the stage of LMC neuron muscle innervation. In light of the considerable diversity of neurotransmitter receptor expression, activity patterns in the LMC are surprisingly similar between neuronal types, however the emergence of patterned activity, in conjunction with the differential expression of transmitter systems likely leads to the development of near-mature patterns of locomotor activity by perinatal ages.	[Law, Chris; Paquet, Michel; Kania, Artur] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Kania, Artur] McGill Univ, Dept Anat & Cell Biol, Div Expt Med, Montreal, PQ, Canada; [Kania, Artur] McGill Univ, Dept Biol, Div Expt Med, Montreal, PQ H3A 1B1, Canada; [Kania, Artur] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Universite de Montreal	Kania, A (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	artur.kania@ircm.qc.ca		Kania, Artur/0000-0002-5209-2520	Canadian Institutes of Health Research [MOP-77556]; Natural Sciences and Engineering Research Council of Canada; Brain Canada; W. Garfield Weston Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Brain Canada; W. Garfield Weston Foundation	This work is funded by grants to Artur Kania from the Canadian Institutes of Health Research (Operating Grant MOP-77556), the Natural Sciences and Engineering Research Council of Canada, Brain Canada and the W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Benjumeda I, 2013, J NEUROSCI, V33, P18208, DOI 10.1523/JNEUROSCI.1931-13.2013; Borda T, 1998, J NEURAL TRANSM, V105, P193, DOI 10.1007/s007020050048; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briz V, 2013, J NEUROSCI, V33, P4317, DOI 10.1523/JNEUROSCI.4907-12.2013; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chub N, 1998, J NEUROSCI, V18, P294; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; Croteau LP, 2011, J NEUROSCI METH, V201, P381, DOI 10.1016/j.jneumeth.2011.08.012; CULLHEIM S, 1977, BRAIN RES, V132, P1, DOI 10.1016/0006-8993(77)90702-8; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Dhande OS, 2012, J COMP NEUROL, V520, P1562, DOI 10.1002/cne.23000; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HOLLEY JA, 1982, J COMP NEUROL, V207, P314, DOI 10.1002/cne.902070403; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jablonski AM, 2013, ANN NY ACAD SCI, V1279, P54, DOI 10.1111/nyas.12053; Kao TJ, 2009, J NEUROSCI, V29, P5690, DOI 10.1523/JNEUROSCI.0265-09.2009; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; Kastanenka KV, 2010, J NEUROSCI, V30, P10575, DOI 10.1523/JNEUROSCI.2773-10.2010; Koch Christof, 1999, P1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; LANDMESSER LT, 1986, J PHYSIOL-LONDON, V380, P157, DOI 10.1113/jphysiol.1986.sp016278; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; MENDELSON B, 1992, NEUROSCI LETT, V138, P72, DOI 10.1016/0304-3940(92)90475-M; Mendez J, 1999, J NEUROCHEM, V73, P162, DOI 10.1046/j.1471-4159.1999.0730162.x; Milner LD, 1999, J NEUROSCI, V19, P3007; Mire E, 2013, NAT NEUROSCI, V15, P1134; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Ni XL, 2010, NEUROPHARMACOLOGY, V58, P593, DOI 10.1016/j.neuropharm.2009.11.016; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; ODONOVAN M, 1994, J NEUROSCI, V14, P6354; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; PERRINS R, 1995, J NEUROPHYSIOL, V73, P1005, DOI 10.1152/jn.1995.73.3.1005; Plazas PV, 2013, P NATL ACAD SCI USA, V110, P1524, DOI 10.1073/pnas.1213048110; PROVINE RR, 1970, P NATL ACAD SCI USA, V65, P508, DOI 10.1073/pnas.65.3.508; Ravary A, 2003, J NEUROSCI, V23, P2228; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; SERNAGOR E, 1991, NEUROSCI LETT, V128, P211, DOI 10.1016/0304-3940(91)90263-S; SERNAGOR E, 1995, J NEUROSCI, V15, P7452; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Temkin R, 1997, MOL BRAIN RES, V52, P38, DOI 10.1016/S0169-328X(97)00249-0; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VOGEL MW, 1995, J NEUROBIOL, V26, P537, DOI 10.1002/neu.480260407; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang S, 2009, J NEUROSCI, V29, P15232, DOI 10.1523/JNEUROSCI.3809-09.2009; Warp E, 2011, CURR BIOL, V22, P93; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	74	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93836	10.1371/journal.pone.0093836	http://dx.doi.org/10.1371/journal.pone.0093836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722186	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100027
J	Linnerth-Petrik, NM; Santry, LA; Petrik, JJ; Wootton, SK				Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Petrik, James J.; Wootton, Sarah K.			Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; JAAGSIEKTE SHEEP; MOUSE MODEL; PROGNOSTIC-SIGNIFICANCE; CELL-PROLIFERATION; NEVER-SMOKERS; CANCER; RETROVIRUS; SURVIVAL; PROTEIN	Background: The phosphatidylinositol 3-kinase-regulated protein kinase, Akt, plays an important role in the initiation and progression of human cancer. Mammalian cells express three Akt isoforms (Akt1-3), which are encoded by distinct genes. Despite sharing a high degree of amino acid identity, phenotypes observed in knockout mice suggest that Akt isoforms are not functionally redundant. The relative contributions of the different Akt isoforms to oncogenesis, and the effect of their deficiencies on tumor development, are not well understood. Methods: Here we demonstrate that Akt isoforms have non-overlapping and sometimes opposing functions in tumor initiation and progression using a viral oncogene-induced mouse model of lung cancer and Akt isoform-specific knockout mice. Results: Akt1 ablation significantly delays initiation of lung tumor growth, whereas Akt2 deficiency dramatically accelerates tumorigenesis in this mouse model. Ablation of Akt3 had a small, not statistically significant, stimulatory effect on tumor induction and growth by the viral oncogene. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and Ki67 immunostaining of lung tissue sections revealed that the delayed tumor induction in Akt1(-/-) mice was due to the inhibitory effects of Akt1 ablation on cell growth and survival. Conversely, the accelerated growth rate of lung tumors in Akt2(-/-) and Akt3(-/-) mice was due to increased cell proliferation and reduced tumor cell apoptosis. Investigation of Akt signaling in tumors from Akt knockout mice revealed that the lack of Akt1 interrupted the propagation of signaling in tumors to the critical downstream targets, GSK-3 alpha/beta and mTOR. Conclusions: These results demonstrate that the degree of functional redundancy between Akt isoforms in the context of lung tumor initiation is minimal. Given that this mouse model exhibits considerable similarities to human lung cancer, these findings have important implications for the design and use of Akt inhibitors for the treatment of lung cancer.	[Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Wootton, Sarah K.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Petrik, James J.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Wootton, SK (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	kwootton@uoguelph.ca			Cancer Research Society; Ontario Veterinary College MSc Fellowship	Cancer Research Society; Ontario Veterinary College MSc Fellowship	This work was supported by funding from the Cancer Research Society. LAS was supported by an Ontario Veterinary College MSc Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caporale M, 2006, J VIROL, V80, P8030, DOI 10.1128/JVI.00474-06; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Ferguson RD, 2013, ENDOCR-RELAT CANCER, V20, P391, DOI 10.1530/ERC-12-0333; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Li YW, 2009, BIOORG MED CHEM LETT, V19, P834, DOI 10.1016/j.bmcl.2008.12.017; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Linnerth-Petrik NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051400; Liu SL, 2007, ONCOGENE, V26, P789, DOI 10.1038/sj.onc.1209850; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mornex JF, 2003, CURR TOP MICROBIOL, V275, P225; Mukohara T, 2004, ANTICANCER RES, V24, P11; MUSCAT JE, 1995, CANCER LETT, V88, P1, DOI 10.1016/0304-3835(94)03608-L; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Palmarini M, 1997, TRENDS MICROBIOL, V5, P478, DOI 10.1016/S0966-842X(97)01162-1; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosenberg N, 2001, P NATL ACAD SCI USA, V98, P4285, DOI 10.1073/pnas.091097698; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Sciacca L, 2013, NUTR METAB CARDIOVAS; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Watson KL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-375; Wootton SK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-94; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2008, AM J RESP CRIT CARE, V178, P60, DOI 10.1164/rccm.200707-1022OC; Xu PZ, 2012, ONCOGENE, V31, P518, DOI 10.1038/onc.2011.243; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	64	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94595	10.1371/journal.pone.0094595	http://dx.doi.org/10.1371/journal.pone.0094595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722238	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100105
J	Truppel, JH; Otomura, F; Teodoro, U; Massafera, R; da Costa-Ribeiro, MCV; Catarino, CM; Dalagrana, L; Ferreira, MEMC; Thomaz-Soccol, V				Truppel, Jesse Henrique; Otomura, Flavio; Teodoro, Ueslei; Massafera, Rubens; Vieira da Costa-Ribeiro, Magda Clara; Catarino, Carolina Motter; Dalagrana, Luana; Moreira Costa Ferreira, Maria Eugenia; Thomaz-Soccol, Vanete			Can Equids Be a Reservoir of Leishmania braziliensis in Endemic Areas?	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; VIANNIA BRAZILIENSIS; EQUUS-CABALLUS; STATE; HORSE; EPIDEMIOLOGY; INFECTION; VENEZUELA; CANINE; HOSTS	In this study, we detected Leishmania (Viannia) braziliensis infection in equids living in endemic regions of cutaneous leishmaniasis. To determine the role of these animals in the Leishmania cycle, we used two approaches: serological and molecular methods. Antibodies to the parasite were assayed using the Enzyme Linked Immunosorbent Assay (ELISA). Blood samples were collected and tested by polymerase chain reaction (PCR), and the positive products were sequenced. The results showed that 11.0% (25/227) of the equids were seropositive for Leishmania sp, and 16.3% (37/227) were PCR positive. Antibodies were detected in 20 horses, 3 donkeys, and 2 mules, and the parasite DNA was detected in 30 horses, 5 donkeys, and 2 mules. Sequencing the amplified DNA revealed 100% similarity with sequences for Viannia complex, corroborating the results of PCR for L. braziliensis. Our results show that equids are infected with L. braziliensis, which could be food sources for phlebotomines in the peridomiciliary environment and consequently play a role in the cutaneous leishmaniasis cycle.	[Truppel, Jesse Henrique] Ctr Zoonoses Control, Dept Hlth Surveillance, Municipal Hlth Dept, Araucaria, Parana, Brazil; [Truppel, Jesse Henrique; Vieira da Costa-Ribeiro, Magda Clara; Catarino, Carolina Motter; Dalagrana, Luana; Thomaz-Soccol, Vanete] Fed Univ Parana UFPR, Postgraduat Program Microbiol Parasitol & Pathol, Dept Pathol, Curitiba, Parana, Brazil; [Otomura, Flavio; Teodoro, Ueslei] Maringa State Univ UEM, Postgraduat Program Hlth Sci, Maringa, Parana, Brazil; [Moreira Costa Ferreira, Maria Eugenia] Maringa State Univ UEM, Dept Geog, Maringa, Parana, Brazil	Universidade Federal do Parana; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Thomaz-Soccol, V (corresponding author), Fed Univ Parana UFPR, Postgraduat Program Microbiol Parasitol & Pathol, Dept Pathol, Curitiba, Parana, Brazil.	vanete.soccol@pq.cnpq.br	Soccol, Vanete Thomaz/F-2392-2015; Soccol, Vanete Thomaz/N-9887-2019	Soccol, Vanete Thomaz/0000-0001-9301-541X; Soccol, Vanete Thomaz/0000-0001-9301-541X	CAPES; CNPq [410550-2006-0, 301906/2008-4]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was co-funded by CAPES and CNPq (Grant number 410550-2006-0, Process number: 301906/2008-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso Margarete Martins dos Santos, 2005, Cad. Saúde Pública, V21, P1816, DOI 10.1590/S0102-311X2005000600030; AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; AGUILAR C M, 1987, Memorias do Instituto Oswaldo Cruz, V82, P143, DOI 10.1590/S0074-02761987000100024; AGUILAR C M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P471, DOI 10.1590/S0074-02761986000400015; AGUILAR CM, 1989, MEM I OSWALDO CRUZ, V84, P19, DOI 10.1590/S0074-02761989000100005; BONFANTEGARRIDO R, 1992, T ROY SOC TROP MED H, V86, P141, DOI 10.1016/0035-9203(92)90544-M; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; Castro EA, 2007, EXP PARASITOL, V117, P13, DOI 10.1016/j.exppara.2007.03.003; Costa-Ribeiro MCV, 2006, THESIS I O CRUZ RIO; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cupolillo E, 2003, J CLIN MICROBIOL, V41, P3126, DOI 10.1128/JCM.41.7.3126-3132.2003; Cupolillo E, 1998, MEM I OSWALDO CRUZ, V93, P663, DOI 10.1590/S0074-02761998000500018; de Castro EA, 2005, ACTA TROP, V93, P141, DOI 10.1016/j.actatropica.2004.10.004; Castro Edilene Alcântara de, 2002, Rev. Soc. Bras. Med. Trop., V35, P445; Falqueto A, 2003, MEM I OSWALDO CRUZ, V98, P1003, DOI 10.1590/S0074-02762003000800004; FALQUETO A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P443, DOI 10.1590/S0074-02761987000300020; Follador I, 1999, Rev Soc Bras Med Trop, V32, P497, DOI 10.1590/S0037-86821999000500005; Ishikawa EAY., 2002, T R SOC TROP MED HYG, V96, P111, DOI DOI 10.1016/S0035-9203(02)90061-1; Koehler K, 2002, VET PARASITOL, V109, P9, DOI 10.1016/S0304-4017(02)00246-7; Lainson R, 2005, TOPLEY WILSONS MICRO, P313; Mazza S., 1927, B U B AIRES, V3, P462; Membrive Norberto Assis, 2004, Entomologia y Vectores, V11, P673, DOI 10.1590/S0328-03812004000400009; Meneses CRV, 2002, J VECTOR ECOL, V27, P207; OLIVEIRA-NETO M P, 1988, Memorias do Instituto Oswaldo Cruz, V83, P427, DOI 10.1590/S0074-02761988000400006; RamosVara JA, 1996, VET PATHOL, V33, P731, DOI 10.1177/030098589603300619; Reuss SM, 2012, EMERG INFECT DIS, V18, P1545, DOI 10.3201/eid1809.120184; Rotureau B, 2006, MED HYPOTHESES, V67, P1235, DOI 10.1016/j.mehy.2006.02.056; Sambrook J, 2001, MOL CLONING LAB MANU; Soares IR, 2013, VET PARASITOL, V197, P665, DOI 10.1016/j.vetpar.2013.06.014; Soccol VT, 2009, ACTA TROP, V111, P308, DOI 10.1016/j.actatropica.2009.05.013; Solano-Gallego L, 2003, EQUINE VET J, V35, P320, DOI 10.2746/042516403776148336; Teodoro U, 2006, REV SAUDE PUBL, V40, P327, DOI 10.1590/S0034-89102006000200022; Teodoro Ueslei, 2010, Revista de Patologia Tropical, V39, P322; THOMAZSOCCOL V, 1993, ANN PARASIT HUM COMP, V68, P104; Vedovello D, 2008, ZOONOSES PUBLIC HLTH, V55, P149, DOI 10.1111/j.1863-2378.2008.01106.x; WHO, 1990, WHO TECHN REP SER, V793; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026	37	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93731	10.1371/journal.pone.0093731	http://dx.doi.org/10.1371/journal.pone.0093731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721908	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100022
J	Nopparat, J; Zhang, J; Lu, JP; Chen, YH; Zheng, D; Neufer, PD; Fan, JM; Hong, H; Boykin, C; Lu, Q				Nopparat, J.; Zhang, J.; Lu, J-P; Chen, Y-H; Zheng, D.; Neufer, P. D.; Fan, J. M.; Hong, H.; Boykin, C.; Lu, Q.			delta-Catenin, a Wnt/beta-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming	ONCOGENE			English	Article							E-CADHERIN; ARMADILLO PROTEIN; PROSTATE; MEMBER; KAISO; GENE; MORPHOGENESIS; P190RHOGEF; EXPRESSION; MUTATIONS	Mutations of Wnt/beta-catenin signaling pathway has essential roles in development and cancer. Although beta-catenin and adenomatous polyposis coli (APC) gene mutations are well established and are known to drive tumorigenesis, discoveries of mutations in other components of the pathway lagged, which hinders the understanding of cancer mechanisms. Here we report that delta-catenin (gene designation: CTNND2), a primarily neural member of the beta-catenin superfamily that promotes canonical Wnt/beta-catenin/LEF-1-mediated transcription, displays exonic mutations in human prostate cancer and promotes cancer cell survival adaptation and metabolic reprogramming. When overexpressed in cells derived from prostate tumor xenografts, delta-catenin gene invariably gives rise to mutations, leading to sequence disruptions predicting functional alterations. Ectopic delta-catenin gene integrating into host chromosomes is locus nonselective. delta-Catenin mutations promote tumor development in mouse prostate with probasin promoter (ARR(2)PB)-driven, prostate-specific expression of Myc oncogene, whereas mutant cells empower survival advantage upon overgrowth and glucose deprivation. Reprogramming energy utilization accompanies the downregulation of glucose transporter-1 and poly (ADP-ribose) polymerase cleavage while preserving tumor type 2 pyruvate kinase expression. delta-Catenin mutations increase beta-catenin translocation to the nucleus and hypoxia-inducible factor 1 alpha (HIF-1 alpha) expression. Therefore, introducing delta-catenin mutations is an important milestone in prostate cancer metabolic adaptation by modulating beta-catenin and HIF-1 alpha signaling under glucose shortage to amplify its tumor-promoting potential.	[Nopparat, J.; Zhang, J.; Lu, J-P; Fan, J. M.; Boykin, C.; Lu, Q.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Lu, J-P] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Y-H; Lu, Q.] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC 27834 USA; [Chen, Y-H; Lu, Q.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zheng, D.; Neufer, P. D.] E Carolina Univ, Dept Kinesiol, Greenville, NC 27834 USA; [Zheng, D.; Neufer, P. D.] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Neufer, P. D.] E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Hong, H.] E Carolina Univ, Brody Sch Med, Dept Pathol & Lab Med, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; Zhejiang University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Lu, Q (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 7N72A Brody Sci Bldg,600 Moye Blvd, Greenville, NC 27834 USA.	luq@ecu.edu	Nopparat, Jongdee/AAX-1690-2020; Lu, Jianping/AFL-6811-2022	Nopparat, Jongdee/0000-0003-3532-1405; Lu, Jianping/0000-0001-9601-0040	DOD [PC040569]; NIH [CA111891, CA165202, ES016888, DK073488, DK074825]; NATIONAL CANCER INSTITUTE [R01CA111891, R15CA165202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096907, R01DK073488, R01DK074825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES016888] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Joani Zary Oswald for technical assistance. This work was supported, in part, by DOD Grant PC040569 (to QL), NIH Grants CA111891 and CA165202 (to QL), ES016888 (to Y-HC) and DK073488 and DK074825 (to PDN).	Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Dai SD, 2011, CANCER SCI, V102, P95, DOI 10.1111/j.1349-7006.2010.01766.x; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deng W, 2003, CYTOM PART A, V51A, P46, DOI 10.1002/cyto.a.10004; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fang Y, 2004, J CANCER RES CLIN, V138, P1769; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; Huang XT, 2007, GENES GENET SYST, V82, P257, DOI 10.1266/ggs.82.257; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim H, 2012, BBA-MOL BASIS DIS, V1822, P509, DOI 10.1016/j.bbadis.2011.12.015; Kim H, 2008, BIOCHEM BIOPH RES CO, V377, P636, DOI 10.1016/j.bbrc.2008.10.030; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Lu BY, 2011, INVEST OPHTH VIS SCI, V52, P8258, DOI 10.1167/iovs.11-7914; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2010, J PATHOL, V222, P119, DOI 10.1002/path.2755; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang T, 2009, ONCOGENE, V28, P555, DOI 10.1038/onc.2008.399; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wilson KF, 2013, TRENDS MOL MED, V19, P74, DOI 10.1016/j.molmed.2012.10.011; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19; Zhang H, 2013, TARGET ONCOL, DOI [10.1007/s11523-013-0269-6, DOI 10.1007/S11523-013-0269-6)]; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	48	23	24	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1542	1552		10.1038/onc.2014.89	http://dx.doi.org/10.1038/onc.2014.89			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24727894	Green Accepted, Green Submitted			2022-12-25	WOS:000351416800007
J	Al-Huseini, LMA; Yeang, HXA; Hamdam, JM; Sethu, S; Alhumeed, N; Wong, W; Sathish, JG				Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.			Heme Oxygenase-1 Regulates Dendritic Cell Function through Modulation of p38 MAPK-CREB/ATF1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-CELLS; NF-KAPPA-B; TRANSCRIPTION FACTOR; CARBON-MONOXIDE; ACTIVATION; MATURATION; LIPOPOLYSACCHARIDE; RECEPTOR; NRF2; COSTIMULATION	Dendritic cells (DCs) are critical for the initiation of immune responses including activation of CD8T cells. Intracellular reactive oxygen species (ROS) levels influence DC maturation and function. Intracellular heme, a product of catabolism of heme-containing metalloproteins, is a key inducer of ROS. Intracellular heme levels are regulated by heme oxygenase-1 (HO-1), which catalyzes the degradation of heme. Heme oxygenase-1 has been implicated in regulating DC maturation; however, its role in other DC functions is unclear. Furthermore, the signaling pathways modulated by HO-1 in DCs are unknown. In this study, we demonstrate that inhibition of HO-1 activity in murine bone marrow-derived immature DCs (iDCs) resulted in DCs with raised intracellular ROS levels, a mature phenotype, impaired phagocytic and endocytic function, and increased capacity to stimulate antigen-specific CD8 T cells. Interestingly, our results reveal that the increased ROS levels following HO-1 inhibition did not underlie the changes in phenotype and functions observed in these iDCs. Importantly, we show that the p38 mitogen-activated protein kinase (p38 MAPK), cAMP-responsive element binding protein (CREB), and activating transcription factor 1 (ATF1) pathway is involved in the mediation of the phenotypic and functional changes arising from HO-1 inhibition. Furthermore, up-regulation of HO-1 activity rendered iDCs refractory to lipopolysaccharide-induced activation of p38 MAPK-CREB/ATF1 pathway and DC maturation. Finally, we demonstrate that treatment of iDC with the HO-1 substrate, heme, recapitulates the effects that result from HO-1 inhibition. Based on these results, we conclude that HO-1 regulates DC maturation and function by modulating the p38 MAPK-CREB/ATF1 signaling axis.	[Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.] Univ Liverpool, Ctr Drug Safety Sci, MRC, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.] Al Qadisiyah Univ, Coll Med, Dept Pharmacol & Therapeut, Diwaniyah 58001, Iraq	University of Liverpool; University of Liverpool; University of Al-Qadisiyah	Sathish, JG (corresponding author), Univ Liverpool, Ctr Drug Safety Sci, MRC, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	Jean.Sathish@liv.ac.uk	Sethu, Swaminathan/R-8577-2019; Alhumeed, Naif/AAR-7956-2021; Al-Huseini, Laith M Abbas/S-6613-2019	Alhumeed, Naif/0000-0001-5221-3073; Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility	University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility	We thank the University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility for expert advice and support.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Al-Huseini LMA, 2013, J BIOL CHEM, V288, P22281, DOI 10.1074/jbc.M113.483420; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bachmann MF, 1999, EUR J IMMUNOL, V29, P2156, DOI 10.1002/(SICI)1521-4141(199907)29:07<2156::AID-IMMU2156>3.0.CO;2-P; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Burnaugh L, 2007, THERIOGENOLOGY, V67, P580, DOI 10.1016/j.theriogenology.2006.07.021; Casals C, 2007, J IMMUNOL, V178, P6307, DOI 10.4049/jimmunol.178.10.6307; Chai JG, 1999, J IMMUNOL, V163, P1298; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Cheng C, 2010, CIRC RES, V106, P1656, DOI 10.1161/CIRCRESAHA.110.216945; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dang TN, 2011, NEUROCHEM INT, V58, P804, DOI 10.1016/j.neuint.2011.03.006; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fanger NA, 1996, J IMMUNOL, V157, P541; FIBACH E, 1995, BLOOD, V85, P2967, DOI 10.1182/blood.V85.10.2967.bloodjournal85102967; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kemball CC, 2006, J IMMUNOL, V176, P1814, DOI 10.4049/jimmunol.176.3.1814; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Matos TJ, 2005, IMMUNOL CELL BIOL, V83, P607, DOI 10.1111/j.1440-1711.2005.01378.x; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Schumacher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042301; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	52	45	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16442	16451		10.1074/jbc.M113.532069	http://dx.doi.org/10.1074/jbc.M113.532069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719331	Green Published, hybrid			2022-12-25	WOS:000337965700046
J	Gupta, RP; Kueppers, P; Hanekop, N; Schmitt, L				Gupta, Rakeshkumar P.; Kueppers, Petra; Hanekop, Nils; Schmitt, Lutz			Generating Symmetry in the Asymmetric ATP-binding Cassette (ABC) Transporter Pdr5 from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; ATPases; Membrane Proteins; Membrane Transport; Multidrug Transporters; Coupling Mechanism	MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; NUCLEOTIDE; YEAST; DOMAIN; HYDROLYSIS; MECHANISM; HLYB; RESISTANCE; PROTEINS	Background: Fungal multidrug efflux pumps possess a degenerate nucleotide-binding site (NBS). Results: Restoring all the nonconserved amino acids in the degenerate NBS of Pdr5 leads to complete loss of function of the protein. Conclusion: The degenerate NBS is essential and acts as a structural platform supporting the canonical NBS. Significance: This is the first study dealing with the entire degenerate NBS and its functional role. Pdr5 is a plasma membrane-bound ABC transporter from Saccharomyces cerevisiae and is involved in the phenomenon of resistance against xenobiotics, which are clinically relevant in bacteria, fungi, and humans. Many fungal ABC transporters such as Pdr5 display an inherent asymmetry in their nucleotide-binding sites (NBS) unlike most of their human counterparts. This degeneracy of the NBSs is very intriguing and needs explanation in terms of structural and functional relevance. In this study, we mutated nonconsensus amino acid residues in the NBSs to its consensus counterpart and studied its effect on the function of the protein and effect on yeast cells. The completely regenerated Pdr5 protein was severely impaired in its function of ATP hydrolysis and of rhodamine 6G transport. Moreover, we observe alternative compensatory mechanisms to counteract drug toxicity in some of the mutants. In essence, we describe here the first attempts to restore complete symmetry in an asymmetric ABC transporter and to study its effects, which might be relevant to the entire class of asymmetric ABC transporters.	[Gupta, Rakeshkumar P.; Kueppers, Petra; Hanekop, Nils; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de			Deutsche Forschungsgemeinschaft [Schm1279/5-3]; European Drug Initiative on Channels and Transporters [Health-2007-2.1.1.-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters	This work was supported by Deutsche Forschungsgemeinschaft Grant Schm1279/5-3 and European Drug Initiative on Channels and Transporters FP7 Theme Health-2007-2.1.1.-5 (to L. S.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DUFOUR JP, 1988, METHOD ENZYMOL, V157, P513; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Furman C, 2013, J BIOL CHEM, V288, P30420, DOI 10.1074/jbc.M113.494682; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Hanekop N, 2006, FEBS LETT, V580, P1036, DOI 10.1016/j.febslet.2005.11.012; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Wada S, 2002, J BIOL CHEM, V277, P46809, DOI 10.1074/jbc.M207817200; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2004, ACTA CRYSTALLOGR D, V60, P1076, DOI 10.1107/S0907444904007437; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	36	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15272	15279		10.1074/jbc.M114.553065	http://dx.doi.org/10.1074/jbc.M114.553065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733388	Green Published, hybrid			2022-12-25	WOS:000337465400012
J	Lopert, P; Patel, M				Lopert, Pamela; Patel, Manisha			Nicotinamide Nucleotide Transhydrogenase (Nnt) Links the Substrate Requirement in Brain Mitochondria for Hydrogen Peroxide Removal to the Thioredoxin/Peroxiredoxin (Trx/Prx) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species (ROS); Thioredoxin Reductase; Nicotinamide Nucleotide Transhydrogenase	FAMILIAL GLUCOCORTICOID DEFICIENCY; ALPHA-KETOGLUTARATE DEHYDROGENASE; NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; CELL-DEATH; RAT-BRAIN; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; OXYGEN	Mitochondrial reactive oxygen species are implicated in the etiology of multiple neurodegenerative diseases, including Parkinson disease. Mitochondria are known to be net producers of ROS, but recently we have shown that brain mitochondria can consume mitochondrial hydrogen peroxide (H2O2) in a respiration-dependent manner predominantly by the thioredoxin/peroxiredoxin system. Here, we sought to determine the mechanism linking mitochondrial respiration with H2O2 catabolism in brain mitochondria and dopaminergic cells. We hypothesized that nicotinamide nucleotide transhydrogenase (Nnt), which utilizes the proton gradient to generate NADPH from NADH and NADP(+), provides the link between mitochondrial respiration and H2O2 detoxification through the thioredoxin/peroxiredoxin system. Pharmacological inhibition of Nnt in isolated brain mitochondria significantly decreased their ability to consume H2O2 in the presence, but not absence, of respiration substrates. Nnt inhibition in liver mitochondria, which do not require substrates to detoxify H2O2, had no effect. Pharmacological inhibition or lentiviral knockdown of Nnt in N27 dopaminergic cells (a) decreased H2O2 catabolism, (b) decreased NADPH and increased NADP(+) levels, and (c) decreased basal, spare, and maximal mitochondrial oxygen consumption rates. Nnt-deficient cells possessed higher levels of oxidized mitochondrial Prx, which rendered them more susceptible to steady-state increases in H2O2 and cell death following exposure to subtoxic levels of paraquat. These data implicate Nnt as the critical link between the metabolic and H2O2 antioxidant function in brain mitochondria and suggests Nnt as a potential therapeutic target to improve the redox balance in conditions of oxidative stress associated with neurodegenerative diseases.	[Lopert, Pamela] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Patel, M (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA.	Manisha.Patel@ucdenver.edu		Lopert, Pamela/0000-0002-6625-7832	National Institutes of Health [RO1NS04748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045748, R01NS086423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1NS04748 (to M. P.).	Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bergmeyer H. U., 1983, METHOD ENZYMAT AN, P118; Bizouarn T, 2000, BBA-BIOENERGETICS, V1457, P211, DOI 10.1016/S0005-2728(00)00103-1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Cox A. G., METHODS ENZYMOL, V474, P51; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Halliwell B., 2007, FREE RADICAL BIO MED, P25; Heiker JT, 2013, OBESITY, V21, P529, DOI 10.1002/oby.20095; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JENNER P, 1992, NEUROLOGY, V42, P2241, DOI 10.1212/WNL.42.12.2241; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; KALHORN TF, 1985, ANAL BIOCHEM, V151, P343, DOI 10.1016/0003-2697(85)90185-X; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; MAVELLI I, 1982, BIOCHEM J, V204, P535, DOI 10.1042/bj2040535; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x; PRASAD KN, 1994, RESTOR NEUROL NEUROS, V7, P13, DOI 10.3233/RNN-1994-7103; RADI R, 1991, J BIOL CHEM, V266, P22028; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; RYDSTROM J, 1972, EUR J BIOCHEM, V31, P496, DOI 10.1111/j.1432-1033.1972.tb02557.x; Rydstrom J, 1979, Methods Enzymol, V55, P261; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tretter L, 2000, J NEUROSCI, V20, P8972; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Yamaguchi R, 2013, ENDOCR J, V60, P855, DOI 10.1507/endocrj.EJ13-0024; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200	60	61	63	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15611	15620		10.1074/jbc.M113.533653	http://dx.doi.org/10.1074/jbc.M113.533653			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722990	hybrid, Green Published			2022-12-25	WOS:000337465400043
J	Shin, M; Bryant, JD; Momb, J; Appling, DR				Shin, Minhye; Bryant, Joshua D.; Momb, Jessica; Appling, Dean R.			Mitochondrial MTHFD2L Is a Dual Redox Cofactor-specific Methylenetetrahydrofolate Dehydrogenase/Methenyltetrahydrofolate Cyclohydrolase Expressed in Both Adult and Embryonic Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Folate Metabolism; Mitochondrial Metabolism; Multifunctional Enzymes; NAD; Neurodevelopment	DEPENDENT 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE; POLYMERASE-CHAIN-REACTION; ONE-CARBON METABOLISM; SACCHAROMYCES-CEREVISIAE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; C-1-TETRAHYDROFOLATE SYNTHASE; C1-TETRAHYDROFOLATE SYNTHASE; RAT-LIVER; CELLS; YEAST	Mammalian mitochondria are able to produce formate from one-carbon donors such as serine, glycine, and sarcosine. This pathway relies on the mitochondrial pool of tetrahydrofolate (THF) and several folate-interconverting enzymes in the mitochondrial matrix. We recently identified MTHFD2L as the enzyme that catalyzes the oxidation of 5,10-methylenetetrahydrofolate (CH2-THF) in adult mammalian mitochondria. We show here that the MTHFD2L enzyme is bifunctional, possessing both CH2-THF dehydrogenase and 5,10-methenyl-THF cyclohydrolase activities. The dehydrogenase activity can use either NAD(+) or NADP(+) but requires both phosphate and Mg2+ when using NAD(+). The NADP(+)-dependent dehydrogenase activity is inhibited by inorganic phosphate. MTHFD2L uses the mono- and polyglutamylated forms of CH2-THF with similar catalytic efficiencies. Expression of the MTHFD2L transcript is low in early mouse embryos but begins to increase at embryonic day 10.5 and remains elevated through birth. In adults, MTHFD2L is expressed in all tissues examined, with the highest levels observed in brain and lung.	[Shin, Minhye; Bryant, Joshua D.; Momb, Jessica; Appling, Dean R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Mol Biosci, Welch Hall A5300, Austin, TX 78712 USA.	dappling@austin.utexas.edu			National Institutes of Health from the Eunice Kennedy Shriver NICHD [F32HD074428]; NIGMS [GM086856]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver NICHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HD074428 (to J. M.) from the Eunice Kennedy Shriver NICHD and GM086856 (to D. R. A.) from NIGMS.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; ALEXIOU M, 1992, DEVELOPMENT, V114, P185; Appling DR, 1997, METHOD ENZYMOL, V281, P178; BARLOWE CK, 1990, BIOCHEMISTRY-US, V29, P7089, DOI 10.1021/bi00482a020; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BLAKLEY RL, 1957, BIOCHEM J, V65, P331, DOI 10.1042/bj0650331; Bolusani S, 2011, J BIOL CHEM, V286, P5166, DOI 10.1074/jbc.M110.196840; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2005, J BIOL CHEM, V280, P34316, DOI 10.1074/jbc.M505210200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; CURTHOYS NP, 1971, J BIOL CHEM, V246, P6942; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Dihazi H, 2001, PROTEIN EXPRES PURIF, V21, P201, DOI 10.1006/prep.2000.1369; ETO I, 1982, ANAL BIOCHEM, V120, P323, DOI 10.1016/0003-2697(82)90353-0; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Jafri MS, 2006, J THEOR BIOL, V242, P801, DOI 10.1016/j.jtbi.2006.05.007; KALLEN RG, 1966, J BIOL CHEM, V241, P5851; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Nijhout HF, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-40; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Pawelek PD, 1998, BIOCHEMISTRY-US, V37, P1109, DOI 10.1021/bi971906t; PELLETIER JN, 1995, BIOCHEMISTRY-US, V34, P12673, DOI 10.1021/bi00039a025; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; SEITHER RL, 1989, J BIOL CHEM, V264, P17016; Sies H., 1982, METABOLIC COMPARTMEN, P205; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Veech R. L., 1987, PYRIDINE NUCLEOTIDE, P79; Wagner W, 2005, BIOCHEMISTRY-US, V44, P13163, DOI 10.1021/bi051038x; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; WEST MG, 1993, J BIOL CHEM, V268, P153; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang X. M., 1993, BIOCHEMISTRY-US, V32, P11118; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	49	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15507	15517		10.1074/jbc.M114.555573	http://dx.doi.org/10.1074/jbc.M114.555573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733394	Green Published, hybrid			2022-12-25	WOS:000337465400033
J	Adams, MK; Belyaeva, OV; Wu, LZ; Kedishvili, NY				Adams, Mark K.; Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.			The Retinaldehyde Reductase Activity of DHRS3 Is Reciprocally Activated by Retinol Dehydrogenase 10 to Control Retinoid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; ACID BIOSYNTHESIS; VITAMIN-A; CELL-LINES; RDH10; METABOLISM; MECHANISM; CLONING; ENZYME; LIVER	The retinoic acid-inducible dehydrogenase reductase 3 (DHRS3) is thought to function as a retinaldehyde reductase that controls the levels of all-trans-retinaldehyde, the immediate precursor for bioactive all-trans-retinoic acid. However, the weak catalytic activity of DHRS3 and the lack of changes in retinaldehyde conversion to retinol and retinoic acid in the cells overexpressing DHRS3 undermine its role as a physiologically important all-transretinaldehyde reductase. This study demonstrates that DHRS3 requires the presence of retinol dehydrogenase 10 (RDH10) to display its full catalytic activity. The RDH10-activated DHRS3 acts as a robust high affinity all-trans-retinaldehyde-specific reductase that effectively converts retinaldehyde back to retinol, decreasing the rate of retinoic acid biosynthesis. In turn, the retinol dehydrogenase activity of RDH10 is reciprocally activated by DHRS3. At E13.5, DHRS3-null embryos have similar to 4-fold lower levels of retinol and retinyl esters, but only slightly elevated levels of retinoic acid. The membrane-associated retinaldehyde reductase and retinol dehydrogenase activities are decreased by similar to 4- and similar to 2-fold, respectively, in Dhrs3(-/-) embryos, and Dhrs3(-/-) mouse embryonic fibroblasts exhibit reduced metabolism of both retinaldehyde and retinol. Neither RDH10 nor DHRS3 has to be itself catalytically active to activate each other. The transcripts encoding DHRS3 and RDH10 are co-localized at least in some tissues during development. The mutually activating interaction between the two related proteins may represent a highly sensitive and conserved mechanism for precise control over the rate of retinoic acid biosynthesis.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, 720 20th St S,Kaul 440B, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	National Institutes of Health [P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, P60 DK079626]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Services provided in this publication through the University of Alabama Transgenic Mouse Facility (RAK) are supported by National Institutes of Health Grants P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, and P60 DK079626. We thank Dr. Hengbin Wang (University of Alabama School of Medicine, Birmingham, AL) for antibodies against the HA tag. We are also very grateful to Dr. Chesnokov for allowing us to use the confocal microscope in his laboratory, and especially to Katarina Akhmetova for excellent technical assistance with confocal microscopy analysis.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Cerignoli F, 2002, CANCER RES, V62, P1196; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hauptmann G, 2001, METHODS, V23, P359, DOI 10.1006/meth.2000.1148; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Nagy A., 2003, MANIPULATING MOUSE E; Napoli J. L., 1998, METHODS MOL BIOL RET, V89; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012	29	63	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14868	14880		10.1074/jbc.M114.552257	http://dx.doi.org/10.1074/jbc.M114.552257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733397	Green Published, hybrid			2022-12-25	WOS:000337248100039
J	Briggs, MA; Kalolella, A; Bruxvoort, K; Wiegand, R; Lopez, G; Festo, C; Lyaruu, P; Kenani, M; Abdulla, S; Goodman, C; Kachur, SP				Briggs, Melissa A.; Kalolella, Admirabilis; Bruxvoort, Katia; Wiegand, Ryan; Lopez, Gerard; Festo, Charles; Lyaruu, Pierre; Kenani, Mitya; Abdulla, Salim; Goodman, Catherine; Kachur, S. Patrick			Prevalence of Malaria Parasitemia and Purchase of Artemisinin-Based Combination Therapies (ACTs) among Drug Shop Clients in Two Regions in Tanzania with ACT Subsidies	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; AFFORDABLE MEDICINES FACILITY; SUB-SAHARAN AFRICA; RURAL TANZANIA; ANTIMALARIALS; QUALITY; IMPACT	Background: Throughout Africa, many people seek care for malaria in private-sector drug shops where diagnostic testing is often unavailable. Recently, subsidized artemisinin-based combination therapies (ACTs), a first-line medication for uncomplicated malaria, were made available in these drug shops in Tanzania. This study assessed the prevalence of malaria among and purchase of ACTs by drug shop clients in the setting of a national ACT subsidy program and sub-national drug shop accreditation program. Method and Findings: A cross-sectional survey of drug shop clients was performed in two regions in Tanzania, one with a government drug shop accreditation program and one without, from March-May, 2012. Drug shops were randomly sampled from non-urban districts. Shop attendants were interviewed about their education, training, and accreditation status. Clients were interviewed about their symptoms and medication purchases, then underwent a limited physical examination and laboratory testing for malaria. Malaria prevalence and predictors of ACT purchase were assessed using univariate analysis and multiple logistic regression. Amongst 777 clients from 73 drug shops, the prevalence of laboratory-confirmed malaria was 12% (95% CI: 6-18%). Less than a third of clients with malaria had purchased ACTs, and less than a quarter of clients who purchased ACTs tested positive for malaria. Clients were more likely to have purchased ACTs if the participant was>5 years old (aOR: 6.6; 95% CI: 3.9-11.0) or the shop attendant had>5 years, experience (aOR: 2.8; 95% CI: 1.2-6.3). Having malaria was only a predictor of ACT purchase in the region with a drug shop accreditation program (aOR: 3.4; 95% CI: 1.5-7.4). Conclusion: Malaria is common amongst persons presenting to drug shops with a complaint of fever. The low proportion of persons with malaria purchasing ACTs, and the high proportion of ACTs going to persons without malaria demonstrates a need to better target who receives ACTs in these drug shops.	[Briggs, Melissa A.; Wiegand, Ryan; Lopez, Gerard; Kachur, S. Patrick] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30333 USA; [Kalolella, Admirabilis; Festo, Charles; Lyaruu, Pierre; Kenani, Mitya; Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Bruxvoort, Katia; Goodman, Catherine] London Sch Hyg & Trop Med, London WC1, England	Centers for Disease Control & Prevention - USA; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine	Briggs, MA (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	MBriggs1@cdc.gov	Kachur, Patrick/ABE-7220-2021	Wiegand, Ryan/0000-0002-9486-1850; Bruxvoort, Katia/0000-0001-8277-2431; Goodman, Catherine/0000-0002-2241-3485	ACT Consortium; Bill & Melinda Gates Foundation	ACT Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was completed under a cooperative agreement between the US Centers for Disease Control and Prevention (CDC) and Ifakara Health Institute (IHI). Additional support was provided by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene & Tropical Medicine (LSHTM). Investigators from the CDC, IHI, and LSHTM were involved in protocol development, data collection, data analysis, and preparation of this manuscript for publication.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albertini A, 2012, TROP MED INT HEALTH, V17, P147, DOI 10.1111/j.1365-3156.2011.02904.x; Arnold F, 2012, INDEPENDENT EVALUATI; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Bruxvoort K, 2013, TROP MED INT HEALTH, V18, P1269, DOI 10.1111/tmi.12168; Chandler CIR, 2011, SOC SCI MED, V72, P937, DOI 10.1016/j.socscimed.2011.01.009; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Festo C, 2011, DETERMINANTS ACCESS; FOSTER S, 1995, J TROP MED HYG, V98, P29; Goodman C, 2004, TROP MED INT HEALTH, V9, P655, DOI 10.1111/j.1365-3156.2004.01245.x; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hansen KS, 2012, HLTH POLICY PLANNING, P1; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Mbonye AK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-131; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; National Bureau of Statistics (NBS) Tanzania Measure DHS, 2012, TANZ HIV AIDS MAL IN; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Program NMC, 2006, NAT GUID DIAGN TREAT; Program NMC, 2010, TANZANIA MALARIA PRO; Rusk A, 2013, MALAR RES TREAT, V2013; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sillo H, ENGAGING PRIVATE SEC; Statistics NBo, 2011, TANZ DEM HLTH SURV 2; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, INT MAN CHILDH ILLN; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization, 2009, MAL CAS MAN OP MAN; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	43	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94074	10.1371/journal.pone.0094074	http://dx.doi.org/10.1371/journal.pone.0094074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6GP	24732258	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000336970400018
J	Dawes, JM; Antunes-Martins, A; Perkins, JR; Paterson, KJ; Sisignano, M; Schmid, R; Rust, W; Hildebrandt, T; Geisslinger, G; Orengo, C; Bennett, DL; McMahon, SB				Dawes, John M.; Antunes-Martins, Ana; Perkins, James R.; Paterson, Kathryn J.; Sisignano, Marco; Schmid, Ramona; Rust, Werner; Hildebrandt, Tobias; Geisslinger, Gerd; Orengo, Christine; Bennett, David L.; McMahon, Stephen B.			Genome-Wide Transcriptional Profiling of Skin and Dorsal Root Ganglia after Ultraviolet-B-Induced Inflammation	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; NEUROPATHIC PAIN; PHYLOGENETIC TREES; GENE-EXPRESSION; SENSORY NEURONS; RNA-SEQ; IN-VIVO; HYPERALGESIA; CHEMOKINE; MODEL	Ultraviolet-B (UVB)-induced inflammation produces a dose-dependent mechanical and thermal hyperalgesia in both humans and rats, most likely via inflammatory mediators acting at the site of injury. Previous work has shown that the gene expression of cytokines and chemokines is positively correlated between species and that these factors can contribute to UVB-induced pain. In order to investigate other potential pain mediators in this model we used RNA-seq to perform genome-wide transcriptional profiling in both human and rat skin at the peak of hyperalgesia. In addition we have also measured transcriptional changes in the L4 and L5 DRG of the rat model. Our data show that UVB irradiation produces a large number of transcriptional changes in the skin: 2186 and 3888 genes are significantly dysregulated in human and rat skin, respectively. The most highly up-regulated genes in human skin feature those encoding cytokines (IL6 and IL24), chemokines (CCL3, CCL20, CXCL1, CXCL2, CXCL3 and CXCL5), the prostanoid synthesising enzyme COX-2 and members of the keratin gene family. Overall there was a strong positive and significant correlation in gene expression between the human and rat (R = 0.8022). In contrast to the skin, only 39 genes were significantly dysregulated in the rat L4 and L5 DRGs, the majority of which had small fold change values. Amongst the most up-regulated genes in DRG were REG3B, CCL2 and VGF. Overall, our data shows that numerous genes were up-regulated in UVB irradiated skin at the peak of hyperalgesia in both human and rats. Many of the top up-regulated genes were cytokines and chemokines, highlighting again their potential as pain mediators. However many other genes were also up-regulated and might play a role in UVB-induced hyperalgesia. In addition, the strong gene expression correlation between species re-emphasises the value of the UVB model as translational tool to study inflammatory pain.	[Dawes, John M.; Bennett, David L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Antunes-Martins, Ana; Paterson, Kathryn J.; McMahon, Stephen B.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Perkins, James R.; Orengo, Christine] UCL, Dept Struct & Mol Biol, London, England; [Sisignano, Marco; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt, Univ Hosp,Zentrum Arzneimittelforsch Entwicklung, D-60054 Frankfurt, Germany; [Schmid, Ramona; Rust, Werner; Hildebrandt, Tobias] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res Germany, Biberach, Germany	University of Oxford; University of London; King's College London; University of London; University College London; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Boehringer Ingelheim	McMahon, SB (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	stephen.mcmahon@kcl.ac.uk	bennett, david/ABG-1184-2020; Perkins, James R/H-8629-2017	Perkins, James R/0000-0003-4108-096X; McMahon, Stephen/0000-0003-4656-5536; Sisignano, Marco/0000-0002-7581-0951	Innovative Medicines Initiative Joint Undertaking [115007]; European Union; EFPIA company	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA company	The research leading to these results is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under Grant agreement 115007, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and EFPIA companies' in-kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angst MS, 2008, PAIN, V139, P15, DOI 10.1016/j.pain.2008.02.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhave G, 2004, J NEUROBIOL, V61, P88, DOI 10.1002/neu.20083; Bishop T, 2007, PAIN, V131, P70, DOI 10.1016/j.pain.2006.12.014; Bishop T, 2010, PAIN, V150, P141, DOI 10.1016/j.pain.2010.04.018; Bishop T, 2009, EUR J PAIN, V13, P524, DOI 10.1016/j.ejpain.2008.06.006; Boettger MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3079; Camu F, 2003, DRUGS, V63, P1, DOI 10.2165/00003495-200363001-00002; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Crichton B, 2002, CURR MED RES OPIN, V18, P92, DOI 10.1185/030079902125000345; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, BRIT J PHARMACOL, V154, P460, DOI 10.1038/bjp.2008.94; Dale CS, 2009, FUND CLIN PHARMACOL, V23, P427, DOI 10.1111/j.1472-8206.2009.00686.x; Dawes JM, 2013, NEUROSCI LETT, V557, P1, DOI 10.1016/j.neulet.2013.10.004; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gambichler T, 2006, PHOTOCHEM PHOTOBIOL, V82, P1103, DOI 10.1562/2005-12-21-RA-757; Gould HJ, 2000, BRAIN RES, V854, P19, DOI 10.1016/S0006-8993(99)02216-7; Gustorff G, 2004, ANESTH ANALG, V98, P401, DOI [10.1213/01/ANE.0000095150.76735.5D, 10.1213/01.ANE.0000095150.76735.5D]; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Harrison GI, 2004, J INVEST DERMATOL, V122, P183, DOI 10.1046/j.0022-202X.2003.22119.x; Hoffmann RT, 1999, EUR J PAIN-LONDON, V3, P131, DOI 10.1053/eujp.1998.0106; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Kienzler JL, 2005, SKIN PHARMACOL PHYS, V18, P144, DOI 10.1159/000084912; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moss A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-62; Ng SC, 2010, CURR OPIN GASTROEN, V26, P611, DOI 10.1097/MOG.0b013e32833e91eb; Okuse K, 1997, MOL CELL NEUROSCI, V10, P196, DOI 10.1006/mcne.1997.0657; Paccola CC, 2008, PEPTIDES, V29, P1806, DOI 10.1016/j.peptides.2008.05.023; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Perkins JR, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-7; Perkins JR, 2013, PAIN, V154, DOI 10.1016/j.pain.2013.09.003; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Perkins JR, 2013, PAIN; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; Rukwied R, 2008, EUR J PAIN, V12, P242, DOI 10.1016/j.ejpain.2007.05.007; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Svensson CI, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3138; Sycha T, 2003, BRIT J CLIN PHARMACO, V56, P165, DOI 10.1046/j.0306-5251.2003.01869.x; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang QW, 2009, J INVEST DERMATOL, V129, P167, DOI 10.1038/jid.2008.181	64	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93338	10.1371/journal.pone.0093338	http://dx.doi.org/10.1371/journal.pone.0093338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732968	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400007
J	Khan, D; Khan, HU; Khan, F; Khan, S; Badshah, S; Khan, AS; Samad, A; Ali, F; Khan, I; Muhammad, N				Khan, Dilfaraz; Khan, Hidayat Ullah; Khan, Farmanullah; Khan, Shafiullah; Badshah, Syed; Khan, Abdul Samad; Samad, Abdul; Ali, Farman; Khan, Ihsanullah; Muhammad, Nawshad			New Cholinesterase Inhibitory Constituents from Lonicera quinquelocularis	PLOS ONE			English	Article							JAPONICA THUNB; HERBAL MIXTURE; ACETYLCHOLINESTERASE; ANTIOXIDANT; MORROWII; IRIDOIDS; GRAY; ACID	A phytochemical investigation on the ethyl acetate soluble fraction of Lonicera quinquelocularis (whole plant) led to the first time isolation of one new phthalate; bis(7-acetoxy-2-ethyl-5-methylheptyl) phthalate (3) and two new benzoates; neopentyl-4-ethoxy-3, 5-bis(3-methyl-2-butenyl benzoate (4) and neopentyl-4-hydroxy-3, 5-bis(3-methyl-2-butenyl benzoate (5) along with two known compounds bis (2-ethylhexyl phthalate (1) and dioctyl phthalate (2). Their structures were established on the basis of spectroscopic analysis and by comparison with available data in the literature. All the compounds (1-5) were tested for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities in dose dependent manner. The IC50 (50% inhibitory effect) values of compounds 3 and 5 against AChE were 1.65 and 3.43 mu M while the values obtained against BChE were 5.98 and 9.84 mu M respectively. Compounds 2 and 4 showed weak inhibition profile.	[Khan, Dilfaraz; Khan, Shafiullah; Badshah, Syed; Samad, Abdul] Gomal Univ, Dept Chem, Dera Ismail Khan, Khyber Pakhtunk, Pakistan; [Khan, Hidayat Ullah] Univ Sci & Technol, Dept Biotechnol, Bannu, Khyber Pakhtunk, Pakistan; [Khan, Farmanullah] Univ Sci & Technol, Dept Chem, Bannu, Khyber Pakhtunk, Pakistan; [Khan, Abdul Samad; Muhammad, Nawshad] COMSATS Inst Informat Technol, Interdisciplinary Res Ctr Biomed Mat, Lahore, Pakistan; [Ali, Farman] Shaheed BBB Univ, Dept Chem, Dir, Khyber Pakhtunk, Pakistan; [Khan, Ihsanullah] Univ Teknol PETRONAS, Ctr Ion Liquid, Dept Fundamental & Appl Sci, Perak, Malaysia	Gomal University; University of Science & Technology Bannu; University of Science & Technology Bannu; COMSATS University Islamabad (CUI); Universiti Teknologi Petronas	Khan, D (corresponding author), Gomal Univ, Dept Chem, Dera Ismail Khan, Khyber Pakhtunk, Pakistan.	faraz_wazir2002@yahoo.com; nawshadchemist@yahoo.com	Muhammad, Nawshad/J-7760-2017; Khan, Ilyas/C-8770-2019; Khan, Abdul/D-9215-2017	Muhammad, Nawshad/0000-0001-6453-0658; Khan, Ilyas/0000-0002-2056-9371; Khan, Abdul/0000-0002-2165-800X	Higher Education Commission, Pakistan under IRSIP Fellowship Program at University of Nottingham, UK	Higher Education Commission, Pakistan under IRSIP Fellowship Program at University of Nottingham, UK	The author is thankful to Higher Education Commission, Pakistan for financial support under IRSIP Fellowship Program at University of Nottingham, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah P, 1972, FLORA PAKISTAN, V1, P694; Akhter R, 1986, ENCY ICONES MAPS KEY, P33; Ali I, 2013, J CHEM SOC PAKISTAN, V35, P139; BAILLEUL F, 1981, J NAT PROD, V44, P573, DOI 10.1021/np50017a011; Basaran A., 1988, Fitoterapia, V59, P389; CALIS I, 1984, HELV CHIM ACTA, V67, P160, DOI 10.1002/hlca.19840670119; CHANG CW, 1995, ANTIVIR RES, V27, P367, DOI 10.1016/0166-3542(95)00020-M; CHANG WC, 1992, PROSTAG LEUKOTR ESS, V45, P307, DOI 10.1016/0952-3278(92)90088-Z; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HOUGHTON PJ, 1993, PHYTOTHER RES, V7, P384, DOI 10.1002/ptr.2650070513; Kahkonen MP, 2001, J AGR FOOD CHEM, V49, P4076, DOI 10.1021/jf010152t; Kumar S, 2000, PHYTOCHEMISTRY, V53, P499, DOI 10.1016/S0031-9422(99)00426-4; LIU YP, 1992, ACTA PHARM SINIC, V13, P209; Mabberley D. J., 1997, PLANT BOOK PORTABLE; MACHIDA K, 1995, PHYTOCHEMISTRY, V39, P111, DOI 10.1016/0031-9422(94)00853-L; Masuoka C, 1997, FOOD SCI TECHNOL INT, V30, P285; Nair JJ, 2012, S AFR J BOT, V80, P21, DOI 10.1016/j.sajb.2012.01.008; PeredaMiranda R, 1997, J NAT PROD, V60, P282, DOI 10.1021/np960601x; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Rocha Joao B. T., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P431; Shi JZ, 1999, CHINA J CHINA MAT ME, V24, P363; SOUZU I, 1970, TETRAHEDRON LETT, P191; SOUZU I, 1969, TETRAHEDRON LETT, P2725; Sullivan VS, 1999, LANGMUIR, V15, P4664, DOI 10.1021/la9813735; Sultan MZ., 2010, J SCI RES, V2, P191; Wang J, 2009, FOOD CHEM TOXICOL, V47, P1716, DOI 10.1016/j.fct.2009.04.034; Yip ECH, 2006, CELL BIOL TOXICOL, V22, P293, DOI 10.1007/s10565-006-0082-4; Yoo HJ, 2008, J PHARM PHARMACOL, V60, P779, DOI 10.1211/jpp.60.6.0014; Zhang X, 2004, CNS NEUROL DISORD-DR, V3, P137, DOI 10.2174/1568007043482499	29	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94952	10.1371/journal.pone.0094952	http://dx.doi.org/10.1371/journal.pone.0094952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733024	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400135
J	Sanchez, G; Varaschin, RK; Bueler, H; Marcogliese, PC; Park, DS; Trudeau, LE				Sanchez, Gonzalo; Varaschin, Rafael K.; Bueeler, Hansruedi; Marcogliese, Paul C.; Park, David S.; Trudeau, Louis-Eric			Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; NEURONAL VULNERABILITY; DJ-1-DEFICIENT MICE; SYNAPTIC PLASTICITY; DISEASE; DEFICITS; BEHAVIOR; NEUROTRANSMISSION; COMPENSATION; INACTIVATION	Parkinson's disease (PD) is one of the most prevalent neurodegenerative brain diseases; it is accompanied by extensive loss of dopamine (DA) neurons of the substantia nigra that project to the putamen, leading to impaired motor functions. Several genes have been associated with hereditary forms of the disease and transgenic mice have been developed by a number of groups to produce animal models of PD and to explore the basic functions of these genes. Surprisingly, most of the various mouse lines generated such as Parkin KO, Pink1 KO, DJ-1 KO and LRRK2 transgenic have been reported to lack degeneration of nigral DA neuron, one of the hallmarks of PD. However, modest impairments of motor behavior have been reported, suggesting the possibility that the models recapitulate at least some of the early stages of PD, including early dysfunction of DA axon terminals. To further evaluate this possibility, here we provide for the first time a systematic comparison of DA release in four different mouse lines, examined at a young age range, prior to potential age-dependent compensations. Using fast scan cyclic voltammetry in striatal sections prepared from young, 6-8 weeks old mice, we examined sub-second DA overflow evoked by single pulses and action potential trains. Unexpectedly, none of the models displayed any dysfunction of DA overflow or reuptake. These results, compatible with the lack of DA neuron loss in these models, suggest that molecular dysfunctions caused by the absence or mutation of these individual genes are not sufficient to perturb the function and survival of mouse DA neurons.	[Sanchez, Gonzalo; Varaschin, Rafael K.; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Sanchez, Gonzalo; Varaschin, Rafael K.; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Neurosci, Montreal, PQ H3C 3J7, Canada; [Bueeler, Hansruedi] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Marcogliese, Paul C.; Park, David S.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada	Universite de Montreal; Universite de Montreal; Harbin Institute of Technology; University of Ottawa	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Cent Nervous Syst Res Grp, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Büeler, Hansruedi/J-6965-2017; Marcogliese, Paul/GQY-7404-2022; Trudeau, Louis-Eric/AAE-4782-2020; Sanchez, Gonzalo/AAB-4566-2019	Büeler, Hansruedi/0000-0002-4892-7177; Trudeau, Louis-Eric/0000-0003-4684-1377; Sanchez, Gonzalo/0000-0003-4415-1866; Park, David/0000-0002-4490-3784; Marcogliese, Paul/0000-0002-8011-7852	Michael J. Fox Foundation for Parkinson's Research; Brain Canada Foundation; Krembil Foundation; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil	Michael J. Fox Foundation for Parkinson's Research; Brain Canada Foundation; Krembil Foundation; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a Rapid Response award from the Michael J. Fox Foundation for Parkinson's Research to L.-E. T. as well as by a grant to L.-E. T. and D. S. P. from the Brain Canada Foundation and the Krembil Foundation. R. K. V. was supported by a Science without Borders fellowship from the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Hornykiewicz O, 2008, NEURODEGENER DIS, V5, P114, DOI 10.1159/000113678; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Martel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020402; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oyama G, 2010, BRAIN RES, V1352, P214, DOI 10.1016/j.brainres.2010.06.065; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Platt NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036397; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; Watson MB, 2012, EXP NEUROL, V237, P318, DOI 10.1016/j.expneurol.2012.06.025; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001	51	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94826	10.1371/journal.pone.0094826	http://dx.doi.org/10.1371/journal.pone.0094826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733019	Green Published, gold			2022-12-25	WOS:000336970400117
J	Awad, A; Yassine, H; Barrier, M; Vorng, H; Marquillies, P; Tsicopoulos, A; Duez, C				Awad, Ali; Yassine, Hanane; Barrier, Mathieu; Vorng, Han; Marquillies, Philippe; Tsicopoulos, Anne; Duez, Catherine			Natural Killer Cells Induce Eosinophil Activation and Apoptosis	PLOS ONE			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; MEDIATED CYTOTOXICITY; DIFFERENTIAL ROLE; PROTEIN-KINASE; DC MATURATION; MOLECULE; RECEPTOR; ALLERGEN; LIGANDS	Eosinophils are potent inflammatory cells with numerous immune functions, including antigen presentation and exacerbation of inflammatory responses through their capacity to release a range of largely preformed cytokines and lipid mediators. Thus, timely regulation of eosinophil activation and apoptosis is crucial to develop beneficial immune response and to avoid tissue damage and induce resolution of inflammation. Natural Killer (NK) cells have been reported to influence innate and adaptive immune responses by multiple mechanisms including cytotoxicity against other immune cells. In this study, we analyzed the effect of the interaction between NK cells and eosinophils. Co-culture experiments revealed that human NK cells could trigger autologous eosinophil activation, as shown by up-regulation of CD69 and down-regulation of CD62L, as well as degranulation, evidenced by increased CD63 surface expression, secretion of eosinophil cationic protein (ECP) and eosinophil derived neurotoxin (EDN). Moreover, NK cells significantly and dose dependently increased eosinophil apoptosis as shown by annexin V and propidium iodide (PI) staining. Direct contact was necessary for eosinophil degranulation and apoptosis. Increased expression of phosphorylated extracellular signal-regulated kinase (ERK) in cocultured eosinophils and inhibition of eosinophil CD63 expression by pharmacologic inhibitors suggest that MAPK and PI3K pathways are involved in NK cell-induced eosinophil degranulation. Finally, we showed that NK cells increased reactive oxygen species (ROS) expression by eosinophils in co-culture and that mitochondrial inhibitors (rotenone and antimycin) partially diminished NK cell-induced eosinophil apoptosis, suggesting the implication of mitochondrial ROS in NK cell-induced eosinophil apoptosis. Pan-caspase inhibitor (ZVAD-FMK) only slightly decreased eosinophil apoptosis in coculture. Altogether, our results suggest that NK cells regulate eosinophil functions by inducing their activation and their apoptosis.	[Awad, Ali; Yassine, Hanane; Barrier, Mathieu; Vorng, Han; Marquillies, Philippe; Tsicopoulos, Anne; Duez, Catherine] INSERM, F-59045 Lille, France; [Awad, Ali; Yassine, Hanane; Barrier, Mathieu; Vorng, Han; Marquillies, Philippe; Tsicopoulos, Anne; Duez, Catherine] Inst Pasteur, Ctr Infect & Immun Lille, Lille, France; [Awad, Ali; Yassine, Hanane; Barrier, Mathieu; Vorng, Han; Marquillies, Philippe; Tsicopoulos, Anne; Duez, Catherine] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Awad, Ali; Yassine, Hanane; Barrier, Mathieu; Vorng, Han; Marquillies, Philippe; Tsicopoulos, Anne; Duez, Catherine] Univ Lille Nord France, Lille, France; [Tsicopoulos, Anne] Clin Malad Resp, Lille, France; [Tsicopoulos, Anne] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Duez, C (corresponding author), INSERM, F-59045 Lille, France.	catherine.duez@pasteur-lille.fr	Duez, Catherine/B-8425-2018; Tsicopoulos, Anne/C-2260-2019	Duez, Catherine/0000-0002-2327-1095; Tsicopoulos, Anne/0000-0002-1579-2763	INSERM; UCB Institute of Allergy; Societe Francaise d'Allergologie; Ministere de l'Education et de la Recherche; Region Nord-pas-de Calais; Agence Nationale de la Recherche SEST	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UCB Institute of Allergy; Societe Francaise d'Allergologie; Ministere de l'Education et de la Recherche; Region Nord-pas-de Calais(Region Hauts-de-FranceEuropean Commission); Agence Nationale de la Recherche SEST(French National Research Agency (ANR))	This work was supported by INSERM, UCB Institute of Allergy and Societe Francaise d'Allergologie. AA was supported by a grant from Ministere de l'Education et de la Recherche. MB was supported by Region Nord-pas-de Calais and Agence Nationale de la Recherche SEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; ARASE H, 1995, J EXP MED, V181, P1235, DOI 10.1084/jem.181.3.1235; Bachelet I, 2006, J BIOL CHEM, V281, P27190, DOI 10.1074/jbc.M602359200; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bhatnagar N, 2010, BLOOD, V116, P1308, DOI 10.1182/blood-2010-01-264903; Blanca IR, 2001, J IMMUNOL, V167, P6132, DOI 10.4049/jimmunol.167.11.6132; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carlson M, 2011, APMIS, V119, P119, DOI 10.1111/j.1600-0463.2010.02701.x; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; El-Shazly AE, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/373589; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; Goodwin W, 2010, J ORTHOP RES, V28, P1057, DOI 10.1002/jor.21091; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Gumbleton M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00047; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Kashii Y, 1999, J IMMUNOL, V163, P5358; Kataoka T, 1996, J IMMUNOL, V156, P3678; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Kumar D, 2009, J IMMUNOL, V182, P1011, DOI 10.4049/jimmunol.182.2.1011; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Mahmudi-Azer S, 2002, BLOOD, V99, P4039, DOI 10.1182/blood.V99.11.4039; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Munitz A, 2006, J IMMUNOL, V177, P77, DOI 10.4049/jimmunol.177.1.77; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Ple C, 2010, SCAND J IMMUNOL, V72, P118, DOI 10.1111/j.1365-3083.2010.02419.x; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Semino C, 2007, J LEUKOCYTE BIOL, V81, P92, DOI 10.1189/jlb.0306172; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Thoren FB, 2012, J IMMUNOL, V188, P1668, DOI 10.4049/jimmunol.1102002; Trotta R, 2000, J IMMUNOL, V165, P1782, DOI 10.4049/jimmunol.165.4.1782; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vujanovic NL, 1996, J IMMUNOL, V157, P1117; Wedi B, 1997, J ALLERGY CLIN IMMUN, V100, P536, DOI 10.1016/S0091-6749(97)70147-7; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	50	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94492	10.1371/journal.pone.0094492	http://dx.doi.org/10.1371/journal.pone.0094492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727794	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200081
J	Soldatini, C; Albores-Barajas, YV; Massa, B; Gimenez, O				Soldatini, Cecilia; Albores-Barajas, Yuri Vladimir; Massa, Bruno; Gimenez, Olivier			Climate Driven Life Histories: The Case of the Mediterranean Storm Petrel	PLOS ONE			English	Article							HYDROBATES-PELAGICUS; SANDEEL ABUNDANCE; BOTTOM-UP; SEABIRDS; SURVIVAL; IMPACT; TESTS; FISH	Seabirds are affected by changes in the marine ecosystem. The influence of climatic factors on marine food webs can be reflected in long-term seabird population changes. We modelled the survival and recruitment of the Mediterranean storm petrel (Hydrobates pelagicus melitensis) using a 21-year mark-recapture dataset involving almost 5000 birds. We demonstrated a strong influence of prebreeding climatic conditions on recruitment age and of rainfall and breeding period conditions on juvenile survival. The results suggest that the juvenile survival rate of the Mediterranean subspecies may not be negatively affected by the predicted features of climate change, i.e., warmer summers and lower rainfall. Based on considerations of winter conditions in different parts of the Mediterranean, we were able to draw inferences about the wintering areas of the species for the first time.	[Soldatini, Cecilia; Albores-Barajas, Yuri Vladimir] AC, Grp Ecol & Conservac Islas, Ensenada, Baja California, Mexico; [Massa, Bruno] Univ Palermo, Dept Agr & Forest Sci, Palermo, Italy; [Gimenez, Olivier] CEFE, UMR5175, Montpellier, France	University of Palermo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Soldatini, C (corresponding author), AC, Grp Ecol & Conservac Islas, Ensenada, Baja California, Mexico.	cecilsol@gmail.com	Albores-Barajas, Yuri V/C-5042-2009; Soldatini, Cecilia/F-2950-2011; Gimenez, Olivier/G-4281-2010	Albores-Barajas, Yuri V/0000-0002-9255-4865; Soldatini, Cecilia/0000-0002-8112-3162; Gimenez, Olivier/0000-0001-7001-5142	Assessorato Regionale Agricoltura e Foreste	Assessorato Regionale Agricoltura e Foreste	This project was funded by the Assessorato Regionale Agricoltura e Foreste to the Bird Ringing Unit of the University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Albores-Barajas YV, 2011, BIRD STUDY, V58, P208, DOI 10.1080/00063657.2011.560244; Albores-Barajas YV, 2010, ARDEOLA, V57, P333; Albores-Barajas Yuri V., 2012, Avocetta, V36, P95; Albores-Barajas YV, 2012, MERILL, V36, P95; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Blade I, 2012, CLIM DYNAM, V39, P709, DOI 10.1007/s00382-011-1195-x; Blight LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022027; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cagnon C, 2004, MAR BIOL, V145, P1257, DOI 10.1007/s00227-004-1407-6; Choquet R, 2009, MODELLING DEMOGRAPHI; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Cutitta A, 2006, FLUTTUAZIONI INTERAN, P537; Daunt F, 2007, BIOL LETTERS, V3, P371, DOI 10.1098/rsbl.2007.0157; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Frederiksen M, 2007, MAR ECOL PROG SER, V337, P279, DOI 10.3354/meps337279; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Gauthier G, 2012, J ORNITHOL, V152, pS457, DOI 10.1007/s10336-010-0541-9; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hemery G., 1985, Annales du C.R.O.P.(Centre Recherches Ornithologiques Provence), P63; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; Lalanne Yann, 2001, Alauda, V69, P475; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Libois E, 2012, BIOL CONSERV, V155, P39, DOI 10.1016/j.biocon.2012.05.020; Lo Valvo F., 2000, Ringing and Migration, V20, P125; Mante A, 2012, MEDITERRANEAN STORM; Massetti L, 2004, IDENTIFICATION ANAL; Patti B., 2004, Chemistry and Ecology, V20, P365; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Renault L., 2012, J GEOPHYS RES OCEANS, V117; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sabates A, 2006, GLOBAL CHANGE BIOL, V12, P2209, DOI 10.1111/j.1365-2486.2006.01246.x; Sanz-Aguilar A, 2009, ECOGRAPHY, V32, P637, DOI 10.1111/j.1600-0587.2009.05596.x; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Thompson DR, 1998, SCI TOTAL ENVIRON, V213, P299, DOI 10.1016/S0048-9697(98)00103-X; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Watanuki Y, 2012, MAR ECOL PROG SER, V454, P183, DOI 10.3354/meps09627; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wolf SG, 2009, ECOLOGY, V90, P742, DOI 10.1890/07-1267.1	50	14	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94526	10.1371/journal.pone.0094526	http://dx.doi.org/10.1371/journal.pone.0094526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728099	Green Published, gold			2022-12-25	WOS:000336736200089
J	Zhao, WT; Cai, BW; Qi, YW; Liu, SF; Hong, LX; Lu, MK; Chen, X; Qiu, CH; Peng, WF; Li, J; Su, XZ				Zhao, Wenting; Cai, Baowei; Qi, Yanwei; Liu, Shengfa; Hong, Lingxian; Lu, Mingke; Chen, Xin; Qiu, Chunhui; Peng, Wenfeng; Li, Jian; Su, Xin-zhuan			Multi-Strain Infections and 'Relapse' of Leucocytozoon sabrazesi Gametocytes in Domestic Chickens in Southern China	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; MIXED INFECTIONS; PLASMODIUM-VIVAX; PREVALENCE; BIRDS; QUANTIFICATION; DIVERSITY; FOREST; OWLS	Leucocytozoon parasites infect many species of avian hosts, including domestic chicken, and can inflict heavy economic loss to he poultry industry. Although the prevalence and distribution of two Leucocytozoon species (L. sabrazesi and L. caulleryi) have been reported in China previously, there are many questions related to the parasite infection that remain unanswered, including population diversity and transmission dynamics in domestic chickens. Here we surveyed chicken blood samples from even sites in four provinces of China to identify Leucocytozoon infection, characterized Parasite diversity within individual infected hosts and between sampling sites, and investigated the dynamics of gametocytemia in chickens over time. We found high infection rates in three of the seven sites. Clustering parasite sequences of the mitochondrial cytochrome oxidase III (coxIII) and cytochrome b (cytb) genes showed lack of grouping according to geographic origins and individual hosts carrying large numbers of L. sabrazesi strains Monitoring gametocytemia in blood samples from infected showed 'relapse' or persistence of low-level gametocytemia for 4-5 months, which could be explored as sting drugs against liver stages of Apicomplexan parasites. This study provides important information on population diversity and transmission dynamics of L. sabrazesi and for disease control.	[Zhao, Wenting; Cai, Baowei; Qi, Yanwei; Liu, Shengfa; Hong, Lingxian; Lu, Mingke; Chen, Xin; Peng, Wenfeng; Li, Jian; Su, Xin-zhuan] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Qi, Yanwei; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Qiu, Chunhui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fujian Agriculture & Forestry University	Li, J (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	jianli_204@xmu.edu.cn; xsu@niaid.nih.gov		Su, Xinzhuan/0000-0003-3246-3248	National Science Foundation of China [81201324, 81271858]; Project 111 of the State Bureau of Foreign Experts; Ministry of Education of China [B06016]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project 111 of the State Bureau of Foreign Experts; Ministry of Education of China(Ministry of Education, China); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Science Foundation of China #81201324 and #81271858, by Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China (B06016), and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RA, 1987, J PROTOZOOL, V34, P363, DOI 10.1111/j.1550-7408.1987.tb03192.x; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P37; Argilla LS, 2013, PARASITOLOGY, V140, P672, DOI 10.1017/S0031182012002089; BENNETT GF, 1975, J PARASITOL, V61, P1091, DOI 10.2307/3279382; Bunbury N, 2007, PARASITOLOGY, V134, P797, DOI 10.1017/S0031182006002149; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Chen X, 1995, CHINA ANI HLTH INSPE, V12, P8; Dezfoulian O, 2013, IRAN J PARASITOL, V8, P171; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HERMAN C M, 1975, Journal of Wildlife Diseases, V11, P404; HONG L, 1990, Acta Zoologica Sinica, V36, P123; Hunter DB, 1997, J WILDLIFE DIS, V33, P486, DOI 10.7589/0090-3558-33.3.486; Imura T, 2012, VET PARASITOL, V183, P244, DOI 10.1016/j.vetpar.2011.07.027; Ishak HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002304; Liu SF, 2008, AM J TROP MED HYG, V79, P178, DOI 10.4269/ajtmh.2008.79.178; Liu W, 1995, CHIN J VET SCI TECHN, V25, P40; MALEY GJM, 1977, CAN J ZOOL, V55, P355, DOI 10.1139/z77-048; Nakamura K, 2001, J PARASITOL, V87, P1202, DOI 10.1645/0022-3395(2001)087[1202:POLCFS]2.0.CO;2; Peirce MA, 2005, VET REC, V157, DOI 10.1136/vr.157.25.819-a; Synek P, 2013, PARASITOL RES, V112, P1667, DOI 10.1007/s00436-013-3323-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valkiunas G, 2005, AVIN MALARIA PARASIT; Wacker MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-180; Weng Z, 1998, FUJIAN J ANI HUSB VE, V2, P10; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	26	6	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94877	10.1371/journal.pone.0094877	http://dx.doi.org/10.1371/journal.pone.0094877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728499	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200137
J	Naqvi, T; Warden, AC; French, N; Sugrue, E; Carr, PD; Jackson, CJ; Scott, C				Naqvi, Tatheer; Warden, Andrew C.; French, Nigel; Sugrue, Elena; Carr, Paul D.; Jackson, Colin J.; Scott, Colin			A 5000-Fold Increase in the Specificity of a Bacterial Phosphotriesterase for Malathion through Combinatorial Active Site Mutagenesis	PLOS ONE			English	Article							ORGANOPHOSPHORUS HYDROLASE; PSEUDOMONAS-DIMINUTA; DIRECTED EVOLUTION; NERVE AGENTS; HYDROLYSIS; MECHANISM; ENZYME; IDENTIFICATION; DEGRADATION; MANAGEMENT	Phosphotriesterases (PTEs) have been isolated from a range of bacterial species, including Agrobcaterium radiobacter (PTEAr), and are efficient enzymes with broad substrate ranges. The turnover rate of PTEAr for the common organophosphorous insecticide malathion is lower than expected based on its physical properties; principally the pk(a) of its leaving group. In this study, we rationalise the turnover rate of PTEAr for malathion using computational docking of the substrate into a high resolution crystal structure of the enzyme, suggesting that malathion is too large for the PTEAr binding pocket. Protein engineering through combinatorial active site saturation testing (CASTing) was then used to increase the rate of malathion turnover. Variants from a CASTing library in which Ser308 and Tyr309 were mutated yielded variants with increased activity towards malathion. The most active PTEAr variant carried Ser308Leu and Tyr309Ala substitutions, which resulted in a ca. 5000-fold increase in k(cat)/K-M for malathion. X-ray crystal structures for the PTEAr Ser308Leu\Tyr309Ala variant demonstrate that the access to the binding pocket was enhanced by the replacement of the bulky Tyr309 residue with the smaller alanine residue.	[Naqvi, Tatheer] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan; [Naqvi, Tatheer; Warden, Andrew C.; French, Nigel; Scott, Colin] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Sugrue, Elena; Carr, Paul D.; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	COMSATS University Islamabad (CUI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Scott, C (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	colin.scott@csiro.au	Scott, Colin/A-4682-2009; Naqvi, Tatheer Alam/GSO-2098-2022; French, Nigel/B-5501-2011; Alam, Tatheer/I-5443-2019; Warden, Andrew C/C-1484-2008; Jackson, Colin J/C-1500-2008	Scott, Colin/0000-0001-6110-6982; Naqvi, Tatheer Alam/0000-0003-4538-6317; Alam, Tatheer/0000-0003-4538-6317; Warden, Andrew C/0000-0003-2683-9798; Jackson, Colin J/0000-0001-6150-3822; Sugrue, Elena/0000-0001-5014-9522	Australian Department of Industry Endeavour Fellowship	Australian Department of Industry Endeavour Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science)	TN was supported by an Australian Department of Industry Endeavour Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert SD, 2004, BIOCHEMISTRY-US, V43, P5707, DOI 10.1021/bi0497805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird SB, 2008, TOXICOLOGY, V247, P88, DOI 10.1016/j.tox.2008.02.005; Bonner MR, 2007, AM J EPIDEMIOL, V166, P1023, DOI 10.1093/aje/kwm182; CALDWELL SR, 1991, BIOCHEMISTRY-US, V30, P7438, DOI 10.1021/bi00244a010; Cho CMH, 2002, APPL ENVIRON MICROB, V68, P2026, DOI 10.1128/AEM.68.4.2026-2030.2002; Cho CMH, 2004, APPL ENVIRON MICROB, V70, P4681, DOI 10.1128/AEM.70.8.4681-4685.2004; Dawson RM, 2008, J HAZARD MATER, V157, P308, DOI 10.1016/j.jhazmat.2007.12.099; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Edwards JW, 2007, ENVIRON RES, V103, P38, DOI 10.1016/j.envres.2006.06.001; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hilal SH, 1995, QUANT STRUCT-ACT REL, V14, P348, DOI 10.1002/qsar.19950140405; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Jackson C, 2005, BBA-PROTEINS PROTEOM, V1752, P56, DOI 10.1016/j.bbapap.2005.06.008; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; Jackson CJ, 2005, ORG BIOMOL CHEM, V3, P4343, DOI 10.1039/b512399b; Jackson CJ, 2008, J MOL BIOL, V375, P1189, DOI 10.1016/j.jmb.2007.10.061; Jackson CJ, 2006, BIOCHEM J, V397, P501, DOI 10.1042/BJ20060276; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Jackson CJ, 2010, BIOCHEM PHARMACOL, V80, P1079, DOI 10.1016/j.bcp.2010.06.008; Jackson CJ, 2009, APPL ENVIRON MICROB, V75, P5153, DOI 10.1128/AEM.00629-09; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paudyal BP, 2008, J NEPAL MED ASSOC, V47, P251; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Schleier JJ, 2012, SCI TOTAL ENVIRON, V438, P72, DOI 10.1016/j.scitotenv.2012.07.059; Scott C, 2011, ACS S SERIES; Scott C, 2008, INDIAN J MICROBIOL, V48, P65, DOI 10.1007/s12088-008-0007-4; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Watkins LM, 1997, J BIOL CHEM, V272, P25596, DOI 10.1074/jbc.272.41.25596; Weston DP, 2009, ENVIRON SCI TECHNOL, V43, P5514, DOI 10.1021/es900434z; Wille T, 2012, BIOCATALYSIS BIOTRAN, V30; Yang H, 2003, PROTEIN ENG, V16, P135, DOI 10.1093/proeng/gzg013	37	28	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94177	10.1371/journal.pone.0094177	http://dx.doi.org/10.1371/journal.pone.0094177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721933	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000336909100042
J	Nigmatullin, RR; Osokin, SI; Baleanu, D; Al-Amri, S; Azam, A; Memic, A				Nigmatullin, Raoul R.; Osokin, Sergey I.; Baleanu, Dumitru; Al-Amri, Sawsan; Azam, Ameer; Memic, Adnan			The First Observation of Memory Effects in the InfraRed (FT-IR) Measurements: Do Successive Measurements Remember Each Other?	PLOS ONE			English	Article							OXIDE THIN-FILMS; FIELD-EMISSION; CUO NANOPARTICLES; CUPROUS-OXIDE; TRANSITION	Over the past couple of decades there have been major advances in the field of nanoscience and nanotechnology. Many applications have sprouted from these fields of research. It is essential, given the scale of the materials, to attain accurate, valid and reproducible measurements. Material properties have shown to be a function of their size and composition. Physiochemical properties of the nanomaterials can significantly alter material behavior compared to bulk counterparts. For example, metal oxide nanoparticles have found broad applications ranging from photo-catalysis to antibacterial agents. In our study, we synthesized CuO nanoparticles using well established sol-gel based methods with varying levels of Ni doping. However, upon analysis of measured infrared data, we discovered the presence of quasi-periodic (QP) processes. Such processes have previously been reported to be tightly associated with measurement memory effects. We were able to detect the desired QP process in these measurements from three highly accurate repetitive experiments performed on each Ni (1-7%) doped CuO sample. In other words, successive measurements performed in a rather short period of time remember each other at least inside a group of neighboring measurements.	[Nigmatullin, Raoul R.; Osokin, Sergey I.] Kazan Fed Univ, Dept Theoret Phys, Kazan, Russia; [Baleanu, Dumitru] King Abdulaziz Univ, Chem & Mat Engn Dept, Jeddah 21413, Saudi Arabia; [Baleanu, Dumitru] Cankaya Univ, Dept Math & Comp Sci, Ankara, Turkey; [Baleanu, Dumitru] Inst Space Sci, Magurele, Romania; [Al-Amri, Sawsan; Azam, Ameer; Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21413, Saudi Arabia; [Al-Amri, Sawsan] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	Kazan Federal University; King Abdulaziz University; Cankaya University; Institute of Space Science; King Abdulaziz University; King Abdulaziz University	Nigmatullin, RR (corresponding author), Kazan Fed Univ, Dept Theoret Phys, Kazan, Russia.	renigmat@gmail.com; memic@mit.edu	Baleanu, Dumitru/B-9936-2012; Nigmatullin, Raoul/AAO-5504-2020; Memić, Adnan/I-6138-2013; Azam, Ameer/C-3346-2011	Baleanu, Dumitru/0000-0002-0286-7244; Nigmatullin, Raoul/0000-0003-2931-4428; Memić, Adnan/0000-0003-4639-8168; 	Kazan Federal University; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [363-903-1433]; DSR	Kazan Federal University; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	R.R.N. and S.I.O. want to express their acknowledgments to the authorities of the Kazan Federal University for the financial support of this research in the frame of the program "Top-100" that was adopted by the university for the period of the years 2014-2018. The publication of this paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 363-903-1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AS, 2011, J LUMIN, V131, P1, DOI 10.1016/j.jlumin.2010.07.017; Allen SE, 2013, CHEM REV, V113, P6234, DOI 10.1021/cr300527g; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Azam A, 2012, INT J NANOMED, V7, P3527, DOI 10.2147/IJN.S29020; Baco-Carles V, 2011, ISRN NANOTECHNOLOGY, V2011, P7; Baleanu CM, 2011, CENT EUR J PHYS, V9, P729, DOI 10.2478/s11534-010-0068-y; Borgohain K, 2000, PHYS REV B, V61, P11093, DOI 10.1103/PhysRevB.61.11093; Chen J, 2003, APPL PHYS LETT, V83, P746, DOI 10.1063/1.1595156; Chowdhuri A, 2004, APPL PHYS LETT, V84, P1180, DOI 10.1063/1.1646760; Das K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3295910; Eliseev AA, 2000, MATER RES INNOV, V3, P308, DOI 10.1007/PL00010877; Gao XP, 2004, J PHYS CHEM B, V108, P5547, DOI 10.1021/jp037075k; GRIFFITHS PR, 1983, SCIENCE, V222, P297, DOI 10.1126/science.6623077; HERION J, 1980, SOL ENERG MATER, V4, P101, DOI 10.1016/0165-1633(80)90022-2; Jayatissa AH, 2009, APPL SURF SCI, V255, P9474, DOI 10.1016/j.apsusc.2009.07.072; Kumar RV, 2000, CHEM MATER, V12, P2301, DOI 10.1021/cm000166z; Nigmatullin RR, 2006, J INSTRUM, V1, DOI 10.1088/1748-0221/1/10/P10002; Nigmatullin R.R., 2012, SIGNAL IMAGE VIDEO P, P1, DOI [10.1007/s11760-012-0386-1, DOI 10.1007/S11760-012-0386-1]; Nigmatullin RR, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/01/015201; Ogwu AA, 2005, J PHYS D APPL PHYS, V38, P266, DOI 10.1088/0022-3727/38/2/011; Ott HR, 2003, PHYSICS OF SUPERCONDUCTORS, VOL I, P385; RAKHSHANI AE, 1986, SOLID STATE ELECTRON, V29, P7, DOI 10.1016/0038-1101(86)90191-7; Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374; Switzer JA, 2003, NATURE, V425, P490, DOI 10.1038/nature01990; TANAKA T, 1990, THIN SOLID FILMS, V189, P9, DOI 10.1016/0040-6090(90)90021-5; Wang C, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145506; Wu DX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235206; Xu JF, 1999, J SOLID STATE CHEM, V147, P516, DOI 10.1006/1999.8409; Yeon SC, 2006, J VAC SCI TECHNOL B, V24, P940, DOI 10.1116/1.2183788; Zhu YW, 2005, NANOTECHNOLOGY, V16, P88, DOI 10.1088/0957-4484/16/1/018	30	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94305	10.1371/journal.pone.0094305	http://dx.doi.org/10.1371/journal.pone.0094305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722337	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100051
J	Roland, WSU; Gouka, RJ; Gruppen, H; Driesse, M; van Buren, L; Smit, G; Vincken, JP				Roland, Wibke S. U.; Gouka, Robin J.; Gruppen, Harry; Driesse, Marianne; van Buren, Leo; Smit, Gerrit; Vincken, Jean-Paul			6-Methoxyflavanones as Bitter Taste Receptor Blockers for hTAS2R39	PLOS ONE			English	Article							STRUCTURAL REQUIREMENTS; ACTIVATE; PEPTIDES; SUBUNITS	Many (dietary) bitter compounds, e. g. flavonoids, activate bitter receptor hTAS2R39 in cell-based assays. Several flavonoids, amongst which some flavanones, are known not to activate this receptor. As certain flavanones are known to mask bitter taste sensorially, flavanones might act as bitter receptor antagonists. Fourteen flavanones were investigated for their potential to reduce activation of hTAS2R39 by epicatechin gallate (ECG), one of the main bitter compounds occurring in green tea. Three flavanones showed inhibitory behavior towards the activation of hTAS2R39 by ECG: 49-fluoro-6-methoxyflavanone, 6,39-dimethoxyflavanone, and 6-methoxyflavanone (in order of decreasing potency). The 6-methoxyflavanones also inhibited activation of hTAS2R14 (another bitter receptor activated by ECG), though to a lesser extent. Dose-response curves of ECG at various concentrations of the full antagonist 49-fluoro-6-methoxyflavanone and wash-out experiments indicated reversible insurmountable antagonism. The same effect was observed for the structurally different agonist denatonium benzoate.	[Roland, Wibke S. U.; Gruppen, Harry; Driesse, Marianne; Smit, Gerrit; Vincken, Jean-Paul] Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands; [Gouka, Robin J.; van Buren, Leo] Unilever R&D, Vlaardingen, Netherlands	Wageningen University & Research; Unilever	Vincken, JP (corresponding author), Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands.	jean-paul.vincken@wur.nl		Vincken, Jean-Paul/0000-0001-8540-4327	Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands [FND 08019]	Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands	This work was financially supported by the Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands (FND 08019, http://www.agentschapnl.nl/subsidies-regelingen/innovatieprogramma-food-nutrition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Fletcher JN, 2011, J AGR FOOD CHEM, V59, P13117, DOI 10.1021/jf204359q; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Kenakin T., 2006, PHARM PRIMER THEORY; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Ley JP, 2012, J AGR FOOD CHEM, V60, P6303, DOI 10.1021/jf301335z; Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Narukawa M, 2011, BIOCHEM BIOPH RES CO, V405, P620, DOI 10.1016/j.bbrc.2011.01.079; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Thalmann S, 2013, BIOCHEM BIOPH RES CO, V435, P267, DOI 10.1016/j.bbrc.2013.04.066; Ueda T, 2003, J NEUROSCI, V23, P7376; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	26	71	73	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94451	10.1371/journal.pone.0094451	http://dx.doi.org/10.1371/journal.pone.0094451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722342	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100071
J	Singh, NJ; Leonardsson, K				Singh, Navinder J.; Leonardsson, Kjell			Partial Migration and Transient Coexistence of Migrants and Residents in Animal Populations	PLOS ONE			English	Article							MOOSE ALCES-ALCES; ENVIRONMENTAL-CHANGE; DENSITY-DEPENDENCE; EVOLUTION; CONSEQUENCES; SELECTION; ECOLOGY; BIRDS; SIZE	Partial migration, whereby a proportion of the population migrates, is common across the animal kingdom. Much of the focus in the literature has been on trying to explain the underlying mechanisms for the coexistence of migrants and residents. In addition, there has been an increasing number of reports on the prevalence and frequency of partially migratory populations. One possible explanation for the occurrence of partial migration, which has received no attention in the literature, is that of 'transient coexistence' during the invasion phase of a superior behaviour. In this study we develop a theoretical basis for explaining partial migration as a transient coexistence and derive a method to predict the frequency of residents and migrants in partially migrating populations. This method is useful to predict the frequencies of migrants and residents in a small set of populations as a complementing hypothesis to 'an Evolutionary Stable Strategy (ESS)'. We use the logistic growth equation to derive a formula for predicting the frequencies of residents and migrants. We also use simulations and empirical data from white perch (Morone americana), moose (Alces alces) and red deer (Cervus elaphus) to demonstrate our approach. We show that the probability of detecting partial migration due to transient coexistence depends upon a minimum number of tracked or marked individuals for a given number of populations. Our approach provides a starting point in searching for explanations to the observed frequencies, by contrasting the observed pattern with both the predicted transient and the uniform random pattern. Aggregating such information on observed patterns (proportions of migrants and residents) may eventually lead to the development of a quantitative theory for the equilibrium (ESS) populations as well.	[Singh, Navinder J.; Leonardsson, Kjell] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Singh, NJ (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	navinder.singh@slu.se; kjell.leonardsson@slu.se			Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences	Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences	NS was supported by the Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; [Anonymous], 2020, ECONOMIST 0326; Bateson P, 2004, BIOL PHILOS, V19, P283, DOI 10.1023/B:BIPH.0000024468.12161.83; BERTHOLD P, 1982, EXPERIENTIA, V38, P805, DOI 10.1007/BF01972282; Berthold P, 1999, OSTRICH, V70, P1, DOI 10.1080/00306525.1999.9639744; BERTHOLD P, 1984, RING, V10, P253; BIEBACH H, 1983, AUK, V100, P601, DOI 10.1093/auk/100.3.601; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; Brusewitz G, 1996, SWEDISH GAME BIOL MA, P40; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chevin LM, 2011, BIOL LETTERS, V7, P210, DOI 10.1098/rsbl.2010.0580; Ducatez S, 2013, ANIM COGN, V16, P525, DOI 10.1007/s10071-013-0612-4; Ericsson G, 1999, WILDLIFE BIOL, V5, P177, DOI 10.2981/wlb.1999.022; Fryxell JM, 2013, ECOLOGY, V94, P1274, DOI 10.1890/12-0668.1; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Griswold CK, 2011, OIKOS, V120, P1847, DOI 10.1111/j.1600-0706.2011.19435.x; Griswold CK, 2010, P ROY SOC B-BIOL SCI, V277, P2711, DOI 10.1098/rspb.2010.0550; KAITALA A, 1993, AM NAT, V142, P59, DOI 10.1086/285529; Kerr LA, 2012, ESTUAR COAST, V35, P227, DOI 10.1007/s12237-011-9434-2; Kokko H, 2001, AM NAT, V157, P188, DOI 10.1086/318632; Kokko H, 2011, OIKOS, V120, P1826, DOI 10.1111/j.1600-0706.2011.19438.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Solberg EJ, 2005, WILDLIFE BIOL, V11, P163, DOI 10.2981/0909-6396(2005)11[163:CRAAEO]2.0.CO;2; Taylor CM, 2007, BIOLOGY LETT, V3, P280, DOI 10.1098/rsbl.2007.0053; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	35	5	5	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94750	10.1371/journal.pone.0094750	http://dx.doi.org/10.1371/journal.pone.0094750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722396	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100129
J	Song, YK; Liu, KJ; Wang, TH				Song, Yunke; Liu, Kelvin J.; Wang, Tza-Huei			Elimination of Ligation Dependent Artifacts in T4 RNA Ligase to Achieve High Efficiency and Low Bias MicroRNA Capture	PLOS ONE			English	Article							MIRNA EXPRESSION; RT-PCR; OLIGONUCLEOTIDE; MICROARRAY; QUANTIFICATION; IDENTIFICATION; DISCOVERY; PLATFORM	Adapter ligation is a critical first step in many microRNA analysis methods including microarray, qPCR, and sequencing. Previous studies have shown that ligation bias can have dramatic effects on both the fidelity of expression profiles and reproducibility across samples. We have developed a method for high efficiency and low bias microRNA capture by 3' adapter ligation using T4 RNA ligase that does not require pooled adapters. Using a panel of 20 microRNA, we investigated the effects of ligase type, PEG concentration, ligase amount, adapter concentration, incubation time, incubation temperature, and adapter design on capture efficiency and bias. Of these factors, high PEG% was found to be critical in suppressing ligation bias. We obtained high average capture efficiency and low CV across the 20 microRNA panel, both in idealized buffer conditions (86% +/- 10%) and total RNA spiking conditions (64% +/- 17%). We demonstrate that this method is reliable across microRNA species that previous studies have had difficulty capturing and that our adapter design performs significantly better than the common adapter designs. Further, we demonstrate that the optimization methodology must be specifically designed for minimizing bias in order to obtain the ideal reaction parameters.	[Song, Yunke; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Liu, Kelvin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Liu, Kelvin J.] Circulomics Inc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Liu, KJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	kliu@circulomics.com; thwang@jhu.edu	Wang, Tza-Huei/A-3337-2010; Liu, Kelvin/F-5432-2010	Liu, Kelvin/0000-0002-1164-582X; Wang, Tza-Huei/0000-0002-3540-9354	National Institutes of Health [R21CA173390, R43GM103360, R01CA155305, U54CA151838]; Maryland Technology Development Corporation [2012- MTTCF-0291-00]; NATIONAL CANCER INSTITUTE [R01CA155305, U54CA151838, R21CA173390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM103360, R44GM103360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Technology Development Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R21CA173390, R43GM103360, R01CA155305, U54CA151838]; and the Maryland Technology Development Corporation [2012- MTTCF-0291-00]. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; HARRISON B, 1984, NUCLEIC ACIDS RES, V12, P8235, DOI 10.1093/nar/12.21.8235; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kilburn D, 2013, J AM CHEM SOC, V135, P10055, DOI 10.1021/ja4030098; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyoshi D, 2008, BIOCHIMIE, V90, P1040, DOI 10.1016/j.biochi.2008.02.009; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Sun GH, 2011, RNA, V17, P2256, DOI 10.1261/rna.028621.111; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; TESSIER DC, 1986, ANAL BIOCHEM, V158, P171, DOI 10.1016/0003-2697(86)90606-8; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vigneault F, 2008, NAT METHODS, V5, P777, DOI 10.1038/NMETH.1244; Viollet S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-72; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang ZJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r109; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	55	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94619	10.1371/journal.pone.0094619	http://dx.doi.org/10.1371/journal.pone.0094619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722341	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100108
J	Uenal, H; Rosenbohm, A; Kufeldt, J; Weydt, P; Goder, K; Ludolph, A; Rothenbacher, D; Nagel, G				Uenal, Hatice; Rosenbohm, Angela; Kufeldt, Johannes; Weydt, Patrick; Goder, Katharina; Ludolph, Albert; Rothenbacher, Dietrich; Nagel, Gabriele		ALS Registry Study Grp	Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany - Completeness of the ALS Registry Swabia	PLOS ONE			English	Article							CAPTURE-RECAPTURE METHODOLOGY; EPIDEMIOLOGY; DIAGNOSIS; PREVALENCE; DISEASE; FRANCE; ASCERTAINMENT; MORTALITY; LIMOUSIN; CRITERIA	Objective of this paper was to investigate the incidence, potential geographical clusters and the completeness of the amyotrophic lateral sclerosis (ALS) registry in Southern Germany (Swabia). Age-standardized incidence rates (ASR) and ratios (SIR) as well as 95% confidence intervals (CI) were estimated at county level. Capture-recapture (CARE) procedures were applied taking data source dependency into account to estimate the quality of case ascertainment in the ALS registry Swabia. We identified 438 ALS cases (53% men, 47% women) in the target population of about 8.4 Mio inhabitants. The gender ratio (men:women) was 1.1:1. The mean age at onset of ALS was 63.8 (SD = 11.9) years for men and 66.0 (12.2) for women. The age distribution peaked in the age group 70-74 years. The ASR of ALS was 2.5 per 100,000 person years (PY; 95% CI:2.3-2.7). The mean SIR was 1.1 per 100,000 PY (95% CI:1.0-1.2). High SIR suggesting geographical clusters were observed in two counties (Goppingen and Bodenseekreis), but the variation was not statistically significant (p-values = 0.2 and 0.5). The percentage of CARE estimated missing cases was 18.9% in the registry yielding an ASR of 3.1 per 100,000 PY. The high coverage of the CARE estimated completeness of the ALS registry Swabia indicates excellent quality for future projects. Regional variations have to be investigated further.	[Uenal, Hatice; Kufeldt, Johannes; Rothenbacher, Dietrich; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Rosenbohm, Angela; Weydt, Patrick; Goder, Katharina; Ludolph, Albert] Ulm Univ Clin, Dept Neurol, Ulm, Germany	Ulm University; Ulm University	Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gabriele.nagel@uni-ulm.de	Weydt, Patrick/F-5114-2015; Rosenbohm, Angela/GOJ-9292-2022; Nagel, Gabriele/C-3635-2012	Weydt, Patrick/0000-0003-2344-5662; Rosenbohm, Angela/0000-0001-9700-0338; Nagel, Gabriele/0000-0001-6185-8535; Schols, Ludger/0000-0001-7774-5025; Rothenbacher, Dietrich/0000-0002-3563-2791; Kufeldt, Johannes/0000-0003-2031-5678	Deutsche Forschungsgemeinschaft [577 631, LU 336/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (main number 577 631, project LU 336/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; ANNEGERS JF, 1991, ARCH NEUROL-CHICAGO, V48, P589, DOI 10.1001/archneur.1991.00530180041015; [Anonymous], 2012, EUROPEAN ALS CONSORT; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; Blasco H, 2012, AMYOTROPH LATERAL SC, V13, P585, DOI 10.3109/17482968.2012.706303; Boumediene F, 2011, J NEUROL SCI, V309, P115, DOI 10.1016/j.jns.2011.07.002; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, pS79; Caller TA, 2013, MUSCLE NERVE, V48, P235, DOI 10.1002/mus.23761; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chao A., 2003, PROGRAM CARE 2 CAPTU; Chapman DG, 1952, INVERSE MULTIPLE SEQ; Chapman DG, 1951, SOME PROPERTIES HYPE; Chio A, 2001, NEUROLOGY, V56, P239; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Federal health monitoring information system Germany (n.d.). Standard_populations, STAND POP; Forbes RB, 2007, J NEUROL, V254, P866, DOI 10.1007/s00415-006-0454-y; Gliklich RE, 2020, REGISTRIES EVALUATIN, V4th, DOI 10.23970/AHRQEPCREGISTRIES4; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Househam E, 2000, J NEUROL SCI, V180, P76, DOI 10.1016/S0022-510X(00)00418-4; Huisman MHB, 2011, J NEUROL NEUROSUR PS, V82, P1165, DOI 10.1136/jnnp.2011.244939; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kulldorff M, 2009, SATSCAN TM V9 1 1 MA; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Maasilta P, 2001, ACTA NEUROL SCAND, V104, P232, DOI 10.1034/j.1600-0404.2001.00361.x; MCCARTY DJ, 1993, INT J EPIDEMIOL, V22, P559, DOI 10.1093/ije/22.3.559; Nagel G, 2004, GESUNDHEITSWESEN, V66, P469, DOI 10.1055/s-2004-813337; Nagel G, 2012, AKTUEL NEUROL, V39, P12, DOI 10.1055/s-0031-1301340; Nagel G, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-22; NEILSON S, 1994, J NEUROL, V241, P448, DOI 10.1007/BF00900964; Preux PM, 2000, J CLIN EPIDEMIOL, V53, P1025, DOI 10.1016/S0895-4356(00)00212-2; Pringle DG, 1996, EC SOCIAL REV; Rocchetti I, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-160; Sabel CE, 2003, AM J EPIDEMIOL, V157, P898, DOI 10.1093/aje/kwg090; Scott KM, 2009, NEUROEPIDEMIOLOGY, V32, P81, DOI 10.1159/000177032; Vazquez MC, 2008, NEUROEPIDEMIOLOGY, V30, P105, DOI 10.1159/000120023; Wittie M, 2013, NEUROEPIDEMIOLOGY, V40, P133, DOI 10.1159/000342156; Wolfson C, 2009, NEUROEPIDEMIOLOGY, V33, P79, DOI 10.1159/000222089	42	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93932	10.1371/journal.pone.0093932	http://dx.doi.org/10.1371/journal.pone.0093932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722455	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100030
J	Boutin, A; Eliseeva, E; Gershengorn, MC; Neumann, S				Boutin, Alisa; Eliseeva, Elena; Gershengorn, Marvin C.; Neumann, Susanne			beta-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation	FASEB JOURNAL			English	Article						TSH receptor; signaling; phosphokinases; bone; osteopontin	THYROID-STIMULATING HORMONE; PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE; KINASE-A; TSH; GROWTH; ACTIVATION; ANTAGONIST; PATHWAYS; PROMOTES	Thyrotropin (TSH) activation of the TSH receptor (TSHR), a 7-transmembrane-spanning receptor (7TMR), may have osteoprotective properties by direct effects on bone. TSHR activation by TSH phosphorylates protein kinases AKT1, p38 alpha, and ERK1/2 in some cells. We found TSH-induced phosphorylation of these kinases in 2 cell lines engineered to express TSHRs, human embryonic kidney HEK-TSHR cells and human osteoblastic U2OS-TSHR cells. In U2OS-TSHR cells, TSH up-regulated pAKT1 (7.1 +/- 0.5-fold), p38 alpha (2.9 +/- 0.4-fold), and pERK1/2 (3.1 +/- 0.2-fold), whereas small molecule TSHR agonist C2 had no or little effect on pAKT1 (1.8 +/- 0.08-fold), p38 alpha (1.2 +/- 0.09-fold), and pERK1/2 (1.6 +/- 0.19-fold). Furthermore, TSH increased expression of osteoblast marker genes ALPL (8.2 +/- 4.6-fold), RANKL (21 +/- 5.9-fold), and osteopontin (OPN; 17 +/- 5.3-fold), whereas C2 had little effect (ALPL, 1.7 +/- 0.5-fold; RANKL, 1.3 +/- 0.6-fold; and OPN, 2.2 +/- 0.7fold). beta-Arrestin-1 and -2 can mediate activatory signals by 7TMRs. TSH stimulated translocation of beta-arrestin-1 and -2 to TSHR, whereas C2 failed to translocate either beta-arrestin. Down-regulation of beta-arrestin-1 by siRNA inhibited TSH-stimulated phosphorylation of ERK1/2, p38 alpha, and AKT1, whereas down-regulation of beta-arrestin-2 increased phosphorylation of AKT1 in both cell types and of ERK1/2 in HEK-TSHR cells. Knockdown of beta-arrestin- 1 inhibited TSH-stimulated up-regulation of mRNAs for OPN by 87 +/- 1.7% and RANKL by 73 +/- 2.4%, and OPN secretion by 74 +/- 10%. We conclude that TSH enhances osteoblast differentiation in U2OS cells that is, in part, caused by activatory signals mediated by beta-arrestin- 1.	[Boutin, Alisa; Eliseeva, Elena; Gershengorn, Marvin C.; Neumann, Susanne] Natl Inst Diabet & Digest & Kidney Dis, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Neumann, S (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, 50 South Dr,Bldg 50 Rm 4128, Bethesda, MD 20892 USA.	susannen@intra.niddk.nih.gov			Intramural Research Program of the U.S. National Institutes of Health [1 Z01 DK047044]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047044, ZIADK011006] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health (1 Z01 DK047044).	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Abe E, 2007, ANN NY ACAD SCI, V1116, P383, DOI 10.1196/annals.1402.062; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Baliram R, 2011, P NATL ACAD SCI USA, V108, P16277, DOI 10.1073/pnas.1110286108; Bisello A, 2002, J BIOL CHEM, V277, P38524, DOI 10.1074/jbc.M202544200; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Frenzel R, 2006, ENDOCRINOLOGY, V147, P3114, DOI 10.1210/en.2005-0687; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Greenspan SL, 1999, ANN INTERN MED, V130, P750, DOI 10.7326/0003-4819-130-9-199905040-00016; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Kumar S, 2011, J MOL ENDOCRINOL, V46, P155, DOI 10.1530/JME-11-0006; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Latif R, 2009, ENDOCRIN METAB CLIN, V38, P319, DOI 10.1016/j.ecl.2009.01.006; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Neumann S., 2013, 83 ANN M AM THYR ASS; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Neumann S, 2008, ENDOCRINOLOGY, V149, P5945, DOI 10.1210/en.2008-0836; Pomerance M, 2000, J BIOL CHEM, V275, P40539, DOI 10.1074/jbc.M002097200; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; RIVKEES SA, 1988, NEW ENGL J MED, V318, P599, DOI 10.1056/NEJM198803103181003; Salvatori L, 2009, J CELL PHYSIOL, V220, P35, DOI 10.1002/jcp.21724; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Turcu AF, 2013, J CLIN ENDOCR METAB, V98, P2153, DOI 10.1210/jc.2013-1149; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vandeput F, 2003, ENDOCRINOLOGY, V144, P1341, DOI 10.1210/en.2001-211316; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wojcicka A, 2013, BBA-GEN SUBJECTS, V1830, P3979, DOI 10.1016/j.bbagen.2012.05.005	36	42	42	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3446	3455		10.1096/fj.14-251124	http://dx.doi.org/10.1096/fj.14-251124			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24723693	Green Published			2022-12-25	WOS:000340265400015
J	Salanga, CL; Dyer, DP; Kiselar, JG; Gupta, S; Chance, MR; Handel, TM				Salanga, Catherina L.; Dyer, Douglas P.; Kiselar, Janna G.; Gupta, Sayan; Chance, Mark R.; Handel, Tracy M.			Multiple Glycosaminoglycan-binding Epitopes of Monocyte Chemoattractant Protein-3/CCL7 Enable It to Function as a Non-oligomerizing Chemokine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMER-DIMER EQUILIBRIUM; HEPARAN-SULFATE; DIFFERENT AFFINITIES; CCR2 CHEMOKINES; RECEPTOR; SITE; IDENTIFICATION; OLIGOSACCHARIDES; ACTIVATION; DYNAMICS	The interaction of chemokines with glycosaminoglycans (GAGs) facilitates the formation of localized chemokine gradients that provide directional signals for migrating cells. In this study, we set out to understand the structural basis and impact of the differing oligomerization propensities of the chemokines monocyte chemoattractant protein (MCP)-1/CCL2 and MCP3/CCL7 on their ability to bind GAGs. These chemokines provide a unique comparison set because CCL2 oligomerizes and oligomerization is required for its full in vivo activity, whereas CCL7 functions as a monomer. To identify the GAG-binding determinants of CCL7, an unbiased hydroxyl radical footprinting approach was employed, followed by a focused mutagenesis study. Compared with the size of the previously defined GAG-binding epitope of CCL2, CCL7 has a larger binding site, consisting of multiple epitopes distributed along its surface. Furthermore, surface plasmon resonance (SPR) studies indicate that CCL7 is able to bind GAGs with an affinity similar to CCL2 but higher than the non-oligomerizing variant, CCL2(P8A), suggesting that, in contrast to CCL2, the large cluster of GAG-binding residues in CCL7 renders oligomerization unnecessary for high affinity binding. However, the affinity of CCL7 is more sensitive than CCL2 to the density of heparan sulfate on the SPR surfaces; this is likely due to the inability of CCL7 to oligomerize because CCL2(P8A) also binds significantly less tightly to low than high density heparan sulfate surfaces compared with CCL2. Together, the data suggest that CCL7 and CCL2 are non-redundant chemokines and that GAG chain density may provide a mechanism for regulating the accumulation of chemokines on cell surfaces.	[Salanga, Catherina L.; Dyer, Douglas P.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kiselar, Janna G.; Gupta, Sayan; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Gupta, Sayan; Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	University of California System; University of California San Diego; Case Western Reserve University; Case Western Reserve University	Handel, TM (corresponding author), 9500 Gilman Dr,MC0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Dyer, Douglas/J-2675-2015; Dyer, Douglas/L-9679-2019	Dyer, Douglas/0000-0001-5567-6241; Dyer, Douglas/0000-0001-5567-6241	Department of Energy [DE-AC02-98CH10886]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688, P30EB009998] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge Dr. Parminder Kaur for assistance with ProtMapMS data analysis. The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the Department of Energy Contract DE-AC02-98CH10886.	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blanpain C, 1999, BLOOD, V94, P1899; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081454; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kiselar JG, 2003, MOL CELL PROTEOMICS, V2, P1120, DOI 10.1074/mcp.M300068-MCP200; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Koopmann W, 1999, J IMMUNOL, V163, P2120; Krohn SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072321; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1997, METHOD ENZYMOL, V287, P369; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Menten P, 2001, EUR CYTOKINE NETW, V12, P554; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Richardson RM, 2000, J BIOL CHEM, V275, P9201, DOI 10.1074/jbc.275.13.9201; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saesen E, 2013, J AM CHEM SOC, V135, P9384, DOI 10.1021/ja4000867; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schenauer MR, 2007, J BIOL CHEM, V282, P25182, DOI 10.1074/jbc.M703387200; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447; Soria G, 2012, NEOPLASIA, V14, P1, DOI 10.1593/neo.111122; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	57	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14896	14912		10.1074/jbc.M114.547737	http://dx.doi.org/10.1074/jbc.M114.547737			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727473	Green Published, hybrid			2022-12-25	WOS:000337248100041
J	Huang, CL; Pollock, CA; Chen, XM				Huang, Chunling; Pollock, Carol A.; Chen, Xin-Ming			High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN DIABETIC-NEPHROPATHY; CA2+-ACTIVATED K+ CHANNEL; INTERMEDIATE-CONDUCTANCE; POTASSIUM CHANNEL; UP-REGULATION; SIGNALING PATHWAYS; MECHANISM; DISEASE; INFLAMMATION	Inflammation plays a key role in the development and progression of diabetic nephropathy (DN). KCa3.1, a calcium activated potassium channel protein, is associated with vascular inflammation, atherogenesis, and proliferation of endothelial cells, macrophages, and fibroblasts. We have previously demonstrated that the KCa3.1 channel is activated by TGF-beta 1 and blockade of KCa3.1 ameliorates renal fibrotic responses in DN through inhibition of the TGF-beta 1 pathway. The present study aimed to identify the role of KCa3.1 in the inflammatory responses inherent in DN. Methods: Human proximal tubular cells (HK2 cells) were exposed to high glucose (HG) in the presence or absence of the KCa3.1 inhibitor TRAM34 for 6 days. The proinflammatory cytokine chemokine (C-C motif) ligand 20 (CCL20) expression was examined by real-time PCR and enzyme-linked immunosorbent assay (ELISA). The activity of nuclear factor-kappa B (NF-kappa B) was measured by nuclear extraction and electrophoretic mobility shift assay (EMSA). In vivo, the expression of CCL20, the activity of NF-kappa B and macrophage infiltration (CD68 positive cells) were examined by real-time PCR and/or immunohistochemistry staining in kidneys from diabetic or KCa3.1-/-mice, and in eNOS-/-diabetic mice treated with the KCa3.1 channel inhibitor TRAM34. Results: In vitro data showed that TRAM34 inhibited CCL20 expression and NF-kappa B activation induced by HG in HK2 cells. Both mRNA and protein levels of CCL20 significantly decreased in kidneys of diabetic KCa3.1-/-mice compared to diabetic wild type mice. Similarly, TRAM34 reduced CCL20 expression and NF-kappa B activation in diabetic eNOS-/- mice compared to diabetic controls. Blocking the KCa3.1 channel in both animal models led to a reduction in phosphorylated NF-kappa B. Conclusions: Overexpression of CCL20 in human proximal tubular cells is inhibited by blockade of KCa3.1 under diabetic conditions through inhibition of the NF-kappa B pathway.	[Huang, Chunling; Pollock, Carol A.; Chen, Xin-Ming] Univ Sydney, Sydney Med Sch, Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Huang, Chunling] Xiamen Univ, Coll Med, Xiamen Zhongshan Hosp, Xiamen Ctr Clin Lab, Xiamen, Peoples R China	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Xiamen University	Pollock, CA (corresponding author), Univ Sydney, Sydney Med Sch, Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW 2006, Australia.	carol.pollock@sydney.edu.au	Chen, Xin-Ming/D-2923-2015	Chen, Xin-Ming/0000-0003-3212-7172	Australian National Health and Medical Research Council [NHMRC APP1025918]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council Project grant (NHMRC APP1025918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Donadelli R, 2003, J AM SOC NEPHROL, V14, P2436, DOI 10.1097/01.ASN.0000089564.55411.7F; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gysemans C, 2009, DIABETOLOGIA, V52, P2374, DOI 10.1007/s00125-009-1514-5; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Huang CL, 2014, LAB INVEST, V94, P309, DOI 10.1038/labinvest.2014.2; Huang CL, 2014, NEPHROL DIAL TRANSPL, V29, P313, DOI 10.1093/ndt/gft431; Huang CL, 2014, INT J BIOCHEM CELL B, V47, P1, DOI [10.1016/j.biocel.2013.11.017, 10.1016/j.bioce1.2013.11.017]; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Ohya S, 2009, J PHARMACOL SCI, V109, P148, DOI 10.1254/jphs.08208SC; Qi W, 2007, NEPHROL DIAL TRANSPL, V22, P3147, DOI 10.1093/ndt/gfm365; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Rodriguez-Pena AB, 2008, KIDNEY INT, V74, P196, DOI 10.1038/ki.2008.160; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Su XL, 2013, CHIN J PHYSL, V56; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Tharp D. L., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P1; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Woltman AM, 2005, AM J TRANSPLANT, V5, P2114, DOI 10.1111/j.1600-6143.2005.00997.x; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186	39	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95173	10.1371/journal.pone.0095173	http://dx.doi.org/10.1371/journal.pone.0095173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733189	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400159
J	Murgiano, L; Jagannathan, V; Benazzi, C; Bolcato, M; Brunetti, B; Muscatello, LV; Dittmer, K; Piffer, C; Gentile, A; Drogemuller, C				Murgiano, Leonardo; Jagannathan, Vidhya; Benazzi, Cinzia; Bolcato, Marilena; Brunetti, Barbara; Muscatello, Luisa Vera; Dittmer, Keren; Piffer, Christian; Gentile, Arcangelo; Droegemueller, Cord			Deletion in the EVC2 Gene Causes Chondrodysplastic Dwarfism in Tyrolean Grey Cattle	PLOS ONE			English	Article							VAN-CREVELD-SYNDROME; HOLSTEIN CALVES; MUTATIONS; CILIA; GENOME; ASSOCIATION; DYSOSTOSIS; GROWTH; BASE	During the summer of 2013 seven Italian Tyrolean Grey calves were born with abnormally short limbs. Detailed clinical and pathological examination revealed similarities to chondrodysplastic dwarfism. Pedigree analysis showed a common founder, assuming autosomal monogenic recessive transmission of the defective allele. A positional cloning approach combining genome wide association and homozygosity mapping identified a single 1.6 Mb genomic region on BTA 6 that was associated with the disease. Whole genome re-sequencing of an affected calf revealed a single candidate causal mutation in the Ellis van Creveld syndrome 2 (EVC2) gene. This gene is known to be associated with chondrodysplastic dwarfism in Japanese Brown cattle, and dwarfism, abnormal nails and teeth, and dysostosis in humans with Ellis-van Creveld syndrome. Sanger sequencing confirmed the presence of a 2 bp deletion in exon 19 (c.2993_2994ACdel) that led to a premature stop codon in the coding sequence of bovine EVC2, and was concordant with the recessive pattern of inheritance in affected and carrier animals. This loss of function mutation confirms the important role of EVC2 in bone development. Genetic testing can now be used to eliminate this form of chondrodysplastic dwarfism from Tyrolean Grey cattle.	[Murgiano, Leonardo; Jagannathan, Vidhya; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Benazzi, Cinzia; Bolcato, Marilena; Brunetti, Barbara; Muscatello, Luisa Vera; Gentile, Arcangelo] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, Italy; [Dittmer, Keren] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Piffer, Christian] Azienda Sanit Alto Adige, Vet Serv, Bolzano, Italy	University of Bern; University of Bologna; Massey University	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019; Bolcato, Marilena/AAO-9483-2020; Brunetti, Barbara/AAK-1860-2021; Dittmer, Keren/AAR-3148-2021	Jagannathan, Vidhya/0000-0002-8155-0041; Dittmer, Keren/0000-0002-1813-2197; Drogemuller, Cord/0000-0001-9773-522X; BRUNETTI, BARBARA/0000-0002-2694-905X				Agerholm JS, 2004, J VET DIAGN INVEST, V16, P293, DOI 10.1177/104063870401600406; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beever JE, 2006, ANIM GENET, V37, P66, DOI 10.1111/j.1365-2052.2005.01398.x; Blair HJ, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-14; Blum JW, 2007, DOMEST ANIM ENDOCRIN, V33, P245, DOI 10.1016/j.domaniend.2006.05.007; Cavanagh JAL, 2007, MAMM GENOME, V18, P808, DOI 10.1007/s00335-007-9066-9; Chen CP, 2010, TAIWAN J OBSTET GYNE, V49, P481, DOI 10.1016/S1028-4559(10)60101-5; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; D'Asdia MC, 2013, EUR J MED GENET, V56, P80, DOI 10.1016/j.ejmg.2012.11.005; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; ESPINASSE J, 1986, VET REC, V118, P328, DOI 10.1136/vr.118.12.328; Flower M., 2007, EMPHASIS, V2, P2; Galdzicka M, 2002, MOL GENET METAB, V77, P291, DOI 10.1016/S1096-7192(02)00178-6; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Koltes JE, 2009, P NATL ACAD SCI USA, V106, P19250, DOI 10.1073/pnas.0904513106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCormack BL, 2009, DOMEST ANIM ENDOCRIN, V37, P104, DOI 10.1016/j.domaniend.2009.04.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; McLaren PJ, 2007, VET PATHOL, V44, P342, DOI 10.1354/vp.44-3-342; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Ruiz-Perez VL, 2009, AM J MED GENET C, V151C, P341, DOI 10.1002/ajmg.c.30226; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Sund KL, 2009, HUM MOL GENET, V18, P1813, DOI 10.1093/hmg/ddp098; Takeda H, 2002, P NATL ACAD SCI USA, V99, P10549, DOI 10.1073/pnas.152337899; Tompson SWJ, 2007, HUM GENET, V120, P663, DOI 10.1007/s00439-006-0237-7; Valencia M, 2009, HUM MUTAT, V30, P1667, DOI 10.1002/humu.21117; Vieux-Rochas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051700; White PJ, 2012, VET J, V193, P336, DOI 10.1016/j.tvjl.2012.04.016; Ye XQ, 2006, HUM GENET, V119, P199, DOI 10.1007/s00439-005-0129-2; Zhang Z, 2012, GENE, V511, P380, DOI 10.1016/j.gene.2012.09.071; Zhao X, 2012, ANIM GENET, V43, P9, DOI 10.1111/j.1365-2052.2011.02304.x	36	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94861	10.1371/journal.pone.0094861	http://dx.doi.org/10.1371/journal.pone.0094861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733244	Green Published, gold			2022-12-25	WOS:000336970400122
J	Ost, M; Werner, F; Dokas, J; Klaus, S; Voigt, A				Ost, Mario; Werner, Franziska; Dokas, Janine; Klaus, Susanne; Voigt, Anja			Activation of AMPK alpha 2 Is Not Crucial for Mitochondrial Uncoupling-Induced Metabolic Effects but Required to Maintain Skeletal Muscle Integrity	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACETYL-COA CARBOXYLASE; PROTEIN-KINASE; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; DIRECT PHOSPHORYLATION; ENERGY HOMEOSTASIS; TRANSGENIC MICE; AMPK ACTIVATION; FA UPTAKE	Transgenic (UCP1-TG) mice with ectopic expression of UCP1 in skeletal muscle (SM) show a phenotype of increased energy expenditure, improved glucose tolerance and increase substrate metabolism in SM. To investigate the potential role of skeletal muscle AMPK alpha 2 activation in the metabolic phenotype of UCP1-TG mice we generated double transgenic (DTG) mice, by crossing of UCP1-TG mice with DN-AMPK alpha 2 mice overexpressing a dominant negative alpha 2 subunit of AMPK in SM which resulted in an impaired AMPK alpha 2 activity by 90 +/- 9% in SM of DTG mice. Biometric analysis of young male mice showed decreased body weight, lean and fat mass for both UCP1-TG and DTG compared to WT and DN-AMPK alpha 2 mice. Energy intake and weight-specific total energy expenditure were increased, both in UCP1-TG and DTG mice. Moreover, glucose tolerance, insulin sensitivity and fatty acid oxidation were not altered in DTG compared to UCP1-TG. Also uncoupling induced induction and secretion of fibroblast growth factor 21 (FGF21) from SM was preserved in DTG mice. However, voluntary physical cage activity as well as ad libitum running wheel access during night uncovered a severe activity intolerance of DTG mice. Histological analysis showed a progressive degenerative morphology in SM of DTG mice which was not observed in SM of UCP1-TG mice. Moreover, ATP-depletion related cellular stress response via heat shock protein 70 was highly induced, whereas capillarization regulator VEGF was suppressed in DTG muscle. In addition, AMPK alpha 2-mediated induction of mitophagy regulator ULK1 was suppressed in DTG mice, as well as mitochondrial respiratory capacity and content. In conclusion, we demonstrate that AMPK alpha 2 is dispensable for SM mitochondrial uncoupling induced metabolic effects on whole body energy balance, glucose homeostasis and insulin sensitivity. But strikingly, activation of AMPK alpha 2 seems crucial for maintaining SM function, integrity and the ability to compensate chronic metabolic stress induced by SM mitochondrial uncoupling.	[Ost, Mario; Werner, Franziska; Dokas, Janine; Klaus, Susanne; Voigt, Anja] German Inst Human Nutr DIfE Potsdam Rehbruecke, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Klaus, S (corresponding author), German Inst Human Nutr DIfE Potsdam Rehbruecke, Nuthetal, Germany.	klaus@dife.de	Klaus, Susanne/P-9299-2018	Klaus, Susanne/0000-0001-8726-185X; Ost, Mario/0000-0002-1811-2049	European Union [244995]; Leibniz Society [SAW-2013-FBN-3]	European Union(European Commission); Leibniz Society	This research received funding from the European Union's Seventh Framework Program FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project) and from the Leibniz Society (SAW-2013-FBN-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Alkhateeb H, 2011, APPL PHYSIOL NUTR ME, V36, P361, DOI [10.1139/h11-024, 10.1139/H11-024]; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boque N, 2009, J PHYSIOL BIOCHEM, V65, P387, DOI 10.1007/BF03185934; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fueger PT, 2005, J PHYSIOL-LONDON, V562, P925, DOI 10.1113/jphysiol.2004.076158; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hepple RT, 1997, J APPL PHYSIOL, V82, P1305, DOI 10.1152/jappl.1997.82.4.1305; Holmes BF, 2004, AM J PHYSIOL-ENDOC M, V287, pE739, DOI 10.1152/ajpendo.00080.2004; Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabakov AE, 2002, AM J PHYSIOL-CELL PH, V283, pC521, DOI 10.1152/ajpcell.00503.2001; Katterle Y, 2008, PHYSIOL GENOMICS, V32, P352, DOI 10.1152/physiolgenomics.00194.2007; Keipert S, 2013, AM J PHYSIOL-ENDOC M, V304, pE495, DOI 10.1152/ajpendo.00518.2012; Keipert S, 2013, AM J PHYSL IN PRESS; Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x; Keipert S, 2010, BBA-BIOENERGETICS, V1797, P324, DOI 10.1016/j.bbabio.2009.11.008; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Klaus S, 2011, GENES NUTR; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lawler JM, 2006, MUSCLE NERVE, V33, P200, DOI 10.1002/mus.20454; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; O'Neill HM, 2013, DIABETES METAB J, V37, P1, DOI 10.4093/dmj.2013.37.1.1; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Raney MA, 2005, AM J PHYSIOL-ENDOC M, V288, pE592, DOI 10.1152/ajpendo.00301.2004; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Turcotte LP, 2005, ACTA PHYSIOL SCAND, V184, P131, DOI 10.1111/j.1365-201X.2005.01445.x; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zwetsloot KA, 2008, J PHYSIOL-LONDON, V586, P6021, DOI 10.1113/jphysiol.2008.159871	85	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94689	10.1371/journal.pone.0094689	http://dx.doi.org/10.1371/journal.pone.0094689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732703	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400075
J	Shikata, F; Sakaue, T; Nakashiro, K; Okazaki, M; Kurata, M; Okamura, T; Okura, M; Ryugo, M; Nakamura, Y; Yasugi, T; Higashiyama, S; Izutani, H				Shikata, Fumiaki; Sakaue, Tomohisa; Nakashiro, Koh-ichi; Okazaki, Mikio; Kurata, Mie; Okamura, Toru; Okura, Masahiro; Ryugo, Masahiro; Nakamura, Yuki; Yasugi, Takumi; Higashiyama, Shigeki; Izutani, Hironori			Pathophysiology of Lung Injury Induced by Common Bile Duct Ligation in Mice	PLOS ONE			English	Article							ENDOTHELIN-B RECEPTOR; NITRIC-OXIDE SYNTHASE; HEPATOPULMONARY-SYNDROME; RAT MODEL; ARTERIOVENOUS-MALFORMATIONS; PORTAL-HYPERTENSION; POTENTIAL ROLE; MATRIX-METALLOPROTEINASE-9; PATHOGENESIS; EXPRESSION	Background: Liver dysfunction and cirrhosis affect vasculature in several organ systems and cause impairment of organ functions, thereby increasing morbidity and mortality. Establishment of a mouse model of hepatopulmonary syndrome (HPS) would provide greater insights into the genetic basis of the disease. Our objectives were to establish a mouse model of lung injury after common bile duct ligation (CBDL) and to investigate pulmonary pathogenesis for application in future therapeutic approaches. Methods: Eight-week-old Balb/c mice were subjected to CBDL. Immunohistochemical analyses and real-time quantitative reverse transcriptional polymerase chain reaction were performed on pulmonary tissues. The presence of HPS markers was detected by western blot and microarray analyses. Results: We observed extensive proliferation of CD31-positive pulmonary vascular endothelial cells at 2 weeks after CBDL and identified 10 upregulated and 9 down-regulated proteins that were associated with angiogenesis. TNF-a and MMP-9 were highly expressed at 3 weeks after CBDL and were less expressed in the lungs of the control group. Conclusions: We constructed a mouse lung injury model by using CBDL. Contrary to our expectation, lung pathology in our mouse model exhibited differences from that of rat models, and the mechanisms responsible for these differences are unknown. This phenomenon may be explained by contrasting processes related to TNF induction of angiogenic signaling pathways in the inflammatory phase. Thus, we suggest that our mouse model can be applied to pulmonary pathological analyses in the inflammatory phase, i.e., to systemic inflammatory response syndrome, acute lung injury, and multiple organ dysfunction syndrome.	[Shikata, Fumiaki; Okazaki, Mikio; Okamura, Toru; Okura, Masahiro; Ryugo, Masahiro; Nakamura, Yuki; Yasugi, Takumi; Izutani, Hironori] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan; [Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Dept Cell Growth & Tumor Regulat, Proteo Sci Ctr, Matsuyama, Ehime 790, Japan; [Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 790, Japan; [Nakashiro, Koh-ichi] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime 790, Japan; [Kurata, Mie] Ehime Univ, Grad Sch Med, Dept Pathol, Div Pathogen, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University	Izutani, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan.	izutani@m.ehime-u.ac.jp	Nakashiro, Koichi/AAV-6317-2020	Kurata, Mie/0000-0001-6596-2436; Nakashiro, Koh-ichi/0000-0002-9975-902X	JSPS KAKENHI [11008958]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI grant number 11008958 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alaish SM, 2005, SHOCK, V24, P412, DOI 10.1097/01.shk.0000183392.83272.97; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Beierle EA, 1996, AM J SURG, V171, P202, DOI 10.1016/S0002-9610(99)80100-7; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; CHANG SW, 1992, AM REV RESPIR DIS, V145, P798, DOI 10.1164/ajrccm/145.4_Pt_1.798; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Fallon MB, 1997, GASTROENTEROLOGY, V113, P606, DOI 10.1053/gast.1997.v113.pm9247483; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Giraudo E, 1998, J BIOL CHEM, V273, P22128, DOI 10.1074/jbc.273.34.22128; Gonzalez-Lopez A, 2012, CRIT CARE, V16, DOI 10.1186/cc11224; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Kato T, 1999, BREAST CANCER RES TR, V53, P19, DOI 10.1023/A:1006193024382; Keck T, 2006, PANCREATOLOGY, V6, P316, DOI 10.1159/000092797; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Kirkland JG, 2010, J SURG RES, V164, P221, DOI 10.1016/j.jss.2009.08.010; Kochar R, 2011, PULMONARY MANIFESTAT, P381; Kong MYF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022596; Kong MYF, 2009, INT J MED SCI, V6, P9; Ling YQ, 2004, HEPATOLOGY, V39, P1593, DOI 10.1002/hep.20244; Liu LC, 2001, HEPATOLOGY, V33, P722, DOI 10.1053/jhep.2001.22701; Luo B, 2004, AM J PHYSIOL-GASTR L, V286, pG294, DOI 10.1152/ajpgi.00298.2003; Machicao VI, 2012, SEMIN RESP CRIT CARE, V33, P11, DOI 10.1055/s-0032-1301730; Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009; Oggionni T, 2006, EUR J HISTOCHEM, V50, P317; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Roberts KE, 2010, GASTROENTEROLOGY, V139, P130, DOI 10.1053/j.gastro.2010.03.044; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sari S, 2012, DIGEST DIS SCI, V57, P175, DOI 10.1007/s10620-011-1832-6; Schranz D, 2004, LANCET, V364, P26, DOI 10.1016/S0140-6736(04)16582-3; Sugiyama M, 1997, ARCH SURG-CHICAGO, V132, P1129; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Tanikella R, 2008, LIVER TRANSPLANT, V14, P1199, DOI 10.1002/lt.21482; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; Tipps RS, 2008, J THORAC CARDIOV SUR, V136, P283, DOI 10.1016/j.jtcvs.2008.02.011; Van Steenkiste C, 2010, LAB INVEST, V90, P1558, DOI 10.1038/labinvest.2010.138; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wang BL, 2011, MOL MED REP, V4, P243, DOI 10.3892/mmr.2011.425; Zhang JL, 2012, NAT REV GASTRO HEPAT, V9, P539, DOI 10.1038/nrgastro.2012.123; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	43	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94550	10.1371/journal.pone.0094550	http://dx.doi.org/10.1371/journal.pone.0094550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733017	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400051
J	Bienholz, A; Al-Taweel, A; Roeser, NF; Kribben, A; Feldkamp, T; Weinberg, JM				Bienholz, Anja; Al-Taweel, Ahmad; Roeser, Nancy F.; Kribben, Andreas; Feldkamp, Thorsten; Weinberg, Joel M.			Substrate Modulation of Fatty Acid Effects on Energization and Respiration of Kidney Proximal Tubules during Hypoxia/Reoxygenation	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; COMPLEX-I; HYPOXIA; DYSFUNCTION; INHIBITION; INJURY; CYCLE; DEHYDROGENASE; GLYCINE; DAMAGE	Kidney proximal tubules subjected to hypoxia/reoxygenation develop a nonesterified fatty acid-induced energetic deficit characterized by persistent partial mitochondrial deenergization that can be prevented and reversed by citric acid cycle substrates. To further assess the role of competition between fatty acids and substrates on inner membrane substrate carriers in the deenergization and the contribution to deenergization of fatty acid effects on respiratory function, digitonin-permeabilized rabbit and mouse tubules were studied using either addition of exogenous oleate after control normoxic incubation or increases of endogenous fatty acids produced by hypoxia/reoxygenation. The results demonstrated major effects of matrix oxaloacetate accumulation on succinate-supported energization and respiration and their modification by fatty acids. Improvements of energization in the presence of fatty acids by glutamate were shown to result predominantly from lowering matrix oxaloacetate rather than from amelioration of transmembrane cycling of fatty acids and uncoupling. Mouse tubules had 2.5 fold higher rates of succinate utilization, which resulted in stronger effects of oxaloacetate accumulation than rabbit tubules. Hypoxia/reoxygenation induced respiratory inhibition that was more severe for complex I-dependent substrates. Fatty acids themselves did not acutely contribute to this respiratory inhibition, but lowering them during 60 min. reoxygenation to allow recovery of ATP during that period alleviated it. These data clarify the basis for the nonesterified fatty acid-induced mitochondrial energetic deficit in kidney proximal tubules that impairs structural and functional recovery and provide insight into interactions that need to be considered in the design of substrate-based interventions to improve mitochondrial function.	[Bienholz, Anja; Al-Taweel, Ahmad; Roeser, Nancy F.; Feldkamp, Thorsten; Weinberg, Joel M.] Vet Affairs Ann Arbor Healthcare Syst, Div Nephrol, Dept Internal Med, Ann Arbor, MI 48105 USA; [Bienholz, Anja; Al-Taweel, Ahmad; Roeser, Nancy F.; Feldkamp, Thorsten; Weinberg, Joel M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Bienholz, Anja; Kribben, Andreas; Feldkamp, Thorsten] Univ Duisburg Essen, Div Nephrol, Dept Internal Med, Essen, Germany; [Feldkamp, Thorsten] Univ Kiel, Dept Internal Med, Div Nephrol & Hypertens, Kiel, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Duisburg Essen; University of Kiel	Weinberg, JM (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Div Nephrol, Dept Internal Med, Ann Arbor, MI 48105 USA.	wnberg@umich.edu	Feldkamp, Thorsten/F-7352-2011		National Institutes of Health [DK-34275]; Dr. Werner Jackstaedt-Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034275, R56DK034275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Werner Jackstaedt-Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK-34275 (J. M. Weinberg). Anja Bienholz and Thorsten Feldkamp received funding from the Dr. Werner Jackstaedt-Foundation (research scholarship and Junior Excellence Group) (www.jackstaedt-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Ackrell B A, 1978, Methods Enzymol, V53, P466; Armstrong C, 2010, J COMP PHYSIOL B, V180, P775, DOI 10.1007/s00360-010-0444-3; BALABAN RS, 1980, AM J PHYSIOL, V238, pF50, DOI 10.1152/ajprenal.1980.238.1.F50; CHANCE B, 1962, J BIOL CHEM, V237, P3540; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Feldkamp T, 2006, AM J PHYSIOL-RENAL, V290, pF465, DOI 10.1152/ajprenal.00305.2005; Feldkamp T, 2005, J AM SOC NEPHROL, V16, P1742, DOI 10.1681/ASN.2005010053; Feldkamp T, 2005, AM J PHYSIOL-RENAL, V288, pF1092, DOI 10.1152/ajprenal.00443.2004; Feldkamp T, 2004, AM J PHYSIOL-RENAL, V286, pF749, DOI 10.1152/ajprenal.00276.2003; Feldkamp T, 2007, AM J PHYSIOL-RENAL, V292, pF1606, DOI 10.1152/ajprenal.00476.2006; Feldkamp T, 2009, AM J PHYSIOL-RENAL, V297, pF1632, DOI 10.1152/ajprenal.00422.2009; Feldkamp T, 2009, NEPHROL DIAL TRANSPL, V24, P43, DOI 10.1093/ndt/gfn436; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; MATTHYS E, 1984, KIDNEY INT, V26, P153, DOI 10.1038/ki.1984.149; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PARDEE AB, 1948, J BIOL CHEM, V176, P1085; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Park JS, 2011, AM J PHYSIOL-RENAL, V301, pF134, DOI 10.1152/ajprenal.00033.2011; Skulachev VP, 1999, J BIOENERG BIOMEMBR, V31, P431, DOI 10.1023/A:1005492205984; Sogabe K, 1996, KIDNEY INT, V50, P845, DOI 10.1038/ki.1996.384; TAKANO T, 1985, J CLIN INVEST, V76, P2377, DOI 10.1172/JCI112250; TYLER DB, 1960, BIOCHEM J, V76, P293, DOI 10.1042/bj0760293; van Timmeren MM, 2005, NEPHROL DIAL TRANSPL, V20, P2349, DOI 10.1093/ndt/gfh964; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927, DOI 10.1152/ajprenal.2000.279.5.F927; Weinberg JM, 1997, KIDNEY INT, V52, P140, DOI 10.1038/ki.1997.313; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Weinberg JM, 2001, AM J PATHOL, V158, P2153, DOI 10.1016/S0002-9440(10)64687-1; WEINBERG JM, 1985, J CLIN INVEST, V76, P1193, DOI 10.1172/JCI112075; Wojtczak L, 1999, J BIOENERG BIOMEMBR, V31, P447, DOI 10.1023/A:1005444322823; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94584	10.1371/journal.pone.0094584	http://dx.doi.org/10.1371/journal.pone.0094584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728405	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200097
J	Coroller, TP; Mak, RH; Lewis, JH; Baldini, EH; Chen, AB; Colson, YL; Hacker, FL; Hermann, G; Kozono, D; Mannarino, E; Molodowitch, C; Wee, JO; Sher, DJ; Killoran, JH				Coroller, Thibaud P.; Mak, Raymond H.; Lewis, John H.; Baldini, Elizabeth H.; Chen, Aileen B.; Colson, Yolonda L.; Hacker, Fred L.; Hermann, Gretchen; Kozono, David; Mannarino, Edward; Molodowitch, Christina; Wee, Jon O.; Sher, David J.; Killoran, Joseph H.			Low Incidence of Chest Wall Pain with a Risk-Adapted Lung Stereotactic Body Radiation Therapy Approach Using Three or Five Fractions Based on Chest Wall Dosimetry	PLOS ONE			English	Article							PHASE-II; RADIOTHERAPY; CANCER; IRRADIATION; TOXICITY; OUTCOMES	Purpose: To examine the frequency and potential of dose-volume predictors for chest wall (CW) toxicity (pain and/or rib fracture) for patients receiving lung stereotactic body radiotherapy (SBRT) using treatment planning methods to minimize CW dose and a risk-adapted fractionation scheme. Methods: We reviewed data from 72 treatment plans, from 69 lung SBRT patients with at least one year of follow-up or CW toxicity, who were treated at our center between 2010 and 2013. Treatment plans were optimized to reduce CW dose and patients received a risk-adapted fractionation of 18 Gyx3 fractions (54 Gy total) if the CW V30 was less than 30 mL or 1012 Gyx5 fractions (50-60 Gy total) otherwise. The association between CW toxicity and patient characteristics, treatment parameters and dose metrics, including biologically equivalent dose, were analyzed using logistic regression. Results: With a median follow-up of 20 months, 6 (8.3%) patients developed CW pain including three (4.2%) grade 1, two (2.8%) grade 2 and one (1.4%) grade 3. Five (6.9%) patients developed rib fractures, one of which was symptomatic. No significant associations between CW toxicity and patient and dosimetric variables were identified on univariate nor multivariate analysis. Conclusions: Optimization of treatment plans to reduce CW dose and a risk-adapted fractionation strategy of three or five fractions based on the CW V30 resulted in a low incidence of CW toxicity. Under these conditions, none of the patient characteristics or dose metrics we examined appeared to be predictive of CW pain.	[Coroller, Thibaud P.; Mak, Raymond H.; Lewis, John H.; Baldini, Elizabeth H.; Chen, Aileen B.; Hacker, Fred L.; Hermann, Gretchen; Kozono, David; Mannarino, Edward; Molodowitch, Christina; Killoran, Joseph H.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Coroller, Thibaud P.; Mak, Raymond H.; Lewis, John H.; Baldini, Elizabeth H.; Chen, Aileen B.; Colson, Yolonda L.; Hacker, Fred L.; Kozono, David; Wee, Jon O.; Killoran, Joseph H.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Colson, Yolonda L.; Wee, Jon O.] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Sher, David J.] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA; [Coroller, Thibaud P.] Univ Grenoble 1, Dept Engn Hlth & Med, Grenoble, France	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Rush University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Killoran, JH (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.	jkilloran@lroc.harvard.edu	Sher, David/K-5118-2019	Coroller, Thibaud/0000-0001-7662-8724; Mak, Raymond/0000-0002-8754-0565	Kayes Family Scholars Award	Kayes Family Scholars Award	This study was supported by a Kayes Family Scholars Award, an internal grant specific to the authors' department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolino DL, 2011, INT J RADIAT ONCOL, V80, P692, DOI 10.1016/j.ijrobp.2010.03.020; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Bongers EM, 2011, J THORAC ONCOL, V6, P2052, DOI 10.1097/JTO.0b013e3182307e74; Dunlap NE, 2010, INT J RADIAT ONCOL, V76, P796, DOI 10.1016/j.ijrobp.2009.02.027; Grills IS, 2010, J CLIN ONCOL, V28, P928, DOI 10.1200/JCO.2009.25.0928; KUTCHER GJ, 1989, INT J RADIAT ONCOL, V16, P1623, DOI 10.1016/0360-3016(89)90972-3; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Park CS, 2005, INT J RADIAT ONCOL, V62, P925, DOI 10.1016/j.ijrobp.2004.11.039; Pettersson N, 2009, RADIOTHER ONCOL, V91, P360, DOI 10.1016/j.radonc.2009.03.022; Senthi S, 2012, LANCET ONCOL, V13, P802, DOI 10.1016/S1470-2045(12)70242-5; Stephans KL, 2012, INT J RADIAT ONCOL, V82, P974, DOI 10.1016/j.ijrobp.2010.12.002; Stephans KL, 2009, J THORAC ONCOL, V4, P976, DOI 10.1097/JTO.0b013e3181adf509; Timmerman R, 2013, JAMA-J AM MED ASSOC, V303, P1070; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Videtic GMM, 2010, CURR ONCOL REP, V12, P235, DOI 10.1007/s11912-010-0108-1; Welsh J, 2011, INT J RADIAT ONCOL, V81, P91, DOI 10.1016/j.ijrobp.2010.04.022; Woody NM, 2012, INT J RADIAT ONCOL, V83, P427, DOI 10.1016/j.ijrobp.2011.06.1971; Xiao Y, 2009, INT J RADIAT ONCOL, V73, P1235, DOI 10.1016/j.ijrobp.2008.11.019	19	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94859	10.1371/journal.pone.0094859	http://dx.doi.org/10.1371/journal.pone.0094859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728448	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200136
J	Erez, O; Novack, L; Beer-Weisel, R; Dukler, D; Press, F; Zlotnik, A; Than, NG; Tomer, A; Mazor, M				Erez, Offer; Novack, Lena; Beer-Weisel, Ruthy; Dukler, Doron; Press, Fernanda; Zlotnik, Alexander; Than, Nandor Gabor; Tomer, Aaron; Mazor, Moshe			DIC Score in Pregnant Women - A Population Based Modification of the International Society on Thrombosis and Hemostasis Score	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; ACTIVATED PROTEIN-C; AMNIOTIC-FLUID EMBOLISM; CRITICALLY-ILL PATIENTS; ELEVATED LIVER-ENZYMES; D-DIMER CONCENTRATIONS; TISSUE FACTOR; HELLP HEMOLYSIS; PROSPECTIVE VALIDATION; DIAGNOSTIC-CRITERIA	Objectives: The objectives of this study were: 1) To determine the component needed to generate a validated DIC score during pregnancy. 2) To validate such scoring system in the identification of patients with clinical diagnosis of DIC. Material and Methods: This is a population based retrospective study, including all women who gave birth at the 'Soroka University Medical Center' during the study period, and have had blood coagulation tests including complete blood cell count, prothrombin time (PT)(seconds), partial thromboplastin time (aPTT), fibrinogen, and D-dimers. Nomograms for pregnancy were established, and DIC score was constructed based on ROC curve analyses. Results: 1) maternal plasma fibrinogen concentrations increased during pregnancy; 2) maternal platelet count decreased gradually during gestation; 3) the PT and PTT values did not change with advancing gestation; 4) PT difference had an area under the curve (AUC) of 0.96 (p<0.001), and a PT difference >= 1.55 had an 87% sensitivity and 90% specificity for the diagnosis of DIC; 5) the platelet count had an AUC of 0.87 (p<0.001), an 86% sensitivity and 71% specificity for the diagnosis of DIC; 6) fibrinogen concentrations had an AUC of 0.95 (p<0.001) and a cutoff point <= 3.9 g/L had a sensitivity of 87% and a specificity of 92% for the development of DIC; and 7) The pregnancy adjusted DIC score had an AUC of 0.975 (p<0.001) and at a cutoff point of >= 26 had a sensitivity of 88%, a specificity of 96%, a LR(+) of 22 and a LR(-) of 0.125 for the diagnosis of DIC. Conclusion: We could establish a sensitive and specific pregnancy adjusted DIC score. The positive likelihood ratio of this score suggests that a patient with a score of >26 has a high probability to have DIC.	[Erez, Offer; Beer-Weisel, Ruthy; Dukler, Doron; Press, Fernanda; Mazor, Moshe] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Obstet & Gynecol, Soroka Univ Med Ctr,Sch Med, Beer Sheva, Israel; [Novack, Lena] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Sch Med, Beer Sheva, Israel; [Zlotnik, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Anesthesiol & Intens Care, Soroka Univ Med Ctr,Sch Med, Beer Sheva, Israel; [Than, Nandor Gabor] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Tomer, Aaron] Ben Gurion Univ Negev, Fac Hlth Sci, Blood Bank & Transfus Med, Soroka Univ Med Ctr,Sch Med, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Wayne State University; Ben Gurion University; Soroka Medical Center	Erez, O (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Obstet & Gynecol, Soroka Univ Med Ctr,Sch Med, Beer Sheva, Israel.	erezof@bgu.ac.il	NOVACK, LENA/AAH-8343-2021; Than, Nandor G/N-1442-2016	NOVACK, LENA/0000-0003-3748-2632; Tomer, Aaron/0000-0002-7025-5792				Angstwurm MWA, 2006, CRIT CARE MED, V34, P314, DOI 10.1097/01.CCM.0000196832.27501.B2; ARIAS F, 1979, AM J OBSTET GYNECOL, V133, P624, DOI 10.1016/0002-9378(79)90008-5; Asakura H, 2006, THROMB HAEMOSTASIS, V95, P282, DOI 10.1160/TH05-04-0286; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; BELLER FK, 1982, EUR J OBSTET GYN R B, V13, P177, DOI 10.1016/0028-2243(82)90028-4; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; BIEZENSKI JJ, 1958, J CLIN PATHOL, V11, P306, DOI 10.1136/jcp.11.4.306; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1016/S1521-6926(03)00021-5; Brenner B, 2005, THROMB RES, V115, P6; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Brown MD, 2002, ANN EMERG MED, V40, P133, DOI 10.1067/mem.2002.124755; Campbell IA, 2003, THORAX, V58, P470; Cauchie P, 2006, AM J HEMATOL, V81, P414, DOI 10.1002/ajh.20597; Cavkaytar S, 2007, ACTA OBSTET GYN SCAN, V86, P648, DOI 10.1080/00016340601185384; Cerneca F, 1997, EUR J OBSTET GYN R B, V73, P31, DOI 10.1016/S0301-2115(97)02734-6; Chakraverty R, 1996, BRIT J HAEMATOL, V93, P460, DOI 10.1046/j.1365-2141.1996.5101050.x; Clark P, 1998, THROMB HAEMOSTASIS, V79, P1166; CUMMING AM, 1995, BRIT J HAEMATOL, V90, P725, DOI 10.1111/j.1365-2141.1995.tb05610.x; Donohoe S, 2002, LUPUS, V11, P11, DOI 10.1191/0961203302lu132oa; Erez O, 2000, Harefuah, V139, P292; Erez O, 2009, J MATERN-FETAL NEO M, V22, P672, DOI 10.1080/14767050902853117; FAUGHT W, 1995, AM J OBSTET GYNECOL, V172, P147, DOI 10.1016/0002-9378(95)90104-3; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; FRANCALANCI I, 1995, THROMB RES, V78, P399, DOI 10.1016/0049-3848(95)00073-Z; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Gando S, 2004, INFLAMMATION, V28, P237, DOI 10.1023/B:IFLA.0000049049.81688.fe; Gando S, 2008, CRIT CARE MED, V36, P145, DOI 10.1097/01.CCM.0000295317.97245.2D; GANROT PO, 1972, SCAND J CLIN LAB INV, V29, P83, DOI 10.3109/00365517209102755; Gasem T, 2009, J MATERN-FETAL NEO M, V22, P1140, DOI 10.3109/14767050903019627; Haddad B, 2000, AM J OBSTET GYNECOL, V183, P444, DOI 10.1067/mob.2000.105915; Hahn L, 1974, Acta Obstet Gynecol Scand Suppl, V28, P7; Hansen AT, 2011, SCAND J CLIN LAB INV, V71, P173, DOI 10.3109/00365513.2010.545432; Hatada T, 2012, CLIN APPL THROMB-HEM, V18, P495, DOI 10.1177/1076029611429786; HELLGREN M, 1981, GYNECOL OBSTET INVES, V12, P141, DOI 10.1159/000299596; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Isler CM, 1999, AM J OBSTET GYNECOL, V181, P924, DOI 10.1016/S0002-9378(99)70343-1; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Kobayashi N, 1983, Bibl Haematol, P265; Lefkowitz JB, 1996, AM J OBSTET GYNECOL, V175, P657; Levi M, 2005, THROMB RES, V115, P54; Levi M, 2003, J THROMB THROMBOLYS, V16, P43, DOI 10.1023/B:THRO.0000014592.27892.11; Levi M, 2001, J CRIT CARE, V16, P167, DOI 10.1053/jcrc.2001.30666; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2008.07445.x, 10.1111/j.1365-2141.2009.07600.x]; LEVI M, 1993, JAMA-J AM MED ASSOC, V270, P975, DOI 10.1001/jama.270.8.975; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Levi M, 2013, THROMB RES, V131, pS32, DOI 10.1016/S0049-3848(13)70017-3; Levi M, 2013, INTERN EMERG MED, V8, P23, DOI 10.1007/s11739-012-0859-9; Levi M, 2011, BLOOD REV, V25, P33, DOI 10.1016/j.blre.2010.09.002; Levi M, 2009, BEST PRACT RES CL HA, V22, P129, DOI 10.1016/j.beha.2008.12.005; Levi M, 2009, THROMB RES, V123, pS63, DOI 10.1016/S0049-3848(09)70013-1; Liao WC, 2011, J MATERN-FETAL NEO M, V24, P1411, DOI 10.3109/14767058.2010.549975; Lockwood CJ, 2001, ANN NY ACAD SCI, V943, P77, DOI 10.1111/j.1749-6632.2001.tb03793.x; LOCKWOOD CJ, 1991, AM J OBSTET GYNECOL, V165, P1335; Lockwood CJ, 1999, SEMIN REPROD ENDOCR, V17, P45, DOI 10.1055/s-2007-1016211; Lurie S, 2000, ARCH GYNECOL OBSTET, V263, P126, DOI 10.1007/s004040050010; Mahieu B, 2007, BLOOD COAGUL FIBRIN, V18, P685, DOI 10.1097/MBC.0b013e3282f09835; Martin JN, 2013, J MATERN-FETAL NEO M, V26, P1201, DOI 10.3109/14767058.2013.773308; Martin JN, 2013, INT J GYNECOL OBSTET, V121, P202, DOI 10.1016/j.ijgo.2013.02.001; Martin JN, 1999, AM J OBSTET GYNECOL, V180, P1373, DOI 10.1016/S0002-9378(99)70022-0; Mimuro S, 1998, AUST NZ J OBSTET GYN, V38, P200, DOI 10.1111/j.1479-828X.1998.tb03002.x; Montagnana M, 2010, SEMIN THROMB HEMOST, V36, P404, DOI 10.1055/s-0030-1254049; MULLERBERGHAUS G, 1978, AM J OBSTET GYNECOL, V131, P655; NAIDOO SS, 1960, J CLIN PATHOL, V13, P224, DOI 10.1136/jcp.13.3.224; Oruc S, 2000, AUST NZ J OBSTET GYN, V40, P448, DOI 10.1111/j.1479-828X.2000.tb01179.x; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Rattray DD, 2012, J OBSTET GYNAECOL CA, V34, P341, DOI 10.1016/S1701-2163(16)35214-8; Rizoli S, 2011, J TRAUMA, V71, pS441, DOI 10.1097/TA.0b013e318232e688; Romero R, 2010, AM J REPROD IMMUNOL, V64, P113, DOI 10.1111/j.1600-0897.2010.00823.x; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; SPERO JA, 1980, THROMB HAEMOSTASIS, V43, P28; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; STIRLING Y, 1984, THROMB HAEMOSTASIS, V52, P176; Sundberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021134; Szecsi PB, 2010, THROMB HAEMOSTASIS, V103, P718, DOI 10.1160/TH09-10-0704; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Terao T, 1987, Asia Oceania J Obstet Gynaecol, V13, P1; Thachil J, 2009, BLOOD REV, V23, P167, DOI 10.1016/j.blre.2009.04.002; THORSEN S, 1973, SCAND J CLIN LAB INV, V31, P51, DOI 10.3109/00365517309082418; TYGART SG, 1986, AM J OBSTET GYNECOL, V154, P883, DOI 10.1016/0002-9378(86)90476-X; Uszynski M, 2001, EUR J OBSTET GYN R B, V95, P163, DOI 10.1016/S0301-2115(00)00448-6; VANBUUL EJA, 1995, NETH J MED, V46, P73, DOI 10.1016/0300-2977(94)00104-H; Voves C, 2006, BLOOD COAGUL FIBRIN, V17, P445, DOI 10.1097/01.mbc.0000240916.63521.2e; Walfish M, 2009, BR J ANAESTH S1, V103, pi47, DOI [DOI 10.1093/BJA/AEP303, DOI 10.1093/bja/aep303]	84	49	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93240	10.1371/journal.pone.0093240	http://dx.doi.org/10.1371/journal.pone.0093240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728139	Green Published, gold			2022-12-25	WOS:000336736200015
J	Okada, T; Nakamura, T; Watanabe, T; Onoda, N; Ashida, A; Okuyama, R; Ito, K				Okada, Toshihiro; Nakamura, Teruo; Watanabe, Takayuki; Onoda, Naoyoshi; Ashida, Atsuko; Okuyama, Ryuhei; Ito, Ken-ichi			Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma	PLOS ONE			English	Article							CELL ADHESION MOLECULE; CANCER STEM-CELLS; EP-CAM; BREAST-CANCER; POOR-PROGNOSIS; EXPRESSION; SURVIVAL; IDENTIFICATION; MARKER; OVEREXPRESSION	Background: Anaplastic thyroid cancer is considered to be one of the most aggressive human malignancies, and the mean survival time after diagnosis is approximately six months, regardless of treatments. This study aimed to examine how EpCAM and its related molecules are involved in the characteristics of anaplastic thyroid carcinoma. Methodology/Principal Findings: Two differentiated thyroid cancer cell lines (TPC-1 and FTC-133), and two anaplastic thyroid cancer cell lines (FRO, ACT-1) were analyzed for expression of CD44 standard isoform (CD44s), CD44 variant isoforms, and EpCAM, and human aldehyde dehydrogenase-1 (ALDH1) enzymatic activity using flow cytometry. CD44s expression was higher in TPC-1 and FTC-133 than in the FRO and ACT-1, whereas ALDH1 activities were higher in FRO and ACT-1 than in TPC-1 and FTC-133. An inverse correlation between CD44s expression and ALDH1 activity was observed in all thyroid cancer cell lines. As for the expressions of CD44 variant isoforms, ACT-1 showed higher and FRO showed moderate CD44v6 expressions, whereas either TPC-1 or FTC-133 showed negative CD44v6 expression. EpCAM expressions in FRO and ACT-1 were higher than those in TPC-1 and FTC-133, and EpCAM expressions inversely correlated with those of CD44s. A positive correlation was observed between EpCAM expression and ALDH1 activity in thyroid cancer cell lines. In the RT-PCR analysis, the expression levels of EpCAM, caludin-7 and ALDH1 in FRO and ATC-1 cells were significantly higher than those in TPC-1 and FTC-133 cells. In clinical specimens of thyroid cancers, nuclear expression of EpCAM and high expression of CD44v6 were detected significantly more frequently in anaplastic carcinomas. Conclusions/Significance: Our study suggests the possibility that EpCAM, together with CD44v6 and claudin-7 as well as ALDH1, may be involved in the development of the aggressive phenotype of anaplastic thyroid carcinoma. Our findings may suggest a novel therapeutic strategy for treatment of anaplastic thyroid carcinoma.	[Okada, Toshihiro; Watanabe, Takayuki; Ito, Ken-ichi] Shinshu Univ, Sch Med, Div Breast & Endocrine Surg, Dept Surg, Matsumoto, Nagano 390, Japan; [Nakamura, Teruo] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 390, Japan; [Onoda, Naoyoshi] Osaka City Univ, Sch Med, Dept Surg Oncol, Osaka 545, Japan; [Ashida, Atsuko; Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University; Osaka Metropolitan University; Shinshu University	Ito, K (corresponding author), Shinshu Univ, Sch Med, Div Breast & Endocrine Surg, Dept Surg, Matsumoto, Nagano 390, Japan.	kenito@shinshu-u.ac.jp		Ashida, Atsuko/0000-0001-9010-7781	JSPS KAKENHI [25461976]; Grants-in-Aid for Scientific Research [23591615] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25461976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Benko G, 2013, UROL ONCOL-SEMIN ORI, V31, P468, DOI 10.1016/j.urolonc.2011.03.007; Bergsagel P L, 1992, Curr Top Microbiol Immunol, V182, P223; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chung SH, 2002, JPN J CANCER RES, V93, P1358, DOI 10.1111/j.1349-7006.2002.tb01245.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; He HCH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042893; HOLTING T, 1994, J CLIN ENDOCR METAB, V79, P806, DOI 10.1210/jc.79.3.806; Ito K, 2012, HEAD NECK-J SCI SPEC, V34, P230, DOI 10.1002/hed.21721; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Kunavisarut Tada, 2012, BMC Cancer, V12, P523, DOI 10.1186/1471-2407-12-523; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mochizuki Y, 2013, THYROID; MOMBURG F, 1987, CANCER RES, V47, P2883; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Piyathilake CJ, 2000, HUM PATHOL, V31, P482, DOI 10.1053/hp.2000.6711; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Seligson DB, 2004, CLIN CANCER RES, V10, P2659, DOI 10.1158/1078-0432.CCR-1132-03; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wiseman SM, 2007, ANN SURG ONCOL, V14, P719, DOI 10.1245/s10434-006-9178-6; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	44	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94487	10.1371/journal.pone.0094487	http://dx.doi.org/10.1371/journal.pone.0094487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727741	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200080
J	Tracy, DJ; Xu, ZY; Choi, L; Acra, S; Chen, KY; Buchowski, MS				Tracy, Dustin J.; Xu, Zhiyi; Choi, Leena; Acra, Sari; Chen, Kong Y.; Buchowski, Maciej S.			Separating Bedtime Rest from Activity Using Waist or Wrist-Worn Accelerometers in Youth	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; SLEEP; CHILDREN; CALIBRATION; VALIDATION; ADIPOSITY; VALIDITY; MONITORS	Recent interest in sedentary behavior and technological advances expanded use of watch-size accelerometers for continuous monitoring of physical activity (PA) over extended periods (e. g., 24 h/day for 1 week) in studies conducted in natural living environment. This approach necessitates the development of new methods separating bedtime rest and activity periods from the accelerometer recordings. The goal of this study was to develop a decision tree with acceptable accuracy for separating bedtime rest from activity in youth using accelerometer placed on waist or wrist. Minute-by-minute accelerometry data were collected from 81 youth (10-18 years old, 47 females) during a monitored 24-h stay in a whole-room indirect calorimeter equipped with a force platform covering the floor to detect movement. Receiver Operating Characteristic (ROC) curve analysis was used to determine the accelerometer cut points for rest and activity. To examine the classification differences, the accelerometer bedtime rest and activity classified by the algorithm in the development group (n = 41) were compared with actual bedtime rest and activity classification obtained from the room calorimeter-measured metabolic rate and movement data. The selected optimal bedtime rest cut points were 20 and 250 counts/min for the waist- and the wrist-worn accelerometer, respectively. The selected optimal activity cut points were 500 and 3,000 counts/min for waist and wrist-worn accelerometers, respectively. Bedtime rest and activity were correctly classified by the algorithm in the validation group (n = 40) by both waist-(sensitivity: 0.983, specificity: 0.946, area under ROC curve: 0.872) and wrist-worn (0.999, 0.980 and 0.943) accelerometers. The decision tree classified bedtime rest correctly with higher accuracy than commonly used automated algorithm for both waist-and wrist-warn accelerometer (all p<0.001). We concluded that cut points developed and validated for waist-and wrist-worn uniaxial accelerometer have a good power for accurate separation of time spent in bedtime rest from activity in youth.	[Tracy, Dustin J.; Xu, Zhiyi; Buchowski, Maciej S.] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Energy Balance Lab, Nashville, TN 37235 USA; [Choi, Leena] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Acra, Sari] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Chen, Kong Y.] NIDDK, Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Buchowski, MS (corresponding author), Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Energy Balance Lab, Nashville, TN 37235 USA.	maciej.buchowski@vanderbilt.edu	Tracy, Dustin/AAQ-2085-2020; Chen, Kong/P-1685-2019; Chen, Kong Y/L-6972-2017	Tracy, Dustin/0000-0002-9618-4507; Chen, Kong/0000-0002-0306-1904; Chen, Kong Y/0000-0002-0306-1904; Buchowski, Maciej/0000-0002-0566-1743	National Institutes of Health (NIH) [RO1HL082988]; National Center for Advancing Translational Sciences of the National Institute of Health [UL1 TR000445]; Vanderbilt Diabetes Research Center [P60DK20593]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071013, P30DK020593, P60DK020593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institute of Health; Vanderbilt Diabetes Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health (NIH) award number RO1HL082988, the National Center for Advancing Translational Sciences of the National Institute of Health under award number UL1 TR000445, and the Vanderbilt Diabetes Research Center under award number P60DK20593. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actigraph, 2011, ACT GT3X MON ACTITRA, P47; Actigraph, 2007, ACT GT1M MON ACTITRA, P47; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Basterfield L, 2012, AM J PREV MED, V42, P445, DOI 10.1016/j.amepre.2012.01.007; Buchowski MS, 2004, EUR J CLIN NUTR, V58, P828, DOI 10.1038/sj.ejcn.1601928; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Choi L, 2010, J APPL PHYSIOL, V108, P314, DOI 10.1152/japplphysiol.00374.2009; De Vries SI, 2009, MED SCI SPORT EXER, V41, P818, DOI 10.1249/MSS.0b013e31818e5819; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Fulton JE, 2009, AM J PREV MED, V37, pS40, DOI 10.1016/j.amepre.2009.04.010; Girschik J, 2012, J EPIDEMIOL, V22, P462, DOI 10.2188/jea.JE20120012; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; Karlen W, 2011, IEEE T BIO-MED ENG, V58, P920, DOI 10.1109/TBME.2010.2097261; Kinder JR, 2012, J PEDIATR NURS, V27, P127, DOI 10.1016/j.pedn.2010.11.004; Lazaratou H, 2012, CURR OPIN PSYCHIATR, V25, P391, DOI 10.1097/YCO.0b013e3283556c7a; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Pearce MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037975; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP, P1; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; SUN M, 1994, J APPL PHYSIOL, V76, P2686, DOI 10.1152/jappl.1994.76.6.2686; SUN M, 1993, J BIOMECH, V26, P229, DOI 10.1016/0021-9290(93)90361-H; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Tudor-Locke Catrine, 2014, Appl Physiol Nutr Metab, V39, P53, DOI 10.1139/apnm-2013-0173; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Winkler EA, 2009, MED SCI SPORTS EXERC, V41, P171; Wrzus C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048089	38	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92512	10.1371/journal.pone.0092512	http://dx.doi.org/10.1371/journal.pone.0092512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727999	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200010
J	Zheng, J; Chan, T; Cheung, FSG; Zhu, L; Murray, M; Zhou, FF				Zheng, Jian; Chan, Ting; Cheung, Florence Shin Gee; Zhu, Ling; Murray, Michael; Zhou, Fanfan			PDZK1 and NHERF1 Regulate the Function of Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2) by Modulating Its Subcellular Trafficking and Stability	PLOS ONE			English	Article							INDUCED INTERNALIZATION; DRUG DISPOSITION; GRAPEFRUIT JUICE; POLYMORPHISMS; EXPRESSION; DOMAINS; CELLS; PHARMACOKINETICS; PHOSPHORYLATION; INHIBITORS	The human organic anion transporting polypeptide 1A2 (OATP1A2) is an important membrane protein that mediates the cellular influx of various substances including drugs. Previous studies have shown that PDZ-domain containing proteins, especially PDZK1 and NHERF1, regulate the function of related membrane transporters in other mammalian species. This study investigated the role of PDZK1 and NHERF1 in the regulation of OATP1A2 in an in vitro cell model. Transporter function and protein expression were assessed in OATP1A2-transfected HEK-293 cells that co-expressed PDZK1 or NHERF1. Substrate (estrone-3-sulfate) uptake by OATP1A2 was significantly increased to similar to 1.6-(PDZK1) and similar to 1.8-(NHERF1) fold of control; this was dependent on the putative PDZ-binding domain within the C-terminus of OATP1A2. The functional increase of OATP1A2 following PDZK1 or NHERF1 over-expression was associated with increased transporter expression at the plasma membrane and in the whole cell, and was reflected by an increase in the apparent maximal velocity of estrone-3-sulfate uptake (V-max: 138.9+/-4.1 (PDZK1) and 181.4+/-16.7 (NHERF1) versus 55.5+/-3.2 pmol*(mu g*4 min)(-1) in control; P<0.01). Co-immunoprecipitation analysis indicated that the regulatory actions of PDZK1 and NHERF1 were mediated by direct interaction with OATP1A2 protein. In further experiments PDZK1 and NHERF1 modulated OATP1A2 expression by decreasing its internalization in a clathrin-dependent (but caveolin-independent) manner. Additionally, PDZK1 and NHERF1 enhanced the stability of OATP1A2 protein in HEK-293 cells. The present findings indicated that PDZK1 and NHERF1 regulate the transport function of OATP1A2 by modulating protein internalization via a clathrin-dependent pathway and by enhancing protein stability.	[Zheng, Jian] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Peoples R China; [Zheng, Jian; Chan, Ting; Cheung, Florence Shin Gee; Zhou, Fanfan] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Zhu, Ling] Univ Sydney, Retinal Therapeut Res Grp, Save Sight Inst, Sydney, NSW 2006, Australia; [Murray, Michael] Univ Sydney, Sch Med Sci, Discipline Pharmacol, Sydney, NSW 2006, Australia	Northeast Forestry University - China; University of Sydney; University of Sydney; University of Sydney	Zhou, FF (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	fanfan.zhou@sydney.edu.au	Zhu, Ling/M-3887-2013; Zhou, Fanfan/J-2327-2019; Zhou, Fanfan/M-4404-2013	Zhu, Ling/0000-0003-0776-1630; Zhou, Fanfan/0000-0002-1982-1541; Zhou, Fanfan/0000-0002-1982-1541	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by The National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Badagnani I, 2006, J PHARMACOL EXP THER, V318, P521, DOI 10.1124/jpet.106.104364; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P705, DOI 10.1159/000185554; Cheng ZQ, 2012, XENOBIOTICA, V42, P880, DOI 10.3109/00498254.2012.675455; Choi JH, 2011, AM J PHYSIOL-GASTR L, V300, pG384, DOI 10.1152/ajpgi.00500.2010; Croons V, 2008, J PHARMACOL EXP THER, V325, P824, DOI 10.1124/jpet.107.132944; DARKEN MA, 1964, PHARMACOL REV, V16, P223; Eechoute K, 2011, CLIN PHARMACOL THER, V89, P816, DOI 10.1038/clpt.2011.42; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Gao B, 2000, J PHARMACOL EXP THER, V294, P73; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Guo GL, 2001, J PHARMACOL EXP THER, V299, P551; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Hu S, 2008, CLIN CANCER RES, V14, P3141, DOI 10.1158/1078-0432.CCR-07-4913; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Kato Y, 2004, PHARM RES-DORDR, V21, P1886, DOI 10.1023/B:PHAM.0000045244.83999.43; Kivisto KT, 2007, PHARM RES-DORDR, V24, P239, DOI 10.1007/s11095-006-9159-2; Kock K, 2010, J BIOL CHEM, V285, P11336, DOI 10.1074/jbc.M109.056457; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Le Vee M, 2008, DRUG METAB DISPOS, V36, P217, DOI 10.1124/dmd.107.016907; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Mandery K, 2010, BIOCHEM PHARMACOL, V80, P1746, DOI 10.1016/j.bcp.2010.08.008; Miyazaki H, 2005, J AM SOC NEPHROL, V16, P3498, DOI 10.1681/ASN.2005030306; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Noshiro R, 2006, KIDNEY INT, V70, P275, DOI 10.1038/sj.ki.5001522; Pawson AJ, 2003, ENDOCRINOLOGY, V144, P3860, DOI 10.1210/en.2003-0028; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Poirier A, 2007, CURR OPIN DRUG DISC, V10, P74; Rebello S, 2012, EUR J CLIN PHARMACOL, V68, P697, DOI 10.1007/s00228-011-1167-4; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Roth M, 2011, DRUG METAB DISPOS, V39, P920, DOI 10.1124/dmd.110.036640; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shirasaka Y, 2010, PHARM RES-DORDR, V27, P2141, DOI 10.1007/s11095-010-0216-5; Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823; Simpson JC, 1998, EXP CELL RES, V239, P293, DOI 10.1006/excr.1997.3921; Su YM, 2004, MOL PHARMACEUT, V1, P49, DOI 10.1021/mp0340136; Sugiura T, 2010, DRUG METAB PHARMACOK, V25, P588, DOI 10.2133/dmpk.DMPK-10-RG-074; Sugiura T, 2006, DRUG METAB PHARMACOK, V21, P375, DOI 10.2133/dmpk.21.375; Toh DSL, 2013, MOL PHARMACEUT, V10, P2509, DOI 10.1021/mp400193r; Toh DSL, 2011, BIOCHEM PHARMACOL, V82, P1692, DOI 10.1016/j.bcp.2011.08.008; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; Vandenbulcke F, 2000, J CELL SCI, V113, P2963; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Wang WJ, 2014, DRUG METAB DISPOS, V42, P62, DOI 10.1124/dmd.113.054536; Watanabe C, 2006, DRUG METAB DISPOS, V34, P1927, DOI 10.1124/dmd.106.010207; Yang CH, 2010, TOXICOL SCI, V117, P294, DOI 10.1093/toxsci/kfq219; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200; Zhang Q, 2010, PHARM RES-DORDR, V27, P589, DOI 10.1007/s11095-009-9983-2; Zhou F, 2008, PHARM RES-DORDR, V25, P475, DOI 10.1007/s11095-007-9359-4; Zhou FF, 2013, AAPS J, V15, P1099, DOI 10.1208/s12248-013-9515-1; Zhou FF, 2011, BRIT J PHARMACOL, V162, P1380, DOI 10.1111/j.1476-5381.2010.01144.x; Zhou FF, 2010, BRIT J PHARMACOL, V159, P419, DOI 10.1111/j.1476-5381.2009.00545.x	56	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94712	10.1371/journal.pone.0094712	http://dx.doi.org/10.1371/journal.pone.0094712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728453	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200118
J	Miao, HS; Choi, BD; Suryadevara, CM; Sanchez-Perez, L; Yang, SC; De Leon, G; Sayour, EJ; McLendon, R; Herndon, JE; Healy, P; Archer, GE; Bigner, DD; Johnson, LA; Sampson, JH				Miao, Hongsheng; Choi, Bryan D.; Suryadevara, Carter M.; Sanchez-Perez, Luis; Yang, Shicheng; De Leon, Gabriel; Sayour, Elias J.; McLendon, Roger; Herndon, James E., II; Healy, Patrick; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.			EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; CLINICAL-TRIAL; ADVERSE EVENT; GLIOMA; CANCER; GENE; IMMUNOTHERAPY; THERAPY; RECOGNITION	Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and is uniformly lethal. T-cell-based immunotherapy offers a promising platform for treatment given its potential to specifically target tumor tissue while sparing the normal brain. However, the diffuse and infiltrative nature of these tumors in the brain parenchyma may pose an exceptional hurdle to successful immunotherapy in patients. Areas of invasive tumor are thought to reside behind an intact blood brain barrier, isolating them from effective immunosurveillance and thereby predisposing the development of "immunologically silent" tumor peninsulas. Therefore, it remains unclear if adoptively transferred T cells can migrate to and mediate regression in areas of invasive GBM. One barrier has been the lack of a preclinical mouse model that accurately recapitulates the growth patterns of human GBM in vivo. Here, we demonstrate that D-270 MG xenografts exhibit the classical features of GBM and produce the diffuse and invasive tumors seen in patients. Using this model, we designed experiments to assess whether T cells expressing third-generation chimeric antigen receptors (CARs) targeting the tumor-specific mutation of the epidermal growth factor receptor, EGFRvIII, would localize to and treat invasive intracerebral GBM. EGFRvIII-targeted CAR (EGFRvIII(+) CAR) T cells demonstrated in vitro EGFRvIII antigen-specific recognition and reactivity to the D-270 MG cell line, which naturally expresses EGFRvIII. Moreover, when administered systemically, EGFRvIII(+) CAR T cells localized to areas of invasive tumor, suppressed tumor growth, and enhanced survival of mice with established intracranial D-270 MG tumors. Together, these data demonstrate that systemically administered T cells are capable of migrating to the invasive edges of GBM to mediate antitumor efficacy and tumor regression.	[Miao, Hongsheng; Choi, Bryan D.; Suryadevara, Carter M.; Sanchez-Perez, Luis; Yang, Shicheng; De Leon, Gabriel; Sayour, Elias J.; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.] Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA; [Choi, Bryan D.; Sayour, Elias J.; McLendon, Roger; Archer, Gary E.; Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [De Leon, Gabriel] Duke Univ, Med Ctr, Dept Mol Canc Biol, Durham, NC USA; [McLendon, Roger; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Herndon, James E., II; Healy, Patrick] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Sampson, JH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA.	john.sampson@duke.edu		Sampson, John/0000-0002-0104-7658	National Institutes of Health [1R01CA177476-01, 5R01-CA135272-05, 5P50-NS020023- 30, 3R25-NS065731-03S1, 1F30CA177152-01]; Pediatric Brain Tumor Foundation; Ben and Catherine Ivy Foundation; Against Brain Cancer; American Brain Tumor Association; Duke Cancer Institute; NATIONAL CANCER INSTITUTE [F30CA177152, R01CA135272, P30CA014236, R01CA177476, DP2CA174502, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023, R25NS065731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Ben and Catherine Ivy Foundation; Against Brain Cancer; American Brain Tumor Association; Duke Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health: 1R01CA177476-01 (J.H. Sampson), 5R01-CA135272-05 (J.H. Sampson), 5P50-NS020023- 30 (D. D. Bigner and J.H. Sampson), 3R25-NS065731-03S1 (J.H. Sampson), 1F30CA177152-01 (B. D. Choi). Additional support was provided by the Pediatric Brain Tumor Foundation (D. D. Bigner and J.H. Sampson), Ben and Catherine Ivy Foundation (J.H. Sampson), Voices Against Brain Cancer (L. A. Johnson), American Brain Tumor Association (L. A. Johnson), and Duke Cancer Institute (J.H. Sampson and B. D. Choi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Ajay Divya, 2012, Curr Drug Discov Technol, V9, P237; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; BIGNER SH, 1990, CANCER RES, V50, P8017; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Choi BD, 2014, J CLIN NEUROSCI, V21, P189, DOI 10.1016/j.jocn.2013.03.012; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hashizume R, 2010, J NEURO-ONCOL, V96, P151, DOI 10.1007/s11060-009-9954-9; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hong JJ, 2010, CLIN CANCER RES, V16, P4892, DOI 10.1158/1078-0432.CCR-10-1507; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; IMPERATO JP, 1990, ANN NEUROL, V28, P818, DOI 10.1002/ana.410280614; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Lal A, 2002, CANCER RES, V62, P3335; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miura FK, 2010, CLINICS, V65, P305, DOI 10.1590/S1807-59322010000300011; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2003, J IMMUNOTHER, V26, P385, DOI 10.1097/00002371-200309000-00001; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sampson JH, 2013, CLIN CANC RES; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	51	74	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94281	10.1371/journal.pone.0094281	http://dx.doi.org/10.1371/journal.pone.0094281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722266	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100049
J	Onoda, A; Umezawa, M; Takeda, K; Ihara, T; Sugamata, M				Onoda, Atsuto; Umezawa, Masakazu; Takeda, Ken; Ihara, Tomomi; Sugamata, Masao			Effects of Maternal Exposure to Ultrafine Carbon Black on Brain Perivascular Macrophages and Surrounding Astrocytes in Offspring Mice	PLOS ONE			English	Article							COMBUSTION-DERIVED NANOPARTICLES; IN-VIVO; PULMONARY EXPOSURE; INTERSTITIAL FLUID; TRANSITION-METALS; CELLS; PARTICLES; MICROGLIA; RAT; CNS	Perivascular macrophages (PVMs) constitute a subpopulation of resident macrophages in the central nervous system (CNS). They are located at the blood-brain barrier and can contribute to maintenance of brain functions in both health and disease conditions. PVMs have been shown to respond to particle substances administered during the prenatal period, which may alter their phenotype over a long period. We aimed to investigate the effects of maternal exposure to ultrafine carbon black (UfCB) on PVMs and astrocytes close to the blood vessels in offspring mice. Pregnant mice were exposed to UfCB suspension by intranasal instillation on gestational days 5 and 9. Brains were collected from their offspring at 6 and 12 weeks after birth. PVM and astrocyte phenotypes were examined by Periodic Acid Schiff (PAS) staining, transmission electron microscopy and PAS-glial fibrillary acidic protein (GFAP) double staining. PVM granules were found to be enlarged and the number of PAS-positive PVMs was decreased in UfCB-exposed offspring. These results suggested that in offspring, "normal" PVMs decreased in a wide area of the CNS through maternal UfCB exposure. The increase in astrocytic GFAP expression level was closely related to the enlargement of granules in the attached PVMs in offspring. Honeycomb-like structures in some PVM granules and swelling of astrocytic end-foot were observed under electron microscopy in the UfCB group. The phenotypic changes in PVMs and astrocytes indicate that maternal UfCB exposure may result in changes to brain blood vessels and be associated with increased risk of dysfunction and disorder in the offspring brain.	[Onoda, Atsuto; Umezawa, Masakazu; Takeda, Ken] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hygien Chem, Noda, Chiba 278, Japan; [Onoda, Atsuto; Ihara, Tomomi; Sugamata, Masao] Tochigi Inst Clin Pathol, Dept Pathol, Nogi, Tochigi, Japan; [Umezawa, Masakazu; Takeda, Ken] Tokyo Univ Sci, Res Inst Sci & Technol, Ctr Environm Hlth Sci Next Generat, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science	Onoda, A (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Hygien Chem, Noda, Chiba 278, Japan.	atsutoyukari@gmail.com	Onoda, Atsuto/J-9291-2019	Onoda, Atsuto/0000-0002-4923-062X	JSPS KAKENHI [24790130]; MEXT; Ministry of Health, Labour and Welfare [12103301]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a JSPS KAKENHI Grant Number 24790130 (http://www.jsps.go.jp/english/e-grants/; 2012-2013), a MEXT-Supported Program for the Strategic Research Foundation at Private Universities (http://www.mext.go.jp/english/; 2011-2015) and a Grant-in-Aid for the Health and Labour Sciences Research Grant (Research on the Risk of Chemical Substances) from the Ministry of Health, Labour and Welfare (Grant Number 12103301, http://www.mhlw.go.jp/english/; 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BeruBe K, 2007, CLIN EXP PHARMACOL P, V34, P1044, DOI 10.1111/j.1440-1681.2007.04733.x; Brown DM, 2000, OCCUP ENVIRON MED, V57, P685, DOI 10.1136/oem.57.10.685; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; CSERR HF, 1974, EXP NEUROL, V45, P50, DOI 10.1016/0014-4886(74)90099-5; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; GRAEBER MB, 1992, J NEUROPATH EXP NEUR, V51, P303, DOI 10.1097/00005072-199205000-00009; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hougaard KS, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P269, DOI 10.1016/B978-0-12-382032-7.10021-9; Ihara T, 1998, VIRCHOWS ARCH, V433, P443, DOI 10.1007/s004280050272; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jackson P, 2011, AIR POLLUTION NEW DE, P59; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jacobsen NR, 2011, ENVIRON MOL MUTAGEN, V52, P331, DOI 10.1002/em.20629; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Kannan Srimathi, 2007, Ciênc. saúde coletiva, V12, P1591, DOI 10.1590/S1413-81232007000600020; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Klatzo I, 1976, J NEUROPATHOL EXP NE, V26, P1; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; LASSMANN H, 1991, J NEUROSCI RES, V28, P236, DOI 10.1002/jnr.490280211; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; MATO M, 1979, EXPERIENTIA, V35, P501, DOI 10.1007/BF01922731; Mato M, 2002, ACTA NEUROPATHOL, V103, P119; Mato T, 2009, J CLIN BIOCHEM NUTR, V44, P142, DOI 10.3164/jcbn.08-209; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Nakazawa T, 2006, J TOKYO WOM MED U, V76, P82; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Peters A, 1976, FINE STRUCTURE THENE; Peters K, 2004, J MATER SCI-MATER M, V15, P321, DOI 10.1023/B:JMSM.0000021095.36878.1b; Pietroiusti A, 2011, ACS NANO, V5, P4624, DOI 10.1021/nn200372g; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; STREIT WJ, 1993, GLIA, V7, P68, DOI 10.1002/glia.440070112; Sugamata M, 2006, J HEALTH SCI, V52, P82, DOI 10.1248/jhs.52.82; Takeda K, 2009, J HEALTH SCI, V55, P95, DOI 10.1248/jhs.55.95; Tin-Tin-Win-Shwe, 2006, TOXICOL LETT, V163, P153, DOI 10.1016/j.toxlet.2005.10.006; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Umezawa M, 2011, J TOXICOL SCI, V36, P461, DOI 10.2131/jts.36.461; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; WELLER RO, 1992, BRAIN PATHOL, V2, P277, DOI 10.1111/j.1750-3639.1992.tb00704.x; Wick P, 2010, ENVIRON HEALTH PERSP, V118, P432, DOI 10.1289/ehp.0901200; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wilson JG, 1972, PATHOPHYSIOLOGY GEST, VII, P270; Wilson MR, 2002, TOXICOL APPL PHARM, V184, P172, DOI 10.1006/taap.2002.9501; Yokota S, 2013, PLOS ONE, V5; ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233, DOI 10.1007/BF00296784	57	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94336	10.1371/journal.pone.0094336	http://dx.doi.org/10.1371/journal.pone.0094336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722459	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100055
J	Tung, EWY; Boudreau, A; Wade, MG; Atlas, E				Tung, Emily W. Y.; Boudreau, Adele; Wade, Michael G.; Atlas, Ella			Induction of Adipocyte Differentiation by Polybrominated Diphenyl Ethers (PBDEs) in 3T3-L1 Cells	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; LIVER-X-RECEPTORS; POLYCHLORINATED-BIPHENYLS; HUMAN EXPOSURE; IN-VITRO; ACCUMULATION; DISRUPTORS; EXPRESSION; MILK	Polybrominated diphenyl ethers (PBDEs) are a class of brominated flame retardants that were extensively used in commercial products. PBDEs are ubiquitous environmental contaminants that are both lipophilic and bioaccumulative. Effects of PBDEs on adipogenesis were studied in the 3T3-L1 preadipocyte cell model in the presence and absence of a known adipogenic agent, dexamethasone (DEX). A PBDE mixture designed to mimic body burden of North Americans was tested, in addition to the technical mixture DE-71 and the individual congener BDE-47. The mixture, DE-71, and BDE-47 all induced adipocyte differentiation as assessed by markers for terminal differentiation [ fatty acid binding protein 4 (aP2) and perilipin] and lipid accumulation. Characterization of the differentiation process in response to PBDEs indicated that adipogenesis induced by a minimally effective dose of DEX was enhanced by these PBDEs. Moreover, C/EBP alpha, PPAR gamma, and LXR alpha were induced late in the differentiation process. Taken together, these data indicate that adipocyte differentiation is induced by PBDEs; they act in the absence of glucocorticoid and enhance glucocorticoid-mediated adipogenesis.	[Tung, Emily W. Y.; Boudreau, Adele; Wade, Michael G.; Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada	Health Canada	Atlas, E (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	ella.atlas@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839	Health Canada Chemicals Management Plan	Health Canada Chemicals Management Plan	E.A. is funded by the Health Canada Chemicals Management Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Chen D, 2010, ENVIRON INT, V36, P800, DOI 10.1016/j.envint.2010.05.013; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; ERNEST SR, TOXICOL SCI, V127, P496; FORTE TM, 1981, LIPIDS, V16, P240, DOI 10.1007/BF02535023; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Hale RC, 2003, ENVIRON INT, V29, P771, DOI 10.1016/S0160-4120(03)00113-2; Hoppe AA, 2007, OBESITY, V15, P2942, DOI 10.1038/oby.2007.351; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P5177, DOI 10.1021/es050399x; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kelly BC, 2008, SCI TOTAL ENVIRON, V401, P60, DOI 10.1016/j.scitotenv.2008.03.045; Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850; Malarvannan G, 2013, ENVIRON INT, V55, P33, DOI 10.1016/j.envint.2013.02.012; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Mercado-Feliciano M, 2008, ENVIRON HEALTH PERSP, V116, P1315, DOI 10.1289/ehp.11343; Montano M, 2012, TOXICOL SCI, V130, P94, DOI 10.1093/toxsci/kfs228; Mundy WR, 2004, TOXICOL SCI, V82, P164, DOI 10.1093/toxsci/kfh239; Pacyniak E, 2011, TOXICOL APPL PHARM, V257, P23, DOI 10.1016/j.taap.2011.08.014; Pereira-Fernandes A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077481; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schecter A, 2003, ENVIRON HEALTH PERSP, V111, P1723, DOI 10.1289/ehp.6466; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; She JW, 2007, CHEMOSPHERE, V67, pS307, DOI 10.1016/j.chemosphere.2006.05.154; Sjodin A, 2003, ENVIRON INT, V29, P829, DOI 10.1016/S0160-4120(03)00108-9; Steffensen KR, 2002, BIOCHEM BIOPH RES CO, V293, P1333, DOI 10.1016/S0006-291X(02)00390-X; Suvorov A, 2009, TOXICOLOGY, V260, P126, DOI 10.1016/j.tox.2009.03.018; Teta D, 2005, NEPHROL DIAL TRANSPL, V20, P1329, DOI 10.1093/ndt/gfh812; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282	33	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94583	10.1371/journal.pone.0094583	http://dx.doi.org/10.1371/journal.pone.0094583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722056	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100102
J	Zhang, JQ; Li, DQ; Ge, PT; Guo, YP; Zhu, KY; Ma, EB; Zhang, JZ				Zhang, Jianqin; Li, Daqi; Ge, Pingting; Guo, Yaping; Zhu, Kun Yan; Ma, Enbo; Zhang, Jianzhen			Molecular and Functional Characterization of cDNAs Putatively Encoding Carboxylesterases from the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							JUVENILE-HORMONE ESTERASE; HUMAN LIVER CARBOXYLESTERASES; AMINO-ACID SUBSTITUTION; APHID MYZUS-PERSICAE; PEACH-POTATO APHID; INSECTICIDE RESISTANCE; MALATHION RESISTANCE; PHYLOGENETIC ANALYSIS; FIELD POPULATIONS; DEGRADING ENZYME	Carboxylesterases (CarEs) belong to a superfamily of metabolic enzymes encoded by a number of genes and are widely distributed in microbes, plants and animals including insects. These enzymes play important roles in detoxification of insecticides and other xenobiotics, degradation of pheromones, regulation of neurodevelopment, and control of animal development. In this study, we characterized a total of 39 full-length cDNAs putatively encoding different CarEs from the migratory locust, Locusta migratoria, one of the most severe insect pests in many regions of the world, and evaluated the role of four CarE genes in insecticide detoxification. Our phylogenetic analysis grouped the 39 CarEs into five different clades including 20 CarEs in clade A, 3 in D, 13 in E, 1 in F and 2 in I. Four CarE genes (LmCesA3, LmCesA20, LmCesD1, LmCesE1), representing three different clades (A, D and E), were selected for further analyses. The transcripts of the four genes were detectable in all the developmental stages and tissues examined. LmCesA3 and LmCesE1 were mainly expressed in the fat bodies and Malpighian tubules, whereas LmCesA20 and LmCesD1 were predominately expressed in the muscles and hemolymph, respectively. The injection of double-stranded RNA (dsRNA) synthesized from each of the four CarE genes followed by the bioassay with each of four insecticides (chlorpyrifos, malathion, carbaryl and deltamethrin) increased the nymphal mortalities by 37.2 and 28.4% in response to malathion after LmCesA20 and LmCesE1 were silenced, respectively. Thus, we proposed that both LmCesA20 and LmCesE1 played an important role in detoxification of malathion in the locust. These results are expected to help researchers reveal the characteristics of diverse CarEs and assess the risk of insecticide resistance conferred by CarEs in the locust and other insect species.	[Zhang, Jianqin; Li, Daqi; Ge, Pingting; Guo, Yaping; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Kansas State University	Zhu, KY (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	kzhu@ksu.edu; maenbo2003@sxu.edu.cn		Zhu, Kun Yan/0000-0001-9372-8030	International Cooperation and Exchange Program [31320103921]; Regular Research Program of the National Natural Science Foundation of China [31172161, 30870302]	International Cooperation and Exchange Program; Regular Research Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the International Cooperation and Exchange Program (Grant No. 31320103921) and Regular Research Program (Grant Nos. 31172161 and 30870302) of the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Akpan Bassey E., 2003, Acta Entomologica Sinica, V46, P558; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; Balakirev ES, 2003, GENETICS, V164, P533; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; CYGLER M, 1993, PROTEIN SCI, V2, P366; DELORME R, 1988, PESTIC BIOCHEM PHYS, V32, P240, DOI 10.1016/0048-3575(88)90107-1; DEVONSHIRE AL, 1979, NATURE, V280, P140, DOI 10.1038/280140a0; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; Field LM, 1998, BIOCHEM J, V330, P169; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; Fleming CD, 2005, J MOL BIOL, V352, P165, DOI 10.1016/j.jmb.2005.07.016; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; He YP, 2004, PESTIC BIOCHEM PHYS, V78, P103, DOI 10.1016/j.pestbp.2003.09.009; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P477, DOI 10.1016/S0965-1748(03)00010-9; Hirai M, 2002, INSECT BIOCHEM MOLEC, V32, P627, DOI 10.1016/S0965-1748(01)00141-2; Holmes RS, 2008, COMP BIOCHEM PHYS D, V3, P195, DOI 10.1016/j.cbd.2008.05.002; Holmes RS, 2010, GENETICA, V138, P695, DOI 10.1007/s10709-010-9438-z; Holmes RS, 2009, COMP BIOCHEM PHYS D, V4, P209, DOI 10.1016/j.cbd.2009.03.002; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Jeon JH, 2011, APPL ENVIRON MICROB, V77, P7830, DOI 10.1128/AEM.05363-11; Kamita SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028392; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Keeley L.L., 1985, P211; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; Lan WS, 2005, BIOTECHNOL LETT, V27, P1141, DOI 10.1007/s10529-005-8464-x; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071970; Ma EB, 2004, PESTIC BIOCHEM PHYS, V78, P67, DOI 10.1016/j.pestbp.2003.09.001; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; Marshall SDG, 2003, J MOL EVOL, V57, P487, DOI 10.1007/s00239-003-2492-8; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Nishi K, 2006, ARCH BIOCHEM BIOPHYS, V445, P115, DOI 10.1016/j.abb.2005.11.005; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Pan YO, 2009, COMP BIOCHEM PHYS B, V152, P266, DOI 10.1016/j.cbpb.2008.12.002; Patnaik BB, 2012, J ENVIRON BIOL, V33, P837; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058410; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Richmond RC, 1990, ECOLOGICAL EVOLUTION, P273; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Su HT, 2007, PRATACULTURAL SCI, V27, P78; Taskin V., 2004, Genetika, V40, P1475; Tsubota T, 2010, J PESTIC SCI, V35, P310, DOI 10.1584/jpestics.R10-04; Tsubota T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-377; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yang M L, 2008, ARCH BIOCH PHYSL, V69, P1; Yang ML, 2008, PESTIC BIOCHEM PHYS, V91, P32, DOI 10.1016/j.pestbp.2007.12.004; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zhang JZ, 2011, PEST MANAG SCI, V67, P183, DOI 10.1002/ps.2049; Zhang NN, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4101; Zhu YC, 1999, PESTIC SCI, V55, P398, DOI 10.1002/(SICI)1096-9063(199904)55:4&lt;398::AID-PS925&gt;3.0.CO;2-O	70	23	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94809	10.1371/journal.pone.0094809	http://dx.doi.org/10.1371/journal.pone.0094809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722667	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100137
J	Zhao, HG; Luo, FL; Li, HZ; Zhang, L; Yi, YF; Wan, JY				Zhao, Hengguang; Luo, Fuling; Li, Hongzhong; Zhang, Li; Yi, Yongfen; Wan, Jingyuan			Antinociceptive Effect of Tetrandrine on LPS-Induced Hyperalgesia via the Inhibition of IKK beta Phosphorylation and the COX-2/PGE(2) Pathway in Mice	PLOS ONE			English	Article							NF-KAPPA-B; PROSTAGLANDIN E-2; ACTIVATION; EXPRESSION; KINASE; ALPHA; AKT; HYPERSENSITIVITY; CYCLOOXYGENASE-2; ENDOTOXEMIA	Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid that is isolated from the Stephania Tetrandra. It is known to possess anti-inflammatory and immunomodulatory effects. We have shown that TET can effectively suppress the production of bacterial lipopolysaccharide (LPS)-induced inflammatory mediators, including cyclooxygenases (COXs), in macrophages. However, whether TET has an antinociceptive effect on LPS-induced hyperalgesia is unknown. In the present study, we investigated the potential antinociceptive effects of TET and the mechanisms by which it elicits its effects on LPS-induced hyperalgesia. LPS effectively evoked hyperalgesia and induced the production of PGE(2) in the sera, brain tissues, and cultured astroglia. TET pretreatment attenuated all of these effects. LPS also activated inhibitor of kappa B (I kappa B) kinase beta (IKK beta) and its downstream components in the I kappa B/nuclear factor (NF)-kappa B signaling pathway, including COX-2; the increase in expression levels of these components was significantly abolished by TET. Furthermore, in primary astroglia, knockdown of IKK beta, but not IKK alpha, reversed the effects of TET on the LPS-induced increase in I kappa B phosphorylation, P65 phosphorylation, and COX-2. Our results suggest that TET can effectively exert antinociceptive effects on LPS-induced hyperalgesia in mice by inhibiting IKK beta phosphorylation, which leads to the reduction in the production of important pain mediators, such as PGE(2) and COX-2, via the IKK beta/I kappa B/NF-kappa B pathway.	[Zhao, Hengguang] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China; [Luo, Fuling] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China; [Li, Hongzhong] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Zhang, Li] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China; [Yi, Yongfen] Chongqing Med Univ, Dept Pathol, Mol Med & Tumor Ctr, Chongqing, Peoples R China; [Wan, Jingyuan] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yi, YF (corresponding author), Chongqing Med Univ, Dept Pathol, Mol Med & Tumor Ctr, Chongqing, Peoples R China.	yiyongfen1953@aliyun.com; jywan@cqmu.edu.cn			National Natural Science Foundation of China [81072650, 81373870]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81072650 and 81373870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou LR, 2000, P NATL ACAD SCI USA, V97, P10272, DOI 10.1073/pnas.180319297; Benson S, 2012, PAIN, V153, P794, DOI 10.1016/j.pain.2011.12.001; Berenbaum F, 2004, JOINT BONE SPINE, V71, P451, DOI 10.1016/j.jbspin.2004.02.003; Cao L, 2009, NEUROSCIENCE, V158, P896, DOI 10.1016/j.neuroscience.2008.10.004; Dajani R, 2007, AM J PHYSIOL-GASTR L, V292, pG242, DOI 10.1152/ajpgi.00043.2006; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Gong X, 2010, INT IMMUNOPHARMACOL, V10, P357, DOI 10.1016/j.intimp.2009.12.010; Haddad JJ, 2011, CELL IMMUNOL, V271, P5, DOI 10.1016/j.cellimm.2011.06.021; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Islam S, 2004, MICROBIOL IMMUNOL, V48, P729, DOI 10.1111/j.1348-0421.2004.tb03598.x; Iturriaga-Vasquez P, 2003, J NAT PROD, V66, P954, DOI 10.1021/np030022+; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Kanngiesser M, 2012, J PAIN, V13, P485, DOI 10.1016/j.jpain.2012.02.010; Kaushik D, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/245431; Koppula S, 2013, AM J CHINESE MED, V41, P927, DOI 10.1142/S0192415X13500626; Kovacs KJ, 2008, PAIN, V136, P75, DOI 10.1016/j.pain.2007.06.017; Lee YS, 2012, FOODBORNE PATHOG DIS, V9, P686, DOI 10.1089/fpd.2011.1119; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Miyachi T, 2001, NEUROSCI RES, V40, P53, DOI 10.1016/S0168-0102(01)00208-5; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Nasrallah R, 2007, CLIN SCI, V113, P297, DOI 10.1042/CS20070089; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Park EJ, 2011, PHYTOCHEM LETT, V4, P426, DOI 10.1016/j.phytol.2011.07.009; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; Shao D, 2008, INFLAMM RES, V57, P601, DOI 10.1007/s00011-008-8053-2; Shen DF, 2010, BRIT J PHARMACOL, V159, P970, DOI 10.1111/j.1476-5381.2009.00605.x; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Thomsen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072110; Wang TH, 2012, ONCOL REP, V28, P1681, DOI 10.3892/or.2012.1999; Xiang Y, 2013, J MOL NEUROSCI; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yu XC, 2004, J PHARM PHARMACOL, V56, P115, DOI 10.1211/0022357022458	39	24	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94586	10.1371/journal.pone.0094586	http://dx.doi.org/10.1371/journal.pone.0094586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722146	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100103
J	Yoon, DS; Kim, YH; Lee, S; Lee, KM; Park, KH; Jang, Y; Lee, JW				Yoon, Dong Suk; Kim, Yun Hee; Lee, Seulgi; Lee, Kyoung-Mi; Park, Kwang Hwan; Jang, Yeonsue; Lee, Jin Woo			Interleukin-6 induces the lineage commitment of bone marrow-derived mesenchymal multipotent cells through down-regulation of Sox2 by osteogenic transcription factors	FASEB JOURNAL			English	Article						stemness; Runx2; Dlx5; cell-cell interaction; heterogeneous population	IN-VITRO CHONDROGENESIS; STEM-CELLS; STROMAL CELLS; PROGENITOR CELLS; OSTEOBLAST DIFFERENTIATION; REPLICATIVE SENESCENCE; CYTOKINE FAMILY; SELF-RENEWAL; CULTURE; EXPRESSION	Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are a heterogeneous population of cells that differ in size and morphology. BM-MSCs become committed to the osteogenic lineage as senescence approaches and lose multipotency. Nevertheless, little is known about the effects of cell-cell interaction between different populations on stemness loss and lineage commitment. The current study aimed to identify mechanisms by which cell-cell interactions between heterogeneous BM-MSCs affect stemness and lineage commitment of multipotent subpopulation. The lineage commitment of primitive multipotent cells was strongly induced in the presence of cytokines secreted by senescent-like cells in a cell culture insert system. Senescent-like cells secreted higher levels of interleukin-6 (IL-6) than primitive multipotent cells in a human cytokine array. IL-6 induced the lineage commitment and stemness loss in multipotent cells by decreasing Sox2 expression. Furthermore, we confirmed that IL-6 decreased the transcriptional activity of Sox2 through up-regulation of Runx2 and Dlx5. We suggest a mechanism by which IL-6 modulates the expression of Sox2, resulting in decreased multipotency and causing primitive multipotent cells to undergo osteogenic lineage commitment. This is the first study to identify mechanisms in which the cell-cell interactions between the different populations play important roles in the stemness loss and lineage commitment of multipotent populations.	[Yoon, Dong Suk; Kim, Yun Hee; Lee, Seulgi; Lee, Kyoung-Mi; Park, Kwang Hwan; Jang, Yeonsue; Lee, Jin Woo] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul 120752, South Korea; [Yoon, Dong Suk; Lee, Seulgi; Lee, Kyoung-Mi; Park, Kwang Hwan; Lee, Jin Woo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Lee, JW (corresponding author), Yonsei Univ, Coll Med, Dept Orthopaed Surg 29, Seoul 120752, South Korea.	ljwos@yuhs.ac	Yoon, Dong Suk/K-1077-2019	Yoon, Dong Suk/0000-0001-5945-5569; Jang, Yeonsue/0000-0001-5683-0001; Park, Kwang Hwan/0000-0002-2110-0559; Lee, Jin Woo/0000-0002-0293-9017	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology [NRF-2012R1A2A2A01012263]	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology	This work (NRF-2012R1A2A2A01012263) was supported by the Midcareer Researcher Program through a National Research Foundation (NRF) of Korea grant funded by the Ministry of Education, Science, and Technology.	Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Behbahaninia M, 2011, NEUROSURGERY, V69, pN19, DOI 10.1227/01.neu.0000405596.78460.20; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Cheleuitte D, 1998, J CLIN ENDOCR METAB, V83, P2043, DOI 10.1210/jc.83.6.2043; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Galderisi U, 2009, STEM CELLS DEV, V18, P1033, DOI 10.1089/scd.2008.0324; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Heymann D, 2000, CYTOKINE, V12, P1455, DOI 10.1006/cyto.2000.0747; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Iwasaki K, 2008, J DENT RES, V87, P937, DOI 10.1177/154405910808701002; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kozhevnikova M N, 2008, Izv Akad Nauk Ser Biol, P156; Krtolica A, 2003, Adv Gerontol, V11, P109; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Ksiazek K, 2009, REJUV RES, V12, P105, DOI 10.1089/rej.2009.0830; Kurz DJ, 2000, J CELL SCI, V113, P3613; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; METS T, 1981, MECH AGEING DEV, V16, P81, DOI 10.1016/0047-6374(81)90035-X; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Muraglia A, 2008, EUR J CELL BIOL, V87, P751, DOI 10.1016/j.ejcb.2008.04.004; Nelson Peter J, 2002, Kidney Int, V61, pS99; Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wang WG, 2003, TISSUE CELL, V35, P69, DOI 10.1016/S0040-8166(02)00106-4; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104	67	33	33	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3273	3286		10.1096/fj.13-248567	http://dx.doi.org/10.1096/fj.13-248567			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24719354				2022-12-25	WOS:000337949400046
J	Klein, G; Kobylak, N; Lindner, B; Stupak, A; Raina, S				Klein, Gracjana; Kobylak, Natalia; Lindner, Buko; Stupak, Anna; Raina, Satish			Assembly of Lipopolysaccharide in Escherichia coli Requires the Essential LapB Heat Shock Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; OUTER-MEMBRANE; FATTY-ACID; LIPID-A; NEISSERIA-MENINGITIDIS; FUNCTIONAL-ANALYSIS; CHROMOSOMAL GENES; EXPORT PATHWAY; CELL-ENVELOPE; TERMINAL END	Here, we describe two new heat shock proteins involved in the assembly of LPS in Escherichia coli, LapA and LapB (lipopolysaccharide assembly protein A and B). lapB mutants were identified based on an increased envelope stress response. Envelope stress-responsive pathways control key steps in LPS biogenesis and respond to defects in the LPS assembly. Accordingly, the LPS content in Delta lapB or Delta(lapA lapB) mutants was elevated, with an enrichment of LPS derivatives with truncations in the core region, some of which were pentaacylated and exhibited carbon chain polymorphism. Further, the levels of LpxC, the enzyme that catalyzes the first committed step of lipid A synthesis, were highly elevated in the Delta(lapA lapB) mutant. Delta(lapA lapB) mutant accumulated extragenic suppressors that mapped either to lpxC, waaC, and gmhA, or to the waaQ operon (LPS biosynthesis) and lpp (Braun's lipoprotein). Increased synthesis of either FabZ (3-R-hydroxymyristoyl acyl carrier protein dehydratase), slrA (novel RpoE-regulated non-coding sRNA), lipoprotein YceK, toxin HicA, or MurA (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) suppressed some of the Delta(lapA lapB) defects. LapB contains six tetratricopeptide repeats and, at the C-terminal end, a rubredoxin-like domain that was found to be essential for its activity. In pull-down experiments, LapA and LapB co-purified with LPS, Lpt proteins, FtsH (protease), DnaK, and DnaJ (chaperones). A specific interaction was also observed between WaaC and LapB. Our data suggest that LapB coordinates assembly of proteins involved in LPS synthesis at the plasma membrane and regulates turnover of LpxC, thereby ensuring balanced biosynthesis of LPS and phospholipids consistent with its essentiality.	[Klein, Gracjana; Kobylak, Natalia; Stupak, Anna; Raina, Satish] Gdansk Univ Technol, Fac Chem, PL-80233 Gdansk, Poland; [Klein, Gracjana; Lindner, Buko; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Fac Chem, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Stupak, Anna/0000-0003-4731-8879; Klein, Gracjana/0000-0001-8695-8065; Kobylak, Natalia/0000-0002-7908-2613	National Science Grant [2011/03/B/NZ1/02825]	National Science Grant	This work was supported by National Science Grant 2011/03/B/NZ1/02825 (to S. R.).	Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; BAIRD L, 1991, J BACTERIOL, V173, P5763, DOI 10.1128/jb.173.18.5763-5770.1991; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; BEALL B, 1987, J BACTERIOL, V169, P5408, DOI 10.1128/jb.169.12.5408-5415.1987; Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kadrmas JL, 1998, J BIOL CHEM, V273, P2799, DOI 10.1074/jbc.273.5.2799; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Putker F, 2014, J BACTERIOL, V196, P780, DOI 10.1128/JB.00943-13; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; SAMPSON BA, 1989, GENETICS, V122, P491; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schwalm J, 2013, J BACTERIOL, V195, P3734, DOI 10.1128/JB.00431-13; Schweiger R, 2013, J BIOL CHEM, V288, P30614, DOI 10.1074/jbc.M113.493015; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Xiao XR, 2013, BIOCHEMISTRY-US, V52, P8304, DOI 10.1021/bi401116n; Zeng DN, 2013, J BIOL CHEM, V288, P5475, DOI 10.1074/jbc.M112.447607; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	68	65	69	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14829	14853		10.1074/jbc.M113.539494	http://dx.doi.org/10.1074/jbc.M113.539494			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722986	Green Published, hybrid			2022-12-25	WOS:000337248100037
J	Liu, YB; Liu, ML; Li, XR; Cao, B; Ma, XF				Liu, Yubing; Liu, Meiling; Li, Xinrong; Cao, Bo; Ma, Xiaofei			Identification of Differentially Expressed Genes in Leaf of Reaumuria soongorica under PEG-Induced Drought Stress by Digital Gene Expression Profiling	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; UV-B RADIATION; DESERT PLANT; RESPONSIVE TRANSCRIPTOME; FLAVONOID BIOSYNTHESIS; MOLECULAR RESPONSES; SIGNAL-TRANSDUCTION; RICE GENOTYPES; SALT STRESS; TOLERANCE	Reaumuria soongorica (Pall.) Maxim., a resurrection semi-shrub, is a typical constructive and dominant species in desert ecosystems in northwestern China. However, the gene expression characteristics of R. soongorica under drought stress have not been elucidated. Digital gene expression analysis was performed using Illumina technique to investigate differentially expressed genes (DEGs) between control and PEG-treated samples of R. soongorica. A total of 212,338 and 211,052 distinct tags were detected in the control and PEG-treated libraries, respectively. A total of 1,325 genes were identified as DEGs, 379 (28.6%) of which were up-regulated and 946 (71.4%) were down-regulated in response to drought stress. Functional annotation analysis identified numerous drought-inducible genes with various functions in response to drought stress. A number of regulatory proteins, functional proteins, and proteins induced by other stress factors in R. soongorica were identified. Alteration in the regulatory proteins (transcription factors and protein kinase) may be involved in signal transduction. Functional proteins, including flavonoid biosynthetic proteins, late embryogenesis abundant (LEA) proteins, small heat shock proteins (sHSP), and aquaporin and proline transporter may play protective roles in response to drought stress. Flavonoids, LEA proteins and sHSP function as reactive oxygen species scavenger or molecular chaperone. Aquaporin and proline transporters regulate the distribution of water and proline throughout the whole plant. The tolerance ability of R. soongorica may be gained through effective signal transduction and enhanced protection of functional proteins to reestablish cellular homeostasis. DEGs obtained in this study may provide useful insights to help further understand the drought-tolerant mechanism of R. soongorica.	[Liu, Yubing; Liu, Meiling; Li, Xinrong; Cao, Bo] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China; [Liu, Yubing; Liu, Meiling; Li, Xinrong; Cao, Bo; Ma, Xiaofei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Lanzhou, Peoples R China; [Liu, Meiling; Cao, Bo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YB (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China.	ybliu13@163.com	Ma, Xiaofei/ABB-5302-2022; Liu, Yubing/AFR-0289-2022; Li, Xinrong/GNW-6025-2022	Ma, Xiaofei/0000-0001-9456-0065; Liu, Yubing/0000-0002-2338-097X; 	State Key Development Program for Basic Research of China (973 Program) [2013CB4229904]; National Science Foundation of China [31070358, 30800122]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the State Key Development Program for Basic Research of China (973 Program, Grant No. 2013CB4229904) and the National Science Foundation of China (Grant Nos. 31070358, 30800122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Albouyeh R, 2010, TREE GENET GENOMES, V6, P601, DOI 10.1007/s11295-010-0275-0; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Andre CM, 2009, PHYTOCHEMISTRY, V70, P1107, DOI 10.1016/j.phytochem.2009.07.008; Bai J, 2009, J PLANT BIOL, V52, P417, DOI 10.1007/s12374-009-9053-7; Banzet N, 1998, PLANT J, V13, P519, DOI 10.1046/j.1365-313X.1998.00056.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bray EA, 1996, TRENDS PLANT SCI, V96, P1360; Caruso A, 2008, J PLANT PHYSIOL, V165, P932, DOI 10.1016/j.jplph.2007.04.006; Castellarin SD, 2007, PLANTA, V227, P101, DOI 10.1007/s00425-007-0598-8; Chen FY, 2010, FISH SHELLFISH IMMUN, V28, P167, DOI 10.1016/j.fsi.2009.10.017; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheng LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054573; Da XL, 2012, PLANT PHYSIOL BIOCH, V56, P97, DOI 10.1016/j.plaphy.2012.04.008; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dinakar C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00482; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gao P, 2013, GENE, V527, P161, DOI 10.1016/j.gene.2013.05.049; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hamid Rifat, 2013, J Pharm Bioallied Sci, V5, P21, DOI 10.4103/0975-7406.106559; Han YP, 2010, PLANT PHYSIOL, V153, P806, DOI 10.1104/pp.109.152801; Hazen Samuel P., 2005, Functional & Integrative Genomics, V5, P104, DOI 10.1007/s10142-004-0126-x; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Isokpehi RD, 2011, BIOINFORM BIOL INSIG, V5, P41, DOI 10.4137/BBI.S6061; Jiang JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-72; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lawson T, 2003, J EXP BOT, V54, P1743, DOI 10.1093/jxb/erg186; Lee KW, 2012, BIOTECHNOL LETT, V34, P167, DOI 10.1007/s10529-011-0750-1; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Lertkiatmongkol P, 2010, J VECTOR ECOL, V35, P197, DOI 10.1111/j.1948-7134.2010.00047.x; Liu ML, 2013, PLANT PHYSIOL BIOCH, V73, P161, DOI 10.1016/j.plaphy.2013.09.016; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Liu YB, 2008, ACTA BIOL CRACOV BOT, V50, P19; Liu YB, 2010, PLANT PHYSIOL BIOCH, V48, P836, DOI 10.1016/j.plaphy.2010.07.001; Lovisolo C, 2006, NEW PHYTOL, V172, P469, DOI 10.1111/j.1469-8137.2006.01852.x; Ma JY, 2005, J INTEGR PLANT BIOL, V47, P1065, DOI 10.1111/j.1744-7909.2005.00129.x; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Morales LO, 2010, TREE PHYSIOL, V30, P923, DOI 10.1093/treephys/tpq051; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036471; Okcu Gamze, 2005, Turkish Journal of Agriculture and Forestry, V29, P237; Park JS, 2007, PLANT CELL REP, V26, P507, DOI 10.1007/s00299-006-0255-x; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Soto A, 1999, PLANT PHYSIOL, V120, P521, DOI 10.1104/pp.120.2.521; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3; Wang XH, 2011, MOL BIOTECHNOL, V48, P165, DOI 10.1007/s12033-010-9357-3; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson VM, 1999, CURR OPIN PLANT BIOL, V2, P327, DOI 10.1016/S1369-5266(99)80057-0; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Zhang L, 2013, ACTA PHYSIOL PLANT, V35, P3191, DOI 10.1007/s11738-013-1354-2; Zhou XA, 2009, PHYSIOL MOL PLANT P, V74, P142, DOI 10.1016/j.pmpp.2009.10.005; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	75	19	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94277	10.1371/journal.pone.0094277	http://dx.doi.org/10.1371/journal.pone.0094277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736242	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600058
J	Huang, KL; Chang, YJ; Chang, CH; Chang, TY; Liu, CH; Hsieh, IC; Wong, HF; Wai, YY; Chen, YW; Yip, BS; Lee, TH				Huang, Kuo-Lun; Chang, Yeu-Jhy; Chang, Chien-Hung; Chang, Ting-Yu; Liu, Chi-Hung; Hsieh, I-Chang; Wong, Ho-Fai; Wai, Yau-Yau; Chen, Yu-Wei; Yip, Bak-Sau; Lee, Tsong-Hai			Impact of Coexisting Coronary Artery Disease on the Occurrence of Cerebral Ischemic Lesions after Carotid Stenting	PLOS ONE			English	Article							HIGH-RISK PATIENTS; STENOSIS; ENDARTERECTOMY; PROTECTION; TAIWAN; ANGIOPLASTY; ANGIOGRAPHY; STROKE; MRI	Background: Coronary artery disease (CAD) may coexist with extracranial carotid artery stenosis (ECAS), but the influence of CAD on procedure-related complications after carotid artery stenting (CAS) has not been well investigated. The study aimed to determine the impact of CAD on the occurrence of peri-CAS cerebral ischemic lesions on diffusion-weighted imaging (DWI) scanning. Methods: Coronary angiography was performed within six months before CAS. DWI scanning was repetitively done within 1 week before and after CAS. Clinical outcome measures were stroke, angina, myocardial infarction and death within 30 days. Results: Among 126 patients (69.5 +/- 9.0 years) recruited for unilateral protected CAS, 33 (26%) patients had peri-CAS DWI-positive lesions. CAD was noted in 79% (26 in 33) and 48% (45 in 93) of patients with and without peri-CAS DWI-positive lesions (OR, 4.0; 95% CI, 1.6-10.0; P = .0018), and the number of concomitant CAD on coronary angiography was positively correlated with the risk for peri-CAS DWI-positive lesions (P = .0032). In patients with no CAD (n = 55), asymptomatic CAD (n = 41) and symptomatic CAD (n = 30), the occurrence rates of peri-CAS DWI-positive lesions were 13%, 41% and 30% (P = .0048), and the peri-CAS stroke rates were 2%, 7% and 0% (P = .2120). Conclusions: The severity of morphological CAD and the presence of either symptomatic or asymptomatic CAD are associated with the occurrence of peri-CAS cerebral ischemic lesions.	[Huang, Kuo-Lun; Chang, Yeu-Jhy; Chang, Chien-Hung; Chang, Ting-Yu; Liu, Chi-Hung; Lee, Tsong-Hai] Linkou Chang Gung Mem Hosp, Stroke Ctr, Taoyuan, Taiwan; [Huang, Kuo-Lun; Chang, Yeu-Jhy; Chang, Chien-Hung; Chang, Ting-Yu; Liu, Chi-Hung; Lee, Tsong-Hai] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Huang, Kuo-Lun; Chang, Yeu-Jhy; Chang, Chien-Hung; Chang, Ting-Yu; Liu, Chi-Hung; Hsieh, I-Chang; Wong, Ho-Fai; Wai, Yau-Yau; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Chien-Hung] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Hsieh, I-Chang] Linkou Chang Gung Mem Hosp, Cardiol Sect, Dept Internal Med, Taoyuan, Taiwan; [Wong, Ho-Fai; Wai, Yau-Yau] Linkou Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Chen, Yu-Wei] Landseed Hosp, Dept Neurol, Taoyuan, Taiwan; [Chen, Yu-Wei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Yu-Wei] Natl Cent Univ, Dept Comp Sci & Informat Engn, Zhongli City, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Hsinchu Branch, Dept Neurol, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Central University; National Taiwan University; National Taiwan University Hospital	Lee, TH (corresponding author), Linkou Chang Gung Mem Hosp, Stroke Ctr, Taoyuan, Taiwan.	thlee@adm.cgmh.org.tw		Chang, Ting-Yu/0000-0003-4642-7352; Yip, Bak-Sau/0000-0001-7942-8293	National Science Council, Taiwan [102-2314-B-182A-114-]; Chang Gung Memorial Hospital, Taiwan [CMRPG350733, CMRPG390821, CMRPG3B0612, CMRPG3A0352, CMRPG3B0111]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was carried out with financial support from the National Science Council, Taiwan (grant number 102-2314-B-182A-114-) and Chang Gung Memorial Hospital, Taiwan (grant CMRPG350733, CMRPG390821, CMRPG3B0612, CMRPG3A0352, and CMRPG3B0111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2013, STROKE, V44, P1186, DOI 10.1161/STROKEAHA.111.000261; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Bruder O, 2009, CEREBROVASC DIS, V28, P80, DOI 10.1159/000219301; Capoccia L, 2010, J VASC SURG, V51, P584, DOI 10.1016/j.jvs.2009.10.079; Chung C, 2010, ANN SURG, V252, P618, DOI 10.1097/SLA.0b013e3181f57ad2; Hammer FD, 2005, J VASC SURG, V42, P847, DOI 10.1016/j.jvs.2005.05.065; Hofmann R, 2006, ANN MED, V38, P137, DOI 10.1080/07853890600582891; Hofmann R, 2005, HEART, V91, P1438, DOI 10.1136/hrt.2004.050906; Hsieh MJ, 2009, AM J MED SCI, V338, P447, DOI 10.1097/MAJ.0b013e3181ab1c96; Huang KL, 2011, EUR NEUROL, V66, P351, DOI 10.1159/000332614; JENG JS, 1994, STROKE, V25, P1989, DOI 10.1161/01.STR.25.10.1989; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Kastrup A, 2008, J VASC SURG, V47, P88, DOI 10.1016/j.jvs.2007.09.045; Kastrup A, 2006, STROKE, V37, P2312, DOI 10.1161/01.STR.0000236492.86303.85; Lee TH, 2011, J FORMOS MED ASSOC, V110, P543, DOI 10.1016/S0929-6646(11)60081-8; Liu X, 2007, AM J ROENTGENOL, V189, P1326, DOI 10.2214/AJR.07.2805; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Maleux G, 2006, AM J NEURORADIOL, V27, P1830; Muller-Hulsbeck S, 2002, J ENDOVASC THER, V9, P793, DOI 10.1583/1545-1550(2002)009<0793:IVCOFC>2.0.CO;2; Pinero P, 2006, AM J NEURORADIOL, V27, P1338; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P611, DOI 10.1161/01.ATV.0000155965.54679.79; Sztriha LK, 2009, J NEUROL SCI, V283, P36, DOI 10.1016/j.jns.2009.02.307; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Underhill HR, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-31; Wehinger A, 2009, ATHEROSCLEROSIS, V206, P234, DOI 10.1016/j.atherosclerosis.2009.01.034; Wu YW, 2007, INT J CARDIOVAS IMAG, V23, P433, DOI 10.1007/s10554-006-9180-x; Xavier AR, 2008, ARCH NEUROL-CHICAGO, V65, P1670, DOI 10.1001/archneurol.2008.508; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Zelinger A, 2002, CHEST, V121, P1684, DOI 10.1378/chest.121.5.1684; Zhao XH, 2010, STROKE, V41, P1157, DOI 10.1161/STROKEAHA.110.580027	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94280	10.1371/journal.pone.0094280	http://dx.doi.org/10.1371/journal.pone.0094280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732408	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400025
J	Liu, MJ; Bao, SY; Napolitano, JR; Burris, DL; Yu, LB; Tridandapani, S; Knoell, DL				Liu, Ming-Jie; Bao, Shengying; Napolitano, Jessica R.; Burris, Dara L.; Yu, Lianbo; Tridandapani, Susheela; Knoell, Daren L.			Zinc Regulates the Acute Phase Response and Serum Amyloid A Production in Response to Sepsis through JAK-STAT3 Signaling	PLOS ONE			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME; TRANSPORTER ZIP14; IMMUNE; EXPRESSION; DISEASE; STAT3; PROTEINS; INTERLEUKIN-6; HOMEOSTASIS	Sepsis rapidly activates the host inflammatory response and acute phase response. Severe sepsis, complicated by multiple organ failure, is associated with overwhelming inflammation and high mortality. We previously observed that zinc (Zn) deficiency significantly increases mortality in a mouse model of polymicrobial sepsis due to over-activation of the inflammatory response. In order to identify potential mechanisms that account for Zn-responsive effects, we generated whole exome expression profiles from the lung tissue of septic mice that were maintained on Zn modified diets. Based on systems analysis, we observed that Zn deficiency enhances the acute phase response and particularly the JAK-STAT3 pathway, resulting in increased serum amyloid A production. In vitro studies of primary hepatocytes and HepG2 cells substantiated that Zn-deficiency augments serum amyloid A production through up-regulation of the JAK-STAT3 and NF-kappa B pathways. In contrast, Zn inhibited STAT3 activation through the up-regulation of SHP1 activity. Collectively, these findings demonstrate that Zn deficiency enhances the acute phase response through up-regulation of the JAK-STAT3 pathway, thereby perpetuating increased inflammation that may lead to increased morbidity and mortality in response to sepsis.	[Liu, Ming-Jie; Bao, Shengying; Napolitano, Jessica R.; Burris, Dara L.; Tridandapani, Susheela; Knoell, Daren L.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Knoell, Daren L.] Ohio State Univ, Dept Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Knoell, DL (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	daren.knoell@osumc.edu	yu, lianbo/B-3472-2010; Tridandapani, Susheela/E-4209-2011		National Institutes of Health [R01 HL086981-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant R01 HL086981-01 to D.L.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; COUSINS RJ, 1988, FASEB J, V2, P2884, DOI 10.1096/fasebj.2.13.2458983; Cvijanovich NZ, 2009, PEDIATR CRIT CARE ME, V10, P29, DOI 10.1097/PCC.0b013e31819371ce; Dhainaut JF, 2001, CRIT CARE MED, V29, pS42, DOI 10.1097/00003246-200107001-00016; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Haase H, 2006, BIOGERONTOLOGY, V7, P421, DOI 10.1007/s10522-006-9057-3; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kahmann L, 2008, REJUV RES, V11, P227, DOI 10.1089/rej.2007.0613; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morrow DA, 2000, J AM COLL CARDIOL, V35, P358, DOI 10.1016/S0735-1097(99)00574-4; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Ochrietor JD, 2000, CYTOKINE, V12, P888, DOI 10.1006/cyto.2000.0668; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Parrish WR, 2008, ANN NY ACAD SCI, V1144, P210, DOI 10.1196/annals.1418.011; Quinton LJ, 2012, J CLIN INVEST, V122, P1758, DOI 10.1172/JCI59408; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Remick DG, 2003, CURR PHARM DESIGN, V9, P75, DOI 10.2174/1381612033392567; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rofe AM, 1996, BIOCHEM J, V314, P793, DOI 10.1042/bj3140793; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; Williams SCP, 2012, NAT MED, V18, P1001, DOI 10.1038/nm0712-1001; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120	56	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94934	10.1371/journal.pone.0094934	http://dx.doi.org/10.1371/journal.pone.0094934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732911	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400133
J	Quaranta, P; Antonini, S; Spiga, S; Mazzanti, B; Curcio, M; Mulas, G; Diana, M; Marzola, P; Mosca, F; Longoni, B				Quaranta, Paola; Antonini, Sara; Spiga, Saturnino; Mazzanti, Benedetta; Curcio, Michele; Mulas, Giovanna; Diana, Marco; Marzola, Pasquina; Mosca, Franco; Longoni, Biancamaria			Co-Transplantation of Endothelial Progenitor Cells and Pancreatic Islets to Induce Long-Lasting Normoglycemia in Streptozotocin-Treated Diabetic Rats	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ISCHEMIA-REPERFUSION INJURY; DECREASED OXYGEN-TENSION; BONE-MARROW; IN-VITRO; GENE-EXPRESSION; REVASCULARIZATION; DONOR; MODEL; MICROVASCULATURE	Graft vascularization is a crucial step to obtain stable normoglycemia in pancreatic islet transplantation. Endothelial progenitor cells (EPCs) contribute to neoangiogenesis and to the revascularization process during ischaemic events and play a key role in the response to pancreatic islet injury. In this work we co-transplanted EPCs and islets in the portal vein of chemically-induced diabetic rats to restore islet vascularization and to improve graft survival. Syngenic islets were transplanted, either alone or with EPCs derived from green fluorescent protein (GFP) transgenic rats, into the portal vein of streptozotocin-induced diabetic rats. Blood glucose levels were monitored and intraperitoneal glucose tolerance tests were performed. Real time-PCR was carried out to evaluate the gene expression of angiogenic factors. Diabetic-induced rats showed long-lasting (6 months) normoglycemia upon co-transplantation of syngenic islets and EPCs. After 3-5 days from transplantation, hyperglycaemic levels dropped to normal values and lasted unmodified as long as they were checked. Further, glucose tolerance tests revealed the animals' ability to produce insulin on-demand as indexed by a prompt response in blood glucose clearance. Graft neovascularization was evaluated by immunohistochemistry: for the first time the measure of endothelial thickness revealed a donor-EPC-related neovascularization supporting viable islets up to six months after transplant. Our results highlight the importance of a newly formed viable vascular network together with pancreatic islets to provide de novo adequate supply in order to obtain enduring normoglycemia and prevent diabetes-related long-term health hazards.	[Quaranta, Paola; Antonini, Sara; Mosca, Franco; Longoni, Biancamaria] Univ Pisa, Dept Translat Res & New Technol Med, Pisa, Italy; [Spiga, Saturnino; Mulas, Giovanna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Mazzanti, Benedetta] Univ Florence, Dept Clin & Expt Med, Haematol Sect, Florence, Italy; [Curcio, Michele] Azienda Osped Univ Pisana, UO Immunohaematol, Pisa, Italy; [Diana, Marco] Univ Sassari, G Minardi Lab Cognit Neurosci, Dept Chem & Pharm, I-07100 Sassari, Italy; [Marzola, Pasquina] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy	University of Pisa; University of Cagliari; University of Florence; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Sassari; University of Verona	Longoni, B (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med, Pisa, Italy.	biancamaria.longoni@med.unipi.it	Quaranta, Paola/GLT-9580-2022; Diana, Marco/D-1475-2011	Quaranta, Paola/0000-0001-8828-0905; Diana, Marco/0000-0002-6561-5642; Spiga, Saturnino/0000-0003-2561-0174; MARZOLA, Pasquina/0000-0001-6936-8901; Mulas, Giovanna/0000-0002-6654-9966	Italian Ministry of Instruction, University and Research; Fondazione ARPA	Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione ARPA	This work was supported by Research Program of National Interest funded by the Italian Ministry of Instruction, University and Research to F. M. and B. L. and by Fondazione ARPA (www.fondazionearpa.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEJANDRO R, 1986, J CLIN INVEST, V78, P1339, DOI 10.1172/JCI112720; Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avogaro A, 2008, DIABETES RES CLIN PR, V82, pS94, DOI 10.1016/j.diabres.2008.09.021; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carlsson PO, 1998, DIABETES, V47, P1586, DOI 10.2337/diabetes.47.10.1586; Carlsson PO, 2000, TRANSPLANTATION, V69, P761; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Contreras JL, 2003, SURGERY, V134, P390, DOI 10.1067/msy.2003.250; Coppens V, 2013, DIABETOLOGIA, V56, P382, DOI 10.1007/s00125-012-2754-3; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fedak PWM, 2001, HEART SURG FORUM, V4, P301; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; JANSSON L, 1994, DIABETES METAB REV, V10, P407, DOI 10.1002/dmr.5610100405; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jiga J, 2013, J SURG RES, V181, P359, DOI 10.1016/j.jss.2012.06.059; Jirak D, 2009, MAGN RESON MATER PHY, V22, P257, DOI 10.1007/s10334-009-0172-4; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kang S, 2012, DIABETES, V61, P866, DOI 10.2337/db10-1492; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056696; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Longoni B, 2010, DIABETES TECHNOL THE, V12, P435, DOI 10.1089/dia.2009.0154; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Moriconi F, 2009, STRAHLENTHER ONKOL, V185, P460, DOI 10.1007/s00066-009-1964-1; MURAKAMI T, 1992, ARCH HISTOL CYTOL, V55, P453, DOI 10.1679/aohc.55.453; Narantuya D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011746; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Nyqvist D, 2011, DIABETES, V60, P2571, DOI 10.2337/db10-1711; Oh BJ, 2013, AM J TRANSPLANT, V13, P1429, DOI 10.1111/ajt.12222; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P710, DOI 10.1016/j.biocel.2006.02.004; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ranjan AK, 2009, ISLETS, V1, P2, DOI 10.4161/isl.1.1.9054; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Shapiro A M, 2000, Diabetes Technol Ther, V2, P449, DOI 10.1089/15209150050194314; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73; Song HJ, 2010, TRANSPL P, V42, P2662, DOI 10.1016/j.transproceed.2010.06.003; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; VAJKOCZY P, 1995, AM J PATHOL, V146, P1397; Vasir B, 2001, TRANSPLANTATION, V71, P924, DOI 10.1097/00007890-200104150-00018; Vella F, 1994, BIOCHEM EDUC, V22, P164, DOI DOI 10.1016/0307-4412(94)90059-0; Vittorio O, 2011, NANOMEDICINE-UK, V6, P43, DOI [10.2217/nnm.10.125, 10.2217/NNM.10.125]; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yan S, 2007, MICROSURG, V27, P569, DOI 10.1002/micr.20404; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963	74	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94783	10.1371/journal.pone.0094783	http://dx.doi.org/10.1371/journal.pone.0094783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733186	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400101
J	Inami, T; Kataoka, M; Ando, M; Fukuda, K; Yoshino, H; Satoh, T				Inami, Takumi; Kataoka, Masaharu; Ando, Motomi; Fukuda, Keiichi; Yoshino, Hideaki; Satoh, Toru			A New Era of Therapeutic Strategies for Chronic Thromboembolic Pulmonary Hypertension by Two Different Interventional Therapies; Pulmonary Endarterectomy and Percutaneous Transluminal Pulmonary Angioplasty	PLOS ONE			English	Article							HEMODYNAMICS	Background: Pulmonary endarterectomy (PEA) is established for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). Recently, percutaneous transluminal pulmonary angioplasty (PTPA) has been added for peripheral-type CTEPH, whose lesions exist in segmental, subsegmental, and more distal pulmonary arteries. A shift in clinical practice of interventional therapies occurred in 2009 (first mainly PEA, later PTPA). We examined the latest clinical outcomes of patients with CTEPH. Methods and Results: This study retrospectively included 136 patients with CTEPH. Twenty-nine were treated only with drug (Drug-group), and the other 107 underwent interventional therapies (Interventions-group) (39 underwent PEA [PEA-group] and 68 underwent PTPA [PTPA-group]). Total 213 PTPA sessions (failures, 0%; mortality rate, 1.47%) was performed in the PTPA-group (complications: reperfusion pulmonary edema, 7.0%; hemosputum or hemoptysis, 5.6%; vessel dissection, 2.3%; wiring perforation, 0.9%). Although baseline hemodynamic parameters were significantly more severe in the Interventions-group, the outcome after the diagnosis was much better in the Interventions-group than in the Drug-group (98% vs. 64% 5-year survival, p < 0.0001). Hemodynamic improvement in the PEA-group was a 46% decrease in mean pulmonary arterial pressure (PAP) and a 49% decrease in total pulmonary resistance (TPR) (follow-up period; 74.7 +/- 32.3 months), while those in the PTPA-group were a 40% decrease in mean PAP and a 49% decrease in TPR (follow-up period; 17.4 +/- 9.3 months). The 2-year survival rate in the Drug-group was 82.0%, and the 2-year survival rate, occurrence of right heart failure, and re-vascularization rate in the PEA-group were 97.4%, 2.6%, and 2.8%, and those in the PTPA-group were 98.5%, 2.9%, and 2.9%, respectively. Conclusion: The patients who underwent interventional therapies had better results than those treated only with drugs. The availability of both of these operative and catheter-based interventional therapies leads us to expect the dawn of a new era of therapeutic strategies for CTEPH.	[Inami, Takumi; Kataoka, Masaharu; Yoshino, Hideaki; Satoh, Toru] Kyorin Univ, Sch Med, Div Cardiol, Dept Internal Med 2, Tokyo, Japan; [Kataoka, Masaharu; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Ando, Motomi] Fujita Hlth Univ, Dept Cardiovasc Surg, Toyoake, Aichi, Japan	Kyorin University; Keio University; Fujita Health University	Kataoka, M (corresponding author), Kyorin Univ, Sch Med, Div Cardiol, Dept Internal Med 2, Tokyo, Japan.	kataoka09@gmail.com; tsatoh@ks.kyorin-u.ac.jp	Fukuda, Keiichi/L-3777-2013		Actelion Phamaceuticals, Ltd.	Actelion Phamaceuticals, Ltd.	Dr. Toru Satoh spoke on pulmonary hypertension in general in lectures sponsored by Actelion Phamaceuticals, Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andreassen AK, 2013, HEART, V99, P1415, DOI 10.1136/heartjnl-2012-303549; Auger WR, 2010, CLIN CHEST MED, V31, P741, DOI 10.1016/j.ccm.2010.07.006; Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Fedullo P, 2011, AM J RESP CRIT CARE, V183, P1605, DOI 10.1164/rccm.201011-1854CI; Feinstein JA, 2001, CIRCULATION, V103, P10; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Inami T, AM J RESPIR IN PRESS; Inami T, 2013, JACC-CARDIOVASC INTE, V6, P725, DOI 10.1016/j.jcin.2013.03.009; Ishiguro H, 2013, JACC-CARDIOVASC INTE, V6, P1212, DOI 10.1016/j.jcin.2013.03.025; Jenkins DP, 2013, EUR RESPIR J, V41, P735, DOI 10.1183/09031936.00058112; Jensen KW, 2009, CIRCULATION, V120, P1248, DOI 10.1161/CIRCULATIONAHA.109.865881; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Madani MM, 2012, ANN THORAC SURG, V94, P97, DOI 10.1016/j.athoracsur.2012.04.004; Matsuda H, 2006, ANN THORAC SURG, V82, P1338, DOI 10.1016/j.athoracsur.2006.03.105; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; McNeil K, 2007, HEART, V93, P1152, DOI 10.1136/hrt.2004.053603; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Nishimura R, 2013, CIRC J, V77, P2110, DOI 10.1253/circj.CJ-12-1391; Pepke-Zaba J, 2013, EUR RESPIR J, V41, P985, DOI 10.1183/09031936.00201612; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Piovella F, 2006, SEMIN THROMB HEMOST, V32, P848, DOI 10.1055/s-2006-955467; Seyfarth HJ, 2010, CLIN RES CARDIOL, V99, P553, DOI 10.1007/s00392-010-0156-4; Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217; Yanagisawa R, EUROINTERVE IN PRESS	32	63	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94587	10.1371/journal.pone.0094587	http://dx.doi.org/10.1371/journal.pone.0094587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728482	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200099
J	Lassaux, P; Conchillo-Sole, O; Manjasetty, BA; Yero, D; Perletti, L; Belrhali, H; Daura, X; Gourlay, LJ; Bolognesi, M				Lassaux, Patricia; Conchillo-Sole, Oscar; Manjasetty, Babu A.; Yero, Daniel; Perletti, Lucia; Belrhali, Hassan; Daura, Xavier; Gourlay, Louise J.; Bolognesi, Martino			Redefining the PF06864 Pfam Family Based on Burkholderia pseudomallei PilO2(Bp) S-SAD Crystal Structure	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; R64 THIN-PILUS; COLONIZATION FACTOR; IV PILI; GENES; BIOGENESIS; MODEL; CONTRIBUTES; SECRETION; ADHERENCE	Type IV pili are surface-exposed filaments and bacterial virulence factors, represented by the Tfpa and Tfpb types, which assemble via specific machineries. The Tfpb group is further divided into seven variants, linked to heterogeneity in the assembly machineries. Here we focus on PilO2(Bp), a protein component of the Tfpb R64 thin pilus variant assembly machinery from the pathogen Burkholderia pseudomallei. PilO2Bp belongs to the PF06864 Pfam family, for which an improved definition is presented based on newly derived Hidden Markov Model (HMM) profiles. The 3D structure of the N-terminal domain of PilO2(Bp) (N-PilO2(Bp)), here reported, is the first structural representative of the PF06864 family. N-PilO2(Bp) presents an actin-like ATPase fold that is shown to be present in BfpC, a different variant assembly protein; the new HMM profiles classify BfpC as a PF06864 member. Our results provide structural insight into the PF06864 family and on the Type IV pili assembly machinery.	[Lassaux, Patricia; Perletti, Lucia; Gourlay, Louise J.; Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy; [Conchillo-Sole, Oscar; Yero, Daniel; Daura, Xavier] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, Bellaterra, Spain; [Manjasetty, Babu A.; Belrhali, Hassan] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [Manjasetty, Babu A.; Belrhali, Hassan] Univ Grenoble Alpes, European Mol Biol Lab, CNRS, Unit Virus Host Cell Interact, Grenoble, France; [Daura, Xavier] Catalan Inst Res & Adv Studies, Barcelona, Spain; [Bolognesi, Martino] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Bolognesi, Martino] Univ Milan, Inst Biophys, CNR, Milan, Italy	University of Milan; Autonomous University of Barcelona; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); ICREA; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Gourlay, LJ (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	louise.gourlay@unimi.it; martino.bolognesi@unimi.it	Yero, Daniel/L-9366-2014; Bolognesi, Martino/B-7924-2017; Daura, Xavier/C-9275-2009; Manjasetty, Babu A/F-8366-2013	Yero, Daniel/0000-0002-6234-4082; Bolognesi, Martino/0000-0002-9253-5170; Daura, Xavier/0000-0001-9235-6730; Manjasetty, Babu A/0000-0002-8229-4748; GOURLAY, LOUISE JANE/0000-0002-6369-2230; Conchillo-Sole, Oscar/0000-0003-4266-246X	Fondazione Cariplo (Milano, Italy) [20093577]; ICREA Funding Source: Custom	Fondazione Cariplo (Milano, Italy)(Fondazione Cariplo); ICREA(ICREA)	This work was supported by Fondazione Cariplo (Milano, Italy; www.fondazionecariplo.it) Project: "From Genome to Antigen: a Multidisciplinary Approach towards the Development of an Effective Vaccine against Burkholderia pseudomallei, the Etiological Agent of Melioidosis" (contract number 20093577). The funder is a non-profit foundation that had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; [Anonymous], 2013, NUCL ACIDS RES; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carter MQ, 2010, J BACTERIOL, V192, P3249, DOI 10.1128/JB.00041-10; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Crowther LJ, 2004, MOL MICROBIOL, V52, P67, DOI 10.1111/j.1365-2958.2003.03963.x; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Giron JA, 1997, GENE, V192, P39, DOI 10.1016/S0378-1119(97)00039-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kim SR, 1997, J BACTERIOL, V179, P3594, DOI 10.1128/jb.179.11.3594-3603.1997; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Morris C, 2003, MICROB PATHOGENESIS, V35, P279, DOI 10.1016/j.micpath.2003.08.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Roux N, 2012, RES MICROBIOL, V163, P659, DOI 10.1016/j.resmic.2012.10.015; Sakai D, 2002, J BACTERIOL, V184, P444, DOI 10.1128/JB.184.2.444-451.2002; Schell MA, 2008, J BACTERIOL, V190, P2306, DOI 10.1128/JB.01735-07; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; SHINAGAWA H, 1993, MICROBIOL IMMUNOL, V37, P689, DOI 10.1111/j.1348-0421.1993.tb01693.x; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Xu QF, 2012, BIOINFORMATICS, V28, P2763, DOI 10.1093/bioinformatics/bts533; Xu QP, 2012, MOL MICROBIOL, V83, P712, DOI 10.1111/j.1365-2958.2011.07954.x; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94981	10.1371/journal.pone.0094981	http://dx.doi.org/10.1371/journal.pone.0094981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728008	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200144
J	Ramanujam, V; Kotamarthi, HC; Ainavarapu, SRK				Ramanujam, Venkatraman; Kotamarthi, Hema Chandra; Ainavarapu, Sri Rama Koti			Ca2+ Binding Enhanced Mechanical Stability of an Archaeal Crystallin	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; SINGLE CALMODULIN MOLECULES; FACTOR A2 DOMAIN; UNFOLDING PATHWAYS; LIGAND-BINDING; PROTEIN; AFM; SIMULATION; ADHESION; COMPLEX	Structural topology plays an important role in protein mechanical stability. Proteins with beta-sandwich topology consisting of Greek key structural motifs, for example, I27 of muscle titin and (FNIII)-F-10 of fibronectin, are mechanically resistant as shown by single-molecule force spectroscopy (SMFS). In proteins with beta-sandwich topology, if the terminal strands are directly connected by backbone H-bonding then this geometry can serve as a "mechanical clamp''. Proteins with this geometry are shown to have very high unfolding forces. Here, we set out to explore the mechanical properties of a protein, M-crystallin, which belongs to beta-sandwich topology consisting of Greek key motifs but its overall structure lacks the "mechanical clamp'' geometry at the termini. M-crystallin is a Ca2+ binding protein from Methanosarcina acetivorans that is evolutionarily related to the vertebrate eye lens beta and gamma-crystallins. We constructed an octamer of crystallin, (M-crystallin)(8), and using SMFS, we show that M-crystallin unfolds in a two-state manner with an unfolding force similar to 90 pN (at a pulling speed of 1000 nm/sec), which is much lower than that of I27. Our study highlights that the b-sandwich topology proteins with a different strand-connectivity than that of I27 and (FNIII)-F-10, as well as lacking "mechanical clamp'' geometry, can be mechanically resistant. Furthermore, Ca2+ binding not only stabilizes M-crystallin by 11.4 kcal/mol but also increases its unfolding force by similar to 35 pN at the same pulling speed. The differences in the mechanical properties of apo and holo M-crystallins are further characterized using pulling speed dependent measurements and they show that Ca2+ binding reduces the unfolding potential width from 0.55 nm to 0.38 nm. These results are explained using a simple two-state unfolding energy landscape.	[Ramanujam, Venkatraman; Kotamarthi, Hema Chandra; Ainavarapu, Sri Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Ainavarapu, SRK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	koti@tifr.res.in	Kotamarthi, Hema Chandra/AEB-3344-2022; Ainavarapu, Sri Rama Koti/D-1231-2011; Ramanujam, Venkatraman/M-5098-2014	Ainavarapu, Sri Rama Koti/0000-0002-1646-2731; Ramanujam, Venkatraman/0000-0001-6745-9199	Tata Institute of Fundamental Research, India	Tata Institute of Fundamental Research, India	This work was funded by Tata Institute of Fundamental Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Arad-Haase G, 2010, BIOPHYS J, V99, P238, DOI 10.1016/j.bpj.2010.04.004; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bertz M, 2009, J MOL BIOL, V393, P1097, DOI 10.1016/j.jmb.2009.08.066; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13; Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2006, ANGEW CHEM INT EDIT, V45, P642, DOI 10.1002/anie.200502623; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; Desmeules P, 2002, BIOPHYS J, V82, P3343, DOI 10.1016/S0006-3495(02)75674-9; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Fuson KL, 2009, BIOPHYS J, V96, P1083, DOI 10.1016/j.bpj.2008.10.025; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Hoffmann T, 2012, CHEM SOC REV; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Kotamarthi HC, 2013, BIOPHYS J, V104, P2273, DOI [10.1016/J.BPJ.2013.04.008, 10.1016/j.bpj.2013.04.008]; Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036; Li HB, 2010, ACCOUNTS CHEM RES, V43, P1331, DOI 10.1021/ar100057a; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Li MS, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3106761; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x; Ng SP, 2005, J MOL BIOL, V350, P776, DOI 10.1016/j.jmb.2005.04.070; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oroz J, 2011, J BIOL CHEM, V286, P9405, DOI 10.1074/jbc.M110.170399; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Ramanujam V, 2012, PROTEIN EXPRES PURIF, V84, P116, DOI 10.1016/j.pep.2012.04.024; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Stahl SW, 2012, P NATL ACAD SCI USA, V109, P20431, DOI 10.1073/pnas.1211929109; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Zhang C, 2000, PROTEINS, V40, P409, DOI 10.1002/1097-0134(20000815)40:3<409::AID-PROT60>3.0.CO;2-6	53	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94513	10.1371/journal.pone.0094513	http://dx.doi.org/10.1371/journal.pone.0094513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728085	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200087
J	Santhanam, R; Groten, K; Meldau, DG; Baldwin, IT				Santhanam, Rakesh; Groten, Karin; Meldau, Dorothea G.; Baldwin, Ian T.			Analysis of Plant-Bacteria Interactions in Their Native Habitat: Bacterial Communities Associated with Wild Tobacco Are Independent of Endogenous Jasmonic Acid Levels and Developmental Stages	PLOS ONE			English	Article							POTATO SOLANUM-TUBEROSUM; BACILLUS SP B55; NICOTIANA-ATTENUATA; DEFENSE PATHWAYS; MICROBIAL COMMUNITIES; ARABIDOPSIS-THALIANA; INDUCED RESISTANCE; GROWTH PROMOTION; SALICYLIC-ACID; CROSS-TALK	Jasmonic acid (JA) mediates defense responses against herbivores and necrotrophic pathogens but does it influence the recruitment of bacterial communities in the field? We conducted field and laboratory experiments with transformed Nicotiana attenuata plants deficient in jasmonate biosynthesis (irAOC) and empty vector controls (EV) to answer this question. Using both culture-dependent and independent techniques, we characterized root and leaf-associated bacterial communities over five developmental stages, from rosette through flowering of plants grown in their natural habitat. Based on the pyrosequencing results, alpha and beta diversity did not differ among EV and irAOC plants or over ontogeny, but some genera were more abundant in one of the genotypes. Furthermore, bacterial communities were significantly different among leaves and roots. Taxa isolated only from one or both plant genotypes and hence classified as 'specialists' and 'generalists' were used in laboratory tests to further evaluate the patterns observed from the field. The putative specialist taxa did not preferentially colonize the jasmonate-deficient genotype, or alter the plant's elicited phytohormone signaling. We conclude that in N. attenuata, JA signaling does not have a major effect on structuring the bacterial communities and infer that colonization of plant tissues is mainly shaped by the local soil community in which the plant grows.	[Santhanam, Rakesh; Groten, Karin; Meldau, Dorothea G.; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Groten, K (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	kgroten@ice.mpg.de; baldwin@ice.mpg.de	Groten, Karin/B-2883-2018; Baldwin, Ian T/K-1809-2013; Groten, Karin/H-9652-2015	Groten, Karin/0000-0003-0177-8810; Groten, Karin/0000-0003-0177-8810; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; ERC [293926]; HFSP [RGP0002/2012]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); HFSP(Human Frontier Science Program)	The Max Planck Society and grants from the ERC (advanced grant Clock work Green: 293926 to ITB) and HFSP (RGP0002/2012) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreote FD, 2008, ANTON LEEUW INT J G, V93, P415, DOI 10.1007/s10482-007-9219-6; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; BALDWIN IT, 1994, J CHEM ECOL, V20, P2139, DOI 10.1007/BF02066250; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bonaventure G, 2011, PLANT CELL ENVIRON, V34, P1507, DOI 10.1111/j.1365-3040.2011.02348.x; Bragazza L, 2013, NAT CLIM CHANGE, V3, P273, DOI [10.1038/nclimate1781, 10.1038/NCLIMATE1781]; Bulgarelli D, 2012, ANNU REV PLANT BIOL, V64; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056457; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen WM, 2012, AQUAT BIOL, V15, P99, DOI 10.3354/ab00422; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Di Rienzo J.A., 2010, INFOSTAT VERSION 201; Diezel C, 2011, J INTEGR PLANT BIOL, V53, P971, DOI 10.1111/j.1744-7909.2011.01086.x; Diezel C, 2011, PLANT PHYSIOL, V155, P1936, DOI 10.1104/pp.110.170936; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Doornbos RF, 2012, AGRON SUSTAIN DEV, V32, P227, DOI 10.1007/s13593-011-0028-y; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Gust AA, 2012, NATURE, V486, P198, DOI 10.1038/486198a; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hamman ST, 2007, SOIL BIOL BIOCHEM, V39, P1703, DOI 10.1016/j.soilbio.2007.01.018; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Inceoglu Al-Soud WA, 2011, PLOS ONE, V6; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Kallenbach M, 2012, P NATL ACAD SCI USA, V109, pE1548, DOI 10.1073/pnas.1200363109; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim SB, 2002, INT J SYST EVOL MICR, V52, P1225, DOI [10.1099/ijs.0.02003-0, 10.1099/00207713-52-4-1225]; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Kobayashi DY, 2000, BOOKS SOIL PLANT ENV, P199; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Lamb TG, 1996, CAN J MICROBIOL, V42, P1112, DOI 10.1139/m96-143; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Liu Y, 2013, ANN MICROBIOL, V63, P71, DOI 10.1007/s13213-012-0446-3; Long HH, 2010, NEW PHYTOL, V185, P554, DOI 10.1111/j.1469-8137.2009.03079.x; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucero ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017693; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Lynds GY, 1998, OECOLOGIA, V115, P531, DOI 10.1007/PL00008820; Machado RAR, 2013, NEW PHYTOL IN PRESS; Magurran A., 1991, ECOLOGICAL DIVERSITY; Mano H, 2007, MICROBES ENVIRON, V22, P175, DOI 10.1264/jsme2.22.175; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meldau DG, 2013, PLANT CELL, V25, P2731, DOI 10.1105/tpc.113.114744; Meldau DG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00112; Okoro CK, 2009, ANTON LEEUW INT J G, V95, P121, DOI 10.1007/s10482-008-9295-2; Ozturk B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02780; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; PIELOU E. C., 1984, INTERPRETATION ECOLO; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Roda A, 2004, MOL ECOL, V13, P2421, DOI 10.1111/j.1365-294X.2004.02260.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Shannon CE, 1964, MATH THEORYL COMMUNI; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Ton J, 2002, MOL PLANT MICROBE IN, V15, P27, DOI 10.1094/MPMI.2002.15.1.27; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Volfson V, 2013, SOIL BIOL BIOCHEM, V67, P255, DOI 10.1016/j.soilbio.2013.09.008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zhang YZ, 2011, PLANT SOIL, V347, P147, DOI 10.1007/s11104-011-0835-6; Zinniel DK, 2002, APPL ENVIRON MICROB, V68, P2198, DOI 10.1128/AEM.68.5.2198-2208.2002	86	28	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94710	10.1371/journal.pone.0094710	http://dx.doi.org/10.1371/journal.pone.0094710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728407	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200117
J	Frentz, D; van de Vijver, D; Abecasis, A; Albert, J; Hamouda, O; Jorgensen, L; Kucherer, C; Struck, D; Schmit, JC; Vercauteren, J; Asjo, B; Balotta, C; Bergin, C; Beshkov, D; Camacho, R; Clotet, B; Griskevicius, A; Grossman, Z; Horban, A; Kolupajeva, T; Korn, K; Kostrikis, L; Linka, KLM; Nielsen, C; Otelea, D; Paraskevis, D; Paredes, R; Poljak, M; Puchhammer-Stockl, E; Sonnerborg, A; Stanekova, D; Stanojevic, M; Vandamme, AM; Boucher, C; Wensing, A				Frentz, Dineke; van de Vijver, David; Abecasis, Ana; Albert, Jan; Hamouda, Osamah; Jorgensen, Louise; Kucherer, Claudia; Struck, Daniel; Schmit, Jean-Claude; Vercauteren, Jurgen; Asjo, Birgitta; Balotta, Claudia; Bergin, Colm; Beshkov, Danail; Camacho, Ricardo; Clotet, Bonaventura; Griskevicius, Algirdas; Grossman, Zehava; Horban, Andrzej; Kolupajeva, Tatjana; Korn, Klaus; Kostrikis, Leondios; Linka, Kirsi Liitsola Marek; Nielsen, Claus; Otelea, Dan; Paraskevis, Dimitrios; Paredes, Roger; Poljak, Mario; Puchhammer-Stoeckl, Elisabeth; Sonnerborg, Anders; Stanekova, Danica; Stanojevic, Maja; Vandamme, Anne-Mieke; Boucher, Charles; Wensing, Annemarie		SPREAD Programme	Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRANSMISSION; PREVALENCE; MUTATIONS; EPIDEMIOLOGY; INDIVIDUALS; POPULATIONS; APPEARANCE; ACCESS; HAART	Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported. Methods: HIV-1 patients newly diagnosed in 27 countries from 2002 through 2007 were included. Inclusion was representative for risk group and geographical distribution in the participating countries in Europe. Trends over time were calculated by logistic regression. Results: From the 4317 patients included, the majority was men-having-sex-with-men -MSM (2084, 48%), followed by heterosexuals (1501, 35%) and injection drug users (IDU) (355, 8%). MSM were more often from Western Europe origin, infected with subtype B virus, and recently infected (<1 year) (p<0.001). The prevalence of TDRM was highest in MSM (prevalence of 11.1%), followed by heterosexuals (6.6%) and IDU (5.1%, p<0.001). TDRM was predominantly ascribed to nucleoside reverse transcriptase inhibitors (NRTI) with a prevalence of 6.6% in MSM, 3.3% in heterosexuals and 2.0% in IDU (p = 0.001). A significant increase in resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and a decrease in resistance to protease inhibitors was observed in MSM (p = 0.008 and p = 0.006, respectively), but not in heterosexual patients (p = 0.68 and p = 0.14, respectively). Conclusions: MSM showed to have significantly higher TDRM prevalence compared to heterosexuals and IDU. The increasing NNRTI resistance in MSM is likely to negatively influence the therapy response of first-line therapy, as most include NNRTI drugs.	[Frentz, Dineke; van de Vijver, David; Boucher, Charles] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Abecasis, Ana; Camacho, Ricardo] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan; Sonnerborg, Anders] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Hamouda, Osamah; Kucherer, Claudia; Nielsen, Claus] Robert Koch Inst, Berlin, Germany; [Jorgensen, Louise] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Struck, Daniel; Schmit, Jean-Claude] CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Schmit, Jean-Claude] Ctr Hosp Luxembourg, Luxembourg, Luxembourg; [Vercauteren, Jurgen; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium; [Asjo, Birgitta] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Balotta, Claudia] Univ Milan, Milan, Italy; [Bergin, Colm] St James Hosp, Dept GU Med & Infect Dis, Dublin 8, Ireland; [Beshkov, Danail; Paredes, Roger] Natl Ctr Infect & Parasit Dis, Dept Virol, Sofia, Bulgaria; [Camacho, Ricardo] Ctr Hosp Lisboa Ocidental, Hosp Egas Moniz, Lisbon, Portugal; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Badalona, Spain; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Badalona, Spain; [Griskevicius, Algirdas] Natl Publ Hlth Surveillance Lab, Vilnius, Lithuania; [Grossman, Zehava] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Horban, Andrzej] Med Univ Warsaw, Warsaw, Poland; [Horban, Andrzej] Hosp Infect Dis, Warsaw, Poland; [Kolupajeva, Tatjana] Infectol Ctr Latvia, Riga, Latvia; [Korn, Klaus] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Kostrikis, Leondios] Univ Cyprus, Nicosia, Cyprus; [Linka, Kirsi Liitsola Marek] Natl Inst Hlth & Welf, Helsinki, Finland; [Linka, Kirsi Liitsola Marek] Natl Inst Publ Hlth, Prague, Czech Republic; [Otelea, Dan] Prof Dr Matei Bals Inst Infect Dis, Bucharest, Romania; [Paraskevis, Dimitrios] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Poljak, Mario] Univ Ljubljana, Ljubljana, Slovenia; [Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Vienna, Austria; [Sonnerborg, Anders] Karolinska Inst, Div Infect Dis, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst, Div Clin Virol, Stockholm, Sweden; [Stanekova, Danica] Slovak Med Univ, Bratislava, Slovakia; [Stanojevic, Maja] Univ Belgrade, Sch Med, Belgrade, Serbia; [Wensing, Annemarie] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Robert Koch Institute; Statens Serum Institut; Luxembourg Institute of Health; Luxembourg Hospital Center; KU Leuven; University of Bergen; University of Milan; Trinity College Dublin; Bulgarian Academy of Sciences; Medical University Sofia; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade de Lisboa; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Chaim Sheba Medical Center; Medical University of Warsaw; University of Erlangen Nuremberg; University of Cyprus; Finland National Institute for Health & Welfare; National Institute of Public Health (SZU) - Czech Republic; National Institute for Infectious Diseases "Matei Bals"; Athens Medical School; National & Kapodistrian University of Athens; University of Ljubljana; Medical University of Vienna; Karolinska Institutet; Karolinska Institutet; Slovak Medical University Bratislava; University of Belgrade; Utrecht University; Utrecht University Medical Center	Wensing, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.M.J.Wensing@umcutrecht.nl	Vandekerckhove, Linos/J-6420-2013; rezza, giovanni/D-4393-2016; Paraskevis, Dimitrios/H-5835-2019; Magiorkinis, Emmanouil/B-1530-2010; Abecasis, Ana/ABF-6657-2020; Van Laethem, Kristel/R-6282-2016; Wiercińska-Drapało, Alicja/V-5930-2018; Vandamme, Anne-Mieke/I-4127-2012; Abecasis, Ana/B-6295-2009; Ciccozzi, Massimo/AAC-3271-2022; Sakka, Vissaria/GLN-7705-2022; Otelea, Dan/AAV-6467-2021; Sönnerborg, Anders/W-2011-2019; KOSTRIKIS, LEONDIOS G/A-5330-2016; Camacho, Ricardo J/I-7629-2012; Van Ranst, Marc/P-7522-2017; Vercauteren, Jurgen/P-7676-2019; Gisslen, Magnus/D-7454-2015; Balotta, Claudia/L-7295-2017	Vandekerckhove, Linos/0000-0002-8600-1631; rezza, giovanni/0000-0003-0268-6790; Paraskevis, Dimitrios/0000-0001-6167-7152; Magiorkinis, Emmanouil/0000-0001-8883-7275; Abecasis, Ana/0000-0002-3903-5265; Van Laethem, Kristel/0000-0001-6036-2271; Wiercińska-Drapało, Alicja/0000-0001-5921-1409; Vandamme, Anne-Mieke/0000-0002-6594-2766; Abecasis, Ana/0000-0002-3903-5265; Ciccozzi, Massimo/0000-0003-3866-9239; Sönnerborg, Anders/0000-0001-8928-3374; KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Camacho, Ricardo J/0000-0002-9129-3237; Van Ranst, Marc/0000-0002-1674-4157; Vercauteren, Jurgen/0000-0003-0698-4736; Otelea, Dan/0000-0002-0821-6346; Duque, Vitor/0000-0003-0000-4004; Ristola, Matti/0000-0001-5115-2811; Gisslen, Magnus/0000-0002-2357-1020; Ribera, Esteban/0000-0002-3752-8808; Stanojevic, Maja/0000-0002-4643-4272; van de Vijver, David/0000-0001-5877-8526; Korn, Klaus/0000-0003-1891-2107; Lunar, Maja/0000-0003-1262-338X; Balotta, Claudia/0000-0002-1107-9119; Walter, Henrik/0000-0002-9403-6121	European Commission [QLK2-CT-2001-01344, LSHP-CT-2006-518211, 233847, 223131]; Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek [G. 0611.09]; Interuniversitaire Attractiepolen (Belgium) [P6/41]; Cyprus Research Promotion Foundation [Health/0104/22]; Danish AIDS Foundation; Ministry of Health (Germany) [1502-686-18]; Ministry of Education and Research (Germany) [01KI501]; Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy) [N 40F.56, 20D.1.6]; Fondation Recherche sur le SiDA; Ministry of Health (Luxembourg); Swedish Research Council; Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network [223131]; European Commission; Ministry of Education and Science (Republic of Serbia) [175024]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/65605/2009]; Slovak Ministry of Health [2005/37-SZU-15]	European Commission(European CommissionEuropean Commission Joint Research Centre); Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek; Interuniversitaire Attractiepolen (Belgium); Cyprus Research Promotion Foundation; Danish AIDS Foundation; Ministry of Health (Germany); Ministry of Education and Research (Germany); Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy); Fondation Recherche sur le SiDA(ANRS); Ministry of Health (Luxembourg); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education and Science (Republic of Serbia); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Slovak Ministry of Health	This work was supported by the European Commission (grant QLK2-CT-2001-01344, fifth framework; grant LSHP-CT-2006-518211, sixth framework, grant DynaNets no. 233847, grant CHAIN no. 223131, seventh framework); Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek (grant G. 0611.09); Interuniversitaire Attractiepolen (Belgium; grant P6/41); Cyprus Research Promotion Foundation (grant Health/0104/22); Danish AIDS Foundation; Ministry of Health (Germany; grant 1502-686-18); Ministry of Education and Research (Germany; grant 01KI501); Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy; grants N 40F.56 and 20D.1.6); Fondation Recherche sur le SiDA; Ministry of Health (Luxembourg); Swedish Research Council; Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, (Integrated Project no. 223131, funded by the European Commission Framework 7 Program); and Ministry of Education and Science (Republic of Serbia; grant 175024). ABA is supported by Fundacao para a Ciencia e Tecnologia (grant no. SFRH/BPD/65605/2009), and Slovak Ministry of Health-project (No. 2005/37-SZU-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Bollerup AR, 2008, SCAND J PUBLIC HEALT, V36, P183, DOI 10.1177/1403494807085191; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P517, DOI 10.1093/jac/dkl501; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Donoghoe MC, 2007, INT J DRUG POLICY, V18, P271, DOI 10.1016/j.drugpo.2007.02.010; Frentz D, 2012, AIDS REV, V14, P17; Gorbach PM, 2004, SEX TRANSM INFECT, V80, P512, DOI 10.1136/sti.2004.010918; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hurt CB, 2009, ANTIVIR THER, V14, P673; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Karlsson A, 2012, PLOS ONE, V7, P33484, DOI DOI 10.1371/JOURNAL.PONE.0033484; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Luber Andrew D, 2005, MedGenMed, V7, P69, DOI 10.1186/1758-2652-7-3-69; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Morrison SD, 2011, CENT EUR J PUBL HEAL, V19, P91, DOI 10.21101/cejph.a3644; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pingen M, 2011, J ANTIMICROB CHEMOTH; Routy JP, 2004, AIDS, V18, P2305, DOI 10.1097/00002030-200411190-00011; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Shoptaw S, 2009, J URBAN HEALTH, V86, pS77, DOI 10.1007/s11524-009-9372-5; *UNAIDS, 2002, REP GLOB HIV AIDS EP; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; WHO, 2011, HIV DRUG RES FACT SH; Wittkop L, 2011, LANCET INFECT DIS; Wood E, 2003, CAN MED ASSOC J, V169, P656; Xiridou M, 2010, AIDS, V24, P2081, DOI 10.1097/QAD.0b013e32833a6071; Yebra G, 2013, ARCH VIROL; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	43	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94495	10.1371/journal.pone.0094495	http://dx.doi.org/10.1371/journal.pone.0094495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721998	Green Published, gold			2022-12-25	WOS:000336909100083
J	Gassowska, M; Czapski, GA; Pajak, B; Cieslik, M; Lenkiewicz, AM; Adamczyk, A				Gassowska, Magdalena; Czapski, Grzegorz A.; Pajak, Beata; Cieslik, Magdalena; Lenkiewicz, Anna M.; Adamczyk, Agata			Extracellular alpha-Synuclein Leads to Microtubule Destabilization via GSK-3 beta-Dependent Tau Phosphorylation in PC12 Cells	PLOS ONE			English	Article							SYNTHASE KINASE-3 GSK3; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CONTRIBUTES; SER(396); PROTEIN; MODEL	alpha-Synuclein (ASN) plays an important role in pathogenesis of Parkinson's disease (PD) and other neurodegenerative disorders. Novel and most interesting data showed elevated tauopathy in PD and suggested relationship between ASN and Tau protein. However, the mechanism of ASN-evoked Tau protein modification is not fully elucidated. In this study we investigated the role of extracellular ASN in Tau hyperphosphorylation in rat pheochromocytoma (PC12) cells and the involvement of glycogen synthase kinase-3 beta (GSK-3 beta) and cyclin-dependent kinase 5 (CDK5) in ASN-dependent Tau modification. Our results indicated that exogenously added ASN increases Tau phosphorylation at Ser396. Accordingly, the GSK-3 beta inhibitor (SB-216763) prevented ASN-evoked Tau hyperphosphorylation, but the CDK5 inhibitor had no effect. Moreover, western blot analysis showed that ASN affected GSK-3 beta via increasing of protein level and activation of this enzyme. GSK-3 beta activity evaluated by its phosphorylation status assay showed that ASN significantly increased the phosphorylation of this enzyme at Tyr216 with parallel decrease in phosphorylation at Ser9, indicative of stimulation of GSK-3 beta activity. Moreover, the effect of ASN on microtubule (MT) destabilization and cell death with simultaneous the involvement of GSK-3 beta in these processes were analyzed. ASN treatment increased the amount of free tubulin and concomitantly reduced the amount of polymerized tubulin and SB-216763 suppressed these ASN-induced changes in tubulin, indicating that GSK-3 beta is involved in ASN-evoked MT destabilization. ASN-induced apoptotic processes lead to decrease in PC12 cells viability and SB-216763 protected those cells against ASN-evoked cytotoxicity. Concluding, extracellular ASN is involved in GSK-3 beta-dependent Tau hyperphosphorylation, which leads to microtubule destabilization. GSK-3 beta inhibition may be an effective strategy for protecting against ASN-induced cytotoxicity.	[Gassowska, Magdalena; Czapski, Grzegorz A.; Cieslik, Magdalena; Lenkiewicz, Anna M.; Adamczyk, Agata] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Warsaw, Poland; [Pajak, Beata] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Adamczyk, A (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Warsaw, Poland.	agataadamczyk72@gmail.com	Lenkiewicz, Anna Magdalena/V-9419-2018; Czapski, Grzegorz/D-6151-2016	Lenkiewicz, Anna Magdalena/0000-0003-2358-8372; Pajak, Beata/0000-0002-3565-8860; Gassowska-Dobrowolska, Magdalena/0000-0001-9777-1378; Czapski, Grzegorz/0000-0002-7541-1571; Cieslik, Magdalena/0000-0002-7604-4371	National Science Centre [2012/05/B/NZ3/02047]	National Science Centre(National Science Centre, Poland)	This project was funded by a grant from The National Science Centre (2012/05/B/NZ3/02047) for AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A, 2005, J PHYSIOL PHARMACOL, V56, P29; Adamczyk A, 2007, FOLIA NEUROPATHOL, V45, P230; Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brown DR, 2010, IUBMB LIFE, V62, P334, DOI 10.1002/iub.316; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Ciofani G, 2013, PHARM RES-DORDR, V30, P2133, DOI 10.1007/s11095-013-1071-y; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Czapski GA, 2013, FEBS LETT, V587, P3135, DOI 10.1016/j.febslet.2013.07.053; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Fornai F, 2007, BRAIN RES, V1129, P174, DOI 10.1016/j.brainres.2006.10.071; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liu GW, 2013, J NEURAL TRANSM, V120, P1331, DOI 10.1007/s00702-013-0999-8; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	40	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94259	10.1371/journal.pone.0094259	http://dx.doi.org/10.1371/journal.pone.0094259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722055	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100045
J	Mishra, R; Thorat, D; Soundararajan, G; Pradhan, SJ; Chakraborty, G; Lohite, K; Karnik, S; Kundu, GC				Mishra, R.; Thorat, D.; Soundararajan, G.; Pradhan, S. J.; Chakraborty, G.; Lohite, K.; Karnik, S.; Kundu, G. C.			Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis	ONCOGENE			English	Article							PROSTATE-CANCER CELLS; TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR; HUMAN-MELANOMA; PTEN; AKT; APOPTOSIS; NEUROPILIN-1; KINASE; PHOSPHORYLATION	Semaphorin 3A (Sema 3A), a member of semaphorin family, serves as a guidance clue during embryonic development and is known as a candidate tumor suppressor that attenuates breast tumor progression by binding with its co-receptor, neuropilin-1 (NRP-1). However, the underlying mechanism by which Sema 3A suppresses breast tumor growth is still unexplored. In this study, we report that Sema 3A regulates phosphorylation and nuclear translocation of phosphatase and tensin homolog (PTEN) and FOXO 3a. Moreover, Sema 3A controls NRP-1-mediated PTEN-dependent FOXO 3a activation. Overexpression of PTEN and FOXO 3a enhances Sema 3A-induced attenuation of breast cancer cell migration. Chromatin immunoprecipitation and electrophoretic mobility shift assay data revealed that FOXO 3a regulates MelCAM at the transcriptional level. Furthermore, Sema 3A induces NRP-1-mediated MelCAM expression through PTEN and FOXO 3a. The data also showed that vascular endothelial growth factor-induced angiogenesis is inhibited by Sema 3A. Loss of or gain in function study revealed that Sema 3A modulates phosphorylation of PTEN and FOXO 3a and expression of MelCAM, leading to suppression of tumor growth and angiogenesis using in vivo mice model. Clinical specimen analysis revealed that reduced expression of Sema 3A and p-PTEN are correlated with enhanced breast cancer progression, further strengthening our in vitro and in vivo findings. Correlation of relapse-free survival of breast cancer patients (n = 2878) with expression levels of Sema 3A, NRP-1, FOXO 3a and MelCAM were studied by Kaplan-Meier analysis. Statistical analysis revealed a close association between reduced expression of Sema 3A and MelCAM with that of poor patient's survival. Our study demonstrated a novel mechanism of regulation of tumor suppression by Sema 3A in coordination with a chain of tumor-suppressor genes, which in turn inhibits breast cancer cell migration, tumor growth and angiogenesis.	[Mishra, R.; Thorat, D.; Soundararajan, G.; Pradhan, S. J.; Kundu, G. C.] Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, Pune 411007, Maharashtra, India; [Chakraborty, G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lohite, K.; Karnik, S.] Ruby Hall Clin, Grant Med Fdn, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Memorial Sloan Kettering Cancer Center	Kundu, GC (corresponding author), Natl Ctr Cell Sci, Lab Tumor Biol Angiogenesis & Nanomed Res, NCCS Complex, Pune 411007, Maharashtra, India.	kundu@nccs.res.in	Kundu, Gopal C./ABA-9897-2020; Chakraborty, Goutam/U-5559-2019; MISHRA, ROSALIN/L-4319-2017	MISHRA, ROSALIN/0000-0002-9808-8797; Pradhan, Saurabh Jagdish/0000-0002-5306-9138	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST), Government of India; CSIR; DST, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST, Government of India(Department of Science & Technology (India))	We thank Dr B Ramanamurthy, In-charge, Experimental Animal Facility, NCCS for breeding and maintaining NOD-SCID mice. This work was supported by a grant from the Council of Scientific and Industrial Research (CSIR) (to RM and GS) and the Department of Science and Technology (DST) (to DT), Government of India. Financial support: This project was funded by the CSIR and DST, Government of India.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; American Cancer Society, 2013, CANC FACTS FIG 2013; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bachelder RE, 2003, CANCER RES, V63, P5230; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chakraborty G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033633; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gabrovska PN, 2011, GENE, V489, P63, DOI 10.1016/j.gene.2011.08.024; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Raja R, 2014, ONCOGENE, V33, P2053, DOI 10.1038/onc.2013.171; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shih IM, 1997, AM J PATHOL, V151, P745; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vacca A, 2006, BLOOD, V108, P1661, DOI 10.1182/blood-2006-04-014563; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang L, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN SECURITY AND DEFENSE APPLICATIONS, P1; Xie SH, 1997, CANCER RES, V57, P2295; Yacoub M, 2009, HISTOPATHOLOGY, V55, P392, DOI 10.1111/j.1365-2559.2009.03406.x; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211	59	41	44	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1584	1595		10.1038/onc.2014.79	http://dx.doi.org/10.1038/onc.2014.79			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24727891				2022-12-25	WOS:000351416800011
J	Masetti, M; Falchi, F; Recanatini, M				Masetti, Matteo; Falchi, Federico; Recanatini, Maurizio			Protein Dynamics of the HIF-2 alpha PAS-B Domain upon Heterodimerization and Ligand Binding	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; FUNCTIONAL TRANSITIONS; STRUCTURAL BASIS; RESIDENCE TIMES; WATER-MOLECULES; BETA-SHEETS; AMBER; OXYGEN; SIMULATIONS	Hypoxia-Inducible Factor (HIF) transcription factors are heterodimeric proteins involved in the regulation of oxygen homeostatis. Their upregulation has been related to several tumors with a remarkably poor clinical outcome. The recent discovery of a druggable cavity in the HIF-2 alpha PAS-B domain has opened an unprecedented opportunity for targeting the HIF-2 alpha transcription factor in view of pharmaceutical strategies. Coincidentally, a novel compound able to selectively disrupt the HIF heterodimerization with a submicromolar activity has been reported. In this work, we investigated the molecular mechanisms responsible for the inhibition by comparing the dynamical features of the HIF-2 alpha PAS-B monomer and the HIF-2 alpha PAS-B/HIF-1 beta PAS-B complex, in the ligand-bound and -unbound states. Plain and biased Molecular Dynamics were used to characterize the differential conformational changes both structurally and energetically.	[Masetti, Matteo; Falchi, Federico; Recanatini, Maurizio] Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy	University of Bologna	Masetti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy.	matteo.masetti4@unibo.it	Falchi, Federico/Q-6970-2016; Recanatini, Maurizio/GXH-1338-2022; Recanatini, Maurizio/AAU-3319-2021; Falchi, Federico/HCI-8485-2022	Falchi, Federico/0000-0001-7385-649X; Recanatini, Maurizio/0000-0002-0039-0518; Falchi, Federico/0000-0001-7385-649X; Masetti, Matteo/0000-0002-3757-7802	Alma Mater Studiorum - University of Bologna	Alma Mater Studiorum - University of Bologna	The authors acknowledge the financial support of Alma Mater Studiorum - University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], 2013, SCHROD REL 2013 1 MA; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bizzarri AR, 2002, J PHYS CHEM B, V106, P6617, DOI 10.1021/jp020100m; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Case DA, 2012, AMBER 12; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emberly EG, 2004, PROTEINS, V55, P91, DOI 10.1002/prot.10618; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falchi F, 2014, FUTURE MED CHEM, V6, P343, DOI 10.4155/fmc.13.204; Frisch M., 2016, GAUSSIAN 16 REVISION; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gumbart JC, 2013, J CHEM THEORY COMPUT, V9, P3789, DOI 10.1021/ct400273t; Henchman RH, 2002, BIOPHYS J, V82, P2671, DOI 10.1016/S0006-3495(02)75609-9; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hua L, 2006, J PHYS CHEM B, V110, P3704, DOI 10.1021/jp055399y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Key J, 2009, J AM CHEM SOC, V131, P17647, DOI 10.1021/ja9073062; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Koh E, 2006, BIOINFORMATICS, V22, P297, DOI 10.1093/bioinformatics/bti775; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Makarov VA, 2000, BIOPHYS J, V79, P2966, DOI 10.1016/S0006-3495(00)76533-7; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Miyashita O, 2005, J PHYS CHEM B, V109, P1959, DOI 10.1021/jp046736q; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rocchi C, 1997, CHEM PHYS, V214, P261, DOI 10.1016/S0301-0104(96)00327-8; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Sun S, 2003, EUR BIOPHYS J BIOPHY, V32, P676, DOI 10.1007/s00249-003-0335-6; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200	58	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94986	10.1371/journal.pone.0094986	http://dx.doi.org/10.1371/journal.pone.0094986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736273	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600118
J	Abeysundera, M; Kenney, T; Field, C; Gu, H				Abeysundera, Melanie; Kenney, Toby; Field, Chris; Gu, Hong			Combining Distance Matrices on Identical Taxon Sets for Multi-Gene Analysis with Singular Value Decomposition	PLOS ONE			English	Article							EARLIEST ANGIOSPERMS; PHYLOGENY; GENES; AMBORELLA; SEQUENCES; CLADE; TREE; ALGORITHM; EVOLUTION; POSITION	We present a simple and effective method for combining distance matrices from multiple genes on identical taxon sets to obtain a single representative distance matrix from which to derive a combined-gene phylogenetic tree. The method applies singular value decomposition (SVD) to extract the greatest common signal present in the distances obtained from each gene. The first right eigenvector of the SVD, which corresponds to a weighted average of the distance matrices of all genes, can thus be used to derive a representative tree from multiple genes. We apply our method to three well known data sets and estimate the uncertainty using bootstrap methods. Our results show that this method works well for these three data sets and that the uncertainty in these estimates is small. A simulation study is conducted to compare the performance of our method with several other distance based approaches (namely SDM, SDM* and ACS97), and we find the performances of all these approaches are comparable in the consensus setting. The computational complexity of our method is similar to that of SDM. Besides constructing a representative tree from multiple genes, we also demonstrate how the subsequent eigenvalues and eigenvectors may be used to identify if there are conflicting signals in the data and which genes might be influential or outliers for the estimated combined-gene tree.	[Abeysundera, Melanie; Kenney, Toby; Field, Chris; Gu, Hong] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University	Kenney, T (corresponding author), Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada.	tkenney@mathstat.dal.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the NSERC funding of the third and fourth authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysundera M, 2012, MOL BIOL EVOL, V29, P579, DOI 10.1093/molbev/msr205; Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Ane C, 2005, MOL BIOL EVOL, V22, P914, DOI 10.1093/molbev/msi076; Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Bevan RB, 2005, SYST BIOL, V54, P900, DOI 10.1080/10635150500354829; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Bryant D, 2002, BIOCONSENSUS DIMACS, V61, P163; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; BULMER M, 1991, MOL BIOL EVOL, V8, P868; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Collins K, 2006, STAT APPL GENET MOL, V5; Cotton JA, 2002, P ROY SOC B-BIOL SCI, V269, P1555, DOI 10.1098/rspb.2002.2074; Criscuolo A, 2006, SYST BIOL, V55, P750; Criscuolo A, 2009, J MOL EVOL, V68, P377, DOI 10.1007/s00239-009-9212-y; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; DEQUEIROZ A, 1993, SYST BIOL, V42, P368; Dopazo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r41; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Edwards SV, 2009, EVOLUTION, V66, P763; Felsenstein J, 1997, SYST BIOL, V46; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Goremykin VV, 2006, GENE, P381; Gruenheit N, 2008, MOL BIOL EVOL, V25, P1512, DOI 10.1093/molbev/msn098; Guenoche A, 2000, LECT NOTES COMPUTER, V2066, P45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huang HT, 2010, SYST BIOL, V59, P573, DOI 10.1093/sysbio/syq047; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kubatko LS, 2009, SYST BIOL, V25; Lapointe FJ, 1997, SYST BIOL, V46, P306, DOI 10.2307/2413625; Liu L, 2007, SYST BIOL, V56; Liu L, 2010, J MATH BIOL, V60, P95, DOI 10.1007/s00285-009-0260-0; Miyamoto M.M., 1985, Cladistics, V1, P186, DOI 10.1111/j.1096-0031.1985.tb00421.x; MIYAMOTO MM, 1995, SYST BIOL, V44, P64, DOI 10.2307/2413483; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; Sanderson MJ, 2003, BIOINFORMATICS, V19; Soltis DE, 2004, AM J BOT, V91, P997, DOI 10.3732/ajb.91.6.997; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stefanovic S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-35; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu JH, 2009, MOL BIOL EVOL, V26, P2689, DOI 10.1093/molbev/msp184; Wu YF, 2012, EVOLUTION, V66, P763, DOI 10.1111/j.1558-5646.2011.01476.x; Zanis MJ, 2002, P NATL ACAD SCI USA, V99, P6848, DOI 10.1073/pnas.092136399; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170	64	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94279	10.1371/journal.pone.0094279	http://dx.doi.org/10.1371/journal.pone.0094279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732341	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400024
J	Combe, BE; Defaye, A; Bozonnet, N; Puthier, D; Royet, J; Leulier, F				Combe, Berra Erkosar; Defaye, Arnaud; Bozonnet, Noemie; Puthier, Denis; Royet, Julien; Leulier, Francois			Drosophila Microbiota Modulates Host Metabolic Gene Expression via IMD/NF-kappa B Signaling	PLOS ONE			English	Article							IMMUNE HOMEOSTASIS; GUT MICROBIOTA; CASPASE DREDD; MELANOGASTER; TOLERANCE; MUTUALISM; RESPONSES; BACTERIA; INSIGHTS; MIDGUT	Most metazoans engage in mutualistic interactions with their intestinal microbiota. Despite recent progress the molecular mechanisms through which microbiota exerts its beneficial influences on host physiology are still largely uncharacterized. Here we use axenic Drosophila melanogaster adults associated with a standardized microbiota composed of a defined set of commensal bacterial strains to study the impact of microbiota association on its host transcriptome. Our results demonstrate that Drosophila microbiota has a marked impact on the midgut transcriptome and promotes the expression of genes involved in host digestive functions and primary metabolism. We identify the IMD/Relish signaling pathway as a central regulator of this microbiota-mediated transcriptional response and we reveal a marked transcriptional trade-off between the midgut response to its beneficial microbiota and to bacterial pathogens. Taken together our results indicate that microbiota association potentiates host nutrition and host metabolic state, two key physiological parameters influencing host fitness. Our work paves the way to subsequent mechanistic studies to reveal how these microbiota-dependent transcriptional signatures translate into host physiological benefits.	[Combe, Berra Erkosar; Bozonnet, Noemie; Leulier, Francois] Univ Lyon 1, Ctr Natl Rech Sci, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69365 Lyon, France; [Combe, Berra Erkosar; Defaye, Arnaud; Royet, Julien; Leulier, Francois] Aix Marseille Univ, Ctr Natl Rech Sci, Inst Biol Dev Marseille Luminy, Marseille, France; [Puthier, Denis] Aix Marseille Univ, Inst Natl Sante & Rech Med, Technol Adv Genom & Clin, Marseille, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Leulier, F (corresponding author), Univ Lyon 1, Ctr Natl Rech Sci, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69365 Lyon, France.	francois.leulier@ens-lyon.fr	Puthier, Denis/N-5018-2016; puthier, denis/AFV-1973-2022	puthier, denis/0000-0002-7240-5280; Leulier, Francois/0000-0002-4542-3053; Erkosar, Berra/0000-0003-1152-6772	ANR [ANR 2010 JCJC 1304 01]; ERC [FP7/2007-2013-Nu309704]; ATIP/AVENIR program; FINOVI fundation; Fondation Schlumberger pour l'Education et la Recherche	ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); ATIP/AVENIR program; FINOVI fundation; Fondation Schlumberger pour l'Education et la Recherche(Schlumberger)	This work was funded by an ANR grant (ANR 2010 JCJC 1304 01) and an ERC starting grant (FP7/2007-2013-Nu309704). The lab of Dr Francois Leulier is sponsored by the ATIP/AVENIR program, the FINOVI fundation and the "Fondation Schlumberger pour l'Education et la Recherche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset A, 2000, P NATL ACAD SCI US; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Okumura T, 2005, DEV BIOL, V278, P576, DOI 10.1016/j.ydbio.2004.11.021; Okumura T, 2007, GENE EXPR PATTERNS, V7, P178, DOI 10.1016/j.modgep.2006.07.001; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Rynes J, 2012, MOL CELL BIOL, V32, P3949, DOI 10.1128/MCB.00429-12; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sieber MH, 2012, CELL METAB, V15, P122, DOI 10.1016/j.cmet.2011.11.011; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	35	70	71	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94729	10.1371/journal.pone.0094729	http://dx.doi.org/10.1371/journal.pone.0094729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733183	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400084
J	Gohar, EY; El-Gowilly, SM; El-Gowelli, HM; El-Demellawy, MA; El-Mas, MM				Gohar, Eman Y.; El-Gowilly, Sahar M.; El-Gowelli, Hanan M.; El-Demellawy, Maha A.; El-Mas, Mahmoud M.			PI3K/Akt-Independent NOS/HO Activation Accounts for the Facilitatory Effect of Nicotine on Acetylcholine Renal Vasodilations: Modulation by Ovarian Hormones	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARBON-MONOXIDE; HEME OXYGENASE-1; ZINC-PROTOPORPHYRIN; INDUCED IMPAIRMENT; CIGARETTE-SMOKE; ETHANOL; INHIBITION; EXPRESSION; INDUCTION	We investigated the effect of chronic nicotine on cholinergically-mediated renal vasodilations in female rats and its modulation by the nitric oxide synthase (NOS)/heme oxygenase (HO) pathways. Dose-vasodilatory response curves of acetylcholine (0.01-2.43 nmol) were established in isolated phenylephrine-preconstricted perfused kidneys obtained from rats treated with or without nicotine (0.5-4.0 mg/kg/day, 2 weeks). Acetylcholine vasodilations were potentiated by low nicotine doses (0.5 and 1 mg/kg/day) in contrast to no effect for higher doses (2 and 4 mg/kg/day). The facilitatory effect of nicotine was acetylcholine specific because it was not observed with other vasodilators such as 5'-N-ethylcarboxamidoadenosine (NECA, adenosine receptor agonist) or papaverine. Increases in NOS and HO-1 activities appear to mediate the nicotine-evoked enhancement of acetylcholine vasodilation because the latter was compromised after pharmacologic inhibition of NOS (L-NAME) or HO-1 (zinc protoporphyrin, ZnPP). The renal protein expression of phosphorylated Akt was not affected by nicotine. We also show that the presence of the two ovarian hormones is necessary for the nicotine augmentation of acetylcholine vasodilations to manifest because nicotine facilitation was lost in kidneys of ovariectomized (OVX) and restored after combined, but not individual, supplementation with medroxyprogesterone acetate (MPA) and estrogen (E2). Together, the data suggests that chronic nicotine potentiates acetylcholine renal vasodilation in female rats via, at least partly, Akt-independent HO-1 upregulation. The facilitatory effect of nicotine is dose dependent and requires the presence of the two ovarian hormones.	[Gohar, Eman Y.; El-Gowilly, Sahar M.; El-Gowelli, Hanan M.; El-Mas, Mahmoud M.] Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt; [El-Demellawy, Maha A.] City Sci Res & Technol Applicat, Med Biotechnol Dept, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	El-Mas, MM (corresponding author), Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt.	mahelm@hotmail.com	Gohar, Eman/AAT-3681-2020; El-Mas, Mahmoud M./B-9047-2009; Demellawy, Maha El/AAF-2300-2021; Gowelli, Hanan M. El/F-9500-2010	El-Mas, Mahmoud M./0000-0001-8855-7070; Demellawy, Maha El/0000-0002-3535-1607; Gowelli, Hanan M. El/0000-0001-8145-7608; Gohar, Eman/0000-0003-0988-6445	Science and Technology Development Fund (STDF), Egypt [502]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	Supported by the Science and Technology Development Fund (STDF), Egypt, Grant No. 502. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2012, AM J PHYSIOL-RENAL, V302, pF895, DOI 10.1152/ajprenal.00507.2011; Annavarajula S K, 2012, Indian J Nephrol, V22, P340, DOI 10.4103/0971-4065.103907; Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Astort F, 2009, DIABETES-METAB RES, V25, P477, DOI 10.1002/dmrr.978; Benakanakere I, 2010, CANCER PREV RES, V3, P1157, DOI 10.1158/1940-6207.CAPR-10-0064; Bhardwaj P, 2014, CARDIOVASC TOXICOL, V14, P41, DOI 10.1007/s12012-013-9226-y; CABLE EE, 1994, EUR J BIOCHEM, V225, P651, DOI 10.1111/j.1432-1033.1994.00651.x; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Csongradi E, 2012, CURR PHARM BIOTECHNO, V13, P819, DOI 10.2174/138920112800399284; da Silva JL, 2001, KIDNEY INT, V59, P1448, DOI 10.1046/j.1523-1755.2001.0590041448.x; Donald JA, 2004, COMP BIOCHEM PHYS A, V137, P21, DOI 10.1016/S1095-6433(03)00260-5; Eguchi S, 2007, BRIT J PHARMACOL, V151, P1216, DOI 10.1038/sj.bjp.0707331; El-Gowilly SM, 2008, CLIN EXP PHARMACOL P, V35, P1164, DOI 10.1111/j.1440-1681.2008.04983.x; El-Mas MA, 2001, BRAIN RES, V912, P79, DOI 10.1016/S0006-8993(01)02727-5; El-Mas MM, 2008, EUR J PHARMACOL, V588, P294, DOI 10.1016/j.ejphar.2008.04.048; El-Mas MM, 2008, J PHARMACOL EXP THER, V324, P368, DOI 10.1124/jpet.107.127498; El-Mas MM, 2012, J PHARMACOL EXP THER, V342, P568, DOI 10.1124/jpet.112.191940; El-Mas MM, 2011, BIOCHEM PHARMACOL, V81, P526, DOI 10.1016/j.bcp.2010.11.013; El-Mas MM, 2011, LIFE SCI, V88, P187, DOI 10.1016/j.lfs.2010.11.009; El-Mas MM, 2009, CAN J PHYSIOL PHARM, V87, P539, DOI [10.1139/Y09-038, 10.1139/y09-038]; El-Mas MM, 2009, ALCOHOL CLIN EXP RES, V33, P1158, DOI 10.1111/j.1530-0277.2009.00939.x; El-Mas MM, 2004, J CARDIOVASC PHARM, V43, P562, DOI 10.1097/00005344-200404000-00012; El-Mas MM, 2003, EUR J PHARMACOL, V468, P217, DOI 10.1016/S0014-2999(03)01720-5; El-Mas MM, 1998, EUR J PHARMACOL, V349, P253, DOI 10.1016/S0014-2999(98)00202-7; El-Mas MM, 1999, ALCOHOL CLIN EXP RES, V23, P624, DOI 10.1111/j.1530-0277.1999.tb04164.x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fonseca CD, 2012, ANTIMICROB AGENTS CH, V56, P5082, DOI 10.1128/AAC.00925-12; Gambaro G, 1998, J AM SOC NEPHROL, V9, P562; Gohar EY, 2013, EUR J PHARMACOL, V710, P1, DOI 10.1016/j.ejphar.2013.04.011; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Halimi JM, 1998, NEPHROL DIAL TRANSPL, V13, P940, DOI 10.1093/ndt/13.4.940; Halmai R, 2011, EUR J CLIN INVEST, V41, P195, DOI 10.1111/j.1365-2362.2010.02386.x; Jiang F, 2006, HYPERTENSION, V48, P950, DOI 10.1161/01.HYP.0000242336.58387.1f; Kawakami T, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/740203; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Leo MDM, 2008, EUR J PHARMACOL, V596, P111, DOI 10.1016/j.ejphar.2008.07.058; Li SD, 2011, TRANSPL P, V43, P1980, DOI 10.1016/j.transproceed.2011.03.032; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; MATSUURA Y, 1988, TOXICOLOGY, V50, P169, DOI 10.1016/0300-483X(88)90089-3; Morin A, 2011, REGUL TOXICOL PHARM, V61, pS3, DOI 10.1016/j.yrtph.2010.09.020; NY L, 1995, BRIT J PHARMACOL, V115, P186, DOI 10.1111/j.1476-5381.1995.tb16337.x; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Perez-de-Puig I, 2013, NEUROSCIENCE, V243, P22, DOI 10.1016/j.neuroscience.2013.03.046; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; Roethig HJ, 2009, NICOTINE TOB RES, V11, P1216, DOI 10.1093/ntr/ntp126; Sacerdoti D, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/236180; SALICIONI AM, 1993, J ENDOCRINOL, V139, P253, DOI 10.1677/joe.0.1390253; Salom MG, 2007, AM J PHYSIOL-HEART C, V293, pH3542, DOI 10.1152/ajpheart.00977.2007; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Sorensen MB, 2002, CIRCULATION, V106, P1646, DOI 10.1161/01.CIR.0000030940.73167.4E; Toda N, 2010, EUR J PHARMACOL, V649, P1, DOI 10.1016/j.ejphar.2010.09.042; TOLINS JP, 1990, AM J PHYSIOL, V258, pH655, DOI 10.1152/ajpheart.1990.258.3.H655; Umit UM, 2012, J INVEST SURG, V25, P345, DOI 10.3109/08941939.2012.665570; Ushiyama M, 2002, HEART VESSELS, V16, P189, DOI 10.1007/s003800200020; Wang XM, 2002, AM J PHYSIOL-RENAL, V282, pF124, DOI 10.1152/ajprenal.0157.2001; Whiting C, 2013, AM J PHYSIOL-RENAL, V305, pF1031, DOI 10.1152/ajprenal.00024.2013; Wilson SJ, 2003, VASC PHARMACOL, V40, P109, DOI 10.1016/S1537-1891(02)00340-3; ZATZ R, 1991, AM J PHYSIOL, V261, pF360	60	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95079	10.1371/journal.pone.0095079	http://dx.doi.org/10.1371/journal.pone.0095079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733557	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400151
J	Kittler, S; Fischer, S; Abdulmawjood, A; Glunder, G; Klein, G				Kittler, Sophie; Fischer, Samuel; Abdulmawjood, Amir; Gluender, Gerhard; Klein, Guenter			Colonisation of a Phage Susceptible Campylobacter jejuni Population in Two Phage Positive Broiler Flocks	PLOS ONE			English	Article							GENE-EXPRESSION; BACTERIOPHAGE; IDENTIFICATION; MOTILITY; STRAINS; DIVERSITY; RESISTANT; INFECTION; VIRULENCE; ADHERENCE	The pathogens Campylobacter jejuni and Campylobacter coli are commensals in the poultry intestine and campylobacteriosis is one of the most frequent foodborne diseases in developed and developing countries. Phages were identified to be effective in reducing intestinal Campylobacter load and this was evaluated, in the first field trials which were recently carried out. The aim of this study was to further investigate Campylobacter population dynamics during phage application on a commercial broiler farm. This study determines the superiority in colonisation of a Campylobacter type found in a field trial that was susceptible to phages in in vitro tests. The colonisation factors, i.e. motility and gamma glutamyl transferase activity, were increased in this type. The clustering in phylogenetic comparisons of MALDI-TOF spectra did not match the ST, biochemical phenotype and phage susceptibility. Occurrence of Campylobacter jejuni strains and phage susceptibility types with different colonisation potential seem to play a very important role in the success of phage therapy in commercial broiler houses. Thus, mechanisms of both, phage susceptibility and Campylobacter colonisation should be further investigated and considered when composing phage cocktails.	[Kittler, Sophie; Abdulmawjood, Amir; Klein, Guenter] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Fischer, Samuel; Gluender, Gerhard] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Klein, G (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	Guenter.Klein@tiho-hannover.de	Klein, Günter/G-5321-2013; Abdulmawjood, Amir/AAL-5523-2020; Abdulmawjood, Amir/C-6083-2015	Klein, Günter/0000-0003-1931-2701; Abdulmawjood, Amir/0000-0001-5189-8381	Lohmann Animal Health Company, Cuxhaven, Germany; Institute for of Food Quality and Food Safety	Lohmann Animal Health Company, Cuxhaven, Germany; Institute for of Food Quality and Food Safety	The phages were supplied by Lohmann Animal Health Company, Cuxhaven, Germany. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was also funded by unrestricted financial resources of the Institute for of Food Quality and Food Safety. The member of the Institute Prof. Dr. vet. med. G. Klein and S. Kittler were involved in all decisions about study design, data collection and analysis, publishing and manuscript preparation.	Abedon Stephen T, 2012, Bacteriophage, V2, P50; Ahmed IH, 2002, MICROBIOL-SGM, V148, P1203, DOI 10.1099/00221287-148-4-1203; Alter T, 2011, VET MICROBIOL, V147, P90, DOI 10.1016/j.vetmic.2010.06.005; Atterbury RJ, 2005, APPL ENVIRON MICROB, V71, P4885, DOI 10.1128/AEM.71.8.4885-4887.2005; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; CHATTERJEE AN, 1969, J BACTERIOL, V100, P846, DOI 10.1128/JB.100.2.846-853.1969; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; Coward C, 2006, APPL ENVIRON MICROB, V72, P4638, DOI 10.1128/AEM.00184-06; Crushell E, 2004, PEDIATR RES, V55, P3, DOI 10.1203/01.PDR.0000099794.06260.71; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; El-Adawy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051582; El-Shibiny A, 2005, APPL ENVIRON MICROB, V71, P1259, DOI 10.1128/AEM.71.3.1259-1266.2005; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078543; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053899; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; Goodridge Lawrence D, 2011, Bacteriophage, V1, P130; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; HEIERSON A, 1986, J BACTERIOL, V167, P18, DOI 10.1128/jb.167.1.18-24.1986; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hiett KL, 2008, FUNCT INTEGR GENOMIC, V8, P407, DOI 10.1007/s10142-008-0087-6; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Hyytiainen H, 2012, ARCH MICROBIOL, V194, P803, DOI 10.1007/s00203-012-0820-3; Janez N, 2013, J MICROBIOL METH, V95, P68, DOI 10.1016/j.mimet.2013.06.024; Kittler S, 2013, APPL ENVIRON MICROB, V79, P7525, DOI 10.1128/AEM.02703-13; KLAENHAMMER TR, 1985, J GEN MICROBIOL, V131, P1531; Klein G, 2007, INT J FOOD MICROBIOL, V117, P324, DOI 10.1016/j.ijfoodmicro.2007.04.011; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Lienau JA, 2007, J FOOD PROTECT, V70, P536, DOI 10.4315/0362-028X-70.3.536; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mertins S, 2013, AVIAN DIS, V57, P116, DOI 10.1637/10235-050412-ResNote.1; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Park SF, 2000, J BACTERIOL, V182, P207, DOI 10.1128/JB.182.1.207-210.2000; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Ridley AM, 2011, APPL ENVIRON MICROB, V77, P98, DOI 10.1128/AEM.01388-10; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Taboada EN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-229; Velayudhan J, 2004, INFECT IMMUN, V72, P260, DOI 10.1128/IAI.72.1.260-268.2004; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; WANDERSMAN C, 1980, J BACTERIOL, V143, P1374, DOI 10.1128/JB.143.3.1374-1383.1980; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zautner AE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-171; Zweifel C, 2008, INT J FOOD MICROBIOL, V125, P182, DOI 10.1016/j.ijfoodmicro.2008.03.038	65	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94782	10.1371/journal.pone.0094782	http://dx.doi.org/10.1371/journal.pone.0094782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733154	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400100
J	Martins, SCV; Araujo, WL; Tohge, T; Fernie, AR; DaMatta, FM				Martins, Samuel C. V.; Araujo, Wagner L.; Tohge, Takayuki; Fernie, Alisdair R.; DaMatta, Fabio M.			In High-Light-Acclimated Coffee Plants the Metabolic Machinery Is Adjusted to Avoid Oxidative Stress Rather than to Benefit from Extra Light Enhancement in Photosynthetic Yield	PLOS ONE			English	Article							MASS-SPECTROMETRY; ARABICA L.; TRANSCRIPTION FACTOR; ELECTRON-TRANSPORT; PROFILING REVEALS; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; GAS-CHROMATOGRAPHY; LIGUSTRUM-VULGARE	Coffee (Coffea arabica L.) has been traditionally considered as shade-demanding, although it performs well without shade and even out-yields shaded coffee. Here we investigated how coffee plants adjust their metabolic machinery to varying light supply and whether these adjustments are supported by a reprogramming of the primary and secondary metabolism. We demonstrate that coffee plants are able to adjust its metabolic machinery to high light conditions through marked increases in its antioxidant capacity associated with enhanced consumption of reducing equivalents. Photorespiration and alternative pathways are suggested to be key players in reductant-consumption under high light conditions. We also demonstrate that both primary and secondary metabolism undergo extensive reprogramming under high light supply, including depression of the levels of intermediates of the tricarboxylic acid cycle that were accompanied by an up-regulation of a range of amino acids, sugars and sugar alcohols, polyamines and flavonoids such as kaempferol and quercetin derivatives. When taken together, the entire dataset is consistent with these metabolic alterations being primarily associated with oxidative stress avoidance rather than representing adjustments in order to facilitate the plants from utilizing the additional light to improve their photosynthetic performance.	[Martins, Samuel C. V.; Araujo, Wagner L.; DaMatta, Fabio M.] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [Araujo, Wagner L.] Univ Fed Vicosa, Dept Biol Vegetal, Max Planck Partner Grp, Vicosa, MG, Brazil; [Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Max Planck Society	DaMatta, FM (corresponding author), Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil.	fdamatta@ufv.br	DaMatta, Fabio/AAZ-1515-2020; Araújo, Wagner L./I-3291-2013; Tohge, Takayuki/G-7924-2017; Rodrigues, Fabricio/AAH-7572-2020	DaMatta, Fabio/0000-0002-9637-8475; Araújo, Wagner L./0000-0002-4796-2616; Tohge, Takayuki/0000-0001-5555-5650; 	Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig) [APQ-01138-12]; National Council for Scientific and Technological Development, Brazil (CNPq) [302605/2010-0, 475780/2012-4]; CNPq	Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig, Grant APQ-01138-12) and by the National Council for Scientific and Technological Development, Brazil (CNPq, Grants 302605/2010-0 and 475780/2012-4) to FMD. A PhD scholarship granted by CNPq to SCVM is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Agati G, 2009, ANN BOT-LONDON, V104, P853, DOI 10.1093/aob/mcp177; Alonso-Salces RM, 2009, RAPID COMMUN MASS SP, V23, P363, DOI 10.1002/rcm.3884; [Anonymous], J EXP BOT, V63, P1637; Araujo WL, 2008, PLANT PHYSIOL BIOCH, V46, P884, DOI 10.1016/j.plaphy.2008.05.005; Araujo WL, 2011, PLANT CELL, V23, P600, DOI 10.1105/tpc.110.081224; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Behnke K, 2010, PLANT MOL BIOL, V74, P61, DOI 10.1007/s11103-010-9654-z; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bergmuller E, 2005, BIOINFORMATICS, V21, P1635, DOI DOI 10.1093/BI0INF0RMATICS/BTI236; Brautigam K, 2009, PLANT CELL, V21, P2715, DOI 10.1105/tpc.108.062018; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Campa C, 2012, ANN BOT-LONDON, V110, P595, DOI 10.1093/aob/mcs119; Cavatte PC, 2012, J EXP BOT, V63, P3071, DOI 10.1093/jxb/ers027; Cavatte PC, 2012, PHYSIOL PLANTARUM, V144, P111, DOI 10.1111/j.1399-3054.2011.01525.x; Chaves ARM, 2008, TREES-STRUCT FUNCT, V22, P351, DOI 10.1007/s00468-007-0190-7; Close DC, 2002, OIKOS, V99, P166, DOI 10.1034/j.1600-0706.2002.990117.x; Coruzzi G., 2000, BIOCH MOL BIOL PLANT, P358; Da Matta FM, 1999, FIELD CROP RES, V60, P223, DOI 10.1016/S0378-4290(98)00127-0; DaMatta FM, 2010, AGR ISSUES POLICIES, P181; DaMatta FM, 2004, FIELD CROP RES, V86, P99, DOI 10.1016/j.fcr.2003.09.001; DIETZ KJ, 1984, BIOCHIM BIOPHYS ACTA, V767, P432, DOI 10.1016/0005-2728(84)90041-0; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Forti G, 2003, PLANT PHYSIOL, V132, P1464, DOI 10.1104/pp.102.018861; Geisler DA, 2012, PLANT CELL, V24, P2792, DOI 10.1105/tpc.112.099424; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; Hernandez I, 2010, PLANT SCI, V179, P297, DOI 10.1016/j.plantsci.2010.06.001; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Howard TP, 2011, PLANT PHYSIOL, V157, P620, DOI 10.1104/pp.111.183806; Huang TF, 2010, PLANT J, V63, P823, DOI 10.1111/j.1365-313X.2010.04287.x; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Jankanpaa HJ, 2012, PLANT CELL ENVIRON, V35, P1824, DOI 10.1111/j.1365-3040.2012.02519.x; JELITTO T, 1992, PLANTA, V188, P238, DOI 10.1007/BF00216819; Kueger S, 2012, PLANT J, V70, P39, DOI 10.1111/j.1365-313X.2012.04902.x; Kusano M, 2011, PLANT J, V67, P354, DOI 10.1111/j.1365-313X.2011.04599.x; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Lima ALS, 2002, ENVIRON EXP BOT, V47, P239, DOI 10.1016/S0098-8472(01)00130-7; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JH, 2007, PLANT BIOTECHNOL-NAR, V24, P117, DOI 10.5511/plantbiotechnology.24.117; Logan BA, 2007, FUNCT PLANT BIOL, V34, P853, DOI 10.1071/FP07113; Logan BA, 2006, PHOTOSYNTH RES, V88, P119, DOI 10.1007/s11120-006-9043-2; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; Martins SCV, 2013, J EXP BOT, V64, P3285, DOI 10.1093/jxb/ert168; Matos FS, 2009, ENVIRON EXP BOT, V67, P421, DOI 10.1016/j.envexpbot.2009.06.018; Miyake C, 2010, PLANT CELL PHYSIOL, V51, P1951, DOI 10.1093/pcp/pcq173; Mondolot L, 2006, ANN BOT-LONDON, V98, P33, DOI 10.1093/aob/mcl080; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noctor G, 2000, J EXP BOT, V51, P347, DOI 10.1093/jexbot/51.suppl_1.347; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Okazaki Y, 2012, PLANT BIOTECHNOL REP, V6, P1, DOI 10.1007/s11816-011-0191-2; OLIVER DJ, 1994, ANNU REV PLANT PHYS, V45, P323, DOI 10.1146/annurev.pp.45.060194.001543; Pompelli MF, 2010, J PLANT PHYSIOL, V167, P1052, DOI 10.1016/j.jplph.2010.03.001; Ramalho JC, 1998, PLANT SCI, V135, P115, DOI 10.1016/S0168-9452(98)00073-9; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Ronchi CP, 2006, FUNCT PLANT BIOL, V33, P1013, DOI 10.1071/FP06147; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Scheibe R, 2005, J EXP BOT, V56, P1481, DOI 10.1093/jxb/eri181; Scheibe R, 2012, PLANT CELL ENVIRON, V35, P202, DOI 10.1111/j.1365-3040.2011.02319.x; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tattini M, 2004, NEW PHYTOL, V163, P547, DOI 10.1111/j.1469-8137.2004.01126.x; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Tohge T, 2009, PHYTOCHEMISTRY, V70, P450, DOI 10.1016/j.phytochem.2009.02.004; Urbanczyk-Wochniak E, 2005, J EXP BOT, V56, P309, DOI 10.1093/jxb/eri059; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; VALENTINI R, 1995, PLANT CELL ENVIRON, V18, P631, DOI 10.1111/j.1365-3040.1995.tb00564.x; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wulff-Zottele C, 2010, PLANT CELL ENVIRON, V33, P1974, DOI 10.1111/j.1365-3040.2010.02199.x	83	26	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94862	10.1371/journal.pone.0094862	http://dx.doi.org/10.1371/journal.pone.0094862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733284	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400023
J	Moeller, S; Canetta, PA; Taylor, AK; Arguelles-Grande, C; Snyder, H; Green, PH; Kiryluk, K; Alaedini, A				Moeller, Sina; Canetta, Pietro A.; Taylor, Annette K.; Arguelles-Grande, Carolina; Snyder, Holly; Green, Peter H.; Kiryluk, Krzysztof; Alaedini, Armin			Lack of Serologic Evidence to Link IgA Nephropathy with Celiac Disease or Immune Reactivity to Gluten	PLOS ONE			English	Article							ANTIGLIADIN ANTIBODIES; FREE DIET; HLA; INDIVIDUALS; PREVALENCE; DISORDER; RISK	IgA nephropathy is the most common form of primary glomerulonephritis worldwide. Mucosal infections and food antigens, including wheat gluten, have been proposed as potential contributing environmental factors. Increased immune reactivity to gluten and/or association with celiac disease, an autoimmune disorder triggered by ingestion of gluten, have been reported in IgA nephropathy. However, studies are inconsistent about this association. We aimed to evaluate the proposed link between IgA nephropathy and celiac disease or immune reactivity to gluten by conducting a comprehensive analysis of associated serologic markers in cohorts of well-characterized patients and controls. Study participants included patients with biopsy-proven IgA nephropathy (n = 99), unaffected controls of similar age, gender, and race (n = 96), and patients with biopsy-proven celiac disease (n = 30). All serum specimens were tested for IgG and IgA antibodies to native gliadin and deamidated gliadin, as well as IgA antibody to transglutaminase 2 (TG2). Anti-TG2 antibody-positive nephropathy patients and unaffected controls were subsequently tested for IgA anti-endomysial antibody and genotyped for celiac disease-associated HLA-DQ2 and -DQ8 alleles. In comparison to unaffected controls, there was not a statistically significant increase in IgA or IgG antibody reactivity to gliadin in individuals with IgA nephropathy. In addition, the levels of celiac disease-specific serologic markers, i. e., antibodies to deamidated gliadin and TG2, did not differ between IgA nephropathy patients and unaffected controls. Results of the additional anti-endomysial antibody testing and HLA genotyping were corroborative. The data from this case-control study do not reveal any evidence to suggest a significant role for celiac disease or immune reactivity to gluten in IgA nephropathy.	[Moeller, Sina; Arguelles-Grande, Carolina; Green, Peter H.; Alaedini, Armin] Columbia Univ, Dept Med, Div Digest & Liver Dis, Med Ctr, New York, NY 10027 USA; [Moeller, Sina; Arguelles-Grande, Carolina; Green, Peter H.; Alaedini, Armin] Columbia Univ, Med Ctr, Celiac Dis Ctr, New York, NY USA; [Canetta, Pietro A.; Snyder, Holly; Kiryluk, Krzysztof] Columbia Univ, Dept Med, Div Nephrol, Med Ctr, New York, NY USA; [Taylor, Annette K.] Esoterix Inc, Lab Corp Amer Holdings, Englewood, CO USA; [Alaedini, Armin] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Alaedini, A (corresponding author), Columbia Univ, Dept Med, Div Digest & Liver Dis, Med Ctr, New York, NY 10027 USA.	aa819@columbia.edu	Canetta, Pietro/I-3823-2019	Canetta, Pietro/0000-0003-1130-5486; Arguelles-Grande, Carolina/0000-0002-4835-1577	National Center for Advancing Translational Sciences, NIH [UL1 TR000040]; Celiac Disease Center at Columbia University Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK090207]; Glomerular Center at Columbia University; Nephrotic Syndrome Study Network (NEPTUNE) [U-54-DK-083912]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083912, K23DK090207] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, NIH; Celiac Disease Center at Columbia University Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Glomerular Center at Columbia University; Nephrotic Syndrome Study Network (NEPTUNE); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the National Center for Advancing Translational Sciences, NIH, through Grant Number UL1 TR000040 (to Dr. Alaedini). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Additional support was provided by the Celiac Disease Center at Columbia University Medical Center. Dr. Kiryluk is supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant K23-DK090207 and the Glomerular Center at Columbia University. Dr. Canetta is supported by a career development grant from the Nephrotic Syndrome Study Network (NEPTUNE), U-54-DK-083912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Briani C, 2008, AUTOIMMUN REV, V7, P644, DOI 10.1016/j.autrev.2008.05.006; Collin P, 2002, AM J GASTROENTEROL, V97, P2572; COPPO R, 1989, LAB INVEST, V60, P499; COPPO R, 1986, NEW ENGL J MED, V315, P1167; COPPO R, 1990, CLIN NEPHROL, V33, P72; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; HALE GM, 1986, KIDNEY INT, V29, P718, DOI 10.1038/ki.1986.57; Heinemann FM, 2009, TRANSFUS MED HEMOTH, V36, P273, DOI 10.1159/000228834; KUMAR V, 1988, LANCET, V2, P1307; KURAMOTO T, 1991, Tokai Journal of Experimental and Clinical Medicine, V16, P239; LAYWARD L, 1994, EXP NEPHROL, V2, P24; Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Lundin Knut E A, 2012, Gastrointest Endosc Clin N Am, V22, P723, DOI 10.1016/j.giec.2012.07.006; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Ots M, 1999, AM J NEPHROL, V19, P453, DOI 10.1159/000013497; Pierucci A, 2002, AM J KIDNEY DIS, V39, P1176, DOI 10.1053/ajkd.2002.33387; ROSTOKER G, 1989, NEW ENGL J MED, V320, P1283; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; SATEGNAGUIDETTI C, 1992, GUT, V33, P476, DOI 10.1136/gut.33.4.476; Schwertz E, 2004, CLIN CHEM, V50, P2370, DOI 10.1373/clinchem.2004.036111; Smerud HK, 2009, NEPHROL DIAL TRANSPL, V24, P2476, DOI 10.1093/ndt/gfp133; Van Dixhoorn MGA, 2000, KIDNEY INT, V58, P90, DOI 10.1046/j.1523-1755.2000.00144.x; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Welander A, 2013, J CLIN GASTROENTEROL, V47, P678, DOI 10.1097/MCG.0b013e318284792e; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WOODROW G, 1993, NEPHROL DIAL TRANSPL, V8, P1382; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793	32	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94677	10.1371/journal.pone.0094677	http://dx.doi.org/10.1371/journal.pone.0094677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732864	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400068
J	Shen, N; Tan, J; Wang, P; Wang, J; Shi, Y; Lv, WQ; Xie, XF; Huang, XS				Shen, Na; Tan, Jun; Wang, Peng; Wang, Jian; Shi, Yuan; Lv, Wenqi; Xie, Xiaofeng; Huang, Xinsheng			Indirect Magnetic Resonance Imaging Lymphography Identifies Lymph Node Metastasis in Rabbit Pyriform Sinus VX2 Carcinoma Using Ultra-Small Super-Paramagnetic Iron Oxide	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PROSTATE-CANCER PATIENTS; ZEALAND WHITE-RABBITS; MR LYMPHOGRAPHY; RECTAL-CANCER; USPIO; PARTICLES; TUMOR; MODEL; NECK	Background: USPIO is a contrast agent for MRI that can generate T2W images with low signal intensities. After subcutaneous or intravenous injection of USPIO, normal lymph node tissues uptake these nano-particles, but tumor cells do not. Thus, tumor metastasis can be detected using this contrast agent. Objective: The aim of this study was to access the feasibility of USPIO enhanced MRI for the detection of cervical lymph node metastasis in a pyriform sinus carcinoma animal model and to investigate the ability of USPIO to enhance images of cervical lymph node metastases. Methods and Findings: Twenty New Zealand rabbits were randomly divided into tumor and inflammatory groups, and each group contained 10 rabbits. In the inflammatory group, a 0.5 ml egg yolk emulsion was injected into the submandibular muscle of the rabbits to induce an inflammatory reaction in their cervical lymph nodes. In the tumor group, a VX2 tumor tissue suspension was transplanted into the pyriform sinus sub-mucosa of the rabbits using direct laryngoscope. Four weeks after the tumor or egg yolk injection, MRIs were performed before and after USPIO injection to observe the imaging enhancement features of USPIO. After that, a histo-pathological analysis was performed for all rabbits. We found the metastatic lymph nodes had no signal reduced intensity or irregular signal reduced intensity on T2-weighted image by using USPIO enhancement. In the tumor group, the sensitivity and specificity of plain MRI were 57.6% and 60.7%. The corresponding values of USPIO-enhanced MRl were 96.1% and 85.7%. (P < 0.05) Conclusion: The features and the extent of the lymph node metastases corresponded to those observed on USPIO-enhanced MR images. USPIO-enhanced MRI is useful for the detection and estimation of lymph node metastasis in this cervical carcinoma animal model.	[Shen, Na; Tan, Jun; Wang, Peng; Xie, Xiaofeng; Huang, Xinsheng] Fudan Univ, ZhongShan Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China; [Wang, Jian] Fudan Univ, ZhongShan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Shi, Yuan] Fudan Univ, ZhongShan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Lv, Wenqi] Fudan Univ, Dept Polymer Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Huang, XS (corresponding author), Fudan Univ, ZhongShan Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.	huang_xinsh@163.com		Huang, Xinsheng/0000-0003-3201-4776; Shen, Na/0000-0001-7586-7061	National Natural Science Foundation of China [81001201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project supported by National Natural Science Foundation of China (81001201) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai Y, 2003, RADIOLOGY, V228, P777, DOI 10.1148/radiol.2283020872; Bellin MF, 1998, RADIOLOGY, V207, P799, DOI 10.1148/radiology.207.3.9609907; Buckley JG, 2000, HEAD NECK-J SCI SPEC, V22, P380, DOI 10.1002/1097-0347(200007)22:4<380::AID-HED11>3.0.CO;2-E; Choi SH, 2007, RADIOLOGY, V242, P137, DOI 10.1148/radiol.2421060093; Dunne AA, 2003, LAB ANIM-UK, V37, P37, DOI 10.1258/002367703762226674; Dunne AA, 2002, ANTICANCER RES, V22, P3273; Durand E, 2007, J VASC RES, V44, P119, DOI 10.1159/000098484; Fortuin AS, 2012, INT J RADIAT ONCOL, V84, P712, DOI 10.1016/j.ijrobp.2011.12.093; Gourin Christine G, 2004, Surg Oncol Clin N Am, V13, P81, DOI 10.1016/S1055-3207(03)00122-4; Guermazi A, 2003, RADIOGRAPHICS, V23, P1541, DOI 10.1148/rg.236035704; Harisinghani MG, 2004, RADIOGRAPHICS, V24, P867, DOI 10.1148/rg.243035190; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; JEFFERIS AF, 1989, ACTA OTO-LARYNGOL, V108, P152, DOI 10.3109/00016488909125513; Kau RJ, 1999, ARCH OTOLARYNGOL, V125, P1322, DOI 10.1001/archotol.125.12.1322; Keller TM, 2004, EUR RADIOL, V14, P937, DOI 10.1007/s00330-004-2258-8; Kimura K, 2010, BREAST CANCER-TOKYO, V17, P241, DOI 10.1007/s12282-009-0143-7; Koh DM, 2004, RADIOLOGY, V231, P91, DOI 10.1148/radiol.2311030142; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Lahaye MJ, 2008, RADIOLOGY, V246, P804, DOI 10.1148/radiol.2463070221; LEE AS, 1991, RADIOLOGY, V178, P519, DOI 10.1148/radiology.178.2.1987619; Lei Jing, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P182; Li Xiao-min, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P741; Lu XL, 2005, J TIANSHUI NORMAL U, V5, P39; MACSWEENEY JE, 1994, CLIN RADIOL, V49, P241, DOI 10.1016/S0009-9260(05)81848-3; Moghimi SM, 1999, ADV DRUG DELIVER REV, V37, P295, DOI 10.1016/S0169-409X(98)00099-4; Pultrum BB, 2009, CANCER IMAGING, V9, P19, DOI 10.1102/1470-7330.2009.0004; Rogers JM, 1998, MAGN RESON IMAGING, V16, P917, DOI 10.1016/S0730-725X(98)00090-3; Ross RW, 2009, CLIN IMAG, V33, P301, DOI 10.1016/j.clinimag.2009.01.013; Saksena MA, 2006, EUR J RADIOL, V58, P367, DOI 10.1016/j.ejrad.2005.12.041; Shen N, 2009, ORL-J OTO-RHIN-LARYN, V71, P129, DOI 10.1159/000209313; Taniguchi I, 2004, ANN ANAT, V186, P337, DOI 10.1016/S0940-9602(04)80053-0; TAUPITZ M, 1993, AM J ROENTGENOL, V161, P193, DOI 10.2214/ajr.161.1.8517301; Torchia MG, 2001, J SURG ONCOL, V78, P151, DOI 10.1002/jso.1139; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Williams AD, 2001, AM J ROENTGENOL, V177, P343, DOI 10.2214/ajr.177.2.1770343; Yang WT, 2000, AM J ROENTGENOL, V175, P759, DOI 10.2214/ajr.175.3.1750759	36	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94876	10.1371/journal.pone.0094876	http://dx.doi.org/10.1371/journal.pone.0094876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733438	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400126
J	Shrivastav, N; Fedeles, BI; Li, DY; Delaney, JC; Frick, LE; Foti, JJ; Walker, GC; Essigmann, JM				Shrivastav, Nidhi; Fedeles, Bogdan I.; Li, Deyu; Delaney, James C.; Frick, Lauren E.; Foti, James J.; Walker, Graham C.; Essigmann, John M.			A Chemical Genetics Analysis of the Roles of Bypass Polymerase DinB and DNA Repair Protein AlkB in Processing N-2-Alkylguanine Lesions In Vivo	PLOS ONE			English	Article							ACETALDEHYDE DERIVED N-2-ETHYL-2'-DEOXYGUANOSINE; ESCHERICHIA-COLI; Y-FAMILY; POL-IV; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; BACTERIAL-DNA; MINOR-GROOVE; MUTAGENESIS; ADDUCTS	DinB, the E. coli translesion synthesis polymerase, has been shown to bypass several N-2-alkylguanine adducts in vitro, including N-2-furfurylguanine, the structural analog of the DNA adduct formed by the antibacterial agent nitrofurazone. Recently, it was demonstrated that the Fe(II)-and alpha-ketoglutarate-dependent dioxygenase AlkB, a DNA repair enzyme, can dealkylate in vitro a series of N-2-alkyguanines, including N-2-furfurylguanine. The present study explored, head to head, the in vivo relative contributions of these two DNA maintenance pathways (replicative bypass vs. repair) as they processed a series of structurally varied, biologically relevant N-2-alkylguanine lesions: N-2-furfurylguanine (FF), 2-tetrahydrofuran-2-yl-methylguanine (HF), 2-methylguanine, and 2-ethylguanine. Each lesion was chemically synthesized and incorporated site-specifically into an M13 bacteriophage genome, which was then replicated in E. coli cells deficient or proficient for DinB and AlkB (4 strains in total). Biochemical tools were employed to analyze the relative replication efficiencies of the phage (a measure of the bypass efficiency of each lesion) and the base composition at the lesion site after replication (a measure of the mutagenesis profile of each lesion). The main findings were: 1) Among the lesions studied, the bulky FF and HF lesions proved to be strong replication blocks when introduced site-specifically on a single-stranded vector in DinB deficient cells. This toxic effect disappeared in the strains expressing physiological levels of DinB. 2) AlkB is known to repair N-2-alkylguanine lesions in vitro; however, the presence of AlkB showed no relief from the replication blocks induced by FF and HF in vivo. 3) The mutagenic properties of the entire series of N-2-alkyguanines adducts were investigated in vivo for the first time. None of the adducts were mutagenic under the conditions evaluated, regardless of the DinB or AlkB cellular status. Taken together, the data indicated that the cellular pathway to combat bulky N-2-alkylguanine DNA adducts was DinB-dependent lesion bypass.	[Shrivastav, Nidhi; Fedeles, Bogdan I.; Li, Deyu; Delaney, James C.; Frick, Lauren E.; Essigmann, John M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Shrivastav, Nidhi; Fedeles, Bogdan I.; Li, Deyu; Delaney, James C.; Frick, Lauren E.; Essigmann, John M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Shrivastav, Nidhi; Fedeles, Bogdan I.; Li, Deyu; Delaney, James C.; Frick, Lauren E.; Essigmann, John M.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Essigmann, JM (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jessig@mit.edu	Shrivastav, Nidhi/AAF-1980-2020	Shrivastav, Nidhi/0000-0002-1349-7568; Fedeles, Bogdan/0000-0001-5252-826X; /0000-0001-7243-8261	National Institutes of Health [CA080024, CA26731, ES002109, CA021615]; NATIONAL CANCER INSTITUTE [R37CA080024, R01CA080024, R01CA021615, P01CA026731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants CA080024, CA26731, ES002109 (to J.M.E.), and CA021615 (to G. C. W.). G. C. W. is an American Cancer Society Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Abraham J, 2011, ALCOHOL CLIN EXP RES, V35, P2113, DOI 10.1111/j.1530-0277.2011.01563.x; [Anonymous], 1999, IARC Monogr Eval Carcinog Risks Hum, V71 Pt 1, Pt 2, Pt 3, P1; Balbo S, 2012, MUTAGENESIS, V27, P485, DOI 10.1093/mutage/ges008; BENASUTTI M, 1988, CHEM RES TOXICOL, V1, P160, DOI 10.1021/tx00003a006; Benson RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019944; Bjedov I, 2003, DNA REPAIR, V2, P417, DOI 10.1016/S1568-7864(02)00241-0; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; BROTCORNELANNOYE A, 1986, P NATL ACAD SCI USA, V83, P3904, DOI 10.1073/pnas.83.11.3904; Chandani S, 2009, J MOL GRAPH MODEL, V27, P759, DOI 10.1016/j.jmgm.2008.11.003; Cheah NP, 2013, TOXICOL IN VITRO, V27, P1072, DOI 10.1016/j.tiv.2013.02.003; Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cohen SE, 2011, TRANSCR-AUSTIN, V2, P37, DOI 10.4161/trns.2.1.14228; Crean C, 2009, J PHYS CHEM B, V113, P12773, DOI 10.1021/jp903554n; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Hiraku Y, 2004, CANCER LETT, V215, P141, DOI 10.1016/j.canlet.2004.05.016; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Jarosz DF, 2009, P NATL ACAD SCI USA, V106, P21137, DOI 10.1073/pnas.0907257106; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jarosz DF, 2007, THESIS MIT; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Lu K, 2012, CHEM RES TOXICOL, V25, P664, DOI 10.1021/tx200426b; Matter B, 2007, CHEM RES TOXICOL, V20, P1379, DOI 10.1021/tx7001146; McCain MD, 2005, BIOCHEMISTRY-US, V44, P5647, DOI 10.1021/bi047460f; MCCALLA DR, 1971, CANCER RES, V31, P2184; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1281, DOI 10.1021/bi00677a029; Morales JC, 1999, J AM CHEM SOC, V121, P2323, DOI 10.1021/ja983502+; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Nieminuszczy J, 2007, ACTA BIOCHIM POL, V54, P459, DOI 10.18388/abp.2007_3221; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ona KR, 2009, J BACTERIOL, V191, P4959, DOI 10.1128/JB.00495-09; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Pence MG, 2011, DNA REPAIR, V10, P56, DOI 10.1016/j.dnarep.2010.09.007; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Rodgers G. L., 1997, Journal of Burn Care and Rehabilitation, V18, P406, DOI 10.1097/00004630-199709000-00006; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Seo KY, 2006, DNA REPAIR, V5, P515, DOI 10.1016/j.dnarep.2005.12.009; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Singh R, 2012, MUTAT RES-FUND MOL M, V737, P8, DOI 10.1016/j.mrfmmm.2012.07.001; Singh R, 2009, CHEM RES TOXICOL, V22, P1181, DOI 10.1021/tx900106y; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Takegawa K, 2000, TOXICOL PATHOL, V28, P649, DOI 10.1177/019262330002800503; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Walsh JM, 2011, FRONT BIOSCI-LANDMRK, V16, P3164, DOI 10.2741/3904; Wang MY, 2006, CHEM RES TOXICOL, V19, P319, DOI 10.1021/tx0502948; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Yamada M, 2006, J BACTERIOL, V188, P4992, DOI 10.1128/JB.00281-06; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yi CQ, 2009, ACCOUNTS CHEM RES, V42, P519, DOI 10.1021/ar800178j; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; ZAMPIERI A, 1964, BIOCHEM BIOPH RES CO, V14, P172, DOI 10.1016/0006-291X(64)90249-9	72	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94716	10.1371/journal.pone.0094716	http://dx.doi.org/10.1371/journal.pone.0094716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733044	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400080
J	Zheng, XT; O'Connor, JK; Huchzermeyer, F; Wang, XL; Wang, Y; Zhang, XM; Zhou, ZH				Zheng, Xiaoting; O'Connor, Jingmai K.; Huchzermeyer, Fritz; Wang, Xiaoli; Wang, Yan; Zhang, Xiaomei; Zhou, Zhonghe			New Specimens of Yanornis Indicate a Piscivorous Diet and Modern Alimentary Canal	PLOS ONE			English	Article							CHINA; BIRD; AVES	A crop adapted for an herbivorous diet of seeds has previously been documented in the Early Cretaceous birds Sapeornis and Hongshanornis. Here we report on several specimens of Yanornis that preserve a crop containing fish. One specimen preserves two whole fish in the oesophagus, indicating that Early Cretaceous birds shared trophic specializations with Neornithes for the increased energetic demands of flight - namely the storing of food for later consumption when the stomach is full. Whole fish also indicate that despite their presence, teeth were not used to orally process food, suggesting the hypertrophied dentition in this taxon were utilized in prey capture. The presence of macerated fish bones in the crop of other specimens indicates the highly efficient advanced muscular system of peristalsis responsible for moving ingested items between different segments of the alimentary canal was also in place. Despite the fact many features of the modern avian alimentary canal are inferred to compensate for the absence of teeth in birds (expandable oesophagus, grinding gizzard), the derived alimentary canal was apparently present in toothed Cretaceous birds. Although Yanornis was considered to have switched their diet from piscivorous to herbivorous, based on position and morphology we reinterpret the gastroliths reported in one specimen as sand impacted in the intestines, and reconstruct the taxon as primarily piscivorous. This is a novel interpretation for fossilized gastroliths, and the first documentation of this condition in the fossil record.	[Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi, Shandong, Peoples R China; [Zheng, Xiaoting; Zhang, Xiaomei] Tianyu Nat Hist Museum Shandong, Pingyi, Shandong, Peoples R China; [O'Connor, Jingmai K.; Zhou, Zhonghe] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Huchzermeyer, Fritz] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Pretoria	O'Connor, JK (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	jingmai.oconnor@gmail.com	Xiaoli, Wang/H-1079-2014		National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [41172020, 41372014]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (973 Program, 2012CB821906), the National Natural Science Foundation of China (41172020 and 41372014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZARELLO MY, 1987, MAR ECOL PROG SER, V37, P295, DOI 10.3354/meps037295; Denbow DM., 2000, AVIAN PHYSL; DOMINGUEZBELLO MG, 1993, J COMP PHYSIOL B, V163, P594, DOI 10.1007/BF00302119; DUFFY DC, 1983, CONDOR, V85, P305, DOI 10.2307/1367066; Duke G.E., 1986, P269; Duncan J. R., 2018, SIDS SUDDEN INFANT E; Ford S, 2010, J EXOT PET MED, V19, P140, DOI 10.1053/j.jepm.2010.05.004; GILL FB, 2007, ORNITHOLOGY; Gillespie MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048363; Grande L, 2002, J VERTEBR PALEONTOL, V22, P209, DOI 10.1671/0272-4634(2002)022[0209:PLAWPP]2.0.CO;2; Gussekloo SWS, 2006, FEEDING IN DOMESTIC VERTEBRATES: FROM STRUCTURE TO BEHAVIOUR, P14, DOI 10.1079/9781845930639.0014; HUCHZERMEYER FW, 1998, DIS OSTRICHES OTHER; Hui CA, 1998, SCI TOTAL ENVIRON, V224, P227, DOI 10.1016/S0048-9697(98)00361-1; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Knight M, 1964, NEW DICT BIRDS; Marsh OC, 1880, PROFESSIONAL PAPERS, V18, P1; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Place AR, 1991, ACT 20 INT C ORN, P913; Proctor NS, 1993, MANUAL ORNITHOLOGY; Roza K, 2006, AVIAN DIS, V50, P460, DOI 10.1637/7500-010906R.1; SMITH CR, 1972, WILSON BULL, V84, P179; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou S, 2013, J VERTEBR PALEONTOL, V33, P141, DOI 10.1080/02724634.2012.714431; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZH, 2002, NATURWISSENSCHAFTEN, V89, P34, DOI 10.1007/s00114-001-0276-9; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P571, DOI 10.1007/s00114-004-0567-z; Zhou ZH, 2002, NATURE, V420, P285, DOI 10.1038/420285a; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x; 王小逸, 1999, [涂料工业, Paint & Coatings Industry], P1	33	49	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95036	10.1371/journal.pone.0095036	http://dx.doi.org/10.1371/journal.pone.0095036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733485	gold, Green Published			2022-12-25	WOS:000336970400147
J	Carrillo-Salinas, FJ; Navarrete, C; Mecha, M; Feliu, A; Collado, JA; Cantarero, I; Bellido, ML; Munoz, E; Guaza, C				Carrillo-Salinas, Francisco J.; Navarrete, Carmen; Mecha, Miriam; Feliu, Ana; Collado, Juan A.; Cantarero, Irene; Bellido, Maria L.; Munoz, Eduardo; Guaza, Carmen			A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; EXPRESSION; RECEPTOR; PATHOGENESIS; INFLAMMATION; LESIONS; TARGET	Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases. A cannabigerol quinone, the compound VCE-003, has been shown to alleviate symptoms in a viral model of multiple sclerosis (MS). Hence, we studied T cells and macrophages as targets for VCE-003 and its efficacy in an autoimmune model of MS. Proliferation, cell cycle, expression of activation markers was assessed by FACs in human primary T cells, and cytokine and chemokine production was evaluated. Transcription was studied in Jurkat cells and RAW264.7 cells were used to study the effects of VCE-003 on IL-17-induced macrophage polarization to a M1 phenotype. Experimental autoimmune encephalomyelitis (EAE) was induced by myelin oligodendrocyte glycoprotein (MOG(35-55)) immunization and spinal cord pathology was assessed by immunohistochemistry. Neurological impairment was evaluated using disease scores. We show here that VCE-003 inhibits CD3/CD28-induced proliferation, cell cycle progression and the expression of the IL-2R alpha and ICAM-1 activation markers in human primary T cells. VCE-003 inhibits the secretion of Th1/Th17 cytokines and chemokines in primary murine T cells, and it reduces the transcriptional activity of the IL-2, IL-17 and TNF alpha promoters induced by CD3/CD28. In addition, VCE-003 and JWH-133, a selective CB2 agonist, dampened the IL-17-induced polarization of macrophages to a pro-inflammatory M1 profile. VCE-003 also prevented LPS-induced iNOS expression in microglia. VCE-003 ameliorates the neurological defects and the severity of MOG-induced EAE in mice through CB2 and PPAR gamma receptor activation. A reduction in cell infiltrates, mainly CD4(+)T cells, was observed, and Th1 and Th17 responses were inhibited in the spinal cord of VCE-003-treated mice, accompanied by weaker microglial activation, structural preservation of myelin sheets and reduced axonal damage. This study highlights the therapeutic potential of VCE-003 as an agent for the treatment of human immune diseases with both inflammatory and autoimmune components.	[Carrillo-Salinas, Francisco J.; Mecha, Miriam; Feliu, Ana; Guaza, Carmen] CSIC, Inst Cajal, Neuroimmunol Grp, Funct & Syst Neurobiol Dept, E-28002 Madrid, Spain; [Navarrete, Carmen; Bellido, Maria L.] Parque Cient Tecnol Cordoba, VivaCell Biotechnol Espana, Cordoba, Spain; [Collado, Juan A.; Cantarero, Irene; Munoz, Eduardo] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Cordoba	Munoz, E (corresponding author), Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Cordoba, Spain.	e.munoz@uco.es; cgjb@cajal.csic.es	Munoz, Eduardo/I-5225-2012; Carrillo-Salinas, Francisco Javier/E-1737-2016; Mecha, Miriam/J-1861-2018; Feliu, Ana/J-2276-2018; Cantarero, I/AAO-7830-2021	Munoz, Eduardo/0000-0001-8478-5842; Carrillo-Salinas, Francisco Javier/0000-0002-7936-5859; Mecha, Miriam/0000-0002-4649-0530; Feliu, Ana/0000-0002-4649-0530; Navarrete, Carmen Maria/0000-0003-1438-9216; Feliu, Ana/0000-0002-1157-1525; Cantarero, Irene/0000-0001-9047-192X	Ministry of the Economy and Competition (MINECO) [IPT-2011-0861-900000, SAF2010-19292, SAF2010-17501]; Red Espanola de Esclerosis Multiple (REEM) [RD12/0032/0008]; Fondo de Investigacion Sanitaria (FIS); FEDER-INTERCONNECTA [ITC-20111029]; VivaCell Biotechnology	Ministry of the Economy and Competition (MINECO); Red Espanola de Esclerosis Multiple (REEM)(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); FEDER-INTERCONNECTA; VivaCell Biotechnology	This work was supported by the Ministry of the Economy and Competition (MINECO) grants IPT-2011-0861-900000 (EM and CG), SAF2010-19292 (EM), SAF2010-17501 (CG) and by Red Espanola de Esclerosis Multiple (REEM) RD12/0032/0008 (CG) sponsored by the Fondo de Investigacion Sanitaria (FIS). MINECO IPT-2011-0861-900000, and FEDER-INTERCONNECTA ITC-20111029 grants to VivaCell Biotechnology Espana supported CN and MLB. VivaCell Biotechnology provided support in the form of salaries for authors (MLB and EM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution's section.	Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Bitsch A, 2000, GLIA, V29, P366, DOI 10.1002/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y; Borrelli F, 2013, BIOCHEM PHARMACOL, V85, P1306, DOI 10.1016/j.bcp.2013.01.017; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fujita K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/324256; Gomez-Nicola D, 2010, EXP NEUROL, V222, P235, DOI 10.1016/j.expneurol.2009.12.034; Granja AG, 2012, J NEUROIMMUNE PHARM, V7, P1002, DOI 10.1007/s11481-012-9399-3; Guillot A, 2013, HEPATOLOGY; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hill AJ, 2012, PHARMACOL THERAPEUT, V133, P79, DOI 10.1016/j.pharmthera.2011.09.002; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; MATSUMOTO Y, 1992, J NEUROIMMUNOL, V37, P23, DOI 10.1016/0165-5728(92)90152-B; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Radvanyi LG, 1996, J IMMUNOL, V156, P1788; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Venken K, 2010, J NEUROIMMUNOL, V226, P185, DOI 10.1016/j.jneuroim.2010.05.025; Zameer A, 2003, J NEUROIMMUNOL, V142, P67, DOI 10.1016/S0165-5728(03)00262-5	38	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94733	10.1371/journal.pone.0094733	http://dx.doi.org/10.1371/journal.pone.0094733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727978	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200124
J	Felix, MA; Braendle, C; Cutter, AD				Felix, Marie-Anne; Braendle, Christian; Cutter, Asher D.			A Streamlined System for Species Diagnosis in Caenorhabditis (Nematoda: Rhabditidae) with Name Designations for 15 Distinct Biological Species	PLOS ONE			English	Article							MOLECULAR HYPERDIVERSITY; OUTBREEDING DEPRESSION; REPRODUCTIVE ISOLATION; GENETIC-VARIATION; BODY-SIZE; SP-N.; ELEGANS; EVOLUTION; IDENTIFICATION; POPULATIONS	The rapid pace of species discovery outstrips the rate of species description in many taxa. This problem is especially acute for Caenorhabditis nematodes, where the naming of distinct species would greatly improve their visibility and usage for biological research, given the thousands of scientists studying Caenorhabditis. Species description and naming has been hampered in Caenorhabditis, in part due to the presence of morphologically cryptic species despite complete biological reproductive isolation and often enormous molecular divergence. With the aim of expediting species designations, here we propose and apply a revised framework for species diagnosis and description in this group. Our solution prioritizes reproductive isolation over traditional morphological characters as the key feature in delineating and diagnosing new species, reflecting both practical considerations and conceptual justifications. DNA sequence divergence criteria help prioritize crosses for establishing patterns of reproductive isolation among the many species of Caenorhabditis known to science, such as with the ribosomal internal transcribed spacer-2 (ITS2) DNA barcode. By adopting this approach, we provide new species name designations for 15 distinct biological species, thus increasing the number of named Caenorhabditis species in laboratory culture by nearly 3-fold. We anticipate that the improved accessibility of these species to the research community will expand the opportunities for study and accelerate our understanding of diverse biological phenomena.	[Felix, Marie-Anne] Ecole Normale Super, Inst Biol ENS IBENS, F-75231 Paris, France; [Felix, Marie-Anne] CNRS, UMR 8197, Paris, France; [Felix, Marie-Anne] INSERM, U1024, Paris, France; [Braendle, Christian] CNRS, Inst Biol Valrose, UMR7277, F-06034 Nice, France; [Braendle, Christian] Fac Med Nice, INSERM, U1091, F-06034 Nice, France; [Braendle, Christian] Univ Nice Sophia Antipolis, UFR Sci, F-06189 Nice, France; [Cutter, Asher D.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto	Felix, MA (corresponding author), Ecole Normale Super, Inst Biol ENS IBENS, 24 Rue Lhomond, F-75231 Paris, France.	felix@biologie.ens.fr	Cutter, Asher/A-5647-2009; Cutter, Asher/ABA-9539-2020; Braendle, Christian/F-2311-2017	Cutter, Asher/0000-0001-7141-0013; Braendle, Christian/0000-0003-0203-4581	Canada Research Chair; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Ecole Normale Superieure; CNRS; Agence Nationale pour la Recherche; Coup d'Elan de la Fondation Bettencourt-Schueller; Fondation Schlumberger pour l'Education et la Recherche	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ecole Normale Superieure; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Coup d'Elan de la Fondation Bettencourt-Schueller; Fondation Schlumberger pour l'Education et la Recherche(Schlumberger)	ADC is supported by funds from a Canada Research Chair, the Natural Sciences and Engineering Research Council of Canada, and the National Institutes of Health. MAF is supported by funds from the Ecole Normale Superieure, the CNRS, the Agence Nationale pour la Recherche and a Coup d'Elan de la Fondation Bettencourt-Schueller. CB is supported by funds from the CNRS, the Agence Nationale pour la Recherche, and the Fondation Schlumberger pour l'Education et la Recherche. The funders had nor role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 1998, J NEMATOL, V30, P1; ANDERSON RV, 1970, CAN J ZOOLOG, V48, P457, DOI 10.1139/z70-078; Baird S. E., 2013, Natural Science, V5, P18; Baird Scott Everet, 2012, Worm, V1, P189, DOI 10.4161/worm.23535; BAIRD SE, 1994, NEMATOLOGICA, V40, P1, DOI 10.1163/003525994X00012; Baird SE, 2000, EVOL DEV, V2, P9, DOI 10.1046/j.1525-142x.2000.00031.x; Baird SE, 2001, NEMATOLOGY, V3, P373, DOI 10.1163/156854101317020295; Baldi C, 2011, CURR BIOL, V21, P1416, DOI 10.1016/j.cub.2011.07.034; Barriere A, 2014, C ELEGANS R IN PRESS; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Coyne JA, 2004, SPECIATION, V37; Cutter AD, 2013, MOL ECOL, V22, P2074, DOI 10.1111/mec.12281; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; De Ley IT, 2007, NEMATOLOGY, V9, P405, DOI 10.1163/156854107781352052; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Derycke S, 2009, ZOOLOGICA SCRIPTA, V39, P276; Dey A, 2013, P NATL ACAD SCI USA, V110, P11056, DOI 10.1073/pnas.1303057110; Dey A, 2012, GENETICS, V191, P1257, DOI 10.1534/genetics.112.140418; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; DOUGHERTY ELLSWORTH C., 1949, JOUR PARASITOL, V35, P11; Eyualem A, 2003, J NEMATOL, V35, P119; Felix MA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-10; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gimond C, 2013, EVOLUTION, V67, P3087, DOI 10.1111/evo.12203; Gutteling EW, 2007, HEREDITY, V98, P206, DOI 10.1038/sj.hdy.6800929; Haag ES, 2007, TRENDS GENET, V23, P101, DOI 10.1016/j.tig.2007.01.002; Hope IA., 1999, C ELEGANS PRACTICAL; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kanzaki N, 2013, J NEMATOL, V45, P172; Kiontke K, 2002, NEMATOLOGY, V4, P933, DOI 10.1163/156854102321122557; Kiontke K, 1997, FUND APPL NEMATOL, V20, P305; Kiontke K, 2006, C ELEGANS RES COMMUN; Kiontke K, 2007, CURR BIOL, V17, P1925, DOI 10.1016/j.cub.2007.10.061; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kozlowska JL, 2012, EVOLUTION, V66, P1180, DOI 10.1111/j.1558-5646.2011.01514.x; Maupas E, 1900, ARCH ZOOL EXP GEN, V8, P463; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; Nadler SA, 2011, PARASITOLOGY, V138, P1688, DOI 10.1017/S003118201000168X; NIGON V, 1949, J EXP ZOOL, V112, P485, DOI 10.1002/jez.1401120307; Nuez I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029811; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sudhaus W, 1996, J ZOOL SYST EVOL RES, V34, P217; SUDHAUS W, 1974, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V101, P417; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Sudhaus W, 2011, NEMATOLOGY, V13, P61, DOI 10.1163/138855410X500334; Volk J., 1950, Zoologische Jahrbuecher Jena Systematik, V79, P1; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Woodruff GC, 2010, GENETICS, V186, P997, DOI 10.1534/genetics.110.120550	55	100	100	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94723	10.1371/journal.pone.0094723	http://dx.doi.org/10.1371/journal.pone.0094723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727800	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200121
J	Ortiz, A; Gorriz, JM; Ramirez, J; Martinez-Murcia, FJ				Ortiz, Andres; Gorriz, Juan M.; Ramirez, Javier; Martinez-Murcia, Francisco J.		Alzheimer's Dis Neuroimaging	Automatic ROI Selection in Structural Brain MRI Using SOM 3D Projection	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; IMAGE CLASSIFICATION; DIAGNOSIS; SEGMENTATION; HIPPOCAMPUS	This paper presents a method for selecting Regions of Interest (ROI) in brain Magnetic Resonance Imaging (MRI) for diagnostic purposes, using statistical learning and vector quantization techniques. The proposed method models the distribution of GM and WM tissues grouping the voxels belonging to each tissue in ROIs associated to a specific neurological disorder. Tissue distribution of normal and abnormal images is modelled by a Self-Organizing map (SOM), generating a set of representative prototypes, and the receptive field (RF) of each SOM prototype defines a ROI. Moreover, the proposed method computes the relative importance of each ROI by means of its discriminative power. The devised method has been assessed using 818 images from the Alzheimer's disease Neuroimaging Initiative (ADNI) which were previously segmented through Statistical Parametric Mapping (SPM). The proposed algorithm was used over these images to parcel ROIs associated to the Alzheimer's Disease (AD). Additionally, this method can be used to extract a reduced set of discriminative features for classification, since it compresses discriminative information contained in the brain. Voxels marked by ROIs which were computed using the proposed method, yield classification results up to 90% of accuracy for controls (CN) and Alzheimer's disease (AD) patients, and 84% of accuracy for Mild Cognitive Impairment (MCI) and AD patients.	[Ortiz, Andres] Univ Malaga, Commun Engn Dept, E-29071 Malaga, Spain; [Gorriz, Juan M.; Ramirez, Javier; Martinez-Murcia, Francisco J.] Univ Granada, Dept Signal Theory Networking & Commun, Granada, Spain	Universidad de Malaga; University of Granada	Ortiz, A (corresponding author), Univ Malaga, Commun Engn Dept, E-29071 Malaga, Spain.	aortiz@ic.uma.es	Ortiz, Andrés/K-4886-2014; Ramírez, Javier/B-1836-2012; Gorriz, Juan Manuel/C-2385-2012; Hsiung, Robin/AAT-1661-2021; Martínez-Murcia, Francisco Jesús/E-6644-2013; Preda, Adrian/K-8889-2013	Ramírez, Javier/0000-0002-6229-2921; Gorriz, Juan Manuel/0000-0001-7069-1714; Hsiung, Robin/0000-0002-8017-0856; Martínez-Murcia, Francisco Jesús/0000-0001-8146-7056; Preda, Adrian/0000-0003-3373-2438; Ponto, Laura/0000-0003-1197-6714	MICINN [TEC2012-34306]; Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia, Spain) [P09-TIC-4530, P11-TIC-7103]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG013846, U19AG010483] Funding Source: NIH RePORTER	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia, Spain)(Junta de Andalucia); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partly supported by the MICINN under the TEC2012-34306 project and the Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia, Spain) under the Excellence Projects P09-TIC-4530 and P11-TIC-7103. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRxResearch; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; Illan IA, 2010, PATTERN RECOGN LETT, V31, P1342, DOI 10.1016/j.patrec.2010.03.004; Bryant C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071723; Canu E, 2011, J ALZHEIMERS DIS, V19; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Chaves R, 2012, PATTERN RECOGN LETT, V33, P1666, DOI 10.1016/j.patrec.2012.04.011; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Chyzhyk D, 2012, NEUROCOMPUTING, V75, P72, DOI 10.1016/j.neucom.2011.02.024; Clarkson P, 1999, INT CONF ACOUST SPEE, P585, DOI 10.1109/ICASSP.1999.759734; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gorriz JM, 2011, APPL SOFT COMPUT, V11, P2313, DOI 10.1016/j.asoc.2010.08.012; Gorriz JM, 2009, NEUROSCI LETT, V460, P108, DOI 10.1016/j.neulet.2009.05.039; HAYKIN S, 1999, NEURAL NETWORKS; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Illan IA, 2011, APPL SOFT COMPUT, V11, P2376, DOI 10.1016/j.asoc.2010.08.019; Illan IA, 2011, INFORM SCIENCES, V181, P903, DOI 10.1016/j.ins.2010.10.027; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kohonen T., 2001, SELF ORG MAPS; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Liu MH, 2012, NEUROIMAGE, V60, P1106, DOI 10.1016/j.neuroimage.2012.01.055; Lopez M, 2011, NEUROCOMPUTING, V74, P1260, DOI 10.1016/j.neucom.2010.06.025; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Mesrob L, 2009, ANN BMVA, V2009, P1; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; O'Brien J, 2007, BR J RADIOL, V80; Ortiz A, 2013, PATTERN RECOGN LETT, V34, P1725, DOI 10.1016/j.patrec.2013.04.014; Ortiz Garcia Andres, 2013, Natural and Artificial Computation in Engineering and Medical Applications. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings: LNCS 7931, P278, DOI 10.1007/978-3-642-38622-0_29; Padilla P, 2012, IEEE T MED IMAGING, V31, P207, DOI 10.1109/TMI.2011.2167628; Platt J, 1999, ADV KERNEL METHODS S; Ramirez J, 2009, IEEE NUCL SCI CONF R, P2738, DOI 10.1109/NSSMIC.2009.5401968; Ramirez J, INFORM SCI IN PRESS; Rohkamm R, 2004, COLOR ATLAS NEUROLOG; Sammut C., 2010, STAT LEARNING THEORY; Segovia F, 2012, NEUROCOMPUTING, V75, P64, DOI 10.1016/j.neucom.2011.03.050; Spetsieris PG, 2009, NEUROIMAGE, V45, P1241, DOI 10.1016/j.neuroimage.2008.12.063; Stoeckel J, 2005, P 5 IEEE INT DAT MIN, DOI [10.1109/ICDM.2005.141, DOI 10.1109/ICDM.2005.141]; Termenon M, 2012, NEURAL PROCESS LETT, V35, P1, DOI 10.1007/s11063-011-9200-2; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Thompson PM, 2007, BRIT J RADIOL, V80, pS78, DOI 10.1259/BJR/20005470; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vapnik V., 1998, STAT LEARNING THEORY; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044	49	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93851	10.1371/journal.pone.0093851	http://dx.doi.org/10.1371/journal.pone.0093851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728041	Green Published, gold			2022-12-25	WOS:000336736200030
J	Non, AL; Rimm, EB; Kawachi, I; Rewak, MA; Kubzansky, LD				Non, Amy L.; Rimm, Eric B.; Kawachi, Ichiro; Rewak, Marissa A.; Kubzansky, Laura D.			The Effects of Stress at Work and at Home on Inflammation and Endothelial Dysfunction	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; CORONARY-HEART-DISEASE; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; WHITEHALL-II; RISK; MEN; BIOMARKERS; WOMEN; ATHEROSCLEROSIS	This study examined whether stress at work and at home may be related to dysregulation of inflammation and endothelial function, two important contributors to the development of cardiovascular disease. In order to explore potential biological mechanisms linking stress with cardiovascular health, we investigated cross-sectional associations between stress at work and at home with an inflammation score (n's range from 406-433) and with two endothelial biomarkers (intercellular and vascular adhesion molecules, sICAM-1 and sVCAM-1; n's range from 205-235) in a cohort of healthy US male health professionals. No associations were found between stress at work or at home and inflammation. Men with high or medium levels of stress at work had significantly higher levels of sVCAM-1 (13% increase) and marginally higher levels of sICAM-1 (9% increase), relative to those reporting low stress at work, independent of health behaviors. Men with high levels of stress at home had marginally higher levels of both sVCAM-1 and sICAM-1 than those with low stress at home. While lack of findings related to inflammation are somewhat surprising, if replicated in future studies, these findings may suggest that endothelial dysfunction is an important biological mechanism linking stress at work with cardiovascular health outcomes in men.	[Non, Amy L.] Vanderbilt Univ, Dept Anthropol, Nashville, TN 37235 USA; [Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Kawachi, Ichiro; Rewak, Marissa A.; Kubzansky, Laura D.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Non, AL (corresponding author), Vanderbilt Univ, Dept Anthropol, 221 Kirkland Hall, Nashville, TN 37235 USA.	amy.non@vanderbilt.edu	Non, Amy/AAW-7116-2021		National Institutes of Health (NIH) [P01 CA055075]; Robert Wood Johnson Health and Society Scholar Fellowship at Harvard University, Cambridge, MA; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Health and Society Scholar Fellowship at Harvard University, Cambridge, MA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The original HPFS data collection was funded by a National Institutes of Health (NIH) Program Grant P01 CA055075. AL Non was supported by the Robert Wood Johnson Health and Society Scholar Fellowship at Harvard University, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertone-Johnson ER, 2012, AM J PREV MED, V43, P611, DOI 10.1016/j.amepre.2012.08.014; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Clays E, 2005, J OCCUP ENVIRON MED, V47, P878, DOI 10.1097/01.jom.0000171056.22917.ad; Eaton CB, 2007, INT J IMPOT RES, V19, P218, DOI 10.1038/sj.ijir.3901519; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Griffin JM, 2002, SOC SCI MED, V54, P783, DOI 10.1016/S0277-9536(01)00109-5; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hemingway H, 2003, AM J CARDIOL, V92, P984, DOI 10.1016/S0002-9149(03)00985-8; Littman AJ, 2006, EPIDEMIOLOGY, V17, P398, DOI 10.1097/01.ede.0000219721.89552.51; Mausbach BT, 2012, HEALTH PSYCHOL, V31, P433, DOI 10.1037/a0027783; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; Meyer KA, 2003, J AM COLL NUTR, V22, P185, DOI 10.1080/07315724.2003.10719292; Miller G, 2006, CURRENT DIRECTIONS P, V15; Nabi H, 2008, ARTERIOSCL THROM VAS, V28, P1398, DOI 10.1161/ATVBAHA.108.167239; Nakata Akinori, 2012, Methods Mol Biol, V934, P39, DOI 10.1007/978-1-62703-071-7_3; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P642, DOI 10.1016/j.bbi.2012.02.003; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Ranjit N, 2007, CIRCULATION, V116, P2383, DOI 10.1161/CIRCULATIONAHA.107.706226; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Schnorpfeil P, 2003, SOC SCI MED, V57, P647, DOI 10.1016/S0277-9536(02)00407-0; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Shai I, 2006, OBESITY, V14, P2099, DOI 10.1038/oby.2006.245; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; Wong IS, 2012, J OCCUP ENVIRON HYG, V9, P467, DOI 10.1080/15459624.2012.693831	30	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94474	10.1371/journal.pone.0094474	http://dx.doi.org/10.1371/journal.pone.0094474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722508	Green Published, gold			2022-12-25	WOS:000336909100076
J	Wiese, E; Wykowska, A; Muller, HJ				Wiese, Eva; Wykowska, Agnieszka; Mueller, Hermann J.			What We Observe Is Biased by What Other People Tell Us: Beliefs about the Reliability of Gaze Behavior Modulate Attentional Orienting to Gaze Cues	PLOS ONE			English	Article							VISUAL-ATTENTION; EYE GAZE; SOCIAL COGNITION; REFLEXIVE; OTHERS; ARROWS; BRAIN	For effective social interactions with other people, information about the physical environment must be integrated with information about the interaction partner. In order to achieve this, processing of social information is guided by two components: a bottom-up mechanism reflexively triggered by stimulus-related information in the social scene and a top-down mechanism activated by task-related context information. In the present study, we investigated whether these components interact during attentional orienting to gaze direction. In particular, we examined whether the spatial specificity of gaze cueing is modulated by expectations about the reliability of gaze behavior. Expectations were either induced by instruction or could be derived from experience with displayed gaze behavior. Spatially specific cueing effects were observed with highly predictive gaze cues, but also when participants merely believed that actually non-predictive cues were highly predictive. Conversely, cueing effects for the whole gazed-at hemifield were observed with non-predictive gaze cues, and spatially specific cueing effects were attenuated when actually predictive gaze cues were believed to be non-predictive. This pattern indicates that (i) information about cue predictivity gained from sampling gaze behavior across social episodes can be incorporated in the attentional orienting to social cues, and that (ii) beliefs about gaze behavior modulate attentional orienting to gaze direction even when they contradict information available from social episodes.	[Wiese, Eva; Wykowska, Agnieszka; Mueller, Hermann J.] Univ Munich, Dept Gen & Expt Psychol, Munich, Germany; [Wiese, Eva] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Wykowska, Agnieszka] Tech Univ Munich, Inst Cognit Syst, D-80290 Munich, Germany; [Mueller, Hermann J.] Univ London Birkbeck Coll, Dept Psychol Sci, London WC1E 7HX, England	University of Munich; George Mason University; Technical University of Munich; University of London; Birkbeck University London	Wiese, E (corresponding author), Univ Munich, Dept Gen & Expt Psychol, Munich, Germany.	wiese@psy.lmu.de		Wykowska, Agnieszka/0000-0003-3323-7357	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [WY-122/1-1]; Graduate School of Systemic Neurosciences (GSN) Munich	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Graduate School of Systemic Neurosciences (GSN) Munich	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) within the Excellence Cluster 'Cognition for Technical Systems' (CoTeSys) and based on the individual grant awarded to AW (WY-122/1-1). The authors also thank the Graduate School of Systemic Neurosciences (GSN) Munich for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Liuzza MT, 2011, PLOS ONE, V6, P1; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nummenmaa L, 2009, J EXP PSYCHOL HUMAN, V35, P1738, DOI 10.1037/a0016472; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ristic J, 2006, Q J EXP PSYCHOL, V59, P1921, DOI 10.1080/17470210500416367; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; Teufel C, 2009, CURR BIOL, V19, P1274, DOI 10.1016/j.cub.2009.05.069; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; Vecera SP, 2006, NEUROPSYCHOLOGIA, V44, P150, DOI 10.1016/j.neuropsychologia.2005.04.010; Wiese E, 2013, ATTEN PERCEPT PSYCHO, V75, P967, DOI 10.3758/s13414-013-0444-y; Wiese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045391; Wykowska A, PLOS ONE IN PRESS	29	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94529	10.1371/journal.pone.0094529	http://dx.doi.org/10.1371/journal.pone.0094529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722348	gold, Green Published, Green Accepted			2022-12-25	WOS:000336909100090
J	Zheng, JX; Kong, H; Wilson, JM; Guo, JL; Chang, YQ; Yang, MJ; Xiao, GK; Sun, PH				Zheng, Junxia; Kong, Hao; Wilson, James M.; Guo, Jialiang; Chang, Yiqun; Yang, Mengjia; Xiao, Gaokeng; Sun, Pinghua			Insight into the Interactions between Novel Isoquinolin-1,3-Dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking	PLOS ONE			English	Article							SELECTIVE INHIBITORS; VARIABLE SELECTION; POTENT; IDENTIFICATION; 3D-QSAR; DISCOVERY; CDK4; DETERMINANTS; SERIES	Several small-molecule CDK inhibitors have been identified, but none have been approved for clinical use in the past few years. A new series of 4-[(3-hydroxybenzylamino)-methylene]-4H-isoquinoline-1,3-diones were reported as highly potent and selective CDK4 inhibitors. In order to find more potent CDK4 inhibitors, the interactions between these novel isoquinoline-1,3-diones and cyclin-dependent kinase 4 was explored via in silico methodologies such as 3D-QSAR and docking on eighty-one compounds displaying potent selective activities against cyclin-dependent kinase 4. Internal and external cross-validation techniques were investigated as well as region focusing, bootstraping and leave-group-out. A training set of 66 compounds gave the satisfactory CoMFA model (q(2) = 0.695, r(2) = 0.947) and CoMSIA model (q(2) = 0.641, r(2) = 0.933). The remaining 15 compounds as a test set also gave good external predictive abilities with r(pred)(2) values of 0.875 and 0.769 for CoMFA and CoMSIA, respectively. The 3D-QSAR models generated here predicted that all five parameters are important for activity toward CDK4. Surflex-dock results, coincident with CoMFA/CoMSIA contour maps, gave the path for binding mode exploration between the inhibitors and CDK4 protein. Based on the QSAR and docking models, twenty new potent molecules have been designed and predicted better than the most active compound 12 in the literatures. The QSAR, docking and interactions analysis expand the structure-activity relationships of constrained isoquinoline-1,3-diones and contribute towards the development of more active CDK4 subtype-selective inhibitors.	[Zheng, Junxia] Guangdong Univ Technol, Fac Chem Engn & Light Ind, Guangzhou, Guangdong, Peoples R China; [Kong, Hao; Guo, Jialiang; Chang, Yiqun; Yang, Mengjia; Xiao, Gaokeng; Sun, Pinghua] Jinan Univ, Dept Med Chem, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Wilson, James M.; Sun, Pinghua] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Sun, Pinghua] Univ S Florida, Coll Pharm, Tampa, FL USA	Guangdong University of Technology; Jinan University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sun, PH (corresponding author), Jinan Univ, Dept Med Chem, Coll Pharm, Guangzhou, Guangdong, Peoples R China.	biochemdoctor@sina.com			National Nature Science Foundation of China [81202889]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from National Nature Science Foundation of China (81202889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afantitis A, 2006, MOL DIVERS, V10, P405, DOI 10.1007/s11030-005-9012-2; Ambure PS, 2012, MOL DIVERS, V16, P377, DOI 10.1007/s11030-011-9353-y; Amendola D, 2009, CELL PROLIFERAT, V42, P94, DOI 10.1111/j.1365-2184.2008.00576.x; CHO SJ, 1995, J MED CHEM, V38, P1060, DOI 10.1021/jm00007a003; Chu XJ, 2006, J MED CHEM, V49, P6549, DOI 10.1021/jm0606138; CLARK M, 1993, QUANT STRUCT-ACT REL, V12, P137, DOI 10.1002/qsar.19930120205; Clark RD, 2008, J COMPUT AID MOL DES, V22, P507, DOI 10.1007/s10822-008-9177-8; Cramer R D 3rd, 1989, Prog Clin Biol Res, V291, P161; Heady L, 2006, J MED CHEM, V49, P5141, DOI 10.1021/jm060190+; Holt PA, 2008, J CHEM INF MODEL, V48, P1602, DOI 10.1021/ci800063v; Horiuchi T, 2009, BIOORG MED CHEM LETT, V19, P305, DOI 10.1016/j.bmcl.2008.11.090; Hu RJ, 2009, BIOORGAN MED CHEM, V17, P2400, DOI 10.1016/j.bmc.2009.02.003; Ikuta M, 2001, J BIOL CHEM, V276, P27548, DOI 10.1074/jbc.M102060200; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones CD, 2008, BIOORG MED CHEM LETT, V18, P6963, DOI 10.1016/j.bmcl.2008.10.102; Klebe G, 1999, J COMPUT AID MOL DES, V13, P1, DOI 10.1023/A:1008047919606; Kuo GH, 2005, J MED CHEM, V48, P4535, DOI 10.1021/jm040214h; Lan P, 2010, INT J MOL SCI, V11, P3357, DOI 10.3390/ijms11093357; LINDGREN F, 1994, J CHEMOMETR, V8, P349, DOI 10.1002/cem.1180080505; Lu H, 2006, J MED CHEM, V49, P3826, DOI 10.1021/jm0600388; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; McInnes C, 2004, CHEM BIOL, V11, P525, DOI 10.1016/j.chembiol.2004.03.022; Misra RN, 2004, J MED CHEM, V47, P1719, DOI 10.1021/jm0305568; Murumkar PR, 2008, CHEM BIOL DRUG DES, V71, P363, DOI 10.1111/j.1747-0285.2008.00639.x; Muthas D, 2008, J MOL GRAPH MODEL, V26, P1237, DOI 10.1016/j.jmgm.2007.11.005; Power DP, 2010, BIOORG MED CHEM LETT, V20, P4940, DOI 10.1016/j.bmcl.2010.06.024; Pratt DJ, 2006, J MED CHEM, V49, P5470, DOI 10.1021/jm060216x; Reddy RN, 2010, J MOL MODEL, V16, P203, DOI 10.1007/s00894-009-0535-9; Roy K, 2010, J MOL MODEL, V16, P951, DOI 10.1007/s00894-009-0596-9; Roy PP, 2008, QSAR COMB SCI, V27, P302, DOI 10.1002/qsar.200710043; Ruppert J, 1997, PROTEIN SCI, V6, P524; Shimamura T, 2006, BIOORG MED CHEM LETT, V16, P3751, DOI 10.1016/j.bmcl.2006.04.048; Sivan SK, 2010, J MOL MODEL, V16, P1169, DOI 10.1007/s00894-009-0625-8; Spitzer GM, 2007, J CHEM INF MODEL, V47, P1580, DOI 10.1021/ci600500v; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Tsou HR, 2008, J MED CHEM, V51, P3507, DOI 10.1021/jm800072z; Tsou HR, 2009, J MED CHEM, V52, P2289, DOI 10.1021/jm801026e; Wang J, 1999, PROTEINS, V36, P1; Zhang N, 2010, EUR J MED CHEM, V45, P292, DOI 10.1016/j.ejmech.2009.10.011; Zheng JX, 2011, CHEM BIOL DRUG DES, V78, P314, DOI 10.1111/j.1747-0285.2011.01146.x	42	5	5	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93704	10.1371/journal.pone.0093704	http://dx.doi.org/10.1371/journal.pone.0093704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722522	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100019
J	Yasuda, S; Sato, T; Maekawa, S; Aoyama, S; Fukao, Y; Yamaguchi, J				Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Fukao, Yoichiro; Yamaguchi, Junji			Phosphorylation of Arabidopsis Ubiquitin Ligase ATL31 Is Critical for Plant Carbon/Nitrogen Nutrient Balance Response and Controls the Stability of 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Plasma Membrane; Protein Phosphorylation; Protein Stability; Protein-Protein Interactions; Signal Transduction	SUCROSE-PHOSPHATE SYNTHASE; MEMBRANE H+-ATPASE; NITRATE REDUCTASE; GENE-EXPRESSION; LARGE NUMBER; C-TERMINUS; THALIANA; BINDING; SYSTEM; FAMILY	Background: Ubiquitin ligase ATL31 and the target, 14-3-3 proteins, function in plant nutrient response. Results: ATL31 binds to 14-3-3 proteins via phosphorylation of specific residues. These residues are essential for the function of ATL31. Conclusion: ATL31 targets 14-3-3 proteins for degradation in a phosphorylation-dependent manner to regulate nutrient response. Significance: Phosphorylation of ubiquitin ligase ATL31 controls plant nutrient response. Ubiquitin ligase plays a fundamental role in regulating multiple cellular events in eukaryotes by fine-tuning the stability and activity of specific target proteins. We have previously shown that ubiquitin ligase ATL31 regulates plant growth in response to nutrient balance between carbon and nitrogen (C/N) in Arabidopsis. Subsequent study demonstrated that ATL31 targets 14-3-3 proteins for ubiquitination and modulates the protein abundance in response to C/N-nutrient status. However, the underlying mechanism for the targeting of ATL31 to 14-3-3 proteins remains unclear. Here, we show that ATL31 interacts with 14-3-3 proteins in a phosphorylation-dependent manner. We identified Thr(209), Ser(247), Ser(270), and Ser(303) as putative 14-3-3 binding sites on ATL31 by motif analysis. Mutation of these Ser/Thr residues to Ala in ATL31 inhibited the interaction with 14-3-3 proteins, as demonstrated by yeast two-hybrid and co-immunoprecipitation analyses. Additionally, we identified in vivo phosphorylation of Thr(209) and Ser(247) on ATL31 by MS analysis. A peptide competition assay showed that the application of synthetic phospho-Thr(209) peptide, but not the corresponding unphosphorylated peptide, suppresses the interaction between ATL31 and 14-3-3 proteins. Moreover, Arabidopsis plants overexpressing mutated ATL31, which could not bind to 14-3-3 proteins, showed accumulation of 14-3-3 proteins and growth arrest in disrupted C/N-nutrient conditions similar to wild-type plants, although overexpression of intact ATL31 resulted in repression of 14-3-3 accumulation and tolerance to the conditions. Together, these results demonstrate that the physiological role of phosphorylation at 14-3-3 binding sites on ATL31 is to modulate the binding ability and stability of 14-3-3 proteins to control plant C/N-nutrient response.	[Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Yamaguchi, Junji] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Yamaguchi, Junji] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma 6300192, Japan	Hokkaido University; Hokkaido University; Nara Institute of Science & Technology	Yamaguchi, J (corresponding author), Hokkaido Univ, Fac Sci, Kita Ku, N10-W8, Sapporo, Hokkaido 0600810, Japan.	jjyama@sci.hokudai.ac.jp	Yamaguchi, Junji/AAG-9118-2021	Maekawa, Shugo/0000-0002-6021-505X; Yasuda, Shigetaka/0000-0002-4602-6404	Japan Society for the Promotion of Science (JSPS) [24770035, 24114701, 25112501]; Akiyama Foundation; JSPS; Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research [23380198] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Akiyama Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research 24770035 (to T. S.) and on Innovation Areas 24114701 and 25112501 (to J. Y.) and in part by The Akiyama Foundation (to T. S.).; Supported by a JSPS Research Fellowship for Young Scientists (2012-2013) and also by the Plant Global Education Project from the Nara Institute of Science and Technology (2012).	Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Bachmann M, 1996, FEBS LETT, V387, P127, DOI 10.1016/0014-5793(96)00478-4; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Bornke F, 2005, J PLANT PHYSIOL, V162, P161, DOI 10.1016/j.jplph.2004.09.006; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Fukao Y, 2009, PLANT CELL PHYSIOL, V50, P2234, DOI 10.1093/pcp/pcp154; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Jaspert N, 2002, PLANTA, V216, P136, DOI 10.1007/s00425-002-0915-1; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim SJ, 2013, FEBS LETT, V587, P2584, DOI 10.1016/j.febslet.2013.06.038; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Menges Margit, 2006, V323, P45; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Sako K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037086; Sato T, 2011, PLANT SIGNAL BEHAV, V6, P1465, DOI 10.4161/psb.6.10.17343; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Sulpice R, 2013, PLANT PHYSIOL, V162, P347, DOI 10.1104/pp.112.210104; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Tsunoda Y, 2005, PROTEIN EXPRES PURIF, V42, P268, DOI 10.1016/j.pep.2005.04.002; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	59	47	48	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15179	15193		10.1074/jbc.M113.533133	http://dx.doi.org/10.1074/jbc.M113.533133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722992	Green Published, hybrid			2022-12-25	WOS:000337465400005
J	Averos, X; Lorea, A; de Heredia, IB; Arranz, J; Ruiz, R; Estevez, I				Averos, Xavier; Lorea, Areta; Beltran de Heredia, Ignacia; Arranz, Josune; Ruiz, Roberto; Estevez, Inma			Space Availability in Confined Sheep during Pregnancy, Effects in Movement Patterns and Use of Space	PLOS ONE			English	Article							GROUP-SIZE; BROILER-CHICKENS; STOCKING DENSITY; SOCIAL COHESION; SHORT-TERM; BEHAVIOR; ALLOWANCE; PERFORMANCE; WELFARE; EWES	Space availability is essential to grant the welfare of animals. To determine the effect of space availability on movement and space use in pregnant ewes (Ovis aries), 54 individuals were studied during the last 11 weeks of gestation. Three treatments were tested (1, 2, and 3 m(2)/ewe; 6 ewes/group). Ewes' positions were collected for 15 minutes using continuous scan samplings two days/week. Total and net distance, net/total distance ratio, maximum and minimum step length, movement activity, angular dispersion, nearest, furthest and mean neighbour distance, peripheral location ratio, and corrected peripheral location ratio were calculated. Restriction in space availability resulted in smaller total travelled distance, net to total distance ratio, maximum step length, and angular dispersion but higher movement activity at 1 m(2)/ewe as compared to 2 and 3 m(2)/ewe (P<0.01). On the other hand, nearest and furthest neighbour distances increased from 1 to 3 m(2)/ewe (P<0.001). Largest total distance, maximum and minimum step length, and movement activity, as well as lowest net/total distance ratio and angular dispersion were observed during the first weeks (P<0.05) while inter-individual distances increased through gestation. Results indicate that movement patterns and space use in ewes were clearly restricted by limitations of space availability to 1 m(2)/ewe. This reflected in shorter, more sinuous trajectories composed of shorter steps, lower inter-individual distances and higher movement activity potentially linked with higher restlessness levels. On the contrary, differences between 2 and 3 m(2)/ewe, for most variables indicate that increasing space availability from 2 to 3 m(2)/ewe would appear to have limited benefits, reflected mostly in a further increment in the inter-individual distances among group members. No major variations in spatial requirements were detected through gestation, except for slight increments in inter-individual distances and an initial adaptation period, with ewes being restless and highly motivated to explore their new environment.	[Averos, Xavier; Lorea, Areta; Beltran de Heredia, Ignacia; Arranz, Josune; Ruiz, Roberto; Estevez, Inma] Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain; [Lorea, Areta] Navarra Publ Univ UPNA, Pamplona, Spain; [Estevez, Inma] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Universidad Publica de Navarra; Basque Foundation for Science	Estevez, I (corresponding author), Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain.	iestevez@neiker.net	Averos, Xavier/K-1185-2014; Santos, Roberto J. Ruiz/F-3352-2019	Averos, Xavier/0000-0002-7279-3420; Santos, Roberto J. Ruiz/0000-0002-3074-7362; Estevez, Inma/0000-0002-9054-9528	European Union [FP7-414 KBBE-2010-4]	European Union(European Commission)	The authors gratefully acknowledge the European Union financial support for conducting the experiments and the salary for X. Averos under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, of the Project Animal Welfare Indicators (AWIN; FP7-414 KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREHART LA, 1969, J ANIM SCI, V29, P638, DOI 10.2527/jas1969.294638x; ARNOLD GW, 1985, APPL ANIM BEHAV SCI, V14, P173, DOI 10.1016/0168-1591(85)90028-0; Averos X, 2012, ANIMAL, V6, P1275, DOI 10.1017/S1751731112000328; Averos X, 2010, ANIMAL, V4, P777, DOI 10.1017/S1751731109991613; Averos X, 2014, APPL ANIM BEHAV SCI, V150, P17, DOI 10.1016/j.applanim.2013.11.002; Averos X, 2010, APPL ANIM BEHAV SCI, V127, P73, DOI 10.1016/j.applanim.2010.09.010; Beecham JA, 1999, J THEOR BIOL, V198, P533, DOI 10.1006/jtbi.1999.0930; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Boe KE, 2006, APPL ANIM BEHAV SCI, V98, P249, DOI 10.1016/j.applanim.2005.10.001; Brambell Committee, 1965, 2836 BRAMB COMM; Buijs S, 2011, ANIM BEHAV, V82, P1235, DOI 10.1016/j.anbehav.2011.08.019; Buijs S, 2011, APPL ANIM BEHAV SCI, V129, P111, DOI 10.1016/j.applanim.2010.11.017; Buijs S, 2010, APPL ANIM BEHAV SCI, V124, P97, DOI 10.1016/j.applanim.2010.02.007; Cornetto T, 2002, APPL ANIM BEHAV SCI, V75, P325, DOI 10.1016/S0168-1591(01)00195-2; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; DANTZER R, 1983, J ANIM SCI, V57, P6, DOI 10.2527/jas1983.5716; DOVE H, 1974, ANIM PROD, V19, P157, DOI 10.1017/S0003356100022728; Dwyer C., 2009, The ethology of domestic animals: an introductory text, modular texts, P161, DOI 10.1079/9781845935368.0161; Dwyer CM, 2004, ANIM WELFARE, V13, P269; Estevez I, 2010, POULTRY SCI, V89, P643, DOI 10.3382/ps.2009-00433; Estevez I, 2007, POULTRY SCI, V86, P1267; evez I. R. C., 1997, ETOLOGIA, V5, P19; Fraser A.F., 1997, FARM ANIMAL BEHAV WE, V3rd; Gonyou HW, 2006, J ANIM SCI, V84, P229, DOI 10.2527/2006.841229x; GONYOU HW, 1985, J ANIM SCI, V60, P1110, DOI 10.2527/jas1985.6051110x; GONYOU HW, 1991, J ANIM SCI, V69, P4155, DOI 10.2527/1991.69104155x; GRIGOR PN, 1995, APPL ANIM BEHAV SCI, V45, P97, DOI 10.1016/0168-1591(95)00596-K; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HORTON GMJ, 1991, APPL ANIM BEHAV SCI, V32, P197, DOI 10.1016/S0168-1591(05)80043-7; INGVARTSEN KL, 1993, ACTA AGR SCAND A-AN, V43, P65, DOI 10.1080/09064709309410147; KEELING L, 1995, APPL ANIM BEHAV SCI, V44, P171, DOI 10.1016/0168-1591(95)00612-V; Krawczel PD, 2012, J DAIRY SCI, V95, P4298, DOI 10.3168/jds.2011-4687; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Leone EH, 2008, POULTRY SCI, V87, P3, DOI 10.3382/ps.2007-00026; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Leone EH, 2010, BEHAV PROCESS, V83, P16, DOI 10.1016/j.beproc.2009.08.009; Mallapur A, 2009, APPL ANIM BEHAV SCI, V117, P28, DOI 10.1016/j.applanim.2008.11.005; MARSDEN MD, 1986, APPL ANIM BEHAV SCI, V15, P178, DOI 10.1016/0168-1591(86)90064-X; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Michelena P, 2008, APPL ANIM BEHAV SCI, V112, P81, DOI 10.1016/j.applanim.2007.06.020; Morand-Fehr P, 2007, SMALL RUMINANT RES, V68, P20, DOI 10.1016/j.smallrumres.2006.09.019; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; Petherick JC, 2007, J VET BEHAV, V2, P197, DOI 10.1016/j.jveb.2007.10.001; Pollard JC, 2006, NEW ZEAL J AGR RES, V49, P395, DOI 10.1080/00288233.2006.9513730; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sanchez C., 1998, CHICKITIZER SOFTWARE; Sevi A, 1999, J DAIRY RES, V66, P489, DOI 10.1017/S0022029999003726; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; Stahl J, 2001, ANIM BEHAV, V61, P257, DOI 10.1006/anbe.2000.1564; Turchin Peter, 1998; Turner SP, 2013, APPL ANIM BEHAV SCI, V146, P26, DOI 10.1016/j.applanim.2013.03.012; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; VANDENHEEDE M, 1993, APPL ANIM BEHAV SCI, V37, P39, DOI 10.1016/0168-1591(93)90069-2; WARBURTON K, 1991, J THEOR BIOL, V150, P473, DOI 10.1016/S0022-5193(05)80441-2; Waterhouse A, 1996, APPL ANIM BEHAV SCI, V49, P29, DOI 10.1016/0168-1591(95)00665-6; Wechsler B, 2011, ANIM WELFARE, V20, P497	56	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94767	10.1371/journal.pone.0094767	http://dx.doi.org/10.1371/journal.pone.0094767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733027	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400097
J	Gierok, P; Harms, M; Richter, E; Hildebrandt, JP; Lalk, M; Mostertz, J; Hochgrafe, F				Gierok, Philipp; Harms, Manuela; Richter, Erik; Hildebrandt, Jan-Peter; Lalk, Michael; Mostertz, Joerg; Hochgraefe, Falko			Staphylococcus aureus Alpha-Toxin Mediates General and Cell Type-Specific Changes in Metabolite Concentrations of Immortalized Human Airway Epithelial Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; CANCER-CELLS; HEMOLYSIN; PORE; ACTIVATION; GLYCOLYSIS; EXPRESSION; GLUTAMINE; METABOLOMICS; LYMPHOCYTES	Staphylococcus aureus alpha-toxin (Hla) is a potent pore-forming cytotoxin that plays an important role in the pathogenesis of S. aureus infections, including pneumonia. The impact of Hla on the dynamics of the metabolome in eukaryotic host cells has not been investigated comprehensively. Using H-1-NMR, GC-MS and HPLC-MS, we quantified the concentrations of 51 intracellular metabolites and assessed alterations in the amount of 25 extracellular metabolites in the two human bronchial epithelial cell lines S9 and 16HBE14o(-) under standard culture conditions and after treatment with sub-lethal amounts (2 mu g/ml) of recombinant Hla (rHla) in a time-dependent manner. Treatment of cells with rHla caused substantial decreases in the concentrations of intracellular metabolites from different metabolic pathways in both cell lines, including ATP and amino acids. Concomitant increases in the extracellular concentrations were detected for various intracellular compounds, including nucleotides, glutathione disulfide and NAD(+). Our results indicate that rHla has a major impact on the metabolome of eukaryotic cells as a consequence of direct rHla-mediated alterations in plasma membrane permeability or indirect effects mediated by cellular signalling. However, cell-specific changes also were observed. Glucose consumption and lactate production rates suggest that the glycolytic activity of S9 cells, but not of 16HBE14o(-) cells, is increased in response to rHla. This could contribute to the observed higher level of resistance of S9 cells against rHla-induced membrane damage.	[Gierok, Philipp; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Greifswald, Germany; [Harms, Manuela; Richter, Erik; Mostertz, Joerg; Hochgraefe, Falko] Ernst Moritz Arndt Univ Greifswald, Competence Ctr Funct Genom, Jr Res Grp Pathoprote, Greifswald, Germany; [Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Hochgrafe, F (corresponding author), Ernst Moritz Arndt Univ Greifswald, Competence Ctr Funct Genom, Jr Res Grp Pathoprote, Greifswald, Germany.	falko.hochgraefe@uni-greifswald.de	Richter, Erik A./Y-8131-2019; Lalk, Michael/C-1618-2010; Westhoff, Philipp/AAV-1542-2020	Richter, Erik A./0000-0002-6850-3056; Lalk, Michael/0000-0002-9230-0267; Westhoff, Philipp/0000-0002-3494-9420; Hildebrandt, Jan-Peter/0000-0001-7827-8481	Bundesminesterium fur Bildung und Forschung [03Z1CN21]; Deutsche Forschungsgemeinschaft [SFB/TRR34]	Bundesminesterium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by funds from the Bundesminesterium fur Bildung und Forschung (http://www.unternehmen-region.de/) to FH (03Z1CN21) and the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) - SFB/TRR34 to PG, ML (Project Z4) and JPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Below S, 2009, AM J PHYSIOL-LUNG C, V296, pL470, DOI 10.1152/ajplung.90498.2008; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; Calder PC, 2007, CURR OPIN CLIN NUTR, V10, P531, DOI 10.1097/MCO.0b013e3281e72ad4; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Eichstaedt S, 2008, J RECEPT SIG TRANSD, V28, P591, DOI 10.1080/10799890802407120; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rath S, 2013, CELL MICROBIOL, V15, P1253, DOI 10.1111/cmi.12113; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Strelkov S, 2004, BIOL CHEM, V385, P853, DOI 10.1515/BC.2004.111; Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	44	19	19	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94818	10.1371/journal.pone.0094818	http://dx.doi.org/10.1371/journal.pone.0094818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733556	gold, Green Submitted, Green Published			2022-12-25	WOS:000336970400112
J	Kramer, P; Gabel, K; Pfeiffer, F; Soppa, J				Kramer, Piet; Gaebel, Katrin; Pfeiffer, Friedhelm; Soppa, Joerg			Haloferax volcanii, a Prokaryotic Species that Does Not Use the Shine Dalgarno Mechanism for Translation Initiation at 5 '-UTRs	PLOS ONE			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; LEADERLESS MESSENGER-RNA; 16S RIBOSOMAL-RNA; ESCHERICHIA-COLI; IN-VIVO; PROTEIN-SYNTHESIS; SEQUENCE; EVOLUTION; GENES; SELECTION	It was long assumed that translation initiation in prokaryotes generally occurs via the so-called Shine Dalgarno (SD) mechanism. Recently, it became clear that translation initiation in prokaryotes is more heterogeneous. In the haloarchaeon Haloferax volcanii, the majority of transcripts is leaderless and most transcripts with a 5'-UTR lack a SD motif. Nevertheless, a bioinformatic analysis predicted that 20-30% of all genes are preceded by a SD motif in haloarchaea. To analyze the importance of the SD mechanism for translation initiation in haloarchaea experimentally the monocistronic sod gene was chosen, which contains a 5'-UTR with an extensive SD motif of seven nucleotides and a length of 19 nt, the average length of 5'UTRs in this organism. A translational fusion of part of the sod gene with the dhfr reporter gene was constructed. A mutant series was generated that matched the SD motif from zero to eight positions, respectively. Surprisingly, there was no correlation between the base pairing ability between transcripts and 16S rRNA and translational efficiency in vivo under several different growth conditions. Furthermore, complete replacement of the SD motif by three unrelated sequences did not reduce translational efficiency. The results indicate that H. volcanii does not make use of the SD mechanism for translation initiation in 5'-UTRs. A genome analysis revealed that while the number of SD motifs in 5'-UTRs is rare, their fraction within open reading frames is high. Possible biological functions for intragenic SD motifs are discussed, including re-initiation of translation at distal genes in operons.	[Kramer, Piet; Gaebel, Katrin; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Bioctr, D-60054 Frankfurt, Germany; [Pfeiffer, Friedhelm] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Goethe University Frankfurt; Max Planck Society	Soppa, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Bioctr, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Soppa, Jorg/0000-0002-6132-5840	German Research Council (Deutsche Forschungsgemeinschaft, DFG) [So264/19-1]	German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The project was funded by the German Research Council (Deutsche Forschungsgemeinschaft, DFG, www.dfg.de) through grant So264/19-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022914; ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Benelli D, 2003, MOL MICROBIOL, V50, P635, DOI 10.1046/j.1365-2958.2003.03721.x; Benelli D, 2009, RES MICROBIOL, V160, P493, DOI 10.1016/j.resmic.2009.06.003; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Brenneis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004484; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Condo I, 1999, MOL MICROBIOL, V34, P377, DOI 10.1046/j.1365-2958.1999.01615.x; Danner S, 1996, MOL MICROBIOL, V19, P1265, DOI 10.1111/j.1365-2958.1996.tb02471.x; FARWELL MA, 1992, MOL MICROBIOL, V6, P3375, DOI 10.1111/j.1365-2958.1992.tb02205.x; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; Gualerzi CO, 2010, ISR J CHEM, V50, P80, DOI 10.1002/ijch.201000006; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hasenohrl D, 2009, RNA, V15, P2288, DOI 10.1261/rna.1662609; Hasenohrl D, 2006, RNA, V12, P674, DOI 10.1261/rna.2289306; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; JACOB WF, 1987, P NATL ACAD SCI USA, V84, P4757, DOI 10.1073/pnas.84.14.4757; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Jin HN, 2006, MOL MICROBIOL, V60, P480, DOI 10.1111/j.1365-2958.2006.05110.x; JOSHI P, 1993, J BACTERIOL, V175, P1561, DOI 10.1128/JB.175.6.1561-1571.1993; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; KORNITZER D, 1989, J BACTERIOL, V171, P2563, DOI 10.1128/jb.171.5.2563-2572.1989; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mawn MV, 2002, J BACTERIOL, V184, P494, DOI 10.1128/JB.184.2.494-502.2002; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Palleja A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-537; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Ponnala L, 2010, BIOINFORM BIOL INSIG, V4, P55; Sartorius-Neef S, 2004, MOL MICROBIOL, V51, P579, DOI 10.1046/j.1365-2958.2003.03858.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Slupska MM, 2001, J MOL BIOL, V309, P347, DOI 10.1006/jmbi.2001.4669; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	57	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94979	10.1371/journal.pone.0094979	http://dx.doi.org/10.1371/journal.pone.0094979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733188	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400140
J	Pinheiro, KAT; Pinheiro, RT; Coelho, FMD; da Silva, RA; Quevedo, LA; Schwanz, CC; Wiener, CD; Manfro, GG; Giovenardi, M; Lucion, AB; de Souza, DO; Portela, LV; Oses, JP				Tavares Pinheiro, Karen Amaral; Pinheiro, Ricardo Tavares; da Cunha Coelho, Fabio Monteiro; da Silva, Ricardo Azevedo; Quevedo, Luciana Avila; Schwanz, Cristina Carvalhal; Wiener, Carolina David; Manfro, Gisele Gus; Giovenardi, Marcia; Lucion, Aldo Bolten; de Souza, Diogo Onofre; Portela, Luis Valmor; Oses, Jean Pierre			Serum NGF, BDNF and IL-6 Levels in Postpartum Mothers As Predictors of Infant Development: The Influence of Affective Disorders	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; EARLY ADVERSE EXPERIENCES; PITUITARY-ADRENAL AXIS; BRAIN STRUCTURE; MATERNAL-CARE; RAT-BRAIN; STRESS; DEPRIVATION; CHILDREN; NEUROBIOLOGY	Background: Early adverse experiences are associated with increased risk of developing psychiatric disorders, although little is known about the neurobiological mediators involved. The mechanisms by which early environmental influences may mediate vulnerability in the development of offspring await further investigation. The present study correlated the NGF, BDNF, IL-6 and cortisol levels of mothers with postpartum affective disorders (PPAD) with infant development. Methods: A longitudinal study was performed with 152 pregnant women and their infants. Between 60 and 120 days after delivery, women were interviewed and provided biological samples for biochemical analysis, and the infants were examined for neurobiological-motor development. Results: Overall, the mothers' history of affective disorders, PPAD and anxiety disorder were associated with infant motor development. Using an adjusted linear regression analysis, PPAD (p = 0.049), maternal anxiety disorder (p = 0.043), NGF level (p = 0.034) and infant cortisol level (p = 0.013) were associated with infant motor development. Using a factorial analysis of primary components, two components were retained. The psychological factor was characterized by a positive loading of a history of affective disorder, PPAD and anxiety disorder. For the biological factor, infant cortisol adhered negatively with infant motor development, but NGF was positively associated. The psychological factor had a negative association, but the biological factor had a positive association with infant motor development. Conclusions: There are few studies that have focused on the relationship of biomarkers and infant neurodevelopment. Our study points that psychological and biological factors are associated with infant motor development, however the causal relationship between these factors is still to be defined.	[Tavares Pinheiro, Karen Amaral; Pinheiro, Ricardo Tavares; da Cunha Coelho, Fabio Monteiro; da Silva, Ricardo Azevedo; Quevedo, Luciana Avila; Schwanz, Cristina Carvalhal; Wiener, Carolina David; Oses, Jean Pierre] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil; [Manfro, Gisele Gus] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil; [Giovenardi, Marcia; Lucion, Aldo Bolten] Univ Fed Ciencias Saude Porto Alegre, Dept Physiol Sci, Porto Alegre, RS, Brazil; [de Souza, Diogo Onofre; Portela, Luis Valmor] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil	Universidade Catolica de Pelotas; Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Rio Grande do Sul	Pinheiro, KAT (corresponding author), Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil.	karenap@terra.com.br	Lucion, Aldo/L-1518-2014; Giovenardi, Márcia/A-7453-2016; Oses, Jean Pierre/E-2534-2013; Manfro, Gisele/V-1167-2019; Souza, Diogo O/J-8894-2014; Pinheiro, Karen/AAF-5108-2020; Portela, Luis V/I-3410-2014; Manfro, Gisele G/B-7020-2009; Pinheiro, Ricardo Tavares/G-2658-2012	Giovenardi, Márcia/0000-0003-3213-2641; Manfro, Gisele/0000-0002-0109-7591; Souza, Diogo O/0000-0002-4322-0404; Manfro, Gisele G/0000-0002-0109-7591; Oses, Jean Pierre/0000-0002-2012-273X; Portela, Luis Valmor/0000-0001-6113-8466	CNPq; CAPES; PRONEX-FAPERGS; FINEP IBN-Net; INCT-Excitotoxicity and Neuroprotection	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX-FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP IBN-Net(Financiadora de Inovacao e Pesquisa (Finep)); INCT-Excitotoxicity and Neuroprotection	The present study was funded by the following governamental agencies: CNPq, CAPES, PRONEX-FAPERGS and FINEP IBN-Net and by the INCT-Excitotoxicity and Neuroprotection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A. L., 2000, PEDIAT PHYS THERAPY, V12, P62, DOI [DOI 10.1097/00001577-200012020-00003, 10.1097/00001577-200012020-00003]; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Bear M.F., 2007, NEUROSCIENCE, Vthird; Carlson M, 1997, ANN NY ACAD SCI, V807, P419, DOI 10.1111/j.1749-6632.1997.tb51936.x; Cassid J, 2008, HDB ATTACHMENT; Cirulli F, 2000, DEV BRAIN RES, V123, P129, DOI 10.1016/S0006-8993(00)02844-4; Cirulli F, 2007, BEHAV BRAIN RES, V178, P208, DOI 10.1016/j.bbr.2006.12.018; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; DENENBERG VH, 1967, ENDOCRINOLOGY, V81, P1047, DOI 10.1210/endo-81-5-1047; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Emanuele E, 2006, PSYCHONEUROENDOCRINO, V31, P288, DOI 10.1016/j.psyneuen.2005.09.002; Field T, 1998, Pediatrics, V102, P1305; Glasser D, 2000, J CHILD PSYCHOL PSYC, V97, P116; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Halpern R, 2000, J Pediatr (Rio J), V76, P421; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 1999, BIOL PSYCHIAT, V46, P1509, DOI 10.1016/S0006-3223(99)00224-3; Kauer-Sant'Anna M, 2009, INT J NEUROPSYCHOPH, V12, P447, DOI 10.1017/S1461145708009310; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Klaus Marshall H., 2000, VINCULO CONSTRUINDO; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; LUPPI P, 1993, NEUROREPORT, V4, P1063, DOI 10.1097/00001756-199308000-00018; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Motta Maria da Graça, 2005, Rev. psiquiatr. Rio Gd. Sul, V27, P165, DOI 10.1590/S0101-81082005000200007; PIPER MC, 1992, CAN J PUBLIC HEALTH, V83, pS46; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; ROSENFELD P, 1992, NEUROSCI BIOBEHAV R, V16, P553, DOI 10.1016/S0149-7634(05)80196-4; Rutter M, 1998, J CHILD PSYCHOL PSYC, V39, P465, DOI 10.1017/S0021963098002236; Santos DCC, 2009, REV BRAS FISIOTER, V13, P173, DOI 10.1590/S1413-35552009005000025; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; Savoia MG, 1999, REV PSIQ CLIN-BRAZIL, V26, P57; Schore A N, 2000, Attach Hum Dev, V2, P23; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Pinheiro KAT, 2011, INFANT BEHAV DEV, V34, P371, DOI 10.1016/j.infbeh.2010.12.006; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Trevarthen C, 2001, J CHILD PSYCHOL PSYC, V42, P3, DOI 10.1111/1469-7610.00701; Tronick E. Z., 1997, P54; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445	46	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94581	10.1371/journal.pone.0094581	http://dx.doi.org/10.1371/journal.pone.0094581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733087	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400053
J	Cabessa, J; Villa, AEP				Cabessa, Jeremie; Villa, Alessandro E. P.			An Attractor-Based Complexity Measurement for Boolean Recurrent Neural Networks	PLOS ONE			English	Article							SPATIOTEMPORAL FIRING PATTERNS; NEURONAL SPIKE TRAINS; BASAL GANGLIA; COMPUTATIONAL POWER; NONLINEAR DYNAMICS; GROUPING ALGORITHM; ASSOCIATIVE MEMORY; AUDITORY THALAMUS; SYSTEMS; RAT	We provide a novel refined attractor-based complexity measurement for Boolean recurrent neural networks that represents an assessment of their computational power in terms of the significance of their attractor dynamics. This complexity measurement is achieved by first proving a computational equivalence between Boolean recurrent neural networks and some specific class of omega-automata, and then translating the most refined classification of omega-automata to the Boolean neural network context. As a result, a hierarchical classification of Boolean neural networks based on their attractive dynamics is obtained, thus providing a novel refined attractor-based complexity measurement for Boolean recurrent neural networks. These results provide new theoretical insights to the computational and dynamical capabilities of neural networks according to their attractive potentialities. An application of our findings is illustrated by the analysis of the dynamics of a simplified model of the basal ganglia-thalamocortical network simulated by a Boolean recurrent neural network. This example shows the significance of measuring network complexity, and how our results bear new founding elements for the understanding of the complexity of real brain circuits.	[Cabessa, Jeremie; Villa, Alessandro E. P.] Univ Lausanne, Fac Business & Econ, Neuroheurist Res Grp, Lausanne, Switzerland; [Cabessa, Jeremie] Univ Paris 02, Lab Math Econ LEMMA, F-75231 Paris 05, France; [Villa, Alessandro E. P.] Univ Grenoble 1, Fac Med, Grenoble Inst Neurosci, Grenoble, France	University of Lausanne; Universite Paris 2 Pantheon-Assas; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Cabessa, J (corresponding author), Univ Lausanne, Fac Business & Econ, Neuroheurist Res Grp, Lausanne, Switzerland.	jcabessa@nhrg.org	Villa, Alessandro/G-6220-2011	Villa, Alessandro/0000-0002-4684-0027; Cabessa, Jeremie/0000-0002-5394-5249	University of Lausanne, Switzerland	University of Lausanne, Switzerland	This work is funded by the University of Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; AMARI SI, 1975, BIOL CYBERN, V17, P211, DOI 10.1007/BF00339367; Amit Daniel J., 1992, MODELING BRAIN FUNCT; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; AMIT DJ, 1989, P NATL ACAD SCI USA, V86, P7871, DOI 10.1073/pnas.86.20.7871; Asai Y, 2012, BRAIN RES, V1434, P17, DOI 10.1016/j.brainres.2011.10.012; ASANUMA C, 1994, EXP BRAIN RES, V101, P439; Balcazar JL, 1997, IEEE T INFORM THEORY, V43, P1175, DOI 10.1109/18.605580; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buchi J.R., 1966, STUDIES LOGIC FDN MA, V44, P1, DOI DOI 10.1016/S0049-237X(09)70564-6; Cabessa J, 2013, LECT NOTES COMPUT SC, V8131, P58, DOI 10.1007/978-3-642-40728-4_8; Cabessa J, 2012, NEURAL COMPUT, V24, P996, DOI 10.1162/NECO_a_00263; Cabessa J, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3200, DOI 10.1109/IJCNN.2011.6033645; Cabessa J, 2012, THEOR COMPUT SCI, V436, P23, DOI 10.1016/j.tcs.2012.01.042; Cebrian C, 2005, J COMP NEUROL, V492, P349, DOI 10.1002/cne.20741; Chao TC, 2005, J COMPUT NEUROSCI, V19, P311, DOI 10.1007/s10827-005-2653-4; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; COOLEN T, 1993, NH MATH LIB, V51, P293, DOI DOI 10.1016/S0924-6509(08)70041-2; Copeland BJ, 2004, THEOR COMPUT SCI, V317, P251, DOI 10.1016/j.tcs.2003.12.014; Copeland BJ, 2002, MIND MACH, V12, P461, DOI 10.1023/A:1021105915386; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; FOGEL DB, 1990, BIOL CYBERN, V63, P487, DOI 10.1007/BF00199581; Freeman WJ, 2003, INT J BIFURCAT CHAOS, V13, P2493, DOI 10.1142/S0218127403008144; FREEMAN WJ, 1990, SPRINGER SERIES SYNE, V45, P126; Freeman WJ, 1975, MASS ACTION NERVOUS; Fujii H, 2004, NEUROCOMPUTING, V58, P151, DOI 10.1016/j.neucom.2004.01.036; FUKAI T, 1990, PHYS REV LETT, V64, P1465, DOI 10.1103/PhysRevLett.64.1465; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Goldin D., 2006, INTERACTIVE COMPUTAT; GRINIASTY M, 1993, NEURAL COMPUT, V5, P1, DOI 10.1162/neco.1993.5.1.1; Groenewegen HJ, 1999, J CHEM NEUROANAT, V16, P167, DOI 10.1016/S0891-0618(99)00009-5; Guthrie M, 2013, J NEUROPHYSIOL, V109, P3025, DOI 10.1152/jn.00026.2013; Hill SL, 1997, NETWORK-COMP NEURAL, V8, P165, DOI 10.1088/0954-898X/8/2/004; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HOPFIELD JJ, 1983, NATURE, V304, P158, DOI 10.1038/304158a0; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hyotyniemi H., 1996, STeP '96 - Genes, Nets and Symbols. Finnish Artificial Intelligence Conference, P13; Iglesias J, 2005, LECT NOTES COMPUT SC, V3696, P127, DOI 10.1007/11550822_21; Iglesias J, 2005, BIOSYSTEMS, V79, P11, DOI 10.1016/j.biosystems.2004.09.016; Iglesias J, 2008, INT J NEURAL SYST, V18, P267, DOI 10.1142/S0129065708001580; Iglesias J, 2007, LECT NOTES COMPUT SC, V4668, P579; Iglesias J, 2007, BIOSYSTEMS, V89, P287, DOI 10.1016/j.biosystems.2006.05.020; Iglesias J, 2010, J PHYSIOL-PARIS, V104, P137, DOI 10.1016/j.jphysparis.2009.11.016; JAPG N, 1997, EUROCAST 97, P361; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kanamaru T, 2005, NEURAL COMPUT, V17, P1315, DOI 10.1162/0899766053630387; Kanamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053854; Kaneko K, 2003, CHAOS, V13, P926, DOI 10.1063/1.1607783; Kauffman S.A., 1993, ORIGINS ORDER; Kerr CC, 2012, IEEE T NEUR SYS REH, V20, P153, DOI 10.1109/TNSRE.2011.2178614; Kerr RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002897; Kilian J, 1996, INFORM COMPUT, V128, P48, DOI 10.1006/inco.1996.0062; KLEENE SC, 1956, ANN MATH STUD, V34, P3; Knierim JJ, 2012, ANNU REV NEUROSCI, V35, P267, DOI 10.1146/annurev-neuro-062111-150351; Knoblauch A, 2011, NEURAL COMPUT, V23, P1393, DOI 10.1162/NECO_a_00127; Kozloski J, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00007; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; KREMER SC, 1995, IEEE T NEURAL NETWOR, V6, P1000, DOI 10.1109/72.392262; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; LINTAS A, 2013, BRAIN RES; LITTLE W A, 1974, Mathematical Biosciences, V19, P101, DOI 10.1016/0025-5564(74)90031-5; LITTLE WA, 1978, MATH BIOSCI, V39, P281, DOI 10.1016/0025-5564(78)90058-5; Maass W, 1999, NEURAL COMPUT, V11, P771, DOI 10.1162/089976699300016656; Maass W, 1998, NEURAL COMPUT, V10, P1071, DOI 10.1162/089976698300017359; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MCNAUGHTON R, 1966, INFORM CONTROL, V9, P521, DOI 10.1016/S0019-9958(66)80013-X; Meijer HGE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066005; Minsky M., 1967, COMPUTATION FINITE I; Moriarty DE, 1997, EVOL COMPUT, V5, P373, DOI 10.1162/evco.1997.5.4.373; Nakahara H, 2002, NEURAL COMPUT, V14, P819, DOI 10.1162/089976602317318974; NARA S, 1993, NEURAL NETWORKS, V6, P963, DOI 10.1016/S0893-6080(09)80006-3; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Perrig S, 2010, CHINESE J PHYSIOL, V53, P382, DOI 10.4077/CJP.2010.AMM039; PERRIN D, 2004, PURE APPL MATH, V141; PHILLIS JW, 1980, CAN J PHYSIOL PHARM, V58, P612, DOI 10.1139/y80-102; Piterman N, 2007, LOG METH COMPUT SCI, V3, P1; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; REINOSOSUAREZ F, 2011, ADV ANAT EMBRYOL CEL, V208, P1; Rubin JE, 2004, J COMPUT NEUROSCI, V16, P211, DOI 10.1023/B:JCNS.0000025686.47117.67; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Segundo JP, 2003, INT J BIFURCAT CHAOS, V13, P2035, DOI 10.1142/S0218127403007886; Selivanov V, 1998, THEOR COMPUT SCI, V191, P37, DOI 10.1016/S0304-3975(97)00301-0; Seung HS, 1998, ADV NEUR IN, V10, P654; Shaposhnyk V, 2012, BRAIN RES, V1434, P266, DOI 10.1016/j.brainres.2011.08.018; Shmiel T, 2005, P NATL ACAD SCI USA, V102, P18655, DOI 10.1073/pnas.0509346102; SIEGELMANN HT, 1994, THEOR COMPUT SCI, V131, P331, DOI 10.1016/0304-3975(94)90178-3; SIEGELMANN HT, 1995, J COMPUT SYST SCI, V50, P132, DOI 10.1006/jcss.1995.1013; Silkis I, 2007, BIOSYSTEMS, V89, P227, DOI 10.1016/j.biosystems.2006.04.020; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Sperduti A, 1997, NEURAL NETWORKS, V10, P395, DOI 10.1016/S0893-6080(96)00105-0; Steriade M., 1990, THALAMIC OSCILLATION; Taylor J.G., 2001, FRONTIERS OF LIFE, V3, P349; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tetko IV, 1997, BIOL CYBERN, V76, P397, DOI 10.1007/s004220050353; Tetko IV, 2001, J NEUROSCI METH, V105, P15, DOI 10.1016/S0165-0270(00)00337-X; Tetko IV, 2001, J NEUROSCI METH, V105, P1, DOI 10.1016/S0165-0270(00)00336-8; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Thom R., 1983, PARABOLES CATASTROPH; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; TSUDA I, 1987, PROG THEOR PHYS, V78, P51, DOI 10.1143/PTP.78.51; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Tsuda I, 1991, WORLD FUTURES, V32, P167, DOI [DOI 10.1080/02604027.1991.9972257, 10.1080/02604027.1991.9972257]; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Turova TS, 2007, BIOSYSTEMS, V89, P280, DOI 10.1016/j.biosystems.2006.05.019; van Albada SJ, 2009, J THEOR BIOL, V257, P642, DOI 10.1016/j.jtbi.2008.12.018; VANLEEUWEN J, 2008, LNCS, V5028, P579; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; VILLA AEP, 1990, BRAIN RES, V509, P325, DOI 10.1016/0006-8993(90)90558-S; Villa AEP, 2000, BIOSYSTEMS, V58, P219, DOI 10.1016/S0303-2647(00)00126-X; Villa AEP, 2000, CONC ADV BRAIN RES, V3, P1; Villa AEP, 1996, BRAIN RES BULL, V39, P139, DOI 10.1016/0361-9230(95)02085-3; Villa AEP, 1999, J NEUROSCI METH, V86, P161, DOI 10.1016/S0165-0270(98)00164-2; Waddington A, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00088; Wadge W. W., 1983, THESIS U CALIFORNIA; WAGNER K, 1979, INFORM CONTROL, V43, P123, DOI 10.1016/S0019-9958(79)90653-3; Watta PB, 1997, IEEE T NEURAL NETWOR, V8, P1268, DOI 10.1109/72.641450; WHITLEY D, 1993, MACH LEARN, V13, P259, DOI 10.1007/BF00993045; WRIGHT JJ, 1990, BIOL CYBERN, V62, P289, DOI 10.1007/BF00201443; Yao X, 1997, IEEE T NEURAL NETWOR, V8, P694, DOI 10.1109/72.572107; Yasukawa T, 2004, J COMP NEUROL, V471, P153, DOI 10.1002/cne.20029; Yon Neumann J, 1958, COMPUTER BRAIN	131	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94204	10.1371/journal.pone.0094204	http://dx.doi.org/10.1371/journal.pone.0094204			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727866	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200044
J	Ikegbunam, MN; Anagu, LO; Iroha, IR; Ejikeugwu, CE; Esimone, CO				Ikegbunam, Moses Nkechukwu; Anagu, Linda Onyeka; Iroha, Ifeanyi R.; Ejikeugwu, Chika Ebiye; Esimone, Charles Okey			Abattoirs as Non-Hospital Source of Extended Spectrum Beta Lactamase Producers: Confirmed by the Double Disc Synergy Test and Characterized by Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INFECTION	In this study, the presence of extended spectrum beta lactamase (ESBL) producing organisms in abattoirs, a non-hospital community was investigated. The presence of ESBL-producing phenotypes was confirmed by the Double Disc Synergy Test (DDST). Out of the 99 isolates screened for ESBL, 28 (28.3%) were confirmed positive. The positive isolates were characterised by using Matrix-Assisted Laser Desorption/Ionization Time of flight Mass Spectrometry. 50% of the isolates were Pseudomonas spp., the rest were different species of Acinetobacter, Stenotrophomonas and Achromobacter. Pseudomonas monteilli and Pseudomonas putida were the most occurring in the intestine. The entire positive ESBL producers were subjected to plasmid curing to ascertain the location of the resistant marker. The result of the plasmid curing indicated that the resistant genes were chromosomally borne. The findings have therefore established the presence of ESBL producing organisms in the gut of animals from abattoirs and the table were the meat are sold, and its rate of occurrence is comparable to hospital ICUs. Abattoir communities could probably be a source of human infection with ESBL expressing pathogens and possible transfer to non-ESBL producers.	[Ikegbunam, Moses Nkechukwu; Anagu, Linda Onyeka; Iroha, Ifeanyi R.; Ejikeugwu, Chika Ebiye; Esimone, Charles Okey] Nnamdi Azikiwe Univ, Dept Pharmaceut Microbiol, Fac Pharmaceut Sci, Awka, Anambra State, Nigeria; [Ikegbunam, Moses Nkechukwu; Anagu, Linda Onyeka; Iroha, Ifeanyi R.; Ejikeugwu, Chika Ebiye; Esimone, Charles Okey] Nnamdi Azikiwe Univ, Dept Biotechnol, Fac Pharmaceut Sci, Awka, Anambra State, Nigeria; [Iroha, Ifeanyi R.] Ebonyi State Univ, Fac Biol Sci, Dept Appl Microbiol, Abakaliki, Ebonyi State, Nigeria		Anagu, LO (corresponding author), Nnamdi Azikiwe Univ, Dept Pharmaceut Microbiol, Fac Pharmaceut Sci, Awka, Anambra State, Nigeria.	onakuonyeka@yahoo.com	Anagu, Linda/ABC-8885-2021; Ejikeugwu, Chika/AHI-0555-2022	Anagu, Linda/0000-0002-2243-1616; Ejikeugwu, Chika/0000-0002-3506-2346				Aibinu IE, 2003, J CLIN MICROBIOL, V41, P2197, DOI 10.1128/JCM.41.5.2197-2200.2003; Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Al-Jasser Asma Marzouq, 2006, Ann Clin Microbiol Antimicrob, V5, P23, DOI 10.1186/1476-0711-5-23; Almuzara MN, 2010, J CLIN MICROBIOL, V48, P660, DOI 10.1128/JCM.01849-09; ARAGONE MD, 1992, J CLIN MICROBIOL, V30, P1583, DOI 10.1128/JCM.30.6.1583-1584.1992; Babini GS, 2000, J ANTIMICROB CHEMOTH, V45, P183, DOI 10.1093/jac/45.2.183; Beidenbach DJ, 2004, DIAGN MICROBIOL INFE, V50, P59; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; BRUNBUISSON C, 1989, ANN INTERN MED, V110, P873, DOI 10.7326/0003-4819-110-11-873; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Enabulele I.O., 1993, NIGER J MICROBIOL, V9, P13; Garcia-Garmendia JL, 1999, CRIT CARE MED, V27, P1794, DOI 10.1097/00003246-199909000-00015; Gianluigi L, 2002, J CLIN MICROBIOL, V40, P4051; Harris AD, 2007, EMERG INFECT DIS, V13; Iroha IR, 2008, SCI RES ESSAYS, V3, P215; Iroha I. R., 2008, Research Journal of Microbiology, V3, P514; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Seok Y, 2010, J CLIN MICROBIOL, V48, P2656, DOI 10.1128/JCM.01609-09; Waters VJ, 2007, INFECT IMMUN, V75, P1698, DOI 10.1128/IAI.01469-06; Yah SC, 2007, AFR J BIOTECHNOL, V6, P1757	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94461	10.1371/journal.pone.0094461	http://dx.doi.org/10.1371/journal.pone.0094461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728403	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200076
J	Kumawat, K; Menzen, MH; Slegtenhorst, RM; Halayko, AJ; Schmidt, M; Gosens, R				Kumawat, Kuldeep; Menzen, Mark H.; Slegtenhorst, Ralph M.; Halayko, Andrew J.; Schmidt, Martina; Gosens, Reinoud			TGF-beta-Activated Kinase 1 (TAK1) Signaling Regulates TGF-beta-Induced WNT-5A Expression in Airway Smooth Muscle Cells via Sp1 and beta-Catenin	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PRODUCTION; GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; TRANSCRIPTION FACTOR; SMAD PATHWAYS; WNT5A; GENE; INHIBITION; SECRETION; PROMOTER	WNT-5A, a key player in embryonic development and post-natal homeostasis, has been associated with a myriad of pathological conditions including malignant, fibroproliferative and inflammatory disorders. Previously, we have identified WNT-5A as a transcriptional target of TGF-beta in airway smooth muscle cells and demonstrated its function as a mediator of airway remodeling. Here, we investigated the molecular mechanisms underlying TGF-beta-induced WNT-5A expression. We show that TGF-beta-activated kinase 1 (TAK1) is a critical mediator of WNT-5A expression as its pharmacological inhibition or siRNA-mediated silencing reduced TGF-beta induction of WNT-5A. Furthermore, we show that TAK1 engages p38 and c-Jun N-terminal kinase (JNK) signaling which redundantly participates in WNT-5A induction as only simultaneous, but not individual, inhibition of p38 and JNK suppressed TGF-beta-induced WNT-5A expression. Remarkably, we demonstrate a central role of beta-catenin in TGF-beta-induced WNT-5A expression. Regulated by TAK1, beta-catenin is required for WNT-5A induction as it silencing repressed WNT-5A expression whereas a constitutively active mutant augmented basal WNT-5A abundance. Furthermore, we identify Sp1 as the transcription factor for WNT-5A and demonstrate its interaction with beta-catenin. We discover that Sp1 is recruited to the WNT-5A promoter in a TGF-beta-induced and TAK1-regulated manner. Collectively, our findings describe a TAK1-dependent, beta-catenin- and Sp1-mediated signaling cascade activated downstream of TGF-beta which regulates WNT-5A induction.	[Kumawat, Kuldeep; Menzen, Mark H.; Slegtenhorst, Ralph M.; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Kumawat, Kuldeep; Menzen, Mark H.; Slegtenhorst, Ralph M.; Schmidt, Martina; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	University of Groningen; University of Groningen; University of Manitoba; University of Manitoba	Kumawat, K (corresponding author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.	k.kumawat@rug.nl	Schmidt, Martina/C-5339-2018	Schmidt, Martina/0000-0003-3075-0630; Halayko, Andrew/0000-0002-7865-4552; Gosens, Reinoud/0000-0002-5595-152X	Compex Medical SA, Ecublens VD	Compex Medical SA, Ecublens VD	The myostimulator Compex 3 Professional was sponsored by Compex Medical SA, Ecublens VD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gosens R, 2008, N-S ARCH PHARMACOL, V378, P185, DOI 10.1007/s00210-008-0269-8; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; IOZZO RV, 1995, CANCER RES, V55, P3495; Jansen SR, 2010, AM J PHYSIOL-LUNG C, V299, pL204, DOI 10.1152/ajplung.00020.2010; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Pera T, 2012, AM J PHYSIOL-LUNG C, V303, pL272, DOI 10.1152/ajplung.00291.2011; Pera T, 2011, AM J PHYSIOL-LUNG C, V301, pL822, DOI 10.1152/ajplung.00017.2011; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu XQ, 2004, J BIOL CHEM, V279, P36158, DOI 10.1074/jbc.M402454200; Xian-Peng G, 2011, OSTEOARTHR CARTILAGE, V19, P111, DOI 10.1016/j.joca.2010.10.016; Xiong WJ, 2012, WORLD J GASTROENTERO, V18, P1745, DOI 10.3748/wjg.v18.i15.1745; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	69	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94801	10.1371/journal.pone.0094801	http://dx.doi.org/10.1371/journal.pone.0094801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728340	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200132
J	Liu, B; Wu, Y; Zhou, Y; Peng, D				Liu, Bo; Wu, Yi; Zhou, Yu; Peng, Dan			Endothelin A Receptor Antagonism Enhances Inhibitory Effects of Anti-Ganglioside GD2 Monoclonal Antibody on Invasiveness and Viability of Human Osteosarcoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; DOWN-REGULATION; MIGRATION; GANGLIOSIDE; INVASION; GROWTH	Endothelin-1 (ET-1)/endothelin A receptor (ETAR) signaling is important for osteosarcoma (OS) progression. Monoclonal antibodies (mAbs) targeting ganglioside GD2 reportedly inhibit tumor cell viability independent of the immune system. A recent study suggests that ganglioside GD2 may play an important role in OS progression. In the present study, we for the first time explored the effects of anti-GD2 mAb alone or in combination with ETAR antagonist on OS cell invasiveness and viability. Human OS cell lines Saos-2, MG-63 and SJSA-1 were treated with control IgG (PK136 mAb, 50 mu g/mL), anti-GD2 14G2a mAb (50 mu g/mL), selective ETAR antagonist BQ123 (5 mu M), or 14G2a (50 mu g/mL)+BQ123 (5 mu M). Cells with knockdown of ETAR (ETAR-shRNA) with or without 14G2a mAb treatment were also tested. Cells treated with selective phosphatidylinositide 3-kinase (PI3K) inhibitor BKM120 (50 mu M) were used as a positive control. Our results showed that BQ123, ETAR-shRNA and 14G2a mAb individually decreased cell invasion and viability, matrix metalloproteinase-2 (MMP-2) expression and activity, PI3k activity, and phosphorylation at serine 473 (ser473) of Akt in OS cells. 14G2a mAb in combination with BQ123 or ETAR-shRNA showed significantly stronger inhibitory effects compared with each individual treatment. In all three cell lines tested, 14G2a mAb in combination with BQ123 showed the strongest inhibitory effects. In conclusion, we provide the first in vitro evidence that anti-ganglioside GD2 14G2a mAb effectively inhibits cell invasiveness, MMP-2 expression and activity, and cell viability in human OS cells. ETAR antagonist BQ123 significantly enhances the inhibitory effects of 14G2a mAb, likely mainly through inhibiting the PI3K/Akt pathway. This study adds novel insights into OS treatment, which will serve as a solid basis for future in vivo studies on the effects of combined treatment of OS with anti-ganglioside GD2 mAbs and ETAR antagonists.	[Liu, Bo; Zhou, Yu; Peng, Dan] Cent S Univ, Xiangya Hosp 2, Dept Orthopaed, Changsha, Hunan, Peoples R China; [Wu, Yi] Hunan Prov Hlth Bur, Changsha, Hunan, Peoples R China	Central South University	Peng, D (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Orthopaed, Changsha, Hunan, Peoples R China.	Xyeypd@163.com						Ahmed M, 2013, J PEDIAT HEMATOL ONC; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Cochonneau D, 2013, CANCER LETT, V333, P194, DOI 10.1016/j.canlet.2013.01.032; Felx M, 2006, CLIN SCI, V110, P645, DOI 10.1042/CS20050286; Feng YK, 2011, EUR J CANCER, V47, P2353, DOI 10.1016/j.ejca.2011.05.006; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Horwacik I, 2013, CANCER LETT, V341, P248, DOI 10.1016/j.canlet.2013.08.018; Jo YK, 2011, BIOCHEM BIOPH RES CO, V404, P1039, DOI 10.1016/j.bbrc.2010.12.106; Li B, 2012, INT J ONCOL, V41, P1809, DOI 10.3892/ijo.2012.1617; Li Y, 2012, MOL MED REP, V5, P1391, DOI 10.3892/mmr.2012.842; Liu ZL, 2013, MOL MED REP, V7, P608, DOI 10.3892/mmr.2012.1220; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Qin J, 2013, LIFE SCI, V93, P655, DOI 10.1016/j.lfs.2013.09.002; Roth M, 2014, CANCER-AM CANCER SOC, V120, P548, DOI 10.1002/cncr.28461; Ruf P, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-219; Song NR, 2014, FOOD CHEM, V142, P66, DOI 10.1016/j.foodchem.2013.07.002; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Wang B, 2009, J HEPATOL, V50, P528, DOI 10.1016/j.jhep.2008.10.025; Wang TF, 2013, BIOCHEM BIOPH RES CO, V440, P229, DOI 10.1016/j.bbrc.2013.09.024; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zheng YH, 2012, J MOL MED, V90, P695, DOI 10.1007/s00109-011-0849-9	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93576	10.1371/journal.pone.0093576	http://dx.doi.org/10.1371/journal.pone.0093576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727660	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200020
J	Schellenberg, A; Ross, R; Abagnale, G; Joussen, S; Schuster, P; Arshi, A; Pallua, N; Jockenhoevel, S; Gries, T; Wagner, W				Schellenberg, Anne; Ross, Robin; Abagnale, Giulio; Joussen, Sylvia; Schuster, Philipp; Arshi, Annahit; Pallua, Norbert; Jockenhoevel, Stefan; Gries, Thomas; Wagner, Wolfgang			3D Non-Woven Polyvinylidene Fluoride Scaffolds: Fibre Cross Section and Texturizing Patterns Have Impact on Growth of Mesenchymal Stromal Cells	PLOS ONE			English	Article							HUMAN PLATELET LYSATE; STEM-CELLS; IN-VITRO; CULTURE; DIFFERENTIATION; PROLIFERATION; EXPANSION; ADHESION; KERATINOCYTES; SURFACES	Several applications in tissue engineering require transplantation of cells embedded in appropriate biomaterial scaffolds. Such structures may consist of 3D non-woven fibrous materials whereas little is known about the impact of mesh size, pore architecture and fibre morphology on cellular behavior. In this study, we have developed polyvinylidene fluoride (PVDF) non-woven scaffolds with round, trilobal, or snowflake fibre cross section and different fibre crimp patterns (10, 16, or 28 needles per inch). Human mesenchymal stromal cells (MSCs) from adipose tissue were seeded in parallel on these scaffolds and their growth was compared. Initial cell adhesion during the seeding procedure was higher on non-wovens with round fibres than on those with snowflake or trilobal cross sections. All PVDF non-woven fabrics facilitated cell growth over a time course of 15 days. Interestingly, proliferation was significantly higher on non-wovens with round or trilobal fibres as compared to those with snowflake profile. Furthermore, proliferation increased in a wider, less dense network. Scanning electron microscopy (SEM) revealed that the MSCs aligned along the fibres and formed cellular layers spanning over the pores. 3D PVDF non-woven scaffolds support growth of MSCs, however fibre morphology and mesh size are relevant: proliferation is enhanced by round fibre cross sections and in rather wide-meshed scaffolds.	[Schellenberg, Anne; Abagnale, Giulio; Joussen, Sylvia; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany; [Ross, Robin; Schuster, Philipp; Arshi, Annahit; Jockenhoevel, Stefan; Gries, Thomas] Rhein Westfal TH Aachen, Inst Text Technol, Aachen, Germany; [Pallua, Norbert] Rhein Westfal TH Aachen, Burn Ctr, Dept Plast & Reconstruct Surg, Aachen, Germany; [Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Dept Appl Med Engn, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de	Gries, Thomas/M-8206-2018	Gries, Thomas/0000-0002-2480-8333; Jockenhoevel, Stefan/0000-0003-0584-9444; Wagner, Wolfgang/0000-0002-1971-3217	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; German Research Foundation [WA 1706/3-2, SPP1327]	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Stem Cell Network North Rhine Westphalia, by the Else-Kroner-Fresenius Stiftung, and by the German Research Foundation (WA 1706/3-2 within SPP1327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumchen F, 2009, ORAL SURG ORAL MED O, V108, P505, DOI 10.1016/j.tripleo.2009.05.004; Berger D, 2009, HERNIA, V13, P167, DOI 10.1007/s10029-008-0435-4; Cardwell RD, 2012, J TISSUE ENG REGEN M; Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084; Chandrasekaran AR, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015001; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]; Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477; Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Garcia JL, 2010, MOLECULES, V15, P2845, DOI 10.3390/molecules15042845; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hegewald AA, 2013, J TISSUE ENG REGEN M; Horn P, 2011, METHODS MOL BIOL, V698, P23, DOI 10.1007/978-1-60761-999-4_3; Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7; Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028; Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4; Klink CD, 2011, J INVEST SURG, V24, P292, DOI 10.3109/08941939.2011.589883; LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209; Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034; Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154; Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839; Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045; Morgan SM, 2009, BIOMATERIALS, V30, P1910, DOI 10.1016/j.biomaterials.2008.12.033; Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puppi D, 2012, BIOMED MICRODEVICES, V14, P1115, DOI 10.1007/s10544-012-9677-0; Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Sun T, 2009, J MATER SCI-MATER M, V20, P1483, DOI 10.1007/s10856-009-3703-7; Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228; Tschoeke B, 2008, ARTIF ORGANS, V32, P800, DOI 10.1111/j.1525-1594.2008.00601.x; Tuzlakoglu K, 2009, TISSUE ENG PART B-RE, V15, P17, DOI 10.1089/ten.teb.2008.0016; Urban E, 1994, ASAIO J, V40, P145; Walenda G, 2012, TISSUE ENG PART C-ME, V18, P924, DOI [10.1089/ten.tec.2011.0541, 10.1089/ten.TEC.2011.0541]; Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052	56	19	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94353	10.1371/journal.pone.0094353	http://dx.doi.org/10.1371/journal.pone.0094353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728045	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200066
J	Zhuang, P; Lu, HP; Li, ZA; Zou, B; McBride, MB				Zhuang, Ping; Lu, Huanping; Li, Zhian; Zou, Bi; McBride, Murray B.			Multiple Exposure and Effects Assessment of Heavy Metals in the Population near Mining Area in South China	PLOS ONE			English	Article							HEALTH-RISK ASSESSMENT; PB-ZN MINE; DABAOSHAN MINE; GUANGDONG PROVINCE; POTENTIAL RISK; SULFIDE MINE; FOOD CROPS; SOIL; LEAD; CONTAMINATION	The objective of this study was to investigate the levels of Cd, Pb, Cu and Zn in the environment and several important food sources grown and consumed in the vicinity of Dabaoshan mine in Southern China, and evaluate potential health risks among local residents. The Cd, Pb, Cu and Zn concentrations of arable soils and well water near the mines exceeded the quality standard values. The concentrations of Cd and Pb in some food crops (rice grain, vegetable and soybean) samples were significantly higher than the maximum permissible level. The Cd and Pb concentrations in half of the chicken and fish meat samples were higher than the national standard. The residents living near Dabaoshan mine had higher Cd and Pb levels in hair than those of a non-exposed population. The intake of rice was identified as a major contributor to the estimated daily intake of these metals by the residents. The hazard index values for adults and children were 10.25 and 11.11, respectively, with most of the estimated risks coming from the intake of home-grown rice and vegetables. This study highlights the importance of multiple pathways in studying health risk assessment of heavy metal exposure in China.	[Zhuang, Ping; Lu, Huanping; Li, Zhian; Zou, Bi] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [McBride, Murray B.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Cornell University	Li, ZA (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn	Zhuang, Ping/B-3624-2009	Zhuang, Ping/0000-0002-6654-1294	National Natural Science Foundation of China [40871221, 41301571]; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology [2013K0008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology	This research work was financially supported by the National Natural Science Foundation of China (No. 40871221 and No. 41301571) and the Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology (No. 2013K0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams PW, 2002, SCI TOTAL ENVIRON, V291, P1, DOI 10.1016/S0048-9697(01)01102-0; Adhikari S., 2006, International Journal of Environmental Science and Technology, V3, P289; Albering HJ, 1999, ENVIRON HEALTH PERSP, V107, P37, DOI [10.2307/3434287, 10.1289/ehp.9910737]; Alonso E, 2001, ARCH ENVIRON HEALTH, V56, P278, DOI 10.1080/00039890109604454; Altshul L, 2004, ENVIRON HEALTH PERSP, V112, P1193, DOI 10.1289/ehp.6916; [Anonymous], [No title captured]; [Anonymous], 1997, EXPOSURE FACTORS HDB; Bao QS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-217; Benin AL, 1999, ENVIRON HEALTH PERSP, V107, P279, DOI 10.2307/3434594; Borgmann U, 2007, ENVIRON POLLUT, V145, P753, DOI 10.1016/j.envpol.2006.05.020; Branan N, 2008, MINING LEAVES NASTY; Chen A, 2007, CHEMOSPHERE, V70, P248, DOI 10.1016/j.chemosphere.2007.06.041; Cui YJ, 2004, ENVIRON INT, V30, P785, DOI 10.1016/j.envint.2004.01.003; Dong ZM, 2012, ENVIRON SCI TECHNOL, V46, P1144, DOI 10.1021/es202800z; Druyan ME, 1998, BIOL TRACE ELEM RES, V62, P183, DOI 10.1007/BF02783970; Dudka S, 1997, J ENVIRON QUAL, V26, P590, DOI 10.2134/jeq1997.00472425002600030003x; Gao Y, 2011, ENVIRON SCI TECHNOL, V45, P8065; Golia EE, 2008, B ENVIRON CONTAM TOX, V81, P80, DOI 10.1007/s00128-008-9416-7; Harmanescu M, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-64; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Ji K, 2013, ENVIRON POLLUT, V178, P322, DOI 10.1016/j.envpol.2013.03.031; Kapusta P, 2011, ENVIRON POLLUT, V159, P1516, DOI 10.1016/j.envpol.2011.03.015; Kerin EJ, 2010, REV ENVIRON CONTAM T, V206, P49, DOI 10.1007/978-1-4419-6260-7_3; Lee CG, 2001, APPL GEOCHEM, V16, P1377, DOI 10.1016/S0883-2927(01)00038-5; Lee JS, 2005, ENVIRON GEOCHEM HLTH, V27, P185, DOI 10.1007/s10653-005-0131-6; Li QS, 2012, J HAZARD MATER, V227, P148, DOI 10.1016/j.jhazmat.2012.05.023; Lim HS, 2008, J GEOCHEM EXPLOR, V96, P223, DOI 10.1016/j.gexplo.2007.04.008; Liu HY, 2005, SCI TOTAL ENVIRON, V339, P153, DOI 10.1016/j.scitotenv.2004.07.030; Liu Y.S., 2005, CHINA TROP MED, Vl15, P1139; McLaughlin MJ, 2006, ENVIRON CHEM, V3, P428, DOI 10.1071/EN06061; MHPRC, 2012, 27622012 MHPRC GB; Moiseenko TI, 2001, ENVIRON POLLUT, V114, P285, DOI 10.1016/S0269-7491(00)00197-4; Nobuntou W, 2010, J ENVIRON SCI HEAL A, V45, P1702, DOI 10.1080/10934529.2010.513232; Paoliello MMB, 2002, ENVIRON RES, V88, P120, DOI 10.1006/enrs.2001.4311; Park JH, 2013, J GEOCHEM EXPLOR, V128, P117, DOI 10.1016/j.gexplo.2013.02.004; Pereira R, 2004, SCI TOTAL ENVIRON, V327, P81, DOI 10.1016/j.scitotenv.2004.01.017; Plant J, 2001, APPL GEOCHEM, V16, P1291, DOI 10.1016/S0883-2927(01)00036-1; Plumlee GS, 2013, ENVIRON HEALTH PERSP, V121, P744, DOI 10.1289/ehp.1206051; Plumlee GS, 2011, ELEMENTS, V7, P399, DOI 10.2113/gselements.7.6.399; Proctor PD, 1984, ENV IMPACTS SMELTERS, P89; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Rieuwerts JS, 2000, WATER AIR SOIL POLL, V122, P203, DOI 10.1023/A:1005251527946; Rodrigues SM, 2012, ENVIRON INT, V39, P27, DOI 10.1016/j.envint.2011.09.005; Rodriguez L, 2009, J ENVIRON MANAGE, V90, P1106, DOI 10.1016/j.jenvman.2008.04.007; Rowland A.P, 1986, METHODS PLANT ECOLOG; Rybicka EH, 1996, APPL GEOCHEM, V11, P3; Shu Wensheng, 2000, ECOLOGIC SCI, V19, P24; Staessen JA, 1992, ENVIRON RES, V58, P24; Sun HF, 2010, T NONFERR METAL SOC, V20, P308, DOI 10.1016/S1003-6326(09)60139-4; Thomas R, 1980, INORGANIC POLLUTION, P142; UNEP/OCHA, 2010, LEAD POLL POIS CRIS; US-EPA, 2007, INT RISK INF SYST DA; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Wang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-319; Wang T, 2009, ENVIRON POLLUT, V157, P2445, DOI 10.1016/j.envpol.2009.03.010; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wcislo E, 2002, CHEMOSPHERE, V47, P507, DOI 10.1016/S0045-6535(01)00301-0; Zhai Feng-ying, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P485; Zhang XW, 2012, ENVIRON MONIT ASSESS, V184, P2261, DOI 10.1007/s10661-011-2115-6; Zheng N, 2007, SCI TOTAL ENVIRON, V383, P81, DOI 10.1016/j.scitotenv.2007.05.002; Zhou JM, 2007, PEDOSPHERE, V17, P588, DOI 10.1016/S1002-0160(07)60069-1; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103; Zhuang P, 2009, SCI TOTAL ENVIRON, V407, P1551, DOI 10.1016/j.scitotenv.2008.10.061; Zhuang P, 2013, ENVIRON SCI POLLUT R, V20, P5844, DOI 10.1007/s11356-013-1606-0	64	98	102	5	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94484	10.1371/journal.pone.0094484	http://dx.doi.org/10.1371/journal.pone.0094484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728502	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200079
J	Bachanek-Bankowska, K; Maan, S; Castillo-Olivares, J; Manning, NM; Maan, NS; Potgieter, AC; Di Nardo, A; Sutton, G; Batten, C; Mertens, PPC				Bachanek-Bankowska, Katarzyna; Maan, Sushila; Castillo-Olivares, Javier; Manning, Nicola M.; Maan, Narender Singh; Potgieter, Abraham C.; Di Nardo, Antonello; Sutton, Geoff; Batten, Carrie; Mertens, Peter P. C.			Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RECOMBINANT CANARYPOX VIRUS; BLUETONGUE-VIRUS; HORSESICKNESS-VIRUS; COMPETITIVE ELISA; COMPLETE SET; VP2 GENES; ORBIVIRUS; SEROTYPES; IDENTIFICATION	Although African horse sickness (AHS) can cause up to 95% mortality in horses, naive animals can be protected by vaccination against the homologous AHSV serotype. Genome segment 2 (Seg-2) encodes outer capsid protein VP2, the most variable of the AHSV proteins. VP2 is also a primary target for AHSV specific neutralising antibodies, and consequently determines the identity of the nine AHSV serotypes. In contrast VP1 (the viral polymerase) and VP3 (the sub-core shell protein), encoded by Seg-1 and Seg-3 respectively, are highly conserved, representing virus species/orbivirus-serogroup-specific antigens. We report development and evaluation of real-time RT-PCR assays targeting AHSV Seg-1 or Seg-3, that can detect any AHSV type (virus species/serogroup-specific assays), as well as type-specific assays targeting Seg-2 of the nine AHSV serotypes. These assays were evaluated using isolates of different AHSV serotypes and other closely related orbiviruses, from the 'Orbivirus Reference Collection' (ORC) at The Pirbright Institute. The assays were shown to be AHSV virus-species-specific, or type-specific (as designed) and can be used for rapid, sensitive and reliable detection and identification (typing) of AHSV RNA in infected blood, tissue samples, homogenised Culicoides, or tissue culture supernatant. None of the assays amplified cDNAs from closely related heterologous orbiviruses, or from uninfected host animals or cell cultures.	[Bachanek-Bankowska, Katarzyna; Maan, Sushila; Castillo-Olivares, Javier; Manning, Nicola M.; Maan, Narender Singh; Di Nardo, Antonello; Batten, Carrie; Mertens, Peter P. C.] Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England; [Potgieter, Abraham C.] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa; [Potgieter, Abraham C.] North West Univ, Dept Biochem, Ctr Human Metabon, Potchefstroom, South Africa; [Sutton, Geoff] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; North West University - South Africa; University of Oxford; Wellcome Centre for Human Genetics	Mertens, PPC (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England.	Peter.mertens@pirbright.ac.uk	Castillo-Olivares, Javier/AAA-7603-2019; Castillo-Olivares, Javier/AAA-8837-2019	Castillo-Olivares, Javier/0000-0003-3453-8557; Batten, Carrie/0000-0003-4274-7375; Mertens, Peter/0000-0002-3438-3738	Defra; Biotechnology and Biological Sciences Research Council; European Commission [245266, 222633-2, K1303206]; Biotechnology and Biological Sciences Research Council [BB/H531478/1, BB/L004690/1, BB/I017259/1, BBS/E/I/00001144, BBS/E/I/00001446] Funding Source: researchfish; BBSRC [BB/L004690/1, BB/H531478/1, BB/I017259/1, BBS/E/I/00001446] Funding Source: UKRI	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge funding from Defra, Biotechnology and Biological Sciences Research Council, and the European Commission (OrbiVac - Grant no.: 245266; WildTech - Grant no.: 222633-2; EMIDA grant OrbiNet - K1303206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2008, J VET DIAGN INVEST, V20, P325, DOI 10.1177/104063870802000310; Aklilu N, 2012, TRANSBOUNDARY EMERGI; Aradaib IE, 2009, J VIROL METHODS, V159, P1, DOI 10.1016/j.jviromet.2009.02.012; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Bachanek-Bankowska K, 2012, GENETIC STUDIES AFRI; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belaganahalli MN, 2012, PLOS ONE, V7; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Bremer CW, 1998, ONDERSTEPOORT J VET, V65, P1; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; Coetzer J. A. W., 2004, Infectious diseases of livestock. Volume Two, P1231; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; El Garch H, 2012, VET IMMUNOL IMMUNOP, V149, P76, DOI 10.1016/j.vetimm.2012.06.009; Fernandez-Pinero J, 2009, RES VET SCI, V86, P353, DOI 10.1016/j.rvsc.2008.07.015; Gibbens N, 2012, VET REC, V170, P58, DOI 10.1136/vr.e292; Guthrie AJ, 2013, J VIROL METHODS, V189, P30, DOI 10.1016/j.jviromet.2012.12.014; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; Hamblin C, 1998, ARCH VIROL, P37; HAMBLIN C, 1991, J VIROL METHODS, V31, P285, DOI 10.1016/0166-0934(91)90166-W; HAMBLIN C, 1990, EPIDEMIOL INFECT, V104, P303, DOI 10.1017/S0950268800059483; Hoffmann B, 2009, J CLIN MICROBIOL, V47, P2992, DOI 10.1128/JCM.00599-09; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; House C, 1990, J Vet Diagn Invest, V2, P44; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; Jimenez-Clavero MA, 2006, J VET DIAGN INVEST, V18, P7, DOI 10.1177/104063870601800103; Koekemoer JJO, 2000, J VIROL METHODS, V88, P135, DOI 10.1016/S0166-0934(00)00191-9; Koekemoer JJO, 2004, J VIROL METHODS, V122, P49, DOI 10.1016/j.jviromet.2004.08.002; Kweon CH, 2003, J VIROL METHODS, V113, P13, DOI 10.1016/S0166-0934(03)00217-9; LAVIADA MD, 1992, J VIROL METHODS, V38, P229, DOI 10.1016/0166-0934(92)90113-R; LeBlanc N, 2010, J VIROL METHODS, V167, P165, DOI 10.1016/j.jviromet.2010.03.032; Lubroth J., 1988, Equine Practice, V10, P26; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025686; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; McINTOSH B. M., 1958, ONDERSTEPOORT JOUR VET RES, V27, P465; McINTOSH B. M., 1956, ONDERSTEPOORT JOUR VET RES, V27, P165; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mertens P. P. C., 2014, REOID PHYLOGENETIC S; Mertens PPC, 2009, BIOL ANIM INFECT, P101, DOI 10.1016/B978-012369368-6.50010-1; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; MIZUKOSHI N, 1994, J VET MED SCI, V56, P347, DOI 10.1292/jvms.56.347; Monaco F, 2011, MOL CELL PROBE, V25, P87, DOI 10.1016/j.mcp.2011.01.006; O'Hara RS, 1998, ARCH VIROL, P259; OIE, 2008, SUMM IMM NOT FOLL UP; OIE, 2007, SUMM IMM NOT FOLL UP; OIE, 2011, TERR AN HLTH COD; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Potgieter AC, 2003, J GEN VIROL, V84, P1317, DOI 10.1099/vir.0.18919-0; ProMED-mail, 2008, AFR HORS SICKN ETH 0; ProMED-mail, 2007, AFR HORS SICKN SEN S; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2010, J VIROL METHODS, V167, P45, DOI 10.1016/j.jviromet.2010.03.009; R Core Team, 2021, R LANG ENV STAT COMP; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Rodriguez-Sanchez B, 2008, J VIROL METHODS, V151, P87, DOI 10.1016/j.jviromet.2008.03.029; Saeed MF, 2001, J GEN VIROL, V82, P2173, DOI 10.1099/0022-1317-82-9-2173; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sailleau C, 2000, J GEN VIROL, V81, P831, DOI 10.1099/0022-1317-81-3-831; Sanchez-Vizcaino JM, 2004, DEV BIOLOGICALS, V119, P255; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STONEMARSCHAT M, 1994, J CLIN MICROBIOL, V32, P697, DOI 10.1128/JCM.32.3.697-700.1994; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Veronesi E, 2012, TEMPERATURE STRAIN R; von Teichman BF, 2010, VACCINE, V28, P6505, DOI 10.1016/j.vaccine.2010.06.105; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; Yin HQ, 2010, J VIROL METHODS, V168, P237, DOI 10.1016/j.jviromet.2010.04.018; ZIENTARA S, 1993, VET RES, V24, P385	78	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93758	10.1371/journal.pone.0093758	http://dx.doi.org/10.1371/journal.pone.0093758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721971	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100023
J	Perfetti, A; Greco, S; Fasanaro, P; Bugiardini, E; Cardani, R; Manteiga, JMG; Riba, M; Cittaro, D; Stupka, E; Meola, G; Martelli, F				Perfetti, Alessandra; Greco, Simona; Fasanaro, Pasquale; Bugiardini, Enrico; Cardani, Rosanna; Manteiga, Jose M. Garcia; Riba, Michela; Cittaro, Davide; Stupka, Elia; Meola, Giovanni; Martelli, Fabio			Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SKELETAL-MUSCLE; MESSENGER-RNA; ISOCITRATE DEHYDROGENASE; GENE-EXPRESSION; MICROARRAY DATA; ALPHA-SUBUNIT; MOUSE MODELS; NUCLEAR FOCI; RECEPTOR	Myotonic dystrophy type 2 (DM2) is a genetic, autosomal dominant disease due to expansion of tetraplet (CCTG) repetitions in the first intron of the ZNF9/CNBP gene. DM2 is a multisystemic disorder affecting the skeletal muscle, the heart, the eye and the endocrine system. According to the proposed pathological mechanism, the expanded tetraplets have an RNA toxic effect, disrupting the splicing of many mRNAs. Thus, the identification of aberrantly spliced transcripts is instrumental for our understanding of the molecular mechanisms underpinning the disease. The aim of this study was the identification of new aberrant alternative splicing events in DM2 patients. By genome wide analysis of 10 DM2 patients and 10 controls (CTR), we identified 273 alternative spliced exons in 218 genes. While many aberrant splicing events were already identified in the past, most were new. A subset of these events was validated by qPCR assays in 19 DM2 and 15 CTR subjects. To gain insight into the molecular pathways involving the identified aberrantly spliced genes, we performed a bioinformatics analysis with Ingenuity system. This analysis indicated a deregulation of development, cell survival, metabolism, calcium signaling and contractility. In conclusion, our genome wide analysis provided a database of aberrant splicing events in the skeletal muscle of DM2 patients. The affected genes are involved in numerous pathways and networks important for muscle physio-pathology, suggesting that the identified variants may contribute to DM2 pathogenesis.	[Perfetti, Alessandra; Greco, Simona; Martelli, Fabio] IRCCS Policlin San Donato, Mol Cardiol Lab, Milan, Italy; [Fasanaro, Pasquale] IRCCS Fdn Santa Lucia, Rome, Italy; [Bugiardini, Enrico; Meola, Giovanni] Univ Milan, Dept Neurol, IRCCS Policlin San Donato, Milan, Italy; [Manteiga, Jose M. Garcia; Riba, Michela; Cittaro, Davide; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Cardani, Rosanna; Meola, Giovanni] IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Santa Lucia; IRCCS Policlinico San Donato; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Policlinico San Donato	Martelli, F (corresponding author), IRCCS Policlin San Donato, Mol Cardiol Lab, Milan, Italy.	fabio.martelli@grupposandonato.it	cardani, rosanna/ABH-6525-2020; greco, simona/AAD-3211-2021; Cittaro, Davide/K-2405-2018; Manteiga, Jose Manuel Garcia/AAN-1954-2020; Riba, Michela/AAG-8955-2019; Martelli, Fabio/AAL-3788-2020; Perfetti, Alessandra/O-4849-2019; Perfetti, Alessandra/J-8166-2016; Meola, Giovanni/K-4775-2016; greco, simona/J-5374-2016	cardani, rosanna/0000-0001-8858-4327; greco, simona/0000-0002-0275-7221; Cittaro, Davide/0000-0003-0384-3700; Manteiga, Jose Manuel Garcia/0000-0002-5481-040X; Martelli, Fabio/0000-0002-8624-7738; Perfetti, Alessandra/0000-0001-9514-9032; Perfetti, Alessandra/0000-0001-9514-9032; Meola, Giovanni/0000-0001-6396-717X; greco, simona/0000-0002-0275-7221; riba, michela/0000-0003-4857-2027; Stupka, Elia/0000-0003-3154-4011; bugiardini, enrico/0000-0002-9709-6699	Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro [AIRC IG-11436]	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro (Grant AIRC IG-11436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachinski LL, 2013, NEUROMUSCUL DISORD; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROOK, 1992, CELL, V69, P385; Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Geller SC, 2003, BIOINFORMATICS, V19, P1817, DOI 10.1093/bioinformatics/btg245; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; Greco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039732; Harmon EB, 2011, J BIOL CHEM, V286, P40296, DOI 10.1074/jbc.M111.241455; Harper P S, 2002, Neuromuscul Disord, V12, P596, DOI 10.1016/S0960-8966(02)00020-2; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Klein AF, 2011, BIOCHIMIE, V93, P2006, DOI 10.1016/j.biochi.2011.06.028; Koebis M, 2011, GENES CELLS, V16, P961, DOI 10.1111/j.1365-2443.2011.01542.x; Kwiatkowski AP, 2000, ARCH BIOCHEM BIOPHYS, V378, P377, DOI 10.1006/abbi.2000.1846; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; McKeown CR, 2006, DEV DYNAM, V235, P530, DOI 10.1002/dvdy.20633; Nakamori Masayuki, 2013, ANN NEUROL; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; Ohsawa N, 2011, BIOCHEM BIOPH RES CO, V409, P64, DOI 10.1016/j.bbrc.2011.04.106; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Sicot G, 2011, HUM MOL GENET, V20, pR116, DOI 10.1093/hmg/ddr343; Singer HA, 1997, J BIOL CHEM, V272, P9393; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soundar S, 2003, J BIOL CHEM, V278, P52146, DOI 10.1074/jbc.M306178200; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sugnet C W, 2004, Pac Symp Biocomput, P66; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Timchenko L, 2013, INT J BIOCHEM CELL B, V45, P2280, DOI 10.1016/j.biocel.2013.06.010; Tombes RM, 1997, BBA-MOL CELL RES, V1355, P281, DOI 10.1016/S0167-4889(96)00141-3; Udd B, 2011, Neuromuscul Disord, V21, P443, DOI 10.1016/j.nmd.2011.03.013; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Ursu Simona-Felicia, 2012, Acta Myol, V31, P144; Vihola A, 2013, NEUROPATH APPL NEURO, V39, P390, DOI 10.1111/j.1365-2990.2012.01289.x; Vihola A, 2010, ACTA NEUROPATHOL, V119, P465, DOI 10.1007/s00401-010-0637-6; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weigand JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042697; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299	68	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93983	10.1371/journal.pone.0093983	http://dx.doi.org/10.1371/journal.pone.0093983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722564	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100033
J	Roulin, AC; Wu, M; Pichon, S; Arbore, R; Kuhn-Buhlmann, S; Kolliker, M; Walser, JC				Roulin, Anne C.; Wu, Min; Pichon, Samuel; Arbore, Roberto; Kuehn-Buehlmann, Simone; Koelliker, Mathias; Walser, Jean-Claude			De Novo Transcriptome Hybrid Assembly and Validation in the European Earwig (Dermaptera, Forficula auricularia)	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; GENOME; CLASSIFICATION; POPULATION; PHYLOGENY; DATABASE; ORDERS; GENES; LIFE; CARE	Background: The European earwig (Forficula auricularia) is an established system for studies of sexual selection, social interactions and the evolution of parental care. Despite its scientific interest, little knowledge exists about the species at the genomic level, limiting the scope of molecular studies and expression analyses of genes of interest. To overcome these limitations, we sequenced and validated the transcriptome of the European earwig. Methodology and Principal Findings: To obtain a comprehensive transcriptome, we sequenced mRNA from various tissues and developmental stages of female and male earwigs using Roche 454 pyrosequencing and Illumina HiSeq. The reads were de novo assembled independently and screened for possible microbial contamination and repeated elements. The remaining contigs were combined into a hybrid assembly and clustered to reduce redundancy. A comparison with the eukaryotic core gene dataset indicates that we sequenced a substantial part of the earwig transcriptome with a low level of fragmentation. In addition, a comparative analysis revealed that more than 8,800 contigs of the hybrid assembly show significant similarity to insect-specific proteins and those were assigned for Gene Ontology terms. Finally, we established a quantitative PCR test for expression stability using commonly used housekeeping genes and applied the method to five homologs of known sex-biased genes of the honeybee. The qPCR pilot study confirmed sex specific expression and also revealed significant expression differences between the brain and antenna tissue samples. Conclusions: By employing two different sequencing approaches and including samples obtained from different tissues, developmental stages, and sexes, we were able to assemble a comprehensive transcriptome of F. auricularia. The transcriptome presented here offers new opportunities to study the molecular bases and evolution of parental care and sociality in arthropods.	[Roulin, Anne C.; Wu, Min; Pichon, Samuel; Arbore, Roberto; Kuehn-Buehlmann, Simone; Koelliker, Mathias; Walser, Jean-Claude] Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland; [Walser, Jean-Claude] ETH, GDC, Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Walser, JC (corresponding author), Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland.	jean-claude.walser@env.ethz.ch	PICHON, Samuel/C-4031-2013	PICHON, Samuel/0000-0002-7161-9666; Walser, Jean-Claude/0000-0003-1513-0783; Arbore, Roberto/0000-0002-1987-0474; Roulin, Anne/0000-0002-6668-3321; Wu, Min/0000-0002-4059-1234	Fonds zur Forderung von Lehre und Forschung, Freie Akademische Gesellschaft (FAG) Basel, Switzerland	Fonds zur Forderung von Lehre und Forschung, Freie Akademische Gesellschaft (FAG) Basel, Switzerland	The transcriptome analysis of the European earwig was supported by the Fonds zur Forderung von Lehre und Forschung, Freie Akademische Gesellschaft (FAG) Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R FDN STAT COMP; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BIGOT Y, 1994, P NATL ACAD SCI USA, V91, P3408, DOI 10.1073/pnas.91.8.3408; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cornman RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-285; Costa J., 2006, OTHER INSECT SOC; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.1111/j.1558-5646.1991.tb05262.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel MS, 2004, J PALEONTOL, V78, P1018, DOI 10.1666/0022-3360(2004)078<1018:APEICA>2.0.CO;2; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Honeybee Genome Sequencing Consortium, 2007, NATURE, V443, P931; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2013, BIOINFORMATICS; Jarvis KJ, 2005, SYST ENTOMOL, V30, P442, DOI 10.1111/j.1365-3113.2004.00276.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krieger MJB, 2003, INSECT MOL BIOL, V12, P155, DOI 10.1046/j.1365-2583.2003.00397.x; LAMB RJ, 1976, CAN ENTOMOL, V108, P609, DOI 10.4039/Ent108609-6; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Latos PA, 2010, RNA BIOL, V6, P100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin M, 2011, CUTADAPT REMOVES ADA; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Meunier J, 2012, BIOL LETTERS, V8, P547, DOI 10.1098/rsbl.2012.0151; Meunier J, 2012, EVOL ECOL, V26, P669, DOI 10.1007/s10682-011-9510-x; Moerkens R, 2011, AGR FOREST ENTOMOL, V13, P301, DOI 10.1111/j.1461-9563.2011.00525.x; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBERTSON HM, 1995, ANNU REV ENTOMOL, V40, P333, DOI 10.1146/annurev.en.40.010195.002001; Sueldo MR, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3801; S iBoos, 2014, BEHAV ECOLO IN PRESS; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simon S, 2012, GENOME BIOL EVOL, V4, P1295, DOI 10.1093/gbe/evs104; Smit AFA., REPEATMODELER OPEN 1; Tomkins JL, 2004, NATURE, V431, P1099, DOI 10.1038/nature02918; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wong JWY, 2012, ETHOLOGY, V118, P450, DOI 10.1111/j.1439-0310.2012.02030.x; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Zayed A, 2012, GENES BRAIN BEHAV, V11, P253, DOI 10.1111/j.1601-183X.2011.00750.x; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303	55	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94098	10.1371/journal.pone.0094098	http://dx.doi.org/10.1371/journal.pone.0094098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722757	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100039
J	Wang, J; Zhang, HZ; Su, CL; Chen, JJ; Zhu, BL; Zhang, HD; Xiao, H; Zhang, JS				Wang, Jun; Zhang, Huazhong; Su, Chenglei; Chen, Junjie; Zhu, Baoli; Zhang, Hengdong; Xiao, Hang; Zhang, Jinsong			Dexamethasone Ameliorates H2S-Induced Acute Lung Injury by Alleviating Matrix Metalloproteinase-2 and-9 Expression	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HYDROGEN-SULFIDE TOXICITY; BRONCHOALVEOLAR LAVAGE FLUID; SPRAGUE-DAWLEY RATS; DOXYCYCLINE; INHIBITION; CELLS; EXPOSURE; LIPOPOLYSACCHARIDE; CORTICOSTEROIDS	Acute lung injury (ALI) is one of the fatal outcomes after exposure to high levels of hydrogen sulfide (H2S), and the matrix metalloproteinases (MMPs) especially MMP-2 and MMP-9 are believed to be involved in the development of ALI by degrading the extracellular matrix (ECM) of blood-air barrier. However, the roles of MMP-2 and MMP-9 in H2S-induced ALI and the mechanisms of dexamethasone (DXM) in treating ALI in clinical practice are still largely unknown. The present work was aimed to investigate the roles of MMP-2 and MMP-9 in H2S-induced ALI and the protective effects of DXM. In our study, SD rats were exposed to H2S to establish the ALI model and in parallel, A549 cells were incubated with NaHS (a H2S donor) to establish cell model. The lung HE staining, immunohistochemisty, electron microscope assay and wet/dry ratio were used to identify the ALI induced by H2S, then the MMP-2 and MMP-9 expression in both rats and A549 cells were detected. Our results revealed that MMP-2 and MMP-9 were obviously increased in both mRNA and protein level after H2S exposure, and they could be inhibited by MMP inhibitor doxycycline (DOX) in rat model. Moreover, DXM significantly ameliorated the symptoms of H2S-induced ALI including alveolar edema, infiltration of inflammatory cells and the protein leakage in BAFL via up-regulating glucocorticoid receptor(GR) to mediate the suppression of MMP-2 and MMP-9. Furthermore, the protective effects of DXM in vivo and vitro study could be partially blocked by co-treated with GR antagonist mifepristone (MIF). Our results, taken together, demonstrated that MMP-2 and MMP-9 were involved in the development of H2S-induced ALI and DXM exerted protective effects by alleviating the expression of MMP-2 and MMP-9. Therefore, MMP-2 and MMP-9 might represent novel pharmacological targets for the treatment of H2S and other hazard gases induced ALI.	[Zhang, Huazhong; Su, Chenglei; Chen, Junjie; Zhang, Jinsong] Nanjing Med Univ, Affiliated Hosp 1, Dept Emergency Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jun; Xiao, Hang] Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhu, Baoli; Zhang, Hengdong] Jiangsu Prov Ctr Dis Prevent & Control, Dept Occupat Dis Prophylacticotherapet Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xiao, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China.	hxiao@njmu.edu.cn; zhangjsojz@163.com			Medical Innovation Team Foundation of Jiangsu Province [LJ201122]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Medical Innovation Team Foundation of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Medical Innovation Team Foundation of Jiangsu Province (LJ201122) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bertorelli G, 2008, PULM PHARMACOL THER, V21, P214, DOI 10.1016/j.pupt.2007.03.001; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Corbel M, 1999, PULM PHARMACOL THER, V12, P165, DOI 10.1006/pupt.1999.0178; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Dong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039695; Dongo K, 2012, ENVIRON SCI POLLUT R, V19, P3192, DOI 10.1007/s11356-012-0823-2; Dorman DC, 2000, NEUROTOXICOL TERATOL, V22, P71, DOI 10.1016/S0892-0362(99)00055-0; Dorman DC, 2002, TOXICOL SCI, V65, P18, DOI 10.1093/toxsci/65.1.18; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Fujita M, 2007, PULM PHARMACOL THER, V20, P669, DOI 10.1016/j.pupt.2006.08.006; Garvican ER, 2010, J ORTHOP RES, V28, P370, DOI 10.1002/jor.21001; Guney S, 2007, AM J PHYSIOL-LUNG C, V293, pL1332, DOI 10.1152/ajplung.00338.2006; Gushima Y, 2001, EUR RESPIR J, V18, P827, DOI 10.1183/09031936.01.00049201; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Haouzi P, 2012, RESP PHYSIOL NEUROBI, V184, P170, DOI 10.1016/j.resp.2012.05.002; He Dai-Kun, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P289; Kanno S, 2013, ARCH TOXICOL, V87, P1245, DOI 10.1007/s00204-013-1027-3; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; Liu XJ, 2008, BRAIN RES, V1207, P237, DOI 10.1016/j.brainres.2008.01.106; LOPEZ A, 1988, VET PATHOL, V25, P376, DOI 10.1177/030098588802500507; Maghni K, 2010, ALLERGY, V65, P722, DOI 10.1111/j.1398-9995.2009.02256.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Moon A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-31; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Nogue S, 2011, OCCUP MED-OXFORD, V61, P212, DOI 10.1093/occmed/kqr021; Oesterhelweg L, 2008, INT J LEGAL MED, V122, P101, DOI 10.1007/s00414-007-0172-8; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Pirrone F, 2009, VET RES COMMUN, V33, pS121, DOI 10.1007/s11259-009-9255-y; PRIOR M, 1990, TOXICOL PATHOL, V18, P279, DOI 10.1177/019262339001800206; PRIOR MG, 1988, CAN J VET RES, V52, P375; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Shivanthan MC, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-9; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; Struve MF, 2001, NEUROTOXICOLOGY, V22, P375, DOI 10.1016/S0161-813X(01)00021-3; TAMAOKI J, 1995, AM J RESP CRIT CARE, V151, P1582, DOI 10.1164/ajrccm.151.5.7735618; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; Umberto Meduri Gianfranco, 2011, Presse Med, V40, pe543, DOI 10.1016/j.lpm.2011.04.023; Wang DL, 2011, BRAIN BEHAV IMMUN, V25, P706, DOI 10.1016/j.bbi.2011.01.011; Warner RL, 2001, AM J PATHOL, V158, P2139, DOI 10.1016/S0002-9440(10)64685-8; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Wei N, 2013, J ORTHOP RES, V31, P760, DOI 10.1002/jor.22298; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yalamanchili C, 2008, AM J EMERG MED, V26; Yang Zhi-hui, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P466	55	20	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94701	10.1371/journal.pone.0094701	http://dx.doi.org/10.1371/journal.pone.0094701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722316	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100125
J	Mailloux, RJ; Xuan, JY; McBride, S; Maharsy, W; Thorn, S; Holterman, CE; Kennedy, CRJ; Rippstein, P; deKemp, R; da Silva, J; Nemer, M; Lou, M; Harper, ME				Mailloux, Ryan J.; Xuan, Jian Ying; McBride, Skye; Maharsy, Wael; Thorn, Stephanie; Holterman, Chet E.; Kennedy, Christopher R. J.; Rippstein, Peter; deKemp, Robert; da Silva, Jean; Nemer, Mona; Lou, Marjorie; Harper, Mary-Ellen			Glutaredoxin-2 Is Required to Control Oxidative Phosphorylation in Cardiac Muscle by Mediating Deglutathionylation Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; COMPLEX-I; REDOX REGULATION; REVERSIBLE GLUTATHIONYLATION; PROTEIN GLUTATHIONYLATION; S-GLUTATHIONYLATION; THIOL PROTEINS; POTENTIAL ROLE; CYS RESIDUES; MECHANISMS	Glutaredoxin-2 (Grx2) modulates the activity of several mitochondrial proteins in cardiac tissue by catalyzing deglutathionylation reactions. However, it remains uncertain whether Grx2 is required to control mitochondrial ATP output in heart. Here, we report that Grx2 plays a vital role modulating mitochondrial energetics and heart physiology by mediating the deglutathionylation of mitochondrial proteins. Deletion of Grx2 (Grx2(-/-)) decreased ATP production by complex I-linked substrates to half that in wild type (WT) mitochondria. Decreased respiration was associated with increased complex I glutathionylation diminishing its activity. Tissue glucose uptake was concomitantly increased. Mitochondrial ATP output and complex I activity could be recovered by restoring the redox environment to that favoring the deglutathionylated states of proteins. Grx2(-/-) hearts also developed left ventricular hypertrophy and fibrosis, and mice became hypertensive. Mitochondrial energetics from Grx2 heterozygotes (Grx2(+/-)) were also dysfunctional, and hearts were hypertrophic. Intriguingly, Grx2(+/-) mice were far less hypertensive than Grx2(-/-) mice. Thus, Grx2 plays a vital role in modulating mitochondrial metabolism in cardiac muscle, and Grx2 deficiency leads to pathology. As mitochondrial ATP production was restored by the addition of reductants, these findings may be relevant to novel redox-related therapies in cardiac disease.	[Mailloux, Ryan J.; Xuan, Jian Ying; McBride, Skye; Maharsy, Wael; Nemer, Mona; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Thorn, Stephanie; Rippstein, Peter; deKemp, Robert; da Silva, Jean] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Holterman, Chet E.; Kennedy, Christopher R. J.] Ottawa Gen Hosp, Kidney Res Ctr, Res Inst, Ottawa, ON K1H 8L6, Canada; [Lou, Marjorie] Univ Nebraska, Ctr Redox Biol, Lincoln, NE 68583 USA; [Lou, Marjorie] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Harper, ME (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca	Thorn, Stephanie/AAD-6988-2022	Mailloux, Ryan/0000-0003-3986-9830; Holterman, Chet/0000-0002-9002-6073; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research [INMD MOP57810]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant INMD MOP57810 (to M. E. H.).	Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Diotte NM, 2009, BBA-MOL CELL RES, V1793, P427, DOI 10.1016/j.bbamcr.2008.10.014; Drose S, 2014, BBA-PROTEINS PROTEOM, V1844, P1344, DOI 10.1016/j.bbapap.2014.02.006; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Giangregorio N, 2013, BBA-GEN SUBJECTS, V1830, P5299, DOI 10.1016/j.bbagen.2013.08.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kang PT, 2012, FREE RADICAL BIO MED, V53, P962, DOI 10.1016/j.freeradbiomed.2012.05.025; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kumar V, 2013, FREE RADICAL BIO MED, V58, P109, DOI 10.1016/j.freeradbiomed.2013.01.021; Lee DW, 2009, ANTIOXID REDOX SIGN, V11, P2083, DOI [10.1089/ars.2009.2489, 10.1089/ARS.2009.2489]; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Passarelli C, 2010, INT J MOL MED, V26, P95, DOI 10.3892/ijmm_00000439; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Schagger H, 2001, J BIOL CHEM, V276, P37861; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Taegtmeyer H, 2002, CIRCULATION, V106, P2043, DOI 10.1161/01.CIR.0000036760.42319.3F; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578	63	70	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14812	14828		10.1074/jbc.M114.550574	http://dx.doi.org/10.1074/jbc.M114.550574			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727547	Green Published, hybrid			2022-12-25	WOS:000337248100036
J	King, IN; Yartseva, V; Salas, D; Kumar, A; Heidersbach, A; Ando, DM; Stallings, NR; Elliott, JL; Srivastava, D; Ivey, KN				King, Isabelle N.; Yartseva, Valeria; Salas, Donaldo; Kumar, Abhishek; Heidersbach, Amy; Ando, D. Michael; Stallings, Nancy R.; Elliott, Jeffrey L.; Srivastava, Deepak; Ivey, Kathryn N.			The RNA-binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-induced Silencing Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac muscle; Gene Regulation; MicroRNA; RNA-binding Protein; RNA-Protein Interaction; Skeletal Muscle	AMYOTROPHIC-LATERAL-SCLEROSIS; MUSCLE; DIFFERENTIATION; PROLIFERATION; EXPRESSION; PROMOTES; MIR-1; HEART; MICE; CARDIOGENESIS	Background: Regulation of microRNA activity independent of processing and biogenesis has not been demonstrated. Results: The RNA-binding protein, TDP-43, interacts with mature miR-1/miR-206, limiting their RNA-induced silencing complex (RISC) association and activity. Conclusion: RNA-binding proteins can selectively control microRNA activity by disrupting RISC incorporation. Significance: This is the first known microRNA-protein interaction that controls microRNA activity independent of processing. MicroRNA (miRNA) maturation is regulated by interaction of particular miRNA precursors with specific RNA-binding proteins. Following their biogenesis, mature miRNAs are incorporated into the RNA-induced silencing complex (RISC) where they interact with mRNAs to negatively regulate protein production. However, little is known about how mature miRNAs are regulated at the level of their activity. To address this, we screened for proteins differentially bound to the mature form of the miR-1 or miR-133 miRNA families. These muscle-enriched, co-transcribed miRNA pairs cooperate to suppress smooth muscle gene expression in the heart. However, they also have opposing roles, with the miR-1 family, composed of miR-1 and miR-206, promoting myogenic differentiation, whereas miR-133 maintains the progenitor state. Here, we describe a physical interaction between TDP-43, an RNA-binding protein that forms aggregates in the neuromuscular disease, amyotrophic lateral sclerosis, and the miR-1, but not miR-133, family. Deficiency of the TDP-43 Drosophila ortholog enhanced dmiR-1 activity in vivo. In mammalian cells, TDP-43 limited the activity of both miR-1 and miR-206, but not the miR-133 family, by disrupting their RISC association. Consistent with TDP-43 dampening miR-1/206 activity, protein levels of the miR-1/206 targets, IGF-1 and HDAC4, were elevated in TDP-43 transgenic mouse muscle. This occurred without corresponding Igf-1 or Hdac4 mRNA increases and despite higher miR-1 and miR-206 expression. Our findings reveal that TDP-43 negatively regulates the activity of the miR-1 family of miRNAs by limiting their bioavailability for RISC loading and suggest a processing-independent mechanism for differential regulation of miRNA activity.	[King, Isabelle N.; Yartseva, Valeria; Salas, Donaldo; Kumar, Abhishek; Heidersbach, Amy; Srivastava, Deepak; Ivey, Kathryn N.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ando, D. Michael] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [King, Isabelle N.; Srivastava, Deepak; Ivey, Kathryn N.] Univ Calif San Francisco, Dept Pediat, Grad Program, San Francisco, CA 94158 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, Grad Program, San Francisco, CA 94158 USA; [Heidersbach, Amy; Ando, D. Michael] Univ Calif San Francisco, Dept Biomed Sci, Grad Program, San Francisco, CA 94158 USA; [Stallings, Nancy R.; Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75235 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ivey, KN (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	kivey@gladstone.ucsf.edu		Stallings, Nancy/0000-0001-6132-1586; Srivastava, Deepak/0000-0002-3480-5953; Ando, Michael/0000-0001-9022-8444	National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant [P41GM103481]; March of Dimes; National Science Foundation; National Institutes of Health/NHLBI Grant [R01HL057181]; William Younger Family Foundation; L. K. Whittier Foundation; Eugene Roddenberry Foundation; American Heart Association [11SDG5190024]; Amyotrophic Lateral Sclerosis Association [679Y22]; National Institutes of Health/National Center for Research Resources Grant [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant; March of Dimes(March of Dimes); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NHLBI Grant; William Younger Family Foundation; L. K. Whittier Foundation; Eugene Roddenberry Foundation; American Heart Association(American Heart Association); Amyotrophic Lateral Sclerosis Association; National Institutes of Health/National Center for Research Resources Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant P41GM103481 to the UCSF Mass Spectrometry Facility; The March of Dimes (to I. N. K.); the National Science Foundation (to A. H.); the National Institutes of Health/NHLBI Grant R01HL057181 (to D. S.); the William Younger Family Foundation (to D. S.); the L. K. Whittier Foundation (to D. S.); the Eugene Roddenberry Foundation (to D. S.); the American Heart Association Grant 11SDG5190024 (to K. N. I.); the Amyotrophic Lateral Sclerosis Association Grant 679Y22 (to K. N. I.); and the National Institutes of Health/National Center for Research Resources Grant RR18928 to The Gladstone Institutes.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bruneteau G, 2013, BRAIN, V136, P2359, DOI 10.1093/brain/awt164; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; Darnell Robert, 2012, Cold Spring Harb Protoc, V2012, P1146, DOI 10.1101/pdb.prot072132; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Gagan J, 2012, CURR OPIN PHARMACOL, V12, P383, DOI 10.1016/j.coph.2012.02.001; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; King IN, 2011, DEV CELL, V20, P497, DOI 10.1016/j.devcel.2011.03.010; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wei YS, 2014, CELL RES, V24, P278, DOI 10.1038/cr.2014.12; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	29	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14263	14271		10.1074/jbc.M114.561902	http://dx.doi.org/10.1074/jbc.M114.561902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719334	Green Published, hybrid			2022-12-25	WOS:000335984600051
J	Enos, RT; Velazquez, KT; McClellan, JL; Cranford, TL; Walla, MD; Murphy, EA				Enos, Reilly T.; Velazquez, Kandy T.; McClellan, Jamie L.; Cranford, Taryn L.; Walla, Michael D.; Murphy, E. Angela			Reducing the Dietary Omega-6: Omega-3 Utilizing alpha-Linolenic Acid; Not a Sufficient Therapy for Attenuating High-Fat-Diet-Induced Obesity Development Nor Related Detrimental Metabolic and Adipose Tissue Inflammatory Outcomes	PLOS ONE			English	Article							INSULIN-RESISTANCE; EVOLUTIONARY ASPECTS; MACROPHAGE; GPR120; OMEGA-3-FATTY-ACIDS; CONTRIBUTES; DISEASES; HEALTH; MICE	Aims: To examine the effect of manipulating the omega-6:omega-3 (1:1, 5:1, 10:1, and 20:1) utilizing only alpha-linolenic and linoleic acid within a clinically-relevant high-fat diet (HFD) composed of up to seven sources of fat and designed to be similar to the standard American diet (MUFA:PUFA of 2:1, 12% and 40% of calories from saturated and total fat, respectively) on body composition, macrophage polarization, inflammation, and metabolic dysfunction in mice. Methods: Diets were administered for 20 weeks. Body composition and metabolism (HOMA index and lipid profile) were examined monthly. GC-MS was utilized to determine the eicosapentaenoic acid (EPA):arachidonic acid (AA) and the docosahexaenoic acid (DHA):AA in AT phospholipids. Adipose tissue (AT) mRNA expression of chemokines (MCP-1, Fetuin-A, CXCL14), marker genes for M1 and M2 macrophages (CD11c and CD206, respectively) and inflammatory markers (TNF-alpha, IL-6, IL-1 beta, TLR-2, TLR-4, IL-10, GPR120) were measured along with activation of NF kappa B, JNK, and STAT-3. Macrophage infiltration into AT was examined using F4/80 immunohistochemistry. Results: Any therapeutic benefit produced by reducing the omega-6:omega-3 was evident only when comparing the 1:1 to 20:1 HFD; the 1:1 HFD resulted in a lower TC:HDL-C and decreased AT CXCL14 gene expression and AT macrophage infiltration, which was linked to a higher EPA: AA and DHA: AA in AT phospholipids. However, despite these effects, and independent of the omega-6:omega-3, all HFDs, in general, led to similar levels of adiposity, insulin resistance, and AT inflammation. Conclusion: Reducing the omega-6:omega-3 using alpha-linolenic acid is not an effective therapy for attenuating obesity and type II diabetes mellitus development.	[Enos, Reilly T.; Velazquez, Kandy T.; McClellan, Jamie L.; Cranford, Taryn L.; Murphy, E. Angela] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Walla, Michael D.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Murphy, EA (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Angela.Murphy@uscmed.sc.edu	Enos, Reilly/AFO-4814-2022; Biguzzi, Felipe A/E-4724-2015	Enos, Reilly/0000-0001-5571-4586; 	National Cancer Institute [R21CA167058]; National Center for Complementary and Alternative Medicine [K01AT007824]; National Institute of General Medical Sciences [P20GM103641]; University of South Carolina Advanced Support Programs for Innovative Research Excellence (ASPIRE); NATIONAL CANCER INSTITUTE [R21CA167058] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K01AT007824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641, R25GM066526, R25GM076277] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of South Carolina Advanced Support Programs for Innovative Research Excellence (ASPIRE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Cancer Institute (R21CA167058), the National Center for Complementary and Alternative Medicine (K01AT007824), the National Institute of General Medical Sciences (P20GM103641), and the University of South Carolina Advanced Support Programs for Innovative Research Excellence (ASPIRE) to E. A. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Chatterjee P, 2013, J BIOL CHEM, V288, P28324, DOI 10.1074/jbc.C113.495473; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; CRAWFORD MA, 1968, LANCET, V1, P1329; Eaton SB, 1998, WORLD REV NUTR DIET, V83, P12; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganesan B, 2014, CRIT REV FOOD SCI, V54, P98, DOI 10.1080/10408398.2011.578221; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Grotto D, 2010, NUTR CLIN PRACT, V25, P603, DOI 10.1177/0884533610386234; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim W, 2010, PROSTAG LEUKOTR ESS, V82, P155, DOI 10.1016/j.plefa.2010.02.028; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Lawrence VJ, 2004, CLIN DERMATOL, V22, P296, DOI 10.1016/j.clindermatol.2004.01.012; LEYTON J, 1987, BRIT J NUTR, V57, P383, DOI 10.1079/BJN19870046; Madsen L, 2012, ADIPOCYTE, V1, P173, DOI 10.4161/adip.20689; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Patterson E, 2011, J NUTR METAB, V2012; SAUNDERS RD, 1984, ANAL BIOCHEM, V143, P71, DOI 10.1016/0003-2697(84)90559-1; Simopoulos AP, 1999, PROSTAG LEUKOTR ESS, V60, P421, DOI 10.1016/S0952-3278(99)80023-4; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Stark AH, 2008, NUTR REV, V66, P326, DOI 10.1111/j.1753-4887.2008.00040.x; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x	30	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94897	10.1371/journal.pone.0094897	http://dx.doi.org/10.1371/journal.pone.0094897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733548	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400129
J	Luo, QG; Zhang, JY; Cheng, WW; Audibert, F; Luo, ZC				Luo, Qi-Guang; Zhang, Ji-Yan; Cheng, Wei-Wei; Audibert, Francois; Luo, Zhong-Cheng			Is Gestational Hypertension Protective against Perinatal Mortality in Twin Pregnancies?	PLOS ONE			English	Article							INFANT-MORTALITY; PREECLAMPSIA	Background: Pregnancy-induced or gestational hypertension is a common pregnancy complication. Paradoxically, gestational hypertension has been associated with a protective effect against perinatal mortality in twin pregnancies in analytic models (logistic regression) without accounting for survival time. Whether this effect is real remains uncertain. This study aimed to validate the impact of gestational hypertension on perinatal mortality in twin pregnancies using a survival analysis approach. Methods: This was a retrospective cohort study of 278,821 twin pregnancies, using the U. S. 1995-2000 matched multiple birth dataset (the largest dataset available for multiple births). Cox proportional hazard models were applied to estimate the adjusted hazard ratios (aHR) of perinatal death (stillbirth and neonatal death) comparing gestational hypertensive vs. non-hypertensive pregnancies controlling for maternal characteristics and twin cluster-level dependence. Results: Comparing births in gestational hypertensive vs. non-hypertensive twin pregnancies, perinatal mortality rates were significantly lower (1.20% vs. 3.38%), so were neonatal mortality (0.72% vs. 2.30%) and stillbirth (0.48% vs. 1.10%) rates. The aHRs (95% confidence intervals) were 0.34 (0.31-0.38) for perinatal death, 0.31 (0.27-0.34) for neonatal death, and 0.45 (0.38-0.53) for stillbirth, respectively. The protective effect of gestational hypertension against perinatal death became weaker over advancing gestational age; the aHRs in very preterm (<32 weeks), mild preterm (32-36 weeks) and term (37+weeks) births were 0.29, 0.48 and 0.76, respectively. The largest risk reductions in neonatal mortality were observed for infections and immaturity-related conditions. Conclusions: Gestational hypertension appears to be beneficial for fetal survival in twin pregnancies, especially in those ending more prematurely or for deaths due to infections and immaturity-related conditions. Prospective studies are required to rule out the possibility of unmeasured confounders.	[Luo, Qi-Guang; Zhang, Ji-Yan; Audibert, Francois; Luo, Zhong-Cheng] Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada; [Cheng, Wei-Wei] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Luo, Qi-Guang] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Minist Educ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Sch Med, Shanghai 200030, Peoples R China	Universite de Montreal; Shanghai Jiao Tong University; University of Waterloo; Shanghai Jiao Tong University	Luo, ZC (corresponding author), Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada.	zc_luo@yahoo.com	Luo, Zhong-Cheng/T-3882-2017; Audibert, François/AAL-1265-2020	Luo, Zhong-Cheng/0000-0002-1794-1312; Audibert, Francois/0000-0002-2697-3826	Canadian Institutes of Health Research [MOP 106521]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	QGL and JYZ were supported by a summer-time research studentship in a research grant from the Canadian Institutes of Health Research (grant number MOP 106521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 1995, INTRO SURVIVAL ANAL, P1; Ananth CV, 2005, ANN EPIDEMIOL, V15, P293, DOI 10.1016/j.annepidem.2004.08.007; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Arulkumaran N, 2013, BEST PRACT RES CL OB, V27, P877, DOI 10.1016/j.bpobgyn.2013.07.003; Centers for Disease Control and Prevention (CDC), NCHS CDROM SER, V20; Chen XK, 2006, HYPERTENS PREGNANCY, V25, P205, DOI 10.1080/10641950600912984; Chittacharoen Apichart, 2005, J Med Assoc Thai, V88 Suppl 2, pS69; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; Duley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001449.pub3; Fell DB, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-103; Hollegaard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056821; Krotz S, 2002, TWIN RES, V5, P8; Luo ZC, 2006, OBSTET GYNECOL, V108, P1138, DOI 10.1097/01.AOG.0000238335.61452.89; Luo ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075354; Michael CA, 1979, BR J CLIN PHARM S2, pS211S; SAS Institute, 2010, STAT AN SYST VERS 9; Solomon CG, 2006, ENDOCRIN METAB CLIN, V35, P157, DOI 10.1016/j.ecl.2005.09.003; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230	19	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94865	10.1371/journal.pone.0094865	http://dx.doi.org/10.1371/journal.pone.0094865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733364	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400124
J	Nogueira-Campos, AA; de Oliveira, LAS; Della-Maggiore, V; Esteves, PO; Rodrigues, ED; Vargas, CD				Nogueira-Campos, Anaelli Aparecida; Santos de Oliveira, Laura Alice; Della-Maggiore, Valeria; Esteves, Paula Oliveira; Rodrigues, Erika de Carvalho; Vargas, Claudia D.			Corticospinal Excitability Preceding the Grasping of Emotion-Laden Stimuli	PLOS ONE			English	Article							TRANSCRANIAL-MAGNETIC-STIMULATION; MOTOR CORTEX EXCITABILITY; INHIBITORY MECHANISMS; SPINAL REFLEXES; MODULATION; TIME; SUPPRESSION; PICTURES; ACTIVATION; READINESS	Evolutionary theories posit that emotions prime organisms for action. This study examined whether corticospinal excitability (CSE) is modulated by the emotional valence of a to-be-grasped stimulus. CSE was estimated based on the amplitude of motor evoked potentials (MEPs) elicited using transcranial magnetic stimulation (TMS) and recorded on the first dorsal interosseous (FDI) muscle. Participants were instructed to grasp (ACTION condition) or just look at (NO-ACTION condition) unpleasant, pleasant and neutral stimuli. TMS pulses were applied randomly at 500 or 250 ms before a go signal. MEP amplitudes were normalized within condition by computing a ratio for the emotion-laden stimuli by reference to the neutral stimuli. A divergent valence effect was observed in the ACTION condition, where the CSE ratio was higher during the preparation to grasp unpleasant compared to pleasant stimuli. In addition, the CSE ratio was lower for pleasant stimuli during the ACTION condition compared to the NO-ACTION condition. Altogether, these results indicate that motor preparation is selectively modulated by the valence of the stimulus to be grasped. The lower CSE for pleasant stimuli may result from the need to refrain from executing an imminent action.	[Nogueira-Campos, Anaelli Aparecida; Santos de Oliveira, Laura Alice; Esteves, Paula Oliveira; Rodrigues, Erika de Carvalho; Vargas, Claudia D.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurobiol Program, Lab Neurobiol 2, Rio De Janeiro, Brazil; [Nogueira-Campos, Anaelli Aparecida] Univ Fed Juiz de Fora, Dept Physiol, Juiz De Fora, Brazil; [Santos de Oliveira, Laura Alice; Rodrigues, Erika de Carvalho] Augusto Motta Univ Ctr, Postgrad Program Rehabil Sci, Rio De Janeiro, Brazil; [Della-Maggiore, Valeria] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Buenos Aires, DF, Argentina	Universidade Federal do Rio de Janeiro; Universidade Federal de Juiz de Fora; Centro Universitario Augusto Motta (UNISUAM); University of Buenos Aires	Vargas, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurobiol Program, Lab Neurobiol 2, Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Rodrigues, Erika/R-6007-2017; de Oliveira, Laura A S/T-2180-2017; de Carvalho Rodrigues, Erika/AAE-9445-2020; Vargas, Claudia D./A-1523-2016	Rodrigues, Erika/0000-0001-5464-2963; de Oliveira, Laura A S/0000-0002-5554-457X; de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Vargas, Claudia D./0000-0001-6202-3580; Della-Maggiore, Valeria/0000-0001-9586-4255	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [550003/2011-8, 480108/2012-9, 478537/2012-3]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/111.655/2012, E-26/110.526/2012]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Grants 550003/2011-8, 480108/2012-9 and 478537/2012-3), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Grants E-26/111.655/2012 and E-26/110.526/2012), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; BONNET M, 1995, PSYCHOPHYSIOLOGY, V32, P367, DOI 10.1111/j.1469-8986.1995.tb01219.x; Borgomaneri S, 2013, SOC COGN AFFECT NEUR; Both S, 2003, PSYCHOPHYSIOLOGY, V40, P174, DOI 10.1111/1469-8986.00019; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Bradley MM., 2000, SER AFFECTIVE SCI, P242; Brunia C. H. M., 2000, HDB PSYCHOPHYSIOLOGY, P507; Burle B, 2004, BRAIN COGNITION, V56, P153, DOI 10.1016/j.bandc.2004.06.004; Calvo MG, 2009, BEHAV RES METHODS, V41, P184, DOI 10.3758/BRM.41.1.184; Cattaneo L, 2005, P NATL ACAD SCI USA, V102, P898, DOI 10.1073/pnas.0409182102; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Cohen O, 2010, CURR OPIN NEUROBIOL, V20, P696, DOI 10.1016/j.conb.2010.09.001; Coombes SA, 2006, NEUROSCI LETT, V396, P192, DOI 10.1016/j.neulet.2005.11.048; Coombes SA, 2007, PSYCHOL SCI, V18, P938, DOI 10.1111/j.1467-9280.2007.02005.x; Coombes SA, 2007, EMOTION, V7, P275, DOI 10.1037/1528-3542.7.2.275; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Cowey A, 2001, PROG BRAIN RES, V134, P411; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; Dirnberger G, 2011, INT J PSYCHOPHYSIOL, V81, P127, DOI 10.1016/j.ijpsycho.2011.04.008; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Ferri F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013126; Grecucci A, 2009, ARCH ITAL BIOL, V147, P37, DOI 10.4449/aib.v147i1/2.755; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Hasbroucq T, 1999, ACTA PSYCHOL, V101, P243, DOI 10.1016/S0001-6918(99)00007-4; Hasbroucq T, 1997, COGNITIVE BRAIN RES, V5, P185, DOI 10.1016/S0926-6410(96)00069-9; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M, 1997, COGNITIVE NEUROSCIEN, P56; Kinoshita H, 2007, BRAIN RES, V1184, P132, DOI 10.1016/j.brainres.2007.09.059; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Marangon M, 2011, J NEUROPHYSIOL, V105, P2536, DOI 10.1152/jn.00796.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Prabhu G, 2007, J PHYSIOL-LONDON, V581, P189, DOI 10.1113/jphysiol.2006.123356; Requin J., 1991, HDB COGNITIVE PSYCHO, P357; Riehle A, 2005, FRON NEUROS, P213; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2010, IEEE ENG MED BIOL, V29, P84, DOI 10.1109/MEMB.2009.935474; de Oliveira LAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045235; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Takei T, 2005, JPN J PHYSIOL, V55, P93, DOI 10.2170/jjphysiol.R2075; Touge T, 1998, ELECTROMYOGR MOTOR C, V109, P489, DOI 10.1016/S0924-980X(98)00050-2; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; van Elswijk G, 2007, J COGNITIVE NEUROSCI, V19, P121, DOI 10.1162/jocn.2007.19.1.121; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; West GL, 2011, EXP BRAIN RES, V209, P153, DOI 10.1007/s00221-010-2508-8	60	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94824	10.1371/journal.pone.0094824	http://dx.doi.org/10.1371/journal.pone.0094824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732961	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400116
J	Sadrolhosseini, AR; Noor, ASM; Bahrami, A; Lim, HN; Talib, ZA; Mahdi, MA				Sadrolhosseini, Amir Reza; Noor, A. S. M.; Bahrami, Afarin; Lim, H. N.; Talib, Zainal Abidin; Mahdi, Mohd. Adzir			Application of Polypyrrole Multi-Walled Carbon Nanotube Composite Layer for Detection of Mercury, Lead and Iron Ions Using Surface Plasmon Resonance Technique	PLOS ONE			English	Article							POLYMER-NANOTUBE; AQUEOUS-SOLUTION; SENSOR; BIODIESEL; MEMBRANE; EXPOSURE; REMOVAL; BINDING; PB(II); CU(II)	Polypyrrole multi-walled carbon nanotube composite layers were used to modify the gold layer to measure heavy metal ions using the surface plasmon resonance technique. The new sensor was fabricated to detect trace amounts of mercury (Hg), lead (Pb), and iron (Fe) ions. In the present research, the sensitivity of a polypyrrole multi-walled carbon nanotube composite layer and a polypyrrole layer were compared. The application of polypyrrole multi-walled carbon nanotubes enhanced the sensitivity and accuracy of the sensor for detecting ions in an aqueous solution due to the binding of mercury, lead, and iron ions to the sensing layer. The Hg ion bonded to the sensing layer more strongly than did the Pb and Fe ions. The limitation of the sensor was calculated to be about 0.1 ppm, which produced an angle shift in the region of 0.3 degrees to 0.6 degrees.	[Sadrolhosseini, Amir Reza; Noor, A. S. M.; Mahdi, Mohd. Adzir] Univ Putra Malaysia, Fac Engn, Wireless & Photon Networks Res Ctr Excellence WiP, Serdang 43400, Selangor, Malaysia; [Noor, A. S. M.; Mahdi, Mohd. Adzir] Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst Engn, Serdang 43400, Selangor, Malaysia; [Bahrami, Afarin] Islamic Azad Univ, Eslamshahr Branch, Fac Sci, Tehran, Iran; [Lim, H. N.] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Lim, H. N.] Univ Putra Malaysia, Inst Adv Technol, Funct Device Lab, Serdang 43400, Selangor, Malaysia; [Talib, Zainal Abidin] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Islamic Azad University; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Sadrolhosseini, AR (corresponding author), Univ Putra Malaysia, Fac Engn, Wireless & Photon Networks Res Ctr Excellence WiP, Serdang 43400, Selangor, Malaysia.	amir1348@gmail.com; ashukri@upm.edu.my	Bahrami, Afarin/F-1229-2016; Lim, HN/C-4927-2011; bin muhammad noor, ahmad shukri/H-3844-2016; MAHDI, MOHD ADZIR/AAH-6171-2021; BIN MAHDI / ENG, MOHD ADZIR/AAD-8841-2020	Bahrami, Afarin/0000-0002-5055-3258; Lim, HN/0000-0003-2436-8953; bin muhammad noor, ahmad shukri/0000-0001-8661-4537; MAHDI, MOHD ADZIR/0000-0002-2843-181X; 				Abdi MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024578; Abdi MM, 2009, J MATER SCI, V44, P3682, DOI 10.1007/s10853-009-3491-y; Adhikari B, 2004, PROG POLYM SCI, V29, P699, DOI 10.1016/j.progpolymsci.2004.03.002; Afarin B, 2012, ADV MATER RES-SWITZ, V364, P50, DOI 10.4028/www.scientific.net/AMR.364.50; AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212; Alexandrou I, 2002, APPL PHYS LETT, V80, P1435, DOI 10.1063/1.1449537; Alizadeh N, 2001, SENSOR ACTUAT B-CHEM, V75, P5, DOI 10.1016/S0925-4005(00)00684-5; [Anonymous], 2009, MAL ENV QUAL REP 200, P73; Bahrami A, 2012, INT J MOL SCI, V13, P918, DOI 10.3390/ijms13010918; Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u; Bi N, 2012, SPECTROCHIM ACTA A, V95, P276, DOI 10.1016/j.saa.2012.04.086; Chah S, 2004, SENSOR ACTUAT B-CHEM, V99, P216, DOI 10.1016/j.snb.2003.11.015; Clifton JC, 2007, PEDIATR CLIN N AM, V54, P237, DOI 10.1016/j.pcl.2007.02.005; Damos FS, 2006, ELECTROCHIM ACTA, V51, P1304, DOI 10.1016/j.electacta.2005.06.019; Diaz-Flores PE, 2009, J COLLOID INTERF SCI, V334, P124, DOI 10.1016/j.jcis.2009.02.045; Dietert RR, 2004, TOXICOL APPL PHARM, V198, P86, DOI 10.1016/j.taap.2003.08.020; Ding H, 2005, SUPRAMOL ENG COND MA, P199; Forzani ES, 2005, ENVIRON SCI TECHNOL, V39, P1257, DOI 10.1021/es049234z; Garland JE, 2003, ANAL CHIM ACTA, V475, P47, DOI 10.1016/S0003-2670(02)01224-2; Gonick HC, 2002, MED HYPOTHESES, V59, P239, DOI 10.1016/S0306-9877(02)00207-4; Goyer RA, 1996, ENVIRON HEALTH PERSP, V104, P1050, DOI 10.2307/3433116; Gurzau ES, 2003, ECOTOX ENVIRON SAFE, V56, P190, DOI 10.1016/S0147-6513(03)00062-9; Joo J, 2005, SYNTHETIC MET, V153, P313, DOI 10.1016/j.synthmet.2005.07.221; Kanoun O, 2008, 5 INT MULT SYST SIGN; Karim MR, 2007, MATER LETT, V61, P1688, DOI 10.1016/j.matlet.2006.07.100; Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068; Lau KT, 2003, CHEM PHYS LETT, V370, P399, DOI 10.1016/S0009-2614(03)00100-3; Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004; Lin CW, 1998, MATER CHEM PHYS, V55, P139, DOI 10.1016/S0254-0584(98)00087-X; Migahed MD, 2004, POLYM TEST, V23, P361, DOI 10.1016/S0142-9418(03)00101-6; Panta YM, 2009, J COLLOID INTERF SCI, V333, P485, DOI 10.1016/j.jcis.2009.02.026; Pruneanu S, 1997, MATER CHEM PHYS, V48, P240, DOI 10.1016/S0254-0584(96)01894-9; Rau JR, 1997, SYNTHETIC MET, V90, P115, DOI 10.1016/S0379-6779(97)81259-3; Sadrolhosseini AR, 2012, AIP CONF PROC, V1482, P200, DOI 10.1063/1.4757465; Sadrolhosseini AR, 2012, PLASMONICS - PRINCIPLES AND APPLICATIONS, P253, DOI 10.5772/51219; Sadrolhosseini AR, 2013, INT J POLYM MATER PO, V62, P284, DOI 10.1080/00914037.2012.664209; Sadrolhosseini AR, 2011, OPT REV, V18, P331, DOI 10.1007/s10043-011-0064-5; Sadrolhosseini AR, 2011, INT J MOL SCI, V12, P2100, DOI 10.3390/ijms12042100; SAKAI Y, 1993, J ELECTROCHEM SOC, V140, P432, DOI 10.1149/1.2221063; Schasfoort RBM, 2008, HDB SURFACE PLASMON, P50; Schasfoort R, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, pX, DOI 10.1039/9781847558220-FP010; Schasfoort RBM, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P221; Shi DL, 2003, APPL PHYS LETT, V83, P5301, DOI 10.1063/1.1636521; Sotiropoulou S, 2003, ANAL BIOANAL CHEM, V375, P103, DOI 10.1007/s00216-002-1617-z; Spain E, 2013, ELECTROCHIM ACTA, V109, P102, DOI 10.1016/j.electacta.2013.07.018; Sun YB, 2012, J ENVIRON RADIOACTIV, V105, P40, DOI 10.1016/j.jenvrad.2011.10.009; TATSUMA T, 1992, ANAL CHEM, V64, P1183, DOI 10.1021/ac00034a019; TIEKE B, 1990, POLYMER, V31, P20, DOI 10.1016/0032-3861(90)90342-V; UMANA M, 1986, ANAL CHEM, V58, P2979, DOI 10.1021/ac00127a018; Wang CW, 2001, CHEM PHYS LETT, V341, P431, DOI 10.1016/S0009-2614(01)00509-7; Xu D, 2008, J HAZARD MATER, V154, P407, DOI 10.1016/j.jhazmat.2007.10.059; Yu JCC, 2004, SENSOR ACTUAT B-CHEM, V101, P236, DOI 10.1016/j.snb.2004.03.007; Yu YJ, 2005, J POLYM SCI POL CHEM, V43, P6105, DOI 10.1002/pola.21114; Zhang C, 2012, CHEM ENG J; Zhang YT, 2007, SENSOR ACTUAT B-CHEM, V123, P784, DOI 10.1016/j.snb.2006.10.019; Zhang YY, 2010, BIOCHEM ENG J, V51, P102, DOI 10.1016/j.bej.2010.06.001	56	46	46	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93962	10.1371/journal.pone.0093962	http://dx.doi.org/10.1371/journal.pone.0093962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733263	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336970400013
J	Serana, F; Imberti, L; Amato, MP; Comi, G; Gasperini, C; Ghezzi, A; Martinelli, V; Provinciali, L; Rottoli, MR; Sotgiu, S; Stecchi, S; Vecchio, M; Zaffaroni, M; Cordioli, C; Capra, R				Serana, Federico; Imberti, Luisa; Amato, Maria Pia; Comi, Giancarlo; Gasperini, Claudio; Ghezzi, Angelo; Martinelli, Vittorio; Provinciali, Leandro; Rottoli, Maria Rosa; Sotgiu, Stefano; Stecchi, Sergio; Vecchio, Michele; Zaffaroni, Mauro; Cordioli, Cinzia; Capra, Ruggero			MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; IFN-BETA; NEUTRALIZING ANTIBODIES; EXPRESSION; RECEPTOR; BIOAVAILABILITY; VARIABILITY; GUIDELINES; RELAPSES; ASSAY	Even though anti-interferon beta (IFN beta) antibodies are the main determinants of IFN beta bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFN beta biological activity in IFN beta-treated multiple sclerosis patients, their usefulness in the routine clinical practice is still debated. Therefore, 118 multiple sclerosis patients naive for treatment were enrolled for a 3-year longitudinal observational study mimicking the conditions of a real-world setting. In order to evaluate the kinetics of bioactivity loss in blood samples obtained every 6 months after therapy initiation, MxA and interferon receptor isoform/subunit mRNA were quantified by real-time PCR, anti-IFN beta binding antibodies were detected by radioimmunoprecipitation, and neutralizing antibodies by cytopathic effect inhibition assay. Clinical measures of disease activity and disability progression were also obtained at all time points. We found that, at the individual-patient level, the response to IFN beta therapy was extremely heterogeneous, including patients with stable or transitory, early or late loss of IFN beta bioactivity, and patients with samples lacking MxA mRNA induction in spite of absence of antibodies. No interferon receptor isoform alterations that could explain these findings were found. At the group level, none of these biological features correlated with the measures of clinical disease activity or progression. However, when MxA mRNA was evaluated not at the single time point as a dichotomic marker (induced vs. non-induced), but as the mean of its values measured over the 6-to-24 month period, the increasing average MxA predicted a decreasing risk of short-term disability progression, independently from the presence of relapses. Therefore, a more bioactive treatment, even if unable to suppress relapses, reduces their severity by an amount that is proportional to MxA levels. Together with its feasibility in the routine laboratory setting, these data warrant the quantification of MxA mRNA as a primary tool for a routine monitoring of IFN beta therapy.	[Serana, Federico; Imberti, Luisa] Spedali Civili Brescia, Diagnost Dept, CREA, Brescia, Italy; [Amato, Maria Pia] Univ Florence, Neurosci Sect, Dept NEUROFARBA, Florence, Italy; [Comi, Giancarlo; Martinelli, Vittorio] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Gasperini, Claudio] S Camillo Forlanini Hosp, Multiple Sclerosis Ctr, Rome, Italy; [Ghezzi, Angelo; Zaffaroni, Mauro] Gallarate Hosp, Multiple Sclerosis Ctr, Gallarate, Italy; [Provinciali, Leandro] Osped Riuniti Ancona, Neurol Clin, Ancona, Italy; [Rottoli, Maria Rosa] Papa Giovanni XXIII Hosp, Multiple Sclerosis Ctr, Bergamo, Italy; [Sotgiu, Stefano] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Stecchi, Sergio] IRCCS Ist Sci Neurol Bologna, UOSI Riabilitaz Sclerosi Multipla, Bologna, Italy; [Vecchio, Michele] St Elia Hosp, Multiple Sclerosis Ctr, Caltanissetta, Italy; [Cordioli, Cinzia; Capra, Ruggero] Spedali Civili Brescia, Multiple Sclerosis Ctr, Brescia, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Hospital Spedali Civili Brescia; University of Florence; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Azienda Ospedaliera San Camillo-Forlanini; ASST Papa Giovanni XXIII; University of Sassari; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Hospital Spedali Civili Brescia	Serana, F (corresponding author), Spedali Civili Brescia, Diagnost Dept, CREA, Brescia, Italy.	federico.serana@gmail.com	ghezzi, angelo/AAJ-9606-2020; sotgiu, stefano/M-1011-2017; Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; Martinelli, Vittorio/AAN-7240-2020; gasperini, claudio/K-5093-2016	amato, Maria Pia/0000-0003-3325-3760; Serana, Federico/0000-0001-6740-4307; Imberti, Luisa/0000-0002-2075-8391; gasperini, claudio/0000-0002-3959-4067	Biogen Idec	Biogen Idec(Biogen)	Biogen Idec sponsored and funded this study. The funders were not responsible for the study design, but monitored clinical data collection; however, they had no role in data analysis and preparation of the manuscript, but provided a critical review before approval for submission.	Antonelli G, 1998, J INTERF CYTOK RES, V18, P345, DOI 10.1089/jir.1998.18.345; Bellomi F, 2009, J IMMUNOASS IMMUNOCH, V30, P40, DOI 10.1080/15321810802569857; Capra R, 2007, J NEUROIMMUNOL, V189, P102, DOI 10.1016/j.jneuroim.2007.06.006; Chiu AW, 2007, CLIN EXP IMMUNOL, V150, P61, DOI 10.1111/j.1365-2249.2007.03467.x; Chiu AW, 2009, ARCH NEUROL-CHICAGO, V66, P39, DOI 10.1001/archneur.66.1.noc80047; Cunningham S, 2005, CLIN PHARMACOL THER, V78, P635, DOI 10.1016/j.clpt.2005.08.018; Feng X, 2012, ARCH NEUROL-CHICAGO, V69, P1303, DOI 10.1001/archneurol.2012.465; Giacomini PS, 2009, ARCH NEUROL-CHICAGO, V66, P19, DOI 10.1001/archneurol.2008.529; Gilli F, 2008, NEUROLOGY, V71, P1940, DOI 10.1212/01.wnl.0000327340.50284.8d; Gilli F, 2007, J NEUROIMMUNOL, V192, P198, DOI 10.1016/j.jneuroim.2007.09.025; Gilli F, 2010, J INTERF CYTOK RES, V30, P733, DOI 10.1089/jir.2010.0098; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Hardy MP, 2001, BLOOD, V97, P473, DOI 10.1182/blood.V97.2.473; Hartung HP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-129; Hemmer B, 2009, NAT CLIN PRACT NEURO, V5, P126, DOI 10.1038/ncpneuro1042; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Lampasona V, 2003, EUR CYTOKINE NETW, V14, P154; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Malucchi S, 2011, J NEUROL, V258, P895, DOI 10.1007/s00415-010-5844-5; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; Oliver B, 2007, J NEUROIMMUNOL, V183, P225, DOI 10.1016/j.jneuroim.2006.11.010; Pachner Andrew, 2003, Mol Diagn, V7, P17, DOI 10.2165/00066982-200307010-00004; Polman CH, 2010, LANCET NEUROL, V9, P740, DOI 10.1016/S1474-4422(10)70103-4; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rio J, 2009, NAT REV NEUROL, V5, P553, DOI 10.1038/nrneurol.2009.139; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Rudick RA, 2010, ARCH NEUROL-CHICAGO, V67, P1329, DOI 10.1001/archneurol.2010.150; Serana F, 2008, J NEUROIMMUNOL, V197, P54, DOI 10.1016/j.jneuroim.2008.03.019; Sorensen PS, 2005, EUR J NEUROL, V12, P817, DOI 10.1111/j.1468-1331.2005.01386.x; Sormani MP, 2009, ANN NEUROL, V65, P268, DOI 10.1002/ana.21606; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Vitale G, 2006, CANCER RES, V66, P554, DOI 10.1158/0008-5472.CAN-05-3043; Zanotti C, 2010, CLIN CHEM LAB MED, V48, P1235, DOI 10.1515/CCLM.2010.263	36	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94794	10.1371/journal.pone.0094794	http://dx.doi.org/10.1371/journal.pone.0094794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733382	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400105
J	Tan, XJ; Fuchs, BB; Wang, Y; Chen, WP; Yuen, GJ; Chen, RB; Jayamani, E; Anastassopoulou, C; Pukkila-Worley, R; Coleman, JJ; Mylonakis, E				Tan, Xiaojiang; Fuchs, Beth Burgwyn; Wang, Yan; Chen, Weiping; Yuen, Grace J.; Chen, Rosalyn B.; Jayamani, Elamparithi; Anastassopoulou, Cleo; Pukkila-Worley, Read; Coleman, Jeffrey J.; Mylonakis, Eleftherios			The Role of Candida albicans SPT20 in Filamentation, Biofilm Formation and Pathogenesis	PLOS ONE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; SIGNALING SPECIFICITY; GALLERIA-MELLONELLA; HYPHAL FORMATION; BINDING PROTEIN; SAGA COMPLEX; HISTONE H2B; IN-VIVO	Candida albicans is a ubiquitous fungus, which can cause very serious and sometimes life-threatening infections in susceptible patients. We used Caenorhabditis elegans as a model host to screen a library of C. albicans mutants for decreased virulence and identified SPT20 as important for virulence. The transcription co-activator SPT20 was identified originally as a suppressor of Ty and solo delta insertion mutations, which can cause transcription defects in Saccharomyces cerevisiae. It is resistant to the toxicity caused by overexpression of GAL4-VP16. We constructed a C. albicans spt20 Delta/Delta mutant and found the spt20 Delta/Delta strain was significantly less virulent than the wild-type strain SC5314 in C. elegans (p < 0.0001), Galleria mellonella (p < 0.01) and mice (p < 0.001). Morphologically, spt20 Delta/Delta mutant cells demonstrated a "snow-flake'' shape and clustered together; prolonged culture times resulted in increased size of the cluster. The clustered morphology was associated with defects in nuclei distribution, as the nuclei were not observed in many cellular compartments. In addition, the C. albicans spt20 Delta/Delta mutant resulted in defects in hyphae and biofilm formation (compared to the wild-type strain, p < 0.05), and sensitivity to cell wall and osmotic stressors, and to antifungal agents. Thus our study demonstrated a role of C. albicans SPT20 in overall morphology and distribution of nuclear material, which may cause the defects in filamentation and biofilm formation directly when this gene is deleted.	[Tan, Xiaojiang; Chen, Weiping] Southern Med Univ, Nanfang Hosp, Overseas Med Ctr, Dept Respirat, Guangzhou, Guangdong, Peoples R China; [Tan, Xiaojiang; Fuchs, Beth Burgwyn; Jayamani, Elamparithi; Coleman, Jeffrey J.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Infect Dis Div, Providence, RI 02903 USA; [Tan, Xiaojiang; Fuchs, Beth Burgwyn; Wang, Yan; Anastassopoulou, Cleo; Pukkila-Worley, Read; Coleman, Jeffrey J.; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Wang, Yan] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Yuen, Grace J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA USA; [Yuen, Grace J.] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA; [Chen, Rosalyn B.] Phillips Acad, Andover, MA USA	Southern Medical University - China; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Massachusetts General Hospital; Naval Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tan, XJ (corresponding author), Southern Med Univ, Nanfang Hosp, Overseas Med Ctr, Dept Respirat, Guangzhou, Guangdong, Peoples R China.	nfyytxj@gmail.com; emylonakis@lifespan.org	Yuen, Grace/M-9383-2019; Coleman, Jeffrey J/E-2981-2015; Anastassopoulou, Cleo/AAO-8539-2020; Chen, Wei/GZK-7348-2022	Yuen, Grace/0000-0002-3253-9575; Anastassopoulou, Cleo/0000-0001-7666-9198; Pukkila-Worley, Read/0000-0001-5340-8294; Coleman, Jeffrey/0000-0001-8579-1996; Wang, Yan/0000-0003-1084-1957	National Institutes of Health [AI075286, AI070569]; Science and Technology Planning Project of Guangdong Province, P.R. China [2011B080701091]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Planning Project of Guangdong Province, P.R. China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health through an R01 award (AI075286), and an R21 award (AI070569) to Eleftherios Mylonakis, and Science and Technology Planning Project of Guangdong Province, P.R. China (2011B080701091) to Xiaojiang Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawi N, 2010, FUNGAL GENET BIOL, V47, P288, DOI 10.1016/j.fgb.2010.01.001; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Brown AJP, 2012, STRESS RESPONSES CAN; Chekanova JA, 2008, RNA, V14, P66, DOI 10.1261/rna.764108; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Fuchs BB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000368; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Hall D, 2002, AM POETRY REV, V31, P16; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Kobayashi SD, 1998, TRENDS MICROBIOL, V6, P92, DOI 10.1016/S0966-842X(98)01218-9; Kopecka M, 2001, EUR J CELL BIOL, V80, P303, DOI 10.1078/0171-9335-00157; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Laprade L, 2002, GENETICS, V161, P509; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; Morillon A, 2002, MOL CELL BIOL, V22, P2078, DOI 10.1128/MCB.22.7.2078-2088.2002; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Spanakis EK, 2010, MAYO CLIN PROC, V85, P1073, DOI 10.4065/mcp.2010.0447; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Vandeputte P, 2012, EUKARYOT CELL, V11, P916, DOI 10.1128/EC.00134-12; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang Y, 2009, CLIN EXP PHARMACOL P, V36, pe40, DOI 10.1111/j.1440-1681.2009.05187.x; Watanabe M, 2009, CURR GENET, V55, P365, DOI 10.1007/s00294-009-0251-0; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923	47	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94468	10.1371/journal.pone.0094468	http://dx.doi.org/10.1371/journal.pone.0094468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732310	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400040
J	An, FF; Fan, J; Li, J; Li, QX; Li, KM; Zhu, WL; Wen, F; Carvalho, LJCB; Chen, SB				An, Feifei; Fan, Jie; Li, Jun; Li, Qing X.; Li, Kaimian; Zhu, Wenli; Wen, Feng; Carvalho, Luiz J. C. B.; Chen, Songbi			Comparison of Leaf Proteomes of Cassava (Manihot esculenta Crantz) Cultivar NZ199 Diploid and Autotetraploid Genotypes	PLOS ONE			English	Article							OXIDATIVE STRESS; HEXAPLOID WHEAT; PROTEINS; POLYPLOIDY; LEAVES; IDENTIFICATION; POLYMORPHISMS; THIOREDOXIN; EVOLUTION; COMPLEX	Cassava polyploid breeding has drastically improved our knowledge on increasing root yield and its significant tolerance to stresses. In polyploid cassava plants, increases in DNA content highly affect cell volumes and anatomical structures. However, the mechanism of this effect is poorly understood. The purpose of the present study was to compare and validate the changes between cassava cultivar NZ199 diploid and autotetraploid at proteomic levels. The results showed that leaf proteome of cassava cultivar NZ199 diploid was clearly differentiated from its autotetraploid genotype using 2-DE combined MS technique. Sixty-five differential protein spots were seen in 2-DE image of autotetraploid genotype in comparison with that of diploid. Fifty-two proteins were identified by MALDI-TOF-MS/MS, of which 47 were up-regulated and 5 were down-regulated in autotetraploid genotype compared with diploid genotype. The classified functions of 32 up-regulated proteins were associated with photosynthesis, defense system, hydrocyanic acid (HCN) metabolism, protein biosynthesis, chaperones, amino acid metabolism and signal transduction. The remarkable variation in photosynthetic activity, HCN content and resistance to salt stress between diploid and autotetraploid genotypes is closely linked with expression levels of proteomic profiles. The analysis of protein interaction networks indicated there are direct interactions between the 15 up-regulation proteins involved in the pathways described above. This work provides an insight into understanding the protein regulation mechanism of cassava polyploid genotype, and gives a clue to improve cassava polyploidy breeding in increasing photosynthesis and resistance efficiencies.	[An, Feifei; Fan, Jie; Li, Kaimian; Zhu, Wenli; Chen, Songbi] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Key Lab, Minist Agr Germplasm Resources Conservat & Utiliz, Hainan, Peoples R China; [Li, Jun] Jiangsu Univ, Anal & Testing Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Qing X.] Univ Hawaii Manoa, Dept Mol Biosciences & Bioengn, Prote Core Facil, Manoa, HI USA; [Wen, Feng] Guangxi Subtrop Crop Res Inst, Nanning, Peoples R China; [Carvalho, Luiz J. C. B.] EMBRAPA, Genet Resources & Biotechnol, Sobral, Ceara, Brazil	Chinese Academy of Tropical Agricultural Sciences; Jiangsu University; University of Hawaii System; University of Hawaii Manoa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Li, KM (corresponding author), Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Key Lab, Minist Agr Germplasm Resources Conservat & Utiliz, Hainan, Peoples R China.	likaimian@sohu.com; songbichen@yahoo.com	Li, Qing/AAO-3938-2020		Chinese National Programs for Fundamental Research and Development Grants [2010CB126606]; National Scientific and Technological Programs in Rural Fields [2012AA101204-2]; Earmarked Fund for Modern Agro-industry Technology Research System [nycytx-17]; Initial Fund of High-level Creative Talents in Hainan Province	Chinese National Programs for Fundamental Research and Development Grants; National Scientific and Technological Programs in Rural Fields; Earmarked Fund for Modern Agro-industry Technology Research System; Initial Fund of High-level Creative Talents in Hainan Province	This work was supported by a Major Project of Chinese National Programs for Fundamental Research and Development Grants (2010CB126606), National Scientific and Technological Programs in Rural Fields (2012AA101204-2), the Earmarked Fund for Modern Agro-industry Technology Research System (nycytx-17) and the Initial Fund of High-level Creative Talents in Hainan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2009, INFECT IMMUN, V77, P4934, DOI 10.1128/IAI.00714-09; Albertin W, 2005, PROTEOMICS, V5, P2131, DOI 10.1002/pmic.200401092; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Amiour N, 2003, THEOR APPL GENET, V108, P62, DOI 10.1007/s00122-003-1411-0; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; Arve LE, 2013, PLANT CELL ENVIRON, V36, P382, DOI 10.1111/j.1365-3040.2012.02580.x; Behr M, 2010, MOL PLANT MICROBE IN, V23, P879, DOI 10.1094/MPMI-23-7-0879; Bhattacharyya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051676; Bombarely A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-406; Broin M, 2000, FEBS LETT, V467, P245, DOI 10.1016/S0014-5793(00)01165-0; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; Carpentier SC, 2011, PHYTOCHEMISTRY, V72, P1243, DOI 10.1016/j.phytochem.2010.10.016; Carvalho Luiz Joaquim Castelo Branco, 2012, Open Biochem J, V6, P116, DOI 10.2174/1874091X01206010116; Cavalier-Smith T., 1985, P105; Chen MJ, 2010, PLANT SIGNAL BEHAV, V5, P583, DOI 10.4161/psb.11496; Chen SB, 2009, J EXP BOT, V60, P2005, DOI 10.1093/jxb/erp075; Coate JE, 2011, PLANT PHYSIOL, V155, P2081, DOI 10.1104/pp.110.169599; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Gulde PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054039; Harada E, 2010, PLANT CELL PHYSIOL, V51, P1627, DOI 10.1093/pcp/pcq118; Hasan SS, 2013, BIOCHEMISTRY-US, V52, P2649, DOI 10.1021/bi301638h; Hoehenwarter W, 2011, J PROTEOME RES, V10, P2979, DOI 10.1021/pr101109a; Hu GJ, 2011, GENETICS, V189, P1103, DOI 10.1534/genetics.111.132407; Islam N, 2003, PROTEOMICS, V3, P549, DOI 10.1002/pmic.200390068; JELLINGS AJ, 1984, NEW PHYTOL, V96, P371, DOI 10.1111/j.1469-8137.1984.tb03573.x; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; Kapralov MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052974; KARLINNEUMANN GA, 1986, EMBO J, V5, P9, DOI 10.1002/j.1460-2075.1986.tb04170.x; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kumagai E, 2011, ANN BOT-LONDON, V108, P1381, DOI 10.1093/aob/mcr245; LEEGOOD RC, 1995, J EXP BOT, V46, P1397, DOI 10.1093/jxb/46.special_issue.1397; Li KM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-10; Merlino M, 2009, THEOR APPL GENET, V118, P1321, DOI 10.1007/s00122-009-0983-8; Narayanan NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021996; Nassar NMA, 2006, GENET MOL RES, V5, P536; Nassar NMA, 2008, GENET MOL RES, V7, P276, DOI 10.4238/vol7-2gmr399; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ng DWK, 2012, HEREDITY, V108, P419, DOI 10.1038/hdy.2011.92; Pankoke H, 2013, PHYTOCHEMISTRY, V94, P99, DOI 10.1016/j.phytochem.2013.04.016; PFOSSER M, 1995, CYTOMETRY, V21, P387, DOI 10.1002/cyto.990210412; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Shi JX, 2008, PLANT SCI, V175, P478, DOI 10.1016/j.plantsci.2008.05.019; Tomy Philip, 1991, Indian Phytopathology, V44, P249; Trummler K, 1997, J BIOL CHEM, V272, P4770, DOI 10.1074/jbc.272.8.4770; Tsukamoto Y, 2013, PLANT CELL PHYSIOL, V54, P484, DOI 10.1093/pcp/pct002; Vysotskii DA, 2012, PLANT SIGNAL BEHAV, V8; WARNER DA, 1993, PHOTOSYNTH RES, V35, P135, DOI 10.1007/BF00014744; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Yaakov Beery, 2011, Int J Plant Genomics, V2011, P569826, DOI 10.1155/2011/569826	53	45	60	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e85991	10.1371/journal.pone.0085991	http://dx.doi.org/10.1371/journal.pone.0085991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727655	Green Published, gold			2022-12-25	WOS:000336736200001
J	Bliddal, M; Olsen, J; Stovring, H; Eriksen, HLF; Kesmodel, US; Sorensen, TIA; Nohr, EA				Bliddal, Mette; Olsen, Jorn; Stovring, Henrik; Eriksen, Hanne-Lise F.; Kesmodel, Ulrik S.; Sorensen, Thorkild I. A.; Nohr, Ellen A.			Maternal Pre-Pregnancy BMI and Intelligence Quotient (IQ) in 5-Year-Old Children: A Cohort Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; OBESITY; PREGNANCY; ASSOCIATIONS; OVERWEIGHT; PERFORMANCE; COGNITION; ALCOHOL	Background: An association between maternal pre-pregnancy BMI and childhood intelligence quotient (IQ) has repeatedly been found but it is unknown if this association is causal or due to confounding caused by genetic or social factors. Methods: We used a cohort of 1,783 mothers and their 5-year-old children sampled from the Danish National Birth Cohort. The children participated between 2003 and 2008 in a neuropsychological assessment of cognitive ability including IQ tests taken by both the mother and the child. Linear regression analyses were used to estimate the associations between parental BMI and child IQ adjusted for a comprehensive set of potential confounders. Child IQ was assessed with the Wechsler Primary and Preschool Scales of Intelligence - Revised (WPPSI-R). Results: The crude association between maternal BMI and child IQ showed that BMI was adversely associated with child IQ with a reduction in IQ of -0.40 point for each one unit increase in BMI. This association was attenuated after adjustment for social factors and maternal IQ to a value of -0.27 (-0.50 to -0.03). After mutual adjustment for the father's BMI and all other factors except maternal IQ, the association between paternal BMI and child IQ yielded a regression coefficient of -0.26 (-0.59 to -0.07), which was comparable to that seen for maternal BMI (-0.20 (-0.44 to 0.04)). Conclusion: Although maternal pre-pregnancy BMI was inversely associated with the IQ of her child, the similar association with paternal BMI suggests that it is not a specific pregnancy related adiposity effect.	[Bliddal, Mette] Univ Southern Denmark, Dept Obstet & Gynaecol, Odense Univ Hosp, Odense, Denmark; [Bliddal, Mette] Univ Southern Denmark, Inst Clin Res, Res Unit Gynaecol & Obstet, Odense, Denmark; [Olsen, Jorn; Nohr, Ellen A.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Stovring, Henrik] Aarhus Univ, Biostat Sect, Dept Publ Hlth, Aarhus, Denmark; [Eriksen, Hanne-Lise F.] Aarhus Univ, Inst Clin Med, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Kesmodel, Ulrik S.] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1168 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Bliddal, M (corresponding author), Univ Southern Denmark, Dept Obstet & Gynaecol, Odense Univ Hosp, Odense, Denmark.	mette.bliddal@rsyd.dk	Olsen, Jørn/F-8801-2015; Støvring, Henrik/H-5754-2019; Bliddal, Mette/AAB-4977-2022	Olsen, Jørn/0000-0001-7462-5140; Støvring, Henrik/0000-0002-5821-2351; Bliddal, Mette/0000-0002-7637-3730	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Danish National Research Foundation established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort was furthermore a result of a major grant from this foundation. Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The study has also received support from Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2008, PEDIATR RES, V64, P659, DOI 10.1203/PDR.0b013e318187cc31; [Anonymous], 1958, STANDARD PROGR MATRI; Basatemur E, 2013, PEDIATRICS, V131, P56, DOI 10.1542/peds.2012-0788; Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651; Brion MJA, 2013, INT J EPIDEMIOL, V42, P518, DOI 10.1093/ije/dyt041; Casas M, 2013, INT J EPIDEMIOL, V42, P506, DOI 10.1093/ije/dyt002; Eriksen HLF, 2012, BJOG-INT J OBSTET GY, V119, P1191, DOI 10.1111/j.1471-0528.2012.03394.x; Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200; Heikura U, 2008, AM J EPIDEMIOL, V167, P169, DOI 10.1093/aje/kwm291; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Hinkle SN, 2013, INT J OBESITY, V37, P1344, DOI 10.1038/ijo.2013.128; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2010, SCAND J PUBLIC HEALT, V38, P208, DOI 10.1177/1403494809357093; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; Mann JR, 2013, BJOG-INT J OBSTET GY, V120, P309, DOI 10.1111/1471-0528.12052; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Nohr EA, 2005, THESIS U AARHUS AARH; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Reed DR, 1998, INT J OBESITY, V22, P827, DOI 10.1038/sj.ijo.0800666; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; SORENSEN TIA, 1983, LANCET, V1, P1105; SORENSEN TIA, 1982, HUM BIOL, V54, P765; SORENSEN TIA, 1985, J BIOSOC SCI, V17, P379; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; TEASDALE TW, 1992, HUM BIOL, V64, P99; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Wechsler D, 1999, MANUAL WECHSLER PRES; Wechsler D., 1990, MANUAL WECHSLER PRES	37	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94498	10.1371/journal.pone.0094498	http://dx.doi.org/10.1371/journal.pone.0094498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727836	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200082
J	Bogren, LK; Olson, JM; Carpluk, J; Moore, JM; Drew, KL				Bogren, Lori K.; Olson, Jasmine M.; Carpluk, JoAnna; Moore, Jeanette M.; Drew, Kelly L.			Resistance to Systemic Inflammation and Multi Organ Damage after Global Ischemia/Reperfusion in the Arctic Ground Squirrel	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HEMORRHAGIC-SHOCK; CARDIAC-ARREST; HIPPOCAMPAL SLICES; COLD ISCHEMIA; BRAIN-INJURY; IN-VITRO; HIBERNATION; LACTATE; GLUCOSE	Introduction: Cardiac arrest (CA) and hemorrhagic shock (HS) are two clinically relevant situations where the body undergoes global ischemia as blood pressure drops below the threshold necessary for adequate organ perfusion. Resistance to ischemia/reperfusion (I/R) injury is a characteristic of hibernating mammals. The present study sought to determine if arctic ground squirrels (AGS) are protected from systemic inflammation and multi organ damage after CA-or HS-induced global I/R and if, for HS, this protection is dependent upon their hibernation season. Methods: For CA, rats and summer euthermic AGS (AGS-EU) were asphyxiated for 8 min, inducing CA. For HS, rats, AGS-EU, and winter interbout arousal AGS (AGS-IBA) were subject to HS by withdrawing blood to a mean arterial pressure of 35 mmHg and maintaining that pressure for 20 min before reperfusion with Ringers. For both I/R models, body temperature (Tb) was kept at 36.5-37.5 degrees C. After reperfusion, animals were monitored for seven days (CA) or 3 hrs (HS) then tissues and blood were collected for histopathology, clinical chemistries, and cytokine level analysis (HS only). For the HS studies, additional groups of rats and AGS were monitored for three days after HS to access survival and physiological impairment. Results: Rats had increased serum markers of liver damage one hour after CA while AGS did not. For HS, AGS survived 72 hours after I/R whereas rats did not survive overnight. Additionally, only rats displayed an inflammatory response after HS. AGS maintained a positive base excess, whereas the base excess in rats was negative during and after hemorrhage. Conclusions: Regardless of season, AGS are resistant to organ damage, systemic inflammation, and multi organ damage after systemic I/R and this resistance is not dependent on their ability to become decrease Tb during insult but may stem from an altered acid/base and metabolic response during I/R.	[Bogren, Lori K.; Olson, Jasmine M.; Carpluk, JoAnna; Drew, Kelly L.] Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA; [Bogren, Lori K.; Moore, Jeanette M.; Drew, Kelly L.] Univ Alaska Fairbanks, Inst Arct Biol, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Bogren, LK (corresponding author), Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA.	lkbogren@alaska.edu			USAMRMC [W81XWH009-2-0134]; a Core Bucks award from the eagle-i consortium; University of Alaska Graduate School Dissertation Completion Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070779] Funding Source: NIH RePORTER	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); a Core Bucks award from the eagle-i consortium; University of Alaska Graduate School Dissertation Completion Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by USAMRMC W81XWH009-2-0134, a Core Bucks award from the eagle-i consortium, and the University of Alaska Graduate School Dissertation Completion Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AK, 2005, J NEUROCHEM, V93, P1327, DOI 10.1111/j.1471-4159.2005.03132.x; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Butt I, 2008, J NEPAL MED ASSOC, V47, P82; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; Candelario-Jalil E, 2003, NEUROSCI RES, V47, P245, DOI 10.1016/S0168-0102(03)00184-6; Candelario-Jalil E, 2002, EUR J PHARMACOL, V453, P189, DOI 10.1016/S0014-2999(02)02422-6; Christian SL, 2008, J CEREBR BLOOD F MET, V28, P1307, DOI 10.1038/jcbfm.2008.20; Cornford EM, 2002, EPILEPSIA, V43, P1360, DOI 10.1046/j.1528-1157.2002.01602.x; CORY T, 2012, INTERRELATIONSHIPS T; Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; Dave KR, 2009, J NEUROCHEM, V110, P1170, DOI 10.1111/j.1471-4159.2009.06196.x; DEITCH EA, 2012, SURGEON; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hall TJ, 1996, INFLAMM RES, V45, P299, DOI 10.1007/BF02280995; HARVEY MCG, 2011, WEBMEDCENTRAL EMERGE, V2; IRWIN RS, 2010, MANUAL INTENSIVE CAR; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Klein AH, 2010, SHOCK, V34, P565, DOI 10.1097/SHK.0b013e3181e15063; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; LEE M, 2009, BASIC SKILLS INTERPR; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Martin SL, 2008, AM J PHYSIOL-REG I, V295, pR316, DOI 10.1152/ajpregu.00418.2007; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Ross AP, 2006, J CEREBR BLOOD F MET, V26, P1148, DOI 10.1038/sj.jcbfm.9600271; *ROW MWMAAN, 1989, ILAR J, V31, P5; Setala LP, 2004, MICROSURG, V24, P223, DOI 10.1002/micr.20045; Steele PM, 1998, J INFECT DIS, V177, P1418, DOI 10.1086/517828; Stein C, 2012, CURR PHARM DESIGN, V18, P6053, DOI 10.2174/138161212803582513; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Tsukamoto T, 2010, INJURY, V41, P21, DOI 10.1016/j.injury.2009.07.010; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Weiss JBW, 2012, AM J CARDIOVASC DIS, V2, P237; Williams CT, 2012, BIOL LETTERS, V8, P31, DOI 10.1098/rsbl.2011.0435; Williams CT, 2011, J EXP BIOL, V214, P1300, DOI 10.1242/jeb.052159; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8; WOODBURN VL, 1993, NEUROPHARMACOLOGY, V32, P1047, DOI 10.1016/0028-3908(93)90070-J	49	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94225	10.1371/journal.pone.0094225	http://dx.doi.org/10.1371/journal.pone.0094225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728042	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200047
J	Koc, A; Bargen, I; Suwandi, A; Roderfeld, M; Tschuschner, A; Rath, T; Gerlach, GF; Hornef, M; Goethe, R; Weiss, S; Roeb, E				Koc, Arzu; Bargen, Imke; Suwandi, Abdulhadi; Roderfeld, Martin; Tschuschner, Annette; Rath, Timo; Gerlach, Gerald F.; Hornef, Mathias; Goethe, Ralph; Weiss, Siegfried; Roeb, Elke			Systemic and Mucosal Immune Reactivity upon Mycobacterium avium ssp paratuberculosis Infection in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; SUBSPECIES PARATUBERCULOSIS; MATRIX METALLOPROTEINASES; ULCERATIVE-COLITIS; TISSUE INHIBITORS; MOUSE MODEL; T-CELLS; MACROPHAGES	Mycobacterium avium ssp. paratuberculosis (MAP) is the cause of Johne's disease, an inflammatory bowel disorder of ruminants. Due to the similar pathology, MAP was also suggested to cause Crohn's disease (CD). Despite of intensive research, this question is still not settled, possibly due to the lack of versatile mouse models. The aim of this study was to identify basic immunologic mechanisms in response to MAP infection. Immune compromised C57BL/6 Rag2(-/-) mice were infected with MAP intraperitoneally. Such chronically infected mice were then reconstituted with CD4(+) and CD8(+)T cells 28 days after infection. A systemic inflammatory response, detected as enlargement of the spleen and granuloma formation in the liver, was observed in mice infected and reconstituted with CD4(+)T cells. Whereby inflammation in infected and CD4(+)CD45RB(hi) T cell reconstituted animals was always higher than in the other groups. Reconstitution of infected animals with CD8(+)T cells did not result in any inflammatory signs. Interestingly, various markers of inflammation were strongly up-regulated in the colon of infected mice reconstituted with CD4(+)CD45RB(lo/int) T cells. We propose, the usual non-colitogenic CD4(+)CD45RB(lo/int) T cells were converted into inflammatory T cells by the interaction with MAP. However, the power of such cells might be not sufficient for a fully established inflammatory response in the colon. Nevertheless, our model system appears to mirror aspects of an inflammatory bowel disease (IBD) like CD and Johne's diseases. Thus, it will provide an experimental platform on which further knowledge on IBD and the involvement of MAP in the induction of CD could be acquired.	[Koc, Arzu; Roderfeld, Martin; Tschuschner, Annette; Rath, Timo; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Bargen, Imke; Suwandi, Abdulhadi; Weiss, Siegfried] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Rath, Timo] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany; [Gerlach, Gerald F.] IVD GmbH, Hannover, Germany; [Hornef, Mathias] Hannover Med Sch, Dept Microbiol, Hannover, Germany; [Goethe, Ralph] Univ Vet Med Hannover, Dept Infect Dis, Inst Microbiol, Hannover, Germany	Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Erlangen Nuremberg; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022	, Martin/0000-0002-3232-1277; Hornef, Mathias/0000-0001-6096-9110; Rath, Timo/0000-0002-7728-9338	German Ministry for Science and Education (BMBF) [ZooMAP 01KI1003E, ZooMAP 01KI0750, ZooMAPII 01KI1003A, 01KI1003B]; Deutsche Forschungsgemeinschaft [RO 957/8-1]; von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg [10/2012 GI]	German Ministry for Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg	This work was supported by the German Ministry for Science and Education (BMBF; ZooMAP 01KI1003E, ZooMAP 01KI0750, ZooMAPII 01KI1003A, 01KI1003B), by grants from the Deutsche Forschungsgemeinschaft (RO 957/8-1), the von-Behring-Roentgen Foundation and the University Medical Center Giessen and Marburg (10/2012 GI, UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abubakar I, 2008, INFLAMM BOWEL DIS, V14, P401, DOI 10.1002/ibd.20276; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Basu S, 2007, CELL MICROBIOL, V9, P2804, DOI 10.1111/j.1462-5822.2007.00997.x; Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Clancy R, 2007, DIGEST LIVER DIS, V39, P445, DOI 10.1016/j.dld.2006.12.006; Dezzutti CS, 1999, J INFECT DIS, V180, P1142, DOI 10.1086/314992; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; El-Zaatari FAK, 2001, TRENDS MOL MED, V7, P247, DOI 10.1016/S1471-4914(01)01983-9; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Grant IR, 2005, J APPL MICROBIOL, V98, P1282, DOI 10.1111/j.1365-2672.2005.02598.x; Hogan LH, 2007, INT IMMUNOL, V19, P627, DOI 10.1093/intimm/dxm028; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logar K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-49; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; MUTWIRI GK, 1992, INFECT IMMUN, V60, P4074, DOI 10.1128/IAI.60.10.4074-4079.1992; Mutwiri GK, 2002, COMPARATIVE MED, V52, P332; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Over K, 2011, CRIT REV MICROBIOL, V37, P141, DOI 10.3109/1040841X.2010.532480; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plain KM, 2010, VET IMMUNOL IMMUNOP, V137, P142, DOI 10.1016/j.vetimm.2010.04.002; Ponnusamy D, 2013, RES VET SCI, V94, P306, DOI 10.1016/j.rvsc.2012.09.023; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Rath T, 2009, Z GASTROENTEROL, V47, P758, DOI 10.1055/s-0028-1109520; Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04; Rath T, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-34; Rath T, 2010, SCAND J GASTROENTERO, V45, P1186, DOI 10.3109/00365521.2010.499961; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Roderfeld M, 2012, MICROBES INFECT, V14, P545, DOI 10.1016/j.micinf.2012.01.004; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Sibartie S, 2010, INFLAMM BOWEL DIS, V16, P296, DOI 10.1002/ibd.21052; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Valentin-Weigand P, 1999, MICROBES INFECT, V1, P1121, DOI 10.1016/S1286-4579(99)00203-8; Waddell LA, 2008, CAN J PUBLIC HEALTH, V99, P145, DOI 10.1007/BF03405464; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Zhao BY, 1999, CAN J VET RES, V63, P56; ZURBRICK BG, 1987, INFECT IMMUN, V55, P1588, DOI 10.1128/IAI.55.7.1588-1593.1987	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94624	10.1371/journal.pone.0094624	http://dx.doi.org/10.1371/journal.pone.0094624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728142	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200110
J	Haigler, CH; Grimson, MJ; Gervais, J; Le Moigne, N; Hofte, H; Monasse, B; Navard, P				Haigler, Candace H.; Grimson, Mark J.; Gervais, Julien; Le Moigne, Nicolas; Hoefte, Herman; Monasse, Bernard; Navard, Patrick			Molecular Modeling and Imaging of Initial Stages of Cellulose Fibril Assembly: Evidence for a Disordered Intermediate Stage	PLOS ONE			English	Article							FORCE-FIELD; MICROFIBRILS; POLYMERIZATION; COMPLEX; BIOMASS	The remarkable mechanical strength of cellulose reflects the arrangement of multiple beta-1,4-linked glucan chains in a paracrystalline fibril. During plant cellulose biosynthesis, a multimeric cellulose synthesis complex (CSC) moves within the plane of the plasma membrane as many glucan chains are synthesized from the same end and in close proximity. Many questions remain about the mechanism of cellulose fibril assembly, for example must multiple catalytic subunits within one CSC polymerize cellulose at the same rate? How does the cellulose fibril bend to align horizontally with the cell wall? Here we used mathematical modeling to investigate the interactions between glucan chains immediately after extrusion on the plasma membrane surface. Molecular dynamics simulations on groups of six glucans, each originating from a position approximating its extrusion site, revealed initial formation of an uncrystallized aggregate of chains from which a protofibril arose spontaneously through a ratchet mechanism involving hydrogen bonds and van der Waals interactions between glucose monomers. Consistent with the predictions from the model, freeze-fracture transmission electron microscopy using improved methods revealed a hemispherical accumulation of material at points of origination of apparent cellulose fibrils on the external surface of the plasma membrane where rosette-type CSCs were also observed. Together the data support the possibility that a zone of uncrystallized chains on the plasma membrane surface buffers the predicted variable rates of cellulose polymerization from multiple catalytic subunits within the CSC and acts as a flexible hinge allowing the horizontal alignment of the crystalline cellulose fibrils relative to the cell wall.	[Haigler, Candace H.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Grimson, Mark J.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Gervais, Julien; Le Moigne, Nicolas; Monasse, Bernard; Navard, Patrick] Mines ParisTech, CNRS, Ctr Mise Forme Mat, Sophia Antipolis, France; [Hoefte, Herman] AgroParisTech, Inst Jean Pierre Bourgin, Unite Mixte Rech, French Natl Inst Agr Res Saclay Plant Sci, Versailles, France	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Texas Tech University System; Texas Tech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Haigler, CH (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	candace_haigler@ncsu.edu; patrick.navard@mines-paristech.fr	le moigne, nicolas/AGH-6115-2022	le moigne, nicolas/0000-0002-1218-7090; Haigler, Candace/0000-0001-7810-4035	"Stimulus Initiative" grant [ANR-11-BTBR-0006-BFF]; Dept. of Biological Sciences, Texas Tech University; Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0001090]	"Stimulus Initiative" grant; Dept. of Biological Sciences, Texas Tech University; Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)	The work of HH and PN to direct and interpret the results of computational modeling was financed in part by the "Stimulus Initiative" grant ANR-11-BTBR-0006-BFF to HH and PN. The work of MJG and CHH to acquire FF-TEM images was financed by the Dept. of Biological Sciences, Texas Tech University. The analysis of FF-TEM images by CHH at North Carolina State University was supported by The Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award # DE-SC0001090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; Bazooyar F, 2012, COMPUT THEOR CHEM, V984, P119, DOI 10.1016/j.comptc.2012.01.020; BENZIMAN M, 1980, P NATL ACAD SCI-BIOL, V77, P6678, DOI 10.1073/pnas.77.11.6678; Bowling AJ, 2008, PROTOPLASMA, V233, P115, DOI 10.1007/s00709-008-0302-2; BRANTON D, 1975, SCIENCE, V190, P54, DOI 10.1126/science.1166299; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; COUSINS SK, 1995, POLYMER, V36, P3885, DOI 10.1016/0032-3861(95)99782-P; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Diotallevi F, 2007, BIOPHYS J, V92, P2666, DOI 10.1529/biophysj.106.099473; EMONS AMC, 1991, BIOSYNTHESIS BIODEGR, P71; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Grimson Mark J., 2006, V346, P339; Grimson MJ, 1996, J CELL SCI, V109, P3079; Haigler CH, 1991, BIOSYNTHESIS BIODEGR, P99; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Lindeboom J, 2008, J MICROSC-OXFORD, V231, P192, DOI 10.1111/j.1365-2818.2008.02035.x; Matthews JF, 2012, J CHEM THEORY COMPUT, V8, P735, DOI 10.1021/ct2007692; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Niklas K.J., 1992, PLANT BIOMECHANICS E, P622; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Queyroy S, 2012, J APPL POLYM SCI, V125, P4358, DOI 10.1002/app.36560; RASH JE, 1992, MICROSC RES TECHNIQ, V20, P187, DOI 10.1002/jemt.1070200207; ROBERTS AW, 1990, PLANTA, V180, P502, DOI 10.1007/BF02411447; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Severs NJ, 2007, NAT PROTOC, V2, P547, DOI 10.1038/nprot.2007.55; Smith W., 1996, DL POLY PACKAGE MOL; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Thomas LH, 2013, PLANT PHYSIOL, V161, P465, DOI 10.1104/pp.112.206359; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Verwer P, 2009, REV COMP CH, V12, P327	39	23	23	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93981	10.1371/journal.pone.0093981	http://dx.doi.org/10.1371/journal.pone.0093981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722535	Green Published, gold			2022-12-25	WOS:000336909100032
J	Liu, J; Ren, YG; Kang, L; Zhang, LH				Liu, Jun; Ren, Yingang; Kang, Li; Zhang, Lihua			Overexpression of CCN3 Inhibits Inflammation and Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; IMMEDIATE-EARLY GENE; EXPRESSION; NOV; RECEPTOR; ATHEROGENESIS; MACROPHAGES; PLAQUES; DISEASE; LESIONS	Background: Cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed (CCN) 3 has been recently reported to play a role in regulating inflammation of vascular endothelial cells. However, the role of CCN3 in atherosclerosis, which is characterized by vascular inflammation, remains unclear. Hypothesis and Objectives: Overexpression of CCN3 may relieve the inflammation response in and inhibit the progress of atherosclerosis. We aimed to explore the potential roles of CCN3 in inflammation in atherosclerosis. Strategy and Main Results: In in vitro studies using cultured human aortic endothelial cells and human umbilical vein endothelial cells, CCN3 mRNA and protein expression significantly decreased in response to tumor necrosis factor-a and interleukin-1 beta treatments (p<0.05), when analyzed by quantitative real-time polymerase chain reaction and Western blot. Using a mouse model of atherosclerosis, the mRNA and protein levels of CCN3 decreased by 72.2% (p = 0.041) and 86.4% (p = 0.036), respectively, compared with levels in wild-type control mice, respectively. Overexpression of CCN3 by adenovirus-mediated gene overexpression decreased low-density lipoprotein cholesterol by 48.9% (p = 0.017), total cholesterol by 58.9% (p = 0.031), and triglycerides by 56.8% (p = 0.022), and it increased high-density lipoprotein cholesterol level by 2.16-fold (p = 0.039), compared with control groups. Additionally, a reduced plaque area and increased fibrous cap were observed (p<0.05). Furthermore, CCN3 overexpression decreased cell adhesion molecule-1 mRNA expression by 84.7% (p = 0.007) and intercellular adhesion molecule-1 mRNA expression by 61.2% (p = 0.044). Inflammatory factors, including matrix metalloproteinases, cyclooxygenase 2, and tissue factor also significantly (p<0.05) decreased with CCN3 overexpression in the atherosclerotic mouse model. Additionally, CCN1 and CCN2, which have been reported to be highly expressed in aortic atherosclerotic plaques, were significantly downregulated (p<0.05) by CCN3 overexpression. Conclusion: CCN3 overexpression is associated with control of inflammatory processes and reversion of dyslipidemia in the process of atherosclerosis, which implies that CCN3 may be a promising target in the treatment of atherosclerosis.	[Liu, Jun; Ren, Yingang; Kang, Li; Zhang, Lihua] Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Zhang, LH (corresponding author), Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China.	lihuazhangcn@163.com						Boden WE, 2000, AM J CARDIOL, V86, p19L; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Fiorucci S, 2001, DIGEST LIVER DIS, V33, pS2, DOI 10.1016/S1590-8658(01)80152-3; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hilfiker A, 2002, CIRCULATION, V106, P254, DOI 10.1161/01.CIR.0000021426.87274.62; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Ito T, 2004, EXP ANIM TOKYO, V53, P339, DOI 10.1538/expanim.53.339; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Jude B, 2005, ARCH MAL COEUR VAISS, V98, P667; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Kim KK, 2013, ENDOCRINOL METAB, V28, P214, DOI 10.3803/EnM.2013.28.3.214; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Kular L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-36; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; Liuzzo G, 2001, Rays, V26, P221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus IM, 2001, EUR J VASC ENDOVASC, V21, P17, DOI 10.1053/ejvs.2000.1278; Lwaleed BA, 2007, BIOL RES NURS, V9, P97, DOI 10.1177/1099800407305733; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal Bernard, 2006, Cell Commun Signal, V4, P6, DOI 10.1186/1478-811X-4-6; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; SHAH PK, 1995, CIRCULATION, V92, P1565; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Sigala F, 2006, EUR J VASC ENDOVASC, V32, P238, DOI 10.1016/j.ejvs.2006.01.026; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; WATANABE T, 1985, LAB INVEST, V53, P80; Yan XL, 2006, ENDOCRINOLOGY, V147, P5268, DOI 10.1210/en.2005-1568; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6	44	19	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94912	10.1371/journal.pone.0094912	http://dx.doi.org/10.1371/journal.pone.0094912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722330	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100146
J	Miller, A; Brooks, GD; McLeod, L; Ruwanpura, S; Jenkins, BJ				Miller, A.; Brooks, G. D.; McLeod, L.; Ruwanpura, S.; Jenkins, B. J.			Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; K-RAS; GASTRIC TUMORIGENESIS; STAT3 ACTIVATION; CIGARETTE-SMOKE; AKT ACTIVATION; CELL-SURVIVAL; MUTANT MICE; CANCER; TUMORS	Interleukin (IL)-6 family cytokines signal exclusively via the gp130 coreceptor, and are implicated in smoking-associated lung cancer, the most lethal cancer worldwide. However, the role of gp130 signalling pathways in transducing the carcinogenic effects of tobacco-related compounds is ill-defined. Here, we report that lung tumourigenesis induced by the potent tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (Nicotine-derived Nitrosamine Ketone; NNK) is suppressed in gp130(F/F) knock-in mice characterized by the contrasting gp130-dependant hypoactivation of extracellular signal-regulated kinase mitogen-activated protein kinase (ERK MAPK) and phosphatidylinositol 3-kinase/Akt, and hyperactivation of signal transducer and activator of transcription (STAT) 3 signalling cascades. Specifically, in response to NNK, the absolute number and size of lung lesions in gp130(F/F) mice were significantly reduced compared with gp130(+/+) littermate controls, and associated with lower cellular proliferation without any alteration to the level of apoptosis in gp130(F/F) lung tumours. At the molecular level, reduced activation of ERK MAPK, but not Akt, was observed in lung tumours of gp130(F/F) mice, and corresponded with impaired expression of several tumour suppressor genes (for example, Trp53, Tsc2). Notably, STAT3 was not activated in the lungs of gp130(+/+) mice by NNK, and genetic normalization of STAT3 activation in gp130(F/F): Stat3(-/+) mice had no effect on NNK-induced tumourigenesis. The expression of tumour suppressor genes was reduced in tumours from current versus never-smoking lung cancer patients, and in vitro pharmacological inhibition of ERK MAPK signalling in human lung cancer cells abrogated NNK-induced downmodulation of tumour suppressor gene expression. Among IL-6 cytokine family members, IL-6 gene expression was specifically upregulated by NNK in vitro and in vivo, and inversely correlated with tumour suppressor gene expression. Collectively, our data reveal that a key molecular mechanism by which NNK promotes tumour cell proliferation during tobacco carcinogen-induced lung carcinogenesis is via upregulation of IL-6 and the preferential usage of gp130-dependant ERK MAPK signalling to downmodulate tumour suppressor gene expression.	[Miller, A.; Brooks, G. D.; McLeod, L.; Ruwanpura, S.; Jenkins, B. J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia	Monash University	Jenkins, BJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	Brendan.Jenkins@monash.edu	Miller, Alistair/AAE-8766-2022	Miller, Alistair/0000-0002-0439-9747; Ruwanpura, saleela/0000-0002-4074-2012; Jenkins, Brendan/0000-0002-7552-4656	National Health and Medical Research Council (NHMRC) of Australia; Operational Infrastructure Support Program by the Victorian Government of Australia; NHMRC Post-doctoral Training Fellowship; Sylvia and Charles Viertel Senior Medical Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program by the Victorian Government of Australia; NHMRC Post-doctoral Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. SMR is supported by a NHMRC Post-doctoral Training Fellowship. BJJ is supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship.	Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Akopyan G, 2006, INT J ONCOL, V29, P745; Brognard J, 2001, CANCER RES, V61, P3986; Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Guo J, 2013, ONCOGENE, V32, P151, DOI 10.1038/onc.2012.39; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Haura EB, 2006, CLIN LUNG CANCER, V7, P273, DOI 10.3816/CLC.2006.n.006; Hayashi H, 2001, LUNG CANCER-J IASLC, V34, P59, DOI 10.1016/S0169-5002(01)00211-2; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Hollander MC, 2008, NEOPLASIA, V10, P866, DOI 10.1593/neo.08406; Hollander MC, 2011, CARCINOGENESIS, V32, P1279, DOI 10.1093/carcin/bgr097; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Ihara S, 2012, CANCER RES, V72, P2990, DOI 10.1158/0008-5472.CAN-11-4062; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Jiang RC, 2011, MOL DIAGN THER, V15, P347, DOI 10.2165/11599190-000000000-00000; Jin ZH, 2004, J BIOL CHEM, V279, P40209, DOI 10.1074/jbc.M404056200; Kennedy CL, 2011, J PATHOL, V225, P255, DOI 10.1002/path.2933; Liu XD, 2007, BIOCHEM BIOPH RES CO, V353, P121, DOI 10.1016/j.bbrc.2006.11.147; Marson VJ, 2004, HISTOPATHOLOGY, V45, P125, DOI 10.1111/j.1365-2559.2004.01893.x; McClelland MR, 2007, AM J RESP CELL MOL, V36, P343, DOI 10.1165/rcmb.2006-0311OC; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Qu P, 2009, LUNG CANCER, V63, P341, DOI 10.1016/j.lungcan.2008.05.025; Ramakrishna G, 2002, TOXICOL APPL PHARM, V179, P21, DOI 10.1006/taap.2001.9344; Razani-Boroujerdi S, 2007, AM J RESP CELL MOL, V36, P13, DOI 10.1165/rcmb.2005-0330OC; Ruwanpura SM, 2012, AM J PHYSIOL-LUNG C, V302, P1627, DOI 10.1152/ajplung.00285.2011; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thiem S, 2013, J CLIN INVEST, V123, P767, DOI 10.1172/JCI65086; Tominaga M, 2003, LUNG CANCER-J IASLC, V40, P45, DOI 10.1016/S0169-5002(02)00529-9; Trejo CL, 2012, CANCER RES, V72, P3048, DOI 10.1158/0008-5472.CAN-11-3649; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Walser Tonya, 2008, Proc Am Thorac Soc, V5, P811, DOI 10.1513/pats.200809-100TH; West KA, 2004, CANCER RES, V64, P446, DOI 10.1158/0008-5472.CAN-03-3241; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; YANAGAWA H, 1995, BRIT J CANCER, V71, P1095, DOI 10.1038/bjc.1995.212; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200	48	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 19	2015	34	12					1510	1519		10.1038/onc.2014.99	http://dx.doi.org/10.1038/onc.2014.99			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD9KI	24727895				2022-12-25	WOS:000351416800004
J	Vaillier, C; Honegger, T; Kermarrec, F; Gidrol, X; Peyrade, D				Vaillier, Clarisse; Honegger, Thibault; Kermarrec, Frederique; Gidrol, Xavier; Peyrade, David			Comprehensive Analysis of Human Cells Motion under an Irrotational AC Electric Field in an Electro-Microfluidic Chip	PLOS ONE			English	Article							DIELECTROPHORESIS; MANIPULATION; SEPARATION; FORCES	AC electrokinetics is a versatile tool for contact-less manipulation or characterization of cells and has been widely used for separation based on genotype translation to electrical phenotypes. Cells responses to an AC electric field result in a complex combination of electrokinetic phenomena, mainly dielectrophoresis and electrohydrodynamic forces. Human cells behaviors to AC electrokinetics remain unclear over a large frequency spectrum as illustrated by the self-rotation effect observed recently. We here report and analyze human cells behaviors in different conditions of medium conductivity, electric field frequency and magnitude. We also observe the self-rotation of human cells, in the absence of a rotational electric field. Based on an analytical competitive model of electrokinetic forces, we propose an explanation of the cell self-rotation. These experimental results, coupled with our model, lead to the exploitation of the cell behaviors to measure the intrinsic dielectric properties of JURKAT, HEK and PC3 human cell lines.	[Vaillier, Clarisse; Honegger, Thibault; Peyrade, David] Univ Grenoble Alpes, LTM, Grenoble, France; [Vaillier, Clarisse; Honegger, Thibault; Peyrade, David] CNRS, LTM, Grenoble, France; [Honegger, Thibault] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Kermarrec, Frederique; Gidrol, Xavier] CEA, Inst Rech Technol & Sci Vivant, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Massachusetts Institute of Technology (MIT); CEA	Peyrade, D (corresponding author), Univ Grenoble Alpes, LTM, Grenoble, France.	david.peyrade@cea.fr		Honegger, Thibault/0000-0002-1716-7363; Gidrol, Xavier/0000-0002-4233-3749	French National Agency ANR through Nanoscience and Nanotechnology Program Project NANOSHARK [ANR-11-NANO-0001]	French National Agency ANR through Nanoscience and Nanotechnology Program Project NANOSHARK(French National Research Agency (ANR))	This work is supported by French National Agency ANR through Nanoscience and Nanotechnology Program Project NANOSHARK No. ANR-11-NANO-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castellanos A, 2003, J PHYS D APPL PHYS, V36, P2584, DOI 10.1088/0022-3727/36/20/023; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chung C., 2011, J ELECT BIOIMP, V2, P64, DOI DOI 10.5617/JEB.196; Desai SP, 2011, INTEGR BIOL-UK, V3, P48, DOI 10.1039/c0ib00067a; Gagnon Z, 2010, LAB CHIP, V10, P718, DOI 10.1039/b917220c; Gagnon ZR, 2011, ELECTROPHORESIS, V32, P2466, DOI 10.1002/elps.201100060; Gascoyne PRC, 2004, LAB CHIP, V4, P299, DOI 10.1039/b404130e; Gonzalez A, 2000, PHYS REV E, V61, P4019, DOI 10.1103/PhysRevE.61.4019; Gupta S, 2010, LANGMUIR, V26, P3441, DOI 10.1021/la902989r; Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b602036d; Honegger T, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4771544; Honegger T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583441; Honegger T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4804304; Honegger T, 2013, LAB CHIP, V13, P1538, DOI 10.1039/c3lc41298a; Honegger T, 2013, LAB CHIP, V13, P589, DOI 10.1039/c2lc41000a; Huang Y, 1997, BIOPHYS J, V73, P1118, DOI 10.1016/S0006-3495(97)78144-X; Jones TB, 1996, J ELECTROSTAT, V37, P121, DOI 10.1016/0304-3886(96)00006-X; Jones TB, 2003, IEEE ENG MED BIOL, V22, P33, DOI 10.1109/MEMB.2003.1304999; KALER KVIS, 1990, BIOPHYS J, V57, P173, DOI 10.1016/S0006-3495(90)82520-0; Kua CH, 2007, ANAL CHEM, V79, P6975, DOI 10.1021/ac070810u; Lenshof A, 2010, CHEM SOC REV, V39, P1203, DOI 10.1039/b915999c; Minerick AR, 2003, ELECTROPHORESIS, V24, P3703, DOI 10.1002/elps.200305644; Morgan H, 2003, IEE Proc Nanobiotechnol, V150, P76, DOI 10.1049/ip-nbt:20031090; Oh J, 2009, LAB CHIP, V9, P62, DOI 10.1039/b801594e; Ouyang MX, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4821169; Pethig R., 2005, IEE Proceedings Nanobiotechnology, V152, P189, DOI 10.1049/ip-nbt:20050040; Pethig R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/182581; POHL HA, 1951, J APPL PHYS, V22, P869, DOI 10.1063/1.1700065; Ramos A, 1999, J ELECTROSTAT, V47, P71, DOI 10.1016/S0304-3886(99)00031-5; Ramos A, 1998, J PHYS D APPL PHYS, V31, P2338, DOI 10.1088/0022-3727/31/18/021; Shafiee H, 2010, LAB CHIP, V10, P438, DOI 10.1039/b920590j; Squires TM, 2004, J FLUID MECH, V509, P217, DOI 10.1017/S0022112004009309; Su HW, 2013, LAB CHIP, V13, P4109, DOI 10.1039/c3lc50392e; Vahey MD, 2009, ANAL CHEM, V81, P2446, DOI 10.1021/ac8019575	34	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95231	10.1371/journal.pone.0095231	http://dx.doi.org/10.1371/journal.pone.0095231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736275	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600158
J	Bickel, ST; Juliano, JD; Nagy, JD				Bickel, Scott T.; Juliano, Joseph D.; Nagy, John D.			Evolution of Proliferation and the Angiogenic Switch in Tumors with High Clonal Diversity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER; SELECTION; HALLMARKS; NECROSIS; VEGF; PDGF	Natural selection among tumor cell clones is thought to produce hallmark properties of malignancy. Efforts to understand evolution of one such hallmark-the angiogenic switch-has suggested that selection for angiogenesis can "run away'' and generate a hypertumor, a form of evolutionary suicide by extreme vascular hypo-or hyperplasia. This phenomenon is predicted by models of tumor angiogenesis studied with the techniques of adaptive dynamics. These techniques also predict that selection drives tumor proliferative potential towards an evolutionarily stable strategy (ESS) that is also convergence-stable. However, adaptive dynamics are predicated on two key assumptions: (i) no more than two distinct clones or evolutionary strategies can exist in the tumor at any given time; and (ii) mutations cause small phenotypic changes. Here we show, using a stochastic simulation, that relaxation of these assumptions has no effect on the predictions of adaptive dynamics in this case. In particular, selection drives proliferative potential towards, and angiogenic potential away from, their respective ESSs. However, these simulations also show that tumor behavior is highly contingent on mutational history, particularly for angiogenesis. Individual tumors frequently grow to lethal size before the evolutionary endpoint is approached. In fact, most tumor dynamics are predicted to be in the evolutionarily transient regime throughout their natural history, so that clinically, the ESS is often largely irrelevant. In addition, we show that clonal diversity as measured by the Shannon Information Index correlates with the speed of approach to the evolutionary endpoint. This observation dovetails with results showing that clonal diversity in Barrett's esophagus predicts progression to malignancy.	[Bickel, Scott T.; Nagy, John D.] Scottsdale Community Coll, Dept Life Sci, Scottsdale, AZ 85256 USA; [Juliano, Joseph D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Nagy, John D.] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Nagy, JD (corresponding author), Scottsdale Community Coll, Dept Life Sci, Scottsdale, AZ 85256 USA.	jdnagy@asu.edu			Scottsdale Community College; Arizona State University's Barrett Honors College	Scottsdale Community College; Arizona State University's Barrett Honors College	This research is supported in part by Scottsdale Community College and Arizona State University's Barrett Honors College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Colombo MP, 1996, AM J PATHOL, V148, P473; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; ESHEL I, 1981, THEOR POPUL BIOL, V19, P420, DOI 10.1016/0040-5809(81)90029-0; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hartl DL, 2006, PRINCIPLES POPULATIO; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KILBURN DG, 1969, J CELL SCI, V4, P645; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Martinov MV, 2000, BBA-GEN SUBJECTS, V1474, P75, DOI 10.1016/S0304-4165(99)00218-4; Maynard Smith J., 1982, pi; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Nagy JD, 2005, MATH BIOSCI ENG, V2, P381, DOI 10.3934/mbe.2005.2.381; Nagy JD, 2004, B MATH BIOL, V66, P663, DOI 10.1016/j.bulm.2003.10.001; Nagy JD, 2007, INTEGR COMP BIOL, V47, P317, DOI 10.1093/icb/icm062; Nagy JD, 2012, MATH BIOSCI ENG, V9, P843, DOI 10.3934/mbe.2012.9.843; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Parvinen K, 2005, ACTA BIOTHEOR, V53, P241, DOI 10.1007/s10441-005-2531-5; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Shannon CE, 1962, MATH THEORY COMMUNIC; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Vermeij GJ, 2006, P NATL ACAD SCI USA, V103, P1804, DOI 10.1073/pnas.0508724103; Weinberg RA, 2007, BIOL CANC	40	7	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e91992	10.1371/journal.pone.0091992	http://dx.doi.org/10.1371/journal.pone.0091992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732428	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400001
J	Feverati, G; Achoch, M; Vuillon, L; Lesieur, C				Feverati, Giovanni; Achoch, Mounia; Vuillon, Laurent; Lesieur, Claire			Intermolecular beta-Strand Networks Avoid Hub Residues and Favor Low Interconnectedness: A Potential Protection Mechanism against Chain Dissociation upon Mutation	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AMYLOID FIBRILS; SIDE-CHAIN; PREDICTION; INTERFACES; DATABASE; MODEL; STATE; DETERMINANTS; AGGREGATION	Altogether few protein oligomers undergo a conformational transition to a state that impairs their function and leads to diseases. But when it happens, the consequences are not harmless and the so-called conformational diseases pose serious public health problems. Notorious examples are the Alzheimer's disease and some cancers associated with a conformational change of the amyloid precursor protein (APP) and of the p53 tumor suppressor, respectively. The transition is linked with the propensity of beta-strands to aggregate into amyloid fibers. Nevertheless, a huge number of protein oligomers associate chains via beta-strand interactions (intermolecular beta-strand interface) without ever evolving into fibers. We analyzed the layout of 1048 intermolecular beta-strand interfaces looking for features that could provide the beta-strands resistance to conformational transitions. The interfaces were reconstructed as networks with the residues as the nodes and the interactions between residues as the links. The networks followed an exponential decay degree distribution, implying an absence of hubs and nodes with few links. Such layout provides robustness to changes. Few links per nodes do not restrict the choices of amino acids capable of making an interface and maintain high sequence plasticity. Few links reduce the "bonding'' cost of making an interface. Finally, few links moderate the vulnerability to amino acid mutation because it entails limited communication between the nodes. This confines the effects of a mutation to few residues instead of propagating them to many residues via hubs. We propose that intermolecular beta-strand interfaces are organized in networks that tolerate amino acid mutation to avoid chain dissociation, the first step towards fiber formation. This is tested by looking at the intermolecular beta-strand network of the p53 tetramer.	[Feverati, Giovanni] Univ Savoie, CNRS, Lab Annecy Le Vieux Phys Theor LAPTH, UMR 5108, Annecy Le Vieux, France; [Achoch, Mounia] Univ Savoie, Lab Informat Syst Traitement Informat & Connaissa, Annecy Le Vieux, France; [Vuillon, Laurent] Univ Savoie, CNRS, Lab Math LAMA, UMR 5127, Le Bourget Du Lac, France; [Lesieur, Claire] Univ Grenoble 1, CNRS, Aging & Imaging AGIM FRE 3405, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Savoie; Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lesieur, C (corresponding author), Univ Grenoble 1, CNRS, Aging & Imaging AGIM FRE 3405, Grenoble, France.	claire.lesieur@agim.eu	Feverati, Giovanni/L-8248-2013; Vuillon, Laurent/AAR-6864-2020		System Complex IXXI	System Complex IXXI	System Complex IXXI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2002, DRUG DEVELOP RES, V56, P184, DOI 10.1002/ddr.10074; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreeva A, 2010, ACTA CRYSTALLOGR F, V66, P1190, DOI 10.1107/S1744309110007177; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Benito A, 2008, CURR PROTEIN PEPT SC, V9, P370, DOI 10.2174/138920308785132695; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cheng P-N, 2013, J AM CHEM SOC; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dou YM, 2004, BIOINFORMATICS, V20, P2767, DOI 10.1093/bioinformatics/bth326; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Faure G, 2008, BIOCHIMIE, V90, P626, DOI 10.1016/j.biochi.2007.11.007; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Feverati G, 2012, SYMMETRIZATION RANKI, P133; Feverati G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032558; Feverati G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009897; Fooks HM, 2006, J MOL BIOL, V356, P32, DOI 10.1016/j.jmb.2005.11.008; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lv GH, 2012, J MOL BIOL, V420, P99, DOI 10.1016/j.jmb.2012.04.009; Ma BY, 2000, J MOL BIOL, V296, P1091, DOI 10.1006/jmbi.2000.3518; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Picone D, 2005, J BIOL CHEM, V280, P13771, DOI 10.1074/jbc.M413157200; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Smith CK, 1997, ACCOUNTS CHEM RES, V30, P153, DOI 10.1021/ar9601048; Smith JM, 2007, PROTEINS, V66, P889, DOI 10.1002/prot.21257; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001	59	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94745	10.1371/journal.pone.0094745	http://dx.doi.org/10.1371/journal.pone.0094745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733378	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400088
J	Ho, A; Lin, N; Charoenvimolphan, N; Stanley, M; Frerichs, KU; Day, AL; Du, R				Ho, Allen; Lin, Ning; Charoenvimolphan, Nareerat; Stanley, Mary; Frerichs, Kai U.; Day, Arthur L.; Du, Rose			Morphological Parameters Associated with Ruptured Posterior Communicating Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; ARTERY ANEURYSM; ENDOVASCULAR TREATMENT; SURGICAL-TREATMENT; FLOW PATTERNS; ASPECT RATIO; HEMODYNAMICS; RISK; SIZE	The rupture risk of unruptured intracranial aneurysms is known to be dependent on the size of the aneurysm. However, the association of morphological characteristics with ruptured aneurysms has not been established in a systematic and location specific manner for the most common aneurysm locations. We evaluated posterior communicating artery (PCoA) aneurysms for morphological parameters associated with aneurysm rupture in that location. CT angiograms were evaluated to generate 3-D models of the aneurysms and surrounding vasculature. Univariate and multivariate analyses were performed to evaluate morphological parameters including aneurysm volume, aspect ratio, size ratio, distance to ICA bifurcation, aneurysm angle, vessel angles, flow angles, and vessel-to-vessel angles. From 2005-2012, 148 PCoA aneurysms were treated in a single institution. Preoperative CTAs from 63 patients (40 ruptured, 23 unruptured) were available and analyzed. Multivariate logistic regression revealed that smaller volume (p = 0.011), larger aneurysm neck diameter (0.048), and shorter ICA bifurcation to aneurysm distance (p = 0.005) were the most strongly associated with aneurysm rupture after adjusting for all other clinical and morphological variables. Multivariate subgroup analysis for patients with visualized PCoA demonstrated that larger neck diameter (p = 0.018) and shorter ICA bifurcation to aneurysm distance (p = 0.011) were significantly associated with rupture. Intracerebral hemorrhage was associated with smaller volume, larger maximum height, and smaller aneurysm angle, in addition to lateral projection, male sex, and lack of hypertension. We found that shorter ICA bifurcation to aneurysm distance is significantly associated with PCoA aneurysm rupture. This is a new physically intuitive parameter that can be measured easily and therefore be readily applied in clinical practice to aid in the evaluation of patients with PCoA aneurysms.	[Ho, Allen; Lin, Ning; Charoenvimolphan, Nareerat; Stanley, Mary; Frerichs, Kai U.; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Ho, Allen; Lin, Ning; Frerichs, Kai U.; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA; [Day, Arthur L.] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lin, Ning/AAP-7745-2020; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Lin, Ning/0000-0002-3638-4814; Du, Rose/0000-0003-2641-6496	Daniel E. Ponton Fund	Daniel E. Ponton Fund	This work was supported by the Daniel E. Ponton Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMURA T, 1991, ACTA NEUROL SCAND, V84, P207, DOI 10.1111/j.1600-0404.1991.tb04939.x; Ardakani SSJ, 2010, SCI IRAN TRANS B, V17, P358; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; BURLESON AC, 1995, NEUROSURGERY, V37, P774, DOI 10.1227/00006123-199510000-00023; Carter BS, 2006, NEUROSURGERY, V58, P217, DOI 10.1227/01.NEU.0000194639.37803.F8; Celi S, 2013, EUR J CARDIOTHORAC S; Clarke G, 2005, ACTA NEUROCHIR, V147, P259, DOI 10.1007/s00701-004-0473-3; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Ecker Robert D, 2004, Neurosurg Focus, V17, pE4; Ford MD, 2008, J BIOMECH, V41, P241, DOI 10.1016/j.jbiomech.2007.09.032; Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006; FREYTAG E, 1966, ARCH PATHOL, V81, P418; Fukazawa K., 2013, WORLD NEUROSURG; Hademenos GJ, 1998, NEURORADIOLOGY, V40, P755, DOI 10.1007/s002340050679; HASHIMOTO N, 1980, SURG NEUROL, V13, P41; He WZ, 2010, J NEUROSURG, V112, P611, DOI 10.3171/2009.8.JNS08731; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Kerber CW, 1999, AM J NEURORADIOL, V20, P2000; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Matsukawa H, 2012, J NEUROSURG; Matsukawa H, 2014, J NEUROSURG, V120, P104, DOI 10.3171/2013.9.JNS13921; Mocco J, 2004, Neurosurg Focus, V17, pE3; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; NAKATANI H, 1991, J NEUROSURG, V74, P258, DOI 10.3171/jns.1991.74.2.0258; Ojemann RG, 1988, SURG MANAGEMENT CERE, P179; Piccinelli M, 2012, ANN BIOMED ENG, V40, P2188, DOI 10.1007/s10439-012-0577-5; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Pieper S, 2006, I S BIOMED IMAGING, P698; Prestigiacomo CJ, 2009, J NEUROSURG, V110, P1, DOI 10.3171/2008.5.17558; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; TOGNETTI F, 1983, SURG NEUROL, V20, P74, DOI 10.1016/0090-3019(83)90112-X; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Ujiie H, 1996, STROKE, V27, P2086, DOI 10.1161/01.STR.27.11.2086; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yasargil MG., 1984, MICRONEUROSURGERY, VVol. 1	39	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94837	10.1371/journal.pone.0094837	http://dx.doi.org/10.1371/journal.pone.0094837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733151	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400120
J	Kettles, NL; Kopriva, S; Malin, G				Kettles, Nicola Louise; Kopriva, Stanislav; Malin, Gill			Insights into the Regulation of DMSP Synthesis in the Diatom Thalassiosira pseudonana through APR Activity, Proteomics and Gene Expression Analyses on Cells Acclimating to Changes in Salinity, Light and Nitrogen	PLOS ONE			English	Article							ASSIMILATORY SULFATE REDUCTION; ARABIDOPSIS-THALIANA; MARINE-ALGAE; SERINE ACETYLTRANSFERASE; METHIONINE BIOSYNTHESIS; SULFUR ASSIMILATION; EMILIANIA-HUXLEYI; BATCH CULTURES; HIGHER-PLANTS; LEMNA-MINOR	Despite the importance of dimethylsulphoniopropionate (DMSP) in the global sulphur cycle and climate regulation, the biological pathways underpinning its synthesis in marine phytoplankton remain poorly understood. The intracellular concentration of DMSP increases with increased salinity, increased light intensity and nitrogen starvation in the diatom Thalassiosira pseudonana. We used these conditions to investigate DMSP synthesis at the cellular level via analysis of enzyme activity, gene expression and proteome comparison. The activity of the key sulphur assimilatory enzyme, adenosine 5'-phosphosulphate reductase was not coordinated with increasing intracellular DMSP concentration. Under all three treatments coordination in the expression of sulphur assimilation genes was limited to increases in sulphite reductase transcripts. Similarly, proteomic 2D gel analysis only revealed an increase in phosphoenolpyruvate carboxylase following increases in DMSP concentration. Our findings suggest that increased sulphur assimilation might not be required for increased DMSP synthesis, instead the availability of carbon and nitrogen substrates may be important in the regulation of this pathway. This contrasts with the regulation of sulphur metabolism in higher plants, which generally involves up-regulation of several sulphur assimilatory enzymes. In T. pseudonana changes relating to sulphur metabolism were specific to the individual treatments and, given that little coordination was seen in transcript and protein responses across the three growth conditions, different patterns of regulation might be responsible for the increase in DMSP concentration seen under each treatment.	[Kettles, Nicola Louise; Malin, Gill] Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England; [Kettles, Nicola Louise; Kopriva, Stanislav] John Innes Ctr, Norwich, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kopriva, S (corresponding author), John Innes Ctr, Norwich, Norfolk, England.	stanislav.kopriva@jic.ac.uk	Kopriva, Stanislav/C-7401-2013; Malin, Gill/C-6985-2009	Kopriva, Stanislav/0000-0002-7416-6551; Malin, Gill/0000-0002-3639-9215	Norwich Research Park Studentship; John Innes Centre and University of East Anglia Earth and Life Systems Alliance; UK Natural Environment Research Council Advanced Fellowship [NE/B501039/1]; Biotechnology and Biological Sciences Research Council [BB/J004561/1]; John Innes Foundation; Natural Environment Research Council [NE/B501039/1] Funding Source: researchfish	Norwich Research Park Studentship; John Innes Centre and University of East Anglia Earth and Life Systems Alliance; UK Natural Environment Research Council Advanced Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Norwich Research Park Studentship and by the John Innes Centre and University of East Anglia Earth and Life Systems Alliance. G. M. was funded through a UK Natural Environment Research Council Advanced Fellowship (NE/B501039/1) and S.K.'s research is supported by BB/J004561/1 grant from the Biotechnology and Biological Sciences Research Council and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ayers GP, 2007, ENVIRON CHEM, V4, P366, DOI 10.1071/EN07080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Blanco J, 1998, J BACTERIOL, V180, P1586, DOI 10.1128/JB.180.6.1586-1591.1998; Bochenek M, 2013, NEW PHYTOL, V199, P650, DOI 10.1111/nph.12303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucciarelli E, 2003, LIMNOL OCEANOGR, V48, P2256, DOI 10.4319/lo.2003.48.6.2256; Caruana AMN, 2012, BIOGEOCHEMISTRY, V110, P87, DOI 10.1007/s10533-012-9705-4; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DICKSON DM, 1980, PLANTA, V150, P158, DOI 10.1007/BF00582360; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; Franklin DJ, 2012, LIMNOL OCEANOGR, V57, P305, DOI 10.4319/lo.2012.57.1.0305; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gao Y, 2000, PLANT PHYSIOL, V123, P1087, DOI 10.1104/pp.123.3.1087; GREENE RC, 1962, J BIOL CHEM, V237, P2251; GRONE T, 1992, MAR BIOL, V112, P497, DOI 10.1007/BF00356296; Gunson JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024982; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Harada E, 2000, J PLANT PHYSIOL, V156, P272, DOI 10.1016/S0176-1617(00)80317-X; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; HARRISON J, 2005, ALGAL CULTURING TECH, P21; Hesse H, 2004, J EXP BOT, V55, P1799, DOI 10.1093/jxb/erh139; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hui Y, 2000, PHOTOCHEM PHOTOBIOL, V72, P508, DOI 10.1562/0031-8655(2000)072<0508:DOTPIC>2.0.CO;2; Karsten U, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P143; KELLER MD, 1989, ACS SYM SER, V393, P167; Keller MD, 1999, MAR BIOL, V135, P249, DOI 10.1007/s002270050622; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Khan MS, 2010, PLANT CELL, V22, P1216, DOI 10.1105/tpc.110.074088; Kopriva S, 1999, PLANT J, V20, P37, DOI 10.1046/j.1365-313X.1999.00573.x; Kopriva S, 2002, PLANT PHYSIOL, V130, P1406, DOI 10.1104/pp.007773; Kopriva S, 2007, J BIOL CHEM, V282, P22930, DOI 10.1074/jbc.M702522200; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; McCoy JG, 2009, PROTEINS, V74, P368, DOI 10.1002/prot.22147; NEUENSCHWANDER U, 1991, PLANT PHYSIOL, V97, P253, DOI 10.1104/pp.97.1.253; Nunn BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075653; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; Ohkama N, 2002, PLANT CELL PHYSIOL, V43, P1493, DOI 10.1093/pcp/pcf183; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rajagopal S, 2005, FEBS J, V272, P892, DOI 10.1111/j.1742-4658.2004.04512.x; Ratti S, 2011, GEOBIOLOGY, V9, P301, DOI 10.1111/j.1472-4669.2011.00284.x; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 2000, J SEA RES, V43, P233, DOI 10.1016/S1385-1101(00)00024-1; Summers PS, 1998, PLANT PHYSIOL, V116, P369, DOI 10.1104/pp.116.1.369; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; VAIRAVAMURTHY A, 1985, LIMNOL OCEANOGR, V30, P59, DOI 10.4319/lo.1985.30.1.0059; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; Zolla L, 2002, BIOCHEMISTRY-US, V41, P14391, DOI 10.1021/bi0265776	61	37	39	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94795	10.1371/journal.pone.0094795	http://dx.doi.org/10.1371/journal.pone.0094795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733415	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000336970400106
J	Smodis, NC; Silar, M; Erzen, R; Rijavec, M; Kosnik, M; Korosec, P				Smodis, Nina Celesnik; Silar, Mira; Erzen, Renato; Rijavec, Matija; Kosnik, Mitja; Korosec, Peter			Down-Regulation of Fc epsilon RI-Mediated CD63 Basophil Response during Short-Term VIT Determined Venom-Nonspecific Desensitization	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; LEUKOCYTE SENSITIVITY; THRESHOLD-SENSITIVITY; INJECTION THERAPY; IGE-SENSITIZATION; HISTAMINE; RELEASE; ACTIVATION; MECHANISMS; CHALLENGE	Background: We recently showed a desensitization of Fc epsilon RI-mediated basophil response after short-term VIT. Our aim was to evaluate the allergen specificity of this desensitization. Methods: In 11 Hymenoptera-venom double positive subjects, basophil threshold sensitivity (CD-sens) to anti-Fc epsilon RI, honeybee, and Vespula venom was assessed at the beginning and just before the first maintenance dose (MD) of single ultra-rush VIT. In some patients we also monitored CD-sens to rApi m 1 and/or rVes v 5 or other co-sensitizations (i.e., grass pollen). In additional 7 patients, basophils were stripped and sensitized with house dust mite (HDM) IgEs at the same time points. Results: We demonstrated a marked reduction of CD-sens to anti-FceRI and VIT-specific venom before the first MD in all 18 subjects included. Furthermore, in 10 out of 11 double positive subjects, a significant and comparable decrease before the first MD was also evident for non-VIT venom; this nonspecific decrease was further supported by the opposite recombinant species-specific major allergen. In one subject with additional grass pollen allergy, a decrease of CD-sens to grass allergen was also demonstrated. Similarly, in 7 cases of patients with passively HDM-sensitized basophils, a significant reduction of CD-sens was also evident to de novo sensitized HDM allergen. Conclusions: Short-term VIT induced basophil desensitization to VIT-specific as well as to VIT-nonspecific venom. As opposed to long-term VIT, which induces venom-specific changes, the effect of short-term VIT seems to be venom-nonspecific.	[Smodis, Nina Celesnik; Silar, Mira; Erzen, Renato; Rijavec, Matija; Kosnik, Mitja; Korosec, Peter] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia	University Clinic Golnik	Smodis, NC (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.	nina.celesnik@klinika-golnik.si	Košnik, Mitja/AAI-2295-2019	Košnik, Mitja/0000-0002-4701-7374; Korosec, Peter/0000-0002-0835-1599; Rijavec, Matija/0000-0002-2596-4952	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The study was supported by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Bieber T, 2011, ALLERGY, V66, P709, DOI 10.1111/j.1398-9995.2011.02595.x; Bilo BM, 2011, IMMUNOTHERAPY-UK, V3, P229, DOI 10.2217/IMT.10.88; Bilo MB, 2011, ALLERGY, V66, P35, DOI 10.1111/j.1398-9995.2011.02630.x; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Bussmann C, 2010, ALLERGY, V65, P1558, DOI 10.1111/j.1398-9995.2010.02430.x; Celesnik N, 2012, ALLERGY, V67, P1594, DOI 10.1111/all.12044; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, P889, DOI 10.1016/j.jaci.2009.09.012; Erzen R, 2012, ALLERGY, V67, P822, DOI 10.1111/j.1398-9995.2012.02817.x; FORCK G, 1986, ALLERGOLOGIE, V9, pS18; Glaumann S, 2012, ALLERGY, V67, P242, DOI 10.1111/j.1398-9995.2011.02754.x; Goldberg A, 2010, ALLERGY, V65, P391, DOI 10.1111/j.1398-9995.2009.02198.x; Johansson SGO, 2009, ALLERGY, V64, P1472, DOI 10.1111/j.1398-9995.2009.02051.x; Johansson SGO, 2005, ALLERGY, V60, P1192, DOI 10.1111/j.1398-9995.2005.00870.x; Jutel M, 1996, CLIN EXP ALLERGY, V26, P1112, DOI 10.1111/j.1365-2222.1996.tb00496.x; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Karasuyama H, 2011, ALLERGY, V66, P1133, DOI 10.1111/j.1398-9995.2011.02613.x; Korosec P, 2013, INT ARCH ALLERGY IMM, V161, P363, DOI 10.1159/000348500; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Kosnik M, 2003, ALLERGY HYPERSENSITI, V1, P33; Lalek N, 2010, CLIN EXP ALLERGY, V40, P1186, DOI 10.1111/j.1365-2222.2010.03524.x; MACGLASHAN DW, 1981, J IMMUNOL, V127, P2410; MAY C D, 1973, Clinical Allergy, V3, P319, DOI 10.1111/j.1365-2222.1973.tb01340.x; MAY CD, 1972, J ALLERGY CLIN IMMUN, V50, P99, DOI 10.1016/0091-6749(72)90005-X; MAY CD, 1971, J ALLERGY CLIN IMMUN, V48, P313, DOI 10.1016/0091-6749(71)90033-9; Mikkelsen Susan, 2010, Clin Mol Allergy, V8, P2, DOI 10.1186/1476-7961-8-2; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Nopp A, 2009, ALLERGY, V64, P811, DOI 10.1111/j.1398-9995.2008.01900.x; Novak N, 2012, J ALLERGY CLIN IMMUN, V130, P1153, DOI 10.1016/j.jaci.2012.04.039; Nullens S, 2013, CYTOM PART B-CLIN CY, V84B, P173, DOI 10.1002/cyto.b.21084; Pierkes M, 1999, J ALLERGY CLIN IMMUN, V103, P326, DOI 10.1016/S0091-6749(99)70509-9; Plewako H, 2006, INT ARCH ALLERGY IMM, V141, P346, DOI 10.1159/000095461; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; SOBOTKA AK, 1979, J IMMUNOL, V122, P511; Varga EM, 2009, CLIN EXP ALLERGY, V39, P1353, DOI 10.1111/j.1365-2222.2009.03303.x; Zitnik SEK, 2012, PEDIAT ALLERG IMM-UK, V23, P167, DOI 10.1111/j.1399-3038.2011.01233.x	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94762	10.1371/journal.pone.0094762	http://dx.doi.org/10.1371/journal.pone.0094762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733549	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400093
J	Wacklin, P; Tuimala, J; Nikkila, J; Tims, S; Makivuokko, H; Alakulppi, N; Laine, P; Rajilic-Stojanovic, M; Paulin, L; de Vos, WM; Matto, J				Wacklin, Pirjo; Tuimala, Jarno; Nikkila, Janne; Tims, Sebastian; Makivuokko, Harri; Alakulppi, Noora; Laine, Pia; Rajilic-Stojanovic, Mirjana; Paulin, Lars; de Vos, Willem M.; Matto, Jaana			Faecal Microbiota Composition in Adults Is Associated with the FUT2 Gene Determining the Secretor Status	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD-GROUP; INTESTINAL MICROBIOTA; CELIAC-DISEASE; GUT MICROBIOME; METABOLISM; SIGNATURES; VARIANCE; ANTIGENS; MUCOSA	The human intestine is colonised with highly diverse and individually defined microbiota, which likely has an impact on the host well-being. Drivers of the individual variation in the microbiota compositions are multifactorial and include environmental, host and dietary factors. We studied the impact of the host secretor status, encoded by fucosyltransferase 2 (FUT2) -gene, on the intestinal microbiota composition. Secretor status determines the expression of the ABH and Lewis histo-blood group antigens in the intestinal mucosa. The study population was comprised of 14 non-secretor (FUT2 rs601338 genotype AA) and 57 secretor (genotypes GG and AG) adult individuals of western European descent. Intestinal microbiota was analyzed by PCR-DGGE and for a subset of 12 non-secretor subjects and 12 secretor subjects additionally by the 16S rRNA gene pyrosequencing and the HITChip phylogenetic microarray analysis. All three methods showed distinct clustering of the intestinal microbiota and significant differences in abundances of several taxa representing dominant microbiota between the non-secretors and the secretors as well as between the FUT2 genotypes. In addition, the non-secretors had lower species richness than the secretors. The soft clustering of microbiota into enterotypes (ET) 1 and 3 showed that the non-secretors had a higher probability of belonging to ET1 and the secretors to ET3. Our study shows that secretor status and FUT2 polymorphism are associated with the composition of human intestinal microbiota, and appears thus to be one of the key drivers affecting the individual variation of human intestinal microbiota.	[Wacklin, Pirjo; Tuimala, Jarno; Nikkila, Janne; Makivuokko, Harri; Alakulppi, Noora; Matto, Jaana] Finnish Red Cross Blood Serv, Helsinki, Finland; [Laine, Pia; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Tims, Sebastian; Rajilic-Stojanovic, Mirjana; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of Helsinki; University of Helsinki; University of Helsinki; Wageningen University & Research	Wacklin, P (corresponding author), Finnish Red Cross Blood Serv, Helsinki, Finland.	pirjo.wacklin@veripalvelu.fi	Alakulppi, Noora/D-7839-2015; Rajilić-Stojanović, Mirjana/AAT-7149-2021	Alakulppi, Noora/0000-0002-2292-9342; Rajilic-Stojanovic, Mirjana/0000-0003-1624-1557; Laine, Pia/0000-0002-3727-8749	Netherlands Organization for Scientific Research (Spinoza Grant); Finnish Academy of Sciences [141140]	Netherlands Organization for Scientific Research (Spinoza Grant); Finnish Academy of Sciences(Academy of Finland)	Part of this work was supported by the Netherlands Organization for Scientific Research (Spinoza Grant 2008 to WMdV) and the Finnish Academy of Sciences (141140 to WMdV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; EXCOFFIER L, 1992, GENETICS, V131, P479; Hata DJ, 2004, ARTIF CELL BLOOD SUB, V32, P263, DOI 10.1081/BIO-120037831; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; HOSKINS LC, 1976, J CLIN INVEST, V57, P63, DOI 10.1172/JCI108270; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Makivuokko H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-94; Manly B.F.J., 1997, RANDOMIZATION MONTE; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Miyoshi J, 2011, J GASTROENTEROL, V46, P1056, DOI 10.1007/s00535-011-0425-7; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nurjadi D, 2012, J INFECTION, V65, P310, DOI 10.1016/j.jinf.2012.05.011; Oksanen J., 2017, R PACKAGE VERSION 26; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2013, P NATL ACAD SCI USA, V110, P654; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1751, DOI DOI 10.1111/j.1462-2920.2009.01900.x; Rajilic-Stojanovic M, 2007, DIVERSITY HUMAN GAST; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Roberts D.W., 2010, LABDSV ORDINATION MU; Rossi J, 2011, RICH SPECIES RICHNES; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stewart CS, 2004, FEMS MICROBIOL LETT, V230, P1, DOI 10.1016/S0378-1097(03)00864-4; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	59	100	103	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94863	10.1371/journal.pone.0094863	http://dx.doi.org/10.1371/journal.pone.0094863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733310	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400123
J	Westrate, LM; Drocco, JA; Martin, KR; Hlavacek, WS; MacKeigan, JP				Westrate, Laura M.; Drocco, Jeffrey A.; Martin, Katie R.; Hlavacek, William S.; MacKeigan, Jeffrey P.			Mitochondrial Morphological Features Are Associated with Fission and Fusion Events	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; HUMAN-CELLS; OPA1	Mitochondria are dynamic organelles that undergo constant remodeling through the regulation of two opposing processes, mitochondrial fission and fusion. Although several key regulators and physiological stimuli have been identified to control mitochondrial fission and fusion, the role of mitochondrial morphology in the two processes remains to be determined. To address this knowledge gap, we investigated whether morphological features extracted from time-lapse live-cell images of mitochondria could be used to predict mitochondrial fate. That is, we asked if we could predict whether a mitochondrion is likely to participate in a fission or fusion event based on its current shape and local environment. Using live-cell microscopy, image analysis software, and supervised machine learning, we characterized mitochondrial dynamics with single-organelle resolution to identify features of mitochondria that are predictive of fission and fusion events. A random forest (RF) model was trained to correctly classify mitochondria poised for either fission or fusion based on a series of morphological and positional features for each organelle. Of the features we evaluated, mitochondrial perimeter positively correlated with mitochondria about to undergo a fission event. Similarly mitochondrial solidity (compact shape) positively correlated with mitochondria about to undergo a fusion event. Our results indicate that fission and fusion are positively correlated with mitochondrial morphological features; and therefore, mitochondrial fission and fusion may be influenced by the mechanical properties of mitochondrial membranes.	[Westrate, Laura M.; Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; [Westrate, Laura M.; MacKeigan, Jeffrey P.] Van Andel Inst, Grad Sch, Grand Rapids, MI USA; [Drocco, Jeffrey A.; Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Div Theoret, Los Alamos, NM 87545 USA; [Hlavacek, William S.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Drocco, Jeffrey A.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA USA	Van Andel Institute; Van Andel Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA.	jeff.mackeigan@vai.org		Martin, Katie/0000-0002-3689-4814; Hlavacek, William/0000-0003-4383-8711; MacKeigan, Jeffrey/0000-0002-0198-5679	National Cancer Institute of the National Institutes of Health [RO1CA138651]; Van Andel Institute Graduate School; NIH [P50GM085273]; Center for Nonlinear Studies (CNLS); Laboratory-directed Research and Development (LDRD) Program at Los Alamos National Laboratory; National Nuclear Security Administration of the US Department of Energy [DE-AC52-06NA25396]; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Institute Graduate School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Nonlinear Studies (CNLS); Laboratory-directed Research and Development (LDRD) Program at Los Alamos National Laboratory; National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by award number RO1CA138651 from the National Cancer Institute of the National Institutes of Health (J.P. MacKeigan) and a fellowship award from the Van Andel Institute Graduate School (L. M. Westrate). This work was also supported in part by NIH grant P50GM085273 (W. S. Hlavacek). J.A. Drocco acknowledges support from the Center for Nonlinear Studies (CNLS) and the Laboratory-directed Research and Development (LDRD) Program at Los Alamos National Laboratory, which is operated for the National Nuclear Security Administration of the US Department of Energy under contract DE-AC52-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jaiantilal A, 2009, CLASSIFICATION REGRE; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; McInnes J, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-12; Mitchell M.W., 2011, OJS, V01, P205, DOI [10.4236/ojs.2011.13024, DOI 10.4236/OJS.2011.13024]; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Santel A, 2001, J CELL SCI, V114, P867; Team RDC, 2012, R LANG ENV STAT COMP; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2010, AM J PHYSIOL-CELL PH, V299, pC477, DOI 10.1152/ajpcell.00427.2009; Wang SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0019879; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933	36	65	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95265	10.1371/journal.pone.0095265	http://dx.doi.org/10.1371/journal.pone.0095265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733410	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400164
J	Baysan, M; Woolard, K; Bozdag, S; Riddick, G; Kotliarova, S; Cam, MC; Belova, GI; Ahn, S; Zhang, W; Song, H; Walling, J; Stevenson, H; Meltzer, P; Fine, HA				Baysan, Mehmet; Woolard, Kevin; Bozdag, Serdar; Riddick, Gregory; Kotliarova, Svetlana; Cam, Margaret C.; Belova, Galina I.; Ahn, Susie; Zhang, Wei; Song, Hua; Walling, Jennifer; Stevenson, Holly; Meltzer, Paul; Fine, Howard A.			Micro-Environment Causes Reversible Changes in DNA Methylation and mRNA Expression Profiles in Patient-Derived Glioma Stem Cells	PLOS ONE			English	Article							GLIOBLASTOMA; HETEROGENEITY; CANCER; EGFR; DIFFERENTIATION; PLURIPOTENT; LANDSCAPE; SUBTYPES; MODELS; PDGFRA	In vitro and in vivo models are widely used in cancer research. Characterizing the similarities and differences between a patient's tumor and corresponding in vitro and in vivo models is important for understanding the potential clinical relevance of experimental data generated with these models. Towards this aim, we analyzed the genomic aberrations, DNA methylation and transcriptome profiles of five parental tumors and their matched in vitro isolated glioma stem cell (GSC) lines and xenografts generated from these same GSCs using high-resolution platforms. We observed that the methylation and transcriptome profiles of in vitro GSCs were significantly different from their corresponding xenografts, which were actually more similar to their original parental tumors. This points to the potentially critical role of the brain microenvironment in influencing methylation and transcriptional patterns of GSCs. Consistent with this possibility, ex vivo cultured GSCs isolated from xenografts showed a tendency to return to their initial in vitro states even after a short time in culture, supporting a rapid dynamic adaptation to the in vitro microenvironment. These results show that methylation and transcriptome profiles are highly dependent on the microenvironment and growth in orthotopic sites partially reverse the changes caused by in vitro culturing.	[Baysan, Mehmet; Fine, Howard A.] NYU, Langone Med Ctr, Inst Canc, Brain Tumor Ctr, New York, NY USA; [Woolard, Kevin] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Riddick, Gregory; Kotliarova, Svetlana; Cam, Margaret C.; Belova, Galina I.; Ahn, Susie; Zhang, Wei; Song, Hua] NINDS, Neurooncol Branch, NCI, NIH, Bethesda, MD 20892 USA; [Walling, Jennifer; Stevenson, Holly; Meltzer, Paul] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	New York University; NYU Langone Medical Center; University of California System; University of California Davis; Marquette University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fine, HA (corresponding author), NYU, Langone Med Ctr, Inst Canc, New York, NY 10012 USA.	Howard.Fine@nyumc.org	baysan, mehmet/O-1710-2018	baysan, mehmet/0000-0001-7359-2965	NATIONAL CANCER INSTITUTE [ZICBC011532] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baysan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047839; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Bozdag S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062982; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gonda DD, 2013, CANC GENOME ATLAS EX; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jones TS, 2011, EXPERT OPIN DRUG DIS, V6, P1271, DOI 10.1517/17460441.2011.632628; Kim HS, 2012, CANCER RES, V72, P6065, DOI 10.1158/0008-5472.CAN-12-2594; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Turcan S, 2012, NATURE; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	35	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94045	10.1371/journal.pone.0094045	http://dx.doi.org/10.1371/journal.pone.0094045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728236	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200035
J	Chen, YY; Chang, JR; Huang, WF; Hsu, SC; Kuo, SC; Sun, JR; Dou, HY				Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Hsu, Shu-Ching; Kuo, Shu-Chen; Sun, Jun-Ren; Dou, Horng-Yunn			The Pattern of Cytokine Production In Vitro Induced by Ancient and Modern Beijing Mycobacterium tuberculosis Strains	PLOS ONE			English	Article							INNATE IMMUNITY; TRANSMISSION; GENOTYPES	It is unclear to what extent the host-responses elicited by Beijing versus non-Beijing strains of Mycobacterium tuberculosis (MTB) contribute to the predominance of modern Beijing strains in Taiwan and some other Asian countries. The purpose of this study was to compare the expression profiles of virulence-related genes in human monocyte-derived macrophages infected in vitro with Beijing (ancient and modern strains) and non-Beijing strains (EAI strains) of MTB that are epidemic in Taiwan. We found that modern Beijing strains induced lower levels of pro-inflammatory cytokines, whereas EAI strains induced higher levels. Notably, the most prevalent modern Beijing sub-lineage, possessing intact RD150 and RD142 chromosomal regions, induced very low levels of pro-inflammatory cytokines, especially interleukin-1 beta. Moreover, in an intracellular growth assay, the survival of the same modern Beijing strain in human monocyte-derived macrophages was significantly higher than that of an ancient Beijing strain and an EAI strain. Taken together, these results may explain why modern Beijing strains of MTB predominate in Taiwan.	[Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Hsu, Shu-Ching; Kuo, Shu-Chen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Sun, Jun-Ren] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Sun, Jun-Ren] Natl Def Med Ctr, Taipei, Taiwan	National Health Research Institutes - Taiwan; Tri-Service General Hospital; National Defense Medical Center	Dou, HY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Hsu, Shu-Ching/E-3869-2010; Dou, Horng-Yunn/B-2652-2010; Dou, horng-yunn/F-1966-2015; Kuo, Shu-Chen/G-9108-2011	Chen, Yih-Yuan/0000-0001-9507-291X; Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council (NSC), Taiwan [102-2320-B-400-006]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from National Health Research Institutes and National Science Council (NSC 102-2320-B-400-006), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; CDC, 2012, TUB CONTR REP 2012; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Dou HY, 2008, INFECT GENET EVOL, V8, P323, DOI 10.1016/j.meegid.2008.02.003; Dou HY, 2011, INT J EVOL BIOL, V2011; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gonzalez-Cortes C, 2012, IMMUNOBIOLOGY, V217, P394, DOI 10.1016/j.imbio.2011.10.015; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; Khajoee V, 2006, CLIN EXP IMMUNOL, V143, P260, DOI 10.1111/j.1365-2249.2005.02985.x; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 1999, J IMMUNOL, V162, P6740; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P1504, DOI 10.1128/JCM.40.4.1504-1507.2002; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594	33	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94296	10.1371/journal.pone.0094296	http://dx.doi.org/10.1371/journal.pone.0094296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728339	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200056
J	Li, WF; Zhang, L; Li, HY; Zheng, SS; Zhao, L				Li, Wen-Feng; Zhang, Li; Li, Hai-Ying; Zheng, Si-Si; Zhao, Liang			WISP-1 Contributes to Fractionated Irradiation-Induced Radioresistance in Esophageal Carcinoma Cell Lines and Mice	PLOS ONE			English	Article							MITOTIC CATASTROPHE; BETA-CATENIN; ACTIVATION; APOPTOSIS; DEATH; P53; CANCER; CHK2	Cancer cells that survive fractionated irradiation can be radioresistant and cause tumor recurrence. However, the molecular mechanisms underlying the development of radioresistance in cancer cells remain elusive. The aim of this study was to investigate the role of WISP-1 in the development of radioresistance in esophageal carcinoma during fractionated irradiation. Radioresistant esophageal cancer cells were generated from normal esophageal cancer cells via fractionated irradiation, and expression levels of related proteins were determined by Western blot. Radiosensitivity of cells was established by clonogenic cell survival assays, and cell cycle distribution was evaluated by flow cytometry. Protein distributions were determined by immunofluorescence, and cell toxicity was evaluated by cell counting kit-8 assays. In vivo validations were performed in a xenograft transplantation mouse model. Our data indicate that WISP-1 plays an important role in the development of radioresistance in esophageal cancer cells during fractionated irradiation. The overexression of WISP-1 in esophageal cancer cells was associated with radioresistance. Depletion of extracellular WISP-1 by antibody neutralizing reversed radioresistance and directly induced mitotic catastrophe resulting in cell death. WISP-1 may be a candidate therapeutic target in the treatment of recurrent esophageal carcinoma after radiotherapy.	[Li, Wen-Feng; Zhang, Li] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Wenzhou, Zhejiang, Peoples R China; [Li, Hai-Ying] Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Si-Si; Zhao, Liang] Wenzhou Med Univ, Affiliated Hosp 1, Div PET CT, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhao, L (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Div PET CT, Wenzhou, Zhejiang, Peoples R China.	Zhao45671@hotmail.com	Zhao, Liang/T-9147-2019		Zhejiang Provincial Natural Science Foundation of China [LQ12H16005]; Wenzhou Science & Technology Bureau [Y20110047, Y20120013]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Science & Technology Bureau	This material is based upon work funded by Zhejiang Provincial Natural Science Foundation of China (No. LQ12H16005) and Wenzhou Science & Technology Bureau (No. Y20110047 and No. Y20120013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhard EJ, 1999, CANCER J SCI AM, V5, P194; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chabalier-Taste C, 2008, BBA-MOL CELL RES, V1783, P2223, DOI 10.1016/j.bbamcr.2008.08.006; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kim Y, 2012, LAB INVEST, V92, P466, DOI 10.1038/labinvest.2011.161; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lock RB, 1996, CANCER RES, V56, P4006; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Nagai Y, 2011, ANTICANCER RES, V31, P991; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; TOUNEKTI O, 1993, CANCER RES, V53, P5462; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xu LF, 2000, GENE DEV, V14, P585; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang XC, 2008, CLIN CANCER RES, V14, P2813, DOI 10.1158/1078-0432.CCR-07-1528	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94751	10.1371/journal.pone.0094751	http://dx.doi.org/10.1371/journal.pone.0094751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728101	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200127
J	Small, K; Kopf, RK; Watts, RJ; Howitt, J				Small, Kade; Kopf, R. Keller; Watts, Robyn J.; Howitt, Julia			Hypoxia, Blackwater and Fish Kills: Experimental Lethal Oxygen Thresholds in Juvenile Predatory Lowland River Fishes	PLOS ONE			English	Article							EUCALYPTUS-CAMALDULENSIS; WATER-QUALITY; TEMPERATURE; RESPONSES; BASIN; RESPIRATION; ENVIRONMENT; TOLERANCES; SYSTEM; EVENT	Hypoxia represents a growing threat to biodiversity in freshwater ecosystems. Here, aquatic surface respiration (ASR) and oxygen thresholds required for survival in freshwater and simulated blackwater are evaluated for four lowland river fishes native to the Murray-Darling Basin (MDB), Australia. Juvenile stages of predatory species including golden perch Macquaria ambigua, silver perch Bidyanus bidyanus, Murray cod Maccullochella peelii, and eel-tailed catfish Tandanus tandanus were exposed to experimental conditions of nitrogen-induced hypoxia in freshwater and hypoxic blackwater simulations using dried river red gum Eucalyptus camaldulensis leaf litter. Australia's largest freshwater fish, M. peelii, was the most sensitive to hypoxia but given that we evaluated tolerances of juveniles (0.99 +/- 0.04 g; mean mass +/- SE), the low tolerance of this species could not be attributed to its large maximum attainable body mass (>100,000 g). Concentrations of dissolved oxygen causing 50% mortality (LC50) in freshwater ranged from 0.25 +/- 0.06 mg l(-1) in T. tandanus to 1.58 +/-.01 mg l(-1) in M. peelii over 48 h at 25-26 degrees C. Logistic models predicted that first mortalities may start at oxygen concentrations ranging from 2.4 mg l(-1) to 3.1 mg l(-1) in T. tandanus and M. peelii respectively within blackwater simulations. Aquatic surface respiration preceded mortality and this behaviour is documented here for the first time in juveniles of all four species. Despite the natural occurrence of hypoxia and blackwater events in lowland rivers of the MDB, juvenile stages of these large-bodied predators are vulnerable to mortality induced by low oxygen concentration and water chemistry changes associated with the decomposition of organic material. Given the extent of natural flow regime alteration and climate change predictions of rising temperatures and more severe drought and flooding, acute episodes of hypoxia may represent an underappreciated risk to riverine fish communities.	[Small, Kade; Watts, Robyn J.] Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia; [Kopf, R. Keller; Watts, Robyn J.; Howitt, Julia] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia; [Howitt, Julia] Charles Sturt Univ, Sch Agr & Wine Sci, Wagga Wagga, NSW, Australia	Charles Sturt University; Charles Sturt University; Charles Sturt University	Kopf, RK (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	rkopf@csu.edu.au	Howitt, Julia A/A-1318-2008	Howitt, Julia A/0000-0003-2209-8670; Kopf, R. Keller/0000-0001-5780-0074; Watts, Robyn/0000-0002-3526-7261	CSU honours scholarship	CSU honours scholarship	Support for this research came from a CSU honours scholarship (K. Small) and from the Ecological Responses to Altered Flow Regimes Research Cluster which represents a collaboration between the CSIRO Water for a Healthy Country Flagship, Griffith University, the University of New South Wales, Monash University, Charles Sturt University, La Trobe University, and the Arthur Rylah Institute of the Victorian Department of Environment and Primary Industries. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Anderson HK, 1919, AUSTR ZOOLOGIST, V1, P157; Anjos MB, 2008, BRAZ J BIOL, V68, P45, DOI 10.1590/S1519-69842008000100007; [Anonymous], 1992, GUIDELINE TESTING CH; [Anonymous], 1998, STANDARD METHODS EXA; CALA P, 1987, J FISH BIOL, V31, P301, DOI 10.1111/j.1095-8649.1987.tb05236.x; Chapman LJ, 2009, FISH PHYSIOL, V27, P25, DOI 10.1016/S1546-5098(08)00002-2; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; GEE JH, 1991, COPEIA, P17, DOI 10.2307/1446244; GEHRKE PC, 1991, AUST J MAR FRESH RES, V42, P707; GEHRKE PC, 1988, COMP BIOCHEM PHYS A, V89, P587, DOI 10.1016/0300-9629(88)90837-7; GEHRKE PC, 1993, J FISH BIOL, V43, P265, DOI 10.1111/j.1095-8649.1993.tb00427.x; Hladyz S, 2011, J HYDROL, V401, P117, DOI 10.1016/j.jhydrol.2011.02.014; Howitt JA, 2007, ECOL MODEL, V203, P229, DOI 10.1016/j.ecolmodel.2006.11.017; Humphries P, 1999, ENVIRON BIOL FISH, V56, P129, DOI 10.1023/A:1007536009916; Jacobson PC, 2008, T AM FISH SOC, V137, P1464, DOI 10.1577/T07-148.1; James KR, 2003, AUST J BOT, V51, P703, DOI 10.1071/BT02110; Jones MJ, 2007, ECOL FRESHW FISH, V16, P210, DOI 10.1111/j.1600-0633.2006.00213.x; KALININ AL, 1993, FISH PHYSIOL BIOCHEM, V12, P47, DOI 10.1007/BF00004321; King AJ, 2012, MAR FRESHWATER RES, V63, P576, DOI 10.1071/MF11275; KOEHN JD, 2004, MANAGEMENT MURRAY CO; KRAMER DL, 1982, ENVIRON BIOL FISH, V7, P47, DOI 10.1007/BF00011822; KRAMER DL, 1978, CAN J ZOOL, V56, P717, DOI 10.1139/z78-101; La VT, 2011, REV FISH SCI, V19, P21, DOI 10.1080/10641262.2010.531793; Landman MJ, 2005, NEW ZEAL J MAR FRESH, V39, P1061, DOI 10.1080/00288330.2005.9517375; LEWIS WM, 1970, COPEIA, P319, DOI 10.2307/1441653; Lintermans M., 2007, FISHES MURRAY DARLIN; McMaster D, 2008, MAR FRESHWATER RES, V59, P177, DOI 10.1071/MF07140; McNeil DG, 2007, FRESHWATER BIOL, V52, P412, DOI 10.1111/j.1365-2427.2006.01705.x; MEYER JL, 1990, BIOSCIENCE, V40, P643, DOI 10.2307/1311431; MOSS D. D., 1961, TRANS AMER FISH SOC, V90, P377, DOI 10.1577/1548-8659(1961)90[377:DROTSO]2.0.CO;2; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Nilsson GE, 2008, BIOL REV, V83, P173, DOI 10.1111/j.1469-185X.2008.00038.x; Ostrand KG, 2004, T AM FISH SOC, V130, P742; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; SMALE MA, 1995, T AM FISH SOC, V124, P698, DOI 10.1577/1548-8659(1995)124<0698:HAHTOH>2.3.CO;2; SYSTAT SOFTWARE, 2006, SIGMAPLOT WINDOWS VE; Vaquer-Sunyer R, 2011, GLOBAL CHANGE BIOL, V17, P1788, DOI 10.1111/j.1365-2486.2010.02343.x; Whitworth KL, 2012, J HYDROL, V450, P190, DOI 10.1016/j.jhydrol.2012.04.057; Zuur Alain F., 2009, P1	39	45	47	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94524	10.1371/journal.pone.0094524	http://dx.doi.org/10.1371/journal.pone.0094524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728094	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200088
J	Lin, CH; Kang, CJ; Tsao, CK; Wallace, CG; Lee, LY; Lin, CY; Wang, HM; Ng, SH; Yen, TC; Liao, CT				Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta			Priority of Fibular Reconstruction in Patients with Oral Cavity Cancer Undergoing Segmental Mandibulectomy	PLOS ONE			English	Article							NECK LYMPH-NODES; BONE INVASION; CARCINOMA; RESECTION; DEFECTS; EXTENT	Background: The fibula osteoseptocutaneous free flap is generally used for segmental mandibular reconstructions following resection of oral cavity squamous cell carcinoma (OSCC). However, less complex reconstructions may be feasible for patients with predicted poor survival. Herein, we sought to identify the main risk factors (RFs) associated with poor prognosis in OSCC patients undergoing segmental mandibulectomy to help decide between fibular and non-fibular reconstructions. Methods: Between 1996 and 2011, we examined the 5-year control, distant metastases, and survival rates in 310 consecutive, previously untreated patients with primary OSCC who underwent segmental mandibulectomy. Results: Margin status was the only independent RF for 5-year local control. Level IV/V metastases, extracapsular spread, and tumor depth >= 15 mm were independent RFs for poor 5-year survival. In the entire study cohort, 23% of the patients had 2 or 3 adverse RFs; such a high-risk group was characterized by a poor prognosis and may be suitable for non-fibular reconstructions. Overall, 70% of the study patients were cT1-4N0, cT1N2, cT2N1, or had tumor depth <15 mm; less than 5% of patients in this subgroup had 2 or 3 adverse RFs and were thus candidates for fibular reconstructions. Among the remaining 30% of patients who showed both advanced clinical stage (cT2N2, cT3-4N1-2) and tumor depth >= 15 mm, 70% exhibited 2 or 3 adverse RFs. Conclusions: Level IV/V metastases, extracapsular spread, and tumor depth >15 mm were independent predictors of poor prognosis in OSCC patients undergoing segmental mandibulectomy. The preoperative or intraoperative identification of adverse RFs may help decide between fibular and non-fibular mandibular reconstruction. High-risk patients bearing 2 or 3 adverse RFs have poor prognosis and should not be considered as candidates for fibular reconstructions.	[Lin, Chih-Hung; Tsao, Chung-Kan; Wallace, Christopher Glenn] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta] Chang Gung Univ, Taoyuan, Taiwan; [Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Head & Neck, Oncol Grp, Taoyuan, Taiwan; [Kang, Chung-Jan; Wallace, Christopher Glenn; Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Lin, Chien-Yu] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liao, CT (corresponding author), Chang Gung Mem Hosp, Dept Head & Neck, Oncol Grp, Taoyuan, Taiwan.	liaoct@adm.cgmh.org.tw	Li-yu, Lee/G-5055-2010		Chang Gung Memorial Hospital [CMRPG1B0591]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grant no. CMRPG1B0591, Chang Gung Memorial Hospital. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1997, AJCC CANC STAGING MA; [Anonymous], 2010, TAIW CANC REG ANN RE; Edge SB, 2010, AJCC CANC STAGING MA; Guerra MFM, 2003, J ORAL MAXIL SURG, V61, P1289, DOI 10.1016/S0278-2391(03)00730-4; Johnson RE, 1997, HEAD NECK-J SCI SPEC, V19, P281, DOI 10.1002/(SICI)1097-0347(199707)19:4<281::AID-HED6>3.0.CO;2-X; Liao CT, 2006, CANCER, V107, P337, DOI 10.1002/cncr.21984; Liao CT, 2013, ORAL ONCOL, V49, P230, DOI 10.1016/j.oraloncology.2012.09.010; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Liao CT, 2011, J NUCL MED, V52, P180, DOI 10.2967/jnumed.110.082370; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; O'Brien CJ, 2003, INT J ORAL MAX SURG, V32, P492, DOI 10.1054/ijom.2003.0420; Patel RS, 2008, LARYNGOSCOPE, V118, P780, DOI 10.1097/MLG.0b013e31816422bb; Saber Tarek K, 2009, J Egypt Natl Canc Inst, V21, P219; Wei FC, 2002, PLAST RECONSTR SURG, V109, P45, DOI 10.1097/00006534-200201000-00008; Wei FC, 1999, PLAST RECONSTR SURG, V103, P39, DOI 10.1097/00006534-199901000-00008	15	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94315	10.1371/journal.pone.0094315	http://dx.doi.org/10.1371/journal.pone.0094315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722353	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100052
J	Sacre, K; Escoubet, B; Pasquet, B; Chauveheid, MP; Zennaro, MC; Tubach, F; Papo, T				Sacre, Karim; Escoubet, Brigitte; Pasquet, Blandine; Chauveheid, Marie-Paule; Zennaro, Maria-Christina; Tubach, Florence; Papo, Thomas			Increased Arterial Stiffness in Systemic Lupus Erythematosus (SLE) Patients at Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ACCELERATED ATHEROSCLEROSIS; WOMEN; CLASSIFICATION; CRITERIA	Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus (SLE) patients. Although the risk for cardiovascular events in patients with SLE is significant, the absolute number of events per year in any given cohort remains small. Thus, CVD risks stratification in patients with SLE focuses on surrogate markers for atherosclerosis at an early stage, such as reduced elasticity of arteries. Our study was designed to determine whether arterial stiffness is increased in SLE patients at low risk for CVD and analyze the role for traditional and non-traditional CVD risk factors on arterial stiffness in SLE. Carotid-femoral pulse wave velocity (PWV) was prospectively assessed as a measure of arterial stiffness in 41 SLE patients and 35 controls (CTL). Adjustment on age or Framingham score was performed using a logistic regression model. Factors associated with PWV were identified separately in SLE patients and in controls using Pearson's correlation coefficient for univariate analysis and multiple linear regression for multivariate analysis. SLE patients and controls displayed a low 10-year risk for CVD according to Framingham score (1.8 +/- 3.6% in SLE vs 1.6 +/- 2.8% in CTL, p = 0.46). Pulse wave velocity was, however, higher in SLE patients (7.1 +/- 1.6 m/s) as compared to controls (6.3 +/- 0.8 m/s; p = 0.01, after Framingham score adjustment) and correlated with internal carotid wall thickness (p = 0.0017). In multivariable analysis, only systolic blood pressure (p = 0.0005) and cumulative dose of glucocorticoids (p = 0.01) were associated with PWV in SLE patients. Interestingly, the link between systolic blood pressure (SBP) and arterial stiffness was also confirmed in SLE patients with normal systolic blood pressure. In conclusion, arterial stiffness is increased in SLE patients despite a low risk for CVD according to Framingham score and is associated with systolic blood pressure and glucocorticoid therapy.	[Sacre, Karim; Chauveheid, Marie-Paule; Papo, Thomas] Univ Paris Diderot, Hop Bichat, AP HP, Dept Med Interne,PRES Sorbonne Paris Cite, Paris, France; [Sacre, Karim; Papo, Thomas] INSERM, U1149, Paris, France; [Sacre, Karim; Papo, Thomas] Dept Hosp Univ FIRE Fibrosis Inflammat & Remodell, Paris, France; [Escoubet, Brigitte] Univ Paris Diderot, Hop Bichat, AP HP,PRES Sorbonne Paris Cite, Dept Physiol,INSERM,U1138, Paris, France; [Pasquet, Blandine; Tubach, Florence] Univ Paris Diderot, Hop Bichat, AP HP,PRES Sorbonne Paris Cite, Dept Epidemiol & Rech Clin,INSERM,CIE 801, Paris, France; [Zennaro, Maria-Christina] Univ Paris Diderot, Hop Europeen Georges Pompidou, AP HP,PRES Sorbonne Paris Cite, Dept Cardiol,INSERM,UMRS 970, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sacre, K (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Dept Med Interne,PRES Sorbonne Paris Cite, Paris, France.	karim.sacre@bch.aphp.fr	Zennaro, Maria-Christina/G-2841-2013	Zennaro, Maria-Christina/0000-0001-5449-9191; Sacre, Karim/0000-0002-6544-234X				Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Bjornadal L, 2004, J RHEUMATOL, V31, P713; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cacciapaglia F, 2009, LUPUS, V18, P249, DOI 10.1177/0961203308097571; Chin CWL, 2013, CLIN EXP RHEUMATOL, V31, P295; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Doria A, 2003, ANN RHEUM DIS, V62, P1071, DOI 10.1136/ard.62.11.1071; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Goldberg RJ, 2009, J RHEUMATOL, V36, P2454, DOI 10.3899/jrheum.090011; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; HARRIS M, 1979, DIABETES, V28, P1039; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Karp I, 2008, ARTHRIT RHEUM-ARTHR, V59, P169, DOI 10.1002/art.23352; Kullo IJ, 2007, J AM COLL CARDIOL, V49, P1413, DOI 10.1016/j.jacc.2006.11.039; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Sabio JM, 2009, J RHEUMATOL, V36, P2204, DOI 10.3899/jrheum.081253; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Parker B, 2013, ANN RHEUM DIS, V72, P1308, DOI 10.1136/annrheumdis-2012-202106; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Rahman P, 2000, LUPUS, V9, P672, DOI 10.1191/096120300669204787; Roman MJ, 2005, HYPERTENSION, V46, P194, DOI 10.1161/01.HYP.0000168055.89955.db; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ruyssen-Witrand A, 2011, JOINT BONE SPINE, V78, P23, DOI 10.1016/j.jbspin.2010.02.040; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAQUET A, 1993, EUR J EPIDEMIOL, V9, P298, DOI 10.1007/BF00146267; Valero-Gonzalez S, 2014, SCAND J RHEUMATOL, V43, P54, DOI 10.3109/03009742.2013.803150; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	32	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94511	10.1371/journal.pone.0094511	http://dx.doi.org/10.1371/journal.pone.0094511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722263	Green Published, gold			2022-12-25	WOS:000336909100087
J	Ganesh, SK; Morissette, R; Xu, Z; Schoenhoff, F; Griswold, BF; Yang, JD; Tong, L; Yang, ML; Hunker, K; Sloper, L; Kuo, SN; Raza, R; Milewicz, DM; Francomano, CA; Dietz, HC; Van Eyk, J; McDonnell, NB				Ganesh, Santhi K.; Morissette, Rachel; Xu, Zhi; Schoenhoff, Florian; Griswold, Benjamin F.; Yang, Jiandong; Tong, Lan; Yang, Min-Lee; Hunker, Kristina; Sloper, Leslie; Kuo, Shinie; Raza, Rafi; Milewicz, Dianna M.; Francomano, Clair A.; Dietz, Harry C.; Van Eyk, Jennifer; McDonnell, Nazli B.			Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-10.1096/fj.14-251207 beta expression and connective tissue features	FASEB JOURNAL			English	Article						biomarker; FMD; TGF-beta; pathway aneurysm; human genetics	GROWTH-FACTOR-BETA; MAGNETIC-RESONANCE SCANS; EHLERS-DANLOS-SYNDROME; MARFAN-SYNDROME; RENOVASCULAR HYPERTENSION; ARTERIAL FIBRODYSPLASIA; ASYMPTOMATIC SUBJECTS; JOINT HYPERMOBILITY; CAROTID-ARTERY; DISORDERS	Fibromuscular dysplasia (FMD) is a rare, nonatherosclerotic arterial disease for which the molecular basis is unknown. We comprehensively studied 47 subjects with FMD, including physical examination, spine magnetic resonance imaging, bone densitometry, and brain magnetic resonance angiography. Inflammatory biomarkers in plasma and transforming growth factor beta (TGF-beta) cytokines in patient-derived dermal fibroblasts were measured by ELISA. Arterial pathology other than medial fibrodysplasia with multifocal stenosis included cerebral aneurysm, found in 12.8% of subjects. Extra-arterial pathology included low bone density (P< 0.001); early onset degenerative spine disease (95.7%); increased incidence of Chiari I malformation (6.4%) and dural ectasia (42.6%); and physical examination findings of a mild connective tissue dysplasia (95.7%). Screening for mutations causing known genetically mediated arteriopathies was unrevealing. We found elevated plasma TGF-beta 1 (P = 0.009), TGF-beta 2 (P = 0.004) and additional inflammatory markers, and increased TGF-beta 1 (P = 0.0009) and TGF-beta 2 (P = 0.0001) secretion in dermal fibroblast cell lines from subjects with FMD compared to age-and gender-matched controls. Detailed phenotyping of patients with FMD allowed us to demonstrate that FMD is a systemic disease with alterations in common with the spectrum of genetic syndromes that involve altered TGF-beta signaling and offers TGF-beta as a marker of FMD.	[Ganesh, Santhi K.; Tong, Lan; Yang, Min-Lee; Hunker, Kristina; Kuo, Shinie] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Ganesh, Santhi K.; Tong, Lan; Yang, Min-Lee; Hunker, Kristina; Kuo, Shinie] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Morissette, Rachel; Xu, Zhi; Griswold, Benjamin F.; Yang, Jiandong; Sloper, Leslie; Raza, Rafi; McDonnell, Nazli B.] NIA, Lab Clin Invest, Baltimore, MD 21225 USA; [Schoenhoff, Florian; Van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Med Genet, Houston, TX 77030 USA; [Francomano, Clair A.] Greater Baltimore Med Ctr, Towson, MD USA; [Dietz, Harry C.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; Greater Baltimore Medical Center; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	McDonnell, NB (corresponding author), NIA, Clin Unit, 5th Floor,3001 S Hanover St, Baltimore, MD 21225 USA.	sganesh@umich.edu; nazli.mcdonnell@gmail.com		Yang, Min-Lee/0000-0003-2823-8320; Schoenhoff, Florian/0000-0002-3311-4595	Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute on Aging; University of Michigan [R00HL089413]; Johns Hopkins Institutional Clinical and Translational Science Award (CTSA) grant [1U54RR023561-01A1]; American Recovery and Reinvestment Act (ARRA) Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection grant [5RC1HL100021-02]; National Heart, Lung, and Blood Institute/NIH [P30HL101290]; Doris Duke Charitable Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL089413, RC1HL100021, P30HL101290] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute on Aging; University of Michigan(University of Michigan System); Johns Hopkins Institutional Clinical and Translational Science Award (CTSA) grant; American Recovery and Reinvestment Act (ARRA) Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection grant; National Heart, Lung, and Blood Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by the Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute on Aging. FACS analysis studies were supported in part by grant R00HL089413 at the University of Michigan. The Johns Hopkins Institutional Clinical and Translational Science Award (CTSA) grant 1U54RR023561-01A1 and the American Recovery and Reinvestment Act (ARRA) Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection grant 5RC1HL100021-02 were used for plasma biomarker studies. S. K. G. was supported by grants from the National Heart, Lung, and Blood Institute/NIH (P30HL101290) and the Doris Duke Charitable Foundation. S. K. G. and N.B.M. are unpaid medical advisors for the nonprofit Fibromuscular Dysplasia Society of America (FMDSA). No FMDSA funds were used in this study.	Akhurst RJ, 2012, NAT GENET, V44, P838, DOI 10.1038/ng.2366; AOYAMA T, 1995, AM J MED GENET, V58, P169, DOI 10.1002/ajmg.1320580216; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; CHATILLON JD, 1990, PRESSE MED, V19, P661; Dolan AL, 2003, J RHEUMATOL, V30, P799; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Erkula G, 2010, J BONE JOINT SURG AM, V92A, P1876, DOI 10.2106/JBJS.I.01140; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GLADSTIEN K, 1980, CLIN GENET, V17, P115; Hakim AJ, 2004, ARTHRITIS RHEUM-US, V50, P2640, DOI 10.1002/art.20376; HARRISON EG, 1971, MAYO CLIN PROC, V46, P161; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; LANCMAN M, 1991, STROKE, V22, P269, DOI 10.1161/01.STR.22.2.269; Leadbetter WF, 1938, J UROLOGY, V39, P611, DOI 10.1016/S0022-5347(17)71895-2; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Ling S, 2012, MINI-REV MED CHEM, V12, P175, DOI 10.2174/138955712798995057; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; MAS JL, 1987, STROKE, V18, P1037, DOI 10.1161/01.STR.18.6.1037; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Milewicz DM, 2010, GENET MED, V12, P196, DOI 10.1097/GIM.0b013e3181cdd687; Milhorat TH, 2007, J NEUROSURG-SPINE, V7, P601, DOI 10.3171/SPI-07/12/601; Morissette R, 2014, CIRC-CARDIOVASC GENE, V7, P80, DOI 10.1161/CIRCGENETICS.113.000280; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Olin JW, 2012, CIRCULATION, V126, P2925, DOI 10.1161/CIRCULATIONAHA.112.149500; Olin JW, 2012, CIRCULATION, V125, P3182, DOI 10.1161/CIRCULATIONAHA.112.091223; Olin JW, 2011, J VASC SURG, V53, P826, DOI 10.1016/j.jvs.2010.10.066; Poloskey SL, 2012, VASC MED, V17, P371, DOI 10.1177/1358863X12459650; Rodrigues VJ, 2009, AM J NEURORADIOL, V30, P1614, DOI 10.3174/ajnr.A1651; Rose PS, 2000, GENET MED, V2, P278, DOI 10.1097/00125817-200009000-00002; Savard S, 2012, CIRCULATION, V126, P3062, DOI 10.1161/CIRCULATIONAHA.112.117499; SCHIEVINK WI, 1994, STROKE, V25, P2492, DOI 10.1161/01.STR.25.12.2492; SCHIEVINK WI, 1989, NEUROSURGERY, V25, P482; Shultz SJ, 2006, J ORTHOP RES, V24, P124, DOI 10.1002/jor.20021; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; Smith WB, 1996, J IMMUNOL, V157, P360; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Stanley J C, 1984, Dis Mon, V30, P1, DOI 10.1016/0011-5029(84)90009-9; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P922; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Tanemoto M, 2007, HYPERTENS RES, V30, P999, DOI 10.1291/hypres.30.999; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	48	49	52	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3313	3324		10.1096/fj.14-251207	http://dx.doi.org/10.1096/fj.14-251207			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24732132	Green Published, Green Submitted			2022-12-25	WOS:000340265400004
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			A Method for Activation of Endogenous Acid-sensing Ion Channel 1a (ASIC1a) in the Nervous System with High Spatial and Temporal Precision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acidosis; Astrocytes; Optogenetics; pH Regulation; Proton Pumps; ASIC1a; ArchT; Extracellular pH	CONTRIBUTES; EXPRESSION; BRAIN; PROMOTERS; PAIN	Protons activate acid-sensing ion channel 1a (ASIC1a) in the central nervous system (CNS) although the impact of such activation on brain outputs remains elusive. Progress elucidating the functional roles of ASIC1a in the CNS has been hindered by technical difficulties of achieving acidification with spatial and temporal precision. We have implemented a method to control optically the opening of ASIC1a in brain slices and also in awake animals. The light-driven H+ pump ArchT was expressed in astrocytes of mouse cortex by injection of adenoviral vectors containing a strong and astrocyte-specific promoter. Illumination with amber light acidified the surrounding interstitium and led to activation of endogenous ASIC1a channels and firing of action potentials in neurons localized in close proximity to ArchT-expressing astrocytes. We conclude that this optogenetic method offers a minimally invasive approach that enables examining the biological consequences of ASIC1a currents in any structure of the CNS and in the modulation of animal behaviors.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	cecilia.canessa@yale.edu						Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Figueiredo M, 2011, EXP PHYSIOL, V96, P40, DOI 10.1113/expphysiol.2010.052597; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Li TB, 2012, J BIOL CHEM, V287, P40680, DOI 10.1074/jbc.M112.418400; Liu BH, 2006, MOL THER, V14, P872, DOI 10.1016/j.ymthe.2006.05.020; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Musa-Aziz R, 2010, METHODS, V51, P134, DOI 10.1016/j.ymeth.2009.12.012; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; van Dijk KW, 2011, METHODS MOL BIOL, V693, P321, DOI 10.1007/978-1-60761-974-1_20; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	27	10	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15441	15448		10.1074/jbc.M114.550012	http://dx.doi.org/10.1074/jbc.M114.550012			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727474	Green Published, hybrid			2022-12-25	WOS:000337465400027
J	Guo, L; Zheng, Z; Ai, JT; Huang, B; Li, XA				Guo, Ling; Zheng, Zhong; Ai, Junting; Huang, Bin; Li, Xiang-An			Hepatic Scavenger Receptor BI Protects Against Polymicrobial-induced Sepsis through Promoting LPS Clearance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NITRIC-OXIDE SYNTHASE; HDL CHOLESTEROL LEVELS; E-DEFICIENT MICE; SR-BI; APOLIPOPROTEIN-E; SELECTIVE UPTAKE; SUBCLINICAL ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; INFLAMMATORY RESPONSE	Recent studies revealed that scavenger receptor BI (SR-BI or Scarb1) plays a critical protective role in sepsis. However, the mechanisms underlying this protection remain largely unknown. In this study, using Scarb1(I179N) mice, a mouse model specifically deficient in hepatic SR-BI, we report that hepatic SR-BI protects against cecal ligation and puncture (CLP)-induced sepsis as shown by 75% fatality in Scarb1(I179N) mice, but only 21% fatality in C57BL/6J control mice. The increase in fatality in Scarb1(I179N) mice was associated with an exacerbated inflammatory cytokine production. Further study demonstrated that hepatic SR-BI exerts its protection against sepsis through its role in promoting LPS clearance without affecting the inflammatory response in macrophages, the glucocorticoid production in adrenal glands, the leukocyte recruitment to peritoneum or the bacterial clearance in liver. Our findings reveal hepatic SR-BI as a critical protective factor in sepsis and point out that promoting hepatic SR-BI-mediated LPS clearance may provide a therapeutic approach for sepsis.	[Guo, Ling; Zheng, Zhong; Ai, Junting; Li, Xiang-An] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Guo, Ling; Li, Xiang-An] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Zheng, Zhong; Ai, Junting] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Huang, Bin; Li, Xiang-An] Univ Kentucky, Coll Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Li, XA (corresponding author), BBSRB B255,741 S Limestone ST, Lexington, KY 40536 USA.	xli2@email.uky.edu			NIGMS/National Institutes of Health [R01GM085231, R01GM085231-2S1, R01GM085231-5S1]; Children's Miracle Network; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Miracle Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01GM085231, R01GM085231-2S1, and R01GM085231-5S1 from NIGMS/National Institutes of Health. This work was also supported by a grant from the Children's Miracle Network.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brodde MF, 2011, ATHEROSCLEROSIS, V215, P374, DOI 10.1016/j.atherosclerosis.2010.12.026; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Brundert M, 2006, J LIPID RES, V47, P2408, DOI 10.1194/jlr.M600136-JLR200; Brunham LR, 2011, CLIN GENET, V79, P575, DOI 10.1111/j.1399-0004.2011.01682.x; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Cai L, 2012, J LIPID RES, V53, P1472, DOI 10.1194/jlr.M023234; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; CALVO D, 1993, J BIOL CHEM, V268, P18929; Chadwick AC, 2013, CURR OPIN ENDOCRINOL, V20, P124, DOI 10.1097/MED.0b013e32835ed575; Clifford AJ, 2012, J NUTR, V142, P1764, DOI 10.3945/jn.112.160333; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716; Feng H, 2011, LIFE SCI, V88, P606, DOI 10.1016/j.lfs.2011.01.020; FREUDENBERG N, 1985, PATHOL RES PRACT, V179, P517, DOI 10.1016/S0344-0338(85)80193-X; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; GE YM, 1994, J INFECT DIS, V169, P95, DOI 10.1093/infdis/169.1.95; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; Guo L, 2014, ARTERIOSCL THROM VAS, V34, P966, DOI 10.1161/ATVBAHA.113.302484; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Guo L, 2012, J IMMUNOL, V189, P501, DOI 10.4049/jimmunol.1290035; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; HAN A, 1983, J BIOL CHEM, V258, P3703; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Holmes RS, 2012, RES REP BIOCHEM, V2, P9, DOI 10.2147/RRBC.S31749; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Kamimoto M, 2005, BIOMED RES-TOKYO, V26, P99, DOI 10.2220/biomedres.26.99; Khovidhunkit W, 2001, J LIPID RES, V42, P1636; Korporaal SJA, 2011, ARTERIOSCL THROM VAS, V31, P34, DOI 10.1161/ATVBAHA.110.210252; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Li XA, 2005, J BIOL CHEM, V280, P19087, DOI 10.1074/jbc.M500944200; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; Manichaikul A, 2012, ARTERIOSCL THROM VAS, V32, P1991, DOI 10.1161/ATVBAHA.112.249714; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Mayumi T, 1999, SHOCK, V11, P82, DOI 10.1097/00024382-199902000-00002; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Naj AC, 2010, CIRC-CARDIOVASC GENE, V3, P47, DOI 10.1161/CIRCGENETICS.109.903195; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Raubenheimer PJ, 2006, CLIN ENDOCRINOL, V65, P22, DOI 10.1111/j.1365-2265.2006.02540.x; Rejeb J, 2012, GENE, V511, P383, DOI 10.1016/j.gene.2012.09.070; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Roberts CGP, 2007, HUM HERED, V64, P107, DOI 10.1159/000101962; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Stylianou IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006521; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Viet LDT, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001785; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Yates M, 2011, HUM REPROD, V26, P1910, DOI 10.1093/humrep/der124; Yeh YC, 2002, ATHEROSCLEROSIS, V161, P95, DOI 10.1016/S0021-9150(01)00642-6; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	75	32	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14666	14673		10.1074/jbc.M113.537258	http://dx.doi.org/10.1074/jbc.M113.537258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719333	hybrid, Green Published			2022-12-25	WOS:000337248100023
J	Sun, LL; Dong, YY; Shi, MM; Jin, M; Zhou, Q; Luo, ZQ; Gao, HC				Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Zhou, Qing; Luo, Zhao-Qing; Gao, Haichun			Two Residues Predominantly Dictate Functional Difference in Motility between Shewanella oneidensis Flagellins FlaA and FlaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; FILAMENT; ROLES; SYSTEMS; POLAR; GLYCOSYLATION; PROTOFILAMENT; EXPRESSION; SEQUENCE; SWITCH	Nearly half of flagellated microorganisms possess a multiple-flagellin system. Although a functional filament can be formed from one of multiple flagellins alone in many bacteria, it is more common that one flagellin is the major constituent and others contribute. Underlying mechanisms proposed for such scenarios cover flagellin regulation of various levels, including transcription, translation, post-translational modification, secretion, and filament assembly. In Shewanella oneidensis, the flagellar filament is composed of FlaA and FlaB flagellins; the latter is the major one in terms of motility. In this study, we showed that regulation of all levels except for filament assembly is indistinguishable between these two flagellins. Further analyses revealed that two amino acid residues predominantly dictated functional difference with respect to motility. Given that Shewanella prefer a solid surface-associated life style, of which filaments consisting of either FlaA or FlaB are equally supportive, we envision that roles of flagella in surface adhesion and formation of bacterial communities are particularly important for their survival and proliferation in these specific niches.	[Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Qing; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Zhejiang University; Zhejiang University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Doctoral Fund of the Ministry of Education of China [20130101110142]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the Major State Basic Research Development Program (973 Program Grant 2010CB833803), National Natural Science Foundation of China Grant 31270097, and Doctoral Fund of the Ministry of Education of China Grant 20130101110142 (to H. G.).	Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Bubendorfer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073444; Bubendorfer S, 2012, MOL MICROBIOL, V83, P335, DOI 10.1111/j.1365-2958.2011.07934.x; Canals R, 2007, MICROBIOL-SGM, V153, P1165, DOI 10.1099/mic.0.2006/000687-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deakin WJ, 1999, MICROBIOL-UK, V145, P1397, DOI 10.1099/13500872-145-6-1397; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201370001, 10.1002/jobm.201100335]; Faulds-Pain A, 2011, J BACTERIOL, V193, P2695, DOI 10.1128/JB.01172-10; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu HH, 2014, ENVIRON MICROBIOL, V16, P3181, DOI 10.1111/1462-2920.12457; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Iida Y, 2009, J MOL BIOL, V394, P1011, DOI 10.1016/j.jmb.2009.10.003; Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075610; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; Koerdt A, 2009, J BACTERIOL, V191, P5085, DOI 10.1128/JB.00206-09; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; LEYING H, 1992, MOL MICROBIOL, V6, P2863, DOI 10.1111/j.1365-2958.1992.tb01466.x; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Luo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062064; Malapaka RRV, 2007, J MOL BIOL, V365, P1102, DOI 10.1016/j.jmb.2006.10.054; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; PLEIER E, 1991, J BACTERIOL, V173, P2077, DOI 10.1128/jb.173.6.2077-2085.1991; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Scharf B, 2001, J BACTERIOL, V183, P5334, DOI 10.1128/JB.183.18.5334-5342.2001; Shi MM, 2013, J BACTERIOL, V195, P1463, DOI 10.1128/JB.02187-12; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SUERBAUM S, 1995, TRENDS MICROBIOL, V3, P168, DOI 10.1016/S0966-842X(00)88913-1; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Warren SM, 2005, J BACTERIOL, V187, P6075, DOI 10.1128/JB.187.17.6075-6083.2005; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yuan J, 2013, BBA-GEN SUBJECTS, V1830, P5248, DOI 10.1016/j.bbagen.2013.07.023	52	16	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14547	14559		10.1074/jbc.M114.552000	http://dx.doi.org/10.1074/jbc.M114.552000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733391	Green Published, hybrid			2022-12-25	WOS:000337248100013
J	Hu, D; Howard, D; Ren, L				Hu, Dan; Howard, David; Ren, Lei			Biomechanical Analysis of the Human Finger Extensor Mechanism during Isometric Pressing	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; FORCES; MODEL; JOINT; HAND; COORDINATION; MOVEMENTS; TENSIONS; MUSCLES	This study investigated the effects of the finger extensor mechanism on the bone-to-bone contact forces at the interphalangeal and metacarpal joints and also on the forces in the intrinsic and extrinsic muscles during finger pressing. This was done with finger postures ranging from very flexed to fully extended. The role of the finger extensor mechanism was investigated by using two alternative finger models, one which omitted the extensor mechanism and another which included it. A six-camera three-dimensional motion analysis system was used to capture the finger posture during maximum voluntary isometric pressing. The fingertip loads were recorded simultaneously using a force plate system. Two three-dimensional biomechanical finger models, a minimal model without extensor mechanism and a full model with extensor mechanism (tendon network), were used to calculate the joint bone-to-bone contact forces and the extrinsic and intrinsic muscle forces. If the full model is assumed to be realistic, then the results suggest some useful biomechanical advantages provided by the tendon network of the extensor mechanism. It was found that the forces in the intrinsic muscles (interosseus group and lumbrical) are significantly reduced by 22% to 61% due to the action of the extensor mechanism, with the greatest reductions in more flexed postures. The bone-to-bone contact force at the MCP joint is reduced by 10% to 41%. This suggests that the extensor mechanism may help to reduce the risk of injury at the finger joints and also to moderate the forces in intrinsic muscles. These apparent biomechanical advantages may be a result of the extensor mechanism's distinctive interconnected fibrous structure, through which the contraction of the intrinsic muscles as flexors of the MCP joint can generate extensions at the DIP and PIP joints.	[Hu, Dan; Ren, Lei] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England; [Howard, David] Univ Salford, Sch Comp Sci & Engn, Manchester, Lancs, England; [Hu, Dan] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun 130023, Peoples R China	University of Manchester; University of Salford; Jilin University	Ren, L (corresponding author), Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England.	lei.ren@manchester.ac.uk	Hu, Dan/M-7671-2018	Hu, Dan/0000-0001-5058-1809	China Scholarship Council (CSC); UK EPSRC [EP/I033602/1]; EPSRC [EP/I033602/1, EP/K019759/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I033602/1, EP/K019759/1] Funding Source: researchfish	China Scholarship Council (CSC)(China Scholarship Council); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The China Scholarship Council (CSC) had partly supported the study design, data collection and analysis. The additional part of the funding of the study has been supported by the UK EPSRC from grant number EP/I033602/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1985, J ORTHOP RES, V3, P202, DOI 10.1002/jor.1100030210; AN KN, 1979, J BIOMECH, V12, P775, DOI 10.1016/0021-9290(79)90163-5; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; BERME N, 1977, J BIOMECH, V10, P409, DOI 10.1016/0021-9290(77)90017-3; BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O; CHAO EY, 1976, J BIOMECH, V9, P387, DOI 10.1016/0021-9290(76)90116-0; CHAO EY, 1978, J BIOMECH ENG-T ASME, V100, P159, DOI 10.1115/1.3426207; COONEY WP, 1977, J BONE JOINT SURG AM, V59, P27, DOI 10.2106/00004623-197759010-00004; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; DARLING WG, 1994, J BIOMECH, V27, P479, DOI 10.1016/0021-9290(94)90023-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2; EYLER DL, 1954, J BONE JOINT SURG AM, V36-A, P1; Fok KS, 2010, J BIOMECH, V43, P701, DOI 10.1016/j.jbiomech.2009.10.020; Fowler NK, 2000, J BIOMECH, V33, P1055, DOI 10.1016/S0021-9290(00)00080-4; GARCIAELIAS M, 1991, J HAND SURG-AM, V16A, P1130, DOI 10.1016/S0363-5023(10)80079-6; GARCIAELIAS M, 1991, J HAND SURG-AM, V16A, P1136, DOI 10.1016/S0363-5023(10)80080-2; HARDING DC, 1993, J BIOMECH, V26, P1403, DOI 10.1016/0021-9290(93)90091-R; HARRIS C, 1972, J BONE JOINT SURG AM, VA 54, P713, DOI 10.2106/00004623-197254040-00003; Kaab MJ, 1998, J ORTHOP RES, V16, P743, DOI 10.1002/jor.1100160617; Ketchum L D, 1978, J Hand Surg Am, V3, P571; Kursa K, 2005, J BIOMECH, V38, P2288, DOI 10.1016/j.jbiomech.2004.07.035; LANDSMEER J M, 1955, Acta Anat Suppl (Basel), V25, P1; LANDSMEER J M, 1961, Acta Morphol Neerl Scand, V3, P287; LANDSMEER JMF, 1963, J BONE JOINT SURG AM, V45, P1654, DOI 10.2106/00004623-196345080-00007; Lee SY, 2008, J VIB ACOUST, V130, DOI 10.1115/1.2775515; Li ZM, 2001, J BIOMECH, V34, P1097, DOI 10.1016/S0021-9290(01)00061-6; Li ZM, 2000, CLIN BIOMECH, V15, P203, DOI 10.1016/S0268-0033(99)00058-3; LONG C, 1968, J BONE JOINT SURG AM, VA 50, P973, DOI 10.2106/00004623-196850050-00009; Sancho-Bru JL, 2001, J BIOMECH, V34, P1491, DOI 10.1016/S0021-9290(01)00106-3; SMITH EM, 1964, ARTHRITIS RHEUM, V7, P467, DOI 10.1002/art.1780070503; SMITH RJ, 1974, CLIN ORTHOP RELAT R, P92, DOI 10.1097/00003086-197410000-00010; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Valero-Cuevas FJ, 2004, P 26 ANN INT C IEEE; Valero-Cuevas FJ, 2007, IEEE T BIO-MED ENG, V54, P1161, DOI 10.1109/TBME.2006.889200; Vigouroux L, 2007, J BIOMECH, V40, P2846, DOI 10.1016/j.jbiomech.2007.03.010; Vigouroux L, 2006, J BIOMECH, V39, P2583, DOI 10.1016/j.jbiomech.2005.08.027; WEIGHTMAN B, 1982, J BIOMED ENG, V4, P197, DOI 10.1016/0141-5425(82)90003-6	38	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94533	10.1371/journal.pone.0094533	http://dx.doi.org/10.1371/journal.pone.0094533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732789	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336970400048
J	Lu, HY; Huang, CY; Su, CT; Lin, CC				Lu, Hsueh-Yi; Huang, Chen-Yuan; Su, Chwen-Tzeng; Lin, Chen-Chiang			Predicting Rotator Cuff Tears Using Data Mining and Bayesian Likelihood Ratios	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; CLINICAL DECISION-MAKING; PHYSICAL-EXAMINATION; CROSS-VALIDATION; TESTS; DIAGNOSIS; MEDICINE; TREE; CLASSIFICATION; ARTHROGRAPHY	Objectives: Rotator cuff tear is a common cause of shoulder diseases. Correct diagnosis of rotator cuff tears can save patients from further invasive, costly and painful tests. This study used predictive data mining and Bayesian theory to improve the accuracy of diagnosing rotator cuff tears by clinical examination alone. Methods: In this retrospective study, 169 patients who had a preliminary diagnosis of rotator cuff tear on the basis of clinical evaluation followed by confirmatory MRI between 2007 and 2011 were identified. MRI was used as a reference standard to classify rotator cuff tears. The predictor variable was the clinical assessment results, which consisted of 16 attributes. This study employed 2 data mining methods (ANN and the decision tree) and a statistical method (logistic regression) to classify the rotator cuff diagnosis into "tear" and "no tear" groups. Likelihood ratio and Bayesian theory were applied to estimate the probability of rotator cuff tears based on the results of the prediction models. Results: Our proposed data mining procedures outperformed the classic statistical method. The correction rate, sensitivity, specificity and area under the ROC curve of predicting a rotator cuff tear were statistical better in the ANN and decision tree models compared to logistic regression. Based on likelihood ratios derived from our prediction models, Fagan's nomogram could be constructed to assess the probability of a patient who has a rotator cuff tear using a pretest probability and a prediction result (tear or no tear). Conclusions: Our predictive data mining models, combined with likelihood ratios and Bayesian theory, appear to be good tools to classify rotator cuff tears as well as determine the probability of the presence of the disease to enhance diagnostic decision making for rotator cuff tears.	[Lu, Hsueh-Yi; Huang, Chen-Yuan; Su, Chwen-Tzeng] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Touliu, Yunlin, Taiwan; [Lin, Chen-Chiang] Natl Taiwan Univ Hosp, Dept Orthoped, Yun Lin Branch, Touliu, Yunlin, Taiwan	National Yunlin University Science & Technology; National Taiwan University; National Taiwan University Hospital	Lin, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped, Yun Lin Branch, Touliu, Yunlin, Taiwan.	g9821806@yuntech.edu.tw			National Science Council of Taiwan (ROC) [NSC-100-2218-E-224-014]	National Science Council of Taiwan (ROC)(Ministry of Science and Technology, Taiwan)	This research was partially supported by National Science Council of Taiwan (ROC) under research grants NSC-100-2218-E-224-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Amendolia SR, 2002, MED DECIS MAKING, V22, P18, DOI 10.1177/02729890222062883; [Anonymous], 2003, ASIA PACIFIC FAMILY, DOI DOI 10.1111/J.1444-1683.2003.00095.X; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bat WG, 1990, NEURAL COMPUT, V2, P480, DOI 10.1162/neco.1990.2.4.480; Beaudreuil J, 2009, JOINT BONE SPINE, V76, P15, DOI 10.1016/j.jbspin.2008.04.015; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; BREIMAN L., 1984, CRC PRESS; Chang L, 2006, NEW DIR I RES, V2006, P53, DOI DOI 10.1002/IR.187; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; DUJARDIN B, 1994, EUR J EPIDEMIOL, V10, P29, DOI 10.1007/BF01717448; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Farin PU, 1996, INVEST RADIOL, V31, P387, DOI 10.1097/00004424-199607000-00001; Fathima AS, 2011, INT J COMPUTER SCI I, V8, P322; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Griffith J, 2000, MED DECIS MAKING, V20, P243, DOI 10.1177/0272989X0002000210; Grossi E, 2007, DIGEST LIVER DIS, V39, P278, DOI 10.1016/j.dld.2006.10.003; Guo F, 2017, J PHYS CONF SER, V910, DOI 10.1088/1742-6596/910/1/012021; Halkin A, 1998, QJM-INT J MED, V91, P247, DOI 10.1093/qjmed/91.4.247; Han J, 2012, MOR KAUF D, P1; Hegedus EJ, 2008, BRIT J SPORT MED, V42, P80, DOI 10.1136/bjsm.2007.038406; JOBE FW, 1982, AM J SPORT MED, V10, P336, DOI 10.1177/036354658201000602; KASSIRER JP, 1989, NEW ENGL J MED, V320, P1489, DOI 10.1056/NEJM198906013202211; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; LANG TA, 1997, REPORT STAT MED ANNO; Lawrence S, 2000, IEEE IJCNN, P114, DOI 10.1109/IJCNN.2000.857823; Lin CS, 2011, MED DECIS MAKING, V31, P308, DOI 10.1177/0272989X10379648; Lin CC, 2010, INJURY, V41, P869, DOI 10.1016/j.injury.2010.04.023; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; Litaker D, 2000, J AM GERIATR SOC, V48, P1633, DOI 10.1111/j.1532-5415.2000.tb03875.x; Longo UG, 2011, SPORTS MED ARTHROSC, V19, P266, DOI 10.1097/JSA.0b013e3182250c8b; MacDonald PB, 2000, J SHOULDER ELB SURG, V9, P299, DOI 10.1067/mse.2000.106918; MAIR J, 1995, CHEST, V108, P1502, DOI 10.1378/chest.108.6.1502; McFarland EG, 2006, EXAMINATION SHOULDER; Murrell GAC, 2001, LANCET, V357, P769, DOI 10.1016/S0140-6736(00)04161-1; NORWOOD LA, 1989, J BONE JOINT SURG AM, V71A, P499, DOI 10.2106/00004623-198971040-00004; Oh CH, 1999, SKELETAL RADIOL, V28, P670; Park HB, 2005, J BONE JOINT SURG AM, V87A, P1446, DOI 10.2106/JBJS.D.02335; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Ramesh AN, 2004, ANN ROY COLL SURG, V86, P334, DOI 10.1308/147870804290; Sox HC, 1996, ANNU REV MED, V47, P463; Sox HC, 1988, MED DECISION MAKING; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Vlahou A, 2003, J BIOMED BIOTECHNOL, P308, DOI 10.1155/S1110724303210032; Wahbeh AH., 2011, INT J ADV COMPUT SCI, V8, P18, DOI 10.14569/specialissue.2011.010304; Walton J, 2012, TECH SHOULDER ELBOW, V13, P17, DOI 10.1097/BTE.0b013e31823b568a; Weinstein MC, 1980, CLIN DECISION ANAL; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Witten I.H FE, 2008, DATA MINING RACTICAL	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94917	10.1371/journal.pone.0094917	http://dx.doi.org/10.1371/journal.pone.0094917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733553	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400131
J	Gkourogianni, A; Kosteria, I; Telonis, AG; Margeli, A; Mantzou, E; Konsta, M; Loutradis, D; Mastorakos, G; Papassotiriou, I; Klapa, MI; Kanaka-Gantenbein, C; Chrousos, GP				Gkourogianni, Alexandra; Kosteria, Ioanna; Telonis, Aristeidis G.; Margeli, Alexandra; Mantzou, Emilia; Konsta, Maria; Loutradis, Dimitrios; Mastorakos, George; Papassotiriou, Ioannis; Klapa, Maria I.; Kanaka-Gantenbein, Christina; Chrousos, George P.			Plasma Metabolomic Profiling Suggests Early Indications for Predisposition to Latent Insulin Resistance in Children Conceived by ICSI	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ASSISTED REPRODUCTIVE TECHNOLOGY; INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; PSYCHOSOCIAL STRESS; BORN; OBESITY; TISSUE; NEUROENDOCRINE; GLUCOSE	Background: There have been increasing indications about an epigenetically-based elevated predisposition of assisted reproductive technology (ART) offspring to insulin resistance, which can lead to an unfavorable cardio-metabolic profile in adult life. However, the relevant long-term systematic molecular studies are limited, especially for the IntraCytoplasmic Sperm Injection (ICSI) method, introduced in 1992. In this study, we carefully defined a group of 42 prepubertal ICSI and 42 naturally conceived (NC) children. We assessed differences in their metabolic profile based on biochemical measurements, while, for a subgroup, plasma metabolomic analysis was also performed, investigating any relevant insulin resistance indices. Methods & Results: Auxological and biochemical parameters of 42 6.8 +/- 2.1 yrs old ICSI-conceived and 42 age-matched controls were measured. Significant differences between the groups were determined using univariate and multivariate statistics, indicating low urea and low-grade inflammation markers (YKL-40, hsCRP) and high triiodothyronine (T3) in ICSI-children compared to controls. Moreover, plasma metabolomic analysis carried out for a subgroup of 10 ICSI-and 10 NC girls using Gas Chromatography-Mass Spectrometry (GC-MS) indicated clear differences between the two groups, characterized by 36 metabolites linked to obesity, insulin resistance and metabolic syndrome. Notably, the distinction between the two girl subgroups was accentuated when both their biochemical and metabolomic measurements were employed. Conclusions: The present study contributes a large auxological and biochemical dataset of a well-defined group of prepubertal ICSI-conceived subjects to the research of the ART effect to the offspring's health. Moreover, it is the first time that the relevant usefulness of metabolomics was investigated. The acquired results are consistent with early insulin resistance in ICSI-offspring, paving the way for further systematic investigations. These data support that metabolomics may unravel metabolic differences before they become clinically or biochemically evident, underlining its utility in the ART research.	[Gkourogianni, Alexandra; Kosteria, Ioanna; Konsta, Maria; Kanaka-Gantenbein, Christina; Chrousos, George P.] Univ Athens Med Sch, Dept Pediat 1, Div Endocrinol Diabet & Metab, Athens, Greece; [Telonis, Aristeidis G.; Klapa, Maria I.] Fdn Res & Technol Hellas FORTH ICE HT, Inst Chem Engn Sci, Metab Engn & Syst Biol Lab, Patras, Greece; [Margeli, Alexandra; Papassotiriou, Ioannis] Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens, Greece; [Mantzou, Emilia] Evgenid Hosp, Dept Endocrinol & Metab, Endocrine Unit, Athens, Greece; [Loutradis, Dimitrios] Univ Athens Med Sch, Div In Vitro Fertilizat, Dept Obstet & Gynecol 1, Athens, Greece; [Mastorakos, George] Univ Athens Med Sch, Div Endocrinol, Dept Obstet & Gynecol 2, Athens, Greece; [Telonis, Aristeidis G.] Univ Patras, Dept Biol, Grad Program Biol Technol, GR-26110 Patras, Greece	National & Kapodistrian University of Athens; Foundation for Research & Technology - Hellas (FORTH); Institute of Chemical Engineering Sciences (ICE-HT); The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University of Patras	Chrousos, GP (corresponding author), Univ Athens Med Sch, Dept Pediat 1, Div Endocrinol Diabet & Metab, Athens, Greece.	chrousog@mail.nih.gov	Kanaka-Gantenbein, Christina/AAP-3697-2020; Kosteria, Ioanna/AAJ-3492-2020	Kosteria, Ioanna/0000-0002-1961-4884; Telonis, Aristeidis/0000-0003-1575-2769; MANTZOU, EMILIA/0000-0001-6606-8647	University of Athens; First Pediatric Clinic; FORTH/ICE-HT internal funds; Panhellenic Endocrinology Society	University of Athens; First Pediatric Clinic; FORTH/ICE-HT internal funds; Panhellenic Endocrinology Society	The study was funded by University of Athens, First Pediatric Clinic and FORTH/ICE-HT internal funds and a fellowship of Panhellenic Endocrinology Society to Dr. Alexandra Gkourogianni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2008, HUM REPROD UPDATE, V14, P593, DOI 10.1093/humupd/dmn032; BARBER T, 1985, BIOCHEM J, V230, P675, DOI 10.1042/bj2300675; Belva F, 2013, HORM RES PAEDIAT, V80, P350, DOI 10.1159/000355515; BIERI JG, 1975, P SOC EXP BIOL MED, V149, P500, DOI 10.3181/00379727-149-38836; Brenta G, 2011, J THROID RES, V2011, DOI 10.4061/2011/152850; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Chrousos GP, 2000, INT J OBESITY, V24, pS50, DOI 10.1038/sj.ijo.0801278; Cori C F, 1981, Curr Top Cell Regul, V18, P377; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grace KS, 2009, SEMIN REPROD MED, V27, P409, DOI 10.1055/s-0029-1237429; Herrero MC, 1999, MOL CELL BIOCHEM, V200, P163, DOI 10.1023/A:1007003519678; Kajantie E, 2007, J CLIN ENDOCR METAB, V92, P4094, DOI 10.1210/jc.2007-1539; Kanaka-Gantenbein C, 2003, ANN NY ACAD SCI, V997, P150, DOI 10.1196/annals.1290.017; Kanaka-Gantenbein C, 2010, PROG BRAIN RES, V182, P161, DOI 10.1016/S0079-6123(10)82006-0; Kanani HH, 2007, METAB ENG, V9, P39, DOI 10.1016/j.ymben.2006.08.001; Kaseva N, 2014, CLIN ENDOCRINOL, V80, P101, DOI 10.1111/cen.12251; Kyrgios I, 2012, METABOLISM, V61, P562, DOI 10.1016/j.metabol.2011.09.004; Laprise SL, 2009, MOL REPROD DEV, V76, P1006, DOI 10.1002/mrd.21058; LESTUNFF C, 1992, DIABETES, V41, P444, DOI 10.2337/diabetes.41.4.444; Lin CH, 2013, CLIN ENDOCRINOL, V79, P185, DOI 10.1111/cen.12015; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Manolescu B, 2008, J Med Life, V1, P376; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; Mitrou P, 2010, ENDOCR REV, V31, P663, DOI 10.1210/er.2009-0046; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Ortega FJ, 2012, INT J OBESITY, V36, P320, DOI 10.1038/ijo.2011.101; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Rathcke CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043498; Sabin MA, 2007, PEDIATRICS, V120, pE1426, DOI 10.1542/peds.2007-0189; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sakka SD, 2013, EUR J CLIN INVEST, V43, P439, DOI 10.1111/eci.12066; Sakka SD, 2010, FERTIL STERIL, V94, P1693, DOI 10.1016/j.fertnstert.2009.09.049; Sakka SD, 2009, J CLIN ENDOCR METAB, V94, P1338, DOI 10.1210/jc.2008-1624; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Spagou K, 2011, J CHROMATOGR B, V879, P1467, DOI 10.1016/j.jchromb.2011.01.028; Traber MG, 2007, ANNU REV NUTR, V27, P347, DOI 10.1146/annurev.nutr.27.061406.093819; Ucar A, 2012, EUR J PEDIATR, V171, P1661, DOI 10.1007/s00431-012-1796-3; Van Steirteghem A, 2002, MOL CELL ENDOCRINOL, V186, P199, DOI 10.1016/S0303-7207(01)00658-X; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Youngson NA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0337; ZAWADZKI JK, 1988, DIABETES, V37, P154, DOI 10.2337/diabetes.37.2.154	48	36	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94001	10.1371/journal.pone.0094001	http://dx.doi.org/10.1371/journal.pone.0094001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728198	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200034
J	Hernandez-Vivanco, A; Hone, AJ; Scadden, M; Carmona-Hidalgo, B; McIntosh, JM; Albillos, A				Hernandez-Vivanco, Alicia; Hone, Arik J.; Scadden, Mickl; Carmona-Hidalgo, Beatriz; McIntosh, J. Michael; Albillos, Almudena			Monkey Adrenal Chromaffin Cells Express alpha 6 beta 4*Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ROOT GANGLION NEURONS; ALPHA-CONOTOXIN-MII; SUBUNIT MESSENGER-RNAS; NICOTINIC RECEPTORS; DOPAMINE RELEASE; RAT; SUBTYPES; ACTIVATION; LIGAND	Nicotinic acetylcholine receptors (nAChRs) that contain alpha 6 and beta 4 subunits have been demonstrated functionally in human adrenal chromaffin cells, rat dorsal root ganglion neurons, and on noradrenergic terminals in the hippocampus of adolescent mice. In human adrenal chromaffin cells, alpha 6 beta 4* nAChRs (the asterisk denotes the possible presence of additional subunits) are the predominant subtype whereas in rodents, the predominant nAChR is the alpha 3 beta 4* subtype. Here we present molecular and pharmacological evidence that chromaffin cells from monkey (Macaca mulatta) also express alpha 6 beta 4* receptors. PCR was used to show the presence of transcripts for alpha 6 and beta 4 subunits and pharmacological characterization was performed using patch-clamp electrophysiology in combination with alpha-conotoxins that target the alpha 6 beta 4* subtype. Acetylcholine-evoked currents were sensitive to inhibition by BuIA[T5A,P6O] and MII[H9A,L15A]; alpha-conotoxins that inhibit alpha 6-containing nAChRs. Two additional agonists were used to probe for the expression of alpha 7 and beta 2-containing nAChRs. Cells with currents evoked by acetylcholine were relatively unresponsive to the alpha 7-selctive agonist choline but responded to the agonist 5-I-A-85380. These studies provide further insights into the properties of natively expressed alpha 6 beta 4* nAChRs.	[Hernandez-Vivanco, Alicia; Hone, Arik J.; Carmona-Hidalgo, Beatriz; Albillos, Almudena] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain; [McIntosh, J. Michael] George E Whalen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA	Autonomous University of Madrid; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Albillos, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid, Spain.	almudena.albillos@uam.es	Carmona-Hidalgo, Beatriz/AAQ-8879-2020; Albillos, Almudena/AAA-9098-2019	Carmona-Hidalgo, Beatriz/0000-0003-1403-4810; Hernandez Vivanco, Alicia/0000-0001-7920-3588	Ministerio de Ciencia e Innovacion [BFU2011-27690, BFU2012-30997]; U.S. National Institutes of Health [GM103801, GM48677]; Universidad Autonoma de Madrid; European Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad Autonoma de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Ministerio de Ciencia e Innovacion No. BFU2011-27690 and BFU2012-30997 awarded to AA and by grants from the U.S. National Institutes of Health GM103801 and GM48677 to JMM. AHV holds a fellowship award from the Universidad Autonoma de Madrid. AJH hold a Marie Curie International Fellowship from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ALMAZAN G, 1984, BRIT J PHARMACOL, V81, P599, DOI 10.1111/j.1476-5381.1984.tb16124.x; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Di Angelantonio S, 2003, EUR J NEUROSCI, V17, P2313, DOI 10.1046/j.1460-9568.2003.02669.x; Engle SE, 2013, MOL PHARMACOL, V84, P393, DOI 10.1124/mol.113.087346; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hone AJ, 2013, J BIOL CHEM; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; Huang LPZ, 2011, NEUROPHARMACOLOGY, V60, P861, DOI 10.1016/j.neuropharm.2010.12.032; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kaiser SA, 1998, J NEUROCHEM, V70, P1069; Kim HW, 2012, FASEB J, V26, P4102, DOI 10.1096/fj.12-204487; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lips KS, 2005, PLACENTA, V26, P735, DOI 10.1016/j.placenta.2004.10.009; Liu J, 2009, INVEST OPHTH VIS SCI, V50, P1408, DOI 10.1167/iovs.08-2398; Liu LW, 2013, BIOCHEM PHARMACOL, V86, P1194, DOI 10.1016/j.bcp.2013.06.015; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mukhin AG, 2000, MOL PHARMACOL, V57, P642, DOI 10.1124/mol.57.3.642; Papke RL, 2005, EUR J PHARMACOL, V524, P11, DOI 10.1016/j.ejphar.2005.08.043; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Perez-Alvarez A, 2011, BR J PHARM; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Perez-Alvarez A, 2011, J NEUROCHEM, V116, P105, DOI 10.1111/j.1471-4159.2010.07089.x; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2005, MOL PHARMACOL, V67, P32, DOI 10.1124/mol.104.006015; Quik M, 2004, J NEUROCHEM, V88, P668, DOI 10.1111/j.1471-4159.2004.02177.x; Rasmussen AH, 2014, BRAIN RES, V1542, P1, DOI 10.1016/j.brainres.2013.10.024; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; SINE SM, 1980, J BIOL CHEM, V255, P144; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wooters TE, 2011, BRIT J PHARMACOL, V163, P346, DOI 10.1111/j.1476-5381.2011.01220.x; Wu PC, 2010, J NEUROCHEM, V112, P1210, DOI 10.1111/j.1471-4159.2009.06533.x; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743	55	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94142	10.1371/journal.pone.0094142	http://dx.doi.org/10.1371/journal.pone.0094142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727685	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200040
J	Papaspyrou, S; Smith, CJ; Dong, LF; Whitby, C; Dumbrell, AJ; Nedwell, DB				Papaspyrou, Sokratis; Smith, Cindy J.; Dong, Liang F.; Whitby, Corinne; Dumbrell, Alex J.; Nedwell, David B.			Nitrate Reduction Functional Genes and Nitrate Reduction Potentials Persist in Deeper Estuarine Sediments. Why?	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTION; DENITRIFICATION RATES; COLNE ESTUARY; ACETYLENE INHIBITION; ELECTRON-ACCEPTOR; ESCHERICHIA-COLI; MARINE SEDIMENT; RIVER COLNE; NITRITE; ANAMMOX	Denitrification and dissimilatory nitrate reduction to ammonium (DNRA) are processes occurring simultaneously under oxygen-limited or anaerobic conditions, where both compete for nitrate and organic carbon. Despite their ecological importance, there has been little investigation of how denitrification and DNRA potentials and related functional genes vary vertically with sediment depth. Nitrate reduction potentials measured in sediment depth profiles along the Colne estuary were in the upper range of nitrate reduction rates reported from other sediments and showed the existence of strong decreasing trends both with increasing depth and along the estuary. Denitrification potential decreased along the estuary, decreasing more rapidly with depth towards the estuary mouth. In contrast, DNRA potential increased along the estuary. Significant decreases in copy numbers of 16S rRNA and nitrate reducing genes were observed along the estuary and from surface to deeper sediments. Both metabolic potentials and functional genes persisted at sediment depths where porewater nitrate was absent. Transport of nitrate by bioturbation, based on macrofauna distributions, could only account for the upper 10 cm depth of sediment. A several fold higher combined freeze-lysable KCl-extractable nitrate pool compared to porewater nitrate was detected. We hypothesised that his could be attributed to intracellular nitrate pools from nitrate accumulating microorganisms like Thioploca or Beggiatoa. However, pyrosequencing analysis did not detect any such organisms, leaving other bacteria, microbenthic algae, or foraminiferans which have also been shown to accumulate nitrate, as possible candidates. The importance and bioavailability of a KCl-extractable nitrate sediment pool remains to be tested. The significant variation in the vertical pattern and abundance of the various nitrate reducing genes phylotypes reasonably suggests differences in their activity throughout the sediment column. This raises interesting questions as to what the alternative metabolic roles for the various nitrate reductases could be, analogous to the alternative metabolic roles found for nitrite reductases.	[Papaspyrou, Sokratis; Smith, Cindy J.; Dong, Liang F.; Whitby, Corinne; Dumbrell, Alex J.; Nedwell, David B.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Papaspyrou, S (corresponding author), Univ Cadiz, Dept Biomed Biotecnol & Salud Publ, Lab Microbiol & Genet, Campus Rio San Pedro S-N, Cadiz, Spain.	sokratis.papaspyrou@uca.es	Smith, Cindy/J-9220-2012; Papaspyrou, Sokratis/H-5022-2011	Smith, Cindy/0000-0003-4905-0730; Papaspyrou, Sokratis/0000-0003-4406-0702; Whitby, Corinne/0000-0003-1998-2748	Marie-Curie Intra-European Fellowship [EU 024108 - DEFUNIREG]; Marie-Curie Reintegration Grant [EU 235005 - NITRICOS]; University of Essex; NERC [NE/J011959/1] Funding Source: UKRI; Natural Environment Research Council [NE/J011959/1] Funding Source: researchfish	Marie-Curie Intra-European Fellowship(European Commission); Marie-Curie Reintegration Grant(European Commission); University of Essex; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SP acknowledges the support from a Marie-Curie Intra-European Fellowship (EU 024108 - DEFUNIREG) and a Marie-Curie Reintegration Grant (EU 235005 - NITRICOS), and CW the financial support from the University of Essex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BELL LC, 1990, FEBS LETT, V265, P85, DOI 10.1016/0014-5793(90)80889-Q; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Buchanan J.B., 1984, METHODS STUDY MARINE, V16, P41, DOI DOI 10.1002/9781118542392; Bulow SE, 2008, ENVIRON MICROBIOL, V10, P3057, DOI 10.1111/j.1462-2920.2008.01765.x; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Canfield DE, 2005, NITROGEN CYCLE; Clarke K, PRIMER V6 USER MANUA; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke TA, 2006, BIOCHEM SOC T, V34, P143, DOI 10.1042/BST0340143; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2003, LIMNOL OCEANOGR, V48, P2138, DOI 10.4319/lo.2003.48.6.2138; DALSGAARD T, 1992, APPL ENVIRON MICROB, V58, P1601, DOI 10.1128/AEM.58.5.1601-1608.1992; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Dong LF, 2000, MAR ECOL PROG SER, V203, P109, DOI 10.3354/meps203109; Dong LF, 2002, APPL ENVIRON MICROB, V68, P1240, DOI 10.1128/AEM.68.3.1240-1249.2002; Dong LF, 2006, LIMNOL OCEANOGR, V51, P545, DOI 10.4319/lo.2006.51.1_part_2.0545; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Garcia-Robledo E, 2010, MAR ECOL PROG SER, V403, P155, DOI 10.3354/meps08470; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hanlon ARM, 2006, LIMNOL OCEANOGR, V51, P79, DOI 10.4319/lo.2006.51.1.0079; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1111/j.1574-6976.1999.tb00414.x; HERBERT RA, 1990, FEMS SYMP, P77; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jensen MM, 2007, APPL ENVIRON MICROB, V73, P3151, DOI 10.1128/AEM.01898-06; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Joye SB, 1996, BIOGEOCHEMISTRY, V33, P197, DOI 10.1007/BF02181072; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Koroleff F., 1976, METHODS SEAWATER ANA, P117; Koskiniemi S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002787; KREKELER D, 1995, FEMS MICROBIOL ECOL, V17, P271; Kucera I, 2006, MICROBIOL-SGM, V152, P3529, DOI 10.1099/mic.0.29276-0; Laverman AM, 2006, FEMS MICROBIOL ECOL, V58, P179, DOI 10.1111/j.1574-6941.2006.00155.x; LOMSTEIN E, 1990, MAR ECOL PROG SER, V61, P97, DOI 10.3354/meps061097; Marietou A, 2009, J BACTERIOL, V191, P882, DOI 10.1128/JB.01171-08; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Miller DN, 2001, J MICROBIOL METH, V44, P49, DOI 10.1016/S0167-7012(00)00228-1; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mosier AC, 2010, ENV MICROBIOL REP, V2, P667, DOI 10.1111/j.1758-2229.2010.00156.x; Nedwell DB, 1999, ADV ECOL RES, V29, P43; Nedwell DB, 2004, AQUAT MICROB ECOL, V37, P209, DOI 10.3354/ame037209; NEDWELL DB, 1995, POLAR BIOL, V15, P57; Nielsen OI, 2004, AQUAT MICROB ECOL, V34, P23, DOI 10.3354/ame034023; Nizzoli D, 2007, ESTUAR COAST SHELF S, V75, P125, DOI 10.1016/j.ecss.2007.03.035; Nogales B, 2002, APPL ENVIRON MICROB, V68, P5017, DOI 10.1128/AEM.68.10.5017-5025.2002; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rich JJ, 2008, MICROB ECOL, V55, P311, DOI 10.1007/s00248-007-9277-3; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P163, DOI 10.1007/PL00000844; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Robinson AD, 1998, MAR ECOL PROG SER, V164, P59, DOI 10.3354/meps164059; SEARS HJ, 1993, FEMS MICROBIOL LETT, V113, P107; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Simon J, 2011, BIOCHEM SOC T, V39, P1864, DOI 10.1042/BST20110713; Smith CJ, 2007, APPL ENVIRON MICROB, V73, P3612, DOI 10.1128/AEM.02894-06; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; SORENSEN J, 1978, APPL ENVIRON MICROB, V36, P139; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Takeuchi J, 2006, GEOMICROBIOL J, V23, P75, DOI 10.1080/01490450500533866; Thompson RC, 1999, J MAR BIOL ASSOC UK, V79, P551, DOI 10.1017/S0025315498000678; Tiquia SM, 2006, FEMS MICROBIOL ECOL, V58, P464, DOI 10.1111/j.1574-6941.2006.00173.x; Trimmer M, 2005, APPL ENVIRON MICROB, V71, P1923, DOI 10.1128/AEM.71.4.1923-1930.2005; Visscher P.T., 2003, BIOGEOCHEMISTRY, V8, P317, DOI DOI 10.1016/B0-08-043751-6/08132-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Yu KW, 2010, COMMUN SOIL SCI PLAN, V41, P2201, DOI 10.1080/00103624.2010.504800; Zopfi J, 2001, APPL ENVIRON MICROB, V67, P5530, DOI 10.1128/AEM.67.12.5530-5537.2001	77	34	36	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94111	10.1371/journal.pone.0094111	http://dx.doi.org/10.1371/journal.pone.0094111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728381	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000336736200039
J	Siewert, C; Luge, T; Duduk, B; Seemuller, E; Buttner, C; Sauer, S; Kube, M				Siewert, Christin; Luge, Toni; Duduk, Bojan; Seemueller, Erich; Buettner, Carmen; Sauer, Sascha; Kube, Michael			Analysis of Expressed Genes of the Bacterium 'Candidatus Phytoplasma Mali' Highlights Key Features of Virulence and Metabolism	PLOS ONE			English	Article							IMMUNODOMINANT MEMBRANE-PROTEIN; COMPLETE GENOME SEQUENCE; AUSTRALIENSE; SECRETION; DISEASE; TAXON; PROLIFERATION; VISUALIZATION; ANNOTATION; ADAPTATION	'Candidatus Phytoplasma mali' is a phytopathogenic bacterium of the family Acholeplasmataceae assigned to the class Mollicutes. This causative agent of the apple proliferation colonizes in Malus domestica the sieve tubes of the plant phloem resulting in a range of symptoms such as witches'-broom formation, reduced vigor and affecting size and quality of the crop. The disease is responsible for strong economical losses in Europe. Although the genome sequence of the pathogen is available, there is only limited information on expression of selected genes and metabolic key features that have not been examined on the transcriptomic or proteomic level so far. This situation is similar to many other phytoplasmas. In the work presented here, RNA-Seq and mass spectrometry shotgun techniques were applied on tissue samples from Nicotiana occidentalis infected by 'Ca. P. mali' strain AT providing insights into transcriptome and proteome of the pathogen. Data analysis highlights expression of 208 genes including 14 proteins located in the terminal inverted repeats of the linear chromosome. Beside a high portion of house keeping genes, the recently discussed chaperone GroES/GroEL is expressed. Furthermore, gene expression involved in formation of a type IVB and of the Sec-dependent secretion system was identified as well as the highly expressed putative pathogenicity-related SAP11-like effector protein. Metabolism of phytoplasmas depends on the uptake of spermidine/putescine, amino acids, co-factors, carbohydrates and in particular malate/citrate. The expression of these transporters was confirmed and the analysis of the carbohydrate cycle supports the suggested alternative energy-providing pathway for phytoplasmas releasing acetate and providing ATP. The phylogenetic analyses of malate dehydrogenase and acetate kinase in phytoplasmas show a closer relatedness to the Firmicutes in comparison to Mycoplasma species indicating an early divergence of the Acholeplasmataceae from the Mollicutes.	[Siewert, Christin; Buettner, Carmen; Kube, Michael] Humboldt Univ, Dept Crop & Anim Sci, Div Phytomed, D-10099 Berlin, Germany; [Luge, Toni; Sauer, Sascha] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Duduk, Bojan] Inst Pesticides & Environm Protect, Belgrade, Serbia; [Seemueller, Erich] Fed Res Ctr Cultivated Plants, Inst Plant Protect Fruit Crops & Viticulture, Julius Kuehn Inst, Dossenheim, Germany	Humboldt University of Berlin; Max Planck Society; Julius Kuhn-Institut	Kube, M (corresponding author), Humboldt Univ, Dept Crop & Anim Sci, Div Phytomed, D-10099 Berlin, Germany.	Michael.Kube@agrar.hu-berlin.de	Duduk, Bojan/AAJ-2600-2020	Duduk, Bojan/0000-0002-8109-7400	German Research Foundation (DFG) [KU 2679/2-1, BU 890/21-1]; German Ministry for Education and Research (BMBF) [0315082, 01EA1303]; Ministry of Education and Science (Republic of Serbia) [TR31043]; German Academic Exchange Service (DAAD/BMBF) [56266384]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Education and Science (Republic of Serbia)(Ministry of Education, Science & Technological Development, Serbia); German Academic Exchange Service (DAAD/BMBF)	The German Research Foundation (DFG) through projects KU 2679/2-1 and BU 890/21-1, the German Ministry for Education and Research (BMBF, grant numbers: 0315082, 01EA1303), the Ministry of Education and Science (Republic of Serbia, Grant No. TR31043) and the German Academic Exchange Service (DAAD/BMBF) through project 56266384 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS U, 1992, PHYTOPATHOLOGY, V82, P828, DOI 10.1094/Phyto-82-828; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen MT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-529; Arocha Y, 2005, INT J SYST EVOL MICR, V55, P2451, DOI 10.1099/ijs.0.63797-0; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boonrod K, 2012, MOL PLANT MICROBE IN, V25, P889, DOI 10.1094/MPMI-11-11-0303; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; COHEN G, 1969, J BACTERIOL, V98, P547, DOI 10.1128/JB.98.2.547-551.1969; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Ctuaglino F, 2013, INT J SYST EVOL MICR, V63, P2879, DOI 10.1099/ijs.0.044750-0; Davis RE, 2005, DNA CELL BIOL, V24, P832, DOI 10.1089/dna.2005.24.832; Davis RE, 1997, INT J SYST BACTERIOL, V47, P262, DOI 10.1099/00207713-47-2-262; Duduk B, 2006, PLANT DIS, V90, P1313, DOI 10.1094/PD-90-1313; Freiwald A, 2013, PROTEOMICS; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ji XL, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-20; Jomantiene R, 2007, DNA CELL BIOL, V26, P557, DOI 10.1089/dna.2007.0610; Jovic J, 2009, PHYTOPATHOLOGY, V99, P1053, DOI 10.1094/PHYTO-99-9-1053; Jung HY, 2003, INT J SYST EVOL MICR, V53, P1925, DOI 10.1099/ijs.0.02531-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kakizawa S, 2004, MICROBIOL-SGM, V150, P135, DOI 10.1099/mic.0.26521-0; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Kube M, 2012, SCI WORLD J, DOI 10.1100/2012/185942; Kube M, 2014, J MOL MICROB BIOTECH, V24, P19, DOI 10.1159/000354322; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Meierhofer D, 2013, MOL CELL PROTEOMICS, V12, P1965, DOI 10.1074/mcp.M112.025031; Mitrovic J, 2014, J MOL MICROB BIOTECH, V24, P1, DOI 10.1159/000353904; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00136; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Oshima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023242; Pedruzzi I, 2013, NUCLEIC ACIDS RES, V41, pD584, DOI 10.1093/nar/gks1157; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Seemuller E, 2013, MOL PLANT MICROBE IN, V26, P367, DOI 10.1094/MPMI-09-12-0221-R; Seemuller E, 2004, INT J SYST EVOL MICR, V54, P1217, DOI 10.1099/ijs.0.02823-0; Seemuller E, 2011, VIRUS VIRUS LIKE DIS, P67; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SONNHAMMER ELL, 1994, COMPUT APPL BIOSCI, V10, P301; Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; ZREIK L, 1995, INT J SYST BACTERIOL, V45, P449, DOI 10.1099/00207713-45-3-449	60	21	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94391	10.1371/journal.pone.0094391	http://dx.doi.org/10.1371/journal.pone.0094391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728201	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336736200070
J	Balhara, J; Redhu, NS; Shan, LY; Gounni, AS				Balhara, Jyoti; Redhu, Naresh Singh; Shan, Lianyu; Gounni, Abdelilah S.			IgE Regulates the Expression of smMLCK in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							FC-EPSILON-RI; CHAIN KINASE CONTENT; EXTRACELLULAR-MATRIX; CYTOKINE PRODUCTION; SIGNALING PATHWAYS; MONOMERIC IGE; MAP KINASES; RECEPTOR; MYOSIN; ASTHMA	Previous studies have shown that enhanced accumulation of contractile proteins such as smooth muscle myosin light chain kinase (smMLCK) plays a major role in human airway smooth muscle cells (HASM) cell hypercontractility and hypertrophy. Furthermore, serum IgE levels play an important role in smooth muscle hyperreactivity. However, the effect of IgE on smMLCK expression has not been investigated. In this study, we demonstrate that IgE increases the expression of smMLCK at mRNA and protein levels. This effect was inhibited significantly with neutralizing abs directed against Fc epsilon RI but not with anti-Fc epsilon RII/CD23. Furthermore, Syk knock down and pharmacological inhibition of mitogen activated protein kinases (MAPK) (ERK1/2, p38, and JNK) and phosphatidylinositol 3-kinase (PI3K) significantly diminished the IgE-mediated upregulation of smMLCK expression in HASM cells. Taken together, our data suggest a role of IgE in regulating smMLCK in HASM cells. Therefore, targeting the FceRI activation on HASM cells may offer a novel approach in controlling the bronchomotor tone in allergic asthma.	[Balhara, Jyoti; Redhu, Naresh Singh; Shan, Lianyu; Gounni, Abdelilah S.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada	University of Manitoba	Gounni, AS (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	Abdel.gounni@med.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Gounni, Abdelilah/0000-0003-1265-6560; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [MOP-115115]; Manitoba Health Research Council Graduate studentship award; Canada Lung Association- Canadian Thoracic Society (CLA-CTS) graduate studentship; Manitoba Research Chairs program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council Graduate studentship award; Canada Lung Association- Canadian Thoracic Society (CLA-CTS) graduate studentship; Manitoba Research Chairs program	This work is supported by the Canadian Institutes of Health Research (CIHR#MOP-115115). J.B. is a recipient of the Manitoba Health Research Council Graduate studentship award. N.S.R. was supported by the Canada Lung Association- Canadian Thoracic Society (CLA-CTS) graduate studentship. A. S. G. is funded by the Manitoba Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Ammit AJ, 2000, AM J RESP CRIT CARE, V161, P257, DOI 10.1164/ajrccm.161.1.9901005; Barbu EA, 2010, J BIOL CHEM, V285, P15761, DOI 10.1074/jbc.M110.109413; Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Gerthoffer WT, 2004, AM J RESP CRIT CARE, pA188; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Griffith QK, 2011, J IMMUNOL, V186, P1060, DOI 10.4049/jimmunol.1002709; Hamid Qutayba, 2003, Journal of Allergy and Clinical Immunology, V111, pS5, DOI 10.1067/mai.2003.22; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Han YJ, 2006, MOL BIOL CELL, V17, P4039, DOI 10.1091/mbc.E06-04-0353; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; JIANG H, 1992, AM J RESP CELL MOL, V7, P567, DOI 10.1165/ajrcmb/7.6.567; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Katoh N, 2000, J CLIN INVEST, V105, P183, DOI 10.1172/JCI6895; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kimata M, 2000, BIOCHEM PHARMACOL, V60, P589, DOI 10.1016/S0006-2952(00)00354-3; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KONG SK, 1990, AM J PHYSIOL, V259, pL53, DOI 10.1152/ajplung.1990.259.2.L53; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lara M, 2001, J IMMUNOL, V167, P4329, DOI 10.4049/jimmunol.167.8.4329; Li HX, 2007, GASTROENTEROLOGY, V133, P1905, DOI 10.1053/j.gastro.2007.09.024; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Ma XF, 1997, RESP PHYSIOL, V110, P57, DOI 10.1016/S0034-5687(97)00066-2; Miura K, 2000, BLOOD, V96, P2199, DOI 10.1182/blood.V96.6.2199.h8002199_2199_2205; Nechansky A, 1997, HYBRIDOMA, V16, P441, DOI 10.1089/hyb.1997.16.441; Nechansky A, 1998, FEBS LETT, V441, P225, DOI 10.1016/S0014-5793(98)01558-0; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ortega E, 1999, J IMMUNOL, V162, P176; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Prausnitz C., 1921, ZENTRALBLATT F UR BA, V86, P160; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Redhu NS, 2013, PULM PHARMACOL THER, V26, P86, DOI 10.1016/j.pupt.2012.04.004; Redhu NS, 2012, AM J RESP CELL MOL, V46, P559, DOI 10.1165/ajrcmb.46.4.559; Redhu NS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006153; Redhu NS, 2011, J ALLERGY CLIN IMMUN; Redhu NS, 2012, PULM PHARM THER; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Slats AM, 2008, J ALLERGY CLIN IMMUN, V121, P1196, DOI 10.1016/j.jaci.2008.02.017; Sly LM, 2008, J IMMUNOL, V181, P3850, DOI 10.4049/jimmunol.181.6.3850; SOUHRADA M, 1984, SCIENCE, V225, P723, DOI 10.1126/science.6087455; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; Watson N, 1997, AM J RESP CRIT CARE, V155, P839, DOI 10.1164/ajrccm.155.3.9117014; Wu LC, 2011, J BIOL CHEM, V286, P32891, DOI 10.1074/jbc.R110.205104; Xia YXC, 2011, AM J RESP CELL MOL, V44, P665, DOI 10.1165/rcmb.2009-0371OC; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhou XL, 2008, CANCER LETT, V270, P312, DOI 10.1016/j.canlet.2008.05.028; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	58	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93946	10.1371/journal.pone.0093946	http://dx.doi.org/10.1371/journal.pone.0093946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722483	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100031
J	Genty, LM; Bouchon, D; Raimond, M; Bertaux, J				Genty, Lise-Marie; Bouchon, Didier; Raimond, Maryline; Bertaux, Joanne			Wolbachia Infect Ovaries in the Course of Their Maturation: Last Minute Passengers and Priority Travellers?	PLOS ONE			English	Article							CELL NICHE TROPISM; ENDOSYMBIONTS; TRANSMISSION; SEGREGATION; BACTERIA; PARASITE; BIOLOGY; ISOPOD; DEATH	Wolbachia are widespread endosymbiotic bacteria of arthropods and nematodes. Studies on such models suggest that Wolbachia's remarkable aptitude to infect offspring may rely on a re-infection of ovaries from somatic tissues instead of direct cellular segregation between oogonia and oocytes. In the terrestrial isopod Armadillidium vulgare, Wolbachia are vertically transmitted to the host offspring, even though ovary cells are cyclically renewed. Using Fluorescence in situ hybridization (FISH), we showed that the proportion of infected oocytes increased in the course of ovary and oocyte maturation, starting with 31.5% of infected oocytes only. At the end of ovary maturation, this proportion reached 87.6% for the most mature oocytes, which is close to the known transmission rate to offspring. This enrichment can be explained by a secondary acquisition of the bacteria by oocytes (Wolbachia can be seen as last minute passengers) and/or by a preferential selection of oocytes infected with Wolbachia (as priority travellers).	[Genty, Lise-Marie; Bouchon, Didier; Raimond, Maryline; Bertaux, Joanne] Univ Poitiers, Equipe Ecol Evolut Symbiose, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Bertaux, J (corresponding author), Univ Poitiers, Equipe Ecol Evolut Symbiose, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France.	joanne.bertaux@univ-poitiers.fr	Bouchon, Didier/B-2419-2012	Bouchon, Didier/0000-0002-4938-408X	CNRS, The University of Poitiers; ANR ImmunSymbArt [ANR-10-BLAN-1701]; ADaWOL [ANR-09-JCJC-0109-01]; Region Poitou-Charentes; French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	CNRS, The University of Poitiers; ANR ImmunSymbArt(French National Research Agency (ANR)); ADaWOL; Region Poitou-Charentes(Region Nouvelle-Aquitaine); French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	Financial support was provided by the CNRS, The University of Poitiers, the ANR ImmunSymbArt (ANR-10-BLAN-1701, coordinator D. Bouchon) and ADaWOL (ANR-09-JCJC-0109-01, coordinator M. Sicard). The authors thank the confocal microscopy facility from at the University of Poitiers (ImageUP), and the CPER Eco-Industrie as well as the Region Poitou-Charentes for their participation in funding of the Apotome microscope. The work of L. Genty was funded by a PhD fellowship from the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2009, J CELL SCI, V122, P4570, DOI 10.1242/jcs.054981; Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Besse G, 1976, THESIS U POITIERS FR; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Casper-Lindley C, 2011, APPL ENVIRON MICROB, V77, P4788, DOI 10.1128/AEM.00215-11; Chevalier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018531; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Fischer K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001174; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; HORNUNG E, 1994, TISSUE CELL, V26, P277, DOI 10.1016/0040-8166(94)90102-3; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; JUCHAULT P, 1994, CR ACAD SCI III-VIE, V317, P225; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; Landmann F, 2012, BIOL OPEN, V1, P536, DOI 10.1242/bio.2012737; Landmann F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002351; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin G, 1973, CR HEBD ACAD SCI, V76, P2313; McCall K, 2004, DEV BIOL, V274, P3, DOI 10.1016/j.ydbio.2004.07.017; Michalik A, 2009, FOLIA BIOL-KRAKOW, V57, P131, DOI 10.3409/fb57_3-4.131-137; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Sacchi L, 2010, TISSUE CELL, V42, P328, DOI 10.1016/j.tice.2010.07.009; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Souty-Grosset C, 1984, CONTRIBUTION ETUDE S; Terry RS, 1997, PARASITOLOGY, V115, P157, DOI 10.1017/S0031182097001236; Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Werren JH, 2005, MICROBIAL EVOLUTION, P290	35	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94577	10.1371/journal.pone.0094577	http://dx.doi.org/10.1371/journal.pone.0094577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722673	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100100
J	Liu, HY; Chen, K; Feng, WQ; Guo, JJ; Li, H				Liu, Hongya; Chen, Kai; Feng, Wenqiang; Guo, Juanjuan; Li, Hui			HSV-2 Increases TLR4-Dependent Phosphorylated IRFs and IFN-beta Induction in Cervical Epithelial Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; HOST SHUTOFF PROTEIN; INTERFERON-BETA; INFECTION; INNATE; TYPE-2; RESPONSES	Our previous studies demonstrated that HSV-2 infection up-regulates TLR4 expression and induces NF-kB activity, thereby facilitating innate immune response in human cervical epithelial cells. This process requires involvement of TLR4 adaptors, Mal and MyD88. In the current study, we found that HSV-2 infection increases levels of phosphoryalted IRF3 and IRF7, then regulating expression of type I IFN. As expected, these changes induced by HSV-2 infection depended upon TLR4. Knockdown of TRIF and/or TRAM by siRNAs indicated that TRIF/TRAM might be involved in expression of IFN-beta. Our results demonstrate for the first time that IRF3 and IRF7 are both involved in inducing TLR4-dependent IFN-beta expression in response to HSV-2 in its primary infected genital epithelial cells. Thus, TLR4-Mal/MyD88 and TLR4-TRIF/TRAM signaling may synergize and/or cooperate in innate immune response of cervical epithelial cells to HSV-2 infection.	[Liu, Hongya; Feng, Wenqiang; Guo, Juanjuan; Li, Hui] Wuhan Univ, State Key Lab Virol, Inst Med Virol, Sch Med, Wuhan 430072, Hubei, Peoples R China; [Liu, Hongya; Feng, Wenqiang; Guo, Juanjuan; Li, Hui] Wuhan Univ, Shenzhen Inst, Shengzhen R&D Ctr, State Key Lab Virol, Shenzhen, Guangdong, Peoples R China; [Chen, Kai] Cent Blood Stn Rizhao, Rizhao, Shandong, Peoples R China	Wuhan University; Wuhan University	Li, H (corresponding author), Wuhan Univ, State Key Lab Virol, Inst Med Virol, Sch Med, Wuhan 430072, Hubei, Peoples R China.	somhli@whu.edu.cn	GUO, JUAN/HIK-2220-2022		National Natural Science Foundation of China [81072419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81072419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Chan T, 2011, J REPROD IMMUNOL, V88, P210, DOI 10.1016/j.jri.2011.01.001; Corey Lawrence, 2007, Herpes, V14 Suppl 1, p5A; Dai PH, 2011, J VIROL, V85, P10814, DOI 10.1128/JVI.00104-11; Ferreira VH, 2013, AM J REPROD IMMUNOL, V70, P199, DOI 10.1111/aji.12133; Finberg RW, 2005, VIRAL IMMUNOL, V18, P457, DOI 10.1089/vim.2005.18.457; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kurt-Jones EA, 2005, J INFECT DIS, V191, P746, DOI 10.1086/427339; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li H, 2009, BIOCHEM BIOPH RES CO, V379, P686, DOI 10.1016/j.bbrc.2008.12.150; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080327; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Miller J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003284; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Peng T, 2009, J VIROL, V83, P12559, DOI 10.1128/JVI.00939-09; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Sin WX, 2012, IMMUNOL RES, V53, P25, DOI 10.1007/s12026-012-8293-7; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	33	7	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94806	10.1371/journal.pone.0094806	http://dx.doi.org/10.1371/journal.pone.0094806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722640	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100136
J	Muniesa, A; Ferreira, C; Fuertes, H; Halaihel, N; de Blas, I				Muniesa, Ana; Ferreira, Chelo; Fuertes, Hector; Halaihel, Nabil; de Blas, Ignacio			Estimation of the Relative Sensitivity of qPCR Analysis Using Pooled Samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PCR; VIRUS	The high sensitivity of qPCR makes it a desirable diagnostic method in epidemiological surveillance programs. However, due to high costs, the use of pooling has been suggested. In this paper, an algorithm based on the Montecarlo method has been designed and implemented. The algorithm had been tested in many different situations, and finally it was validated with a real dataset. Moreover, based on the results obtained and depending on pooling conditions, a drastic decrease of sensitivity is observed.	[Muniesa, Ana; Fuertes, Hector; Halaihel, Nabil; de Blas, Ignacio] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Zaragoza, Spain; [Ferreira, Chelo] Univ Zaragoza, Dept Appl Math, Fac Vet, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	de Blas, I (corresponding author), Univ Zaragoza, Fac Vet, Dept Anim Pathol, Zaragoza, Spain.	deblas@unizar.es	de Blas, Ignacio/E-2125-2013; Ferreira, Chelo/ABA-1370-2020; Muniesa, Ana/B-3523-2015; Halaihel, Nabil/J-2973-2016	de Blas, Ignacio/0000-0002-1204-4356; Muniesa, Ana/0000-0003-3074-5778	Ministerio de Educacion of Spain; Departamento de Industria e Innovacion del Gobierno de Aragon; Fondo Social Europeo; Direccion General de Ciencia y Tecnologia [MTM2010-21037]	Ministerio de Educacion of Spain(Spanish Government); Departamento de Industria e Innovacion del Gobierno de Aragon; Fondo Social Europeo(European Social Fund (ESF)European Commission); Direccion General de Ciencia y Tecnologia	Ministerio de Educacion of Spain is funding a FPU/MEC doctorate fellowship for Ana Muniesa. Also the Departamento de Industria e Innovacion del Gobierno de Aragon, Fondo Social Europeo and Direccion General de Ciencia y Tecnologia (REF. MTM2010-21037) provides financial support to Research Groups A35 and T53 for their basic running costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MA, 1988, J INFECT DIS, V158, P1158, DOI 10.1093/infdis/158.6.1158; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Gerber PF, 2013, J CLIN MICROBIOL, V51, P547, DOI 10.1128/JCM.02685-12; Koskinen MT, 2009, J DAIRY SCI, V92, P952, DOI 10.3168/jds.2008-1549; MARTIN SW, 1992, PREV VET MED, V14, P33, DOI 10.1016/0167-5877(92)90082-Q; Mehta T, 2010, J CLIN MICROBIOL, V48, P4326, DOI 10.1128/JCM.01190-10; OIE, 2013, MANUAL DIAGNOSTIC TE; REISS J, 1990, HUM GENET, V85, P1; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Thrusfield M.V., 2010, VET EPIDEMIOLOGY, V3rd; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	13	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93491	10.1371/journal.pone.0093491	http://dx.doi.org/10.1371/journal.pone.0093491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722485	Green Published, gold			2022-12-25	WOS:000336909100018
J	Shin, EH; Roh, JY; Park, WI; Song, BG; Chang, KS; Lee, WG; Lee, HI; Park, C; Park, MY; Shin, EH				Shin, Eun Hee; Roh, Jong Yul; Park, Won Il; Song, Bong Gu; Chang, Kyu-Sik; Lee, Wook-Gyo; Lee, Hee Il; Park, Chan; Park, Mi-Yeoun; Shin, E-Hyun			Transovarial Transmission of Orientia tsutsugamushi in Leptotrombidium palpale (Acari: Trombiculidae)	PLOS ONE			English	Article							RICKETTSIA-TSUTSUGAMUSHI; VERTICAL TRANSMISSION; PALLIDUM; IMPHALUM	Transovarial transmission of Orientia tsutsugamushi in colonies of Leptotrombidium palpale was studied in the parent and F-1 and F2 generations. Both transovarial transmission and filial infection rates were 100% in the parent and F-1 generations of Leptotrombidium palpale. The filial infection rate in the F-1 generation was 100%, but it declined to 94.3% in the F-2 progeny. The sex ratio of the F-1 generation from infected L. palpale was 1:0.8 (male:female) and the proportion of males was relatively high. This study is the first to report on the transovarial transmission of O. tsutsugamushi in L. palpale. High transovarial transmission rates in L. palpale suggest that this species might be one of the major vectors of tsutsugamushi disease in Korea.	[Shin, Eun Hee; Roh, Jong Yul; Park, Won Il; Song, Bong Gu; Chang, Kyu-Sik; Lee, Wook-Gyo; Park, Mi-Yeoun; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongwon, South Korea; [Lee, Hee Il] Korea Natl Inst Hlth, Div Biosafety Evaluat & Control, Cheongwon, South Korea; [Park, Chan] Korea Natl Inst Hlth, Div Arboviruses, Ctr Immunol & Pathol, Cheongwon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Division of Biosafety Evaluation & Control; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongwon, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019; Shin, Eun-Hee/D-5757-2012		Research of Korea Centers for Disease Control and Prevention [211-N55002-22]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (211-N55002-22) by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Asanuma K., 1959, Japanese Journal of Sanitary Zoology, V10, P232; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; Frances SP, 2001, J MED ENTOMOL, V38, P17, DOI 10.1603/0022-2585-38.1.17; FURUYA Y, 1993, J CLIN MICROBIOL, V31, P1637, DOI 10.1128/JCM.31.6.1637-1640.1993; Kawamura A., 1995, TSUTSUGAMUSHI DIS; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; MUNRO-FAURE A D, 1951, J R Army Med Corps, V97, P227; Phasomkusolsil S, 2012, J MED ENTOMOL, V49, P1270, DOI 10.1603/ME12100; Phasomkusolsil S, 2009, J MED ENTOMOL, V46, P1442, DOI 10.1603/033.046.0628; RAPMUND G, 1984, J INFECT DIS, V149, P330, DOI 10.1093/infdis/149.3.330; RAPMUND G, 1972, J MED ENTOMOL, V9, P71, DOI 10.1093/jmedent/9.1.71; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Ree Han-Il, 1992, Korean Journal of Parasitology, V30, P341, DOI 10.3347/kjp.1992.30.4.341; Ree HI, 1997, J MED ENTOMOL, V48, P13; ROBERTS LW, 1977, J MED ENTOMOL, V14, P89, DOI 10.1093/jmedent/14.1.89; Takahashi M., 1990, Japanese Journal of Sanitary Zoology, V41, P389; TAKAHASHI M, 1988, JPN J EXP MED, V58, P213; URAKAMI H, 1994, AM J TROP MED HYG, V50, P219, DOI 10.4269/ajtmh.1994.50.219; URAKAMI H, 1994, JPN J MED SCI BIOL, V47, P127, DOI 10.7883/yoken1952.47.127; Wormersley H, 1951, REC S AUSTR MUS, V10, P1	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e88453	10.1371/journal.pone.0088453	http://dx.doi.org/10.1371/journal.pone.0088453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721932	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100003
J	Sytykiewicz, H				Sytykiewicz, Hubert			Differential Expression of Superoxide Dismutase Genes in Aphid-Stressed Maize (Zea mays L.) Seedlings	PLOS ONE			English	Article							CHERRY-OAT APHID; ANTIOXIDANT ENZYME-ACTIVITIES; IN-VITRO ANTIOXIDANT; DWARF-MOSAIC-VIRUS; OXIDATIVE STRESS; RHOPALOSIPHUM-PADI; BIOCHEMICAL INTERACTIONS; TRITICALE TRITICOSECALE; LIPID-PEROXIDATION; DEFENSE-MECHANISMS	The aim of this study was to compare the expression patterns of superoxide dismutase genes (sod2, sod3.4, sod9 and sodB) in seedling leaves of the Zea mays L. Tasty Sweet (susceptible) and Ambrozja (relatively resistant) cultivars infested with one of two hemipteran species, namely monophagous Sitobion avenae F. (grain aphid) or oligophagous Rhopalosiphum padi L. (bird cherry-oat aphid). Secondarily, aphid-elicited alternations in the antioxidative capacity towards DPPH (1,1-diphenyl-2-picrylhydrazyl) radical in insect-stressed plants were evaluated. Comprehensive comparison of expression profiles of the four sod genes showed that both insect species evoked significant upregulation of three genes sod2, sod3.4 and sod9). However, aphid infestation affected non-significant fluctuations in expression of sodB gene in seedlings of both maize genotypes. The highest levels of transcript accumulation occurred at 8 h (sod2 and sod3.4) or 24 h (sod9) post-infestation, and aphid-induced changes in the expression of sod genes were more dramatic in the Ambrozja cultivar than in the Tasty Sweet variety. Furthermore, bird cherry-oat aphid colonization had a more substantial impact on levels of DPPH radical scavenging activity in infested host seedlings than grain aphid colonization. Additionally, Ambrozja plants infested by either hemipteran species showed markedly lower antioxidative capacity compared with attacked Tasty Sweet plants.	Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland		Sytykiewicz, H (corresponding author), Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland.	huberts@uph.edu.pl	Sytykiewicz, Hubert/AAC-1431-2020	Sytykiewicz, Hubert/0000-0002-6540-0561	National Science Centre (NSC, Poland) [N N310 733940]	National Science Centre (NSC, Poland)	This study was supported by the National Science Centre (NSC, Poland) under the grant no. N N310 733940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asghar MN, 2011, FOOD SCI TECHNOL INT, V17, P481, DOI 10.1177/1082013211399495; Aslan M. Murat, 2005, Turkish Journal of Zoology, V29, P1; Barah P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058987; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Boue S M, 2008, J Food Sci, V73, pH43, DOI 10.1111/j.1750-3841.2008.00707.x; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Camejo D, 2007, PHYSIOL PLANTARUM, V131, P367, DOI 10.1111/j.1399-3054.2007.00953.x; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celik O, 2009, POL J ENVIRON STUD, V18, P175; Chrzanowski G, 2012, CROP PROT, V35, P71, DOI 10.1016/j.cropro.2012.01.005; Clarke G, 2013, ANTIOXIDANTS, V2, P1, DOI 10.3390/antiox2010001; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; Coulette Q, 2013, J ECON ENTOMOL, V106, P683, DOI 10.1603/EC12147; Czerniewicz P, 2011, ALLELOPATHY J, V27, P309; de Carvalho K, 2013, MOL BIOL REP, V40, P3269, DOI 10.1007/s11033-012-2402-5; Demiral MA, 2011, TURK J BIOL, V35, P433, DOI 10.3906/biy-0912-47; Ehsani-Moghaddam B, 2006, J PLANT PHYSIOL, V163, P147, DOI 10.1016/j.jplph.2005.04.025; Fang XP, 2012, J PROTEOMICS, V75, P4074, DOI 10.1016/j.jprot.2012.05.022; Fornale S, 2012, MOL PLANT, V5, P817, DOI 10.1093/mp/ssr097; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gao SX, 2013, J ECON ENTOMOL, V106, P1294, DOI 10.1603/EC13017; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Golawska S, 2012, ACTA BIOL CRACOV BOT, V54, P39, DOI 10.2478/v10182-012-0022-y; Golawska S, 2010, ACTA BIOL CRACOV BOT, V52, P76, DOI 10.2478/v10182-010-0026-4; Halarewicz A, 2012, ARTHROPOD-PLANT INTE, V6, P497, DOI 10.1007/s11829-012-9228-x; Hasheminasab H., 2012, Journal of Agricultural Science (Toronto), V4, P20, DOI 10.5539/jas.v4n8p20; Herrmann A, 2013, BIOENERG RES, V6, P372, DOI 10.1007/s12155-012-9227-x; Horsakova J., 2013, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V61, P1693, DOI 10.11118/actaun201361061693; Islam MR, 2011, J SCI FOOD AGR, V91, P813, DOI 10.1002/jsfa.4252; Jevremovic S, 2010, ARCH BIOL SCI, V62, P553, DOI 10.2298/ABS1003553J; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P244, DOI 10.1034/j.1399-3054.2002.1150210.x; Kang HM, 2002, J AGR FOOD CHEM, V50, P513, DOI 10.1021/jf011124d; Kar RK, 2011, PLANT SIGNAL BEHAV, V6, P1741, DOI 10.4161/psb.6.11.17729; Kayihan C, 2012, BIOL PLANTARUM, V56, P693, DOI 10.1007/s10535-012-0143-x; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P430, DOI 10.1111/j.1365-3040.2011.02395.x; Krzepilko A, 2010, ECOL CHEM ENG A, V17, P1629; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-423; Lee YP, 2010, J EXP BOT, V61, P2499, DOI 10.1093/jxb/erq085; LESAK I, 2006, ACTA BIOL CRACOV BOT, V48, P93; Lewis MF, 2010, CROP SCI, V50, P516, DOI 10.2135/cropsci2009.03.0148; Li FQ, 2013, J ECON ENTOMOL, V106, P1473, DOI 10.1603/EC12327; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis Joe, 2012, Arabidopsis Book, V10, pe0159, DOI 10.1199/tab.0159; Lukasik I, 2012, POL J ENVIRON STUD, V21, P1937; Lukasik I, 2011, B INSECTOL, V64, P153; Moloi MJ, 2006, J PLANT PHYSIOL, V163, P1118, DOI 10.1016/j.jplph.2005.07.014; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Morkunas I, 2008, PHYSIOL MOL PLANT P, V72, P167, DOI 10.1016/j.pmpp.2008.09.003; Morkunas I, 2008, J PLANT PHYSIOL, V165, P262, DOI 10.1016/j.jplph.2007.01.020; Morkunas I, 2011, ACTA PHYSIOL PLANT, V33, P2057, DOI 10.1007/s11738-011-0751-7; Morkunas I, 2013, PROTOPLASMA, V250, P63, DOI 10.1007/s00709-012-0374-x; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Navascues J, 2012, NEW PHYTOL, V193, P625, DOI 10.1111/j.1469-8137.2011.03978.x; Parida AK, 2004, J PLANT PHYSIOL, V161, P531, DOI 10.1078/0176-1617-01084; Pawlak S, 2009, ACTA PHYSIOL PLANT, V31, P741, DOI 10.1007/s11738-009-0286-3; Pienkosz Aneta, 2005, Progress in Plant Protection, V45, P989; Pilon M, 2011, BBA-BIOENERGETICS, V1807, P989, DOI 10.1016/j.bbabio.2010.11.002; de Leon IP, 2013, INT J MOL SCI, V14, P3178, DOI 10.3390/ijms14023178; Qian HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019451; Rady M. M., 2012, African Journal of Agricultural Research, V7, P3249; Radyukina NL, 2011, RUSS J PLANT PHYSL+, V58, P51, DOI 10.1134/S1021443711010122; Rahman MM, 2014, PHARMACOGN RES, V6, P36, DOI 10.4103/0974-8490.122915; Rasoulnia A, 2011, MOL BIOL REP, V38, P5055, DOI 10.1007/s11033-010-0651-8; Reddy K. R., 2013, American Journal of Experimental Agriculture, V3, P1; Rodriguez-Serrano M, 2009, PLANT PHYSIOL, V150, P229, DOI 10.1104/pp.108.131524; Rubio MC, 2007, MOL PLANT MICROBE IN, V20, P262, DOI 10.1094/MPMI-20-3-0262; Rubio-Wilhelmi MM, 2011, ENVIRON EXP BOT, V72, P167, DOI 10.1016/j.envexpbot.2011.03.005; Sanchez-Rodriguez E, 2012, PLANT SCI, V188, P89, DOI 10.1016/j.plantsci.2011.12.019; Sanchez-Venegas Jaime R, 2009, BMC Res Notes, V2, P198, DOI 10.1186/1756-0500-2-198; Semencenko VV, 2013, J SCI FOOD AGR, V93, P811, DOI 10.1002/jsfa.5801; Sempruch C, 2010, ACTA BIOL HUNG, V61, P512, DOI 10.1556/ABiol.61.2010.4.13; Sempruch C, 2013, ACTA BIOL CRACOV BOT, V55, P45, DOI 10.2478/abcsb-2013-0021; Sempruch C, 2013, BIOCHEM SYST ECOL, V51, P349, DOI 10.1016/j.bse.2013.10.001; Sempruch C, 2012, BIOCHEM SYST ECOL, V40, P162, DOI 10.1016/j.bse.2011.10.004; SPRAWKA I, 2014, J INSECT SC IN PRESS; Sprawka I, 2014, J PLANT INTERACT, V9, P425, DOI 10.1080/17429145.2013.848947; Sprawka I, 2013, APPL ENTOMOL ZOOL, V48, P525, DOI 10.1007/s13355-013-0214-2; Sprawka I, 2012, ACTA BIOL HUNG, V63, P342, DOI 10.1556/ABiol.63.2012.3.4; Sprawka I, 2011, PESTIC BIOCHEM PHYS, V100, P64, DOI 10.1016/j.pestbp.2011.02.006; Stewart LR, 2012, VIRUS RES, V165, P219, DOI 10.1016/j.virusres.2012.02.004; Stoetzel MB, 2001, FLA ENTOMOL, V84, P83, DOI 10.2307/3496667; Strazynski P, 2008, APHIDS OTHER HOMOPTE, V14, P123; Svobodova E., 2013, PEST MANAG SCI, DOI [DOI 10.1002/PS.3622, 10.1002/ps.3622]; Sytykiewicz H, 2012, FEBS J, V279, P70; Sytykiewicz H, 2011, ACTA BIOL HUNG, V62, P316, DOI 10.1556/ABiol.62.2011.3.10; SYTYKIEWICZ H, 2007, THESIS AKAD PODLASKA; Sytykiewicz H, 2013, ACTA BIOL CRACOV BOT, V55, P51, DOI 10.2478/abcsb-2013-0023; Sytykiewicz H, 2013, ACTA BIOCHIM POL, V60, P457; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Sytykiewicz H, 2011, POL J ECOL, V59, P329; Tayyaba Khatoon, 2010, World Applied Sciences Journal, V8, P1294; Tian ZG, 2012, HORTIC ENVIRON BIOTE, V53, P183, DOI 10.1007/s13580-012-0069-4; Urbanska A, 1990, ZESZ PROBL POST NAUK, V392, P201; URBANSKA A, 2010, EJPAU B, V13; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Zhang WN, 2013, HORTIC ENVIRON BIOTE, V54, P1, DOI 10.1007/s13580-013-0070-6; Zhu ZB, 2009, ENVIRON EXP BOT, V66, P326, DOI 10.1016/j.envexpbot.2009.03.017; Zielinska L, 2012, ACTA BIOL CRACOV BOT, V54, P97, DOI 10.2478/v10182-012-0010-2	104	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94847	10.1371/journal.pone.0094847	http://dx.doi.org/10.1371/journal.pone.0094847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722734	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100139
J	Wang, WY; Kim, HJ; Lee, JH; Wong, V; Sihn, CR; Lv, P; Flores, MCP; Mousavi-Nik, A; Doyle, KJ; Xu, YF; Yamoah, EN				Wang, Wenying; Kim, Hyo Jeong; Lee, Jeong-Han; Wong, Victor; Sihn, Choong-Ryoul; Lv, Ping; Flores, Maria Cristina Perez; Mousavi-Nik, Atefeh; Doyle, Karen Jo; Xu, Yanfang; Yamoah, Ebenezer N.			Functional Significance of K+ Channel beta-Subunit KCNE3 in Auditory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIRAL GANGLION NEURONS; GATED POTASSIUM CHANNELS; LANGE-NIELSEN-SYNDROME; INNER HAIR-CELLS; LONG QT SYNDROME; HEARING-LOSS; PLASMA-MEMBRANE; FIRING FEATURES; XENOPUS-OOCYTES; CAUSE JERVELL	The KCNE3 beta-subunit interacts with and regulates the voltage-dependent gating, kinetics, and pharmacology of a variety of Kv channels in neurons. Because a single neuron may express multiple KCNE3 partners, it is impossible to predict the overall functional relevance of the single transmembrane domain peptide on the pore-forming K+ channel subunits with which it associates. In the inner ear, the role of KCNE3 is undefined, despite its association with Meniere disease and tinnitus. To gain insights on the functional significance of KCNE3 in auditory neurons, we examined the properties of spiral ganglion neurons (SGNs) in Kcne3 null mutant neurons relative to their age-matched controls. We demonstrate that null deletion of Kcne3 abolishes characteristic wide variations in the resting membrane potentials of SGNs and yields age-dependent alterations in action potential and firing properties of neurons along the contour of the cochlear axis, in comparison with age-matched wild-type neurons. The properties of basal SGNs were markedly altered in Kcne3(-/-) mice compared with the wild-type controls; these include reduced action potential latency, amplitude, and increased firing frequency. Analyses of the underlying conductance demonstrate that null mutation of Kcne3 results in enhanced outward K+ currents, which is sufficient to explain the ensuing membrane potential changes. Additionally, we have demonstrated that KCNE3 may regulate the activity of Kv4.2 channels in SGNs. Finally, there were developmentally mediated compensatory changes that occurred such that, by 8 weeks after birth, the electrical properties of the null mutant neurons were virtually indistinguishable from the wild-type neurons, suggesting that ion channel remodeling in auditory neurons progresses beyond hearing onset.	[Wang, Wenying; Xu, Yanfang] Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China; [Wang, Wenying; Kim, Hyo Jeong; Lee, Jeong-Han; Wong, Victor; Sihn, Choong-Ryoul; Lv, Ping; Flores, Maria Cristina Perez; Mousavi-Nik, Atefeh; Doyle, Karen Jo; Yamoah, Ebenezer N.] Univ Calif Davis, Sch Med, Program Commun & Sensory Sci, Dept Anesthesiol & Pain Med, Davis, CA 95618 USA; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Peoples R China	Hebei Medical University; University of California System; University of California Davis; Hebei Medical University	Xu, YF (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China.	yanfangxu@hotmail.com; enyamoah@ucdavis.edu	Wong, Victor/I-7722-2019	Wong, Victor/0000-0003-1415-2825	National Institutes of Health, NIDCD [DC-010386]; National Natural Science Foundation of China [1200746]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC003826] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant DC-010386 (to E. N. Y.) from NIDCD. This work was also supported by National Natural Science Foundation of China Grant 1200746 (to P. L.).; Supported by the Canadian Institutes of Health Research.	Abbott G W, 2001, Mol Interv, V1, P95; Adamson CL, 2002, J NEUROSCI, V22, P1385, DOI 10.1523/JNEUROSCI.22-04-01385.2002; Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; BLUMENTHAL EM, 1994, J NEUROSCI, V14, P3097; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; De Castro MP, 2006, ANAT REC PART A, V288A, P304, DOI 10.1002/ar.a.20312; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Doi K, 2005, ORL-J OTO-RHIN-LARYN, V67, P289, DOI 10.1159/000089410; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Lv P, 2012, J NEUROSCI, V32, P16314, DOI 10.1523/JNEUROSCI.2097-12.2012; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nin F, 2012, P NATL ACAD SCI USA, V109, P9191, DOI 10.1073/pnas.1120067109; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Oliver D, 2003, J NEUROSCI, V23, P2141; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; ROMAND R, 1983, NEUROSCI LETT, V35, P271, DOI 10.1016/0304-3940(83)90329-4; Sand PG, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-39; Sanguinetti MC, 2000, J CARDIOVASC ELECTR, V11, P710, DOI 10.1111/j.1540-8167.2000.tb00035.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Sonntag M, 2011, J NEUROSCI, V31, P6699, DOI 10.1523/JNEUROSCI.0575-11.2011; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang ZR, 2013, J GEN PHYSIOL, V141, P431, DOI 10.1085/jgp.201210942; Wei L, 2004, PFLUG ARCH EUR J PHY, V448, P325, DOI 10.1007/s00424-004-1277-2; Werner L. A, 1998, DEV AUDITORY SYSTEM, P12; Wu T, 2010, J NEUROPHYSIOL, V103, P1969, DOI 10.1152/jn.01057.2009; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yamoah EN, 1998, J NEUROSCI, V18, P610	49	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16802	16813		10.1074/jbc.M113.545236	http://dx.doi.org/10.1074/jbc.M113.545236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24727472	hybrid, Green Published			2022-12-25	WOS:000338016200018
J	Tulley, S; Chen, WT				Tulley, Shaun; Chen, Wen-Tien			Transcriptional Regulation of Seprase in Invasive Melanoma Cells by Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Gene Transcription; Invasion; Melanoma; Serine Protease; Transcription Promoter; Transcription Regulation	FIBROBLAST-ACTIVATION-PROTEIN; HUMAN-MALIGNANT MELANOMA; REACTIVE STROMAL FIBROBLASTS; MEMBRANE-BOUND PROTEASE; SKI-MEDIATED REPRESSION; TGF-BETA; SERINE-PROTEASE; C-SKI; DIFFERENTIAL EXPRESSION; CLINICAL-IMPLICATIONS	Background: Seprase is an integral membrane serine protease implicated in the cellular invasiveness of tumor, endothelial, and fibroblast cells of various human tumors. Results: Seprase is transcriptionally targeted in invasive melanoma cells via TGF- signaling. Conclusion: Seprase-expressing melanoma cells produce high levels of autocrine TGF- and display invasive phenotypes in vitro. Significance: This study provides the first insight into TGF--driven seprase transcription in cancer. The tumor invasive phenotype driven by seprase expression/activity has been widely examined in an array of malignant tumor cell types; however, very little is known about the transcriptional regulation of this critical protease. Seprase (also named fibroblast activation protein-, antiplasmin-cleaving enzyme, and dipeptidyl prolyl peptidase 5) is expressed at high levels by stromal fibroblast, endothelial, and tumor cells in a variety of invasive tumors but is undetectable in the majority of normal adult tissues. To examine the transcriptional regulation of the gene, we cloned the human seprase promoter and demonstrated that endogenous seprase expression and exogenous seprase promoter activity are high in invasive melanoma cells but not in non-invasive melanoma cells/primary melanocytes. In addition, we identified a crucial TGF--responsive cis-regulatory element in the proximal seprase promoter region that enabled robust transcriptional activation of the gene. Treatment of metastatic but not normal/non-invasive cells with TGF-1 caused a rapid and profound up-regulation of endogenous seprase mRNA, which coincided with an abolishment of the negative regulator c-Ski, and an increase in binding of Smad3/4 to the seprase promoter in vivo. Blocking TGF- signaling in invasive melanoma cells through overexpression of c-Ski, chemically using SB-431542, or with a neutralizing antibody against TGF- significantly reduced seprase mRNA levels. Strikingly, RNAi of seprase in invasive cells greatly diminished their invasive potential in vitro as did blocking TGF- signaling using SB-431542. Altogether, we found that seprase is transcriptionally up-regulated in invasive melanoma cells via the canonical TGF- signaling pathway, supporting the roles of both TGF- and seprase in tumor invasion and metastasis.	[Tulley, Shaun; Chen, Wen-Tien] Stony Brook Med, Div Gynecol Oncol, Metastasis Res Lab, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Chen, WT (corresponding author), Stony Brook Med, HSC,T9,Rm 027-028, Stony Brook, NY 11794 USA.	Wen-Tien.Chen@stonybrookmedicine.edu			National Institutes of Health [R01CA0039077, R01EB002065]; NATIONAL CANCER INSTITUTE [R01CA039077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA0039077 and R01EB002065 (to W.-T. C.).	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; ALBINO AP, 1991, CANCER RES, V51, P4815; AOYAMA A, 1990, P NATL ACAD SCI USA, V87, P8296, DOI 10.1073/pnas.87.21.8296; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen DH, 2006, CANCER RES, V66, P9977, DOI 10.1158/0008-5472.CAN-06-1499; Chen H, 2009, EXP MOL PATHOL, V87, P189, DOI 10.1016/j.yexmp.2009.09.001; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Freudenberg JA, 2007, INT J CANCER, V121, P966, DOI 10.1002/ijc.22754; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; Goscinski MA, 2008, ULTRASTRUCT PATHOL, V32, P89, DOI 10.1080/01913120802034934; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Iwasa S, 2003, CANCER LETT, V199, P91, DOI 10.1016/S0304-3835(03)00315-X; Jin X, 2003, ANTICANCER RES, V23, P3195; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Kelly T, 1998, MODERN PATHOL, V11, P855; Kennedy A, 2009, INT J CANCER, V124, P27, DOI 10.1002/ijc.23871; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Krasagakis K, 1999, J CELL PHYSIOL, V178, P179, DOI 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5; KRASAGAKIS K, 1994, ANTICANCER RES, V14, P2565; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1877; MONSKY WL, 1994, CANCER RES, V54, P5702; Mori Y, 2004, ONCOLOGY-BASEL, V67, P411, DOI 10.1159/000082926; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; Nicol R, 1998, J BIOL CHEM, V273, P3588, DOI 10.1074/jbc.273.6.3588; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; RETTIG WJ, 1994, INT J CANCER, V58, P385, DOI 10.1002/ijc.2910580314; RETTIG WJ, 1986, CANCER RES, V46, P6406; Rodeck U, 1999, CANCER RES, V59, P547; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; RODECK U, 1994, CANCER RES, V54, P575; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Ueki N, 2003, J BIOL CHEM, V278, P32489, DOI 10.1074/jbc.C300276200; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Yang WW, 2013, EXP MOL PATHOL, V95, P105, DOI 10.1016/j.yexmp.2013.06.007; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Jiping, 2010, Front Biosci (Elite Ed), V2, P1154; Zhang MZ, 2007, CHINESE MED J-PEKING, V120, P663, DOI 10.1097/00029330-200704020-00010	66	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15280	15296		10.1074/jbc.M114.568501	http://dx.doi.org/10.1074/jbc.M114.568501			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727589	Green Published, hybrid			2022-12-25	WOS:000337465400013
J	Breuer, R; Becker, MS; Brechmann, M; Mock, T; Arnold, R; Krammer, PH				Breuer, Rebecca; Becker, Michael S.; Brechmann, Markus; Mock, Thomas; Arnold, Ruediger; Krammer, Peter H.			The Protein Phosphatase 2A Regulatory Subunit B56 gamma Mediates Suppression of T Cell Receptor (TCR)-induced Nuclear Factor-kappa B (NF-kappa B) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; OKADAIC ACID; ACTIVATION; PP2A; LYMPHOMA; MALT1; ALPHA; GENE; IDENTIFICATION; HOMEOSTASIS	NF-kappa B is an important transcription factor in the immune system, and aberrant NF-kappa B activity contributes to malignant diseases and autoimmunity. In T cells, NF-kappa B is activated upon TCR stimulation, and signal transduction to NF-kappa B activation is triggered by a cascade of phosphorylation events. However, fine tuning and termination of TCR signaling are only partially understood. Phosphatases oppose the role of kinases by removing phosphate moieties. The catalytic activity of the protein phosphatase PP2A has been implicated in the regulation of NF-kappa B. PP2A acts in trimeric complexes in which the catalytic subunit is promiscuous and the regulatory subunit confers substrate specificity. To understand and eventually target NF-kappa Bspecific PP2A functions it is essential to define the regulatory PP2A subunit involved. So far, the regulatory PP2A subunit that mediates NF-kappa B suppression in T cells remained undefined. By performing a siRNA screen in Jurkat T cells harboring a NF-kappa B-responsive luciferase reporter, we identified the PP2A regulatory subunit B56 gamma as negative regulator of NF-kappa B in TCR signaling. B56 gamma was strongly up-regulated upon primary human T cell activation, and B56 gamma silencing induced increased I kappa B kinase (IKK) and I kappa B alpha phosphorylation upon TCR stimulation. B56 gamma silencing enhanced NF-kappa B activity, resulting in increased NF-kappa B target gene expression including the T cell cytokine IL-2. In addition, T cell proliferation was increased upon B56 gamma silencing. These data help to understand the physiology of PP2A function in T cells and the pathophysiology of diseases involving PP2A and NF-kappa B.	[Breuer, Rebecca; Becker, Michael S.; Brechmann, Markus; Mock, Thomas; Arnold, Ruediger; Krammer, Peter H.] German Canc Res Ctr, Div Immunogenet, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krammer, PH (corresponding author), German Canc Res Ctr, Div Immunogenet D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.krammer@dkfz.de		Becker, Michael/0000-0001-5502-7444	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture, and Sport (MOST); Deutsche Krebshilfe; Wilhelm Sander Stiftung; Helmholtz Alliance-Immunotherapy of Cancer [HA202]; Jose Carreras Leukamie-Stiftung	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture, and Sport (MOST); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Stiftung; Helmholtz Alliance-Immunotherapy of Cancer; Jose Carreras Leukamie-Stiftung	This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and the Israeli Ministry of Science, Culture, and Sport (MOST), the Deutsche Krebshilfe, the Wilhelm Sander Stiftung, and Helmholtz Alliance-Immunotherapy of Cancer Grant HA202.; Supported by the Jose Carreras Leukamie-Stiftung.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Deichmann M, 2001, MELANOMA RES, V11, P577, DOI 10.1097/00008390-200112000-00004; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Morgan JA, 1999, CANCER RES, V59, P6205; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; RIECKMANN P, 1992, BIOCHEM BIOPH RES CO, V187, P51, DOI 10.1016/S0006-291X(05)81457-3; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Weyd H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062449; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200	39	29	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14996	15004		10.1074/jbc.M113.533547	http://dx.doi.org/10.1074/jbc.M113.533547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719332	hybrid, Green Published			2022-12-25	WOS:000337248100051
J	Guney, E; Oliva, B				Guney, Emre; Oliva, Baldo			Analysis of the Robustness of Network-Based Disease-Gene Prioritization Methods Reveals Redundancy in the Human Interactome and Functional Diversity of Disease-Genes	PLOS ONE			English	Article							SEMANTIC SIMILARITY; BREAST-CANCER; PROTEIN; SOFTWARE	Complex biological systems usually pose a trade-off between robustness and fragility where a small number of perturbations can substantially disrupt the system. Although biological systems are robust against changes in many external and internal conditions, even a single mutation can perturb the system substantially, giving rise to a pathophenotype. Recent advances in identifying and analyzing the sequential variations beneath human disorders help to comprehend a systemic view of the mechanisms underlying various disease phenotypes. Network-based disease-gene prioritization methods rank the relevance of genes in a disease under the hypothesis that genes whose proteins interact with each other tend to exhibit similar phenotypes. In this study, we have tested the robustness of several network-based disease-gene prioritization methods with respect to the perturbations of the system using various disease phenotypes from the Online Mendelian Inheritance in Man database. These perturbations have been introduced either in the protein-protein interaction network or in the set of known disease-gene associations. As the network-based disease-gene prioritization methods are based on the connectivity between known disease-gene associations, we have further used these methods to categorize the pathophenotypes with respect to the recoverability of hidden disease-genes. Our results have suggested that, in general, disease-genes are connected through multiple paths in the human interactome. Moreover, even when these paths are disturbed, network-based prioritization can reveal hidden disease-gene associations in some pathophenotypes such as breast cancer, cardiomyopathy, diabetes, leukemia, parkinson disease and obesity to a greater extend compared to the rest of the pathophenotypes tested in this study. Gene Ontology (GO) analysis highlighted the role of functional diversity for such diseases.	[Guney, Emre] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Oliva, Baldo] Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Dept Ciencies Expt & Salut, Barcelona, Catalonia, Spain	Northeastern University; Pompeu Fabra University	Oliva, B (corresponding author), Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Dept Ciencies Expt & Salut, Barcelona, Catalonia, Spain.	baldo.oliva@upf.edu	Guney, Emre/B-2568-2017; Gasull, Martina/J-4076-2019; Oliva, Baldomero/A-2690-2009	Guney, Emre/0000-0002-3466-6535; Oliva, Baldomero/0000-0003-0702-0250	Spanish Ministry of Science and Innovation (MICINN) FEDER [BIO2011-22568]; EU [EUI2009-04018]	Spanish Ministry of Science and Innovation (MICINN) FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); EU(European Commission)	Spanish Ministry of Science and Innovation (MICINN) FEDER BIO2011-22568 (http://www.mineco.gob.es/portal/site/mineco/); and by EU grant EraSysbio+ (SHIPREC http://www.erasysbio.net/index.php?index=279) Euroinvestigacion (EUI2009-04018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cotterchio M, 2002, MED HYPOTHESES, V59, P492, DOI 10.1016/S0306-9877(02)00204-9; Demongeot J, 2009, INT J MOL SCI, V10, P4437, DOI 10.3390/ijms10104437; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Garcia-Garcia J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-56; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guan YF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002694; Guney E, 2012, SYSTEMS BIOL CANC RE, P167; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Guney E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S11-A12; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang C-H, 2006, LECT NOTES COMPUTER, P166; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Motter AE, 2010, BIOESSAYS, V32, P236, DOI 10.1002/bies.200900128; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Vazquez A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-81; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Whitacre James Michael, 2012, Frontiers in Genetics, V3, P67, DOI 10.3389/fgene.2012.00067; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001	46	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94686	10.1371/journal.pone.0094686	http://dx.doi.org/10.1371/journal.pone.0094686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733074	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400072
J	Mellott, TJ; Pender, SM; Burke, RM; Langley, EA; Blusztajn, JK				Mellott, Tiffany J.; Pender, Sarah M.; Burke, Rebecca M.; Langley, Erika A.; Blusztajn, Jan Krzysztof			IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; APPSWE/PS1DE9 MOUSE MODEL; BASAL FOREBRAIN NEURONS; APP TRANSGENIC MICE; RAT SEPTAL NEURONS; KINASE 1 ALK1; MEMORY DEFICITS; ACETYLCHOLINE-RELEASE; IMPAIRED NEUROGENESIS; COGNITIVE IMPAIRMENT	The development of an effective therapy for Alzheimer's disease (AD) is a major challenge to biomedical sciences. Because much of early AD pathophysiology includes hippocampal abnormalities, a viable treatment strategy might be to use trophic factors that support hippocampal integrity and function. IGF2 is an attractive candidate as it acts in the hippocampus to enhance memory consolidation, stimulate adult neurogenesis and upregulate cholinergic marker expression and acetylcholine (ACh) release. We performed a seven-day intracerebroventricular infusion of IGF2 in transgenic APPswe.PS1dE9 AD model mice that express green fluorescent protein in cholinergic neurons (APP.PS1/CHGFP) and in wild type WT/CHGFP littermates at 6 months of age representing early AD-like disease. IGF2 reduced the number of hippocampal A beta 40- and A beta 42-positive amyloid plaques in APP.PS1/CHGFP mice. Moreover, IGF2 increased hippocampal protein levels of the ACh-synthesizing enzyme, choline acetyltransferase in both WT/CHGFP and APP.PS1/CHGFP mice. The latter effect was likely mediated by increased protein expression of the cholinergic differentiating factor, BMP9, observed in IGF2-treated mice as compared to controls. IGF2 also increased the protein levels of hippocampal NGF, BDNF, NT3 and IGF1 and of doublecortin, a marker of neurogenesis. These data show that IGF2 administration is effective in reversing and preventing several pathophysiologic processes associated with AD and suggest that IGF2 may constitute a therapeutic target for AD.	[Mellott, Tiffany J.; Pender, Sarah M.; Burke, Rebecca M.; Langley, Erika A.; Blusztajn, Jan Krzysztof] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University	Mellott, TJ (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	tmellott@bu.edu		/0000-0001-8438-3122	NIH [AG032709, T32 AG00015]; Boston University Alzheimer's Disease Center; Boston University Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG032709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Alzheimer's Disease Center; Boston University Alzheimer's Association; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an NIH grant AG032709 to JKB and by a Boston University Alzheimer's Disease Center Pilot- and an Alzheimer's Association New Investigator grants to TJM. RMB was supported by an NIH T32 AG00015 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; BOWEN DM, 1976, BRAIN, V99, P459, DOI 10.1093/brain/99.3.459; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burgess A, 2006, J NEUROCHEM, V99, P797, DOI 10.1111/j.1471-4159.2006.04110.x; Burke RM, P NATL ACAD IN PRESS; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; GAGE SL, 1990, PROG BRAIN RES, V82, P73; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Goto Y, 2008, EUR J PHARMACOL, V583, P84, DOI 10.1016/j.ejphar.2008.01.030; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Grothe M, 2012, BIOL PSYCHIAT, V71, P805, DOI 10.1016/j.biopsych.2011.06.019; Hawkes C, 2007, MOL NEUROBIOL, V35, P329, DOI 10.1007/s12035-007-0021-2; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jarvis K, 2007, NEUROSCI LETT, V423, P184, DOI 10.1016/j.neulet.2007.06.058; Ramos-Rodriguez JJ, 2013, J NEUROPATH EXP NEUR, V72, P272, DOI 10.1097/NEN.0b013e318288a8dd; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kar S, 1996, J NEUROSCI, V16, P1034; Kar S, 1998, J NEUROCHEM, V70, P2179; Kar S, 1997, P NATL ACAD SCI USA, V94, P14054, DOI 10.1073/pnas.94.25.14054; Kemppainen S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.006; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kiyota T, 2011, P NATL ACAD SCI USA, V108, pE1339, DOI 10.1073/pnas.1102349108; KNUSEL B, 1991, ADV EXP MED BIOL, V293, P351; KNUSEL B, 1990, J NEUROSCI, V10, P558; KNUSEL B, 1992, J NEUROSCI, V12, P4391; KONISHI Y, 1994, BRAIN RES, V649, P53, DOI 10.1016/0006-8993(94)91048-0; Laursen B, 2013, BEHAV BRAIN RES, V240, P146, DOI 10.1016/j.bbr.2012.11.012; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Lesne S, 2005, J BIOL CHEM, V280, P24941, DOI 10.1074/jbc.M413495200; Li DB, 2008, HIPPOCAMPUS, V18, P692, DOI 10.1002/hipo.20428; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Lopez-Coviella I, 2005, P NATL ACAD SCI USA, V102, P6984, DOI 10.1073/pnas.0502097102; Lopez-Coviella I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021166; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Machova E, 2010, NEUROBIOL DIS, V38, P27, DOI 10.1016/j.nbd.2009.12.023; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Medeiros R, 2011, AM J PATHOL, V179, P980, DOI 10.1016/j.ajpath.2011.04.041; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MORSE JK, 1993, J NEUROSCI, V13, P4146; Mufson EJ, 2002, NEUROCHEM RES, V27, P1035, DOI 10.1023/A:1020952704398; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; Nikolajsen GN, 2011, NEUROBIOL AGING, V32, P1927, DOI 10.1016/j.neurobiolaging.2011.05.006; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Nonner D, 2004, J NEUROCHEM, V91, P77, DOI 10.1111/j.1471-4159.2004.02687.x; Nonner D, 2000, J NEUROCHEM, V74, P988, DOI 10.1046/j.1471-4159.2000.0740988.x; NONOMURA T, 1992, NEUROSCI RES, V14, P226, DOI 10.1016/0168-0102(92)90083-O; Nunes-Tavares N, 2012, J BIOL CHEM; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Payette DJ, 2007, BRAIN RES, V1135, P12, DOI 10.1016/j.brainres.2006.12.005; Pedersen WA, 1996, P NATL ACAD SCI USA, V93, P8068, DOI 10.1073/pnas.93.15.8068; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Poirier R, 2012, NEUROSCI LETT, V509, P101, DOI 10.1016/j.neulet.2011.12.048; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Robertson RT, 2006, NEUROSCIENCE, V143, P523, DOI 10.1016/j.neuroscience.2006.09.003; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Schnitzler AC, 2010, J NEUROSCI, V30, P8221, DOI 10.1523/JNEUROSCI.5611-09.2010; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Ward NL, 2000, EXP NEUROL, V162, P297, DOI 10.1006/exnr.1999.7346; Wong-Goodrich SJE, 2008, NEUROBIOL DIS, V30, P255, DOI 10.1016/j.nbd.2008.01.008; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945	96	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94287	10.1371/journal.pone.0094287	http://dx.doi.org/10.1371/journal.pone.0094287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732467	Green Submitted, gold, Green Published			2022-12-25	WOS:000336970400026
J	Zerulla, K; Chimileski, S; Nather, D; Gophna, U; Papke, RT; Soppa, J				Zerulla, Karolin; Chimileski, Scott; Naether, Daniela; Gophna, Uri; Papke, R. Thane; Soppa, Joerg			DNA as a Phosphate Storage Polymer and the Alternative Advantages of Polyploidy for Growth or Survival	PLOS ONE			English	Article							GENE CONVERSION; RECOMBINATION; METABOLISM	Haloferax volcanii uses extracellular DNA as a source for carbon, nitrogen, and phosphorous. However, it can also grow to a limited extend in the absence of added phosphorous, indicating that it contains an intracellular phosphate storage molecule. As Hfx. volcanii is polyploid, it was investigated whether DNA might be used as storage polymer, in addition to its role as genetic material. It could be verified that during phosphate starvation cells multiply by distributing as well as by degrading their chromosomes. In contrast, the number of ribosomes stayed constant, revealing that ribosomes are distributed to descendant cells, but not degraded. These results suggest that the phosphate of phosphate-containing biomolecules (other than DNA and RNA) originates from that stored in DNA, not in rRNA. Adding phosphate to chromosome depleted cells rapidly restores polyploidy. Quantification of desiccation survival of cells with different ploidy levels showed that under phosphate starvation Hfx. volcanii diminishes genetic advantages of polyploidy in favor of cell multiplication. The consequences of the usage of genomic DNA as phosphate storage polymer are discussed as well as the hypothesis that DNA might have initially evolved in evolution as a storage polymer, and the various genetic benefits evolved later.	[Zerulla, Karolin; Naether, Daniela; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Bioctr, D-60054 Frankfurt, Germany; [Chimileski, Scott; Papke, R. Thane] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Goethe University Frankfurt; University of Connecticut; Tel Aviv University	Soppa, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Bioctr, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652; Soppa, Jorg/0000-0002-6132-5840; Papke, Robertson/0000-0003-1371-2341	German Research Council (DFG) [So264/16]; National Science Foundation, USA [0919290, 0830024]; US-Israel Binational Science Foundation [2007043]; NASA Astrobiology Program [NNX12AD70G]	German Research Council (DFG)(German Research Foundation (DFG)); National Science Foundation, USA(National Science Foundation (NSF)); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NASA Astrobiology Program(National Aeronautics & Space Administration (NASA))	This project has been supported by the German Research Council (DFG grant So264/16), the National Science Foundation, USA (0919290 and 0830024), the US-Israel Binational Science Foundation (award No. 2007043), and the NASA Astrobiology Program (Grant NNX12AD70G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Bremer H, 1996, ESCHERICHIA COLI SAL; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; Herrmann U, 2002, MOL MICROBIOL, V46, P395, DOI 10.1046/j.1365-2958.2002.03181.x; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; KARL DM, 1989, LIMNOL OCEANOGR, V34, P543, DOI 10.4319/lo.1989.34.3.0543; KATES M, 1993, EXPERIENTIA, V49, P1027, DOI 10.1007/BF01929909; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; Kulakova AN, 2011, ENVIRON SCI TECHNOL, V45, P7799, DOI 10.1021/es201123r; Kuzuya A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1452; Lange C, 2011, MOL MICROBIOL, V80, P666, DOI 10.1111/j.1365-2958.2011.07600.x; Lennon JT, 2007, APPL ENVIRON MICROB, V73, P2799, DOI 10.1128/AEM.02674-06; Mancinelli RL, 1998, ADV SPACE RES, V22, P327, DOI 10.1016/S0273-1177(98)00189-6; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Naor A, 2012, CURR BIOL, V22, P1444, DOI 10.1016/j.cub.2012.05.056; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; NIEUWLANDT DT, 1990, J BACTERIOL, V172, P7104, DOI 10.1128/jb.172.12.7104-7110.1990; OTTO SP, 1992, GENETICS, V131, P745; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; PAUL JH, 1991, APPL ENVIRON MICROB, V57, P2197, DOI 10.1128/AEM.57.8.2197-2204.1991; Pecoraro V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016392; Pinchuk GE, 2008, APPL ENVIRON MICROB, V74, P1198, DOI 10.1128/AEM.02026-07; Rashchi F, 2000, MINER ENG, V13, P1029; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Siuda W, 1996, AQUAT MICROB ECOL, V11, P193, DOI 10.3354/ame011193; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Soppa J, 2013, BIOCHEM SOC T, V41, P339, DOI 10.1042/BST20120315; Soppa J, 2011, BIOCHEM SOC T, V39, P150, DOI 10.1042/BST0390150; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williams D, 2012, GENOME BIOL EVOL, V4, P1223, DOI 10.1093/gbe/evs098; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	40	52	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94819	10.1371/journal.pone.0094819	http://dx.doi.org/10.1371/journal.pone.0094819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733558	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400113
J	Klix, S; Hezel, F; Fuchs, K; Ruff, J; Dieringer, MA; Niendorf, T				Klix, Sabrina; Hezel, Fabian; Fuchs, Katharina; Ruff, Jan; Dieringer, Matthias A.; Niendorf, Thoralf			Accelerated Fast Spin-Echo Magnetic Resonance Imaging of the Heart Using a Self-Calibrated Split-Echo Approach	PLOS ONE			English	Article							K-T BLAST; 3.0 TESLA; CARDIOVASCULAR MRI; CMR PROTOCOLS; CORONARY MRA; BREATH-HOLD; CARDIAC MRI; ARRAY COILS; AUTO-SMASH; PARALLEL	Purpose: Design, validation and application of an accelerated fast spin-echo (FSE) variant that uses a split-echo approach for self-calibrated parallel imaging. Methods: For self-calibrated, split-echo FSE (SCSE-FSE), extra displacement gradients were incorporated into FSE to decompose odd and even echo groups which were independently phase encoded to derive coil sensitivity maps, and to generate undersampled data (reduction factor up to R = 3). Reference and undersampled data were acquired simultaneously. SENSE reconstruction was employed. Results: The feasibility of SCSE-FSE was demonstrated in phantom studies. Point spread function performance of SCSE-FSE was found to be competitive with traditional FSE variants. The immunity of SCSE-FSE for motion induced mis-registration between reference and undersampled data was shown using a dynamic left ventricular model and cardiac imaging. The applicability of black blood prepared SCSE-FSE for cardiac imaging was demonstrated in healthy volunteers including accelerated multi-slice per breath-hold imaging and accelerated high spatial resolution imaging. Conclusion: SCSE-FSE obviates the need of external reference scans for SENSE reconstructed parallel imaging with FSE. SCSE-FSE reduces the risk for mis-registration between reference scans and accelerated acquisitions. SCSE-FSE is feasible for imaging of the heart and of large cardiac vessels but also meets the needs of brain, abdominal and liver imaging.	[Klix, Sabrina; Hezel, Fabian; Fuchs, Katharina; Dieringer, Matthias A.; Niendorf, Thoralf] Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany; [Ruff, Jan] Siemens Healthcare, Erlangen, Germany; [Dieringer, Matthias A.] ECRC, Berlin, Germany; [Dieringer, Matthias A.] Max Delbrueck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Siemens AG; Siemens Germany; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Niendorf, T (corresponding author), Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013	Niendorf, Thoralf/0000-0001-7584-6527				Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2009, JACC-CARDIOVASC IMAG, V2, P832, DOI 10.1016/j.jcmg.2009.04.007; Abdel-Aty Hassan, 2007, Recent Pat Cardiovasc Drug Discov, V2, P63, DOI 10.2174/157489007779606167; Alsop DC, 1997, MAGNET RESON MED, V37, P176, DOI 10.1002/mrm.1910370206; American College of Cardiology Foundation Task Force on Expert Consensus Documents, 2010, J Am Coll Cardiol, V55, P2614, DOI [10.1161/CIR.0b013e3181d44a8f, 10.1016/j.jacc.2009.11.011]; Anumula S, 2005, ACAD RADIOL, V12, P1521, DOI 10.1016/j.acra.2005.08.009; Becker M, 2010, EUR RADIOL, V20, P1344, DOI 10.1007/s00330-009-1676-z; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Dieringer MA, 2012, MED PHYS, V39, P4800, DOI 10.1118/1.4736954; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Fuchs K, 2013, MAGN RESON MED, DOI 101002/mrm25066.; Goldfarb JW, 2014, MAGN RESON MED, V71, P1210, DOI 10.1002/mrm.24747; Graessl A, 2013, MAGN RESON MED; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gutberlet M, 2006, INVEST RADIOL, V41, P154, DOI 10.1097/01.rli.0000195840.50230.10; Guttman MA, 2003, MAGN RESON MED, V50, P315, DOI 10.1002/mrm.10504; Hansen MS, 2004, MAGNET RESON MED, V52, P1175, DOI 10.1002/mrm.20256; Hardy CJ, 2006, MAGN RESON MED, V55, P1142, DOI 10.1002/mrm.20870; Heidemann RM, 2001, MAGN RESON MED, V45, P1066, DOI 10.1002/mrm.1141; Heinrichs U, 2009, MAGN RESON MED, V62, P822, DOI 10.1002/mrm.22054; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P179, DOI 10.1002/cmr.1820030402; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P125, DOI [10.1002/cmr.1820030302, DOI 10.1002/CMR.1820030302]; Huber ME, 2004, MAGN RESON MED, V52, P221, DOI [10.1002/mrm.20062, 10.1002/MRM.20062]; Jakob PM, 1998, MAGN RESON MATER PHY, V7, P42; Ji JX, 2007, CONCEPT MAGN RESON B, V31B, P24, DOI 10.1002/cmr.b.20081; Keil B, 2013, J MAGN RESON, V229, P75, DOI 10.1016/j.jmr.2013.02.001; Kellman P, 2004, MAGN RESON MED, V51, P200, DOI 10.1002/mrm.10663; Kellman P, 2001, MAGNET RESON MED, V45, P846, DOI 10.1002/mrm.1113; Kim D, 2009, MAGN RESON MED, V62, P300, DOI 10.1002/mrm.22047; Kostler H, 2003, J MAGN RESON IMAGING, V18, P702, DOI 10.1002/jmri.10419; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Madore B, 2004, MAGN RESON MED, V52, P310, DOI 10.1002/mrm.20133; Madore B, 2002, MAGNET RESON MED, V48, P493, DOI 10.1002/mrm.10229; McGee KP, 2004, J MAGN RESON IMAGING, V19, P291, DOI 10.1002/jmri.20015; McKenzie CA, 2002, MAGNET RESON MED, V47, P529, DOI 10.1002/mrm.10087; MULKERN RV, 1990, MAGN RESON IMAGING, V8, P557, DOI 10.1016/0730-725X(90)90132-L; Niendorf T, 1999, MAGNET RESON MED, V41, P1189, DOI 10.1002/(SICI)1522-2594(199906)41:6<1189::AID-MRM15>3.0.CO;2-1; Niendorf T, 2006, ROFO-FORTSCHR RONTG, V178, P15, DOI 10.1055/s-2005-858686; Niendorf T, 2005, MAGN RESON MED, V53, P885, DOI 10.1002/mrm.20446; Niendorf T, 2008, EUR RADIOL, V18, P87, DOI 10.1007/s00330-007-0692-0; Niendorf T, 2006, MAGN RESON MED, V56, P167, DOI 10.1002/mrm.20923; Niendorf T, 2006, NMR BIOMED, V19, P325, DOI 10.1002/nbm.1051; Niendorf T, 2013, J MAGN RESON, V229, P208, DOI 10.1016/j.jmr.2012.11.015; Niendorf T, 2010, EUR RADIOL, V20, P2806, DOI 10.1007/s00330-010-1902-8; NORRIS DG, 1992, MAGNET RESON MED, V27, P142, DOI 10.1002/mrm.1910270114; NORRIS DG, 1993, J MAGN RESON SER A, V105, P123, DOI 10.1006/jmra.1993.1263; NORRIS DG, 1993, MAGN RESON IMAGING, V11, P921, DOI 10.1016/0730-725X(93)90210-5; O h-Ici Darach, 2012, J Cardiovasc Magn Reson, V14, P22, DOI 10.1186/1532-429X-14-22; OSHIO K, 1991, MAGNET RESON MED, V20, P344, DOI 10.1002/mrm.1910200219; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Priatna A, 2003, DOUBLE TRIPLE IR DUA, P1562; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Pruessmann KP, 2001, J CARDIOV MAGN RESON, V3, P1, DOI 10.1081/JCMR-100000143; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schick F, 1997, MAGNET RESON MED, V38, P638, DOI 10.1002/mrm.1910380418; Schmitt M, 2008, MAGN RESON MED, V59, P1431, DOI 10.1002/mrm.21598; Simonetti OP, 1996, RADIOLOGY, V199, P49, DOI 10.1148/radiology.199.1.8633172; Sodickson DK, 2005, ACAD RADIOL, V12, P626, DOI 10.1016/j.acra.2005.01.012; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Tsao J, 2005, MAGNET RESON MED, V53, P1372, DOI 10.1002/mrm.20483; Tsao J, 2003, MAGNET RESON MED, V50, P1031, DOI 10.1002/mrm.10611; Utting JF, 2010, J MAGN RESON IMAGING, V32, P235, DOI 10.1002/jmri.22212; Utting JF, 2009, INVEST RADIOL, V44, P495, DOI 10.1097/RLI.0b013e3181b4c070; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Wassmuth R, 2011, EUR RADIOL, V21, P1643, DOI 10.1007/s00330-011-2109-3; Weiger M, 2000, MAGNET RESON MED, V43, P177, DOI 10.1002/(SICI)1522-2594(200002)43:2<177::AID-MRM3>3.0.CO;2-1; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Zhu YD, 2004, MAGNET RESON MED, V52, P869, DOI 10.1002/mrm.20209	73	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94654	10.1371/journal.pone.0094654	http://dx.doi.org/10.1371/journal.pone.0094654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728341	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200114
J	Kumaran, NKP; Padmalal, D; Nair, MK; Limaye, RB; Guleria, JS; Srivastava, R; Shukla, A				Kumaran, Navnith K. P.; Padmalal, Damodaran; Nair, Madhavan K.; Limaye, Ruta B.; Guleria, Jaswant S.; Srivastava, Rashmi; Shukla, Anumeha			Vegetation Response and Landscape Dynamics of Indian Summer Monsoon Variations during Holocene: An Eco-Geomorphological Appraisal of Tropical Evergreen Forest Subfossil Logs	PLOS ONE			English	Article							KERALA SEDIMENTARY BASIN; ENVIRONMENTAL-CHANGES; CONTINENTAL-MARGIN; QUATERNARY GEOLOGY; SOUTHWEST COAST; CLIMATE-CHANGE; PALEOCLIMATE; HISTORY; EXAMPLE; CARBON	The high rainfall and low sea level during Early Holocene had a significant impact on the development and sustenance of dense forest and swamp-marsh cover along the southwest coast of India. This heavy rainfall flooded the coastal plains, forest flourishing in the abandoned river channels and other low-lying areas in midland. The coastline and other areas in lowland of southwestern India supply sufficient evidence of tree trunks of wet evergreen forests getting buried during the Holocene period under varying thickness of clay, silty-clay and even in sand sequences. This preserved subfossil log assemblage forms an excellent proxy for eco-geomorphological and palaeoclimate appraisal reported hitherto from Indian subcontinent, and complements the available palynological data. The bulk of the subfossil logs and partially carbonized wood remains have yielded age prior to the Holocene transgression of 6.5 k yrs BP, suggesting therein that flooding due to heavy rainfall drowned the forest cover, even extending to parts of the present shelf. These preserved logs represent a unique palaeoenvironmental database as they contain observable cellular structure. Some of them can even be compared to modern analogues. As these woods belong to the Late Pleistocene and Holocene, they form a valuable source of climate data that alleviates the lack of contemporaneous meteorological records. These palaeoforests along with pollen proxies depict the warmer environment in this region, which is consistent with a Mid Holocene Thermal Maximum often referred to as Holocene Climate Optimum. Thus, the subfossil logs of tropical evergreen forests constitute new indices of Asian palaeomonsoon, while their occurrence and preservation are attributed to eco-geomorphology and hydrological regimes associated with the intensified Asian Summer Monsoon, as recorded elsewhere.	[Kumaran, Navnith K. P.; Limaye, Ruta B.] Agharkar Res Inst, Palynol & Palaeoclimate Lab, Pune, Maharashtra, India; [Padmalal, Damodaran; Nair, Madhavan K.] Ctr Earth Sci Studies, Thiruvananthapuram, Kerala, India; [Guleria, Jaswant S.; Srivastava, Rashmi; Shukla, Anumeha] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India	Department of Science & Technology (India); Agharkar Research Institute (ARI); Ministry of Earth Sciences (MoES) - India; National Centre for Earth Science Studies (NCESS); Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Kumaran, NKP (corresponding author), Agharkar Res Inst, Palynol & Palaeoclimate Lab, Pune, Maharashtra, India.	kpnkumaran@gmail.com	Shukla, Anumeha/AAB-3084-2019	Kumaran, Navnith/0000-0002-3304-7898; Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252	Council of Scientific and Industrial Research, New Delhi [24(0275)/05/EMR-II]; Kerala State Council for Science, Technology and Environment, Thiruvananthapuram [56/2007/KSCSTE]; CSIR for ES; CSIR for SRA; Agharkar Research Institute, Pune, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Kerala State Council for Science, Technology and Environment, Thiruvananthapuram; CSIR for ES; CSIR for SRA; Agharkar Research Institute, Pune, India(Department of Science & Technology (India))	Council of Scientific and Industrial Research, New Delhi and Kerala State Council for Science, Technology and Environment, Thiruvananthapuram provided financial support in the form of sponsored Research projects [24(0275)/05/EMR-II] and [56/2007/KSCSTE] respectively. KPNK and RBL acknowledge the CSIR for ES and SRA awards respectively. Publication fee has been provided by the Director, Agharkar Research Institute, Pune, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DP, 1970, CURR SCI, V30, P219; Ajaykumar B, 2012, J EARTH SYST SCI, V121, P1093, DOI 10.1007/s12040-012-0210-x; Ajaykumar B, 2010, ENVIRON EARTH SCI, V59, P1409, DOI 10.1007/s12665-009-0127-0; [Anonymous], 1958, INDIAN WOODS THEIR I; Ansari MH, 2007, REV PALAEOBOT PALYNO, V145, P201, DOI 10.1016/j.revpalbo.2006.10.005; Arun PR, 2006, THESIS COCHIN U SCI; Awasthi N, 1992, GEOPHYTOLOGY, V20, P148; Awasthi N, 1995, PALEOBOTANIST, V44, P157; Awasthi N, 2005, GLEANINGS PLANT SCI, P265; BOROLE DV, 1982, QUATERNARY RES, V18, P236, DOI 10.1016/0033-5894(82)90072-2; BRYSON RA, 1981, QUATERNARY RES, V16, P135, DOI 10.1016/0033-5894(81)90041-7; CESS, 1984, RES ATL KER; Cherian PJ, 2009, CURR SCI INDIA, V97, P236; Chowdhury K., 1958, INDIAN WOODS THEIR I; FISCHER G, 1991, MAR CHEM, V35, P581, DOI 10.1016/S0304-4203(09)90044-5; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Ghienne JF, 2002, QUATERN INT, V87, P81, DOI 10.1016/S1040-6182(01)00063-5; Guleria JS, 2004, SCI CULTURE, V70, P169; Guleria JS, 2010, GEOPHYTOLOGY, V38, P1; Gupta S, 2007, ATLAS INDIAN HARDWOO; Hayashi S, 1973, MONOGRAPHIC ATLAS SE; Ilic J., 1991, CSIRO ATLAS HARDWOOD, P525; International Association of Wood Anatomists, 1989, IAWA Bulletin, V10, P219; Jansen S, 1997, IAWA J, V18, P169, DOI 10.1163/22941932-90001478; Janssonius HH, 1926, MICROGRAPHIE HOLZER, VIV; Jayalakshmi K, 2004, GONDWANA RES, V7, P585, DOI 10.1016/S1342-937X(05)70808-X; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Kale VS, 2007, QUATERNARY SCI REV, V26, P1610, DOI 10.1016/j.quascirev.2007.03.012; Kale VS, 2004, J GEOL SOC INDIA, V64, P403; Kale VS, 2005, P 18 CONV IGI NAT SE, P15; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kazmi HSM, 1982, FAMILY EBENACEAE THE, VIV, P122; KOEKNOORMAN J, 1977, BER DEUT BOT GES, V90, P183; Kribs D.A., 1959, COMMERCIAL FOREIGN W; Kumaran KPN, 2008, CURR SCI INDIA, V95, P515; Kumaran KPN, 2013, QUATERN INT, V286, P3, DOI 10.1016/j.quaint.2012.03.010; Kumaran K. P. N., 2012, Proceedings of the Indian National Science Academy, V78, P343; Kumaran KPN, 2005, QUATERNARY RES, V64, P418, DOI 10.1016/j.yqres.2005.08.015; Kumaran KPN, 2013, CLIMATE CHANGE ISLAN, P217, DOI [10.1007/978-94-007-6016-5_15, DOI 10.1007/978-94-007-6016-5_15]; Kumaran KPN, 2012, JAPANESE J PALYNOLOG, V58, P117; Kumaran KPN, 2005, PAGES NEWS, V13, P15; Lens F, 2007, AM J BOT, V94, P483, DOI 10.3732/ajb.94.4.483; Lim SC, 2005, TIMBER TECH B, V32, P1; Limaye RB, 2012, QUATERN INT, V263, P114, DOI 10.1016/j.quaint.2012.01.034; Mabberley D. J, 2005, PLANT BOOK PORTABLE; Meena D, 2012, INT J CONSERV SCI, V3, P231; Metcalfe C. R., 1950, Anatomy of the Dicotyledons: leaves, stem, and wood, in relation to taxonomy, with notes on economic uses.; Miles A, 1978, PHOTOMICROGRAPHS WOR, P233; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Morimoto M, 2007, QUATERNARY RES, V67, P204, DOI 10.1016/j.yqres.2006.12.005; Nair KM, 2006, J GEOL SOC INDIA, V67, P165; Nair KM, 2010, J ASIAN EARTH SCI, V37, P361, DOI 10.1016/j.jseaes.2009.09.004; Nair KM, 2006, EFFECTS HOLOCENE CLI, P1; Nair KM, 2009, TECTONIC HYDROLOGIC, P1; Nair KM, 2003, QUATERNARY SEA UNPUB; Nair MV, 2004, CURR SCI INDIA, V86, P709; Negi BS, 1992, INDIAN FOREST RECORD, V4, P1; Padmalal D, 2014, QUATERN INT, V333, P156, DOI 10.1016/j.quaint.2013.12.018; Padmalal D, 2011, QUATERN INT, V237, P123, DOI 10.1016/j.quaint.2010.12.021; Padmalal D., 2013, CLIMATE CHANGE ISLAN, P191, DOI [DOI 10.1007/978-94-007-6016-5_13, 10.1007/978-94-007-6016-5_13]; Padmalal D., 2010, ENV APPRAISAL SAND A; Padmalal D, 2005, WATER RESOURCES KERA, P80; PAWAR NJ, 1988, J GEOL SOC INDIA, V32, P513; Pawar SD, 1983, SYSTEMATIC GEOLOGICA; Pearson, 1932, COMMERCIAL TIMBERS I, V2; Pearson R., 1932, COMMERCIAL TIMBERS I, V1; Petit-Maire N, 1995, J COAST RES SPEC ISS, P87; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; Purkayastha SK, 1976, INDIAN FOREST REC, V2, P1; Purkayastha SK, 1982, INDIAN WOODS THEIR I, VIV, P66; Purkayastha SK, 1982, INDIAN WOODS THEIR I; Rajagopalan G, 1997, CURR SCI INDIA, V73, P60; RAJENDRAN CP, 1989, J GEOL SOC INDIA, V33, P218; Rajimol TR, 2013, 23 KER SWAD SCI C MG, P336; Ramesh R, 2001, CURR SCI INDIA, V81, P1432; Raturi RD, 2001, INDIAN WOODS THEIR I, VVI; Razafimandimbison SG, 2002, AM J BOT, V89, P1027, DOI 10.3732/ajb.89.7.1027; Ridsdale C. E., 1978, BLUMEA, V24, P307; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Shajan KP, 1998, THESIS COCHIN U SCI; Sharma S, 2004, QUATERNARY SCI REV, V23, P145, DOI 10.1016/j.quascirev.2003.10.005; Shukla A, 2012, J EARTH SYST SCI, V121, P195, DOI 10.1007/s12040-012-0142-5; Singhvi AK, 2009, IGBP WCRP SCOPE REPO, V4, P1; Sinha R, 2009, GEOMORPHOLOGY, V113, P173, DOI 10.1016/j.geomorph.2009.03.011; Soman K., 2002, GEOLOGY KERALA; Srivastava R, 2006, BSIP DIAMOND JUBILEE, V1-76; Srivastava Rashmi, 1998, Phytomorphology, V48, P391; SUKUMAR R, 1993, NATURE, V364, P703, DOI 10.1038/364703a0; Thamban M, 2001, PALAEOGEOGR PALAEOCL, V165, P113, DOI 10.1016/S0031-0182(00)00156-5; Thrivikramji K.P., 2007, P KER ENV C 2007 TRI, P36; Tomalin V, 2004, INT J NAUT ARCHAEOL, V33, P253, DOI 10.1111/j.1095-9270.2004.00022.x; Troup RS, 1986, INDIAN WOODS THEIR U; Wils THG, 2011, TREES-STRUCT FUNCT, V25, P345, DOI 10.1007/s00468-010-0521-y; Wong KM, 1989, TREE FLORA MALAYSIA, V4, P381; WORBES M, 1989, IAWA BULL, V10, P109, DOI 10.1163/22941932-90000479; WORBES M, 1985, AMAZONIANA, V9, P459	96	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e93596	10.1371/journal.pone.0093596	http://dx.doi.org/10.1371/journal.pone.0093596			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727672	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200022
J	Bailey, K; Balaei, MR; Mannan, A; Del Bigio, MR; Marzban, H				Bailey, Karen; Balaei, Maryam Rahimi; Mannan, Ashraf; Del Bigio, Marc R.; Marzban, Hassan			Purkinje Cell Compartmentation in the Cerebellum of the Lysosomal Acid Phosphatase 2 Mutant Mouse (Nax - Naked-Ataxia Mutant Mouse)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; LOPEZ-HERNANDEZ-SYNDROME; ZEBRIN-II; PHOSPHOLIPASE-C-BETA-4 EXPRESSION; ANTIGEN-EXPRESSION; RAT; REVEALS; TOPOGRAPHY; CORTEX; VERMIS	The Acp2 gene encodes the beta subunit of lysosomal acid phosphatase, which is an isoenzyme that hydrolyzes orthophosphoric monoesters. In mice, a spontaneous mutation in Acp2 results in severe cerebellar defects. These include a reduced size, abnormal lobulation, and an apparent anterior cerebellar disorder with an absent or hypoplastic vermis. Based on differential gene expression in the cerebellum, the mouse cerebellar cortex can normally be compartmentalized anteroposteriorly into four transverse zones and mediolaterally into parasagittal stripes. In this study, immunohistochemistry was performed using various Purkinje cell compartmentation markers to examine their expression patterns in the Acp2 mutant. Despite the abnormal lobulation and anterior cerebellar defects, zebrin II and PLC beta 4 showed similar expression patterns in the nax mutant and wild type cerebellum. However, fewer stripes were found in the anterior zone of the nax mutant, which could be due to a lack of Purkinje cells or altered expression of the stripe markers. HSP25 expression was uniform in the central zone of the nax mutant cerebellum at around postnatal day (P) 18-19, suggesting that HSP25 immunonegative Purkinje cells are absent or delayed in stripe pattern expression compared to the wild type. HSP25 expression became heterogeneous around P22-23, with twice the number of parasagittal stripes in the nax mutant compared to the wild type. Aside from reduced size and cortical disorganization, both the posterior zone and nodular zone in the nax mutant appeared less abnormal than the rest of the cerebellum. From these results, it is evident that the anterior zone of the nax mutant cerebellum is the most severely affected, and this extends beyond the primary fissure into the rostral central zone/vermis. This suggests that ACP2 has critical roles in the development of the anterior cerebellum and it may regulate anterior and central zone compartmentation.	[Bailey, Karen; Balaei, Maryam Rahimi; Del Bigio, Marc R.; Marzban, Hassan] Univ Manitoba, Fac Med, MICH, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mannan, Ashraf] Univ Gottingen, Inst Human Genet, Univ Med Ctr Goettingen, Gottingen, Germany; [Del Bigio, Marc R.] Univ Manitoba, Fac Med, Dept Pathol, Winnipeg, MB, Canada	University of Manitoba; University of Gottingen; University of Manitoba	Marzban, H (corresponding author), Univ Manitoba, Fac Med, MICH, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.	hassan.marzban@med.umanitoba.ca	Hawkes, Richard/F-7971-2011	Marzban, Hassan/0000-0001-6885-2590; Del Bigio, Marc/0000-0001-8366-0394	Manitoba Health Research Council (MHRC); University of Manitoba	Manitoba Health Research Council (MHRC); University of Manitoba	This work is supported by funds from the Manitoba Health Research Council (MHRC) Operating Award and University of Manitoba Research Grants Program (URGP) to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong C, 2001, J COMP NEUROL, V439, P151, DOI 10.1002/cne.1339; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Armstrong CL, 2001, J COMP NEUROL, V429, P7, DOI 10.1002/1096-9861(20000101)429:1<7::AID-CNE2>3.0.CO;2-Q; Armstrong CL, 2005, J COMP NEUROL, V491, P69, DOI 10.1002/cne.20703; Bailey K, 2013, CEREBELLUM, V12, P870, DOI 10.1007/s12311-013-0502-y; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Beierbach E, 2001, J COMP NEUROL, V436, P42; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Carletti B, 2008, DEV BIOL, V317, P147, DOI 10.1016/j.ydbio.2008.02.005; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; Consalez GG, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00123; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; EDWARDS MA, 1994, ANAT EMBRYOL, V190, P417; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; Fernandez-Jaen A, 2009, PEDIATR NEUROL, V40, P58, DOI 10.1016/j.pediatrneurol.2008.10.001; Fortin M, 1998, NEUROSCI RES, V30, P155, DOI 10.1016/S0168-0102(97)00124-7; GEIER C, 1992, J HISTOCHEM CYTOCHEM, V40, P1275, DOI 10.1177/40.9.1506664; Goldowitz D, 1997, J NEUROSCI, V17, P8767; GOTTSCHALK S, 1989, EMBO J, V8, P3215, DOI 10.1002/j.1460-2075.1989.tb08480.x; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ji ZQ, 1996, J COMP NEUROL, V371, P578; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; Krishnamurthy S, 2008, INDIAN J PEDIATR, V75, P1178, DOI 10.1007/S12098-008-0183-6; Kuwamura M, 1997, ACTA NEUROPATHOL, V94, P549, DOI 10.1007/s004010050749; Larouche M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001653; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; Mannan AU, 2004, NEUROGENETICS, V5, P229, DOI 10.1007/s10048-004-0197-9; Marzban H, 2008, NEUROSCIENCE, V153, P1190, DOI 10.1016/j.neuroscience.2008.02.036; Marzban H, 2007, J COMP NEUROL, V502, P857, DOI 10.1002/cne.21352; Marzban H, 2007, BRAIN RES, V1141, P25, DOI 10.1016/j.brainres.2007.01.031; Melquist S, 2007, AM J HUM GENET, V80, P769, DOI 10.1086/513320; Namba K, 2011, J COMP NEUROL, V519, P2594, DOI 10.1002/cne.22640; Ozol K, 1999, J COMP NEUROL, V412, P95; Pohl S, 2007, J NEUROCHEM, V103, P2177, DOI 10.1111/j.1471-4159.2007.04920.x; Ramaekers VT, 1997, BRAIN, V120, P1739, DOI 10.1093/brain/120.10.1739; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; SATO H, 1987, J NEUROCHEM, V48, P1823, DOI 10.1111/j.1471-4159.1987.tb05742.x; SEIL FJ, 1995, J COMP NEUROL, V356, P398, DOI 10.1002/cne.903560307; Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Sillitoe RV, 2012, BRAIN STRUCT FUNCT; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; Vastagh C, 2005, ANAT EMBRYOL, V209, P471, DOI 10.1007/s00429-005-0458-x; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; Whetsell W, 2006, PEDIATR RADIOL, V36, P552, DOI 10.1007/s00247-006-0150-1	61	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94327	10.1371/journal.pone.0094327	http://dx.doi.org/10.1371/journal.pone.0094327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722417	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100054
J	de Vrij, EL; Vogelaar, PC; Goris, M; Houwertjes, MC; Herwig, A; Dugbartey, GJ; Boerema, AS; Strijkstra, AM; Bouma, HR; Henning, RH				de Vrij, Edwin L.; Vogelaar, Pieter C.; Goris, Maaike; Houwertjes, Martin C.; Herwig, Annika; Dugbartey, George J.; Boerema, Ate S.; Strijkstra, Arjen M.; Bouma, Hjalmar R.; Henning, Robert H.			Platelet Dynamics during Natural and Pharmacologically Induced Torpor and Forced Hypothermia	PLOS ONE			English	Article							HIBERNATING GROUND-SQUIRRELS; ISCHEMIA-REPERFUSION INJURY; LOW-TEMPERATURE; SYRIAN-HAMSTER; COLD-STORAGE; BLOOD-FLOW; ACTIVATION; MECHANISM; AGGREGATION; COAGULATION	Hibernation is an energy-conserving behavior in winter characterized by two phases: torpor and arousal. During torpor, markedly reduced metabolic activity results in inactivity and decreased body temperature. Arousal periods intersperse the torpor bouts and feature increased metabolism and euthermic body temperature. Alterations in physiological parameters, such as suppression of hemostasis, are thought to allow hibernators to survive periods of torpor and arousal without organ injury. While the state of torpor is potentially procoagulant, due to low blood flow, increased viscosity, immobility, hypoxia, and low body temperature, organ injury due to thromboembolism is absent. To investigate platelet dynamics during hibernation, we measured platelet count and function during and after natural torpor, pharmacologically induced torpor and forced hypothermia. Splenectomies were performed to unravel potential storage sites of platelets during torpor. Here we show that decreasing body temperature drives thrombocytopenia during torpor in hamster with maintained functionality of circulating platelets. Interestingly, hamster platelets during torpor do not express P-selectin, but expression is induced by treatment with ADP. Platelet count rapidly restores during arousal and rewarming. Platelet dynamics in hibernation are not affected by splenectomy before or during torpor. Reversible thrombocytopenia was also induced by forced hypothermia in both hibernating (hamster) and non-hibernating (rat and mouse) species without changing platelet function. Pharmacological torpor induced by injection of 5'-AMP in mice did not induce thrombocytopenia, possibly because 5'-AMP inhibits platelet function. The rapidness of changes in the numbers of circulating platelets, as well as marginal changes in immature platelet fractions upon arousal, strongly suggest that storage-and-release underlies the reversible thrombocytopenia during natural torpor. Possibly, margination of platelets, dependent on intrinsic platelet functionality, governs clearance of circulating platelets during torpor.	[de Vrij, Edwin L.; Goris, Maaike; Dugbartey, George J.; Strijkstra, Arjen M.; Bouma, Hjalmar R.; Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Vogelaar, Pieter C.] Sulfateq BV, Groningen, Netherlands; [Houwertjes, Martin C.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Herwig, Annika] Univ Hamburg, Inst Zool, Hamburg, Germany; [Boerema, Ate S.; Strijkstra, Arjen M.] Univ Groningen, Dept Chronobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Bouma, Hjalmar R.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Hamburg; University of Groningen; University of Groningen; University of Groningen; University of Groningen	de Vrij, EL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	E.L.de.Vrij@umcg.nl	Henning, Robert H/AAY-5222-2020; Bouma, Hjalmar/F-9737-2015; Boerema, A.S./W-9810-2018	Bouma, Hjalmar/0000-0003-1032-321X; Boerema, A.S./0000-0002-4771-5156; Vogelaar, Pieter/0000-0001-8271-3204; Herwig, Annika/0000-0003-3048-0618; Dugbartey, George/0000-0001-8161-7202; Henning, Robert/0000-0002-5135-4621	University Medical Center Groningen	University Medical Center Groningen	An MD/PhD grant was provided by the University Medical Center Groningen on behalf of Hjalmar Bouma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombeli T, 1998, J EXP MED, V187, P329, DOI 10.1084/jem.187.3.329; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2013, J LEUKOCYTE BIOL, V94, P89, DOI 10.1189/jlb.1212613; Bouma HR, 2011, P NATL ACAD SCI USA, V108, P2052, DOI 10.1073/pnas.1008823108; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; BULLARD RW, 1962, AM J PHYSIOL, V203, P266, DOI 10.1152/ajplegacy.1962.203.2.266; Carey HV, 2012, CIRC RES, V110, P915, DOI 10.1161/CIRCRESAHA.111.255398; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cooper ST, 2012, AM J PHYSIOL-REG I, V302, pR1202, DOI 10.1152/ajpregu.00018.2012; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Egidi MG, 2010, BLOOD TRANSFUS-ITALY, V8, pS73, DOI 10.2450/2010.012S; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Ghasemzadeh M, 2013, THROMB RES, V131, P191, DOI 10.1016/j.thromres.2012.11.028; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Henning RH, 2002, LIFE SCI, V70, P2071, DOI 10.1016/S0024-3205(02)01505-9; HEYNS ADP, 1980, BRIT J HAEMATOL, V44, P269, DOI 10.1111/j.1365-2141.1980.tb01209.x; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Hut RA, 2002, J COMP PHYSIOL B, V172, P47; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; KLONIZAKIS I, 1981, J CLIN PATHOL, V34, P377, DOI 10.1136/jcp.34.4.377; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krause S, 2001, PLATELETS, V12, P423, DOI 10.1080/09537100120071040; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; LECHLER E, 1963, AM J PHYSIOL, V205, P985, DOI 10.1152/ajplegacy.1963.205.5.985; Leng XH, 2004, ARTERIOSCL THROM VAS, V24, P376, DOI 10.1161/01.ATV.0000110445.95304.91; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; Miglis M, 2002, PLATELETS, V13, P5, DOI 10.1080/09537100120112558; Milsom WK, 1999, COMP BIOCHEM PHYS A, V124, P383, DOI 10.1016/S1095-6433(99)00130-0; Miyazawa S, 2008, AM J PHYSIOL-REG I, V295, pR991, DOI 10.1152/ajpregu.00142.2008; Moran N, 2006, ANAL BIOCHEM, V357, P77, DOI 10.1016/j.ab.2006.06.037; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; PIVORUN EB, 1981, CRYOBIOLOGY, V18, P515, DOI 10.1016/0011-2240(81)90212-1; Reasor D., 2012, ANN BIOMED ENG; REDDICK RL, 1973, LAB INVEST, V28, P270; Rittiner JE, 2012, J BIOL CHEM, V287, P5301, DOI 10.1074/jbc.M111.291666; Russell J, 2003, AM J PHYSIOL-GASTR L, V284, pG123, DOI 10.1152/ajpgi.00303.2002; Ruzicka K, 2001, ARCH PATHOL LAB MED, V125, P391; Sandovici M, 2004, NITRIC OXIDE-BIOL CH, V11, P194, DOI 10.1016/j.niox.2004.08.002; Saunders DK, 2000, J EXP ZOOL, V287, P459, DOI 10.1002/1097-010X(20001201)287:7<459::AID-JEZ1>3.3.CO;2-Y; SCHAFFNER A, 1985, ARCH INTERN MED, V145, P651, DOI 10.1001/archinte.145.4.651; Scharbert G, 2010, PLATELETS, V21, P44, DOI 10.3109/09537100903420269; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Tailor A, 2005, MICROCIRCULATION, V12, P275, DOI 10.1080/10739680590925691; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Thon JN, 2008, TRANSFUS MED REV, V22, P268, DOI 10.1016/j.tmrv.2008.05.004; TILLES AW, 1987, MICROVASC RES, V33, P211, DOI 10.1016/0026-2862(87)90018-5; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Vostal JG, 1997, TRANSFUS MED REV, V11, P286, DOI 10.1016/S0887-7963(97)80094-6; Wandall HH, 2008, BLOOD, V111, P3249, DOI 10.1182/blood-2007-06-097295; Yasuma Yoshihide, 1997, American Journal of Physiology, V273, pR1861; ZUCKER MB, 1954, BLOOD, V9, P602, DOI 10.1182/blood.V9.6.602.602	56	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93218	10.1371/journal.pone.0093218	http://dx.doi.org/10.1371/journal.pone.0093218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722364	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100014
J	Lin, HH; Hwang, SM; Wu, SJ; Hsu, LF; Liao, YH; Sheen, YS; Chuang, WH; Huang, SY				Lin, Hsiu-Hsia; Hwang, Shiaw-Min; Wu, Shang-Ju; Hsu, Lee-Feng; Liao, Yi-Hua; Sheen, Yi-Shuan; Chuang, Wen-Hui; Huang, Shang-Yi			The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy	PLOS ONE			English	Article							MULTIPLE-MYELOMA; BONE-DISEASE; OSTEOGENIC DIFFERENTIATION; TISSUE; MARROW; PROLIFERATION; PATHOGENESIS; LESIONS	Multiple myeloma (MM) is characterized by advanced osteolytic lesions resulting from the activation of osteoclasts (OCs) and inhibition of osteoblasts (OBs). OBs are derived from mesenchymal stem cells (MSCs) from the bone marrow (BM), however the pool and function of BMMSCs in MM patients (MM-BMMSCs) are reduced by myeloma cells (MCs) and cytokines secreted from MCs and related anti-MM treatment. Such reduction in MM-BMMSCs currently cannot be restored by any means. Recently, genetic aberrations of MM-BMMSCs have been noted, which further impaired their differentiation toward OBs. We hypothesize that the MSCs derived from adipose tissue (ADMSCs) can be used as alternative MSC sources to enhance the pool and function of OBs. Therefore, the purpose of this study was to compare the osteogenesis ability of paired ADMSCs and BMMSCs in MM patients who had completed intensive therapy. Fifteen MM patients who had received bortezomib-based induction and autologous transplantation were enrolled. At the third month after the transplant, the paired ADMSCs and BMMSCs were obtained and cultured. Compared with the BMMSCs, the ADMSCs exhibited a significantly higher expansion capacity (100% vs 13%, respectively; P=.001) and shorter doubling time (28 hours vs 115 hours, respectively; P=.019). After inducing osteogenic differentiation, although the ALP activity did not differ between the ADMSCs and BMMSCs (0.78 U/mu g vs 0.74+/-0.14 U/mg, respectively; P=.834), the ADMSCs still exhibited higher calcium mineralization, which was determined using Alizarin red S (1029 nmole vs 341 nmole, respectively; P=.001) and von Kossa staining (2.6 E+05 mu m(2) vs 5 E+04 mu m(2), respectively; P=.042), than the BMMSCs did. Our results suggested that ADMSCs are a feasible MSC source for enhancing the pool and function of OBs in MM patients who have received intensive therapy.	[Lin, Hsiu-Hsia; Wu, Shang-Ju; Chuang, Wen-Hui; Huang, Shang-Yi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hwang, Shiaw-Min; Hsu, Lee-Feng] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Liao, Yi-Hua; Sheen, Yi-Shuan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Huang, SY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	syhuang55@ntuh.gov.tw	Sheen, Yi-Shuan/HGA-1172-2022	Huang, Shang-Yi/0000-0001-5688-3410; LIAO, YI-HUA/0000-0002-4434-3780; Sheen, Yi-Shuan/0000-0002-8743-7496	National Science Council [NSC97-2314-B-002-036-MY3, NSC101-2314-B-002-086, NSC102-2628-B-002-052-MY3]; National Taiwan University Hospital [NTUH 94A19-1, 99-S0131, 100-S1659, 101-S1801, 102-S2161]; Department of Health, Taiwan, Republic of China [DOH100-TD-C-111-001]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Department of Health, Taiwan, Republic of China	This study was supported by grants from the National Science Council (NSC97-2314-B-002-036-MY3; NSC101-2314-B-002-086; NSC102-2628-B-002-052-MY3) and National Taiwan University Hospital (NTUH 94A19-1, 99-S0131, 100-S1659, 101-S1801, 102-S2161) and Department of Health (DOH100-TD-C-111-001), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059756; Cao YR, 2010, EXP HEMATOL, V38, P860, DOI 10.1016/j.exphem.2010.06.012; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Charbord P, 2011, STEM CELL REV REP, V7, P32, DOI 10.1007/s12015-010-9125-6; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Choi YS, 2012, BIOMATERIALS, V33, P2482, DOI 10.1016/j.biomaterials.2011.12.004; Christoulas D, 2009, EXPERT REV HEMATOL, V2, P385, DOI 10.1586/ehm.09.36; Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Cournil-Henrionnet C, 2008, BIORHEOLOGY, V45, P513, DOI 10.3233/BIR-2008-0487; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Ginis I, 2012, TISSUE ENG PART C-ME, V18, P453, DOI [10.1089/ten.TEC.2011.0395, 10.1089/ten.tec.2011.0395]; Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Konno M, 2013, DEV GROWTH DIFFER, V55, P309, DOI 10.1111/dgd.12049; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li X, 2012, J BONE MINER RES, V27, P1635, DOI 10.1002/jbmr.1620; Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92; Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K; Moroni L, 2013, J CELL PHYSIOL, V228, P680, DOI 10.1002/jcp.24223; Naito H, 2011, TISSUE ENG PT A, V17, P2321, DOI [10.1089/ten.tea.2011.0099, 10.1089/ten.TEA.2011.0099]; Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Papadopoulou EC, 2010, HIPPOKRATIA, V14, P76; Pevsner-Fischer M, 2012, STEM CELL REV REP, V8, P343, DOI 10.1007/s12015-011-9310-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Reagan MR, 2012, CLIN CANCER RES, V18, P342, DOI 10.1158/1078-0432.CCR-11-2212; Roodman G David, 2008, Hematology Am Soc Hematol Educ Program, P313, DOI 10.1182/asheducation-2008.1.313; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Zhang HT, 2012, CYTOTHERAPY, V14, P1203, DOI 10.3109/14653249.2012.711470; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94395	10.1371/journal.pone.0094395	http://dx.doi.org/10.1371/journal.pone.0094395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722177	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100066
J	Wu, WF; Sun, LY; Pan, XD; Yang, SW; Wang, LY				Wu, Wen-Feng; Sun, Li-Yuan; Pan, Xiao-Dong; Yang, Shi-Wei; Wang, Lv-Ya			Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia	PLOS ONE			English	Article							LDL-RECEPTOR GENE; SHORT READ ALIGNMENT; MUTATIONS; REARRANGEMENTS; SIMVASTATIN; POPULATION; EXPRESSION; EFFICACY; DISEASE; TOOL	Familial hypercholesterolemia is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is mainly caused by mutations of the low-density lipoprotein receptor (LDLR) gene. Currently, the methods of whole genome sequencing or whole exome sequencing for screening mutations in familial hypercholesterolemia are not applicable in China due to high cost. We performed targeted exome sequencing of 167 genes implicated in the homozygous phenotype of a proband pedigree to identify candidate mutations, validated them in the family of the proband, studied the functions of the mutant protein, and followed up serum lipid levels after treatment. We discovered that exon 9 c. 1268 T>C and exon 8 c. 1129 T>G compound heterozygous mutations in the LDLR gene in the proband derived from the mother and father, respectively, in which the mutation of c. 1129 T>G has not been reported previously. The mutant LDL-R protein had 57% and 52% binding and internalization functions, respectively, compared with that of the wild type. After 6 months of therapy, the LDL-C level of the proband decreased by more than 50% and the LDL-C of the other family members with heterozygous mutation also reduced to normal. Targeted exome sequencing is an effective method for screening mutation genes in familial hypercholesterolemia. The exon 8 and 9 mutations of the LDLR gene were pedigree mutations. The functions of the mutant LDL-R protein were decreased significantly compared with that of the wild type. Simvastatin plus ezetimibe was proven safe and effective in this preschool-age child.	[Wu, Wen-Feng; Sun, Li-Yuan; Yang, Shi-Wei] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Wu, Wen-Feng; Pan, Xiao-Dong; Yang, Shi-Wei; Wang, Lv-Ya] Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China	Capital Medical University	Wang, LY (corresponding author), Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China.	wanglvya2012@163.com			Natural Science Foundation of Beijing [7112040]; National Natural Science Foundation of China [81170810, 81271923]	Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of Beijing (No. 7112040) and National Natural Science Foundation of China (No. 81170810 and 81271923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonsol R, 2013, EXPERT REV CARDIOVAS, V11, P327, DOI [10.1586/ERC.13.7, 10.1586/erc.13.7]; Amsellem S, 2002, HUM GENET, V111, P501, DOI 10.1007/s00439-002-0813-4; Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023; Bertolini S, 1999, ARTERIOSCL THROM VAS, V19, P408, DOI 10.1161/01.ATV.19.2.408; Catapano AL, 2006, CURR MED RES OPIN, V22, P2041, DOI 10.1185/030079906X132721; Chang JH, 2003, J LIPID RES, V44, P1850, DOI 10.1194/jlr.M200470-JLR200; Chiou KR, 2010, AM J CARDIOL, V105, P1752, DOI 10.1016/j.amjcard.2010.01.356; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EKSTROM U, 1995, HUM GENET, V96, P147, DOI 10.1007/BF00207370; Ekstrom U, 1998, EUR J CLIN INVEST, V28, P740; Elis A, 2013, CARDIOL YOUNG, V10, P1; Espinheira MC, 2013, REV PORT CARDIOL, V32, P379, DOI 10.1016/j.repc.2012.09.008; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; He J, 2011, ONCOTARGET, V2, P178; Hou HB, 2010, NUCLEIC ACIDS RES, V38, pW732, DOI 10.1093/nar/gkq302; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Khoo KL, 2000, CLIN GENET, V58, P98, DOI 10.1034/j.1399-0004.2000.580202.x; Kim YR, 2013, KOREAN CIRC J, V43, P363, DOI 10.4070/kcj.2013.43.6.363; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Motazacker MM, 2012, EUR HEART J, V33, P1360, DOI 10.1093/eurheartj/ehs010; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Wu WF, 2013, CLIN BIOCHEM, V46, P993, DOI 10.1016/j.clinbiochem.2013.04.003	30	89	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94697	10.1371/journal.pone.0094697	http://dx.doi.org/10.1371/journal.pone.0094697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722143	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100122
J	Zhang, J; Wang, WD; Geng, QR; Wang, L; Chen, XQ; Liu, CC; Lv, Y				Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue			Serum Levels of Interleukin-9 Correlate with Negative Prognostic Factors in Extranodal NK/T-Cell Lymphoma	PLOS ONE			English	Article							LETHAL MIDLINE GRANULOMA; T-CELLS; IN-VIVO; MALIGNANT-LYMPHOMAS; IL-9 RECEPTOR; NASAL-TYPE; GROWTH; EXPRESSION; ASTHMA; ACTIVATION	Interleukin-9 (IL-9) is more functionally diverse than previously expected, especially with regards to lymphomagenesis. However, the relationship between IL-9 and the clinicopathological features of extranodal NK/T-cell lymphoma is less well established. Patients with this lymphoma in Sun Yat-Sen University Cancer Center between January 2003 and March 2013 were systematically reviewed in an intention-to-treat analysis. Baseline serum IL-9 levels were determined using sandwich enzyme-linked immunosorbent assays. A total of seventy-four patients were enrolled in this study. The mean concentration of serum IL-9 for all patients was 6.48 pg/mL (range: 1.38-51.87 pg/mL). Age, B symptoms and local lymph node involvement were found to be related to high serum IL-9 levels. Patients with low IL-9 levels tended to have higher rates of complete remission. Notably, the median progression-free survival (PFS) and overall survival (OS) were longer in the low IL-9 level group than in the high IL-9 level group (PFS: 68.7 months vs. 28.3 months, P < 0.001; OS: 86 months vs. 42.8 months, P = 0.001). Multivariate analysis revealed independent prognostic factors for PFS. Similarly, high IL-9 levels (P = 0.003) and old age (P = 0.007) were independently predictive of shorter OS. Serum IL-9 is closely related to several clinical features, such as age, B symptoms and local lymph node involvement. It can also be a significant independent prognostic factor for extranodal NK/T-cell lymphoma, which suggests a role for IL-9 in the pathogenesis of this disease and offers new insight into potential therapeutic strategies.	[Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue] Sun Yat Sen Univ, Dept Hematol Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Jing] Hubei Canc Hosp, Dept Med Oncol, Wuhan, Hubei, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Lv, Y (corresponding author), Sun Yat Sen Univ, Dept Hematol Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	lvyue@sysucc.org.cn	Wang, Weida/HGV-1933-2022		National Natural Science Foundation of China [30471976, 81272620]; Science and Technology projects of Guangdong Province [2010B031600233, 2010A090200019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology projects of Guangdong Province	This work was supported by the following funds: National Natural Science Foundation of China (contract/grant numbers 30471976 and 81272620) and Science and Technology projects of Guangdong Province (contract/grant numbers 2010B031600233 and 2010A090200019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 2001, CELL GROWTH DIFFER, V12, P169; EICHEL BS, 1966, AM J SURG, V112, P597, DOI 10.1016/0002-9610(66)90328-X; Fischer M, 2003, LEUKEMIA, V17, P2513, DOI 10.1038/sj.leu.2403123; HARRIS NL, 1994, BLOOD, V84, P1361; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Jaffe ES, 1996, AM J SURG PATHOL, V20, P103, DOI 10.1097/00000478-199601000-00012; KASSEL SH, 1969, CANCER-AM CANCER SOC, V23, P920, DOI 10.1002/1097-0142(196904)23:4<920::AID-CNCR2820230430>3.0.CO;2-M; KELLEHER K, 1991, BLOOD, V77, P1436; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Levitt RC, 1999, J ALLERGY CLIN IMMUN, V103, pS485, DOI 10.1016/S0091-6749(99)70165-X; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Lv X, 2013, LEUKEMIA LYMPHOMA, V54, P1367, DOI 10.3109/10428194.2012.745072; Lv X, 2013, INT J CLIN EXP PATHO, V6, P911; MERZ H, 1991, BLOOD, V78, P1311; Moriai S, 2009, CLIN CANCER RES, V15, P6771, DOI 10.1158/1078-0432.CCR-09-1052; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; Shang Y, 2008, IN VIVO, V22, P713; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Sun J, 2012, AM J CLIN PATHOL, V138, P429, DOI 10.1309/AJCP7YLTQPUSDQ5C; TeruyaFeldstein J, 1997, BLOOD, V90, P4099, DOI 10.1182/blood.V90.10.4099; Wang L, 2013, CANCER-AM CANCER SOC, V119, P348, DOI 10.1002/cncr.27752; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622	39	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94637	10.1371/journal.pone.0094637	http://dx.doi.org/10.1371/journal.pone.0094637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722378	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100110
J	Perez-Burgos, A; Mao, YK; Bienenstock, J; Kunze, WA				Perez-Burgos, Azucena; Mao, Yu-Kang; Bienenstock, John; Kunze, Wolfgang A.			The gut-brain axis rewired: adding a functional vagal nicotinic "sensory synapse"	FASEB JOURNAL			English	Article						synaptic transmission; enteric nervous system; primary afferent neuron; Lactobacillus; vagus	INTRAGANGLIONIC LAMINAR ENDINGS; ENTERIC NERVOUS-SYSTEM; LACTOBACILLUS-REUTERI; MYENTERIC NEURONS; INTERSTITIAL-CELLS; ACTION-POTENTIALS; RAT; MOUSE; RELEASE; STIMULATION	It is generally accepted that intestinal sensory vagal fibers are primary afferent, responding nonsynaptically to luminal stimuli. The gut also contains intrinsic primary afferent neurons (IPANs) that respond to luminal stimuli. A psychoactive Lactobacillus rhamnosus (JB-1) that affects brain function excites both vagal fibers and IPANs. We wondered whether, contrary to its primary afferent designation, the sensory vagus response to JB-1 might depend on IPAN to vagal fiber synaptic transmission. We recorded ex vivo single- and multiunit afferent action potentials from mesenteric nerves supplying mouse jejunal segments. Intramural synaptic blockade with Ca2+ channel blockers reduced constitutive or JB-1-evoked vagal sensory discharge. Firing of 60% of spontaneously active units was reduced by synaptic blockade. Synaptic or nicotinic receptor blockade reduced firing in 60% of vagal sensory units that were stimulated by luminal JB-1. In control experiments, increasing or decreasing IPAN excitability, respectively increased or decreased nerve firing that was abolished by synaptic blockade or vagotomy. We conclude that >50% of vagal afferents function as interneurons for stimulation by JB-1, receiving input from an intramural functional "sensory synapse." This was supported by myenteric plexus nicotinic receptor immunohistochemistry. These data offer a novel therapeutic target to modify pathological gut-brain axis activity.	[Perez-Burgos, Azucena; Mao, Yu-Kang; Bienenstock, John; Kunze, Wolfgang A.] St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON L8N 4A6, Canada; [Bienenstock, John] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Kunze, WA (corresponding author), St Josephs Healthcare, McMaster Brain Body Inst, Juravinski Innovat Tower,50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada.	kunzew@mcmaster.ca			National Science and Engineering Research Council (NSERC) [371955-2009]; Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship	The authors thank the McMaster Brain-Body Institute for financial support for this research. The research was also supported by a grant to W.A.K. from the National Science and Engineering Research Council (NSERC; 371955-2009). A.P.B. was supported by the Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship. A.P.B. performed the experiments, analyzed the data, and contributed to drafting and editing the manuscript. Y.M. performed the vagotomies and immunohistochemistry. J.B. contributed to editing the manuscript. W.A.K. designed the research, helped analyze the data, and drafted the manuscript. All authors approved the manuscript for publication. Experiments were conducted in the McMaster Brain-Body Institute at St Joseph's Healthcare Hamilton. The authors declare no conflicts of interest.	Bercik P, 2012, NEUROGASTROENT MOTIL, V24, P405, DOI 10.1111/j.1365-2982.2012.01906.x; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Berthoud HR, 1997, ANAT EMBRYOL, V195, P183, DOI 10.1007/s004290050037; Berthoud HR, 2004, NEUROGASTROENT MOTIL, V16, P28, DOI 10.1111/j.1743-3150.2004.00471.x; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bertrand PP, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.21.003.2009; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Bertrand PP, 2003, NEUROSCIENTIST, V9, P243, DOI 10.1177/1073858403253768; Bertrand PP, 1997, AM J PHYSIOL-GASTR L, V273, pG422; Blackshaw LA, 2007, NEUROGASTROENT MOTIL, V19, P1, DOI 10.1111/j.1365-2982.2006.00871.x; Blackshaw LA, 2011, NEUROGASTROENT MOTIL, V23, P591, DOI 10.1111/j.1365-2982.2011.01719.x; BLAIR EL, 1959, J PHYSIOL-LONDON, V148, P437, DOI 10.1113/jphysiol.1959.sp006298; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Booth CE, 2008, NEUROGASTROENT MOTIL, V20, P149, DOI 10.1111/j.1365-2982.2007.01003.x; Bravo JA, 2012, CURR OPIN PHARMACOL, V12, P667, DOI 10.1016/j.coph.2012.09.010; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; BULBRING EDITH, 1958, QUART JOUR EXPTL PHYSIOL, V43, P26; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Dochray G. J., 2009, TXB GASTROENTEROLOGY, P86; Dogiel A. S., 1899, Arch Anat, P130; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Forsythe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041234; Furness J. B., 2009, TXB GASTROENTEROLOGY, P40; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 1998, PROG NEUROBIOL, V54, P1, DOI 10.1016/S0301-0082(97)00051-8; GERSHON MD, 1993, J NEUROBIOL, V24, P199, DOI 10.1002/neu.480240207; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Hirst G. D., 1972, J PHYSL, V225, p60P; HIRST GDS, 1974, J PHYSIOL-LONDON, V236, P303, DOI 10.1113/jphysiol.1974.sp010436; HIRST GDS, 1973, NATURE-NEW BIOL, V243, P54; Hubsch M, 2013, NEUROGASTROENT MOTIL, V25, pE560, DOI 10.1111/nmo.12161; Kamiya T, 2006, GUT, V55, P191, DOI 10.1136/gut.2005.070987; KUNZE WAA, 1995, NEUROSCIENCE, V66, P1, DOI 10.1016/0306-4522(95)00067-S; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Langley JN, 1905, J PHYSIOL-LONDON, V33, P34; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McCarthy E L, 1934, Science, V80, P100, DOI 10.1126/science.80.2065.100; Mueller MH, 2009, AM J PHYSIOL-GASTR L, V297, pG655, DOI 10.1152/ajpgi.00128.2009; Naidoo V, 2010, NEUROGASTROENT MOTIL, V22, pE353, DOI 10.1111/j.1365-2982.2010.01596.x; Nguyen TV, 2007, J NEUROPHYSIOL, V97, P2024, DOI 10.1152/jn.00935.2006; PALOUZIERPAULIGNAN B, 1992, EUR J NEUROSCI, V4, P1123, DOI 10.1111/j.1460-9568.1992.tb00139.x; Pan H, 2000, J NEUROSCI, V20, P3295, DOI 10.1523/JNEUROSCI.20-09-03295.2000; Perez-Burgos A, 2013, AM J PHYSIOL-GASTR L, V304, pG211, DOI 10.1152/ajpgi.00128.2012; Phillips RJ, 2010, AUTON NEUROSCI-BASIC, V153, P90, DOI 10.1016/j.autneu.2009.07.009; Powley TL, 2008, NEUROGASTROENT MOTIL, V20, P69, DOI 10.1111/j.1365-2982.2007.00990.x; Powley TL, 2011, J COMP NEUROL, V519, P644, DOI 10.1002/cne.22541; Raab M, 2004, HISTOCHEM CELL BIOL, V122, P445, DOI 10.1007/s00418-004-0703-z; Raab M, 2003, CELL TISSUE RES, V312, P141, DOI 10.1007/s00441-003-0721-5; Racke K, 1996, BEHAV BRAIN RES, V73, P83; Rugiero F, 2002, J PHYSIOL-LONDON, V538, P447, DOI 10.1113/jphysiol.2001.013051; SCHEMANN M, 1992, AM J PHYSIOL, V263, pG709, DOI 10.1152/ajpgi.1992.263.5.G709; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Tan LL, 2010, NEUROSCIENCE, V166, P564, DOI 10.1016/j.neuroscience.2009.12.034; Trueta C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00319; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Walter GC, 2009, J NEUROSCI METH, V178, P1, DOI 10.1016/j.jneumeth.2008.11.003; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Winston JH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00022; Wood JD, 2010, CURR OPIN GASTROEN, V26, P102, DOI 10.1097/MOG.0b013e328334df4f; Zaidi ZF, 1997, NEUROSCIENCE, V80, P861, DOI 10.1016/S0306-4522(96)00664-1	68	63	63	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3064	3074		10.1096/fj.13-245282	http://dx.doi.org/10.1096/fj.13-245282			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24719355				2022-12-25	WOS:000337949400028
J	Zhang, J; Lazarenko, OP; Blackburn, ML; Badger, TM; Ronis, MJJ; Chen, JR				Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran			Soy protein isolate down-regulates caveolin-1 expression to suppress osteoblastic cell senescence pathways	FASEB JOURNAL			English	Article						isoflavone; estrogen; p53	MESENCHYMAL STEM-CELLS; FEMALE RATS; GENISTEIN AGLYCONE; GENE-EXPRESSION; BONE LOSS; IN-VIVO; ESTROGEN; DIFFERENTIATION; CONSUMPTION; SKIN	It has been suggested that the beneficial effects of soy protein isolate (SPI) on bone quality are due to either stimulation of estrogenic signaling via isoflavones or through a novel and as yet uncharacterized nonestrogenic pathway. In our study, SPI-fed rat serum inhibited the osteoblastic cell senescence pathway. This effect was accompanied by stimulation of cell differentiation, proliferation, and significant restoration of replicative senescent bone marrow mesenchymal ST2 cells (passaged 30 times). These effects were reproduced in bone from 5-wk-old intact and 10-wk-old ovariectomized female rats fed SPI diets. Caveolin-1 and p53 expression was decreased in bone in SPI-fed, but not in 17 beta-estradiol (E2)-treated rats. In cell culture studies, membranous caveolin-1 and nuclear p53 expression was greater in replicative senescent ST2 cell cultures than in earlier passaged cells. SPI-fed rat serum significantly down-regulated both caveolin-1 and p53 in senescent and nonsenescent cells. Replicative senescent ST2 cells exhibited a strong association among caveolin-1, p53, and mouse double minute 2 homologue (mdm2), which was inhibited by SPI-fed rat serum. Overexpression of caveolin-1 in ST2 cells resulted in increased expression of p53 and p21, whereas, knockdown of caveolin-1 using shRNA led to increases in mdm2 and eliminated SPI-fed rat serum's effects on p53 and p21 expression. In contrast, manipulation of caveolin-1 expression did not affect the actions of E2 or isoflavones on p53 expression in either ST2 or OB6 cells. These results suggest that caveolin-1 is a mediator of nonestrogenic SPI effects on bone cells.	[Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.; Chen, Jin-Ran] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Slot 512-20B,15 Childrens Way, Little Rock, AR 72202 USA.	chenjinran@uams.edu			U.S. Department of Agriculture/Agricultural Research Service [6251-51000-003]	U.S. Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank M. Ferguson and H. Pittman for technical assistance. This work was supported in part by a U.S. Department of Agriculture/Agricultural Research Service grant (Current Research Information System ID 6251-51000-003) to the Arkansas Children's Nutrition Center.	Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121; Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Badger TM, 2002, J NUTR, V132, p559S, DOI 10.1093/jn/132.3.559S; Baker N, 2012, J CELL BIOCHEM, V113, P3773, DOI 10.1002/jcb.24252; Bitto A, 2010, CURR MED CHEM, V17, P3007, DOI 10.2174/092986710791959738; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Cho KA, 2003, J BIOL CHEM, V278, P27789, DOI 10.1074/jbc.M208105200; Choi HR, 2011, AGING CELL, V10, P148, DOI 10.1111/j.1474-9726.2010.00654.x; Dewi FN, 2012, J NUTR, V142, P1829, DOI 10.3945/jn.112.161711; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Finch CE, 2014, J STEROID BIOCHEM, V142, P132, DOI 10.1016/j.jsbmb.2013.03.010; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gu LW, 2006, J NUTR, V136, P1215, DOI 10.1093/jn/136.5.1215; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Huang W, 2012, ACTA PHARMACOL SIN, V33, P668, DOI 10.1038/aps.2011.189; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kurzer M. S., 2008, Inflammopharmacology, V16, P227, DOI 10.1007/s10787-008-8021-z; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Messina M, 2010, J NUTR, V140, p2289S, DOI 10.3945/jn.110.124107; Nechuta SJ, 2012, AM J CLIN NUTR, V96, P123, DOI 10.3945/ajcn.112.035972; Park NH, 2013, INT J COSMETIC SCI, V35, P136, DOI 10.1111/ics.12014; Polito F, 2012, BRIT J PHARMACOL, V165, P994, DOI 10.1111/j.1476-5381.2011.01619.x; Prisby RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048564; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Ronis MJJ, 2012, ENDOCRINOLOGY, V153, P6021, DOI 10.1210/en.2012-1591; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Setchell KDR, 2001, J AM COLL NUTR, V20, p354S, DOI 10.1080/07315724.2001.10719168; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Shupnik MA, 1998, J CLIN ENDOCR METAB, V83, P3965, DOI 10.1210/jc.83.11.3965; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Tai TY, 2012, OSTEOPOROSIS INT, V23, P1571, DOI 10.1007/s00198-011-1750-7; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Zhang J, 2013, AGE, V35, P807, DOI 10.1007/s11357-012-9412-z; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035736; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024486; Zou HF, 2011, MECH AGEING DEV, V132, P533, DOI 10.1016/j.mad.2011.11.001	44	14	15	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3134	3145		10.1096/fj.13-243659	http://dx.doi.org/10.1096/fj.13-243659			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24719353				2022-12-25	WOS:000337949400034
J	Dixit, G; Baker, R; Sacks, CM; Torres, MP; Dohlman, HG				Dixit, Gauri; Baker, Rachael; Sacks, Carly M.; Torres, Matthew P.; Dohlman, Henrik G.			Guanine Nucleotide-binding Protein (G alpha) Endocytosis by a Cascade of Ubiquitin Binding Domain Proteins Is Required for Sustained Morphogenesis and Proper Mating in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; CELL-SURFACE RECEPTORS; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; PLASMA-MEMBRANE; HELICAL DOMAIN; K-RAS; SUBUNIT; REGULATORS; LIGASE	Heterotrimeric G proteins are well known to transmit signals from cell surface receptors to intracellular effector proteins. There is growing appreciation that G proteins are also present at endomembrane compartments, where they can potentially interact with a distinct set of signaling proteins. Here, we examine the cellular trafficking function of the G protein alpha subunit in yeast, Gpa1. Gpa1 contains a unique 109-amino acid insert within the alpha-helical domain that undergoes a variety of post-translational modifications. Among these is monoubiquitination, catalyzed by the NEDD4 family ubiquitin ligase Rsp5. Using a newly optimized method for G protein purification together with biophysical measures of structure and function, we show that the ubiquitination domain does not influence enzyme activity. By screening a panel of 39 gene deletion mutants, each lacking a different ubiquitin binding domain protein, we identify seven that are necessary to deliver Gpa1 to the vacuole compartment including four proteins (Ede1, Bul1, Ddi1, and Rup1) previously not known to be involved in this process. Finally, we show that proper endocytosis of the G protein is needed for sustained cellular morphogenesis and mating in response to pheromone stimulation. We conclude that a cascade of ubiquitin-binding proteins serves to deliver the G protein to its final destination within the cell. In this instance and in contrast to the previously characterized visual system, endocytosis from the plasma membrane is needed for proper signal transduction rather than for signal desensitization.	[Dixit, Gauri; Baker, Rachael; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sacks, Carly M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Torres, Matthew P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Torres, Matthew/0000-0001-7296-4536; Shanks, Carly/0000-0001-6229-6845; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [GM101560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101560 (to H. G. D.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Brachmann CB, 1998, YEAST, V14, P115; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Dores MR, 2010, TRAFFIC, V11, P151, DOI 10.1111/j.1600-0854.2009.01003.x; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Gabriely G, 2008, MOL BIOL CELL, V19, P3625, DOI 10.1091/mbc.E07-05-0462; Gagny B, 2000, J CELL SCI, V113, P3309; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Lam MHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075372; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu YL, 1997, MOL MICROBIOL, V23, P777, DOI 10.1046/j.1365-2958.1997.2701631.x; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Pruyne D, 2000, J CELL SCI, V113, P571; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rojas AM, 2012, J CELL BIOL, V196, P545, DOI 10.1083/jcb.2011030081964c; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shaw JD, 2001, EXP CELL RES, V271, P1, DOI 10.1006/excr.2001.5373; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tanaka H, 2010, BIOPHYS J, V99, P1007, DOI 10.1016/j.bpj.2010.04.078; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Wedegaertner Philip B, 2012, Subcell Biochem, V63, P193, DOI 10.1007/978-94-007-4765-4_11; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zhu M, 2011, J BIOL CHEM, V286, P27147, DOI 10.1074/jbc.M111.254193; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	73	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15052	15063		10.1074/jbc.M114.566117	http://dx.doi.org/10.1074/jbc.M114.566117			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722989	Green Published, hybrid			2022-12-25	WOS:000337248100057
J	Oh, JH; Chuck, RS; Do, JR; Park, CY				Oh, Jong-Hyun; Chuck, Roy S.; Do, Jae Rock; Park, Choul Yong			Vitreous Hyper-Reflective Dots in Optical Coherence Tomography and Cystoid Macular Edema after Uneventful Phacoemulsification Surgery	PLOS ONE			English	Article							RETROCAPSULAR LENS FRAGMENTS; CATARACT-SURGERY; VITREORETINAL INTERFACE; CONTRAST SENSITIVITY; ASTEROID HYALOSIS; DISEASE; MORPHOLOGY; DIAGNOSIS; EYES	Purpose: To report the observation of hyper-reflective dots in the vitreous cavity using spectral domain optical coherence tomography (SD-OCT) after uneventful phacoemulsification cataract surgery and to investigate their association with cystoid macular edema (CME). Materials and Methods: Medical records of consecutive Asian patients who had no preoperative retinopathy and underwent uneventful phacoemulsification cataract surgery from March 2012 through February 2013 were reviewed. SD-OCTs were performed before, 1 week, and 1 month after surgery. The number of vitreous hyper-reflective dots (VHDs) was counted in 5 OCT images of high-definition 5-line raster scans. The development of CME was assessed using postoperative 1-month OCT. Results: In 74 eyes of 74 patients, all of three SD-OCTs with a signal to noise ratio of 0.6 or more were available and were analyzed in this study. In preoperative OCT, the VHD was observed in 2 (2.7%) of 74 eyes; one eye had 1 VHD and the other eye had 2 VHDs. In 72 eyes with no preoperative VHD, VHDs were observed in 40 (55.6%) eyes at 1 week after the surgery. In the multivariate analysis, the number of VHDs measured at 1 week after the surgery was significantly associated with CME development at 1 month after the surgery (odds ratio = 1.93, 95% confidence interval = 1.15 to 3.24, P = 0.012). Conclusions: VHDs were frequently observed in OCT after uneventful phacoemulsification cataract surgery. VHDs observed at 1 week after the surgery may be a risk factor for the development of pseudophakic CME. Further studies are needed to identify the source of the VHDs.	[Oh, Jong-Hyun; Do, Jae Rock; Park, Choul Yong] Dongguk Univ, Ilsan Hosp, Dept Ophthalmol, Goyang, South Korea; [Chuck, Roy S.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Dongguk University; NHIS Ilsan Hospital; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Park, CY (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Ophthalmol, Goyang, South Korea.	oph0112@gmail.com						Ang A, 2004, J CATARACT REFR SURG, V30, P849, DOI 10.1016/j.jcrs.2003.08.026; Belair ML, 2009, AM J OPHTHALMOL, V148, P128, DOI 10.1016/j.ajo.2009.02.029; Benitah Nicole R, 2010, Int Ophthalmol Clin, V50, P139, DOI 10.1097/IIO.0b013e3181c551da; BLOOM GUNNAR D., 1965, EXP EYE RES, V4, P249, DOI 10.1016/S0014-4835(65)80038-0; Diniz B, 2011, CLIN OPHTHALMOL, V5, P645, DOI 10.2147/OPTH.S20033; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; GINSBURG AP, 1995, J CATARACT REFR SURG, V21, P82, DOI 10.1016/S0886-3350(13)80485-3; Hayashi K, 2009, EYE, V23, P389, DOI 10.1038/sj.eye.6703022; Henderson BA, 2007, J CATARACT REFR SURG, V33, P1550, DOI 10.1016/j.jcrs.2007.05.013; Hwang JC, 2006, RETINA-J RET VIT DIS, V26, P661, DOI 10.1097/00006982-200607000-00012; IBANEZ HE, 1993, ARCH OPHTHALMOL-CHIC, V111, P1635, DOI 10.1001/archopht.1993.01090120057022; Ibrahim OMA, 2010, OPHTHALMOLOGY, V117, P1923, DOI 10.1016/j.ophtha.2010.01.057; Kim SJ, 2008, RETINA-J RET VIT DIS, V28, P870, DOI 10.1097/IAE.0b013e318169d04e; Kim SJ, 2009, CURR OPIN OPHTHALMOL, V20, P46, DOI 10.1097/ICU.0b013e3283199162; Kusbeci T, 2012, CURR EYE RES, V37, P327, DOI 10.3109/02713683.2011.635402; Li Y, 2008, OPHTHALMOLOGY, V115, P2159, DOI 10.1016/j.ophtha.2008.08.004; Liu DTL, 2008, CLIN EXP OPHTHALMOL, V36, P31, DOI 10.1111/j.1442-9071.2007.01650.x; Liu DTL, 2005, J CATARACT REFR SURG, V31, P1856, DOI 10.1016/j.jcrs.2005.10.015; Lobo C, 2012, OPHTHALMOLOGICA, V227, P61, DOI 10.1159/000331277; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Mochizuki Y, 2009, GRAEF ARCH CLIN EXP, V247, P1173, DOI 10.1007/s00417-009-1095-5; Orefice JL, 2013, ACTA OPHTHALMOL, V91, pe41, DOI 10.1111/j.1755-3768.2012.02531.x; Perente I, 2007, CURR EYE RES, V32, P241, DOI 10.1080/02713680601160610; Ponsioen TL, 2010, PROG RETIN EYE RES, V29, P580, DOI 10.1016/j.preteyeres.2010.07.001; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; Saito M, 2013, RETINA-J RET VIT DIS, V33, P559, DOI 10.1097/IAE.0b013e31826710ea; SEBAG J, 1989, INVEST OPHTH VIS SCI, V30, P1867; STERN AL, 1981, OPHTHALMOLOGY, V88, P942; Sukha AY, 2009, OPTOMETRY VISION SCI, V86, P1086, DOI 10.1097/OPX.0b013e3181b48635; Vukicevic M, 2012, CLIN EXP OPHTHALMOL, V40, P282, DOI 10.1111/j.1442-9071.2011.02638.x; Yonekawa Y, 2012, CURR OPIN OPHTHALMOL, V23, P26, DOI 10.1097/ICU.0b013e32834cd5f8; YOSHIMOTO H, 1984, GRAEF ARCH CLIN EXP, V221, P276, DOI 10.1007/BF02134123	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95066	10.1371/journal.pone.0095066	http://dx.doi.org/10.1371/journal.pone.0095066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736274	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600138
J	Beck, MR; Hong, SL; van Lamsweerde, AE; Ericson, JM				Beck, Melissa R.; Hong, S. Lee; van Lamsweerde, Amanda E.; Ericson, Justin M.			The Effects of Incidentally Learned Temporal and Spatial Predictability on Response Times and Visual Fixations during Target Detection and Discrimination	PLOS ONE			English	Article							ORIENTING ATTENTION; INFORMATION; PROBABILITY; POTENTIALS; MODULATION; COMPONENTS; CONTEXT; MEMORY; SPACE; TASK	Responses are quicker to predictable stimuli than if the time and place of appearance is uncertain. Studies that manipulate target predictability often involve overt cues to speed up response times. However, less is known about whether individuals will exhibit faster response times when target predictability is embedded within the inter-trial relationships. The current research examined the combined effects of spatial and temporal target predictability on reaction time (RT) and allocation of overt attention in a sustained attention task. Participants responded as quickly as possible to stimuli while their RT and eye movements were measured. Target temporal and spatial predictability were manipulated by altering the number of: 1) different time intervals between a response and the next target; and 2) possible spatial locations of the target. The effects of target predictability on target detection (Experiment 1) and target discrimination (Experiment 2) were tested. For both experiments, shorter RTs as target predictability increased across both space and time were found. In addition, the influences of spatial and temporal target predictability on RT and the overt allocation of attention were task dependent; suggesting that effective orienting of attention relies on both spatial and temporal predictability. These results indicate that stimulus predictability can be increased without overt cues and detected purely through inter-trial relationships over the course of repeated stimulus presentations.	[Beck, Melissa R.; van Lamsweerde, Amanda E.; Ericson, Justin M.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Hong, S. Lee] Ohio Univ, Athens, OH 45701 USA	Louisiana State University System; Louisiana State University; University System of Ohio; Ohio University	Beck, MR (corresponding author), Louisiana State Univ, Baton Rouge, LA 70803 USA.	mbeck@lsu.edu; hongs@ohio.edu			Louisiana State University Faculty Research Grant; State of Louisiana Board of Regents support fund: Research Competitiveness Subprogram Grant	Louisiana State University Faculty Research Grant; State of Louisiana Board of Regents support fund: Research Competitiveness Subprogram Grant	This research was supported by a Louisiana State University Faculty Research Grant and a State of Louisiana Board of Regents support fund: Research Competitiveness Subprogram Grant to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2004, PSYCHOL SCI, V15, P460, DOI 10.1111/j.0956-7976.2004.00702.x; Beck MR, 2008, CONSCIOUS COGN, V17, P1192, DOI 10.1016/j.concog.2008.06.011; Capizzi M, 2013, NEUROPSYCHOLOGIA, V51, P326, DOI 10.1016/j.neuropsychologia.2012.10.005; CHELAZZI L, 1988, VISION RES, V28, P95, DOI 10.1016/0042-6989(88)90011-9; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Coull JT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000166; Coull JT, 1998, J NEUROSCI, V18, P7426; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fitts PM., 1967, HUM PERFORM; Geng JJ, 2002, PSYCHOL SCI, V13, P520, DOI 10.1111/1467-9280.00491; Girardi G, 2013, CORTEX, V49, P211, DOI 10.1016/j.cortex.2011.08.010; Griffin IC, 2002, NEUROPSYCHOLOGIA, V40, P2325, DOI 10.1016/S0028-3932(02)00087-8; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Jaffard M, 2007, BRAIN RES, V1179, P106, DOI 10.1016/j.brainres.2007.08.032; Jiang YH, 2001, J EXP PSYCHOL HUMAN, V27, P664, DOI 10.1037//0096-1523.27.3.664; Jimenez L., 2003, ATTENTION IMPLICIT L; JUOLA JF, 1991, J EXP PSYCHOL HUMAN, V17, P125, DOI 10.1037/0096-1523.17.1.125; Kahneman D., 1982, JUDGMENT UNCERTAINTY; KITTERLE FL, 1986, BRAIN COGNITION, V5, P131, DOI 10.1016/0278-2626(86)90052-7; KLEMMER ET, 1957, J EXP PSYCHOL, V54, P195, DOI 10.1037/h0046227; Lambert A, 2000, VIS COGN, V7, P545, DOI 10.1080/135062800407194; MacKay A, 2007, PERCEPT PSYCHOPHYS, V69, P972, DOI 10.3758/BF03193935; Marzi CA, 2006, NEUROPSYCHOLOGIA, V44, P1489, DOI 10.1016/j.neuropsychologia.2005.11.012; MARZI CA, 1981, DOC OPHTHALMOL, V30, P273; Milliken B, 2003, PSYCHON B REV, V10, P877, DOI 10.3758/BF03196547; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Wardak C, 2012, EUR J NEUROSCI, V36, P3568, DOI 10.1111/j.1460-9568.2012.08264.x; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94539	10.1371/journal.pone.0094539	http://dx.doi.org/10.1371/journal.pone.0094539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6GP	24732965	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400050
J	Kaswa, MK; Bisuta, S; Kabuya, G; Lunguya, O; Ndongosieme, A; Muyembe, JJ; Van Deun, A; Boelaert, M				Kaswa, Michel Kayomo; Bisuta, Serge; Kabuya, Georges; Lunguya, Octavie; Ndongosieme, Andre; Muyembe, Jean Jacques; Van Deun, Armand; Boelaert, Marleen			Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; AMPLIFICATION; MULTICENTER; INDICATOR; STRAINS; SYSTEM; TESTS; ASSAY; MGIT	Multidrug Resistant Tuberculosis (MDR-TB) is a serious threat which jeopardizes the worldwide efforts to control TB. The Democratic Republic of Congo (DRC) is one of 27 countries with a high burden of MDR-TB. Data on the magnitude, trends, and the distribution of MDR-TB in DRC are scanty. Kinshasa, the capital city of DRC which accounts for 20% of all TB cases nationwide, is notifying more than 80% of all MDR suspects. We report here a cluster of MDR-TB cases that was investigated in the Mosango health district, in the Bandundu south Province, DRC in 2008. Phenotypic Drug Sensitivity Testing and DNA sequencing were performed on 18 sputum specimens collected from 4 MDR-TB suspects and 5 household contacts. Sequencing data confirmed that the 4 suspects were indeed Rifampicin resistant cases. Sequencing of the rpoB gene showed that 3 cases (patients A, B and D) had a single mutation encoding a substitution to 526Tyr, 531Trp and 526Leu respectively. Patient C had a double mutation encoding a change to 531Leu and 633Leu. Two of the investigated cases died within 4 months of a second-line treatment course. Results highlight the need to enhance adequate laboratory services within the country for both clinical as well as surveillance purposes.	[Kaswa, Michel Kayomo; Bisuta, Serge; Kabuya, Georges; Ndongosieme, Andre] Natl TB Program, Kinshasa, DEM REP CONGO; [Kaswa, Michel Kayomo; Lunguya, Octavie; Muyembe, Jean Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Kaswa, Michel Kayomo; Van Deun, Armand; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium	Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM)	Kaswa, MK (corresponding author), Natl TB Program, Kinshasa, DEM REP CONGO.	Meckkay2002@yahoo.fr	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Kaswa, Michel/0000-0003-3260-7248	National TB Program; Global Fund to Fight AIDS, Tuberculosis and Malaria, 8 Chemin de Blandonnet, Vernier, Geneva, Switzerland	National TB Program; Global Fund to Fight AIDS, Tuberculosis and Malaria, 8 Chemin de Blandonnet, Vernier, Geneva, Switzerland	The field visit in Mosango Health District was funded by the National TB Program grant 5 supported by The Global Fund to Fight AIDS, Tuberculosis and Malaria, 8 Chemin de Blandonnet, 1214 Vernier, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET INFECT DIS, V11, P333, DOI 10.1016/S1473-3099(11)70105-0; [Anonymous], 2013, WHO GLOB TB REP 2013, P120; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bogard M, 2001, EUR J CLIN MICROBIOL, V20, P724, DOI 10.1007/s100960100565; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Lan NTN, 2001, INT J TUBERC LUNG D, V5, P575; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Ohno H, 1996, ANTIMICROB AGENTS CH, V40, P1053, DOI 10.1128/AAC.40.4.1053; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P364, DOI 10.1128/JCM.35.2.364-368.1997; Piersimoni C, 2002, J CLIN MICROBIOL, V40, P4138, DOI 10.1128/JCM.40.11.4138-4142.2002; Quezada CM, 2007, J CLIN MICROBIOL, V45, P3111, DOI 10.1128/JCM.00590-07; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rigouts L, 2007, J CLIN MICROBIOL, V45, P252, DOI 10.1128/JCM.01489-06; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schreiber YS, 2009, INT J TUBERC LUNG D, V13, P1274; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; Van Der Zanden AGM, 2003, J CLIN MICROBIOL, V41, P1101, DOI 10.1128/JCM.41.3.1101-1108.2003; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P23; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; *WHO, 2008, ANT DRUG RES WORLD; Yip CW, 2006, INT J TUBERC LUNG D, V10, P625	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94618	10.1371/journal.pone.0094618	http://dx.doi.org/10.1371/journal.pone.0094618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732233	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400058
J	Rubio, AE; Abraha, A; Carpenter, CA; Troyer, RM; Reyes-Rodriguez, AL; Salomon, H; Arts, EJ; Tebit, DM				Rubio, Andrea E.; Abraha, Awet; Carpenter, Crystal A.; Troyer, Ryan M.; Reyes-Rodriguez, Angel L.; Salomon, Horacio; Arts, Eric J.; Tebit, Denis M.			Similar Replicative Fitness Is Shared by the Subtype B and Unique BF Recombinant HIV-1 Isolates that Dominate the Epidemic in Argentina	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL DRUG-RESISTANCE; NEWLY-DIAGNOSED INDIVIDUALS; BUENOS-AIRES; SAO-PAULO; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; POL RECOMBINANTS; GROUP-O; IDENTIFICATION	The HIV-1 epidemic in South America is dominated by pure subtypes (mostly B and C) and more than 7 BF and BC recombinant forms. In Argentina, circulating recombinant forms (CRFs) comprised of subtypes B and F make up more than 50% of HIV infections. For this study, 28 HIV-1 primary isolates were obtained from patients in Buenos Aires, Argentina and initially classified into subtype B (n = 9, 32.1%), C (n = 1, 3.6%), and CRFs (n = 18, 64.3%) using partial pol and vpu-env sequences, which proved to be inconsistent and inaccurate for these phylogenetic analyses. Near full length genome sequences of these primary HIV-1 isolates revealed that nearly all intersubtype BF recombination sites were unique and countered previous "CRF'' B/F classifications. The majority of these Argentinean HIV-1 isolates were CCR5-using but 4 had a dual/mixed tropism as predicted by both phenotypic and genotypic assays. Comparison of the replicative fitness of these BF primary HIV-1 isolates to circulating B, F, and C HIV-1 using pairwise competitions in peripheral blood mononuclear cells (PBMCs) indicated a similarity in fitness of these BF recombinants to subtypes B and F HIV-1 (of the same co-receptor usage) whereas subtype C HIV-1 was significantly less fit than all as previously reported. These results suggest that the multitude of BF HIV-1 strains present within the Argentinean population do not appear to have gained replicative fitness following recent B and F recombination events.	[Rubio, Andrea E.; Salomon, Horacio] Univ Buenos Aires, Fac Med, Dept Microbiol, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Abraha, Awet; Carpenter, Crystal A.; Troyer, Ryan M.; Reyes-Rodriguez, Angel L.; Arts, Eric J.; Tebit, Denis M.] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA	University of Buenos Aires; Case Western Reserve University	Tebit, DM (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Myles Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22903 USA.	dmt6u@virginia.edu	Troyer, Ryan/ABE-2221-2021; Tebit, Denis/ABE-1824-2020	Troyer, Ryan/0000-0001-8908-5853; Tebit, Denis/0000-0002-4540-6245; Arts, Eric/0000-0002-4880-7968	NIAID, NIH [AI49170]; PICT-PRH from the National Scientific and Technical Research Agency (Argentina) [2008-120]; PIP from CONICET [11420090100254]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049170, P30AI036219, R56AI049170, R21AI049170] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PICT-PRH from the National Scientific and Technical Research Agency (Argentina); PIP from CONICET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, NIH grant AI49170, Grant PICT-PRH 2008-120 from the National Scientific and Technical Research Agency (Argentina), and PIP 11420090100254 from CONICET. All virus work was performed in the biosafety level 2 and 3 facilities of the Case Western Reserve University Hospitals Center for AIDS Research (AI36219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; ANDERSON R M, 1991; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Arts EJ, 2003, AIDS, V17, P780, DOI 10.1097/00002030-200303280-00026; Aulicino PC, 2007, AIDS RES HUM RETROV, V23, P1176, DOI 10.1089/aid.2007.0038; Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Avila MM, 2002, J ACQ IMMUN DEF SYND, V29, P422, DOI 10.1097/00126334-200204010-00015; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; Carobene MG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-107; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carrillo MG, 2002, AIDS RES HUM RETROV, V18, P477, DOI 10.1089/088922202317406619; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Coetzer M, 2006, VIROLOGY, V356, P95, DOI 10.1016/j.virol.2006.07.030; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Dilernia DA, 2011, AIDS RES HUM RETROV, V27, P569, DOI 10.1089/aid.2010.0118; Espinosa A, 2004, JAIDS-J ACQ IMM DEF, V36, P630, DOI 10.1097/00126334-200405010-00012; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gomez Carrillo Manuel, 1992, Revista Argentina de Microbiologia, V24, P91; Gomez-Carrillo M, 2006, AIDS RES HUM RETROV, V22, P1186, DOI 10.1089/aid.2006.22.1186; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; KARLSSON A, 1994, J INFECT DIS, V170, P1367, DOI 10.1093/infdis/170.6.1367; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Low AJ, 2008, AIDS REV, V10, P143; de Souza ACMF, 2008, AIDS RES HUM RETROV, V24, P1521, DOI 10.1089/aid.2008.0089; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; NKENGASONG JN, 1994, AIDS, V8, P1405, DOI 10.1097/00002030-199410000-00006; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-59; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Quinones-Mateu ME, 2002, J VIROL, V76, P9600, DOI 10.1128/JVI.76.19.9600-9613.2002; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Ruchansky D, 2009, AIDS RES HUM RETROV, V25, P351, DOI 10.1089/aid.2008.0248; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Tebit DM, 2007, AIDS REV, V9, P75; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Tebit DM, 2010, J VIROL, V84, P9817, DOI 10.1128/JVI.00991-10; Tebit DM, 2002, AIDS RES HUM RETROV, V18, P39, DOI 10.1089/088922202753394709; Temereanca A, 2013, J MED VIROL, V85, P1139, DOI 10.1002/jmv.23572; Thomson MM, 2000, AIDS, V14, P897, DOI 10.1097/00002030-200005050-00020; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Wang WH, 2008, AIDS RES HUM RETROV, V24, P1245, DOI 10.1089/aid.2008.0095; WOLFS TFW, 1990, P NATL ACAD SCI USA, V87, P9938, DOI 10.1073/pnas.87.24.9938	69	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92084	10.1371/journal.pone.0092084	http://dx.doi.org/10.1371/journal.pone.0092084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727861	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200008
J	Ruusuvuori, P; Paavolainen, L; Rutanen, K; Maki, A; Huttunen, H; Marjomaki, V				Ruusuvuori, Pekka; Paavolainen, Lassi; Rutanen, Kalle; Maki, Anita; Huttunen, Heikki; Marjomaki, Varpu			Quantitative Analysis of Dynamic Association in Live Biological Fluorescent Samples	PLOS ONE			English	Article							COLOCALIZATION; REGISTRATION; TRACKING; OBJECTS	Determining vesicle localization and association in live microscopy may be challenging due to non-simultaneous imaging of rapidly moving objects with two excitation channels. Besides errors due to movement of objects, imaging may also introduce shifting between the image channels, and traditional colocalization methods cannot handle such situations. Our approach to quantifying the association between tagged proteins is to use an object-based method where the exact match of object locations is not assumed. Point-pattern matching provides a measure of correspondence between two point-sets under various changes between the sets. Thus, it can be used for robust quantitative analysis of vesicle association between image channels. Results for a large set of synthetic images shows that the novel association method based on point-pattern matching demonstrates robust capability to detect association of closely located vesicles in live cell-microscopy where traditional colocalization methods fail to produce results. In addition, the method outperforms compared Iterated Closest Points registration method. Results for fixed and live experimental data shows the association method to perform comparably to traditional methods in colocalization studies for fixed cells and to perform favorably in association studies for live cells.	[Ruusuvuori, Pekka; Rutanen, Kalle; Huttunen, Heikki] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Ruusuvuori, Pekka; Paavolainen, Lassi; Maki, Anita; Marjomaki, Varpu] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla, Finland; [Paavolainen, Lassi] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland; [Rutanen, Kalle] Tampere Univ Technol, Dept Math, FIN-33101 Tampere, Finland	Tampere University; University of Jyvaskyla; University of Jyvaskyla; Tampere University	Ruusuvuori, P (corresponding author), Tampere Univ Technol, Pori, Finland.	pekka.ruusuvuori@tut.fi	Ruusuvuori, Pekka/AAC-2617-2022; Ruusuvuori, Pekka/C-9229-2016	Ruusuvuori, Pekka/0000-0001-9086-9591; Marjomaki, Varpu/0000-0002-4592-5926; Maki, Anita/0000-0003-2333-9480; Huttunen, Heikki/0000-0002-6571-0797	Academy of Finland [140052, 114727]	Academy of Finland(Academy of Finland)	The authors would like to thank Academy of Finland projects #140052 (PR), #114727 (VM) for funding (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiger D, 2010, PATTERN RECOGN, V43, P153, DOI 10.1016/j.patcog.2009.05.014; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boulanger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013190; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chessel A, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1747, DOI 10.1109/ISBI.2012.6235918; Chetverikov D, 2005, IMAGE VISION COMPUT, V23, P299, DOI 10.1016/j.imavis.2004.05.007; Cho MY, 2005, LECT NOTES COMPUT SC, V3608, P432; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dodgson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2813; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Goodrich MT, 1999, IEEE T PATTERN ANAL, V21, P371, DOI 10.1109/34.761267; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Villalta JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019031; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Lagache T, 2013, I S BIOMED IMAGING, P896; Lei Zhang, 2011, 2011 International Conference on 3D Imaging, Modeling, Processing, Visualization and Transmission (3DIMPVT), P80, DOI 10.1109/3DIMPVT.2011.18; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maneewongvatana S, 1999, CTR GEOM COMP 4 ANN; Paavolainen L, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P672, DOI 10.1109/ISBI.2012.6235637; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Ruusuvuori P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-248; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Van Wamelen PB, 2004, PATTERN RECOGN, V37, P1699, DOI 10.1016/j.patcog.2003.12.009; Weston DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036841; Worz S, 2010, IEEE T MED IMAGING, V29, P1474, DOI 10.1109/TMI.2010.2049857; Zhang B, 2008, I S BIOMED IMAGING, P1327	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94245	10.1371/journal.pone.0094245	http://dx.doi.org/10.1371/journal.pone.0094245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728133	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200051
J	van Rijt, WG; Secher, N; Keller, AK; Moldrup, U; Chynau, Y; Ploeg, RJ; van Goor, H; Norregaard, R; Birn, H; Frokiaer, J; Nielsen, S; Leuvenink, HGD; Jespersen, B				van Rijt, Willem G.; Secher, Niels; Keller, Anna K.; Moldrup, Ulla; Chynau, Yahor; Ploeg, Rutger J.; van Goor, Harry; Norregaard, Rikke; Birn, Henrik; Frokiaer, Jorgen; Nielsen, Soren; Leuvenink, Henri G. D.; Jespersen, Bente			alpha-Melanocyte Stimulating Hormone Treatment in Pigs Does Not Improve Early Graft Function in Kidney Transplants from Brain Dead Donors	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SODIUM TRANSPORTERS; DOWN-REGULATION; CARDIAC DEATH; RATS; ISCHEMIA; INJURY; ACTIVATION; EXPRESSION; RECEPTORS	Delayed graft function and primary non-function are serious complications following transplantation of kidneys derived from deceased brain dead (DBD) donors. alpha-melanocyte stimulating hormone (alpha-MSH) is a pleiotropic neuropeptide and its renoprotective effects have been demonstrated in models of acute kidney injury. We hypothesized that alpha-MSH treatment of the recipient improves early graft function and reduces inflammation following DBD kidney transplantation. Eight Danish landrace pigs served as DBD donors. After four hours of brain death both kidneys were removed and stored for 18 hours at 4 degrees C in Custodiol preservation solution. Sixteen recipients were randomized in a paired design into two treatment groups, transplanted simultaneously. alpha-MSH or a vehicle was administered at start of surgery, during reperfusion and two hours post-reperfusion. The recipients were observed for ten hours following reperfusion. Blood, urine and kidney tissue samples were collected during and at the end of follow-up. alpha-MSH treatment reduced urine flow and impaired recovery of glomerular filtration rate (GFR) compared to controls. After each dose of alpha-MSH, a trend towards reduced mean arterial blood pressure and increased heart rate was observed. alpha-MSH did not affect expression of inflammatory markers. Surprisingly, alpha-MSH impaired recovery of renal function in the first ten hours following DBD kidney transplantation possibly due to hemodynamic changes. Thus, in a porcine experimental model alpha-MSH did not reduce renal inflammation and did not improve short-term graft function following DBD kidney transplantation.	[van Rijt, Willem G.; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [Secher, Niels] Aarhus Univ Hosp, Dept Anesthesiol, DK-8000 Aarhus, Denmark; [Keller, Anna K.; Moldrup, Ulla; Chynau, Yahor] Aarhus Univ Hosp, Dept Urol, DK-8000 Aarhus, Denmark; [Ploeg, Rutger J.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [van Rijt, Willem G.; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Norregaard, Rikke] Aarhus Univ Hosp, Dept Clin Med, DK-8000 Aarhus, Denmark; [Birn, Henrik; Jespersen, Bente] Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark; [Birn, Henrik; Nielsen, Soren] Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, Aarhus, Denmark; [Frokiaer, Jorgen] Aarhus Univ, Dept Clin Med, Water & Salt Res Ctr, Aarhus, Denmark	University of Groningen; Aarhus University; Aarhus University; University of Oxford; University of Groningen; Aarhus University; Aarhus University; Aarhus University; Aarhus University	van Rijt, WG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands.	w.g.van.rijt@umcg.nl	Birn, Henrik/C-3931-2009	Birn, Henrik/0000-0003-3715-7266; Frokiaer, Jorgen/0000-0002-6206-8065; Secher, Niels/0000-0002-5207-9932; Norregaard, Rikke/0000-0002-0580-373X; Leuvenink, Henri/0000-0001-5036-2999; Norregaard, Rikke/0000-0002-1287-4181; Jespersen, Bente/0000-0001-7196-2870; van Goor, Harry/0000-0002-6670-1577	Aarhus University; Helen and Ejnar Bjornow Foundation; Danish kidney foundation; ESOT	Aarhus University; Helen and Ejnar Bjornow Foundation; Danish kidney foundation; ESOT	This study was supported by Aarhus University stipendium for W. G. van Rijt; Unrestricted grant from the Helen and Ejnar Bjornow Foundation; Unrestricted grant from the Danish kidney foundation; ESOT short stay and study grant - W. G. van Rijt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barklin A, 2008, ACTA ANAESTH SCAND, V52, P621, DOI 10.1111/j.1399-6576.2008.01607.x; Barlow AD, 2009, BRIT J SURG, V96, P685, DOI 10.1002/bjs.6607; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Chiao H, 1998, KIDNEY INT, V54, P765, DOI 10.1046/j.1523-1755.1998.00075.x; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; de Vries DK, 2011, AM J TRANSPLANT, V11, P1064, DOI 10.1111/j.1600-6143.2011.03466.x; DYSTERAAS HK, 1965, ACTA ENDOCRINOL-COP, V48, P609, DOI 10.1530/acta.0.0480609; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Hussein AAM, 2012, ACTA PHYSIOL, V204, P308, DOI 10.1111/j.1748-1716.2011.02372.x; Jensen AM, 2006, AM J PHYSIOL-RENAL, V291, pF1021, DOI 10.1152/ajprenal.00387.2005; Jo SK, 2001, NEPHROL DIAL TRANSPL, V16, P1583, DOI 10.1093/ndt/16.8.1583; Kohda Y, 1998, CURR OPIN NEPHROL HY, V7, P413, DOI 10.1097/00041552-199807000-00011; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF413, DOI 10.1152/ajprenal.1999.277.3.F413; Lee SY, 2004, TRANSPLANTATION, V78, P1756, DOI 10.1097/01.TP.0000144332.44435.AB; Lee YS, 2008, TRANSPL P, V40, P2142, DOI 10.1016/j.transproceed.2008.07.101; Li CL, 2006, AM J PHYSIOL-RENAL, V290, pF384, DOI 10.1152/ajprenal.00282.2004; Lindskog A, 2010, J AM SOC NEPHROL, V21, P1290, DOI 10.1681/ASN.2009101025; LLANOS AJ, 1983, PEDIATR RES, V17, P903, DOI 10.1203/00006450-198311000-00013; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Nijboer WN, 2004, TRANSPLANTATION, V78, P978, DOI 10.1097/01.TP.0000135565.49535.60; Rahmel A, 2012, ANN REPORT 2012; Rinne P, 2013, CARDIOVASC RES, V97, P360, DOI 10.1093/cvr/cvs335; Rinne P, 2012, PEPTIDES, V38, P150, DOI 10.1016/j.peptides.2012.09.004; Simmons MN, 2010, J UROLOGY, V183, P1625, DOI 10.1016/j.juro.2009.12.007; Snoeijs MGJ, 2010, TRANSPLANTATION, V90, P1106, DOI 10.1097/TP.0b013e3181f83b0b; Soendergaard P, 2012, TRANSPL INT, V25, P1002, DOI 10.1111/j.1432-2277.2012.01522.x; Spaccapelo L, 2011, EUR J PHARMACOL, V670, P479, DOI 10.1016/j.ejphar.2011.09.015; van der Hoeven JAB, 2003, KIDNEY INT, V64, P1874, DOI 10.1046/j.1523-1755.2003.00272.x; van Werkhoven MB, 2013, AM J TRANSPLANT, V13, P875, DOI 10.1111/ajt.12130; VanBergen P, 1997, BRIT J PHARMACOL, V120, P1561, DOI 10.1038/sj.bjp.0701065; Wadei HM, 2013, TRANSPLANTATION, V96, P274, DOI 10.1097/TP.0b013e31829807d1; Watts RP, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/521369	34	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94609	10.1371/journal.pone.0094609	http://dx.doi.org/10.1371/journal.pone.0094609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728087	gold, Green Submitted, Green Published			2022-12-25	WOS:000336736200107
J	Ishikawa, KI; Saiki, S; Furuya, N; Yamada, D; Imamichi, Y; Li, YZ; Kawajiri, S; Sasaki, H; Koike, M; Tsuboi, Y; Hattori, N				Ishikawa, Kei-Ichi; Saiki, Shinji; Furuya, Norihiko; Yamada, Daisuke; Imamichi, Yoko; Li, Yuanzhe; Kawajiri, Sumihiro; Sasaki, Hironori; Koike, Masato; Tsuboi, Yoshio; Hattori, Nobutaka			p150(glued)-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; NEURODEGENERATIVE DISEASES; CYTOPLASMIC DYNEIN; MUTANT DYNACTIN; PERRY SYNDROME; G59S MUTATION; TRANSPORT; EXCITOTOXICITY; DEGENERATION; MITOCHONDRIA	Mutations in p150(glued) cause hereditary motor neuropathy with vocal cord paralysis (HMN7B) and Perry syndrome (PS). Here we show that both overexpression of p150(glued) mutants and knockdown of endogenous p150(glued) induce apoptosis. Overexpression of a p150(glued) plasmid containing either a HMN7B or PS mutation resulted in cytoplasmic p150(glued)-positive aggregates and was associated with cell death. Cells containing mutant p150(glued) aggregates underwent apoptosis that was characterized by an increase in cleaved caspase-3- or Annexin V-positive cells and was attenuated by both zVAD-fmk (a pan-caspase inhibitor) application and caspase-3 siRNA knockdown. In addition, overexpression of mutant p150(glued) decreased mitochondrial membrane potentials and increased levels of translocase of the mitochondrial outer membrane (Tom20) protein, indicating accumulation of damaged mitochondria. Importantly, siRNA knockdown of endogenous p150(glued) independently induced apoptosis via caspase-8 activation and was not associated with mitochondrial morphological changes. Simultaneous knockdown of endogenous p150(glued) and overexpression of mutant p150(glued) had additive apoptosis induction effects. These findings suggest that both p150(glued) gain-of-toxic-function and loss-of-physiological-function can cause apoptosis and may underlie the pathogenesis of p150(glued)-associated disorders.	[Ishikawa, Kei-Ichi; Saiki, Shinji; Furuya, Norihiko; Yamada, Daisuke; Imamichi, Yoko; Li, Yuanzhe; Kawajiri, Sumihiro; Sasaki, Hironori; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Furuya, Norihiko; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo 113, Japan; [Koike, Masato] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan; [Tsuboi, Yoshio] Fukuoka Univ, Sch Med, Dept Neurol, Fukuoka 81401, Japan	Juntendo University; Juntendo University; Juntendo University; Fukuoka University	Hattori, N (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan.	nhattori@juntendo.ac.jp	Saiki, Shinji/ABC-8214-2021; Hattori, Nobutaka/ACR-0069-2022; Furuya, Norihiko/K-7299-2015; Koike, Masato/F-9584-2010; Ishikawa, Kei-Ichi/AAV-9045-2021	Saiki, Shinji/0000-0002-9732-8488; Furuya, Norihiko/0000-0001-7695-4271; Koike, Masato/0000-0002-3174-5684; Ishikawa, Kei-ichi/0000-0003-2305-301X	Japanese Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Life Science Foundation; Takeda Scientific Foundation; Cell Science Research Foundation; Nakajima Foundation; Grants-in-Aid for Scientific Research [25111001] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Life Science Foundation; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Nakajima Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful for these 9 grants: the Grant from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html) (N.H.), the Grant-in-Aid for Young Scientists (A) (S. S.), the Grant-in-Aid for Scientific Research (C) (N.F.), the Grant-in-Aid for Challenging Exploratory Research (S. S.) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/index.html), Grant-in-Aid for Scientific Research on Priority Areas (S. S.) from Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm), and grants from the Life Science Foundation (http://www.lifesci-found.com/), the Takeda Scientific Foundation (http://www.takeda-sci.or.jp/), the Cell Science Research Foundation (http://www.shionogi.co.jp/zaidan/), and the Nakajima Foundation (http://www.nakajimafound.or.jp/index.html) (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Fujiwara T, 2012, BIOCHEM BIOPH RES CO, V424, P82, DOI 10.1016/j.bbrc.2012.06.071; Fujiwara T, 2012, J NEUROCHEM, V122, P162, DOI 10.1111/j.1471-4159.2012.07746.x; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lipka J, 2013, BIOCHEM SOC T, V41, P1605, DOI 10.1042/BST20130188; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Morlino G, 2014, MOL CELL BIOL; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Schwarz TL, 2013, COLD SPRING HARB PER, V5; Stockmann M, 2013, J NEURAL TRANSM, V120, P785, DOI 10.1007/s00702-012-0910-z; van der Bliek AM, 2013, COLD SPRING HARB PER, V5; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Wider C, 2008, PARKINSONISM RELAT D, V14, P1, DOI 10.1016/j.parkreldis.2007.07.014; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	30	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94645	10.1371/journal.pone.0094645	http://dx.doi.org/10.1371/journal.pone.0094645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722468	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100113
J	Sterling, JT; Springer, AM; Iverson, SJ; Johnson, SP; Pelland, NA; Johnson, DS; Lea, MA; Bond, NA				Sterling, Jeremy T.; Springer, Alan M.; Iverson, Sara J.; Johnson, Shawn P.; Pelland, Noel A.; Johnson, Devin S.; Lea, Mary-Anne; Bond, Nicholas A.			The Sun, Moon, Wind, and Biological Imperative-Shaping Contrasting Wintertime Migration and Foraging Strategies of Adult Male and Female Northern Fur Seals (Callorhinus ursinus)	PLOS ONE			English	Article							MIXED-LAYER DEPTH; ARCTOCEPHALUS-GAZELLA; ZOOPLANKTON DISTRIBUTION; SEXUAL SEGREGATION; VERTICAL MIGRATION; MARINE PREDATOR; ELEPHANT SEALS; COASTAL ORIGIN; PACIFIC EDDY; NE PACIFIC	Adult male and female northern fur seals (Callorhinus ursinus) are sexually segregated in different regions of the North Pacific Ocean and Bering Sea during their winter migration. Explanations for this involve interplay between physiology, predator-prey dynamics, and ecosystem characteristics, however possible mechanisms lack empirical support. To investigate factors influencing the winter ecology of both sexes, we deployed five satellite-linked conductivity, temperature, and depth data loggers on adult males, and six satellite-linked depth data loggers and four satellite transmitters on adult females from St. Paul Island (Bering Sea, Alaska, USA) in October 2009. Males and females migrated to different regions of the North Pacific Ocean: males wintered in the Bering Sea and northern North Pacific Ocean, while females migrated to the Gulf of Alaska and California Current. Horizontal and vertical movement behaviors of both sexes were influenced by wind speed, season, light (sun and moon), and the ecosystem they occupied, although the expression of the behaviors differed between sexes. Male dive depths were aligned with the depth of the mixed layer during daylight periods and we suspect this was the case for females upon their arrival to the California Current. We suggest that females, because of their smaller size and physiological limitations, must avoid severe winters typical of the northern North Pacific Ocean and Bering Sea and migrate long distances to areas of more benign environmental conditions and where prey is shallower and more accessible. In contrast, males can better tolerate often extreme winter ocean conditions and exploit prey at depth because of their greater size and physiological capabilities. We believe these contrasting winter behaviors 1) are a consequence of evolutionary selection for large size in males, important to the acquisition and defense of territories against rivals during the breeding season, and 2) ease environmental/physiological constraints imposed on smaller females.	[Sterling, Jeremy T.; Johnson, Devin S.] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Springer, Alan M.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA; [Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Johnson, Shawn P.] Johnson Vet Serv, Marine Mammal Ctr, Sausalito, CA USA; [Pelland, Noel A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Lea, Mary-Anne] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bond, Nicholas A.] Univ Washington, JISAO, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; Dalhousie University; University of Washington; University of Washington Seattle; University of Tasmania; University of Washington; University of Washington Seattle	Sterling, JT (corresponding author), NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Jeremy.Sterling@noaa.gov	Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299; Iverson, Sara/0000-0003-2842-4094	NOAA's Undersea Research Program; NOAA's National Cooperative Research Program	NOAA's Undersea Research Program; NOAA's National Cooperative Research Program	Principal financial support for this study was provided by NOAA's Undersea Research Program (http://www.nurp.noaa.gov). Additional crucial support was provided by the National Marine Fisheries Service (http://www.nmfs.noaa.gov), Alaska Sea Life Center (http://www.alaskasealife.org), and the TEMPEST project funded by NOAA's National Cooperative Research Program (http://www.st.nmfs.noaa.gov/ cooperative-research/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JC, 2006, J COASTAL RES, V22, P511, DOI 10.2112/03-0108.1; [Anonymous], 2004, MARINE FISHERIES REV; Atwood E, 2010, FISH OCEANOGR, V19, P493, DOI 10.1111/j.1365-2419.2010.00559.x; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Bigg DM, 1987, KILLER WHALES STUDY; Bigg MA, 1990, CANADIAN TECHNICAL R; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Crawford W, 2007, PROG OCEANOGR, V75, P161, DOI 10.1016/j.pocean.2007.08.017; Dalton AJM, MARINE MAMM IN PRESS; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Frost B, 1979, FISHERY B, V76, P717; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Graham NE, 2001, B AM METEOROL SOC, V82, P1869, DOI 10.1175/1520-0477(2001)082<1869:EFIONP>2.3.CO;2; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Hindell MA, 2000, PHYSIOL BIOCHEM ZOOL, V73, P790, DOI 10.1086/318104; Hooper CL, 1895, REPORT HOOPER DATED, P228; ISAACS JD, 1974, DEEP-SEA RES, V21, P651, DOI 10.1016/0011-7471(74)90049-7; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Jordan David Starr, 1898, FUR SEALS FUR SEAL I; Kajimura H, 1984, SSRF779 NOAA NMFS, P49; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Ladd C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001157; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Le Boeuf Burney J., 1994, P237; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; Loughlin TR, 1999, DYNAMICS BERING SEA, P615; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mackas DL, 2002, J OCEANOGR, V58, P725, DOI 10.1023/A:1022802625242; MCGOWAN J A, 1973, Journal of Experimental Marine Biology and Ecology, V12, P187, DOI 10.1016/0022-0981(73)90013-0; Nesis KN, 1997, ADV MAR BIOL, V32, P243; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; PEARCY WG, 1977, DEEP-SEA RES, V24, P223, DOI 10.1016/S0146-6291(77)80002-7; PEREZ MA, 1986, FISH B-NOAA, V84, P957; Peterson R.S., 1965, THESIS J HOPKINS U; Pinheiro J., 2008, LINEAR NONLINEAR MIX; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Roper FE, 1975, VERTICAL DISTRIBUTIO; Rosen DAS, MARINE MAMM IN PRESS; Rutishauser MR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P669, DOI 10.1086/421749; SCHEFFER VB, 1953, GROWTH, V17, P129; Schumacher J.D., 1994, Fisheries Oceanography, V3, P182, DOI 10.1111/j.1365-2419.1994.tb00095.x; Schumacher JD, P 5 N PAC RIM FISH C; Sherman K, 2007, NMFSNE208 NOAA; Sherman K., 1992, LARGE MARINE ECOSYST; Spalding DJ, 1964, B FISHERIES RES BOAR, V146, P52; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Sterling J.T., 2009, NO SEAL FORAGING BEH; Stewart BS, 1997, J MAMMAL, V78, P1101, DOI 10.2307/1383053; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; TABATA S, 1978, J PHYS OCEANOGR, V8, P970, DOI 10.1175/1520-0485(1978)008<0970:AEOTQO>2.0.CO;2; Tont S. A., 1976, CALIFORNIA COOPERATI, V18, P112, DOI DOI 10.1046/J.1365-2419.1999.00103.X.; Towell RG, 2008, NMFSAFSC188 NOAA, P8; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Villegas-Amtmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023166; Watanabe H, 2006, MAR ECOL PROG SER, V315, P187, DOI 10.3354/meps315187; Weise MJ, 2007, J EXP BIOL, V210, P278, DOI 10.1242/jeb.02643; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whitehead H., 2003, SPERM WHALES SOCIAL	74	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93068	10.1371/journal.pone.0093068	http://dx.doi.org/10.1371/journal.pone.0093068			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722344	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100013
J	Gho, JMIH; van Es, R; Stathonikos, N; Harakalova, M; te Rijdt, WP; Suurmeijer, AJH; van der Heijden, JF; de Jonge, N; Chamuleau, SAJ; de Weger, RA; Asselbergs, FW; Vink, A				Gho, Johannes M. I. H.; van Es, Rene; Stathonikos, Nikolas; Harakalova, Magdalena; te Rijdt, Wouter P.; Suurmeijer, Albert J. H.; van der Heijden, Jeroen F.; de Jonge, Nicolaas; Chamuleau, Steven A. J.; de Weger, Roel A.; Asselbergs, Folkert W.; Vink, Aryan			High Resolution Systematic Digital Histological Quantification of Cardiac Fibrosis and Adipose Tissue in Phospholamban p.Arg14del Mutation Associated Cardiomyopathy	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; CARDIOVASCULAR MAGNETIC-RESONANCE; DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; CRITERIA; THERAPY; BIOPSY; LETHAL	Myocardial fibrosis can lead to heart failure and act as a substrate for cardiac arrhythmias. In dilated cardiomyopathy diffuse interstitial reactive fibrosis can be observed, whereas arrhythmogenic cardiomyopathy is characterized by fibrofatty replacement in predominantly the right ventricle. The p.Arg14del mutation in the phospholamban (PLN) gene has been associated with dilated cardiomyopathy and recently also with arrhythmogenic cardiomyopathy. Aim of the present study is to determine the exact pattern of fibrosis and fatty replacement in PLN p.Arg14del mutation positive patients, with a novel method for high resolution systematic digital histological quantification of fibrosis and fatty tissue in cardiac tissue. Transversal mid-ventricular slices (n = 8) from whole hearts were collected from patients with the PLN p.Arg14del mutation (age 48616 years; 4 (50%) male). An in-house developed open source MATLAB script was used for digital analysis of Masson's trichrome stained slides (http://sourceforge.net/projects/fibroquant/). Slides were divided into trabecular, inner and outer compact myocardium. Per region the percentage of connective tissue, cardiomyocytes and fatty tissue was quantified. In PLN p.Arg14del mutation associated cardiomyopathy, myocardial fibrosis is predominantly present in the left posterolateral wall and to a lesser extent in the right ventricular wall, whereas fatty changes are more pronounced in the right ventricular wall. No difference in distribution pattern of fibrosis and adipocytes was observed between patients with a clinical predominantly dilated and arrhythmogenic cardiomyopathy phenotype. In the future, this novel method for quantifying fibrosis and fatty tissue can be used to assess cardiac fibrosis and fatty tissue in animal models and a broad range of human cardiomyopathies.	[Gho, Johannes M. I. H.; van Es, Rene; Harakalova, Magdalena; van der Heijden, Jeroen F.; de Jonge, Nicolaas; Chamuleau, Steven A. J.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Stathonikos, Nikolas; Harakalova, Magdalena; de Weger, Roel A.; Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [te Rijdt, Wouter P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Suurmeijer, Albert J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of London; University College London	Vink, A (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	a.vink@umcutrecht.nl	van der Heijden, Jeroen/AAA-1352-2021; Asselbergs, Folkert W./ABD-6752-2021	Asselbergs, Folkert W./0000-0002-1692-8669; Chamuleau, Steven/0000-0002-9952-6701; van Es, Rene/0000-0001-9950-4388; Suurmeijer, Albert/0000-0003-1361-9454	Stichting Genetische Hartspierziekte PLN (Middenmeer, the Netherlands); BioMedical Materials Institute [P1.04 SMARTCARE]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; UCL Hospitals NIHR Biomedical Research Centre	Stichting Genetische Hartspierziekte PLN (Middenmeer, the Netherlands); BioMedical Materials Institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; UCL Hospitals NIHR Biomedical Research Centre	This work was supported by "Stichting Genetische Hartspierziekte PLN" (http://stichtingpln.nl, Middenmeer, the Netherlands). This research also forms part of the Project P1.04 SMARTCARE of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Nederlandse Hartstichting is gratefully acknowledged. Folkert W. Asselbergs is supported by UCL Hospitals NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso C, 2008, EUR HEART J, V29, P2760, DOI 10.1093/eurheartj/ehn415; Basso C, 2012, NAT REV CARDIOL, V9, P223, DOI 10.1038/nrcardio.2011.173; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; de Jong S, 2012, NETH HEART J, V20, P44, DOI 10.1007/s12471-011-0226-x; Elnakish MT, 2013, J PATHOL, V229, P347, DOI 10.1002/path.4111; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Gho JMIH, 2013, J CARD FAIL, V19, P494, DOI 10.1016/j.cardfail.2013.05.006; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Huisman A, 2010, HUM PATHOL, V41, P751, DOI 10.1016/j.humpath.2009.08.026; Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260; Koudstaal S, 2014, J VIS EXP IN PRESS; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Masci PG, 2012, INT J CARDIOL, V157, P43, DOI 10.1016/j.ijcard.2010.11.005; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; Osman OS, 2013, ADIPOCYTE, V2, P160, DOI 10.4161/adip.24652; Pop M, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5009; Pratt WK, 2007, DIGITAL IMAGE PROCES, Vxix; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schalla S, 2010, EUR J HEART FAIL, V12, P227, DOI 10.1093/eurjhf/hfq004; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Te Riele ASJM, 2013, J CARDIOVASC ELECTR, V24, P1311, DOI 10.1111/jce.12222; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158	31	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94820	10.1371/journal.pone.0094820	http://dx.doi.org/10.1371/journal.pone.0094820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732829	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400114
J	Weiterer, S; Uhle, F; Bhuju, S; Jarek, M; Weigand, MA; Bartkuhn, M				Weiterer, Sebastian; Uhle, Florian; Bhuju, Sabin; Jarek, Michael; Weigand, Markus A.; Bartkuhn, Marek			From Human Monocytes to Genome-Wide Binding Sites A Protocol for Small Amounts of Blood: Monocyte Isolation/ChIP-Protocol/Library Amplification/Genome Wide Computational Data Analysis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CHIP-SEQ; DENDRITIC CELLS; CHROMATIN; INFECTION; SEPSIS; IMMUNOSUPPRESSION; TRANSCRIPTION; RECEPTOR; GENES	Chromatin immunoprecipitation in combination with a genome-wide analysis via high-throughput sequencing is the state of the art method to gain genome-wide representation of histone modification or transcription factor binding profiles. However, chromatin immunoprecipitation analysis in the context of human experimental samples is limited, especially in the case of blood cells. The typically extremely low yields of precipitated DNA are usually not compatible with library amplification for next generation sequencing. We developed a highly reproducible protocol to present a guideline from the first step of isolating monocytes from a blood sample to analyse the distribution of histone modifications in a genome-wide manner. Conclusion: The protocol describes the whole work flow from isolating monocytes from human blood samples followed by a high-sensitivity and small-scale chromatin immunoprecipitation assay with guidance for generating libraries compatible with next generation sequencing from small amounts of immunoprecipitated DNA.	[Weiterer, Sebastian; Uhle, Florian; Weigand, Markus A.] Univ Giessen, Dept Anesthesiol & Intens Care Med, D-35390 Giessen, Germany; [Weiterer, Sebastian; Weigand, Markus A.] German Ctr Infect Res DZIF, Giessen, Germany; [Bhuju, Sabin; Jarek, Michael] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany	Justus Liebig University Giessen; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Justus Liebig University Giessen	Bartkuhn, M (corresponding author), Univ Giessen, Inst Genet, D-35390 Giessen, Germany.	Marek.Bartkuhn@gen.bio.uni-giessen.de	Uhle, Florian/Q-6191-2019	Bartkuhn, Marek/0000-0001-6872-9082	German Centre for Infection Research (DZIF)	German Centre for Infection Research (DZIF)	This project was supported by a Clinical Leave grant by German Centre for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyoun P., HPAML GENOMICRANGES; Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Carlson M. HP, GENOMICFEATURES TOOL; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Deepayan Sarkar RG, CHIPSEQ CHIPSEQ PACK; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139; Fernandez-Real JM, 2003, J CLIN ENDOCR METAB, V88, P1780, DOI 10.1210/jc.2002-020173; Giamarellos-Bourboulis EJ, 2012, EXPERT REV ANTI-INFE, V10, P369, DOI [10.1586/eri.12.2, 10.1586/ERI.12.2]; Giamarellos-Bourboulis EJ, 2010, INT J ANTIMICROB AG, V36, pS2, DOI 10.1016/j.ijantimicag.2010.11.003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mokart D, 2011, MINERVA ANESTESIOL, V77, P522; Monneret G, 2011, PATHOL BIOL, V59, P329, DOI 10.1016/j.patbio.2011.02.001; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94164	10.1371/journal.pone.0094164	http://dx.doi.org/10.1371/journal.pone.0094164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732314	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400021
J	Zhang, WP; Bougouffa, S; Wang, Y; Lee, OO; Yang, JK; Chan, C; Song, XY; Qian, PY				Zhang, Weipeng; Bougouffa, Salim; Wang, Yong; Lee, On On; Yang, Jiangke; Chan, Colin; Song, Xingyu; Qian, Pei-Yuan			Toward Understanding the Dynamics of Microbial Communities in an Estuarine System	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ANAEROBIC AMMONIUM OXIDATION; PEARL RIVER ESTUARY; GEN. NOV.; BACTERIA; SEDIMENTS; NUTRIENTS; SEQUENCES; LAKE	Community assembly theories such as species sorting theory provide a framework for understanding the structures and dynamics of local communities. The effect of theoretical mechanisms can vary with the scales of observation and effects of specific environmental factors. Based on 16S rRNA gene tag pyrosequencing, different structures and temporal succession patterns were discovered between the surface sediments and bottom water microbial communities in the Pearl River Estuary (PRE). The microbial communities in the surface sediment samples were more diverse than those in the bottom water samples, and several genera were specific for the water or sediment communities. Moreover, water temperature was identified as the main variable driving community dynamics and the microbial communities in the sediment showed a greater temporal change. We speculate that nutrient-based species sorting and bacterial plasticity to the temperature contribute to the variations observed between sediment and water communities in the PRE. This study provides a more comprehensive understanding of the microbial community structures in a highly dynamic estuarine system and sheds light on the applicability of ecological theoretical mechanisms.	[Zhang, Weipeng; Bougouffa, Salim; Wang, Yong; Lee, On On; Yang, Jiangke; Chan, Colin; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Partnership Program, Hong Kong, Hong Kong, Peoples R China; [Wang, Yong; Song, Xingyu; Qian, Pei-Yuan] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China; Chinese Acad Sci, South China Sea Inst Oceanol, CAS SAFEA Int Partnership Program Creat Res Teams, Beijing 100864, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Partnership Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Bougouffa, Salim/AAG-8976-2020	Bougouffa, Salim/0000-0001-9218-6452; wang, yong/0000-0003-3595-3867; Qian, Pei-Yuan/0000-0003-4074-9078	National Basic Research Program of China (973 Program) [2012CB417304]; COMAR program of China [COMRRDA12SC02]; Sanya Institute of Deep Sea Science and Engineering [SIDSSE-201206, SIDSSE-BR-201303, SIDSSE-201305]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); COMAR program of China; Sanya Institute of Deep Sea Science and Engineering; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by the National Basic Research Program of China (973 Program, No. 2012CB417304), COMAR program of China (COMRRDA12SC02) and awards from the Sanya Institute of Deep Sea Science and Engineering (SIDSSE-201206, SIDSSE-BR-201303 and SIDSSE-201305) and the King Abdullah University of Science and Technology (SA-C0040/UK-C0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen MC, 2002, BIODIVERS CONSERV, V11, P113, DOI 10.1023/A:1014098917535; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Huang XP, 2003, MAR POLLUT BULL, V47, P30, DOI 10.1016/S0025-326X(02)00474-5; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Kirkwood DS, 1996, MAR POLLUT BULL, V32, P640, DOI 10.1016/0025-326X(96)00076-8; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li RG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2401; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luo XJ, 2006, ENVIRON POLLUT, V139, P9, DOI 10.1016/j.envpol.2005.05.001; Mai BX, 2001, APPL GEOCHEM, V16, P1429; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021541; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Risgaard-Petersen N, 2004, APPL ENVIRON MICROB, V70, P5528, DOI 10.1128/AEM.70.9.5528-5537.2004; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinbauer MG, 1998, APPL ENVIRON MICROB, V64, P5000; Wilkinson L., 1992, SYSTAT WINDOWS STAT; Wu GJ, 2013, EXTREMOPHILES, V17, P809, DOI 10.1007/s00792-013-0562-4; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Yong YC, 2013, PROCESS BIOCHEM, V48, P1947, DOI 10.1016/j.procbio.2013.09.008	43	20	24	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94449	10.1371/journal.pone.0094449	http://dx.doi.org/10.1371/journal.pone.0094449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732211	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400038
J	Goodin, DS; Khankhanian, P				Goodin, Douglas S.; Khankhanian, Pouya			Single Nucleotide Polymorphism (SNP)-Strings: An Alternative Method for Assessing Genetic Associations	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; HAPLOTYPE FREQUENCIES; SUSCEPTIBILITY; METAANALYSIS; THOUSANDS; INFERENCE; RISK	Background: Genome-wide association studies (GWAS) identify disease-associations for single-nucleotide-polymorphisms (SNPs) from scattered genomic-locations. However, SNPs frequently reside on several different SNP-haplotypes, only some of which may be disease-associated. This circumstance lowers the observed odds-ratio for disease-association. Methodology/Principal Findings: Here we develop a method to identify the two SNP-haplotypes, which combine to produce each person's SNP-genotype over specified chromosomal segments. Two multiple sclerosis (MS)-associated genetic regions were modeled; DRB1 (a Class II molecule of the major histocompatibility complex) and MMEL1 (an endopeptidase that degrades both neuropeptides and beta-amyloid). For each locus, we considered sets of eleven adjacent SNPs, surrounding the putative disease-associated gene and spanning similar to 200 kb of DNA. The SNP-information was converted into an ordered-set of eleven-numbers (subject-vectors) based on whether a person had zero, one, or two copies of particular SNP-variant at each sequential SNP-location. SNP-strings were defined as those ordered-combinations of eleven-numbers (0 or 1), representing a haplotype, two of which combined to form the observed subject-vector. Subject-vectors were resolved using probabilistic methods. In both regions, only a small number of SNP-strings were present. We compared our method to the SHAPEIT-2 phasing-algorithm. When the SNP-information spanning 200 kb was used, SHAPEIT-2 was inaccurate. When the SHAPEIT-2 window was increased to 2,000 kb, the concordance between the two methods, in both of these eleven-SNP regions, was over 99%, suggesting that, in these regions, both methods were quite accurate. Nevertheless, correspondence was not uniformly high over the entire DNA-span but, rather, was characterized by alternating peaks and valleys of concordance. Moreover, in the valleys of poor-correspondence, SHAPEIT-2 was also inconsistent with itself, suggesting that the SNP-string method is more accurate across the entire region. Conclusions/Significance: Accurate haplotype identification will enhance the detection of genetic-associations. The SNP-string method provides a simple means to accomplish this and can be extended to cover larger genomic regions, thereby improving a GWAS's power, even for those published previously.	[Goodin, Douglas S.; Khankhanian, Pouya] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Goodin, Douglas S.; Khankhanian, Pouya] Univ Calif San Francisco, UCSF Multiple Sclerosis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu						Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2010, GENES IMMUN, V11, P660, DOI 10.1038/gene.2010.36; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2006, MCALPINES MULTIPLE S, V4th; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Goodin DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047875; Goodin DS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-101; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Muller CR, 2003, HUM IMMUNOL, V64, P137, DOI 10.1016/S0198-8859(02)00706-1; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e90034	10.1371/journal.pone.0090034	http://dx.doi.org/10.1371/journal.pone.0090034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727690	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200004
J	Wang, AL; Fu, MC; Jiang, XQ; Mao, YH; Li, XC; Tao, SH				Wang, Ailan; Fu, Mingchuan; Jiang, Xiaoqian; Mao, Yuanhui; Li, Xiangchen; Tao, Shiheng			Evolution of the F-Box Gene Family in Euarchontoglires: Gene Number Variation and Selection Patterns	PLOS ONE			English	Article							PROTEIN; SEQUENCE; IDENTIFICATION; COMPLEX; DUPLICATIONS; INTERPROSCAN; RECOGNITION; DIVERGENCE; DIVERSITY; ALIGNMENT	F-box proteins are substrate adaptors used by the SKP1-CUL1-F-box protein (SCF) complex, a type of E3 ubiquitin ligase complex in the ubiquitin proteasome system (UPS). SCF-mediated ubiquitylation regulates proteolysis of hundreds of cellular proteins involved in key signaling and disease systems. However, our knowledge of the evolution of the F-box gene family in Euarchontoglires is limited. In the present study, 559 F-box genes and nine related pseudogenes were identified in eight genomes. Lineage-specific gene gain and loss events occurred during the evolution of Euarchontoglires, resulting in varying F-box gene numbers ranging from 66 to 81 among the eight species. Both tandem duplication and retrotransposition were found to have contributed to the increase of F-box gene number, whereas mutation in the F-box domain was the main mechanism responsible for reduction in the number of F-box genes, resulting in a balance of expansion and contraction in the F-box gene family. Thus, the Euarchontoglire F-box gene family evolved under a birth-and-death model. Signatures of positive selection were detected in substrate-recognizing domains of multiple F-box proteins, and adaptive changes played a role in evolution of the Euarchontoglire F-box gene family. In addition, single nucleotide polymorphism (SNP) distributions were found to be highly non-random among different regions of F-box genes in 1092 human individuals, with domain regions having a significantly lower number of non-synonymous SNPs.	[Wang, Ailan; Fu, Mingchuan; Jiang, Xiaoqian; Mao, Yuanhui; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Ailan; Fu, Mingchuan; Jiang, Xiaoqian; Mao, Yuanhui; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wang, Ailan; Fu, Mingchuan; Jiang, Xiaoqian; Mao, Yuanhui; Li, Xiangchen; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn		Wang, Ailan/0000-0002-1329-017X	National Natural Science Fund Program of China [31271917]	National Natural Science Fund Program of China(National Natural Science Foundation of China (NSFC))	The work was the project from National Natural Science Fund Program of China (31271917) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bellieny-Rabelo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055127; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HEIM MH, 1992, GENOMICS, V14, P49, DOI 10.1016/S0888-7543(05)80282-4; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim HS, 2002, PLANT CELL, V14, P1469, DOI 10.1105/tpc.001867; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li An, 2011, Shengwu Duoyangxing, V19, P3, DOI 10.3724/SP.J.1003.2011.14256; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lufkin T, 2005, ENCY HUMAN GENOME; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mohrenweiser Harvey, 1996, Cytogenetics and Cell Genetics, V74, P161, DOI 10.1159/000134408; Navarro-Quezada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068672; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ohno S., 1967, SEX CHROMOSOMES SEX; OHTA T, 1990, THEOR POPUL BIOL, V37, P213, DOI 10.1016/0040-5809(90)90036-U; Ohta T, 2008, ENCY HUMAN GENOME; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schumann N, 2011, PLANT PHYSIOL, V155, P835, DOI 10.1104/pp.110.166579; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Wang A, 2012, SNPS IDENTIFICATION, P181; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeats CA, 2007, ENCY HUMAN GENOME; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	64	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94899	10.1371/journal.pone.0094899	http://dx.doi.org/10.1371/journal.pone.0094899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727786	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200140
J	Zhao, YL; Chen, R; Wang, B; Wu, T; Huang, YF; Guo, AM				Zhao, Yali; Chen, Rui; Wang, Bo; Wu, Tao; Huang, Yafang; Guo, Aimin			General Practice On-the-Job Training in Chinese Urban Community: A Qualitative Study on Needs and Challenges	PLOS ONE			English	Article							MEDICAL-STUDENTS; CURRICULUM; RESOURCE	Background: On-the-job training is an important strategy for general practitioners to deliver appropriately community health services in China. The development of basic professional competence for general practitioners is the main goal of on-the-job training program. The aim of this study was to explore the needs of and the challenges to on-the-job training for general practitioners, and to provide advices for policy-makers to carry out this program more effectively. Methods: We conducted 3 nominal group techniques, 17 in-depth interviews and 3 focus groups to identify the status of, needs of and challenges to on-the-job training for general practitioners in Liaoning, Ningxia, and Fujian provinces from September 2011 until December 2011. Audiotapes and transcripts were analyzed to identify major themes. Content analysis of the data was completed from January 2012 to March 2012. Results: Basic theoretical knowledge and clinical skills were the main needs for general practitioners during on-the-job training. The challenges during training included the time contradiction between work and training, deficiencies of qualified preceptors, and lack of training funds. Participants gave recommendations how to resolve the above problems. Conclusions: In order to improve the outcomes of general practice on-the-job training, it is necessary for government officials to resolve the contradiction between work and training, train preceptors continuously, and increase financial support in the training program.	[Zhao, Yali; Chen, Rui; Huang, Yafang; Guo, Aimin] Capital Med Univ, Sch Gen Practice & Continuing Educ, Beijing, Peoples R China; [Wang, Bo] Natl Hlth & Family Planning Commiss, Beijing, Peoples R China; [Wu, Tao] Beijing An Zhen Hosp, Beijing, Peoples R China	Capital Medical University	Guo, AM (corresponding author), Capital Med Univ, Sch Gen Practice & Continuing Educ, Beijing, Peoples R China.	guoaiminlaoshi@163.com			National Health and Family Planning Commission	National Health and Family Planning Commission	Grant from National Health and Family Planning Commission. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	HEWSON MG, 1992, J GEN INTERN MED, V7, P76, DOI 10.1007/BF02599107; Huang YF, 2011, BRIT J GEN PRACT, V61, P304, DOI 10.3399/bjgp11X568134; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed; Lam TP, 2002, MED EDUC, V36, P233, DOI 10.1046/j.1365-2923.2002.01142.x; [李伟明 LI Weiming], 2011, [中国全科医学, Chinese General Practice], V14, P2841; Lu ZX., 2011, CLIN ED GEN PRACT, V9, P121; Lv ZF, 2010, GEN PRACTICE, V13; Ministry of Health, 2011, SHANGH ACT PROM CONS; Ministry of Health, 2011, GUID GEN PRACT JOB T; Murtagh J, 2007, GEN PRACTICE; National Development and Reform Commission, 2010, NOT CONSTR PLAN PRIM; People's Republic of China: Ministry of Health; State Administration of Traditional Chinese Medicine, 2006, APPR MAN COMM HLTH S; Shen Q, 2009, RES MED ED, V8, P1515; South-Paul JE, 2004, ANN FAM MED, V2, P619, DOI 10.1370/afm.255; State Council, 2011, STAT COUNC GUID OP E; Sturman N, 2011, MED EDUC, V45, P722, DOI 10.1111/j.1365-2923.2011.03930.x; [孙虹 SUN Hong], 2011, [中国全科医学, Chinese General Practice], V14, P1752; Tuggy M, 2012, ANN FAM MED, V10, P174, DOI 10.1370/afm.1394; Vagan A, 2009, MED EDUC, V43, P254, DOI 10.1111/j.1365-2923.2008.03278.x; Wang HHX, 2013, ANN FAM MED, V11, P517, DOI 10.1370/afm.1545; Xu JL, 2010, RES ASTRON ASTROPHYS, V10, P151, DOI 10.1088/1674-4527/10/2/006; Xu J, 2010, J HUAZHONG U SCI-MED, V30, P141, DOI 10.1007/s11596-010-0201-6; [徐庆锋 Xu Qingfeng], 2011, [中国全科医学, Chinese General Practice], V14, P3950; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888; Zhang TH, 2009, GUIDE CHINA MED, V7, P17; Zhao Y, 2011, PUBLIC HEALTH, V125, P37, DOI 10.1016/j.puhe.2010.09.003; Zhou C, 2011, CHIN PRIM HLTH CARE, V25, P12; [朱福 Zhu Fu], 2011, [中国全科医学, Chinese General Practice], V14, P3601	28	23	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94301	10.1371/journal.pone.0094301	http://dx.doi.org/10.1371/journal.pone.0094301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728399	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200058
J	Andrews, KR; Moriwake, VN; Wilcox, C; Grau, EG; Kelley, C; Pyle, RL; Bowen, BW				Andrews, Kimberly R.; Moriwake, Virginia N.; Wilcox, Christie; Grau, E. Gordon; Kelley, Christopher; Pyle, Richard L.; Bowen, Brian W.			Phylogeographic Analyses of Submesophotic Snappers Etelis coruscans and Etelis "marshi" (Family Lutjanidae) Reveal Concordant Genetic Structure across the Hawaiian Archipelago	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; JOHNSTON ATOLL; SOFTWARE; PATTERNS; ECOLOGY; DIFFERENTIATION; CONNECTIVITY; NEUTRALITY; HISTORIES	The Hawaiian Archipelago has become a natural laboratory for understanding genetic connectivity in marine organisms as a result of the large number of population genetics studies that have been conducted across this island chain for a wide taxonomic range of organisms. However, population genetic studies have been conducted for only two species occurring in the mesophotic or submesophotic zones (30+m) in this archipelago. To gain a greater understanding of genetic connectivity in these deepwater habitats, we investigated the genetic structure of two submesophotic fish species (occurring similar to 200-360 m) in this archipelago. We surveyed 16 locations across the archipelago for submesophotic snappers Etelis coruscans (N = 787) and E. "marshi'' (formerly E. carbunculus; N = 770) with 436-490 bp of mtDNA cytochrome b and 10-11 microsatellite loci. Phylogeographic analyses reveal no geographic structuring of mtDNA lineages and recent coalescence times that are typical of shallow reef fauna. Population genetic analyses reveal no overall structure across most of the archipelago, a pattern also typical of dispersive shallow fishes. However some sites in the mid-archipelago (Raita Bank to French Frigate Shoals) had significant population differentiation. This pattern of no structure between ends of the Hawaiian range, and significant structure in the middle, was previously observed in a submesophotic snapper (Pristipomoides filamentosus) and a submesophotic grouper (Hyporthodus quernus). Three of these four species also have elevated genetic diversity in the mid-archipelago. Biophysical larval dispersal models from previous studies indicate that this elevated diversity may result from larval supplement from Johnston Atoll,similar to 800 km southwest of Hawaii. In this case the boundaries of stocks for fishery management cannot be defined simply in terms of geography, and fishery management in Hawaii may need to incorporate external larval supply into management plans.	[Andrews, Kimberly R.; Moriwake, Virginia N.; Wilcox, Christie; Grau, E. Gordon; Kelley, Christopher; Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Andrews, Kimberly R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3HP, England; [Moriwake, Virginia N.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Wilcox, Christie] Univ Hawaii, Cell & Mol Biol Grad Program, Honolulu, HI 96822 USA; [Kelley, Christopher] Univ Hawaii, Hawaii Undersea Res Lab, Honolulu, HI 96822 USA; [Pyle, Richard L.] Bernice P Bishop Museum, Honolulu, HI USA	University of Hawaii System; Durham University; University of Hawaii System; University of Hawaii System; University of Hawaii System	Andrews, KR (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	kimandrews@gmail.com		Wilcox, Christie/0000-0002-7356-2552	National Oceanic and Atmospheric Administration [R/FM-18]; University of Hawaii Sea Grant College Program; SOEST under NOAA Office of Sea Grant, Department of Commerce [NA05OAR4171048]; Seaver Institute; NOAA Pacific Island Fisheries Science Center [NA10NMF4520121]; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant [NA07NOS4780188]; NOAA National Marine Sanctuaries Program; MOA [2005-008/66882]; National Science Foundation [OIA0554657, OCE-0929031]; NOAA Coral Reef Conservation Program; Hawai'i Undersea Research Laboratory [NA05OAR4301108]; Western Pacific Regional Fisheries Management Council [05-WPC-033]; Hawai'i Division of Aquatic Resources	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program; SOEST under NOAA Office of Sea Grant, Department of Commerce; Seaver Institute; NOAA Pacific Island Fisheries Science Center; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant; NOAA National Marine Sanctuaries Program(National Oceanic Atmospheric Admin (NOAA) - USA); MOA; National Science Foundation(National Science Foundation (NSF)); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawai'i Undersea Research Laboratory; Western Pacific Regional Fisheries Management Council; Hawai'i Division of Aquatic Resources	This paper is funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/FM-18, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA05OAR4171048 (B. W. B) from NOAA Office of Sea Grant, Department of Commerce. This paper is also funded in part by generous support from the Seaver Institute (B. W. B. and R. L. P.), NOAA Pacific Island Fisheries Science Center (http://www.pifsc.noaa.gov/) Grant NA10NMF4520121, NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant (http://ccma.nos.noaa.gov/ecosystems/coralreef/coral_grant.aspx) NA07NOS4780188 (R. L. P.), NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov/) MOA grant No. 2005-008/66882 (R.J. Toonen), National Science Foundation (http://www.nsf.gov/) grants No. OIA0554657, and OCE-0929031 (B. W. B.), NOAA Coral Reef Conservation Program and Hawai'i Undersea Research Laboratory (http://www.soest.hawaii.edu/HURL/) Grant NA05OAR4301108, Western Pacific Regional Fisheries Management Council (http://www.wpcouncil.org/; contract No. 05-WPC-033), and Hawai'i Division of Aquatic Resources (http://hawaii.gov/dlnr/dar/). The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies. UNIHI-SEAGRANT-JC-05-53. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2011, MAR FRESHWATER RES, V62, P1259, DOI 10.1071/MF11080; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J.C., 2004, MOL MARKERS NATURAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brodziak J., 2011, NOAATMNMFSPIFSC29; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Craig MT, 2010, J BIOGEOGR, V37, P2125, DOI 10.1111/j.1365-2699.2010.02358.x; CUMMINGS SA, 1994, BIOTECHNIQUES, V17, P426; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DeMartini EE, 1999, FISH B-NOAA, V97, P449; DiBattista JD, 2011, J MAR BIOL, DOI DOI 10.1155/2011/839134; DiBattista JD, 2012, J HERED, V103, P617, DOI 10.1093/jhered/ess056; Eble Jeff A., 2011, Journal of Marine Biology, V2011, P1; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gaither MR, 2010, CONSERV GENET RESOUR, V2, P169, DOI 10.1007/s12686-009-9119-3; Gaither MR, 2010, MOL ECOL, V19, P1107, DOI 10.1111/j.1365-294X.2010.04535.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GRIGG RW, 1981, PAC SCI, V35, P1; GRIGG RW, 1981, PAC SCI, V35, P15; HOSPITAL J, 2009, NOAATMNMFSPIFSC20; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Leis J.M., 1987, P189; LEIS JM, 1994, B MAR SCI, V55, P46; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Ludt WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038042; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; MARTEL SJD, 2011, SSTATUS TRENS UNPUB; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MEYER A, 1993, EVOLUTION GENTICS AQ; Moffitt Robert B., 1996, Pacific Science, V50, P371; Mundy B.C, 2005, CHECKLIST FISHES HAW; Ovenden JR, 2004, MOL ECOL, V13, P1991, DOI 10.1111/j.1365-294X.2004.02210.x; Park S.D.E., 2001, THESIS; Pooley SG, 1987, TROPICAL SNAPPERS GR, P605; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ralston S, 1979, DESCRIPTION BOTTOMFI; Ramon ML, 2008, MAR BIOL, V153, P1207, DOI 10.1007/s00227-007-0894-7; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RANDALL JE, 2007, REFF SHORE FISHES HA; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reece JS, 2011, MAR ECOL PROG SER, V437, P269, DOI 10.3354/meps09248; Reece JS, 2010, MOL PHYLOGENET EVOL, V57, P829, DOI 10.1016/j.ympev.2010.07.013; Rivera M.A.J., 2011, J MAR BIOL; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; RIVERA MAJ, 2002, THESIS U CALIFORNIA; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Taberlet P, 1992, MOL ECOL, V1, P27, DOI 10.1111/j.1365-294X.1992.tb00152.x; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Timmers MA, 2011, J MARINE BIOL; Toonen RJ, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/460173; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2008, EVOL APPL, V1, P183, DOI 10.1111/j.1752-4571.2008.00035.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; *WPRFMC, 2012, FIN FISH MAN PLAN CO, V3	79	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91665	10.1371/journal.pone.0091665	http://dx.doi.org/10.1371/journal.pone.0091665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722193	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000336909100008
J	Fu, SP; He, SY; Xu, B; Hu, CJ; Lu, SF; Shen, WX; Huang, Y; Hong, H; Li, Q; Wang, N; Liu, XL; Liang, FR; Zhu, BM				Fu, Shu-Ping; He, Su-Yun; Xu, Bin; Hu, Chen-Jun; Lu, Sheng-Feng; Shen, Wei-Xing; Huang, Yan; Hong, Hao; Li, Qian; Wang, Ning; Liu, Xuan-Liang; Liang, Fanrong; Zhu, Bing-Mei			Acupuncture Promotes Angiogenesis after Myocardial Ischemia through H3K9 Acetylation Regulation at VEGF Gene	PLOS ONE			English	Article							RNA-SEQ; ELECTROACUPUNCTURE; RATS; PRETREATMENT; REPERFUSION; INJURY; HEART; INVOLVEMENT; HYPOXIA; KINASE	Background: Acupuncture exerts cardioprotective effects on several types of cardiac injuries, especially myocardial ischemia (MI), but the mechanisms have not yet been well elucidated. Angiogenesis mediated by VEGF gene expression and its modification through histone acetylation has been considered a target in treating myocardial ischemia. This study aims to exam whether modulation of angiogenesis through H3K9 acetylation regulation at VEGF gene is one possible cardioprotective mechanism of acupuncture. Results: We generated rat MI models by ligating the left anterior descending coronary artery and applied electroacupuncture (EA) treatment at the Neiguan (PC6) acupoint. Our results showed that acupuncture reversed the S-T segment change, reduced Q-wave area, decreased CK, CK-MB, LDH levels, mitigated myocardial remodeling, and promoted microvessel formation in the MI heart. RNA-seq analysis showed that VEGF-induced angiogenesis signaling was involved in the modulation of EA. Western blot results verified that the protein expressions of VEGF, Ras, phospho-p44/42 MAPK, phospho-p38 MAPK, phospho-SAPK/JNK and Akt, were all elevated significantly by EA treatment in the MI heart. Furthermore, increased H3K9 acetylation was also observed according with the VEGF. ChIP assay confirmed that EA treatment could notably stimulate the recruitment of H3K9ace at the VEGF promoter. Conclusions: Our study demonstrates for the first time that acupuncture can effectively up-regulate VEGF expression through H3K9 acetylation modification directly at the VEGF promoter and hence activate VEGF-induced angiogenesis in rat MI models. We employed high throughput sequencing in this study and, for the first time, generated genome-wide gene expression profiles both in the rat MI model and in acupuncture treatment.	[Fu, Shu-Ping; He, Su-Yun; Xu, Bin; Lu, Sheng-Feng; Shen, Wei-Xing; Huang, Yan; Hong, Hao; Li, Qian; Wang, Ning; Liu, Xuan-Liang; Zhu, Bing-Mei] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Jiangsu, Peoples R China; [Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Sichuan, Peoples R China; [Hu, Chen-Jun] Nanjing Univ Chinese Med, Sch Informat Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Chengdu University of Traditional Chinese Medicine; Nanjing University of Chinese Medicine	Liang, FR (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Sichuan, Peoples R China.	0001170@cdutcm.edu.cn; zhubm64@hotmail.com		huang, yan/0000-0002-5588-0274; Liang, Fanrong/0000-0003-2210-2027	national basic research program of China (973 program) [2012CB518501]; National Natural Science Foundation of China [81273838]; Natural Science Foundation of the Jiangsu Hager Education Institutions of China [12KJB360005]; Natural Science Foundation of the Jiangsu Province of China [BK20130956]; Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province	national basic research program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Hager Education Institutions of China; Natural Science Foundation of the Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province	This work was supported by grants from the national basic research program of China (973 program, No. 2012CB518501), the National Natural Science Foundation of China (No. 81273838), the Natural Science Foundation of the Jiangsu Hager Education Institutions of China (No. 12KJB360005), the Natural Science Foundation of the Jiangsu Province of China (No. BK20130956) and the Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YH, 2010, BLOOD, V115, P2336, DOI 10.1182/blood-2009-12-256933; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Dasgupta Piyali, 2007, V383, P135, DOI 10.1007/978-1-59745-335-6_9; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gao JH, 2006, J PHYSIOL SCI, V56, P275, DOI 10.2170/physiolsci.RP006606; Gao JH, 2008, J PHYSIOL SCI, V58, P389, DOI 10.2170/physiolsci.RP007108; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hu Jinsheng, 2008, J Tradit Chin Med, V28, P228; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Lorier G, 2011, ARQ BRAS CARDIOL, V97, pE140, DOI 10.1590/S0066-782X2011001500019; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Lujan HL, 2007, AM J PHYSIOL-HEART C, V292, pH2550, DOI 10.1152/ajpheart.00979.2006; Meng Jingbi, 2004, J Tradit Chin Med, V24, P16; Ni XL, 2012, PEDIATR ANESTH, V22, P805, DOI 10.1111/j.1460-9592.2012.03822.x; Park SI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/464586; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sun XC, 2010, EXP NEUROL, V224, P347, DOI 10.1016/j.expneurol.2010.04.009; Tjen-A-Looi SC, 2003, AUTON NEUROSCI-BASIC, V106, P119, DOI 10.1016/S1566-0702(03)00076-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Tsou MT, 2004, AM J CHINESE MED, V32, P951, DOI 10.1142/S0192415X04002557; Wang SB, 2008, WORLD J GASTROENTERO, V14, P6496, DOI 10.3748/wjg.14.6496; Xu Feng-hua, 2005, Zhongguo Zhen Jiu, V25, P89; Yang LF, 2010, ANN THORAC SURG, V89, P781, DOI 10.1016/j.athoracsur.2009.12.003; Zhang F, 2011, BRAIN INJURY, V25, P895, DOI 10.3109/02699052.2011.581639; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhao L, 2013, BRAIN RES, V1503, P78, DOI 10.1016/j.brainres.2013.01.051	33	51	68	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94604	10.1371/journal.pone.0094604	http://dx.doi.org/10.1371/journal.pone.0094604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722278	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100106
J	Moretti, RM; Marelli, MM; Taylor, DM; Martini, PGV; Marzagalli, M; Limonta, P				Moretti, Roberta M.; Marelli, Marina Montagnani; Taylor, Deanne M.; Martini, Paolo G. V.; Marzagalli, Monica; Limonta, Patrizia			Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; ENDOMETRIAL CANCER; GENE-EXPRESSION; OVARIAN-CANCER; LHRH AGONISTS; KAPPA-B; RECEPTOR; APOPTOSIS; GROWTH; P53	Gonadotropin-releasing hormone (GnRH) receptors are expressed in prostate cancer, specifically in the most aggressive stage of the tumor (castration-resistant prostate cancer, CRPC) for which the standard treatment, docetaxel-based chemotherapy, can only improve the median survival time by few months. We previously showed that GnRH agonists exert an antitumor activity in CRPC cells; however, a link between GnRH receptors and the apoptotic machinery remains to be defined. Aim of this study was to evaluate whether, in CRPC cells, GnRH agonists might affect the expression/activity of apoptosis-related proteins and might sensitize, or resensitize, cancer cells to chemotherapeutics. We demonstrated that, in p53-positive DU145 cells, GnRH agonists: a) increase the expression of the proapoptotic protein Bax; this effect is mediated by the phosphorylation (activation) of p53, triggered by the p38 MAPK; b) potentiate the antiproliferative/proapoptotic activity of docetaxel; c) resensitize docetaxel-resistant cells to the antitumor activity of the cytotoxic drug. These data indicate that GnRH agonists sensitize and, more importantly, resensitize DU145 CRPC cells to chemotherapy in a p53-dependent manner. To confirm the crucial role of p53 in the activity of GnRH agonists, experiments were performed in p53-null PC3 cells. We found that GnRH agonists fail to increase Bax expression and do not potentiate the cytotoxic activity of docetaxel. These results may provide a rationale for novel combination treatment strategies, especially for docetaxel-resistant CRPC patients expressing a functional p53 protein.	[Moretti, Roberta M.; Marelli, Marina Montagnani; Marzagalli, Monica; Limonta, Patrizia] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Taylor, Deanne M.] UMDNJ Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, Morristown, NJ USA; [Martini, Paolo G. V.] Shire Rare Dis Unit, Lexington, MA USA	University of Milan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Shire Pharmaceuticals Limited	Limonta, P (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	patrizia.limonta@unimi.it	Taylor, Deanne/AAY-6296-2020; marelli, marina montagnani/G-7521-2012; Taylor, Deanne M/Q-4777-2017; Marzagalli, Monica/AAS-2938-2020; Moretti, Roberta Manuela/G-7514-2012	Taylor, Deanne/0000-0002-3302-4610; marelli, marina montagnani/0000-0002-3739-6278; Taylor, Deanne M/0000-0002-3302-4610; Moretti, Roberta Manuela/0000-0001-6456-5869; Marzagalli, Monica/0000-0001-7684-606X	Universita degli Studi di Milano, PUR program [12-1-95, 12-1-104]	Universita degli Studi di Milano, PUR program	This work was funded by Universita degli Studi di Milano, PUR program (grants n. 12-1-95 and 12-1-104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2012, EUR UROL, V61, P950, DOI 10.1016/j.eururo.2011.12.028; Angelucci C, 2004, ANTICANCER RES, V24, P2729; BAUMANN KH, 1993, BREAST CANCER RES TR, V25, P37, DOI 10.1007/BF00662399; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Castellon E, 2006, CANCER INVEST, V24, P261, DOI 10.1080/07357900600629591; Chatzaki E, 1996, CANCER RES, V56, P2059; Clementi M, 2009, PROSTATE, V69, P1025, DOI 10.1002/pros.20954; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; CONNOR JP, 1994, GYNECOL ONCOL, V54, P80, DOI 10.1006/gyno.1994.1170; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; Dondi D, 1998, INT J CANCER, V76, P506, DOI 10.1002/(SICI)1097-0215(19980518)76:4<506::AID-IJC11>3.0.CO;2-5; Dondi D, 2006, ONCOL REP, V15, P393; DONDI D, 1994, CANCER RES, V54, P4091; EIDNE KA, 1987, J CLIN ENDOCR METAB, V64, P425, DOI 10.1210/jcem-64-3-425; EMONS G, 1993, J CLIN ENDOCR METAB, V77, P1458, DOI 10.1210/jc.77.6.1458; EMONS G, 1990, J STEROID BIOCHEM, V37, P1003, DOI 10.1016/0960-0760(90)90457-V; Engel JB, 2007, NAT CLIN PRACT ENDOC, V3, P157, DOI 10.1038/ncpendmet0399; Fu WH, 2012, BBA-REV CANCER, V1825, P140, DOI 10.1016/j.bbcan.2011.11.003; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gnanapragasam VJ, 2005, J PATHOL, V206, P205, DOI 10.1002/path.1767; Grundker C, 2002, EUR J ENDOCRINOL, V146, P1, DOI 10.1530/eje.0.1460001; Halmos G, 2000, INT J ONCOL, V17, P367; IMAI A, 1994, GYNECOL ONCOL, V55, P144, DOI 10.1006/gyno.1994.1264; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; IRMER G, 1995, CANCER RES, V55, P817; ISAACS WB, 1991, CANCER RES, V51, P4716; Kakar SS, 1997, EUR J ENDOCRINOL, V137, P183, DOI 10.1530/eje.0.1370183; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; Kutikov A, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.07.1384; Labrie F, 2005, ENDOCR REV, V26, P361, DOI 10.1210/er.2004-0017; Lama G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052530; Lassi K, 2010, CURR OPIN ONCOL, V22, P263, DOI 10.1097/CCO.0b013e3283380939; LIMONTA P, 1992, J CLIN ENDOCR METAB, V75, P207, DOI 10.1210/jcem.75.1.1320049; Limonta P, 1999, ENDOCRINOLOGY, V140, P5250, DOI 10.1210/en.140.11.5250; Limonta P, 2013, CANCER TREAT REV, V39, P647, DOI 10.1016/j.ctrv.2012.12.003; Lin HY, 2002, J UROLOGY, V168, P748, DOI 10.1016/S0022-5347(05)64739-8; Liu SV, 2010, CLIN CANCER RES, V16, P4675, DOI 10.1158/1078-0432.CCR-10-1113; Marelli MM, 2007, INT J ONCOL, V30, P261; Marelli MM, 2009, J CLIN ENDOCR METAB, V94, P1761, DOI 10.1210/jc.2008-1741; Marelli MM, 1999, ENDOCRINOLOGY, V140, P329; Marin-Aguilera M, 2012, MOL CANCER THER, V11, P329, DOI 10.1158/1535-7163.MCT-11-0289; Meyer C, 2013, ENDOCR-RELAT CANCER, V20, P123, DOI 10.1530/ERC-12-0192; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Morgan K, 2011, PROSTATE, V71, P915, DOI 10.1002/pros.21308; Murray S, 2012, CANCER TREAT REV, V38, P890, DOI 10.1016/j.ctrv.2012.02.011; Oudard S, 2013, CANCER TREAT REV, V39, P275, DOI 10.1016/j.ctrv.2012.09.005; Paller CJ, 2011, DRUG DES DEV THER, V5, P117, DOI 10.2147/DDDT.S13029; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Scott SL, 2003, CANCER RES, V63, P7190; SEGALABRAMSON T, 1992, P NATL ACAD SCI USA, V89, P2336, DOI 10.1073/pnas.89.6.2336; Sica G, 1999, EUR UROL, V35, P2, DOI 10.1159/000052300; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh P, 2010, CANCER LETT, V293, P1, DOI 10.1016/j.canlet.2009.11.019; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volate SR, 2010, MOL CANCER THER, V9, P461, DOI 10.1158/1535-7163.MCT-09-0507; Volker P, 2002, AM J OBSTET GYNECOL, V186, P171, DOI 10.1067/mob.2002.119633; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842; Ye QF, 2012, ONCOL LETT, V3, P879, DOI 10.3892/ol.2012.572	67	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93713	10.1371/journal.pone.0093713	http://dx.doi.org/10.1371/journal.pone.0093713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722580	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100021
J	Ronot, M; Lambert, SA; Wagner, M; Garteiser, P; Doblas, S; Albuquerque, M; Paradis, V; Vilgrain, V; Sinkus, R; Van Beers, BE				Ronot, Maxime; Lambert, Simon A.; Wagner, Mathilde; Garteiser, Philippe; Doblas, Sabrina; Albuquerque, Miguel; Paradis, Valerie; Vilgrain, Valerie; Sinkus, Ralph; Van Beers, Bernard E.			Viscoelastic Parameters for Quantifying Liver Fibrosis: Three-Dimensional Multifrequency MR Elastography Study on Thin Liver Rat Slices	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; MAGNETIC-RESONANCE ELASTOGRAPHY; EX-VIVO MODEL; NONINVASIVE ASSESSMENT; TRANSIENT ELASTOGRAPHY; DIAGNOSTIC-ACCURACY; GOLD STANDARD; STIFFNESS; DISEASE; LESIONS	Objective: To assess in a high-resolution model of thin liver rat slices which viscoelastic parameter at three-dimensional multifrequency MR elastography has the best diagnostic performance for quantifying liver fibrosis. Materials and Methods: The study was approved by the ethics committee for animal care of our institution. Eight normal rats and 42 rats with carbon tetrachloride induced liver fibrosis were used in the study. The rats were sacrificed, their livers were resected and three-dimensional MR elastography of 5 +/- 2 mm liver slices was performed at 7T with mechanical frequencies of 500, 600 and 700 Hz. The complex shear, storage and loss moduli, and the coefficient of the frequency power law were calculated. At histopathology, fibrosis and inflammation were assessed with METAVIR score, fibrosis was further quantified with morphometry. The diagnostic value of the viscoelastic parameters for assessing fibrosis severity was evaluated with simple and multiple linear regressions, receiver operating characteristic analysis and Obuchowski measures. Results: At simple regression, the shear, storage and loss moduli were associated with the severity of fibrosis. At multiple regression, the storage modulus at 600 Hz was the only parameter associated with fibrosis severity (r = 0.86, p < 0.0001). This parameter had an Obuchowski measure of 0.89+/-0.03. This measure was significantly larger than that of the loss modulus (0.78+/-0.04, p = 0.028), but not than that of the complex shear modulus (0.88+/-0.03, p = 0.84). Conclusion: Our high resolution, three-dimensional multifrequency MR elastography study of thin liver slices shows that the storage modulus is the viscoelastic parameter that has the best association with the severity of liver fibrosis. However, its diagnostic performance does not differ significantly from that of the complex shear modulus.	[Ronot, Maxime; Wagner, Mathilde; Vilgrain, Valerie; Van Beers, Bernard E.] Beaujon Univ Hosp Paris Nord Val de Seine, Dept Radiol, Clichy, France; [Ronot, Maxime; Lambert, Simon A.; Wagner, Mathilde; Garteiser, Philippe; Doblas, Sabrina; Paradis, Valerie; Vilgrain, Valerie; Sinkus, Ralph; Van Beers, Bernard E.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ronot, Maxime; Lambert, Simon A.; Wagner, Mathilde; Garteiser, Philippe; Doblas, Sabrina; Albuquerque, Miguel; Paradis, Valerie; Vilgrain, Valerie; Sinkus, Ralph; Van Beers, Bernard E.] Ctr Rech Biomed Bichat Beaujon, INSERM, U773, IPMA, Paris, France; [Albuquerque, Miguel; Paradis, Valerie] Beaujon Univ Hosp Paris Nord Val de Seine, Dept Pathol, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP	Ronot, M (corresponding author), Beaujon Univ Hosp Paris Nord Val de Seine, Dept Radiol, Clichy, France.	maxime.ronot@bjn.aphp.fr	Paradis, Valerie/X-9097-2019; Garteiser, Philippe/P-5719-2017; Lambert, Simon/N-8773-2016; Ronot, Maxime/AAM-9968-2021; Van Beers, Bernard/N-2816-2016; Albuquerque, Miguel/X-9008-2019	Garteiser, Philippe/0000-0003-0157-8851; Lambert, Simon/0000-0002-8975-5332; Ronot, Maxime/0000-0001-7464-3939; Van Beers, Bernard/0000-0001-6429-1140; Albuquerque, Miguel/0000-0001-7311-1623; Paradis, Valerie/0000-0003-3142-3762; Sinkus, Ralph/0000-0002-6093-1654; Doblas, Sabrina/0000-0002-5194-3872; Wagner, Mathilde/0000-0003-1172-4592				Asbach P, 2010, RADIOLOGY, V257, P80, DOI 10.1148/radiol.10092489; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Garteiser P, 2012, EUR RADIOL, V22, P2169, DOI 10.1007/s00330-012-2474-6; Hadi M, 2013, CHEM RES TOXICOL, V26, P710, DOI 10.1021/tx300519p; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lagaye S, 2012, HEPATOLOGY, V56, P861, DOI 10.1002/hep.25738; Lambert J, 2008, CLIN CHEM, V54, P1372, DOI 10.1373/clinchem.2007.097923; Leclerc GE, 2013, J MAGN RESON IMAGING, V38, P422, DOI 10.1002/jmri.23986; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Obuchowski NA, 2006, STAT MED, V25, P481, DOI 10.1002/sim.2228; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Obuchowski NA, 2001, STAT MED, V20, P3261, DOI 10.1002/sim.944.abs; Oliveri F, 2008, WORLD J GASTROENTERO, V14, P6154, DOI 10.3748/wjg.14.6154; Payan C, 2005, J VIRAL HEPATITIS, V12, P405, DOI 10.1111/j.1365-2893.2005.00605.x; Salameh N, 2007, J MAGN RESON IMAGING, V26, P956, DOI 10.1002/jmri.21099; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Starkel P, 2001, BEST PRACT RES CLIN, V25, P319; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Yin M, 2007, MAGN RESON MED, V58, P346, DOI 10.1002/mrm.21286; Yoshioka K, 2013, HEPATOL RES, V43, P182, DOI 10.1111/j.1872-034X.2012.01096.x; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	31	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94679	10.1371/journal.pone.0094679	http://dx.doi.org/10.1371/journal.pone.0094679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722733	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100121
J	Soussan, M; Orlhac, F; Boubaya, M; Zelek, L; Ziol, M; Eder, V; Buvat, I				Soussan, Michael; Orlhac, Fanny; Boubaya, Marouane; Zelek, Laurent; Ziol, Marianne; Eder, Veronique; Buvat, Irene			Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer	PLOS ONE			English	Article							ENHANCED MR-IMAGES; TEXTURAL FEATURES; CARCINOMA	Background: There is currently little support to understand which pathological factors led to differences in tumor texture as measured from FDG PET/CT images. We studied whether tumor heterogeneity measured using texture analysis in FDG-PET/CT images is correlated with pathological prognostic factors in invasive breast cancer. Methods: Fifty-four patients with locally advanced breast cancer who had an initial FDG-PET/CT were retrospectively included. In addition to SUVmax, three robust textural indices extracted from 3D matrices: High-Gray-level Run Emphasis (HGRE), Entropy and Homogeneity were studied. Univariate and multivariate logistic regression was used to identify PET parameters associated with poor prognosis pathological factors: hormone receptor negativity, presence of HER-2 and triple negative phenotype. Receiver operating characteristic (ROC) curves and the (AUC) analysis, and reclassification measures, were performed in order to evaluate the performance of combining texture analysis and SUVmax for characterizing breast tumors. Results: Tumor heterogeneity, measured with HGRE, was higher in negative estrogen receptor (p = 0.039) and negative progesterone receptor tumors (p = 0.036), and in Scarff-Bloom-Richardson grade 3 tumors (p = 0.047). None of the PET indices could identify HER-2 positive tumors. Only SUVmax was positively correlated with Ki-67 (p<0.0004). Triple negative breast cancer (TNBC) exhibited higher SUVmax (Odd Ratio = 1.22, 95% CI [1.06-1.39], p = 0.004), lower Homogeneity (OR = 3.57[0.98-12.5], p = 0.05) and higher HGRE (OR = 8.06[1.88-34.51], p = 0.005) than non-TNBC. Multivariate analysis showed that HGRE remained associated with TNBC (OR = 5.27[1.12-1.38], p = 0.03) after adjustment for SUVmax. Combining SUVmax and HGRE yielded in higher area under the ROC curves (AUC) than SUVmax for identifying TNBC: AUC = 0.83 and 0.77, respectively. Probability of correct classification also increased in 77% (10/13) of TNBC and 71% (29/41) of non-TNBC (p = 0.003), when combining SUVmax and HGRE. Conclusions: Tumor heterogeneity measured on FDG-PET/CT was higher in invasive breast cancer with poor prognosis pathological factors. Texture analysis might be used, in addition to SUVmax, as a new tool to assess invasive breast cancer aggressiveness.	[Soussan, Michael; Zelek, Laurent; Ziol, Marianne; Eder, Veronique] Univ Paris 13, Sorbonne Paris Cite, Bobigny, France; [Soussan, Michael; Eder, Veronique] Avicenne Univ Hosp, AP HP, Dept Nucl Med, Bobigny, France; [Soussan, Michael; Orlhac, Fanny] Univ Paris 07, CNRS, UMR 8165, IMNC, Orsay, France; [Soussan, Michael; Orlhac, Fanny] Univ Paris 11, CNRS, UMR 8165, IMNC, F-91405 Orsay, France; [Boubaya, Marouane] Avicenne Univ Hosp, AP HP, Clin Res Unit, Bobigny, France; [Zelek, Laurent] Avicenne Univ Hosp, AP HP, Dept Oncol, Bobigny, France; [Ziol, Marianne] Jean Verdier Hosp, AP HP, Dept Pathol, Bondy, France; [Buvat, Irene] CEA, Serv Hosp Frederic Joliot, F-91406 Orsay, France	Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CEA; UDICE-French Research Universities; Universite Paris Saclay	Soussan, M (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Bobigny, France.	michael.soussan@avc.aphp.fr	Laurent, Zelek/F-2906-2017; Ziol, Marianne/AAC-5801-2019; Buvat, Irene/U-8447-2018; Orlhac, Fanny/AAC-6428-2019	Laurent, Zelek/0000-0001-7455-2009; Ziol, Marianne/0000-0001-5117-4842; Buvat, Irene/0000-0002-7053-6471; Orlhac, Fanny/0000-0002-5588-1867; Soussan, Michael/0000-0002-0798-4749				Accorsi R, 2004, PHYS MED BIOL, V49, P2577, DOI 10.1088/0031-9155/49/12/008; Ahmed A, 2012, J MAGN RESON IMAGING; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Basu S, 2008, CANCER-AM CANCER SOC, V112, P995, DOI 10.1002/cncr.23226; Bhooshan N, 2010, RADIOLOGY, V254, P680, DOI 10.1148/radiol.09090838; Bolouri MS, 2013, RADIOLOGY; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fornier M, 2012, BREAST J, V18, P41, DOI 10.1111/j.1524-4741.2011.01175.x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibbs P, 2003, MAGN RESON MED, V50, P92, DOI 10.1002/mrm.10496; Groheux D, 2013, RADIOLOGY, V266, P388, DOI 10.1148/radiol.12110853; Groheux D, 2011, EUR J NUCL MED MOL I, V38, P426, DOI 10.1007/s00259-010-1640-9; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Jimenez RE, 2001, AM J SURG PATHOL, V25, P331, DOI 10.1097/00000478-200103000-00007; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Maisonobe JA, 2013, EUR J NUCL MED MOL I, V40, P166, DOI 10.1007/s00259-012-2274-x; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Nestle U, 2005, J NUCL MED, V46, P1342; Orlhac F SM, 2013, J NUCL MED IN PRESS; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Uematsu T, 2011, BREAST CANCER-TOKYO, V18, P161, DOI 10.1007/s12282-010-0236-3; Wang MC, 2013, LIFETIME DATA ANAL, V19, P257, DOI 10.1007/s10985-012-9233-5; Xu D.H., 2004, HEART, V27, P452; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	30	119	120	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94017	10.1371/journal.pone.0094017	http://dx.doi.org/10.1371/journal.pone.0094017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722644	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100035
J	Hu, YW; Hu, YR; Zhao, JY; Li, SF; Ma, X; Wu, SG; Lu, JB; Qiu, YR; Sha, YH; Wang, YC; Gao, JJ; Zheng, L; Wang, Q				Hu, Yan-Wei; Hu, Ya-Rong; Zhao, Jia-Yi; Li, Shu-Fen; Ma, Xin; Wu, Shao-Guo; Lu, Jing-Bo; Qiu, Yu-Rong; Sha, Yan-Hua; Wang, Yan-Chao; Gao, Ji-Juan; Zheng, Lei; Wang, Qian			An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CELLULAR CHOLESTEROL; DENSITY-LIPOPROTEIN; IN-VIVO; CIRCULATING MICRORNAS; BIOCHEMICAL MARKERS; ATHEROSCLEROSIS; DISEASE; ABCA1; BIOMARKERS	Aims: ATP-binding cassette transporter A1 (ABCA1) mediates the efflux of cholesterol and phospholipids to lipid-poor apolipoproteins, which then form nascent HDL, a key step in the mechanism of reverse cholesterol transport (RCT). While a series of microRNAs (miRNAs) have been identified as potent post-transcriptional regulators of lipid metabolism, their effects on ABCA1 function and associated mechanisms remain unclear. Methods and Results: ABCA1 was identified as a potential target of miR-144-3p, based on the results of bioinformatic analysis and the luciferase reporter assay, and downregulated after transfection of cells with miR-144-3p mimics, as observed with real-time PCR and western blot. Moreover, miR-144-3p mimics (agomir) enhanced the expression of inflammatory factors, including IL-1 beta, IL-6 and TNF-alpha, in vivo and in vitro, inhibited cholesterol efflux in THP-1 macrophage-derived foam cells, decreased HDL-C circulation and impaired RCT in vivo, resulting in accelerated pathological progression of atherosclerosis in apoE(-/-) mice. Clinical studies additionally revealed a positive correlation of circulating miR-144-3p with serum CK, CK-MB, LDH and AST in subjects with AMI. Conclusions: Our findings clearly indicate that miR-144-3p is essential for the regulation of cholesterol homeostasis and inflammatory reactions, supporting its utility as a potential therapeutic target of atherosclerosis and a promising diagnostic biomarker of AMI.	[Hu, Yan-Wei; Hu, Ya-Rong; Zhao, Jia-Yi; Li, Shu-Fen; Wu, Shao-Guo; Qiu, Yu-Rong; Sha, Yan-Hua; Wang, Yan-Chao; Gao, Ji-Juan; Zheng, Lei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Ma, Xin] Southern Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Lu, Jing-Bo] Southern Med Univ, Nanfang Hosp, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfyyzl@163.com; nfyywangqian@163.com	Duarte, Graziela Biude Silva/Q-7728-2016		National Natural Sciences Foundation of China [81301489, 81271905]; Guangdong Provincial Natural Sciences Foundation of China [S2012020010920]; President Foundation of Nanfang Hospital, Southern Medical University	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Sciences Foundation of China; President Foundation of Nanfang Hospital, Southern Medical University	The authors gratefully acknowledge financial support from the National Natural Sciences Foundation of China (81301489 and 81271905), Guangdong Provincial Natural Sciences Foundation of China (S2012020010920), and the President Foundation of Nanfang Hospital, Southern Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KM, 2012, BRIT J PHARMACOL, V167, P1177, DOI 10.1111/j.1476-5381.2012.02081.x; Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P267, DOI 10.1016/S1567-5688(11)70885-6; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; BHAYANA V, 1995, CLIN BIOCHEM, V28, P1, DOI 10.1016/0009-9120(94)00065-4; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Dean M, 2001, J LIPID RES, V42, P1007; Dekker MS, 2010, HEART, V96, P1001, DOI 10.1136/hrt.2009.189886; Devaux Y, 2015, J INTERN MED, V277, P260, DOI 10.1111/joim.12183; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Farmer JA, 2011, CURR ATHEROSCLER REP, V13, P107, DOI 10.1007/s11883-011-0166-3; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Huang S, 2014, CIRC CARDIOVASC GENE; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Jahangiri A, 2009, ARTERIOSCL THROM VAS, V29, P261, DOI 10.1161/ATVBAHA.108.178681; Kelley WE, 2009, CLIN BIOCHEM, V42, P1444, DOI 10.1016/j.clinbiochem.2009.05.020; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; Long GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050926; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Morrow David A, 2007, Circulation, V115, pe356; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; NAWROTH PP, 1987, ONKOLOGIE, V10, P254, DOI 10.1159/000216415; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2001, J LIPID RES, V42, P1173; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; RECALDE HR, 1984, J IMMUNOL METHODS, V69, P71, DOI 10.1016/0022-1759(84)90278-3; Recchioni R, 2013, BIOMARKERS, V18, P547, DOI 10.3109/1354750X.2013.833294; Redondo S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-175; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sayed ASM, 2013, DIS MARKERS, V2013, P561, DOI 10.1155/2013/217948; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	48	83	86	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94997	10.1371/journal.pone.0094997	http://dx.doi.org/10.1371/journal.pone.0094997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733347	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400143
J	Lindsly, C; Gonzalez-Islas, C; Wenner, P				Lindsly, Casie; Gonzalez-Islas, Carlos; Wenner, Peter			Activity Blockade and GABA(A) Receptor Blockade Produce Synaptic Scaling through Chloride Accumulation in Embryonic Spinal Motoneurons and Interneurons	PLOS ONE			English	Article							HOMEOSTATIC PLASTICITY; QUANTAL AMPLITUDE; NETWORK ACTIVITY; AMPA RECEPTORS; INHIBITION; SHIFT; TRANSMISSION; CONTRIBUTES; INCREASES; INDICATOR	Synaptic scaling represents a process whereby the distribution of a cell's synaptic strengths are altered by a multiplicative scaling factor. Scaling is thought to be a compensatory response that homeostatically controls spiking activity levels in the cell or network. Previously, we observed GABAergic synaptic scaling in embryonic spinal motoneurons following in vivo blockade of either spiking activity or GABA(A) receptors (GABA(A)Rs). We had determined that activity blockade triggered upward GABAergic scaling through chloride accumulation, thus increasing the driving force for these currents. To determine whether chloride accumulation also underlies GABAergic scaling following GABA(A)R blockade we have developed a new technique. We expressed a genetically encoded chloride-indicator, Clomeleon, in the embryonic chick spinal cord, which provides a non-invasive fast measure of intracellular chloride. Using this technique we now show that chloride accumulation underlies GABAergic scaling following blockade of either spiking activity or the GABA(A)R. The finding that GABA(A)R blockade and activity blockade trigger scaling via a common mechanism supports our hypothesis that activity blockade reduces GABA(A)R activation, which triggers synaptic scaling. In addition, Clomeleon imaging demonstrated the time course and widespread nature of GABAergic scaling through chloride accumulation, as it was also observed in spinal interneurons. This suggests that homeostatic scaling via chloride accumulation is a common feature in many neuronal classes within the embryonic spinal cord and opens the possibility that this process may occur throughout the nervous system at early stages of development.	[Lindsly, Casie; Gonzalez-Islas, Carlos; Wenner, Peter] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Wenner, P (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	pwenner@emory.edu		Wenner, Peter/0000-0002-7072-2194; Lindsly, Casie/0000-0002-3640-4483	Neurological Disorders and Stroke [NS065992, NS065992-03S1]; Whitehall Foundation [2010-05-42]; Neilsen Foundation [161414]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065992] Funding Source: NIH RePORTER	Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Whitehall Foundation; Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Neurological Disorders and Stroke - NS065992, NS065992-03S1 Whitehall Foundation - Grant # 2010-05-42, Neilsen Foundation - Grant # 161414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Blank Marissa C, 2007, J Vis Exp, P408, DOI 10.3791/408; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Caldero J, 2009, J NEUROSCI RES; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Galante M, 2000, J PHYSIOL-LONDON, V523, P639, DOI 10.1111/j.1469-7793.2000.t01-1-00639.x; Garcia-Bereguiain MA, 2013, J NEUROSCI, V33, P6791, DOI 10.1523/JNEUROSCI.4025-12.2013; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Gonzalez-Islas C, 2012, J NEUROSCI, V32, P13597, DOI 10.1523/JNEUROSCI.1229-12.2012; Gonzalez-Islas C, 2010, J NEUROSCI, V30, P13016, DOI 10.1523/JNEUROSCI.1659-10.2010; Gonzalez-Islas C, 2009, J NEUROPHYSIOL, V101, P507, DOI 10.1152/jn.90986.2008; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hennig MH, 2011, J NEUROSCI, V31, P12159, DOI 10.1523/JNEUROSCI.3112-11.2011; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Karayannis T, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00066; Karmarkar UR, 2006, EUR J NEUROSCI, V23, P1575, DOI 10.1111/j.1460-9568.2006.04692.x; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lee KJ, 2013, NEURON, V77, P99, DOI 10.1016/j.neuron.2012.10.033; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sim KB, 2002, CHILD NERV SYST, V18, P694, DOI 10.1007/s00381-002-0662-4; Turrigiano G., 2012, COLD SPRING HARB PER, V4; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Viemari JC, 2011, PROG BRAIN RES, V188, P3, DOI 10.1016/B978-0-444-53825-3.00006-1; Vitureira N, 2011, CURR OPIN NEUROBIOL; Wang HX, 2012, NEUROPHARMACOLOGY, V62, P1808, DOI 10.1016/j.neuropharm.2011.11.024; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Wenner P, 2013, NEUROPHARMACOLOGY; Wenner P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/489470; Wilhelm JC, 2008, P NATL ACAD SCI USA, V105, P11412, DOI 10.1073/pnas.0806037105; Xu HY, 2005, J NEUROPHYSIOL, V93, P2922, DOI 10.1152/jn.01091.2004	50	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94559	10.1371/journal.pone.0094559	http://dx.doi.org/10.1371/journal.pone.0094559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733046	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400052
J	Petchampai, N; Sunyakumthorn, P; Guillotte, ML; Verhoeve, VI; Banajee, KH; Kearney, MT; Macaluso, KR				Petchampai, Natthida; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Verhoeve, Victoria I.; Banajee, Kaikhushroo H.; Kearney, Michael T.; Macaluso, Kevin R.			Novel Identification of Dermacentor variabilis Arp2/3 Complex and Its Role in Rickettsial Infection of the Arthropod Vector	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ALDRICH-SYNDROME PROTEIN; FEVER GROUP RICKETTSIAE; ATP HYDROLYSIS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; HOST-CELLS; TICK; INVASION	Tick-borne spotted fever group (SFG) Rickettsia species must be able to infect both vertebrate and arthropod host cells. The host actin-related protein 2/3 (Arp2/3) complex is important in the invasion process and actin-based motility for several intracellular bacteria, including SFG Rickettsia in Drosophila and mammalian cells. To investigate the role of the tick Arp2/3 complex in tick-Rickettsia interactions, open reading frames of all subunits of the protein including Arp2, Arp3, ARPC1, ARPC2, ARPC3, ARPC4, and ARPC5 were identified from Dermacentor variabilis. Amino acid sequence analysis showed variation (ranging from 25-88%) in percent identity compared to the corresponding subunits of the complex from Drosophila melanogaster, Mus musculus, Homo sapiens, and Saccharomyces cerevisiae. Potential ATP binding sites were identified in D. variabilis (Dv) Arp2 and Arp3 subunits as well as five putative WD (Trp-Asp) motifs which were observed in DvARPC1. Transcriptional profiles of all subunits of the DvArp2/3 complex revealed greater mRNA expression in both Rickettsia-infected and -uninfected ovary compared to midgut and salivary glands. In response to R. montanensis infection of the tick ovary, the mRNA level of only DvARPC4 was significantly upregulated compared to uninfected tissues. Arp2/3 complex inhibition bioassays resulted in a decrease in the ability of R. montanensis to invade tick tissues with a significant difference in the tick ovary, indicating a role for the Arp2/3 complex in rickettsial invasion of tick cells. Characterization of tick-derived molecules associated with rickettsial infection is imperative in order to better comprehend the ecology of tick-borne rickettsial diseases.	[Petchampai, Natthida; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Verhoeve, Victoria I.; Banajee, Kaikhushroo H.; Kearney, Michael T.; Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Petchampai, N (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA.	npetch29@lsu.edu		Guillotte, Mark/0000-0002-1826-8879	National Institutes of Health [AI077784]; T32 training grant [OD011124-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR021309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (http://www.nih.gov/; grant number: AI077784). KB was supported by T32 training grant# OD011124-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Ammerman NC, 2004, EMERG INFECT DIS, V10, P1478, DOI 10.3201/eid1008.030882; ANDERSON JF, 1986, AM J TROP MED HYG, V35, P187, DOI 10.4269/ajtmh.1986.35.187; Balraj P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002582; BELL EJ, 1963, J IMMUNOL, V90, P770; BELL EJ, 1953, J IMMUNOL, V70, P461; BELL LJ, 1980, ACTA TROP, V37, P319; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; FENG WC, 1980, AM J TROP MED HYG, V29, P691, DOI 10.4269/ajtmh.1980.29.691; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Harlander RS, 2003, INFECT IMMUN, V71, P1551, DOI 10.1128/IAI.71.3.1551-1556.2003; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Hudson AM, 2000, PHYLOGENETIC STRUCTU; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Macaluso KR, 2001, VECTOR-BORNE ZOONOT, V1, P45, DOI 10.1089/153036601750137660; Macaluso KR, 2003, INFECT IMMUN, V71, P6165, DOI 10.1128/IAI.71.11.6165-6170.2003; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; McQuiston JH, 2012, VECTOR-BORNE ZOONOT, V12, P1059, DOI 10.1089/vbz.2012.1078; Mulenga A, 2003, INSECT MOL BIOL, V12, P185, DOI 10.1046/j.1365-2583.2003.00400.x; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oliver JD, 2014, APPL ENVIRON MICROB, V80, P1170, DOI 10.1128/AEM.03352-13; Petchampai N, 2014, INSECT MOL BIOL, V23, P42, DOI 10.1111/imb.12059; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; PRETZMAN C, 1990, ANN NY ACAD SCI, V590, P227, DOI 10.1111/j.1749-6632.1990.tb42224.x; Reed SCO, 2012, CELL MICROBIOL, V14, P529, DOI 10.1111/j.1462-5822.2011.01739.x; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sonenshine DE, 2008, FRONT BIOSCI-LANDMRK, V13, P7046, DOI 10.2741/3209; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Sunyakumthorn P, 2012, INSECT MOL BIOL, V21, P197, DOI 10.1111/j.1365-2583.2011.01126.x; Sunyakumthorn P, 2013, J MED ENTOMOL, V50, P1089, DOI 10.1603/ME12162; TEYSSEIRE N, 1995, INFECT IMMUN, V63, P366, DOI 10.1128/IAI.63.1.366-374.1995; Thepparit C, 2010, MICROBIOL-SGM, V156, P2855, DOI 10.1099/mic.0.041400-0; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; WEISS E, 1973, BACTERIOL REV, V37, P259, DOI 10.1128/MMBR.37.3.259-283.1973; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e93768	10.1371/journal.pone.0093768	http://dx.doi.org/10.1371/journal.pone.0093768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733187	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400012
J	Amer, S; Abd El Wahab, T; Metwaly, A; Ye, JB; Roellig, D; Feng, YY; Xiao, LH				Amer, Said; Abd El Wahab, Taher; Metwaly, Abd El Naby; Ye, Jianbin; Roellig, Dawn; Feng, Yaoyu; Xiao, Lihua			Preliminary Molecular Characterizations of Sarcoptes scaibiei (Acari: Sarcoptidae) from Farm Animals in Egypt	PLOS ONE			English	Article							NORTHERN AUSTRALIA; SCABIES; MITES; MANGE; DISEASE; BIOLOGY; SHEEP; EPIDEMIOLOGY; POPULATIONS; PREVALENCE	Little is known about the genetic diversity of Sarcoptes scabiei mites in farm animals in Egypt. In this study, we characterized S. scabiei in 25 skin scrapes from water buffalo, cattle, sheep, and rabbits at the nuclear marker ITS2 and mitochondrial markers COX1 and 16S rRNA. Sequences of the ITS2 showed no host segregation or geographical isolation, whereas those of the mitochondrial COX1 and 16S rRNA genes indicated the presence of both host-adapted and geographically segregated populations of S. scabiei. Host adaptation may limit inter-species transmission of. S. scabiei, thus restrict gene flow among S. scabiei from different hosts. This is the first report on the molecular characterization of sarcoptic mites in Egypt. Further genetic studies involving larger numbers of specimens, especially those from humans and companion animals, are needed to understand the molecular epidemiology of sarcoptic mange in Egypt.	[Amer, Said; Ye, Jianbin; Roellig, Dawn; Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Amer, Said] Kafr El Sheikh Univ, Dept Zool, Kafr Al Sheikh, Egypt; [Abd El Wahab, Taher; Metwaly, Abd El Naby] Anim Hlth Res Inst, Kafr El Sheikh Prov Lab, Kafr Al Sheikh, Egypt; [Ye, Jianbin; Feng, Yaoyu] E China Univ Sci & Technol, State Environm Protect Key Lab Environm Risk Asse, Shanghai 200237, Peoples R China	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Animal Health Research Institute (AHRI); East China University of Science & Technology	Feng, YY (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	yyfeng@ecust.edu.cn; lxiao@cdc.gov	Xiao, Lihua/B-1704-2013; Feng, Yaoyu/B-3076-2014; Feng, Yaoyu/S-1979-2019; Metwaly, Mohamed/H-9450-2012	Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246; Feng, Yaoyu/0000-0002-8380-1246; Metwaly, Mohamed/0000-0001-8770-0306	Arab Fund for Economic and Social Development (Zamalat Program); National Natural Science Foundation of China [31110103901]; Centers for Disease Control and Prevention	Arab Fund for Economic and Social Development (Zamalat Program)(Arab Fund for Economic and Social Development); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by the Arab Fund for Economic and Social Development (Zamalat Program), National Natural Science Foundation of China (Project No. 31110103901), and Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2008, PARASITOL RES, V104, P101, DOI 10.1007/s00436-008-1165-3; Alasaad S, 2009, VET PARASITOL, V159, P181, DOI 10.1016/j.vetpar.2008.10.001; Alasaad S, 2013, INFECT GENET EVOL, V17, P253, DOI 10.1016/j.meegid.2013.04.018; Anbar T S, 2007, Dermatol Online J, V13, P18; Ariza L, 2013, EUR J CLIN MICROBIOL, V32, P373, DOI 10.1007/s10096-012-1752-1; ARLIAN LG, 1984, J AM ACAD DERMATOL, V10, P979, DOI 10.1016/S0190-9622(84)80318-7; Arlian LG, 1996, J PARASITOL, V82, P66, DOI 10.2307/3284117; Berrilli F, 2002, PARASITOL RES, V88, P772, DOI 10.1007/s00436-002-0655-y; Bradberry Sally M, 2005, Toxicol Rev, V24, P93, DOI 10.2165/00139709-200524020-00003; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; Currier R, 2012, ANN NY ACAD SCI, V1230, pE50; Dagleish MP, 2007, J WILDLIFE DIS, V43, P512, DOI 10.7589/0090-3558-43.3.512; Damriyasa IM, 2004, MED VET ENTOMOL, V18, P361, DOI 10.1111/j.0269-283X.2004.00520.x; FAIN A, 1994, INT J PARASITOL, V24, P1273, DOI 10.1016/0020-7519(94)90194-5; FAIN A, 1978, INT J DERMATOL, V17, P20, DOI 10.1111/j.1365-4362.1978.tb06040.x; Feanneret LA, 2007, SWISS MED WKLY, V137, P695, DOI 2007/49/smw-11904; Felt SA, 2009, J ZOO WILDLIFE MED, V40, P217, DOI 10.1638/2008-0138.1; Fthenakis GC, 2001, VET PARASITOL, V95, P63, DOI 10.1016/S0304-4017(00)00417-9; Fuller LC, 2013, CURR OPIN INFECT DIS, V26, P123, DOI 10.1097/QCO.0b013e32835eb851; Gilmore SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015990; Gu XB, 2008, INT J ACAROL, V34, P183, DOI 10.1080/01647950808683722; Haas N, 2005, ARCH DERMATOL RES, V296, P327, DOI 10.1007/s00403-004-0524-x; Hay RJ, 2012, CLIN MICROBIOL INFEC, V18, P313, DOI 10.1111/j.1469-0691.2012.03798.x; Holt DC, 2013, CURR OPIN INFECT DIS, V26, P110, DOI 10.1097/QCO.0b013e32835eb986; Kenawi Mohamed Z., 1993, Journal of the Egyptian Society of Parasitology, V23, P247; Mazyad Said A. M., 2001, Journal of the Egyptian Society of Parasitology, V31, P213; Morsy Tosson A., 2003, Journal of the Egyptian Society of Parasitology, V33, P47; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Mounsey KE, 2013, TRENDS PARASITOL, V29, P35, DOI 10.1016/j.pt.2012.09.006; Nimmervoll H, 2013, J WILDLIFE DIS, V49, P91, DOI 10.7589/2010-11-316; Nofal A, 2009, J EUR ACAD DERMATOL, V23, P793, DOI 10.1111/j.1468-3083.2009.03177.x; Osman SA, 2006, VET PARASITOL, V141, P191, DOI 10.1016/j.vetpar.2006.04.039; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; RAFFERTY DE, 1987, J PARASITOL, V73, P901, DOI 10.2307/3282508; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson H, 2007, AQUAT TOXICOL, V85, P229, DOI 10.1016/j.aquatox.2007.08.011; Skerratt LF, 2002, PARASITOL RES, V88, P376, DOI 10.1007/s00436-001-0556-5; TARRY DW, 1974, VET REC, V95, P530, DOI 10.1136/vr.95.23.530; Terry BC, 2001, PUBLIC HEALTH, V115, P208, DOI 10.1016/S0033-3506(01)00445-0; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 1999, AM J TROP MED HYG, V61, P542, DOI 10.4269/ajtmh.1999.61.542; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Wells B, 2012, MOL CELL PROBE, V26, P47, DOI 10.1016/j.mcp.2011.07.002; Yassin Mohammad K., 2011, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V41, P55; Zahler M, 1999, INT J PARASITOL, V29, P759, DOI 10.1016/S0020-7519(99)00034-X	46	22	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94705	10.1371/journal.pone.0094705	http://dx.doi.org/10.1371/journal.pone.0094705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728386	Green Submitted, gold, Green Published			2022-12-25	WOS:000336736200116
J	Castonguay, A; Thomas, S; Lesage, F; Casanova, C				Castonguay, Alexandre; Thomas, Sebastien; Lesage, Frederic; Casanova, Christian			Repetitive and Retinotopically Restricted Activation of the Dorsal Lateral Geniculate Nucleus with Optogenetics	PLOS ONE			English	Article							OPTICAL-PROPERTIES; TRANSGENIC MICE; LIGHT DELIVERY; MOTOR CORTEX; BRAIN; PROBE; CHANNELRHODOPSIN-2; TECHNOLOGY; CIRCUITS	Optogenetics allows the control of cellular activity using focused delivery of light pulses. In neuroscience, optogenetic protocols have been shown to efficiently inhibit or stimulate neuronal activity with a high temporal resolution. Among the technical challenges associated with the use of optogenetics, one is the ability to target a spatially specific population of neurons in a given brain structure. To address this issue, we developed a side-illuminating optical fiber capable of delivering light to specific sites in a target nucleus with added flexibility through rotation and translation of the fiber and by varying the output light power. The designed optical fiber was tested in vivo in visual structures of ChR2-expressing transgenic mice. To assess the spatial extent of neuronal activity modulation, we took advantage of the hallmark of the visual system: its retinotopic organization. Indeed, the relative position of ganglion cells in the retina is transposed in the cellular topography of both the dorsal lateral geniculate nucleus (LGN) in the thalamus and the primary visual cortex (V1). The optical fiber was inserted in the LGN and by rotating it with a motor, it was possible to sequentially activate different neuronal populations within this structure. The activation of V1 neurons by LGN projections was recorded using intrinsic optical imaging. Increasing light intensity (from 1.4 to 8.9 mW/mm(2)) led to increasing activation surfaces in V1. Optogenetic stimulation of the LGN at different translational and rotational positions was associated with different activation maps in V1. The position and/or orientation of the fiber inevitably varied across experiments, thus limiting the capacity to pool data. With the optogenetic design presented here, we demonstrate for the first time a transitory and spatially-concise activation of a deep neuronal structure. The optogenetic design presented here thus opens a promising avenue for studying the function of deep brain structures.	[Castonguay, Alexandre; Thomas, Sebastien; Casanova, Christian] Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada; [Lesage, Frederic] Ecole Polytech, Montreal, PQ H3C 3A7, Canada	Universite de Montreal; Universite de Montreal; Polytechnique Montreal	Casanova, C (corresponding author), Univ Montreal, Ecole Optometrie, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	christian.casanova@umontreal.ca		Thomas, Sebastien/0000-0002-9263-2296	Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT) [165075]; Natural Sciences and Engineering Research Council of Canada (NSERC) [194670, 239876]; Fonds de Recherche en Sante du Quebec (FRSQ) vision network; Faculte des Etudes Superieures et Postdoctorales-Institut de Genie Biomedical (FESP-IGB) of the Universite de Montreal	Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche en Sante du Quebec (FRSQ) vision network; Faculte des Etudes Superieures et Postdoctorales-Institut de Genie Biomedical (FESP-IGB) of the Universite de Montreal	This work was supported by a Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT) grant # 165075 (Projet de recherche en equipe) to FL and CC and by Natural Sciences and Engineering Research Council of Canada (NSERC) grants #194670 and 239876 to CC and FL, respectively. AC was supported in part by scholarships from the Fonds de Recherche en Sante du Quebec (FRSQ) vision network and the Faculte des Etudes Superieures et Postdoctorales-Institut de Genie Biomedical (FESP-IGB) of the Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chalupa LM, 2008, EYE RETINA VISUAL SY; Chou K., 2011, DEEP BRAIN STIMULATI; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; FROSTIG RD, 1995, INT J IMAG SYST TECH, V6, P216, DOI 10.1002/ima.1850060212; George MS, 2007, TRANSCRANIAL MAGNETI; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Nishidate I, 2010, APPL OPTICS, V49, P6617, DOI 10.1364/AO.49.006617; Parpura V, 2013, J NEUROCHEM, V124, P436, DOI 10.1111/jnc.12105; Pashaie R, 2013, BIOMEDICAL ENG IEEE, V60, P268; Paxinos G, 2008, MOUSE BRAIN STREREOT; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Scott NA, 2012, PLOS ONE, V7, P176, DOI 10.1371/journal.pone.0029859; Stuber GD, 2013, PHARMACOL REV, V65, P156, DOI 10.1124/pr.111.005611; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016001; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zorzos AN, 2012, OPT LETT, V37, P4841, DOI 10.1364/OL.37.004841; Zorzos AN, 2010, OPT LETT, V35, P4133, DOI 10.1364/OL.35.004133	27	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94633	10.1371/journal.pone.0094633	http://dx.doi.org/10.1371/journal.pone.0094633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728275	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000336736200112
J	Laukkanen, L; Mutikainen, P; Muola, A; Leimu, R				Laukkanen, Liisa; Mutikainen, Pia; Muola, Anne; Leimu, Roosa			Plant-Species Diversity Correlates with Genetic Variation of an Oligophagous Seed Predator	PLOS ONE			English	Article							HOST-PLANT; POPULATION-STRUCTURE; LYGAEUS-EQUESTRIS; SPECIALIZED HERBIVORE; ONCOPELTUS-FASCIATUS; FEEDING BUG; DYNAMICS; SIZE; INSECT; MARKERS	Several characteristics of habitats of herbivores and their food-plant communities, such as plant-species composition and plant quality, influence population genetics of both herbivores and their host plants. We investigated how different ecological and geographic factors affect genetic variation in and differentiation of 23 populations of the oligophagous seed predator Lygaeus equestris (Heteroptera) in southwestern Finland and in eastern Sweden. We tested whether genetic differentiation of the L. equestris populations was related to the similarity of vegetation, and whether there was more within-population genetic variation in habitats with a high number of plant species or in those with a large population of the primary food plant, Vincetoxicum hirundinaria. We also tested whether genetic differentiation of the populations was related to the geographic distance, and whether location of the populations on islands or on mainland, island size, or population size affected within-population genetic variation. Pairwise FST ranged from 0 to 0.1 indicating low to moderate genetic differentiation of populations. Differentiation increased with geographic distance between the populations, but was not related to the similarity of vegetation between the habitats. Genetic variation within the L. equestris populations did not increase with the population size of the primary food plant. However, the more diverse the plant community the higher was the level of genetic variation within the L. equestris population. Furthermore, the level of genetic variation did not vary significantly between island and mainland populations. The effect of the population size on within-population genetic variation was related to island size. Usually small populations are susceptible to loss of genetic variation, but small L. equestris populations on large islands seemed to maintain a relatively high level of within-population genetic variation. Our findings suggest that, in addition to geographic and species-specific ecological factors, the plant community affects population genetic structure of oligophagous herbivores.	[Laukkanen, Liisa; Muola, Anne] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Mutikainen, Pia] ETH, Inst Integrat Biol, Zurich, Switzerland; [Leimu, Roosa] Univ Oxford, Dept Plant Sci, Oxford, England	University of Turku; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford	Laukkanen, L (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	liisa.laukkanen@utu.fi		Muola, Anne/0000-0003-1828-6425	Academy of Finland [109859, 138308]; Turku University Foundation; Betty Vaananen Fund; Societas Biologica Fennica Vanamo; Societas Pro Fauna et Flora Fennica; Finnish Cultural Foundation; North Savo Regional fund	Academy of Finland(Academy of Finland); Turku University Foundation; Betty Vaananen Fund; Societas Biologica Fennica Vanamo; Societas Pro Fauna et Flora Fennica; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); North Savo Regional fund	This study was financially supported by the grants 109859 and 138308 of the Academy of Finland (http://www.aka.fi) for RL, and grants of Turku University Foundation, Betty Vaananen Fund, Societas Biologica Fennica Vanamo, Societas Pro Fauna et Flora Fennica and Finnish Cultural Foundation, and North Savo Regional fund for LL The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; [Anonymous], 2006, SAS MIXED MODELS; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BACH CE, 1980, ECOLOGY, V61, P1515, DOI 10.2307/1939058; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; Colling G, 2004, OIKOS, V105, P71, DOI 10.1111/j.0030-1299.2004.12783.x; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Evans LM, 2013, EVOL ECOL, V27, P65, DOI 10.1007/s10682-012-9582-2; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; Gaudeul M, 2000, MOL ECOL, V9, P1625, DOI 10.1046/j.1365-294x.2000.01063.x; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hartl D., 2007, PRINCIPLES POPULATIO; Karlsson T, 2007, SMALANDS FLORA; Keese MC, 1998, J EVOLUTION BIOL, V11, P403, DOI 10.1007/s000360050096; Kelley ST, 2000, HEREDITY, V84, P218, DOI 10.1046/j.1365-2540.2000.00662.x; Kneeland K, 2012, ENTOMOL EXP APPL, V143, P120, DOI 10.1111/j.1570-7458.2012.01239.x; Krumm JT, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.7201; KUGELBERG O, 1973, Entomologica Scandinavica, V4, P181; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Laukkanen L, 2013, J EVOLUTION BIOL, V26, P141, DOI 10.1111/jeb.12037; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Leimu R, 2002, OIKOS, V98, P229, DOI 10.1034/j.1600-0706.2002.980205.x; LOWE AS, 2004, ECOLOGICAL GENETICS; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Magalhaes IS, 2011, MOL ECOL, V20, P4618, DOI 10.1111/j.1365-294X.2011.05296.x; MCCAULEY DE, 1991, EVOLUTION, V45, P1675, DOI 10.1111/j.1558-5646.1991.tb02672.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; MICHALAKIS Y, 1993, EVOLUTION, V47, P1611, DOI 10.1111/j.1558-5646.1993.tb02180.x; Mopper S, 2000, ECOLOGY, V81, P1577, DOI 10.1890/0012-9658(2000)081[1577:SVILPS]2.0.CO;2; Muola A, 2010, ECOLOGY, V91, P2650, DOI 10.1890/09-0589.1; Nei M., 1987, MOL EVOLUTIONARY GEN; NEVO E, 1978, THEOR POPUL BIOL, V13, P121, DOI 10.1016/0040-5809(78)90039-4; Pekkala N, 2012, ECOL EVOL, V2, P1791, DOI 10.1002/ece3.293; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; RALPH CP, 1977, ANN ENTOMOL SOC AM, V70, P337, DOI 10.1093/aesa/70.3.337; RALPH CP, 1977, ECOLOGY, V58, P799, DOI 10.2307/1936215; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Rintala T, 2010, SUOMEN LUTEET; Rydberg H., 2001, SORMLANDS FLORA; Schoonhoven L. M., 2005, Insect-plant biology; SILLENTULLBERG B, 1983, HEREDITAS, V99, P153, DOI 10.1111/j.1601-5223.1983.tb00741.x; SILLENTULLBERG B, 1990, OIKOS, V58, P210, DOI 10.2307/3545428; Singer MS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P29; SOLBRECK C, 1995, RES POPUL ECOL, V37, P129, DOI 10.1007/BF02515770; SOLBRECK C, 1986, OECOLOGIA, V71, P51, DOI 10.1007/BF00377320; SOLBRECK C, 1972, Entomologica Scandinavica, V3, P189; SOLBRECK C, 1990, OIKOS, V58, P199, DOI 10.2307/3545427; SOLBRECK C, 1971, Acta Entomologica Fennica, V28, P74; Solbreck Christer, 1995, P279, DOI 10.1016/B978-012159270-7/50015-4; SOUTHWOOD T.R.E., 1959, LAND WATER BUGS BRIT; Stanton M.L., 1983, P125; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wright S., 1978, EVOLUTION GENETICS P, V4; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	67	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94105	10.1371/journal.pone.0094105	http://dx.doi.org/10.1371/journal.pone.0094105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728342	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200038
J	Yang, XW; Yang, J; Li, L; Yan, XZ; Zhang, BH; Shen, F; Wu, MC				Yang, Xin-wei; Yang, Jue; Li, Liang; Yan, Xing-zhou; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao			The Outcome of Ipsilateral Hemihepatectomy in Mucin-Producing Bile Duct Tumors	PLOS ONE			English	Article							BILIARY PAPILLOMATOSIS; PATHOLOGICAL FEATURES; PAPILLARY NEOPLASM; HEPATOLITHIASIS; EXPRESSION; PANCREAS; LESIONS; TRACT; LIVER	Background: Mucin-producing bile duct tumors (MPBTs) are unusual, and we present our experience with nine surgically proven cases. Methods: Between November 2002 and November 2012, 9 patients with surgically proven MPBTs (including history of relevant hepatobiliary surgery in 6 patients) were encountered. Their clinical, imaging, and surgical findings were reviewed. Results: The most common symptom is intermittent jaundice, which occurs in seven patients. The diagnostic specificity was 77.8% by preoperative Magnetic Resonance Cholangiopancreatography (MRCP). All the patients underwent ipsilateral hemihepatectomy or remnant hemihepatectomy, accompanied caudate lobectomy in one case and concomitant Roux-en-Y choledochojejunostomy in four cases. Postoperative course was uneventful. One patient, who had intra-abdominal recurrence 59 months after surgery, was received reoperation without recurrence at the last follow-up. The remaining eight patients were alive without disease recurrence. Conclusion: Based on our follow up of 9 cases that were surgically treated for MPBTs, we conclude that ipsilateral hemihepatectomy is a safe surgical procedure with an observed recurrence risk of 11.1% and all long-term survival.	[Yang, Xin-wei; Yang, Jue; Li, Liang; Yan, Xing-zhou; Zhang, Bao-hua; Shen, Feng; Wu, Meng-chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University	Zhang, BH (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	weicelia@163.com; shenfengdfgd@yahoo.com.cn	Shen, Feng/GSD-2508-2022; Li, Liang/AAY-9298-2020	Li, Liang/0000-0002-9410-6513				Amaya S, 2001, HISTOPATHOLOGY, V38, P550, DOI 10.1046/j.1365-2559.2001.01103.x; Chen MF, 1998, ANN SURG, V227, P63, DOI 10.1097/00000658-199801000-00010; Chen TC, 2001, HEPATOLOGY, V34, P651, DOI 10.1053/jhep.2001.28199; Jang KT, 2008, VIRCHOWS ARCH, V453, P589, DOI 10.1007/s00428-008-0682-x; Kim HJ, 2000, ENDOSCOPY, V32, P389, DOI 10.1055/s-2000-8996; Kloppel G, 2006, J HEPATOL, V44, P249, DOI 10.1016/j.jhep.2005.11.035; Lee SS, 2004, CANCER-AM CANCER SOC, V100, P783, DOI 10.1002/cncr.20031; Lim J, 2010, J HEPATO-BIL-PAN SCI, V17, P223, DOI 10.1007/s00534-009-0154-y; Lim JH, 2004, RADIOGRAPHICS, V24, P53, DOI 10.1148/rg.241035002; Nakanuma Y, 2002, HISTOL HISTOPATHOL, V17, P851, DOI 10.14670/HH-17.851; Nakanuma Y, 2010, J HEPATO-BIL-PAN SCI, V17, P211, DOI 10.1007/s00534-009-0158-7; Ohtsuka M, 2010, J HEPATO-BIL-PAN SCI, V17, P236, DOI 10.1007/s00534-009-0152-0; Rouzbahman M, 2007, PATHOLOGY, V39, P413, DOI 10.1080/00313020701444531; Sakamoto E, 1999, WORLD J SURG, V23, P1038, DOI 10.1007/s002689900620; Shibahara H, 2004, AM J SURG PATHOL, V28, P327, DOI 10.1097/00000478-200403000-00005; SHORVON PJ, 1984, BRIT J SURG, V71, P694, DOI 10.1002/bjs.1800710916; Takanami K, 2011, ABDOM IMAGING, V36, P447, DOI 10.1007/s00261-010-9649-x; Terris B, 2002, J PATHOL, V197, P632, DOI 10.1002/path.1146; Yeh TS, 2006, ANN SURG, V244, P248, DOI 10.1097/01.sla.0000217636.40050.54; Zen Y, 2005, PATHOL INT, V55, P180, DOI 10.1111/j.1440-1827.2005.01816.x; Zen Y, 2006, HEPATOLOGY, V44, P1333, DOI 10.1002/hep.21387	21	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92010	10.1371/journal.pone.0092010	http://dx.doi.org/10.1371/journal.pone.0092010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727803	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200007
J	Baumgartner, S; Tolic, IM				Baumgaertner, Stephan; Tolic, Iva M.			Astral Microtubule Pivoting Promotes Their Search for Cortical Anchor Sites during Mitosis in Budding Yeast	PLOS ONE			English	Article							MITOTIC SPINDLE; DYNEIN; ORIENTATION; MECHANISM; KAR9	Positioning of the mitotic spindle is crucial for proper cell division. In the budding yeast Saccharomyces cerevisiae, two mechanisms contribute to spindle positioning. In the Kar9 pathway, astral microtubules emanating from the daughter-bound spindle pole body interact via the linker protein Kar9 with the myosin Myo2, which moves the microtubule along the actin cables towards the neck. In the dynein pathway, astral microtubules off-load dynein onto the cortical anchor protein Num1, which is followed by dynein pulling on the spindle. Yet, the mechanism by which microtubules target cortical anchor sites is unknown. Here we quantify the pivoting motion of astral microtubules around the spindle pole bodies, which occurs during spindle translocation towards the neck and through the neck. We show that this pivoting is largely driven by the Kar9 pathway. The microtubules emanating from the daughter-bound spindle pole body pivot faster than those at the mother-bound spindle pole body. The Kar9 pathway reduces the time needed for an astral microtubule inside the daughter cell to start pulling on the spindle. Thus, we propose a new role for microtubule pivoting: By pivoting around the spindle pole body, microtubules explore the space laterally, which helps them search for cortical anchor sites in the context of spindle positioning in budding yeast.	[Baumgaertner, Stephan; Tolic, Iva M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Tolic, Iva M.] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	Max Planck Society; Rudjer Boskovic Institute	Tolic, IM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	tolic@mpi-cbg.de	Tolić, Iva/F-1704-2014	Tolić, Iva/0000-0003-1305-7922	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society, http://www.mpg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Berg, 2018, RANDOM WALKS BIOL; BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Gerson-Gurwitz A, 2009, CELL MOL LIFE SCI, V66, P301, DOI 10.1007/s00018-008-8479-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Markus SM, 2012, EXP CELL RES, V318, P1400, DOI 10.1016/j.yexcr.2012.04.006; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Pavin N, 2014, SYST SYNTH BIOL; Pavin N, 2013, BIOCHEM SOC T, V41, P1731, DOI 10.1042/BST20130235; R Core Team, 2021, R LANG ENV STAT COMP; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93781	10.1371/journal.pone.0093781	http://dx.doi.org/10.1371/journal.pone.0093781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721997	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100024
J	Ho-Pham, LT; Lai, TQ; Mai, LD; Doan, MC; Pham, HN; Nguyen, TV				Ho-Pham, Lan T.; Lai, Thai Q.; Mai, Linh D.; Doan, Minh C.; Pham, Hoa N.; Nguyen, Tuan V.			Prevalence of Radiographic Osteoarthritis of the Knee and Its Relationship to Self-Reported Pain	PLOS ONE			English	Article							GENERAL-POPULATION; SEX-DIFFERENCES; OLDER-ADULTS; RISK-FACTORS; EPIDEMIOLOGY; OBESITY; IMPACT	Background and Aim: Osteoarthritis (OA) of the knee is one of the most common skeletal disorders, yet little data are available in Asian populations. We sought to assess the prevalence and pattern of radiographic OA of the knee, and its relationship to self-reported pain in a Vietnamese population. Methods: The study was based on a sample of 170 men and 488 women aged >= 40 years who were randomly sampled from the Ho Chi Minh City (Vietnam). Radiographs of the knee were graded from 0 to 4 according to the Kellgren and Lawrence scale. Osteoarthritis was defined as being present in a knee if radiographic grades of 2 or higher were detected. Knee pain and symptoms were ascertained by direct interview using a structured questionnaire. Results: The point prevalence of radiographic OA of the knee was 34.2%, with women having higher rate than men (35.3% vs 31.2%). The prevalence of knee OA increased with advancing age: 8% among those aged 40-49 years, 30% in those aged 50-59 years, and 61.1% in those aged >= 60 years. Greater BMI was associated with higher risk of knee OA. Self-reported knee pain was found in 35% of men and 62% of women. There was a statistically significant association between self-reported knee pain and knee OA (prevalence ratio 3.1; 95% CI 2.0 to 4.6). Conclusions: These data indicate that approximately a third of Vietnamese men and women have radiographic OA in the knee, and that self-reported knee pain may be used as an indicator of knee osteoarthritis.	[Ho-Pham, Lan T.; Nguyen, Tuan V.] Ton Duc Thang Univ, Fac Sci Appl, Div Bone & Muscle Res, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.; Mai, Linh D.; Doan, Minh C.; Pham, Hoa N.] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.; Lai, Thai Q.] Peoples Hosp 115, Dept Rheumatol, Ho Chi Minh City, Vietnam; [Nguyen, Tuan V.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia	Ton Duc Thang University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Technology Sydney	Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Fac Sci Appl, Div Bone & Muscle Res, Ho Chi Minh City, Vietnam.	thuclanhopham@pnt.edu.vn	Nguyen, Tuan V./AAD-9503-2020	Nguyen, Tuan V./0000-0002-3246-6281	Department of Science and Technology, Ho Chi Minh City; University Commission for Development (CUD) program, Belgium; Australian National Health and Medical Research Council	Department of Science and Technology, Ho Chi Minh City(Department of Science & Technology (India)); University Commission for Development (CUD) program, Belgium; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was partially supported by a grant from the Department of Science and Technology, Ho Chi Minh City, and a grant from the University Commission for Development (CUD) program, Belgium. Professor T. V. Nguyen is supported by a fellowship of the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Conde J, 2011, ARTHRITIS, DOI 10.1155/2011/203901; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; Donald IP, 2004, RHEUMATOLOGY, V43, P1256, DOI 10.1093/rheumatology/keh298; Du H, 2005, RHEUMATOL INT, V25, P585, DOI 10.1007/s00296-004-0492-7; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132; GUNN DR, 1964, J BONE JOINT SURG BR, V46, P156; Hoa TTM, 2003, J RHEUMATOL, V30, P2252; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Kinsella K, 2009, AGEING WORLD; Lacey RJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-82; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; March LM, 1998, OSTEOARTHR CARTILAGE, V6, P87, DOI 10.1053/joca.1997.0098; Miro J, 2007, EUR J PAIN, V11, P83, DOI 10.1016/j.ejpain.2006.01.001; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; R Core Team, 2022, R LANG ENV STAT COMP; Shiozaki H, 1999, KNEE, V6, P183, DOI 10.1016/S0968-0160(99)00011-3; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Thiem U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060753; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Zeng QY, 2006, CHINESE MED J-PEKING, V119, P1522, DOI 10.1097/00029330-200609020-00004; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z	37	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94563	10.1371/journal.pone.0094563	http://dx.doi.org/10.1371/journal.pone.0094563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722559	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100097
J	Zhao, CL; Mahboobi, SH; Moussavi-Baygi, R; Mofrad, MRK				Zhao, Charles L.; Mahboobi, Seyed Hanif; Moussavi-Baygi, Ruhollah; Mofrad, Mohammad R. K.			The Interaction of CRM1 and the Nuclear Pore Protein Tpr	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NUCLEOCYTOPLASMIC TRANSPORT; CONFORMATIONAL-CHANGES; MOLECULAR SIMULATIONS; EXPORT RECEPTOR; COMPLEX; PREDICTION; DYNAMICS; SURFACE; IMPORT	While much has been devoted to the study of transport mechanisms through the nuclear pore complex (NPC), the specifics of interactions and binding between export transport receptors and the NPC periphery have remained elusive. Recent work has demonstrated a binding interaction between the exportin CRM1 and the unstructured carboxylic tail of Tpr, on the nuclear basket. Strong evidence suggests that this interaction is vital to the functions of CRM1. Using molecular dynamics simulations and a newly refined method for determining binding regions, we have identified nine candidate binding sites on CRM1 for C-Tpr. These include two adjacent to RanGTP - from which one is blocked in the absence of RanGTP - and three next to the binding region of the cargo Snurportin. We report two additional interaction sites between C-Tpr and Snurportin, suggesting a possible role for Tpr import into the nucleus. Using bioinformatics tools we have conducted conservation analysis and functional residue prediction investigations to identify which parts of the obtained binding sites are inherently more important and should be highlighted. Also, a novel measure based on the ratio of available solvent accessible surface (RASAS) is proposed for monitoring the ligand/receptor binding process.	[Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu		Zhao, Charles/0000-0001-6266-5735; Mahboobi, Seyed Hanif/0000-0003-1249-6018	XSEDE supercomputing system [TG-MCB100146]; Texas Advanced Computing Center (TACC); San Diego Supercomputer Center (SDSC)	XSEDE supercomputing system; Texas Advanced Computing Center (TACC); San Diego Supercomputer Center (SDSC)	Computational grants from the XSEDE supercomputing system (TG-MCB100146), especially the Texas Advanced Computing Center (TACC) and the San Diego Supercomputer Center (SDSC) are thankfully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2009, FEBS J, V276, P9; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Ben-Efraim I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-74; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Coyle JH, 2011, RNA, V17, P1344, DOI 10.1261/rna.2616111; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Lapalombella R, 2012, BLOOD; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Porollo A, 2012, PROTEIN-PROTEIN INTERACTIONS - COMPUTATIONAL AND EXPERIMENTAL TOOLS, P3; Rajanala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029921; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Shibata S, 2002, GENES CELLS, V7, P421, DOI 10.1046/j.1365-2443.2002.00525.x; Singh B, 2004, NUCLEIC ACIDS RES, V32, pW559, DOI 10.1093/nar/gkh472; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wente SR, 2010, COLD SPRING HARB PER; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zhang K, 2012, EXP HEMATOL; Zimowska G, 1997, J CELL SCI, V110, P927	55	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93709	10.1371/journal.pone.0093709	http://dx.doi.org/10.1371/journal.pone.0093709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722547	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100020
J	Zou, J; Yue, F; Li, WJ; Song, K; Jiang, XH; Yi, JL; Liu, LY				Zou, Jing; Yue, Fei; Li, Wenjiao; Song, Kun; Jiang, Xianhan; Yi, Jinglin; Liu, Leyuan			Autophagy Inhibitor LRPPRC Suppresses Mitophagy through Interaction with Mitophagy Initiator Parkin	PLOS ONE			English	Article							IN-VIVO; MITOCHONDRIAL; MICROTUBULE; PROTEIN; BCL-2; DISEASE; CANCER; RASSF1; DEGRADATION; MODULATION	Autophagy plays an important role in tumorigenesis. Mitochondrion-associated protein LRPPRC interacts with MAP1S that interacts with LC3 and bridges autophagy components with microtubules and mitochondria to affect autophagy flux. Dysfunction of LRPPRC and MAP1S is associated with poor survival of ovarian cancer patients. Furthermore, elevated levels of LRPPRC predict shorter overall survival in patients with prostate adenocarcinomas or gastric cancer. To understand the role of LRPPRC in tumor development, previously we reported that LRPPRC forms a ternary complex with Beclin 1 and Bcl-2 to inhibit autophagy. Here we further show that LRPPRC maintains the stability of Parkin that mono-ubiquitinates Bcl-2 to increase Bcl-2 stability to inhibit autophagy. Under mitophagy stress, Parkin translocates to mitochondria to cause rupture of outer mitochondrial membrane and bind with exposed LRPPRC. Consequently, LRPPRC and Parkin help mitochondria being engulfed in autophagosomes to be degraded. In cells under long-term mitophagy stress, both LRPPRC and Parkin become depleted coincident with disappearance of mitochondria and final autophagy inactivation due to depletion of ATG5-ATG12 conjugates. LRPPRC functions as a checkpoint protein that prevents mitochondria from autophagy degradation and impact tumorigenesis.	[Zou, Jing; Yue, Fei; Li, Wenjiao; Song, Kun; Jiang, Xianhan; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Zou, Jing; Yi, Jinglin] Nanchang Univ, Jiangxi Res Inst Ophthalmol & Visual Sci, Affiliated Eye Hosp, Nanchang, Jiangxi, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Nanchang University	Liu, LY (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	Li, Wenjiao/J-2198-2019; Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Zou, Jing/0000-0002-0976-7078; Song, Kun/0000-0003-3822-2891	DOD [W81XWH]; NCI [R01CA142862]; NATIONAL CANCER INSTITUTE [R01CA142862, P30CA016672] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOD New Investigator Award W81XWH and NCI R01CA142862 to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Galindo MF, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/131058; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kayaba H, 2000, J ALLERGY CLIN IMMUN, V106, pS40, DOI 10.1067/mai.2000.106060; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Li XS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0818-y; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Parr R, 2013, DISCOV MED, V15, P213; Plun-Favreau H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001257; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	48	26	28	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94903	10.1371/journal.pone.0094903	http://dx.doi.org/10.1371/journal.pone.0094903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722279	Green Submitted, gold, Green Published			2022-12-25	WOS:000336909100145
J	Lin, W; Wang, Y; Han, XB; Zhang, ZL; Wang, CY; Wang, J; Yang, HY; Lu, YH; Jiang, WH; Zhao, GP; Zhang, P				Lin, Wei; Wang, Ying; Han, Xiaobiao; Zhang, Zilong; Wang, Chengyuan; Wang, Jin; Yang, Huaiyu; Lu, Yinhua; Jiang, Weihong; Zhao, Guo-Ping; Zhang, Peng			Atypical OmpR/PhoB Subfamily Response Regulator GlnR of Actinomycetes Functions as a Homodimer, Stabilized by the Unphosphorylated Conserved Asp-focused Charge Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actinobacteria; Crystal Structure; Gene Regulation; Phosphorylation; Protein Conformation; OmpR; PhoB Subfamily; Homodimer; Receiver Domain; Unphosphorylated Aspartate	2-COMPONENT SIGNAL-TRANSDUCTION; AMYCOLATOPSIS-MEDITERRANEI U32; STREPTOMYCES-COELICOLOR A3(2); MYCOBACTERIUM-TUBERCULOSIS; NITROGEN-METABOLISM; RECEIVER DOMAIN; ACTIVATION; MECHANISM; PHOSPHORYLATION; TRANSCRIPTION	Background: Orphan response transcription factor GlnR regulates nitrogen metabolism in important actinomycetes. Results: GlnR has no typical phosphorylation pocket, where the only conserved Asp is unphosphorylated but is essential for functional homodimerization. Conclusion: Actinomycete GlnR is an atypical response regulator functioning as a homodimer. Significance: Conserved Asp-focused charge interactions of actinomycete GlnR are probably the mechanism that stabilizes the homodimer for physiological function. The OmpR/PhoB subfamily protein GlnR of actinomycetes is an orphan response regulator that globally coordinates the expression of genes related to nitrogen metabolism. Biochemical and genetic analyses reveal that the functional GlnR from Amycolatopsis mediterranei is unphosphorylated at the potential phosphorylation Asp(50) residue in the N-terminal receiver domain. The crystal structure of this receiver domain demonstrates that it forms a homodimer through the 4-5-5 dimer interface highly similar to the phosphorylated typical response regulator, whereas the so-called phosphorylation pocket is not conserved, with its space being occupied by an Arg(52) from the 3-3 loop. Both in vitro and in vivo experiments confirm that GlnR forms a functional homodimer via its receiver domain and suggest that the charge interactions of Asp(50) with the highly conserved Arg(52) and Thr(9) in the receiver domain may be crucial in maintaining the proper conformation for homodimerization, as also supported by molecular dynamics simulations of the wild type GlnR versus the deficient mutant GlnR(D50A). This model is backed by the distinct phenotypes of the total deficient GlnR(R52A/T9A) double mutant versus the single mutants of GlnR (i.e. D50N, D50E, R52A and T9A), which have only minor effects upon both dimerization and physiological function of GlnR in vivo, albeit their DNA binding ability is weakened compared with that of the wild type. By integrating the supportive data of GlnRs from the model Streptomyces coelicolor and the pathogenic Mycobacterium tuberculosis, we conclude that the actinomycete GlnR is atypical with respect to its unphosphorylated conserved Asp residue being involved in the critical Arg/Asp/Thr charge interactions, which is essential for maintaining the biologically active homodimer conformation.	[Lin, Wei; Wang, Ying; Han, Xiaobiao; Zhang, Zilong; Wang, Jin; Lu, Yinhua; Jiang, Weihong; Zhao, Guo-Ping; Zhang, Peng] Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Wang, Chengyuan; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, State Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; [Wang, Ying; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Yang, Huaiyu] Chinese Acad Sci, Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhao, GP (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	gpzhao@sibs.ac.cn; pengzhang01@sibs.ac.cn	Wang, Jin/P-5458-2019; WANG, Jin/K-2085-2016	Wang, Jin/0000-0003-4008-9284; WANG, Jin/0000-0003-4008-9284; zhang, peng/0000-0003-0408-2923; Zhao, Guo-Ping/0000-0002-7621-6620	National Basic Research Program of China [2012CB721102]; National Nature Science Foundation [31322016, 31121001, 30830002]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012OHTP, 2009CSP001, KSCX2-EW-J-12]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by National Basic Research Program of China Grant 2012CB721102; National Nature Science Foundation Grants 31322016, 31121001, and 30830002; and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grants 2012OHTP, 2009CSP001, and KSCX2-EW-J-12.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; Appleby JL, 1999, MOL MICROBIOL, V34, P915, DOI 10.1046/j.1365-2958.1999.01653.x; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Darbon E, 2012, APPL MICROBIOL BIOT, V95, P1553, DOI 10.1007/s00253-012-3995-2; Ding Xiao-Ming, 2002, Sheng Wu Gong Cheng Xue Bao, V18, P431; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2006, J BACTERIOL, V188, P5204, DOI 10.1128/JB.00387-06; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Jenkins VA, 2012, FEMS MICROBIOL LETT, V330, P38, DOI 10.1111/j.1574-6968.2012.02530.x; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; KIESER T, 1991, METHOD ENZYMOL, V204, P430; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lewis Richard A, 2011, BMC Res Notes, V4, P78, DOI 10.1186/1756-0500-4-78; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Mejia A, 1998, J ANTIBIOT, V51, P58, DOI 10.7164/antibiotics.51.58; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; O'Connor TJ, 2005, J MOL BIOL, V351, P1030, DOI 10.1016/j.jmb.2005.06.053; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Sheridan R. C., 2007, INORG SYN, P23; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Tiffert Y, 2011, APPL MICROBIOL BIOT, V89, P1149, DOI 10.1007/s00253-011-3086-9; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Wang J, 2009, BIOCHEM BIOPH RES CO, V386, P77, DOI 10.1016/j.bbrc.2009.05.147; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang Y, 2013, J BACTERIOL, V195, P2595, DOI 10.1128/JB.00182-13; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu H, 2006, ACTA BIOCH BIOPH SIN, V38, P831, DOI 10.1111/j.1745-7270.2006.00238.x; Zhao W, 2010, CELL RES, V20, P1096, DOI 10.1038/cr.2010.87	54	24	25	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15413	15425		10.1074/jbc.M113.543504	http://dx.doi.org/10.1074/jbc.M113.543504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733389	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000337465400025
J	Thomas, S; Underwood, JG; Tseng, E; Holloway, AK				Thomas, Sean; Underwood, Jason G.; Tseng, Elizabeth; Holloway, Alisha K.		Bench Basinet CvDC Informatics	Long-Read Sequencing of Chicken Transcripts and Identification of New Transcript Isoforms	PLOS ONE			English	Article							HUMAN GENOME; GENE-EXPRESSION; DNA ELEMENTS; ENCYCLOPEDIA; MODENCODE; ALIGNMENT; EVOLUTION; RNA	The chicken has long served as an important model organism in many fields, and continues to aid our understanding of animal development. Functional genomics studies aimed at probing the mechanisms that regulate development require high-quality genomes and transcript annotations. The quality of these resources has improved dramatically over the last several years, but many isoforms and genes have yet to be identified. We hope to contribute to the process of improving these resources with the data presented here: a set of long cDNA sequencing reads, and a curated set of new genes and transcript isoforms not currently represented in the most up-to-date genome annotation currently available to the community of researchers who rely on the chicken genome.	[Thomas, Sean; Holloway, Alisha K.] Gladstone Inst, San Francisco, CA 94158 USA; [Thomas, Sean; Holloway, Alisha K.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Underwood, Jason G.] Univ Washington, Seattle, WA 98195 USA; [Underwood, Jason G.; Tseng, Elizabeth] Pacific Biosci, Menlo Pk, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Thomas, S (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	sean.thomas@gladstone.ucsf.edu			Bench to Bassinet Program (B2B) [U01-HL098188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098188] Funding Source: NIH RePORTER	Bench to Bassinet Program (B2B); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Bench to Bassinet Program (B2B) award number U01-HL098188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Anonymous, 1998, GENOME SEQUENCE OF T, V0282; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubbard SJ, 2005, GENOME RES, V15, P174, DOI 10.1101/gr.3011405; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Semina EV, 2001, HUM MOL GENET, V10, P231, DOI 10.1093/hmg/10.3.231; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	23	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94650	10.1371/journal.pone.0094650	http://dx.doi.org/10.1371/journal.pone.0094650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736250	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600078
J	Galbany, J; Romero, A; Mayo-Aleson, M; Itsoma, F; Gamarra, B; Perez-Perez, A; Willaume, E; Kappeler, PM; Charpentier, MJE				Galbany, Jordi; Romero, Alejandro; Mayo-Aleson, Mercedes; Itsoma, Fiacre; Gamarra, Beatriz; Perez-Perez, Alejandro; Willaume, Eric; Kappeler, Peter M.; Charpentier, Marie J. E.			Age-Related Tooth Wear Differs between Forest and Savanna Primates	PLOS ONE			English	Article							DENTAL MICROWEAR; MOLAR WEAR; FUNCTIONAL-MORPHOLOGY; MANDRILLUS-SPHINX; LEMUR-CATTA; WILD; LIFE; DIETARY; TOPOGRAPHY; BEHAVIOR	Tooth wear in primates is caused by aging and ecological factors. However, comparative data that would allow us to delineate the contribution of each of these factors are lacking. Here, we contrast age-dependent molar tooth wear by scoring percent of dentine exposure (PDE) in two wild African primate populations from Gabonese forest and Kenyan savanna habitats. We found that forest-dwelling mandrills exhibited significantly higher PDE with age than savanna yellow baboons. Mandrills mainly feed on large tough food items, such as hard-shell fruits, and inhabit an ecosystem with a high presence of mineral quartz. By contrast, baboons consume large amounts of exogenous grit that adheres to underground storage organs but the proportion of quartz in the soils where baboons live is low. Our results support the hypothesis that not only age but also physical food properties and soil composition, particularly quartz richness, are factors that significantly impact tooth wear. We further propose that the accelerated dental wear in mandrills resulting in flatter molars with old age may represent an adaptation to process hard food items present in their environment.	[Galbany, Jordi] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Galbany, Jordi; Mayo-Aleson, Mercedes; Gamarra, Beatriz; Perez-Perez, Alejandro] Univ Barcelona, Seccio Antropol, Dept Biol Anim, Barcelona, Spain; [Romero, Alejandro] Univ Alicante, Dept Biotecnol, E-03080 Alicante, Spain; [Itsoma, Fiacre; Willaume, Eric] SODEPAL Soc Parc Exploitat Lekedi, COMILOG Soc, Bakoumba, Gabon; [Kappeler, Peter M.] German Primate Ctr DPZ, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Charpentier, Marie J. E.] CNRS, Ctr Ecol Fonct & Evolut UMR 5175, Montpellier 5, France	George Washington University; University of Barcelona; Universitat d'Alacant; Deutsches Primatenzentrum (DPZ); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Galbany, J (corresponding author), George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA.	jgalbany@gwu.edu	Romero, Alejandro/J-9405-2014; Pérez-Pérez, Alejandro/K-6715-2014; Gamarra, Beatriz/J-1969-2017; Charpentier, Marie JE/A-5108-2016; Galbany, Jordi/K-8609-2017	Romero, Alejandro/0000-0002-5743-0613; Pérez-Pérez, Alejandro/0000-0002-1442-1397; Gamarra, Beatriz/0000-0003-3764-497X; Galbany, Jordi/0000-0001-6724-3451; Charpentier, Marie/0000-0001-6530-5874	Ministerio de Investigacion, desarrollo e innovacion, Spanish project [CGL2011-22999]; Deutsche Forschungsgemeinschaft (DFG) [KA 1082-20-1]; Station d'Etudes en Ecologie Globale (INEE-CNRS), Projets Exploratoires Pluridisciplinaires (PEPS)	Ministerio de Investigacion, desarrollo e innovacion, Spanish project; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Station d'Etudes en Ecologie Globale (INEE-CNRS), Projets Exploratoires Pluridisciplinaires (PEPS)	This work was supported by Ministerio de Investigacion, desarrollo e innovacion, Spanish project (CGL2011-22999, http://www.idi.mineco.gob.es/); Deutsche Forschungsgemeinschaft (DFG, KA 1082-20-1, http://www.dfg.de/); and Station d'Etudes en Ecologie Globale (INEE-CNRS), Projets Exploratoires Pluridisciplinaires (PEPS) 2012 (http://www.cnrs.fr/inee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Alberts Susan C., 2012, P261; Altmann J, 2010, ANN NY ACAD SCI, V1204, P127, DOI 10.1111/j.1749-6632.2010.05531.x; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Berthaume MA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0240; Bunn JM, 2009, AM J PRIMATOL, V71, P466, DOI 10.1002/ajp.20676; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; Cuozzo FP, 2006, J HUM EVOL, V51, P490, DOI 10.1016/j.jhevol.2006.07.001; Cuozzo FP, 2012, AM J PHYS ANTHROPOL, V148, P163, DOI 10.1002/ajpa.21656; Daegling DJ, 2007, AM J PHYS ANTHROPOL, V134, P50, DOI 10.1002/ajpa.20621; Daegling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023095; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; Dennis JC, 2004, AM J PHYS ANTHROPOL, V125, P152, DOI 10.1002/ajpa.10379; Estebaranz F, 2012, J ANTHROPOL SCI, V90, P163, DOI [10.4436/JASS.90006, 10.4436/jass.90006]; Fleagle JG, 2002, J HUM EVOL, V42, P267, DOI 10.1006/jhev.2001.0526; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Glowacka H, 2013, AM J PHYS ANTHROPOL, V150, P131; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; LAHM SA, 1986, AM J PRIMATOL, V11, P9, DOI 10.1002/ajp.1350110103; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; Logan M, 2002, J ZOOL, V256, P63, DOI 10.1017/S0952836902000080; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Lucas PW, 2012, J R SOC INTERFACE, V9, P34, DOI 10.1098/rsif.2011.0188; LUKE DA, 1983, J ORAL REHABIL, V10, P197, DOI 10.1111/j.1365-2842.1983.tb00113.x; McGraw WS, 2011, AM J PHYS ANTHROPOL, V144, P140, DOI 10.1002/ajpa.21402; Peignot P, 2008, ORYX, V42, P122, DOI 10.1017/S0030605308000136; Phillips-Conroy JE, 2001, OLD WORLD MONKEYS, P321; PHILLIPSCONROY JE, 1988, AM J PRIMATOL, V15, P17, DOI 10.1002/ajp.1350150104; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Rogers ME, 1996, AM J PRIMATOL, V40, P297, DOI 10.1002/(SICI)1098-2345(1996)40:4<297::AID-AJP1>3.0.CO;2-T; Romero A, 2012, AM J PHYS ANTHROPOL, V148, P467, DOI 10.1002/ajpa.22054; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Setchell JM, 2004, FOLIA PRIMATOL, V75, P121, DOI 10.1159/000078302; Teaford MF, 2006, AM J PHYS ANTHROPOL, V129, P99, DOI 10.1002/ajpa.20225; Teaford MF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P433; TEAFORD MF, 1989, J DENT RES, V68, P1513, DOI 10.1177/00220345890680110901; Ungar PS, 2005, P NATL ACAD SCI USA, V102, P16533, DOI 10.1073/pnas.0508642102; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Veiberg V, 2007, BIOLOGY LETT, V3, P268, DOI 10.1098/rsbl.2006.0610; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; White EC, 2010, INT J PRIMATOL, V31, P627, DOI 10.1007/s10764-010-9417-3; Yamashita N, 1998, AM J PHYS ANTHROPOL, V106, P169, DOI 10.1002/(SICI)1096-8644(199806)106:2<169::AID-AJPA5>3.3.CO;2-O; Yamashita N, 2012, AM J PHYS ANTHROPOL, V148, P205, DOI 10.1002/ajpa.21549; Yeakel JD, 2014, EVOLUTION, V68, P190, DOI 10.1111/evo.12240	54	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94938	10.1371/journal.pone.0094938	http://dx.doi.org/10.1371/journal.pone.0094938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732967	Green Published, gold			2022-12-25	WOS:000336970400134
J	Islam, MA; Waller, AS; Hug, LA; Provart, NJ; Edwards, EA; Mahadevan, R				Islam, M. Ahsanul; Waller, Alison S.; Hug, Laura A.; Provart, Nicholas J.; Edwards, Elizabeth A.; Mahadevan, Radhakrishnan			New Insights into Dehalococcoides mccartyi Metabolism from a Reconstructed Metabolic Network-Based Systems-Level Analysis of D. mccartyi Transcriptomes	PLOS ONE			English	Article							ETHENOGENES STRAIN 195; VINYL-CHLORIDE REDUCTASE; MICROARRAY ANALYSIS; GENOME SEQUENCE; GEOBACTER-SULFURREDUCENS; PRINCIPAL-COMPONENTS; ENERGY-CONSERVATION; ANAEROBIC BACTERIUM; GENE-EXPRESSION; DATA SETS	Organohalide respiration, mediated by Dehalococcoides mccartyi, is a useful bioremediation process that transforms ground water pollutants and known human carcinogens such as trichloroethene and vinyl chloride into benign ethenes. Successful application of this process depends on the fundamental understanding of the respiration and metabolism of D. mccartyi. Reductive dehalogenases, encoded by rdhA genes of these anaerobic bacteria, exclusively catalyze organohalide respiration and drive metabolism. To better elucidate D. mccartyi metabolism and physiology, we analyzed available transcriptomic data for a pure isolate (Dehalococcoides mccartyi strain 195) and a mixed microbial consortium (KB-1) using the previously developed pan-genome-scale reconstructed metabolic network of D. mccartyi. The transcriptomic data, together with available proteomic data helped confirm transcription and expression of the majority genes in D. mccartyi genomes. A composite genome of two highly similar D. mccartyi strains (KB-1 Dhc) from the KB-1 metagenome sequence was constructed, and operon prediction was conducted for this composite genome and other single genomes. This operon analysis, together with the quality threshold clustering analysis of transcriptomic data helped generate experimentally testable hypotheses regarding the function of a number of hypothetical proteins and the poorly understood mechanism of energy conservation in D. mccartyi. We also identified functionally enriched important clusters (13 for strain 195 and 11 for KB-1 Dhc) of co-expressed metabolic genes using information from the reconstructed metabolic network. This analysis highlighted some metabolic genes and processes, including lipid metabolism, energy metabolism, and transport that potentially play important roles in organohalide respiration. Overall, this study shows the importance of an organism's metabolic reconstruction in analyzing various "omics" data to obtain improved understanding of the metabolism and physiology of the organism.	[Islam, M. Ahsanul; Edwards, Elizabeth A.; Mahadevan, Radhakrishnan] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Provart, Nicholas J.; Edwards, Elizabeth A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Mahadevan, Radhakrishnan] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Waller, Alison S.] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Hug, Laura A.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of Toronto; University of Toronto; University of Toronto; European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley	Mahadevan, R (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	krishna.mahadevan@utoronto.ca	Edwards, Elizabeth/GXV-2307-2022; Mahadevan, Radhakrishnan/A-8502-2008	Mahadevan, Radhakrishnan/0000-0002-1270-9063; Islam, M. Ahsanul/0000-0001-9585-6263; Edwards, Elizabeth/0000-0002-8071-338X	University of Toronto; Natural Sciences and Engineering Research Council of Canada (NSERC); Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; United States Department of Defense Strategic Environmental Research and Development Program (SERDP); Ontario Graduate Scholarship (OGS); SERDP; Genome Canada; departmental faculty start-up funds	University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; United States Department of Defense Strategic Environmental Research and Development Program (SERDP); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); SERDP; Genome Canada(Genome Canada); departmental faculty start-up funds	This research was funded by the University of Toronto, the Natural Sciences and Engineering Research Council of Canada (NSERC), the Government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405) and the United States Department of Defense Strategic Environmental Research and Development Program (SERDP). MAI was funded by the Ontario Graduate Scholarship (OGS), the SERDP and Genome Canada funds to EAE and the departmental faculty start-up funds to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Bergman NH, 2007, APPL ENVIRON MICROB, V73, P846, DOI 10.1128/AEM.01686-06; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biel S, 1996, ARCH MICROBIOL, V166, P122, DOI 10.1007/s002030050365; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Clark NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001967; CURLEY GP, 1988, FEMS MICROBIOL LETT, V49, P295; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DRUMMOND AJ, 2010, GENEIOUS V 5 0; Duhamel M, 2004, APPL ENVIRON MICROB, V70, P5538, DOI 10.1128/AEM.70.9.5538-5545.2004; Duhamel M, 2006, FEMS MICROBIOL ECOL, V58, P538, DOI 10.1111/j.1574-6941.2006.00191.x; Edwards EA, 1997, BIOREMED SER, V4(3), P261; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Empadinhas N, 2004, J BACTERIOL, V186, P4075, DOI 10.1128/JB.186.13.4075-4084.2004; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Holscher T, 2003, APPL ENVIRON MICROB, V69, P2999, DOI 10.1128/AEM.69.5.2999-3001.2003; Hotelling H, 1933, J EDUC PSYCHOL, V24, P498, DOI 10.1037/h0070888; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hug L, 2012, THESIS U TORONTO TOR; Hug LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-327; Hug LA, 2011, APPL ENVIRON MICROB, V77, P5361, DOI 10.1128/AEM.00063-11; Islam MA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000887; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jayachandran G, 2004, ARCH MICROBIOL, V182, P498, DOI 10.1007/s00203-004-0734-9; Johnson DR, 2008, APPL ENVIRON MICROB, V74, P2864, DOI 10.1128/AEM.02208-07; Johnson DR, 2009, FEMS MICROBIOL LETT, V294, P198, DOI 10.1111/j.1574-6968.2009.01569.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kemp LE, 2002, P NATL ACAD SCI USA, V99, P6591, DOI 10.1073/pnas.102679799; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Krajmalnik-Brown R, 2004, APPL ENVIRON MICROB, V70, P6347, DOI 10.1128/AEM.70.10.6347-6351.2004; Kube M, 2005, NAT BIOTECHNOL, V23, P1269, DOI 10.1038/nbt1131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee PKH, 2006, APPL ENVIRON MICROB, V72, P6161, DOI 10.1128/AEM.01070-06; Lee PKH, 2012, APPL ENVIRON MICROB, V78, P1424, DOI 10.1128/AEM.06792-11; Lee PKH, 2011, ISME J, V5, P1014, DOI 10.1038/ismej.2010.202; Loffler FE, 2012, INT J SYSTEMATIC EVO; Macdonald NJ, 2012, NUCLEIC ACIDS RES, DOI [10.1093/nar/gks1335, DOI 10.1093/NAR/GKS1335]; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Magnuson JK, 1998, APPL ENVIRON MICROB, V64, P1270; Mahadevan R, 2008, OMICS, V12, P33, DOI 10.1089/omi.2007.0043; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marco-Urrea E, 2011, J BACTERIOL, V193, P5171, DOI 10.1128/JB.05120-11; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; McMurdie PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000714; Methe BA, 2005, APPL ENVIRON MICROB, V71, P2530, DOI 10.1128/AEM.71.5.2530-2538.2005; Morris RM, 2007, APPL ENVIRON MICROB, V73, P320, DOI 10.1128/AEM.02129-06; Morris RM, 2006, ENVIRON MICROBIOL, V8, P1499, DOI 10.1111/j.1462-2920.2006.01090.x; Muller JA, 2004, APPL ENVIRON MICROB, V70, P4880, DOI 10.1128/AEM.70.8.4880-4888.2004; Nelson D.L., 2006, LEHNINGER PRINCIPLES; Nijenhuis I, 2005, APPL ENVIRON MICROB, V71, P1664, DOI 10.1128/AEM.71.3.1664-1667.2005; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; PIRT SJ, 1982, ARCH MICROBIOL, V133, P300, DOI 10.1007/BF00521294; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Poritz M, 2013, FEMS MICROBIOL LETT, V343, DOI 10.1111/1574-6968.12160; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P5099, DOI 10.1021/es702912t; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P416, DOI 10.1021/es071455s; Ramsden NL, 2009, J MED CHEM, V52, P2531, DOI 10.1021/jm801475n; Richardson RE, 2002, ENVIRON SCI TECHNOL, V36, P2652, DOI 10.1021/es0157797; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Tang SQ, 2013, APPL ENVIRON MICROB, V79, P974, DOI 10.1128/AEM.01873-12; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Tas N, 2010, MICROB BIOTECHNOL, V3, P389, DOI 10.1111/j.1751-7915.2009.00147.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; THOMPSON J, 1995, J BACTERIOL, V177, P2505, DOI 10.1128/jb.177.9.2505-2512.1995; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Waller AS, 2012, APPL ENVIRON MICROB, V78, P1178, DOI 10.1128/AEM.06416-11; Waller AS, 2010, THESIS U TORONTO TOR; West KA, 2008, APPL ENVIRON MICROB, V74, P3533, DOI 10.1128/AEM.01835-07; Zhuang WQ, 2011, APPL ENV MICROBIOLOG	87	5	5	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94808	10.1371/journal.pone.0094808	http://dx.doi.org/10.1371/journal.pone.0094808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733489	Green Published, gold			2022-12-25	WOS:000336970400108
J	Vermehren-Schmaedick, A; Krueger, W; Jacob, T; Ramunno-Johnson, D; Balkowiec, A; Lidke, KA; Vu, TQ				Vermehren-Schmaedick, Anke; Krueger, Wesley; Jacob, Thomas; Ramunno-Johnson, Damien; Balkowiec, Agnieszka; Lidke, Keith A.; Vu, Tania Q.			Heterogeneous Intracellular Trafficking Dynamics of Brain-Derived Neurotrophic Factor Complexes in the Neuronal Soma Revealed by Single Quantum Dot Tracking	PLOS ONE			English	Article							AXONAL-TRANSPORT; PARTICLE TRACKING; ENDOCYTIC TRAFFICKING; ARTERIAL BARORECEPTOR; SURFACE TRAFFICKING; SENSORY NEURONS; TRKB RECEPTOR; LIVING CELLS; BDNF; ENDOSOMES	Accumulating evidence underscores the importance of ligand-receptor dynamics in shaping cellular signaling. In the nervous system, growth factor-activated Trk receptor trafficking serves to convey biochemical signaling that underlies fundamental neural functions. Focus has been placed on axonal trafficking but little is known about growth factor-activated Trk dynamics in the neuronal soma, particularly at the molecular scale, due in large part to technical hurdles in observing individual growth factor-Trk complexes for long periods of time inside live cells. Quantum dots (QDs) are intensely fluorescent nanoparticles that have been used to study the dynamics of ligand-receptor complexes at the plasma membrane but the value of QDs for investigating ligand-receptor intracellular dynamics has not been well exploited. The current study establishes that QD conjugated brain-derived neurotrophic factor (QD-BDNF) binds to TrkB receptors with high specificity, activates TrkB downstream signaling, and allows single QD tracking capability for long recording durations deep within the soma of live neurons. QD-BDNF complexes undergo internalization, recycling, and intracellular trafficking in the neuronal soma. These trafficking events exhibit little time-synchrony and diverse heterogeneity in underlying dynamics that include phases of sustained rapid motor transport without pause as well as immobility of surprisingly long-lasting duration (several minutes). Moreover, the trajectories formed by dynamic individual BDNF complexes show no apparent end destination; BDNF complexes can be found meandering over long distances of several microns throughout the expanse of the neuronal soma in a circuitous fashion. The complex, heterogeneous nature of neuronal soma trafficking dynamics contrasts the reported linear nature of axonal transport data and calls for models that surpass our generally limited notions of nuclear-directed transport in the soma. QD-ligand probes are poised to provide understanding of how the molecular mechanisms underlying intracellular ligand-receptor trafficking shape cell signaling under conditions of both healthy and dysfunctional neurological disease models.	[Vermehren-Schmaedick, Anke; Jacob, Thomas; Ramunno-Johnson, Damien; Vu, Tania Q.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Vermehren-Schmaedick, Anke; Jacob, Thomas; Ramunno-Johnson, Damien; Vu, Tania Q.] Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Portland, OR 97201 USA; [Krueger, Wesley; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Balkowiec, Agnieszka] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; University of New Mexico; Oregon Health & Science University	Vu, TQ (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	vuta@ohsu.edu			NIH-NINDS [R01 NS071116 01, W81XWH-07-2-0107]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071116] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-NINDS R01 NS071116 01 and W81XWH-07-2-0107 to T. Q. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; [Anonymous], 1999, FAC APPL SCI DELFT U; Ascano M, 2012, TRENDS CELL BIOL, V22, P266, DOI 10.1016/j.tcb.2012.02.005; Baba K, 2012, THERANOSTICS, V2, P655, DOI 10.7150/thno.3890; Balint S., 2013, PNAS, P1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Brady R, 1999, J NEUROSCI, V19, P2131; Brosenitsch TA, 1998, J NEUROSCI, V18, P1047; Brown A, 2000, NAT REV MOL CELL BIO, V1, P153, DOI 10.1038/35040102; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen YF, 2002, ANAL CHEM, V74, P5132, DOI 10.1021/ac0258251; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Chowdary PD, 2012, ANNU REV PHYS CHEM, V63, P571, DOI 10.1146/annurev-physchem-032511-143704; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Courty S, 2013, COLD SPRING HARB PRO, P11; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Erickson JT, 1996, J NEUROSCI, V16, P5361; Fichter KM, 2010, P NATL ACAD SCI USA, V107, P18658, DOI 10.1073/pnas.1013763107; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Huang SH, 2009, J BIOL CHEM, V284, P15126, DOI 10.1074/jbc.M809763200; HUMPEL C, 1994, EXP NEUROL, V127, P171, DOI 10.1006/exnr.1994.1092; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Martin JL, 2009, J NEUROCHEM, V108, P450, DOI 10.1111/j.1471-4159.2008.05781.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Ouyang Q, 2013, NEURON; Parthasarathy R, 2012, NAT METHODS, V9, P724, DOI [10.1038/NMETH.2071, 10.1038/nmeth.2071]; Philippidou P, 2011, PNAS, V108, P582; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Poon WW, 2013, J BIOL CHEM, V288, P16937, DOI 10.1074/jbc.M113.463711; Rajan SS, 2008, ACS NANO, V2, P1153, DOI 10.1021/nn700399e; Rajan SS, 2006, NANO LETT, V6, P2049, DOI 10.1021/nl0612650; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Schlessinger J, 2002, MOL CELL, V10, P218, DOI 10.1016/S1097-2765(02)00607-X; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; SPANHEL L, 1987, J AM CHEM SOC, V109, P6632, DOI 10.1021/ja00256a012; Suh J, 2003, P NATL ACAD SCI USA, V100, P3878, DOI 10.1073/pnas.0636277100; Svenningsson P, 2013, NATURE REV NEUROSCIE, P14; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Wells NP, 2010, NANO LETT, V10, P4732, DOI 10.1021/nl103247v; Xie WJ, 2012, INTEGR BIOL-UK, V4, P953, DOI 10.1039/c2ib20062g; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou P, NEURON, V55, P53; Zhuo H, 1996, MOL BRAIN RES, V38, P63; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	80	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e95113	10.1371/journal.pone.0095113	http://dx.doi.org/10.1371/journal.pone.0095113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732948	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400153
J	Vreeker, A; van Stuijvenberg, L; Hund, TJ; Mohler, PJ; Nikkels, PGJ; van Veen, TAB				Vreeker, Arnold; van Stuijvenberg, Leonie; Hund, Thomas J.; Mohler, Peter J.; Nikkels, Peter G. J.; van Veen, Toon A. B.			Assembly of the Cardiac Intercalated Disk during Pre- and Postnatal Development of the Human Heart	PLOS ONE			English	Article							SODIUM-CHANNEL NA(V)1.5; GAP-JUNCTIONS; VENTRICULAR MYOCYTES; NA+ CHANNELS; MOUSE HEART; RAT-HEART; EXPRESSION; CONDUCTION; CONNEXIN43; PLAKOPHILIN-2	Background: In cardiac muscle, the intercalated disk (ID) at the longitudinal cell-edges of cardiomyocytes provides as a macromolecular infrastructure that integrates mechanical and electrical coupling within the heart. Pathophysiological disturbance in composition of this complex is well known to trigger cardiac arrhythmias and pump failure. The mechanisms underlying assembly of this important cellular domain in human heart is currently unknown. Methods: We collected 18 specimens from individuals that died from non-cardiovascular causes. Age of the specimens ranged from a gestational age of 15 weeks through 11 years postnatal. Immunohistochemical labeling was performed against proteins comprising desmosomes, adherens junctions, the cardiac sodium channel and gap junctions to visualize spatiotemporal alterations in subcellular location of the proteins. Results: Changes in spatiotemporal localization of the adherens junction proteins (N-cadherin and ZO-1) and desmosomal proteins (plakoglobin, desmoplakin and plakophilin-2) were identical in all subsequent ages studied. After an initial period of diffuse and lateral labelling, all proteins were fully localized in the ID at approximately 1 year after birth. Na(v)1.5 that composes the cardiac sodium channel and the gap junction protein Cx43 follow a similar pattern but their arrival in the ID is detected at (much) later stages (two years for Nav1.5 and seven years for Cx43, respectively). Conclusion: Our data on developmental maturation of the ID in human heart indicate that generation of the mechanical junctions at the ID precedes that of the electrical junctions with a significant difference in time. In addition arrival of the electrical junctions (Nav1.5 and Cx43) is not uniform since sodium channels localize much earlier than gap junction channels.	[Vreeker, Arnold; van Stuijvenberg, Leonie; van Veen, Toon A. B.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Med Ctr,Dept Internal Med,Div Cardiovasc Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	van Veen, TAB (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands.	a.a.b.vanveen@umcutrecht.nl			Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences; National Institutes of Health [HL084583, HL083422, HL114383, HL096805, HL114893]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL084583, R00HL096805, R01HL114893, R01HL114383] Funding Source: NIH RePORTER	Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the support from the Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences (CVON-PREDICT, TABvV, LvS), the National Institutes of Health (HL084583, HL083422, HL114383 to PJM; HL096805, HL114893 to TJH, and American Heart Association (PJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; CHEN SC, 1994, PEDIATR RES, V36, P561, DOI 10.1203/00006450-199411000-00002; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; FAST VG, 1994, CIRC RES, V75, P591, DOI 10.1161/01.RES.75.3.591; Franke WW, 2009, CELL TISSUE RES, V338, P1, DOI 10.1007/s00441-009-0849-z; FRIEDMAN W F, 1972, Progress in Cardiovascular Diseases, V15, P87, DOI 10.1016/0033-0620(72)90006-0; Furnes MW, 2009, J PHYSIOL PHARMACOL, V60, P25; Geisler SB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/624719; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jansen JA, 2012, HEART RHYTHM, V9, P600, DOI 10.1016/j.hrthm.2011.11.025; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Kostin S, 1999, CIRC RES, V85, P154, DOI 10.1161/01.RES.85.2.154; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Lin XM, 2011, HEART RHYTHM, V8, P1923, DOI 10.1016/j.hrthm.2011.07.016; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Noorman M, 2013, HEART RHYTHM, V10, P412, DOI 10.1016/j.hrthm.2012.11.018; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; PETERS NS, 1994, CIRCULATION, V90, P713, DOI 10.1161/01.CIR.90.2.713; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; Stokes DL, 2007, CURR OPIN CELL BIOL, V19, P565, DOI 10.1016/j.ceb.2007.09.003; van Rijen HVM, 2005, CARDIOVASC RES, V66, P9, DOI 10.1016/j.cardiores.2005.02.003; van Veen TAB, 2005, CIRCULATION, V112, P2235, DOI 10.1161/CIRCULATIONAHA.105.547893; van Veen TAB, 2002, J MOL CELL CARDIOL, V34, P1411, DOI 10.1006/jmcc.2002.2102; VanKempen MJA, 1996, CARDIOVASC RES, V32, P886; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wang QC, 2012, FRONT BIOSCI-LANDMRK, V17, P2566, DOI 10.2741/4072; Wang QC, 2010, CIRC RES, V106, P1468, DOI 10.1161/CIRCRESAHA.109.212787; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081420	39	81	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94722	10.1371/journal.pone.0094722	http://dx.doi.org/10.1371/journal.pone.0094722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733085	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400081
J	Yang, F; Nam, S; Brown, CE; Zhao, R; Starr, R; Horne, DA; Malkas, LH; Jove, R; Hickey, RJ				Yang, Fan; Nam, Sangkil; Brown, Christine E.; Zhao, Robin; Starr, Renate; Horne, David A.; Malkas, Linda H.; Jove, Richard; Hickey, Robert J.			A Novel Berbamine Derivative Inhibits Cell Viability and Induces Apoptosis in Cancer Stem-Like Cells of Human Glioblastoma, via Up-Regulation of miRNA-4284 and JNK/AP-1 Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; JNK; GROWTH; MICRORNAS	Glioblastoma (GBM) is the most common primary brain tumor, accounting for approximately 40% of all central nervous system malignancies. Despite standard treatment consisting of surgical resection, radiotherapy and/or chemotherapy, the prognosis for GBM is poor; with a median survival of 14.6 months. The cancer stem cell or cancer-initiating cell model has provided a new paradigm for understanding development and recurrence of GBM following treatment. Berbamine (BBM) is a natural compound derived from the Berberis amurensis plant, and along with its derivatives, has been shown to exhibit antitumor activity in several cancers. Here, we reported that a novel synthetic Berbamine derivative, BBMD3, inhibits cell viability and induces apoptosis of cancer stem-like cells (CSCs) in a time-and dose-dependent manner when the CSCs from four GBM patients (PBT003, PBT008, PBT022, and PBT030) were cultured. These CSCs grew in neurospheres and expressed CD133 and nestin as markers. Treatment with BBMD3 destroyed the neurosphere morphology, and led to the induction of apoptosis in the CSCs. Induction of apoptosis in these CSCs is dependent upon activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase (PARP). MicroRNA-4284 (miR-4284) was shown to be over-expressed about 4-fold in the CSCs following BBMD3 treatment. Furthermore, transfection of synthetic anti-sense oligonucleotide against human miR-4284 partially blocked the anticancer effects of BBMD3 on the GBM derived CSCs. BBMD3 also increased phosphorylation of the c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK), resulting in an increase expression of phosphorylated c-Jun and total c-Fos; the major components of transcriptional factor AP-1. The JNK-c-Jun/AP-1 signaling pathway plays an important role in the induction of apoptosis in response to UV irradiation and some drug treatments. Targeting glioblastoma stem-like cells with BBMD3 is therefore novel, and may have promise as an effective therapeutic strategy for treating GBM patients.	[Yang, Fan; Hickey, Robert J.] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Translat Biomarker Discovery Core, Duarte, CA 91010 USA; [Nam, Sangkil; Brown, Christine E.; Zhao, Robin; Starr, Renate; Horne, David A.; Malkas, Linda H.; Hickey, Robert J.] City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Duarte, CA USA; [Jove, Richard] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Vaccine & Gene Therapy Institute of Florida	Hickey, RJ (corresponding author), City Hope Natl Med Ctr, Ctr Comprehens Canc, Beckman Res Inst, Translat Biomarker Discovery Core, Duarte, CA 91010 USA.	rohickey@coh.org		Brown, Christine/0000-0003-4915-8207	National Institutes of Health/National Cancer Institute [CA-1155674]; Beckman Research Institute; National Cancer Institute of the National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beckman Research Institute; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the study was provided by a grant from the National Institutes of Health/National Cancer Institute #CA-1155674 to RJ and start-up funding to RH from the Beckman Research Institute. Research reported in this publication included work performed in the Translational Biomarker Discovery Core, which is supported in part by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dimov I, 2011, THESCIENTIFICWORLDJO, V11, P930, DOI 10.1100/tsw.2011.42; Du HP, 2010, ONCOL REP, V23, P709, DOI 10.3892/or_00000688; Duan HY, 2010, CYTOTECHNOLOGY, V62, P341, DOI 10.1007/s10616-009-9240-x; Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Liang Y, 2009, ACTA PHARMACOL SIN, V30, P1659, DOI 10.1038/aps.2009.167; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mizoguchi M, 2012, J ONCOL, V2012, DOI 10.1155/2012/732874; Mizoguchi M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00019; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Nam S, 2012, MOL ONCOL, V6, P484, DOI 10.1016/j.molonc.2012.05.002; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang GY, 2009, J ASIAN NAT PROD RES, V11, P219, DOI 10.1080/10286020802675076; Wang S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-81; Wei G, 2010, J CELL PHYSIOL, V224, P112, DOI 10.1002/jcp.22099; Yang F, 2013, CANC BIOL THER, V14	35	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94443	10.1371/journal.pone.0094443	http://dx.doi.org/10.1371/journal.pone.0094443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732116	gold, Green Published, Green Submitted			2022-12-25	WOS:000336970400037
J	Zhang, LL; Shao, XM; Zhou, CL; Guo, XQ; Jin, L; Lian, LL; Yu, XJ; Dong, ZH; Mo, YD; Fang, JQ				Zhang, Lele; Shao, Xiaomei; Zhou, Chuanlong; Guo, Xiaoqing; Jin, Ling; Lian, Linli; Yu, Xiaojing; Dong, Zhenhua; Mo, Yadi; Fang, Jianqiao			Transcutaneous Electrical Nerve Stimulation Regulates Organ Blood Flow and Apoptosis during Controlled Hypotension in Dogs	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OPIOID RECEPTORS; ELECTROACUPUNCTURE; ACUPUNCTURE; HIPPOCAMPAL; MOXIBUSTION; ANESTHESIA; PREVENTS; ACUPOINT; BLOCKADE	Transcutaneous electrical nerve stimulation (TENS) is commonly used in clinical practice for alleviating pains and physiological disorders. It has been reported that TENS could counteract the ischemic injury happened in some vital organs. To determine the protective effect of TENS on internal organs during CH in dogs, target hypotension was maintained for 60 min at 50% of the baseline mean arterial pressure (MAP). The perfusion to the brain, liver, stomach, and kidney was recorded and apoptosis within these organs was observed. Results showed that when arriving at the target MAP, and during the maintaining stage for 10 min, perfusion to the stomach and liver in the CH+TENS group was much higher than in the CH group (P<0.05). Perfusion to the cerebral cortex greatly declined in both the controlled pressure groups when compared with the general anesthesia (GA) group (P<0.05). After withdrawing CH, the hepatic blood flow in both the CH and CH+TENS groups, and the gastric and cerebral cortical blood flow in the CH+TENS group, were rapidly increased. By the end of MAP restoration, gastric blood flow in the CH group was still low. At 72 h after applying CH, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL)-positive cells in stomach and kidney tissue from the CH group were significantly increased compared with those in the GA group (P<0.05). There was no significant difference in TUNEL-positive cells in the liver and hippocampus among the three groups. Our results demonstrated that CH with a 50% MAP level could cause lower perfusion to the liver, stomach, cerebral cortex, and kidney, with apoptosis subsequently occurring in the stomach and kidney. TENS combined GA is able to improve the blood flow to the liver, stomach, and reduce the apoptosis in the stomach and kidney.	[Zhang, Lele; Shao, Xiaomei; Zhou, Chuanlong; Guo, Xiaoqing; Jin, Ling; Lian, Linli; Yu, Xiaojing; Dong, Zhenhua; Mo, Yadi; Fang, Jianqiao] Zhejiang Chinese Med Univ, Clin Med Coll 3, Dept Neurobiol & Acupuncture Res, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University	Fang, JQ (corresponding author), Zhejiang Chinese Med Univ, Clin Med Coll 3, Dept Neurobiol & Acupuncture Res, Hangzhou, Zhejiang, Peoples R China.	fangjianqiao7532@163.com		Fang, Jianqiao/0000-0002-5155-8544	National Basic Research Program of China [2007CB512506]; First-foremost Key Subject of Acupuncture and Moxibustion Foundation of Zhejiang [[2008] 255]	National Basic Research Program of China(National Basic Research Program of China); First-foremost Key Subject of Acupuncture and Moxibustion Foundation of Zhejiang	This study was supported by the National Basic Research Program of China (2007CB512506) and the First-foremost Key Subject of Acupuncture and Moxibustion Foundation of Zhejiang ([2008] 255). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Arai YCP, 2008, BRIT J ANAESTH, V100, P78, DOI 10.1093/bja/aem306; Arai YCP, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/727121; Chen AZ, 2012, INT J MOL MED, V30, P791, DOI 10.3892/ijmm.2012.1074; Chen L, 1998, ANESTH ANALG, V87, P1129, DOI 10.1097/00000539-199811000-00028; Dolman RM, 2000, J ORAL MAXIL SURG, V58, P834, DOI 10.1053/joms.2000.8194; Fang Jian-Qiao, 2011, Zhongguo Zhen Jiu, V31, P625; Fang JQ, 1999, J ZHEJIANG COLL TRAD, V23, P52; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Hallen K, 2010, J PAIN SYMPTOM MANAG, V40, P95, DOI 10.1016/j.jpainsymman.2009.12.009; Jang MH, 2003, NEUROSCI LETT, V347, P5, DOI 10.1016/S0304-3940(03)00512-3; Jessurun G, 2003, EUR J PAIN, V7, P507, DOI 10.1016/S1090-3801(03)00022-3; Kalra A, 2001, J PHARMACOL EXP THER, V298, P257; Kawahara N, 2004, J CEREBR BLOOD F MET, V24, P212, DOI 10.1097/01.WCB.0000106012.33322.A2; Khalil Z, 2000, J GERONTOL A-BIOL, V55, pB257, DOI 10.1093/gerona/55.6.B257; Kurt F, 2005, ADV THER, V22, P234, DOI 10.1007/BF02849932; LESSARD MR, 1989, ANESTH ANALG, V69, P379; Li P, 2004, CLIN AUTON RES, V14, P182, DOI 10.1007/s10286-004-0175-1; Li ZY, 2005, EUR J APPL PHYSIOL, V94, P633, DOI 10.1007/s00421-005-1362-z; Liebano RE, 2013, EUR J PAIN; MCDOWALL DG, 1985, BRIT J ANAESTH, V57, P110, DOI 10.1093/bja/57.1.110; Schneider MP, 2013, BJU INT; [邵晓梅 Shao Xiaomei], 2012, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V28, P599; Shi X, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/750620; Sluka KA, 1999, J PHARMACOL EXP THER, V289, P840; Stener-Victorin E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-44; Syuu Y, 2003, AM J PHYSIOL-REG I, V285, pR1446, DOI 10.1152/ajpregu.00243.2003; Syuu Y, 2001, JPN J PHYSIOL, V51, P231, DOI 10.2170/jjphysiol.51.231; Takeda S, 2004, CAN J ANAESTH, V51, P348, DOI 10.1007/BF03018238; Tellenbach M, 2012, WORLD J UROL; Vassal F, 2013, CLIN NEUROPHYSIOL; Wang B, 2007, ANESTH ANALG, V85, P406; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; WANG JQ, 1992, INT J NEUROSCI, V65, P117, DOI 10.3109/00207459209003283; Wiessner C, 2000, CELL MOL BIOL, V46, P53; Wu HG, 2007, DIGEST DIS SCI, V52, P379, DOI 10.1007/s10620-006-9561-y; Wu HG, 2004, WORLD J GASTROENTERO, V10, P682, DOI 10.3748/wjg.v10.i5.682; Xie HS, 2007, XIES VET ACUPUNCTURE, P129; Zhang D., 2011, EVID-BASED COMPL ALT, V2011; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhang LL, 2012, CHINESE ARCH TRADITI, V30, P2167; Zhao JX, 2011, J TRADIT CHIN MED, V31, P349, DOI 10.1016/S0254-6272(12)60017-X; Zhong SB, 2009, EVID-BASED COMPL ALT, V6, P51, DOI 10.1093/ecam/nem062; Zhou Hai-peng, 2011, Zhonghua Yi Xue Za Zhi, V91, P1203	43	5	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94368	10.1371/journal.pone.0094368	http://dx.doi.org/10.1371/journal.pone.0094368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732970	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400033
J	Zheng, JY; Wei, CC; Hase, N; Shi, K; Killingsworth, CR; Litovsky, SH; Powell, PC; Kobayashi, T; Ferrario, CM; Rab, A; Aban, I; Collawn, JF; Dell'Italia, LJ				Zheng, Junying; Wei, Chih-Chang; Hase, Naoki; Shi, Ke; Killingsworth, Cheryl R.; Litovsky, Silvio H.; Powell, Pamela C.; Kobayashi, Tsunefumi; Ferrario, Carlos M.; Rab, Andras; Aban, Inmaculada; Collawn, James F.; Dell'Italia, Louis J.			Chymase Mediates Injury and Mitochondrial Damage in Cardiomyocytes during Acute Ischemia/Reperfusion in the Dog	PLOS ONE			English	Article							MAST-CELL CHYMASE; ISOLATED MITRAL REGURGITATION; ENDOPLASMIC-RETICULUM STRESS; NEUTROPHIL ELASTASE; CARDIAC INJURY; CATHEPSIN-G; ER STRESS; APOPTOSIS; INHIBITION; KINASE	Cardiac ischemia and reperfusion (I/R) injury occurs because the acute increase in oxidative/inflammatory stress during reperfusion culminates in the death of cardiomyocytes. Currently, there is no drug utilized clinically that attenuates I/R injury in patients. Previous studies have demonstrated degranulation of mast cell contents into the interstitium after I/R. Using a dog model of I/R, we tested the role of chymase, a mast cell protease, in cardiomyocyte injury using a specific oral chymase inhibitor (CI). 15 adult mongrel dogs had left anterior descending artery occlusion for 60 min and reperfusion for 100 minutes. 9 dogs received vehicle and 6 were pretreated with a specific CI. In vivo cardiac microdialysis demonstrated a 3-fold increase in interstitial fluid chymase activity in I/R region that was significantly decreased by CI. CI pretreatment significantly attenuated loss of laminin, focal adhesion complex disruption, and release of troponin I into the circulation. Microarray analysis identified an I/R induced 17-fold increase in nuclear receptor subfamily 4A1 (NR4A1) and significantly decreased by CI. NR4A1 normally resides in the nucleus but can induce cell death on migration to the cytoplasm. I/R caused significant increase in NR4A1 protein expression and cytoplasmic translocation, and mitochondrial degradation, which were decreased by CI. Immunohistochemistry also revealed a high concentration of chymase within cardiomyocytes after I/R. In vitro, chymase added to culture HL-1 cardiomyocytes entered the cytoplasm and nucleus in a dynamin-dependent fashion, and promoted cytoplasmic translocation of NR4A1 protein. shRNA knockdown of NR4A1 on pre-treatment of HL-1 cells with CI significantly decreased chymase-induced cell death and mitochondrial damage. These results suggest that the beneficial effects of an orally active CI during I/R are mediated in the cardiac interstitium as well as within the cardiomyocyte due to a heretofore-unrecognized chymase entry into cardiomyocytes.	[Zheng, Junying; Wei, Chih-Chang; Shi, Ke; Killingsworth, Cheryl R.; Powell, Pamela C.; Dell'Italia, Louis J.] Univ Alabama Birmingham, Dept Med, Birmingham Veteran Affairs Med Ctr, Birmingham, AL 35294 USA; [Zheng, Junying; Wei, Chih-Chang; Shi, Ke; Killingsworth, Cheryl R.; Powell, Pamela C.; Dell'Italia, Louis J.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Hase, Naoki; Kobayashi, Tsunefumi] Teijin Pharma Ltd, Teijin Inst Biomed Res, Tokyo, Japan; [Litovsky, Silvio H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Ferrario, Carlos M.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Rab, Andras; Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Aban, Inmaculada] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Teijin Pharma Limited; University of Alabama System; University of Alabama Birmingham; Wake Forest University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dell'Italia, LJ (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham Veteran Affairs Med Ctr, Birmingham, AL 35294 USA.	Louis.Dellitalia@va.gov	Ferrario, Carlos/ABD-2791-2020; Rab, András/AAR-7804-2021; Ferrario, Carlos/ABB-4165-2021; Rab, Andras/AAI-9402-2021	Ferrario, Carlos/0000-0003-0792-6239; Rab, András/0000-0003-2154-0017; Collawn, James/0000-0002-2528-2759	Department of Veteran Affairs [1CX000993-01, 84781]; National Heart, Lung and Blood Institute SCCOR in Cardiac Dysfunction [HL077100]; Teijin Pharma Limited, Tokyo, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, P50HL077100] Funding Source: NIH RePORTER	Department of Veteran Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute SCCOR in Cardiac Dysfunction; Teijin Pharma Limited, Tokyo, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by Department of Veteran Affairs (Grant 1CX000993-01 to LJD and Grant 84781 to CCW) and National Heart, Lung and Blood Institute SCCOR in Cardiac Dysfunction (Grant HL077100 to LDJ) and Teijin Pharma Limited, Tokyo, Japan (to LDJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZONO N, 1990, LAB INVEST, V62, P626; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baldus S, 2001, J CLIN INVEST, V108, P1759; Bouzas-Rodriguez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046422; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; Fang KC, 1996, J CLIN INVEST, V97, P1589, DOI 10.1172/JCI118583; Frangogiannis NG, 1998, CIRCULATION, V98, P687, DOI 10.1161/01.CIR.98.7.687; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hara M, 1999, CIRCULATION, V100, P1443, DOI 10.1161/01.CIR.100.13.1443; Hoshino F, 2003, J CARDIOVASC PHARM, V41, pS11; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Leskinen MJ, 2006, EXP CELL RES, V312, P1289, DOI 10.1016/j.yexcr.2005.12.033; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeda Y, 2010, AM J PHYSIOL-RENAL, V299, pF1328, DOI 10.1152/ajprenal.00337.2010; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; Ogawa E, 2000, J MOL CELL CARDIOL, V32, P765, DOI 10.1006/jmcc.2000.1119; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Pat B, 2010, CIRCULATION, V122, P1488, DOI 10.1161/CIRCULATIONAHA.109.921619; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Rybin VO, 2003, AM J PHYSIOL-HEART C, V285, pH325, DOI 10.1152/ajpheart.00946.2002; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; VARTIO T, 1981, J BIOL CHEM, V256, P471; Veugelers K, 2006, MOL BIOL CELL, V17, P623, DOI 10.1091/mbc.E05-07-0631; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; Woters PJ, 2001, J BIOL CHEM, V276, P18551; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zheng JY, 2009, CIRCULATION, V119, P2086, DOI 10.1161/CIRCULATIONAHA.108.826230	39	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94732	10.1371/journal.pone.0094732	http://dx.doi.org/10.1371/journal.pone.0094732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733352	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400087
J	Liao, DL; Huang, CY; Hu, SE; Fang, SC; Wu, CS; Chen, WT; Lee, TSH; Chen, PC; Li, CSR				Liao, Ding-Lieh; Huang, Cheng-Yi; Hu, Sien; Fang, Su-Chen; Wu, Chi-Shin; Chen, Wei-Ti; Lee, Tony Szu-Hsien; Chen, Pau-Chung; Li, Chiang-shan R.			Cognitive Control in Opioid Dependence and Methadone Maintenance Treatment	PLOS ONE			English	Article							STOP SIGNAL TASK; RESPONSE-INHIBITION; GENDER-DIFFERENCES; NEURAL PROCESSES; INDIRECT ANALOG; WORKING-MEMORY; RISK-TAKING; HEROIN; PERFORMANCE; DEFICITS	Background: Substance misuse is associated with cognitive dysfunction. We used a stop signal task to examine deficits in cognitive control in individuals with opioid dependence (OD). We examined how response inhibition and post-error slowing are compromised and whether methadone maintenance treatment (MMT), abstinence duration, and psychiatric comorbidity are related to these measures in individuals with OD. Methods: Two-hundred-and-sixty-four men with OD who were incarcerated at a detention center and abstinent for up to 2 months (n = 108) or at a correctional facility and abstinent for approximately 6 months (n = 156), 65 OD men under MMT at a psychiatric clinic, and 64 age and education matched healthy control (HC) participants were assessed. We computed the stop signal reaction time (SSRT) to index the capacity of response inhibition and post-error slowing (PES) to represent error-related behavioral adjustment, as in our previous work. We examined group effects with analyses of variance and covariance analyses, followed by planned comparisons. Specifically, we compared OD and HC participants to examine the effects of opioid dependence and MMT and compared OD sub-groups to examine the effects of abstinence duration and psychiatric comorbidity. Results: The SSRT was significantly prolonged in OD but not MMT individuals, as compared to HC. The extent of post-error slowing diminished in OD and MMT, as compared to HC (trend; p = 0.061), and there was no difference between the OD and MMT groups. Individuals in longer abstinence were no less impaired in these measures. Furthermore, these results remained when psychiatric comorbidities including misuse of other substances were accounted for. Conclusions: Methadone treatment appears to be associated with relatively intact cognitive control in opioid dependent individuals. MMT may facilitate public health by augmenting cognitive control and thereby mitigating risky behaviors in heroin addicts.	[Liao, Ding-Lieh; Huang, Cheng-Yi] Bali Psychiat Ctr, Dept Addict Psychiat, Dept Hlth, New Taipei City, Taiwan; [Liao, Ding-Lieh; Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Hu, Sien; Li, Chiang-shan R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Fang, Su-Chen] Oriental Inst Technol, Dept Nursing, New Taipei City, Taiwan; [Wu, Chi-Shin] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Chen, Wei-Ti] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Lee, Tony Szu-Hsien] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Taiwan University; Yale University; Asia Eastern University of Science & Technology; Far Eastern Memorial Hospital; Yale University; National Taiwan Normal University	Liao, DL (corresponding author), Bali Psychiat Ctr, Dept Addict Psychiat, Dept Hlth, New Taipei City, Taiwan.	dlliao@balipc.gov.tw; chiang-shan.li@yale.edu	Chen, Wei-Ti/L-3935-2019; Chen, Pau-Chung/H-5686-2011; Li, Chiang-Shan Ray/J-2813-2016; Wu, Chi-Shin/GQP-4970-2022; Fang, Su-Chen/GOP-0356-2022; Chen, Weiti/L-6222-2019	Chen, Wei-Ti/0000-0002-2342-045X; Chen, Pau-Chung/0000-0002-6242-5974; Li, Chiang-Shan Ray/0000-0002-9393-1212; Fang, Su-Chen/0000-0001-6916-4511; WU, CHI-SHIN/0000-0003-2762-7295; Lee, Tony Szu-Hsien/0000-0003-2574-3372	National Health Research Institute (NHRI) [PH-099-PP-40]; Department of Health (DOH), Taiwan [DOH99-TD-PH-27]; National Institutes of Health (NIH), U.S.A. [K02DA026990]; NATIONAL INSTITUTE OF NURSING RESEARCH [K23NR014107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026990] Funding Source: NIH RePORTER	National Health Research Institute (NHRI)(National Health Research Institutes - Taiwan); Department of Health (DOH), Taiwan; National Institutes of Health (NIH), U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants PH-099-PP-40 (Liao) from the National Health Research Institute (NHRI) and DOH99-TD-PH-27 (Liao) from the Department of Health (DOH), Taiwan; and a grant K02DA026990 (Li) from the National Institutes of Health (NIH), U.S.A. The NHRI, DOH, and NIH have no further role in data collection and analysis or the decision in publishing these results.	Bach P, 2012, CLIN NEUROPHARMACOL, V35, P153, DOI 10.1097/WNF.0b013e31825c38f5; Bednarski SR, 2012, ALCOHOL CLIN EXP RES, V36, P768, DOI 10.1111/j.1530-0277.2011.01672.x; Bracken BK, 2012, DRUG ALCOHOL DEPEN, V125, P132, DOI 10.1016/j.drugalcdep.2012.04.004; Brooks DJ, 2006, J ADDICT DIS, V25, P15, DOI 10.1300/J069v25n04_02; Brown TG, 2009, DRUG ALCOHOL REV, V28, P406, DOI 10.1111/j.1465-3362.2009.00053.x; Byrd DA, 2013, J INT NEUROPSYCH SOC, V19, P463, DOI 10.1017/S1355617712001634; Cheng JQ, 2012, EXP CLIN PSYCHOPHARM, V20, P400, DOI 10.1037/a0029657; Chou YC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-190; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Connolly CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059645; Connolly CG, 2012, DRUG ALCOHOL DEPEN, V121, P45, DOI 10.1016/j.drugalcdep.2011.08.007; Corsenac P, 2012, DRUG ALCOHOL DEPEN, V123, P91, DOI 10.1016/j.drugalcdep.2011.10.022; Darke S, 2000, ADDICTION, V95, P687, DOI 10.1046/j.1360-0443.2000.9556874.x; Darke S, 2012, DRUG ALCOHOL DEPEN, V126, P309, DOI 10.1016/j.drugalcdep.2012.05.032; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Gruber SA, 2006, EXP CLIN PSYCHOPHARM, V14, P157, DOI 10.1037/1064-1297.14.2.157; Hakansson A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-111; Hendrick OM, 2012, OBESITY, V20, P1796, DOI 10.1038/oby.2011.180; Henry PK, 2012, DRUG ALCOHOL DEPEN, V124, P167, DOI 10.1016/j.drugalcdep.2011.12.009; Hu S, 2013, BRAIN STRUCT FUNCT; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Hu S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00004; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Kaufman MJ, 1999, PSYCHIAT RES-NEUROIM, V90, P143, DOI 10.1016/S0925-4927(99)00017-7; Levitt H, 1971, J ACOUST SOC AM S2, V49, P467; Li CSR, 2010, DRUG ALCOHOL DEPEN, V109, P181, DOI 10.1016/j.drugalcdep.2010.01.008; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Li CSR, 2009, BRAIN IMAGING BEHAV, V3, P262, DOI 10.1007/s11682-009-9068-1; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033809; Lin WC, 2012, PSYCHIAT RES-NEUROIM, V201, P89, DOI 10.1016/j.pscychresns.2011.05.009; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luo X, 2013, BRAIN, V136, P1231, DOI 10.1093/brain/awt040; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Marvel CL, 2012, CEREBELLUM, V11, P300, DOI 10.1007/s12311-011-0311-0; McDonald S, 2013, ADDICTION, V108, P566, DOI 10.1111/add.12040; Messinis L, 2009, HUM PSYCHOPHARM CLIN, V24, P524, DOI 10.1002/hup.1050; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Pirastu R, 2006, DRUG ALCOHOL DEPEN, V83, P163, DOI 10.1016/j.drugalcdep.2005.11.008; Pluck G, 2012, DRUG ALCOHOL DEPEN, V124, P181, DOI 10.1016/j.drugalcdep.2012.01.001; Prosser J, 2006, DRUG ALCOHOL DEPEN, V84, P240, DOI 10.1016/j.drugalcdep.2006.02.006; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rapeli Pekka, 2007, BMC Clin Pharmacol, V7, P5, DOI 10.1186/1472-6904-7-5; Rapeli Pekka, 2011, BMC Clin Pharmacol, V11, P13, DOI 10.1186/1472-6904-11-13; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Soyka M, 2008, J CLIN PSYCHOPHARM, V28, P699, DOI 10.1097/JCP.0b013e31818a6d38; Soyka M, 2011, AM J DRUG ALCOHOL AB, V37, P497, DOI 10.3109/00952990.2011.600381; Soyka M, 2010, WORLD J BIOL PSYCHIA, V11, P400, DOI [10.1080/15622970902995604, 10.3109/15622970902995604]; Streel Emmanuel, 2005, J Opioid Manag, V1, P49; van Holst Ruth Janke, 2011, Curr Drug Abuse Rev, V4, P42; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Walters GD, 2012, LAW HUMAN BEHAV, V36, P506, DOI 10.1037/h0093936; Wang GY, 2013, CURR DRUG ABUSE REV; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; WETHERIL.GB, 1966, BIOMETRIKA, V53, P439, DOI 10.2307/2333650; Wilson SJ, 2013, SOC COGN AFFECT NEUR; Yucel M, 2007, MOL PSYCHIATR, V12, P691, DOI 10.1038/sj.mp.4001955	69	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94589	10.1371/journal.pone.0094589	http://dx.doi.org/10.1371/journal.pone.0094589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727743	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200100
J	Pross, N; Demazieres, A; Girard, N; Barnouin, R; Metzger, D; Klein, A; Perrier, E; Guelinckx, I				Pross, Nathalie; Demazieres, Agnes; Girard, Nicolas; Barnouin, Romain; Metzger, Deborah; Klein, Alexis; Perrier, Erica; Guelinckx, Isabelle			Effects of Changes in Water Intake on Mood of High and Low Drinkers	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; SUBJECTIVE FEELINGS; FLUID RESTRICTION; DEHYDRATION; DEPRIVATION; WOMEN; THIRST; HEAT; MEN	Objective: To evaluate the effects of a change in water intake on mood and sensation in 22 habitual high-volume (HIGH; 24 L/d) and 30 low-volume (LOW;<1.2 L/d) drinkers who were asked to respectively decrease and increase their daily water intake. Method: During baseline HIGH consumed 2.5 L and LOW 1 L of water/day. During 3 controlled intervention days HIGH's water intake was restricted to 1 L/day whereas LOW's was increased to 2.5 L water/day. Several mood scales (Bond & Lader Visual Analog Scale (VAS), Profile of Mood States, Karolinska Sleepiness Scale, Thirst & Emotional VAS) were administered at different time points during the study. ANOVA including intervention, time point and intervention by time point as fixed effects on mean values (i.e.; baseline data vs. mean of 3 intervention days) for each mood scale was performed. Results: At baseline HIGH and LOW were comparable in mood state, except for thirst scores (estimate = 17.16, p<0.001) and POMS depression-dejection scores (estimate = 0.55, p<0.05) which were both higher in the HIGH vs. LOW. In HIGH the restricted water intake resulted in a significant increase in thirst (p<0.001) and a decrease in contentedness (p<0.05), calmness (p<0.01), positive emotions (p<0.05) and vigor/activity (p<0.001). In LOW, increased water consumption resulted in a significant decrease in fatigue/inertia (p<0.001), confusion/bewilderment (p = 0.05) and thirst (p<0.001) and a trend to lower sleepiness (p = 0.07) compared to baseline. Conclusion: Increasing water intake has beneficial effects in LOW, especially sleep/wake feelings, whereas decreasing water intake has detrimental effects on HIGH's mood. These deleterious effects in HIGH were observed in some sleep/wake moods as well as calmness, satisfaction and positive emotions.	[Pross, Nathalie; Demazieres, Agnes; Girard, Nicolas; Barnouin, Romain; Metzger, Deborah] Forenap, Rouffach, France; [Pross, Nathalie] Biotrial Neurosci, Didenheim, France; [Klein, Alexis; Perrier, Erica; Guelinckx, Isabelle] Danone Res, Palaiseau, France	Danone Nutricia	Guelinckx, I (corresponding author), Danone Res, Palaiseau, France.	isabelle.guelinckx@danone.com	Girard, Nicolas/ABE-3618-2021	Girard, Nicolas/0000-0001-9909-2299	Danone Research	Danone Research(Danone Nutricia)	This study was funded by Danone Research. The funder (Danone Research) was involved in the decision to publish, but had no role in study design, data collection and analysis, and preparation of the manuscript.	Adam GE, 2008, PHYSIOL BEHAV, V93, P748, DOI 10.1016/j.physbeh.2007.11.028; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Bandelow S, 2010, SCAND J MED SCI SPOR, V20, P148, DOI 10.1111/j.1600-0838.2010.01220.x; Benton D, 2011, NUTRIENTS, V3, P555, DOI 10.3390/nu3050555; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Booth P., 2012, ED HLTH, V30, P75; Das RN, 2012, RES REP UROL, V4, P9, DOI 10.2147/RRU.S27801; Edmonds CJ, 2013, APPETITE, V60, P148, DOI 10.1016/j.appet.2012.10.016; Edmonds CJ, 2009, APPETITE, V53, P469, DOI 10.1016/j.appet.2009.10.002; Edmonds CJ, 2009, APPETITE, V52, P776, DOI 10.1016/j.appet.2009.02.010; Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005; Le Bellego L, 2010, NUTR TODAY, V47, P77; Lees N, 1999, EUR J CANCER CARE, V8, P220; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; McNair D., 1981, MANUAL PROFILE MOOD; Neave N, 2001, APPETITE, V37, P255, DOI 10.1006/appe.2001.0429; Patel AV, 2007, J ATHL TRAINING, V42, P66; Perrier E, 2013, EUR J APPL PHYSIOL, V113, P2143, DOI 10.1007/s00421-013-2649-0; Petri NM, 2006, CROAT MED J, V47, P855; Pross N, 2013, BRIT J NUTR, V109, P313, DOI 10.1017/S0007114512001080; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; ROLLS BJ, 1980, AM J PHYSIOL, V239, pR476, DOI 10.1152/ajpregu.1980.239.5.R476; Shirreffs SM, 2004, BRIT J NUTR, V91, P951, DOI 10.1079/BJN20041149; Szinnai G, 2005, AM J PHYSIOL-REG I, V289, pR275, DOI 10.1152/ajpregu.00501.2004; Vergne S., 2012, Nutrition Today, V47, pS7	29	40	40	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94754	10.1371/journal.pone.0094754	http://dx.doi.org/10.1371/journal.pone.0094754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728141	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200128
J	Ritterhouse, LL; Lu, RF; Shah, HB; Robertson, JM; Fife, DA; Maecker, HT; Du, HW; Fathman, CG; Chakravarty, EF; Scofield, RH; Kamen, DL; Guthridge, JM; James, JA				Ritterhouse, Lauren L.; Lu, Rufei; Shah, Hemangi B.; Robertson, Julie M.; Fife, Dustin A.; Maecker, Holden T.; Du, Hongwu; Fathman, Charles G.; Chakravarty, Eliza F.; Scofield, R. Hal; Kamen, Diane L.; Guthridge, Joel M.; James, Judith A.			Vitamin D Deficiency in a Multiethnic Healthy Control Cohort and Altered Immune Response in Vitamin D Deficient European-American Healthy Controls	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN-D LEVELS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLONY-STIMULATING FACTOR; 3RD NATIONAL-HEALTH; REGULATORY T-CELLS; D-RECEPTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; IN-VITRO; IMMUNOGLOBULIN PRODUCTION	Objective: In recent years, vitamin D has been shown to possess a wide range of immunomodulatory effects. Although there is extensive amount of research on vitamin D, we lack a comprehensive understanding of the prevalence of vitamin D deficiency or the mechanism by which vitamin D regulates the human immune system. This study examined the prevalence and correlates of vitamin D deficiency and the relationship between vitamin D and the immune system in healthy individuals. Methods: Healthy individuals (n = 774) comprised of European-Americans (EA, n = 470), African-Americans (AA, n = 125), and Native Americans (NA, n = 179) were screened for 25-hydroxyvitamin D [25(OH)D] levels by ELISA. To identify the most noticeable effects of vitamin D on the immune system, 20 EA individuals with severely deficient (<11.3 ng/mL) and sufficient (>24.8 ng/mL) vitamin D levels were matched and selected for further analysis. Serum cytokine level measurement, immune cell phenotyping, and phosphoflow cytometry were performed. Results: Vitamin D sufficiency was observed in 37.5% of the study cohort. By multivariate analysis, AA, NA, and females with a high body mass index (BMI, >30) demonstrate higher rates of vitamin D deficiency (p < 0.05). Individuals with vitamin D deficiency had significantly higher levels of serum GM-CSF (p = 0.04), decreased circulating activated CD4(+) (p = 0.04) and CD8(+) T (p = 0.04) cell frequencies than individuals with sufficient vitamin D levels. Conclusion: A large portion of healthy individuals have vitamin D deficiency. These individuals have altered T and B cell responses, indicating that the absence of sufficient vitamin D levels could result in undesirable cellular and molecular alterations ultimately contributing to immune dysregulation.	[Ritterhouse, Lauren L.; Lu, Rufei; Shah, Hemangi B.; Robertson, Julie M.; Fife, Dustin A.; Chakravarty, Eliza F.; Scofield, R. Hal; Guthridge, Joel M.; James, Judith A.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Ritterhouse, Lauren L.; Lu, Rufei; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Ritterhouse, Lauren L.; Lu, Rufei; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Maecker, Holden T.; Du, Hongwu; Fathman, Charles G.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Kamen, Diane L.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University; Medical University of South Carolina	Guthridge, JM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Judith-James@omrf.org	Scofield, Robert Hal/AEJ-8314-2022	Guthridge, Joel/0000-0002-9308-237X	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI1082714, P30AR053483, P30GM103510, U01AI101934, S10RR026735]; J. Donald and Patricia Capra Fellowship; Rheuminations, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101934, U19AI082714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483, P60AR062755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510, U54GM104938] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); J. Donald and Patricia Capra Fellowship; Rheuminations, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of General Medical Sciences, and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers U19AI1082714, P30AR053483, P30GM103510, U01AI101934, and S10RR026735. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also made possible by the J. Donald and Patricia Capra Fellowship, the Lou Kerr Chair in Biomedical Research, and the Kirkland Scholar Award Program at the Hospital for Special Surgery in New York City. The Kirkland Scholar Award Program is funded exclusively by Rheuminations, Inc., a non-profit foundation dedicated to supporting research leading to the treatment and cure of lupus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Abou-Raya A, 2013, J RHEUMATOL, V40, P265, DOI 10.3899/jrheum.111594; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; BARSHAVIT Z, 1983, P NATL ACAD SCI-BIOL, V80, P5907, DOI 10.1073/pnas.80.19.5907; Ben-Zvi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009193; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Bikle DD, 2011, VITAM HORM, V86, P1, DOI 10.1016/B978-0-12-386960-9.00001-0; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bonakdar ZS, 2011, LUPUS, V20, P1155, DOI 10.1177/0961203311405703; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Bruce D, 2009, INT IMMUNOL, V21, P113, DOI 10.1093/intimm/dxn129; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, 2011, DIET REF INT CALC VI; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cottam D, 2010, SURG OBES RELAT DIS, V6, P538, DOI 10.1016/j.soard.2010.04.011; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; DAVIES PDO, 1985, THORAX, V40, P187, DOI 10.1136/thx.40.3.187; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dossus L, 2009, J IMMUNOL METHODS, V350, P125, DOI 10.1016/j.jim.2009.09.001; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Engelsen O, 2010, NUTRIENTS, V2, P482, DOI 10.3390/nu2050482; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Gagnon C, 2010, EUR J ENDOCRINOL, V163, P819, DOI 10.1530/EJE-10-0441; Geldmeyer-Hilt K, 2011, BIOCHEM BIOPH RES CO, V407, P699, DOI 10.1016/j.bbrc.2011.03.078; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; GRANGE JM, 1985, TUBERCLE, V66, P187, DOI 10.1016/0041-3879(85)90035-2; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Griffin MD, 2007, ARCH BIOCHEM BIOPHYS, V460, P218, DOI 10.1016/j.abb.2007.01.034; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Harris SS, 1998, J AM COLL NUTR, V17, P282, DOI 10.1080/07315724.1998.10718760; Heine G, 2002, EUR J IMMUNOL, V32, P3395, DOI 10.1002/1521-4141(2002012)32:12<3395::AID-IMMU3395>3.0.CO;2-I; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hewison M, 2012, SCAND J CLIN LAB INV, V72, P92, DOI 10.3109/00365513.2012.682862; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; IHS, 2011, IND HLTH SERV HLTH D; Ikeda U, 2010, IMMUNOL LETT, V134, P7, DOI 10.1016/j.imlet.2010.07.002; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kamen Diane L, 2008, Curr Rheumatol Rep, V10, P273, DOI 10.1007/s11926-008-0044-3; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Khoo AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029250; Kimmons Joel E, 2006, MedGenMed, V8, P59; Knippenberg S, 2011, MULT SCLER J, V17, P1418, DOI 10.1177/1352458511412655; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lerman MA, 2011, LUPUS, V20, P749, DOI 10.1177/0961203310394542; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; MATSUOKA LY, 1991, ARCH DERMATOL, V127, P536, DOI 10.1001/archderm.127.4.536; Mattner F, 2000, EUR J IMMUNOL, V30, P498, DOI 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Milovanovic M, 2010, J ALLERGY CLIN IMMUN, V126, P1016, DOI 10.1016/j.jaci.2010.08.020; MULLER K, 1991, IMMUNOPHARMACOLOGY, V21, P121, DOI 10.1016/0162-3109(91)90015-Q; Muller K, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P68; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Pei FH, 2011, J DIGEST DIS, V12, P90, DOI 10.1111/j.1751-2980.2011.00483.x; Pelajo CF, 2010, AUTOIMMUN REV, V9, P507, DOI 10.1016/j.autrev.2010.02.011; Pfeiffer CM, 2013, J NUTR, V143, p938S, DOI 10.3945/jn.112.172858; Pilz S, 2008, CANCER EPIDEM BIOMAR, V17, P1228, DOI 10.1158/1055-9965.EPI-08-0002; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Raghuwanshi A, 2008, J CELL BIOCHEM, V105, P338, DOI 10.1002/jcb.21858; Renzaho AMN, 2011, NUTRITION, V27, P868, DOI 10.1016/j.nut.2010.12.014; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; Smolders J, 2011, NAT IMMUNOL, V12, P3, DOI 10.1038/ni0111-3a; Sozzani S, 2010, AUTOIMMUNITY, V43, P196, DOI 10.3109/08916930903510872; Sullivan SS, 2005, J AM DIET ASSOC, V105, P971, DOI 10.1016/j.jada.2005.03.002; Terrier B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4060; Thien R, 2005, J ALLERGY CLIN IMMUN, V116, P683, DOI 10.1016/j.jaci.2005.05.013; TOBLER A, 1987, J CLIN INVEST, V79, P1700, DOI 10.1172/JCI113009; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; Unek IT, 2010, CLIN MED RES, V8, P89, DOI 10.3121/cmr.2010.889; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; von Scheven E, 2011, CURR RHEUMATOL REP, V13, P110, DOI 10.1007/s11926-010-0161-7; Willheim M, 1999, J CLIN ENDOCR METAB, V84, P3739, DOI 10.1210/jc.84.10.3739; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright TB, 2009, J PEDIATR-US, V155, P260, DOI 10.1016/j.jpeds.2009.02.033; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu SH, 2011, J IMMUNOL, V187, P4907, DOI 10.4049/jimmunol.1101519; Yusupov E, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/305054	101	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94500	10.1371/journal.pone.0094500	http://dx.doi.org/10.1371/journal.pone.0094500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727903	gold, Green Published, Green Submitted			2022-12-25	WOS:000336736200083
J	Beltrame, V; Ortolan, P; Coran, A; Zanato, R; Gazzola, M; Frigo, A; Bello, L; Pegoraro, E; Stramare, R				Beltrame, Valeria; Ortolan, Paolo; Coran, Alessandro; Zanato, Riccardo; Gazzola, Matteo; Frigo, Annachiara; Bello, Luca; Pegoraro, Elena; Stramare, Roberto			Muscle MR Imaging in Tubular Aggregate Myopathy	PLOS ONE			English	Article							DOMINANTLY INHERITED MYOPATHY; SKELETAL-MUSCLE	Purpose: To evaluate with Magnetic Resonance (MR) the degree of fatty replacement and edematous involvement in skeletal muscles in patients with Tubular Aggregate Myopathy (TAM). To asses the inter-observer agreement in evaluating muscle involvement and the symmetry index of fatty replacement. Materials and Methods: 13 patients were evaluated by MR to ascertain the degree of fatty replacement (T1W sequences) according to Mercuri's scale, and edema score (STIR sequences) according to extent and site. Results: Fatty replacement mainly affects the posterior superficial compartment of the leg; the anterior compartment is generally spared. Edema was generally poor and almost only in the superficial compartment of the leg. The inter-observer agreement is very good with a Krippendorff's coefficient >0.9. Data show a total symmetry in the muscular replacement (McNemar-Bowker test with p = 1). Conclusions: MR reveals characteristic muscular involvement, and is a reproducible technique for evaluation of TAM. There may also be a characteristic involvement of the long and short heads of the biceps femoris. It is useful for aimed biopsies, diagnostic hypotheses and evaluation of disease progression.	[Beltrame, Valeria; Ortolan, Paolo; Coran, Alessandro; Zanato, Riccardo; Gazzola, Matteo; Stramare, Roberto] Univ Padua, Sect Radiol, Dept Med, Padua, Italy; [Frigo, Annachiara] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy	University of Padua; University of Padua; University of Padua	Stramare, R (corresponding author), Univ Padua, Sect Radiol, Dept Med, Padua, Italy.	roberto.stramare@unipd.it	Stramare, Roberto/ABH-6752-2020	Stramare, Roberto/0000-0002-1818-2290; Bello, Luca/0000-0002-3075-6525; Coran, Alessandro/0000-0002-1037-0393				Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; CASTILLO J, 1993, EUR J RADIOL, V17, P141, DOI 10.1016/0720-048X(93)90091-Z; CHUI LA, 1975, NEUROLOGY, V25, P405, DOI 10.1212/WNL.25.5.405; Cupler EJ, 1998, NEUROMUSCULAR DISORD, V8, P321, DOI 10.1016/S0960-8966(98)00026-1; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ENGEL AG, 1966, MAYO CLIN PROC, V41, P797; ENGEL WK, 1970, J ULTRA MOL STRUCT R, V31, P507, DOI 10.1016/S0022-5320(70)90166-8; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Martin JJ, 1997, NEUROMUSCULAR DISORD, V7, P512, DOI 10.1016/S0960-8966(97)00119-3; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Messineo D, 1998, MAGN RESON IMAGING, V16, P731, DOI 10.1016/S0730-725X(98)00080-0; Morgan-Hughes JA, 1998, CURR OPIN NEUROL, V11, P439, DOI 10.1097/00019052-199810000-00005; Muller HD, 2001, ACTA NEUROPATHOL, V102, P27; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; SCHEDEL H, 1992, EUR J RADIOL, V15, P230, DOI 10.1016/0720-048X(92)90113-N; SCHREIBER A, 1987, PEDIATR RADIOL, V17, P495, DOI 10.1007/BF02388288; Stramare R, 2010, RADIOL MED, V115, P585, DOI 10.1007/s11547-010-0531-2; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2	20	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94427	10.1371/journal.pone.0094427	http://dx.doi.org/10.1371/journal.pone.0094427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722334	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100070
J	Creswell, J; Sahu, S; Blok, L; Bakker, MI; Stevens, R; Ditiu, L				Creswell, Jacob; Sahu, Suvanand; Blok, Lucie; Bakker, Mirjam I.; Stevens, Robert; Ditiu, Lucica			A Multi-Site Evaluation of Innovative Approaches to Increase Tuberculosis Case Notification: Summary Results	PLOS ONE			English	Article							SOUTHERN ETHIOPIA; TREATMENT SUCCESS; STRATEGIES; COMMUNITIES; PREVALENCE; DIAGNOSIS; DISEASE	Background: Globally, TB notifications have stagnated since 2007, and sputum smear positive notifications have been declining despite policies to improve case detection. We evaluate results of 28 interventions focused on improving TB case detection. Methods: We measured additional sputum smear positive cases treated, defined as the intervention area's increase in case notification during the project compared to the previous year. Projects were encouraged to select control areas and collect historical notification data. We used time series negative binomial regression for over-dispersed cross-sectional data accounting for fixed and random effects to test the individual projects' effects on TB notification while controlling for trend and control populations. Results: Twenty-eight projects, 19 with control populations, completed at least four quarters of case finding activities, covering a population of 89.2 million. Among all projects sputum smear positive (SS+) TB notifications increased 24.9% and annualized notification rates increased from 69.1 to 86.2/100,000 (p = 0.0209) during interventions. Among the 19 projects with control populations, SS+ TB case notifications increased 36.9% increase while in the control populations a 3.6% decrease was observed. Fourteen (74%) of the 19 projects' SS+ TB notification rates in intervention areas increased from the baseline to intervention period when controlling for historical trends and notifications in control areas. Conclusions: Interventions were associated with large increases in TB notifications across many settings, using an array of interventions. Many people with TB are not reached using current approaches. Different methods and interventions tailored to local realities are urgently needed.	[Creswell, Jacob; Sahu, Suvanand; Ditiu, Lucica] Stop TB Partnership, Geneva, Switzerland; [Blok, Lucie] Royal Trop Inst KIT, Amsterdam, Netherlands; [Bakker, Mirjam I.] Royal Trop Inst KIT Biomed Res, Amsterdam, Netherlands; [Stevens, Robert] HLSP, London, England		Creswell, J (corresponding author), Stop TB Partnership, Geneva, Switzerland.	creswellj@who.int		Creswell, Jacob/0000-0002-4885-940X	Department of Foreign Affairs, Trade and Development of Canada	Department of Foreign Affairs, Trade and Development of Canada	TB REACH is supported by the Department of Foreign Affairs, Trade and Development of Canada. www.international.gc.ca/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077517; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; El-Sony AI, 2003, INT J TUBERC LUNG D, V7, P445; Global Fund, 2011, GLOB FUND INF NOT MO; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Horie T, 2007, INT J TUBERC LUNG D, V11, P562; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Saly Saint, 2006, Kekkaku, V81, P467; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Stop TB Partnership, TB REACH; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CARE I; UNAIDS, 2007, PRACTICAL GUIDELINE; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Veron LJ, 2004, INT J TUBERC LUNG D, V8, P139; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, INT POL COLL TB HIV; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2013, WHOHTMTB201304; World Health Organization, 2011, WHOHTMTB20118; Yanjindulam P, 2012, INT J TUBERC LUNG D, V16, P327, DOI 10.5588/ijtld.11.0251; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	36	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94465	10.1371/journal.pone.0094465	http://dx.doi.org/10.1371/journal.pone.0094465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722399	gold, Green Submitted, Green Published			2022-12-25	WOS:000336909100073
J	Gfeller, D; Ernst, A; Jarvik, N; Sidhu, SS; Bader, GD				Gfeller, David; Ernst, Andreas; Jarvik, Nick; Sidhu, Sachdev S.; Bader, Gary D.			Prediction and Experimental Characterization of nsSNPs Altering Human PDZ-Binding Motifs	PLOS ONE			English	Article							PROTEIN INTERACTIONS; HUMAN GENOME; DATABASE; POLYMORPHISMS; SPECIFICITY; MUTATION; CONTEXT; SERVER; ELM	Single nucleotide polymorphisms (SNPs) are a major contributor to genetic and phenotypic variation within populations. Non-synonymous SNPs (nsSNPs) modify the sequence of proteins and can affect their folding or binding properties. Experimental analysis of all nsSNPs is currently unfeasible and therefore computational predictions of the molecular effect of nsSNPs are helpful to guide experimental investigations. While some nsSNPs can be accurately characterized, for instance if they fall into strongly conserved or well annotated regions, the molecular consequences of many others are more challenging to predict. In particular, nsSNPs affecting less structured, and often less conserved regions, are difficult to characterize. Binding sites that mediate protein-protein or other protein interactions are an important class of functional sites on proteins and can be used to help interpret nsSNPs. Binding sites targeted by the PDZ modular peptide recognition domain have recently been characterized. Here we use this data to show that it is possible to computationally identify nsSNPs in PDZ binding motifs that modify or prevent binding to the proteins containing the motifs. We confirm these predictions by experimentally validating a selected subset with ELISA. Our work also highlights the importance of better characterizing linear motifs in proteins as many of these can be affected by genetic variations.	[Gfeller, David; Ernst, Andreas; Jarvik, Nick; Sidhu, Sachdev S.; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Gfeller, David] Swiss Inst Bioinformat, Lausanne, Switzerland; [Sidhu, Sachdev S.; Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; Swiss Institute of Bioinformatics; University of Toronto; University of Toronto	Bader, GD (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	gary.bader@utoronto.ca	Bader, Gary/C-1176-2009; Gfeller, David/A-6493-2019; gfeller, david/D-3395-2009	Bader, Gary/0000-0003-0185-8861; Gfeller, David/0000-0002-3952-0930; gfeller, david/0000-0002-3952-0930	Canadian Institutes of Health Research [MOP-84324]; EMBO [EMBO-ALTF 241-2010]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant MOP-84324. David Gfeller acknowledges the financial support of EMBO (http://www.embo.org/) grant EMBO-ALTF 241-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Gfeller D, 2012, FEBS LETT, V586, P2764, DOI 10.1016/j.febslet.2012.03.054; Gfeller D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.18; Gonzalez-Perez A, 2013, NAT METHODS, V10, P723, DOI 10.1038/nmeth.2562; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Kono H, 2008, NUCLEIC ACIDS RES, V36, pD409, DOI 10.1093/nar/gkm801; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Luck K, 2011, BIOINFORMATICS, V27, P899, DOI 10.1093/bioinformatics/btr060; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Van Roey K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003345; Warnock DG, 1998, KIDNEY INT, V53, P18, DOI 10.1046/j.1523-1755.1998.00728.x; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Xin XF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.9; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94507	10.1371/journal.pone.0094507	http://dx.doi.org/10.1371/journal.pone.0094507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722214	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100086
J	Scheffler, K; Murrell, B; Pond, SLK				Scheffler, Konrad; Murrell, Ben; Pond, Sergei L. Kosakovsky			On the Validity of Evolutionary Models with Site-Specific Parameters	PLOS ONE			English	Article							AMINO-ACID SITES; SELECTION	Evolutionary models that make use of site-specific parameters have recently been criticized on the grounds that parameter estimates obtained under such models can be unreliable and lack theoretical guarantees of convergence. We present a simulation study providing empirical evidence that a simple version of the models in question does exhibit sensible convergence behavior and that additional taxa, despite not being independent of each other, lead to improved parameter estimates. Although it would be desirable to have theoretical guarantees of this, we argue that such guarantees would not be sufficient to justify the use of these models in practice. Instead, we emphasize the importance of taking the variance of parameter estimates into account rather than blindly trusting point estimates - this is standardly done by using the models to construct statistical hypothesis tests, which are then validated empirically via simulation studies.	[Scheffler, Konrad; Murrell, Ben; Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Scheffler, Konrad] Univ Stellenbosch, Dept Math Sci, ZA-7600 Stellenbosch, South Africa	University of California System; University of California San Diego; Stellenbosch University	Scheffler, K (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	kscheffler@ucsd.edu	Pond, Sergei LK/G-9830-2012; Murrell, Ben/AAM-1188-2021	Pond, Sergei LK/0000-0003-4817-4029; Murrell, Ben/0000-0002-0393-4445; Scheffler, Konrad/0000-0002-6041-8367	National Institutes of Health [AI47745, AI57167, AI74621, AI036214, DA034978, MH083552, MH101012, GM093939]; UC Laboratory Fees Research Program [12-LR-236617]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047745, P30AI036214, R56AI047745, R21AI047745, R01AI057167, P01AI074621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083552, R01MH101012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Laboratory Fees Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institutes of Health grants AI47745, AI57167, AI74621, AI036214, DA034978, MH083552, MH101012, and GM093939, and the UC Laboratory Fees Research Program grant 12-LR-236617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Murrell B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002507; Neyman J, 1948, ECONOMETRICA, V16, P1, DOI 10.2307/1914288; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rodrigue N, 2013, GENETICS, V193, P557, DOI 10.1534/genetics.112.145722; Steel M, 2011, SYST BIOL, V60, P96, DOI 10.1093/sysbio/syq069; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhai WW, 2012, MOL BIOL EVOL, V29, P2889, DOI 10.1093/molbev/mss104	17	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94534	10.1371/journal.pone.0094534	http://dx.doi.org/10.1371/journal.pone.0094534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722425	Green Published, gold			2022-12-25	WOS:000336909100093
J	Schurch, NJ; Cole, C; Sherstnev, A; Song, J; Duc, C; Storey, KG; McLean, WHI; Brown, SJ; Simpson, GG; Barton, GJ				Schurch, Nicholas J.; Cole, Christian; Sherstnev, Alexander; Song, Junfang; Duc, Celine; Storey, Kate G.; McLean, W. H. Irwin; Brown, Sara J.; Simpson, Gordon G.; Barton, Geoffrey J.			Improved Annotation of 3 ' Untranslated Regions and Complex Loci by Combination of Strand-Specific Direct RNA Sequencing, RNA-Seq and ESTs	PLOS ONE			English	Article							GENE ANNOTATION; GENOME; POLYADENYLATION; ZEBRAFISH; REANNOTATION; TRANSCRIPTS; EXPRESSION; RECEPTORS; ULTRAFAST; PROTEINS	The reference annotations made for a genome sequence provide the framework for all subsequent analyses of the genome. Correct and complete annotation in addition to the underlying genomic sequence is particularly important when interpreting the results of RNA-seq experiments where short sequence reads are mapped against the genome and assigned to genes according to the annotation. Inconsistencies in annotations between the reference and the experimental system can lead to incorrect interpretation of the effect on RNA expression of an experimental treatment or mutation in the system under study. Until recently, the genome-wide annotation of 39 untranslated regions received less attention than coding regions and the delineation of intron/exon boundaries. In this paper, data produced for samples in Human, Chicken and A. thaliana by the novel single-molecule, strand-specific, Direct RNA Sequencing technology from Helicos Biosciences which locates 3' polyadenylation sites to within +/- 2 nt, were combined with archival EST and RNA-Seq data. Nine examples are illustrated where this combination of data allowed: (1) gene and 3' UTR re-annotation (including extension of one 3' UTR by 5.9 kb); (2) disentangling of gene expression in complex regions; (3) clearer interpretation of small RNA expression and (4) identification of novel genes. While the specific examples displayed here may become obsolete as genome sequences and their annotations are refined, the principles laid out in this paper will be of general use both to those annotating genomes and those seeking to interpret existing publically available annotations in the context of their own experimental data.	[Schurch, Nicholas J.; Cole, Christian; Sherstnev, Alexander; Barton, Geoffrey J.] Univ Dundee, Div Computat Biol, Dundee, Scotland; [Song, Junfang; Storey, Kate G.] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [McLean, W. H. Irwin; Brown, Sara J.] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland; [Duc, Celine; Simpson, Gordon G.] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Schurch, Nicholas J.; Cole, Christian; Barton, Geoffrey J.] Univ Dundee, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Schurch, Nicholas J.; Cole, Christian; Barton, Geoffrey J.] Univ Dundee, Ctr Gene Regulat & Express, Dundee, Scotland; [Simpson, Gordon G.] James Hutton Inst, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; James Hutton Institute	Barton, GJ (corresponding author), Univ Dundee, Div Computat Biol, Dundee, Scotland.	g.j.barton@dundee.ac.uk	Brown, Sara J/AAF-7095-2019; Schurch, Nicholas/I-4339-2019; Barton, Geoffrey/N-1037-2019; Barton, Geoffrey J/C-6267-2011; duc, celine/F-1372-2015	Brown, Sara J/0000-0002-3232-5251; Schurch, Nicholas/0000-0001-9068-9654; Barton, Geoffrey/0000-0002-9014-5355; Simpson, Gordon/0000-0001-6744-5889; Cole, Christian/0000-0002-2560-2484; Storey, Kate/0000-0003-3506-1287; duc, celine/0000-0001-7426-4541	MRC [G1100552]; Wellcome Trust [086398/Z/08/Z, 92530/Z/10/Z, 100476/Z/12/Z, 097945/Z/11/Z]; National Childrena(sic)(TM)s Research Centre Dublin; BBSRC [BB/H002286/1]; Scottish Government; Biotechnology and Biological Sciences Research Council [BB/H002286/1, BB/J00247X/1] Funding Source: researchfish; Medical Research Council [G1100552] Funding Source: researchfish; BBSRC [BB/J00247X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Childrena(sic)(TM)s Research Centre Dublin; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Kate G. Storey and Junfang Song are supported by MRC (www.mrc.ac.uk) grant (G1100552). Sara J. Brown is supported by a Wellcome Trust (www.wellcome.ac.uk) Intermediate Clinical Fellowship (086398/Z/08/Z) and funding from the National Childrena(sic)(TM) s Research Centre Dublin (http://www.nationalchildrensresearchcentre.ie/). The authors are grateful to the Tayside Tissue Bank (tissuebank.dundee.ac.uk) for help in obtaining the human skin sample. CA (c) line Duc and Gordon G. Simpson are supported by the BBSRC (www.bbsrc.ac.uk) (BB/H002286/1) and Scottish Government. Christian Cole is supported by Wellcome Trust (www.wellcome.ac.uk) Grant (92530/Z/10/Z). Geoff Barton acknowledges support from Wellcome Trust (www.wellcome.ac.uk) Strategic Grants (100476/Z/12/Z) and (097945/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TS, 2012, DEV NEUROBIOL, V72, P415, DOI 10.1002/dneu.20888; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Graber JH, 2013, GENOME RES; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kurihara Y, 2012, G3-GENES GENOM GENET, V2, P487, DOI 10.1534/g3.111.001362; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Moqtaderi Z, 2013, P NATL ACAD SCI USA, V110, P11073, DOI 10.1073/pnas.1309384110; Ozsolak F, 2011, WIRES RNA, V2, P565, DOI 10.1002/wrna.84; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Reese MG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s1; Reid AI, 2002, INT J DEV BIOL, V46, P209; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sherstnev A, 2012, NAT STRUCT MOL BIOL, V19, P845, DOI 10.1038/nsmb.2345; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	47	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94270	10.1371/journal.pone.0094270	http://dx.doi.org/10.1371/journal.pone.0094270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722185	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100047
J	Andersson, E; Steven, K; Guldberg, P				Andersson, Elin; Steven, Kenneth; Guldberg, Per			Size-Based Enrichment of Exfoliated Tumor Cells in Urine Increases the Sensitivity for DNA-Based Detection of Bladder Cancer	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FGFR3 MUTATION ASSAY; FOLLOW-UP; UROTHELIAL CARCINOMA; COST-EFFECTIVENESS; MULTIPLE GENES; VOIDED URINE; P53 GENE; METHYLATION; MARKERS	Bladder cancer is diagnosed by cystoscopy, a costly and invasive procedure that is associated with patient discomfort. Analysis of tumor-specific markers in DNA from sediments of voided urine has the potential for non-invasive detection of bladder cancer; however, the sensitivity is limited by low fractions and small numbers of tumor cells exfoliated into the urine from low-grade tumors. The purpose of this study was to improve the sensitivity for non-invasive detection of bladder cancer by size-based capture and enrichment of tumor cells in urine. In a split-sample set-up, urine from a consecutive series of patients with primary or recurrent bladder tumors (N = 189) was processed by microfiltration using a membrane filter with a defined pore-size, and sedimentation by centrifugation, respectively. DNA from the samples was analyzed for seven bladder tumor-associated methylation markers using MethyLight and pyrosequencing assays. The fraction of tumor-derived DNA was higher in the filter samples than in the corresponding sediments for all markers (p<0.000001). Across all tumor stages, the number of cases positive for one or more markers was 87% in filter samples compared to 80% in the corresponding sediments. The largest increase in sensitivity was achieved in low-grade Ta tumors, with 82 out of 98 cases positive in the filter samples (84%) versus 74 out of 98 in the sediments (75%). Our results show that pre-analytic processing of voided urine by size-based filtration can increase the sensitivity for DNA-based detection of bladder cancer.	[Andersson, Elin; Guldberg, Per] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Steven, Kenneth] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark	Danish Cancer Society; University of Copenhagen	Guldberg, P (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.	perg@cancer.dk			Candy Foundation	Candy Foundation	Grant support: The Candy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhahn M, 2013, EUR J CANCER, V49, P3159, DOI 10.1016/j.ejca.2013.04.033; Cairns P, 2007, NAT REV CANCER, V7, P531, DOI 10.1038/nrc2170; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; CROFT WA, 1979, SCAND J UROL NEPHROL, V13, P43, DOI 10.3109/00365597909179998; Dulaimi E, 2004, CLIN CANCER RES, V10, P1887, DOI 10.1158/1078-0432.CCR-03-0127; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Falke J, 2011, NAT REV UROL, V8, P42, DOI 10.1038/nrurol.2010.208; Feinberg AP, 2005, COLD SH Q B, V70, P335, DOI 10.1101/sqb.2005.70.027; Ferlay J, 2010, IARC CANCERBASE, V2; Galvan AB, 2011, CANCER CYTOPATHOL, V119, P395, DOI 10.1002/cncy.20168; Guldberg Per, 2002, Methods Mol Med, V68, P125; Herr HW, 2000, J UROLOGY, V163, P60, DOI 10.1016/S0022-5347(05)67972-4; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Kandimalla R, 2013, NAT REV UROL, V10, P327, DOI 10.1038/nrurol.2013.89; Kandimalla R, 2012, EUR UROL, V61, P1245, DOI 10.1016/j.eururo.2012.01.011; Kipp BR, 2006, DIAGN CYTOPATHOL, V34, P479, DOI 10.1002/dc.20488; Kumar A, 2006, JPN J CLIN ONCOL, V36, P172, DOI 10.1093/jjco/hyi244; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Lotan Y, 2002, J UROLOGY, V167, P75, DOI 10.1016/S0022-5347(05)65386-4; Meiers I, 2007, ARCH PATHOL LAB MED, V131, P1574; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Nedergaard T, 1997, INT J CANCER, V71, P364, DOI 10.1002/(SICI)1097-0215(19970502)71:3<364::AID-IJC10>3.0.CO;2-G; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Renard Isabelle, 2010, Eur Urol, V58, P96, DOI 10.1016/j.eururo.2009.07.041; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; Sanchez-Carbayo M, 2012, TUMOR BIOL, V33, P347, DOI 10.1007/s13277-011-0310-2; Serizawa RR, 2011, INT J CANCER, V129, P78, DOI 10.1002/ijc.25651; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; Sugano K, 1997, INT J CANCER, V74, P403, DOI 10.1002/(SICI)1097-0215(19970822)74:4<403::AID-IJC7>3.3.CO;2-V; Sullivan PS, 2010, AM J TRANSL RES, V2, P412; Tetu B, 2009, MODERN PATHOL, V22, pS53, DOI 10.1038/modpathol.2008.193; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Vinci S, 2011, UROL ONCOL-SEMIN ORI, V29, P150, DOI 10.1016/j.urolonc.2009.01.003; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wadhwa N, 2012, J CLIN PATHOL, V65, P970, DOI 10.1136/jclinpath-2012-200812; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zabaglo L, 2003, CYTOM PART A, V55A, P102, DOI 10.1002/cyto.a.10071; Zieger K, 2000, BJU INT, V85, P824, DOI 10.1046/j.1464-410x.2000.00547.x; Zuiverloon TCM, 2011, J UROLOGY, V186, P707, DOI 10.1016/j.juro.2011.03.141	46	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94023	10.1371/journal.pone.0094023	http://dx.doi.org/10.1371/journal.pone.0094023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732047	Green Published, gold, Green Submitted			2022-12-25	WOS:000336970400015
J	Cyphert, HA; Alonge, KM; Ippagunta, SM; Hillgartner, FB				Cyphert, Holly A.; Alonge, Kimberly M.; Ippagunta, Siri M.; Hillgartner, F. Bradley			Glucagon Stimulates Hepatic FGF21 Secretion through a PKA- and EPAC-Dependent Posttranscriptional Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR 21; ACTIVATED PROTEIN-KINASE; RAT HEPATOCYTES; PPAR-ALPHA; CYCLIC-AMP; INSULIN SENSITIVITY; GLUCOSE-PRODUCTION; COACTIVATOR PGC-1; MAMMALIAN TARGET; X RECEPTOR	Previous studies have shown that whole body deletion of the glucagon receptor suppresses the ability of starvation to increase hepatic fibroblast growth factor 21 (FGF21) expression and plasma FGF21 concentration. Here, we investigate the mechanism by which glucagon receptor activation increases hepatic FGF21 production. Incubating primary rat hepatocyte cultures with glucagon, dibutyryl cAMP or forskolin stimulated a 3-4-fold increase in FGF21 secretion. The effect of these agents on FGF21 secretion was not associated with an increase in FGF21 mRNA abundance. Glucagon induction of FGF21 secretion was additive with the stimulatory effect of a PPAR alpha activator (GW7647) on FGF21 secretion. Inhibition of protein kinase A (PKA) and downstream components of the PKA pathway [i.e. AMP-activated protein kinase and p38 MAPK] suppressed glucagon activation of FGF21 secretion. Incubating hepatocytes with an exchange protein directly activated by cAMP (EPAC)-selective cAMP analog [i.e. 8-(4-chlorophenylthio)-2'-O-methyladenosine-3', 5'-cyclic monophosphate (cpTOME)], stimulated a 3.9-fold increase FGF21 secretion, whereas inhibition of the EPAC effector, Rap1, suppressed glucagon activation of FGF21 secretion. Treatment of hepatocytes with insulin also increased FGF21 secretion. In contrast to glucagon, insulin activation of FGF21 secretion was associated with an increase in FGF21 mRNA abundance. Glucagon synergistically interacted with insulin to stimulate a further increase in FGF21 secretion and FGF21 mRNA abundance. These results demonstrate that glucagon increases hepatic FGF21 secretion via a posttranscriptional mechanism and provide evidence that both the PKA branch and EPAC branch of the cAMP pathway play a role in mediating this effect. These results also identify a novel synergistic interaction between glucagon and insulin in the regulation of FGF21 secretion and FGF21 mRNA abundance. We propose that this insulin/glucagon synergism plays a role in mediating the elevation in FGF21 production during starvation and conditions related to metabolic syndrome.	[Cyphert, Holly A.; Alonge, Kimberly M.; Ippagunta, Siri M.; Hillgartner, F. Bradley] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu	Ippagunta, Siri Manasa/Y-6606-2019	Ippagunta, Siri Manasa/0000-0002-4714-8390; Alonge, Kimberly/0000-0002-2171-1640	American Diabetes Association Basic Science Award [1-12-BS-75]	American Diabetes Association Basic Science Award(American Diabetes Association)	This work was supported by American Diabetes Association Basic Science Award 1-12-BS-75. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; AZROLAN N, 1995, J BIOL CHEM, V270, P19833, DOI 10.1074/jbc.270.34.19833; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BALKS HJ, 1984, EUR J BIOCHEM, V141, P645, DOI 10.1111/j.1432-1033.1984.tb08240.x; Baum JI, 2009, AM J PHYSIOL-ENDOC M, V297, pE410, DOI 10.1152/ajpendo.00042.2009; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Bucher ML, 1975, P NATL ACAD SCI USA, V72, P1157; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cullen KA, 2004, AM J PHYSIOL-GASTR L, V287, pG334, DOI 10.1152/ajpgi.00517.2003; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Domouzoglou EM, 2011, AM J CLIN NUTR, V93, p901S, DOI 10.3945/ajcn.110.001941; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Giacca A, 1997, ENDOCRINOLOGY, V138, P999, DOI 10.1210/en.138.3.999; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Graf D, 2003, ARCH BIOCHEM BIOPHYS, V415, P34, DOI 10.1016/S0003-9861(03)00224-8; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito Y, 1997, BIOCHEM J, V324, P379, DOI 10.1042/bj3240379; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimura M, 1997, EUR J PHARMACOL, V327, P87, DOI 10.1016/S0014-2999(97)89682-3; Lewis GF, 1997, AM J PHYSIOL-ENDOC M, V272, pE371, DOI 10.1152/ajpendo.1997.272.3.E371; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; PEREA A, 1995, HORM METAB RES, V27, P372, DOI 10.1055/s-2007-979981; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; RICHTER WO, 1989, PEPTIDES, V10, P333, DOI 10.1016/0196-9781(89)90039-9; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Sinclair EM, 2008, GASTROENTEROLOGY, V135, P2096, DOI 10.1053/j.gastro.2008.07.075; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Stabile LP, 1998, J LIPID RES, V39, P1951; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; Vuguin PM, 2011, DIABETES OBES METAB, V13, P144, DOI 10.1111/j.1463-1326.2011.01447.x; Wu SF, 2012, J BIOL CHEM, V287, P26060, DOI 10.1074/jbc.M112.343707; Xiao Y, 2012, J CLIN ENDOCR METAB, V97, pE54, DOI 10.1210/jc.2011-1930; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	73	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94996	10.1371/journal.pone.0094996	http://dx.doi.org/10.1371/journal.pone.0094996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24733293	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400142
J	Martin, E; Harel, S; Nkengfac, B; Hamiche, K; Neault, M; Jenna, S				Martin, Emmanuel; Harel, Sharon; Nkengfac, Bernard; Hamiche, Karim; Neault, Mathieu; Jenna, Sarah			pix-1 Controls Early Elongation in Parallel with mel-11 and let-502 in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; EMBRYONIC MORPHOGENESIS; MYOSIN PHOSPHATASE; CELL-MIGRATION; KINASE; PATHWAY; EPIDERMIS; PROTEINS; GTPASE	Cell shape changes are crucial for metazoan development. During Caenorhabditis elegans embryogenesis, epidermal cell shape changes transform ovoid embryos into vermiform larvae. This process is divided into two phases: early and late elongation. Early elongation involves the contraction of filamentous actin bundles by phosphorylated non-muscle myosin in a subset of epidermal (hypodermal) cells. The genes controlling early elongation are associated with two parallel pathways. The first one involves the rho-1/RHOA-specific effector let-502/Rho-kinase and mel-11/myosin phosphatase regulatory subunit. The second pathway involves the CDC42/RAC-specific effector pak-1. Late elongation is driven by mechanotransduction in ventral and dorsal hypodermal cells in response to body-wall muscle contractions, and involves the CDC42/RAC-specific Guanine-nucleotide Exchange Factor (GEF) pix-1, the GTPase ced-10/RAC and pak-1. In this study, pix-1 is shown to control early elongation in parallel with let-502/mel-11, as previously shown for pak-1. We show that pix-1, pak-1 and let-502 control the rate of elongation, and the antero-posterior morphology of the embryos. In particular, pix-1 and pak-1 are shown to control head, but not tail width, while let-502 controls both head and tail width. This suggests that let-502 function is required throughout the antero-posterior axis of the embryo during early elongation, while pix-1/pak-1 function may be mostly required in the anterior part of the embryo. Supporting this hypothesis we show that low pix-1 expression level in the dorsal-posterior hypodermal cells is required to ensure high elongation rate during early elongation.	[Martin, Emmanuel; Harel, Sharon; Nkengfac, Bernard; Hamiche, Karim; Neault, Mathieu; Jenna, Sarah] Univ Quebec Montreal UQAM, Dept Chem, Pharmaqam, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal	Jenna, S (corresponding author), Univ Quebec Montreal UQAM, Dept Chem, Pharmaqam, Montreal, PQ, Canada.	jenna.sarah@uqam.ca		Neault, Mathieu/0000-0002-0479-1001; Martin, Emmanuel/0000-0003-3878-8633	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation; Canada Research Chair program; NSERC; "Fonds de recherche en sante du Quebec"; FARE UQAM research fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds de recherche en sante du Quebec"(Fonds de la Recherche en Sante du Quebec); FARE UQAM research fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada and The Canada Foundation for Innovation. SJ is funded by the Canada Research Chair program. SH is funded by the NSERC and. by the "Fonds de recherche en sante du Quebec" EM is funded by the FARE UQAM research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; BRENNER S, 1974, GENETICS, V77, P71; Chen WN, 1996, J BIOL CHEM, V271, P26362, DOI 10.1074/jbc.271.42.26362; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Lin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031499; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017; Peters EC, 2013, G3-GENES GENOM GENET, V3, P181, DOI 10.1534/g3.112.004416; Piekny AJ, 2000, GENETICS, V156, P1671; Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vanneste Chrisotpher A, 2013, Worm, V2, pe25040, DOI 10.4161/worm.25040; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wissmann A, 1999, DEV BIOL, V209, P111, DOI 10.1006/dbio.1999.9242; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	23	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94684	10.1371/journal.pone.0094684	http://dx.doi.org/10.1371/journal.pone.0094684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732978	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400070
J	Zhang, XM; Guo, LL; Niu, T; Shao, L; Li, HJ; Wu, WW; Wang, WJ; Lv, LM; Qin, QY; Wang, F; Tang, DQ; Wang, XL; Cui, TX				Zhang, Xiaoming; Guo, Linlin; Niu, Ting; Shao, Lei; Li, Huanjie; Wu, Weiwei; Wang, Wenjuan; Lv, Linmao; Qin, Qingyun; Wang, Fang; Tang, Dongqi; Wang, Xing Li; Cui, Taixing			Ubiquitin Carboxyl Terminal Hydrolyase L1-Suppressed Autophagic Degradation of p21(WAF1/Cip1) as a Novel Feedback Mechanism in the Control of Cardiac Fibroblast Proliferation	PLOS ONE			English	Article							HYDROLASE L1; PROTEASOME SYSTEM; DEUBIQUITINATING ENZYMES; COMPLEX 1; ACTIVATION; UCH-L1; CELLS; APOPTOSIS; FIBROSIS; HEART	Aims: Deubiquitinating enzymes (DUBs) appear to be critical regulators of a multitude of processes such as proliferation, apoptosis, differentiation, and inflammation; however, the potential roles of DUBs in the heart remain to be determined. This study was aimed to explore the role of a DUB, ubiquitin carboxyl terminal hydrolyase L1 (UCH-L1) in maladaptive cardiac remodeling and dysfunction. Methods and Results: Maladaptive cardiac remodeling and dysfunction were induced in mice by transverse aortic constriction (TAC). UCH-L1 expression was transiently increased and then declined near to the basal level while impairment of cardiac function proceeded. The upregulation of UCH-L1 was observed in cardiac myocytes and fibroblasts. In primary culture of cardiac fibroblasts, UCH-L1 was upregulated by platelet-derived growth factor (PDGF)-BB and PDGF-DD. Adenoviral overexpession of UCH-L1 inhibited the PDGF-induced cardiac fibroblast proliferation without affecting the activation of mitogen activated protein kinases (MAPKs), Akt, and signal transducers and activators of transcription 3 (STAT3). Further signaling dissection revealed that PDGF-BB posttranscriptional upregulated p21(WAF1/Cip1) protein expression, which was inhibited by rapamycin, an activator of autophagy via suppressing mammalian target of rapamycin (mTOR), rather than MG132, a proteasome inhibitor. Overexpression of UCH-L1 enhanced PDGF-BB-induced mTOR phosphorylation and upregulation of p21(WAF1/Cip1) protein expression while suppressed autophagic flux in cardiac fibroblasts. Conclusion: UCH-L1 facilitates PDGF-BB-induced suppression of autophagic degradation of p21(WAF1/Cip1) proteins in cardiac fibroblasts, which may serve as a novel negative feedback mechanism in the control of cardiac fibroblast proliferation contributing to cardiac fibrosis and dysfunction.	[Zhang, Xiaoming; Guo, Linlin; Niu, Ting; Shao, Lei; Li, Huanjie; Wu, Weiwei; Wang, Wenjuan; Lv, Linmao; Qin, Qingyun; Wang, Fang; Tang, Dongqi; Wang, Xing Li; Cui, Taixing] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiaoming] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan 250100, Shandong, Peoples R China; [Tang, Dongqi; Cui, Taixing] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA	Shandong University; Shandong University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wang, XL (corresponding author), Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	xingliwang@sdu.edu.cn; taixing.cui@uscmed.sc.edu	zhang, xiaoming/A-7126-2018	Cui, Taixing/0000-0002-9528-7299	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund; National Natural Science Foundation of China [81100064]	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shandong University National Qianren Scholar Fund; Taishan Scholar Fund; and the National Natural Science Foundation of China (Grant Number 81100064) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Campbell LK, 2003, MODERN PATHOL, V16, P963, DOI 10.1097/01.MP.0000087088.88280.B0; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Han S, 2012, J BIOL CHEM, V287, P30063, DOI 10.1074/jbc.M112.353987; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hiripi L, 2010, TRANSGENIC RES, V19, P799, DOI 10.1007/s11248-009-9356-y; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Ichikawa T, 2010, BIOCHEM BIOPH RES CO, V391, P852, DOI 10.1016/j.bbrc.2009.11.151; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2013, J BIOL CHEM, V288, P12615, DOI 10.1074/jbc.M112.435701; Kwon J, 2007, EXP ANIM TOKYO, V56, P71, DOI 10.1538/expanim.56.71; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Weber B, 2009, CELL SIGNAL, V21, P1513, DOI 10.1016/j.cellsig.2009.05.011; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yohn NL, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-19; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94658	10.1371/journal.pone.0094658	http://dx.doi.org/10.1371/journal.pone.0094658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732420	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400064
J	Dai, YH; Xiong, XP; Huang, G; Liu, JJ; Sheng, SL; Wang, HJ; Qin, WX				Dai, Yunhai; Xiong, Xiaopeng; Huang, Gang; Liu, Jianjun; Sheng, Shile; Wang, Hongjian; Qin, Wenxin			Dichloroacetate Enhances Adriamycin-Induced Hepatoma Cell Toxicity In Vitro and In Vivo by Increasing Reactive Oxygen Species Levels	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; TUMOR-CELLS; APOPTOSIS; CYTOTOXICITY; PACLITAXEL; GLYCOLYSIS; THERAPY; GROWTH	A unique bioenergetic feature of cancer, aerobic glycolysis is considered an attractive therapeutic target for cancer therapy. Recently, dichloroacetate (DCA), a small-molecule metabolic modulator, was shown to reverse the glycolytic phenotype, induce reactive oxygen species (ROS) generation, and trigger apoptosis in various tumor cells. In this work, the capacity of DCA to enhance Adriamycin (ADM) efficacy in hepatoma cells by modulating glucose metabolism and redox status was evaluated. Two human hepatoma (HCC-LM3 and SMMC-7721) and a normal liver (LO2) cell lines were treated with DCA or ADM alone, or in combination. Exposure of hepatoma cells to DCA/ADM combination resulted in significantly decreased cell viability and increased percentage of apoptotic cells as well as intracellular ROS levels, in comparison with treatment with DCA or ADM alone. However, simultaneous treatment with the thiol antioxidant N-acetylcysteine (NAC, 10 mmol/L) reduced the elevated ROS levels and protected hepatoma cells from the cytotoxic effects of DCA/ADM combination. L-buthionine-[S,R]-sulfoximine, an inhibitor of glutathione synthesis, enhanced hepatoma cell sensitivity to DCA/ADM combination. Interestingly, treatment with DCA/ADM combination did not significantly increase cytotoxicity in normal hepatocytes in comparison with the drugs administered individually. Finally, DCA reduced tumor growth and enhanced ADM efficacy on HCC-LM3 hepatoma in mice. Overall, our data suggest that DCA enhances ADM cytotoxicity in hepatoma cells by increasing intracellular ROS levels and provide a strong biochemical rationale for the use of DCA in combination with ADM for treatment of hepatoma.	[Dai, Yunhai; Xiong, Xiaopeng; Huang, Gang; Liu, Jianjun; Sheng, Shile] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Dai, Yunhai; Xiong, Xiaopeng; Huang, Gang; Liu, Jianjun; Sheng, Shile] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200030, Peoples R China; [Dai, Yunhai; Xiong, Xiaopeng; Huang, Gang; Liu, Jianjun; Sheng, Shile] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Hongjian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 6, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Qin, Wenxin] Shanghai Jiao Tong Univ, Shanghai Canc Inst, WHO Collaborating Ctr Res Canc, Natl Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	huanggangmed@163.com	xiong, xiaopeng/M-2120-2017; huang, gang/D-6427-2012	huang, gang/0000-0002-8692-7856	National Natural Science Foundation of China [30830038, 30970842]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Works in Gang Huang's lab were supported by Major Program of National Natural Science Foundation of China (NO. 30830038) and National Natural Science Foundation of China (NO. 30970842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Alexandre J, 2006, J NATL CANCER I, V98, P236, DOI 10.1093/jnci/djj049; Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; Ayyanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039949; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Coleman MC, 2008, FREE RADICAL BIO MED, V44, P322, DOI 10.1016/j.freeradbiomed.2007.08.032; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; Flavin D, 2010, ONCOL LETT, V1, P889, DOI 10.3892/ol_00000158; Friesen C, 1999, CELL DEATH DIFFER, V6, P471, DOI 10.1038/sj.cdd.4400512; GANEY PE, 1988, MOL PHARMACOL, V34, P695; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GREENE RF, 1983, CANCER RES, V43, P3417; Hoshida Y, 2007, HEPATO-GASTROENTEROL, V54, P489; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Lin X, 2003, CANCER RES, V63, P3413; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rabelo E, 2001, HYPERTENSION, V38, P576, DOI 10.1161/hy09t1.096185; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Rodriguez-Enriquez S, 2000, ARCH BIOCHEM BIOPHYS, V375, P21, DOI 10.1006/abbi.1999.1582; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Staniek K, 2002, FREE RADICAL RES, V36, P381, DOI 10.1080/10715760290021225; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Zhang Xiaodong, 1997, Zhonghua Zhongliu Zazhi, V19, P260	39	30	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e92962	10.1371/journal.pone.0092962	http://dx.doi.org/10.1371/journal.pone.0092962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728083	Green Published, Green Submitted, gold			2022-12-25	WOS:000336736200012
J	Malki, I; Simenel, C; Wojtowicz, H; de Amorim, GC; Prochnicka-Chalufour, A; Hoos, S; Raynal, B; England, P; Chaffotte, A; Delepierre, M; Delepelaire, P; Izadi-Pruneyre, N				Malki, Idir; Simenel, Catherine; Wojtowicz, Halina; de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Hoos, Sylviane; Raynal, Bertrand; England, Patrick; Chaffotte, Alain; Delepierre, Muriel; Delepelaire, Philippe; Izadi-Pruneyre, Nadia			Interaction of a Partially Disordered Antisigma Factor with Its Partner, the Signaling Domain of the TonB-Dependent Transporter HasR	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; FERRIC CITRATE TRANSPORT; ECF SIGMA-FACTOR; OUTER-MEMBRANE; SERRATIA-MARCESCENS; HEME; NMR; TRANSDUCTION; FECA; RECEPTOR	Bacteria use diverse signaling pathways to control gene expression in response to external stimuli. In Gram-negative bacteria, the binding of a nutrient is sensed by an outer membrane transporter. This signal is then transmitted to an antisigma factor and subsequently to the cytoplasm where an ECF sigma factor induces expression of genes related to the acquisition of this nutrient. The molecular interactions involved in this transmembrane signaling are poorly understood and structural data on this family of antisigma factor are rare. Here, we present the first structural study of the periplasmic domain of an antisigma factor and its interaction with the transporter. The study concerns the signaling in the heme acquisition system (Has) of Serratia marcescens. Our data support unprecedented partially disordered periplasmic domain of an anti-sigma factor HasS in contact with a membrane-mimicking environment. We solved the 3D structure of the signaling domain of HasR transporter and identified the residues at the HasS-HasR interface. Their conservation in several bacteria suggests wider significance of the proposed model for the understanding of bacterial transmembrane signaling.	[Malki, Idir; Simenel, Catherine; Wojtowicz, Halina; de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Chaffotte, Alain; Delepierre, Muriel; Izadi-Pruneyre, Nadia] Inst Pasteur, Dept Biol Struct & Chim, Unite RMN Biomol, Paris, France; [Malki, Idir; Simenel, Catherine; Wojtowicz, Halina; de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Chaffotte, Alain; Delepierre, Muriel; Izadi-Pruneyre, Nadia] CNRS, UMR 3528, Paris, France; [Malki, Idir] Univ Paris 06, Cellule Pasteur UPMC, Paris, France; [Hoos, Sylviane; Raynal, Bertrand; England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, Paris, France; [Delepelaire, Philippe] Univ Paris Diderot, CNRS, UMR 7099, Inst Biol Physicochim, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Izadi-Pruneyre, N (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Unite RMN Biomol, Paris, France.	nadia.izadi@pasteur.fr	Amorim, Gisele/GRN-8305-2022; Amorim, Gisele/O-9231-2019; Amorim, Gisele/D-7876-2013	Amorim, Gisele/0000-0003-4348-9515; Amorim, Gisele/0000-0003-4348-9515; Amorim, Gisele/0000-0003-4348-9515; raynal, Bertrand/0000-0001-5634-0408; Delepelaire, Philippe/0000-0002-5190-7118; ENGLAND, Patrick/0000-0001-6410-5918; Izadi-Pruneyre, Nadia/0000-0002-6864-2961	Institut Pasteur; CNRS; ANR (Agence Nationale de la Recherche) [08-BLAN-HEMETRANS, Blanc-SVS3-HEMESTOCKEXCHANGE]; Ministere de l'Enseignement Superieur et la Recherche; Ecole doctorale iViv; Mairie de Paris; ANR [08-BLANHEMETRANS]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et la Recherche; Ecole doctorale iViv; Mairie de Paris(Region Ile-de-France); ANR(French National Research Agency (ANR))	This work was funded by the Institut Pasteur, the CNRS and two grants from the ANR (Agence Nationale de la Recherche) 08-BLAN-HEMETRANS and Blanc-SVS3-HEMESTOCKEXCHANGE. IM was a recipient of fellowships from the Ministere de l'Enseignement Superieur et la Recherche and the Ecole doctorale iViv. HW was funded by postdoctoral fellowships from the Mairie de Paris. GCA was funded by ANR (08-BLANHEMETRANS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthaud A, 2012, J AM CHEM SOC, V134, P10080, DOI 10.1021/ja301667n; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Breidenstein E, 2006, J BACTERIOL, V188, P6440, DOI 10.1128/JB.00741-06; Brillet K, 2007, STRUCTURE, V15, P1383, DOI 10.1016/j.str.2007.08.013; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t; de Amorim GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058964; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; Enz S, 2003, J BACTERIOL, V185, P3745, DOI 10.1128/JB.185.13.3745-3752.2003; Enz S, 2000, J BACTERIOL, V182, P637, DOI 10.1128/JB.182.3.637-646.2000; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Franzin CM, 2007, METHODS, V41, P398, DOI 10.1016/j.ymeth.2006.08.011; Garcia-Herrero A, 2005, MOL MICROBIOL, V58, P1226, DOI 10.1111/j.1365-2958.2005.04889.x; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Gumbart J, 2009, J MOL BIOL, V393, P1129, DOI 10.1016/j.jmb.2009.09.004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Izadi-Pruneyre N, 2011, ENCY INORGANIC BIOIN, DOI [10.1002/9781119951438.eibc0690, DOI 10.1002/9781119951438.EIBC0690]; Karaca E, 2013, METHODS, V59, P372, DOI 10.1016/j.ymeth.2012.12.004; Kirby AE, 2004, INFECT IMMUN, V72, P896, DOI 10.1128/IAI.72.2.896-907.2004; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Ma WK, 2013, BBA-PROTEINS PROTEOM, V1834, P808, DOI 10.1016/j.bbapap.2013.01.010; MALKI I, 2013, J BIOMOL NMR ASSIGN, V7, P43; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mokdad A, 2012, J MOL BIOL, V423, P818, DOI 10.1016/j.jmb.2012.09.003; Nanga RPR, 2009, J AM CHEM SOC, V131, P17972, DOI 10.1021/ja908170s; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Schalk IJ, 2009, BIOMETALS, V22, P671, DOI 10.1007/s10534-008-9203-2; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Trellet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058769; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wandersman C, 2012, MOL MICROBIOL, V85, P618, DOI 10.1111/j.1365-2958.2012.08136.x; Wirth C, 2007, J MOL BIOL, V368, P398, DOI 10.1016/j.jmb.2007.02.023; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	50	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e89502	10.1371/journal.pone.0089502	http://dx.doi.org/10.1371/journal.pone.0089502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24727671	Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200003
J	Nielsen, TO; Friis-Hansen, L; Poulsen, SS; Federspiel, B; Sorensen, BS				Nielsen, Trine Ostergaard; Friis-Hansen, Lennart; Poulsen, Steen Seier; Federspiel, Birgitte; Sorensen, Boe Sandahl			Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4	PLOS ONE			English	Article							ERBB RECEPTORS; CLEAVAGE; SURVIVAL; GENE; OVEREXPRESSION; AMPLIFICATION; CARCINOMA; ISOFORM; BLADDER; TARGET	Gastric cancer is a major cause of cancer-related deaths in both men and women. The epidermal growth factor receptors are EGFR, HER2, HER3 and HER4. Of the four epidermal growth factor receptors, EGFR and HER2 are well-known oncogenes involved in gastric cancer. Little, however, is known about the role played by HER3 and HER4 in this disease. We obtained paired samples from the tumor and the adjacent normal tissue from the same patient undergoing surgery for gastric cancer. Using RT-qPCR, we quantified the mRNA expression of the four receptors including the HER4 splicing isoforms and all the ligands activating these receptors. Using immunohistochemistry, the protein expression of HER4 was also quantified. We found that HER2 mRNA expression was upregulated in the tumor tissue compared to the matched normal tissue (p = 0.0520). All ligands with affinity for EGFR were upregulated, whereas the expression of EGFR was unchanged. Interestingly, we found the mRNA expression of HER4 (p = 0.0002) and its ligand NRG4 (p = 0.0009) to be downregulated in the tumor tissue compared to the matched normal tissue. HER4 downregulation was demonstrated for all the alternatively spliced isoforms of this receptor. These results support the involvement of EGFR and HER2 in gastric cancer and suggest an interesting association of reduced HER4 expression with development of gastric cancer.	[Nielsen, Trine Ostergaard; Sorensen, Boe Sandahl] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; [Friis-Hansen, Lennart] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Friis-Hansen, Lennart] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Poulsen, Steen Seier] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Federspiel, Birgitte] Rigshosp, Copenhagen Univ Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark	Aarhus University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, TO (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark.	trine.ostergaad@ki.au.dk		Sorensen, Boe/0000-0002-9472-8099; Friis-Hansen, Lennart/0000-0002-7222-0163; Poulsen, Steen Seier/0000-0003-4419-4911	Danish Cancer Society [R2-A247-09-S2]; Danish MRC [FSS 09072153]	Danish Cancer Society(Danish Cancer Society); Danish MRC(Danish Medical Research Council)	Danish Cancer Society #R2-A247-09-S2, Danish MRC #FSS 09072153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Chan JA, 2011, ANN ONCOL, V22, P1367, DOI 10.1093/annonc/mdq604; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; De Vita F, 2012, EXPERT OPIN THER TAR, V16, pS29, DOI 10.1517/14728222.2011.652616; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; HYNES NE, 1993, SEMIN CANCER BIOL, V4, P19; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kato M, 2010, JPN J CLIN ONCOL, V40, P828, DOI 10.1093/jjco/hyq119; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Lee CM, 2005, GYNECOL ONCOL, V99, P415, DOI 10.1016/j.ygyno.2005.05.045; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Li L, 2012, ASIAN PAC J CANCER P, V13, P2069, DOI 10.7314/APJCP.2012.13.5.2069; Lo Nigro C, 2010, INT J ONCOL, V37, P1219, DOI 10.3892/ijo_00000773; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Memon AA, 2004, BRIT J CANCER, V91, P2034, DOI 10.1038/sj.bjc.6602251; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Saglam O, 2007, DIAGN MOL PATHOL, V16, P218, DOI 10.1097/PDM.0b013e3180d0aab5; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Thybusch-Bernhardt A, 2001, Int J Surg Investig, V2, P393; Trarbach T, 2013, INVEST NEW DRUG, V31, P642, DOI 10.1007/s10637-012-9848-0; Wang YK, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-14; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Wu WKK, 2009, ANTICANCER RES, V29, P229; Xia WY, 1999, CLIN CANCER RES, V5, P4164; Zhang XL, 2009, WORLD J SURG, V33, P2112, DOI 10.1007/s00268-009-0142-z	38	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94606	10.1371/journal.pone.0094606	http://dx.doi.org/10.1371/journal.pone.0094606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728052	Green Submitted, Green Published, gold			2022-12-25	WOS:000336736200106
J	Quigley, KM; Davies, SW; Kenkel, CD; Willis, BL; Matz, MV; Bay, LK				Quigley, Kate M.; Davies, Sarah W.; Kenkel, Carly D.; Willis, Bette L.; Matz, Mikhail V.; Bay, Line K.			Deep-Sequencing Method for Quantifying Background Abundances of Symbiodinium Types: Exploring the Rare Symbiodinium Biosphere in Reef-Building Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MONTASTRAEA-ANNULARIS; SCLERACTINIAN CORALS; ALGAL ENDOSYMBIONTS; OCEAN ACIDIFICATION; GENETIC DIVERSITY; CLIMATE-CHANGE; CLADE-D; SPECIFICITY; ZOOXANTHELLAE	The capacity of reef-building corals to associate with environmentally-appropriate types of endosymbionts from the dinoflagellate genus Symbiodinium contributes significantly to their success at local scales. Additionally, some corals are able to acclimatize to environmental perturbations by shuffling the relative proportions of different Symbiodinium types hosted. Understanding the dynamics of these symbioses requires a sensitive and quantitative method of Symbiodinium genotyping. Electrophoresis methods, still widely utilized for this purpose, are predominantly qualitative and cannot guarantee detection of a background type below 10% of the total Symbiodinium population. Here, the relative abundances of four Symbiodinium types (A13, C1, C3, and D1) in mixed samples of known composition were quantified using deep sequencing of the internal transcribed spacer of the ribosomal RNA gene (ITS-2) by means of Next Generation Sequencing (NGS) using Roche 454. In samples dominated by each of the four Symbiodinium types tested, background levels of the other three types were detected when present at 5%, 1%, and 0.1% levels, and their relative abundances were quantified with high (A13, C1, D1) to variable (C3) accuracy. The potential of this deep sequencing method for resolving fine-scale genetic diversity within a symbiont type was further demonstrated in a natural symbiosis using ITS-1, and uncovered reef-specific differences in the composition of Symbiodinium microadriaticum in two species of acroporid corals (Acropora digitifera and A. hyacinthus) from Palau. The ability of deep sequencing of the ITS locus (1 and 2) to detect and quantify low-abundant Symbiodinium types, as well as finer-scale diversity below the type level, will enable more robust quantification of local genetic diversity in Symbiodinium populations. This method will help to elucidate the role that background types have in maximizing coral fitness across diverse environments and in response to environmental change.	[Quigley, Kate M.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Quigley, Kate M.; Willis, Bette L.] Australian Inst Marine Sci, JCU 2AIMS, Townsville, Qld 4810, Australia; [Quigley, Kate M.; Willis, Bette L.] James Cook Univ, Townsville, Qld 4811, Australia; [Davies, Sarah W.; Kenkel, Carly D.; Matz, Mikhail V.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Bay, Line K.] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; University of Texas System; University of Texas Austin; Australian Institute of Marine Science	Quigley, KM (corresponding author), James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	katemarie.quigley@my.jcu.edu.au	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Quigley, Kate/0000-0001-5558-1904; Bay, Line/0000-0002-9760-2977; Kenkel, Carly/0000-0003-1126-4311	Australian Institute of Marine Sciences (AIMS); AIMS@JCU; Australian Research Council Centre of Excellence [CEO561435]; National Oceanic and Atmospheric Administration (Coral Reef Conservation Program); National Science Foundation [DEB-1054766]; Division Of Environmental Biology [1054766] Funding Source: National Science Foundation	Australian Institute of Marine Sciences (AIMS); AIMS@JCU; Australian Research Council Centre of Excellence(Australian Research Council); National Oceanic and Atmospheric Administration (Coral Reef Conservation Program); National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The dilution portion of this study was supported by the Australian Institute of Marine Sciences (AIMS), AIMS@JCU, and funding from the Australian Research Council Centre of Excellence for Coral Reef Studies (CEO561435) to Bette Willis. The collection and analysis of the Palau data set was supported by the National Oceanic and Atmospheric Administration (Coral Reef Conservation Program) and a National Science Foundation grant DEB-1054766 to Mikhail Matz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Apprill AM, 2007, MOL ECOL, V16, P1127, DOI 10.1111/j.1365-294X.2006.03214.x; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; Bay LK, 2009, CONSERV GENET RESOUR, V1, P199, DOI 10.1007/s12686-009-9048-1; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bodenhofer U, 2008, MATHWARE SOFT COMPUT, V15, P5; Bodenhofer U, 2012, INFORM SCI; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Chen CA, 2004, ZOOL STUD, V43, P759; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Davies SW, 2012, MARINE BIODIVERSITY, V2013, P1; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Gaidos E, 2011, ENVIRON MICROBIOL, V13, P1138, DOI 10.1111/j.1462-2920.2010.02392.x; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Gates RD, 2011, J EXP MAR BIOL ECOL, V408, P94, DOI 10.1016/j.jembe.2011.07.029; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Harrell FE, 2007, R PACKAGE HARRELL MI; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Howells EJ, 2013, MOL ECOL, V22, P3693, DOI 10.1111/mec.12342; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kenkel CD, 2013, MOL ECOL, V22, P4335, DOI 10.1111/mec.12391; Kenkel CD, MOL ECOL IN PRESS; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2007, CORAL REEFS, V26, P265, DOI 10.1007/s00338-006-0189-3; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Leggat W, 2011, J EXP MAR BIOL ECOL, V408, P120, DOI 10.1016/j.jembe.2011.07.032; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Lin SJ, 2006, J PHYCOL, V42, P746, DOI 10.1111/j.1529-8817.2006.00213.x; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loram JE, 2007, MOL ECOL, V16, P4849, DOI 10.1111/j.1365-294X.2007.03491.x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029816; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; R Core Team, 2012, R LANG ENV STAT COMP; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sanders JG, 2011, BIOL BULL-US, V220, P199, DOI 10.1086/BBLv220n3p199; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Smith RT, 2009, J PHYCOL, V45, P1030, DOI 10.1111/j.1529-8817.2009.00730.x; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat M, 2008, BIOL INVASIONS, V10, P579, DOI 10.1007/s10530-007-9167-0; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Thornhill DJ, 2008, J PHYCOL, V44, P1126, DOI 10.1111/j.1529-8817.2008.00567.x; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Tonk L, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-7; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen Madeleine J. H., 2009, V205, P83; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Zhang ZD, 2000, J MOL EVOL, V51, P26, DOI 10.1007/s002390010064; [No title captured]	97	77	78	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2014	9	4							e94297	10.1371/journal.pone.0094297	http://dx.doi.org/10.1371/journal.pone.0094297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3CI	24728373	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000336736200057
J	Borg, MK; Ivarsen, P; Brondum, E; Povlsen, JV; Aalkjaer, C				Borg, Morten K.; Ivarsen, Per; Brondum, Emil; Povlsen, Johan V.; Aalkjaer, Christian			Hemodynamics and Function of Resistance Arteries in Healthy Persons and End Stage Renal Disease Patients	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL DYSFUNCTION; ESRD; VASODILATION; INFLAMMATION; VENTILATION; BIOMARKERS; STIFFNESS; MORTALITY; UREMIA	Introduction: Cardiovascular disease is the leading cause of death in patients with end stage renal disease (ESRD). The vasodilator mechanisms in small resistance arteries are in earlier studies shown to be reduced in patients with end stage renal disease. We studied whether endothelium dependent vasodilatation were diminished in ESRD patients and the interaction between the macro- and microcirculation. Methods: Eleven patients with ESRD had prior to renal transplant or insertion of peritoneal dialysis catheter measured pulse wave velocity. During surgery, a subcutaneous fat biopsy was extracted. Resistance arteries were then dissected and mounted on a wire myograph for measurements of dilator response to increasing concentrations of acetylcholine after preconstriction with noradrenaline. Twelve healthy kidney donors served as controls. Results: Systolic blood pressure was elevated in patients compared to the healthy controls; no difference in the concentration of asymmetric dimethyl arginine was seen. No significant difference in the endothelium dependent vasodilatation between patients and controls was found. Correlation of small artery properties showed an inverse relationship between diastolic blood pressure and nitric oxide dependent vasodilatation in controls. Pulse pressure was positively correlated to the total endothelial vasodilatation in patients. A negative association between S-phosphate and endothelial derived hyperpolarisation-like vasodilatation was seen in resistance arteries from controls. Conclusion: This study finds similar vasodilator properties in kidney patients and controls. However, correlations of pulse pressure and diastolic blood pressure with resistance artery function indicate compensating measures in the microcirculation during end stage renal disease.	[Borg, Morten K.; Brondum, Emil; Aalkjaer, Christian] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ivarsen, Per; Povlsen, Johan V.] Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark; [Ivarsen, Per; Povlsen, Johan V.] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Aalkjaer, C (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ca@fi.au.dk		Ivarsen, Per/0000-0001-9626-6070; Borg, Morten/0000-0002-6204-2623; Aalkjaer, Christian/0000-0003-2618-4015	P Carl Petersen Foundation; Danish Kidney Association	P Carl Petersen Foundation; Danish Kidney Association	The study was funded by the P Carl Petersen Foundation and the Danish Kidney Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1986, CLIN SCI, V71, P657, DOI 10.1042/cs0710657; [Anonymous], 2013, NEPHROL DIAL TRAN S1, V28, pi1; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; CLEMENSEN P, 1994, J APPL PHYSIOL, V76, P2832, DOI 10.1152/jappl.1994.76.6.2832; Damgaard M, 2005, CLIN PHYSIOL FUNCT I, V25, P142, DOI 10.1111/j.1475-097X.2005.00602.x; Foley RN, 1998, J NEPHROL, V11, P239; FRIEDMAN M, 1984, J APPL PHYSIOL, V56, P364, DOI 10.1152/jappl.1984.56.2.364; HALPERN W, 1977, J PHYSIOL-LONDON, V265, pP21; Isakova T, 2009, KIDNEY INT, V76, P705, DOI 10.1038/ki.2009.246; London GM, 2004, KIDNEY INT, V65, P700, DOI 10.1111/j.1523-1755.2004.00434.x; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Mallamaci F, 2005, KIDNEY INT, V67, P2330, DOI 10.1111/j.1523-1755.2005.00338.x; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Olsen MH, 2001, AM J HYPERTENS, V14, P861, DOI 10.1016/S0895-7061(01)02148-3; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Passauer J, 2005, J AM SOC NEPHROL, V16, P959, DOI 10.1681/ASN.2004070582; PETRINI MF, 1978, J APPL PHYSIOL, V44, P795, DOI 10.1152/jappl.1978.44.5.795; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Tripepi G, 2011, CLIN J AM SOC NEPHRO, V6, P1714, DOI 10.2215/CJN.11291210; Verbeke FH, 2011, CLIN J AM SOC NEPHRO, V6, P2009, DOI 10.2215/CJN.01260211; Yilmaz MI, 2013, AM J NEPHROL, V37, P126, DOI 10.1159/000346711	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94638	10.1371/journal.pone.0094638	http://dx.doi.org/10.1371/journal.pone.0094638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722412	Green Published, gold, Green Submitted			2022-12-25	WOS:000336909100111
J	Cocuzza, CE; Piazza, F; Musumeci, R; Oggioni, D; Andreoni, S; Gardinetti, M; Fusco, L; Frigo, M; Banfi, P; Rottoli, MR; Confalonieri, P; Rezzonico, M; Ferro, MT; Cavaletti, G				Cocuzza, Clementina E.; Piazza, Fabrizio; Musumeci, Rosario; Oggioni, Davide; Andreoni, Simona; Gardinetti, Margherita; Fusco, Letizia; Frigo, Maura; Banfi, Paola; Rottoli, Maria R.; Confalonieri, Paolo; Rezzonico, Monica; Ferro, Maria T.; Cavaletti, Guido		EBV-MS Italian Study Grp	Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; BRAIN; INFECTION; PCR; MS; ASSOCIATION; ACTIVATION; SYSTEM; EBV	The presence of Epstein-Barr Virus (EBV) DNA in cerebrospinal fluid (CSF) and peripheral blood (PB) samples collected from 55 patients with clinical and radiologically-active relapsing-remitting MS (RRMS) and 51 subjects with other neurological diseases was determined using standardized commercially available kits for viral nucleic acid extraction and quantitative EBV DNA detection. Both cell-free and cell-associated CSF and PB fractions were analyzed, to distinguish latent from lytic EBV infection. EBV DNA was detected in 5.5% and 18.2% of cell-free and cell-associated CSF fractions of patients with RRMS as compared to 7.8% and 7.8% of controls; plasma and peripheral blood mononuclear cells (PBMC) positivity rates were 7.3% and 47.3% versus 5.8% and 31.4%, respectively. No significant difference in median EBV viral loads of positive samples was found between RRMS and control patients in all tested samples. Absence of statistically significant differences in EBV positivity rates between RRMS and control patients, despite the use of highly sensitive standardized methods, points to the lack of association between EBV and MS disease activity.	[Cocuzza, Clementina E.; Piazza, Fabrizio; Musumeci, Rosario; Oggioni, Davide; Andreoni, Simona; Gardinetti, Margherita; Fusco, Letizia; Cavaletti, Guido] Univ Milano Bicocca, Dipartimento Chirurg & Med Traslaz, Monza, Italy; [Frigo, Maura] AOS Gerardo, Clin Neurol, Monza, Italy; [Banfi, Paola] Osped Circolo & Fdn Macchi, Dipartimento Neurol, Varese, Italy; [Rottoli, Maria R.] AO Osped Papa Giovanni XXIII, Ctr Sclerosi Multipla, Bergamo, Italy; [Confalonieri, Paolo] Fdn Ist Neurol Carlo Besta, Ctr Sclerosi Multipla, UO Neurol 4, Milan, Italy; [Rezzonico, Monica] AO St Anna, Dipartimento Neurol, Como, Italy; [Ferro, Maria T.] AO Osped Maggiore, Dipartimento Neurol, Ctr Sclerosi Multipla, Crema, Italy	University of Milano-Bicocca; Ospedale Circolo & Fondazione Macchi; ASST Papa Giovanni XXIII; IRCCS Istituto Neurologico Besta; Ospedale Sant'Anna di Como	Musumeci, R (corresponding author), Univ Milano Bicocca, Dipartimento Chirurg & Med Traslaz, Monza, Italy.		Confalonieri, Paolo/AAS-8513-2021; Cocuzza, Clementina Elvezia/AAE-2064-2019; Musumeci, Rosario/B-8306-2008; Piazza, Fabrizio/L-2094-2016; Andreetta, Francesca/J-9957-2018; Cavaletti, Guido/AAA-7063-2022; Antozzi, Carlo/AAB-8787-2019	Confalonieri, Paolo/0000-0001-8030-5725; Cocuzza, Clementina Elvezia/0000-0001-6166-1134; Musumeci, Rosario/0000-0003-0143-3601; Piazza, Fabrizio/0000-0002-3385-3224; Andreetta, Francesca/0000-0001-8239-8830; Cavaletti, Guido/0000-0003-4128-2406; Antozzi, Carlo/0000-0001-9270-5224	Univesrioty of Milano Bicocca	Univesrioty of Milano Bicocca	The study has been supported by Institutional research funds of the Univesrioty of Milano Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle SW, 2002, J CLIN VIROL, V25, pS79, DOI 10.1016/S1386-6532(02)00037-9; Alvarez R, 2000, Enferm Infecc Microbiol Clin, V18, P223; Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Alvarez-Lafuente R, 2006, BRAIN PATHOL, V16, P20, DOI 10.1111/j.1750-3639.2006.tb00558.x; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Broccolo F, 2008, J VIROL METHODS, V148, P48, DOI 10.1016/j.jviromet.2007.10.003; Denne C, 2007, EUR J PAEDIATR NEURO, V11, P29, DOI 10.1016/j.ejpn.2006.10.003; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Francesca P, 2009, DIAGN MICR INFEC DIS, V64, P158, DOI 10.1016/j.diagmicrobio.2009.02.013; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Germi R, 2012, J CLIN MICROBIOL, V50, P1384, DOI 10.1128/JCM.05593-11; Jaquiery E, 2010, EUR J IMMUNOL, V40, P878, DOI 10.1002/eji.200939761; Kim S, 2009, J VIROL METHODS, V162, P208, DOI 10.1016/j.jviromet.2009.08.007; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Lindsey JW, 2009, MULT SCLER J, V15, P153, DOI 10.1177/1352458508097920; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Lucas RM, 2011, NEUROLOGY, V77, P371, DOI 10.1212/WNL.0b013e318227062a; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Lunemann JD, 2007, J VIROL, V78, P11; Mancuso R, 2010, J MED VIROL, V82, P1051, DOI 10.1002/jmv.21764; Owens GP, 2012, MULT SCLER J, V18, P1204, DOI 10.1177/1352458512448109; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Sotelo J, 2007, J NEUROL, V254, P493, DOI 10.1007/s00415-006-0402-x; Tzartos JS, 2012, NEUROLOGY, V78, P15, DOI 10.1212/WNL.0b013e31823ed057; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Yang GY, 2011, J VIROL METHODS, V171, P195, DOI 10.1016/j.jviromet.2010.10.024	33	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94497	10.1371/journal.pone.0094497	http://dx.doi.org/10.1371/journal.pone.0094497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722060	gold, Green Published, Green Submitted			2022-12-25	WOS:000336909100084
J	Ye, J; Zhu, R; He, XS; Feng, YY; Yang, LL; Zhu, XY; Deng, QF; Wu, TC; Zhang, XM				Ye, Jian; Zhu, Rui; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin			Association of Plasma IL-6 and Hsp70 with HRV at Different Levels of PAHs Metabolites	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POLYCYCLIC AROMATIC-HYDROCARBONS; INFLAMMATORY MARKERS; AIR-POLLUTION; CARDIOVASCULAR-DISEASES; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; HEAT-SHOCK-PROTEIN-70; EXPOSURE; ATHEROSCLEROSIS	Background: Exposure to polycyclic aromatic hydrocarbons (PAHs) is associated with reduced heart rate variability (HRV), a strong predictor of cardiovascular diseases, but the mechanism is not well understood. Objectives: We hypothesized that PAHs might induce systemic inflammation and stress response, contributing to altered cardiac autonomic function. Methods: HRV indices were measured using a 3-channel digital Holter monitor in 800 coke oven workers. Plasma levels of interleukin-6 (IL-6) and heat shock protein 70 (Hsp70) were determined using ELISA. Twelve urinary PAHs metabolites (OH-PAHs) were measured by gas chromatography-mass spectrometry. Results: We found that significant dose-dependent relationships between four urinary OH-PAHs and IL-6 (all P-trend<0.05); and an increase in quartiles of IL-6 was significantly associated with a decrease in total power (TP) and low frequency (LF) (P-trend = 0.014 and 0.006, respectively). In particular, elevated IL-6 was associated in a dose-dependent manner with decreased TP and LF in the high-PAHs metabolites groups (all P-trend<0.05), but not in the low-PAHs metabolites groups. No significant association between Hsp70 and HRV in total population was found after multivariate adjustment. However, increased Hsp70 was significantly associated with elevated standard deviation of NN intervals (SDNN), TP and LF in the low-PAHs metabolites groups (all P-trend<0.05). We also observed that both IL-6 and Hsp70 significantly interacted with multiple PAHs metabolites in relation to HRV. Conclusions: In coke oven workers, increased IL-6 was associated with a dose-response decreased HRV in the high-PAHs metabolites groups, whereas increase of Hsp70 can result in significant dose-related increase in HRV in the low-PAHs metabolites groups.	[Ye, Jian; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Ye, Jian; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhu, Rui] Huazhong Univ Sci & Technol, Dept Tradit Chinese Med, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, XM (corresponding author), Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	mingxz117@hust.edu.cn	Zhang, Xiaomin/F-3206-2018; Zhang, Xiaomin/GVT-8927-2022		Program for New Century Excellent Talents in University [NCET-10-0420]; National Natural Science Foundation of China [NNSFC 30972453, 81373093]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the funds from Program for New Century Excellent Talents in University (NCET-10-0420) and the National Natural Science Foundation of China (NNSFC 30972453 and 81373093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bielecka-Dabrowa A, 2009, EXPERT OPIN THER TAR, V13, P307, DOI [10.1517/14728220902725149 , 10.1517/14728220902725149]; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; Chuang HC, 2012, TOXICOL LETT, V214, P131, DOI 10.1016/j.toxlet.2012.08.012; Clark JD, 2012, ENVIRON RES, V117, P132, DOI 10.1016/j.envres.2012.04.012; Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407; Dulin E, 2010, CELL STRESS CHAPERON, V15, P929, DOI 10.1007/s12192-010-0201-2; Dybdahl B, 2005, HEART, V91, P299, DOI 10.1136/hrt.2003.028092; Everett CJ, 2010, ENVIRON RES, V110, P79, DOI 10.1016/j.envres.2009.09.010; Gidron Y, 2007, ATHEROSCLEROSIS, V195, pE1, DOI 10.1016/j.atherosclerosis.2006.10.009; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Gonzalez-Clemente JM, 2007, EUR J ENDOCRINOL, V157, P31, DOI 10.1530/EJE-07-0090; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Huang WL, 2006, TOXICOL LETT, V163, P10, DOI 10.1016/j.toxlet.2005.08.003; International Programme on Chemical Safety (IPCS), 1998, ENV HLTH CRIT; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; Lee MS, 2011, OCCUP ENVIRON MED, V68, P474, DOI 10.1136/oem.2010.055681; Li XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044562; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41; Luttmann-Gibson H, 2010, OCCUP ENVIRON MED, V67, P625, DOI 10.1136/oem.2009.050625; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Pockley AG, 2009, CELL STRESS CHAPERON, V14, P545, DOI 10.1007/s12192-009-0113-1; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; Rich DQ, 2012, ENVIRON HEALTH PERSP, V120, P1162, DOI 10.1289/ehp.1104262; Riojas-Rodriguez H, 2011, ENVIRON HEALTH PERSP, V119, P1301, DOI 10.1289/ehp.1002927; Satoh M, 2006, EUR J HEART FAIL, V8, P810, DOI 10.1016/j.ejheart.2006.03.004; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Tateishi Y, 2007, SHOCK, V28, P549, DOI 10.1097/shk.0b013e3180638d1; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; von Kanel R, 2008, BRAIN BEHAV IMMUN, V22, P461, DOI 10.1016/j.bbi.2007.09.009; von Kanel R, 2011, CLIN RES CARDIOL, V100, P241, DOI 10.1007/s00392-010-0236-5; Weichenthal S, 2011, ENVIRON HEALTH PERSP, V119, P1373, DOI 10.1289/ehp.1003321; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang XB, 2007, ENVIRON HEALTH PERSP, V115, P1573, DOI 10.1289/ehp.10104; Zanobetti A, 2010, ENVIRON HEALTH PERSP, V118, P324, DOI 10.1289/ehp.0901003; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3; Zhu JH, 2003, ARTERIOSCL THROM VAS, V23, P1055, DOI 10.1161/01.ATV.0000074899.60898.FD	39	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e92964	10.1371/journal.pone.0092964	http://dx.doi.org/10.1371/journal.pone.0092964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722336	Green Submitted, Green Published, gold			2022-12-25	WOS:000336909100012
J	Mick, E; McGough, J; Deutsch, CK; Frazier, JA; Kennedy, D; Goldberg, RJ				Mick, Eric; McGough, James; Deutsch, Curtis K.; Frazier, Jean A.; Kennedy, David; Goldberg, Robert J.			Genome-Wide Association Study of Proneness to Anger	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PEDIATRIC BIPOLAR DISORDER; LONG-TERM POTENTIATION; DEFICIT HYPERACTIVITY DISORDER; ATHEROSCLEROSIS RISK; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; COMMON VARIANTS; SELF-REGULATION; CELLULAR PRION	Background: Community samples suggest that approximately 1 in 20 children and adults exhibit clinically significant anger, hostility, and aggression. Individuals with dysregulated emotional control have a greater lifetime burden of psychiatric morbidity, severe impairment in role functioning, and premature mortality due to cardiovascular disease. Methods: With publically available data secured from dbGaP, we conducted a genome-wide association study of proneness to anger using the Spielberger State-Trait Anger Scale in the Atherosclerosis Risk in Communities (ARIC) study (n = 8,747). Results: Subjects were, on average, 54 (range 45-64) years old at baseline enrollment, 47% (n = 4,117) were male, and all were of European descent by self-report. The mean Angry Temperament and Angry Reaction scores were 5.861.8 and 7.662.2. We observed a nominally significant finding (p = 2.9E-08, lambda = 1.027 - corrected p(gc) = 2.2E-07, lambda = 1.0015) on chromosome 6q21 in the gene coding for the non-receptor protein-tyrosine kinase, Fyn. Conclusions: Fyn interacts with NDMA receptors and inositol-1,4,5-trisphosphate (IP3)-gated channels to regulate calcium influx and intracellular release in the post-synaptic density. These results suggest that signaling pathways regulating intracellular calcium homeostasis, which are relevant to memory, learning, and neuronal survival, may in part underlie the expression of Angry Temperament.	[Mick, Eric; Goldberg, Robert J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [McGough, James] Univ Calif Los Angeles, David Geffen Sch Med, Div Child & Adolescent Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Deutsch, Curtis K.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr, Worcester, MA USA; [Frazier, Jean A.] Univ Massachusetts, Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat, Worcester, MA 01655 USA; [Kennedy, David] Univ Massachusetts, Sch Med, Dept Psychiat, Div Neuroinformat, Worcester, MA 01655 USA; [Kennedy, David] Univ Massachusetts, Sch Med, Child & Adolescent NeuroDev Initiat, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mick, E (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA.	eric.mick@umassmed.edu		Mick, Eric/0000-0001-8505-8145; Garin-Bastuji, Bruno/0000-0002-4486-1182; Jay, Maryne/0000-0003-0443-5565	department of Psychiatry at the University of Massachusetts Medical School; department of Quantitative Health Sciences at the University of Massachusetts Medical School; UMass Center for Clinical and Translational Science [P30HD004147]; NIH; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC- -55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694]; National Human Genome Research Institute [U01-HG-004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055022, N01HC055019, N01HC055021, N01HC055015, N01HC055016, N01HC055018] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083320] Funding Source: NIH RePORTER	department of Psychiatry at the University of Massachusetts Medical School; department of Quantitative Health Sciences at the University of Massachusetts Medical School; UMass Center for Clinical and Translational Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by institutional funds provided by the departments of Psychiatry and Quantitative Health Sciences at the University of Massachusetts Medical School and by the UMass Center for Clinical and Translational Science (P30HD004147) supported by the NIH. Phenotypes and genotypes were downloaded from the National Center for Biotechnology Information (NCBI) database of genotypes and phenotypes (dbGaP) for the NHLBI funded Atherosclerosis Risk in Communities (ARIC) Study (Accessions: phs000280.v1.p1 and phs000090.v1.p1). ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC- -55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01-HL-087641, R01-HL-59367 and R01-HL-086694; National Human Genome Research Institute contract U01-HG-004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The individual institutions represented had no further role in study design; in the collection, analysis or interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ahern CA, 2005, CIRC RES, V96, P991, DOI 10.1161/01.RES.0000166324.00524.dd; Althoff RR, 2006, BIOL PSYCHIAT, V60, P903, DOI 10.1016/j.biopsych.2006.02.025; Althoff RR, 2010, J AM ACAD CHILD PSY, V49, P1105, DOI 10.1016/j.jaac.2010.08.006; Arantes C, 2009, GLIA, V57, P1439, DOI 10.1002/glia.20861; Ayer L, 2009, J CHILD PSYCHOL PSYC, V50, P1291, DOI 10.1111/j.1469-7610.2009.02089.x; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Biederman J, 2009, J CLIN PSYCHIAT, V70, P732, DOI 10.4088/JCP.08m04821; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Coccaro EF, 2011, J AFFECTIVE DISORDER; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Diler RS, 2009, J CHILD ADOL PSYCHOP, V19, P23, DOI 10.1089/cap.2008.067; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Gold AE, 1996, CURRENT DEV HLTH PSY, P105; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Greene R W, 1999, Clin Child Fam Psychol Rev, V2, P129, DOI 10.1023/A:1021850921476; Greene RW, 2003, J PSYCHOSOM RES, V55, P67, DOI 10.1016/S0022-3999(02)00585-8; Hudziak JJ, 2005, BIOL PSYCHIAT, V58, P562, DOI 10.1016/j.biopsych.2005.03.024; Hudziak JJ, 2005, AM J PSYCHIAT, V162, P1614, DOI 10.1176/appi.ajp.162.9.1614; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; Iribarren C, 2005, SOC SCI MED, V60, P471, DOI 10.1016/j.socscimed.2004.06.007; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krebs B, 2007, J NEUROCHEM, V100, P358, DOI 10.1111/j.1471-4159.2006.04256.x; Kubzansky LD, 2011, ARCH GEN PSYCHIAT, V68, P400, DOI 10.1001/archgenpsychiatry.2011.23; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meyer SE, 2009, J AFFECT DISORDERS, V113, P227, DOI 10.1016/j.jad.2008.05.024; Mick E, 2010, GENETIC ASS STUDY EM; Mick E, 2011, J AM ACAD CHILD PSY, V50, P807, DOI 10.1016/j.jaac.2011.05.001; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Player MS, 2007, ANN FAM MED, V5, P403, DOI 10.1370/afm.738; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Spielberger C.D., 1983, ADV PERSONAL ASSESS, V2, P161; Surman CBH, 2011, AM J PSYCHIAT, V168, P617, DOI 10.1176/appi.ajp.2010.10081172; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Vansteelandt S, 2009, GENET EPIDEMIOL, V33, P394, DOI 10.1002/gepi.20393; Volk HE, 2007, BIOL PSYCHIAT, V62, P115, DOI 10.1016/j.biopsych.2006.05.036; Williams Janice E, 2006, Prev Cardiol, V9, P14, DOI 10.1111/j.1520-037X.2006.1610.x; Williams JE, 2007, AM J EPIDEMIOL, V165, P1296, DOI 10.1093/aje/kwm001; Williams JE, 2000, CIRCULATION, V101, P2034, DOI 10.1161/01.CIR.101.17.2034; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625; Williams JE, 2001, AM J EPIDEMIOL, V154, P230, DOI 10.1093/aje/154.3.230; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Youngstrom E, 2005, BIOL PSYCHIAT, V58, P569, DOI 10.1016/j.biopsych.2005.04.004	57	81	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87257	10.1371/journal.pone.0087257	http://dx.doi.org/10.1371/journal.pone.0087257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489884	gold, Green Published			2022-12-25	WOS:000330510000122
J	Wang, JF; Ruan, Z; Feng, Y; Fu, Y; Jiang, Y; Wang, HP; Yu, YS				Wang, Jianfeng; Ruan, Zhi; Feng, Ye; Fu, Ying; Jiang, Yan; Wang, Haiping; Yu, Yunsong			Species Distribution of Clinical Acinetobacter Isolates Revealed by Different Identification Techniques	PLOS ONE			English	Article							RPOB GENE; CARBAPENEM-RESISTANT; MASS-SPECTROMETRY; MULTIPLEX PCR; BAUMANNII; BLA(OXA-51-LIKE)	A total of 2582 non-duplicate clinical Acinetobacter spp. isolates were collected to evaluate the performance of four identification methods because it is important to identify Acinetobacter spp. accurately and survey the species distribution to determine the appropriate antimicrobial treatment. Phenotyping (VITEK 2 and VITEK MS) and genotyping (16S rRNA and rpoB gene sequencing) methods were applied for species identification, and antimicrobial susceptibility test of imipenem and meropenem was performed with a disk diffusion assay. Generally, the phenotypic identification results were quite different from the genotyping results, and their discrimination ability was unsatisfactory, whereas 16S rRNA and rpoB gene sequencing showed consistent typing results, with different resolution. Additionally, A. pittii, A. calcoaceticus and A. nosocomialis, which were phylogenetically close to A. baumannii, accounted for 85.5% of the non-A. baumannii isolates. One group, which could not be clustered with any reference strains, consisted of 11 isolates and constituted a novel Acinetobacter species that was entitled genomic species 33YU. None of the non-A. baumannii isolates harbored a bla(OXA-51)-like gene, and this gene was disrupted by ISAba19 in only one isolate; it continues to be appropriate as a genetic marker for A. baumannii identification. The resistance rate of non-A. baumannii isolates to imipenem and/or meropenem was only 2.6%, which was significantly lower than that of A. baumannii. Overall, rpoB gene sequencing was the most accurate identification method for Acinetobacter species. Except for A. baumannii, the most frequently isolated species from the nosocomial setting were A. pittii, A. calcoaceticus and A. nosocomialis.	[Wang, Jianfeng; Ruan, Zhi; Feng, Ye; Fu, Ying; Jiang, Yan; Wang, Haiping; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Ye] Zhejiang Univ, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com	Yang, Ming/G-4705-2012; Ruan, Zhi/P-3987-2015; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; Ruan, Zhi/0000-0001-8648-4592; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	National Natural Science Foundation of China [NSFC81378158, NSFC81230039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. NSFC81378158 and NSFC81230039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Alvarez-Buylla A, 2012, INFECT GENET EVOL, V12, P345, DOI 10.1016/j.meegid.2012.01.002; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bitrian M, 2012, INT MICROBIOL, V15, P79, DOI 10.2436/20.1501.01.161; Cockerill FR, 2012, PERFORMANCE STANDARD; GERISCHER U., 2008, ACINETOBACTER MOL BI; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kaase M, 2013, J ANTIMICROB CHEMOTH; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kiyota N, 2013, J MED MICROBIOL, V62, P610, DOI 10.1099/jmm.0.049072-0; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lee MJ, 2014, DIAGN MICR INFEC DIS, V78, P29, DOI 10.1016/j.diagmicrobio.2013.07.013; Lee MJ, 2013, DIAGN MICROBIOL INFE; Lee YT, 2012, ANTIMICROB AGENTS CH, V56, P1124, DOI 10.1128/AAC.00622-11; Li Y, 2013, INT J SYST EVOL MICR, V63, P2963, DOI 10.1099/ijs.0.047274-0; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Ruan Z, 2013, INT J ANTIMICROB AG, V42, P322, DOI 10.1016/j.ijantimicag.2013.06.019; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sedo O, 2013, SYST APPL MICROBIOL, V36, P572, DOI 10.1016/j.syapm.2013.08.001; Sieniawski Karol, 2013, Pol Przegl Chir, V85, P483, DOI 10.2478/pjs-2013-0075; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Vaneechoutte M, 2008, INT J SYST EVOL MICR, V58, P937, DOI 10.1099/ijs.0.65129-0; Zander E, 2013, INT J MED MICROBIOL, V303, P88, DOI 10.1016/j.ijmm.2012.12.007	29	194	203	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104882	10.1371/journal.pone.0104882	http://dx.doi.org/10.1371/journal.pone.0104882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	24722735	Green Submitted, Green Published, gold			2022-12-25	WOS:000340900600098
J	Wang, JW; Wei, JY; Xu, XL; Pan, WT; Ge, YX; Zhou, CC; Liu, C; Gao, J; Yang, M; Mao, WM				Wang, Jiwen; Wei, Jinyu; Xu, Xiaoling; Pan, Wenting; Ge, Yunxia; Zhou, Changchun; Liu, Chao; Gao, Jia; Yang, Ming; Mao, Weimin			Replication Study of ESCC Susceptibility Genetic Polymorphisms Locating in the ADH1B-ADH1C-ADH7 Cluster Identified by GWAS	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENOME-WIDE ASSOCIATION; ESOPHAGEAL CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; VARIANTS CONTRIBUTE; CHINESE POPULATION; RISK-FACTORS; ALCOHOL; LOCI	China was one of the countries with highest esophageal squamous cell carcinoma (ESCC) incidence and mortality worldwide. Alcohol drinking has been identified as a major environmental risk-factor related to ESCC. The alcohol dehydrogenase (ADH) family are major enzymes involved in the alcohol-metabolizing pathways, including alcohol dehydrogenase 1B (ADH1B) and ADH1C. Interestingly, ADH1B and ADH1C genes locate tandemly with ADH7 in a genomic segment as a gene cluster, and are all polymorphic. Several ESCC susceptibility single nucleotide polymorphisms (SNPs) of the ADH1B-ADH1C-ADH7 cluster have been identified previously through a genome-wide association study (GWAS). In the study, we examined the association between five ADH1B-ADH1C-ADH7 cluster SNPs (rs1042026, rs17033, rs1614972, rs1789903 and rs17028973) and risk of developing ESCC. Genotypes were determined in two independent case-control sets from two regions of China. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. Our data demonstrated that these ADH1B-ADH1C-ADH7 cluster SNPs confer susceptibility to ESCC in these two case-control sets, which were consistent to results of the previous GWAS.	[Wang, Jiwen; Xu, Xiaoling; Mao, Weimin] Zhejiang Canc Hosp, Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Jiwen; Mao, Weimin] Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Zhejiang, Peoples R China; [Wei, Jinyu; Pan, Wenting; Ge, Yunxia; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Liu, Chao] Zhejiang Canc Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Gao, Jia] Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China; [Gao, Jia] Peking Union Med Coll, Beijing 100021, Peoples R China; [Mao, Weimin] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Zhejiang Cancer Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang Cancer Hospital	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.	yangm@mail.buct.edu.cn; weiminmao@126.com	Yang, Ming/G-4705-2012; Ruan, Zhi/P-3987-2015; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; Ruan, Zhi/0000-0001-8648-4592; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	Key Research Project of Medicine of Zhejiang Province [2011c13039-1]	Key Research Project of Medicine of Zhejiang Province	This work was supported by Key Research Project of Medicine of Zhejiang Province (2011c13039-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Agrawal A, 2012, ALCOHOL RES-CURR REV, V34, P274; Akbari MR, 2009, CANCER RES, V69, P7994, DOI 10.1158/0008-5472.CAN-09-1149; Bass AJ, 2009, GASTROENTEROLOGY, V137, P1573, DOI 10.1053/j.gastro.2009.09.026; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Liu JB, 2013, BREAST CANCER RES TR, V140, P151, DOI 10.1007/s10549-013-2615-x; Liu L, 2013, EUR J CANCER, V49, P2143, DOI 10.1016/j.ejca.2013.01.028; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lv Z, 2014, GENE, V538, P42, DOI 10.1016/j.gene.2014.01.025; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Ng D, 2008, INT J CANCER, V123, P1610, DOI 10.1002/ijc.23682; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Wu M, 2013, INT J CANCER, V132, P1868, DOI 10.1002/ijc.27803; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Yang M, 2011, INT J RADIAT ONCOL, V79, P1402, DOI 10.1016/j.ijrobp.2009.12.042; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yao JR, 2014, GENE, V533, P21, DOI 10.1016/j.gene.2013.09.054; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zhong R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04147; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331; Zhou LQ, 2012, GENE, V506, P295, DOI 10.1016/j.gene.2012.07.007	41	194	203	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94096	10.1371/journal.pone.0094096	http://dx.doi.org/10.1371/journal.pone.0094096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722735	Green Published, Green Submitted, gold			2022-12-25	WOS:000336909100038
J	Shen, XY; Cheng, YL; Cai, CJ; Fan, L; Gao, J; Hou, CL				Shen, Xiao-Ye; Cheng, Yan-Lin; Cai, Chun-Ju; Fan, Li; Gao, Jian; Hou, Cheng-Lin			Diversity and Antimicrobial Activity of Culturable Endophytic Fungi Isolated from Moso Bamboo Seeds	PLOS ONE			English	Article							DERIVATIVES; TAXOL; SPOT	Bamboos, regarded as therapeutic agents in ethnomedicine, have been used to inhibit inflammation and enhance natural immunity for a long time in Asia, and there are many bamboo associated fungi with medical and edible value. In the present study, a total of 350 fungal strains were isolated from the uncommon moso bamboo (Phyllostachys edulis) seeds for the first time. The molecular diversity of these endophytic fungi was investigated and bioactive compound producers were screened for the first time. All the fungal endophytes were categorized into 69 morphotypes according to culturable characteristics and their internal transcriber spacer (ITS) regions were analyzed by BLAST search with the NCBI database. The fungal isolates showed high diversity and were divided in Ascomycota (98.0%) and Basidiomycota (2.0%), including at least 19 genera in nine orders. Four particular genera were considered to be newly recorded bambusicolous fungi, including Leptosphaerulina, Simplicillium, Sebacina and an unknown genus in Basidiomycetes. Furthermore, inhibitory effects against clinical pathogens and phytopathogens were screened preliminarily and strains B09 (Cladosporium sp.), B34 (Curvularia sp.), B35 (undefined genus 1), B38 (Penicillium sp.) and zzz816 (Shiraia sp.) displayed broad-spectrum activity against clinical bacteria and yeasts by the agar diffusion method. The crude extracts of isolates B09, B34, B35, B38 and zzz816 under submerged fermentation, also demonstrated various levels of bioactivities against bambusicolous pathogenic fungi. This study is the first report on the antimicrobial activity of endophytic fungi associated with moso bamboo seeds, and the results show that they could be exploited as a potential source of bioactive compounds and plant defense activators. In addition, it is the first time that strains of Shiraia sp. have been isolated and cultured from moso bamboo seeds, and one of them (zzz816) could produce hypocrellin A at high yield, which is significantly different from the other strains published.	[Shen, Xiao-Ye; Cheng, Yan-Lin; Fan, Li; Hou, Cheng-Lin] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Cai, Chun-Ju; Gao, Jian] Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol SFA, Beijing, Peoples R China	Capital Normal University; International Centre for Bamboo & Rattan	Gao, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	gaojian@icbr.ac.cn; chenglin.hou@gmail.com		Shyam, Rajalekshmy/0000-0003-2154-4173	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission [KZ201110028036]; National Science and Technology [2012BAD23B0503]; National Nature Science Foundation of China [31170019]; Beijing Natural Science Foundation [5133033, 5132009]; NATIONAL EYE INSTITUTE [P30EY001792, R01EY018828, R01EY005628] Funding Source: NIH RePORTER	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission; National Science and Technology; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Key Program of Science and Technology Development Project of Beijing Municipal Education Commission (KZ201110028036), The "Twelfth Five-Year Plan'' of National Science and Technology Support Project (2012BAD23B0503), National Nature Science Foundation of China (No. 31170019), and Beijing Natural Science Foundation (5133033 and 5132009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2002, INT J ONCOL, V21, P1229; Cai CJ, 2008, CHINESE AGR SCI B, V12; Cai L, 2003, FUNGAL DIVERS, V13, P1; Cai YJ, 2011, NEW BIOTECHNOL, V28, P588, DOI 10.1016/j.nbt.2011.02.001; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; Chen RS, 2008, PLANT DIS, V92, P1589, DOI 10.1094/PDIS-92-11-1589C; Chunguang R, 2008, FOREST PEST DIS, V1; de Medeiros LS, 2011, HELV CHIM ACTA, V94, P1077, DOI 10.1002/hlca.201000387; de Siqueira VM, 2011, SYMBIOSIS, V53, P89, DOI 10.1007/s13199-011-0113-7; Faeth SH, 2002, INTEGR COMP BIOL, V42, P360, DOI 10.1093/icb/42.2.360; Ganley RJ, 2006, MYCOL RES, V110, P318, DOI 10.1016/j.mycres.2005.10.005; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gure A, 2005, FOREST PATHOL, V35, P23, DOI 10.1111/j.1439-0329.2004.00387.x; HARA C, 1995, FOOD REV INT, V11, P225, DOI 10.1080/87559129509541037; Hino I., 1961, ICONES FUNGORUM BAMB; Hormazabal E, 2009, WORLD J MICROB BIOT, V25, P813, DOI 10.1007/s11274-008-9953-6; Hyde KD, 2002, FUNGAL DIVERS, V11, P109; Hyde KD, 2002, FUNGAL DIVERS, V9, P1; John CK, 2002, CURR SCI INDIA, V82, P261; Jordaan A, 2006, S AFR J BOT, V72, P245, DOI 10.1016/j.sajb.2005.09.007; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Kharkwal A. C., 2007, V11, P247; Li Xiang-min, 2009, Forest Research, V22, P279; [刘凤 LIU Feng], 2009, [种子, Seed], P12; Liu JK, 2002, HELV CHIM ACTA, V85, P1439, DOI 10.1002/1522-2675(200205)85:5&lt;1439::AID-HLCA1439&gt;3.0.CO;2-X; Ma GY, 2004, ANTIMICROB AGENTS CH, V48, P4450, DOI 10.1128/AAC.48.11.4450-4452.2004; Ma Y, 2008, BIOL CONTROL, V44, P24, DOI 10.1016/j.biocontrol.2007.10.005; Mohanan C., 1991, Commonwealth Forestry Review, V70, P133; Mohanan C, 1990, BAMBOOS CURRENT RES, P173; Mohanan C, 1997, DIS BAMBOOS ASIA ILL; Morakotkarn D, 2008, MYCOSCIENCE, V49, P258, DOI 10.1007/s10267-008-0419-3; Morakotkarn D, 2007, FEMS MICROBIOL LETT, V266, P10, DOI 10.1111/j.1574-6968.2006.00489.x; Nicoletti R, 2007, MYCOPATHOLOGIA, V163, P295, DOI 10.1007/s11046-007-9015-x; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Pezzuto J, 1996, NAT BIOTECHNOL, V14, P1083, DOI 10.1038/nbt0996-1083; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Shen XY, 2012, BANGL J PHARMACOL, V7, P249, DOI 10.3329/bjp.v7i4.12068; Shukla A. N., 1988, Indian Forester, V114, P714; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; THAL WM, 1986, PHYTOPATHOLOGY, V76, P190, DOI 10.1094/Phyto-76-190; Trisuwan K, 2011, ARCH PHARM RES, V34, P709, DOI 10.1007/s12272-011-0502-8; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Varma GB, 2006, PHYTOCHEMISTRY, V67, P1925, DOI 10.1016/j.phytochem.2006.05.032; Wan XY., 1981, CHINESE SCI BULL, V26, P1040; Wilson D, 2000, BOOK SOIL P, P389; Xia LM, 1995, J NANJING FORESTRY U, V19, P23; Xu Mei-qing, 2006, Forest Research, V19, P692; Yang HL, 2009, DYES PIGMENTS, V82, P142, DOI 10.1016/j.dyepig.2008.12.012; Zhan ZJ, 2003, ACTA BOT SIN, V45, P248; Zhang P, 2009, CURR MICROBIOL, V59, P227, DOI 10.1007/s00284-008-9270-1; Zhang SX, 1995, J NANJING FORESTRY U, V1, P1; Zhou LH, 2010, CHINESE J CHEM ENG, V18, P122, DOI 10.1016/S1004-9541(08)60332-8; Zhou Zhong-bo, 2005, Journal of Fungal Research, V3, P35	53	55	58	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e95838	10.1371/journal.pone.0095838	http://dx.doi.org/10.1371/journal.pone.0095838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24732711	gold, Green Published, Green Submitted			2022-12-25	WOS:000335298200096
J	Qiu, Y; Shen, X; Shyam, R; Yue, BYJT; Ying, HY				Qiu, Ye; Shen, Xiang; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.; Ying, Hongyu			Cellular Processing of Myocilin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; UBIQUITIN-PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM STRESS; TRABECULAR MESHWORK CELLS; RETINAL GANGLION-CELLS; MOLECULAR-BIOLOGY; QUALITY-CONTROL; NON-SECRETION; PROTEINS; MUTATIONS	Background: Myocilin (MYOC) is a gene linked directly to juvenile-and adult-onset open angle glaucoma. Mutations including Pro370Leu (P370L) and Gln368stop (Q368X) have been identified in patients. In the present study, we investigated the processing of myocilin in human trabecular meshwork (TM) cells as well as in inducible, stable RGC5 cell lines. Methodology/Principal Findings: The turnover and photoactivation experiments revealed that the endogenous myocilin in human trabecular meshwork (TM) cells was a short-lived protein. It was found that the endogenous myocilin level in TM cells was increased by treatment of lysosomal and proteasomal inhibitors, but not by autophagic inhibitor. Multiple bands immunoreactive to anti-ubiquitin were seen in the myocilin pull down, indicating that myocilin was ubiquitinated. In inducible cell lines, the turnover rate of overexpressed wild-type and mutant P370L and Q368X myocilin-GFP fusion proteins was much prolonged. The proteasome function was compromised and autophagy was induced. A decreased PSMB5 level and an increased level of autophagic marker, LC3, were demonstrated. Conclusions/Significance: The current study provided evidence that in normal homeostatic situation, the turnover of endogenous myocilin involves ubiquitin-proteasome and lysosomal pathways. When myocilin was upregulated or mutated, the ubiquitin-proteasome function is compromised and autophagy is induced. Knowledge of the degradation pathways acting on myocilin can help in design of novel therapeutic strategies for myocilin-related glaucoma.	[Qiu, Ye; Shen, Xiang; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.; Ying, Hongyu] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago Coll Med, Chicago, IL 60607 USA.	beatyue@uic.edu; hying@uic.edu		Shyam, Rajalekshmy/0000-0003-2154-4173	National Eye Institute, Bethesda, MD [EY005628, EY018828, EY001792]; Research to Prevent Blindness, New York, NY; Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago; NATIONAL EYE INSTITUTE [P30EY001792, R01EY018828, R01EY005628] Funding Source: NIH RePORTER	National Eye Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The present study was supported by grants EY005628, EY018828, and EY001792 (core) from the National Eye Institute, Bethesda, MD, an unrestricted departmental grant from Research to Prevent Blindness, New York, NY, as well as the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agarwal N, 2013, INVEST OPHTH VIS SCI, V54, P7884, DOI 10.1167/iovs.13-13292; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Bikkavilli RK, 2010, J CELL SCI, V123, P1352, DOI 10.1242/jcs.056176; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Caballero M, 2004, BIOCHEM BIOPH RES CO, V323, P1048, DOI 10.1016/j.bbrc.2004.08.195; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Fukasawa H, 2012, CLIN EXP NEPHROL, V16, P507, DOI 10.1007/s10157-012-0643-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; He LQ, 2005, CELL RES, V15, P455, DOI 10.1038/sj.cr.7290314; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lippincott-Schwartz J, 2008, METHOD CELL BIOL, V85, P45, DOI 10.1016/S0091-679X(08)85003-0; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; NODA T, 1992, J CELL BIOL, V119, P85, DOI 10.1083/jcb.119.1.85; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Plantier JL, 2005, THROMB HAEMOSTASIS, V93, P824, DOI 10.1160/TH04-09-0579; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Rozsa F W, 1998, Mol Vis, V4, P20; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Sohn S, 2009, MOL VIS, V15, P545; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Ueda J, 2000, J HISTOCHEM CYTOCHEM, V48, P1321, DOI 10.1177/002215540004801003; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wiggs JL, 2012, INVEST OPHTH VIS SCI, V53, P2467, DOI 10.1167/iovs.12-9483e; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Ying HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047307; Yue Beatrice Y J T, 2011, Taiwan J Ophthalmol, V1, P6	71	55	58	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e92845	10.1371/journal.pone.0092845	http://dx.doi.org/10.1371/journal.pone.0092845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	24732711	Green Published, Green Submitted, gold			2022-12-25	WOS:000336970400004
J	Li, Y; Yang, D; Wang, JY; Yao, Y; Zhang, WZ; Wang, LJ; Cheng, DC; Yang, FK; Zhang, FM; Zhuang, M; Ling, H				Li, Yan; Yang, Dan; Wang, Jia-Ye; Yao, Yuan; Zhang, Wei-Zhe; Wang, Lu-Jing; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry	PLOS ONE			English	Article							HIV-1 GP120; NEUTRALIZING ANTIBODIES; DISEASE PROGRESSION; VIRAL ENTRY; V3 LOOP; CORECEPTOR; INFECTION; EVOLUTION; CCR5; REGIONS	The importance of the fourth variable (V4) region of the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein (Env) in virus infection has not been well clarified, though the polymorphism of this region has been found to be associated with disease progression to acquired immunodeficiency syndrome (AIDS). In the present work, we focused on the correlation between HIV-1 gp120 V4 region polymorphism and the function of the region on virus entry, and the possible mechanisms for how the V4 region contributes to virus infectivity. Therefore, we analyzed the differences in V4 sequences along with coreceptor usage preference from CCR5 to CXCR4 and examined the importance of the amino acids within the V4 region for CCR5- and CXCR4-tropic virus entry. In addition, we determined the influence of the V4 amino acids on Env expression and gp160 processing intracellularly, as well as the amount of Env on the pseudovirus surface. The results indicated that V4 tended to have a shorter length, fewer potential N-linked glycosylation sites (PNGS), greater evolutionary distance, and a lower negative net charge when HIV-1 isolates switched from a coreceptor usage preference for CCR5 to CXCR4. The N- and C-terminals of the HIV-1 V4 region are highly conserved and critical to maintain virus entry ability, but only the mutation at position 417 in the context of ADA (a R5-tropic HIV-1 strain) resulted in the ability to utilize CXCR4. In addition, 390L, 391F, 414I, and 416L are critical to maintain gp160 processing and maturation. It is likely that the hydrophobic properties and the electrostatic surface potential of gp120, rather than the conformational structure, greatly contribute to this V4 functionality. The findings provide information to aid in the understanding of the functions of V4 in HIV-1 entry and offer a potential target to aid in the development of entry inhibitors.	[Li, Yan; Wang, Jia-Ye; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Yang, Dan] Harbin Med Univ, Dept Forens Med, Harbin, Peoples R China; [Yao, Yuan] Harbin Inst Technol, Acad Fundamental & Interdisciplinary Sci, Harbin 150006, Peoples R China; [Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Wang, Lu-Jing] Harbin Med Univ, Dept Biochem, Harbin, Peoples R China; [Li, Yan; Wang, Jia-Ye; Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Heilongjiang Prov Educ Bur, Key Lab Etiol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Scientific Research Foundation of Heilongjiang Provincial Education Department [12511184]; Heilongjiang Innovation Program in Graduate Education [YJSCX2009-222HLJ]; Harbin Medical University Innovation Program in Graduate Education [HCXB2009014]; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province [ZJY0601-01]	Scientific Research Foundation of Heilongjiang Provincial Education Department; Heilongjiang Innovation Program in Graduate Education; Harbin Medical University Innovation Program in Graduate Education; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by Scientific Research Foundation of Heilongjiang Provincial Education Department (Grant 12511184); Heilongjiang Innovation Program in Graduate Education (YJSCX2009-222HLJ); Harbin Medical University Innovation Program in Graduate Education (HCXB2009014); Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province (Grant ZJY0601-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Belair M, 2009, AIDS RES HUM RETROV, V25, P199, DOI 10.1089/aid.2008.0162; Berger EA, 1997, AIDS, V11, pS3; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Castro E, 2008, AIDS RES HUM RETROV, V24, P106, DOI 10.1089/aid.2007.0139; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Guo HY, 2012, J GEN VIROL, V93, P2635, DOI 10.1099/vir.0.046771-0; HATTORI T, 1987, JPN J CANCER RES, V78, P235; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Ling H, 2002, BIOCHEM BIOPH RES CO, V297, P625, DOI 10.1016/S0006-291X(02)02253-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Riddle TM, 2006, J VIROL, V80, P10591, DOI 10.1128/JVI.00644-06; Rivera-Amill V, 2007, VIROLOGY, V358, P373, DOI 10.1016/j.virol.2006.08.039; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yeh WW, 2012, J VIROL, V86, P7052, DOI 10.1128/JVI.00107-12; Zhuang M, 2012, J BIOL CHEM, V287, P8297, DOI 10.1074/jbc.M111.324483	39	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86083	10.1371/journal.pone.0086083	http://dx.doi.org/10.1371/journal.pone.0086083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500179
J	Li, YP; Song, B; Fang, H; Gao, Y; Zhao, L; Xu, YM				Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming			External Validation of the A(2)DS(2) Score to Predict Stroke-Associated Pneumonia in a Chinese Population: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IN-HOSPITAL MORTALITY; MEDICAL COMPLICATIONS; RISK-FACTORS; INFECTION; CARE; TRANSIENT; OUTCOMES; COST	Background and Purpose: The A(2)DS(2) score was recently developed from the Berlin Stroke Registry for predicting in-hospital pneumonia after acute ischemic stroke and performed well in an external validation in the North-west Germany Stroke Registry. It could be a useful tool for risk stratification in clinical practice or stroke trials. We aimed to prospectively validate the predictive value of A(2)DS(2) score in a Chinese stroke population. Methods: The prognostic model was used to predict stroke-associated pneumonia (SAP) from Henan Province Stroke Registry (HNSR) in which data were prospectively collected. The receiver-operating characteristic curves were plotted, and the C statistics were calculated to assess the discrimination ability. The Hosmer-Lemeshow goodness-of-fit test and the plot of observed versus predicted SAP risk were used to assess model calibration. Results: Among 1142 eligible patients, the overall in-hospital SAP was 18.8%, which ranged from 9.0% in patients with lower A(2)DS(2) scores (0-4) to 65.0% in those with higher scores of 5 to 10 (P for trend <0.001). The C statistic was 0.836 (95% confidence interval, 0.803-0.868) through the A(2)DS(2) score, suggesting excellent discrimination in the HNSR. The A(2)DS(2) score also showed excellent calibration (Cox and Snell R-2 = 0.243) in the external validation sample from the HNSR. Conclusions: The A(2)DS(2) score could reliably predict in-hospital SAP in Chinese stroke patients. It might be helpful for the assessment of increased risk monitoring and prophylactic treatment in identified high-risk patients for SAP in clinical routine.	[Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China.	xuyuming@zzu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Health Department of Henan Province [201202005]; Education Department of Henan Province [12A320046]	Health Department of Henan Province; Education Department of Henan Province	This study was funded by the Health Department of Henan Province (201202005) and the Education Department of Henan Province (12A320046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Forti P, 2013, NEUROLOGY, V80, P29, DOI 10.1212/WNL.0b013e31827b1a41; Galovic M, 2013, STROKE, V44, P2760, DOI 10.1161/STROKEAHA.113.001690; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Grube MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075719; Harms H, 2013, ACTA NEUROL SCAND, V128, P178, DOI 10.1111/ane.12095; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar Sandeep, 2010, Lancet Neurol, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Pandian JD, 2012, J STROKE CEREBROVASC, V21, P695, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.003; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Song B, 2013, STROKE, V44, P1244, DOI 10.1161/STROKEAHA.113.000969; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002	33	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109665	10.1371/journal.pone.0109665	http://dx.doi.org/10.1371/journal.pone.0109665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299226	Green Published, Green Submitted, gold			2022-12-25	WOS:000343941200068
